interaction_id,DRUG_NAME,TARGET_NAME,TARGET_CLASS,ACTION_TYPE,interaction_text
0,levobupivacaine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: levobupivacaine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1,levobupivacaine,sodium channel protein type 1 subunit alpha,ion channel,,Drug: levobupivacaine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: nan
2,levobupivacaine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: levobupivacaine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
3,levobupivacaine,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: levobupivacaine | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
4,levobupivacaine,cytochrome p450 2d6,enzyme,,Drug: levobupivacaine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
5,levobupivacaine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: levobupivacaine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
6,levobupivacaine,potassium voltage-gated channel subfamily d member 3,ion channel,,Drug: levobupivacaine | Target: potassium voltage-gated channel subfamily d member 3 | Type: ion channel | Action: nan
7,levobupivacaine,potassium voltage-gated channel subfamily a member 5,ion channel,,Drug: levobupivacaine | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: nan
8,(s)-nicardipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: (s)-nicardipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
9,(s)-nitrendipine,intermediate conductance calcium-activated potassium channel protein 4,ion channel,BLOCKER,Drug: (s)-nitrendipine | Target: intermediate conductance calcium-activated potassium channel protein 4 | Type: ion channel | Action: BLOCKER
10,(s)-nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,GATING INHIBITOR,Drug: (s)-nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: GATING INHIBITOR
11,(s)-nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1f,ion channel,GATING INHIBITOR,Drug: (s)-nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1f | Type: ion channel | Action: GATING INHIBITOR
12,(s)-nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,GATING INHIBITOR,Drug: (s)-nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: GATING INHIBITOR
13,(s)-nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1s,ion channel,GATING INHIBITOR,Drug: (s)-nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1s | Type: ion channel | Action: GATING INHIBITOR
14,(s)-nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: (s)-nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
15,levdobutamine,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: levdobutamine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
16,aminopterin,dihydrofolate reductase,enzyme,,Drug: aminopterin | Target: dihydrofolate reductase | Type: enzyme | Action: nan
17,aminopterin,dihydrofolate reductase,enzyme,,Drug: aminopterin | Target: dihydrofolate reductase | Type: enzyme | Action: nan
18,aminopterin,dihydrofolate reductase,enzyme,,Drug: aminopterin | Target: dihydrofolate reductase | Type: enzyme | Action: nan
19,aminopterin,folylpoly-gamma-glutamate synthetase,enzyme,,Drug: aminopterin | Target: folylpoly-gamma-glutamate synthetase | Type: enzyme | Action: nan
20,aminopterin,dihydrofolate reductase,enzyme,INHIBITOR,Drug: aminopterin | Target: dihydrofolate reductase | Type: enzyme | Action: INHIBITOR
21,phenylbutanoic acid,aldose reductase,enzyme,,Drug: phenylbutanoic acid | Target: aldose reductase | Type: enzyme | Action: nan
22,phenylbutanoic acid,histone deacetylase 2,enzyme,,Drug: phenylbutanoic acid | Target: histone deacetylase 2 | Type: enzyme | Action: nan
23,phenylbutanoic acid,histone deacetylase 1,enzyme,,Drug: phenylbutanoic acid | Target: histone deacetylase 1 | Type: enzyme | Action: nan
24,phenylbutanoic acid,histone deacetylase 8,enzyme,,Drug: phenylbutanoic acid | Target: histone deacetylase 8 | Type: enzyme | Action: nan
25,azacitidine,dna (cytosine-5)-methyltransferase 1,enzyme,INHIBITOR,Drug: azacitidine | Target: dna (cytosine-5)-methyltransferase 1 | Type: enzyme | Action: INHIBITOR
26,azacitidine,dna (cytosine-5)-methyltransferase 3a,enzyme,INHIBITOR,Drug: azacitidine | Target: dna (cytosine-5)-methyltransferase 3a | Type: enzyme | Action: INHIBITOR
27,fluorouracil,thymidylate synthase,enzyme,INHIBITOR,Drug: fluorouracil | Target: thymidylate synthase | Type: enzyme | Action: INHIBITOR
28,fluorouracil,multidrug resistance-associated protein 5,transporter,,Drug: fluorouracil | Target: multidrug resistance-associated protein 5 | Type: transporter | Action: nan
29,fluorouracil,atp-binding cassette sub-family c member 11,transporter,,Drug: fluorouracil | Target: atp-binding cassette sub-family c member 11 | Type: transporter | Action: nan
30,fluorouracil,thymidylate synthase,enzyme,,Drug: fluorouracil | Target: thymidylate synthase | Type: enzyme | Action: nan
31,fluorouracil,uracil phosphoribosyltransferase,enzyme,,Drug: fluorouracil | Target: uracil phosphoribosyltransferase | Type: enzyme | Action: nan
32,azaribine,orotidine 5'-phosphate decarboxylase,enzyme,,Drug: azaribine | Target: orotidine 5'-phosphate decarboxylase | Type: enzyme | Action: nan
33,azaribine,orotidine 5'-phosphate decarboxylase,enzyme,,Drug: azaribine | Target: orotidine 5'-phosphate decarboxylase | Type: enzyme | Action: nan
34,methoxsalen,acetylcholinesterase,enzyme,,Drug: methoxsalen | Target: acetylcholinesterase | Type: enzyme | Action: nan
35,methoxsalen,cytochrome p450 1a2,enzyme,,Drug: methoxsalen | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
36,methoxsalen,amine oxidase [flavin-containing] a,enzyme,,Drug: methoxsalen | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
37,methoxsalen,polyphenol oxidase 2,enzyme,,Drug: methoxsalen | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
39,abacavir,gag-pol polyprotein,polyprotein,,Drug: abacavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
40,abacavir,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: abacavir | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
41,abacavir,reverse transcriptase,enzyme,,Drug: abacavir | Target: reverse transcriptase | Type: enzyme | Action: nan
42,abarelix,gonadotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: abarelix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
43,acamprosate,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE MODULATOR,Drug: acamprosate | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
44,acamprosate,glutamate [nmda] receptor,ion channel,ANTAGONIST,Drug: acamprosate | Target: glutamate [nmda] receptor | Type: ion channel | Action: ANTAGONIST
45,acarbose,"maltase-glucoamylase, intestinal",enzyme,INHIBITOR,"Drug: acarbose | Target: maltase-glucoamylase, intestinal | Type: enzyme | Action: INHIBITOR"
46,acarbose,pancreatic alpha-amylase,enzyme,INHIBITOR,Drug: acarbose | Target: pancreatic alpha-amylase | Type: enzyme | Action: INHIBITOR
47,acarbose,alpha-amylase 1,enzyme,,Drug: acarbose | Target: alpha-amylase 1 | Type: enzyme | Action: nan
48,acarbose,lysosomal alpha-glucosidase,enzyme,,Drug: acarbose | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: nan
49,acarbose,"sucrase-isomaltase, intestinal",enzyme,,"Drug: acarbose | Target: sucrase-isomaltase, intestinal | Type: enzyme | Action: nan"
50,acarbose,lysosomal alpha-glucosidase,enzyme,,Drug: acarbose | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: nan
51,acarbose,alpha-amylase,enzyme,,Drug: acarbose | Target: alpha-amylase | Type: enzyme | Action: nan
52,acarbose,"oligo-1,6-glucosidase",enzyme,,"Drug: acarbose | Target: oligo-1,6-glucosidase | Type: enzyme | Action: nan"
53,acarbose,pancreatic alpha-amylase,enzyme,,Drug: acarbose | Target: pancreatic alpha-amylase | Type: enzyme | Action: nan
54,acarbose,"sucrase-isomaltase, intestinal",enzyme,,"Drug: acarbose | Target: sucrase-isomaltase, intestinal | Type: enzyme | Action: nan"
55,acebutolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: acebutolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
56,acebutolol,beta-2 adrenergic receptor,gpcr,,Drug: acebutolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
57,acebutolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: acebutolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
58,aceclofenac,transthyretin,secreted,,Drug: aceclofenac | Target: transthyretin | Type: secreted | Action: nan
59,aceclofenac,aldose reductase,enzyme,,Drug: aceclofenac | Target: aldose reductase | Type: enzyme | Action: nan
60,aceclofenac,mitogen-activated protein kinase 1,kinase,,Drug: aceclofenac | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
61,aceclofenac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: aceclofenac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
62,acediasulfone,aldose reductase,enzyme,,Drug: acediasulfone | Target: aldose reductase | Type: enzyme | Action: nan
63,acediasulfone,"dihydropteroate synthetase, putative",unclassified,,"Drug: acediasulfone | Target: dihydropteroate synthetase, putative | Type: unclassified | Action: nan"
64,acediasulfone,"6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase",unclassified,,"Drug: acediasulfone | Target: 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | Type: unclassified | Action: nan"
65,acemetacin,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: acemetacin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
66,acemetacin,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: acemetacin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
67,acemetacin,lactoylglutathione lyase,enzyme,,Drug: acemetacin | Target: lactoylglutathione lyase | Type: enzyme | Action: nan
68,acenocoumarol,vitamin k epoxide reductase complex subunit 1,unclassified,INHIBITOR,Drug: acenocoumarol | Target: vitamin k epoxide reductase complex subunit 1 | Type: unclassified | Action: INHIBITOR
69,acenocoumarol,vitamin k epoxide reductase complex subunit 1,enzyme,INHIBITOR,Drug: acenocoumarol | Target: vitamin k epoxide reductase complex subunit 1 | Type: enzyme | Action: INHIBITOR
70,acefylline,adenosine receptor a2b,gpcr,,Drug: acefylline | Target: adenosine receptor a2b | Type: gpcr | Action: nan
71,aceprometazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: aceprometazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
72,paracetamol,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: paracetamol | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
73,paracetamol,transient receptor potential cation channel subfamily v member 1,ion channel,OPENER,Drug: paracetamol | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: OPENER
74,paracetamol,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: paracetamol | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
75,paracetamol,carbonic anhydrase 2,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
76,paracetamol,carbonic anhydrase 1,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
77,paracetamol,carbonic anhydrase 4,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
78,paracetamol,carbonic anhydrase 9,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
79,paracetamol,carbonic anhydrase 12,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
80,paracetamol,carbonic anhydrase 7,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
81,paracetamol,carbonic anhydrase 3,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
82,paracetamol,carbonic anhydrase 14,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
83,paracetamol,arachidonate 5-lipoxygenase-activating protein,cytosolic other,,Drug: paracetamol | Target: arachidonate 5-lipoxygenase-activating protein | Type: cytosolic other | Action: nan
84,paracetamol,arachidonate 15-lipoxygenase,enzyme,,Drug: paracetamol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
85,paracetamol,carbonic anhydrase 13,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
86,paracetamol,carbonic anhydrase 15,enzyme,,Drug: paracetamol | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
87,paracetamol,myoglobin,unclassified,,Drug: paracetamol | Target: myoglobin | Type: unclassified | Action: nan
88,paracetamol,cannabinoid receptor 1,gpcr,AGONIST,Drug: paracetamol | Target: cannabinoid receptor 1 | Type: gpcr | Action: AGONIST
89,acetanilide,nicotinate phosphoribosyltransferase,enzyme,,Drug: acetanilide | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
90,acetazolamide,"carbonic anhydrase 2, isoform a; ld26647p",enzyme,,"Drug: acetazolamide | Target: carbonic anhydrase 2, isoform a; ld26647p | Type: enzyme | Action: nan"
91,acetazolamide,carbonic anhydrase 1; gh09688p,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 1; gh09688p | Type: enzyme | Action: nan
92,acetazolamide,carbonic anhydrase 2,enzyme,INHIBITOR,Drug: acetazolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: INHIBITOR
93,acetazolamide,carbonic anhydrase 1,enzyme,INHIBITOR,Drug: acetazolamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: INHIBITOR
94,acetazolamide,carbonic anhydrase 4,enzyme,INHIBITOR,Drug: acetazolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: INHIBITOR
95,acetazolamide,carbonic anhydrase 9,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
96,acetazolamide,carbonic anhydrase 12,enzyme,INHIBITOR,Drug: acetazolamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: INHIBITOR
97,acetazolamide,aquaporin-1,transporter,,Drug: acetazolamide | Target: aquaporin-1 | Type: transporter | Action: nan
98,acetazolamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: acetazolamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
99,acetazolamide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: acetazolamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
100,acetazolamide,carbonic anhydrase 7,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
101,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
102,acetazolamide,carbonic anhydrase 3,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
103,acetazolamide,carbonic anhydrase 6,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
104,acetazolamide,carbonic anhydrase 14,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
105,acetazolamide,carbonic anhydrase 13,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
106,acetazolamide,carbonic anhydrase 4,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
107,acetazolamide,carbonic anhydrase 7,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
108,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
109,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
110,acetazolamide,carbonic anhydrase 13,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
111,acetazolamide,carbonic anhydrase 15,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
112,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
113,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
114,acetazolamide,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
115,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
116,acetazolamide,alpha carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
117,acetazolamide,endochitinase,enzyme,,Drug: acetazolamide | Target: endochitinase | Type: enzyme | Action: nan
118,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
119,acetazolamide,carbonic anhydrase 2,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
120,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
121,acetazolamide,astrosclerin-3,enzyme,,Drug: acetazolamide | Target: astrosclerin-3 | Type: enzyme | Action: nan
122,acetazolamide,beta-carbonic anhydrase 1,enzyme,,Drug: acetazolamide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
123,acetazolamide,delta carbonic anhydrase,unclassified,,Drug: acetazolamide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
124,acetazolamide,carbonic anhydrase 2,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
125,acetazolamide,carbonic anhydrase 2,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
126,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
127,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
128,acetazolamide,carbonic anhydrase v,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase v | Type: enzyme | Action: nan
129,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
130,acetazolamide,carbonic anhydrase 3,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
131,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
132,acetazolamide,carbonic anhydrase,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
133,acetazolamide,"carbonic anhydrase, alpha family",unclassified,,"Drug: acetazolamide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
134,acetazolamide,carbonate dehydratase,enzyme,,Drug: acetazolamide | Target: carbonate dehydratase | Type: enzyme | Action: nan
135,acetazolamide,carbonic anhydrase-related protein 11,enzyme,,Drug: acetazolamide | Target: carbonic anhydrase-related protein 11 | Type: enzyme | Action: nan
136,acetohexamide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: acetohexamide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
137,acetohydroxamic acid,carbonic anhydrase 2,enzyme,,Drug: acetohydroxamic acid | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
138,acetohydroxamic acid,bacterial urease,enzyme,INHIBITOR,Drug: acetohydroxamic acid | Target: bacterial urease | Type: enzyme | Action: INHIBITOR
139,acetohydroxamic acid,urease,enzyme,,Drug: acetohydroxamic acid | Target: urease | Type: enzyme | Action: nan
140,acetohydroxamic acid,urease subunit beta,enzyme,,Drug: acetohydroxamic acid | Target: urease subunit beta | Type: enzyme | Action: nan
141,acetophenazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: acetophenazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
142,acetophenazine,androgen receptor,transcription factor,,Drug: acetophenazine | Target: androgen receptor | Type: transcription factor | Action: nan
143,racecadotril,angiotensin-converting enzyme,enzyme,,Drug: racecadotril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
144,racecadotril,neprilysin,enzyme,INHIBITOR,Drug: racecadotril | Target: neprilysin | Type: enzyme | Action: INHIBITOR
145,racecadotril,angiotensin-converting enzyme,enzyme,,Drug: racecadotril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
146,racecadotril,neprilysin,enzyme,,Drug: racecadotril | Target: neprilysin | Type: enzyme | Action: nan
147,racecadotril,neprilysin,enzyme,,Drug: racecadotril | Target: neprilysin | Type: enzyme | Action: nan
148,racecadotril,neprilysin,enzyme,,Drug: racecadotril | Target: neprilysin | Type: enzyme | Action: nan
149,racecadotril,endothelin-converting enzyme 1,enzyme,,Drug: racecadotril | Target: endothelin-converting enzyme 1 | Type: enzyme | Action: nan
150,racecadotril,thermolysin,enzyme,,Drug: racecadotril | Target: thermolysin | Type: enzyme | Action: nan
151,acetoxolone,liver carboxylesterase 1,enzyme,,Drug: acetoxolone | Target: liver carboxylesterase 1 | Type: enzyme | Action: nan
152,acetoxolone,estradiol 17-beta-dehydrogenase 1,enzyme,,Drug: acetoxolone | Target: estradiol 17-beta-dehydrogenase 1 | Type: enzyme | Action: nan
153,acetoxolone,estradiol 17-beta-dehydrogenase 2,enzyme,,Drug: acetoxolone | Target: estradiol 17-beta-dehydrogenase 2 | Type: enzyme | Action: nan
154,acetoxolone,corticosteroid 11-beta-dehydrogenase isozyme 2,enzyme,,Drug: acetoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 2 | Type: enzyme | Action: nan
155,acetoxolone,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: acetoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
156,acetoxolone,cocaine esterase,enzyme,,Drug: acetoxolone | Target: cocaine esterase | Type: enzyme | Action: nan
157,acetylcholine,muscarinic acetylcholine receptor m1,gpcr,,Drug: acetylcholine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
158,acetylcholine,muscarinic acetylcholine receptor m2,gpcr,AGONIST,Drug: acetylcholine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: AGONIST
159,acetylcholine,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: acetylcholine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
160,acetylcholine,muscarinic acetylcholine receptor m4,gpcr,AGONIST,Drug: acetylcholine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: AGONIST
161,acetylcholine,muscarinic acetylcholine receptor m5,gpcr,,Drug: acetylcholine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
162,acetylcholine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: acetylcholine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
163,acetylcholine,acetylcholine-binding protein,unclassified,,Drug: acetylcholine | Target: acetylcholine-binding protein | Type: unclassified | Action: nan
164,acetylcholine,acetylcholine receptor subunit delta,ion channel,,Drug: acetylcholine | Target: acetylcholine receptor subunit delta | Type: ion channel | Action: nan
165,acetylcholine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: acetylcholine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
166,acetylcholine,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: acetylcholine | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
167,acetylcholine,neuronal acetylcholine receptor; alpha3/beta2,ion channel,,Drug: acetylcholine | Target: neuronal acetylcholine receptor; alpha3/beta2 | Type: ion channel | Action: nan
168,acetylcholine,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: acetylcholine | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
169,acetylcholine,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: acetylcholine | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
170,acetylcholine,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: acetylcholine | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
171,acetylcholine,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: acetylcholine | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
172,acetylcholine,muscarinic acetylcholine receptor,gpcr,,Drug: acetylcholine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
173,acetylcholine,nicotinic acetylcholine receptor alpha8 subunit,ion channel,,Drug: acetylcholine | Target: nicotinic acetylcholine receptor alpha8 subunit | Type: ion channel | Action: nan
174,acetylcysteine,cytochrome c,enzyme,,Drug: acetylcysteine | Target: cytochrome c | Type: enzyme | Action: nan
175,acetylcysteine,vascular endothelial growth factor a,secreted,,Drug: acetylcysteine | Target: vascular endothelial growth factor a | Type: secreted | Action: nan
176,acetylcysteine,"superoxide dismutase [mn], mitochondrial",enzyme,,"Drug: acetylcysteine | Target: superoxide dismutase [mn], mitochondrial | Type: enzyme | Action: nan"
177,acetylcysteine,glutathione synthetase,enzyme,MODULATOR,Drug: acetylcysteine | Target: glutathione synthetase | Type: enzyme | Action: MODULATOR
178,acetylcysteine,cystine/glutamate transporter,transporter,MODULATOR,Drug: acetylcysteine | Target: cystine/glutamate transporter | Type: transporter | Action: MODULATOR
179,acetyldigitoxin,sodium/potassium-transporting atpase,transporter,INHIBITOR,Drug: acetyldigitoxin | Target: sodium/potassium-transporting atpase | Type: transporter | Action: INHIBITOR
180,acepromazine,d(1a) dopamine receptor,gpcr,ANTAGONIST,Drug: acepromazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: ANTAGONIST
181,acepromazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: acepromazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
182,acepromazine,major prion protein,surface antigen,,Drug: acepromazine | Target: major prion protein | Type: surface antigen | Action: nan
183,acetylsalicylic acid,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: acetylsalicylic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
184,acetylsalicylic acid,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: acetylsalicylic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
185,acetylsalicylic acid,acidic phospholipase a2 3,enzyme,,Drug: acetylsalicylic acid | Target: acidic phospholipase a2 3 | Type: enzyme | Action: nan
186,acetylsalicylic acid,gamma-glutamyltranspeptidase 1,enzyme,,Drug: acetylsalicylic acid | Target: gamma-glutamyltranspeptidase 1 | Type: enzyme | Action: nan
187,acetylsalicylic acid,prostaglandin g/h synthase 1,enzyme,,Drug: acetylsalicylic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
188,acetylsalicylic acid,prostaglandin g/h synthase 2,enzyme,,Drug: acetylsalicylic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
189,acetylsalicylic acid,prostaglandin g/h synthase 1,enzyme,,Drug: acetylsalicylic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
190,acetylsalicylic acid,acid-sensing ion channel 3,ion channel,BLOCKER,Drug: acetylsalicylic acid | Target: acid-sensing ion channel 3 | Type: ion channel | Action: BLOCKER
191,acetylsalicylic acid,nicotinate phosphoribosyltransferase,enzyme,,Drug: acetylsalicylic acid | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
192,acipimox,hydroxycarboxylic acid receptor 2,gpcr,AGONIST,Drug: acipimox | Target: hydroxycarboxylic acid receptor 2 | Type: gpcr | Action: AGONIST
193,acitretin,retinoic acid receptor alpha,nuclear hormone receptor,AGONIST,Drug: acitretin | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
194,acitretin,bile salt export pump,transporter,,Drug: acitretin | Target: bile salt export pump | Type: transporter | Action: nan
195,acitretin,retinoic acid receptor gamma,nuclear hormone receptor,AGONIST,Drug: acitretin | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
196,acitretin,bile salt export pump,transporter,,Drug: acitretin | Target: bile salt export pump | Type: transporter | Action: nan
197,aclarubicin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: aclarubicin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
198,aclarubicin,72 kda type iv collagenase,enzyme,,Drug: aclarubicin | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
199,aclarubicin,dna topoisomerase 1,enzyme,INHIBITOR,Drug: aclarubicin | Target: dna topoisomerase 1 | Type: enzyme | Action: INHIBITOR
200,aclarubicin,dna topoisomerase ii,enzyme,INHIBITOR,Drug: aclarubicin | Target: dna topoisomerase ii | Type: enzyme | Action: INHIBITOR
201,aclatonium,muscarinic acetylcholine receptor,gpcr,AGONIST,Drug: aclatonium | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: AGONIST
202,acrivastine,multidrug resistance protein 1,transporter,,Drug: acrivastine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
203,acrivastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: acrivastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
204,acrivastine,histamine h1 receptor,gpcr,,Drug: acrivastine | Target: histamine h1 receptor | Type: gpcr | Action: nan
205,acyclovir,purine nucleoside phosphorylase,enzyme,,Drug: acyclovir | Target: purine nucleoside phosphorylase | Type: enzyme | Action: nan
206,acyclovir,thymidine kinase,kinase,,Drug: acyclovir | Target: thymidine kinase | Type: kinase | Action: nan
207,acyclovir,purine nucleoside phosphorylase,enzyme,,Drug: acyclovir | Target: purine nucleoside phosphorylase | Type: enzyme | Action: nan
209,acyclovir,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: acyclovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
210,acyclovir,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: acyclovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
211,acyclovir,thymidine kinase,kinase,INHIBITOR,Drug: acyclovir | Target: thymidine kinase | Type: kinase | Action: INHIBITOR
212,acyclovir,thymidine kinase,kinase,INHIBITOR,Drug: acyclovir | Target: thymidine kinase | Type: kinase | Action: INHIBITOR
213,adapalene,glycine receptor subunit alpha-1,ion channel,,Drug: adapalene | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
214,adapalene,retinoic acid receptor alpha,nuclear hormone receptor,,Drug: adapalene | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: nan
215,adapalene,retinoic acid receptor beta,nuclear hormone receptor,AGONIST,Drug: adapalene | Target: retinoic acid receptor beta | Type: nuclear hormone receptor | Action: AGONIST
216,adapalene,retinoic acid receptor gamma,nuclear hormone receptor,AGONIST,Drug: adapalene | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
217,adefovir dipivoxil,protein p,polyprotein,INHIBITOR,Drug: adefovir dipivoxil | Target: protein p | Type: polyprotein | Action: INHIBITOR
218,adefovir dipivoxil,dna polymerase subunit gamma-1,enzyme,,Drug: adefovir dipivoxil | Target: dna polymerase subunit gamma-1 | Type: enzyme | Action: nan
219,adefovir dipivoxil,capsid protein,unclassified,,Drug: adefovir dipivoxil | Target: capsid protein | Type: unclassified | Action: nan
220,adenine,xanthine dehydrogenase/oxidase,enzyme,,Drug: adenine | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
221,adenine,"phosphatidylinositol 4-kinase, pi4k",kinase,,"Drug: adenine | Target: phosphatidylinositol 4-kinase, pi4k | Type: kinase | Action: nan"
222,adenosine,adenosine receptor a2a,gpcr,AGONIST,Drug: adenosine | Target: adenosine receptor a2a | Type: gpcr | Action: AGONIST
223,adenosine,adenosine receptor a1,gpcr,AGONIST,Drug: adenosine | Target: adenosine receptor a1 | Type: gpcr | Action: AGONIST
224,adenosine,adenosine receptor a2b,gpcr,AGONIST,Drug: adenosine | Target: adenosine receptor a2b | Type: gpcr | Action: AGONIST
225,adenosine,adenosine receptor a3,gpcr,AGONIST,Drug: adenosine | Target: adenosine receptor a3 | Type: gpcr | Action: AGONIST
226,adenosine,adenosine kinase,kinase,,Drug: adenosine | Target: adenosine kinase | Type: kinase | Action: nan
227,adenosine,adenosine deaminase,enzyme,,Drug: adenosine | Target: adenosine deaminase | Type: enzyme | Action: nan
228,adenosine,adenosine receptor a1,gpcr,,Drug: adenosine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
229,adenosine,adenosine receptor a2a,gpcr,,Drug: adenosine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
230,adenosine,adenosine receptor a3,gpcr,,Drug: adenosine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
231,adenosine,adenosine kinase,kinase,,Drug: adenosine | Target: adenosine kinase | Type: kinase | Action: nan
232,adenosine,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: adenosine | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
233,adenosine,adenosylhomocysteinase,enzyme,,Drug: adenosine | Target: adenosylhomocysteinase | Type: enzyme | Action: nan
234,adenosine,adenosine a2 receptor,gpcr,,Drug: adenosine | Target: adenosine a2 receptor | Type: gpcr | Action: nan
235,adenosine,phosphatidylinositol 4-kinase type 2-alpha,kinase,INHIBITOR,Drug: adenosine | Target: phosphatidylinositol 4-kinase type 2-alpha | Type: kinase | Action: INHIBITOR
236,adenosine,phosphatidylinositol 4-kinase type 2-beta,kinase,INHIBITOR,Drug: adenosine | Target: phosphatidylinositol 4-kinase type 2-beta | Type: kinase | Action: INHIBITOR
237,adenosine,glyceraldehyde-3-phosphate dehydrogenase liver,enzyme,,Drug: adenosine | Target: glyceraldehyde-3-phosphate dehydrogenase liver | Type: enzyme | Action: nan
238,adenosine,camp-dependent protein kinase a,kinase,,Drug: adenosine | Target: camp-dependent protein kinase a | Type: kinase | Action: nan
239,adenosine,"histone-lysine n-methyltransferase, h3 lysine-79 specific",enzyme,,"Drug: adenosine | Target: histone-lysine n-methyltransferase, h3 lysine-79 specific | Type: enzyme | Action: nan"
240,adenosine triphosphate,p2y purinoceptor 1,gpcr,,Drug: adenosine triphosphate | Target: p2y purinoceptor 1 | Type: gpcr | Action: nan
241,adenosine triphosphate,p2x purinoceptor 1,ion channel,AGONIST,Drug: adenosine triphosphate | Target: p2x purinoceptor 1 | Type: ion channel | Action: AGONIST
242,adenosine triphosphate,p2y purinoceptor 4,gpcr,,Drug: adenosine triphosphate | Target: p2y purinoceptor 4 | Type: gpcr | Action: nan
243,adenosine triphosphate,tyrosine-protein kinase jak2,kinase,,Drug: adenosine triphosphate | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
244,adenosine triphosphate,p2y purinoceptor 1,gpcr,,Drug: adenosine triphosphate | Target: p2y purinoceptor 1 | Type: gpcr | Action: nan
245,adenosine triphosphate,p2y purinoceptor 2,gpcr,AGONIST,Drug: adenosine triphosphate | Target: p2y purinoceptor 2 | Type: gpcr | Action: AGONIST
246,adenosine triphosphate,p2y purinoceptor 11,gpcr,,Drug: adenosine triphosphate | Target: p2y purinoceptor 11 | Type: gpcr | Action: nan
247,adenosine triphosphate,transient receptor potential cation channel subfamily m member 4,ion channel,BLOCKER,Drug: adenosine triphosphate | Target: transient receptor potential cation channel subfamily m member 4 | Type: ion channel | Action: BLOCKER
248,adenosine triphosphate,p2y purinoceptor 13,gpcr,AGONIST,Drug: adenosine triphosphate | Target: p2y purinoceptor 13 | Type: gpcr | Action: AGONIST
249,adenosine triphosphate,endoplasmin,membrane other,,Drug: adenosine triphosphate | Target: endoplasmin | Type: membrane other | Action: nan
250,adenosine triphosphate,map kinase-activated protein kinase 2,kinase,,Drug: adenosine triphosphate | Target: map kinase-activated protein kinase 2 | Type: kinase | Action: nan
251,adenosine triphosphate,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: adenosine triphosphate | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
252,adenosine triphosphate,p2x purinoceptor 4,ion channel,AGONIST,Drug: adenosine triphosphate | Target: p2x purinoceptor 4 | Type: ion channel | Action: AGONIST
253,adenosine triphosphate,uracil nucleotide/cysteinyl leukotriene receptor,gpcr,AGONIST,Drug: adenosine triphosphate | Target: uracil nucleotide/cysteinyl leukotriene receptor | Type: gpcr | Action: AGONIST
254,adenosine triphosphate,p2x purinoceptor 3,ion channel,,Drug: adenosine triphosphate | Target: p2x purinoceptor 3 | Type: ion channel | Action: nan
255,adenosine triphosphate,"heat shock protein 75 kda, mitochondrial",unclassified,,"Drug: adenosine triphosphate | Target: heat shock protein 75 kda, mitochondrial | Type: unclassified | Action: nan"
256,adenosine triphosphate,adenylate kinase 2,kinase,,Drug: adenosine triphosphate | Target: adenylate kinase 2 | Type: kinase | Action: nan
257,adenosine triphosphate,heat shock cognate 71 kda protein,unclassified,,Drug: adenosine triphosphate | Target: heat shock cognate 71 kda protein | Type: unclassified | Action: nan
258,adenosine triphosphate,heat shock 70 kda protein 1a,unclassified,,Drug: adenosine triphosphate | Target: heat shock 70 kda protein 1a | Type: unclassified | Action: nan
259,adenosine triphosphate,transient receptor potential cation channel subfamily m member 4,ion channel,BLOCKER,Drug: adenosine triphosphate | Target: transient receptor potential cation channel subfamily m member 4 | Type: ion channel | Action: BLOCKER
260,adenosine triphosphate,p2x purinoceptor 2,unclassified,AGONIST,Drug: adenosine triphosphate | Target: p2x purinoceptor 2 | Type: unclassified | Action: AGONIST
261,adenosine triphosphate,p2x purinoceptor 4,unclassified,AGONIST,Drug: adenosine triphosphate | Target: p2x purinoceptor 4 | Type: unclassified | Action: AGONIST
262,adenosine triphosphate,p2y purinoceptor 4,gpcr,AGONIST,Drug: adenosine triphosphate | Target: p2y purinoceptor 4 | Type: gpcr | Action: AGONIST
263,adenosine triphosphate,p2x purinoceptor 4,unclassified,AGONIST,Drug: adenosine triphosphate | Target: p2x purinoceptor 4 | Type: unclassified | Action: AGONIST
264,adenosine triphosphate,p2x purinoceptor 6,unclassified,AGONIST,Drug: adenosine triphosphate | Target: p2x purinoceptor 6 | Type: unclassified | Action: AGONIST
265,adenosine triphosphate,p2x purinoceptor 5,unclassified,AGONIST,Drug: adenosine triphosphate | Target: p2x purinoceptor 5 | Type: unclassified | Action: AGONIST
268,adenosine phosphate,"fructose-1,6-bisphosphatase 1",enzyme,,"Drug: adenosine phosphate | Target: fructose-1,6-bisphosphatase 1 | Type: enzyme | Action: nan"
269,adenosine phosphate,"fructose-1,6-bisphosphatase 1",enzyme,,"Drug: adenosine phosphate | Target: fructose-1,6-bisphosphatase 1 | Type: enzyme | Action: nan"
270,adenosine phosphate,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: adenosine phosphate | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
271,adenosine phosphate,transient receptor potential cation channel subfamily m member 2,ion channel,,Drug: adenosine phosphate | Target: transient receptor potential cation channel subfamily m member 2 | Type: ion channel | Action: nan
272,adenosine phosphate,transient receptor potential cation channel subfamily m member 4,ion channel,GATING INHIBITOR,Drug: adenosine phosphate | Target: transient receptor potential cation channel subfamily m member 4 | Type: ion channel | Action: GATING INHIBITOR
273,adenosine phosphate,pol polyprotein,enzyme,,Drug: adenosine phosphate | Target: pol polyprotein | Type: enzyme | Action: nan
274,adenosine phosphate,alcohol dehydrogenase,enzyme,,Drug: adenosine phosphate | Target: alcohol dehydrogenase | Type: enzyme | Action: nan
275,adenosine phosphate,l-lactate dehydrogenase a chain,enzyme,,Drug: adenosine phosphate | Target: l-lactate dehydrogenase a chain | Type: enzyme | Action: nan
276,adenosine phosphate,ketopantoate reductase,enzyme,,Drug: adenosine phosphate | Target: ketopantoate reductase | Type: enzyme | Action: nan
277,adenosine phosphate,adenylate kinase 2,kinase,,Drug: adenosine phosphate | Target: adenylate kinase 2 | Type: kinase | Action: nan
278,adenosine phosphate,2'-deoxynucleoside 5'-phosphate n-hydrolase 1,enzyme,,Drug: adenosine phosphate | Target: 2'-deoxynucleoside 5'-phosphate n-hydrolase 1 | Type: enzyme | Action: nan
279,adenosine phosphate,2'-deoxynucleoside 5'-phosphate n-hydrolase 1,enzyme,,Drug: adenosine phosphate | Target: 2'-deoxynucleoside 5'-phosphate n-hydrolase 1 | Type: enzyme | Action: nan
280,adinazolam,translocator protein,transporter,,Drug: adinazolam | Target: translocator protein | Type: transporter | Action: nan
281,adinazolam,gaba-a receptor,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: adinazolam | Target: gaba-a receptor | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
282,adiphenine,histamine h1 receptor,gpcr,,Drug: adiphenine | Target: histamine h1 receptor | Type: gpcr | Action: nan
283,adiphenine,muscarinic acetylcholine receptor,gpcr,,Drug: adiphenine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
284,agomelatine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: agomelatine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
285,agomelatine,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: agomelatine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
286,agomelatine,melatonin receptor,gpcr,,Drug: agomelatine | Target: melatonin receptor | Type: gpcr | Action: nan
287,agomelatine,melatonin receptor,gpcr,,Drug: agomelatine | Target: melatonin receptor | Type: gpcr | Action: nan
288,agomelatine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: agomelatine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
289,agomelatine,melatonin receptor type 1a,gpcr,AGONIST,Drug: agomelatine | Target: melatonin receptor type 1a | Type: gpcr | Action: AGONIST
290,agomelatine,melatonin receptor type 1b,gpcr,AGONIST,Drug: agomelatine | Target: melatonin receptor type 1b | Type: gpcr | Action: AGONIST
291,ajmaline,sodium channel protein type 5 subunit alpha,ion channel,INHIBITOR,Drug: ajmaline | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: INHIBITOR
292,ajmaline,cytochrome p450 2d6,enzyme,,Drug: ajmaline | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
293,ajmaline,potassium voltage-gated channel subfamily d member 3,ion channel,INHIBITOR,Drug: ajmaline | Target: potassium voltage-gated channel subfamily d member 3 | Type: ion channel | Action: INHIBITOR
294,ajmaline,potassium voltage-gated channel subfamily a member 5,ion channel,INHIBITOR,Drug: ajmaline | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: INHIBITOR
295,alacepril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: alacepril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
296,alatrofloxacin,topoisomerase iv,enzyme,INHIBITOR,Drug: alatrofloxacin | Target: topoisomerase iv | Type: enzyme | Action: INHIBITOR
297,alatrofloxacin,dna gyrase,enzyme,INHIBITOR,Drug: alatrofloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
298,albendazole,tubulin alpha chain,structural,,Drug: albendazole | Target: tubulin alpha chain | Type: structural | Action: nan
299,albendazole,tubulin,structural,INHIBITOR,Drug: albendazole | Target: tubulin | Type: structural | Action: INHIBITOR
300,albendazole,tubulin,structural,INHIBITOR,Drug: albendazole | Target: tubulin | Type: structural | Action: INHIBITOR
301,albendazole sulfoxide,tubulin alpha chain,structural,,Drug: albendazole sulfoxide | Target: tubulin alpha chain | Type: structural | Action: nan
302,salbutamol,beta-1 adrenergic receptor,gpcr,,Drug: salbutamol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
303,salbutamol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: salbutamol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
304,salbutamol,beta-2 adrenergic receptor,gpcr,,Drug: salbutamol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
305,salbutamol,beta-2 adrenergic receptor,gpcr,,Drug: salbutamol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
306,alclofenac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: alclofenac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
307,alclofenac,prostaglandin g/h synthase 1,enzyme,,Drug: alclofenac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
308,alcuronium,muscarinic acetylcholine receptor m1,gpcr,ALLOSTERIC MODULATOR,Drug: alcuronium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ALLOSTERIC MODULATOR
309,alcuronium,muscarinic acetylcholine receptor m2,gpcr,ALLOSTERIC MODULATOR,Drug: alcuronium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ALLOSTERIC MODULATOR
310,alcuronium,muscarinic acetylcholine receptor m3,gpcr,ALLOSTERIC MODULATOR,Drug: alcuronium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ALLOSTERIC MODULATOR
311,alcuronium,muscarinic acetylcholine receptor m4,gpcr,,Drug: alcuronium | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
312,alcuronium,neuronal acetylcholine receptor subunit alpha-2,ion channel,,Drug: alcuronium | Target: neuronal acetylcholine receptor subunit alpha-2 | Type: ion channel | Action: nan
313,alcuronium,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: alcuronium | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
314,alcuronium,muscarinic acetylcholine receptor m2,gpcr,,Drug: alcuronium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
315,alcuronium,acetylcholine receptor,ion channel,,Drug: alcuronium | Target: acetylcholine receptor | Type: ion channel | Action: nan
316,alcuronium,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: alcuronium | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
317,aldosterone,mineralocorticoid receptor,nuclear hormone receptor,,Drug: aldosterone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
318,aldosterone,corticosteroid-binding globulin,secreted,,Drug: aldosterone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
319,aldosterone,sex hormone-binding globulin,secreted,,Drug: aldosterone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
320,aldosterone,mineralocorticoid receptor,transcription factor,,Drug: aldosterone | Target: mineralocorticoid receptor | Type: transcription factor | Action: nan
321,alendronic acid,farnesyl pyrophosphate synthase,enzyme,INHIBITOR,Drug: alendronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: INHIBITOR
322,alendronic acid,farnesyl pyrophosphate synthase,enzyme,,Drug: alendronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
323,alendronic acid,protein farnesyltransferase subunit beta,enzyme,,Drug: alendronic acid | Target: protein farnesyltransferase subunit beta | Type: enzyme | Action: nan
324,alendronic acid,farnesyl pyrophosphate synthase,enzyme,,Drug: alendronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
326,alexidine,toll-like receptor 9,membrane receptor,,Drug: alexidine | Target: toll-like receptor 9 | Type: membrane receptor | Action: nan
327,alexidine,replicase polyprotein 1ab,enzyme,,Drug: alexidine | Target: replicase polyprotein 1ab | Type: enzyme | Action: nan
328,alexidine,beta-lactamase,enzyme,,Drug: alexidine | Target: beta-lactamase | Type: enzyme | Action: nan
329,alexidine,phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1,enzyme,INHIBITOR,Drug: alexidine | Target: phosphatidylglycerophosphatase and protein-tyrosine phosphatase 1 | Type: enzyme | Action: INHIBITOR
330,alfentanil,mu-type opioid receptor,gpcr,AGONIST,Drug: alfentanil | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
331,alfentanil,multidrug resistance protein 1,transporter,,Drug: alfentanil | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
332,alfentanil,mu-type opioid receptor,gpcr,,Drug: alfentanil | Target: mu-type opioid receptor | Type: gpcr | Action: nan
333,alfentanil,mu-type opioid receptor,gpcr,,Drug: alfentanil | Target: mu-type opioid receptor | Type: gpcr | Action: nan
334,alfentanil,opioid receptor,gpcr,,Drug: alfentanil | Target: opioid receptor | Type: gpcr | Action: nan
335,alfuzosin,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: alfuzosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
336,alfuzosin,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: alfuzosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
337,alfuzosin,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: alfuzosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
338,alfuzosin,acetylcholinesterase,enzyme,,Drug: alfuzosin | Target: acetylcholinesterase | Type: enzyme | Action: nan
339,alfuzosin,solute carrier family 22 member 1,transporter,,Drug: alfuzosin | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
340,alfuzosin,alpha-1d adrenergic receptor,gpcr,,Drug: alfuzosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
341,alfuzosin,alpha-1a adrenergic receptor,gpcr,,Drug: alfuzosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
342,aliskiren,cytochrome p450 3a4,enzyme,,Drug: aliskiren | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
343,aliskiren,multidrug resistance protein 1,transporter,,Drug: aliskiren | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
344,aliskiren,renin,enzyme,INHIBITOR,Drug: aliskiren | Target: renin | Type: enzyme | Action: INHIBITOR
345,aliskiren,renin,enzyme,,Drug: aliskiren | Target: renin | Type: enzyme | Action: nan
346,aliskiren,renin,enzyme,,Drug: aliskiren | Target: renin | Type: enzyme | Action: nan
347,aliskiren,renin,enzyme,,Drug: aliskiren | Target: renin | Type: enzyme | Action: nan
348,aliskiren,renin-1,enzyme,,Drug: aliskiren | Target: renin-1 | Type: enzyme | Action: nan
349,aliskiren,renin,enzyme,,Drug: aliskiren | Target: renin | Type: enzyme | Action: nan
350,aliskiren,protease,enzyme,,Drug: aliskiren | Target: protease | Type: enzyme | Action: nan
351,aliskiren,renin,enzyme,,Drug: aliskiren | Target: renin | Type: enzyme | Action: nan
352,alizapride,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: alizapride | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
353,alizapride,alpha-2c adrenergic receptor,gpcr,,Drug: alizapride | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
354,alizapride,d(2) dopamine receptor,gpcr,,Drug: alizapride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
355,allopurinol,xanthine dehydrogenase/oxidase,enzyme,INHIBITOR,Drug: allopurinol | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: INHIBITOR
356,allopurinol,hypoxanthine-guanine phosphoribosyltransferase,enzyme,,Drug: allopurinol | Target: hypoxanthine-guanine phosphoribosyltransferase | Type: enzyme | Action: nan
357,allopurinol,xanthine dehydrogenase/oxidase,enzyme,,Drug: allopurinol | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
358,allopurinol,xanthine dehydrogenase/oxidase,enzyme,,Drug: allopurinol | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
359,allopurinol,shiga toxin subunit a,unclassified,,Drug: allopurinol | Target: shiga toxin subunit a | Type: unclassified | Action: nan
360,almotriptan,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: almotriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
361,almotriptan,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: almotriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
362,almotriptan,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: almotriptan | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
363,alosetron,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: alosetron | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
364,alosetron,5-hydroxytryptamine receptor 2b,gpcr,,Drug: alosetron | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
365,alosetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: alosetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
366,alosetron,cytochrome p450 1a2,enzyme,,Drug: alosetron | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
367,alfacalcidol,sodium-dependent noradrenaline transporter,transporter,,Drug: alfacalcidol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
368,alfacalcidol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: alfacalcidol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
369,alfaxalone,sodium- and chloride-dependent gaba transporter 1,transporter,,Drug: alfaxalone | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: nan
370,alfaxalone,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: alfaxalone | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
371,alfaxalone,gaba-a receptor; anion channel,ion channel,,Drug: alfaxalone | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
372,alfaxalone,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,,Drug: alfaxalone | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: nan
373,alpidem,translocator protein,transporter,,Drug: alpidem | Target: translocator protein | Type: transporter | Action: nan
374,alpidem,bile salt export pump,transporter,,Drug: alpidem | Target: bile salt export pump | Type: transporter | Action: nan
375,alpidem,translocator protein,membrane receptor,,Drug: alpidem | Target: translocator protein | Type: membrane receptor | Action: nan
376,alpidem,gaba-a receptor; anion channel,ion channel,,Drug: alpidem | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
377,alpidem,bile salt export pump,transporter,,Drug: alpidem | Target: bile salt export pump | Type: transporter | Action: nan
378,alpidem,translocator protein,unclassified,,Drug: alpidem | Target: translocator protein | Type: unclassified | Action: nan
379,alpidem,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,PARTIAL AGONIST,Drug: alpidem | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: PARTIAL AGONIST
380,alprazolam,cytochrome p450 3a4,enzyme,,Drug: alprazolam | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
381,alprazolam,platelet-activating factor receptor,gpcr,,Drug: alprazolam | Target: platelet-activating factor receptor | Type: gpcr | Action: nan
382,alprazolam,cholecystokinin receptor type a,gpcr,,Drug: alprazolam | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
383,alprazolam,bromodomain-containing protein 4,unclassified,,Drug: alprazolam | Target: bromodomain-containing protein 4 | Type: unclassified | Action: nan
384,alprazolam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: alprazolam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
385,alprazolam,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: alprazolam | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
386,alprazolam,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: alprazolam | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
387,alprazolam,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: alprazolam | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
388,alprenolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: alprenolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
389,alprenolol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: alprenolol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
390,alprenolol,beta-3 adrenergic receptor,gpcr,,Drug: alprenolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
391,alprenolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: alprenolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
392,alprenolol,squalene synthase,enzyme,,Drug: alprenolol | Target: squalene synthase | Type: enzyme | Action: nan
393,alprenolol,beta-2 adrenergic receptor,gpcr,,Drug: alprenolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
395,alprenolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: alprenolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
396,alprenolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: alprenolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
397,alprostadil,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: alprostadil | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
398,alprostadil,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: alprostadil | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
399,alprostadil,prostacyclin receptor,gpcr,,Drug: alprostadil | Target: prostacyclin receptor | Type: gpcr | Action: nan
400,alprostadil,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: alprostadil | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
401,alprostadil,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: alprostadil | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
402,alprostadil,prostaglandin d2 receptor,gpcr,,Drug: alprostadil | Target: prostaglandin d2 receptor | Type: gpcr | Action: nan
403,alprostadil,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: alprostadil | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
404,alprostadil,prostaglandin e2 receptor ep2 subtype,gpcr,,Drug: alprostadil | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: nan
405,alprostadil,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: alprostadil | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
406,alprostadil,prostaglandin e2 receptor ep4 subtype,gpcr,,Drug: alprostadil | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: nan
407,alprostadil,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: alprostadil | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
408,alprostadil,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: alprostadil | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
409,alprostadil,cation channel sperm-associated protein 1,ion channel,ACTIVATOR,Drug: alprostadil | Target: cation channel sperm-associated protein 1 | Type: ion channel | Action: ACTIVATOR
410,alprostadil,cation channel sperm-associated protein 2,ion channel,ACTIVATOR,Drug: alprostadil | Target: cation channel sperm-associated protein 2 | Type: ion channel | Action: ACTIVATOR
411,alprostadil,cation channel sperm-associated protein 3,ion channel,ACTIVATOR,Drug: alprostadil | Target: cation channel sperm-associated protein 3 | Type: ion channel | Action: ACTIVATOR
412,alprostadil,cation channel sperm-associated protein 4,ion channel,ACTIVATOR,Drug: alprostadil | Target: cation channel sperm-associated protein 4 | Type: ion channel | Action: ACTIVATOR
413,alprostadil,prostacyclin receptor,gpcr,AGONIST,Drug: alprostadil | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
414,alprostadil,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: alprostadil | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
415,alprostadil,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: alprostadil | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
416,altretamine,cytochrome p450 1a2,enzyme,,Drug: altretamine | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
417,alvimopan,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: alvimopan | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
418,alvimopan,kappa-type opioid receptor,gpcr,,Drug: alvimopan | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
419,alvimopan,delta-type opioid receptor,gpcr,,Drug: alvimopan | Target: delta-type opioid receptor | Type: gpcr | Action: nan
420,alvimopan,kappa-type opioid receptor,gpcr,,Drug: alvimopan | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
421,amantadine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: amantadine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
422,amantadine,multidrug and toxin extrusion protein 1,transporter,,Drug: amantadine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
423,amantadine,matrix protein 2,ion channel,INHIBITOR,Drug: amantadine | Target: matrix protein 2 | Type: ion channel | Action: INHIBITOR
424,amantadine,glutamate [nmda] receptor,ion channel,BLOCKER,Drug: amantadine | Target: glutamate [nmda] receptor | Type: ion channel | Action: BLOCKER
425,amantadine,matrix protein 2,unclassified,,Drug: amantadine | Target: matrix protein 2 | Type: unclassified | Action: nan
426,amantadine,matrix protein 2,unclassified,,Drug: amantadine | Target: matrix protein 2 | Type: unclassified | Action: nan
427,amantadine,matrix protein 2,unclassified,,Drug: amantadine | Target: matrix protein 2 | Type: unclassified | Action: nan
428,ambenonium,acetylcholinesterase,enzyme,INHIBITOR,Drug: ambenonium | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
429,ambenonium,acetylcholinesterase,enzyme,,Drug: ambenonium | Target: acetylcholinesterase | Type: enzyme | Action: nan
430,ambenonium,acetylcholinesterase,enzyme,,Drug: ambenonium | Target: acetylcholinesterase | Type: enzyme | Action: nan
431,ambroxol,sodium-dependent serotonin transporter,transporter,,Drug: ambroxol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
432,ambroxol,cytochrome p450 2d6,enzyme,,Drug: ambroxol | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
433,ambroxol,sodium channel protein type 10 subunit alpha,ion channel,,Drug: ambroxol | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: nan
434,ambroxol,glucosylceramidase,enzyme,,Drug: ambroxol | Target: glucosylceramidase | Type: enzyme | Action: nan
435,amcinonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: amcinonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
436,amidefrine,adrenergic receptor alpha-2,gpcr,,Drug: amidefrine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
437,amidefrine,adrenergic receptor alpha-1,gpcr,,Drug: amidefrine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
438,amifostine,d(3) dopamine receptor,gpcr,,Drug: amifostine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
439,amifostine,"alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,"Drug: amifostine | Target: alkaline phosphatase, tissue-nonspecific isozyme | Type: enzyme | Action: nan"
440,amikacin,"macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b)",enzyme,,"Drug: amikacin | Target: macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b) | Type: enzyme | Action: nan"
441,amiloride,amiloride-sensitive sodium channel subunit alpha,ion channel,,Drug: amiloride | Target: amiloride-sensitive sodium channel subunit alpha | Type: ion channel | Action: nan
442,amiloride,urokinase-type plasminogen activator,enzyme,,Drug: amiloride | Target: urokinase-type plasminogen activator | Type: enzyme | Action: nan
443,amiloride,adenosine receptor a2a,gpcr,,Drug: amiloride | Target: adenosine receptor a2a | Type: gpcr | Action: nan
444,amiloride,amine oxidase [flavin-containing] a,enzyme,,Drug: amiloride | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
445,amiloride,sodium/hydrogen exchanger 1,transporter,,Drug: amiloride | Target: sodium/hydrogen exchanger 1 | Type: transporter | Action: nan
446,amiloride,solute carrier family 22 member 1,transporter,,Drug: amiloride | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
447,amiloride,acid-sensing ion channel 2,ion channel,BLOCKER,Drug: amiloride | Target: acid-sensing ion channel 2 | Type: ion channel | Action: BLOCKER
448,amiloride,acid-sensing ion channel 1,ion channel,,Drug: amiloride | Target: acid-sensing ion channel 1 | Type: ion channel | Action: nan
449,amiloride,membrane primary amine oxidase,enzyme,,Drug: amiloride | Target: membrane primary amine oxidase | Type: enzyme | Action: nan
450,amiloride,acid-sensing ion channel 3,ion channel,,Drug: amiloride | Target: acid-sensing ion channel 3 | Type: ion channel | Action: nan
451,amiloride,"amiloride-sensitive sodium channel, enac",ion channel,BLOCKER,"Drug: amiloride | Target: amiloride-sensitive sodium channel, enac | Type: ion channel | Action: BLOCKER"
452,amiloride,sodium/hydrogen exchanger,transporter,,Drug: amiloride | Target: sodium/hydrogen exchanger | Type: transporter | Action: nan
453,amiloride,sodium/hydrogen exchanger 5,transporter,INHIBITOR,Drug: amiloride | Target: sodium/hydrogen exchanger 5 | Type: transporter | Action: INHIBITOR
454,amiloride,sodium/hydrogen exchanger 1,transporter,INHIBITOR,Drug: amiloride | Target: sodium/hydrogen exchanger 1 | Type: transporter | Action: INHIBITOR
455,amiloride,sodium/hydrogen exchanger 2,transporter,,Drug: amiloride | Target: sodium/hydrogen exchanger 2 | Type: transporter | Action: nan
456,amiloride,urokinase-type plasminogen activator,enzyme,,Drug: amiloride | Target: urokinase-type plasminogen activator | Type: enzyme | Action: nan
457,amiloride,acid-sensing ion channel 1,ion channel,,Drug: amiloride | Target: acid-sensing ion channel 1 | Type: ion channel | Action: nan
458,aminoacridine,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: aminoacridine | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
459,aminoacridine,trypanothione reductase,enzyme,,Drug: aminoacridine | Target: trypanothione reductase | Type: enzyme | Action: nan
461,amineptine,sodium-dependent dopamine transporter,transporter,,Drug: amineptine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
462,aminocaproic acid,plasminogen,enzyme,INHIBITOR,Drug: aminocaproic acid | Target: plasminogen | Type: enzyme | Action: INHIBITOR
463,aminocaproic acid,tissue-type plasminogen activator,enzyme,INHIBITOR,Drug: aminocaproic acid | Target: tissue-type plasminogen activator | Type: enzyme | Action: INHIBITOR
464,aminoglutethimide,aromatase,enzyme,INHIBITOR,Drug: aminoglutethimide | Target: aromatase | Type: enzyme | Action: INHIBITOR
465,aminoglutethimide,thromboxane-a synthase,enzyme,,Drug: aminoglutethimide | Target: thromboxane-a synthase | Type: enzyme | Action: nan
466,aminoglutethimide,"cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,INHIBITOR,"Drug: aminoglutethimide | Target: cholesterol side-chain cleavage enzyme, mitochondrial | Type: enzyme | Action: INHIBITOR"
467,aminoglutethimide,aromatase,enzyme,,Drug: aminoglutethimide | Target: aromatase | Type: enzyme | Action: nan
468,aminoglutethimide,cytochrome p450 11a1,enzyme,,Drug: aminoglutethimide | Target: cytochrome p450 11a1 | Type: enzyme | Action: nan
469,aminohippuric acid,solute carrier family 22 member 6,transporter,,Drug: aminohippuric acid | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
470,aminohippuric acid,solute carrier family 22 member 6,transporter,,Drug: aminohippuric acid | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
471,aminophenazone,prostaglandin g/h synthase 2,enzyme,,Drug: aminophenazone | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
472,aminophenazone,prostaglandin g/h synthase 1,enzyme,,Drug: aminophenazone | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
473,aminophenazone,nicotinate phosphoribosyltransferase,enzyme,,Drug: aminophenazone | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
474,aminopicoline,"nitric oxide synthase, inducible",enzyme,INHIBITOR,"Drug: aminopicoline | Target: nitric oxide synthase, inducible | Type: enzyme | Action: INHIBITOR"
475,aminoquinuride,matrix metalloproteinase-9,enzyme,,Drug: aminoquinuride | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
476,aminoquinuride,interstitial collagenase,enzyme,,Drug: aminoquinuride | Target: interstitial collagenase | Type: enzyme | Action: nan
477,aminoquinuride,lethal factor,enzyme,,Drug: aminoquinuride | Target: lethal factor | Type: enzyme | Action: nan
478,aminoquinuride,botulinum neurotoxin type a,enzyme,,Drug: aminoquinuride | Target: botulinum neurotoxin type a | Type: enzyme | Action: nan
479,amiodarone,beta-1 adrenergic receptor,gpcr,,Drug: amiodarone | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
480,amiodarone,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: amiodarone | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
481,amiodarone,mu-type opioid receptor,gpcr,,Drug: amiodarone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
482,amiodarone,d(1a) dopamine receptor,gpcr,,Drug: amiodarone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
483,amiodarone,d(2) dopamine receptor,gpcr,,Drug: amiodarone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
484,amiodarone,alpha-2a adrenergic receptor,gpcr,,Drug: amiodarone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
485,amiodarone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: amiodarone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
486,amiodarone,thyroid hormone receptor alpha,nuclear hormone receptor,,Drug: amiodarone | Target: thyroid hormone receptor alpha | Type: nuclear hormone receptor | Action: nan
487,amiodarone,thyroid hormone receptor beta,nuclear hormone receptor,,Drug: amiodarone | Target: thyroid hormone receptor beta | Type: nuclear hormone receptor | Action: nan
488,amiodarone,potassium voltage-gated channel subfamily h member 2,ion channel,BLOCKER,Drug: amiodarone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: BLOCKER
489,amiodarone,cytochrome p450 3a4,enzyme,,Drug: amiodarone | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
490,amiodarone,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: amiodarone | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
491,amiodarone,multidrug resistance protein 1,transporter,,Drug: amiodarone | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
492,amiodarone,sodium-dependent serotonin transporter,transporter,,Drug: amiodarone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
493,amiodarone,sodium-dependent noradrenaline transporter,transporter,,Drug: amiodarone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
494,amiodarone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: amiodarone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
495,amiodarone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: amiodarone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
496,amiodarone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: amiodarone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
497,amiodarone,5-hydroxytryptamine receptor 6,gpcr,,Drug: amiodarone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
498,amiodarone,alpha-2b adrenergic receptor,gpcr,,Drug: amiodarone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
499,amiodarone,d(3) dopamine receptor,gpcr,,Drug: amiodarone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
500,amiodarone,histamine h2 receptor,gpcr,,Drug: amiodarone | Target: histamine h2 receptor | Type: gpcr | Action: nan
501,amiodarone,muscarinic acetylcholine receptor m1,gpcr,,Drug: amiodarone | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
502,amiodarone,muscarinic acetylcholine receptor m2,gpcr,,Drug: amiodarone | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
503,amiodarone,muscarinic acetylcholine receptor m3,gpcr,,Drug: amiodarone | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
504,amiodarone,muscarinic acetylcholine receptor m4,gpcr,,Drug: amiodarone | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
505,amiodarone,muscarinic acetylcholine receptor m5,gpcr,,Drug: amiodarone | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
506,amiodarone,beta-3 adrenergic receptor,gpcr,,Drug: amiodarone | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
507,amiodarone,sodium-dependent dopamine transporter,transporter,,Drug: amiodarone | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
508,amiodarone,adenosine receptor a3,gpcr,,Drug: amiodarone | Target: adenosine receptor a3 | Type: gpcr | Action: nan
509,amiodarone,d(4) dopamine receptor,gpcr,,Drug: amiodarone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
510,amiodarone,kappa-type opioid receptor,gpcr,,Drug: amiodarone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
511,amiodarone,delta-type opioid receptor,gpcr,,Drug: amiodarone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
512,amiodarone,cytochrome p450 2c9,enzyme,,Drug: amiodarone | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
513,amiodarone,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: amiodarone | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
514,amiodarone,endothelin-1 receptor,gpcr,,Drug: amiodarone | Target: endothelin-1 receptor | Type: gpcr | Action: nan
515,amiodarone,squalene monooxygenase,enzyme,,Drug: amiodarone | Target: squalene monooxygenase | Type: enzyme | Action: nan
516,amiodarone,tyrosine-protein kinase fyn,kinase,,Drug: amiodarone | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
517,amiodarone,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: amiodarone | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
518,amiodarone,squalene synthase,enzyme,,Drug: amiodarone | Target: squalene synthase | Type: enzyme | Action: nan
519,amiodarone,c-c chemokine receptor type 2,gpcr,,Drug: amiodarone | Target: c-c chemokine receptor type 2 | Type: gpcr | Action: nan
520,amiodarone,substance-k receptor,gpcr,,Drug: amiodarone | Target: substance-k receptor | Type: gpcr | Action: nan
521,amiodarone,androgen receptor,transcription factor,,Drug: amiodarone | Target: androgen receptor | Type: transcription factor | Action: nan
522,amiodarone,lethal factor,enzyme,,Drug: amiodarone | Target: lethal factor | Type: enzyme | Action: nan
523,amiodarone,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: amiodarone | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
524,amiodarone,potassium voltage-gated channel subfamily a member 7,ion channel,,Drug: amiodarone | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: nan
525,amiodarone,5-hydroxytryptamine receptor 1b,gpcr,,Drug: amiodarone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
526,amiodarone,b2 bradykinin receptor,gpcr,,Drug: amiodarone | Target: b2 bradykinin receptor | Type: gpcr | Action: nan
527,amiodarone,melanocortin receptor 4,gpcr,,Drug: amiodarone | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
528,amiodarone,melanocortin receptor 5,gpcr,,Drug: amiodarone | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
529,amiodarone,melanocortin receptor 3,gpcr,,Drug: amiodarone | Target: melanocortin receptor 3 | Type: gpcr | Action: nan
530,amiodarone,c-c chemokine receptor type 4,gpcr,,Drug: amiodarone | Target: c-c chemokine receptor type 4 | Type: gpcr | Action: nan
531,amiodarone,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: amiodarone | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
532,amiodarone,c-8 sterol isomerase,enzyme,,Drug: amiodarone | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
533,amiodarone,cruzipain,enzyme,,Drug: amiodarone | Target: cruzipain | Type: enzyme | Action: nan
534,amiodarone,thap domain-containing protein 1,unclassified,,Drug: amiodarone | Target: thap domain-containing protein 1 | Type: unclassified | Action: nan
535,amiodarone,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: amiodarone | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
536,amiodarone,lysine-specific demethylase phf2,enzyme,,Drug: amiodarone | Target: lysine-specific demethylase phf2 | Type: enzyme | Action: nan
537,amiodarone,lysine-specific demethylase 5a,enzyme,,Drug: amiodarone | Target: lysine-specific demethylase 5a | Type: enzyme | Action: nan
538,amiodarone,lysine-specific demethylase 7a,enzyme,,Drug: amiodarone | Target: lysine-specific demethylase 7a | Type: enzyme | Action: nan
539,amisulpride,alpha-2a adrenergic receptor,gpcr,,Drug: amisulpride | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
540,amisulpride,5-hydroxytryptamine receptor 2a,gpcr,,Drug: amisulpride | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
541,amisulpride,5-hydroxytryptamine receptor 2b,gpcr,,Drug: amisulpride | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
542,amisulpride,5-hydroxytryptamine receptor 6,gpcr,,Drug: amisulpride | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
543,amisulpride,5-hydroxytryptamine receptor 7,gpcr,,Drug: amisulpride | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
544,amisulpride,5-hydroxytryptamine receptor 1b,gpcr,,Drug: amisulpride | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
545,amisulpride,5-hydroxytryptamine receptor 1d,gpcr,,Drug: amisulpride | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
546,amisulpride,alpha-2c adrenergic receptor,gpcr,,Drug: amisulpride | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
547,amisulpride,d(4) dopamine receptor,gpcr,,Drug: amisulpride | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
548,amisulpride,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: amisulpride | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
549,amisulpride,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: amisulpride | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
550,amisulpride,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: amisulpride | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
551,amitriptyline,sodium channel protein type 5 subunit alpha,ion channel,,Drug: amitriptyline | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
552,amitriptyline,d(1a) dopamine receptor,gpcr,,Drug: amitriptyline | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
553,amitriptyline,d(2) dopamine receptor,gpcr,,Drug: amitriptyline | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
554,amitriptyline,alpha-2a adrenergic receptor,gpcr,,Drug: amitriptyline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
555,amitriptyline,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: amitriptyline | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
556,amitriptyline,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: amitriptyline | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
557,amitriptyline,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: amitriptyline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
558,amitriptyline,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: amitriptyline | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
559,amitriptyline,5-hydroxytryptamine receptor 1a,gpcr,,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
560,amitriptyline,5-hydroxytryptamine receptor 2a,gpcr,,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
561,amitriptyline,5-hydroxytryptamine receptor 2b,gpcr,,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
562,amitriptyline,5-hydroxytryptamine receptor 2c,gpcr,,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
563,amitriptyline,5-hydroxytryptamine receptor 6,gpcr,,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
564,amitriptyline,5-hydroxytryptamine receptor 7,gpcr,,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
565,amitriptyline,alpha-1a adrenergic receptor,gpcr,,Drug: amitriptyline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
566,amitriptyline,alpha-2b adrenergic receptor,gpcr,,Drug: amitriptyline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
567,amitriptyline,d(3) dopamine receptor,gpcr,,Drug: amitriptyline | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
568,amitriptyline,d(1b) dopamine receptor,gpcr,,Drug: amitriptyline | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
569,amitriptyline,histamine h1 receptor,gpcr,ANTAGONIST,Drug: amitriptyline | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
570,amitriptyline,histamine h2 receptor,gpcr,,Drug: amitriptyline | Target: histamine h2 receptor | Type: gpcr | Action: nan
571,amitriptyline,histamine h4 receptor,gpcr,,Drug: amitriptyline | Target: histamine h4 receptor | Type: gpcr | Action: nan
572,amitriptyline,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: amitriptyline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
573,amitriptyline,muscarinic acetylcholine receptor m2,gpcr,,Drug: amitriptyline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
574,amitriptyline,muscarinic acetylcholine receptor m3,gpcr,,Drug: amitriptyline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
575,amitriptyline,muscarinic acetylcholine receptor m4,gpcr,,Drug: amitriptyline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
576,amitriptyline,muscarinic acetylcholine receptor m5,gpcr,,Drug: amitriptyline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
577,amitriptyline,aldehyde oxidase,enzyme,,Drug: amitriptyline | Target: aldehyde oxidase | Type: enzyme | Action: nan
578,amitriptyline,alpha-2c adrenergic receptor,gpcr,,Drug: amitriptyline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
579,amitriptyline,sodium channel protein type 2 subunit alpha,ion channel,,Drug: amitriptyline | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: nan
580,amitriptyline,sodium channel protein type 9 subunit alpha,ion channel,,Drug: amitriptyline | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: nan
581,amitriptyline,sodium-dependent dopamine transporter,transporter,,Drug: amitriptyline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
582,amitriptyline,alpha-1d adrenergic receptor,gpcr,,Drug: amitriptyline | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
583,amitriptyline,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: amitriptyline | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
584,amitriptyline,high affinity nerve growth factor receptor,kinase,,Drug: amitriptyline | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
585,amitriptyline,solute carrier family 22 member 1,transporter,,Drug: amitriptyline | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
586,amitriptyline,alpha-1b adrenergic receptor,gpcr,,Drug: amitriptyline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
587,amitriptyline,5-hydroxytryptamine receptor 1b,gpcr,,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
588,amitriptyline,alpha-1a adrenergic receptor,gpcr,,Drug: amitriptyline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
589,amitriptyline,5-hydroxytryptamine receptor 1a,gpcr,,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
590,amitriptyline,sodium-dependent serotonin transporter,transporter,,Drug: amitriptyline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
591,amitriptyline,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
592,amitriptyline,transporter,transporter,,Drug: amitriptyline | Target: transporter | Type: transporter | Action: nan
593,amitriptyline,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
594,amitriptyline,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
595,amitriptyline,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
596,amitriptyline,histamine h1 receptor,gpcr,,Drug: amitriptyline | Target: histamine h1 receptor | Type: gpcr | Action: nan
597,amitriptyline,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: amitriptyline | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
598,amitriptyline,solute carrier family 22 member 2,transporter,,Drug: amitriptyline | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
599,amitriptyline,muscarinic acetylcholine receptor,gpcr,,Drug: amitriptyline | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
600,amitriptyline,g protein-activated inward rectifier potassium channel 2,ion channel,BLOCKER,Drug: amitriptyline | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: BLOCKER
601,amitriptylinoxide,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: amitriptylinoxide | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
602,amlexanox,inhibitor of nuclear factor kappa-b kinase subunit epsilon,kinase,INHIBITOR,Drug: amlexanox | Target: inhibitor of nuclear factor kappa-b kinase subunit epsilon | Type: kinase | Action: INHIBITOR
603,amlexanox,serine/threonine-protein kinase tbk1,kinase,INHIBITOR,Drug: amlexanox | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: INHIBITOR
604,amlexanox,g-protein coupled receptor 35,gpcr,,Drug: amlexanox | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
605,amlexanox,phosphodiesterase 4,enzyme,INHIBITOR,Drug: amlexanox | Target: phosphodiesterase 4 | Type: enzyme | Action: INHIBITOR
606,amlodipine,alpha-2a adrenergic receptor,gpcr,,Drug: amlodipine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
607,amlodipine,5-hydroxytryptamine receptor 6,gpcr,,Drug: amlodipine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
608,amlodipine,alpha-1a adrenergic receptor,gpcr,,Drug: amlodipine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
609,amlodipine,aldehyde oxidase,enzyme,,Drug: amlodipine | Target: aldehyde oxidase | Type: enzyme | Action: nan
610,amlodipine,alpha-2c adrenergic receptor,gpcr,,Drug: amlodipine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
611,amlodipine,sodium-dependent dopamine transporter,transporter,,Drug: amlodipine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
612,amlodipine,alpha-1d adrenergic receptor,gpcr,,Drug: amlodipine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
613,amlodipine,alpha-1b adrenergic receptor,gpcr,,Drug: amlodipine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
614,amlodipine,voltage-dependent calcium channel gamma-1 subunit,ion channel,,Drug: amlodipine | Target: voltage-dependent calcium channel gamma-1 subunit | Type: ion channel | Action: nan
615,amlodipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: amlodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
616,amlodipine,carbonic anhydrase 1,enzyme,,Drug: amlodipine | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
617,amlodipine,voltage-dependent calcium channel subunit alpha-2/delta-1,ion channel,,Drug: amlodipine | Target: voltage-dependent calcium channel subunit alpha-2/delta-1 | Type: ion channel | Action: nan
618,amlodipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,BLOCKER,Drug: amlodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: BLOCKER
619,amlodipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: amlodipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
620,amlodipine,potassium channel subfamily k member 2,ion channel,,Drug: amlodipine | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
621,amlodipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: amlodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
622,amlodipine,potassium channel subfamily k member 2,ion channel,,Drug: amlodipine | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
623,amodiaquine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: amodiaquine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
624,amodiaquine,histamine n-methyltransferase,enzyme,,Drug: amodiaquine | Target: histamine n-methyltransferase | Type: enzyme | Action: nan
625,amodiaquine,heparanase,enzyme,,Drug: amodiaquine | Target: heparanase | Type: enzyme | Action: nan
626,amodiaquine,amyloid beta a4 protein,unclassified,,Drug: amodiaquine | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
627,amoxapine,d(1a) dopamine receptor,gpcr,,Drug: amoxapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
628,amoxapine,d(2) dopamine receptor,gpcr,,Drug: amoxapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
629,amoxapine,alpha-2a adrenergic receptor,gpcr,,Drug: amoxapine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
630,amoxapine,multidrug resistance protein 1,transporter,,Drug: amoxapine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
631,amoxapine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: amoxapine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
632,amoxapine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: amoxapine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
633,amoxapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
634,amoxapine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
635,amoxapine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
636,amoxapine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
637,amoxapine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
638,amoxapine,5-hydroxytryptamine receptor 7,gpcr,,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
639,amoxapine,alpha-2b adrenergic receptor,gpcr,,Drug: amoxapine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
640,amoxapine,d(3) dopamine receptor,gpcr,,Drug: amoxapine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
641,amoxapine,histamine h1 receptor,gpcr,,Drug: amoxapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
642,amoxapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: amoxapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
643,amoxapine,muscarinic acetylcholine receptor m2,gpcr,,Drug: amoxapine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
644,amoxapine,muscarinic acetylcholine receptor m3,gpcr,,Drug: amoxapine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
645,amoxapine,muscarinic acetylcholine receptor m4,gpcr,,Drug: amoxapine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
646,amoxapine,muscarinic acetylcholine receptor m5,gpcr,,Drug: amoxapine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
647,amoxapine,alpha-2c adrenergic receptor,gpcr,,Drug: amoxapine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
648,amoxapine,sodium-dependent dopamine transporter,transporter,,Drug: amoxapine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
649,amoxapine,cytochrome p450 2d6,enzyme,,Drug: amoxapine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
650,amoxapine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: amoxapine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
651,amoxapine,alpha-1d adrenergic receptor,gpcr,,Drug: amoxapine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
652,amoxapine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
653,amoxapine,sodium- and chloride-dependent glycine transporter 2,transporter,,Drug: amoxapine | Target: sodium- and chloride-dependent glycine transporter 2 | Type: transporter | Action: nan
654,amoxapine,alpha-1b adrenergic receptor,gpcr,,Drug: amoxapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
655,amoxapine,alpha-1a adrenergic receptor,gpcr,,Drug: amoxapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
656,amoxapine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
657,amoxapine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
658,amoxapine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
659,amoxapine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: amoxapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
660,amoxapine,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: amoxapine | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
661,amoxicillin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: amoxicillin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
662,amoxicillin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: amoxicillin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
663,amoxicillin,5-hydroxytryptamine receptor 2c,gpcr,,Drug: amoxicillin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
664,amoxicillin,penicillin-binding protein 1a,enzyme,,Drug: amoxicillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
665,amoxicillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: amoxicillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
666,amperozide,fatty-acid amide hydrolase 1,enzyme,,Drug: amperozide | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
667,amperozide,5-hydroxytryptamine receptor 6,gpcr,,Drug: amperozide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
668,amfetamine,alpha-2a adrenergic receptor,gpcr,,Drug: amfetamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
669,amfetamine,sodium-dependent serotonin transporter,transporter,,Drug: amfetamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
670,amfetamine,sodium-dependent noradrenaline transporter,transporter,RELEASING AGENT,Drug: amfetamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: RELEASING AGENT
671,amfetamine,alpha-1a adrenergic receptor,gpcr,,Drug: amfetamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
672,amfetamine,sodium-dependent dopamine transporter,transporter,RELEASING AGENT,Drug: amfetamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: RELEASING AGENT
673,amfetamine,cocaine- and amphetamine-regulated transcript protein,transcription factor,,Drug: amfetamine | Target: cocaine- and amphetamine-regulated transcript protein | Type: transcription factor | Action: nan
674,amfetamine,sodium-dependent dopamine transporter,transporter,,Drug: amfetamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
675,amfetamine,amine oxidase [flavin-containing] a,enzyme,,Drug: amfetamine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
676,amfetamine,sodium-dependent noradrenaline transporter,transporter,,Drug: amfetamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
677,amfetamine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: amfetamine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
678,amfetamine,sodium-dependent serotonin transporter,transporter,,Drug: amfetamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
679,amfetamine,transporter,transporter,,Drug: amfetamine | Target: transporter | Type: transporter | Action: nan
680,amfetamine,serotonin (5-ht) receptor,gpcr,,Drug: amfetamine | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
681,amfetamine,serotonin 1 (5-ht1) receptor,gpcr,,Drug: amfetamine | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
682,amfetamine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: amfetamine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
683,amfetamine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: amfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
684,ampicillin,penicillin-binding protein 1a,enzyme,,Drug: ampicillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
685,ampicillin,angiopoietin-1 receptor,kinase,,Drug: ampicillin | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
686,ampicillin,transient receptor potential cation channel subfamily m member 4,ion channel,,Drug: ampicillin | Target: transient receptor potential cation channel subfamily m member 4 | Type: ion channel | Action: nan
687,ampicillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: ampicillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
688,amprenavir,cytochrome p450 3a4,enzyme,,Drug: amprenavir | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
689,amprenavir,gag-pol polyprotein,polyprotein,,Drug: amprenavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
690,amprenavir,thromboxane-a synthase,enzyme,,Drug: amprenavir | Target: thromboxane-a synthase | Type: enzyme | Action: nan
691,amprenavir,cathepsin d,enzyme,,Drug: amprenavir | Target: cathepsin d | Type: enzyme | Action: nan
692,amprenavir,pol polyprotein,enzyme,INHIBITOR,Drug: amprenavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
693,amprenavir,protease,enzyme,,Drug: amprenavir | Target: protease | Type: enzyme | Action: nan
694,amprenavir,protease,unclassified,,Drug: amprenavir | Target: protease | Type: unclassified | Action: nan
695,amprenavir,protease,unclassified,,Drug: amprenavir | Target: protease | Type: unclassified | Action: nan
696,amrinone,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,INHIBITOR,"Drug: amrinone | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: INHIBITOR"
697,amrinone,dual specificity protein kinase ttk,kinase,,Drug: amrinone | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
698,amrinone,"cgmp-inhibited 3',5'-cyclic phosphodiesterase b",enzyme,INHIBITOR,"Drug: amrinone | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase b | Type: enzyme | Action: INHIBITOR"
699,amrinone,phosphodiesterase 4,enzyme,,Drug: amrinone | Target: phosphodiesterase 4 | Type: enzyme | Action: nan
700,amsacrine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: amsacrine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
701,amsacrine,cytochrome p450 2d6,enzyme,,Drug: amsacrine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
702,amsacrine,dna topoisomerase 2-alpha,enzyme,,Drug: amsacrine | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: nan
703,amsacrine,"dna topoisomerase i, mitochondrial",enzyme,,"Drug: amsacrine | Target: dna topoisomerase i, mitochondrial | Type: enzyme | Action: nan"
704,amsacrine,dna topoisomerase 1,enzyme,,Drug: amsacrine | Target: dna topoisomerase 1 | Type: enzyme | Action: nan
705,amsacrine,dna topoisomerase 2-beta,enzyme,,Drug: amsacrine | Target: dna topoisomerase 2-beta | Type: enzyme | Action: nan
706,amsacrine,solute carrier family 22 member 1,transporter,,Drug: amsacrine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
707,amsacrine,dna topoisomerase ii,enzyme,,Drug: amsacrine | Target: dna topoisomerase ii | Type: enzyme | Action: nan
708,anagrelide,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,INHIBITOR,"Drug: anagrelide | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: INHIBITOR"
709,anagrelide,"cgmp-dependent 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: anagrelide | Target: cgmp-dependent 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
710,anastrozole,aromatase,enzyme,INHIBITOR,Drug: anastrozole | Target: aromatase | Type: enzyme | Action: INHIBITOR
711,androisoxazole,androgen receptor,nuclear hormone receptor,,Drug: androisoxazole | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
712,androstenediol,estrogen receptor,nuclear hormone receptor,,Drug: androstenediol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
713,androstenediol,androgen receptor,nuclear hormone receptor,,Drug: androstenediol | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
714,androstenediol,estrogen receptor beta,nuclear hormone receptor,,Drug: androstenediol | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
715,androstenediol,corticosteroid-binding globulin,secreted,,Drug: androstenediol | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
716,androstenediol,sex hormone-binding globulin,secreted,,Drug: androstenediol | Target: sex hormone-binding globulin | Type: secreted | Action: nan
717,androstenediol,androgen receptor,transcription factor,,Drug: androstenediol | Target: androgen receptor | Type: transcription factor | Action: nan
718,androstenedione,aromatase,enzyme,,Drug: androstenedione | Target: aromatase | Type: enzyme | Action: nan
719,androstenedione,corticosteroid-binding globulin,secreted,,Drug: androstenedione | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
720,androstenedione,sex hormone-binding globulin,secreted,,Drug: androstenedione | Target: sex hormone-binding globulin | Type: secreted | Action: nan
721,androstenedione,testosterone 17-beta-dehydrogenase 3,enzyme,,Drug: androstenedione | Target: testosterone 17-beta-dehydrogenase 3 | Type: enzyme | Action: nan
722,androstenedione,androgen receptor,transcription factor,,Drug: androstenedione | Target: androgen receptor | Type: transcription factor | Action: nan
723,androstenedione,testosterone 17-beta-dehydrogenase 3,enzyme,,Drug: androstenedione | Target: testosterone 17-beta-dehydrogenase 3 | Type: enzyme | Action: nan
724,anecortave,plasminogen activator inhibitor 1,secreted,,Drug: anecortave | Target: plasminogen activator inhibitor 1 | Type: secreted | Action: nan
725,anhydrovinblastine,multidrug resistance protein 1,transporter,,Drug: anhydrovinblastine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
726,anhydrovinblastine,canalicular multispecific organic anion transporter 1,transporter,,Drug: anhydrovinblastine | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
727,anhydrovinblastine,multidrug resistance-associated protein 1,transporter,,Drug: anhydrovinblastine | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
728,anhydrovinblastine,multidrug resistance-associated protein 7,transporter,,Drug: anhydrovinblastine | Target: multidrug resistance-associated protein 7 | Type: transporter | Action: nan
729,anhydrovinblastine,tubulin beta-4b chain,structural,,Drug: anhydrovinblastine | Target: tubulin beta-4b chain | Type: structural | Action: nan
730,anileridine,mu-type opioid receptor,gpcr,AGONIST,Drug: anileridine | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
731,anisindione,vitamin k-dependent gamma-carboxylase,enzyme,INHIBITOR,Drug: anisindione | Target: vitamin k-dependent gamma-carboxylase | Type: enzyme | Action: INHIBITOR
732,anisindione,arachidonate 5-lipoxygenase,enzyme,,Drug: anisindione | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
733,octatropine methylbromide,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: octatropine methylbromide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
734,octatropine methylbromide,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: octatropine methylbromide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
735,antazoline,histamine h1 receptor,gpcr,ANTAGONIST,Drug: antazoline | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
736,antazoline,histamine h1 receptor,gpcr,,Drug: antazoline | Target: histamine h1 receptor | Type: gpcr | Action: nan
737,dithranol,"arachidonate 12-lipoxygenase, 12r-type",enzyme,,"Drug: dithranol | Target: arachidonate 12-lipoxygenase, 12r-type | Type: enzyme | Action: nan"
738,dithranol,5-lipoxygenase,enzyme,,Drug: dithranol | Target: 5-lipoxygenase | Type: enzyme | Action: nan
739,dithranol,"nad-dependent protein deacylase sirtuin-5, mitochondrial",enzyme,,"Drug: dithranol | Target: nad-dependent protein deacylase sirtuin-5, mitochondrial | Type: enzyme | Action: nan"
740,dithranol,serine protease hepsin,enzyme,,Drug: dithranol | Target: serine protease hepsin | Type: enzyme | Action: nan
741,dithranol,trypsin,enzyme,,Drug: dithranol | Target: trypsin | Type: enzyme | Action: nan
742,apomorphine,d(1a) dopamine receptor,gpcr,,Drug: apomorphine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
743,apomorphine,d(2) dopamine receptor,gpcr,AGONIST,Drug: apomorphine | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
744,apomorphine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: apomorphine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
745,apomorphine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: apomorphine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
746,apomorphine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: apomorphine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
747,apomorphine,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: apomorphine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
748,apomorphine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: apomorphine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
749,apomorphine,alpha-1a adrenergic receptor,gpcr,,Drug: apomorphine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
750,apomorphine,alpha-2b adrenergic receptor,gpcr,ANTAGONIST,Drug: apomorphine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
751,apomorphine,d(3) dopamine receptor,gpcr,AGONIST,Drug: apomorphine | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
752,apomorphine,d(1b) dopamine receptor,gpcr,AGONIST,Drug: apomorphine | Target: d(1b) dopamine receptor | Type: gpcr | Action: AGONIST
753,apomorphine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: apomorphine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
754,apomorphine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: apomorphine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
755,apomorphine,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: apomorphine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
756,apomorphine,d(4) dopamine receptor,gpcr,AGONIST,Drug: apomorphine | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
757,apomorphine,alpha-1d adrenergic receptor,gpcr,,Drug: apomorphine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
758,apomorphine,alpha-1b adrenergic receptor,gpcr,,Drug: apomorphine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
759,apomorphine,solute carrier family 22 member 1,transporter,,Drug: apomorphine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
760,apomorphine,transient receptor potential cation channel subfamily a member 1,ion channel,ACTIVATOR,Drug: apomorphine | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: ACTIVATOR
761,apomorphine,d(2) dopamine receptor,gpcr,,Drug: apomorphine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
762,apomorphine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: apomorphine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
763,apomorphine,5-hydroxytryptamine receptor 7,gpcr,,Drug: apomorphine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
764,apomorphine,d(1a) dopamine receptor,gpcr,,Drug: apomorphine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
765,apomorphine,d(2) dopamine receptor,gpcr,,Drug: apomorphine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
766,apomorphine,d(3) dopamine receptor,gpcr,,Drug: apomorphine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
767,apomorphine,d(4) dopamine receptor,gpcr,,Drug: apomorphine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
768,apomorphine,d(1a) dopamine receptor,gpcr,,Drug: apomorphine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
769,apomorphine,zinc finger protein mex-5,cytosolic other,,Drug: apomorphine | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
770,apomorphine,opioid receptor,gpcr,,Drug: apomorphine | Target: opioid receptor | Type: gpcr | Action: nan
771,apomorphine,serotonin (5-ht) receptor,gpcr,,Drug: apomorphine | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
772,apomorphine,adrenergic receptor alpha-2,gpcr,,Drug: apomorphine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
773,apomorphine,dopamine receptor,gpcr,,Drug: apomorphine | Target: dopamine receptor | Type: gpcr | Action: nan
774,apomorphine,dopamine receptor,gpcr,,Drug: apomorphine | Target: dopamine receptor | Type: gpcr | Action: nan
775,apomorphine,adrenergic receptor alpha-1,gpcr,,Drug: apomorphine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
776,apomorphine,mannose-6-phosphate isomerase,enzyme,,Drug: apomorphine | Target: mannose-6-phosphate isomerase | Type: enzyme | Action: nan
777,apomorphine,cytoplasmic zinc-finger protein,unclassified,,Drug: apomorphine | Target: cytoplasmic zinc-finger protein | Type: unclassified | Action: nan
778,apomorphine,e3 ubiquitin-protein ligase mdm2,nuclear other,,Drug: apomorphine | Target: e3 ubiquitin-protein ligase mdm2 | Type: nuclear other | Action: nan
779,apraclonidine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: apraclonidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
780,apraclonidine,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: apraclonidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
781,apraclonidine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: apraclonidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
782,apraclonidine,alpha-2b adrenergic receptor,gpcr,,Drug: apraclonidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
783,apraclonidine,adrenergic receptor alpha-1,gpcr,,Drug: apraclonidine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
784,aprepitant,cytochrome p450 3a4,enzyme,,Drug: aprepitant | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
785,aprepitant,substance-p receptor,gpcr,ANTAGONIST,Drug: aprepitant | Target: substance-p receptor | Type: gpcr | Action: ANTAGONIST
786,aprepitant,neuromedin-k receptor,gpcr,,Drug: aprepitant | Target: neuromedin-k receptor | Type: gpcr | Action: nan
787,aprepitant,substance-p receptor,gpcr,,Drug: aprepitant | Target: substance-p receptor | Type: gpcr | Action: nan
788,aprindine,sodium channel protein type 5 subunit alpha,ion channel,,Drug: aprindine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
789,aprindine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: aprindine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
790,aprindine,cytochrome p450 2d6,enzyme,,Drug: aprindine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
791,aprindine,proteasome subunit alpha type-1,enzyme,,Drug: aprindine | Target: proteasome subunit alpha type-1 | Type: enzyme | Action: nan
792,aprindine,sodium/calcium exchanger 1,transporter,,Drug: aprindine | Target: sodium/calcium exchanger 1 | Type: transporter | Action: nan
793,aprindine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: aprindine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
794,aprindine,calmodulin,cytosolic other,INHIBITOR,Drug: aprindine | Target: calmodulin | Type: cytosolic other | Action: INHIBITOR
795,aranidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: aranidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
796,arbutamine,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: arbutamine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
797,argatroban,prothrombin,enzyme,INHIBITOR,Drug: argatroban | Target: prothrombin | Type: enzyme | Action: INHIBITOR
798,argatroban,coagulation factor x,enzyme,,Drug: argatroban | Target: coagulation factor x | Type: enzyme | Action: nan
799,argatroban,tissue-type plasminogen activator,enzyme,,Drug: argatroban | Target: tissue-type plasminogen activator | Type: enzyme | Action: nan
800,argatroban,cationic trypsin,enzyme,,Drug: argatroban | Target: cationic trypsin | Type: enzyme | Action: nan
801,argatroban,prothrombin,enzyme,,Drug: argatroban | Target: prothrombin | Type: enzyme | Action: nan
802,aripiprazole,beta-1 adrenergic receptor,gpcr,,Drug: aripiprazole | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
803,aripiprazole,beta-2 adrenergic receptor,gpcr,,Drug: aripiprazole | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
804,aripiprazole,d(1a) dopamine receptor,gpcr,,Drug: aripiprazole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
805,aripiprazole,d(2) dopamine receptor,gpcr,PARTIAL AGONIST,Drug: aripiprazole | Target: d(2) dopamine receptor | Type: gpcr | Action: PARTIAL AGONIST
806,aripiprazole,alpha-2a adrenergic receptor,gpcr,,Drug: aripiprazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
807,aripiprazole,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: aripiprazole | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
808,aripiprazole,multidrug resistance protein 1,transporter,,Drug: aripiprazole | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
809,aripiprazole,sodium-dependent serotonin transporter,transporter,,Drug: aripiprazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
810,aripiprazole,sodium-dependent noradrenaline transporter,transporter,,Drug: aripiprazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
811,aripiprazole,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
812,aripiprazole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
813,aripiprazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
814,aripiprazole,5-hydroxytryptamine receptor 6,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
815,aripiprazole,5-hydroxytryptamine receptor 7,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
816,aripiprazole,alpha-1a adrenergic receptor,gpcr,,Drug: aripiprazole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
817,aripiprazole,alpha-2b adrenergic receptor,gpcr,,Drug: aripiprazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
818,aripiprazole,d(3) dopamine receptor,gpcr,,Drug: aripiprazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
819,aripiprazole,d(1b) dopamine receptor,gpcr,,Drug: aripiprazole | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
820,aripiprazole,histamine h1 receptor,gpcr,,Drug: aripiprazole | Target: histamine h1 receptor | Type: gpcr | Action: nan
821,aripiprazole,muscarinic acetylcholine receptor m1,gpcr,,Drug: aripiprazole | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
822,aripiprazole,muscarinic acetylcholine receptor m2,gpcr,,Drug: aripiprazole | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
823,aripiprazole,muscarinic acetylcholine receptor m3,gpcr,,Drug: aripiprazole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
824,aripiprazole,muscarinic acetylcholine receptor m4,gpcr,,Drug: aripiprazole | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
825,aripiprazole,muscarinic acetylcholine receptor m5,gpcr,,Drug: aripiprazole | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
826,aripiprazole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
827,aripiprazole,5-hydroxytryptamine receptor 1d,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
828,aripiprazole,alpha-2c adrenergic receptor,gpcr,,Drug: aripiprazole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
829,aripiprazole,sodium-dependent dopamine transporter,transporter,,Drug: aripiprazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
830,aripiprazole,d(4) dopamine receptor,gpcr,,Drug: aripiprazole | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
831,aripiprazole,5-hydroxytryptamine receptor 3a,ion channel,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
832,aripiprazole,alpha-1b adrenergic receptor,gpcr,,Drug: aripiprazole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
833,aripiprazole,5-hydroxytryptamine receptor 5a,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
834,aripiprazole,5-hydroxytryptamine receptor 1e,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
835,aripiprazole,histamine h1 receptor,gpcr,,Drug: aripiprazole | Target: histamine h1 receptor | Type: gpcr | Action: nan
836,aripiprazole,d(2) dopamine receptor,gpcr,,Drug: aripiprazole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
837,aripiprazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
838,aripiprazole,sodium-dependent serotonin transporter,transporter,,Drug: aripiprazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
839,aripiprazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
840,aripiprazole,5-hydroxytryptamine receptor 7,gpcr,AGONIST,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: AGONIST
841,aripiprazole,d(1a) dopamine receptor,gpcr,,Drug: aripiprazole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
842,aripiprazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
843,aripiprazole,d(3) dopamine receptor,gpcr,,Drug: aripiprazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
844,aripiprazole,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: aripiprazole | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
845,aripiprazole,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
846,aripiprazole,histone h1.0,nuclear other,,Drug: aripiprazole | Target: histone h1.0 | Type: nuclear other | Action: nan
847,aripiprazole,5-hydroxytryptamine receptor 1a,gpcr,PARTIAL AGONIST,Drug: aripiprazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: PARTIAL AGONIST
848,arsenic trioxide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: arsenic trioxide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
849,arsenic trioxide,"thioredoxin reductase 1, cytoplasmic",enzyme,INHIBITOR,"Drug: arsenic trioxide | Target: thioredoxin reductase 1, cytoplasmic | Type: enzyme | Action: INHIBITOR"
850,astemizole,sodium/nucleoside cotransporter 1,transporter,,Drug: astemizole | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
851,astemizole,beta-1 adrenergic receptor,gpcr,,Drug: astemizole | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
852,astemizole,mu-type opioid receptor,gpcr,,Drug: astemizole | Target: mu-type opioid receptor | Type: gpcr | Action: nan
853,astemizole,d(1a) dopamine receptor,gpcr,,Drug: astemizole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
854,astemizole,d(2) dopamine receptor,gpcr,,Drug: astemizole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
855,astemizole,alpha-2a adrenergic receptor,gpcr,,Drug: astemizole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
856,astemizole,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: astemizole | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
857,astemizole,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: astemizole | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
858,astemizole,cytochrome p450 3a4,enzyme,,Drug: astemizole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
859,astemizole,multidrug resistance protein 1,transporter,,Drug: astemizole | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
860,astemizole,sodium-dependent serotonin transporter,transporter,,Drug: astemizole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
861,astemizole,sodium-dependent noradrenaline transporter,transporter,,Drug: astemizole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
862,astemizole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: astemizole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
863,astemizole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: astemizole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
864,astemizole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: astemizole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
865,astemizole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: astemizole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
866,astemizole,5-hydroxytryptamine receptor 6,gpcr,,Drug: astemizole | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
867,astemizole,alpha-2b adrenergic receptor,gpcr,,Drug: astemizole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
868,astemizole,d(3) dopamine receptor,gpcr,,Drug: astemizole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
869,astemizole,histamine h2 receptor,gpcr,,Drug: astemizole | Target: histamine h2 receptor | Type: gpcr | Action: nan
870,astemizole,histamine h4 receptor,gpcr,,Drug: astemizole | Target: histamine h4 receptor | Type: gpcr | Action: nan
871,astemizole,muscarinic acetylcholine receptor m1,gpcr,,Drug: astemizole | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
872,astemizole,muscarinic acetylcholine receptor m2,gpcr,,Drug: astemizole | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
873,astemizole,muscarinic acetylcholine receptor m3,gpcr,,Drug: astemizole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
874,astemizole,muscarinic acetylcholine receptor m4,gpcr,,Drug: astemizole | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
875,astemizole,muscarinic acetylcholine receptor m5,gpcr,,Drug: astemizole | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
876,astemizole,beta-3 adrenergic receptor,gpcr,,Drug: astemizole | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
877,astemizole,alpha-2c adrenergic receptor,gpcr,,Drug: astemizole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
878,astemizole,sodium-dependent dopamine transporter,transporter,,Drug: astemizole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
879,astemizole,adenosine receptor a3,gpcr,,Drug: astemizole | Target: adenosine receptor a3 | Type: gpcr | Action: nan
880,astemizole,d(4) dopamine receptor,gpcr,,Drug: astemizole | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
881,astemizole,alpha-1d adrenergic receptor,gpcr,,Drug: astemizole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
882,astemizole,5-hydroxytryptamine receptor 3a,ion channel,,Drug: astemizole | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
883,astemizole,kappa-type opioid receptor,gpcr,,Drug: astemizole | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
884,astemizole,atp-binding cassette sub-family g member 2,transporter,,Drug: astemizole | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
885,astemizole,glycine receptor subunit alpha-1,ion channel,,Drug: astemizole | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
886,astemizole,calmodulin,cytosolic other,,Drug: astemizole | Target: calmodulin | Type: cytosolic other | Action: nan
887,astemizole,delta-type opioid receptor,gpcr,,Drug: astemizole | Target: delta-type opioid receptor | Type: gpcr | Action: nan
888,astemizole,somatostatin receptor type 5,gpcr,,Drug: astemizole | Target: somatostatin receptor type 5 | Type: gpcr | Action: nan
889,astemizole,epidermal growth factor receptor,kinase,,Drug: astemizole | Target: epidermal growth factor receptor | Type: kinase | Action: nan
890,astemizole,substance-p receptor,gpcr,,Drug: astemizole | Target: substance-p receptor | Type: gpcr | Action: nan
891,astemizole,tyrosine-protein kinase lck,kinase,,Drug: astemizole | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
892,astemizole,tyrosine-protein kinase fyn,kinase,,Drug: astemizole | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
893,astemizole,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: astemizole | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
894,astemizole,substance-k receptor,gpcr,,Drug: astemizole | Target: substance-k receptor | Type: gpcr | Action: nan
895,astemizole,potassium voltage-gated channel subfamily h member 1,ion channel,BLOCKER,Drug: astemizole | Target: potassium voltage-gated channel subfamily h member 1 | Type: ion channel | Action: BLOCKER
896,astemizole,alpha-1b adrenergic receptor,gpcr,,Drug: astemizole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
897,astemizole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: astemizole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
898,astemizole,melanocortin receptor 4,gpcr,,Drug: astemizole | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
899,astemizole,melanocortin receptor 5,gpcr,,Drug: astemizole | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
900,astemizole,melanocortin receptor 3,gpcr,,Drug: astemizole | Target: melanocortin receptor 3 | Type: gpcr | Action: nan
901,astemizole,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: astemizole | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
902,astemizole,alpha-1a adrenergic receptor,gpcr,,Drug: astemizole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
903,astemizole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: astemizole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
904,astemizole,multidrug and toxin extrusion protein 1,transporter,,Drug: astemizole | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
905,astemizole,protein farnesyltransferase,enzyme,,Drug: astemizole | Target: protein farnesyltransferase | Type: enzyme | Action: nan
906,astemizole,polycomb protein eed,unclassified,,Drug: astemizole | Target: polycomb protein eed | Type: unclassified | Action: nan
907,astemizole,"hla class i histocompatibility antigen, a-3 alpha chain",unclassified,,"Drug: astemizole | Target: hla class i histocompatibility antigen, a-3 alpha chain | Type: unclassified | Action: nan"
908,astemizole,transmembrane protein 97,enzyme,,Drug: astemizole | Target: transmembrane protein 97 | Type: enzyme | Action: nan
909,astemizole,histamine h1 receptor,gpcr,ANTAGONIST,Drug: astemizole | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
910,asulacrine,dna topoisomerase 2-alpha,enzyme,,Drug: asulacrine | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: nan
911,atazanavir,cytochrome p450 3a4,enzyme,,Drug: atazanavir | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
912,atazanavir,multidrug resistance protein 1,transporter,,Drug: atazanavir | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
913,atazanavir,cytochrome p450 2c9,enzyme,,Drug: atazanavir | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
914,atazanavir,cytochrome p450 1a2,enzyme,,Drug: atazanavir | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
915,atazanavir,gag-pol polyprotein,polyprotein,,Drug: atazanavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
916,atazanavir,pol polyprotein,enzyme,INHIBITOR,Drug: atazanavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
917,atazanavir,reverse transcriptase/rnaseh,enzyme,,Drug: atazanavir | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: nan
918,atazanavir,udp-glucuronosyltransferase 1-1,enzyme,,Drug: atazanavir | Target: udp-glucuronosyltransferase 1-1 | Type: enzyme | Action: nan
919,atazanavir,protease,enzyme,,Drug: atazanavir | Target: protease | Type: enzyme | Action: nan
920,atazanavir,protease,unclassified,,Drug: atazanavir | Target: protease | Type: unclassified | Action: nan
921,atazanavir,protease,unclassified,,Drug: atazanavir | Target: protease | Type: unclassified | Action: nan
922,atenolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: atenolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
923,atenolol,beta-2 adrenergic receptor,gpcr,,Drug: atenolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
924,atenolol,adenosine receptor a3,gpcr,,Drug: atenolol | Target: adenosine receptor a3 | Type: gpcr | Action: nan
925,atenolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: atenolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
926,atenolol,beta-2 adrenergic receptor,gpcr,,Drug: atenolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
927,atenolol,beta-1 adrenergic receptor,gpcr,,Drug: atenolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
928,atomoxetine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: atomoxetine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
929,atomoxetine,sodium-dependent serotonin transporter,transporter,,Drug: atomoxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
930,atomoxetine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: atomoxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
931,atomoxetine,sodium-dependent dopamine transporter,transporter,,Drug: atomoxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
932,atomoxetine,cytochrome p450 2d6,enzyme,,Drug: atomoxetine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
933,atomoxetine,g protein-activated inward rectifier potassium channel 2,ion channel,,Drug: atomoxetine | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: nan
934,atomoxetine,sodium-dependent serotonin transporter,transporter,,Drug: atomoxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
935,atomoxetine,sodium-dependent dopamine transporter,transporter,,Drug: atomoxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
936,atomoxetine,transporter,transporter,,Drug: atomoxetine | Target: transporter | Type: transporter | Action: nan
937,atomoxetine,transporter,transporter,,Drug: atomoxetine | Target: transporter | Type: transporter | Action: nan
938,atomoxetine,kir3.1/kir3.2,ion channel,,Drug: atomoxetine | Target: kir3.1/kir3.2 | Type: ion channel | Action: nan
939,atomoxetine,kir3.1/kir3.4,ion channel,,Drug: atomoxetine | Target: kir3.1/kir3.4 | Type: ion channel | Action: nan
940,atomoxetine,krueppel-like factor 10,nuclear other,,Drug: atomoxetine | Target: krueppel-like factor 10 | Type: nuclear other | Action: nan
941,atorvastatin,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: atorvastatin | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
942,atorvastatin,cytochrome p450 3a4,enzyme,,Drug: atorvastatin | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
943,atorvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: atorvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
944,atorvastatin,histone deacetylase 2,enzyme,,Drug: atorvastatin | Target: histone deacetylase 2 | Type: enzyme | Action: nan
945,atorvastatin,histone deacetylase 1,enzyme,,Drug: atorvastatin | Target: histone deacetylase 1 | Type: enzyme | Action: nan
946,atorvastatin,histone deacetylase 6,enzyme,,Drug: atorvastatin | Target: histone deacetylase 6 | Type: enzyme | Action: nan
947,atorvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: atorvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
948,atorvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: atorvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
949,atovaquone,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: atovaquone | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
950,atovaquone,"ubiquinol-cytochrome-c reductase complex core protein i, mitochondrial",enzyme,,"Drug: atovaquone | Target: ubiquinol-cytochrome-c reductase complex core protein i, mitochondrial | Type: enzyme | Action: nan"
951,atovaquone,cytochrome b,enzyme,INHIBITOR,Drug: atovaquone | Target: cytochrome b | Type: enzyme | Action: INHIBITOR
952,atovaquone,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: atovaquone | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
953,atovaquone,dihydroorotate dehydrogenase,enzyme,,Drug: atovaquone | Target: dihydroorotate dehydrogenase | Type: enzyme | Action: nan
954,atracurium,neuronal acetylcholine receptor subunit alpha-2,ion channel,,Drug: atracurium | Target: neuronal acetylcholine receptor subunit alpha-2 | Type: ion channel | Action: nan
955,atracurium,neuronal acetylcholine receptor subunit alpha-7,ion channel,ANTAGONIST,Drug: atracurium | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: ANTAGONIST
956,atracurium,small conductance calcium-activated potassium channel protein 3,ion channel,,Drug: atracurium | Target: small conductance calcium-activated potassium channel protein 3 | Type: ion channel | Action: nan
957,atracurium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: atracurium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
958,atracurium,neuronal acetylcholine receptor subunit alpha-3,ion channel,ANTAGONIST,Drug: atracurium | Target: neuronal acetylcholine receptor subunit alpha-3 | Type: ion channel | Action: ANTAGONIST
959,atracurium,neuronal acetylcholine receptor subunit alpha-4,ion channel,ANTAGONIST,Drug: atracurium | Target: neuronal acetylcholine receptor subunit alpha-4 | Type: ion channel | Action: ANTAGONIST
960,atropine,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: atropine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
961,atropine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: atropine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
962,atropine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: atropine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
963,atropine,histamine h1 receptor,gpcr,,Drug: atropine | Target: histamine h1 receptor | Type: gpcr | Action: nan
964,atropine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: atropine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
965,atropine,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: atropine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
966,atropine,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: atropine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
967,atropine,muscarinic acetylcholine receptor m4,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
968,atropine,muscarinic acetylcholine receptor m5,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
969,atropine,alpha-1d adrenergic receptor,gpcr,,Drug: atropine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
970,atropine,solute carrier family 22 member 1,transporter,,Drug: atropine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
971,atropine,muscarinic acetylcholine receptor m2,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
972,atropine,muscarinic acetylcholine receptor m1,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
973,atropine,acetylcholinesterase,enzyme,,Drug: atropine | Target: acetylcholinesterase | Type: enzyme | Action: nan
974,atropine,muscarinic acetylcholine receptor m2,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
975,atropine,muscarinic acetylcholine receptor m3,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
976,atropine,muscarinic receptor m1,gpcr,,Drug: atropine | Target: muscarinic receptor m1 | Type: gpcr | Action: nan
977,atropine,muscarinic acetylcholine receptor m5,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
978,atropine,muscarinic acetylcholine receptor m4,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
979,atropine,muscarinic acetylcholine receptor,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
980,atropine,nicotinic acetylcholine receptor alpha 5 subunit,ion channel,,Drug: atropine | Target: nicotinic acetylcholine receptor alpha 5 subunit | Type: ion channel | Action: nan
981,atropine,muscarinic acetylcholine receptor,gpcr,,Drug: atropine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
983,azapetine,adrenergic receptor alpha-2,gpcr,,Drug: azapetine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
984,azapetine,adrenergic receptor alpha-1,gpcr,,Drug: azapetine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
985,azapropazone,prostaglandin g/h synthase 1,enzyme,,Drug: azapropazone | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
986,azapropazone,xanthine dehydrogenase/oxidase,enzyme,,Drug: azapropazone | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
987,azasetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: azasetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
988,azatadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: azatadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
989,azatadine,histamine h1 receptor,gpcr,,Drug: azatadine | Target: histamine h1 receptor | Type: gpcr | Action: nan
990,azathioprine,atp-binding cassette sub-family g member 2,transporter,,Drug: azathioprine | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
991,azathioprine,multidrug resistance-associated protein 5,transporter,,Drug: azathioprine | Target: multidrug resistance-associated protein 5 | Type: transporter | Action: nan
992,azathioprine,multidrug resistance-associated protein 4,transporter,,Drug: azathioprine | Target: multidrug resistance-associated protein 4 | Type: transporter | Action: nan
993,azathioprine,ras-related c3 botulinum toxin substrate 1,enzyme,,Drug: azathioprine | Target: ras-related c3 botulinum toxin substrate 1 | Type: enzyme | Action: nan
994,azathioprine,thiopurine s-methyltransferase,enzyme,,Drug: azathioprine | Target: thiopurine s-methyltransferase | Type: enzyme | Action: nan
995,azelaic acid,3-oxo-5-alpha-steroid 4-dehydrogenase 2,enzyme,,Drug: azelaic acid | Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Type: enzyme | Action: nan
996,azelastine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: azelastine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
997,azelastine,multidrug resistance protein 1,transporter,,Drug: azelastine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
998,azelastine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: azelastine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
999,azelastine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: azelastine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
1000,azelastine,alpha-1a adrenergic receptor,gpcr,,Drug: azelastine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1001,azelastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: azelastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
1002,azelastine,muscarinic acetylcholine receptor m1,gpcr,,Drug: azelastine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1003,azelastine,alpha-1b adrenergic receptor,gpcr,,Drug: azelastine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1004,azelastine,histamine h3 receptor,gpcr,,Drug: azelastine | Target: histamine h3 receptor | Type: gpcr | Action: nan
1005,azelastine,alpha-1a adrenergic receptor,gpcr,,Drug: azelastine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1006,azelnidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: azelnidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
1007,azimilide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: azimilide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1008,azimilide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: azimilide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1009,azimilide,potassium voltage-gated channel subfamily kqt member 1,ion channel,,Drug: azimilide | Target: potassium voltage-gated channel subfamily kqt member 1 | Type: ion channel | Action: nan
1010,azimilide,potassium voltage-gated channel subfamily kqt member 1,ion channel,BLOCKER,Drug: azimilide | Target: potassium voltage-gated channel subfamily kqt member 1 | Type: ion channel | Action: BLOCKER
1011,azithromycin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: azithromycin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1012,azithromycin,multidrug resistance protein 1,transporter,,Drug: azithromycin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
1013,azithromycin,canalicular multispecific organic anion transporter 1,transporter,,Drug: azithromycin | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
1014,azithromycin,motilin receptor,gpcr,AGONIST,Drug: azithromycin | Target: motilin receptor | Type: gpcr | Action: AGONIST
1015,azlocillin,penicillin-binding protein,enzyme,INHIBITOR,Drug: azlocillin | Target: penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1016,aztreonam,peptidoglycan synthase ftsi,enzyme,INHIBITOR,Drug: aztreonam | Target: peptidoglycan synthase ftsi | Type: enzyme | Action: INHIBITOR
1017,aztreonam,penicillin-binding protein 1a,enzyme,,Drug: aztreonam | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1018,aztreonam,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: aztreonam | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
1019,aztreonam,penicillin-binding protein 1b,enzyme,INHIBITOR,Drug: aztreonam | Target: penicillin-binding protein 1b | Type: enzyme | Action: INHIBITOR
1020,aztreonam,beta-lactamase,enzyme,,Drug: aztreonam | Target: beta-lactamase | Type: enzyme | Action: nan
1021,aztreonam,beta-lactamase,enzyme,,Drug: aztreonam | Target: beta-lactamase | Type: enzyme | Action: nan
1022,aztreonam,ampc,unclassified,,Drug: aztreonam | Target: ampc | Type: unclassified | Action: nan
1023,aztreonam,efflux transporter; suge,transporter,,Drug: aztreonam | Target: efflux transporter; suge | Type: transporter | Action: nan
1024,aztreonam,beta-lactamase,enzyme,,Drug: aztreonam | Target: beta-lactamase | Type: enzyme | Action: nan
1025,aztreonam,beta-lactamase,enzyme,,Drug: aztreonam | Target: beta-lactamase | Type: enzyme | Action: nan
1026,aztreonam,beta-lactamase,enzyme,,Drug: aztreonam | Target: beta-lactamase | Type: enzyme | Action: nan
1027,bacampicillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: bacampicillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1028,bacitracin,epidermal growth factor receptor,kinase,,Drug: bacitracin | Target: epidermal growth factor receptor | Type: kinase | Action: nan
1029,bacitracin,tyrosine-protein kinase lck,kinase,,Drug: bacitracin | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
1030,bacitracin,5-hydroxytryptamine receptor 1b,gpcr,,Drug: bacitracin | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
1031,bacitracin,undecaprenyl-diphosphatase,unclassified,,Drug: bacitracin | Target: undecaprenyl-diphosphatase | Type: unclassified | Action: nan
1032,baclofen,gaba b receptor,gpcr,,Drug: baclofen | Target: gaba b receptor | Type: gpcr | Action: nan
1033,baclofen,gaba-b receptor,gpcr,AGONIST,Drug: baclofen | Target: gaba-b receptor | Type: gpcr | Action: AGONIST
1034,baclofen,adenosine receptor a3,gpcr,,Drug: baclofen | Target: adenosine receptor a3 | Type: gpcr | Action: nan
1035,baclofen,gaba-a receptor; anion channel,ion channel,,Drug: baclofen | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
1036,balsalazide,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: balsalazide | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
1037,balsalazide,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: balsalazide | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
1038,balsalazide,arachidonate 5-lipoxygenase,enzyme,INHIBITOR,Drug: balsalazide | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: INHIBITOR
1039,balsalazide,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: balsalazide | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
1040,bambuterol,beta-2 adrenergic receptor,gpcr,,Drug: bambuterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1041,bambuterol,cytochrome p450 2d6,enzyme,,Drug: bambuterol | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1042,bambuterol,acetylcholinesterase,enzyme,,Drug: bambuterol | Target: acetylcholinesterase | Type: enzyme | Action: nan
1043,bambuterol,cholinesterase,enzyme,INHIBITOR,Drug: bambuterol | Target: cholinesterase | Type: enzyme | Action: INHIBITOR
1044,bambuterol,cholinesterase,enzyme,,Drug: bambuterol | Target: cholinesterase | Type: enzyme | Action: nan
1045,bamipine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: bamipine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
1046,barnidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: barnidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
1047,beclometasone dipropionate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: beclometasone dipropionate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
1048,beclometasone dipropionate,interleukin-5,cytokine,,Drug: beclometasone dipropionate | Target: interleukin-5 | Type: cytokine | Action: nan
1049,beclometasone dipropionate,mineralocorticoid receptor,nuclear hormone receptor,,Drug: beclometasone dipropionate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
1050,beclometasone dipropionate,progesterone receptor,nuclear hormone receptor,,Drug: beclometasone dipropionate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
1051,beclometasone dipropionate,matrix metalloproteinase-9,enzyme,,Drug: beclometasone dipropionate | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
1052,beclometasone dipropionate,androgen receptor,transcription factor,,Drug: beclometasone dipropionate | Target: androgen receptor | Type: transcription factor | Action: nan
1053,beclometasone dipropionate,progesterone receptor,transcription factor,,Drug: beclometasone dipropionate | Target: progesterone receptor | Type: transcription factor | Action: nan
1054,beclometasone dipropionate,glucocorticoid receptor,transcription factor,,Drug: beclometasone dipropionate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
1055,beclometasone dipropionate,probable g-protein coupled receptor 97,gpcr,AGONIST,Drug: beclometasone dipropionate | Target: probable g-protein coupled receptor 97 | Type: gpcr | Action: AGONIST
1056,beclometasone dipropionate,interleukin-5,unclassified,,Drug: beclometasone dipropionate | Target: interleukin-5 | Type: unclassified | Action: nan
1058,belotecan,dna topoisomerase 1,enzyme,INHIBITOR,Drug: belotecan | Target: dna topoisomerase 1 | Type: enzyme | Action: INHIBITOR
1059,benazepril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: benazepril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
1060,benazepril,angiotensin-converting enzyme,enzyme,,Drug: benazepril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
1061,benazepril,angiotensin-converting enzyme,enzyme,,Drug: benazepril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
1062,bendamustine,histone deacetylase 2,enzyme,,Drug: bendamustine | Target: histone deacetylase 2 | Type: enzyme | Action: nan
1063,bendamustine,histone deacetylase 1,enzyme,,Drug: bendamustine | Target: histone deacetylase 1 | Type: enzyme | Action: nan
1064,bendamustine,histone deacetylase 3,enzyme,,Drug: bendamustine | Target: histone deacetylase 3 | Type: enzyme | Action: nan
1065,bendamustine,histone deacetylase 6,enzyme,,Drug: bendamustine | Target: histone deacetylase 6 | Type: enzyme | Action: nan
1066,bendamustine,histone deacetylase 8,enzyme,,Drug: bendamustine | Target: histone deacetylase 8 | Type: enzyme | Action: nan
1067,bendamustine,histone deacetylase 10,enzyme,,Drug: bendamustine | Target: histone deacetylase 10 | Type: enzyme | Action: nan
1068,bendroflumethiazide,carbonic anhydrase 2,enzyme,,Drug: bendroflumethiazide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1069,bendroflumethiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: bendroflumethiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
1070,bendroflumethiazide,carbonic anhydrase 1,enzyme,,Drug: bendroflumethiazide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
1071,bendroflumethiazide,carbonic anhydrase 4,enzyme,,Drug: bendroflumethiazide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
1072,bendroflumethiazide,calcium-activated potassium channel subunit alpha-1,ion channel,,Drug: bendroflumethiazide | Target: calcium-activated potassium channel subunit alpha-1 | Type: ion channel | Action: nan
1073,benoxaprofen,arachidonate 5-lipoxygenase,enzyme,INHIBITOR,Drug: benoxaprofen | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: INHIBITOR
1074,benoxaprofen,bile salt export pump,transporter,,Drug: benoxaprofen | Target: bile salt export pump | Type: transporter | Action: nan
1075,benperidol,d(2) dopamine receptor,gpcr,,Drug: benperidol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1076,benperidol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: benperidol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1077,benperidol,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: benperidol | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1078,benperidol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: benperidol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1079,benperidol,d(3) dopamine receptor,gpcr,,Drug: benperidol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1080,benperidol,d(4) dopamine receptor,gpcr,,Drug: benperidol | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
1081,diphenidol,d(2) dopamine receptor,gpcr,,Drug: diphenidol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1082,diphenidol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: diphenidol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1083,diphenidol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: diphenidol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1084,diphenidol,d(3) dopamine receptor,gpcr,,Drug: diphenidol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1085,diphenidol,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: diphenidol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
1086,diphenidol,muscarinic acetylcholine receptor m2,gpcr,,Drug: diphenidol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1087,diphenidol,muscarinic acetylcholine receptor m3,gpcr,,Drug: diphenidol | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
1088,diphenidol,muscarinic acetylcholine receptor m4,gpcr,,Drug: diphenidol | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
1089,diphenidol,muscarinic acetylcholine receptor m5,gpcr,,Drug: diphenidol | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
1090,diphenidol,cytochrome p450 2d6,enzyme,,Drug: diphenidol | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1091,diphenidol,alpha-1b adrenergic receptor,gpcr,,Drug: diphenidol | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1092,diphenidol,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: diphenidol | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
1093,benserazide,aromatic-l-amino-acid decarboxylase,enzyme,,Drug: benserazide | Target: aromatic-l-amino-acid decarboxylase | Type: enzyme | Action: nan
1094,benserazide,estrogen receptor beta,nuclear hormone receptor,,Drug: benserazide | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
1095,benserazide,zinc finger protein mex-5,cytosolic other,,Drug: benserazide | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
1096,benserazide,sumo-activating enzyme,enzyme,,Drug: benserazide | Target: sumo-activating enzyme | Type: enzyme | Action: nan
1097,benserazide,cytoplasmic zinc-finger protein,unclassified,,Drug: benserazide | Target: cytoplasmic zinc-finger protein | Type: unclassified | Action: nan
1098,benserazide,genome polyprotein [cleaved into: p1; capsid protein vp0,unclassified,,Drug: benserazide | Target: genome polyprotein [cleaved into: p1; capsid protein vp0 | Type: unclassified | Action: nan
1099,benserazide,hexokinase-2,kinase,,Drug: benserazide | Target: hexokinase-2 | Type: kinase | Action: nan
1100,benzarone,solute carrier family 22 member 12,transporter,,Drug: benzarone | Target: solute carrier family 22 member 12 | Type: transporter | Action: nan
1101,benzarone,eyes absent homolog 3,enzyme,,Drug: benzarone | Target: eyes absent homolog 3 | Type: enzyme | Action: nan
1102,benzbromarone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: benzbromarone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
1103,benzbromarone,adenosine receptor a3,gpcr,,Drug: benzbromarone | Target: adenosine receptor a3 | Type: gpcr | Action: nan
1104,benzbromarone,multidrug resistance-associated protein 1,transporter,,Drug: benzbromarone | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
1105,benzbromarone,cytochrome p450 2c9,enzyme,,Drug: benzbromarone | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
1106,benzbromarone,aldo-keto reductase family 1 member c1,enzyme,,Drug: benzbromarone | Target: aldo-keto reductase family 1 member c1 | Type: enzyme | Action: nan
1107,benzbromarone,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: benzbromarone | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
1108,benzbromarone,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: benzbromarone | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
1109,benzbromarone,mitogen-activated protein kinase 14,kinase,,Drug: benzbromarone | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
1110,benzbromarone,mitogen-activated protein kinase 1,kinase,,Drug: benzbromarone | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
1111,benzbromarone,m1-family alanyl aminopeptidase,enzyme,,Drug: benzbromarone | Target: m1-family alanyl aminopeptidase | Type: enzyme | Action: nan
1112,benzbromarone,envelope glycoprotein gp160,viral envelope protein,,Drug: benzbromarone | Target: envelope glycoprotein gp160 | Type: viral envelope protein | Action: nan
1113,benzbromarone,polymerase acidic protein,enzyme,,Drug: benzbromarone | Target: polymerase acidic protein | Type: enzyme | Action: nan
1114,benzbromarone,eyes absent homolog 2,enzyme,,Drug: benzbromarone | Target: eyes absent homolog 2 | Type: enzyme | Action: nan
1115,benzbromarone,eyes absent homolog 3,enzyme,,Drug: benzbromarone | Target: eyes absent homolog 3 | Type: enzyme | Action: nan
1116,benzbromarone,solute carrier family 22 member 12,transporter,INHIBITOR,Drug: benzbromarone | Target: solute carrier family 22 member 12 | Type: transporter | Action: INHIBITOR
1117,benziodarone,baculoviral iap repeat-containing protein 5,unclassified,,Drug: benziodarone | Target: baculoviral iap repeat-containing protein 5 | Type: unclassified | Action: nan
1118,benziodarone,eyes absent homolog 3,enzyme,,Drug: benziodarone | Target: eyes absent homolog 3 | Type: enzyme | Action: nan
1119,benzocaine,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
1120,benzocaine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
1121,benzocaine,sodium channel protein type 3 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 3 subunit alpha | Type: ion channel | Action: BLOCKER
1122,benzocaine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
1123,benzocaine,sodium channel protein type 8 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 8 subunit alpha | Type: ion channel | Action: BLOCKER
1124,benzocaine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
1125,benzocaine,sodium channel protein type 11 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 11 subunit alpha | Type: ion channel | Action: BLOCKER
1126,benzocaine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
1127,benzocaine,sodium channel protein type 7 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 7 subunit alpha | Type: ion channel | Action: BLOCKER
1128,benzocaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: benzocaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
1129,benzonatate,sodium channel protein type 5 subunit alpha,ion channel,,Drug: benzonatate | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
1130,benzphetamine,alpha-2a adrenergic receptor,gpcr,,Drug: benzphetamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
1131,benzphetamine,sodium-dependent noradrenaline transporter,transporter,RELEASING AGENT,Drug: benzphetamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: RELEASING AGENT
1132,benzphetamine,alpha-1a adrenergic receptor,gpcr,,Drug: benzphetamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1133,benzphetamine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: benzphetamine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
1134,benzquinamide,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: benzquinamide | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
1135,benzquinamide,d(2) dopamine receptor,gpcr,AGONIST,Drug: benzquinamide | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
1136,benzquinamide,d(3) dopamine receptor,gpcr,,Drug: benzquinamide | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1137,benzquinamide,d(4) dopamine receptor,gpcr,,Drug: benzquinamide | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
1138,benzquinamide,alpha-2a adrenergic receptor,gpcr,,Drug: benzquinamide | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
1139,benzquinamide,alpha-2b adrenergic receptor,gpcr,,Drug: benzquinamide | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
1140,benzquinamide,alpha-2c adrenergic receptor,gpcr,,Drug: benzquinamide | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
1141,benzthiazide,carbonic anhydrase 2,enzyme,,Drug: benzthiazide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1142,benzthiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: benzthiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
1143,benzthiazide,carbonic anhydrase 1,enzyme,,Drug: benzthiazide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
1144,benzthiazide,carbonic anhydrase 4,enzyme,,Drug: benzthiazide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
1145,benzthiazide,calcium-activated potassium channel subunit alpha-1,ion channel,,Drug: benzthiazide | Target: calcium-activated potassium channel subunit alpha-1 | Type: ion channel | Action: nan
1146,benzatropine,alpha-2a adrenergic receptor,gpcr,,Drug: benzatropine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
1147,benzatropine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: benzatropine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1148,benzatropine,sodium-dependent serotonin transporter,transporter,,Drug: benzatropine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1149,benzatropine,sodium-dependent noradrenaline transporter,transporter,,Drug: benzatropine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
1150,benzatropine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: benzatropine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1151,benzatropine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: benzatropine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
1152,benzatropine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: benzatropine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
1153,benzatropine,5-hydroxytryptamine receptor 6,gpcr,,Drug: benzatropine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
1154,benzatropine,alpha-2b adrenergic receptor,gpcr,,Drug: benzatropine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
1155,benzatropine,d(3) dopamine receptor,gpcr,,Drug: benzatropine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1156,benzatropine,histamine h1 receptor,gpcr,,Drug: benzatropine | Target: histamine h1 receptor | Type: gpcr | Action: nan
1157,benzatropine,histamine h2 receptor,gpcr,,Drug: benzatropine | Target: histamine h2 receptor | Type: gpcr | Action: nan
1158,benzatropine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: benzatropine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
1159,benzatropine,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: benzatropine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
1160,benzatropine,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: benzatropine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
1161,benzatropine,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: benzatropine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
1162,benzatropine,muscarinic acetylcholine receptor m5,gpcr,ANTAGONIST,Drug: benzatropine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: ANTAGONIST
1163,benzatropine,alpha-2c adrenergic receptor,gpcr,,Drug: benzatropine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
1164,benzatropine,sodium-dependent dopamine transporter,transporter,,Drug: benzatropine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1165,benzatropine,alpha-1d adrenergic receptor,gpcr,,Drug: benzatropine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
1166,benzatropine,alpha-1b adrenergic receptor,gpcr,,Drug: benzatropine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1167,benzatropine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: benzatropine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
1168,benzatropine,alpha-1a adrenergic receptor,gpcr,,Drug: benzatropine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1169,benzatropine,muscarinic acetylcholine receptor m2,gpcr,,Drug: benzatropine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1170,benzatropine,muscarinic acetylcholine receptor m1,gpcr,,Drug: benzatropine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1171,benzatropine,sodium-dependent serotonin transporter,transporter,,Drug: benzatropine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1172,benzatropine,sodium-dependent dopamine transporter,transporter,,Drug: benzatropine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1173,benzatropine,sodium-dependent neutral amino acid transporter b(0)at1,transporter,INHIBITOR,Drug: benzatropine | Target: sodium-dependent neutral amino acid transporter b(0)at1 | Type: transporter | Action: INHIBITOR
1174,benzyl benzoate,beta-lactamase,enzyme,,Drug: benzyl benzoate | Target: beta-lactamase | Type: enzyme | Action: nan
1175,benzyl benzoate,hormone-sensitive lipase,enzyme,,Drug: benzyl benzoate | Target: hormone-sensitive lipase | Type: enzyme | Action: nan
1176,bepotastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: bepotastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
1177,bepridil,sodium channel protein type 5 subunit alpha,ion channel,,Drug: bepridil | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
1178,bepridil,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: bepridil | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1179,bepridil,voltage-dependent p/q-type calcium channel subunit alpha-1a,ion channel,BLOCKER,Drug: bepridil | Target: voltage-dependent p/q-type calcium channel subunit alpha-1a | Type: ion channel | Action: BLOCKER
1180,bepridil,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,BLOCKER,Drug: bepridil | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: BLOCKER
1181,bepridil,lethal factor,enzyme,,Drug: bepridil | Target: lethal factor | Type: enzyme | Action: nan
1182,bepridil,potassium voltage-gated channel subfamily kqt member 4,ion channel,BLOCKER,Drug: bepridil | Target: potassium voltage-gated channel subfamily kqt member 4 | Type: ion channel | Action: BLOCKER
1183,bepridil,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: bepridil | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
1184,bepridil,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: bepridil | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
1185,bepridil,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: bepridil | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
1186,bepridil,potassium channel subfamily t member 1,ion channel,GATING INHIBITOR,Drug: bepridil | Target: potassium channel subfamily t member 1 | Type: ion channel | Action: GATING INHIBITOR
1187,bepridil,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: bepridil | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
1188,bepridil,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,BLOCKER,Drug: bepridil | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: BLOCKER
1189,beraprost,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: beraprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
1190,beraprost,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: beraprost | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
1191,beraprost,prostacyclin receptor,gpcr,AGONIST,Drug: beraprost | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
1192,beraprost,prostacyclin receptor,gpcr,AGONIST,Drug: beraprost | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
1193,beraprost,prostacyclin receptor,gpcr,AGONIST,Drug: beraprost | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
1194,betacarotene,core protein,unclassified,,Drug: betacarotene | Target: core protein | Type: unclassified | Action: nan
1195,betahistine,histamine h3 receptor,gpcr,,Drug: betahistine | Target: histamine h3 receptor | Type: gpcr | Action: nan
1196,betahistine,histamine h3 receptor,gpcr,INVERSE AGONIST,Drug: betahistine | Target: histamine h3 receptor | Type: gpcr | Action: INVERSE AGONIST
1197,betamethasone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: betamethasone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
1198,betamethasone,annexin a1,cytosolic other,,Drug: betamethasone | Target: annexin a1 | Type: cytosolic other | Action: nan
1199,betamethasone acetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: betamethasone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
1200,betamethasone benzoate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: betamethasone benzoate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
1201,betamethasone dipropionate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: betamethasone dipropionate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
1202,betamethasone dipropionate,glucocorticoid receptor,transcription factor,,Drug: betamethasone dipropionate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
1203,betamethasone valerate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: betamethasone valerate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
1204,betamipron,solute carrier family 22 member 6,transporter,,Drug: betamipron | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
1205,betamipron,solute carrier family 22 member 8,transporter,,Drug: betamipron | Target: solute carrier family 22 member 8 | Type: transporter | Action: nan
1206,betaxolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: betaxolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1207,betaxolol,beta-2 adrenergic receptor,gpcr,,Drug: betaxolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1208,betaxolol,beta-2 adrenergic receptor,gpcr,,Drug: betaxolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1209,betaxolol,beta-2 adrenergic receptor,gpcr,,Drug: betaxolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1210,betaxolol,beta-1 adrenergic receptor,gpcr,,Drug: betaxolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
1211,betaxolol,beta-1 adrenergic receptor,gpcr,,Drug: betaxolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
1212,betazole,histamine h2 receptor,gpcr,AGONIST,Drug: betazole | Target: histamine h2 receptor | Type: gpcr | Action: AGONIST
1213,bethanechol,muscarinic acetylcholine receptor m1,gpcr,AGONIST,Drug: bethanechol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: AGONIST
1214,bethanechol,muscarinic acetylcholine receptor m2,gpcr,AGONIST,Drug: bethanechol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: AGONIST
1215,bethanechol,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: bethanechol | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
1216,bethanechol,muscarinic acetylcholine receptor m4,gpcr,AGONIST,Drug: bethanechol | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: AGONIST
1217,bethanechol,muscarinic acetylcholine receptor,gpcr,,Drug: bethanechol | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
1218,bethanechol,muscarinic receptor 2,gpcr,,Drug: bethanechol | Target: muscarinic receptor 2 | Type: gpcr | Action: nan
1219,betanidine,sodium-dependent noradrenaline transporter,transporter,SUBSTRATE,Drug: betanidine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: SUBSTRATE
1220,bevantolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: bevantolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1221,bexarotene,retinoic acid receptor alpha,nuclear hormone receptor,,Drug: bexarotene | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: nan
1222,bexarotene,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,ANTAGONIST,Drug: bexarotene | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: ANTAGONIST
1223,bexarotene,retinoic acid receptor rxr-alpha,nuclear hormone receptor,AGONIST,Drug: bexarotene | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: AGONIST
1224,bexarotene,retinoic acid receptor rxr-beta,nuclear hormone receptor,AGONIST,Drug: bexarotene | Target: retinoic acid receptor rxr-beta | Type: nuclear hormone receptor | Action: AGONIST
1225,bexarotene,retinoic acid receptor rxr-gamma,nuclear hormone receptor,AGONIST,Drug: bexarotene | Target: retinoic acid receptor rxr-gamma | Type: nuclear hormone receptor | Action: AGONIST
1226,bexarotene,retinoic acid receptor beta,nuclear hormone receptor,,Drug: bexarotene | Target: retinoic acid receptor beta | Type: nuclear hormone receptor | Action: nan
1227,bexarotene,retinoic acid receptor gamma,nuclear hormone receptor,,Drug: bexarotene | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: nan
1228,bexarotene,retinoic acid receptor rxr-beta,transcription factor,,Drug: bexarotene | Target: retinoic acid receptor rxr-beta | Type: transcription factor | Action: nan
1229,bexarotene,retinoic acid receptor rxr-gamma,transcription factor,,Drug: bexarotene | Target: retinoic acid receptor rxr-gamma | Type: transcription factor | Action: nan
1230,bexarotene,retinoic acid receptor rxr-alpha,transcription factor,,Drug: bexarotene | Target: retinoic acid receptor rxr-alpha | Type: transcription factor | Action: nan
1231,bexarotene,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: bexarotene | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
1232,bexarotene,cytochrome p450 26a1,enzyme,,Drug: bexarotene | Target: cytochrome p450 26a1 | Type: enzyme | Action: nan
1233,bexarotene,cytochrome p450 26b1,enzyme,,Drug: bexarotene | Target: cytochrome p450 26b1 | Type: enzyme | Action: nan
1234,bexarotene,oxysterols receptor lxr-beta,nuclear other,,Drug: bexarotene | Target: oxysterols receptor lxr-beta | Type: nuclear other | Action: nan
1235,bexarotene,oxysterols receptor lxr-alpha,nuclear other,,Drug: bexarotene | Target: oxysterols receptor lxr-alpha | Type: nuclear other | Action: nan
1236,bezafibrate,lipoprotein lipase,enzyme,,Drug: bezafibrate | Target: lipoprotein lipase | Type: enzyme | Action: nan
1237,bezafibrate,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: bezafibrate | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
1238,bezafibrate,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: bezafibrate | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
1239,bezafibrate,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: bezafibrate | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
1240,bezafibrate,"fatty acid-binding protein, intestinal",cytosolic other,,"Drug: bezafibrate | Target: fatty acid-binding protein, intestinal | Type: cytosolic other | Action: nan"
1241,bezafibrate,"fatty acid-binding protein, liver",unclassified,,"Drug: bezafibrate | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
1242,bezafibrate,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: bezafibrate | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
1243,biapenem,penicillin-binding protein 2,enzyme,,Drug: biapenem | Target: penicillin-binding protein 2 | Type: enzyme | Action: nan
1244,biapenem,penicillin-binding protein 4,enzyme,,Drug: biapenem | Target: penicillin-binding protein 4 | Type: enzyme | Action: nan
1245,biapenem,d-ala-d-ala-carboxypeptidase; d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase family protein; penicillin-binding protein 5,enzyme,,Drug: biapenem | Target: d-ala-d-ala-carboxypeptidase; d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase family protein; penicillin-binding protein 5 | Type: enzyme | Action: nan
1246,biapenem,penicillin-binding protein 1,enzyme,,Drug: biapenem | Target: penicillin-binding protein 1 | Type: enzyme | Action: nan
1247,biapenem,d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase penicillin-binding protein 6,enzyme,,Drug: biapenem | Target: d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase penicillin-binding protein 6 | Type: enzyme | Action: nan
1248,bicalutamide,androgen receptor,nuclear hormone receptor,ANTAGONIST,Drug: bicalutamide | Target: androgen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
1249,bicalutamide,cytochrome p450 2c19,enzyme,,Drug: bicalutamide | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
1250,bicalutamide,androgen receptor,transcription factor,,Drug: bicalutamide | Target: androgen receptor | Type: transcription factor | Action: nan
1251,bicalutamide,androgen receptor,transcription factor,,Drug: bicalutamide | Target: androgen receptor | Type: transcription factor | Action: nan
1252,bicalutamide,progesterone receptor,transcription factor,,Drug: bicalutamide | Target: progesterone receptor | Type: transcription factor | Action: nan
1253,bicalutamide,progesterone receptor,transcription factor,,Drug: bicalutamide | Target: progesterone receptor | Type: transcription factor | Action: nan
1254,bifemelane,lethal(3)malignant brain tumor-like protein 1,unclassified,,Drug: bifemelane | Target: lethal(3)malignant brain tumor-like protein 1 | Type: unclassified | Action: nan
1255,bifonazole,cytochrome p450 3a4,enzyme,,Drug: bifonazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
1256,bifonazole,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,,"Drug: bifonazole | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: nan"
1257,bifonazole,lanosterol 14-alpha demethylase,enzyme,,Drug: bifonazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
1258,bifonazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: bifonazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
1259,bimatoprost,aldo-keto reductase family 1 member c3,enzyme,,Drug: bimatoprost | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
1260,bimatoprost,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: bimatoprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
1261,biotin,insulin-degrading enzyme,enzyme,,Drug: biotin | Target: insulin-degrading enzyme | Type: enzyme | Action: nan
1262,biperiden,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: biperiden | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
1263,biperiden,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: biperiden | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
1264,biperiden,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: biperiden | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
1265,biperiden,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: biperiden | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
1266,biperiden,muscarinic acetylcholine receptor m5,gpcr,,Drug: biperiden | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
1267,biperiden,neuronal acetylcholine receptor subunit alpha-2,ion channel,,Drug: biperiden | Target: neuronal acetylcholine receptor subunit alpha-2 | Type: ion channel | Action: nan
1268,bisacodyl,sodium-dependent dopamine transporter,transporter,,Drug: bisacodyl | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1269,bisacodyl,kappa-type opioid receptor,gpcr,,Drug: bisacodyl | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
1270,bisacodyl,cytochrome p450 2c9,enzyme,,Drug: bisacodyl | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
1271,bisantrene,nad(p)h dehydrogenase [quinone] 1,enzyme,,Drug: bisantrene | Target: nad(p)h dehydrogenase [quinone] 1 | Type: enzyme | Action: nan
1272,bisoprolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: bisoprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1273,bisoprolol,beta-2 adrenergic receptor,gpcr,,Drug: bisoprolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1274,bisoprolol,beta-3 adrenergic receptor,gpcr,,Drug: bisoprolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
1275,bisoprolol,beta-1 adrenergic receptor,gpcr,,Drug: bisoprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
1277,bisulepine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: bisulepine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
1278,bitolterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: bitolterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
1279,bivalirudin,prothrombin,enzyme,INHIBITOR,Drug: bivalirudin | Target: prothrombin | Type: enzyme | Action: INHIBITOR
1280,blonanserin,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: blonanserin | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1281,blonanserin,alpha-1a adrenergic receptor,gpcr,,Drug: blonanserin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1282,blonanserin,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: blonanserin | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
1283,blonanserin,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: blonanserin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
1284,bopindolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: bopindolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1285,bopindolol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: bopindolol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1286,bopindolol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: bopindolol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
1287,bopindolol,beta-3 adrenergic receptor,gpcr,,Drug: bopindolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
1288,bopindolol,cytochrome p450 2d6,enzyme,,Drug: bopindolol | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1289,bopindolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: bopindolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1290,bopindolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: bopindolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1291,bopindolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: bopindolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1292,bortezomib,carbonic anhydrase 2,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1293,bortezomib,carbonic anhydrase 1,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
1294,bortezomib,carbonic anhydrase 4,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
1295,bortezomib,carbonic anhydrase 9,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
1296,bortezomib,carbonic anhydrase 12,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
1297,bortezomib,prothrombin,enzyme,,Drug: bortezomib | Target: prothrombin | Type: enzyme | Action: nan
1298,bortezomib,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: bortezomib | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
1299,bortezomib,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: bortezomib | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
1300,bortezomib,carbonic anhydrase 7,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
1301,bortezomib,cytochrome p450 2c19,enzyme,,Drug: bortezomib | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
1302,bortezomib,26s proteasome non-atpase regulatory subunit 1,cytosolic other,,Drug: bortezomib | Target: 26s proteasome non-atpase regulatory subunit 1 | Type: cytosolic other | Action: nan
1303,bortezomib,proteasome subunit alpha type-1,enzyme,INHIBITOR,Drug: bortezomib | Target: proteasome subunit alpha type-1 | Type: enzyme | Action: INHIBITOR
1304,bortezomib,neutrophil elastase,enzyme,,Drug: bortezomib | Target: neutrophil elastase | Type: enzyme | Action: nan
1305,bortezomib,carbonic anhydrase 3,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
1306,bortezomib,carbonic anhydrase 6,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
1307,bortezomib,cathepsin g,enzyme,,Drug: bortezomib | Target: cathepsin g | Type: enzyme | Action: nan
1308,bortezomib,carbonic anhydrase 14,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
1309,bortezomib,chymase,enzyme,,Drug: bortezomib | Target: chymase | Type: enzyme | Action: nan
1310,bortezomib,chymotrypsinogen b,enzyme,,Drug: bortezomib | Target: chymotrypsinogen b | Type: enzyme | Action: nan
1311,bortezomib,proteasome subunit beta type-8,enzyme,INHIBITOR,Drug: bortezomib | Target: proteasome subunit beta type-8 | Type: enzyme | Action: INHIBITOR
1312,bortezomib,lysosomal protective protein,enzyme,,Drug: bortezomib | Target: lysosomal protective protein | Type: enzyme | Action: nan
1313,bortezomib,carbonic anhydrase 13,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
1314,bortezomib,carbonic anhydrase 15,enzyme,,Drug: bortezomib | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
1315,bortezomib,proteasome subunit beta type-1,enzyme,INHIBITOR,Drug: bortezomib | Target: proteasome subunit beta type-1 | Type: enzyme | Action: INHIBITOR
1316,bortezomib,proteasome subunit beta type-2,enzyme,INHIBITOR,Drug: bortezomib | Target: proteasome subunit beta type-2 | Type: enzyme | Action: INHIBITOR
1317,bortezomib,proteasome subunit beta type-5,enzyme,INHIBITOR,Drug: bortezomib | Target: proteasome subunit beta type-5 | Type: enzyme | Action: INHIBITOR
1318,bortezomib,beta-carbonic anhydrase 1,enzyme,,Drug: bortezomib | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
1319,bortezomib,ph and sec7 domain-containing protein 1,unclassified,,Drug: bortezomib | Target: ph and sec7 domain-containing protein 1 | Type: unclassified | Action: nan
1320,bortezomib,nuclear factor nf-kappa-b complex,transcription factor,,Drug: bortezomib | Target: nuclear factor nf-kappa-b complex | Type: transcription factor | Action: nan
1321,bortezomib,alpha-chymotrypsin,enzyme,,Drug: bortezomib | Target: alpha-chymotrypsin | Type: enzyme | Action: nan
1322,bortezomib,proteasome subunit beta,enzyme,,Drug: bortezomib | Target: proteasome subunit beta | Type: enzyme | Action: nan
1323,bortezomib,proteasome subunit beta type-8,enzyme,,Drug: bortezomib | Target: proteasome subunit beta type-8 | Type: enzyme | Action: nan
1324,bortezomib,proteasome subunit beta type-9,enzyme,,Drug: bortezomib | Target: proteasome subunit beta type-9 | Type: enzyme | Action: nan
1325,bortezomib,proteasome subunit beta type-10,enzyme,,Drug: bortezomib | Target: proteasome subunit beta type-10 | Type: enzyme | Action: nan
1326,bosentan,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: bosentan | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
1327,bosentan,bile salt export pump,transporter,,Drug: bosentan | Target: bile salt export pump | Type: transporter | Action: nan
1328,bosentan,endothelin-1 receptor,gpcr,ANTAGONIST,Drug: bosentan | Target: endothelin-1 receptor | Type: gpcr | Action: ANTAGONIST
1329,bosentan,endothelin b receptor,gpcr,ANTAGONIST,Drug: bosentan | Target: endothelin b receptor | Type: gpcr | Action: ANTAGONIST
1330,bosentan,endothelin-1 receptor,gpcr,,Drug: bosentan | Target: endothelin-1 receptor | Type: gpcr | Action: nan
1331,bosentan,endothelin-1 receptor,gpcr,,Drug: bosentan | Target: endothelin-1 receptor | Type: gpcr | Action: nan
1332,bosentan,bile salt export pump,transporter,,Drug: bosentan | Target: bile salt export pump | Type: transporter | Action: nan
1333,bosentan,endothelin b receptor,gpcr,,Drug: bosentan | Target: endothelin b receptor | Type: gpcr | Action: nan
1334,bretylium,beta-1 adrenergic receptor,gpcr,,Drug: bretylium | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
1335,bretylium,beta-2 adrenergic receptor,gpcr,,Drug: bretylium | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1336,bretylium,sodium-dependent noradrenaline transporter,transporter,SUBSTRATE,Drug: bretylium | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: SUBSTRATE
1337,brimonidine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: brimonidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
1338,brimonidine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: brimonidine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1339,brimonidine,alpha-1a adrenergic receptor,gpcr,,Drug: brimonidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1340,brimonidine,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: brimonidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
1341,brimonidine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: brimonidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
1342,brimonidine,alpha-1d adrenergic receptor,gpcr,,Drug: brimonidine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
1343,brimonidine,alpha-1b adrenergic receptor,gpcr,,Drug: brimonidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1344,brimonidine,alpha-2b adrenergic receptor,gpcr,,Drug: brimonidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
1345,brimonidine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: brimonidine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1346,brimonidine,alpha-1a adrenergic receptor,gpcr,,Drug: brimonidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1347,brimonidine,adrenergic receptor alpha-2,gpcr,,Drug: brimonidine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
1348,brimonidine,adrenergic receptor alpha-1,gpcr,,Drug: brimonidine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
1349,brimonidine,alpha-1b adrenergic receptor,gpcr,,Drug: brimonidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1350,brinzolamide,carbonic anhydrase 2,enzyme,INHIBITOR,Drug: brinzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: INHIBITOR
1351,brinzolamide,carbonic anhydrase 1,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
1352,brinzolamide,carbonic anhydrase 4,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
1353,brinzolamide,carbonic anhydrase 9,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
1354,brinzolamide,carbonic anhydrase 12,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
1355,brinzolamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: brinzolamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
1356,brinzolamide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: brinzolamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
1357,brinzolamide,carbonic anhydrase 7,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
1358,brinzolamide,carbonic anhydrase,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
1359,brinzolamide,carbonic anhydrase 6,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
1360,brinzolamide,carbonic anhydrase 14,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
1361,brinzolamide,carbonic anhydrase 13,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
1362,brinzolamide,carbonic anhydrase 4,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
1363,brinzolamide,carbonic anhydrase 13,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
1364,brinzolamide,carbonic anhydrase 15,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
1365,brinzolamide,carbonic anhydrase,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
1366,brinzolamide,carbonic anhydrase,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
1367,brinzolamide,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: brinzolamide | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
1368,brinzolamide,carbonic anhydrase,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
1369,brinzolamide,alpha carbonic anhydrase,enzyme,,Drug: brinzolamide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
1370,brinzolamide,carbonic anhydrase,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
1371,brinzolamide,carbonic anhydrase 2,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1372,brinzolamide,astrosclerin-3,enzyme,,Drug: brinzolamide | Target: astrosclerin-3 | Type: enzyme | Action: nan
1373,brinzolamide,beta-carbonic anhydrase 1,enzyme,,Drug: brinzolamide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
1374,brinzolamide,delta carbonic anhydrase,unclassified,,Drug: brinzolamide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
1375,brinzolamide,carbonic anhydrase 2,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1376,brinzolamide,carbonic anhydrase,enzyme,,Drug: brinzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
1377,brinzolamide,"carbonic anhydrase, alpha family",unclassified,,"Drug: brinzolamide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
1378,brinzolamide,carbonate dehydratase,enzyme,,Drug: brinzolamide | Target: carbonate dehydratase | Type: enzyme | Action: nan
1379,brivudine,thymidine kinase,kinase,,Drug: brivudine | Target: thymidine kinase | Type: kinase | Action: nan
1380,brivudine,"thymidine kinase, cytosolic",kinase,,"Drug: brivudine | Target: thymidine kinase, cytosolic | Type: kinase | Action: nan"
1381,brivudine,thymidine kinase,kinase,,Drug: brivudine | Target: thymidine kinase | Type: kinase | Action: nan
1382,brivudine,thymidine kinase,kinase,,Drug: brivudine | Target: thymidine kinase | Type: kinase | Action: nan
1383,brodimoprim,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: brodimoprim | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
1384,brodimoprim,dihydrofolate reductase,enzyme,,Drug: brodimoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
1385,brodimoprim,dihydrofolate reductase,enzyme,,Drug: brodimoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
1386,brodimoprim,dihydrofolate reductase,enzyme,,Drug: brodimoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
1387,brodimoprim,dihydrofolate reductase,enzyme,,Drug: brodimoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
1388,brodimoprim,dihydrofolate reductase,enzyme,,Drug: brodimoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
1389,brodimoprim,dihydrofolate reductase,enzyme,,Drug: brodimoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
1390,brodimoprim,dihydrofolate reductase,enzyme,,Drug: brodimoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
1391,bromazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: bromazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
1392,bromfenac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: bromfenac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
1393,bromfenac,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: bromfenac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
1394,bromfenac,cyclooxygenase,enzyme,,Drug: bromfenac | Target: cyclooxygenase | Type: enzyme | Action: nan
1395,bromhexine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: bromhexine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1396,bromhexine,sodium-dependent serotonin transporter,transporter,,Drug: bromhexine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1397,bromhexine,cytochrome p450 2d6,enzyme,,Drug: bromhexine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1398,bromhexine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: bromhexine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
1399,bromocriptine,beta-1 adrenergic receptor,gpcr,,Drug: bromocriptine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
1400,bromocriptine,beta-2 adrenergic receptor,gpcr,,Drug: bromocriptine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1401,bromocriptine,d(1a) dopamine receptor,gpcr,AGONIST,Drug: bromocriptine | Target: d(1a) dopamine receptor | Type: gpcr | Action: AGONIST
1402,bromocriptine,d(2) dopamine receptor,gpcr,AGONIST,Drug: bromocriptine | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
1403,bromocriptine,alpha-2a adrenergic receptor,gpcr,,Drug: bromocriptine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
1404,bromocriptine,cytochrome p450 3a4,enzyme,,Drug: bromocriptine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
1405,bromocriptine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1406,bromocriptine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1407,bromocriptine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
1408,bromocriptine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
1409,bromocriptine,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
1410,bromocriptine,alpha-1a adrenergic receptor,gpcr,,Drug: bromocriptine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1411,bromocriptine,alpha-2b adrenergic receptor,gpcr,,Drug: bromocriptine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
1412,bromocriptine,d(3) dopamine receptor,gpcr,AGONIST,Drug: bromocriptine | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
1413,bromocriptine,d(1b) dopamine receptor,gpcr,AGONIST,Drug: bromocriptine | Target: d(1b) dopamine receptor | Type: gpcr | Action: AGONIST
1414,bromocriptine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
1415,bromocriptine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
1416,bromocriptine,alpha-2c adrenergic receptor,gpcr,,Drug: bromocriptine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
1417,bromocriptine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: bromocriptine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
1418,bromocriptine,alpha-1d adrenergic receptor,gpcr,,Drug: bromocriptine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
1419,bromocriptine,alpha-1b adrenergic receptor,gpcr,,Drug: bromocriptine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1420,bromocriptine,androgen receptor,transcription factor,,Drug: bromocriptine | Target: androgen receptor | Type: transcription factor | Action: nan
1421,bromocriptine,alpha-1b adrenergic receptor,gpcr,,Drug: bromocriptine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1422,bromocriptine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
1423,bromocriptine,alpha-1a adrenergic receptor,gpcr,,Drug: bromocriptine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1424,bromocriptine,d(2) dopamine receptor,gpcr,,Drug: bromocriptine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1425,bromocriptine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1426,bromocriptine,5-hydroxytryptamine receptor 7,gpcr,AGONIST,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: AGONIST
1427,bromocriptine,vesicular glutamate transporter 3,transporter,,Drug: bromocriptine | Target: vesicular glutamate transporter 3 | Type: transporter | Action: nan
1428,bromocriptine,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: bromocriptine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
1429,bromocriptine,adrenergic receptor alpha-2,gpcr,,Drug: bromocriptine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
1430,bromocriptine,dopamine receptor,gpcr,,Drug: bromocriptine | Target: dopamine receptor | Type: gpcr | Action: nan
1431,bromocriptine,cerebral cortex alpha adrenergic receptor,gpcr,,Drug: bromocriptine | Target: cerebral cortex alpha adrenergic receptor | Type: gpcr | Action: nan
1432,bromazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: bromazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
1433,bromopride,d(2) dopamine receptor,gpcr,,Drug: bromopride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1434,bromopride,acetylcholinesterase,enzyme,,Drug: bromopride | Target: acetylcholinesterase | Type: enzyme | Action: nan
1435,bromperidol,d(1a) dopamine receptor,gpcr,,Drug: bromperidol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
1436,bromperidol,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: bromperidol | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
1437,bromperidol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: bromperidol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1438,bromperidol,alpha-1a adrenergic receptor,gpcr,,Drug: bromperidol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1439,bromperidol,d(3) dopamine receptor,gpcr,,Drug: bromperidol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1440,bromperidol,histamine h1 receptor,gpcr,,Drug: bromperidol | Target: histamine h1 receptor | Type: gpcr | Action: nan
1441,bromperidol,muscarinic acetylcholine receptor m1,gpcr,,Drug: bromperidol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1442,bromperidol,muscarinic acetylcholine receptor m2,gpcr,,Drug: bromperidol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1443,bromperidol,muscarinic acetylcholine receptor m3,gpcr,,Drug: bromperidol | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
1444,bromperidol,muscarinic acetylcholine receptor m4,gpcr,,Drug: bromperidol | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
1445,bromperidol,muscarinic acetylcholine receptor m5,gpcr,,Drug: bromperidol | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
1446,bromperidol,d(4) dopamine receptor,gpcr,,Drug: bromperidol | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
1447,brompheniramine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: brompheniramine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1448,brompheniramine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: brompheniramine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
1449,brompheniramine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: brompheniramine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
1450,brotizolam,platelet-activating factor receptor,gpcr,,Drug: brotizolam | Target: platelet-activating factor receptor | Type: gpcr | Action: nan
1451,broxyquinoline,catechol o-methyltransferase,enzyme,,Drug: broxyquinoline | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
1452,buclizine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: buclizine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
1453,budesonide,multidrug resistance protein 1,transporter,,Drug: budesonide | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
1454,budesonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: budesonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
1455,budesonide,interleukin-5,cytokine,,Drug: budesonide | Target: interleukin-5 | Type: cytokine | Action: nan
1456,budesonide,interferon gamma,cytokine,,Drug: budesonide | Target: interferon gamma | Type: cytokine | Action: nan
1457,budesonide,mineralocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: budesonide | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
1458,budesonide,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: budesonide | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
1459,budesonide,matrix metalloproteinase-9,enzyme,,Drug: budesonide | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
1460,budesonide,androgen receptor,transcription factor,,Drug: budesonide | Target: androgen receptor | Type: transcription factor | Action: nan
1461,budesonide,progesterone receptor,transcription factor,,Drug: budesonide | Target: progesterone receptor | Type: transcription factor | Action: nan
1462,budesonide,glucocorticoid receptor,transcription factor,,Drug: budesonide | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
1463,budesonide,interleukin-5,unclassified,,Drug: budesonide | Target: interleukin-5 | Type: unclassified | Action: nan
1464,budipine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: budipine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1465,budipine,glutamate [nmda] receptor,ion channel,,Drug: budipine | Target: glutamate [nmda] receptor | Type: ion channel | Action: nan
1466,buflomedil,alpha-2a adrenergic receptor,gpcr,,Drug: buflomedil | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
1467,buflomedil,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: buflomedil | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1468,buflomedil,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: buflomedil | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
1469,buflomedil,alpha-1a adrenergic receptor,gpcr,,Drug: buflomedil | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1470,buflomedil,alpha-2c adrenergic receptor,gpcr,,Drug: buflomedil | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
1471,buflomedil,alpha-1d adrenergic receptor,gpcr,,Drug: buflomedil | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
1472,buflomedil,alpha-1b adrenergic receptor,gpcr,,Drug: buflomedil | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1473,buflomedil,voltage-dependent calcium channel gamma-1 subunit,ion channel,,Drug: buflomedil | Target: voltage-dependent calcium channel gamma-1 subunit | Type: ion channel | Action: nan
1474,buflomedil,c-8 sterol isomerase,enzyme,,Drug: buflomedil | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
1475,bufuralol,beta-1 adrenergic receptor,gpcr,,Drug: bufuralol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
1476,bufuralol,beta-2 adrenergic receptor,gpcr,,Drug: bufuralol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1477,bufuralol,multidrug resistance protein 1,transporter,,Drug: bufuralol | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
1478,bufuralol,cytochrome p450 2d6,enzyme,,Drug: bufuralol | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1479,bumetanide,solute carrier family 12 member 1,transporter,INHIBITOR,Drug: bumetanide | Target: solute carrier family 12 member 1 | Type: transporter | Action: INHIBITOR
1480,bumetanide,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: bumetanide | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
1481,bumetanide,solute carrier family 12 member 2,transporter,INHIBITOR,Drug: bumetanide | Target: solute carrier family 12 member 2 | Type: transporter | Action: INHIBITOR
1482,bumetanide,g-protein coupled receptor 35,gpcr,AGONIST,Drug: bumetanide | Target: g-protein coupled receptor 35 | Type: gpcr | Action: AGONIST
1483,bunazosin,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: bunazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1484,bunazosin,alpha-2b adrenergic receptor,gpcr,,Drug: bunazosin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
1485,bunazosin,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: bunazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1486,bunazosin,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: bunazosin | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
1487,levobunolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: levobunolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1488,levobunolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: levobunolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1489,levobunolol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: levobunolol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1490,levobunolol,sodium-dependent serotonin transporter,transporter,,Drug: levobunolol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1491,levobunolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: levobunolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1492,levobunolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: levobunolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1493,levobunolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: levobunolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1494,levobunolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: levobunolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1495,levobunolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: levobunolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1496,bupivacaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: bupivacaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
1497,bupivacaine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: bupivacaine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1498,bupivacaine,sodium channel protein type 1 subunit alpha,ion channel,,Drug: bupivacaine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: nan
1499,bupivacaine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: bupivacaine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
1500,bupivacaine,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: bupivacaine | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
1501,bupivacaine,cytochrome p450 2d6,enzyme,,Drug: bupivacaine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1502,bupivacaine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: bupivacaine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
1503,bupivacaine,potassium voltage-gated channel subfamily d member 3,ion channel,,Drug: bupivacaine | Target: potassium voltage-gated channel subfamily d member 3 | Type: ion channel | Action: nan
1504,bupivacaine,potassium voltage-gated channel subfamily a member 5,ion channel,BLOCKER,Drug: bupivacaine | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: BLOCKER
1505,bupivacaine,potassium channel subfamily k member 3,ion channel,,Drug: bupivacaine | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: nan
1506,bupivacaine,potassium voltage-gated channel subfamily d member 3,ion channel,BLOCKER,Drug: bupivacaine | Target: potassium voltage-gated channel subfamily d member 3 | Type: ion channel | Action: BLOCKER
1508,bupranolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: bupranolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1509,bupranolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: bupranolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1510,bupranolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: bupranolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1511,buprenorphine,mu-type opioid receptor,gpcr,PARTIAL AGONIST,Drug: buprenorphine | Target: mu-type opioid receptor | Type: gpcr | Action: PARTIAL AGONIST
1512,buprenorphine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: buprenorphine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1513,buprenorphine,kappa-type opioid receptor,gpcr,ANTAGONIST,Drug: buprenorphine | Target: kappa-type opioid receptor | Type: gpcr | Action: ANTAGONIST
1514,buprenorphine,delta-type opioid receptor,gpcr,ANTAGONIST,Drug: buprenorphine | Target: delta-type opioid receptor | Type: gpcr | Action: ANTAGONIST
1515,buprenorphine,nociceptin receptor,gpcr,,Drug: buprenorphine | Target: nociceptin receptor | Type: gpcr | Action: nan
1516,buprenorphine,mu-type opioid receptor,gpcr,,Drug: buprenorphine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
1517,buprenorphine,mu-type opioid receptor,gpcr,,Drug: buprenorphine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
1518,buprenorphine,delta-type opioid receptor,gpcr,,Drug: buprenorphine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
1519,buprenorphine,kappa-type opioid receptor,gpcr,,Drug: buprenorphine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
1520,bupropion,sodium-dependent serotonin transporter,transporter,,Drug: bupropion | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1521,bupropion,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: bupropion | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
1522,bupropion,alpha-1a adrenergic receptor,gpcr,,Drug: bupropion | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1523,bupropion,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: bupropion | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
1524,bupropion,cytochrome p450 2d6,enzyme,,Drug: bupropion | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1525,bupropion,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: bupropion | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
1526,bupropion,cytochrome p450 2c19,enzyme,,Drug: bupropion | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
1527,bupropion,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: bupropion | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
1528,bupropion,sodium-dependent dopamine transporter,transporter,,Drug: bupropion | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1529,bupropion,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: bupropion | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
1530,bupropion,neuronal acetylcholine receptor; alpha3/beta2,ion channel,,Drug: bupropion | Target: neuronal acetylcholine receptor; alpha3/beta2 | Type: ion channel | Action: nan
1531,buserelin,lutropin-choriogonadotropic hormone receptor,gpcr,,Drug: buserelin | Target: lutropin-choriogonadotropic hormone receptor | Type: gpcr | Action: nan
1532,buserelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: buserelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
1533,buserelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: buserelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
1534,buspirone,d(2) dopamine receptor,gpcr,,Drug: buspirone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1535,buspirone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: buspirone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1536,buspirone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: buspirone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1537,buspirone,cytochrome p450 3a4,enzyme,,Drug: buspirone | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
1538,buspirone,5-hydroxytryptamine receptor 1a,gpcr,PARTIAL AGONIST,Drug: buspirone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: PARTIAL AGONIST
1539,buspirone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: buspirone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1540,buspirone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: buspirone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
1541,buspirone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: buspirone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
1542,buspirone,alpha-1a adrenergic receptor,gpcr,,Drug: buspirone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1543,buspirone,d(3) dopamine receptor,gpcr,,Drug: buspirone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1544,buspirone,d(4) dopamine receptor,gpcr,,Drug: buspirone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
1545,buspirone,alpha-1d adrenergic receptor,gpcr,,Drug: buspirone | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
1546,buspirone,5-hydroxytryptamine receptor 1b,gpcr,,Drug: buspirone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
1547,buspirone,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: buspirone | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
1548,buspirone,d(2) dopamine receptor,gpcr,,Drug: buspirone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1549,buspirone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: buspirone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1550,buspirone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: buspirone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1551,buspirone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: buspirone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1552,buspirone,5-hydroxytryptamine receptor 7,gpcr,AGONIST,Drug: buspirone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: AGONIST
1553,buspirone,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: buspirone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
1554,buspirone,d(1a) dopamine receptor,gpcr,,Drug: buspirone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
1555,buspirone,d(2) dopamine receptor,gpcr,,Drug: buspirone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1556,buspirone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: buspirone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
1557,buspirone,alpha-1a adrenergic receptor,gpcr,,Drug: buspirone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1558,buspirone,alpha-2a adrenergic receptor,gpcr,,Drug: buspirone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
1559,buspirone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: buspirone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1560,buspirone,solute carrier family 22 member 2,transporter,,Drug: buspirone | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
1561,buspirone,multidrug and toxin extrusion protein 1,transporter,,Drug: buspirone | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
1562,buspirone,multidrug and toxin extrusion protein 2,transporter,,Drug: buspirone | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
1563,buspirone,serotonin 1 (5-ht1) receptor,gpcr,,Drug: buspirone | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
1564,buspirone,adrenergic receptor alpha-2,gpcr,,Drug: buspirone | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
1565,buspirone,dopamine receptor,gpcr,,Drug: buspirone | Target: dopamine receptor | Type: gpcr | Action: nan
1566,buspirone,adrenergic receptor alpha-1,gpcr,,Drug: buspirone | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
1567,buspirone,serotonin 2 (5-ht2) receptor,gpcr,,Drug: buspirone | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
1568,busulfan,matrix metalloproteinase-9,enzyme,,Drug: busulfan | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
1569,secbutabarbital,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: secbutabarbital | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
1570,butalbital,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: butalbital | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
1571,butenafine,alpha-2a adrenergic receptor,gpcr,,Drug: butenafine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
1572,butenafine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: butenafine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1573,butenafine,sodium-dependent serotonin transporter,transporter,,Drug: butenafine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1574,butenafine,sodium-dependent noradrenaline transporter,transporter,,Drug: butenafine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
1575,butenafine,cytochrome p450 2d6,enzyme,,Drug: butenafine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1576,butenafine,acetylcholinesterase,enzyme,,Drug: butenafine | Target: acetylcholinesterase | Type: enzyme | Action: nan
1577,butenafine,squalene epoxidase,enzyme,INHIBITOR,Drug: butenafine | Target: squalene epoxidase | Type: enzyme | Action: INHIBITOR
1578,butenafine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: butenafine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
1579,butenafine,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,,Drug: butenafine | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: nan
1580,butenafine,squalene monooxygenase,enzyme,,Drug: butenafine | Target: squalene monooxygenase | Type: enzyme | Action: nan
1581,butoconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: butoconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
1582,butorphanol,mu-type opioid receptor,gpcr,PARTIAL AGONIST,Drug: butorphanol | Target: mu-type opioid receptor | Type: gpcr | Action: PARTIAL AGONIST
1583,butorphanol,kappa-type opioid receptor,gpcr,PARTIAL AGONIST,Drug: butorphanol | Target: kappa-type opioid receptor | Type: gpcr | Action: PARTIAL AGONIST
1584,butorphanol,delta-type opioid receptor,gpcr,,Drug: butorphanol | Target: delta-type opioid receptor | Type: gpcr | Action: nan
1585,butriptyline,sodium-dependent serotonin transporter,transporter,,Drug: butriptyline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1586,butriptyline,sodium-dependent noradrenaline transporter,transporter,,Drug: butriptyline | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
1587,butriptyline,sodium-dependent dopamine transporter,transporter,,Drug: butriptyline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1588,scopolamine butylbromide,muscarinic acetylcholine receptor m1,gpcr,,Drug: scopolamine butylbromide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1589,scopolamine butylbromide,muscarinic acetylcholine receptor m2,gpcr,,Drug: scopolamine butylbromide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1590,scopolamine butylbromide,muscarinic acetylcholine receptor m3,gpcr,,Drug: scopolamine butylbromide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
1591,scopolamine butylbromide,muscarinic acetylcholine receptor m4,gpcr,,Drug: scopolamine butylbromide | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
1592,cabergoline,d(1a) dopamine receptor,gpcr,AGONIST,Drug: cabergoline | Target: d(1a) dopamine receptor | Type: gpcr | Action: AGONIST
1593,cabergoline,d(2) dopamine receptor,gpcr,AGONIST,Drug: cabergoline | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
1594,cabergoline,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: cabergoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1595,cabergoline,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: cabergoline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
1596,cabergoline,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: cabergoline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
1597,cabergoline,5-hydroxytryptamine receptor 2b,gpcr,,Drug: cabergoline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
1598,cabergoline,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: cabergoline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
1599,cabergoline,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: cabergoline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1600,cabergoline,alpha-2b adrenergic receptor,gpcr,ANTAGONIST,Drug: cabergoline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1601,cabergoline,d(3) dopamine receptor,gpcr,AGONIST,Drug: cabergoline | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
1602,cabergoline,d(1b) dopamine receptor,gpcr,AGONIST,Drug: cabergoline | Target: d(1b) dopamine receptor | Type: gpcr | Action: AGONIST
1603,cabergoline,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: cabergoline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
1604,cabergoline,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: cabergoline | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
1605,cabergoline,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: cabergoline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1606,cabergoline,d(4) dopamine receptor,gpcr,AGONIST,Drug: cabergoline | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
1607,cabergoline,alpha-1d adrenergic receptor,gpcr,,Drug: cabergoline | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
1608,cabergoline,alpha-1b adrenergic receptor,gpcr,,Drug: cabergoline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1609,cadralazine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: cadralazine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
1610,cadralazine,myeloperoxidase,enzyme,,Drug: cadralazine | Target: myeloperoxidase | Type: enzyme | Action: nan
1611,caffeine,adenosine receptor a2a,gpcr,ANTAGONIST,Drug: caffeine | Target: adenosine receptor a2a | Type: gpcr | Action: ANTAGONIST
1612,caffeine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: caffeine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1613,caffeine,adenosine receptor a1,gpcr,ANTAGONIST,Drug: caffeine | Target: adenosine receptor a1 | Type: gpcr | Action: ANTAGONIST
1614,caffeine,adenosine receptor a2b,gpcr,ANTAGONIST,Drug: caffeine | Target: adenosine receptor a2b | Type: gpcr | Action: ANTAGONIST
1615,caffeine,adenosine receptor a3,gpcr,ANTAGONIST,Drug: caffeine | Target: adenosine receptor a3 | Type: gpcr | Action: ANTAGONIST
1616,caffeine,acetylcholinesterase,enzyme,,Drug: caffeine | Target: acetylcholinesterase | Type: enzyme | Action: nan
1617,caffeine,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,,"Drug: caffeine | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: nan"
1618,caffeine,"glycogen phosphorylase, muscle form",enzyme,,"Drug: caffeine | Target: glycogen phosphorylase, muscle form | Type: enzyme | Action: nan"
1619,caffeine,adenosine receptor a1,gpcr,,Drug: caffeine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
1620,caffeine,adenosine receptor a2a,gpcr,,Drug: caffeine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
1621,caffeine,adenosine receptor a1,gpcr,,Drug: caffeine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
1622,caffeine,adenosine receptor a1,gpcr,,Drug: caffeine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
1623,caffeine,adenosine a2 receptor,gpcr,,Drug: caffeine | Target: adenosine a2 receptor | Type: gpcr | Action: nan
1624,caffeine,adenosine receptor,gpcr,,Drug: caffeine | Target: adenosine receptor | Type: gpcr | Action: nan
1625,caffeine,guanine deaminase,enzyme,,Drug: caffeine | Target: guanine deaminase | Type: enzyme | Action: nan
1626,caffeine,adenosine a2a receptor,gpcr,,Drug: caffeine | Target: adenosine a2a receptor | Type: gpcr | Action: nan
1627,caffeine,adenosine receptor a2b,gpcr,ANTAGONIST,Drug: caffeine | Target: adenosine receptor a2b | Type: gpcr | Action: ANTAGONIST
1628,calcifediol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: calcifediol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
1629,calcipotriene,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: calcipotriene | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
1630,calcitriol,"25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial",enzyme,,"Drug: calcitriol | Target: 25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial | Type: enzyme | Action: nan"
1631,calcitriol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: calcitriol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
1632,calcitriol,vitamin d 25-hydroxylase,enzyme,,Drug: calcitriol | Target: vitamin d 25-hydroxylase | Type: enzyme | Action: nan
1633,calcitriol,vitamin d-binding protein,secreted,,Drug: calcitriol | Target: vitamin d-binding protein | Type: secreted | Action: nan
1634,calcitriol,vitamin d3 receptor,transcription factor,,Drug: calcitriol | Target: vitamin d3 receptor | Type: transcription factor | Action: nan
1635,calcitriol,vitamin d3 receptor,transcription factor,,Drug: calcitriol | Target: vitamin d3 receptor | Type: transcription factor | Action: nan
1636,calcitriol,vitamin d3 receptor,transcription factor,,Drug: calcitriol | Target: vitamin d3 receptor | Type: transcription factor | Action: nan
1637,calcitriol,vitamin d3 receptor,nuclear hormone receptor,,Drug: calcitriol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: nan
1638,calcitriol,vitamin d3 receptor a,nuclear hormone receptor,,Drug: calcitriol | Target: vitamin d3 receptor a | Type: nuclear hormone receptor | Action: nan
1639,camphor,acetylcholinesterase,enzyme,,Drug: camphor | Target: acetylcholinesterase | Type: enzyme | Action: nan
1640,camphor,transient receptor potential cation channel subfamily a member 1,ion channel,GATING INHIBITOR,Drug: camphor | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: GATING INHIBITOR
1641,camostat,prothrombin,enzyme,,Drug: camostat | Target: prothrombin | Type: enzyme | Action: nan
1642,camostat,trypsin-1,enzyme,INHIBITOR,Drug: camostat | Target: trypsin-1 | Type: enzyme | Action: INHIBITOR
1643,camostat,kallikrein-1,enzyme,,Drug: camostat | Target: kallikrein-1 | Type: enzyme | Action: nan
1644,camostat,plasminogen,enzyme,,Drug: camostat | Target: plasminogen | Type: enzyme | Action: nan
1645,camostat,solute carrier family 22 member 2,transporter,,Drug: camostat | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
1646,camostat,multidrug and toxin extrusion protein 1,transporter,,Drug: camostat | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
1647,camostat,multidrug and toxin extrusion protein 2,transporter,,Drug: camostat | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
1648,camostat,serine protease hepsin,enzyme,,Drug: camostat | Target: serine protease hepsin | Type: enzyme | Action: nan
1649,camostat,hepatocyte growth factor activator,enzyme,,Drug: camostat | Target: hepatocyte growth factor activator | Type: enzyme | Action: nan
1650,camostat,transmembrane protease serine 2,enzyme,INHIBITOR,Drug: camostat | Target: transmembrane protease serine 2 | Type: enzyme | Action: INHIBITOR
1651,camylofin,solute carrier family 22 member 1,transporter,,Drug: camylofin | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
1652,candesartan cilexetil,thromboxane-a synthase,enzyme,,Drug: candesartan cilexetil | Target: thromboxane-a synthase | Type: enzyme | Action: nan
1653,candesartan cilexetil,type-1 angiotensin ii receptor,gpcr,,Drug: candesartan cilexetil | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
1654,candesartan cilexetil,cruzipain,enzyme,,Drug: candesartan cilexetil | Target: cruzipain | Type: enzyme | Action: nan
1655,candesartan cilexetil,type-1 angiotensin ii receptor,gpcr,,Drug: candesartan cilexetil | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
1656,candesartan cilexetil,dnull polymerase kappa,enzyme,,Drug: candesartan cilexetil | Target: dnull polymerase kappa | Type: enzyme | Action: nan
1657,candesartan cilexetil,dnull polymerase iota,enzyme,,Drug: candesartan cilexetil | Target: dnull polymerase iota | Type: enzyme | Action: nan
1658,candesartan cilexetil,dnull polymerase eta,enzyme,,Drug: candesartan cilexetil | Target: dnull polymerase eta | Type: enzyme | Action: nan
1659,candesartan cilexetil,cytochrome p450 3a4,enzyme,,Drug: candesartan cilexetil | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
1660,candesartan cilexetil,sodium-dependent noradrenaline transporter,transporter,,Drug: candesartan cilexetil | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
1661,candesartan cilexetil,alpha-2b adrenergic receptor,gpcr,,Drug: candesartan cilexetil | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
1662,candesartan cilexetil,beta-3 adrenergic receptor,gpcr,,Drug: candesartan cilexetil | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
1663,candesartan cilexetil,adenosine receptor a3,gpcr,,Drug: candesartan cilexetil | Target: adenosine receptor a3 | Type: gpcr | Action: nan
1664,candesartan cilexetil,cytochrome p450 2c9,enzyme,,Drug: candesartan cilexetil | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
1665,candesartan cilexetil,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: candesartan cilexetil | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
1666,candesartan cilexetil,epidermal growth factor receptor,kinase,,Drug: candesartan cilexetil | Target: epidermal growth factor receptor | Type: kinase | Action: nan
1667,candesartan cilexetil,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: candesartan cilexetil | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
1668,canrenone,mineralocorticoid receptor,nuclear hormone receptor,ANTAGONIST,Drug: canrenone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
1669,capecitabine,thymidylate synthase,enzyme,INHIBITOR,Drug: capecitabine | Target: thymidylate synthase | Type: enzyme | Action: INHIBITOR
1670,captopril,prostaglandin g/h synthase 2,enzyme,,Drug: captopril | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
1671,captopril,prostaglandin g/h synthase 1,enzyme,,Drug: captopril | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1672,captopril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: captopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
1673,captopril,prothrombin,enzyme,,Drug: captopril | Target: prothrombin | Type: enzyme | Action: nan
1674,captopril,renin,enzyme,,Drug: captopril | Target: renin | Type: enzyme | Action: nan
1675,captopril,leukotriene a-4 hydrolase,enzyme,,Drug: captopril | Target: leukotriene a-4 hydrolase | Type: enzyme | Action: nan
1676,captopril,angiotensin-converting enzyme,enzyme,,Drug: captopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
1677,captopril,angiotensin-converting enzyme,enzyme,,Drug: captopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
1678,captopril,succinyl-diaminopimelate desuccinylase,enzyme,,Drug: captopril | Target: succinyl-diaminopimelate desuccinylase | Type: enzyme | Action: nan
1679,captopril,beta-lactamase,enzyme,,Drug: captopril | Target: beta-lactamase | Type: enzyme | Action: nan
1680,captopril,beta-lactamase ii,enzyme,,Drug: captopril | Target: beta-lactamase ii | Type: enzyme | Action: nan
1681,captopril,beta-lactamase class b vim-2,unclassified,,Drug: captopril | Target: beta-lactamase class b vim-2 | Type: unclassified | Action: nan
1682,captopril,beta-lactamase ndm-1,enzyme,,Drug: captopril | Target: beta-lactamase ndm-1 | Type: enzyme | Action: nan
1683,caramiphen,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: caramiphen | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1684,caramiphen,lysosomal pro-x carboxypeptidase,enzyme,,Drug: caramiphen | Target: lysosomal pro-x carboxypeptidase | Type: enzyme | Action: nan
1685,caramiphen,muscarinic acetylcholine receptor m2,gpcr,,Drug: caramiphen | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1686,caramiphen,muscarinic acetylcholine receptor m1,gpcr,,Drug: caramiphen | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1687,caramiphen,sodium-dependent dopamine transporter,transporter,,Drug: caramiphen | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1688,carazolol,beta-2 adrenergic receptor,gpcr,,Drug: carazolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
1689,carazolol,beta-3 adrenergic receptor,gpcr,AGONIST,Drug: carazolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: AGONIST
1690,carazolol,beta-3 adrenergic receptor,gpcr,AGONIST,Drug: carazolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: AGONIST
1691,carazolol,beta-3 adrenergic receptor,gpcr,AGONIST,Drug: carazolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: AGONIST
1692,carazolol,beta-1 adrenergic receptor,gpcr,,Drug: carazolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
1694,carbachol,muscarinic acetylcholine receptor m1,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1695,carbachol,muscarinic acetylcholine receptor m2,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1696,carbachol,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: carbachol | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
1697,carbachol,muscarinic acetylcholine receptor m4,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
1698,carbachol,muscarinic acetylcholine receptor m5,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
1699,carbachol,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: carbachol | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
1700,carbachol,muscarinic acetylcholine receptor m2,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1701,carbachol,muscarinic acetylcholine receptor m1,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1702,carbachol,acetylcholine receptor subunit delta,ion channel,,Drug: carbachol | Target: acetylcholine receptor subunit delta | Type: ion channel | Action: nan
1703,carbachol,acetylcholinesterase,enzyme,,Drug: carbachol | Target: acetylcholinesterase | Type: enzyme | Action: nan
1704,carbachol,muscarinic acetylcholine receptor m1,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1705,carbachol,muscarinic acetylcholine receptor m2,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1706,carbachol,muscarinic acetylcholine receptor m4,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
1707,carbachol,muscarinic acetylcholine receptor,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
1708,carbachol,acetylcholine receptor subunit alpha,ion channel,,Drug: carbachol | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
1709,carbachol,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: carbachol | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
1710,carbachol,neuronal acetylcholine receptor; alpha3/beta2,ion channel,,Drug: carbachol | Target: neuronal acetylcholine receptor; alpha3/beta2 | Type: ion channel | Action: nan
1711,carbachol,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: carbachol | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
1712,carbachol,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: carbachol | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
1713,carbachol,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: carbachol | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
1714,carbachol,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: carbachol | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
1715,carbachol,muscarinic acetylcholine receptor,gpcr,,Drug: carbachol | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
1716,carbamazepine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: carbamazepine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
1717,carbamazepine,sodium-dependent serotonin transporter,transporter,,Drug: carbamazepine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1718,carbamazepine,histamine h1 receptor,gpcr,,Drug: carbamazepine | Target: histamine h1 receptor | Type: gpcr | Action: nan
1719,carbamazepine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: carbamazepine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
1720,carbamazepine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: carbamazepine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
1721,carbamazepine,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: carbamazepine | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
1722,carbamazepine,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: carbamazepine | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
1723,carbamazepine,neuronal acetylcholine receptor; alpha2/beta4,ion channel,,Drug: carbamazepine | Target: neuronal acetylcholine receptor; alpha2/beta4 | Type: ion channel | Action: nan
1724,carbamazepine,frizzled-8,gpcr,ALLOSTERIC MODULATOR,Drug: carbamazepine | Target: frizzled-8 | Type: gpcr | Action: ALLOSTERIC MODULATOR
1725,carbenicillin,muscarinic acetylcholine receptor m1,gpcr,,Drug: carbenicillin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1726,carbenicillin,muscarinic acetylcholine receptor m3,gpcr,,Drug: carbenicillin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
1727,carbenicillin,penicillin-binding protein 1a,enzyme,,Drug: carbenicillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1728,carbenicillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: carbenicillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1729,carbenoxolone,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,INHIBITOR,Drug: carbenoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: INHIBITOR
1730,carbenoxolone,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: carbenoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
1731,carbenoxolone,corticosteroid 11-beta-dehydrogenase isozyme 2,enzyme,,Drug: carbenoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 2 | Type: enzyme | Action: nan
1732,pentoxyverine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: pentoxyverine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1733,pentoxyverine,muscarinic acetylcholine receptor m1,gpcr,,Drug: pentoxyverine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
1734,pentoxyverine,muscarinic acetylcholine receptor m2,gpcr,,Drug: pentoxyverine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
1735,pentoxyverine,lysosomal pro-x carboxypeptidase,enzyme,,Drug: pentoxyverine | Target: lysosomal pro-x carboxypeptidase | Type: enzyme | Action: nan
1736,pentoxyverine,solute carrier family 22 member 1,transporter,,Drug: pentoxyverine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
1737,pentoxyverine,sodium-dependent dopamine transporter,transporter,,Drug: pentoxyverine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1738,pentoxyverine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: pentoxyverine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1739,carbetocin,vasopressin v1a receptor,gpcr,,Drug: carbetocin | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
1740,carbetocin,vasopressin v2 receptor,gpcr,,Drug: carbetocin | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
1741,carbetocin,oxytocin receptor,gpcr,AGONIST,Drug: carbetocin | Target: oxytocin receptor | Type: gpcr | Action: AGONIST
1742,carbidopa,aromatic-l-amino-acid decarboxylase,enzyme,INHIBITOR,Drug: carbidopa | Target: aromatic-l-amino-acid decarboxylase | Type: enzyme | Action: INHIBITOR
1743,carbidopa,tyrosine-protein kinase lck,kinase,,Drug: carbidopa | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
1744,carbidopa,tyrosine-protein kinase fyn,kinase,,Drug: carbidopa | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
1745,carbidopa,lysine-specific demethylase 4e,enzyme,,Drug: carbidopa | Target: lysine-specific demethylase 4e | Type: enzyme | Action: nan
1746,carbimazole,lactoperoxidase,enzyme,,Drug: carbimazole | Target: lactoperoxidase | Type: enzyme | Action: nan
1747,carbimazole,thyroid peroxidase,enzyme,INHIBITOR,Drug: carbimazole | Target: thyroid peroxidase | Type: enzyme | Action: INHIBITOR
1748,carbinoxamine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: carbinoxamine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
1749,carboprost,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: carboprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
1750,carbutamide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: carbutamide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
1751,carindacillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: carindacillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1752,carubicin,dna topoisomerase 2-alpha,enzyme,,Drug: carubicin | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: nan
1753,carmofur,cytochrome p450 2d6,enzyme,,Drug: carmofur | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1754,carmofur,mitogen-activated protein kinase 3,kinase,,Drug: carmofur | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
1755,carmofur,acid ceramidase,enzyme,,Drug: carmofur | Target: acid ceramidase | Type: enzyme | Action: nan
1756,carmofur,acid ceramidase,enzyme,,Drug: carmofur | Target: acid ceramidase | Type: enzyme | Action: nan
1757,carmofur,"sulfide:quinone oxidoreductase, mitochondrial",unclassified,,"Drug: carmofur | Target: sulfide:quinone oxidoreductase, mitochondrial | Type: unclassified | Action: nan"
1758,carmustine,"glutathione reductase, mitochondrial",enzyme,INHIBITOR,"Drug: carmustine | Target: glutathione reductase, mitochondrial | Type: enzyme | Action: INHIBITOR"
1759,levocarnitine,"carnitine o-palmitoyltransferase 1, liver isoform",enzyme,,"Drug: levocarnitine | Target: carnitine o-palmitoyltransferase 1, liver isoform | Type: enzyme | Action: nan"
1760,levocarnitine,"carnitine o-palmitoyltransferase 1, muscle isoform",enzyme,,"Drug: levocarnitine | Target: carnitine o-palmitoyltransferase 1, muscle isoform | Type: enzyme | Action: nan"
1761,levocarnitine,carnitine palmitoyltransferase 2,enzyme,,Drug: levocarnitine | Target: carnitine palmitoyltransferase 2 | Type: enzyme | Action: nan
1762,carperitide,atrial natriuretic peptide receptor 1,enzyme,,Drug: carperitide | Target: atrial natriuretic peptide receptor 1 | Type: enzyme | Action: nan
1763,carperitide,atrial natriuretic peptide receptor 1,enzyme,,Drug: carperitide | Target: atrial natriuretic peptide receptor 1 | Type: enzyme | Action: nan
1764,carfenazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: carfenazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
1765,carfenazine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: carfenazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
1766,carpipramine,d(2) dopamine receptor,gpcr,,Drug: carpipramine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1767,carpipramine,d(3) dopamine receptor,gpcr,,Drug: carpipramine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1768,carprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: carprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
1769,carprofen,prostaglandin g/h synthase 1,enzyme,,Drug: carprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1770,carprofen,prostaglandin g/h synthase 1,enzyme,,Drug: carprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1771,carprofen,fatty-acid amide hydrolase 1,enzyme,,Drug: carprofen | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
1772,carprofen,complement c5,secreted,,Drug: carprofen | Target: complement c5 | Type: secreted | Action: nan
1773,carprofen,complement c5,unclassified,,Drug: carprofen | Target: complement c5 | Type: unclassified | Action: nan
1774,carteolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: carteolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1775,carteolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: carteolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1776,carumonam,peptidoglycan synthase ftsi,enzyme,,Drug: carumonam | Target: peptidoglycan synthase ftsi | Type: enzyme | Action: nan
1777,carvedilol,ryanodine receptor 2,ion channel,INHIBITOR,Drug: carvedilol | Target: ryanodine receptor 2 | Type: ion channel | Action: INHIBITOR
1778,carvedilol,5-hydroxytryptamine receptor 4,gpcr,,Drug: carvedilol | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
1779,carvedilol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: carvedilol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1780,carvedilol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: carvedilol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1781,carvedilol,d(1a) dopamine receptor,gpcr,,Drug: carvedilol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
1782,carvedilol,d(2) dopamine receptor,gpcr,,Drug: carvedilol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1783,carvedilol,alpha-2a adrenergic receptor,gpcr,,Drug: carvedilol | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
1784,carvedilol,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: carvedilol | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
1785,carvedilol,sodium-dependent serotonin transporter,transporter,,Drug: carvedilol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1786,carvedilol,sodium-dependent noradrenaline transporter,transporter,,Drug: carvedilol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
1787,carvedilol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: carvedilol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1788,carvedilol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: carvedilol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
1789,carvedilol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: carvedilol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
1790,carvedilol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: carvedilol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
1791,carvedilol,5-hydroxytryptamine receptor 6,gpcr,,Drug: carvedilol | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
1792,carvedilol,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: carvedilol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1793,carvedilol,alpha-2b adrenergic receptor,gpcr,,Drug: carvedilol | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
1794,carvedilol,d(3) dopamine receptor,gpcr,,Drug: carvedilol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1795,carvedilol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: carvedilol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1796,carvedilol,alpha-2c adrenergic receptor,gpcr,,Drug: carvedilol | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
1797,carvedilol,sodium-dependent dopamine transporter,transporter,,Drug: carvedilol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1798,carvedilol,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: carvedilol | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1799,carvedilol,potassium channel subfamily k member 2,ion channel,,Drug: carvedilol | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
1800,carvedilol,solute carrier family 22 member 1,transporter,,Drug: carvedilol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
1801,carvedilol,potassium channel subfamily k member 10,ion channel,,Drug: carvedilol | Target: potassium channel subfamily k member 10 | Type: ion channel | Action: nan
1802,carvedilol,alpha-1b adrenergic receptor,gpcr,,Drug: carvedilol | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
1803,carvedilol,5-hydroxytryptamine receptor 1b,gpcr,,Drug: carvedilol | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
1804,carvedilol,alpha-1a adrenergic receptor,gpcr,,Drug: carvedilol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
1805,carvedilol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: carvedilol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1806,carvedilol,beta-1 adrenergic receptor,gpcr,,Drug: carvedilol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
1807,carvedilol,solute carrier family 22 member 2,transporter,,Drug: carvedilol | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
1808,carvedilol,multidrug and toxin extrusion protein 1,transporter,,Drug: carvedilol | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
1809,carvedilol,toll-like receptor 4,membrane receptor,,Drug: carvedilol | Target: toll-like receptor 4 | Type: membrane receptor | Action: nan
1810,carvedilol,amyloid beta a4 protein,unclassified,,Drug: carvedilol | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
1811,cefacetrile,penicillin-binding protein 1a,enzyme,,Drug: cefacetrile | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1812,cefaclor,penicillin-binding protein 1a,enzyme,,Drug: cefaclor | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1813,cefaclor,streptokinase a,enzyme,,Drug: cefaclor | Target: streptokinase a | Type: enzyme | Action: nan
1814,cefaclor,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefaclor | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1815,cefadroxil,solute carrier family 15 member 1,transporter,,Drug: cefadroxil | Target: solute carrier family 15 member 1 | Type: transporter | Action: nan
1816,cefadroxil,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefadroxil | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1817,cefamandole,solute carrier family 15 member 1,transporter,,Drug: cefamandole | Target: solute carrier family 15 member 1 | Type: transporter | Action: nan
1818,cefamandole nafate,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefamandole nafate | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1819,cefazolin,penicillin-binding protein 1a,enzyme,,Drug: cefazolin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1820,cefazolin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefazolin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1821,cefdinir,"pencillin binding protein 2a; penicillin binding protein 2'; penicillin binding protein, pbp2; penicillin-binding protein 2; penicillin-binding protein 2'; peptidase",enzyme,,"Drug: cefdinir | Target: pencillin binding protein 2a; penicillin binding protein 2'; penicillin binding protein, pbp2; penicillin-binding protein 2; penicillin-binding protein 2'; peptidase | Type: enzyme | Action: nan"
1822,cefdinir,penicillin-binding protein 3,enzyme,,Drug: cefdinir | Target: penicillin-binding protein 3 | Type: enzyme | Action: nan
1823,cefdinir,zinc finger protein mex-5,cytosolic other,,Drug: cefdinir | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
1824,cefdinir,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefdinir | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1825,cefdinir,cytoplasmic zinc-finger protein,unclassified,,Drug: cefdinir | Target: cytoplasmic zinc-finger protein | Type: unclassified | Action: nan
1826,cefditoren pivoxil,penicillin-binding protein 3,enzyme,,Drug: cefditoren pivoxil | Target: penicillin-binding protein 3 | Type: enzyme | Action: nan
1827,cefditoren pivoxil,penicillin-binding protein,enzyme,,Drug: cefditoren pivoxil | Target: penicillin-binding protein | Type: enzyme | Action: nan
1828,cefditoren pivoxil,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefditoren pivoxil | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1829,cefepime,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefepime | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1830,cefetamet pivoxil,penicillin-binding protein 3,enzyme,,Drug: cefetamet pivoxil | Target: penicillin-binding protein 3 | Type: enzyme | Action: nan
1831,cefetamet pivoxil,penicillin-binding protein 1,enzyme,,Drug: cefetamet pivoxil | Target: penicillin-binding protein 1 | Type: enzyme | Action: nan
1832,cefixime,d(2) dopamine receptor,gpcr,,Drug: cefixime | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1833,cefixime,streptokinase a,enzyme,,Drug: cefixime | Target: streptokinase a | Type: enzyme | Action: nan
1834,cefixime,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefixime | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1835,cefixime,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1",enzyme,,"Drug: cefixime | Target: 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-1 | Type: enzyme | Action: nan"
1836,cefmenoxime,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefmenoxime | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1837,cefmetazole,penicillin-binding protein 1a,enzyme,,Drug: cefmetazole | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1838,cefmetazole,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefmetazole | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1839,cefmetazole,insulin-degrading enzyme,enzyme,,Drug: cefmetazole | Target: insulin-degrading enzyme | Type: enzyme | Action: nan
1841,cefonicid,prostaglandin g/h synthase 2,enzyme,,Drug: cefonicid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
1842,cefonicid,penicillin-binding protein 1a,enzyme,,Drug: cefonicid | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1843,cefonicid,matrix metalloproteinase-9,enzyme,,Drug: cefonicid | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
1844,cefonicid,somatostatin receptor type 4,gpcr,,Drug: cefonicid | Target: somatostatin receptor type 4 | Type: gpcr | Action: nan
1845,cefonicid,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefonicid | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1846,cefoperazone,penicillin-binding protein 1a,enzyme,,Drug: cefoperazone | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1847,cefoperazone,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefoperazone | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1848,ceforanide,penicillin-binding protein 1a,enzyme,,Drug: ceforanide | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1849,ceforanide,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: ceforanide | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1850,cefotaxime,peptidoglycan synthase ftsi,enzyme,INHIBITOR,Drug: cefotaxime | Target: peptidoglycan synthase ftsi | Type: enzyme | Action: INHIBITOR
1851,cefotaxime,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: cefotaxime | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
1852,cefotaxime,penicillin-binding protein 1b,enzyme,INHIBITOR,Drug: cefotaxime | Target: penicillin-binding protein 1b | Type: enzyme | Action: INHIBITOR
1853,cefotaxime,beta-lactamase,enzyme,,Drug: cefotaxime | Target: beta-lactamase | Type: enzyme | Action: nan
1854,cefotaxime,beta-lactamase,enzyme,,Drug: cefotaxime | Target: beta-lactamase | Type: enzyme | Action: nan
1855,cefotaxime,penicillin-binding protein 2,enzyme,INHIBITOR,Drug: cefotaxime | Target: penicillin-binding protein 2 | Type: enzyme | Action: INHIBITOR
1856,cefotetan,prostaglandin g/h synthase 2,enzyme,,Drug: cefotetan | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
1857,cefotetan,penicillin-binding protein 1a,enzyme,,Drug: cefotetan | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1858,cefotetan,72 kda type iv collagenase,enzyme,,Drug: cefotetan | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
1859,cefotetan,catechol o-methyltransferase,enzyme,,Drug: cefotetan | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
1860,cefotetan,matrix metalloproteinase-9,enzyme,,Drug: cefotetan | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
1861,cefotetan,interstitial collagenase,enzyme,,Drug: cefotetan | Target: interstitial collagenase | Type: enzyme | Action: nan
1862,cefotetan,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefotetan | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1863,cefotiam,penicillin-binding protein 1a,enzyme,,Drug: cefotiam | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1864,cefotiam,matrix metalloproteinase-9,enzyme,,Drug: cefotiam | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
1865,cefotiam,vasoactive intestinal polypeptide receptor 1,gpcr,,Drug: cefotiam | Target: vasoactive intestinal polypeptide receptor 1 | Type: gpcr | Action: nan
1866,cefotiam,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefotiam | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1867,cefoxitin,penicillin-binding protein 1a,enzyme,,Drug: cefoxitin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1868,cefoxitin,beta-lactamase,enzyme,,Drug: cefoxitin | Target: beta-lactamase | Type: enzyme | Action: nan
1869,cefoxitin,beta-lactamase,enzyme,,Drug: cefoxitin | Target: beta-lactamase | Type: enzyme | Action: nan
1870,cefoxitin,beta-lactamase,enzyme,,Drug: cefoxitin | Target: beta-lactamase | Type: enzyme | Action: nan
1871,cefoxitin,beta-lactamase,enzyme,,Drug: cefoxitin | Target: beta-lactamase | Type: enzyme | Action: nan
1872,cefoxitin,streptokinase a,enzyme,,Drug: cefoxitin | Target: streptokinase a | Type: enzyme | Action: nan
1873,cefoxitin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefoxitin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1874,cefpiramide,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefpiramide | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1875,cefprozil,penicillin-binding protein 1a,enzyme,,Drug: cefprozil | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1876,cefsulodin,beta-adrenergic receptor kinase 1,kinase,,Drug: cefsulodin | Target: beta-adrenergic receptor kinase 1 | Type: kinase | Action: nan
1877,cefsulodin,penicillin-binding protein 1a,enzyme,,Drug: cefsulodin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1878,cefsulodin,penicillin-binding protein 1b,enzyme,,Drug: cefsulodin | Target: penicillin-binding protein 1b | Type: enzyme | Action: nan
1879,cefsulodin,tyrosine-protein phosphatase non-receptor type 11,enzyme,,Drug: cefsulodin | Target: tyrosine-protein phosphatase non-receptor type 11 | Type: enzyme | Action: nan
1880,cefsulodin,lethal(3)malignant brain tumor-like protein 1,unclassified,,Drug: cefsulodin | Target: lethal(3)malignant brain tumor-like protein 1 | Type: unclassified | Action: nan
1881,cefsulodin,protein-tyrosine phosphatase 1c,enzyme,,Drug: cefsulodin | Target: protein-tyrosine phosphatase 1c | Type: enzyme | Action: nan
1882,cefsulodin,trna 2'-phosphotransferase,unclassified,,Drug: cefsulodin | Target: trna 2'-phosphotransferase | Type: unclassified | Action: nan
1883,ceftazidime,peptidoglycan synthase ftsi,enzyme,INHIBITOR,Drug: ceftazidime | Target: peptidoglycan synthase ftsi | Type: enzyme | Action: INHIBITOR
1884,ceftazidime,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: ceftazidime | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
1885,ceftazidime,penicillin-binding protein 1b,enzyme,INHIBITOR,Drug: ceftazidime | Target: penicillin-binding protein 1b | Type: enzyme | Action: INHIBITOR
1886,ceftibuten,penicillin-binding protein,enzyme,,Drug: ceftibuten | Target: penicillin-binding protein | Type: enzyme | Action: nan
1887,ceftibuten,penicillin-binding protein 3,enzyme,,Drug: ceftibuten | Target: penicillin-binding protein 3 | Type: enzyme | Action: nan
1888,ceftibuten,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: ceftibuten | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1889,ceftizoxime,penicillin-binding protein 1a,enzyme,,Drug: ceftizoxime | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1890,ceftizoxime,beta-lactamase,enzyme,,Drug: ceftizoxime | Target: beta-lactamase | Type: enzyme | Action: nan
1891,ceftizoxime,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: ceftizoxime | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1892,ceftriaxone,peptidoglycan synthase ftsi,enzyme,INHIBITOR,Drug: ceftriaxone | Target: peptidoglycan synthase ftsi | Type: enzyme | Action: INHIBITOR
1893,ceftriaxone,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: ceftriaxone | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
1894,ceftriaxone,penicillin-binding protein 1b,enzyme,INHIBITOR,Drug: ceftriaxone | Target: penicillin-binding protein 1b | Type: enzyme | Action: INHIBITOR
1895,ceftriaxone,penicillin-binding protein 2,enzyme,INHIBITOR,Drug: ceftriaxone | Target: penicillin-binding protein 2 | Type: enzyme | Action: INHIBITOR
1896,ceftriaxone,d-amino-acid oxidase,enzyme,,Drug: ceftriaxone | Target: d-amino-acid oxidase | Type: enzyme | Action: nan
1897,cefuroxime,penicillin-binding protein 1a,enzyme,,Drug: cefuroxime | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1898,cefuroxime,carbonic anhydrase 2,enzyme,,Drug: cefuroxime | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1899,cefuroxime,72 kda type iv collagenase,enzyme,,Drug: cefuroxime | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
1900,cefuroxime,matrix metalloproteinase-9,enzyme,,Drug: cefuroxime | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
1901,cefuroxime,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefuroxime | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1902,cefuroxime axetil,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefuroxime axetil | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1903,celecoxib,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: celecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
1904,celecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1905,celecoxib,d(1a) dopamine receptor,gpcr,,Drug: celecoxib | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
1906,celecoxib,sodium-dependent serotonin transporter,transporter,,Drug: celecoxib | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
1907,celecoxib,sodium-dependent noradrenaline transporter,transporter,,Drug: celecoxib | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
1908,celecoxib,alpha-2b adrenergic receptor,gpcr,,Drug: celecoxib | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
1909,celecoxib,beta-3 adrenergic receptor,gpcr,,Drug: celecoxib | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
1910,celecoxib,sodium-dependent dopamine transporter,transporter,,Drug: celecoxib | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
1911,celecoxib,cytochrome p450 2d6,enzyme,,Drug: celecoxib | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1912,celecoxib,adenosine receptor a3,gpcr,,Drug: celecoxib | Target: adenosine receptor a3 | Type: gpcr | Action: nan
1913,celecoxib,carbonic anhydrase 2,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1914,celecoxib,carbonic anhydrase 1,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
1915,celecoxib,carbonic anhydrase 4,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
1916,celecoxib,carbonic anhydrase 9,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
1917,celecoxib,carbonic anhydrase 12,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
1918,celecoxib,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: celecoxib | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
1919,celecoxib,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: celecoxib | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
1920,celecoxib,carbonic anhydrase 7,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
1921,celecoxib,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: celecoxib | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
1922,celecoxib,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: celecoxib | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
1923,celecoxib,histone deacetylase 1,enzyme,,Drug: celecoxib | Target: histone deacetylase 1 | Type: enzyme | Action: nan
1924,celecoxib,histone deacetylase 6,enzyme,,Drug: celecoxib | Target: histone deacetylase 6 | Type: enzyme | Action: nan
1925,celecoxib,carbonic anhydrase 3,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
1926,celecoxib,carbonic anhydrase 6,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
1927,celecoxib,carbonic anhydrase 14,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
1928,celecoxib,mitogen-activated protein kinase 14,kinase,,Drug: celecoxib | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
1929,celecoxib,cytochrome c oxidase subunit 2,enzyme,,Drug: celecoxib | Target: cytochrome c oxidase subunit 2 | Type: enzyme | Action: nan
1930,celecoxib,3-phosphoinositide-dependent protein kinase 1,kinase,,Drug: celecoxib | Target: 3-phosphoinositide-dependent protein kinase 1 | Type: kinase | Action: nan
1931,celecoxib,progesterone receptor,transcription factor,,Drug: celecoxib | Target: progesterone receptor | Type: transcription factor | Action: nan
1932,celecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
1933,celecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1934,celecoxib,cyclooxygenase 2; prostaglandin g/h synthase-2; uncharacterized protein,enzyme,,Drug: celecoxib | Target: cyclooxygenase 2; prostaglandin g/h synthase-2; uncharacterized protein | Type: enzyme | Action: nan
1935,celecoxib,carbonic anhydrase 4,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
1936,celecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1937,celecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
1938,celecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
1939,celecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1940,celecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1941,celecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
1942,celecoxib,carbonic anhydrase,enzyme,,Drug: celecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
1943,celecoxib,carbonic anhydrase,enzyme,,Drug: celecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
1944,celecoxib,carbonic anhydrase 13,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
1945,celecoxib,carbonic anhydrase 15,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
1946,celecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: celecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
1947,celecoxib,carbonic anhydrase,enzyme,,Drug: celecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
1948,celecoxib,carbonic anhydrase,enzyme,,Drug: celecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
1949,celecoxib,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: celecoxib | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
1950,celecoxib,carbonic anhydrase,enzyme,,Drug: celecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
1951,celecoxib,alpha carbonic anhydrase,enzyme,,Drug: celecoxib | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
1952,celecoxib,cytochrome c oxidase subunit 2,enzyme,,Drug: celecoxib | Target: cytochrome c oxidase subunit 2 | Type: enzyme | Action: nan
1953,celecoxib,carbonic anhydrase,enzyme,,Drug: celecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
1954,celecoxib,carbonic anhydrase 2,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1955,celecoxib,astrosclerin-3,enzyme,,Drug: celecoxib | Target: astrosclerin-3 | Type: enzyme | Action: nan
1956,celecoxib,beta-carbonic anhydrase 1,enzyme,,Drug: celecoxib | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
1957,celecoxib,delta carbonic anhydrase,unclassified,,Drug: celecoxib | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
1958,celecoxib,carbonic anhydrase 2,enzyme,,Drug: celecoxib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
1959,celecoxib,prostaglandin e synthase,enzyme,,Drug: celecoxib | Target: prostaglandin e synthase | Type: enzyme | Action: nan
1960,celecoxib,cytochrome c oxidase subunit 1,enzyme,,Drug: celecoxib | Target: cytochrome c oxidase subunit 1 | Type: enzyme | Action: nan
1961,celecoxib,carbonic anhydrase,enzyme,,Drug: celecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
1962,celecoxib,"carbonic anhydrase, alpha family",unclassified,,"Drug: celecoxib | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
1963,celecoxib,carbonate dehydratase,enzyme,,Drug: celecoxib | Target: carbonate dehydratase | Type: enzyme | Action: nan
1964,celiprolol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: celiprolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
1965,celiprolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: celiprolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1966,celiprolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: celiprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
1967,cefalexin,penicillin-binding protein 3,enzyme,,Drug: cefalexin | Target: penicillin-binding protein 3 | Type: enzyme | Action: nan
1968,cefalexin,solute carrier family 15 member 2,transporter,,Drug: cefalexin | Target: solute carrier family 15 member 2 | Type: transporter | Action: nan
1969,cefalexin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefalexin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1970,cefaloglycin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefaloglycin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1971,cefalotin,prostaglandin g/h synthase 2,enzyme,,Drug: cefalotin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
1972,cefalotin,penicillin-binding protein 1a,enzyme,,Drug: cefalotin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1973,cefalotin,solute carrier family 22 member 8,transporter,INHIBITOR,Drug: cefalotin | Target: solute carrier family 22 member 8 | Type: transporter | Action: INHIBITOR
1974,cefalotin,matrix metalloproteinase-9,enzyme,,Drug: cefalotin | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
1975,cefalotin,solute carrier family 22 member 11,transporter,INHIBITOR,Drug: cefalotin | Target: solute carrier family 22 member 11 | Type: transporter | Action: INHIBITOR
1976,cefalotin,somatostatin receptor type 4,gpcr,,Drug: cefalotin | Target: somatostatin receptor type 4 | Type: gpcr | Action: nan
1977,cefalotin,tyrosine-protein phosphatase non-receptor type 7,enzyme,,Drug: cefalotin | Target: tyrosine-protein phosphatase non-receptor type 7 | Type: enzyme | Action: nan
1978,cefalotin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefalotin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
1979,cefapirin,cannabinoid receptor 1,gpcr,,Drug: cefapirin | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
1980,cefapirin,mu-type opioid receptor,gpcr,,Drug: cefapirin | Target: mu-type opioid receptor | Type: gpcr | Action: nan
1981,cefapirin,d(2) dopamine receptor,gpcr,,Drug: cefapirin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
1982,cefapirin,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: cefapirin | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
1983,cefapirin,cytochrome p450 3a4,enzyme,,Drug: cefapirin | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
1984,cefapirin,5-hydroxytryptamine receptor 1a,gpcr,,Drug: cefapirin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
1985,cefapirin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: cefapirin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
1986,cefapirin,d(3) dopamine receptor,gpcr,,Drug: cefapirin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
1987,cefapirin,histamine h2 receptor,gpcr,,Drug: cefapirin | Target: histamine h2 receptor | Type: gpcr | Action: nan
1988,cefapirin,penicillin-binding protein 1a,enzyme,,Drug: cefapirin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
1989,cefapirin,alpha-2c adrenergic receptor,gpcr,,Drug: cefapirin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
1990,cefapirin,cytochrome p450 2d6,enzyme,,Drug: cefapirin | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
1991,cefapirin,d(4) dopamine receptor,gpcr,,Drug: cefapirin | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
1992,cefapirin,kappa-type opioid receptor,gpcr,,Drug: cefapirin | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
1993,cefapirin,delta-type opioid receptor,gpcr,,Drug: cefapirin | Target: delta-type opioid receptor | Type: gpcr | Action: nan
1994,cefapirin,substance-p receptor,gpcr,,Drug: cefapirin | Target: substance-p receptor | Type: gpcr | Action: nan
1995,cefapirin,nischarin,membrane receptor,,Drug: cefapirin | Target: nischarin | Type: membrane receptor | Action: nan
1996,cefapirin,interstitial collagenase,enzyme,,Drug: cefapirin | Target: interstitial collagenase | Type: enzyme | Action: nan
1997,cefapirin,substance-k receptor,gpcr,,Drug: cefapirin | Target: substance-k receptor | Type: gpcr | Action: nan
1998,cefapirin,cytochrome p450 3a5,enzyme,,Drug: cefapirin | Target: cytochrome p450 3a5 | Type: enzyme | Action: nan
1999,cefapirin,somatostatin receptor type 4,gpcr,,Drug: cefapirin | Target: somatostatin receptor type 4 | Type: gpcr | Action: nan
2000,cefapirin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefapirin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
2001,cefradine,penicillin-binding protein 1a,enzyme,,Drug: cefradine | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
2002,cefradine,matrix metalloproteinase-9,enzyme,,Drug: cefradine | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
2003,cefradine,somatostatin receptor type 4,gpcr,,Drug: cefradine | Target: somatostatin receptor type 4 | Type: gpcr | Action: nan
2004,cefradine,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cefradine | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
2005,cerivastatin,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: cerivastatin | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
2006,cerivastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: cerivastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
2007,cerivastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: cerivastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
2008,cerulenin,fatty acid synthase,enzyme,,Drug: cerulenin | Target: fatty acid synthase | Type: enzyme | Action: nan
2009,cerulenin,coagulation factor xiii a chain,enzyme,,Drug: cerulenin | Target: coagulation factor xiii a chain | Type: enzyme | Action: nan
2010,cerulenin,pol polyprotein,enzyme,,Drug: cerulenin | Target: pol polyprotein | Type: enzyme | Action: nan
2011,ceruletide,cholecystokinin receptor type a,gpcr,AGONIST,Drug: ceruletide | Target: cholecystokinin receptor type a | Type: gpcr | Action: AGONIST
2012,cetirizine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: cetirizine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2013,cetirizine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: cetirizine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
2014,cetirizine,angiopoietin-1 receptor,kinase,,Drug: cetirizine | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
2015,cetrorelix,lutropin-choriogonadotropic hormone receptor,gpcr,,Drug: cetrorelix | Target: lutropin-choriogonadotropic hormone receptor | Type: gpcr | Action: nan
2016,cetrorelix,gonadotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: cetrorelix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
2017,cevimeline,muscarinic acetylcholine receptor m1,gpcr,AGONIST,Drug: cevimeline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: AGONIST
2018,cevimeline,muscarinic acetylcholine receptor m2,gpcr,,Drug: cevimeline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2019,cevimeline,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: cevimeline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
2020,cevimeline,muscarinic acetylcholine receptor m4,gpcr,,Drug: cevimeline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2021,cevimeline,muscarinic acetylcholine receptor m5,gpcr,,Drug: cevimeline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2022,chlorambucil,delta-type opioid receptor,gpcr,,Drug: chlorambucil | Target: delta-type opioid receptor | Type: gpcr | Action: nan
2023,chlorambucil,cathepsin d,enzyme,,Drug: chlorambucil | Target: cathepsin d | Type: enzyme | Action: nan
2024,chlorambucil,aldose reductase,enzyme,,Drug: chlorambucil | Target: aldose reductase | Type: enzyme | Action: nan
2025,chlorambucil,cathepsin e,enzyme,,Drug: chlorambucil | Target: cathepsin e | Type: enzyme | Action: nan
2026,chlorambucil,disintegrin and metalloproteinase domain-containing protein 9,enzyme,,Drug: chlorambucil | Target: disintegrin and metalloproteinase domain-containing protein 9 | Type: enzyme | Action: nan
2027,chloramphenicol,cytochrome p450 3a4,enzyme,,Drug: chloramphenicol | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
2028,chloramphenicol,chloramphenicol acetyltransferase,enzyme,,Drug: chloramphenicol | Target: chloramphenicol acetyltransferase | Type: enzyme | Action: nan
2029,chloramphenicol,streptokinase a,enzyme,,Drug: chloramphenicol | Target: streptokinase a | Type: enzyme | Action: nan
2030,chloramphenicol,probable hth-type transcriptional regulator ttgr,unclassified,,Drug: chloramphenicol | Target: probable hth-type transcriptional regulator ttgr | Type: unclassified | Action: nan
2031,chlorcyclizine,apoptosis regulator bcl-2,cytosolic other,,Drug: chlorcyclizine | Target: apoptosis regulator bcl-2 | Type: cytosolic other | Action: nan
2032,chlordiazepoxide,histamine h1 receptor,gpcr,,Drug: chlordiazepoxide | Target: histamine h1 receptor | Type: gpcr | Action: nan
2033,chlordiazepoxide,thyrotropin-releasing hormone receptor,gpcr,,Drug: chlordiazepoxide | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: nan
2034,chlordiazepoxide,acetylcholinesterase,enzyme,,Drug: chlordiazepoxide | Target: acetylcholinesterase | Type: enzyme | Action: nan
2035,chlordiazepoxide,translocator protein,membrane receptor,,Drug: chlordiazepoxide | Target: translocator protein | Type: membrane receptor | Action: nan
2036,chlordiazepoxide,thyrotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: chlordiazepoxide | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
2037,chlordiazepoxide,cholinesterase,enzyme,,Drug: chlordiazepoxide | Target: cholinesterase | Type: enzyme | Action: nan
2038,chlordiazepoxide,thyrotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: chlordiazepoxide | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
2039,chlordiazepoxide,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: chlordiazepoxide | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2040,chlordiazepoxide,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: chlordiazepoxide | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2041,chlordiazepoxide,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: chlordiazepoxide | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2042,chlordiazepoxide,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: chlordiazepoxide | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2043,chlordiazepoxide,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,,Drug: chlordiazepoxide | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: nan
2044,chlordiazepoxide,gaba-a receptor; anion channel,ion channel,,Drug: chlordiazepoxide | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
2045,chlordiazepoxide,gaba-a receptor; anion channel,ion channel,,Drug: chlordiazepoxide | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
2046,chlordiazepoxide,cholecystokinin receptor,gpcr,,Drug: chlordiazepoxide | Target: cholecystokinin receptor | Type: gpcr | Action: nan
2047,chlordiazepoxide,cholecystokinin receptor,gpcr,,Drug: chlordiazepoxide | Target: cholecystokinin receptor | Type: gpcr | Action: nan
2048,chlorhexidine,72 kda type iv collagenase,enzyme,,Drug: chlorhexidine | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
2049,chlorhexidine,matrix metalloproteinase-9,enzyme,,Drug: chlorhexidine | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
2050,chlorhexidine,solute carrier family 22 member 1,transporter,,Drug: chlorhexidine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2051,chlorhexidine,trypanothione reductase,enzyme,,Drug: chlorhexidine | Target: trypanothione reductase | Type: enzyme | Action: nan
2052,chlorhexidine,solute carrier family 22 member 2,transporter,,Drug: chlorhexidine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
2053,chlorhexidine,multidrug and toxin extrusion protein 1,transporter,,Drug: chlorhexidine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
2054,chlorhexidine,multidrug and toxin extrusion protein 2,transporter,,Drug: chlorhexidine | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
2055,chlorhexidine,solute carrier family 22 member 3,transporter,,Drug: chlorhexidine | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
2056,chlorhexidine,caax prenyl protease 2,enzyme,,Drug: chlorhexidine | Target: caax prenyl protease 2 | Type: enzyme | Action: nan
2057,chlorhexidine,synaptojanin-2,enzyme,,Drug: chlorhexidine | Target: synaptojanin-2 | Type: enzyme | Action: nan
2058,chlormadinone,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: chlormadinone | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
2059,chlormadinone,glucocorticoid receptor,nuclear hormone receptor,,Drug: chlormadinone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
2060,chlormadinone,cytochrome p450 2c19,enzyme,,Drug: chlormadinone | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
2061,chlormadinone,androgen receptor,transcription factor,,Drug: chlormadinone | Target: androgen receptor | Type: transcription factor | Action: nan
2062,chlormadinone,progesterone receptor,transcription factor,,Drug: chlormadinone | Target: progesterone receptor | Type: transcription factor | Action: nan
2063,clomethiazole,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,,Drug: clomethiazole | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: nan
2064,chloroprocaine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: chloroprocaine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
2065,chloropyramine,focal adhesion kinase 1,kinase,,Drug: chloropyramine | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
2066,chloroquine,alpha-2a adrenergic receptor,gpcr,,Drug: chloroquine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2067,chloroquine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: chloroquine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2068,chloroquine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: chloroquine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2069,chloroquine,alpha-2b adrenergic receptor,gpcr,,Drug: chloroquine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2070,chloroquine,muscarinic acetylcholine receptor m1,gpcr,,Drug: chloroquine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2071,chloroquine,muscarinic acetylcholine receptor m2,gpcr,,Drug: chloroquine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2072,chloroquine,muscarinic acetylcholine receptor m3,gpcr,,Drug: chloroquine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2073,chloroquine,muscarinic acetylcholine receptor m4,gpcr,,Drug: chloroquine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2074,chloroquine,muscarinic acetylcholine receptor m5,gpcr,,Drug: chloroquine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2075,chloroquine,alpha-2c adrenergic receptor,gpcr,,Drug: chloroquine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
2076,chloroquine,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: chloroquine | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
2077,chloroquine,beta-secretase 1,enzyme,,Drug: chloroquine | Target: beta-secretase 1 | Type: enzyme | Action: nan
2078,chloroquine,major prion protein,surface antigen,,Drug: chloroquine | Target: major prion protein | Type: surface antigen | Action: nan
2079,chloroquine,histidine-rich protein pfhrp-ii,cytosolic other,,Drug: chloroquine | Target: histidine-rich protein pfhrp-ii | Type: cytosolic other | Action: nan
2080,chloroquine,riboflavin-binding protein,unclassified,,Drug: chloroquine | Target: riboflavin-binding protein | Type: unclassified | Action: nan
2081,chloroquine,dihydrofolate reductase,enzyme,,Drug: chloroquine | Target: dihydrofolate reductase | Type: enzyme | Action: nan
2082,chloroquine,amyloid beta a4 protein,unclassified,,Drug: chloroquine | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
2083,chloroquine,transmembrane protein 97,enzyme,,Drug: chloroquine | Target: transmembrane protein 97 | Type: enzyme | Action: nan
2084,chloroquine,cysteine proteinase falcipain 2a,enzyme,,Drug: chloroquine | Target: cysteine proteinase falcipain 2a | Type: enzyme | Action: nan
2085,chlorothiazide,carbonic anhydrase 2,enzyme,,Drug: chlorothiazide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
2086,chlorothiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: chlorothiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
2087,chlorotrianisene,estrogen receptor,nuclear hormone receptor,,Drug: chlorotrianisene | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
2088,chlorotrianisene,estrogen receptor beta,nuclear hormone receptor,MODULATOR,Drug: chlorotrianisene | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: MODULATOR
2089,chloroxine,arachidonate 5-lipoxygenase,enzyme,,Drug: chloroxine | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
2090,chloroxine,arachidonate 15-lipoxygenase,enzyme,,Drug: chloroxine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
2091,chloroxine,"arachidonate 12-lipoxygenase, 12s-type",enzyme,,"Drug: chloroxine | Target: arachidonate 12-lipoxygenase, 12s-type | Type: enzyme | Action: nan"
2092,chloroxine,botulinum neurotoxin type a,enzyme,,Drug: chloroxine | Target: botulinum neurotoxin type a | Type: enzyme | Action: nan
2093,chloroxine,"arachidonate 15-lipoxygenase, type ii",enzyme,,"Drug: chloroxine | Target: arachidonate 15-lipoxygenase, type ii | Type: enzyme | Action: nan"
2094,chlorphenamine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: chlorphenamine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2095,chlorphenamine,sodium-dependent serotonin transporter,transporter,,Drug: chlorphenamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2096,chlorphenamine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: chlorphenamine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2097,chlorphenamine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: chlorphenamine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
2098,chlorphenamine,histamine h4 receptor,gpcr,,Drug: chlorphenamine | Target: histamine h4 receptor | Type: gpcr | Action: nan
2099,chlorphenamine,cytochrome p450 2d6,enzyme,,Drug: chlorphenamine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
2100,chlorphenamine,histamine h1 receptor,gpcr,,Drug: chlorphenamine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2101,chlorphenamine,histamine h1 receptor,gpcr,,Drug: chlorphenamine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2102,chlorphenamine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: chlorphenamine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
2103,chlorphenamine,lethal(3)malignant brain tumor-like protein 1,unclassified,,Drug: chlorphenamine | Target: lethal(3)malignant brain tumor-like protein 1 | Type: unclassified | Action: nan
2104,chlorphenamine,lethal(3)malignant brain tumor-like protein 3,unclassified,,Drug: chlorphenamine | Target: lethal(3)malignant brain tumor-like protein 3 | Type: unclassified | Action: nan
2105,chlorphenamine,mbt domain-containing protein 1,unclassified,,Drug: chlorphenamine | Target: mbt domain-containing protein 1 | Type: unclassified | Action: nan
2106,chlorphenamine,chloroquine resistance transporter,transporter,,Drug: chlorphenamine | Target: chloroquine resistance transporter | Type: transporter | Action: nan
2107,chlorphenamine,sodium-dependent noradrenaline transporter,transporter,,Drug: chlorphenamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2108,chlorphenamine,sodium-dependent dopamine transporter,transporter,,Drug: chlorphenamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2109,chlorphentermine,sodium-dependent serotonin transporter,transporter,SUBSTRATE,Drug: chlorphentermine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: SUBSTRATE
2110,chlorphentermine,sodium-dependent dopamine transporter,transporter,,Drug: chlorphentermine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2111,chlorproethazine,d(2) dopamine receptor,gpcr,,Drug: chlorproethazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2112,chlorproethazine,d(3) dopamine receptor,gpcr,,Drug: chlorproethazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2113,chlorproethazine,d(4) dopamine receptor,gpcr,,Drug: chlorproethazine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
2114,chlorpromazine,mu-type opioid receptor,gpcr,,Drug: chlorpromazine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
2115,chlorpromazine,d(1a) dopamine receptor,gpcr,,Drug: chlorpromazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2116,chlorpromazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: chlorpromazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
2117,chlorpromazine,alpha-2a adrenergic receptor,gpcr,,Drug: chlorpromazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2118,chlorpromazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: chlorpromazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2119,chlorpromazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: chlorpromazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2120,chlorpromazine,multidrug resistance protein 1,transporter,,Drug: chlorpromazine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
2121,chlorpromazine,sodium-dependent serotonin transporter,transporter,,Drug: chlorpromazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2122,chlorpromazine,sodium-dependent noradrenaline transporter,transporter,,Drug: chlorpromazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2123,chlorpromazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2124,chlorpromazine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
2125,chlorpromazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2126,chlorpromazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2127,chlorpromazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
2128,chlorpromazine,5-hydroxytryptamine receptor 7,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
2129,chlorpromazine,alpha-1a adrenergic receptor,gpcr,,Drug: chlorpromazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2130,chlorpromazine,alpha-2b adrenergic receptor,gpcr,,Drug: chlorpromazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2131,chlorpromazine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: chlorpromazine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
2132,chlorpromazine,d(1b) dopamine receptor,gpcr,,Drug: chlorpromazine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
2133,chlorpromazine,histamine h1 receptor,gpcr,,Drug: chlorpromazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2134,chlorpromazine,histamine h2 receptor,gpcr,,Drug: chlorpromazine | Target: histamine h2 receptor | Type: gpcr | Action: nan
2135,chlorpromazine,histamine h4 receptor,gpcr,,Drug: chlorpromazine | Target: histamine h4 receptor | Type: gpcr | Action: nan
2136,chlorpromazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: chlorpromazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2137,chlorpromazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: chlorpromazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2138,chlorpromazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: chlorpromazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2139,chlorpromazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: chlorpromazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2140,chlorpromazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: chlorpromazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2141,chlorpromazine,aldehyde oxidase,enzyme,,Drug: chlorpromazine | Target: aldehyde oxidase | Type: enzyme | Action: nan
2142,chlorpromazine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
2143,chlorpromazine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
2144,chlorpromazine,alpha-2c adrenergic receptor,gpcr,,Drug: chlorpromazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
2145,chlorpromazine,sodium-dependent dopamine transporter,transporter,,Drug: chlorpromazine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2146,chlorpromazine,cytochrome p450 2d6,enzyme,,Drug: chlorpromazine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
2147,chlorpromazine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: chlorpromazine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
2148,chlorpromazine,alpha-1d adrenergic receptor,gpcr,,Drug: chlorpromazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2149,chlorpromazine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
2150,chlorpromazine,alpha-1b adrenergic receptor,gpcr,,Drug: chlorpromazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2151,chlorpromazine,kappa-type opioid receptor,gpcr,,Drug: chlorpromazine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
2152,chlorpromazine,calmodulin,cytosolic other,,Drug: chlorpromazine | Target: calmodulin | Type: cytosolic other | Action: nan
2153,chlorpromazine,delta-type opioid receptor,gpcr,,Drug: chlorpromazine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
2154,chlorpromazine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
2155,chlorpromazine,5-hydroxytryptamine receptor 1e,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
2156,chlorpromazine,epidermal growth factor receptor,kinase,,Drug: chlorpromazine | Target: epidermal growth factor receptor | Type: kinase | Action: nan
2157,chlorpromazine,potassium channel subfamily k member 2,ion channel,,Drug: chlorpromazine | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
2158,chlorpromazine,tyrosine-protein kinase fyn,kinase,,Drug: chlorpromazine | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
2159,chlorpromazine,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: chlorpromazine | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
2160,chlorpromazine,ryanodine receptor 1,ion channel,,Drug: chlorpromazine | Target: ryanodine receptor 1 | Type: ion channel | Action: nan
2161,chlorpromazine,major prion protein,surface antigen,,Drug: chlorpromazine | Target: major prion protein | Type: surface antigen | Action: nan
2162,chlorpromazine,solute carrier family 22 member 1,transporter,,Drug: chlorpromazine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2163,chlorpromazine,substance-k receptor,gpcr,,Drug: chlorpromazine | Target: substance-k receptor | Type: gpcr | Action: nan
2164,chlorpromazine,trypanothione reductase,enzyme,,Drug: chlorpromazine | Target: trypanothione reductase | Type: enzyme | Action: nan
2165,chlorpromazine,arachidonate 15-lipoxygenase,enzyme,,Drug: chlorpromazine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
2166,chlorpromazine,alpha-1b adrenergic receptor,gpcr,,Drug: chlorpromazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2167,chlorpromazine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
2168,chlorpromazine,melanocortin receptor 4,gpcr,,Drug: chlorpromazine | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
2169,chlorpromazine,melanocortin receptor 5,gpcr,,Drug: chlorpromazine | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
2170,chlorpromazine,melanocortin receptor 3,gpcr,,Drug: chlorpromazine | Target: melanocortin receptor 3 | Type: gpcr | Action: nan
2171,chlorpromazine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: chlorpromazine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
2172,chlorpromazine,alpha-1a adrenergic receptor,gpcr,,Drug: chlorpromazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2173,chlorpromazine,histamine h1 receptor,gpcr,,Drug: chlorpromazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2174,chlorpromazine,d(2) dopamine receptor,gpcr,,Drug: chlorpromazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2175,chlorpromazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2176,chlorpromazine,5-hydroxytryptamine receptor 7,gpcr,,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
2177,chlorpromazine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
2178,chlorpromazine,d(1a) dopamine receptor,gpcr,,Drug: chlorpromazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2179,chlorpromazine,d(2) dopamine receptor,gpcr,,Drug: chlorpromazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2180,chlorpromazine,transient receptor potential cation channel subfamily v member 1,ion channel,,Drug: chlorpromazine | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: nan
2181,chlorpromazine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: chlorpromazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
2182,chlorpromazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: chlorpromazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
2183,chlorpromazine,solute carrier family 22 member 2,transporter,,Drug: chlorpromazine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
2184,chlorpromazine,acetylcholine receptor subunit alpha,ion channel,,Drug: chlorpromazine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
2185,chlorpromazine,glutamate [nmda] receptor,ion channel,,Drug: chlorpromazine | Target: glutamate [nmda] receptor | Type: ion channel | Action: nan
2186,chlorpromazine,glutamate nmda receptor,ion channel,,Drug: chlorpromazine | Target: glutamate nmda receptor | Type: ion channel | Action: nan
2187,chlorpromazine,muscarinic acetylcholine receptor,gpcr,,Drug: chlorpromazine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
2188,chlorpromazine,dopamine receptor,gpcr,,Drug: chlorpromazine | Target: dopamine receptor | Type: gpcr | Action: nan
2189,chlorpromazine,dopamine receptor,gpcr,,Drug: chlorpromazine | Target: dopamine receptor | Type: gpcr | Action: nan
2190,chlorpromazine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: chlorpromazine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
2191,chlorpromazine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: chlorpromazine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
2192,chlorpromazine,adenylate cyclase,enzyme,,Drug: chlorpromazine | Target: adenylate cyclase | Type: enzyme | Action: nan
2193,chlorpromazine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: chlorpromazine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
2194,chlorpromazine,calmodulin,cytosolic other,,Drug: chlorpromazine | Target: calmodulin | Type: cytosolic other | Action: nan
2195,chlorpromazine,major prion protein,unclassified,,Drug: chlorpromazine | Target: major prion protein | Type: unclassified | Action: nan
2196,chlorpromazine,sphingomyelin phosphodiesterase,enzyme,,Drug: chlorpromazine | Target: sphingomyelin phosphodiesterase | Type: enzyme | Action: nan
2197,chlorpropamide,solute carrier family 22 member 6,transporter,,Drug: chlorpropamide | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
2198,chlorpropamide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: chlorpropamide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
2199,chlorprothixene,d(1a) dopamine receptor,gpcr,,Drug: chlorprothixene | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2200,chlorprothixene,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: chlorprothixene | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
2201,chlorprothixene,5-hydroxytryptamine receptor 2a,gpcr,,Drug: chlorprothixene | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2202,chlorprothixene,5-hydroxytryptamine receptor 6,gpcr,,Drug: chlorprothixene | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
2203,chlorprothixene,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: chlorprothixene | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
2204,chlorprothixene,d(1b) dopamine receptor,gpcr,,Drug: chlorprothixene | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
2205,chlorprothixene,histamine h1 receptor,gpcr,,Drug: chlorprothixene | Target: histamine h1 receptor | Type: gpcr | Action: nan
2206,chlorprothixene,muscarinic acetylcholine receptor m1,gpcr,,Drug: chlorprothixene | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2207,chlorprothixene,muscarinic acetylcholine receptor m2,gpcr,,Drug: chlorprothixene | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2208,chlorprothixene,muscarinic acetylcholine receptor m3,gpcr,,Drug: chlorprothixene | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2209,chlorprothixene,muscarinic acetylcholine receptor m4,gpcr,,Drug: chlorprothixene | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2210,chlorprothixene,muscarinic acetylcholine receptor m5,gpcr,,Drug: chlorprothixene | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2211,chlorprothixene,d(4) dopamine receptor,gpcr,,Drug: chlorprothixene | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
2212,chlorprothixene,solute carrier family 22 member 1,transporter,,Drug: chlorprothixene | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2213,chlorprothixene,5-hydroxytryptamine receptor 7,gpcr,,Drug: chlorprothixene | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
2214,chlorprothixene,histamine h1 receptor,gpcr,,Drug: chlorprothixene | Target: histamine h1 receptor | Type: gpcr | Action: nan
2215,chlorprothixene,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: chlorprothixene | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
2216,chlortetracycline,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: chlortetracycline | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
2217,chlortetracycline,major prion protein,surface antigen,,Drug: chlortetracycline | Target: major prion protein | Type: surface antigen | Action: nan
2218,chlortetracycline,protein-arginine deiminase type-4,enzyme,,Drug: chlortetracycline | Target: protein-arginine deiminase type-4 | Type: enzyme | Action: nan
2219,chlortalidone,carbonic anhydrase 2,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
2220,chlortalidone,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: chlortalidone | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
2221,chlortalidone,carbonic anhydrase 1,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
2222,chlortalidone,carbonic anhydrase 4,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
2223,chlortalidone,carbonic anhydrase 9,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
2224,chlortalidone,carbonic anhydrase 12,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
2225,chlortalidone,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: chlortalidone | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
2226,chlortalidone,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: chlortalidone | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
2227,chlortalidone,carbonic anhydrase 7,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
2228,chlortalidone,carbonic anhydrase 3,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
2229,chlortalidone,carbonic anhydrase 6,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
2230,chlortalidone,carbonic anhydrase 14,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
2231,chlortalidone,carbonic anhydrase 13,enzyme,,Drug: chlortalidone | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
2232,chlorzoxazone,intermediate conductance calcium-activated potassium channel protein 4,ion channel,ACTIVATOR,Drug: chlorzoxazone | Target: intermediate conductance calcium-activated potassium channel protein 4 | Type: ion channel | Action: ACTIVATOR
2233,chlorzoxazone,"nitric oxide synthase, inducible",enzyme,,"Drug: chlorzoxazone | Target: nitric oxide synthase, inducible | Type: enzyme | Action: nan"
2234,chlorzoxazone,"nitric oxide synthase, brain",enzyme,,"Drug: chlorzoxazone | Target: nitric oxide synthase, brain | Type: enzyme | Action: nan"
2235,chlorzoxazone,"nitric oxide synthase, endothelial",enzyme,,"Drug: chlorzoxazone | Target: nitric oxide synthase, endothelial | Type: enzyme | Action: nan"
2236,chlorzoxazone,"nitric oxide synthase, brain",enzyme,,"Drug: chlorzoxazone | Target: nitric oxide synthase, brain | Type: enzyme | Action: nan"
2237,chlorzoxazone,small conductance calcium-activated potassium channel protein 2,ion channel,ACTIVATOR,Drug: chlorzoxazone | Target: small conductance calcium-activated potassium channel protein 2 | Type: ion channel | Action: ACTIVATOR
2238,chlorzoxazone,calcium-activated potassium channel subunit alpha-1,ion channel,OPENER,Drug: chlorzoxazone | Target: calcium-activated potassium channel subunit alpha-1 | Type: ion channel | Action: OPENER
2239,cianidanol,prostaglandin g/h synthase 2,enzyme,,Drug: cianidanol | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
2240,cianidanol,prostaglandin g/h synthase 1,enzyme,,Drug: cianidanol | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
2241,cianidanol,carbonic anhydrase 2,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
2242,cianidanol,carbonic anhydrase 1,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
2243,cianidanol,carbonic anhydrase 4,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
2244,cianidanol,carbonic anhydrase 9,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
2245,cianidanol,carbonic anhydrase 12,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
2246,cianidanol,prothrombin,enzyme,,Drug: cianidanol | Target: prothrombin | Type: enzyme | Action: nan
2247,cianidanol,mast/stem cell growth factor receptor kit,kinase,,Drug: cianidanol | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
2248,cianidanol,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: cianidanol | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
2249,cianidanol,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: cianidanol | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
2250,cianidanol,carbonic anhydrase 7,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
2251,cianidanol,carbonic anhydrase 3,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
2252,cianidanol,carbonic anhydrase 6,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
2253,cianidanol,carbonic anhydrase 14,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
2254,cianidanol,beta-secretase 1,enzyme,,Drug: cianidanol | Target: beta-secretase 1 | Type: enzyme | Action: nan
2255,cianidanol,prostaglandin g/h synthase 1,enzyme,,Drug: cianidanol | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
2256,cianidanol,polyphenol oxidase 2,enzyme,,Drug: cianidanol | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
2257,cianidanol,carbonic anhydrase 13,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
2258,cianidanol,carbonic anhydrase 15,enzyme,,Drug: cianidanol | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
2259,cianidanol,prostaglandin g/h synthase 1,enzyme,,Drug: cianidanol | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
2260,cianidanol,arginase,enzyme,,Drug: cianidanol | Target: arginase | Type: enzyme | Action: nan
2261,cianidanol,amyloid beta a4 protein,unclassified,,Drug: cianidanol | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
2262,cianidanol,dihydroorotate dehydrogenase,enzyme,,Drug: cianidanol | Target: dihydroorotate dehydrogenase | Type: enzyme | Action: nan
2264,cianidanol,amyloid beta a4 protein,unclassified,,Drug: cianidanol | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
2266,cibenzoline,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: cibenzoline | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2267,cibenzoline,atp-sensitive inward rectifier potassium channel 11,ion channel,,Drug: cibenzoline | Target: atp-sensitive inward rectifier potassium channel 11 | Type: ion channel | Action: nan
2268,cibenzoline,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: cibenzoline | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
2269,cicaprost,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: cicaprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
2270,cicaprost,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: cicaprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
2271,cicaprost,prostacyclin receptor,gpcr,,Drug: cicaprost | Target: prostacyclin receptor | Type: gpcr | Action: nan
2272,cicaprost,prostaglandin e2 receptor ep4 subtype,gpcr,,Drug: cicaprost | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: nan
2273,cicaprost,prostaglandin d2 receptor,gpcr,,Drug: cicaprost | Target: prostaglandin d2 receptor | Type: gpcr | Action: nan
2274,cicaprost,prostaglandin f2-alpha receptor,gpcr,,Drug: cicaprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: nan
2275,cicaprost,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: cicaprost | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
2276,cicaprost,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: cicaprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
2277,cicaprost,prostacyclin receptor,gpcr,AGONIST,Drug: cicaprost | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
2278,cyclacillin,penicillin-binding protein 1a,enzyme,,Drug: cyclacillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
2279,cyclacillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: cyclacillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
2280,ciclesonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: ciclesonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
2281,ciclopirox,poly [adp-ribose] polymerase 1,enzyme,INHIBITOR,Drug: ciclopirox | Target: poly [adp-ribose] polymerase 1 | Type: enzyme | Action: INHIBITOR
2282,ciclopirox,poly [adp-ribose] polymerase 1,unclassified,INHIBITOR,Drug: ciclopirox | Target: poly [adp-ribose] polymerase 1 | Type: unclassified | Action: INHIBITOR
2283,ciclopirox,deoxyhypusine hydroxylase,enzyme,,Drug: ciclopirox | Target: deoxyhypusine hydroxylase | Type: enzyme | Action: nan
2284,cicloprolol,beta-1 adrenergic receptor,gpcr,,Drug: cicloprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
2285,cicloprolol,beta-2 adrenergic receptor,gpcr,,Drug: cicloprolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
2286,cidofovir,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: cidofovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
2287,cilastatin,dipeptidase 1,enzyme,INHIBITOR,Drug: cilastatin | Target: dipeptidase 1 | Type: enzyme | Action: INHIBITOR
2288,cilastatin,dipeptidase 1,enzyme,,Drug: cilastatin | Target: dipeptidase 1 | Type: enzyme | Action: nan
2289,cilazapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: cilazapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
2290,cilnidipine,voltage-dependent n-type calcium channel subunit alpha-1b,ion channel,BLOCKER,Drug: cilnidipine | Target: voltage-dependent n-type calcium channel subunit alpha-1b | Type: ion channel | Action: BLOCKER
2291,cilnidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: cilnidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
2292,cilostazol,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,INHIBITOR,"Drug: cilostazol | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: INHIBITOR"
2293,cilostazol,cytochrome p450 2c9,enzyme,,Drug: cilostazol | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
2294,cilostazol,"cgmp-inhibited 3',5'-cyclic phosphodiesterase b",enzyme,INHIBITOR,"Drug: cilostazol | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase b | Type: enzyme | Action: INHIBITOR"
2295,cimetidine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: cimetidine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2296,cimetidine,histamine h2 receptor,gpcr,ANTAGONIST,Drug: cimetidine | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
2297,cimetidine,histamine h2 receptor,gpcr,,Drug: cimetidine | Target: histamine h2 receptor | Type: gpcr | Action: nan
2298,cimetidine,multidrug and toxin extrusion protein 1,transporter,,Drug: cimetidine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
2299,cimetidine,multidrug and toxin extrusion protein 2,transporter,INHIBITOR,Drug: cimetidine | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: INHIBITOR
2300,cimetidine,histamine h2 receptor,gpcr,ANTAGONIST,Drug: cimetidine | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
2301,cinacalcet,cytochrome p450 2d6,enzyme,,Drug: cinacalcet | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
2302,cinacalcet,glycine receptor subunit alpha-1,ion channel,,Drug: cinacalcet | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
2303,cinacalcet,extracellular calcium-sensing receptor,gpcr,POSITIVE ALLOSTERIC MODULATOR,Drug: cinacalcet | Target: extracellular calcium-sensing receptor | Type: gpcr | Action: POSITIVE ALLOSTERIC MODULATOR
2304,cinacalcet,metabotropic glutamate receptor 5,gpcr,ALLOSTERIC MODULATOR,Drug: cinacalcet | Target: metabotropic glutamate receptor 5 | Type: gpcr | Action: ALLOSTERIC MODULATOR
2305,cinalukast,cysteinyl leukotriene receptor 1,gpcr,,Drug: cinalukast | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
2306,cinalukast,cysteinyl leukotriene receptor 1,gpcr,ANTAGONIST,Drug: cinalukast | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: ANTAGONIST
2307,cinnarizine,mu-type opioid receptor,gpcr,,Drug: cinnarizine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
2308,cinnarizine,d(2) dopamine receptor,gpcr,,Drug: cinnarizine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2309,cinnarizine,alpha-2a adrenergic receptor,gpcr,,Drug: cinnarizine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2310,cinnarizine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: cinnarizine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2311,cinnarizine,sodium-dependent serotonin transporter,transporter,,Drug: cinnarizine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2312,cinnarizine,sodium-dependent noradrenaline transporter,transporter,,Drug: cinnarizine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2313,cinnarizine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: cinnarizine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2314,cinnarizine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: cinnarizine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2315,cinnarizine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: cinnarizine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2316,cinnarizine,alpha-2b adrenergic receptor,gpcr,,Drug: cinnarizine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2317,cinnarizine,d(3) dopamine receptor,gpcr,,Drug: cinnarizine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2318,cinnarizine,histamine h1 receptor,gpcr,,Drug: cinnarizine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2319,cinnarizine,histamine h4 receptor,gpcr,,Drug: cinnarizine | Target: histamine h4 receptor | Type: gpcr | Action: nan
2320,cinnarizine,muscarinic acetylcholine receptor m1,gpcr,,Drug: cinnarizine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2321,cinnarizine,muscarinic acetylcholine receptor m3,gpcr,,Drug: cinnarizine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2322,cinnarizine,muscarinic acetylcholine receptor m4,gpcr,,Drug: cinnarizine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2323,cinnarizine,muscarinic acetylcholine receptor m5,gpcr,,Drug: cinnarizine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2324,cinnarizine,alpha-2c adrenergic receptor,gpcr,,Drug: cinnarizine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
2325,cinnarizine,sodium-dependent dopamine transporter,transporter,,Drug: cinnarizine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2326,cinnarizine,alpha-1d adrenergic receptor,gpcr,,Drug: cinnarizine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2327,cinnarizine,alpha-1b adrenergic receptor,gpcr,,Drug: cinnarizine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2328,cinnarizine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: cinnarizine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
2329,cinnarizine,alpha-1a adrenergic receptor,gpcr,,Drug: cinnarizine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2330,cinnarizine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: cinnarizine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2331,cinnarizine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: cinnarizine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
2332,cinoxacin,carbonic anhydrase 2,enzyme,,Drug: cinoxacin | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
2333,cinoxacin,dna gyrase,enzyme,INHIBITOR,Drug: cinoxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
2334,ciprofibrate,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: ciprofibrate | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
2335,ciprofloxacin,dna topoisomerase 4 subunit a,enzyme,,Drug: ciprofloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: nan
2336,ciprofloxacin,dna topoisomerase 4 subunit a,enzyme,,Drug: ciprofloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: nan
2337,ciprofloxacin,dna topoisomerase 4 subunit a,enzyme,INHIBITOR,Drug: ciprofloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: INHIBITOR
2338,ciprofloxacin,dna gyrase subunit a,enzyme,,Drug: ciprofloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
2339,ciprofloxacin,dna gyrase subunit a,enzyme,INHIBITOR,Drug: ciprofloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: INHIBITOR
2340,ciprofloxacin,histamine h3 receptor,gpcr,,Drug: ciprofloxacin | Target: histamine h3 receptor | Type: gpcr | Action: nan
2341,ciprofloxacin,gaba-a receptor; anion channel,ion channel,,Drug: ciprofloxacin | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
2342,ciprofloxacin,dna topoisomerase ii,enzyme,,Drug: ciprofloxacin | Target: dna topoisomerase ii | Type: enzyme | Action: nan
2343,ciprofloxacin,multidrug resistance protein mdtk,unclassified,,Drug: ciprofloxacin | Target: multidrug resistance protein mdtk | Type: unclassified | Action: nan
2344,cisapride,5-hydroxytryptamine receptor 4,gpcr,,Drug: cisapride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
2345,cisapride,d(1a) dopamine receptor,gpcr,,Drug: cisapride | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2346,cisapride,d(2) dopamine receptor,gpcr,,Drug: cisapride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2347,cisapride,alpha-2a adrenergic receptor,gpcr,,Drug: cisapride | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2348,cisapride,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: cisapride | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2349,cisapride,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: cisapride | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2350,cisapride,cytochrome p450 3a4,enzyme,,Drug: cisapride | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
2351,cisapride,sodium-dependent serotonin transporter,transporter,,Drug: cisapride | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2352,cisapride,5-hydroxytryptamine receptor 1a,gpcr,,Drug: cisapride | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2353,cisapride,5-hydroxytryptamine receptor 2a,gpcr,,Drug: cisapride | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2354,cisapride,5-hydroxytryptamine receptor 2b,gpcr,,Drug: cisapride | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2355,cisapride,5-hydroxytryptamine receptor 2c,gpcr,,Drug: cisapride | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2356,cisapride,5-hydroxytryptamine receptor 7,gpcr,,Drug: cisapride | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
2357,cisapride,alpha-2b adrenergic receptor,gpcr,,Drug: cisapride | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2358,cisapride,d(3) dopamine receptor,gpcr,,Drug: cisapride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2359,cisapride,alpha-2c adrenergic receptor,gpcr,,Drug: cisapride | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
2360,cisapride,cytochrome p450 2d6,enzyme,,Drug: cisapride | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
2361,cisapride,alpha-1d adrenergic receptor,gpcr,,Drug: cisapride | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2362,cisapride,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: cisapride | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
2363,cisapride,5-hydroxytryptamine receptor 4,gpcr,AGONIST,Drug: cisapride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: AGONIST
2364,cisapride,alpha-1b adrenergic receptor,gpcr,,Drug: cisapride | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2365,cisapride,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: cisapride | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
2366,cisapride,alpha-1a adrenergic receptor,gpcr,,Drug: cisapride | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2367,cisapride,d(2) dopamine receptor,gpcr,,Drug: cisapride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2368,cisapride,5-hydroxytryptamine receptor 7,gpcr,AGONIST,Drug: cisapride | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: AGONIST
2369,cisapride,d(1a) dopamine receptor,gpcr,,Drug: cisapride | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2370,cisapride,alpha-2a adrenergic receptor,gpcr,,Drug: cisapride | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2371,cisapride,5-hydroxytryptamine receptor 4,gpcr,AGONIST,Drug: cisapride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: AGONIST
2372,cisapride,5-hydroxytryptamine receptor 2a,gpcr,,Drug: cisapride | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2373,cisapride,serotonin 3 (5-ht3) receptor,ion channel,,Drug: cisapride | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
2374,cisapride,serotonin 3 (5-ht3) receptor,ion channel,,Drug: cisapride | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
2375,cisapride,serotonin 1 (5-ht1) receptor,gpcr,,Drug: cisapride | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
2376,cisapride,adrenergic receptor alpha-2,gpcr,,Drug: cisapride | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
2377,cisapride,serotonin 2 (5-ht2) receptor,gpcr,,Drug: cisapride | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
2378,cisapride,5-hydroxytryptamine receptor 4,gpcr,AGONIST,Drug: cisapride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: AGONIST
2379,cisatracurium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: cisatracurium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
2380,citalopram,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: citalopram | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2381,citalopram,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: citalopram | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2382,citalopram,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: citalopram | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
2383,citalopram,sodium-dependent noradrenaline transporter,transporter,,Drug: citalopram | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2384,citalopram,5-hydroxytryptamine receptor 2a,gpcr,,Drug: citalopram | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2385,citalopram,5-hydroxytryptamine receptor 2b,gpcr,,Drug: citalopram | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2386,citalopram,5-hydroxytryptamine receptor 2c,gpcr,,Drug: citalopram | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2387,citalopram,histamine h1 receptor,gpcr,,Drug: citalopram | Target: histamine h1 receptor | Type: gpcr | Action: nan
2388,citalopram,muscarinic acetylcholine receptor m1,gpcr,,Drug: citalopram | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2389,citalopram,sodium-dependent dopamine transporter,transporter,,Drug: citalopram | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2390,citalopram,alpha-1d adrenergic receptor,gpcr,,Drug: citalopram | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2391,citalopram,solute carrier family 22 member 1,transporter,,Drug: citalopram | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2392,citalopram,alpha-1b adrenergic receptor,gpcr,,Drug: citalopram | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2393,citalopram,alpha-1a adrenergic receptor,gpcr,,Drug: citalopram | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2394,citalopram,5-hydroxytryptamine receptor 1a,gpcr,,Drug: citalopram | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2395,citalopram,sodium-dependent serotonin transporter,transporter,,Drug: citalopram | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2396,citalopram,sodium-dependent dopamine transporter,transporter,,Drug: citalopram | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2397,citalopram,transporter,transporter,,Drug: citalopram | Target: transporter | Type: transporter | Action: nan
2398,citalopram,sodium-dependent dopamine transporter,transporter,,Drug: citalopram | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2399,citalopram,transporter,transporter,,Drug: citalopram | Target: transporter | Type: transporter | Action: nan
2400,citric acid,3-dehydroquinate dehydratase,enzyme,,Drug: citric acid | Target: 3-dehydroquinate dehydratase | Type: enzyme | Action: nan
2401,citric acid,3-dehydroquinate dehydratase,enzyme,,Drug: citric acid | Target: 3-dehydroquinate dehydratase | Type: enzyme | Action: nan
2402,citric acid,transient receptor potential cation channel subfamily v member 4,ion channel,ACTIVATOR,Drug: citric acid | Target: transient receptor potential cation channel subfamily v member 4 | Type: ion channel | Action: ACTIVATOR
2403,cladribine,deoxycytidine kinase,kinase,,Drug: cladribine | Target: deoxycytidine kinase | Type: kinase | Action: nan
2404,cladribine,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: cladribine | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
2405,cladribine,adenosine receptor a1,gpcr,,Drug: cladribine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
2406,cladribine,adenosine receptor a2a,gpcr,,Drug: cladribine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
2407,clarithromycin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: clarithromycin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2408,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2409,clavulanic acid,beta-lactamase tem,enzyme,INHIBITOR,Drug: clavulanic acid | Target: beta-lactamase tem | Type: enzyme | Action: INHIBITOR
2410,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2411,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2412,clavulanic acid,beta-lactamase shv-1,enzyme,,Drug: clavulanic acid | Target: beta-lactamase shv-1 | Type: enzyme | Action: nan
2413,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2414,clavulanic acid,beta-lactamase oxa-1,enzyme,,Drug: clavulanic acid | Target: beta-lactamase oxa-1 | Type: enzyme | Action: nan
2415,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2416,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2417,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2418,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2419,clavulanic acid,carbapenem-hydrolizing beta-lactamase sfc-1,enzyme,,Drug: clavulanic acid | Target: carbapenem-hydrolizing beta-lactamase sfc-1 | Type: enzyme | Action: nan
2420,clavulanic acid,carbepenem-hydrolyzing beta-lactamase kpc,enzyme,,Drug: clavulanic acid | Target: carbepenem-hydrolyzing beta-lactamase kpc | Type: enzyme | Action: nan
2421,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2422,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2423,clavulanic acid,beta-lactamase shv-1,enzyme,,Drug: clavulanic acid | Target: beta-lactamase shv-1 | Type: enzyme | Action: nan
2424,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2425,clavulanic acid,beta-lactamase ges-13,enzyme,,Drug: clavulanic acid | Target: beta-lactamase ges-13 | Type: enzyme | Action: nan
2426,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2427,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2428,clavulanic acid,class d beta-lactamase,unclassified,,Drug: clavulanic acid | Target: class d beta-lactamase | Type: unclassified | Action: nan
2429,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2430,clavulanic acid,beta-lactamase shv-5,enzyme,,Drug: clavulanic acid | Target: beta-lactamase shv-5 | Type: enzyme | Action: nan
2431,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2432,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2433,clavulanic acid,beta-lactamase,enzyme,,Drug: clavulanic acid | Target: beta-lactamase | Type: enzyme | Action: nan
2434,clebopride,5-hydroxytryptamine receptor 4,gpcr,,Drug: clebopride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
2435,clebopride,d(2) dopamine receptor,gpcr,,Drug: clebopride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2436,clebopride,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: clebopride | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2437,clebopride,d(3) dopamine receptor,gpcr,,Drug: clebopride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2438,clebopride,d(4) dopamine receptor,gpcr,,Drug: clebopride | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
2439,clebopride,acetylcholinesterase,enzyme,,Drug: clebopride | Target: acetylcholinesterase | Type: enzyme | Action: nan
2440,clebopride,d(2) dopamine receptor,gpcr,,Drug: clebopride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2441,clebopride,d(1a) dopamine receptor,gpcr,,Drug: clebopride | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2442,clebopride,5-hydroxytryptamine receptor 4,gpcr,,Drug: clebopride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
2443,clebopride,adrenergic receptor alpha-2,gpcr,,Drug: clebopride | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
2444,clebopride,serotonin 2 (5-ht2) receptor,gpcr,,Drug: clebopride | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
2445,clemastine,d(1a) dopamine receptor,gpcr,,Drug: clemastine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2446,clemastine,d(2) dopamine receptor,gpcr,,Drug: clemastine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2447,clemastine,alpha-2a adrenergic receptor,gpcr,,Drug: clemastine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2448,clemastine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: clemastine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2449,clemastine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: clemastine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2450,clemastine,sodium-dependent noradrenaline transporter,transporter,,Drug: clemastine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2451,clemastine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: clemastine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2452,clemastine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: clemastine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2453,clemastine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: clemastine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2454,clemastine,5-hydroxytryptamine receptor 6,gpcr,,Drug: clemastine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
2455,clemastine,alpha-2b adrenergic receptor,gpcr,,Drug: clemastine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2456,clemastine,d(3) dopamine receptor,gpcr,,Drug: clemastine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2457,clemastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: clemastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
2458,clemastine,histamine h2 receptor,gpcr,,Drug: clemastine | Target: histamine h2 receptor | Type: gpcr | Action: nan
2459,clemastine,muscarinic acetylcholine receptor m1,gpcr,,Drug: clemastine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2460,clemastine,muscarinic acetylcholine receptor m2,gpcr,,Drug: clemastine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2461,clemastine,muscarinic acetylcholine receptor m3,gpcr,,Drug: clemastine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2462,clemastine,muscarinic acetylcholine receptor m4,gpcr,,Drug: clemastine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2463,clemastine,muscarinic acetylcholine receptor m5,gpcr,,Drug: clemastine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2464,clemastine,alpha-2c adrenergic receptor,gpcr,,Drug: clemastine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
2465,clemastine,sodium-dependent dopamine transporter,transporter,,Drug: clemastine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2466,clemastine,cytochrome p450 2d6,enzyme,,Drug: clemastine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
2467,clemastine,alpha-1d adrenergic receptor,gpcr,,Drug: clemastine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2468,clemastine,cytochrome p450 2c19,enzyme,,Drug: clemastine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
2469,clemastine,solute carrier family 22 member 1,transporter,,Drug: clemastine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2470,clemastine,alpha-1b adrenergic receptor,gpcr,,Drug: clemastine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2471,clemastine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: clemastine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
2472,clemastine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: clemastine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
2473,clemastine,alpha-1a adrenergic receptor,gpcr,,Drug: clemastine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2474,clemastine,transmembrane protein 97,enzyme,,Drug: clemastine | Target: transmembrane protein 97 | Type: enzyme | Action: nan
2475,clemizole,histamine h4 receptor,gpcr,,Drug: clemizole | Target: histamine h4 receptor | Type: gpcr | Action: nan
2476,clemizole,heme oxygenase 2,enzyme,,Drug: clemizole | Target: heme oxygenase 2 | Type: enzyme | Action: nan
2477,clemizole,short transient receptor potential channel 4,ion channel,BLOCKER,Drug: clemizole | Target: short transient receptor potential channel 4 | Type: ion channel | Action: BLOCKER
2478,clemizole,short transient receptor potential channel 5,ion channel,BLOCKER,Drug: clemizole | Target: short transient receptor potential channel 5 | Type: ion channel | Action: BLOCKER
2479,clemizole,short transient receptor potential channel 3,ion channel,BLOCKER,Drug: clemizole | Target: short transient receptor potential channel 3 | Type: ion channel | Action: BLOCKER
2480,clemizole,short transient receptor potential channel 6,ion channel,BLOCKER,Drug: clemizole | Target: short transient receptor potential channel 6 | Type: ion channel | Action: BLOCKER
2481,clenbuterol,beta-1 adrenergic receptor,gpcr,,Drug: clenbuterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
2482,clenbuterol,beta-2 adrenergic receptor,gpcr,,Drug: clenbuterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
2483,clenbuterol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clenbuterol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2484,clenbuterol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clenbuterol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2485,clenbuterol,beta-2 adrenergic receptor,gpcr,,Drug: clenbuterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
2486,clevidipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: clevidipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
2487,clevidipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,BLOCKER,Drug: clevidipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: BLOCKER
2488,clidinium,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: clidinium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
2489,clidinium,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: clidinium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
2490,clindamycin,50s ribosomal protein l10,ribosomal protein,,Drug: clindamycin | Target: 50s ribosomal protein l10 | Type: ribosomal protein | Action: nan
2491,clioquinol,catechol o-methyltransferase,enzyme,,Drug: clioquinol | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
2492,clioquinol,botulinum neurotoxin type a,enzyme,,Drug: clioquinol | Target: botulinum neurotoxin type a | Type: enzyme | Action: nan
2493,clioquinol,carbonic anhydrase 15,enzyme,,Drug: clioquinol | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
2494,clioquinol,amyloid beta a4 protein,unclassified,,Drug: clioquinol | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
2495,clobazam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: clobazam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2496,clodronic acid,adp/atp translocase 2,enzyme,,Drug: clodronic acid | Target: adp/atp translocase 2 | Type: enzyme | Action: nan
2497,clodronic acid,adp/atp translocase 1,transporter,,Drug: clodronic acid | Target: adp/atp translocase 1 | Type: transporter | Action: nan
2498,clodronic acid,adp/atp translocase 3,enzyme,,Drug: clodronic acid | Target: adp/atp translocase 3 | Type: enzyme | Action: nan
2499,clodronic acid,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: clodronic acid | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
2500,clodronic acid,solute carrier family 17 member 9,transporter,INHIBITOR,Drug: clodronic acid | Target: solute carrier family 17 member 9 | Type: transporter | Action: INHIBITOR
2501,clodronic acid,type iv secretion-like conjugative transfer relaxase protein trai,unclassified,,Drug: clodronic acid | Target: type iv secretion-like conjugative transfer relaxase protein trai | Type: unclassified | Action: nan
2502,clofarabine,dna polymerase alpha catalytic subunit,enzyme,INHIBITOR,Drug: clofarabine | Target: dna polymerase alpha catalytic subunit | Type: enzyme | Action: INHIBITOR
2503,clofarabine,ribonucleoside-diphosphate reductase large subunit,enzyme,INHIBITOR,Drug: clofarabine | Target: ribonucleoside-diphosphate reductase large subunit | Type: enzyme | Action: INHIBITOR
2504,clofarabine,ribonucleoside-diphosphate reductase subunit m2,enzyme,INHIBITOR,Drug: clofarabine | Target: ribonucleoside-diphosphate reductase subunit m2 | Type: enzyme | Action: INHIBITOR
2505,clofarabine,ribose-phosphate pyrophosphokinase 1,kinase,,Drug: clofarabine | Target: ribose-phosphate pyrophosphokinase 1 | Type: kinase | Action: nan
2506,clofarabine,uridine-cytidine kinase 1,kinase,,Drug: clofarabine | Target: uridine-cytidine kinase 1 | Type: kinase | Action: nan
2507,clofarabine,uridine-cytidine kinase 2,kinase,,Drug: clofarabine | Target: uridine-cytidine kinase 2 | Type: kinase | Action: nan
2508,clofarabine,"cgmp-dependent 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: clofarabine | Target: cgmp-dependent 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
2509,clofazimine,uncharacterized oxidoreductase czco-like,enzyme,,Drug: clofazimine | Target: uncharacterized oxidoreductase czco-like | Type: enzyme | Action: nan
2510,clofazimine,cruzipain,enzyme,,Drug: clofazimine | Target: cruzipain | Type: enzyme | Action: nan
2511,clofibrate,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: clofibrate | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
2512,clofibrate,"fatty acid-binding protein, liver",unclassified,,"Drug: clofibrate | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
2513,clofibric acid,lipoprotein lipase,enzyme,,Drug: clofibric acid | Target: lipoprotein lipase | Type: enzyme | Action: nan
2514,clofibric acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: clofibric acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
2515,clofibric acid,peroxisome proliferator-activated receptor alpha,transcription factor,,Drug: clofibric acid | Target: peroxisome proliferator-activated receptor alpha | Type: transcription factor | Action: nan
2516,clometacin,prostaglandin-h2 d-isomerase,enzyme,,Drug: clometacin | Target: prostaglandin-h2 d-isomerase | Type: enzyme | Action: nan
2517,clomifene,prostaglandin g/h synthase 1,enzyme,,Drug: clomifene | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
2518,clomifene,alpha-2a adrenergic receptor,gpcr,,Drug: clomifene | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2519,clomifene,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: clomifene | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2520,clomifene,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: clomifene | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2521,clomifene,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: clomifene | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
2522,clomifene,sodium-dependent serotonin transporter,transporter,,Drug: clomifene | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2523,clomifene,sodium-dependent noradrenaline transporter,transporter,,Drug: clomifene | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2524,clomifene,5-hydroxytryptamine receptor 2a,gpcr,,Drug: clomifene | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2525,clomifene,5-hydroxytryptamine receptor 2b,gpcr,,Drug: clomifene | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2526,clomifene,5-hydroxytryptamine receptor 2c,gpcr,,Drug: clomifene | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2527,clomifene,5-hydroxytryptamine receptor 6,gpcr,,Drug: clomifene | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
2528,clomifene,alpha-2b adrenergic receptor,gpcr,,Drug: clomifene | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2529,clomifene,d(3) dopamine receptor,gpcr,,Drug: clomifene | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2530,clomifene,histamine h1 receptor,gpcr,,Drug: clomifene | Target: histamine h1 receptor | Type: gpcr | Action: nan
2531,clomifene,muscarinic acetylcholine receptor m1,gpcr,,Drug: clomifene | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2532,clomifene,muscarinic acetylcholine receptor m2,gpcr,,Drug: clomifene | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2533,clomifene,muscarinic acetylcholine receptor m3,gpcr,,Drug: clomifene | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2534,clomifene,muscarinic acetylcholine receptor m4,gpcr,,Drug: clomifene | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2535,clomifene,muscarinic acetylcholine receptor m5,gpcr,,Drug: clomifene | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2536,clomifene,beta-3 adrenergic receptor,gpcr,,Drug: clomifene | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
2537,clomifene,alpha-2c adrenergic receptor,gpcr,,Drug: clomifene | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
2538,clomifene,sodium-dependent dopamine transporter,transporter,,Drug: clomifene | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2539,clomifene,cytochrome p450 2d6,enzyme,,Drug: clomifene | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
2540,clomifene,adenosine receptor a3,gpcr,,Drug: clomifene | Target: adenosine receptor a3 | Type: gpcr | Action: nan
2541,clomifene,estrogen receptor,nuclear hormone receptor,MODULATOR,Drug: clomifene | Target: estrogen receptor | Type: nuclear hormone receptor | Action: MODULATOR
2542,clomifene,epidermal growth factor receptor,kinase,,Drug: clomifene | Target: epidermal growth factor receptor | Type: kinase | Action: nan
2543,clomifene,tyrosine-protein kinase fyn,kinase,,Drug: clomifene | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
2544,clomifene,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: clomifene | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
2545,clomifene,substance-k receptor,gpcr,,Drug: clomifene | Target: substance-k receptor | Type: gpcr | Action: nan
2546,clomifene,androgen receptor,transcription factor,,Drug: clomifene | Target: androgen receptor | Type: transcription factor | Action: nan
2547,clomifene,alpha-1b adrenergic receptor,gpcr,,Drug: clomifene | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2548,clomifene,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: clomifene | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
2549,clomifene,c-8 sterol isomerase,enzyme,,Drug: clomifene | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
2550,clomipramine,d(1a) dopamine receptor,gpcr,,Drug: clomipramine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2551,clomipramine,d(2) dopamine receptor,gpcr,,Drug: clomipramine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2552,clomipramine,alpha-2a adrenergic receptor,gpcr,,Drug: clomipramine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2553,clomipramine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: clomipramine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2554,clomipramine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: clomipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
2555,clomipramine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: clomipramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
2556,clomipramine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: clomipramine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2557,clomipramine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: clomipramine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2558,clomipramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: clomipramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2559,clomipramine,5-hydroxytryptamine receptor 6,gpcr,,Drug: clomipramine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
2560,clomipramine,alpha-1a adrenergic receptor,gpcr,,Drug: clomipramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2561,clomipramine,alpha-2b adrenergic receptor,gpcr,,Drug: clomipramine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2562,clomipramine,d(3) dopamine receptor,gpcr,,Drug: clomipramine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2563,clomipramine,histamine h1 receptor,gpcr,,Drug: clomipramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2564,clomipramine,histamine h2 receptor,gpcr,,Drug: clomipramine | Target: histamine h2 receptor | Type: gpcr | Action: nan
2565,clomipramine,muscarinic acetylcholine receptor m1,gpcr,,Drug: clomipramine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2566,clomipramine,muscarinic acetylcholine receptor m2,gpcr,,Drug: clomipramine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2567,clomipramine,muscarinic acetylcholine receptor m3,gpcr,,Drug: clomipramine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2568,clomipramine,muscarinic acetylcholine receptor m4,gpcr,,Drug: clomipramine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2569,clomipramine,muscarinic acetylcholine receptor m5,gpcr,,Drug: clomipramine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2570,clomipramine,aldehyde oxidase,enzyme,,Drug: clomipramine | Target: aldehyde oxidase | Type: enzyme | Action: nan
2571,clomipramine,alpha-2c adrenergic receptor,gpcr,,Drug: clomipramine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
2572,clomipramine,sodium-dependent dopamine transporter,transporter,,Drug: clomipramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2573,clomipramine,cytochrome p450 2d6,enzyme,,Drug: clomipramine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
2574,clomipramine,alpha-1d adrenergic receptor,gpcr,,Drug: clomipramine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2575,clomipramine,glutathione s-transferase p,enzyme,,Drug: clomipramine | Target: glutathione s-transferase p | Type: enzyme | Action: nan
2576,clomipramine,solute carrier family 22 member 1,transporter,,Drug: clomipramine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2577,clomipramine,trypanothione reductase,enzyme,,Drug: clomipramine | Target: trypanothione reductase | Type: enzyme | Action: nan
2578,clomipramine,alpha-1b adrenergic receptor,gpcr,,Drug: clomipramine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2579,clomipramine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: clomipramine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
2580,clomipramine,alpha-1a adrenergic receptor,gpcr,,Drug: clomipramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2581,clomipramine,d(2) dopamine receptor,gpcr,,Drug: clomipramine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2582,clomipramine,sodium-dependent noradrenaline transporter,transporter,,Drug: clomipramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2583,clomipramine,sodium-dependent serotonin transporter,transporter,,Drug: clomipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2584,clomipramine,histamine h1 receptor,gpcr,,Drug: clomipramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2585,clomipramine,serotonin (5-ht) receptor,gpcr,,Drug: clomipramine | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
2586,clomipramine,serotonin 1 (5-ht1) receptor,gpcr,,Drug: clomipramine | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
2587,clomipramine,adrenergic receptor alpha-2,gpcr,,Drug: clomipramine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
2588,clomipramine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: clomipramine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
2589,clomipramine,trypanothione reductase,enzyme,,Drug: clomipramine | Target: trypanothione reductase | Type: enzyme | Action: nan
2590,clomipramine,g protein-activated inward rectifier potassium channel 2,ion channel,BLOCKER,Drug: clomipramine | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: BLOCKER
2591,clonazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: clonazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2592,clonazepam,gaba-a receptor; anion channel,ion channel,,Drug: clonazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
2593,clonazepam,gaba-a receptor; anion channel,ion channel,,Drug: clonazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
2594,clonazepam,gaba-a receptor; anion channel,ion channel,,Drug: clonazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
2595,clonidine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: clonidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
2596,clonidine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clonidine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2597,clonidine,alpha-1a adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2598,clonidine,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: clonidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
2599,clonidine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: clonidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
2600,clonidine,alpha-1d adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2601,clonidine,alpha-1b adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2602,clonidine,nischarin,membrane receptor,,Drug: clonidine | Target: nischarin | Type: membrane receptor | Action: nan
2603,clonidine,solute carrier family 22 member 1,transporter,,Drug: clonidine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2604,clonidine,alpha-1b adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2605,clonidine,alpha-1a adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2606,clonidine,alpha-2b adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2607,clonidine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: clonidine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
2608,clonidine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clonidine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2609,clonidine,alpha-2a adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2610,clonidine,alpha-1a adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2611,clonidine,alpha-2a adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2612,clonidine,beta-1 adrenergic receptor,gpcr,,Drug: clonidine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
2613,clonidine,nischarin,unclassified,,Drug: clonidine | Target: nischarin | Type: unclassified | Action: nan
2614,clonidine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,ion channel,BLOCKER,Drug: clonidine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | Type: ion channel | Action: BLOCKER
2615,clonidine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,ion channel,BLOCKER,Drug: clonidine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | Type: ion channel | Action: BLOCKER
2616,clonidine,solute carrier family 22 member 2,transporter,,Drug: clonidine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
2617,clonidine,multidrug and toxin extrusion protein 1,transporter,,Drug: clonidine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
2618,clonidine,adrenergic receptor alpha-2,gpcr,,Drug: clonidine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
2619,clonidine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,BLOCKER,Drug: clonidine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: BLOCKER
2620,clonidine,alpha-1b adrenergic receptor,gpcr,,Drug: clonidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2621,clonixin,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: clonixin | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
2622,cloperastine,solute carrier family 22 member 1,transporter,,Drug: cloperastine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2623,clopidogrel,sodium-dependent serotonin transporter,transporter,,Drug: clopidogrel | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2624,clopidogrel,p2y purinoceptor 12,gpcr,ANTAGONIST,Drug: clopidogrel | Target: p2y purinoceptor 12 | Type: gpcr | Action: ANTAGONIST
2625,clopidogrel,cytochrome p450 2b6,enzyme,,Drug: clopidogrel | Target: cytochrome p450 2b6 | Type: enzyme | Action: nan
2626,clorazepate,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: clorazepate | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2627,clorazepate,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: clorazepate | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2628,clorazepate,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: clorazepate | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2629,clorazepate,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: clorazepate | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
2630,clorprenaline,beta-1 adrenergic receptor,gpcr,,Drug: clorprenaline | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
2631,clorprenaline,beta-2 adrenergic receptor,gpcr,,Drug: clorprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
2632,clotiapine,d(2) dopamine receptor,gpcr,,Drug: clotiapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2633,clotiapine,d(2) dopamine receptor,gpcr,,Drug: clotiapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2634,clotiapine,d(1a) dopamine receptor,gpcr,,Drug: clotiapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2635,clotiapine,muscarinic acetylcholine receptor,gpcr,,Drug: clotiapine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
2636,clotiapine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: clotiapine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
2637,clotrimazole,beta-1 adrenergic receptor,gpcr,,Drug: clotrimazole | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
2638,clotrimazole,prostaglandin g/h synthase 2,enzyme,,Drug: clotrimazole | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
2639,clotrimazole,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,ANTAGONIST,Drug: clotrimazole | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: ANTAGONIST
2640,clotrimazole,mu-type opioid receptor,gpcr,,Drug: clotrimazole | Target: mu-type opioid receptor | Type: gpcr | Action: nan
2641,clotrimazole,d(1a) dopamine receptor,gpcr,,Drug: clotrimazole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2642,clotrimazole,d(2) dopamine receptor,gpcr,,Drug: clotrimazole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2643,clotrimazole,adenosine receptor a2a,gpcr,,Drug: clotrimazole | Target: adenosine receptor a2a | Type: gpcr | Action: nan
2644,clotrimazole,alpha-2a adrenergic receptor,gpcr,,Drug: clotrimazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2645,clotrimazole,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: clotrimazole | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2646,clotrimazole,cytochrome p450 3a4,enzyme,,Drug: clotrimazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
2647,clotrimazole,multidrug resistance protein 1,transporter,,Drug: clotrimazole | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
2648,clotrimazole,sodium-dependent serotonin transporter,transporter,,Drug: clotrimazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2649,clotrimazole,sodium-dependent noradrenaline transporter,transporter,,Drug: clotrimazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2650,clotrimazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clotrimazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2651,clotrimazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: clotrimazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2652,clotrimazole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: clotrimazole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2653,clotrimazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: clotrimazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2654,clotrimazole,5-hydroxytryptamine receptor 6,gpcr,,Drug: clotrimazole | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
2655,clotrimazole,alpha-2b adrenergic receptor,gpcr,,Drug: clotrimazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2656,clotrimazole,d(3) dopamine receptor,gpcr,,Drug: clotrimazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2657,clotrimazole,histamine h1 receptor,gpcr,,Drug: clotrimazole | Target: histamine h1 receptor | Type: gpcr | Action: nan
2658,clotrimazole,histamine h2 receptor,gpcr,,Drug: clotrimazole | Target: histamine h2 receptor | Type: gpcr | Action: nan
2659,clotrimazole,muscarinic acetylcholine receptor m1,gpcr,,Drug: clotrimazole | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2660,clotrimazole,muscarinic acetylcholine receptor m2,gpcr,,Drug: clotrimazole | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2661,clotrimazole,muscarinic acetylcholine receptor m3,gpcr,,Drug: clotrimazole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2662,clotrimazole,muscarinic acetylcholine receptor m4,gpcr,,Drug: clotrimazole | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2663,clotrimazole,glucocorticoid receptor,nuclear hormone receptor,,Drug: clotrimazole | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
2664,clotrimazole,beta-3 adrenergic receptor,gpcr,,Drug: clotrimazole | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
2665,clotrimazole,sodium-dependent dopamine transporter,transporter,,Drug: clotrimazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2666,clotrimazole,adenosine receptor a1,gpcr,,Drug: clotrimazole | Target: adenosine receptor a1 | Type: gpcr | Action: nan
2667,clotrimazole,adenosine receptor a3,gpcr,,Drug: clotrimazole | Target: adenosine receptor a3 | Type: gpcr | Action: nan
2668,clotrimazole,intermediate conductance calcium-activated potassium channel protein 4,ion channel,,Drug: clotrimazole | Target: intermediate conductance calcium-activated potassium channel protein 4 | Type: ion channel | Action: nan
2669,clotrimazole,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: clotrimazole | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
2670,clotrimazole,d(4) dopamine receptor,gpcr,,Drug: clotrimazole | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
2671,clotrimazole,carbonic anhydrase 2,enzyme,,Drug: clotrimazole | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
2672,clotrimazole,alpha-1d adrenergic receptor,gpcr,,Drug: clotrimazole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2673,clotrimazole,kappa-type opioid receptor,gpcr,,Drug: clotrimazole | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
2674,clotrimazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: clotrimazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
2675,clotrimazole,delta-type opioid receptor,gpcr,,Drug: clotrimazole | Target: delta-type opioid receptor | Type: gpcr | Action: nan
2676,clotrimazole,beta-lactamase,enzyme,,Drug: clotrimazole | Target: beta-lactamase | Type: enzyme | Action: nan
2677,clotrimazole,acetylcholinesterase,enzyme,,Drug: clotrimazole | Target: acetylcholinesterase | Type: enzyme | Action: nan
2678,clotrimazole,cytochrome p450 2c9,enzyme,,Drug: clotrimazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
2679,clotrimazole,platelet-activating factor receptor,gpcr,,Drug: clotrimazole | Target: platelet-activating factor receptor | Type: gpcr | Action: nan
2680,clotrimazole,aromatase,enzyme,,Drug: clotrimazole | Target: aromatase | Type: enzyme | Action: nan
2681,clotrimazole,cysteinyl leukotriene receptor 1,gpcr,,Drug: clotrimazole | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
2682,clotrimazole,epidermal growth factor receptor,kinase,,Drug: clotrimazole | Target: epidermal growth factor receptor | Type: kinase | Action: nan
2683,clotrimazole,vasopressin v2 receptor,gpcr,,Drug: clotrimazole | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
2684,clotrimazole,substance-p receptor,gpcr,,Drug: clotrimazole | Target: substance-p receptor | Type: gpcr | Action: nan
2685,clotrimazole,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,,"Drug: clotrimazole | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: nan"
2686,clotrimazole,potassium voltage-gated channel subfamily a member 3,ion channel,,Drug: clotrimazole | Target: potassium voltage-gated channel subfamily a member 3 | Type: ion channel | Action: nan
2687,clotrimazole,cytochrome p450 2c19,enzyme,,Drug: clotrimazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
2688,clotrimazole,tyrosine-protein kinase fyn,kinase,,Drug: clotrimazole | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
2689,clotrimazole,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: clotrimazole | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
2690,clotrimazole,thromboxane-a synthase,enzyme,,Drug: clotrimazole | Target: thromboxane-a synthase | Type: enzyme | Action: nan
2691,clotrimazole,bile acid receptor,nuclear hormone receptor,,Drug: clotrimazole | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
2692,clotrimazole,lanosterol 14-alpha demethylase,enzyme,,Drug: clotrimazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
2693,clotrimazole,solute carrier family 22 member 1,transporter,,Drug: clotrimazole | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
2694,clotrimazole,substance-k receptor,gpcr,,Drug: clotrimazole | Target: substance-k receptor | Type: gpcr | Action: nan
2695,clotrimazole,androgen receptor,transcription factor,,Drug: clotrimazole | Target: androgen receptor | Type: transcription factor | Action: nan
2696,clotrimazole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: clotrimazole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
2697,clotrimazole,c-c chemokine receptor type 4,gpcr,,Drug: clotrimazole | Target: c-c chemokine receptor type 4 | Type: gpcr | Action: nan
2698,clotrimazole,cysteinyl leukotriene receptor 1,gpcr,,Drug: clotrimazole | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
2699,clotrimazole,progesterone receptor,transcription factor,,Drug: clotrimazole | Target: progesterone receptor | Type: transcription factor | Action: nan
2700,clotrimazole,alpha-1a adrenergic receptor,gpcr,,Drug: clotrimazole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2701,clotrimazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clotrimazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2702,clotrimazole,lanosterol 14-alpha demethylase,enzyme,,Drug: clotrimazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
2703,clotrimazole,c-x-c chemokine receptor type 1,gpcr,,Drug: clotrimazole | Target: c-x-c chemokine receptor type 1 | Type: gpcr | Action: nan
2704,clotrimazole,14-alpha sterol demethylase cyp51a,enzyme,,Drug: clotrimazole | Target: 14-alpha sterol demethylase cyp51a | Type: enzyme | Action: nan
2705,clotrimazole,14-alpha sterol demethylase,enzyme,,Drug: clotrimazole | Target: 14-alpha sterol demethylase | Type: enzyme | Action: nan
2706,clotrimazole,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: clotrimazole | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
2707,clotrimazole,mycocyclosin synthase,enzyme,,Drug: clotrimazole | Target: mycocyclosin synthase | Type: enzyme | Action: nan
2708,clotrimazole,transitional endoplasmic reticulum atpase,enzyme,,Drug: clotrimazole | Target: transitional endoplasmic reticulum atpase | Type: enzyme | Action: nan
2709,clotrimazole,malate dehydrogenase cytoplasmic,enzyme,,Drug: clotrimazole | Target: malate dehydrogenase cytoplasmic | Type: enzyme | Action: nan
2710,clotrimazole,putative cytochrome p450 130,enzyme,,Drug: clotrimazole | Target: putative cytochrome p450 130 | Type: enzyme | Action: nan
2711,clotrimazole,alpha-chymotrypsin,enzyme,,Drug: clotrimazole | Target: alpha-chymotrypsin | Type: enzyme | Action: nan
2712,clotrimazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: clotrimazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
2714,clotrimazole,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,enzyme,,Drug: clotrimazole | Target: 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase | Type: enzyme | Action: nan
2715,cloxacillin,penicillin-binding protein 1a,enzyme,,Drug: cloxacillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
2716,cloxacillin,beta-lactamase tem,enzyme,,Drug: cloxacillin | Target: beta-lactamase tem | Type: enzyme | Action: nan
2717,cloxacillin,beta-lactamase,enzyme,,Drug: cloxacillin | Target: beta-lactamase | Type: enzyme | Action: nan
2718,cloxacillin,efflux transporter; suge,transporter,,Drug: cloxacillin | Target: efflux transporter; suge | Type: transporter | Action: nan
2719,cloxacillin,beta-lactamase,enzyme,,Drug: cloxacillin | Target: beta-lactamase | Type: enzyme | Action: nan
2720,cloxacillin,beta-lactamase tem,enzyme,,Drug: cloxacillin | Target: beta-lactamase tem | Type: enzyme | Action: nan
2721,cloxacillin,penicillin-binding protein,enzyme,INHIBITOR,Drug: cloxacillin | Target: penicillin-binding protein | Type: enzyme | Action: INHIBITOR
2722,cloxazolam,aldo-keto reductase family 1 member c3,enzyme,,Drug: cloxazolam | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
2723,clozapine,beta-1 adrenergic receptor,gpcr,,Drug: clozapine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
2724,clozapine,beta-2 adrenergic receptor,gpcr,,Drug: clozapine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
2725,clozapine,d(1a) dopamine receptor,gpcr,,Drug: clozapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2726,clozapine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: clozapine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
2727,clozapine,alpha-2a adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2728,clozapine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: clozapine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2729,clozapine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: clozapine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2730,clozapine,sodium-dependent serotonin transporter,transporter,,Drug: clozapine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2731,clozapine,sodium-dependent noradrenaline transporter,transporter,,Drug: clozapine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2732,clozapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2733,clozapine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: clozapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
2734,clozapine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2735,clozapine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2736,clozapine,5-hydroxytryptamine receptor 6,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
2737,clozapine,5-hydroxytryptamine receptor 7,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
2738,clozapine,alpha-1a adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2739,clozapine,alpha-2b adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
2740,clozapine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: clozapine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
2741,clozapine,d(1b) dopamine receptor,gpcr,,Drug: clozapine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
2742,clozapine,histamine h1 receptor,gpcr,,Drug: clozapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2743,clozapine,histamine h2 receptor,gpcr,,Drug: clozapine | Target: histamine h2 receptor | Type: gpcr | Action: nan
2744,clozapine,histamine h4 receptor,gpcr,,Drug: clozapine | Target: histamine h4 receptor | Type: gpcr | Action: nan
2745,clozapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: clozapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2746,clozapine,muscarinic acetylcholine receptor m2,gpcr,,Drug: clozapine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2747,clozapine,muscarinic acetylcholine receptor m3,gpcr,,Drug: clozapine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2748,clozapine,muscarinic acetylcholine receptor m4,gpcr,,Drug: clozapine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2749,clozapine,muscarinic acetylcholine receptor m5,gpcr,,Drug: clozapine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2750,clozapine,aldehyde oxidase,enzyme,,Drug: clozapine | Target: aldehyde oxidase | Type: enzyme | Action: nan
2751,clozapine,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: clozapine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
2752,clozapine,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: clozapine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
2753,clozapine,alpha-2c adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
2754,clozapine,adenosine receptor a3,gpcr,,Drug: clozapine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
2755,clozapine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: clozapine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
2756,clozapine,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: clozapine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
2757,clozapine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
2758,clozapine,alpha-1b adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2759,clozapine,udp-glucuronosyltransferase 1-4,enzyme,,Drug: clozapine | Target: udp-glucuronosyltransferase 1-4 | Type: enzyme | Action: nan
2760,clozapine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
2761,clozapine,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: clozapine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
2762,clozapine,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: clozapine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
2763,clozapine,alpha-1b adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2764,clozapine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
2765,clozapine,alpha-1a adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2766,clozapine,histamine h1 receptor,gpcr,,Drug: clozapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2767,clozapine,muscarinic acetylcholine receptor m2,gpcr,,Drug: clozapine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2768,clozapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: clozapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2769,clozapine,d(2) dopamine receptor,gpcr,,Drug: clozapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2770,clozapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2771,clozapine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2772,clozapine,transporter,transporter,,Drug: clozapine | Target: transporter | Type: transporter | Action: nan
2773,clozapine,5-hydroxytryptamine receptor 7,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
2774,clozapine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: clozapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
2775,clozapine,d(1a) dopamine receptor,gpcr,,Drug: clozapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2776,clozapine,beta-1 adrenergic receptor,gpcr,,Drug: clozapine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
2777,clozapine,d(1a) dopamine receptor,gpcr,,Drug: clozapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2778,clozapine,d(2) dopamine receptor,gpcr,,Drug: clozapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2779,clozapine,alpha-2a adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2780,clozapine,d(2) dopamine receptor,gpcr,,Drug: clozapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2781,clozapine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2782,clozapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2783,clozapine,alpha-1a adrenergic receptor,gpcr,,Drug: clozapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2784,clozapine,histamine h1 receptor,gpcr,,Drug: clozapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2785,clozapine,d(3) dopamine receptor,gpcr,,Drug: clozapine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2786,clozapine,d(4) dopamine receptor,gpcr,,Drug: clozapine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
2787,clozapine,d(2) dopamine receptor,gpcr,,Drug: clozapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2788,clozapine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2789,clozapine,histamine h3 receptor,gpcr,ANTAGONIST,Drug: clozapine | Target: histamine h3 receptor | Type: gpcr | Action: ANTAGONIST
2790,clozapine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: clozapine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
2791,clozapine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: clozapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
2792,clozapine,d(1a) dopamine receptor,gpcr,,Drug: clozapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2793,clozapine,transporter,transporter,,Drug: clozapine | Target: transporter | Type: transporter | Action: nan
2794,clozapine,d(3) dopamine receptor,gpcr,,Drug: clozapine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2795,clozapine,histamine h4 receptor,gpcr,ANTAGONIST,Drug: clozapine | Target: histamine h4 receptor | Type: gpcr | Action: ANTAGONIST
2796,clozapine,histamine h4 receptor,gpcr,ANTAGONIST,Drug: clozapine | Target: histamine h4 receptor | Type: gpcr | Action: ANTAGONIST
2797,clozapine,serotonin 3 (5-ht3) receptor,ion channel,,Drug: clozapine | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
2798,clozapine,muscarinic acetylcholine receptor,gpcr,,Drug: clozapine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
2799,clozapine,serotonin 1 (5-ht1) receptor,gpcr,,Drug: clozapine | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
2800,clozapine,adrenergic receptor alpha-2,gpcr,,Drug: clozapine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
2801,clozapine,dopamine receptor,gpcr,,Drug: clozapine | Target: dopamine receptor | Type: gpcr | Action: nan
2802,clozapine,dopamine receptor,gpcr,,Drug: clozapine | Target: dopamine receptor | Type: gpcr | Action: nan
2803,clozapine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: clozapine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
2804,clozapine,adenylate cyclase,enzyme,,Drug: clozapine | Target: adenylate cyclase | Type: enzyme | Action: nan
2805,clozapine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: clozapine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
2806,clozapine,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: clozapine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
2807,clozapine,histone h1.0,nuclear other,,Drug: clozapine | Target: histone h1.0 | Type: nuclear other | Action: nan
2808,clozapine,calmodulin,cytosolic other,,Drug: clozapine | Target: calmodulin | Type: cytosolic other | Action: nan
2809,clozapine,calmodulin-1,cytosolic other,,Drug: clozapine | Target: calmodulin-1 | Type: cytosolic other | Action: nan
2810,cocaine,sodium channel protein type 5 subunit alpha,ion channel,,Drug: cocaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
2811,cocaine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: cocaine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
2812,cocaine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: cocaine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2813,cocaine,sodium-dependent serotonin transporter,transporter,,Drug: cocaine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2814,cocaine,sodium-dependent noradrenaline transporter,transporter,,Drug: cocaine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2815,cocaine,alpha-1a adrenergic receptor,gpcr,,Drug: cocaine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
2816,cocaine,histamine h1 receptor,gpcr,,Drug: cocaine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2817,cocaine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: cocaine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
2818,cocaine,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: cocaine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
2819,cocaine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: cocaine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
2820,cocaine,sodium- and chloride-dependent gaba transporter 1,transporter,,Drug: cocaine | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: nan
2821,cocaine,sodium channel protein type 11 subunit alpha,ion channel,,Drug: cocaine | Target: sodium channel protein type 11 subunit alpha | Type: ion channel | Action: nan
2822,cocaine,kappa-type opioid receptor,gpcr,,Drug: cocaine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
2823,cocaine,cocaine- and amphetamine-regulated transcript protein,transcription factor,,Drug: cocaine | Target: cocaine- and amphetamine-regulated transcript protein | Type: transcription factor | Action: nan
2824,cocaine,muscarinic acetylcholine receptor m1,gpcr,,Drug: cocaine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2825,cocaine,sodium-dependent serotonin transporter,transporter,,Drug: cocaine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2826,cocaine,sodium-dependent dopamine transporter,transporter,,Drug: cocaine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2827,cocaine,transporter,transporter,,Drug: cocaine | Target: transporter | Type: transporter | Action: nan
2828,cocaine,sodium-dependent dopamine transporter,transporter,,Drug: cocaine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2829,cocaine,transporter,transporter,,Drug: cocaine | Target: transporter | Type: transporter | Action: nan
2830,cocaine,serotonin 3 receptor (5ht3),ion channel,ANTAGONIST,Drug: cocaine | Target: serotonin 3 receptor (5ht3) | Type: ion channel | Action: ANTAGONIST
2831,cocaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: cocaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
2832,cocaine,dopamine transporter,transporter,,Drug: cocaine | Target: dopamine transporter | Type: transporter | Action: nan
2833,cocaine,dopamine transporter,transporter,,Drug: cocaine | Target: dopamine transporter | Type: transporter | Action: nan
2834,codeine,mu-type opioid receptor,gpcr,AGONIST,Drug: codeine | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
2835,codeine,kappa-type opioid receptor,gpcr,AGONIST,Drug: codeine | Target: kappa-type opioid receptor | Type: gpcr | Action: AGONIST
2836,codeine,delta-type opioid receptor,gpcr,AGONIST,Drug: codeine | Target: delta-type opioid receptor | Type: gpcr | Action: AGONIST
2837,codeine,opioid receptor,gpcr,,Drug: codeine | Target: opioid receptor | Type: gpcr | Action: nan
2838,colchicine,cytochrome p450 3a4,enzyme,,Drug: colchicine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
2839,colchicine,multidrug resistance protein 1,transporter,,Drug: colchicine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
2840,colchicine,multidrug resistance-associated protein 1,transporter,,Drug: colchicine | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
2841,colchicine,glycine receptor subunit alpha-1,ion channel,,Drug: colchicine | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
2842,colchicine,glycine receptor subunit alpha-2,ion channel,,Drug: colchicine | Target: glycine receptor subunit alpha-2 | Type: ion channel | Action: nan
2843,colchicine,tubulin beta chain,structural,INHIBITOR,Drug: colchicine | Target: tubulin beta chain | Type: structural | Action: INHIBITOR
2844,colchicine,serine/threonine-protein kinase pim-1,kinase,,Drug: colchicine | Target: serine/threonine-protein kinase pim-1 | Type: kinase | Action: nan
2845,colchicine,tubulin alpha-1a chain,structural,,Drug: colchicine | Target: tubulin alpha-1a chain | Type: structural | Action: nan
2846,colchicine,tubulin beta-2b chain,structural,,Drug: colchicine | Target: tubulin beta-2b chain | Type: structural | Action: nan
2847,colchicine,bromodomain-containing protein 4,unclassified,INHIBITOR,Drug: colchicine | Target: bromodomain-containing protein 4 | Type: unclassified | Action: INHIBITOR
2848,colchicine,tubulin polymerization-promoting protein,unclassified,,Drug: colchicine | Target: tubulin polymerization-promoting protein | Type: unclassified | Action: nan
2849,colchicine,tubulin beta-4b chain,structural,,Drug: colchicine | Target: tubulin beta-4b chain | Type: structural | Action: nan
2850,colchicine,tubulin,structural,,Drug: colchicine | Target: tubulin | Type: structural | Action: nan
2851,colchicine,tubulin,structural,,Drug: colchicine | Target: tubulin | Type: structural | Action: nan
2852,colforsin daropate,adenylate cyclase type 1,enzyme,,Drug: colforsin daropate | Target: adenylate cyclase type 1 | Type: enzyme | Action: nan
2853,colforsin daropate,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: colforsin daropate | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
2854,colforsin daropate,"solute carrier family 2, facilitated glucose transporter member 1",transporter,,"Drug: colforsin daropate | Target: solute carrier family 2, facilitated glucose transporter member 1 | Type: transporter | Action: nan"
2855,colforsin daropate,adenylate cyclase type 1,enzyme,,Drug: colforsin daropate | Target: adenylate cyclase type 1 | Type: enzyme | Action: nan
2856,conivaptan,vasopressin v1a receptor,gpcr,ANTAGONIST,Drug: conivaptan | Target: vasopressin v1a receptor | Type: gpcr | Action: ANTAGONIST
2857,conivaptan,vasopressin v2 receptor,gpcr,ANTAGONIST,Drug: conivaptan | Target: vasopressin v2 receptor | Type: gpcr | Action: ANTAGONIST
2858,conivaptan,oxytocin receptor,gpcr,,Drug: conivaptan | Target: oxytocin receptor | Type: gpcr | Action: nan
2859,conivaptan,vasopressin v2 receptor,gpcr,,Drug: conivaptan | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
2860,conivaptan,vasopressin v1a receptor,gpcr,,Drug: conivaptan | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
2861,cortisone acetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: cortisone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
2862,cortisone acetate,annexin a1,cytosolic other,,Drug: cortisone acetate | Target: annexin a1 | Type: cytosolic other | Action: nan
2863,cortisone acetate,corticosteroid-binding globulin,secreted,,Drug: cortisone acetate | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
2864,cortisone acetate,potassium voltage-gated channel subfamily a member 1,ion channel,,Drug: cortisone acetate | Target: potassium voltage-gated channel subfamily a member 1 | Type: ion channel | Action: nan
2865,cortisone acetate,sex hormone-binding globulin,secreted,,Drug: cortisone acetate | Target: sex hormone-binding globulin | Type: secreted | Action: nan
2866,cortisone acetate,multidrug and toxin extrusion protein 1,transporter,,Drug: cortisone acetate | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
2867,cortisone acetate,protein farnesyltransferase,enzyme,,Drug: cortisone acetate | Target: protein farnesyltransferase | Type: enzyme | Action: nan
2868,cortivazol,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: cortivazol | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
2869,cotinine,neuronal acetylcholine receptor subunit alpha-2,ion channel,,Drug: cotinine | Target: neuronal acetylcholine receptor subunit alpha-2 | Type: ion channel | Action: nan
2870,coumarin,carbonic anhydrase 2,enzyme,,Drug: coumarin | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
2871,coumarin,carbonic anhydrase 1,enzyme,,Drug: coumarin | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
2872,coumarin,carbonic anhydrase 4,enzyme,,Drug: coumarin | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
2873,coumarin,carbonic anhydrase 9,enzyme,,Drug: coumarin | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
2874,coumarin,carbonic anhydrase 12,enzyme,,Drug: coumarin | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
2875,coumarin,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: coumarin | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
2876,coumarin,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: coumarin | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
2877,coumarin,carbonic anhydrase 7,enzyme,,Drug: coumarin | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
2878,coumarin,carbonic anhydrase 3,enzyme,,Drug: coumarin | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
2879,coumarin,carbonic anhydrase 6,enzyme,,Drug: coumarin | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
2880,coumarin,carbonic anhydrase 14,enzyme,,Drug: coumarin | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
2881,coumarin,carbonic anhydrase 13,enzyme,,Drug: coumarin | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
2882,coumarin,amine oxidase [flavin-containing] b,enzyme,,Drug: coumarin | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
2883,coumarin,amine oxidase [flavin-containing] a,enzyme,,Drug: coumarin | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
2884,coumarin,carbonic anhydrase 15,enzyme,,Drug: coumarin | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
2885,cromoglicic acid,g protein-coupled receptor gpr35,gpcr,,Drug: cromoglicic acid | Target: g protein-coupled receptor gpr35 | Type: gpcr | Action: nan
2886,cromoglicic acid,g-protein coupled receptor 35,gpcr,,Drug: cromoglicic acid | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
2887,cromoglicic acid,g-protein coupled receptor 35,gpcr,,Drug: cromoglicic acid | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
2888,cromoglicic acid,protein s100-p,cytosolic other,,Drug: cromoglicic acid | Target: protein s100-p | Type: cytosolic other | Action: nan
2889,cyamemazine,d(1a) dopamine receptor,gpcr,,Drug: cyamemazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2890,cyamemazine,d(2) dopamine receptor,gpcr,,Drug: cyamemazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2891,cyamemazine,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: cyamemazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
2892,cyamemazine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: cyamemazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
2893,cyamemazine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: cyamemazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
2894,cyamemazine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: cyamemazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
2895,cyamemazine,d(3) dopamine receptor,gpcr,,Drug: cyamemazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2896,cyamemazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: cyamemazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2897,cyamemazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: cyamemazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2898,cyamemazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: cyamemazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2899,cyamemazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: cyamemazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2900,cyamemazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: cyamemazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2901,cyamemazine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: cyamemazine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
2902,cyclizine,alpha-2a adrenergic receptor,gpcr,,Drug: cyclizine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2903,cyclizine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: cyclizine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2904,cyclizine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: cyclizine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2905,cyclizine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: cyclizine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
2906,cyclizine,d(3) dopamine receptor,gpcr,,Drug: cyclizine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
2907,cyclizine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: cyclizine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
2908,cyclizine,muscarinic acetylcholine receptor m1,gpcr,,Drug: cyclizine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2909,cyclizine,muscarinic acetylcholine receptor m2,gpcr,,Drug: cyclizine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2910,cyclizine,muscarinic acetylcholine receptor m3,gpcr,,Drug: cyclizine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2911,cyclizine,muscarinic acetylcholine receptor m4,gpcr,,Drug: cyclizine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
2912,cyclizine,muscarinic acetylcholine receptor m5,gpcr,,Drug: cyclizine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
2913,cyclizine,sodium-dependent dopamine transporter,transporter,,Drug: cyclizine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
2914,cyclizine,cytochrome p450 2d6,enzyme,,Drug: cyclizine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
2915,cyclizine,alpha-1d adrenergic receptor,gpcr,,Drug: cyclizine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
2916,cyclizine,amine oxidase [flavin-containing] b,enzyme,,Drug: cyclizine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
2917,cyclizine,alpha-1b adrenergic receptor,gpcr,,Drug: cyclizine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
2918,cyclobenzaprine,multidrug resistance protein 1,transporter,,Drug: cyclobenzaprine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
2919,cyclobenzaprine,sodium-dependent serotonin transporter,transporter,,Drug: cyclobenzaprine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2920,cyclobenzaprine,sodium-dependent noradrenaline transporter,transporter,,Drug: cyclobenzaprine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2921,cyclobenzaprine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: cyclobenzaprine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
2922,cyclobenzaprine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: cyclobenzaprine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2923,cyclobenzaprine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: cyclobenzaprine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
2924,cyclobenzaprine,5-hydroxytryptamine receptor 6,gpcr,,Drug: cyclobenzaprine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
2925,cyclobenzaprine,5-hydroxytryptamine receptor 7,gpcr,,Drug: cyclobenzaprine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
2926,cyclobenzaprine,histamine h1 receptor,gpcr,,Drug: cyclobenzaprine | Target: histamine h1 receptor | Type: gpcr | Action: nan
2927,cyclobenzaprine,muscarinic acetylcholine receptor m1,gpcr,,Drug: cyclobenzaprine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
2928,cyclobenzaprine,muscarinic acetylcholine receptor m2,gpcr,,Drug: cyclobenzaprine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
2929,cyclobenzaprine,muscarinic acetylcholine receptor m3,gpcr,,Drug: cyclobenzaprine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
2930,cyclobenzaprine,aldehyde oxidase,enzyme,,Drug: cyclobenzaprine | Target: aldehyde oxidase | Type: enzyme | Action: nan
2931,cyclobenzaprine,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: cyclobenzaprine | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
2932,cyclofenil,estrogen receptor,nuclear hormone receptor,,Drug: cyclofenil | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
2933,cyclofenil,estrogen receptor,nuclear other,,Drug: cyclofenil | Target: estrogen receptor | Type: nuclear other | Action: nan
2934,cycloguanil,dihydrofolate reductase,enzyme,,Drug: cycloguanil | Target: dihydrofolate reductase | Type: enzyme | Action: nan
2935,cycloguanil,dihydrofolate reductase,enzyme,,Drug: cycloguanil | Target: dihydrofolate reductase | Type: enzyme | Action: nan
2936,cycloguanil,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,INHIBITOR,Drug: cycloguanil | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: INHIBITOR
2937,cycloguanil,dihydrofolate reductase,enzyme,,Drug: cycloguanil | Target: dihydrofolate reductase | Type: enzyme | Action: nan
2938,cycloguanil,dihydrofolate reductase,enzyme,,Drug: cycloguanil | Target: dihydrofolate reductase | Type: enzyme | Action: nan
2939,cycloguanil,dihydrofolate reductase,enzyme,,Drug: cycloguanil | Target: dihydrofolate reductase | Type: enzyme | Action: nan
2940,cycloguanil,dihydrofolate reductase,enzyme,,Drug: cycloguanil | Target: dihydrofolate reductase | Type: enzyme | Action: nan
2941,cyclopentolate,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: cyclopentolate | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
2942,cyclophosphamide,cytochrome p450 3a4,enzyme,,Drug: cyclophosphamide | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
2943,cycloserine,"glutamate receptor ionotropic, nmda 2a",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 2a | Type: ion channel | Action: nan"
2944,cycloserine,cytochrome p450 3a4,enzyme,,Drug: cycloserine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
2945,cycloserine,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
2946,cycloserine,"glutamate receptor ionotropic, nmda 2b",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 2b | Type: ion channel | Action: nan"
2947,cycloserine,"glutamate receptor ionotropic, nmda 2c",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 2c | Type: ion channel | Action: nan"
2948,cycloserine,"glutamate receptor ionotropic, nmda 2d",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 2d | Type: ion channel | Action: nan"
2949,cycloserine,alanine racemase,enzyme,,Drug: cycloserine | Target: alanine racemase | Type: enzyme | Action: nan
2950,cycloserine,"glutamate receptor ionotropic, nmda 1",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 1 | Type: ion channel | Action: nan"
2951,cycloserine,"glutamate receptor ionotropic, nmda 3b",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 3b | Type: ion channel | Action: nan"
2952,cycloserine,d-alanine--d-alanine ligase,enzyme,INHIBITOR,Drug: cycloserine | Target: d-alanine--d-alanine ligase | Type: enzyme | Action: INHIBITOR
2953,cycloserine,alanine racemase,enzyme,INHIBITOR,Drug: cycloserine | Target: alanine racemase | Type: enzyme | Action: INHIBITOR
2954,cycloserine,"glutamate receptor ionotropic, nmda 1",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 1 | Type: ion channel | Action: nan"
2955,cycloserine,"glutamate receptor ionotropic, nmda 2c",ion channel,,"Drug: cycloserine | Target: glutamate receptor ionotropic, nmda 2c | Type: ion channel | Action: nan"
2956,cycloserine,glutamate nmda receptor,ion channel,,Drug: cycloserine | Target: glutamate nmda receptor | Type: ion channel | Action: nan
2957,ciclosporin,cytochrome p450 3a4,enzyme,,Drug: ciclosporin | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
2958,ciclosporin,multidrug resistance protein 1,transporter,,Drug: ciclosporin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
2959,ciclosporin,canalicular multispecific organic anion transporter 1,transporter,,Drug: ciclosporin | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
2960,ciclosporin,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,,Drug: ciclosporin | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: nan
2961,ciclosporin,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: ciclosporin | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
2962,ciclosporin,peptidyl-prolyl cis-trans isomerase a,enzyme,MODULATOR,Drug: ciclosporin | Target: peptidyl-prolyl cis-trans isomerase a | Type: enzyme | Action: MODULATOR
2963,ciclosporin,multidrug resistance-associated protein 1,transporter,,Drug: ciclosporin | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
2964,ciclosporin,atp-binding cassette sub-family g member 2,transporter,,Drug: ciclosporin | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
2965,ciclosporin,fmet-leu-phe receptor,gpcr,ANTAGONIST,Drug: ciclosporin | Target: fmet-leu-phe receptor | Type: gpcr | Action: ANTAGONIST
2966,ciclosporin,bile salt export pump,transporter,,Drug: ciclosporin | Target: bile salt export pump | Type: transporter | Action: nan
2967,ciclosporin,solute carrier organic anion transporter family member 1b1,transporter,INHIBITOR,Drug: ciclosporin | Target: solute carrier organic anion transporter family member 1b1 | Type: transporter | Action: INHIBITOR
2968,ciclosporin,peptidyl-prolyl cis-trans isomerase fkbp4,enzyme,,Drug: ciclosporin | Target: peptidyl-prolyl cis-trans isomerase fkbp4 | Type: enzyme | Action: nan
2969,ciclosporin,substance-k receptor,gpcr,,Drug: ciclosporin | Target: substance-k receptor | Type: gpcr | Action: nan
2970,ciclosporin,peptidyl-prolyl cis-trans isomerase b,enzyme,,Drug: ciclosporin | Target: peptidyl-prolyl cis-trans isomerase b | Type: enzyme | Action: nan
2971,ciclosporin,serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform,enzyme,,Drug: ciclosporin | Target: serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform | Type: enzyme | Action: nan
2972,ciclosporin,reverse transcriptase/rnaseh,enzyme,,Drug: ciclosporin | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: nan
2973,ciclosporin,peptidyl-prolyl cis-trans isomerase fkbp1b,enzyme,,Drug: ciclosporin | Target: peptidyl-prolyl cis-trans isomerase fkbp1b | Type: enzyme | Action: nan
2974,ciclosporin,peptidyl-prolyl cis-trans isomerase d,enzyme,,Drug: ciclosporin | Target: peptidyl-prolyl cis-trans isomerase d | Type: enzyme | Action: nan
2975,ciclosporin,solute carrier organic anion transporter family member 1b3,transporter,INHIBITOR,Drug: ciclosporin | Target: solute carrier organic anion transporter family member 1b3 | Type: transporter | Action: INHIBITOR
2976,ciclosporin,sodium/bile acid cotransporter,transporter,INHIBITOR,Drug: ciclosporin | Target: sodium/bile acid cotransporter | Type: transporter | Action: INHIBITOR
2977,ciclosporin,bile salt export pump,transporter,,Drug: ciclosporin | Target: bile salt export pump | Type: transporter | Action: nan
2978,ciclosporin,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,,"Drug: ciclosporin | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: nan"
2979,cyclothiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: cyclothiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
2980,cyclothiazide,glutamate receptor 1,ion channel,,Drug: cyclothiazide | Target: glutamate receptor 1 | Type: ion channel | Action: nan
2981,cyclothiazide,glutamate receptor 2,ion channel,,Drug: cyclothiazide | Target: glutamate receptor 2 | Type: ion channel | Action: nan
2982,cyclothiazide,glutamate receptor 4,ion channel,ALLOSTERIC MODULATOR,Drug: cyclothiazide | Target: glutamate receptor 4 | Type: ion channel | Action: ALLOSTERIC MODULATOR
2983,cyclothiazide,glutamate receptor 3,ion channel,ALLOSTERIC MODULATOR,Drug: cyclothiazide | Target: glutamate receptor 3 | Type: ion channel | Action: ALLOSTERIC MODULATOR
2984,cyclothiazide,"glutamate receptor ionotropic, ampa",ion channel,,"Drug: cyclothiazide | Target: glutamate receptor ionotropic, ampa | Type: ion channel | Action: nan"
2985,cyclovalone,nuclear factor nf-kappa-b p105 subunit,cytosolic other,,Drug: cyclovalone | Target: nuclear factor nf-kappa-b p105 subunit | Type: cytosolic other | Action: nan
2986,cyclovalone,integrase,enzyme,,Drug: cyclovalone | Target: integrase | Type: enzyme | Action: nan
2987,cyclovalone,transcription factor ap-1,transcription factor,,Drug: cyclovalone | Target: transcription factor ap-1 | Type: transcription factor | Action: nan
2988,cycrimine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: cycrimine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
2989,cyproheptadine,d(1a) dopamine receptor,gpcr,,Drug: cyproheptadine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
2990,cyproheptadine,d(2) dopamine receptor,gpcr,,Drug: cyproheptadine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
2991,cyproheptadine,alpha-2a adrenergic receptor,gpcr,,Drug: cyproheptadine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
2992,cyproheptadine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: cyproheptadine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
2993,cyproheptadine,multidrug resistance protein 1,transporter,,Drug: cyproheptadine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
2994,cyproheptadine,sodium-dependent serotonin transporter,transporter,,Drug: cyproheptadine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
2995,cyproheptadine,sodium-dependent noradrenaline transporter,transporter,,Drug: cyproheptadine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
2996,cyproheptadine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
2997,cyproheptadine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
2998,cyproheptadine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
2999,cyproheptadine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3000,cyproheptadine,5-hydroxytryptamine receptor 6,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3001,cyproheptadine,5-hydroxytryptamine receptor 7,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
3002,cyproheptadine,alpha-1a adrenergic receptor,gpcr,,Drug: cyproheptadine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3003,cyproheptadine,alpha-2b adrenergic receptor,gpcr,,Drug: cyproheptadine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3004,cyproheptadine,d(3) dopamine receptor,gpcr,,Drug: cyproheptadine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3005,cyproheptadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: cyproheptadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
3006,cyproheptadine,histamine h2 receptor,gpcr,,Drug: cyproheptadine | Target: histamine h2 receptor | Type: gpcr | Action: nan
3007,cyproheptadine,histamine h4 receptor,gpcr,,Drug: cyproheptadine | Target: histamine h4 receptor | Type: gpcr | Action: nan
3008,cyproheptadine,muscarinic acetylcholine receptor m1,gpcr,,Drug: cyproheptadine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3009,cyproheptadine,muscarinic acetylcholine receptor m2,gpcr,,Drug: cyproheptadine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3010,cyproheptadine,muscarinic acetylcholine receptor m3,gpcr,,Drug: cyproheptadine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3011,cyproheptadine,muscarinic acetylcholine receptor m4,gpcr,,Drug: cyproheptadine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3012,cyproheptadine,muscarinic acetylcholine receptor m5,gpcr,,Drug: cyproheptadine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
3013,cyproheptadine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
3014,cyproheptadine,alpha-2c adrenergic receptor,gpcr,,Drug: cyproheptadine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
3015,cyproheptadine,alpha-1d adrenergic receptor,gpcr,,Drug: cyproheptadine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3016,cyproheptadine,alpha-1b adrenergic receptor,gpcr,,Drug: cyproheptadine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3017,cyproheptadine,calmodulin,cytosolic other,,Drug: cyproheptadine | Target: calmodulin | Type: cytosolic other | Action: nan
3018,cyproheptadine,alpha-1b adrenergic receptor,gpcr,,Drug: cyproheptadine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3019,cyproheptadine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
3020,cyproheptadine,alpha-1a adrenergic receptor,gpcr,,Drug: cyproheptadine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3021,cyproheptadine,histamine h1 receptor,gpcr,,Drug: cyproheptadine | Target: histamine h1 receptor | Type: gpcr | Action: nan
3022,cyproheptadine,d(2) dopamine receptor,gpcr,,Drug: cyproheptadine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3023,cyproheptadine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3024,cyproheptadine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3025,cyproheptadine,5-hydroxytryptamine receptor 7,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
3026,cyproheptadine,sodium-dependent noradrenaline transporter,transporter,,Drug: cyproheptadine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
3027,cyproheptadine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3028,cyproheptadine,d(2) dopamine receptor,gpcr,,Drug: cyproheptadine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3029,cyproheptadine,sodium-dependent serotonin transporter,transporter,,Drug: cyproheptadine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3030,cyproheptadine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: cyproheptadine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
3031,cyproheptadine,muscarinic acetylcholine receptor,gpcr,,Drug: cyproheptadine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
3032,cyproheptadine,dopamine receptor,gpcr,,Drug: cyproheptadine | Target: dopamine receptor | Type: gpcr | Action: nan
3033,cyproheptadine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: cyproheptadine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
3034,cyproheptadine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: cyproheptadine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
3035,cyproheptadine,histone-lysine n-methyltransferase setd7,enzyme,,Drug: cyproheptadine | Target: histone-lysine n-methyltransferase setd7 | Type: enzyme | Action: nan
3036,cyproterone acetate,mu-type opioid receptor,gpcr,,Drug: cyproterone acetate | Target: mu-type opioid receptor | Type: gpcr | Action: nan
3037,cyproterone acetate,glucocorticoid receptor,nuclear hormone receptor,,Drug: cyproterone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
3038,cyproterone acetate,androgen receptor,nuclear hormone receptor,ANTAGONIST,Drug: cyproterone acetate | Target: androgen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
3039,cyproterone acetate,progesterone receptor,nuclear hormone receptor,,Drug: cyproterone acetate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
3040,cyproterone acetate,androgen receptor,transcription factor,,Drug: cyproterone acetate | Target: androgen receptor | Type: transcription factor | Action: nan
3041,cyproterone acetate,progesterone receptor,transcription factor,,Drug: cyproterone acetate | Target: progesterone receptor | Type: transcription factor | Action: nan
3042,cyproterone acetate,adenosine receptor a1,gpcr,,Drug: cyproterone acetate | Target: adenosine receptor a1 | Type: gpcr | Action: nan
3043,cysteine,cystine/glutamate transporter,transporter,,Drug: cysteine | Target: cystine/glutamate transporter | Type: transporter | Action: nan
3044,cytarabine,prostatic acid phosphatase,enzyme,,Drug: cytarabine | Target: prostatic acid phosphatase | Type: enzyme | Action: nan
3045,cytarabine,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,,Drug: cytarabine | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: nan
3046,cytarabine,dna polymerase beta,enzyme,,Drug: cytarabine | Target: dna polymerase beta | Type: enzyme | Action: nan
3047,cytarabine,dna polymerase (alpha/delta/epsilon),enzyme,INHIBITOR,Drug: cytarabine | Target: dna polymerase (alpha/delta/epsilon) | Type: enzyme | Action: INHIBITOR
3048,cytarabine,e3 ubiquitin-protein ligase mdm2,nuclear other,,Drug: cytarabine | Target: e3 ubiquitin-protein ligase mdm2 | Type: nuclear other | Action: nan
3049,dacarbazine,matrix metalloproteinase-9,enzyme,,Drug: dacarbazine | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
3050,dacarbazine,dna polymerase alpha subunit b,enzyme,,Drug: dacarbazine | Target: dna polymerase alpha subunit b | Type: enzyme | Action: nan
3051,dactinomycin,growth factor receptor-bound protein 2,cytosolic other,,Drug: dactinomycin | Target: growth factor receptor-bound protein 2 | Type: cytosolic other | Action: nan
3052,dactinomycin,discoidin domain-containing receptor 2,kinase,,Drug: dactinomycin | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
3053,dactinomycin,growth factor receptor-bound protein 2,cytosolic other,,Drug: dactinomycin | Target: growth factor receptor-bound protein 2 | Type: cytosolic other | Action: nan
3054,dactinomycin,peptide-n(4)-(n-acetyl-beta-glucosaminyl)asparagine amidase,enzyme,,Drug: dactinomycin | Target: peptide-n(4)-(n-acetyl-beta-glucosaminyl)asparagine amidase | Type: enzyme | Action: nan
3055,dabigatran etexilate,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: dabigatran etexilate | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
3056,dabigatran etexilate,plasminogen,enzyme,,Drug: dabigatran etexilate | Target: plasminogen | Type: enzyme | Action: nan
3057,dabigatran etexilate,prothrombin,enzyme,INHIBITOR,Drug: dabigatran etexilate | Target: prothrombin | Type: enzyme | Action: INHIBITOR
3058,dabigatran etexilate,coagulation factor x,enzyme,,Drug: dabigatran etexilate | Target: coagulation factor x | Type: enzyme | Action: nan
3059,dabigatran etexilate,tissue-type plasminogen activator,enzyme,,Drug: dabigatran etexilate | Target: tissue-type plasminogen activator | Type: enzyme | Action: nan
3060,dabigatran etexilate,vitamin k-dependent protein c,enzyme,,Drug: dabigatran etexilate | Target: vitamin k-dependent protein c | Type: enzyme | Action: nan
3061,dabigatran etexilate,solute carrier family 22 member 2,transporter,,Drug: dabigatran etexilate | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
3062,dabigatran etexilate,multidrug and toxin extrusion protein 1,transporter,,Drug: dabigatran etexilate | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
3063,dabigatran etexilate,multidrug and toxin extrusion protein 2,transporter,,Drug: dabigatran etexilate | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
3064,dabigatran etexilate,trypsin,enzyme,,Drug: dabigatran etexilate | Target: trypsin | Type: enzyme | Action: nan
3065,dabigatran etexilate,serine protease hepsin,enzyme,,Drug: dabigatran etexilate | Target: serine protease hepsin | Type: enzyme | Action: nan
3066,dabigatran etexilate,thrombin,unclassified,,Drug: dabigatran etexilate | Target: thrombin | Type: unclassified | Action: nan
3067,danazol,mu-type opioid receptor,gpcr,,Drug: danazol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
3068,danazol,d(1a) dopamine receptor,gpcr,,Drug: danazol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
3069,danazol,alpha-2a adrenergic receptor,gpcr,,Drug: danazol | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3070,danazol,sodium-dependent serotonin transporter,transporter,,Drug: danazol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3071,danazol,sodium-dependent noradrenaline transporter,transporter,,Drug: danazol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
3072,danazol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: danazol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3073,danazol,alpha-2b adrenergic receptor,gpcr,,Drug: danazol | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3074,danazol,d(3) dopamine receptor,gpcr,,Drug: danazol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3075,danazol,muscarinic acetylcholine receptor m3,gpcr,,Drug: danazol | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3076,danazol,glucocorticoid receptor,nuclear hormone receptor,,Drug: danazol | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
3077,danazol,beta-3 adrenergic receptor,gpcr,,Drug: danazol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
3078,danazol,alpha-2c adrenergic receptor,gpcr,,Drug: danazol | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
3079,danazol,sodium-dependent dopamine transporter,transporter,,Drug: danazol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3080,danazol,adenosine receptor a3,gpcr,,Drug: danazol | Target: adenosine receptor a3 | Type: gpcr | Action: nan
3081,danazol,kappa-type opioid receptor,gpcr,,Drug: danazol | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
3082,danazol,estrogen receptor,nuclear hormone receptor,,Drug: danazol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
3083,danazol,androgen receptor,nuclear hormone receptor,AGONIST,Drug: danazol | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
3084,danazol,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: danazol | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
3085,danazol,cytochrome p450 2c9,enzyme,,Drug: danazol | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
3086,danazol,steryl-sulfatase,enzyme,,Drug: danazol | Target: steryl-sulfatase | Type: enzyme | Action: nan
3087,danazol,sex hormone-binding globulin,secreted,,Drug: danazol | Target: sex hormone-binding globulin | Type: secreted | Action: nan
3088,danazol,substance-k receptor,gpcr,,Drug: danazol | Target: substance-k receptor | Type: gpcr | Action: nan
3089,danazol,androgen receptor,transcription factor,,Drug: danazol | Target: androgen receptor | Type: transcription factor | Action: nan
3090,danazol,progesterone receptor,transcription factor,,Drug: danazol | Target: progesterone receptor | Type: transcription factor | Action: nan
3091,dantrolene,ryanodine receptor 1,ion channel,ANTAGONIST,Drug: dantrolene | Target: ryanodine receptor 1 | Type: ion channel | Action: ANTAGONIST
3092,dantrolene,ryanodine receptor 3,ion channel,ANTAGONIST,Drug: dantrolene | Target: ryanodine receptor 3 | Type: ion channel | Action: ANTAGONIST
3093,dantrolene,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: dantrolene | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
3094,dapiprazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dapiprazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3095,dapiprazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: dapiprazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3096,dapiprazole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: dapiprazole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3097,dapiprazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: dapiprazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3098,dapiprazole,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: dapiprazole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
3099,dapiprazole,alpha-2b adrenergic receptor,gpcr,,Drug: dapiprazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3100,dapiprazole,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: dapiprazole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
3101,dapiprazole,alpha-1b adrenergic receptor,gpcr,,Drug: dapiprazole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3102,dapiprazole,alpha-1b adrenergic receptor,gpcr,,Drug: dapiprazole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3103,dapiprazole,alpha-1a adrenergic receptor,gpcr,,Drug: dapiprazole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3104,dapiprazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dapiprazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3105,dapsone,cytochrome p450 3a4,enzyme,,Drug: dapsone | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
3106,dapsone,5-hydroxytryptamine receptor 6,gpcr,,Drug: dapsone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3107,dapsone,dihydropteroate synthase 1,enzyme,INHIBITOR,Drug: dapsone | Target: dihydropteroate synthase 1 | Type: enzyme | Action: INHIBITOR
3108,dapsone,dihydrofolate reductase,enzyme,,Drug: dapsone | Target: dihydrofolate reductase | Type: enzyme | Action: nan
3109,dapsone,myeloperoxidase,enzyme,,Drug: dapsone | Target: myeloperoxidase | Type: enzyme | Action: nan
3110,dapsone,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: dapsone | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
3111,dapsone,"dihydropteroate synthetase, putative",unclassified,,"Drug: dapsone | Target: dihydropteroate synthetase, putative | Type: unclassified | Action: nan"
3112,dapsone,"6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase",unclassified,,"Drug: dapsone | Target: 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | Type: unclassified | Action: nan"
3114,daptomycin,outer membrane porin protein ompd,transporter,,Drug: daptomycin | Target: outer membrane porin protein ompd | Type: transporter | Action: nan
3115,darifenacin,beta-1 adrenergic receptor,gpcr,,Drug: darifenacin | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
3116,darifenacin,beta-2 adrenergic receptor,gpcr,,Drug: darifenacin | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
3117,darifenacin,d(2) dopamine receptor,gpcr,,Drug: darifenacin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3118,darifenacin,muscarinic acetylcholine receptor m1,gpcr,,Drug: darifenacin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3119,darifenacin,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: darifenacin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
3120,darifenacin,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: darifenacin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
3121,darifenacin,muscarinic acetylcholine receptor m4,gpcr,,Drug: darifenacin | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3122,darifenacin,muscarinic acetylcholine receptor m5,gpcr,,Drug: darifenacin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
3123,darifenacin,muscarinic acetylcholine receptor m2,gpcr,,Drug: darifenacin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3124,darifenacin,muscarinic acetylcholine receptor m3,gpcr,,Drug: darifenacin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3125,dasatinib,tyrosine-protein kinase jak3,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
3126,dasatinib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: dasatinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
3127,dasatinib,tyrosine-protein kinase abl1,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: INHIBITOR
3128,dasatinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: dasatinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
3129,dasatinib,epidermal growth factor receptor,kinase,,Drug: dasatinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
3130,dasatinib,serine/threonine-protein kinase mtor,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase mtor | Type: kinase | Action: nan
3131,dasatinib,breakpoint cluster region protein,kinase,,Drug: dasatinib | Target: breakpoint cluster region protein | Type: kinase | Action: nan
3132,dasatinib,proto-oncogene tyrosine-protein kinase src,kinase,INHIBITOR,Drug: dasatinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: INHIBITOR
3133,dasatinib,tyrosine-protein kinase lck,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: INHIBITOR
3134,dasatinib,tyrosine-protein kinase yes,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: INHIBITOR
3135,dasatinib,tyrosine-protein kinase fyn,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: INHIBITOR
3136,dasatinib,ephrin type-a receptor 2,kinase,INHIBITOR,Drug: dasatinib | Target: ephrin type-a receptor 2 | Type: kinase | Action: INHIBITOR
3137,dasatinib,raf proto-oncogene serine/threonine-protein kinase,kinase,,Drug: dasatinib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: nan
3138,dasatinib,serine/threonine-protein kinase b-raf,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
3139,dasatinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: dasatinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
3140,dasatinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: dasatinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
3141,dasatinib,vascular endothelial growth factor receptor 1,kinase,,Drug: dasatinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
3142,dasatinib,vascular endothelial growth factor receptor 2,kinase,,Drug: dasatinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
3143,dasatinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: dasatinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
3144,dasatinib,platelet-derived growth factor receptor alpha,kinase,,Drug: dasatinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
3145,dasatinib,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: dasatinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
3146,dasatinib,fibroblast growth factor receptor 3,kinase,,Drug: dasatinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
3147,dasatinib,tyrosine-protein kinase hck,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: INHIBITOR
3148,dasatinib,receptor tyrosine-protein kinase erbb-4,kinase,,Drug: dasatinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: nan
3149,dasatinib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,,"Drug: dasatinib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: nan"
3150,dasatinib,tyrosine-protein kinase jak2,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
3151,dasatinib,tyrosine-protein kinase syk,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
3152,dasatinib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: dasatinib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
3153,dasatinib,tyrosine-protein kinase csk,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
3154,dasatinib,ephrin type-a receptor 8,kinase,,Drug: dasatinib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
3155,dasatinib,tyrosine-protein kinase lyn,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: INHIBITOR
3156,dasatinib,cytoplasmic tyrosine-protein kinase bmx,kinase,,Drug: dasatinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: nan
3157,dasatinib,serine/threonine-protein kinase nek2,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase nek2 | Type: kinase | Action: nan
3158,dasatinib,lim domain kinase 1,kinase,,Drug: dasatinib | Target: lim domain kinase 1 | Type: kinase | Action: nan
3159,dasatinib,fibroblast growth factor receptor 1,kinase,,Drug: dasatinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
3160,dasatinib,serine/threonine-protein kinase 10,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
3161,dasatinib,abelson tyrosine-protein kinase 2,kinase,,Drug: dasatinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
3162,dasatinib,mitogen-activated protein kinase 11,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase 11 | Type: kinase | Action: nan
3163,dasatinib,ephrin type-a receptor 5,kinase,,Drug: dasatinib | Target: ephrin type-a receptor 5 | Type: kinase | Action: nan
3164,dasatinib,ephrin type-a receptor 4,kinase,,Drug: dasatinib | Target: ephrin type-a receptor 4 | Type: kinase | Action: nan
3165,dasatinib,fibroblast growth factor receptor 2,kinase,,Drug: dasatinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
3166,dasatinib,ephrin type-a receptor 6,kinase,,Drug: dasatinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
3167,dasatinib,traf2 and nck-interacting protein kinase,kinase,,Drug: dasatinib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
3168,dasatinib,casein kinase i isoform epsilon,kinase,,Drug: dasatinib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
3169,dasatinib,tyrosine-protein kinase fgr,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: INHIBITOR
3170,dasatinib,aurora kinase a,kinase,,Drug: dasatinib | Target: aurora kinase a | Type: kinase | Action: nan
3171,dasatinib,serine/threonine-protein kinase 36,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase 36 | Type: kinase | Action: nan
3172,dasatinib,ephrin type-a receptor 3,kinase,,Drug: dasatinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
3173,dasatinib,mitogen-activated protein kinase 14,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
3174,dasatinib,tyrosine-protein kinase frk,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: INHIBITOR
3175,dasatinib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
3176,dasatinib,mitogen-activated protein kinase kinase kinase 4,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase 4 | Type: kinase | Action: nan
3177,dasatinib,cyclin-g-associated kinase,kinase,,Drug: dasatinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
3178,dasatinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: dasatinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
3179,dasatinib,ephrin type-b receptor 1,kinase,,Drug: dasatinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
3180,dasatinib,serine/threonine-protein kinase 4,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
3181,dasatinib,activated cdc42 kinase 1,kinase,,Drug: dasatinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
3182,dasatinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: dasatinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
3183,dasatinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: dasatinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
3184,dasatinib,ephrin type-b receptor 4,kinase,,Drug: dasatinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
3185,dasatinib,activin receptor type-1b,kinase,,Drug: dasatinib | Target: activin receptor type-1b | Type: kinase | Action: nan
3186,dasatinib,serine/threonine-protein kinase receptor r3,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase receptor r3 | Type: kinase | Action: nan
3187,dasatinib,activin receptor type-1,kinase,,Drug: dasatinib | Target: activin receptor type-1 | Type: kinase | Action: nan
3188,dasatinib,tgf-beta receptor type-2,kinase,,Drug: dasatinib | Target: tgf-beta receptor type-2 | Type: kinase | Action: nan
3189,dasatinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: dasatinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
3190,dasatinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: dasatinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
3191,dasatinib,tyrosine-protein kinase itk/tsk,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: nan
3192,dasatinib,protein-tyrosine kinase 6,kinase,,Drug: dasatinib | Target: protein-tyrosine kinase 6 | Type: kinase | Action: nan
3193,dasatinib,proto-oncogene tyrosine-protein kinase lck,kinase,,Drug: dasatinib | Target: proto-oncogene tyrosine-protein kinase lck | Type: kinase | Action: nan
3194,dasatinib,tyrosine-protein kinase btk,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
3195,dasatinib,tyrosine-protein kinase tec,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase tec | Type: kinase | Action: nan
3196,dasatinib,ephrin type-b receptor 2,kinase,,Drug: dasatinib | Target: ephrin type-b receptor 2 | Type: kinase | Action: nan
3197,dasatinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: dasatinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
3198,dasatinib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,,"Drug: dasatinib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: nan"
3199,dasatinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: dasatinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
3200,dasatinib,wee1-like protein kinase,kinase,,Drug: dasatinib | Target: wee1-like protein kinase | Type: kinase | Action: nan
3201,dasatinib,serine/threonine-protein kinase 25,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase 25 | Type: kinase | Action: nan
3202,dasatinib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
3203,dasatinib,tyrosine-protein kinase txk,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
3204,dasatinib,lim domain kinase 2,kinase,,Drug: dasatinib | Target: lim domain kinase 2 | Type: kinase | Action: nan
3205,dasatinib,serine/threonine-protein kinase 26,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase 26 | Type: kinase | Action: nan
3206,dasatinib,serine/threonine-protein kinase nlk,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase nlk | Type: kinase | Action: nan
3207,dasatinib,eukaryotic translation initiation factor 2-alpha kinase 4,kinase,,Drug: dasatinib | Target: eukaryotic translation initiation factor 2-alpha kinase 4 | Type: kinase | Action: nan
3208,dasatinib,serine/threonine-protein kinase sik2,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
3209,dasatinib,activin receptor type-2a,kinase,,Drug: dasatinib | Target: activin receptor type-2a | Type: kinase | Action: nan
3210,dasatinib,activin receptor type-2b,kinase,,Drug: dasatinib | Target: activin receptor type-2b | Type: kinase | Action: nan
3211,dasatinib,serine/threonine-protein kinase tnni3k,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
3212,dasatinib,discoidin domain-containing receptor 2,kinase,,Drug: dasatinib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
3213,dasatinib,myotonin-protein kinase,kinase,,Drug: dasatinib | Target: myotonin-protein kinase | Type: kinase | Action: nan
3214,dasatinib,"chaperone activity of bc1 complex-like, mitochondrial",kinase,,"Drug: dasatinib | Target: chaperone activity of bc1 complex-like, mitochondrial | Type: kinase | Action: nan"
3215,dasatinib,serine/threonine-protein kinase mrck gamma,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase mrck gamma | Type: kinase | Action: nan
3216,dasatinib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
3217,dasatinib,membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,kinase,,Drug: dasatinib | Target: membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Type: kinase | Action: nan
3218,dasatinib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
3219,dasatinib,aurora kinase b,kinase,,Drug: dasatinib | Target: aurora kinase b | Type: kinase | Action: nan
3220,dasatinib,tyrosine-protein kinase blk,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: INHIBITOR
3221,dasatinib,bone morphogenetic protein receptor type-1a,kinase,,Drug: dasatinib | Target: bone morphogenetic protein receptor type-1a | Type: kinase | Action: nan
3222,dasatinib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
3223,dasatinib,serine/threonine-protein kinase mrck alpha,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase mrck alpha | Type: kinase | Action: nan
3224,dasatinib,serine/threonine-protein kinase mrck beta,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase mrck beta | Type: kinase | Action: nan
3225,dasatinib,serine/threonine-protein kinase sik1,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
3226,dasatinib,tyrosine-protein kinase srms,kinase,INHIBITOR,Drug: dasatinib | Target: tyrosine-protein kinase srms | Type: kinase | Action: INHIBITOR
3227,dasatinib,dual specificity testis-specific protein kinase 1,kinase,,Drug: dasatinib | Target: dual specificity testis-specific protein kinase 1 | Type: kinase | Action: nan
3228,dasatinib,tgf-beta receptor type-1,kinase,,Drug: dasatinib | Target: tgf-beta receptor type-1 | Type: kinase | Action: nan
3229,dasatinib,ephrin type-a receptor 1,kinase,,Drug: dasatinib | Target: ephrin type-a receptor 1 | Type: kinase | Action: nan
3230,dasatinib,ephrin type-b receptor 3,kinase,,Drug: dasatinib | Target: ephrin type-b receptor 3 | Type: kinase | Action: nan
3231,dasatinib,tubulin alpha-1a chain,structural,,Drug: dasatinib | Target: tubulin alpha-1a chain | Type: structural | Action: nan
3232,dasatinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
3233,dasatinib,misshapen-like kinase 1,kinase,,Drug: dasatinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
3234,dasatinib,tyrosine-protein kinase blk,kinase,,Drug: dasatinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
3235,dasatinib,ephrin type-b receptor 6,kinase,,Drug: dasatinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
3236,dasatinib,mitogen-activated protein kinase kinase kinase 13,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase 13 | Type: kinase | Action: nan
3237,dasatinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
3238,dasatinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
3239,dasatinib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
3240,dasatinib,serine/threonine-protein kinase tao3,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
3241,dasatinib,serine/threonine-protein kinase ulk3,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
3242,dasatinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: dasatinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
3243,dasatinib,serine/threonine-protein kinase 35,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase 35 | Type: kinase | Action: nan
3244,dasatinib,receptor tyrosine-protein kinase erbb-3,kinase,,Drug: dasatinib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: nan
3245,dasatinib,serine/threonine-protein kinase sik3,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase sik3 | Type: kinase | Action: nan
3246,dasatinib,wee1-like protein kinase 2,kinase,,Drug: dasatinib | Target: wee1-like protein kinase 2 | Type: kinase | Action: nan
3247,dasatinib,bone morphogenetic protein receptor type-1b,kinase,,Drug: dasatinib | Target: bone morphogenetic protein receptor type-1b | Type: kinase | Action: nan
3248,dasatinib,quinolone resistance protein nora,transporter,,Drug: dasatinib | Target: quinolone resistance protein nora | Type: transporter | Action: nan
3249,dasatinib,serine/threonine-protein kinase sbk1,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
3250,dasatinib,serine/threonine-protein kinase vrk2,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase vrk2 | Type: kinase | Action: nan
3251,dasatinib,serine/threonine-protein kinase tao2,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase tao2 | Type: kinase | Action: nan
3252,dasatinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: dasatinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
3253,dasatinib,serine/threonine-protein kinase nek11,kinase,,Drug: dasatinib | Target: serine/threonine-protein kinase nek11 | Type: kinase | Action: nan
3254,dasatinib,calcium-dependent protein kinase 1,kinase,,Drug: dasatinib | Target: calcium-dependent protein kinase 1 | Type: kinase | Action: nan
3255,dasatinib,map kinase p38,kinase,,Drug: dasatinib | Target: map kinase p38 | Type: kinase | Action: nan
3256,dasatinib,dual specificity mitogen-activated protein kinase kinase; mek1/2,kinase,,Drug: dasatinib | Target: dual specificity mitogen-activated protein kinase kinase; mek1/2 | Type: kinase | Action: nan
3257,dasatinib,bcr/abl fusion protein,kinase,,Drug: dasatinib | Target: bcr/abl fusion protein | Type: kinase | Action: nan
3258,dasatinib,myelin transcription factor 1,transcription factor,,Drug: dasatinib | Target: myelin transcription factor 1 | Type: transcription factor | Action: nan
3259,daunorubicin,multidrug resistance protein 1,transporter,,Drug: daunorubicin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
3260,daunorubicin,dna topoisomerase 2-alpha,enzyme,INHIBITOR,Drug: daunorubicin | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: INHIBITOR
3261,daunorubicin,multidrug resistance-associated protein 1,transporter,,Drug: daunorubicin | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
3262,daunorubicin,atp-binding cassette sub-family g member 2,transporter,,Drug: daunorubicin | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
3263,daunorubicin,multidrug resistance-associated protein 6,transporter,,Drug: daunorubicin | Target: multidrug resistance-associated protein 6 | Type: transporter | Action: nan
3264,daunorubicin,72 kda type iv collagenase,enzyme,,Drug: daunorubicin | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
3265,daunorubicin,orf 73,unclassified,,Drug: daunorubicin | Target: orf 73 | Type: unclassified | Action: nan
3266,deanol,high affinity choline transporter 1,transporter,,Drug: deanol | Target: high affinity choline transporter 1 | Type: transporter | Action: nan
3267,deanol,creatine transporter,transporter,,Drug: deanol | Target: creatine transporter | Type: transporter | Action: nan
3268,debrisoquine,amine oxidase [flavin-containing] b,enzyme,,Drug: debrisoquine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
3269,debrisoquine,amine oxidase [flavin-containing] a,enzyme,,Drug: debrisoquine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
3270,decamethonium,muscarinic acetylcholine receptor m2,gpcr,,Drug: decamethonium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3271,decamethonium,acetylcholinesterase,enzyme,,Drug: decamethonium | Target: acetylcholinesterase | Type: enzyme | Action: nan
3272,decamethonium,histamine h3 receptor,gpcr,,Drug: decamethonium | Target: histamine h3 receptor | Type: gpcr | Action: nan
3273,decamethonium,acetylcholinesterase,enzyme,,Drug: decamethonium | Target: acetylcholinesterase | Type: enzyme | Action: nan
3274,decamethonium,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: decamethonium | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
3275,decamethonium,muscle-type nicotinic acetylcholine receptor,ion channel,PARTIAL AGONIST,Drug: decamethonium | Target: muscle-type nicotinic acetylcholine receptor | Type: ion channel | Action: PARTIAL AGONIST
3276,decitabine,dna (cytosine-5)-methyltransferase 1,enzyme,INHIBITOR,Drug: decitabine | Target: dna (cytosine-5)-methyltransferase 1 | Type: enzyme | Action: INHIBITOR
3277,decitabine,dna (cytosine-5)-methyltransferase 3a,enzyme,INHIBITOR,Drug: decitabine | Target: dna (cytosine-5)-methyltransferase 3a | Type: enzyme | Action: INHIBITOR
3278,deferoxamine,hypoxia-inducible factor 1-alpha,transcription factor,,Drug: deferoxamine | Target: hypoxia-inducible factor 1-alpha | Type: transcription factor | Action: nan
3279,deferoxamine,deoxyhypusine hydroxylase,enzyme,,Drug: deferoxamine | Target: deoxyhypusine hydroxylase | Type: enzyme | Action: nan
3280,prasterone,corticosteroid-binding globulin,secreted,,Drug: prasterone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
3281,prasterone,sex hormone-binding globulin,secreted,,Drug: prasterone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
3282,prasterone,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: prasterone | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
3283,prasterone,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: prasterone | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
3284,delapril,angiotensin-converting enzyme,enzyme,,Drug: delapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
3285,delapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: delapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
3286,delavirdine,histamine h4 receptor,gpcr,,Drug: delavirdine | Target: histamine h4 receptor | Type: gpcr | Action: nan
3287,delavirdine,beta-lactamase,enzyme,,Drug: delavirdine | Target: beta-lactamase | Type: enzyme | Action: nan
3288,delavirdine,gag-pol polyprotein,polyprotein,,Drug: delavirdine | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
3289,delavirdine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: delavirdine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
3290,delavirdine,reverse transcriptase,enzyme,,Drug: delavirdine | Target: reverse transcriptase | Type: enzyme | Action: nan
3291,delavirdine,malate dehydrogenase cytoplasmic,enzyme,,Drug: delavirdine | Target: malate dehydrogenase cytoplasmic | Type: enzyme | Action: nan
3292,delorazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: delorazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
3293,delorazepam,gaba-a receptor; anion channel,ion channel,,Drug: delorazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
3294,demecarium,acetylcholinesterase,enzyme,INHIBITOR,Drug: demecarium | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
3295,demeclocycline,30s ribosomal protein s4,ribosomal protein,,Drug: demeclocycline | Target: 30s ribosomal protein s4 | Type: ribosomal protein | Action: nan
3296,demeclocycline,30s ribosomal protein s9,ribosomal protein,,Drug: demeclocycline | Target: 30s ribosomal protein s9 | Type: ribosomal protein | Action: nan
3297,demeclocycline,estrogen receptor beta,nuclear hormone receptor,,Drug: demeclocycline | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
3298,denopamine,solute carrier family 22 member 1,transporter,,Drug: denopamine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
3299,denopamine,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: denopamine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
3300,deptropine,acetylcholine-binding protein,unclassified,,Drug: deptropine | Target: acetylcholine-binding protein | Type: unclassified | Action: nan
3301,deptropine,soluble acetylcholine receptor,unclassified,,Drug: deptropine | Target: soluble acetylcholine receptor | Type: unclassified | Action: nan
3302,desalkylflurazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: desalkylflurazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
3303,deserpidine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: deserpidine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
3304,desflurane,potassium channel subfamily k member 2,ion channel,OPENER,Drug: desflurane | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: OPENER
3305,desflurane,potassium channel subfamily k member 3,ion channel,OPENER,Drug: desflurane | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: OPENER
3306,desflurane,potassium channel subfamily k member 9,ion channel,OPENER,Drug: desflurane | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: OPENER
3307,desflurane,potassium channel subfamily k member 10,ion channel,OPENER,Drug: desflurane | Target: potassium channel subfamily k member 10 | Type: ion channel | Action: OPENER
3308,desflurane,potassium channel subfamily k member 18,ion channel,OPENER,Drug: desflurane | Target: potassium channel subfamily k member 18 | Type: ion channel | Action: OPENER
3309,desflurane,glycine receptor (alpha-1/beta),ion channel,POSITIVE MODULATOR,Drug: desflurane | Target: glycine receptor (alpha-1/beta) | Type: ion channel | Action: POSITIVE MODULATOR
3310,desflurane,gaba-a receptor; anion channel,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: desflurane | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3311,desipramine,d(1a) dopamine receptor,gpcr,,Drug: desipramine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
3312,desipramine,d(2) dopamine receptor,gpcr,,Drug: desipramine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3313,desipramine,alpha-2a adrenergic receptor,gpcr,,Drug: desipramine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3314,desipramine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: desipramine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3315,desipramine,sodium-dependent serotonin transporter,transporter,,Drug: desipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3316,desipramine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: desipramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
3317,desipramine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: desipramine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3318,desipramine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: desipramine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3319,desipramine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: desipramine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3320,desipramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: desipramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3321,desipramine,alpha-1a adrenergic receptor,gpcr,,Drug: desipramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3322,desipramine,alpha-2b adrenergic receptor,gpcr,,Drug: desipramine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3323,desipramine,histamine h1 receptor,gpcr,,Drug: desipramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
3324,desipramine,muscarinic acetylcholine receptor m1,gpcr,,Drug: desipramine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3325,desipramine,muscarinic acetylcholine receptor m2,gpcr,,Drug: desipramine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3326,desipramine,muscarinic acetylcholine receptor m3,gpcr,,Drug: desipramine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3327,desipramine,muscarinic acetylcholine receptor m4,gpcr,,Drug: desipramine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3328,desipramine,muscarinic acetylcholine receptor m5,gpcr,,Drug: desipramine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
3329,desipramine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: desipramine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
3330,desipramine,sodium-dependent dopamine transporter,transporter,,Drug: desipramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3331,desipramine,voltage-dependent calcium channel gamma-1 subunit,ion channel,,Drug: desipramine | Target: voltage-dependent calcium channel gamma-1 subunit | Type: ion channel | Action: nan
3332,desipramine,solute carrier family 22 member 1,transporter,,Drug: desipramine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
3333,desipramine,alpha-1a adrenergic receptor,gpcr,,Drug: desipramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3334,desipramine,sodium-dependent serotonin transporter,transporter,,Drug: desipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3335,desipramine,sodium-dependent dopamine transporter,transporter,,Drug: desipramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3336,desipramine,transporter,transporter,,Drug: desipramine | Target: transporter | Type: transporter | Action: nan
3337,desipramine,sodium-dependent noradrenaline transporter,transporter,,Drug: desipramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
3338,desipramine,sodium-dependent serotonin transporter,transporter,,Drug: desipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3339,desipramine,histamine h1 receptor,gpcr,,Drug: desipramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
3340,desipramine,transporter,transporter,,Drug: desipramine | Target: transporter | Type: transporter | Action: nan
3341,desipramine,serotonin (5-ht) receptor,gpcr,,Drug: desipramine | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
3342,desipramine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: desipramine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
3343,desipramine,equilibrative nucleoside transporter 4,transporter,INHIBITOR,Drug: desipramine | Target: equilibrative nucleoside transporter 4 | Type: transporter | Action: INHIBITOR
3344,desipramine,g protein-activated inward rectifier potassium channel 4,ion channel,BLOCKER,Drug: desipramine | Target: g protein-activated inward rectifier potassium channel 4 | Type: ion channel | Action: BLOCKER
3345,desipramine,g protein-activated inward rectifier potassium channel 2,ion channel,BLOCKER,Drug: desipramine | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: BLOCKER
3346,deslanoside,sodium/potassium-transporting atpase,transporter,INHIBITOR,Drug: deslanoside | Target: sodium/potassium-transporting atpase | Type: transporter | Action: INHIBITOR
3347,desloratadine,multidrug resistance protein 1,transporter,,Drug: desloratadine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
3348,desloratadine,sodium-dependent serotonin transporter,transporter,,Drug: desloratadine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3349,desloratadine,sodium-dependent noradrenaline transporter,transporter,,Drug: desloratadine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
3350,desloratadine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: desloratadine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3351,desloratadine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: desloratadine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3352,desloratadine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: desloratadine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3353,desloratadine,5-hydroxytryptamine receptor 6,gpcr,,Drug: desloratadine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3354,desloratadine,alpha-2b adrenergic receptor,gpcr,,Drug: desloratadine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3355,desloratadine,d(3) dopamine receptor,gpcr,,Drug: desloratadine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3356,desloratadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: desloratadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
3357,desloratadine,histamine h2 receptor,gpcr,,Drug: desloratadine | Target: histamine h2 receptor | Type: gpcr | Action: nan
3358,desloratadine,histamine h4 receptor,gpcr,,Drug: desloratadine | Target: histamine h4 receptor | Type: gpcr | Action: nan
3359,desloratadine,muscarinic acetylcholine receptor m1,gpcr,,Drug: desloratadine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3360,desloratadine,muscarinic acetylcholine receptor m2,gpcr,,Drug: desloratadine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3361,desloratadine,muscarinic acetylcholine receptor m3,gpcr,,Drug: desloratadine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3362,desloratadine,muscarinic acetylcholine receptor m4,gpcr,,Drug: desloratadine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3363,desloratadine,muscarinic acetylcholine receptor m5,gpcr,,Drug: desloratadine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
3364,desloratadine,sodium-dependent dopamine transporter,transporter,,Drug: desloratadine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3365,desloratadine,alpha-1b adrenergic receptor,gpcr,,Drug: desloratadine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3366,nordazepam,gamma-aminobutyric acid type b receptor subunit 2,gpcr,,Drug: nordazepam | Target: gamma-aminobutyric acid type b receptor subunit 2 | Type: gpcr | Action: nan
3367,nordazepam,gamma-aminobutyric acid receptor subunit rho-2,ion channel,,Drug: nordazepam | Target: gamma-aminobutyric acid receptor subunit rho-2 | Type: ion channel | Action: nan
3368,nordazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: nordazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
3369,nordazepam,gaba-a receptor; anion channel,ion channel,,Drug: nordazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
3370,desmopressin,vasopressin v1a receptor,gpcr,,Drug: desmopressin | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
3371,desmopressin,vasopressin v1b receptor,gpcr,,Drug: desmopressin | Target: vasopressin v1b receptor | Type: gpcr | Action: nan
3372,desmopressin,oxytocin receptor,gpcr,AGONIST,Drug: desmopressin | Target: oxytocin receptor | Type: gpcr | Action: AGONIST
3373,desmopressin,oxytocin receptor,gpcr,,Drug: desmopressin | Target: oxytocin receptor | Type: gpcr | Action: nan
3374,desmopressin,vasopressin v2 receptor,gpcr,,Drug: desmopressin | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
3375,desmopressin,vasopressin v1a receptor,gpcr,,Drug: desmopressin | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
3376,desmopressin,vasopressin v1b receptor,gpcr,,Drug: desmopressin | Target: vasopressin v1b receptor | Type: gpcr | Action: nan
3377,desmopressin,vasopressin v2 receptor,gpcr,AGONIST,Drug: desmopressin | Target: vasopressin v2 receptor | Type: gpcr | Action: AGONIST
3378,desogestrel,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: desogestrel | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
3379,desogestrel,sex hormone-binding globulin,secreted,,Drug: desogestrel | Target: sex hormone-binding globulin | Type: secreted | Action: nan
3380,desoximetasone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: desoximetasone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
3381,desoximetasone,annexin a1,cytosolic other,,Drug: desoximetasone | Target: annexin a1 | Type: cytosolic other | Action: nan
3382,desoximetasone,progesterone receptor,transcription factor,,Drug: desoximetasone | Target: progesterone receptor | Type: transcription factor | Action: nan
3383,desoxycortone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: desoxycortone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3384,desoxycortone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: desoxycortone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3385,desoxycortone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: desoxycortone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3386,desoxycortone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: desoxycortone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
3387,desoxycortone,mineralocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: desoxycortone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
3388,desoxycortone,corticosteroid-binding globulin,secreted,,Drug: desoxycortone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
3389,desoxycortone,sex hormone-binding globulin,secreted,,Drug: desoxycortone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
3390,desoxycorticosterone acetate,mineralocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: desoxycorticosterone acetate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
3391,desoxycorticosterone pivalate,mineralocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: desoxycorticosterone pivalate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
3392,dexamethasone,prostaglandin g/h synthase 2,enzyme,,Drug: dexamethasone | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
3393,dexamethasone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: dexamethasone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
3394,dexamethasone,annexin a1,cytosolic other,,Drug: dexamethasone | Target: annexin a1 | Type: cytosolic other | Action: nan
3395,dexamethasone,interleukin-5,cytokine,,Drug: dexamethasone | Target: interleukin-5 | Type: cytokine | Action: nan
3396,dexamethasone,mineralocorticoid receptor,nuclear hormone receptor,,Drug: dexamethasone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
3397,dexamethasone,interleukin-4,cytokine,,Drug: dexamethasone | Target: interleukin-4 | Type: cytokine | Action: nan
3398,dexamethasone,androgen receptor,nuclear hormone receptor,,Drug: dexamethasone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
3399,dexamethasone,progesterone receptor,nuclear hormone receptor,,Drug: dexamethasone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
3400,dexamethasone,androgen receptor,transcription factor,,Drug: dexamethasone | Target: androgen receptor | Type: transcription factor | Action: nan
3401,dexamethasone,"fatty acid-binding protein, liver",unclassified,,"Drug: dexamethasone | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
3402,dexamethasone,progesterone receptor,transcription factor,,Drug: dexamethasone | Target: progesterone receptor | Type: transcription factor | Action: nan
3403,dexamethasone,glucocorticoid receptor,transcription factor,,Drug: dexamethasone | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
3404,dexamethasone,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,AGONIST,Drug: dexamethasone | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: AGONIST
3405,dexamethasone acetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: dexamethasone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
3406,dexamethasone palmitate,glucocorticoid receptor,nuclear hormone receptor,,Drug: dexamethasone palmitate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
3407,dexamethasone palmitate,mineralocorticoid receptor,nuclear hormone receptor,,Drug: dexamethasone palmitate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
3408,dexamethasone palmitate,androgen receptor,nuclear hormone receptor,,Drug: dexamethasone palmitate | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
3409,dexamethasone palmitate,progesterone receptor,nuclear hormone receptor,,Drug: dexamethasone palmitate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
3410,dexamethasone palmitate,androgen receptor,transcription factor,,Drug: dexamethasone palmitate | Target: androgen receptor | Type: transcription factor | Action: nan
3411,dexamethasone palmitate,"fatty acid-binding protein, liver",unclassified,,"Drug: dexamethasone palmitate | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
3412,dexamethasone palmitate,progesterone receptor,transcription factor,,Drug: dexamethasone palmitate | Target: progesterone receptor | Type: transcription factor | Action: nan
3413,dexamethasone palmitate,glucocorticoid receptor,transcription factor,,Drug: dexamethasone palmitate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
3414,dexamethasone valerate,glucocorticoid receptor,nuclear hormone receptor,,Drug: dexamethasone valerate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
3415,dexamethasone valerate,mineralocorticoid receptor,nuclear hormone receptor,,Drug: dexamethasone valerate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
3416,dexamethasone valerate,androgen receptor,nuclear hormone receptor,,Drug: dexamethasone valerate | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
3417,dexamethasone valerate,progesterone receptor,nuclear hormone receptor,,Drug: dexamethasone valerate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
3418,dexamethasone valerate,androgen receptor,transcription factor,,Drug: dexamethasone valerate | Target: androgen receptor | Type: transcription factor | Action: nan
3419,dexamethasone valerate,"fatty acid-binding protein, liver",unclassified,,"Drug: dexamethasone valerate | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
3420,dexamethasone valerate,progesterone receptor,transcription factor,,Drug: dexamethasone valerate | Target: progesterone receptor | Type: transcription factor | Action: nan
3421,dexamethasone valerate,glucocorticoid receptor,transcription factor,,Drug: dexamethasone valerate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
3422,dexbrompheniramine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: dexbrompheniramine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
3423,dexetimide,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: dexetimide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
3424,dexetimide,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: dexetimide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
3425,dexetimide,muscarinic acetylcholine receptor,gpcr,,Drug: dexetimide | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
3426,dexfenfluramine,beta-1 adrenergic receptor,gpcr,,Drug: dexfenfluramine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
3427,dexfenfluramine,alpha-2a adrenergic receptor,gpcr,,Drug: dexfenfluramine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3428,dexfenfluramine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: dexfenfluramine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
3429,dexfenfluramine,sodium-dependent serotonin transporter,transporter,,Drug: dexfenfluramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3430,dexfenfluramine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3431,dexfenfluramine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3432,dexfenfluramine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3433,dexfenfluramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3434,dexfenfluramine,5-hydroxytryptamine receptor 6,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3435,dexfenfluramine,5-hydroxytryptamine receptor 7,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
3436,dexfenfluramine,alpha-1a adrenergic receptor,gpcr,,Drug: dexfenfluramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3437,dexfenfluramine,alpha-2b adrenergic receptor,gpcr,,Drug: dexfenfluramine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3438,dexfenfluramine,muscarinic acetylcholine receptor m1,gpcr,,Drug: dexfenfluramine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3439,dexfenfluramine,muscarinic acetylcholine receptor m2,gpcr,,Drug: dexfenfluramine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3440,dexfenfluramine,muscarinic acetylcholine receptor m3,gpcr,,Drug: dexfenfluramine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3441,dexfenfluramine,muscarinic acetylcholine receptor m4,gpcr,,Drug: dexfenfluramine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3442,dexfenfluramine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
3443,dexfenfluramine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
3444,dexfenfluramine,alpha-2c adrenergic receptor,gpcr,,Drug: dexfenfluramine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
3445,dexfenfluramine,alpha-1b adrenergic receptor,gpcr,,Drug: dexfenfluramine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3446,dexfenfluramine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dexfenfluramine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3447,dexketoprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: dexketoprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
3448,dexketoprofen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: dexketoprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
3449,dexloxiglumide,cholecystokinin receptor type a,gpcr,,Drug: dexloxiglumide | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
3450,dexmedetomidine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: dexmedetomidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
3451,dexmedetomidine,alpha-1a adrenergic receptor,gpcr,,Drug: dexmedetomidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3452,dexmedetomidine,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: dexmedetomidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
3453,dexmedetomidine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: dexmedetomidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
3454,dexmedetomidine,alpha-1d adrenergic receptor,gpcr,,Drug: dexmedetomidine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3455,dexmedetomidine,alpha-1b adrenergic receptor,gpcr,,Drug: dexmedetomidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3456,dexmedetomidine,alpha-2a adrenergic receptor,gpcr,,Drug: dexmedetomidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3457,dexmedetomidine,alpha-1a adrenergic receptor,gpcr,,Drug: dexmedetomidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3458,dexmedetomidine,adrenergic receptor alpha-2,gpcr,,Drug: dexmedetomidine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
3459,dexmedetomidine,adrenergic receptor alpha-1,gpcr,,Drug: dexmedetomidine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
3460,dexmedetomidine,alpha-1b adrenergic receptor,gpcr,,Drug: dexmedetomidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3461,dexmethylphenidate,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: dexmethylphenidate | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
3462,dexmethylphenidate,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: dexmethylphenidate | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
3463,dexmethylphenidate,sodium-dependent dopamine transporter,transporter,,Drug: dexmethylphenidate | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3464,dexmethylphenidate,transporter,transporter,,Drug: dexmethylphenidate | Target: transporter | Type: transporter | Action: nan
3465,dexmethylphenidate,dopamine receptor,gpcr,,Drug: dexmethylphenidate | Target: dopamine receptor | Type: gpcr | Action: nan
3466,dexniguldipine,alpha-2a adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3467,dexniguldipine,multidrug resistance protein 1,transporter,,Drug: dexniguldipine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
3468,dexniguldipine,alpha-1a adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3469,dexniguldipine,alpha-2b adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3470,dexniguldipine,alpha-2c adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
3471,dexniguldipine,adenosine receptor a3,gpcr,,Drug: dexniguldipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
3472,dexniguldipine,alpha-1d adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3473,dexniguldipine,alpha-1b adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3474,dexniguldipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: dexniguldipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
3475,dexniguldipine,alpha-1b adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3476,dexniguldipine,alpha-1a adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3477,dexniguldipine,alpha-1d adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3478,dexniguldipine,d(2) dopamine receptor,gpcr,,Drug: dexniguldipine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3479,dexniguldipine,adenosine receptor a1,gpcr,,Drug: dexniguldipine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
3480,dexniguldipine,alpha-1a adrenergic receptor,gpcr,,Drug: dexniguldipine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3481,dexniguldipine,voltage-gated l-type calcium channel,ion channel,,Drug: dexniguldipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: nan
3482,dexniguldipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: dexniguldipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
3483,dexamfetamine,alpha-2a adrenergic receptor,gpcr,,Drug: dexamfetamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3484,dexamfetamine,sodium-dependent serotonin transporter,transporter,,Drug: dexamfetamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3485,dexamfetamine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: dexamfetamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
3486,dexamfetamine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dexamfetamine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3487,dexamfetamine,alpha-1a adrenergic receptor,gpcr,,Drug: dexamfetamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3488,dexamfetamine,sodium-dependent dopamine transporter,transporter,RELEASING AGENT,Drug: dexamfetamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: RELEASING AGENT
3489,dexamfetamine,cocaine- and amphetamine-regulated transcript protein,transcription factor,,Drug: dexamfetamine | Target: cocaine- and amphetamine-regulated transcript protein | Type: transcription factor | Action: nan
3490,dexamfetamine,amine oxidase [flavin-containing] a,enzyme,,Drug: dexamfetamine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
3491,dexamfetamine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: dexamfetamine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
3492,dexamfetamine,trace amine-associated receptor 1,gpcr,,Drug: dexamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
3493,dexamfetamine,sodium-dependent serotonin transporter,transporter,,Drug: dexamfetamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3494,dexamfetamine,sodium-dependent dopamine transporter,transporter,,Drug: dexamfetamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3495,dexamfetamine,amine oxidase [flavin-containing] a,enzyme,,Drug: dexamfetamine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
3496,dexamfetamine,trace amine-associated receptor 1,gpcr,,Drug: dexamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
3497,dexamfetamine,trace amine-associated receptor 1,gpcr,,Drug: dexamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
3498,dexamfetamine,trace amine-associated receptor 1,gpcr,,Drug: dexamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
3499,dexamfetamine,serotonin (5-ht) receptor,gpcr,,Drug: dexamfetamine | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
3500,dextromethorphan,sigma non-opioid intracellular receptor 1,membrane receptor,AGONIST,Drug: dextromethorphan | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: AGONIST
3501,dextromethorphan,sodium-dependent serotonin transporter,transporter,,Drug: dextromethorphan | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3502,dextromethorphan,cytochrome p450 2d6,enzyme,,Drug: dextromethorphan | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
3503,dextromethorphan,"glutamate receptor ionotropic, nmda 3a",ion channel,ANTAGONIST,"Drug: dextromethorphan | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: ANTAGONIST"
3504,dextromethorphan,"glutamate receptor ionotropic, nmda 2c",ion channel,BLOCKER,"Drug: dextromethorphan | Target: glutamate receptor ionotropic, nmda 2c | Type: ion channel | Action: BLOCKER"
3505,dextromethorphan,solute carrier family 22 member 1,transporter,,Drug: dextromethorphan | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
3506,dextromethorphan,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: dextromethorphan | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
3507,dextromethorphan,sigma non-opioid intracellular receptor 1,membrane other,,Drug: dextromethorphan | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
3508,dextromethorphan,glutamate nmda receptor,ion channel,,Drug: dextromethorphan | Target: glutamate nmda receptor | Type: ion channel | Action: nan
3509,dextromethorphan,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: dextromethorphan | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
3510,dextromethorphan,taste receptor type 2 member 46,gpcr,,Drug: dextromethorphan | Target: taste receptor type 2 member 46 | Type: gpcr | Action: nan
3512,dextropropoxyphene,sodium channel protein type 5 subunit alpha,ion channel,,Drug: dextropropoxyphene | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
3513,dextropropoxyphene,mu-type opioid receptor,gpcr,AGONIST,Drug: dextropropoxyphene | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
3514,dextropropoxyphene,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: dextropropoxyphene | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
3515,dextrothyroxine,thyroid hormone receptor beta,transcription factor,,Drug: dextrothyroxine | Target: thyroid hormone receptor beta | Type: transcription factor | Action: nan
3516,dextrothyroxine,thyroid hormone receptor,nuclear hormone receptor,AGONIST,Drug: dextrothyroxine | Target: thyroid hormone receptor | Type: nuclear hormone receptor | Action: AGONIST
3517,dextrothyroxine,glutamate nmda receptor,ion channel,,Drug: dextrothyroxine | Target: glutamate nmda receptor | Type: ion channel | Action: nan
3518,dezocine,mu-type opioid receptor,gpcr,PARTIAL AGONIST,Drug: dezocine | Target: mu-type opioid receptor | Type: gpcr | Action: PARTIAL AGONIST
3519,dezocine,kappa-type opioid receptor,gpcr,ANTAGONIST,Drug: dezocine | Target: kappa-type opioid receptor | Type: gpcr | Action: ANTAGONIST
3520,diacerein,caspase-3,enzyme,,Drug: diacerein | Target: caspase-3 | Type: enzyme | Action: nan
3521,diacerein,caspase-7,enzyme,,Drug: diacerein | Target: caspase-7 | Type: enzyme | Action: nan
3522,diacerein,female germline-specific tumor suppressor gld-1,unclassified,,Drug: diacerein | Target: female germline-specific tumor suppressor gld-1 | Type: unclassified | Action: nan
3523,diacerein,n-acylethanolamine-hydrolyzing acid amidase,enzyme,,Drug: diacerein | Target: n-acylethanolamine-hydrolyzing acid amidase | Type: enzyme | Action: nan
3524,diazepam,gaba a receptor alpha-5/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba a receptor alpha-5/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3525,diazepam,gamma-aminobutyric acid receptor subunit alpha-5,ion channel,,Drug: diazepam | Target: gamma-aminobutyric acid receptor subunit alpha-5 | Type: ion channel | Action: nan
3526,diazepam,cytochrome p450 3a4,enzyme,,Drug: diazepam | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
3527,diazepam,alpha-1a adrenergic receptor,gpcr,ALLOSTERIC MODULATOR,Drug: diazepam | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ALLOSTERIC MODULATOR
3528,diazepam,adenosine receptor a3,gpcr,,Drug: diazepam | Target: adenosine receptor a3 | Type: gpcr | Action: nan
3529,diazepam,aldo-keto reductase family 1 member c1,enzyme,,Drug: diazepam | Target: aldo-keto reductase family 1 member c1 | Type: enzyme | Action: nan
3530,diazepam,aldo-keto reductase family 1 member c2,enzyme,,Drug: diazepam | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
3531,diazepam,aldo-keto reductase family 1 member c3,enzyme,,Drug: diazepam | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
3532,diazepam,"fatty acid-binding protein, liver",unclassified,,"Drug: diazepam | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
3533,diazepam,acetylcholinesterase,enzyme,,Drug: diazepam | Target: acetylcholinesterase | Type: enzyme | Action: nan
3534,diazepam,translocator protein,membrane receptor,,Drug: diazepam | Target: translocator protein | Type: membrane receptor | Action: nan
3535,diazepam,thyrotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: diazepam | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
3536,diazepam,cholinesterase,enzyme,,Drug: diazepam | Target: cholinesterase | Type: enzyme | Action: nan
3537,diazepam,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,,Drug: diazepam | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: nan
3538,diazepam,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,,Drug: diazepam | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: nan
3539,diazepam,gamma-aminobutyric acid receptor subunit alpha-5,ion channel,,Drug: diazepam | Target: gamma-aminobutyric acid receptor subunit alpha-5 | Type: ion channel | Action: nan
3540,diazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3541,diazepam,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3542,diazepam,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3543,diazepam,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3544,diazepam,gaba-a receptor alpha-1/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3545,diazepam,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3546,diazepam,gaba-a receptor; anion channel,ion channel,,Drug: diazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
3547,diazepam,gaba-a receptor; anion channel,ion channel,,Drug: diazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
3548,diazepam,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,,Drug: diazepam | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: nan
3549,diazepam,gaba a receptor alpha-6/beta-2/gamma-2,ion channel,,Drug: diazepam | Target: gaba a receptor alpha-6/beta-2/gamma-2 | Type: ion channel | Action: nan
3550,diazepam,gaba-a receptor; alpha-1/beta-2/gamma-2,ion channel,,Drug: diazepam | Target: gaba-a receptor; alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
3551,diazepam,gaba-a receptor; anion channel,ion channel,,Drug: diazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
3552,diazepam,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,,Drug: diazepam | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: nan
3553,diazepam,gaba a receptor alpha-5/beta-3/gamma-2,ion channel,,Drug: diazepam | Target: gaba a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: nan
3554,diazepam,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3555,diazepam,gaba a receptor alpha-3/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba a receptor alpha-3/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3556,diazepam,gaba a receptor alpha-5/beta-3/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba a receptor alpha-5/beta-3/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3557,diazepam,gaba a receptor alpha-5/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: diazepam | Target: gaba a receptor alpha-5/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
3558,diazoxide,nicotinamide phosphoribosyltransferase,enzyme,,Drug: diazoxide | Target: nicotinamide phosphoribosyltransferase | Type: enzyme | Action: nan
3559,diazoxide,"sulfonylurea receptor 1, kir6.2",ion channel,OPENER,"Drug: diazoxide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: OPENER"
3560,diazoxide,atp-sensitive inward rectifier potassium channel 11,ion channel,ACTIVATOR,Drug: diazoxide | Target: atp-sensitive inward rectifier potassium channel 11 | Type: ion channel | Action: ACTIVATOR
3561,dibekacin,"macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b)",enzyme,,"Drug: dibekacin | Target: macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b) | Type: enzyme | Action: nan"
3562,cinchocaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: cinchocaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
3563,cinchocaine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: cinchocaine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
3564,cinchocaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: cinchocaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
3565,phenazone,nicotinate phosphoribosyltransferase,enzyme,,Drug: phenazone | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
3566,phenazone,transient receptor potential cation channel subfamily a member 1,ion channel,BLOCKER,Drug: phenazone | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: BLOCKER
3567,dichloroacetic acid,"[pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial",kinase,INHIBITOR,"Drug: dichloroacetic acid | Target: [pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | Type: kinase | Action: INHIBITOR"
3568,dichloroacetic acid,"[pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial",kinase,INHIBITOR,"Drug: dichloroacetic acid | Target: [pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | Type: kinase | Action: INHIBITOR"
3569,dichloroacetic acid,"[pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial",kinase,INHIBITOR,"Drug: dichloroacetic acid | Target: [pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | Type: kinase | Action: INHIBITOR"
3570,dichloroacetic acid,"[pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial",kinase,INHIBITOR,"Drug: dichloroacetic acid | Target: [pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | Type: kinase | Action: INHIBITOR"
3571,dichlorophen,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: dichlorophen | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
3572,dichlorophen,solute carrier family 22 member 1,transporter,,Drug: dichlorophen | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
3573,dichlorophen,78 kda glucose-regulated protein,unclassified,,Drug: dichlorophen | Target: 78 kda glucose-regulated protein | Type: unclassified | Action: nan
3574,dichlorphenamide,carbonic anhydrase 2,enzyme,INHIBITOR,Drug: dichlorphenamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: INHIBITOR
3575,dichlorphenamide,carbonic anhydrase 1,enzyme,INHIBITOR,Drug: dichlorphenamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: INHIBITOR
3576,dichlorphenamide,carbonic anhydrase 4,enzyme,INHIBITOR,Drug: dichlorphenamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: INHIBITOR
3577,dichlorphenamide,cytochrome p450 2c9,enzyme,,Drug: dichlorphenamide | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
3578,dichlorphenamide,carbonic anhydrase 9,enzyme,INHIBITOR,Drug: dichlorphenamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: INHIBITOR
3579,dichlorphenamide,carbonic anhydrase 12,enzyme,INHIBITOR,Drug: dichlorphenamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: INHIBITOR
3580,dichlorphenamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: dichlorphenamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
3581,dichlorphenamide,"carbonic anhydrase 5b, mitochondrial",enzyme,INHIBITOR,"Drug: dichlorphenamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: INHIBITOR"
3582,dichlorphenamide,carbonic anhydrase 7,enzyme,INHIBITOR,Drug: dichlorphenamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: INHIBITOR
3583,dichlorphenamide,carbonic anhydrase,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
3584,dichlorphenamide,carbonic anhydrase 6,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
3585,dichlorphenamide,carbonic anhydrase 14,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
3586,dichlorphenamide,carbonic anhydrase 13,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
3587,dichlorphenamide,carbonic anhydrase 4,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
3588,dichlorphenamide,carbonic anhydrase,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
3589,dichlorphenamide,carbonic anhydrase 13,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
3590,dichlorphenamide,carbonic anhydrase 15,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
3591,dichlorphenamide,carbonic anhydrase,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
3592,dichlorphenamide,carbonic anhydrase,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
3593,dichlorphenamide,carbonic anhydrase,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
3594,dichlorphenamide,alpha carbonic anhydrase,enzyme,,Drug: dichlorphenamide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
3595,dichlorphenamide,carbonic anhydrase,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
3596,dichlorphenamide,carbonic anhydrase 2,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
3597,dichlorphenamide,astrosclerin-3,enzyme,,Drug: dichlorphenamide | Target: astrosclerin-3 | Type: enzyme | Action: nan
3598,dichlorphenamide,beta-carbonic anhydrase 1,enzyme,,Drug: dichlorphenamide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
3599,dichlorphenamide,delta carbonic anhydrase,unclassified,,Drug: dichlorphenamide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
3600,dichlorphenamide,carbonic anhydrase 2,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
3601,dichlorphenamide,carbonic anhydrase,enzyme,,Drug: dichlorphenamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
3602,dichlorphenamide,"carbonic anhydrase, alpha family",unclassified,,"Drug: dichlorphenamide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
3603,dichlorphenamide,carbonate dehydratase,enzyme,,Drug: dichlorphenamide | Target: carbonate dehydratase | Type: enzyme | Action: nan
3604,diclofenac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: diclofenac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
3605,diclofenac,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: diclofenac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
3606,diclofenac,transthyretin,secreted,,Drug: diclofenac | Target: transthyretin | Type: secreted | Action: nan
3607,diclofenac,aldo-keto reductase family 1 member c3,enzyme,,Drug: diclofenac | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
3608,diclofenac,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,ANTAGONIST,Drug: diclofenac | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: ANTAGONIST
3609,diclofenac,"fatty acid-binding protein, liver",unclassified,,"Drug: diclofenac | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
3610,diclofenac,interleukin-8,cytokine,,Drug: diclofenac | Target: interleukin-8 | Type: cytokine | Action: nan
3611,diclofenac,transient receptor potential cation channel subfamily a member 1,ion channel,,Drug: diclofenac | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: nan
3612,diclofenac,prostaglandin g/h synthase 2,enzyme,,Drug: diclofenac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
3613,diclofenac,prostaglandin g/h synthase 1,enzyme,,Drug: diclofenac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
3614,diclofenac,prostaglandin g/h synthase 2,enzyme,,Drug: diclofenac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
3615,diclofenac,aldo-keto reductase family 1 member b10,enzyme,,Drug: diclofenac | Target: aldo-keto reductase family 1 member b10 | Type: enzyme | Action: nan
3616,diclofenac,prostaglandin g/h synthase 1,enzyme,,Drug: diclofenac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
3617,diclofenac,acid-sensing ion channel 3,ion channel,BLOCKER,Drug: diclofenac | Target: acid-sensing ion channel 3 | Type: ion channel | Action: BLOCKER
3618,diclofenac,c-x-c chemokine receptor type 1,gpcr,,Drug: diclofenac | Target: c-x-c chemokine receptor type 1 | Type: gpcr | Action: nan
3619,diclofenac,udp-glucuronosyltransferase 1-1,enzyme,,Drug: diclofenac | Target: udp-glucuronosyltransferase 1-1 | Type: enzyme | Action: nan
3620,diclofenac,udp-glucuronosyltransferase 1-7,enzyme,,Drug: diclofenac | Target: udp-glucuronosyltransferase 1-7 | Type: enzyme | Action: nan
3621,diclofenac,udp-glucuronosyltransferase 1-6,enzyme,,Drug: diclofenac | Target: udp-glucuronosyltransferase 1-6 | Type: enzyme | Action: nan
3622,diclofenac,udp-glucuronosyltransferase 1-9,enzyme,,Drug: diclofenac | Target: udp-glucuronosyltransferase 1-9 | Type: enzyme | Action: nan
3623,diclofenac,udp-glucuronosyltransferase 1-10,enzyme,,Drug: diclofenac | Target: udp-glucuronosyltransferase 1-10 | Type: enzyme | Action: nan
3624,diclofenac,transient receptor potential cation channel subfamily m member 3,ion channel,BLOCKER,Drug: diclofenac | Target: transient receptor potential cation channel subfamily m member 3 | Type: ion channel | Action: BLOCKER
3626,dicloxacillin,histamine h2 receptor,gpcr,,Drug: dicloxacillin | Target: histamine h2 receptor | Type: gpcr | Action: nan
3627,dicloxacillin,muscarinic acetylcholine receptor m1,gpcr,,Drug: dicloxacillin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3628,dicloxacillin,muscarinic acetylcholine receptor m2,gpcr,,Drug: dicloxacillin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3629,dicloxacillin,muscarinic acetylcholine receptor m3,gpcr,,Drug: dicloxacillin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3630,dicloxacillin,penicillin-binding protein 1a,enzyme,,Drug: dicloxacillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
3631,dicloxacillin,sodium-dependent dopamine transporter,transporter,,Drug: dicloxacillin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3632,dicloxacillin,bile salt export pump,transporter,,Drug: dicloxacillin | Target: bile salt export pump | Type: transporter | Action: nan
3633,dicloxacillin,"cgmp-dependent 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: dicloxacillin | Target: cgmp-dependent 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
3634,dicloxacillin,streptokinase a,enzyme,,Drug: dicloxacillin | Target: streptokinase a | Type: enzyme | Action: nan
3635,dicloxacillin,penicillin-binding protein,enzyme,INHIBITOR,Drug: dicloxacillin | Target: penicillin-binding protein | Type: enzyme | Action: INHIBITOR
3636,dicoumarol,cytochrome p450 2c9,enzyme,,Drug: dicoumarol | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
3637,dicoumarol,nad(p)h dehydrogenase [quinone] 1,enzyme,,Drug: dicoumarol | Target: nad(p)h dehydrogenase [quinone] 1 | Type: enzyme | Action: nan
3638,dicoumarol,aldose reductase,enzyme,,Drug: dicoumarol | Target: aldose reductase | Type: enzyme | Action: nan
3639,dicoumarol,mitogen-activated protein kinase 1,kinase,,Drug: dicoumarol | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
3640,dicoumarol,proprotein convertase subtilisin/kexin type 7,enzyme,,Drug: dicoumarol | Target: proprotein convertase subtilisin/kexin type 7 | Type: enzyme | Action: nan
3641,dicoumarol,g-protein coupled receptor 35,gpcr,,Drug: dicoumarol | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
3642,dicoumarol,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,,Drug: dicoumarol | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: nan
3643,dicoumarol,urease,enzyme,,Drug: dicoumarol | Target: urease | Type: enzyme | Action: nan
3644,dicoumarol,atp phosphoribosyltransferase,enzyme,,Drug: dicoumarol | Target: atp phosphoribosyltransferase | Type: enzyme | Action: nan
3645,dicoumarol,nulld(p)h dehydrogenase [quinone] 1,enzyme,,Drug: dicoumarol | Target: nulld(p)h dehydrogenase [quinone] 1 | Type: enzyme | Action: nan
3646,dicoumarol,vitamin k epoxide reductase complex subunit 1,enzyme,INHIBITOR,Drug: dicoumarol | Target: vitamin k epoxide reductase complex subunit 1 | Type: enzyme | Action: INHIBITOR
3647,dicycloverine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: dicycloverine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
3648,dicycloverine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: dicycloverine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3649,dicycloverine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: dicycloverine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3650,dicycloverine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: dicycloverine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3651,dicycloverine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: dicycloverine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3652,dicycloverine,5-hydroxytryptamine receptor 6,gpcr,,Drug: dicycloverine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3653,dicycloverine,d(3) dopamine receptor,gpcr,,Drug: dicycloverine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3654,dicycloverine,histamine h2 receptor,gpcr,,Drug: dicycloverine | Target: histamine h2 receptor | Type: gpcr | Action: nan
3655,dicycloverine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: dicycloverine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
3656,dicycloverine,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: dicycloverine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
3657,dicycloverine,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: dicycloverine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
3658,dicycloverine,muscarinic acetylcholine receptor m4,gpcr,,Drug: dicycloverine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3659,dicycloverine,muscarinic acetylcholine receptor m5,gpcr,,Drug: dicycloverine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
3660,dicycloverine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: dicycloverine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
3661,dicycloverine,smr1-alpha2,unclassified,,Drug: dicycloverine | Target: smr1-alpha2 | Type: unclassified | Action: nan
3662,dicycloverine,muscarinic acetylcholine receptor m2,gpcr,,Drug: dicycloverine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3663,dicycloverine,muscarinic acetylcholine receptor m1,gpcr,,Drug: dicycloverine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3664,dicycloverine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: dicycloverine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
3665,didanosine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: didanosine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
3666,dienestrol,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: dienestrol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
3667,dienogest,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: dienogest | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
3668,diethazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: diethazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
3669,diethylcarbamazine,prostaglandin g/h synthase 1,enzyme,,Drug: diethylcarbamazine | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
3670,diethylcarbamazine,arachidonate 5-lipoxygenase,enzyme,,Drug: diethylcarbamazine | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
3671,diethylcarbamazine,nematode gaba-a receptor,ion channel,POSITIVE MODULATOR,Drug: diethylcarbamazine | Target: nematode gaba-a receptor | Type: ion channel | Action: POSITIVE MODULATOR
3672,diethylpropion,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: diethylpropion | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
3673,diethylpropion,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: diethylpropion | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
3674,diethylstilbestrol,sodium/nucleoside cotransporter 1,transporter,,Drug: diethylstilbestrol | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
3675,diethylstilbestrol,beta-1 adrenergic receptor,gpcr,,Drug: diethylstilbestrol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
3676,diethylstilbestrol,prostaglandin g/h synthase 1,enzyme,,Drug: diethylstilbestrol | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
3677,diethylstilbestrol,mu-type opioid receptor,gpcr,,Drug: diethylstilbestrol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
3678,diethylstilbestrol,d(1a) dopamine receptor,gpcr,,Drug: diethylstilbestrol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
3679,diethylstilbestrol,d(2) dopamine receptor,gpcr,,Drug: diethylstilbestrol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3680,diethylstilbestrol,adenosine receptor a2a,gpcr,,Drug: diethylstilbestrol | Target: adenosine receptor a2a | Type: gpcr | Action: nan
3681,diethylstilbestrol,alpha-2a adrenergic receptor,gpcr,,Drug: diethylstilbestrol | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3682,diethylstilbestrol,sodium-dependent serotonin transporter,transporter,,Drug: diethylstilbestrol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3683,diethylstilbestrol,sodium-dependent noradrenaline transporter,transporter,,Drug: diethylstilbestrol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
3684,diethylstilbestrol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: diethylstilbestrol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3685,diethylstilbestrol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: diethylstilbestrol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3686,diethylstilbestrol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: diethylstilbestrol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3687,diethylstilbestrol,5-hydroxytryptamine receptor 6,gpcr,,Drug: diethylstilbestrol | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3688,diethylstilbestrol,alpha-2b adrenergic receptor,gpcr,,Drug: diethylstilbestrol | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3689,diethylstilbestrol,d(3) dopamine receptor,gpcr,,Drug: diethylstilbestrol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3690,diethylstilbestrol,muscarinic acetylcholine receptor m1,gpcr,,Drug: diethylstilbestrol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3691,diethylstilbestrol,muscarinic acetylcholine receptor m3,gpcr,,Drug: diethylstilbestrol | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3692,diethylstilbestrol,glucocorticoid receptor,nuclear hormone receptor,,Drug: diethylstilbestrol | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
3693,diethylstilbestrol,alpha-2c adrenergic receptor,gpcr,,Drug: diethylstilbestrol | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
3694,diethylstilbestrol,sodium-dependent dopamine transporter,transporter,,Drug: diethylstilbestrol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3695,diethylstilbestrol,adenosine receptor a1,gpcr,,Drug: diethylstilbestrol | Target: adenosine receptor a1 | Type: gpcr | Action: nan
3696,diethylstilbestrol,adenosine receptor a3,gpcr,,Drug: diethylstilbestrol | Target: adenosine receptor a3 | Type: gpcr | Action: nan
3697,diethylstilbestrol,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: diethylstilbestrol | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
3698,diethylstilbestrol,alpha-1d adrenergic receptor,gpcr,,Drug: diethylstilbestrol | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3699,diethylstilbestrol,kappa-type opioid receptor,gpcr,,Drug: diethylstilbestrol | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
3700,diethylstilbestrol,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: diethylstilbestrol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
3701,diethylstilbestrol,delta-type opioid receptor,gpcr,,Drug: diethylstilbestrol | Target: delta-type opioid receptor | Type: gpcr | Action: nan
3702,diethylstilbestrol,acetylcholinesterase,enzyme,,Drug: diethylstilbestrol | Target: acetylcholinesterase | Type: enzyme | Action: nan
3703,diethylstilbestrol,estrogen receptor beta,nuclear hormone receptor,,Drug: diethylstilbestrol | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
3704,diethylstilbestrol,estrogen-related receptor gamma,nuclear hormone receptor,ANTAGONIST,Drug: diethylstilbestrol | Target: estrogen-related receptor gamma | Type: nuclear hormone receptor | Action: ANTAGONIST
3705,diethylstilbestrol,cysteinyl leukotriene receptor 1,gpcr,,Drug: diethylstilbestrol | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
3706,diethylstilbestrol,vasopressin v1a receptor,gpcr,,Drug: diethylstilbestrol | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
3707,diethylstilbestrol,tyrosine-protein kinase fyn,kinase,,Drug: diethylstilbestrol | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
3708,diethylstilbestrol,thromboxane-a synthase,enzyme,,Drug: diethylstilbestrol | Target: thromboxane-a synthase | Type: enzyme | Action: nan
3709,diethylstilbestrol,steroid hormone receptor err2,nuclear hormone receptor,ANTAGONIST,Drug: diethylstilbestrol | Target: steroid hormone receptor err2 | Type: nuclear hormone receptor | Action: ANTAGONIST
3710,diethylstilbestrol,mitogen-activated protein kinase 14,kinase,,Drug: diethylstilbestrol | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
3711,diethylstilbestrol,substance-k receptor,gpcr,,Drug: diethylstilbestrol | Target: substance-k receptor | Type: gpcr | Action: nan
3712,diethylstilbestrol,androgen receptor,transcription factor,,Drug: diethylstilbestrol | Target: androgen receptor | Type: transcription factor | Action: nan
3713,diethylstilbestrol,arachidonate 15-lipoxygenase,enzyme,,Drug: diethylstilbestrol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
3714,diethylstilbestrol,cysteinyl leukotriene receptor 1,gpcr,,Drug: diethylstilbestrol | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
3715,diethylstilbestrol,progesterone receptor,transcription factor,,Drug: diethylstilbestrol | Target: progesterone receptor | Type: transcription factor | Action: nan
3716,diethylstilbestrol,alpha-1a adrenergic receptor,gpcr,,Drug: diethylstilbestrol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3717,diethylstilbestrol,udp-glucose 4-epimerase,enzyme,,Drug: diethylstilbestrol | Target: udp-glucose 4-epimerase | Type: enzyme | Action: nan
3718,diethylstilbestrol,steroid hormone receptor err1,nuclear hormone receptor,ANTAGONIST,Drug: diethylstilbestrol | Target: steroid hormone receptor err1 | Type: nuclear hormone receptor | Action: ANTAGONIST
3719,difenoxin,mu-type opioid receptor,gpcr,AGONIST,Drug: difenoxin | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
3720,diflunisal,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: diflunisal | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
3721,diflunisal,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: diflunisal | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
3722,diflunisal,carbonic anhydrase 2,enzyme,,Drug: diflunisal | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
3723,diflunisal,transthyretin,secreted,,Drug: diflunisal | Target: transthyretin | Type: secreted | Action: nan
3724,diflunisal,carbonic anhydrase 1,enzyme,,Drug: diflunisal | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
3725,diflunisal,dihydrofolate reductase,enzyme,INHIBITOR,Drug: diflunisal | Target: dihydrofolate reductase | Type: enzyme | Action: INHIBITOR
3727,digitoxin,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: digitoxin | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
3728,digitoxin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: digitoxin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3729,digitoxin,sodium/potassium-transporting atpase subunit alpha-1,transporter,INHIBITOR,Drug: digitoxin | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: INHIBITOR
3730,digitoxin,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: digitoxin | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
3731,digitoxin,signal transducer and activator of transcription 3,transcription factor,,Drug: digitoxin | Target: signal transducer and activator of transcription 3 | Type: transcription factor | Action: nan
3732,digitoxin,sodium/potassium-transporting atpase,transporter,,Drug: digitoxin | Target: sodium/potassium-transporting atpase | Type: transporter | Action: nan
3733,digoxin,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: digoxin | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
3734,digoxin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: digoxin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3735,digoxin,nuclear receptor ror-gamma,nuclear hormone receptor,,Drug: digoxin | Target: nuclear receptor ror-gamma | Type: nuclear hormone receptor | Action: nan
3736,digoxin,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: digoxin | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
3737,digoxin,signal transducer and activator of transcription 3,transcription factor,,Drug: digoxin | Target: signal transducer and activator of transcription 3 | Type: transcription factor | Action: nan
3738,digoxin,sodium/potassium-transporting atpase,transporter,INHIBITOR,Drug: digoxin | Target: sodium/potassium-transporting atpase | Type: transporter | Action: INHIBITOR
3739,digoxin,nuclear receptor ror-gamma,nuclear hormone receptor,,Drug: digoxin | Target: nuclear receptor ror-gamma | Type: nuclear hormone receptor | Action: nan
3740,alpha-ergocryptine,mu-type opioid receptor,gpcr,,Drug: alpha-ergocryptine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
3741,alpha-ergocryptine,d(1a) dopamine receptor,gpcr,,Drug: alpha-ergocryptine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
3742,alpha-ergocryptine,d(2) dopamine receptor,gpcr,,Drug: alpha-ergocryptine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3743,alpha-ergocryptine,alpha-2a adrenergic receptor,gpcr,,Drug: alpha-ergocryptine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3744,alpha-ergocryptine,cytochrome p450 3a4,enzyme,,Drug: alpha-ergocryptine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
3745,alpha-ergocryptine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: alpha-ergocryptine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3746,alpha-ergocryptine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: alpha-ergocryptine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3747,alpha-ergocryptine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: alpha-ergocryptine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3748,alpha-ergocryptine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: alpha-ergocryptine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3749,alpha-ergocryptine,5-hydroxytryptamine receptor 6,gpcr,,Drug: alpha-ergocryptine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3750,alpha-ergocryptine,alpha-2b adrenergic receptor,gpcr,,Drug: alpha-ergocryptine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3751,alpha-ergocryptine,d(3) dopamine receptor,gpcr,,Drug: alpha-ergocryptine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3752,alpha-ergocryptine,beta-3 adrenergic receptor,gpcr,,Drug: alpha-ergocryptine | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
3753,alpha-ergocryptine,alpha-2c adrenergic receptor,gpcr,,Drug: alpha-ergocryptine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
3754,alpha-ergocryptine,alpha-1d adrenergic receptor,gpcr,,Drug: alpha-ergocryptine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3755,alpha-ergocryptine,cytochrome p450 2c9,enzyme,,Drug: alpha-ergocryptine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
3756,alpha-ergocryptine,alpha-1b adrenergic receptor,gpcr,,Drug: alpha-ergocryptine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3757,alpha-ergocryptine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: alpha-ergocryptine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
3758,alpha-ergocryptine,alpha-1a adrenergic receptor,gpcr,,Drug: alpha-ergocryptine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3759,alpha-ergocryptine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: alpha-ergocryptine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3760,dihydrocodeine,mu-type opioid receptor,gpcr,AGONIST,Drug: dihydrocodeine | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
3761,dihydroergocristine,5-hydroxytryptamine receptor 4,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
3762,dihydroergocristine,mu-type opioid receptor,gpcr,,Drug: dihydroergocristine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
3763,dihydroergocristine,d(1a) dopamine receptor,gpcr,,Drug: dihydroergocristine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
3764,dihydroergocristine,d(2) dopamine receptor,gpcr,,Drug: dihydroergocristine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3765,dihydroergocristine,alpha-2a adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3766,dihydroergocristine,cytochrome p450 3a4,enzyme,,Drug: dihydroergocristine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
3767,dihydroergocristine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3768,dihydroergocristine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3769,dihydroergocristine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3770,dihydroergocristine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3771,dihydroergocristine,5-hydroxytryptamine receptor 6,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3772,dihydroergocristine,alpha-1a adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3773,dihydroergocristine,alpha-2b adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3774,dihydroergocristine,d(3) dopamine receptor,gpcr,,Drug: dihydroergocristine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3775,dihydroergocristine,beta-3 adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
3776,dihydroergocristine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
3777,dihydroergocristine,alpha-2c adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
3778,dihydroergocristine,alpha-1d adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3779,dihydroergocristine,alpha-1b adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3780,dihydroergocristine,cytochrome p450 2c9,enzyme,,Drug: dihydroergocristine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
3781,dihydroergocristine,cytochrome p450 2c19,enzyme,,Drug: dihydroergocristine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
3782,dihydroergocristine,alpha-1b adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3783,dihydroergocristine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
3784,dihydroergocristine,alpha-1a adrenergic receptor,gpcr,,Drug: dihydroergocristine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3785,dihydroergocristine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3786,dihydroergocristine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: dihydroergocristine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
3787,dihydroergotamine,5-hydroxytryptamine receptor 4,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
3788,dihydroergotamine,d(1a) dopamine receptor,gpcr,,Drug: dihydroergotamine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
3789,dihydroergotamine,d(2) dopamine receptor,gpcr,,Drug: dihydroergotamine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3790,dihydroergotamine,alpha-2a adrenergic receptor,gpcr,,Drug: dihydroergotamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3791,dihydroergotamine,cytochrome p450 3a4,enzyme,,Drug: dihydroergotamine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
3792,dihydroergotamine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3793,dihydroergotamine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3794,dihydroergotamine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3795,dihydroergotamine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3796,dihydroergotamine,5-hydroxytryptamine receptor 6,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3797,dihydroergotamine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
3798,dihydroergotamine,alpha-1a adrenergic receptor,gpcr,,Drug: dihydroergotamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3799,dihydroergotamine,alpha-2b adrenergic receptor,gpcr,,Drug: dihydroergotamine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3800,dihydroergotamine,d(3) dopamine receptor,gpcr,,Drug: dihydroergotamine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3801,dihydroergotamine,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
3802,dihydroergotamine,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
3803,dihydroergotamine,alpha-2c adrenergic receptor,gpcr,,Drug: dihydroergotamine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
3804,dihydroergotamine,alpha-1d adrenergic receptor,gpcr,,Drug: dihydroergotamine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3805,dihydroergotamine,alpha-1b adrenergic receptor,gpcr,,Drug: dihydroergotamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3806,dihydroergotamine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
3807,dihydroergotamine,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
3808,dihydroergotamine,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
3809,dihydroergotamine,alpha-1b adrenergic receptor,gpcr,,Drug: dihydroergotamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3810,dihydroergotamine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
3811,dihydroergotamine,alpha-1a adrenergic receptor,gpcr,,Drug: dihydroergotamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3812,dihydroergotamine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3813,dihydroergotamine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
3814,dihydroergotamine,gastrin/cholecystokinin type b receptor,gpcr,,Drug: dihydroergotamine | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
3815,dihydroergotamine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: dihydroergotamine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
3816,dihydroergotamine,solute carrier family 22 member 2,transporter,,Drug: dihydroergotamine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
3817,dihydroergotamine,multidrug and toxin extrusion protein 1,transporter,,Drug: dihydroergotamine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
3818,dihydroergotamine,multidrug and toxin extrusion protein 2,transporter,,Drug: dihydroergotamine | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
3819,dihydroergotamine,adrenergic receptor alpha-2,gpcr,,Drug: dihydroergotamine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
3820,hydroquinidine,sodium channel protein type 5 subunit alpha,ion channel,,Drug: hydroquinidine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
3821,hydroquinidine,sodium channel subunit beta-1,ion channel,,Drug: hydroquinidine | Target: sodium channel subunit beta-1 | Type: ion channel | Action: nan
3822,hydroquinidine,sodium channel subunit beta-2,ion channel,,Drug: hydroquinidine | Target: sodium channel subunit beta-2 | Type: ion channel | Action: nan
3823,hydroquinidine,sodium channel subunit beta-3,ion channel,,Drug: hydroquinidine | Target: sodium channel subunit beta-3 | Type: ion channel | Action: nan
3824,hydroquinidine,sodium channel subunit beta-4,ion channel,,Drug: hydroquinidine | Target: sodium channel subunit beta-4 | Type: ion channel | Action: nan
3825,hydroquinidine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: hydroquinidine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3826,dilazep,equilibrative nucleoside transporter 1,transporter,,Drug: dilazep | Target: equilibrative nucleoside transporter 1 | Type: transporter | Action: nan
3827,dilazep,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: dilazep | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
3828,dilazep,equilibrative nucleoside transporter 2,transporter,,Drug: dilazep | Target: equilibrative nucleoside transporter 2 | Type: transporter | Action: nan
3829,dilevalol,beta-1 adrenergic receptor,gpcr,,Drug: dilevalol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
3830,dilevalol,beta-2 adrenergic receptor,gpcr,,Drug: dilevalol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
3831,dilevalol,alpha-1a adrenergic receptor,gpcr,,Drug: dilevalol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
3832,dilevalol,alpha-1b adrenergic receptor,gpcr,,Drug: dilevalol | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
3833,dilevalol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dilevalol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
3834,diltiazem,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: diltiazem | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3835,diltiazem,cytochrome p450 3a4,enzyme,,Drug: diltiazem | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
3836,diltiazem,multidrug resistance protein 1,transporter,,Drug: diltiazem | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
3837,diltiazem,5-hydroxytryptamine receptor 2a,gpcr,,Drug: diltiazem | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3838,diltiazem,5-hydroxytryptamine receptor 3a,ion channel,BLOCKER,Drug: diltiazem | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: BLOCKER
3839,diltiazem,voltage-dependent calcium channel gamma-1 subunit,ion channel,,Drug: diltiazem | Target: voltage-dependent calcium channel gamma-1 subunit | Type: ion channel | Action: nan
3840,diltiazem,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: diltiazem | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
3841,diltiazem,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: diltiazem | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
3842,diltiazem,voltage-dependent l-type calcium channel subunit alpha-1s,ion channel,,Drug: diltiazem | Target: voltage-dependent l-type calcium channel subunit alpha-1s | Type: ion channel | Action: nan
3843,diltiazem,solute carrier family 22 member 1,transporter,,Drug: diltiazem | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
3844,diltiazem,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: diltiazem | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
3845,diltiazem,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: diltiazem | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
3846,diltiazem,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,,Drug: diltiazem | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: nan
3847,diltiazem,5-hydroxytryptamine receptor 3a,ion channel,BLOCKER,Drug: diltiazem | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: BLOCKER
3848,diltiazem,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: diltiazem | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
3849,diltiazem,voltage-gated l-type calcium channel,ion channel,,Drug: diltiazem | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: nan
3850,diltiazem,potassium voltage-gated channel subfamily c member 1,ion channel,BLOCKER,Drug: diltiazem | Target: potassium voltage-gated channel subfamily c member 1 | Type: ion channel | Action: BLOCKER
3851,diltiazem,potassium voltage-gated channel subfamily a member 7,ion channel,BLOCKER,Drug: diltiazem | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: BLOCKER
3852,diltiazem,voltage-dependent l-type calcium channel subunit alpha-1f,ion channel,BLOCKER,Drug: diltiazem | Target: voltage-dependent l-type calcium channel subunit alpha-1f | Type: ion channel | Action: BLOCKER
3853,dimemorfan,sigma non-opioid intracellular receptor 1,membrane receptor,INHIBITOR,Drug: dimemorfan | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: INHIBITOR
3854,dimenhydrinate,alpha-2a adrenergic receptor,gpcr,,Drug: dimenhydrinate | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3855,dimenhydrinate,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: dimenhydrinate | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
3856,dimenhydrinate,sodium-dependent noradrenaline transporter,transporter,,Drug: dimenhydrinate | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
3857,dimenhydrinate,5-hydroxytryptamine receptor 2a,gpcr,,Drug: dimenhydrinate | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3858,dimenhydrinate,5-hydroxytryptamine receptor 2b,gpcr,,Drug: dimenhydrinate | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3859,dimenhydrinate,5-hydroxytryptamine receptor 2c,gpcr,,Drug: dimenhydrinate | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3860,dimenhydrinate,alpha-2b adrenergic receptor,gpcr,,Drug: dimenhydrinate | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3861,dimenhydrinate,histamine h1 receptor,gpcr,ANTAGONIST,Drug: dimenhydrinate | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
3862,dimenhydrinate,muscarinic acetylcholine receptor m1,gpcr,,Drug: dimenhydrinate | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3863,dimenhydrinate,muscarinic acetylcholine receptor m2,gpcr,,Drug: dimenhydrinate | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3864,dimenhydrinate,muscarinic acetylcholine receptor m3,gpcr,,Drug: dimenhydrinate | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3865,dimenhydrinate,muscarinic acetylcholine receptor m4,gpcr,,Drug: dimenhydrinate | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3866,dimenhydrinate,muscarinic acetylcholine receptor m5,gpcr,,Drug: dimenhydrinate | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
3867,dimenhydrinate,sodium-dependent dopamine transporter,transporter,,Drug: dimenhydrinate | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3868,dimenhydrinate,cytochrome p450 2d6,enzyme,,Drug: dimenhydrinate | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
3869,dimenhydrinate,alpha-1d adrenergic receptor,gpcr,,Drug: dimenhydrinate | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
3870,dimetacrine,apical membrane antigen 1,unclassified,,Drug: dimetacrine | Target: apical membrane antigen 1 | Type: unclassified | Action: nan
3871,dimetindene,histamine h1 receptor,gpcr,,Drug: dimetindene | Target: histamine h1 receptor | Type: gpcr | Action: nan
3872,dimetindene,muscarinic acetylcholine receptor m1,gpcr,,Drug: dimetindene | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3873,dimetindene,muscarinic acetylcholine receptor m2,gpcr,,Drug: dimetindene | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3874,dimetindene,muscarinic acetylcholine receptor m3,gpcr,,Drug: dimetindene | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3875,dimetindene,muscarinic acetylcholine receptor m4,gpcr,,Drug: dimetindene | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3876,dimetindene,muscarinic acetylcholine receptor m5,gpcr,,Drug: dimetindene | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
3877,dimethyltubocurarinium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: dimethyltubocurarinium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
3878,dimethyltubocurarinium,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: dimethyltubocurarinium | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
3879,dioxyline,methionine aminopeptidase 2,enzyme,,Drug: dioxyline | Target: methionine aminopeptidase 2 | Type: enzyme | Action: nan
3880,dioxyline,methionine aminopeptidase 1,enzyme,,Drug: dioxyline | Target: methionine aminopeptidase 1 | Type: enzyme | Action: nan
3881,dinoprost,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: dinoprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
3882,dinoprost,prostaglandin d2 receptor 2,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: AGONIST
3883,dinoprost,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: dinoprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
3884,dinoprost,thromboxane a2 receptor,gpcr,AGONIST,Drug: dinoprost | Target: thromboxane a2 receptor | Type: gpcr | Action: AGONIST
3885,dinoprost,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
3886,dinoprost,prostaglandin e2 receptor ep4 subtype,gpcr,,Drug: dinoprost | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: nan
3887,dinoprost,prostaglandin d2 receptor,gpcr,,Drug: dinoprost | Target: prostaglandin d2 receptor | Type: gpcr | Action: nan
3888,dinoprost,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
3889,dinoprost,prostaglandin f2-alpha receptor,gpcr,,Drug: dinoprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: nan
3890,dinoprost,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
3891,dinoprost,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
3892,dinoprost,prostaglandin f2-alpha receptor,gpcr,,Drug: dinoprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: nan
3893,dinoprost,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
3894,dinoprost,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
3895,dinoprost,prostaglandin d2 receptor 2,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: AGONIST
3896,dinoprost,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
3897,dinoprost,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: dinoprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
3898,dinoprostone,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
3899,dinoprostone,prostaglandin d2 receptor 2,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: AGONIST
3900,dinoprostone,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
3901,dinoprostone,prostacyclin receptor,gpcr,,Drug: dinoprostone | Target: prostacyclin receptor | Type: gpcr | Action: nan
3902,dinoprostone,thromboxane a2 receptor,gpcr,AGONIST,Drug: dinoprostone | Target: thromboxane a2 receptor | Type: gpcr | Action: AGONIST
3903,dinoprostone,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
3904,dinoprostone,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
3905,dinoprostone,prostaglandin d2 receptor,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin d2 receptor | Type: gpcr | Action: AGONIST
3906,dinoprostone,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
3907,dinoprostone,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: dinoprostone | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
3908,dinoprostone,prostaglandin e2 receptor ep2 subtype,gpcr,,Drug: dinoprostone | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: nan
3909,dinoprostone,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: dinoprostone | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
3910,dinoprostone,prostaglandin e2 receptor ep4 subtype,gpcr,,Drug: dinoprostone | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: nan
3911,dinoprostone,solute carrier family 22 member 6,transporter,,Drug: dinoprostone | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
3912,dinoprostone,solute carrier family 22 member 20,transporter,,Drug: dinoprostone | Target: solute carrier family 22 member 20 | Type: transporter | Action: nan
3913,dinoprostone,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
3914,dinoprostone,prostaglandin e2 receptor ep2 subtype,gpcr,,Drug: dinoprostone | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: nan
3915,dinoprostone,prostaglandin e2 receptor ep4 subtype,gpcr,,Drug: dinoprostone | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: nan
3916,dinoprostone,cation channel sperm-associated protein 1,ion channel,ACTIVATOR,Drug: dinoprostone | Target: cation channel sperm-associated protein 1 | Type: ion channel | Action: ACTIVATOR
3917,dinoprostone,cation channel sperm-associated protein 2,ion channel,ACTIVATOR,Drug: dinoprostone | Target: cation channel sperm-associated protein 2 | Type: ion channel | Action: ACTIVATOR
3918,dinoprostone,cation channel sperm-associated protein 3,ion channel,ACTIVATOR,Drug: dinoprostone | Target: cation channel sperm-associated protein 3 | Type: ion channel | Action: ACTIVATOR
3919,dinoprostone,cation channel sperm-associated protein 4,ion channel,ACTIVATOR,Drug: dinoprostone | Target: cation channel sperm-associated protein 4 | Type: ion channel | Action: ACTIVATOR
3920,dinoprostone,prostaglandin d2 receptor 2,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: AGONIST
3921,dinoprostone,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
3922,dinoprostone,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: dinoprostone | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
3923,diphemanil,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: diphemanil | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
3924,diphemanil,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: diphemanil | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
3925,diphenhydramine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: diphenhydramine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3926,diphenhydramine,sodium-dependent noradrenaline transporter,transporter,,Drug: diphenhydramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
3927,diphenhydramine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: diphenhydramine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
3928,diphenhydramine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: diphenhydramine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3929,diphenhydramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: diphenhydramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
3930,diphenhydramine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: diphenhydramine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
3931,diphenhydramine,histamine h4 receptor,gpcr,,Drug: diphenhydramine | Target: histamine h4 receptor | Type: gpcr | Action: nan
3932,diphenhydramine,muscarinic acetylcholine receptor m1,gpcr,,Drug: diphenhydramine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3933,diphenhydramine,muscarinic acetylcholine receptor m2,gpcr,,Drug: diphenhydramine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3934,diphenhydramine,muscarinic acetylcholine receptor m3,gpcr,,Drug: diphenhydramine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3935,diphenhydramine,muscarinic acetylcholine receptor m4,gpcr,,Drug: diphenhydramine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
3936,diphenhydramine,muscarinic acetylcholine receptor m5,gpcr,,Drug: diphenhydramine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
3937,diphenhydramine,cytochrome p450 2d6,enzyme,,Drug: diphenhydramine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
3938,diphenhydramine,histamine h1 receptor,gpcr,,Drug: diphenhydramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
3939,diphenhydramine,solute carrier family 22 member 2,transporter,,Drug: diphenhydramine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
3940,diphenhydramine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: diphenhydramine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
3941,diphenhydramine,sodium-dependent serotonin transporter,transporter,,Drug: diphenhydramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
3942,diphenhydramine,sodium-dependent dopamine transporter,transporter,,Drug: diphenhydramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3943,diphenoxylate,mu-type opioid receptor,gpcr,AGONIST,Drug: diphenoxylate | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
3944,diphenoxylate,potassium voltage-gated channel subfamily a member 3,ion channel,,Drug: diphenoxylate | Target: potassium voltage-gated channel subfamily a member 3 | Type: ion channel | Action: nan
3945,diphenylpyraline,histamine h1 receptor,gpcr,ANTAGONIST,Drug: diphenylpyraline | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
3946,diphenylpyraline,muscarinic acetylcholine receptor m1,gpcr,,Drug: diphenylpyraline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3947,diphenylpyraline,sodium-dependent dopamine transporter,transporter,,Drug: diphenylpyraline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3948,diphenylpyraline,cytochrome p450 2d6,enzyme,,Drug: diphenylpyraline | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
3949,diphenylpyraline,sodium-dependent dopamine transporter,transporter,,Drug: diphenylpyraline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3950,dipivefrine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: dipivefrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
3951,dipivefrine,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: dipivefrine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
3952,dipivefrine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: dipivefrine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
3953,diprafenone,beta-1 adrenergic receptor,gpcr,,Drug: diprafenone | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
3954,diprafenone,sodium channel protein type 5 subunit alpha,ion channel,,Drug: diprafenone | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
3955,diprafenone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: diprafenone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3956,dipyridamole,sodium/nucleoside cotransporter 1,transporter,INHIBITOR,Drug: dipyridamole | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: INHIBITOR
3957,dipyridamole,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: dipyridamole | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
3958,dipyridamole,"dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a",enzyme,,"Drug: dipyridamole | Target: dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a | Type: enzyme | Action: nan"
3959,dipyridamole,"camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a",enzyme,INHIBITOR,"Drug: dipyridamole | Target: camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | Type: enzyme | Action: INHIBITOR"
3960,dipyridamole,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,INHIBITOR,"Drug: dipyridamole | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: INHIBITOR"
3961,dipyridamole,equilibrative nucleoside transporter 1,transporter,INHIBITOR,Drug: dipyridamole | Target: equilibrative nucleoside transporter 1 | Type: transporter | Action: INHIBITOR
3962,dipyridamole,"high affinity camp-specific and ibmx-insensitive 3',5'-cyclic phosphodiesterase 8b",enzyme,INHIBITOR,"Drug: dipyridamole | Target: high affinity camp-specific and ibmx-insensitive 3',5'-cyclic phosphodiesterase 8b | Type: enzyme | Action: INHIBITOR"
3963,dipyridamole,"cgmp-dependent 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: dipyridamole | Target: cgmp-dependent 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
3964,dipyridamole,"camp-specific 3',5'-cyclic phosphodiesterase 7b",enzyme,INHIBITOR,"Drug: dipyridamole | Target: camp-specific 3',5'-cyclic phosphodiesterase 7b | Type: enzyme | Action: INHIBITOR"
3965,dipyridamole,"high affinity camp-specific and ibmx-insensitive 3',5'-cyclic phosphodiesterase 8a",enzyme,INHIBITOR,"Drug: dipyridamole | Target: high affinity camp-specific and ibmx-insensitive 3',5'-cyclic phosphodiesterase 8a | Type: enzyme | Action: INHIBITOR"
3966,dipyridamole,arachidonate 15-lipoxygenase,enzyme,,Drug: dipyridamole | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
3967,dipyridamole,cyclic nucleotide phosphodiesterase pde3a,enzyme,,Drug: dipyridamole | Target: cyclic nucleotide phosphodiesterase pde3a | Type: enzyme | Action: nan
3968,dipyridamole,cyclic amp-specific phosphodiesterase sspde4a1a,enzyme,,Drug: dipyridamole | Target: cyclic amp-specific phosphodiesterase sspde4a1a | Type: enzyme | Action: nan
3969,dipyridamole,phosphodiesterase 3,enzyme,INHIBITOR,Drug: dipyridamole | Target: phosphodiesterase 3 | Type: enzyme | Action: INHIBITOR
3970,dipyridamole,phosphodiesterase 7,enzyme,INHIBITOR,Drug: dipyridamole | Target: phosphodiesterase 7 | Type: enzyme | Action: INHIBITOR
3971,dipyridamole,phosphodiesterase 6,enzyme,INHIBITOR,Drug: dipyridamole | Target: phosphodiesterase 6 | Type: enzyme | Action: INHIBITOR
3972,dipyridamole,phosphodiesterase 1,enzyme,INHIBITOR,Drug: dipyridamole | Target: phosphodiesterase 1 | Type: enzyme | Action: INHIBITOR
3973,dipyridamole,equilibrative nucleoside transporter 4,transporter,INHIBITOR,Drug: dipyridamole | Target: equilibrative nucleoside transporter 4 | Type: transporter | Action: INHIBITOR
3974,dipyridamole,protein prune homolog,enzyme,,Drug: dipyridamole | Target: protein prune homolog | Type: enzyme | Action: nan
3975,dipyridamole,orf 73,unclassified,,Drug: dipyridamole | Target: orf 73 | Type: unclassified | Action: nan
3976,dipyridamole,replicase polyprotein 1ab,enzyme,INHIBITOR,Drug: dipyridamole | Target: replicase polyprotein 1ab | Type: enzyme | Action: INHIBITOR
3977,disopyramide,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: disopyramide | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
3978,disopyramide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: disopyramide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
3979,disopyramide,histamine h1 receptor,gpcr,,Drug: disopyramide | Target: histamine h1 receptor | Type: gpcr | Action: nan
3980,disopyramide,muscarinic acetylcholine receptor m1,gpcr,,Drug: disopyramide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
3981,disopyramide,muscarinic acetylcholine receptor m2,gpcr,,Drug: disopyramide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
3982,disopyramide,muscarinic acetylcholine receptor m3,gpcr,,Drug: disopyramide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
3983,disopyramide,g protein-activated inward rectifier potassium channel 4,ion channel,,Drug: disopyramide | Target: g protein-activated inward rectifier potassium channel 4 | Type: ion channel | Action: nan
3984,disopyramide,solute carrier family 22 member 1,transporter,,Drug: disopyramide | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
3985,disopyramide,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: disopyramide | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
3986,distigmine,acetylcholinesterase,enzyme,INHIBITOR,Drug: distigmine | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
3987,disulfiram,sodium/nucleoside cotransporter 1,transporter,,Drug: disulfiram | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
3988,disulfiram,mu-type opioid receptor,gpcr,,Drug: disulfiram | Target: mu-type opioid receptor | Type: gpcr | Action: nan
3989,disulfiram,translocator protein,transporter,,Drug: disulfiram | Target: translocator protein | Type: transporter | Action: nan
3990,disulfiram,d(1a) dopamine receptor,gpcr,,Drug: disulfiram | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
3991,disulfiram,d(2) dopamine receptor,gpcr,,Drug: disulfiram | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
3992,disulfiram,alpha-2a adrenergic receptor,gpcr,,Drug: disulfiram | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
3993,disulfiram,sodium-dependent noradrenaline transporter,transporter,,Drug: disulfiram | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
3994,disulfiram,5-hydroxytryptamine receptor 2b,gpcr,,Drug: disulfiram | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
3995,disulfiram,5-hydroxytryptamine receptor 6,gpcr,,Drug: disulfiram | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
3996,disulfiram,alpha-2b adrenergic receptor,gpcr,,Drug: disulfiram | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
3997,disulfiram,d(3) dopamine receptor,gpcr,,Drug: disulfiram | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
3998,disulfiram,sodium-dependent dopamine transporter,transporter,,Drug: disulfiram | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
3999,disulfiram,adenosine receptor a3,gpcr,,Drug: disulfiram | Target: adenosine receptor a3 | Type: gpcr | Action: nan
4000,disulfiram,d(4) dopamine receptor,gpcr,,Drug: disulfiram | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
4001,disulfiram,kappa-type opioid receptor,gpcr,,Drug: disulfiram | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
4002,disulfiram,cytochrome p450 1a2,enzyme,,Drug: disulfiram | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
4003,disulfiram,amine oxidase [flavin-containing] a,enzyme,,Drug: disulfiram | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
4004,disulfiram,"aldehyde dehydrogenase, mitochondrial",enzyme,INHIBITOR,"Drug: disulfiram | Target: aldehyde dehydrogenase, mitochondrial | Type: enzyme | Action: INHIBITOR"
4005,disulfiram,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: disulfiram | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
4006,disulfiram,c-c chemokine receptor type 5,gpcr,,Drug: disulfiram | Target: c-c chemokine receptor type 5 | Type: gpcr | Action: nan
4007,disulfiram,c-x-c chemokine receptor type 2,gpcr,,Drug: disulfiram | Target: c-x-c chemokine receptor type 2 | Type: gpcr | Action: nan
4008,disulfiram,c-c chemokine receptor type 2,gpcr,,Drug: disulfiram | Target: c-c chemokine receptor type 2 | Type: gpcr | Action: nan
4009,disulfiram,mitogen-activated protein kinase 3,kinase,,Drug: disulfiram | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
4010,disulfiram,arachidonate 15-lipoxygenase,enzyme,,Drug: disulfiram | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
4011,disulfiram,5-hydroxytryptamine receptor 1b,gpcr,,Drug: disulfiram | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
4012,disulfiram,c-c chemokine receptor type 4,gpcr,,Drug: disulfiram | Target: c-c chemokine receptor type 4 | Type: gpcr | Action: nan
4013,disulfiram,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: disulfiram | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
4014,disulfiram,"aldehyde dehydrogenase, mitochondrial",enzyme,,"Drug: disulfiram | Target: aldehyde dehydrogenase, mitochondrial | Type: enzyme | Action: nan"
4015,disulfiram,monoglyceride lipase,enzyme,,Drug: disulfiram | Target: monoglyceride lipase | Type: enzyme | Action: nan
4016,disulfiram,bifunctional protein glmu,enzyme,,Drug: disulfiram | Target: bifunctional protein glmu | Type: enzyme | Action: nan
4017,disulfiram,protein-lysine 6-oxidase,enzyme,,Drug: disulfiram | Target: protein-lysine 6-oxidase | Type: enzyme | Action: nan
4018,disulfiram,lysine-specific demethylase 5a,enzyme,,Drug: disulfiram | Target: lysine-specific demethylase 5a | Type: enzyme | Action: nan
4019,disulfiram,lysyl oxidase homolog 3,enzyme,,Drug: disulfiram | Target: lysyl oxidase homolog 3 | Type: enzyme | Action: nan
4020,disulfiram,lysyl oxidase homolog 4,enzyme,,Drug: disulfiram | Target: lysyl oxidase homolog 4 | Type: enzyme | Action: nan
4021,disulfiram,histone-lysine n-methyltransferase ehmt2,enzyme,,Drug: disulfiram | Target: histone-lysine n-methyltransferase ehmt2 | Type: enzyme | Action: nan
4022,disulfiram,histone-lysine n-methyltransferase ehmt1,enzyme,,Drug: disulfiram | Target: histone-lysine n-methyltransferase ehmt1 | Type: enzyme | Action: nan
4023,disulfiram,lysyl oxidase homolog 2,enzyme,,Drug: disulfiram | Target: lysyl oxidase homolog 2 | Type: enzyme | Action: nan
4024,disulfiram,gasdermin-d,unclassified,,Drug: disulfiram | Target: gasdermin-d | Type: unclassified | Action: nan
4025,ditiocarb,"carbonic anhydrase 2, isoform a; ld26647p",enzyme,,"Drug: ditiocarb | Target: carbonic anhydrase 2, isoform a; ld26647p | Type: enzyme | Action: nan"
4026,ditiocarb,carbonic anhydrase 1; gh09688p,enzyme,,Drug: ditiocarb | Target: carbonic anhydrase 1; gh09688p | Type: enzyme | Action: nan
4027,ditiocarb,carbonic anhydrase 2,enzyme,,Drug: ditiocarb | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
4028,ditiocarb,carbonic anhydrase 1,enzyme,,Drug: ditiocarb | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
4029,ditiocarb,carbonic anhydrase 4,enzyme,,Drug: ditiocarb | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
4030,ditiocarb,carbonic anhydrase 9,enzyme,,Drug: ditiocarb | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
4031,ditiocarb,carbonic anhydrase 12,enzyme,,Drug: ditiocarb | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
4032,ditiocarb,cytochrome p450 2e1,enzyme,,Drug: ditiocarb | Target: cytochrome p450 2e1 | Type: enzyme | Action: nan
4033,ditiocarb,carbonic anhydrase 13,enzyme,,Drug: ditiocarb | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
4034,ditiocarb,histone-lysine n-methyltransferase ehmt2,enzyme,,Drug: ditiocarb | Target: histone-lysine n-methyltransferase ehmt2 | Type: enzyme | Action: nan
4035,ditiocarb,histone-lysine n-methyltransferase ehmt1,enzyme,,Drug: ditiocarb | Target: histone-lysine n-methyltransferase ehmt1 | Type: enzyme | Action: nan
4036,ditiocarb,gasdermin-d,unclassified,,Drug: ditiocarb | Target: gasdermin-d | Type: unclassified | Action: nan
4037,levomenthol,transient receptor potential cation channel subfamily a member 1,ion channel,ACTIVATOR,Drug: levomenthol | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: ACTIVATOR
4038,levomenthol,transient receptor potential cation channel subfamily m member 8,ion channel,ACTIVATOR,Drug: levomenthol | Target: transient receptor potential cation channel subfamily m member 8 | Type: ion channel | Action: ACTIVATOR
4039,levomenthol,transient receptor potential cation channel subfamily m member 8,ion channel,ACTIVATOR,Drug: levomenthol | Target: transient receptor potential cation channel subfamily m member 8 | Type: ion channel | Action: ACTIVATOR
4040,levomenthol,transient receptor potential cation channel subfamily a member 1,ion channel,GATING INHIBITOR,Drug: levomenthol | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: GATING INHIBITOR
4041,levomenthol,transient receptor potential cation channel subfamily m member 8,ion channel,ACTIVATOR,Drug: levomenthol | Target: transient receptor potential cation channel subfamily m member 8 | Type: ion channel | Action: ACTIVATOR
4042,dobutamine,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: dobutamine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
4043,dobutamine,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: dobutamine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
4044,dobutamine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: dobutamine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
4045,dobutamine,sodium-dependent serotonin transporter,transporter,,Drug: dobutamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4046,dobutamine,sodium-dependent noradrenaline transporter,transporter,,Drug: dobutamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4047,dobutamine,alpha-2b adrenergic receptor,gpcr,,Drug: dobutamine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4048,dobutamine,d(3) dopamine receptor,gpcr,,Drug: dobutamine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4049,dobutamine,sodium-dependent dopamine transporter,transporter,,Drug: dobutamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4050,dobutamine,carbonic anhydrase 2,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
4051,dobutamine,alpha-1d adrenergic receptor,gpcr,,Drug: dobutamine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
4052,dobutamine,carbonic anhydrase 1,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
4053,dobutamine,carbonic anhydrase 4,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
4054,dobutamine,carbonic anhydrase 9,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
4055,dobutamine,carbonic anhydrase 12,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
4056,dobutamine,epidermal growth factor receptor,kinase,,Drug: dobutamine | Target: epidermal growth factor receptor | Type: kinase | Action: nan
4057,dobutamine,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: dobutamine | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
4058,dobutamine,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: dobutamine | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
4059,dobutamine,carbonic anhydrase 7,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
4060,dobutamine,tyrosine-protein kinase lck,kinase,,Drug: dobutamine | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
4061,dobutamine,tyrosine-protein kinase fyn,kinase,,Drug: dobutamine | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
4062,dobutamine,catechol o-methyltransferase,enzyme,,Drug: dobutamine | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
4063,dobutamine,carbonic anhydrase 3,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
4064,dobutamine,carbonic anhydrase 6,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
4065,dobutamine,carbonic anhydrase 14,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
4066,dobutamine,solute carrier family 22 member 1,transporter,,Drug: dobutamine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
4067,dobutamine,arachidonate 15-lipoxygenase,enzyme,,Drug: dobutamine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
4068,dobutamine,alpha-1b adrenergic receptor,gpcr,,Drug: dobutamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4069,dobutamine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: dobutamine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
4070,dobutamine,alpha-1a adrenergic receptor,gpcr,,Drug: dobutamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4071,dobutamine,carbonic anhydrase 13,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
4072,dobutamine,carbonic anhydrase 15,enzyme,,Drug: dobutamine | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
4073,docetaxel,cytochrome p450 3a4,enzyme,,Drug: docetaxel | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
4074,docetaxel,multidrug resistance protein 1,transporter,,Drug: docetaxel | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
4075,docetaxel,multidrug resistance-associated protein 7,transporter,,Drug: docetaxel | Target: multidrug resistance-associated protein 7 | Type: transporter | Action: nan
4076,docetaxel,epidermal growth factor receptor,kinase,INHIBITOR,Drug: docetaxel | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
4077,docetaxel,substance-k receptor,gpcr,,Drug: docetaxel | Target: substance-k receptor | Type: gpcr | Action: nan
4078,docetaxel,growth hormone-releasing hormone receptor,gpcr,,Drug: docetaxel | Target: growth hormone-releasing hormone receptor | Type: gpcr | Action: nan
4079,docetaxel,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: docetaxel | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
4080,docetaxel,nucleotide-binding oligomerization domain-containing protein 2,cytosolic other,,Drug: docetaxel | Target: nucleotide-binding oligomerization domain-containing protein 2 | Type: cytosolic other | Action: nan
4081,docosanol,envelope glycoprotein,membrane other,INHIBITOR,Drug: docosanol | Target: envelope glycoprotein | Type: membrane other | Action: INHIBITOR
4082,dofetilide,potassium voltage-gated channel subfamily h member 2,ion channel,BLOCKER,Drug: dofetilide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: BLOCKER
4083,dofetilide,potassium channel subfamily k member 2,ion channel,,Drug: dofetilide | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
4084,dofetilide,potassium voltage-gated channel subfamily h member 1,ion channel,BLOCKER,Drug: dofetilide | Target: potassium voltage-gated channel subfamily h member 1 | Type: ion channel | Action: BLOCKER
4085,domperidone,mu-type opioid receptor,gpcr,,Drug: domperidone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
4086,domperidone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: domperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
4087,domperidone,alpha-2a adrenergic receptor,gpcr,,Drug: domperidone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4088,domperidone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: domperidone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
4089,domperidone,multidrug resistance protein 1,transporter,,Drug: domperidone | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
4090,domperidone,sodium-dependent serotonin transporter,transporter,,Drug: domperidone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4091,domperidone,sodium-dependent noradrenaline transporter,transporter,,Drug: domperidone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4092,domperidone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: domperidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
4093,domperidone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: domperidone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4094,domperidone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: domperidone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4095,domperidone,alpha-1a adrenergic receptor,gpcr,,Drug: domperidone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4096,domperidone,alpha-2b adrenergic receptor,gpcr,,Drug: domperidone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4097,domperidone,d(3) dopamine receptor,gpcr,,Drug: domperidone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4098,domperidone,histamine h1 receptor,gpcr,,Drug: domperidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
4099,domperidone,aldehyde oxidase,enzyme,,Drug: domperidone | Target: aldehyde oxidase | Type: enzyme | Action: nan
4100,domperidone,alpha-2c adrenergic receptor,gpcr,,Drug: domperidone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
4101,domperidone,cytochrome p450 2d6,enzyme,,Drug: domperidone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
4102,domperidone,alpha-1d adrenergic receptor,gpcr,,Drug: domperidone | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
4103,domperidone,alpha-1b adrenergic receptor,gpcr,,Drug: domperidone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4104,domperidone,kappa-type opioid receptor,gpcr,,Drug: domperidone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
4105,domperidone,calmodulin,cytosolic other,,Drug: domperidone | Target: calmodulin | Type: cytosolic other | Action: nan
4106,domperidone,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: domperidone | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
4107,domperidone,alpha-1b adrenergic receptor,gpcr,,Drug: domperidone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4108,domperidone,alpha-1a adrenergic receptor,gpcr,,Drug: domperidone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4109,domperidone,d(2) dopamine receptor,gpcr,,Drug: domperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4110,domperidone,d(3) dopamine receptor,gpcr,,Drug: domperidone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4111,domperidone,solute carrier family 22 member 2,transporter,,Drug: domperidone | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
4112,domperidone,multidrug and toxin extrusion protein 1,transporter,,Drug: domperidone | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
4113,domperidone,multidrug and toxin extrusion protein 2,transporter,,Drug: domperidone | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
4114,donepezil,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: donepezil | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
4115,donepezil,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: donepezil | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
4116,donepezil,multidrug resistance protein 1,transporter,,Drug: donepezil | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
4117,donepezil,sodium-dependent serotonin transporter,transporter,,Drug: donepezil | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4118,donepezil,acetylcholinesterase,enzyme,INHIBITOR,Drug: donepezil | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
4119,donepezil,amine oxidase [flavin-containing] b,enzyme,,Drug: donepezil | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
4120,donepezil,cholinesterase,enzyme,,Drug: donepezil | Target: cholinesterase | Type: enzyme | Action: nan
4121,donepezil,histamine h3 receptor,gpcr,,Drug: donepezil | Target: histamine h3 receptor | Type: gpcr | Action: nan
4122,donepezil,beta-secretase 1,enzyme,,Drug: donepezil | Target: beta-secretase 1 | Type: enzyme | Action: nan
4123,donepezil,acetylcholinesterase,enzyme,,Drug: donepezil | Target: acetylcholinesterase | Type: enzyme | Action: nan
4124,donepezil,acetylcholinesterase,enzyme,,Drug: donepezil | Target: acetylcholinesterase | Type: enzyme | Action: nan
4125,donepezil,butyrylcholinesterase; protein bche,enzyme,,Drug: donepezil | Target: butyrylcholinesterase; protein bche | Type: enzyme | Action: nan
4126,donepezil,acetylcholinesterase,enzyme,,Drug: donepezil | Target: acetylcholinesterase | Type: enzyme | Action: nan
4127,donepezil,acetylcholinesterase,enzyme,,Drug: donepezil | Target: acetylcholinesterase | Type: enzyme | Action: nan
4128,donepezil,acetylcholinesterase,enzyme,,Drug: donepezil | Target: acetylcholinesterase | Type: enzyme | Action: nan
4129,donepezil,choline o-acetyltransferase,enzyme,,Drug: donepezil | Target: choline o-acetyltransferase | Type: enzyme | Action: nan
4130,donepezil,amine oxidase [flavin-containing] b,enzyme,,Drug: donepezil | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
4131,donepezil,cholinesterase,enzyme,,Drug: donepezil | Target: cholinesterase | Type: enzyme | Action: nan
4132,donepezil,butyrylcholinesterase,enzyme,,Drug: donepezil | Target: butyrylcholinesterase | Type: enzyme | Action: nan
4133,donepezil,sigma non-opioid intracellular receptor 1,membrane other,,Drug: donepezil | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
4134,donepezil,cholinesterase,enzyme,,Drug: donepezil | Target: cholinesterase | Type: enzyme | Action: nan
4135,dopamine,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: dopamine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
4136,dopamine,beta-2 adrenergic receptor,gpcr,,Drug: dopamine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
4137,dopamine,d(1a) dopamine receptor,gpcr,AGONIST,Drug: dopamine | Target: d(1a) dopamine receptor | Type: gpcr | Action: AGONIST
4138,dopamine,d(2) dopamine receptor,gpcr,AGONIST,Drug: dopamine | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
4139,dopamine,sodium-dependent noradrenaline transporter,transporter,,Drug: dopamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4140,dopamine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: dopamine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4141,dopamine,d(3) dopamine receptor,gpcr,AGONIST,Drug: dopamine | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
4142,dopamine,d(1b) dopamine receptor,gpcr,AGONIST,Drug: dopamine | Target: d(1b) dopamine receptor | Type: gpcr | Action: AGONIST
4143,dopamine,sodium-dependent dopamine transporter,transporter,,Drug: dopamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4144,dopamine,d(4) dopamine receptor,gpcr,AGONIST,Drug: dopamine | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
4145,dopamine,trace amine-associated receptor 1,gpcr,,Drug: dopamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
4146,dopamine,melatonin receptor type 1a,gpcr,,Drug: dopamine | Target: melatonin receptor type 1a | Type: gpcr | Action: nan
4147,dopamine,melatonin receptor type 1b,gpcr,,Drug: dopamine | Target: melatonin receptor type 1b | Type: gpcr | Action: nan
4148,dopamine,d(2) dopamine receptor,gpcr,,Drug: dopamine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4149,dopamine,sodium-dependent dopamine transporter,transporter,,Drug: dopamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4150,dopamine,d(1a) dopamine receptor,gpcr,,Drug: dopamine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4151,dopamine,beta-1 adrenergic receptor,gpcr,,Drug: dopamine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
4152,dopamine,d(1a) dopamine receptor,gpcr,,Drug: dopamine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4153,dopamine,d(2) dopamine receptor,gpcr,,Drug: dopamine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4154,dopamine,beta-2 adrenergic receptor,gpcr,,Drug: dopamine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
4155,dopamine,d(3) dopamine receptor,gpcr,,Drug: dopamine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4156,dopamine,d(4) dopamine receptor,gpcr,,Drug: dopamine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
4157,dopamine,lysine-specific demethylase 4e,enzyme,,Drug: dopamine | Target: lysine-specific demethylase 4e | Type: enzyme | Action: nan
4158,dopamine,dopamine beta-hydroxylase,enzyme,,Drug: dopamine | Target: dopamine beta-hydroxylase | Type: enzyme | Action: nan
4159,dopamine,opioid receptor,gpcr,,Drug: dopamine | Target: opioid receptor | Type: gpcr | Action: nan
4160,dopamine,adrenergic receptor alpha-2,gpcr,,Drug: dopamine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
4161,dopamine,dopamine receptor,gpcr,,Drug: dopamine | Target: dopamine receptor | Type: gpcr | Action: nan
4162,dopamine,dopamine receptor,gpcr,,Drug: dopamine | Target: dopamine receptor | Type: gpcr | Action: nan
4163,dopamine,adrenergic receptor alpha-1,gpcr,,Drug: dopamine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
4164,dopamine,adenylate cyclase,enzyme,,Drug: dopamine | Target: adenylate cyclase | Type: enzyme | Action: nan
4165,dopamine,adenosine a2b receptor,gpcr,,Drug: dopamine | Target: adenosine a2b receptor | Type: gpcr | Action: nan
4166,dopamine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: dopamine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
4167,dopamine,m18 aspartyl aminopeptidase,enzyme,,Drug: dopamine | Target: m18 aspartyl aminopeptidase | Type: enzyme | Action: nan
4168,dopexamine,beta-2 adrenergic receptor,gpcr,,Drug: dopexamine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
4169,dopexamine,d(1a) dopamine receptor,gpcr,,Drug: dopexamine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4170,dorzolamide,carbonic anhydrase 2,enzyme,INHIBITOR,Drug: dorzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: INHIBITOR
4171,dorzolamide,carbonic anhydrase 1,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
4172,dorzolamide,carbonic anhydrase 4,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
4173,dorzolamide,carbonic anhydrase 9,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
4174,dorzolamide,carbonic anhydrase 12,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
4175,dorzolamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: dorzolamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
4176,dorzolamide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: dorzolamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
4177,dorzolamide,carbonic anhydrase 7,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
4178,dorzolamide,carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4179,dorzolamide,carbonic anhydrase 3,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
4180,dorzolamide,carbonic anhydrase 6,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
4181,dorzolamide,carbonic anhydrase 14,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
4182,dorzolamide,carbonic anhydrase 13,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
4183,dorzolamide,carbonic anhydrase 4,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
4184,dorzolamide,carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4185,dorzolamide,carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4186,dorzolamide,carbonic anhydrase 13,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
4187,dorzolamide,carbonic anhydrase 15,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
4188,dorzolamide,carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4189,dorzolamide,carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4190,dorzolamide,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
4191,dorzolamide,carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4192,dorzolamide,alpha carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
4193,dorzolamide,carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4194,dorzolamide,carbonic anhydrase 2,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
4195,dorzolamide,astrosclerin-3,enzyme,,Drug: dorzolamide | Target: astrosclerin-3 | Type: enzyme | Action: nan
4196,dorzolamide,beta-carbonic anhydrase 1,enzyme,,Drug: dorzolamide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
4197,dorzolamide,delta carbonic anhydrase,unclassified,,Drug: dorzolamide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
4198,dorzolamide,carbonic anhydrase 2,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
4199,dorzolamide,carbonic anhydrase,enzyme,,Drug: dorzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4200,dorzolamide,"carbonic anhydrase, alpha family",unclassified,,"Drug: dorzolamide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
4201,dorzolamide,carbonate dehydratase,enzyme,,Drug: dorzolamide | Target: carbonate dehydratase | Type: enzyme | Action: nan
4202,dosulepin,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: dosulepin | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
4203,dosulepin,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: dosulepin | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
4204,dosulepin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: dosulepin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
4205,dosulepin,alpha-1a adrenergic receptor,gpcr,,Drug: dosulepin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4206,dosulepin,alpha-2b adrenergic receptor,gpcr,,Drug: dosulepin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4207,dosulepin,histamine h1 receptor,gpcr,,Drug: dosulepin | Target: histamine h1 receptor | Type: gpcr | Action: nan
4208,dosulepin,muscarinic acetylcholine receptor m1,gpcr,,Drug: dosulepin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
4209,dosulepin,muscarinic acetylcholine receptor m2,gpcr,,Drug: dosulepin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
4210,dosulepin,muscarinic acetylcholine receptor m3,gpcr,,Drug: dosulepin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
4211,dosulepin,muscarinic acetylcholine receptor m4,gpcr,,Drug: dosulepin | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
4212,dosulepin,muscarinic acetylcholine receptor m5,gpcr,,Drug: dosulepin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
4213,dosulepin,sodium-dependent dopamine transporter,transporter,,Drug: dosulepin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4214,doxapram,cytochrome p450 2d6,enzyme,,Drug: doxapram | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
4215,doxapram,potassium channel subfamily k member 3,ion channel,BLOCKER,Drug: doxapram | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: BLOCKER
4216,doxapram,potassium channel subfamily k member 9,ion channel,BLOCKER,Drug: doxapram | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: BLOCKER
4217,doxazosin,5-hydroxytryptamine receptor 4,gpcr,,Drug: doxazosin | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
4218,doxazosin,beta-2 adrenergic receptor,gpcr,,Drug: doxazosin | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
4219,doxazosin,alpha-2a adrenergic receptor,gpcr,,Drug: doxazosin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4220,doxazosin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: doxazosin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
4221,doxazosin,multidrug resistance protein 1,transporter,,Drug: doxazosin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
4222,doxazosin,sodium-dependent serotonin transporter,transporter,,Drug: doxazosin | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4223,doxazosin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: doxazosin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4224,doxazosin,5-hydroxytryptamine receptor 2c,gpcr,,Drug: doxazosin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4225,doxazosin,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: doxazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
4226,doxazosin,alpha-2c adrenergic receptor,gpcr,,Drug: doxazosin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
4227,doxazosin,sodium-dependent dopamine transporter,transporter,,Drug: doxazosin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4228,doxazosin,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: doxazosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
4229,doxazosin,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: doxazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
4230,doxazosin,interstitial collagenase,enzyme,,Drug: doxazosin | Target: interstitial collagenase | Type: enzyme | Action: nan
4231,doxazosin,alpha-1b adrenergic receptor,gpcr,,Drug: doxazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4232,doxazosin,alpha-1a adrenergic receptor,gpcr,,Drug: doxazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4233,doxazosin,"hla class i histocompatibility antigen, a-3 alpha chain",unclassified,,"Drug: doxazosin | Target: hla class i histocompatibility antigen, a-3 alpha chain | Type: unclassified | Action: nan"
4234,doxepin,d(1a) dopamine receptor,gpcr,,Drug: doxepin | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4235,doxepin,d(2) dopamine receptor,gpcr,,Drug: doxepin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4236,doxepin,alpha-2a adrenergic receptor,gpcr,,Drug: doxepin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4237,doxepin,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: doxepin | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
4238,doxepin,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: doxepin | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
4239,doxepin,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: doxepin | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
4240,doxepin,5-hydroxytryptamine receptor 1a,gpcr,,Drug: doxepin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4241,doxepin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: doxepin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
4242,doxepin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: doxepin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4243,doxepin,5-hydroxytryptamine receptor 2c,gpcr,,Drug: doxepin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4244,doxepin,5-hydroxytryptamine receptor 6,gpcr,,Drug: doxepin | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
4245,doxepin,5-hydroxytryptamine receptor 7,gpcr,,Drug: doxepin | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
4246,doxepin,alpha-1a adrenergic receptor,gpcr,,Drug: doxepin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4247,doxepin,alpha-2b adrenergic receptor,gpcr,,Drug: doxepin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4248,doxepin,d(3) dopamine receptor,gpcr,,Drug: doxepin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4249,doxepin,histamine h2 receptor,gpcr,,Drug: doxepin | Target: histamine h2 receptor | Type: gpcr | Action: nan
4250,doxepin,histamine h4 receptor,gpcr,,Drug: doxepin | Target: histamine h4 receptor | Type: gpcr | Action: nan
4251,doxepin,muscarinic acetylcholine receptor m1,gpcr,,Drug: doxepin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
4252,doxepin,muscarinic acetylcholine receptor m2,gpcr,,Drug: doxepin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
4253,doxepin,muscarinic acetylcholine receptor m3,gpcr,,Drug: doxepin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
4254,doxepin,muscarinic acetylcholine receptor m4,gpcr,,Drug: doxepin | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
4255,doxepin,muscarinic acetylcholine receptor m5,gpcr,,Drug: doxepin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
4256,doxepin,alpha-2c adrenergic receptor,gpcr,,Drug: doxepin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
4257,doxepin,alpha-1d adrenergic receptor,gpcr,,Drug: doxepin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
4258,doxepin,solute carrier family 22 member 1,transporter,,Drug: doxepin | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
4259,doxepin,alpha-1b adrenergic receptor,gpcr,,Drug: doxepin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4260,doxepin,alpha-1a adrenergic receptor,gpcr,,Drug: doxepin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4261,doxepin,solute carrier family 22 member 2,transporter,,Drug: doxepin | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
4262,doxepin,serotonin (5-ht) receptor,gpcr,,Drug: doxepin | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
4263,doxepin,histamine h1 receptor,gpcr,ANTAGONIST,Drug: doxepin | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
4264,doxercalciferol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: doxercalciferol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
4265,doxifluridine,thymidylate synthase,enzyme,,Drug: doxifluridine | Target: thymidylate synthase | Type: enzyme | Action: nan
4266,doxorubicin,5-hydroxytryptamine receptor 4,gpcr,,Drug: doxorubicin | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
4267,doxorubicin,multidrug resistance protein 1,transporter,,Drug: doxorubicin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
4268,doxorubicin,muscarinic acetylcholine receptor m1,gpcr,,Drug: doxorubicin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
4269,doxorubicin,canalicular multispecific organic anion transporter 1,transporter,,Drug: doxorubicin | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
4270,doxorubicin,dna topoisomerase 2-alpha,enzyme,INHIBITOR,Drug: doxorubicin | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: INHIBITOR
4271,doxorubicin,multidrug resistance-associated protein 1,transporter,,Drug: doxorubicin | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
4272,doxorubicin,atp-binding cassette sub-family g member 2,transporter,,Drug: doxorubicin | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
4273,doxorubicin,multidrug resistance-associated protein 6,transporter,,Drug: doxorubicin | Target: multidrug resistance-associated protein 6 | Type: transporter | Action: nan
4274,doxorubicin,caspase-1,enzyme,,Drug: doxorubicin | Target: caspase-1 | Type: enzyme | Action: nan
4275,doxorubicin,tyrosine-protein kinase lck,kinase,,Drug: doxorubicin | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
4276,doxorubicin,tyrosine-protein kinase fyn,kinase,,Drug: doxorubicin | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
4277,doxorubicin,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: doxorubicin | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
4278,doxorubicin,72 kda type iv collagenase,enzyme,,Drug: doxorubicin | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
4279,doxorubicin,dna topoisomerase 1,enzyme,,Drug: doxorubicin | Target: dna topoisomerase 1 | Type: enzyme | Action: nan
4280,doxorubicin,telomerase reverse transcriptase,enzyme,,Drug: doxorubicin | Target: telomerase reverse transcriptase | Type: enzyme | Action: nan
4281,doxorubicin,dna topoisomerase 2-beta,enzyme,,Drug: doxorubicin | Target: dna topoisomerase 2-beta | Type: enzyme | Action: nan
4282,doxorubicin,aurora kinase a,kinase,,Drug: doxorubicin | Target: aurora kinase a | Type: kinase | Action: nan
4283,doxorubicin,ribonuclease pancreatic,enzyme,,Drug: doxorubicin | Target: ribonuclease pancreatic | Type: enzyme | Action: nan
4284,doxorubicin,arachidonate 15-lipoxygenase,enzyme,,Drug: doxorubicin | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
4285,doxorubicin,5-hydroxytryptamine receptor 1b,gpcr,,Drug: doxorubicin | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
4286,doxorubicin,integrase,enzyme,,Drug: doxorubicin | Target: integrase | Type: enzyme | Action: nan
4287,doxorubicin,reverse transcriptase,enzyme,,Drug: doxorubicin | Target: reverse transcriptase | Type: enzyme | Action: nan
4288,doxorubicin,type-2 restriction enzyme hindiii,unclassified,,Drug: doxorubicin | Target: type-2 restriction enzyme hindiii | Type: unclassified | Action: nan
4289,doxorubicin,type-2 restriction enzyme scai,unclassified,,Drug: doxorubicin | Target: type-2 restriction enzyme scai | Type: unclassified | Action: nan
4290,doxorubicin,orf 73,unclassified,,Drug: doxorubicin | Target: orf 73 | Type: unclassified | Action: nan
4291,doxorubicin,udp-galactopyranose mutase,enzyme,,Drug: doxorubicin | Target: udp-galactopyranose mutase | Type: enzyme | Action: nan
4292,doxorubicin,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: doxorubicin | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
4293,doxycycline,50s ribosomal protein l10,ribosomal protein,,Drug: doxycycline | Target: 50s ribosomal protein l10 | Type: ribosomal protein | Action: nan
4294,doxycycline,72 kda type iv collagenase,enzyme,,Drug: doxycycline | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
4295,doxycycline,stromelysin-1,enzyme,,Drug: doxycycline | Target: stromelysin-1 | Type: enzyme | Action: nan
4296,doxycycline,neutrophil collagenase,enzyme,INHIBITOR,Drug: doxycycline | Target: neutrophil collagenase | Type: enzyme | Action: INHIBITOR
4297,doxycycline,collagenase 3,enzyme,INHIBITOR,Drug: doxycycline | Target: collagenase 3 | Type: enzyme | Action: INHIBITOR
4298,doxycycline,"tetracycline resistance protein, class b",transporter,,"Drug: doxycycline | Target: tetracycline resistance protein, class b | Type: transporter | Action: nan"
4299,doxycycline,zinc finger protein mex-5,cytosolic other,,Drug: doxycycline | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
4300,doxycycline,matrilysin,enzyme,INHIBITOR,Drug: doxycycline | Target: matrilysin | Type: enzyme | Action: INHIBITOR
4301,doxylamine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: doxylamine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
4302,drostanolone propionate,androgen receptor,nuclear hormone receptor,AGONIST,Drug: drostanolone propionate | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
4303,droperidol,5-hydroxytryptamine receptor 4,gpcr,,Drug: droperidol | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
4304,droperidol,d(1a) dopamine receptor,gpcr,,Drug: droperidol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4305,droperidol,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: droperidol | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
4306,droperidol,alpha-2a adrenergic receptor,gpcr,,Drug: droperidol | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4307,droperidol,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: droperidol | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
4308,droperidol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: droperidol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4309,droperidol,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: droperidol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
4310,droperidol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: droperidol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4311,droperidol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: droperidol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4312,droperidol,alpha-2b adrenergic receptor,gpcr,,Drug: droperidol | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4313,droperidol,d(3) dopamine receptor,gpcr,,Drug: droperidol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4314,droperidol,histamine h1 receptor,gpcr,,Drug: droperidol | Target: histamine h1 receptor | Type: gpcr | Action: nan
4315,droperidol,muscarinic acetylcholine receptor m4,gpcr,,Drug: droperidol | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
4316,droperidol,muscarinic acetylcholine receptor m5,gpcr,,Drug: droperidol | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
4317,droperidol,alpha-2c adrenergic receptor,gpcr,,Drug: droperidol | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
4318,droperidol,d(4) dopamine receptor,gpcr,,Drug: droperidol | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
4319,droperidol,alpha-1d adrenergic receptor,gpcr,,Drug: droperidol | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
4320,droperidol,alpha-1b adrenergic receptor,gpcr,,Drug: droperidol | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4321,droperidol,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: droperidol | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
4322,droperidol,alpha-1a adrenergic receptor,gpcr,,Drug: droperidol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4323,droperidol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: droperidol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4324,droperidol,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: droperidol | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
4325,drospirenone,mineralocorticoid receptor,nuclear hormone receptor,ANTAGONIST,Drug: drospirenone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
4326,drospirenone,androgen receptor,nuclear hormone receptor,,Drug: drospirenone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
4327,drospirenone,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: drospirenone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
4328,drotaverine,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,,"Drug: drotaverine | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: nan"
4329,drotaverine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: drotaverine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
4330,droxidopa,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: droxidopa | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
4331,droxidopa,adrenergic receptor,gpcr,AGONIST,Drug: droxidopa | Target: adrenergic receptor | Type: gpcr | Action: AGONIST
4333,duloxetine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: duloxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
4334,duloxetine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: duloxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
4335,duloxetine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4336,duloxetine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
4337,duloxetine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4338,duloxetine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
4339,duloxetine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
4340,duloxetine,5-hydroxytryptamine receptor 7,gpcr,,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
4341,duloxetine,histamine h1 receptor,gpcr,,Drug: duloxetine | Target: histamine h1 receptor | Type: gpcr | Action: nan
4342,duloxetine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
4343,duloxetine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
4344,duloxetine,sodium-dependent dopamine transporter,transporter,,Drug: duloxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4345,duloxetine,5-hydroxytryptamine receptor 1f,gpcr,,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
4346,duloxetine,5-hydroxytryptamine receptor 1e,gpcr,,Drug: duloxetine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
4347,duloxetine,sodium-dependent serotonin transporter,transporter,,Drug: duloxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4348,duloxetine,sodium-dependent dopamine transporter,transporter,,Drug: duloxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4349,duloxetine,transporter,transporter,,Drug: duloxetine | Target: transporter | Type: transporter | Action: nan
4350,duloxetine,"serine hydroxymethyltransferase, mitochondrial",enzyme,,"Drug: duloxetine | Target: serine hydroxymethyltransferase, mitochondrial | Type: enzyme | Action: nan"
4351,dutasteride,glycine receptor subunit alpha-1,ion channel,,Drug: dutasteride | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
4352,dutasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 2,enzyme,INHIBITOR,Drug: dutasteride | Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Type: enzyme | Action: INHIBITOR
4353,dutasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 1,enzyme,INHIBITOR,Drug: dutasteride | Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Type: enzyme | Action: INHIBITOR
4354,dyclonine,acetylcholinesterase,enzyme,,Drug: dyclonine | Target: acetylcholinesterase | Type: enzyme | Action: nan
4355,dyclonine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: dyclonine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
4356,dydrogesterone,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: dydrogesterone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
4357,dydrogesterone,nuclear receptor subfamily 2 group e member 1,nuclear hormone receptor,,Drug: dydrogesterone | Target: nuclear receptor subfamily 2 group e member 1 | Type: nuclear hormone receptor | Action: nan
4358,diprophylline,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,INHIBITOR,"Drug: diprophylline | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: INHIBITOR"
4359,diprophylline,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,INHIBITOR,"Drug: diprophylline | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: INHIBITOR"
4360,ebastine,d(1a) dopamine receptor,gpcr,,Drug: ebastine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4361,ebastine,d(2) dopamine receptor,gpcr,,Drug: ebastine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4362,ebastine,alpha-2a adrenergic receptor,gpcr,,Drug: ebastine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4363,ebastine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ebastine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
4364,ebastine,multidrug resistance protein 1,transporter,,Drug: ebastine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
4365,ebastine,sodium-dependent serotonin transporter,transporter,,Drug: ebastine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4366,ebastine,sodium-dependent noradrenaline transporter,transporter,,Drug: ebastine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4367,ebastine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ebastine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4368,ebastine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ebastine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
4369,ebastine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: ebastine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4370,ebastine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: ebastine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4371,ebastine,5-hydroxytryptamine receptor 6,gpcr,,Drug: ebastine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
4372,ebastine,alpha-2b adrenergic receptor,gpcr,,Drug: ebastine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4373,ebastine,d(3) dopamine receptor,gpcr,,Drug: ebastine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4374,ebastine,histamine h2 receptor,gpcr,,Drug: ebastine | Target: histamine h2 receptor | Type: gpcr | Action: nan
4375,ebastine,muscarinic acetylcholine receptor m1,gpcr,,Drug: ebastine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
4376,ebastine,muscarinic acetylcholine receptor m2,gpcr,,Drug: ebastine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
4377,ebastine,muscarinic acetylcholine receptor m3,gpcr,,Drug: ebastine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
4378,ebastine,muscarinic acetylcholine receptor m4,gpcr,,Drug: ebastine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
4379,ebastine,muscarinic acetylcholine receptor m5,gpcr,,Drug: ebastine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
4380,ebastine,beta-3 adrenergic receptor,gpcr,,Drug: ebastine | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
4381,ebastine,alpha-2c adrenergic receptor,gpcr,,Drug: ebastine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
4382,ebastine,sodium-dependent dopamine transporter,transporter,,Drug: ebastine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4383,ebastine,adenosine receptor a3,gpcr,,Drug: ebastine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
4384,ebastine,d(4) dopamine receptor,gpcr,,Drug: ebastine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
4385,ebastine,alpha-1d adrenergic receptor,gpcr,,Drug: ebastine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
4386,ebastine,acetylcholinesterase,enzyme,,Drug: ebastine | Target: acetylcholinesterase | Type: enzyme | Action: nan
4387,ebastine,epidermal growth factor receptor,kinase,,Drug: ebastine | Target: epidermal growth factor receptor | Type: kinase | Action: nan
4388,ebastine,tyrosine-protein kinase fyn,kinase,,Drug: ebastine | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
4389,ebastine,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: ebastine | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
4390,ebastine,substance-k receptor,gpcr,,Drug: ebastine | Target: substance-k receptor | Type: gpcr | Action: nan
4391,ebastine,alpha-1b adrenergic receptor,gpcr,,Drug: ebastine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4392,ebastine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: ebastine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
4393,ebastine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: ebastine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
4394,ebastine,alpha-1a adrenergic receptor,gpcr,,Drug: ebastine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4395,ebastine,histamine h1 receptor,gpcr,,Drug: ebastine | Target: histamine h1 receptor | Type: gpcr | Action: nan
4396,ebastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: ebastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
4397,ebrotidine,histamine h2 receptor,gpcr,ANTAGONIST,Drug: ebrotidine | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
4398,echothiophate,acetylcholinesterase,enzyme,INHIBITOR,Drug: echothiophate | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
4399,econazole,beta-1 adrenergic receptor,gpcr,,Drug: econazole | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
4400,econazole,cannabinoid receptor 1,gpcr,,Drug: econazole | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
4401,econazole,mu-type opioid receptor,gpcr,,Drug: econazole | Target: mu-type opioid receptor | Type: gpcr | Action: nan
4402,econazole,d(1a) dopamine receptor,gpcr,,Drug: econazole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4403,econazole,d(2) dopamine receptor,gpcr,,Drug: econazole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4404,econazole,adenosine receptor a2a,gpcr,,Drug: econazole | Target: adenosine receptor a2a | Type: gpcr | Action: nan
4405,econazole,alpha-2a adrenergic receptor,gpcr,,Drug: econazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4406,econazole,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: econazole | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
4407,econazole,cytochrome p450 3a4,enzyme,,Drug: econazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
4408,econazole,sodium-dependent serotonin transporter,transporter,,Drug: econazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4409,econazole,sodium-dependent noradrenaline transporter,transporter,,Drug: econazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4410,econazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: econazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4411,econazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: econazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
4412,econazole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: econazole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4413,econazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: econazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4414,econazole,5-hydroxytryptamine receptor 6,gpcr,,Drug: econazole | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
4415,econazole,alpha-2b adrenergic receptor,gpcr,,Drug: econazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4416,econazole,d(3) dopamine receptor,gpcr,,Drug: econazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4417,econazole,histamine h2 receptor,gpcr,,Drug: econazole | Target: histamine h2 receptor | Type: gpcr | Action: nan
4418,econazole,muscarinic acetylcholine receptor m1,gpcr,,Drug: econazole | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
4419,econazole,muscarinic acetylcholine receptor m2,gpcr,,Drug: econazole | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
4420,econazole,muscarinic acetylcholine receptor m3,gpcr,,Drug: econazole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
4421,econazole,muscarinic acetylcholine receptor m4,gpcr,,Drug: econazole | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
4422,econazole,beta-3 adrenergic receptor,gpcr,,Drug: econazole | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
4423,econazole,sodium-dependent dopamine transporter,transporter,,Drug: econazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4424,econazole,cytochrome p450 2d6,enzyme,,Drug: econazole | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
4425,econazole,adenosine receptor a1,gpcr,,Drug: econazole | Target: adenosine receptor a1 | Type: gpcr | Action: nan
4426,econazole,adenosine receptor a3,gpcr,,Drug: econazole | Target: adenosine receptor a3 | Type: gpcr | Action: nan
4427,econazole,d(4) dopamine receptor,gpcr,,Drug: econazole | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
4428,econazole,alpha-1d adrenergic receptor,gpcr,,Drug: econazole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
4429,econazole,kappa-type opioid receptor,gpcr,,Drug: econazole | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
4430,econazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: econazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
4431,econazole,delta-type opioid receptor,gpcr,,Drug: econazole | Target: delta-type opioid receptor | Type: gpcr | Action: nan
4432,econazole,beta-lactamase,enzyme,,Drug: econazole | Target: beta-lactamase | Type: enzyme | Action: nan
4433,econazole,acetylcholinesterase,enzyme,,Drug: econazole | Target: acetylcholinesterase | Type: enzyme | Action: nan
4434,econazole,cytochrome p450 2c9,enzyme,,Drug: econazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
4435,econazole,cytochrome p450 1a2,enzyme,,Drug: econazole | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
4436,econazole,epidermal growth factor receptor,kinase,,Drug: econazole | Target: epidermal growth factor receptor | Type: kinase | Action: nan
4437,econazole,substance-p receptor,gpcr,,Drug: econazole | Target: substance-p receptor | Type: gpcr | Action: nan
4438,econazole,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,,"Drug: econazole | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: nan"
4439,econazole,cytochrome p450 2c19,enzyme,,Drug: econazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
4440,econazole,tyrosine-protein kinase fyn,kinase,,Drug: econazole | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
4441,econazole,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: econazole | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
4442,econazole,thromboxane-a synthase,enzyme,,Drug: econazole | Target: thromboxane-a synthase | Type: enzyme | Action: nan
4443,econazole,lanosterol 14-alpha demethylase,enzyme,,Drug: econazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
4444,econazole,matrix metalloproteinase-9,enzyme,,Drug: econazole | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
4445,econazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: econazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
4446,econazole,substance-k receptor,gpcr,,Drug: econazole | Target: substance-k receptor | Type: gpcr | Action: nan
4447,econazole,androgen receptor,transcription factor,,Drug: econazole | Target: androgen receptor | Type: transcription factor | Action: nan
4448,econazole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: econazole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
4449,econazole,melanocortin receptor 5,gpcr,,Drug: econazole | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
4450,econazole,melanocortin receptor 3,gpcr,,Drug: econazole | Target: melanocortin receptor 3 | Type: gpcr | Action: nan
4451,econazole,neuropeptide y receptor type 2,gpcr,,Drug: econazole | Target: neuropeptide y receptor type 2 | Type: gpcr | Action: nan
4452,econazole,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: econazole | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
4453,econazole,progesterone receptor,transcription factor,,Drug: econazole | Target: progesterone receptor | Type: transcription factor | Action: nan
4454,econazole,alpha-1a adrenergic receptor,gpcr,,Drug: econazole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4455,econazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: econazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4456,econazole,acetylcholinesterase,enzyme,,Drug: econazole | Target: acetylcholinesterase | Type: enzyme | Action: nan
4457,econazole,cholinesterase,enzyme,,Drug: econazole | Target: cholinesterase | Type: enzyme | Action: nan
4458,econazole,lanosterol 14-alpha demethylase,enzyme,,Drug: econazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
4459,econazole,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: econazole | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
4460,econazole,mycocyclosin synthase,enzyme,,Drug: econazole | Target: mycocyclosin synthase | Type: enzyme | Action: nan
4461,econazole,malate dehydrogenase cytoplasmic,enzyme,,Drug: econazole | Target: malate dehydrogenase cytoplasmic | Type: enzyme | Action: nan
4462,econazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: econazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
4463,econazole,calcium release-activated calcium channel protein 1,ion channel,,Drug: econazole | Target: calcium release-activated calcium channel protein 1 | Type: ion channel | Action: nan
4464,econazole,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,enzyme,,Drug: econazole | Target: 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase | Type: enzyme | Action: nan
4465,edatrexate,dihydrofolate reductase,enzyme,INHIBITOR,Drug: edatrexate | Target: dihydrofolate reductase | Type: enzyme | Action: INHIBITOR
4466,edatrexate,"folylpolyglutamate synthase, mitochondrial",enzyme,,"Drug: edatrexate | Target: folylpolyglutamate synthase, mitochondrial | Type: enzyme | Action: nan"
4467,edatrexate,dihydrofolate reductase,enzyme,,Drug: edatrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
4468,edatrexate,dihydrofolate reductase,enzyme,,Drug: edatrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
4469,edetic acid,angiotensin-converting enzyme,enzyme,,Drug: edetic acid | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
4470,edetic acid,ceramide glucosyltransferase,enzyme,,Drug: edetic acid | Target: ceramide glucosyltransferase | Type: enzyme | Action: nan
4471,edetic acid,beta-lactamase,enzyme,,Drug: edetic acid | Target: beta-lactamase | Type: enzyme | Action: nan
4472,edetic acid,beta-lactamase vim-1; class b carbapenemase vim-1; metallo-beta-lactamase; metallo-beta-lactamase vim-1; metallobeta-lactamase; vim-1; vim-1 metallo-beta lactamase; vim-1 metallo-beta-lactamase; vim-1,unclassified,,Drug: edetic acid | Target: beta-lactamase vim-1; class b carbapenemase vim-1; metallo-beta-lactamase; metallo-beta-lactamase vim-1; metallobeta-lactamase; vim-1; vim-1 metallo-beta lactamase; vim-1 metallo-beta-lactamase; vim-1 | Type: unclassified | Action: nan
4473,edetic acid,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,,"Drug: edetic acid | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: nan"
4474,edetic acid,amyloid beta a4 protein,unclassified,,Drug: edetic acid | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
4475,edetic acid,eyes absent homolog 2,enzyme,,Drug: edetic acid | Target: eyes absent homolog 2 | Type: enzyme | Action: nan
4477,edrophonium,acetylcholinesterase,enzyme,INHIBITOR,Drug: edrophonium | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
4478,edrophonium,acetylcholinesterase,enzyme,,Drug: edrophonium | Target: acetylcholinesterase | Type: enzyme | Action: nan
4479,efavirenz,cytochrome p450 3a4,enzyme,INHIBITOR,Drug: efavirenz | Target: cytochrome p450 3a4 | Type: enzyme | Action: INHIBITOR
4480,efavirenz,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: efavirenz | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
4481,efavirenz,gag-pol polyprotein,polyprotein,INHIBITOR,Drug: efavirenz | Target: gag-pol polyprotein | Type: polyprotein | Action: INHIBITOR
4482,efavirenz,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: efavirenz | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
4483,efavirenz,reverse transcriptase,enzyme,,Drug: efavirenz | Target: reverse transcriptase | Type: enzyme | Action: nan
4485,efavirenz,reverse transcriptase protein,unclassified,,Drug: efavirenz | Target: reverse transcriptase protein | Type: unclassified | Action: nan
4486,eflornithine,ornithine decarboxylase,enzyme,INHIBITOR,Drug: eflornithine | Target: ornithine decarboxylase | Type: enzyme | Action: INHIBITOR
4487,eflornithine,ornithine decarboxylase,enzyme,,Drug: eflornithine | Target: ornithine decarboxylase | Type: enzyme | Action: nan
4488,eflornithine,ornithine decarboxylase,enzyme,INHIBITOR,Drug: eflornithine | Target: ornithine decarboxylase | Type: enzyme | Action: INHIBITOR
4489,efonidipine,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,BLOCKER,Drug: efonidipine | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: BLOCKER
4490,efonidipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,BLOCKER,Drug: efonidipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: BLOCKER
4491,efonidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: efonidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
4492,eletriptan,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: eletriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
4493,eletriptan,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: eletriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
4494,eletriptan,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: eletriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
4495,eletriptan,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: eletriptan | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
4496,eletriptan,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: eletriptan | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
4497,elliptinium,mast/stem cell growth factor receptor kit,kinase,,Drug: elliptinium | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
4498,elliptinium,platelet-derived growth factor receptor alpha,kinase,,Drug: elliptinium | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
4499,elliptinium,fibroblast growth factor receptor 3,kinase,,Drug: elliptinium | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
4500,eltanolone,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: eltanolone | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
4501,eltanolone,gaba-a receptor; anion channel,ion channel,,Drug: eltanolone | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
4502,emedastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: emedastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
4503,emetine,alpha-2a adrenergic receptor,gpcr,,Drug: emetine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4504,emetine,alpha-2c adrenergic receptor,gpcr,,Drug: emetine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
4505,emetine,alpha-1d adrenergic receptor,gpcr,,Drug: emetine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
4506,emetine,alpha-1b adrenergic receptor,gpcr,,Drug: emetine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4507,emetine,alpha-1a adrenergic receptor,gpcr,,Drug: emetine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4508,emetine,putative hydrolase rbbp9,enzyme,,Drug: emetine | Target: putative hydrolase rbbp9 | Type: enzyme | Action: nan
4509,emtricitabine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: emtricitabine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
4510,enalapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: enalapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
4511,enalapril,angiotensin-converting enzyme,enzyme,,Drug: enalapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
4512,enalapril,angiotensin-converting enzyme,enzyme,,Drug: enalapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
4513,enalaprilat,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: enalaprilat | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
4514,enalaprilat,angiotensin-converting enzyme,enzyme,,Drug: enalaprilat | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
4515,enalaprilat,angiotensin-converting enzyme,enzyme,,Drug: enalaprilat | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
4516,enalaprilat,angiotensin-converting enzyme 2,enzyme,,Drug: enalaprilat | Target: angiotensin-converting enzyme 2 | Type: enzyme | Action: nan
4517,enalaprilat,angiotensin-converting enzyme,enzyme,,Drug: enalaprilat | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
4518,encainide,sodium channel protein type 5 subunit alpha,ion channel,,Drug: encainide | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
4519,encainide,sodium channel subunit beta-1,ion channel,,Drug: encainide | Target: sodium channel subunit beta-1 | Type: ion channel | Action: nan
4520,encainide,sodium channel subunit beta-2,ion channel,,Drug: encainide | Target: sodium channel subunit beta-2 | Type: ion channel | Action: nan
4521,encainide,sodium channel subunit beta-3,ion channel,,Drug: encainide | Target: sodium channel subunit beta-3 | Type: ion channel | Action: nan
4522,encainide,sodium channel subunit beta-4,ion channel,,Drug: encainide | Target: sodium channel subunit beta-4 | Type: ion channel | Action: nan
4523,endralazine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: endralazine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
4524,enflurane,glycine receptor subunit alpha-1,ion channel,POSITIVE MODULATOR,Drug: enflurane | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: POSITIVE MODULATOR
4525,enflurane,potassium channel subfamily k member 2,ion channel,OPENER,Drug: enflurane | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: OPENER
4526,enflurane,potassium channel subfamily k member 3,ion channel,OPENER,Drug: enflurane | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: OPENER
4527,enflurane,potassium channel subfamily k member 9,ion channel,OPENER,Drug: enflurane | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: OPENER
4528,enflurane,potassium channel subfamily k member 10,ion channel,OPENER,Drug: enflurane | Target: potassium channel subfamily k member 10 | Type: ion channel | Action: OPENER
4529,enflurane,potassium channel subfamily k member 18,ion channel,OPENER,Drug: enflurane | Target: potassium channel subfamily k member 18 | Type: ion channel | Action: OPENER
4530,enfuvirtide,envelope glycoprotein,viral envelope protein,,Drug: enfuvirtide | Target: envelope glycoprotein | Type: viral envelope protein | Action: nan
4531,enfuvirtide,transmembrane glycoprotein gp41,membrane other,INHIBITOR,Drug: enfuvirtide | Target: transmembrane glycoprotein gp41 | Type: membrane other | Action: INHIBITOR
4532,enfuvirtide,gp41,unclassified,,Drug: enfuvirtide | Target: gp41 | Type: unclassified | Action: nan
4533,enoxacin,dna gyrase subunit a,enzyme,,Drug: enoxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
4534,enoxacin,"v-type proton atpase subunit b, brain isoform",enzyme,,"Drug: enoxacin | Target: v-type proton atpase subunit b, brain isoform | Type: enzyme | Action: nan"
4535,enoxacin,topoisomerase iv,enzyme,INHIBITOR,Drug: enoxacin | Target: topoisomerase iv | Type: enzyme | Action: INHIBITOR
4536,enoxacin,dna gyrase,enzyme,INHIBITOR,Drug: enoxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
4537,enoximone,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,,"Drug: enoximone | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: nan"
4538,enoximone,phosphodiesterase 4,enzyme,,Drug: enoximone | Target: phosphodiesterase 4 | Type: enzyme | Action: nan
4539,enprofylline,adenosine receptor a2a,gpcr,,Drug: enprofylline | Target: adenosine receptor a2a | Type: gpcr | Action: nan
4540,enprofylline,adenosine receptor a1,gpcr,,Drug: enprofylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
4541,enprofylline,adenosine receptor a2b,gpcr,,Drug: enprofylline | Target: adenosine receptor a2b | Type: gpcr | Action: nan
4542,enprofylline,adenosine receptor a3,gpcr,,Drug: enprofylline | Target: adenosine receptor a3 | Type: gpcr | Action: nan
4543,enprofylline,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,,"Drug: enprofylline | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: nan"
4544,enprofylline,adenosine receptor a1,gpcr,,Drug: enprofylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
4545,enprofylline,adenosine receptor a2a,gpcr,,Drug: enprofylline | Target: adenosine receptor a2a | Type: gpcr | Action: nan
4546,enprofylline,adenosine receptor a3,gpcr,,Drug: enprofylline | Target: adenosine receptor a3 | Type: gpcr | Action: nan
4547,enprofylline,adenosine receptor a1,gpcr,,Drug: enprofylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
4548,enprofylline,adenosine a2a receptor,gpcr,,Drug: enprofylline | Target: adenosine a2a receptor | Type: gpcr | Action: nan
4549,enprostil,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: enprostil | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
4550,enprostil,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: enprostil | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
4551,enprostil,prostacyclin receptor,gpcr,,Drug: enprostil | Target: prostacyclin receptor | Type: gpcr | Action: nan
4552,enprostil,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: enprostil | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
4553,enprostil,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: enprostil | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
4554,enprostil,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: enprostil | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
4555,enprostil,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: enprostil | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
4556,entacapone,catechol o-methyltransferase,enzyme,,Drug: entacapone | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
4557,entacapone,g-protein coupled receptor 35,gpcr,,Drug: entacapone | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
4558,entacapone,alpha-ketoglutarate-dependent dioxygenase fto,unclassified,,Drug: entacapone | Target: alpha-ketoglutarate-dependent dioxygenase fto | Type: unclassified | Action: nan
4560,entacapone,catechol o-methyltransferase,enzyme,INHIBITOR,Drug: entacapone | Target: catechol o-methyltransferase | Type: enzyme | Action: INHIBITOR
4561,entecavir,protein p,polyprotein,,Drug: entecavir | Target: protein p | Type: polyprotein | Action: nan
4562,entecavir,protein p,polyprotein,INHIBITOR,Drug: entecavir | Target: protein p | Type: polyprotein | Action: INHIBITOR
4563,entecavir,capsid protein,unclassified,,Drug: entecavir | Target: capsid protein | Type: unclassified | Action: nan
4564,epalrestat,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: epalrestat | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
4565,epalrestat,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: epalrestat | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
4566,epalrestat,aldose reductase,enzyme,,Drug: epalrestat | Target: aldose reductase | Type: enzyme | Action: nan
4567,epalrestat,aldose reductase,enzyme,,Drug: epalrestat | Target: aldose reductase | Type: enzyme | Action: nan
4568,epalrestat,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: epalrestat | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
4569,epalrestat,aldo-keto reductase family 1 member b10,enzyme,,Drug: epalrestat | Target: aldo-keto reductase family 1 member b10 | Type: enzyme | Action: nan
4570,epalrestat,sorbitol dehydrogenase,enzyme,,Drug: epalrestat | Target: sorbitol dehydrogenase | Type: enzyme | Action: nan
4571,epalrestat,cytochrome p450 4a11,enzyme,INHIBITOR,Drug: epalrestat | Target: cytochrome p450 4a11 | Type: enzyme | Action: INHIBITOR
4572,epalrestat,aldose reductase,enzyme,INHIBITOR,Drug: epalrestat | Target: aldose reductase | Type: enzyme | Action: INHIBITOR
4573,eperisone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: eperisone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
4574,eperisone,alpha-2b adrenergic receptor,gpcr,,Drug: eperisone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4575,eperisone,muscarinic acetylcholine receptor m2,gpcr,,Drug: eperisone | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
4576,eperisone,cytochrome p450 2d6,enzyme,,Drug: eperisone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
4577,ephedrine,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: ephedrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
4578,epinastine,alpha-2a adrenergic receptor,gpcr,,Drug: epinastine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4579,epinastine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: epinastine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
4580,epinastine,multidrug resistance protein 1,transporter,,Drug: epinastine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
4581,epinastine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: epinastine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
4582,epinastine,alpha-1a adrenergic receptor,gpcr,,Drug: epinastine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4583,epinastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: epinastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
4584,epinastine,histamine h2 receptor,gpcr,,Drug: epinastine | Target: histamine h2 receptor | Type: gpcr | Action: nan
4585,epinastine,histamine h1 receptor,gpcr,,Drug: epinastine | Target: histamine h1 receptor | Type: gpcr | Action: nan
4586,epinastine,solute carrier family 22 member 2,transporter,,Drug: epinastine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
4587,epinastine,multidrug and toxin extrusion protein 1,transporter,,Drug: epinastine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
4588,epinastine,multidrug and toxin extrusion protein 2,transporter,,Drug: epinastine | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
4589,epinephrine,beta-1 adrenergic receptor,gpcr,,Drug: epinephrine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
4590,epinephrine,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: epinephrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
4591,epinephrine,d(1a) dopamine receptor,gpcr,,Drug: epinephrine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4592,epinephrine,d(2) dopamine receptor,gpcr,,Drug: epinephrine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4593,epinephrine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: epinephrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
4594,epinephrine,sodium-dependent noradrenaline transporter,transporter,,Drug: epinephrine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4595,epinephrine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: epinephrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
4596,epinephrine,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: epinephrine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
4597,epinephrine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: epinephrine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
4598,epinephrine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: epinephrine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
4599,epinephrine,alpha-1b adrenergic receptor,gpcr,AGONIST,Drug: epinephrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: AGONIST
4600,epinephrine,arachidonate 15-lipoxygenase,enzyme,,Drug: epinephrine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
4601,epinephrine,alpha-1b adrenergic receptor,gpcr,,Drug: epinephrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4602,epinephrine,alpha-1a adrenergic receptor,gpcr,,Drug: epinephrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4603,epinephrine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: epinephrine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
4604,epinephrine,mu-type opioid receptor,gpcr,,Drug: epinephrine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
4605,epinephrine,beta-1 adrenergic receptor,gpcr,,Drug: epinephrine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
4606,epinephrine,beta-2 adrenergic receptor,gpcr,,Drug: epinephrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
4607,epinephrine,beta-2 adrenergic receptor,gpcr,,Drug: epinephrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
4608,epinephrine,beta-1 adrenergic receptor,gpcr,,Drug: epinephrine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
4609,epinephrine,adrenergic receptor alpha-2,gpcr,,Drug: epinephrine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
4610,epinephrine,adrenergic receptor beta,gpcr,,Drug: epinephrine | Target: adrenergic receptor beta | Type: gpcr | Action: nan
4611,epinephrine,m18 aspartyl aminopeptidase,enzyme,,Drug: epinephrine | Target: m18 aspartyl aminopeptidase | Type: enzyme | Action: nan
4612,epirubicin,5-hydroxytryptamine receptor 4,gpcr,,Drug: epirubicin | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
4613,epirubicin,tyrosine-protein kinase fyn,kinase,,Drug: epirubicin | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
4614,epirubicin,ns3,enzyme,,Drug: epirubicin | Target: ns3 | Type: enzyme | Action: nan
4615,eplerenone,glucocorticoid receptor,nuclear hormone receptor,,Drug: eplerenone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
4616,eplerenone,mineralocorticoid receptor,nuclear hormone receptor,ANTAGONIST,Drug: eplerenone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
4617,eplerenone,progesterone receptor,nuclear hormone receptor,,Drug: eplerenone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
4618,eplerenone,mineralocorticoid receptor,transcription factor,,Drug: eplerenone | Target: mineralocorticoid receptor | Type: transcription factor | Action: nan
4620,eplerenone,progesterone receptor,nuclear other,,Drug: eplerenone | Target: progesterone receptor | Type: nuclear other | Action: nan
4621,eplerenone,mineralocorticoid receptor,nuclear hormone receptor,,Drug: eplerenone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
4622,epoprostenol,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: epoprostenol | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
4623,epoprostenol,p2y purinoceptor 12,gpcr,,Drug: epoprostenol | Target: p2y purinoceptor 12 | Type: gpcr | Action: nan
4624,epoprostenol,prostacyclin receptor,gpcr,AGONIST,Drug: epoprostenol | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
4625,epoprostenol,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: epoprostenol | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
4626,eprosartan,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: eprosartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
4627,eprosartan,type-1b angiotensin ii receptor,gpcr,,Drug: eprosartan | Target: type-1b angiotensin ii receptor | Type: gpcr | Action: nan
4628,eprosartan,type-2 angiotensin ii receptor,gpcr,,Drug: eprosartan | Target: type-2 angiotensin ii receptor | Type: gpcr | Action: nan
4629,eprosartan,angiotensin ii receptor (at-1) type-1,gpcr,,Drug: eprosartan | Target: angiotensin ii receptor (at-1) type-1 | Type: gpcr | Action: nan
4630,eprosartan,angiotensin ii receptor,gpcr,,Drug: eprosartan | Target: angiotensin ii receptor | Type: gpcr | Action: nan
4631,eptifibatide,integrin alpha-iib/beta-3,adhesion,INHIBITOR,Drug: eptifibatide | Target: integrin alpha-iib/beta-3 | Type: adhesion | Action: INHIBITOR
4632,ergometrine,d(1a) dopamine receptor,gpcr,,Drug: ergometrine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4633,ergometrine,d(2) dopamine receptor,gpcr,,Drug: ergometrine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4634,ergometrine,alpha-2a adrenergic receptor,gpcr,,Drug: ergometrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4635,ergometrine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4636,ergometrine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
4637,ergometrine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4638,ergometrine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4639,ergometrine,5-hydroxytryptamine receptor 6,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
4640,ergometrine,alpha-2b adrenergic receptor,gpcr,,Drug: ergometrine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4641,ergometrine,d(3) dopamine receptor,gpcr,,Drug: ergometrine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4642,ergometrine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
4643,ergometrine,alpha-1b adrenergic receptor,gpcr,,Drug: ergometrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4644,ergometrine,5-hydroxytryptamine receptor 1e,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
4645,ergometrine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
4646,ergometrine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4647,ergometrine,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: ergometrine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
4648,ergotamine,5-hydroxytryptamine receptor 4,gpcr,,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
4649,ergotamine,beta-1 adrenergic receptor,gpcr,,Drug: ergotamine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
4650,ergotamine,beta-2 adrenergic receptor,gpcr,,Drug: ergotamine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
4651,ergotamine,d(1a) dopamine receptor,gpcr,,Drug: ergotamine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
4652,ergotamine,d(2) dopamine receptor,gpcr,,Drug: ergotamine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
4653,ergotamine,alpha-2a adrenergic receptor,gpcr,,Drug: ergotamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
4654,ergotamine,cytochrome p450 3a4,enzyme,,Drug: ergotamine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
4655,ergotamine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4656,ergotamine,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
4657,ergotamine,5-hydroxytryptamine receptor 2b,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: AGONIST
4658,ergotamine,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
4659,ergotamine,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
4660,ergotamine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: ergotamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
4661,ergotamine,alpha-2b adrenergic receptor,gpcr,,Drug: ergotamine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
4662,ergotamine,d(3) dopamine receptor,gpcr,,Drug: ergotamine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
4663,ergotamine,d(1b) dopamine receptor,gpcr,,Drug: ergotamine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
4664,ergotamine,muscarinic acetylcholine receptor m1,gpcr,,Drug: ergotamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
4665,ergotamine,muscarinic acetylcholine receptor m2,gpcr,,Drug: ergotamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
4666,ergotamine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
4667,ergotamine,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
4668,ergotamine,alpha-2c adrenergic receptor,gpcr,,Drug: ergotamine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
4669,ergotamine,alpha-1d adrenergic receptor,gpcr,,Drug: ergotamine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
4670,ergotamine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
4671,ergotamine,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
4672,ergotamine,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
4673,ergotamine,tyrosine-protein kinase lck,kinase,,Drug: ergotamine | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
4674,ergotamine,tyrosine-protein kinase fyn,kinase,,Drug: ergotamine | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
4675,ergotamine,thromboxane-a synthase,enzyme,,Drug: ergotamine | Target: thromboxane-a synthase | Type: enzyme | Action: nan
4676,ergotamine,alpha-1b adrenergic receptor,gpcr,,Drug: ergotamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
4677,ergotamine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
4678,ergotamine,alpha-1a adrenergic receptor,gpcr,,Drug: ergotamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4679,ergotamine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
4680,ergotamine,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
4681,ergotamine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
4682,ergotamine,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
4683,ergotamine,gastrin/cholecystokinin type b receptor,gpcr,,Drug: ergotamine | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
4684,ergotamine,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
4685,ergotamine,cholecystokinin a receptor,gpcr,,Drug: ergotamine | Target: cholecystokinin a receptor | Type: gpcr | Action: nan
4686,ergotamine,adenylate cyclase,unclassified,,Drug: ergotamine | Target: adenylate cyclase | Type: unclassified | Action: nan
4687,ergotamine,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
4688,ergotamine,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
4689,ergotamine,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: ergotamine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
4690,eritoran,toll-like receptor 4,membrane receptor,,Drug: eritoran | Target: toll-like receptor 4 | Type: membrane receptor | Action: nan
4691,erlotinib,tyrosine-protein kinase jak3,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
4692,erlotinib,platelet-derived growth factor receptor beta,kinase,,Drug: erlotinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
4693,erlotinib,tyrosine-protein kinase abl1,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
4694,erlotinib,mast/stem cell growth factor receptor kit,kinase,,Drug: erlotinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
4695,erlotinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: erlotinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
4696,erlotinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: erlotinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
4697,erlotinib,tyrosine-protein kinase lck,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
4698,erlotinib,tyrosine-protein kinase yes,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
4699,erlotinib,serine/threonine-protein kinase b-raf,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
4700,erlotinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: erlotinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
4701,erlotinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: erlotinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
4702,erlotinib,vascular endothelial growth factor receptor 1,kinase,,Drug: erlotinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
4703,erlotinib,vascular endothelial growth factor receptor 2,kinase,,Drug: erlotinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
4704,erlotinib,vascular endothelial growth factor receptor 3,kinase,,Drug: erlotinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: nan
4705,erlotinib,platelet-derived growth factor receptor alpha,kinase,,Drug: erlotinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
4706,erlotinib,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: erlotinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
4707,erlotinib,death-associated protein kinase 3,kinase,,Drug: erlotinib | Target: death-associated protein kinase 3 | Type: kinase | Action: nan
4708,erlotinib,focal adhesion kinase 1,kinase,,Drug: erlotinib | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
4709,erlotinib,tyrosine-protein kinase hck,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
4710,erlotinib,receptor tyrosine-protein kinase erbb-4,kinase,,Drug: erlotinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: nan
4711,erlotinib,mitogen-activated protein kinase 10,kinase,,Drug: erlotinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
4712,erlotinib,tyrosine-protein kinase jak2,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
4713,erlotinib,calcium/calmodulin-dependent protein kinase type ii subunit delta,kinase,,Drug: erlotinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit delta | Type: kinase | Action: nan
4714,erlotinib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: erlotinib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
4715,erlotinib,tyrosine-protein kinase csk,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
4716,erlotinib,ephrin type-a receptor 8,kinase,,Drug: erlotinib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
4717,erlotinib,ap2-associated protein kinase 1,kinase,,Drug: erlotinib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
4718,erlotinib,hepatocyte growth factor receptor,kinase,,Drug: erlotinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
4719,erlotinib,tyrosine-protein kinase lyn,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
4720,erlotinib,serine/threonine-protein kinase 17b,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase 17b | Type: kinase | Action: nan
4721,erlotinib,serine/threonine-protein kinase 10,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
4722,erlotinib,serine/threonine-protein kinase plk4,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
4723,erlotinib,aurora kinase c,kinase,,Drug: erlotinib | Target: aurora kinase c | Type: kinase | Action: nan
4724,erlotinib,dual specificity protein kinase ttk,kinase,,Drug: erlotinib | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
4725,erlotinib,abelson tyrosine-protein kinase 2,kinase,,Drug: erlotinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
4726,erlotinib,ephrin type-a receptor 5,kinase,,Drug: erlotinib | Target: ephrin type-a receptor 5 | Type: kinase | Action: nan
4727,erlotinib,fibroblast growth factor receptor 2,kinase,,Drug: erlotinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
4728,erlotinib,serine/threonine-protein kinase 17a,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
4729,erlotinib,ephrin type-a receptor 6,kinase,,Drug: erlotinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
4730,erlotinib,traf2 and nck-interacting protein kinase,kinase,,Drug: erlotinib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
4731,erlotinib,casein kinase i isoform epsilon,kinase,,Drug: erlotinib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
4732,erlotinib,tyrosine-protein kinase fgr,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
4733,erlotinib,aurora kinase a,kinase,,Drug: erlotinib | Target: aurora kinase a | Type: kinase | Action: nan
4734,erlotinib,alk tyrosine kinase receptor,kinase,,Drug: erlotinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
4735,erlotinib,serine/threonine-protein kinase 36,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase 36 | Type: kinase | Action: nan
4736,erlotinib,ephrin type-a receptor 3,kinase,,Drug: erlotinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
4737,erlotinib,bmp-2-inducible protein kinase,kinase,,Drug: erlotinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
4738,erlotinib,tyrosine-protein kinase frk,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
4739,erlotinib,cyclin-g-associated kinase,kinase,,Drug: erlotinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
4740,erlotinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: erlotinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
4741,erlotinib,ephrin type-b receptor 1,kinase,,Drug: erlotinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
4742,erlotinib,ephrin type-a receptor 7,kinase,,Drug: erlotinib | Target: ephrin type-a receptor 7 | Type: kinase | Action: nan
4743,erlotinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: erlotinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
4744,erlotinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: erlotinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
4745,erlotinib,mitogen-activated protein kinase 9,kinase,,Drug: erlotinib | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
4746,erlotinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: erlotinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
4747,erlotinib,solute carrier family 22 member 1,transporter,,Drug: erlotinib | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
4748,erlotinib,ephrin type-b receptor 4,kinase,,Drug: erlotinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
4749,erlotinib,serine/threonine-protein kinase ulk3,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
4750,erlotinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
4751,erlotinib,tyrosine-protein kinase receptor tyro3,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase receptor tyro3 | Type: kinase | Action: nan
4752,erlotinib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: erlotinib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
4753,erlotinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: erlotinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
4754,erlotinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: erlotinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
4755,erlotinib,casein kinase i isoform delta,kinase,,Drug: erlotinib | Target: casein kinase i isoform delta | Type: kinase | Action: nan
4756,erlotinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
4757,erlotinib,tyrosine-protein kinase txk,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
4758,erlotinib,map kinase-interacting serine/threonine-protein kinase 1,kinase,,Drug: erlotinib | Target: map kinase-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
4759,erlotinib,eukaryotic translation initiation factor 2-alpha kinase 4,kinase,,Drug: erlotinib | Target: eukaryotic translation initiation factor 2-alpha kinase 4 | Type: kinase | Action: nan
4760,erlotinib,serine/threonine-protein kinase sik2,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
4761,erlotinib,serine/threonine-protein kinase tnni3k,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
4762,erlotinib,myotonin-protein kinase,kinase,,Drug: erlotinib | Target: myotonin-protein kinase | Type: kinase | Action: nan
4763,erlotinib,"chaperone activity of bc1 complex-like, mitochondrial",kinase,,"Drug: erlotinib | Target: chaperone activity of bc1 complex-like, mitochondrial | Type: kinase | Action: nan"
4764,erlotinib,serine/threonine-protein kinase mrck gamma,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase mrck gamma | Type: kinase | Action: nan
4765,erlotinib,leukocyte tyrosine kinase receptor,kinase,,Drug: erlotinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
4766,erlotinib,aurora kinase b,kinase,,Drug: erlotinib | Target: aurora kinase b | Type: kinase | Action: nan
4767,erlotinib,tyrosine-protein kinase blk,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
4768,erlotinib,tyrosine-protein kinase mer,kinase,,Drug: erlotinib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
4769,erlotinib,citron rho-interacting kinase,kinase,,Drug: erlotinib | Target: citron rho-interacting kinase | Type: kinase | Action: nan
4770,erlotinib,aarf domain-containing protein kinase 4,kinase,,Drug: erlotinib | Target: aarf domain-containing protein kinase 4 | Type: kinase | Action: nan
4771,erlotinib,tubulin alpha-1a chain,structural,,Drug: erlotinib | Target: tubulin alpha-1a chain | Type: structural | Action: nan
4772,erlotinib,mitogen-activated protein kinase 4,kinase,,Drug: erlotinib | Target: mitogen-activated protein kinase 4 | Type: kinase | Action: nan
4773,erlotinib,"interferon-induced, double-stranded rna-activated protein kinase",kinase,,"Drug: erlotinib | Target: interferon-induced, double-stranded rna-activated protein kinase | Type: kinase | Action: nan"
4774,erlotinib,ribosomal protein s6 kinase alpha-4,kinase,,Drug: erlotinib | Target: ribosomal protein s6 kinase alpha-4 | Type: kinase | Action: nan
4775,erlotinib,misshapen-like kinase 1,kinase,,Drug: erlotinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
4776,erlotinib,serine/threonine-protein kinase tbk1,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
4777,erlotinib,dual specificity tyrosine-phosphorylation-regulated kinase 2,kinase,,Drug: erlotinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 2 | Type: kinase | Action: nan
4778,erlotinib,ephrin type-b receptor 6,kinase,,Drug: erlotinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
4779,erlotinib,g protein-coupled receptor kinase 4,kinase,,Drug: erlotinib | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
4780,erlotinib,homeodomain-interacting protein kinase 4,kinase,,Drug: erlotinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
4781,erlotinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: erlotinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
4782,erlotinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: erlotinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
4783,erlotinib,srsf protein kinase 3,kinase,,Drug: erlotinib | Target: srsf protein kinase 3 | Type: kinase | Action: nan
4784,erlotinib,serine/threonine-protein kinase ulk3,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
4785,erlotinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: erlotinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
4786,erlotinib,receptor-interacting serine/threonine-protein kinase 4,kinase,,Drug: erlotinib | Target: receptor-interacting serine/threonine-protein kinase 4 | Type: kinase | Action: nan
4787,erlotinib,receptor tyrosine-protein kinase erbb-3,kinase,,Drug: erlotinib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: nan
4788,erlotinib,serine/threonine-protein kinase sbk1,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
4789,erlotinib,phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,kinase,,Drug: erlotinib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Type: kinase | Action: nan
4790,erlotinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: erlotinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
4791,erlotinib,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: erlotinib | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
4792,erlotinib,solute carrier organic anion transporter family member 2b1,transporter,INHIBITOR,Drug: erlotinib | Target: solute carrier organic anion transporter family member 2b1 | Type: transporter | Action: INHIBITOR
4793,erlotinib,serine/threonine-protein kinase b-raf,kinase,,Drug: erlotinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
4794,ertapenem,penicillin-binding protein 2,enzyme,,Drug: ertapenem | Target: penicillin-binding protein 2 | Type: enzyme | Action: nan
4795,ertapenem,penicillin-binding protein 4,enzyme,,Drug: ertapenem | Target: penicillin-binding protein 4 | Type: enzyme | Action: nan
4796,ertapenem,d-ala-d-ala-carboxypeptidase; d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase family protein; penicillin-binding protein 5,enzyme,,Drug: ertapenem | Target: d-ala-d-ala-carboxypeptidase; d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase family protein; penicillin-binding protein 5 | Type: enzyme | Action: nan
4797,ertapenem,penicillin-binding protein 1,enzyme,,Drug: ertapenem | Target: penicillin-binding protein 1 | Type: enzyme | Action: nan
4798,ertapenem,d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase penicillin-binding protein 6,enzyme,,Drug: ertapenem | Target: d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase penicillin-binding protein 6 | Type: enzyme | Action: nan
4799,ertapenem,d-alanyl-d-alanine carboxypeptidase dacb,enzyme,INHIBITOR,Drug: ertapenem | Target: d-alanyl-d-alanine carboxypeptidase dacb | Type: enzyme | Action: INHIBITOR
4800,ertapenem,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: ertapenem | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
4801,ertapenem,penicillin-binding protein 1b,enzyme,INHIBITOR,Drug: ertapenem | Target: penicillin-binding protein 1b | Type: enzyme | Action: INHIBITOR
4802,erythromycin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: erythromycin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
4803,erythromycin,aldehyde oxidase,enzyme,,Drug: erythromycin | Target: aldehyde oxidase | Type: enzyme | Action: nan
4804,erythromycin,bile salt export pump,transporter,,Drug: erythromycin | Target: bile salt export pump | Type: transporter | Action: nan
4805,erythromycin,motilin receptor,gpcr,,Drug: erythromycin | Target: motilin receptor | Type: gpcr | Action: nan
4806,erythromycin,cytochrome p450 1b1,enzyme,,Drug: erythromycin | Target: cytochrome p450 1b1 | Type: enzyme | Action: nan
4807,erythromycin propionate,bile salt export pump,transporter,,Drug: erythromycin propionate | Target: bile salt export pump | Type: transporter | Action: nan
4808,erythromycin propionate,bile salt export pump,transporter,,Drug: erythromycin propionate | Target: bile salt export pump | Type: transporter | Action: nan
4809,escitalopram,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: escitalopram | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
4810,escitalopram,sodium-dependent noradrenaline transporter,transporter,,Drug: escitalopram | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4811,escitalopram,5-hydroxytryptamine receptor 2c,gpcr,,Drug: escitalopram | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4812,escitalopram,alpha-1a adrenergic receptor,gpcr,,Drug: escitalopram | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
4813,escitalopram,histamine h1 receptor,gpcr,,Drug: escitalopram | Target: histamine h1 receptor | Type: gpcr | Action: nan
4814,escitalopram,muscarinic acetylcholine receptor m1,gpcr,,Drug: escitalopram | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
4815,escitalopram,sodium-dependent serotonin transporter,transporter,,Drug: escitalopram | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4816,escitalopram,sodium-dependent dopamine transporter,transporter,,Drug: escitalopram | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4817,escitalopram,transporter,transporter,,Drug: escitalopram | Target: transporter | Type: transporter | Action: nan
4818,esmolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: esmolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
4819,esmolol,beta-2 adrenergic receptor,gpcr,,Drug: esmolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
4820,esmolol,beta-1 adrenergic receptor,gpcr,,Drug: esmolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
4821,esomeprazole,potassium-transporting atpase,transporter,INHIBITOR,Drug: esomeprazole | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
4822,estazolam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: estazolam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4823,estazolam,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: estazolam | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4824,estazolam,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: estazolam | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4825,estazolam,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: estazolam | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4826,estradiol,sodium-dependent serotonin transporter,transporter,,Drug: estradiol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4827,estradiol,aldehyde oxidase,enzyme,,Drug: estradiol | Target: aldehyde oxidase | Type: enzyme | Action: nan
4828,estradiol,glucocorticoid receptor,nuclear hormone receptor,,Drug: estradiol | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
4829,estradiol,sodium-dependent dopamine transporter,transporter,,Drug: estradiol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4830,estradiol,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: estradiol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
4831,estradiol,androgen receptor,nuclear hormone receptor,,Drug: estradiol | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
4832,estradiol,calcium-activated potassium channel subunit alpha-1,ion channel,ACTIVATOR,Drug: estradiol | Target: calcium-activated potassium channel subunit alpha-1 | Type: ion channel | Action: ACTIVATOR
4833,estradiol,estrogen receptor beta,nuclear hormone receptor,,Drug: estradiol | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
4834,estradiol,g-protein coupled estrogen receptor 1,gpcr,,Drug: estradiol | Target: g-protein coupled estrogen receptor 1 | Type: gpcr | Action: nan
4835,estradiol,corticosteroid-binding globulin,secreted,,Drug: estradiol | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
4836,estradiol,steryl-sulfatase,enzyme,,Drug: estradiol | Target: steryl-sulfatase | Type: enzyme | Action: nan
4837,estradiol,sex hormone-binding globulin,secreted,,Drug: estradiol | Target: sex hormone-binding globulin | Type: secreted | Action: nan
4838,estradiol,steroid hormone receptor err1,nuclear hormone receptor,,Drug: estradiol | Target: steroid hormone receptor err1 | Type: nuclear hormone receptor | Action: nan
4839,estradiol,steroid hormone receptor err2,nuclear hormone receptor,,Drug: estradiol | Target: steroid hormone receptor err2 | Type: nuclear hormone receptor | Action: nan
4840,estradiol,androgen receptor,transcription factor,,Drug: estradiol | Target: androgen receptor | Type: transcription factor | Action: nan
4841,estradiol,arachidonate 15-lipoxygenase,enzyme,,Drug: estradiol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
4842,estradiol,progesterone receptor,transcription factor,,Drug: estradiol | Target: progesterone receptor | Type: transcription factor | Action: nan
4843,estradiol,estrogen receptor,transcription factor,,Drug: estradiol | Target: estrogen receptor | Type: transcription factor | Action: nan
4844,estradiol,estrogen receptor beta,transcription factor,,Drug: estradiol | Target: estrogen receptor beta | Type: transcription factor | Action: nan
4845,estradiol,estrogen receptor beta,transcription factor,,Drug: estradiol | Target: estrogen receptor beta | Type: transcription factor | Action: nan
4846,estradiol,estrogen receptor,transcription factor,,Drug: estradiol | Target: estrogen receptor | Type: transcription factor | Action: nan
4847,estradiol,cytochrome p450 1b1,enzyme,,Drug: estradiol | Target: cytochrome p450 1b1 | Type: enzyme | Action: nan
4848,estradiol,estrogen receptor,transcription factor,,Drug: estradiol | Target: estrogen receptor | Type: transcription factor | Action: nan
4849,estradiol benzoate,sodium-dependent serotonin transporter,transporter,,Drug: estradiol benzoate | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4850,estradiol benzoate,sodium-dependent noradrenaline transporter,transporter,,Drug: estradiol benzoate | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4851,estradiol benzoate,5-hydroxytryptamine receptor 2b,gpcr,,Drug: estradiol benzoate | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4852,estradiol benzoate,glucocorticoid receptor,nuclear hormone receptor,,Drug: estradiol benzoate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
4853,estradiol benzoate,alpha-2c adrenergic receptor,gpcr,,Drug: estradiol benzoate | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
4854,estradiol benzoate,adenosine receptor a3,gpcr,,Drug: estradiol benzoate | Target: adenosine receptor a3 | Type: gpcr | Action: nan
4855,estradiol benzoate,estrogen receptor,nuclear hormone receptor,,Drug: estradiol benzoate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
4856,estradiol benzoate,sex hormone-binding globulin,secreted,,Drug: estradiol benzoate | Target: sex hormone-binding globulin | Type: secreted | Action: nan
4857,estradiol benzoate,tyrosine-protein kinase fyn,kinase,,Drug: estradiol benzoate | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
4858,estradiol benzoate,androgen receptor,transcription factor,,Drug: estradiol benzoate | Target: androgen receptor | Type: transcription factor | Action: nan
4859,estradiol benzoate,progesterone receptor,transcription factor,,Drug: estradiol benzoate | Target: progesterone receptor | Type: transcription factor | Action: nan
4860,estradiol cypionate,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: estradiol cypionate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
4861,estradiol mustard,estrogen receptor,transcription factor,,Drug: estradiol mustard | Target: estrogen receptor | Type: transcription factor | Action: nan
4862,estradiol valerate,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: estradiol valerate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
4863,estramustine phosphate,estrogen receptor beta,nuclear hormone receptor,MODULATOR,Drug: estramustine phosphate | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: MODULATOR
4864,estramustine phosphate,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: estramustine phosphate | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
4865,estramustine phosphate,tyrosine-protein phosphatase non-receptor type 11,enzyme,,Drug: estramustine phosphate | Target: tyrosine-protein phosphatase non-receptor type 11 | Type: enzyme | Action: nan
4866,estramustine phosphate,protein-tyrosine phosphatase 1c,enzyme,,Drug: estramustine phosphate | Target: protein-tyrosine phosphatase 1c | Type: enzyme | Action: nan
4867,estriol succinate,sodium-dependent serotonin transporter,transporter,,Drug: estriol succinate | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4868,estriol succinate,glucocorticoid receptor,nuclear hormone receptor,,Drug: estriol succinate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
4869,estriol succinate,estrogen receptor,nuclear hormone receptor,,Drug: estriol succinate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
4870,estriol succinate,estrogen receptor beta,nuclear hormone receptor,,Drug: estriol succinate | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
4871,estriol succinate,corticosteroid-binding globulin,secreted,,Drug: estriol succinate | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
4872,estriol succinate,sex hormone-binding globulin,secreted,,Drug: estriol succinate | Target: sex hormone-binding globulin | Type: secreted | Action: nan
4873,estriol succinate,arachidonate 15-lipoxygenase,enzyme,,Drug: estriol succinate | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
4874,estriol succinate,lanosterol 14-alpha demethylase,enzyme,,Drug: estriol succinate | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
4875,estriol succinate,olfactory receptor 51e2,gpcr,,Drug: estriol succinate | Target: olfactory receptor 51e2 | Type: gpcr | Action: nan
4876,eszopiclone,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,,Drug: eszopiclone | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: nan
4877,eszopiclone,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: eszopiclone | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4878,eszopiclone,gamma-aminobutyric acid receptor subunit alpha-3,ion channel,,Drug: eszopiclone | Target: gamma-aminobutyric acid receptor subunit alpha-3 | Type: ion channel | Action: nan
4879,eszopiclone,gamma-aminobutyric acid receptor subunit alpha-4,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: eszopiclone | Target: gamma-aminobutyric acid receptor subunit alpha-4 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4880,eszopiclone,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: eszopiclone | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4881,eszopiclone,gaba-a receptor alpha-1/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: eszopiclone | Target: gaba-a receptor alpha-1/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4882,eszopiclone,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: eszopiclone | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4883,eszopiclone,gaba a receptor alpha-3/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: eszopiclone | Target: gaba a receptor alpha-3/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4884,eszopiclone,gaba a receptor alpha-5/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: eszopiclone | Target: gaba a receptor alpha-5/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4885,eszopiclone,gaba a receptor alpha-5/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: eszopiclone | Target: gaba a receptor alpha-5/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
4886,ethacrynic acid,solute carrier family 12 member 1,transporter,INHIBITOR,Drug: ethacrynic acid | Target: solute carrier family 12 member 1 | Type: transporter | Action: INHIBITOR
4887,ethacrynic acid,glutathione s-transferase p,enzyme,,Drug: ethacrynic acid | Target: glutathione s-transferase p | Type: enzyme | Action: nan
4888,ethacrynic acid,glutathione s-transferase a1,enzyme,,Drug: ethacrynic acid | Target: glutathione s-transferase a1 | Type: enzyme | Action: nan
4889,ethacrynic acid,aldose reductase,enzyme,,Drug: ethacrynic acid | Target: aldose reductase | Type: enzyme | Action: nan
4890,ethacrynic acid,udp-glucose 4-epimerase,enzyme,,Drug: ethacrynic acid | Target: udp-glucose 4-epimerase | Type: enzyme | Action: nan
4891,ethacrynic acid,glutathione s-transferase omega-1,unclassified,,Drug: ethacrynic acid | Target: glutathione s-transferase omega-1 | Type: unclassified | Action: nan
4892,ethambutol,cytochrome p450 3a4,enzyme,,Drug: ethambutol | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
4893,ethambutol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ethambutol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
4894,ethambutol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: ethambutol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
4895,ethambutol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: ethambutol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
4896,ethambutol,probable arabinosyltransferase a,enzyme,,Drug: ethambutol | Target: probable arabinosyltransferase a | Type: enzyme | Action: nan
4897,ethambutol,probable arabinosyltransferase b,enzyme,,Drug: ethambutol | Target: probable arabinosyltransferase b | Type: enzyme | Action: nan
4898,ethambutol,probable arabinosyltransferase c,enzyme,,Drug: ethambutol | Target: probable arabinosyltransferase c | Type: enzyme | Action: nan
4899,ethambutol,cytochrome p450 3a5,enzyme,,Drug: ethambutol | Target: cytochrome p450 3a5 | Type: enzyme | Action: nan
4900,ethambutol,probable arabinosyltransferase a,enzyme,INHIBITOR,Drug: ethambutol | Target: probable arabinosyltransferase a | Type: enzyme | Action: INHIBITOR
4901,ethanol,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: ethanol | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
4902,ethanol,glycine receptor subunit alpha-1,ion channel,,Drug: ethanol | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
4903,ethanol,glycine receptor subunit alpha-2,ion channel,,Drug: ethanol | Target: glycine receptor subunit alpha-2 | Type: ion channel | Action: nan
4904,ethanol,gaba a receptor alpha-4/beta-2/delta,ion channel,,Drug: ethanol | Target: gaba a receptor alpha-4/beta-2/delta | Type: ion channel | Action: nan
4905,ethchlorvynol,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE MODULATOR,Drug: ethchlorvynol | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
4906,ethinylestradiol,5-hydroxytryptamine receptor 4,gpcr,,Drug: ethinylestradiol | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
4907,ethinylestradiol,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: ethinylestradiol | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
4908,ethinylestradiol,mu-type opioid receptor,gpcr,,Drug: ethinylestradiol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
4909,ethinylestradiol,adenosine receptor a2a,gpcr,,Drug: ethinylestradiol | Target: adenosine receptor a2a | Type: gpcr | Action: nan
4910,ethinylestradiol,sodium-dependent serotonin transporter,transporter,,Drug: ethinylestradiol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4911,ethinylestradiol,sodium-dependent noradrenaline transporter,transporter,,Drug: ethinylestradiol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4912,ethinylestradiol,aldehyde oxidase,enzyme,,Drug: ethinylestradiol | Target: aldehyde oxidase | Type: enzyme | Action: nan
4913,ethinylestradiol,glucocorticoid receptor,nuclear hormone receptor,,Drug: ethinylestradiol | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
4914,ethinylestradiol,sodium-dependent dopamine transporter,transporter,,Drug: ethinylestradiol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
4915,ethinylestradiol,adenosine receptor a3,gpcr,,Drug: ethinylestradiol | Target: adenosine receptor a3 | Type: gpcr | Action: nan
4916,ethinylestradiol,kappa-type opioid receptor,gpcr,,Drug: ethinylestradiol | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
4917,ethinylestradiol,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: ethinylestradiol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
4918,ethinylestradiol,androgen receptor,nuclear hormone receptor,,Drug: ethinylestradiol | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
4919,ethinylestradiol,estrogen receptor beta,nuclear hormone receptor,,Drug: ethinylestradiol | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
4920,ethinylestradiol,sex hormone-binding globulin,secreted,,Drug: ethinylestradiol | Target: sex hormone-binding globulin | Type: secreted | Action: nan
4921,ethinylestradiol,androgen receptor,transcription factor,,Drug: ethinylestradiol | Target: androgen receptor | Type: transcription factor | Action: nan
4922,ethinylestradiol,arachidonate 15-lipoxygenase,enzyme,,Drug: ethinylestradiol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
4923,ethinylestradiol,progesterone receptor,transcription factor,,Drug: ethinylestradiol | Target: progesterone receptor | Type: transcription factor | Action: nan
4924,ethinylestradiol,solute carrier family 22 member 2,transporter,,Drug: ethinylestradiol | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
4925,ethinylestradiol,multidrug and toxin extrusion protein 1,transporter,,Drug: ethinylestradiol | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
4926,ethinylestradiol,multidrug and toxin extrusion protein 2,transporter,,Drug: ethinylestradiol | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
4927,ethionamide,catalase-peroxidase,enzyme,,Drug: ethionamide | Target: catalase-peroxidase | Type: enzyme | Action: nan
4928,ethionamide,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,INHIBITOR,Drug: ethionamide | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: INHIBITOR
4929,ethionamide,polyphenol oxidase 2,enzyme,,Drug: ethionamide | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
4930,ethisterone,glucocorticoid receptor,nuclear hormone receptor,,Drug: ethisterone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
4931,ethisterone,sex hormone-binding globulin,secreted,,Drug: ethisterone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
4932,ethisterone,androgen receptor,transcription factor,,Drug: ethisterone | Target: androgen receptor | Type: transcription factor | Action: nan
4933,ethisterone,progesterone receptor,transcription factor,,Drug: ethisterone | Target: progesterone receptor | Type: transcription factor | Action: nan
4934,ethisterone,polyphenol oxidase 2,enzyme,,Drug: ethisterone | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
4935,profenamine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: profenamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
4936,profenamine,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: profenamine | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
4937,profenamine,acetylcholinesterase,enzyme,,Drug: profenamine | Target: acetylcholinesterase | Type: enzyme | Action: nan
4938,profenamine,cholinesterase,enzyme,,Drug: profenamine | Target: cholinesterase | Type: enzyme | Action: nan
4939,profenamine,solute carrier family 22 member 1,transporter,,Drug: profenamine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
4940,profenamine,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: profenamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
4941,profenamine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: profenamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
4942,profenamine,butyrylcholinesterase,enzyme,,Drug: profenamine | Target: butyrylcholinesterase | Type: enzyme | Action: nan
4943,profenamine,cholinesterase,enzyme,,Drug: profenamine | Target: cholinesterase | Type: enzyme | Action: nan
4944,ethosuximide,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,BLOCKER,Drug: ethosuximide | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: BLOCKER
4945,ethotoin,sodium channel alpha subunit,ion channel,BLOCKER,Drug: ethotoin | Target: sodium channel alpha subunit | Type: ion channel | Action: BLOCKER
4946,ethoxzolamide,carbonic anhydrase 2,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: INHIBITOR
4947,ethoxzolamide,carbonic anhydrase 1,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: INHIBITOR
4948,ethoxzolamide,carbonic anhydrase 4,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: INHIBITOR
4949,ethoxzolamide,carbonic anhydrase 9,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: INHIBITOR
4950,ethoxzolamide,carbonic anhydrase 12,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: INHIBITOR
4951,ethoxzolamide,"carbonic anhydrase 5a, mitochondrial",enzyme,INHIBITOR,"Drug: ethoxzolamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: INHIBITOR"
4952,ethoxzolamide,"carbonic anhydrase 5b, mitochondrial",enzyme,INHIBITOR,"Drug: ethoxzolamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: INHIBITOR"
4953,ethoxzolamide,carbonic anhydrase 7,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: INHIBITOR
4954,ethoxzolamide,carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4955,ethoxzolamide,carbonic anhydrase 3,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: INHIBITOR
4956,ethoxzolamide,carbonic anhydrase 6,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: INHIBITOR
4957,ethoxzolamide,carbonic anhydrase 14,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: INHIBITOR
4958,ethoxzolamide,carbonic anhydrase 13,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
4959,ethoxzolamide,carbonic anhydrase 4,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
4960,ethoxzolamide,carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4961,ethoxzolamide,carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4962,ethoxzolamide,carbonic anhydrase 13,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: INHIBITOR
4963,ethoxzolamide,carbonic anhydrase 15,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
4964,ethoxzolamide,carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4965,ethoxzolamide,carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4966,ethoxzolamide,carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4967,ethoxzolamide,alpha carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
4968,ethoxzolamide,carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4969,ethoxzolamide,carbonic anhydrase 2,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
4970,ethoxzolamide,astrosclerin-3,enzyme,,Drug: ethoxzolamide | Target: astrosclerin-3 | Type: enzyme | Action: nan
4971,ethoxzolamide,beta-carbonic anhydrase 1,enzyme,,Drug: ethoxzolamide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
4972,ethoxzolamide,delta carbonic anhydrase,unclassified,,Drug: ethoxzolamide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
4973,ethoxzolamide,carbonic anhydrase 2,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
4974,ethoxzolamide,carbonic anhydrase v,enzyme,INHIBITOR,Drug: ethoxzolamide | Target: carbonic anhydrase v | Type: enzyme | Action: INHIBITOR
4975,ethoxzolamide,carbonic anhydrase 3,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
4976,ethoxzolamide,carbonic anhydrase,enzyme,,Drug: ethoxzolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
4977,ethoxzolamide,"carbonic anhydrase, alpha family",unclassified,,"Drug: ethoxzolamide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
4978,ethoxzolamide,carbonate dehydratase,enzyme,,Drug: ethoxzolamide | Target: carbonate dehydratase | Type: enzyme | Action: nan
4979,ethyl biscoumacetate,vitamin k epoxide reductase complex subunit 1,enzyme,,Drug: ethyl biscoumacetate | Target: vitamin k epoxide reductase complex subunit 1 | Type: enzyme | Action: nan
4980,ethylestrenol,sodium-dependent serotonin transporter,transporter,,Drug: ethylestrenol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
4981,ethylestrenol,sodium-dependent noradrenaline transporter,transporter,,Drug: ethylestrenol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
4982,ethylestrenol,muscarinic acetylcholine receptor m2,gpcr,,Drug: ethylestrenol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
4983,ethylestrenol,estrogen receptor,nuclear hormone receptor,,Drug: ethylestrenol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
4984,ethylestrenol,androgen receptor,nuclear hormone receptor,AGONIST,Drug: ethylestrenol | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
4985,ethylestrenol,acetylcholinesterase,enzyme,,Drug: ethylestrenol | Target: acetylcholinesterase | Type: enzyme | Action: nan
4986,ethylestrenol,cytochrome p450 2c19,enzyme,,Drug: ethylestrenol | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
4987,ethylestrenol,androgen receptor,transcription factor,,Drug: ethylestrenol | Target: androgen receptor | Type: transcription factor | Action: nan
4988,ethylestrenol,progesterone receptor,transcription factor,,Drug: ethylestrenol | Target: progesterone receptor | Type: transcription factor | Action: nan
4989,etynodiol,estrogen receptor,nuclear hormone receptor,,Drug: etynodiol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
4990,etynodiol,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: etynodiol | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
4991,etynodiol,amine oxidase [flavin-containing] a,enzyme,,Drug: etynodiol | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
4992,etynodiol,androgen receptor,transcription factor,,Drug: etynodiol | Target: androgen receptor | Type: transcription factor | Action: nan
4993,etynodiol,progesterone receptor,transcription factor,,Drug: etynodiol | Target: progesterone receptor | Type: transcription factor | Action: nan
4994,etidocaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: etidocaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
4995,etidocaine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: etidocaine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
4996,etidocaine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: etidocaine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
4997,etidocaine,potassium channel subfamily k member 3,ion channel,,Drug: etidocaine | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: nan
4998,etidocaine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: etidocaine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
5000,etidronic acid,type iv secretion-like conjugative transfer relaxase protein trai,unclassified,,Drug: etidronic acid | Target: type iv secretion-like conjugative transfer relaxase protein trai | Type: unclassified | Action: nan
5001,etilamfetamine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: etilamfetamine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5002,etilefrine,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: etilefrine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
5003,etizolam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: etizolam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
5004,etizolam,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,,Drug: etizolam | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: nan
5005,etizolam,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,,Drug: etizolam | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: nan
5006,etizolam,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,,Drug: etizolam | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: nan
5007,etodolac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: etodolac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
5008,etodolac,prostaglandin g/h synthase 1,enzyme,,Drug: etodolac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
5009,etofylline,adenosine receptor a2b,gpcr,,Drug: etofylline | Target: adenosine receptor a2b | Type: gpcr | Action: nan
5010,etomidate,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,,Drug: etomidate | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: nan
5011,etomidate,"cytochrome p450 11b1, mitochondrial",enzyme,,"Drug: etomidate | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: nan"
5012,etomidate,"cytochrome p450 11b2, mitochondrial",enzyme,,"Drug: etomidate | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: nan"
5013,etomidate,acetylcholine receptor subunit delta,ion channel,,Drug: etomidate | Target: acetylcholine receptor subunit delta | Type: ion channel | Action: nan
5014,etomidate,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE MODULATOR,Drug: etomidate | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
5015,etomidate,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,,Drug: etomidate | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: nan
5016,etonogestrel,estrogen receptor,nuclear hormone receptor,,Drug: etonogestrel | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
5017,etonogestrel,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: etonogestrel | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
5018,etonogestrel,sex hormone-binding globulin,secreted,,Drug: etonogestrel | Target: sex hormone-binding globulin | Type: secreted | Action: nan
5019,etoperidone,d(2) dopamine receptor,gpcr,,Drug: etoperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5020,etoperidone,sodium-dependent serotonin transporter,transporter,,Drug: etoperidone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5021,etoperidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: etoperidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5022,etoperidone,histamine h1 receptor,gpcr,,Drug: etoperidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
5023,etoposide,multidrug resistance protein 1,transporter,,Drug: etoposide | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
5024,etoposide,canalicular multispecific organic anion transporter 1,transporter,,Drug: etoposide | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
5025,etoposide,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: etoposide | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
5026,etoposide,dna topoisomerase 2-alpha,enzyme,INHIBITOR,Drug: etoposide | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: INHIBITOR
5027,etoposide,multidrug resistance-associated protein 1,transporter,,Drug: etoposide | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
5028,etoposide,atp-binding cassette sub-family g member 2,transporter,,Drug: etoposide | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
5029,etoposide,multidrug resistance-associated protein 6,transporter,,Drug: etoposide | Target: multidrug resistance-associated protein 6 | Type: transporter | Action: nan
5030,etoposide,canalicular multispecific organic anion transporter 2,transporter,,Drug: etoposide | Target: canalicular multispecific organic anion transporter 2 | Type: transporter | Action: nan
5031,etoposide,dna topoisomerase 2-beta,enzyme,,Drug: etoposide | Target: dna topoisomerase 2-beta | Type: enzyme | Action: nan
5032,etoposide,arachidonate 15-lipoxygenase,enzyme,,Drug: etoposide | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
5033,etoricoxib,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: etoricoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
5034,etoricoxib,prostaglandin g/h synthase 1,enzyme,,Drug: etoricoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
5035,etoricoxib,prostaglandin e2 receptor ep2 subtype,gpcr,,Drug: etoricoxib | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: nan
5036,etoricoxib,mitogen-activated protein kinase 14,kinase,,Drug: etoricoxib | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
5037,etoricoxib,prostaglandin g/h synthase 2,enzyme,,Drug: etoricoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
5039,etravirine,multidrug resistance protein 1,transporter,,Drug: etravirine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
5040,etravirine,canalicular multispecific organic anion transporter 1,transporter,,Drug: etravirine | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
5041,etravirine,multidrug resistance-associated protein 1,transporter,,Drug: etravirine | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
5042,etravirine,atp-binding cassette sub-family g member 2,transporter,,Drug: etravirine | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
5043,etravirine,canalicular multispecific organic anion transporter 2,transporter,,Drug: etravirine | Target: canalicular multispecific organic anion transporter 2 | Type: transporter | Action: nan
5044,etravirine,gag-pol polyprotein,polyprotein,,Drug: etravirine | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
5045,etravirine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: etravirine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
5046,etravirine,cruzipain,enzyme,,Drug: etravirine | Target: cruzipain | Type: enzyme | Action: nan
5047,etravirine,reverse transcriptase,enzyme,,Drug: etravirine | Target: reverse transcriptase | Type: enzyme | Action: nan
5048,etravirine,reverse transcriptase protein,unclassified,,Drug: etravirine | Target: reverse transcriptase protein | Type: unclassified | Action: nan
5049,etretinate,retinoic acid receptor alpha,nuclear hormone receptor,AGONIST,Drug: etretinate | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
5050,etretinate,retinoic acid receptor rxr-gamma,nuclear hormone receptor,AGONIST,Drug: etretinate | Target: retinoic acid receptor rxr-gamma | Type: nuclear hormone receptor | Action: AGONIST
5051,etryptamine,sodium-dependent serotonin transporter,transporter,,Drug: etryptamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5052,etryptamine,sodium-dependent dopamine transporter,transporter,,Drug: etryptamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
5053,etryptamine,transporter,transporter,,Drug: etryptamine | Target: transporter | Type: transporter | Action: nan
5054,everolimus,multidrug resistance protein 1,transporter,,Drug: everolimus | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
5055,everolimus,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,INHIBITOR,Drug: everolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: INHIBITOR
5056,everolimus,serine/threonine-protein kinase mtor,kinase,INHIBITOR,Drug: everolimus | Target: serine/threonine-protein kinase mtor | Type: kinase | Action: INHIBITOR
5057,exemestane,androgen receptor,nuclear hormone receptor,,Drug: exemestane | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
5058,exemestane,aromatase,enzyme,INHIBITOR,Drug: exemestane | Target: aromatase | Type: enzyme | Action: INHIBITOR
5059,exenatide,glucagon-like peptide 1 receptor,gpcr,AGONIST,Drug: exenatide | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: AGONIST
5060,exenatide,glucagon-like peptide 1 receptor,gpcr,,Drug: exenatide | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: nan
5061,ezetimibe,niemann-pick c1-like protein 1,membrane other,ANTAGONIST,Drug: ezetimibe | Target: niemann-pick c1-like protein 1 | Type: membrane other | Action: ANTAGONIST
5062,ezetimibe,niemann-pick c1-like protein 1,unclassified,,Drug: ezetimibe | Target: niemann-pick c1-like protein 1 | Type: unclassified | Action: nan
5063,fadrozole,"cytochrome p450 11b1, mitochondrial",enzyme,INHIBITOR,"Drug: fadrozole | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: INHIBITOR"
5064,fadrozole,"cytochrome p450 11b2, mitochondrial",enzyme,INHIBITOR,"Drug: fadrozole | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: INHIBITOR"
5065,fadrozole,"cytochrome p450 11b2, mitochondrial",enzyme,,"Drug: fadrozole | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: nan"
5066,fadrozole,aromatase,enzyme,INHIBITOR,Drug: fadrozole | Target: aromatase | Type: enzyme | Action: INHIBITOR
5067,famciclovir,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: famciclovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
5068,famciclovir,dna polymerase catalytic subunit,enzyme,,Drug: famciclovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: nan
5069,famotidine,histamine h2 receptor,gpcr,ANTAGONIST,Drug: famotidine | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
5070,famotidine,carbonic anhydrase 2,enzyme,,Drug: famotidine | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
5071,famotidine,carbonic anhydrase 1,enzyme,,Drug: famotidine | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
5072,famotidine,carbonic anhydrase 4,enzyme,,Drug: famotidine | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
5073,famotidine,carbonic anhydrase 9,enzyme,,Drug: famotidine | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
5074,famotidine,carbonic anhydrase 12,enzyme,,Drug: famotidine | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
5075,famotidine,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: famotidine | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
5076,famotidine,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: famotidine | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
5077,famotidine,carbonic anhydrase 7,enzyme,,Drug: famotidine | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
5078,famotidine,carbonic anhydrase 6,enzyme,,Drug: famotidine | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
5079,famotidine,carbonic anhydrase 14,enzyme,,Drug: famotidine | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
5080,famotidine,histamine h2 receptor,gpcr,,Drug: famotidine | Target: histamine h2 receptor | Type: gpcr | Action: nan
5081,famotidine,carbonic anhydrase 13,enzyme,,Drug: famotidine | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
5082,famotidine,solute carrier family 22 member 2,transporter,,Drug: famotidine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
5083,famotidine,multidrug and toxin extrusion protein 1,transporter,,Drug: famotidine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
5084,famotidine,multidrug and toxin extrusion protein 2,transporter,,Drug: famotidine | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
5085,famotidine,heat shock protein hsp 90-alpha,cytosolic other,,Drug: famotidine | Target: heat shock protein hsp 90-alpha | Type: cytosolic other | Action: nan
5086,famotidine,solute carrier family 22 member 3,transporter,,Drug: famotidine | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
5087,famprofazone,nuclear receptor subfamily 2 group e member 1,nuclear hormone receptor,,Drug: famprofazone | Target: nuclear receptor subfamily 2 group e member 1 | Type: nuclear hormone receptor | Action: nan
5088,fasudil,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: fasudil | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5089,fasudil,"myosin light chain kinase, smooth muscle",kinase,,"Drug: fasudil | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
5090,fasudil,protein kinase c epsilon type,kinase,,Drug: fasudil | Target: protein kinase c epsilon type | Type: kinase | Action: nan
5091,fasudil,serine/threonine-protein kinase n1,kinase,,Drug: fasudil | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
5092,fasudil,ribosomal protein s6 kinase alpha-5,kinase,,Drug: fasudil | Target: ribosomal protein s6 kinase alpha-5 | Type: kinase | Action: nan
5093,fasudil,c-c motif chemokine 2,cytokine,,Drug: fasudil | Target: c-c motif chemokine 2 | Type: cytokine | Action: nan
5094,fasudil,serine/threonine-protein kinase n2,kinase,,Drug: fasudil | Target: serine/threonine-protein kinase n2 | Type: kinase | Action: nan
5095,fasudil,camp-dependent protein kinase catalytic subunit alpha,kinase,,Drug: fasudil | Target: camp-dependent protein kinase catalytic subunit alpha | Type: kinase | Action: nan
5096,fasudil,rho-associated protein kinase 2,kinase,,Drug: fasudil | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
5097,fasudil,rho-associated protein kinase 1,kinase,INHIBITOR,Drug: fasudil | Target: rho-associated protein kinase 1 | Type: kinase | Action: INHIBITOR
5098,fasudil,rho-associated protein kinase 2,kinase,INHIBITOR,Drug: fasudil | Target: rho-associated protein kinase 2 | Type: kinase | Action: INHIBITOR
5099,febuxostat,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: febuxostat | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5100,febuxostat,xanthine dehydrogenase/oxidase,enzyme,INHIBITOR,Drug: febuxostat | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: INHIBITOR
5101,febuxostat,xanthine dehydrogenase/oxidase,enzyme,,Drug: febuxostat | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
5102,febuxostat,xanthine dehydrogenase/oxidase,enzyme,,Drug: febuxostat | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
5103,felbamate,"glutamate receptor ionotropic, nmda 2a",ion channel,ANTAGONIST,"Drug: felbamate | Target: glutamate receptor ionotropic, nmda 2a | Type: ion channel | Action: ANTAGONIST"
5104,felbamate,"glutamate receptor ionotropic, nmda 2b",ion channel,ANTAGONIST,"Drug: felbamate | Target: glutamate receptor ionotropic, nmda 2b | Type: ion channel | Action: ANTAGONIST"
5105,felbinac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: felbinac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
5106,felbinac,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: felbinac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
5107,felodipine,aldehyde oxidase,enzyme,,Drug: felodipine | Target: aldehyde oxidase | Type: enzyme | Action: nan
5108,felodipine,adenosine receptor a3,gpcr,,Drug: felodipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
5109,felodipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: felodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
5110,felodipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,BLOCKER,Drug: felodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: BLOCKER
5111,felodipine,cytochrome p450 2c9,enzyme,,Drug: felodipine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
5112,felodipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: felodipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
5113,felodipine,bile acid receptor,nuclear hormone receptor,,Drug: felodipine | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
5114,felodipine,cystic fibrosis transmembrane conductance regulator,ion channel,ACTIVATOR,Drug: felodipine | Target: cystic fibrosis transmembrane conductance regulator | Type: ion channel | Action: ACTIVATOR
5115,felodipine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: felodipine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
5116,fenbufen,prostaglandin g/h synthase 1,enzyme,,Drug: fenbufen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
5117,fenbufen,prostaglandin g/h synthase 2,enzyme,,Drug: fenbufen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
5118,fenbufen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: fenbufen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
5119,fenbufen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: fenbufen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
5120,fendiline,5-hydroxytryptamine receptor 2b,gpcr,,Drug: fendiline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
5121,fendiline,extracellular calcium-sensing receptor,gpcr,,Drug: fendiline | Target: extracellular calcium-sensing receptor | Type: gpcr | Action: nan
5122,fendiline,transcriptional activator protein luxr,unclassified,,Drug: fendiline | Target: transcriptional activator protein luxr | Type: unclassified | Action: nan
5123,fendiline,calmodulin,cytosolic other,,Drug: fendiline | Target: calmodulin | Type: cytosolic other | Action: nan
5124,fendiline,extracellular calcium-sensing receptor,gpcr,POSITIVE ALLOSTERIC MODULATOR,Drug: fendiline | Target: extracellular calcium-sensing receptor | Type: gpcr | Action: POSITIVE ALLOSTERIC MODULATOR
5125,fenfluramine,beta-1 adrenergic receptor,gpcr,,Drug: fenfluramine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
5126,fenfluramine,beta-2 adrenergic receptor,gpcr,,Drug: fenfluramine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
5127,fenfluramine,alpha-2a adrenergic receptor,gpcr,,Drug: fenfluramine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5128,fenfluramine,sodium-dependent serotonin transporter,transporter,,Drug: fenfluramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5129,fenfluramine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: fenfluramine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5130,fenfluramine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: fenfluramine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5131,fenfluramine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: fenfluramine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
5132,fenfluramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: fenfluramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5133,fenfluramine,5-hydroxytryptamine receptor 6,gpcr,,Drug: fenfluramine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
5134,fenfluramine,5-hydroxytryptamine receptor 7,gpcr,,Drug: fenfluramine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
5135,fenfluramine,alpha-1a adrenergic receptor,gpcr,,Drug: fenfluramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5136,fenfluramine,alpha-2b adrenergic receptor,gpcr,,Drug: fenfluramine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
5137,fenfluramine,muscarinic acetylcholine receptor m1,gpcr,,Drug: fenfluramine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
5138,fenfluramine,muscarinic acetylcholine receptor m2,gpcr,,Drug: fenfluramine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
5139,fenfluramine,muscarinic acetylcholine receptor m3,gpcr,,Drug: fenfluramine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
5140,fenfluramine,muscarinic acetylcholine receptor m4,gpcr,,Drug: fenfluramine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
5141,fenfluramine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: fenfluramine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
5142,fenfluramine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: fenfluramine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
5143,fenfluramine,alpha-2c adrenergic receptor,gpcr,,Drug: fenfluramine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
5144,fenfluramine,alpha-1b adrenergic receptor,gpcr,,Drug: fenfluramine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
5145,fenfluramine,sodium-dependent serotonin transporter,transporter,,Drug: fenfluramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5146,fenofibrate,sodium-dependent noradrenaline transporter,transporter,,Drug: fenofibrate | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
5147,fenofibrate,5-hydroxytryptamine receptor 2a,gpcr,,Drug: fenofibrate | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5148,fenofibrate,5-hydroxytryptamine receptor 2c,gpcr,,Drug: fenofibrate | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5149,fenofibrate,d(3) dopamine receptor,gpcr,,Drug: fenofibrate | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5150,fenofibrate,beta-3 adrenergic receptor,gpcr,,Drug: fenofibrate | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
5151,fenofibrate,sodium-dependent dopamine transporter,transporter,,Drug: fenofibrate | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
5152,fenofibrate,adenosine receptor a3,gpcr,,Drug: fenofibrate | Target: adenosine receptor a3 | Type: gpcr | Action: nan
5153,fenofibrate,acetylcholinesterase,enzyme,,Drug: fenofibrate | Target: acetylcholinesterase | Type: enzyme | Action: nan
5154,fenofibrate,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: fenofibrate | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
5155,fenofibrate,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: fenofibrate | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
5156,fenofibrate,"fatty acid-binding protein, liver",unclassified,,"Drug: fenofibrate | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
5157,fenofibrate,cruzipain,enzyme,,Drug: fenofibrate | Target: cruzipain | Type: enzyme | Action: nan
5158,fenoldopam,d(1a) dopamine receptor,gpcr,AGONIST,Drug: fenoldopam | Target: d(1a) dopamine receptor | Type: gpcr | Action: AGONIST
5159,fenoldopam,d(2) dopamine receptor,gpcr,,Drug: fenoldopam | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5160,fenoldopam,d(1b) dopamine receptor,gpcr,,Drug: fenoldopam | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
5161,fenoldopam,d(4) dopamine receptor,gpcr,AGONIST,Drug: fenoldopam | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
5162,fenoldopam,d(2) dopamine receptor,gpcr,,Drug: fenoldopam | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5163,fenoldopam,d(1a) dopamine receptor,gpcr,,Drug: fenoldopam | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5164,fenoldopam,d(2) dopamine receptor,gpcr,,Drug: fenoldopam | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5165,fenoldopam,lysine-specific demethylase 4e,enzyme,,Drug: fenoldopam | Target: lysine-specific demethylase 4e | Type: enzyme | Action: nan
5166,fenoldopam,adrenergic receptor alpha-1,gpcr,,Drug: fenoldopam | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
5167,fenoldopam,adenosine a2b receptor,gpcr,,Drug: fenoldopam | Target: adenosine a2b receptor | Type: gpcr | Action: nan
5168,fenoldopam,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: fenoldopam | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
5169,fenoprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: fenoprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
5170,fenoprofen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: fenoprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
5171,fenoprofen,prostaglandin g/h synthase 2,enzyme,,Drug: fenoprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
5172,fenoprofen,cyclooxygenase,enzyme,,Drug: fenoprofen | Target: cyclooxygenase | Type: enzyme | Action: nan
5173,fenoprofen,sodium-coupled monocarboxylate transporter 1,transporter,INHIBITOR,Drug: fenoprofen | Target: sodium-coupled monocarboxylate transporter 1 | Type: transporter | Action: INHIBITOR
5174,fenoterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: fenoterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
5175,fenoterol,beta-2 adrenergic receptor,gpcr,,Drug: fenoterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
5176,fentanyl,mu-type opioid receptor,gpcr,AGONIST,Drug: fentanyl | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
5177,fentanyl,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: fentanyl | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5178,fentanyl,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: fentanyl | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5179,fentanyl,kappa-type opioid receptor,gpcr,,Drug: fentanyl | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
5180,fentanyl,delta-type opioid receptor,gpcr,,Drug: fentanyl | Target: delta-type opioid receptor | Type: gpcr | Action: nan
5181,fentanyl,solute carrier family 22 member 1,transporter,,Drug: fentanyl | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
5182,fentanyl,mu-type opioid receptor,gpcr,,Drug: fentanyl | Target: mu-type opioid receptor | Type: gpcr | Action: nan
5183,fentanyl,mu-type opioid receptor,gpcr,,Drug: fentanyl | Target: mu-type opioid receptor | Type: gpcr | Action: nan
5184,fentanyl,mu-type opioid receptor,gpcr,,Drug: fentanyl | Target: mu-type opioid receptor | Type: gpcr | Action: nan
5185,fentanyl,delta-type opioid receptor,gpcr,,Drug: fentanyl | Target: delta-type opioid receptor | Type: gpcr | Action: nan
5186,fentanyl,delta-type opioid receptor,gpcr,,Drug: fentanyl | Target: delta-type opioid receptor | Type: gpcr | Action: nan
5187,fentanyl,kappa-type opioid receptor,gpcr,,Drug: fentanyl | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
5188,fentanyl,histamine h1 receptor,gpcr,,Drug: fentanyl | Target: histamine h1 receptor | Type: gpcr | Action: nan
5189,fentanyl,sigma non-opioid intracellular receptor 1,membrane other,,Drug: fentanyl | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
5190,fentanyl,opioid receptor,gpcr,,Drug: fentanyl | Target: opioid receptor | Type: gpcr | Action: nan
5191,fentanyl,monoamine oxidase,enzyme,,Drug: fentanyl | Target: monoamine oxidase | Type: enzyme | Action: nan
5193,fentanyl,sigma non-opioid intracellular receptor 1,unclassified,,Drug: fentanyl | Target: sigma non-opioid intracellular receptor 1 | Type: unclassified | Action: nan
5194,fentanyl,sigma non-opioid intracellular receptor 1,unclassified,,Drug: fentanyl | Target: sigma non-opioid intracellular receptor 1 | Type: unclassified | Action: nan
5195,fentiazac,prostaglandin d2 receptor 2,gpcr,,Drug: fentiazac | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: nan
5196,fexofenadine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: fexofenadine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5197,fexofenadine,multidrug resistance protein 1,transporter,,Drug: fexofenadine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
5198,fexofenadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: fexofenadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
5199,fexofenadine,solute carrier organic anion transporter family member 1a2,transporter,,Drug: fexofenadine | Target: solute carrier organic anion transporter family member 1a2 | Type: transporter | Action: nan
5200,finasteride,cytochrome p450 2c9,enzyme,,Drug: finasteride | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
5201,finasteride,cytochrome p450 2c19,enzyme,,Drug: finasteride | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
5202,finasteride,3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type 1,enzyme,,Drug: finasteride | Target: 3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type 1 | Type: enzyme | Action: nan
5203,finasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 1,enzyme,,Drug: finasteride | Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Type: enzyme | Action: nan
5204,finasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 2,enzyme,,Drug: finasteride | Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Type: enzyme | Action: nan
5205,finasteride,steroid 5-alpha-reductase,enzyme,,Drug: finasteride | Target: steroid 5-alpha-reductase | Type: enzyme | Action: nan
5206,finasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 2,enzyme,INHIBITOR,Drug: finasteride | Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Type: enzyme | Action: INHIBITOR
5207,finasteride,3-oxo-5-alpha-steroid 4-dehydrogenase 1,enzyme,INHIBITOR,Drug: finasteride | Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 1 | Type: enzyme | Action: INHIBITOR
5208,flavoxate,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: flavoxate | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5209,flavoxate,phosphodiesterase 4,enzyme,INHIBITOR,Drug: flavoxate | Target: phosphodiesterase 4 | Type: enzyme | Action: INHIBITOR
5210,flavoxate,phosphodiesterase 7,enzyme,INHIBITOR,Drug: flavoxate | Target: phosphodiesterase 7 | Type: enzyme | Action: INHIBITOR
5211,flavoxate,phosphodiesterase 8,enzyme,INHIBITOR,Drug: flavoxate | Target: phosphodiesterase 8 | Type: enzyme | Action: INHIBITOR
5212,flecainide,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: flecainide | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
5213,flecainide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: flecainide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5214,flecainide,sodium channel protein type 4 subunit alpha,ion channel,,Drug: flecainide | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: nan
5215,flecainide,potassium voltage-gated channel subfamily a member 5,ion channel,BLOCKER,Drug: flecainide | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: BLOCKER
5216,flecainide,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: flecainide | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
5217,flecainide,potassium voltage-gated channel subfamily a member 7,ion channel,BLOCKER,Drug: flecainide | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: BLOCKER
5218,flecainide,potassium voltage-gated channel subfamily d member 2,ion channel,,Drug: flecainide | Target: potassium voltage-gated channel subfamily d member 2 | Type: ion channel | Action: nan
5219,flecainide,potassium voltage-gated channel subfamily c member 1,ion channel,BLOCKER,Drug: flecainide | Target: potassium voltage-gated channel subfamily c member 1 | Type: ion channel | Action: BLOCKER
5220,fleroxacin,dna gyrase subunit a,enzyme,,Drug: fleroxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
5221,floctafenine,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: floctafenine | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
5222,floctafenine,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: floctafenine | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
5223,flopropione,catechol o-methyltransferase,enzyme,INHIBITOR,Drug: flopropione | Target: catechol o-methyltransferase | Type: enzyme | Action: INHIBITOR
5224,floxacillin,penicillin-binding protein 1a,enzyme,,Drug: floxacillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
5225,floxacillin,androgen receptor,nuclear hormone receptor,,Drug: floxacillin | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
5226,floxacillin,matrix metalloproteinase-9,enzyme,,Drug: floxacillin | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
5227,floxuridine,thymidylate synthase,enzyme,INHIBITOR,Drug: floxuridine | Target: thymidylate synthase | Type: enzyme | Action: INHIBITOR
5228,floxuridine,thymidylate synthase,enzyme,,Drug: floxuridine | Target: thymidylate synthase | Type: enzyme | Action: nan
5229,fluconazole,cytochrome p450 3a4,enzyme,,Drug: fluconazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
5230,fluconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: fluconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
5231,fluconazole,cytochrome p450 2c9,enzyme,,Drug: fluconazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
5232,fluconazole,cytochrome p450 2c19,enzyme,,Drug: fluconazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
5233,fluconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: fluconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
5234,fluconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: fluconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
5235,fluconazole,14-alpha sterol demethylase cyp51a,enzyme,,Drug: fluconazole | Target: 14-alpha sterol demethylase cyp51a | Type: enzyme | Action: nan
5236,fluconazole,14-alpha sterol demethylase,enzyme,,Drug: fluconazole | Target: 14-alpha sterol demethylase | Type: enzyme | Action: nan
5237,fluconazole,mycocyclosin synthase,enzyme,,Drug: fluconazole | Target: mycocyclosin synthase | Type: enzyme | Action: nan
5238,fluconazole,sterol 14-alpha demethylase,enzyme,,Drug: fluconazole | Target: sterol 14-alpha demethylase | Type: enzyme | Action: nan
5239,flucytosine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: flucytosine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5240,flucytosine,thymidylate synthase,enzyme,INHIBITOR,Drug: flucytosine | Target: thymidylate synthase | Type: enzyme | Action: INHIBITOR
5241,flucytosine,thymidylate synthase,enzyme,INHIBITOR,Drug: flucytosine | Target: thymidylate synthase | Type: enzyme | Action: INHIBITOR
5242,flucytosine,atp-dependent molecular chaperone hsp82,cytosolic other,,Drug: flucytosine | Target: atp-dependent molecular chaperone hsp82 | Type: cytosolic other | Action: nan
5243,fludarabine phosphate,ribonucleoside-diphosphate reductase large subunit,enzyme,INHIBITOR,Drug: fludarabine phosphate | Target: ribonucleoside-diphosphate reductase large subunit | Type: enzyme | Action: INHIBITOR
5244,fludarabine phosphate,ribonucleoside-diphosphate reductase subunit m2,enzyme,INHIBITOR,Drug: fludarabine phosphate | Target: ribonucleoside-diphosphate reductase subunit m2 | Type: enzyme | Action: INHIBITOR
5245,fludarabine phosphate,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: fludarabine phosphate | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
5246,fludarabine phosphate,adenosine receptor a1,gpcr,,Drug: fludarabine phosphate | Target: adenosine receptor a1 | Type: gpcr | Action: nan
5247,fludarabine phosphate,adenosine receptor a2a,gpcr,,Drug: fludarabine phosphate | Target: adenosine receptor a2a | Type: gpcr | Action: nan
5248,fludarabine phosphate,adenosine receptor a3,gpcr,,Drug: fludarabine phosphate | Target: adenosine receptor a3 | Type: gpcr | Action: nan
5250,fludarabine phosphate,dna polymerase alpha catalytic subunit,enzyme,INHIBITOR,Drug: fludarabine phosphate | Target: dna polymerase alpha catalytic subunit | Type: enzyme | Action: INHIBITOR
5251,fludrocortisone acetate,glucocorticoid receptor,nuclear hormone receptor,,Drug: fludrocortisone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
5252,fludrocortisone acetate,annexin a1,cytosolic other,,Drug: fludrocortisone acetate | Target: annexin a1 | Type: cytosolic other | Action: nan
5253,fludrocortisone acetate,mineralocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fludrocortisone acetate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5254,flufenamic acid,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: flufenamic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
5255,flufenamic acid,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: flufenamic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
5256,flufenamic acid,transthyretin,secreted,,Drug: flufenamic acid | Target: transthyretin | Type: secreted | Action: nan
5257,flufenamic acid,androgen receptor,nuclear hormone receptor,,Drug: flufenamic acid | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
5258,flufenamic acid,aldose reductase,enzyme,,Drug: flufenamic acid | Target: aldose reductase | Type: enzyme | Action: nan
5259,flufenamic acid,aldo-keto reductase family 1 member c1,enzyme,,Drug: flufenamic acid | Target: aldo-keto reductase family 1 member c1 | Type: enzyme | Action: nan
5260,flufenamic acid,aldo-keto reductase family 1 member c2,enzyme,,Drug: flufenamic acid | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
5261,flufenamic acid,aldo-keto reductase family 1 member c3,enzyme,,Drug: flufenamic acid | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
5262,flufenamic acid,potassium channel subfamily k member 2,ion channel,,Drug: flufenamic acid | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
5263,flufenamic acid,myeloperoxidase,enzyme,,Drug: flufenamic acid | Target: myeloperoxidase | Type: enzyme | Action: nan
5264,flufenamic acid,potassium channel subfamily t member 2,ion channel,ACTIVATOR,Drug: flufenamic acid | Target: potassium channel subfamily t member 2 | Type: ion channel | Action: ACTIVATOR
5265,flufenamic acid,transient receptor potential cation channel subfamily a member 1,ion channel,,Drug: flufenamic acid | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: nan
5266,flufenamic acid,transient receptor potential cation channel subfamily m member 2,ion channel,,Drug: flufenamic acid | Target: transient receptor potential cation channel subfamily m member 2 | Type: ion channel | Action: nan
5267,flufenamic acid,transient receptor potential cation channel subfamily m member 4,ion channel,,Drug: flufenamic acid | Target: transient receptor potential cation channel subfamily m member 4 | Type: ion channel | Action: nan
5268,flufenamic acid,prostaglandin g/h synthase 1,enzyme,,Drug: flufenamic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
5269,flufenamic acid,aldo-keto reductase family 1 member b10,enzyme,,Drug: flufenamic acid | Target: aldo-keto reductase family 1 member b10 | Type: enzyme | Action: nan
5270,flufenamic acid,transient receptor potential cation channel subfamily m member 5,ion channel,,Drug: flufenamic acid | Target: transient receptor potential cation channel subfamily m member 5 | Type: ion channel | Action: nan
5271,flufenamic acid,transient receptor potential cation channel subfamily m member 4,ion channel,GATING INHIBITOR,Drug: flufenamic acid | Target: transient receptor potential cation channel subfamily m member 4 | Type: ion channel | Action: GATING INHIBITOR
5272,flufenamic acid,transcriptional enhancer factor tef-3,transcription factor,,Drug: flufenamic acid | Target: transcriptional enhancer factor tef-3 | Type: transcription factor | Action: nan
5275,flufenamic acid,nicotinate phosphoribosyltransferase,enzyme,,Drug: flufenamic acid | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
5276,flufenamic acid,taste receptor type 2 member 14,gpcr,AGONIST,Drug: flufenamic acid | Target: taste receptor type 2 member 14 | Type: gpcr | Action: AGONIST
5277,fluindione,arachidonate 5-lipoxygenase,enzyme,,Drug: fluindione | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
5278,flumazenil,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,,Drug: flumazenil | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: nan
5279,flumazenil,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,,Drug: flumazenil | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: nan
5280,flumazenil,gamma-aminobutyric acid receptor subunit alpha-3,ion channel,,Drug: flumazenil | Target: gamma-aminobutyric acid receptor subunit alpha-3 | Type: ion channel | Action: nan
5281,flumazenil,gamma-aminobutyric acid receptor subunit alpha-5,ion channel,,Drug: flumazenil | Target: gamma-aminobutyric acid receptor subunit alpha-5 | Type: ion channel | Action: nan
5282,flumazenil,gamma-aminobutyric acid receptor subunit alpha-4,ion channel,ALLOSTERIC ANTAGONIST,Drug: flumazenil | Target: gamma-aminobutyric acid receptor subunit alpha-4 | Type: ion channel | Action: ALLOSTERIC ANTAGONIST
5283,flumazenil,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,ALLOSTERIC ANTAGONIST,Drug: flumazenil | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: ALLOSTERIC ANTAGONIST
5284,flumazenil,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,ALLOSTERIC ANTAGONIST,Drug: flumazenil | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: ALLOSTERIC ANTAGONIST
5285,flumazenil,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,ALLOSTERIC ANTAGONIST,Drug: flumazenil | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: ALLOSTERIC ANTAGONIST
5286,flumazenil,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,ALLOSTERIC ANTAGONIST,Drug: flumazenil | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: ALLOSTERIC ANTAGONIST
5287,flumazenil,gaba-a receptor; anion channel,ion channel,,Drug: flumazenil | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
5288,flumazenil,gaba-a receptor; anion channel,ion channel,,Drug: flumazenil | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
5289,flumazenil,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,,Drug: flumazenil | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: nan
5290,flumazenil,gaba a receptor alpha-6/beta-2/gamma-2,ion channel,,Drug: flumazenil | Target: gaba a receptor alpha-6/beta-2/gamma-2 | Type: ion channel | Action: nan
5291,flumazenil,gaba-a receptor; alpha-1/beta-2/gamma-2,ion channel,,Drug: flumazenil | Target: gaba-a receptor; alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
5292,flumazenil,gaba-a receptor alpha-6/beta-3/gamma-2,ion channel,ALLOSTERIC ANTAGONIST,Drug: flumazenil | Target: gaba-a receptor alpha-6/beta-3/gamma-2 | Type: ion channel | Action: ALLOSTERIC ANTAGONIST
5293,flumazenil,gaba-a receptor; anion channel,ion channel,,Drug: flumazenil | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
5294,flumetasone pivalate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: flumetasone pivalate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5295,flunarizine,cannabinoid receptor 1,gpcr,,Drug: flunarizine | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
5296,flunarizine,mu-type opioid receptor,gpcr,,Drug: flunarizine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
5297,flunarizine,d(1a) dopamine receptor,gpcr,,Drug: flunarizine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5298,flunarizine,d(2) dopamine receptor,gpcr,,Drug: flunarizine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5299,flunarizine,alpha-2a adrenergic receptor,gpcr,,Drug: flunarizine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5300,flunarizine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: flunarizine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5301,flunarizine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: flunarizine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5302,flunarizine,sodium-dependent serotonin transporter,transporter,,Drug: flunarizine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5303,flunarizine,sodium-dependent noradrenaline transporter,transporter,,Drug: flunarizine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
5304,flunarizine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: flunarizine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5305,flunarizine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: flunarizine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5306,flunarizine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: flunarizine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
5307,flunarizine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: flunarizine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5308,flunarizine,alpha-2b adrenergic receptor,gpcr,,Drug: flunarizine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
5309,flunarizine,d(3) dopamine receptor,gpcr,,Drug: flunarizine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5310,flunarizine,histamine h1 receptor,gpcr,,Drug: flunarizine | Target: histamine h1 receptor | Type: gpcr | Action: nan
5311,flunarizine,muscarinic acetylcholine receptor m1,gpcr,,Drug: flunarizine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
5312,flunarizine,muscarinic acetylcholine receptor m3,gpcr,,Drug: flunarizine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
5313,flunarizine,muscarinic acetylcholine receptor m4,gpcr,,Drug: flunarizine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
5314,flunarizine,muscarinic acetylcholine receptor m5,gpcr,,Drug: flunarizine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
5315,flunarizine,alpha-2c adrenergic receptor,gpcr,,Drug: flunarizine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
5316,flunarizine,sodium channel protein type 1 subunit alpha,ion channel,,Drug: flunarizine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: nan
5317,flunarizine,sodium-dependent dopamine transporter,transporter,,Drug: flunarizine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
5318,flunarizine,adenosine receptor a3,gpcr,,Drug: flunarizine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
5319,flunarizine,alpha-1d adrenergic receptor,gpcr,,Drug: flunarizine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
5320,flunarizine,kappa-type opioid receptor,gpcr,,Drug: flunarizine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
5321,flunarizine,delta-type opioid receptor,gpcr,,Drug: flunarizine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
5322,flunarizine,voltage-dependent n-type calcium channel subunit alpha-1b,ion channel,,Drug: flunarizine | Target: voltage-dependent n-type calcium channel subunit alpha-1b | Type: ion channel | Action: nan
5323,flunarizine,alpha-1b adrenergic receptor,gpcr,,Drug: flunarizine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
5324,flunarizine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: flunarizine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
5325,flunarizine,alpha-1a adrenergic receptor,gpcr,,Drug: flunarizine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5326,flunarizine,d(2) dopamine receptor,gpcr,,Drug: flunarizine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5327,flunarizine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: flunarizine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5328,flunarizine,sodium channel protein type 2 subunit alpha,ion channel,,Drug: flunarizine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: nan
5329,flunarizine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: flunarizine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
5330,flunarizine,caax prenyl protease 2,enzyme,,Drug: flunarizine | Target: caax prenyl protease 2 | Type: enzyme | Action: nan
5331,flunarizine,caax prenyl protease 2,enzyme,,Drug: flunarizine | Target: caax prenyl protease 2 | Type: enzyme | Action: nan
5332,flunarizine,potassium channel subfamily k member 2,ion channel,,Drug: flunarizine | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
5333,flunarizine,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,BLOCKER,Drug: flunarizine | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: BLOCKER
5334,flunarizine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,BLOCKER,Drug: flunarizine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: BLOCKER
5335,flunarizine,voltage-dependent t-type calcium channel subunit alpha-1i,ion channel,BLOCKER,Drug: flunarizine | Target: voltage-dependent t-type calcium channel subunit alpha-1i | Type: ion channel | Action: BLOCKER
5336,flunisolide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: flunisolide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5337,flunisolide,progesterone receptor,transcription factor,,Drug: flunisolide | Target: progesterone receptor | Type: transcription factor | Action: nan
5338,flunitrazepam,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,ALLOSTERIC MODULATOR,Drug: flunitrazepam | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: ALLOSTERIC MODULATOR
5339,flunitrazepam,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,ALLOSTERIC MODULATOR,Drug: flunitrazepam | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: ALLOSTERIC MODULATOR
5340,flunitrazepam,gamma-aminobutyric acid receptor subunit alpha-3,ion channel,ALLOSTERIC MODULATOR,Drug: flunitrazepam | Target: gamma-aminobutyric acid receptor subunit alpha-3 | Type: ion channel | Action: ALLOSTERIC MODULATOR
5341,flunitrazepam,gamma-aminobutyric acid receptor subunit alpha-5,ion channel,ALLOSTERIC MODULATOR,Drug: flunitrazepam | Target: gamma-aminobutyric acid receptor subunit alpha-5 | Type: ion channel | Action: ALLOSTERIC MODULATOR
5342,flunitrazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: flunitrazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
5343,flunitrazepam,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,,Drug: flunitrazepam | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: nan
5344,flunitrazepam,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,,Drug: flunitrazepam | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: nan
5345,flunitrazepam,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,,Drug: flunitrazepam | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: nan
5346,flunitrazepam,gaba-a receptor alpha-1/beta-2/gamma-3,ion channel,,Drug: flunitrazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-3 | Type: ion channel | Action: nan
5347,flunitrazepam,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,,Drug: flunitrazepam | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: nan
5348,flunitrazepam,gaba-a receptor; anion channel,ion channel,,Drug: flunitrazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
5349,flunitrazepam,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,,Drug: flunitrazepam | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: nan
5350,flunitrazepam,gaba a receptor alpha-3/beta-2/gamma-3,ion channel,,Drug: flunitrazepam | Target: gaba a receptor alpha-3/beta-2/gamma-3 | Type: ion channel | Action: nan
5351,flunitrazepam,gaba a receptor alpha-5/beta-3/gamma-3,ion channel,,Drug: flunitrazepam | Target: gaba a receptor alpha-5/beta-3/gamma-3 | Type: ion channel | Action: nan
5352,flunitrazepam,gaba a receptor alpha-5/beta-2/gamma-2,ion channel,,Drug: flunitrazepam | Target: gaba a receptor alpha-5/beta-2/gamma-2 | Type: ion channel | Action: nan
5353,flunitrazepam,gaba a receptor alpha-5/beta-2/gamma-3,ion channel,,Drug: flunitrazepam | Target: gaba a receptor alpha-5/beta-2/gamma-3 | Type: ion channel | Action: nan
5354,fluocinolone acetonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fluocinolone acetonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5355,fluocinolone acetonide,progesterone receptor,transcription factor,,Drug: fluocinolone acetonide | Target: progesterone receptor | Type: transcription factor | Action: nan
5356,fluocinonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fluocinonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5357,fluocinonide,progesterone receptor,transcription factor,,Drug: fluocinonide | Target: progesterone receptor | Type: transcription factor | Action: nan
5358,fluorescein,cytochrome p450 2c19,enzyme,,Drug: fluorescein | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
5359,fluorescein,protein arginine n-methyltransferase 1,enzyme,,Drug: fluorescein | Target: protein arginine n-methyltransferase 1 | Type: enzyme | Action: nan
5360,fluorescein,solute carrier family 22 member 6,transporter,,Drug: fluorescein | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
5361,fluorescein,solute carrier family 22 member 20,transporter,,Drug: fluorescein | Target: solute carrier family 22 member 20 | Type: transporter | Action: nan
5362,fluorometholone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fluorometholone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5363,fluorometholone,androgen receptor,transcription factor,,Drug: fluorometholone | Target: androgen receptor | Type: transcription factor | Action: nan
5364,fluorometholone,progesterone receptor,transcription factor,,Drug: fluorometholone | Target: progesterone receptor | Type: transcription factor | Action: nan
5365,fluoxetine,beta-1 adrenergic receptor,gpcr,,Drug: fluoxetine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
5366,fluoxetine,alpha-2a adrenergic receptor,gpcr,,Drug: fluoxetine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5367,fluoxetine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: fluoxetine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5368,fluoxetine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: fluoxetine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5369,fluoxetine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: fluoxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
5370,fluoxetine,sodium-dependent noradrenaline transporter,transporter,,Drug: fluoxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
5371,fluoxetine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: fluoxetine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5372,fluoxetine,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: fluoxetine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
5373,fluoxetine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: fluoxetine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5374,fluoxetine,5-hydroxytryptamine receptor 6,gpcr,,Drug: fluoxetine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
5375,fluoxetine,alpha-1a adrenergic receptor,gpcr,,Drug: fluoxetine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5376,fluoxetine,alpha-2b adrenergic receptor,gpcr,,Drug: fluoxetine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
5377,fluoxetine,d(3) dopamine receptor,gpcr,,Drug: fluoxetine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5378,fluoxetine,histamine h1 receptor,gpcr,,Drug: fluoxetine | Target: histamine h1 receptor | Type: gpcr | Action: nan
5379,fluoxetine,muscarinic acetylcholine receptor m1,gpcr,,Drug: fluoxetine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
5380,fluoxetine,muscarinic acetylcholine receptor m2,gpcr,,Drug: fluoxetine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
5381,fluoxetine,muscarinic acetylcholine receptor m3,gpcr,,Drug: fluoxetine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
5382,fluoxetine,muscarinic acetylcholine receptor m4,gpcr,,Drug: fluoxetine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
5383,fluoxetine,muscarinic acetylcholine receptor m5,gpcr,,Drug: fluoxetine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
5384,fluoxetine,sodium-dependent dopamine transporter,transporter,,Drug: fluoxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
5385,fluoxetine,cytochrome p450 2d6,enzyme,,Drug: fluoxetine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
5386,fluoxetine,acetylcholinesterase,enzyme,,Drug: fluoxetine | Target: acetylcholinesterase | Type: enzyme | Action: nan
5387,fluoxetine,potassium channel subfamily k member 2,ion channel,,Drug: fluoxetine | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
5388,fluoxetine,histamine h3 receptor,gpcr,,Drug: fluoxetine | Target: histamine h3 receptor | Type: gpcr | Action: nan
5389,fluoxetine,sodium-dependent serotonin transporter,transporter,,Drug: fluoxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5390,fluoxetine,sodium-dependent dopamine transporter,transporter,,Drug: fluoxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
5391,fluoxetine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: fluoxetine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
5392,fluoxetine,transporter,transporter,,Drug: fluoxetine | Target: transporter | Type: transporter | Action: nan
5393,fluoxetine,sodium-dependent dopamine transporter,transporter,,Drug: fluoxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
5394,fluoxetine,sodium-dependent noradrenaline transporter,transporter,,Drug: fluoxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
5395,fluoxetine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: fluoxetine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5396,fluoxetine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: fluoxetine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
5397,fluoxetine,transporter,transporter,,Drug: fluoxetine | Target: transporter | Type: transporter | Action: nan
5398,fluoxetine,serotonin 1 (5-ht1) receptor,gpcr,,Drug: fluoxetine | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
5399,fluoxetine,adrenergic receptor alpha-2,gpcr,,Drug: fluoxetine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
5400,fluoxetine,adrenergic receptor alpha-1,gpcr,,Drug: fluoxetine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
5401,fluoxetine,equilibrative nucleoside transporter 4,transporter,INHIBITOR,Drug: fluoxetine | Target: equilibrative nucleoside transporter 4 | Type: transporter | Action: INHIBITOR
5402,fluoxetine,potassium voltage-gated channel subfamily c member 1,ion channel,,Drug: fluoxetine | Target: potassium voltage-gated channel subfamily c member 1 | Type: ion channel | Action: nan
5403,fluoxetine,g protein-activated inward rectifier potassium channel 2,ion channel,GATING INHIBITOR,Drug: fluoxetine | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: GATING INHIBITOR
5404,fluoxymesterone,androgen receptor,nuclear hormone receptor,AGONIST,Drug: fluoxymesterone | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
5405,flupentixol,d(1a) dopamine receptor,gpcr,ANTAGONIST,Drug: flupentixol | Target: d(1a) dopamine receptor | Type: gpcr | Action: ANTAGONIST
5406,flupentixol,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: flupentixol | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
5407,flupentixol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: flupentixol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5408,flupentixol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: flupentixol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5409,flupentixol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: flupentixol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5410,flupentixol,alpha-1a adrenergic receptor,gpcr,,Drug: flupentixol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5411,flupentixol,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: flupentixol | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
5412,flupentixol,d(1b) dopamine receptor,gpcr,ANTAGONIST,Drug: flupentixol | Target: d(1b) dopamine receptor | Type: gpcr | Action: ANTAGONIST
5413,flupentixol,histamine h1 receptor,gpcr,,Drug: flupentixol | Target: histamine h1 receptor | Type: gpcr | Action: nan
5414,flupentixol,d(4) dopamine receptor,gpcr,,Drug: flupentixol | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
5415,flupentixol,potassium channel subfamily k member 2,ion channel,,Drug: flupentixol | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
5416,flupentixol,solute carrier family 22 member 1,transporter,,Drug: flupentixol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
5417,flupentixol,d(1a) dopamine receptor,gpcr,,Drug: flupentixol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5418,flupentixol,d(1a) dopamine receptor,gpcr,,Drug: flupentixol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5419,flupentixol,dopamine receptor,gpcr,,Drug: flupentixol | Target: dopamine receptor | Type: gpcr | Action: nan
5420,fluphenazine,mu-type opioid receptor,gpcr,,Drug: fluphenazine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
5421,fluphenazine,d(1a) dopamine receptor,gpcr,,Drug: fluphenazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5422,fluphenazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: fluphenazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
5423,fluphenazine,alpha-2a adrenergic receptor,gpcr,,Drug: fluphenazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5424,fluphenazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: fluphenazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5425,fluphenazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: fluphenazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5426,fluphenazine,sodium-dependent serotonin transporter,transporter,,Drug: fluphenazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5427,fluphenazine,sodium-dependent noradrenaline transporter,transporter,,Drug: fluphenazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
5428,fluphenazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5429,fluphenazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5430,fluphenazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
5431,fluphenazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5432,fluphenazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
5433,fluphenazine,5-hydroxytryptamine receptor 7,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
5434,fluphenazine,alpha-1a adrenergic receptor,gpcr,,Drug: fluphenazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5435,fluphenazine,alpha-2b adrenergic receptor,gpcr,,Drug: fluphenazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
5436,fluphenazine,d(3) dopamine receptor,gpcr,,Drug: fluphenazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5437,fluphenazine,d(1b) dopamine receptor,gpcr,,Drug: fluphenazine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
5438,fluphenazine,histamine h1 receptor,gpcr,,Drug: fluphenazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
5439,fluphenazine,histamine h2 receptor,gpcr,,Drug: fluphenazine | Target: histamine h2 receptor | Type: gpcr | Action: nan
5440,fluphenazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: fluphenazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
5441,fluphenazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: fluphenazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
5442,fluphenazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: fluphenazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
5443,fluphenazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: fluphenazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
5444,fluphenazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: fluphenazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
5445,fluphenazine,beta-3 adrenergic receptor,gpcr,,Drug: fluphenazine | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
5446,fluphenazine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
5447,fluphenazine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
5448,fluphenazine,alpha-2c adrenergic receptor,gpcr,,Drug: fluphenazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
5449,fluphenazine,sodium-dependent dopamine transporter,transporter,,Drug: fluphenazine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
5450,fluphenazine,adenosine receptor a3,gpcr,,Drug: fluphenazine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
5451,fluphenazine,d(4) dopamine receptor,gpcr,,Drug: fluphenazine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
5452,fluphenazine,alpha-1d adrenergic receptor,gpcr,,Drug: fluphenazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
5453,fluphenazine,alpha-1b adrenergic receptor,gpcr,,Drug: fluphenazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
5454,fluphenazine,kappa-type opioid receptor,gpcr,,Drug: fluphenazine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
5455,fluphenazine,delta-type opioid receptor,gpcr,,Drug: fluphenazine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
5456,fluphenazine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
5457,fluphenazine,5-hydroxytryptamine receptor 1e,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
5458,fluphenazine,epidermal growth factor receptor,kinase,,Drug: fluphenazine | Target: epidermal growth factor receptor | Type: kinase | Action: nan
5459,fluphenazine,potassium channel subfamily k member 2,ion channel,,Drug: fluphenazine | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
5460,fluphenazine,tyrosine-protein kinase fyn,kinase,,Drug: fluphenazine | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
5461,fluphenazine,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: fluphenazine | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
5462,fluphenazine,substance-k receptor,gpcr,,Drug: fluphenazine | Target: substance-k receptor | Type: gpcr | Action: nan
5463,fluphenazine,androgen receptor,transcription factor,,Drug: fluphenazine | Target: androgen receptor | Type: transcription factor | Action: nan
5464,fluphenazine,trypanothione reductase,enzyme,,Drug: fluphenazine | Target: trypanothione reductase | Type: enzyme | Action: nan
5465,fluphenazine,alpha-1b adrenergic receptor,gpcr,,Drug: fluphenazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
5466,fluphenazine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
5467,fluphenazine,melanocortin receptor 5,gpcr,,Drug: fluphenazine | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
5468,fluphenazine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: fluphenazine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
5469,fluphenazine,alpha-1a adrenergic receptor,gpcr,,Drug: fluphenazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5470,fluphenazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5471,fluphenazine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
5472,fluphenazine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: fluphenazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
5473,fluphenazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: fluphenazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
5474,fluphenazine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: fluphenazine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
5475,fluphenazine,adenylate cyclase,enzyme,,Drug: fluphenazine | Target: adenylate cyclase | Type: enzyme | Action: nan
5476,fluphenazine decanoate,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: fluphenazine decanoate | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
5477,fluphenazine enanthate,d(1a) dopamine receptor,gpcr,,Drug: fluphenazine enanthate | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5478,fluphenazine enanthate,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: fluphenazine enanthate | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
5479,fluphenazine enanthate,alpha-2a adrenergic receptor,gpcr,,Drug: fluphenazine enanthate | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5480,fluphenazine enanthate,sodium-dependent serotonin transporter,transporter,,Drug: fluphenazine enanthate | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5481,fluphenazine enanthate,5-hydroxytryptamine receptor 1a,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5482,fluphenazine enanthate,5-hydroxytryptamine receptor 2a,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5483,fluphenazine enanthate,5-hydroxytryptamine receptor 2c,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5484,fluphenazine enanthate,5-hydroxytryptamine receptor 6,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
5485,fluphenazine enanthate,5-hydroxytryptamine receptor 7,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
5486,fluphenazine enanthate,alpha-1a adrenergic receptor,gpcr,,Drug: fluphenazine enanthate | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5487,fluphenazine enanthate,alpha-2b adrenergic receptor,gpcr,,Drug: fluphenazine enanthate | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
5488,fluphenazine enanthate,d(3) dopamine receptor,gpcr,,Drug: fluphenazine enanthate | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5489,fluphenazine enanthate,d(1b) dopamine receptor,gpcr,,Drug: fluphenazine enanthate | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
5490,fluphenazine enanthate,histamine h1 receptor,gpcr,,Drug: fluphenazine enanthate | Target: histamine h1 receptor | Type: gpcr | Action: nan
5491,fluphenazine enanthate,histamine h2 receptor,gpcr,,Drug: fluphenazine enanthate | Target: histamine h2 receptor | Type: gpcr | Action: nan
5492,fluphenazine enanthate,muscarinic acetylcholine receptor m1,gpcr,,Drug: fluphenazine enanthate | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
5493,fluphenazine enanthate,muscarinic acetylcholine receptor m2,gpcr,,Drug: fluphenazine enanthate | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
5494,fluphenazine enanthate,muscarinic acetylcholine receptor m3,gpcr,,Drug: fluphenazine enanthate | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
5495,fluphenazine enanthate,muscarinic acetylcholine receptor m4,gpcr,,Drug: fluphenazine enanthate | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
5496,fluphenazine enanthate,muscarinic acetylcholine receptor m5,gpcr,,Drug: fluphenazine enanthate | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
5497,fluphenazine enanthate,5-hydroxytryptamine receptor 1b,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
5498,fluphenazine enanthate,5-hydroxytryptamine receptor 1d,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
5499,fluphenazine enanthate,alpha-2c adrenergic receptor,gpcr,,Drug: fluphenazine enanthate | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
5500,fluphenazine enanthate,d(4) dopamine receptor,gpcr,,Drug: fluphenazine enanthate | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
5501,fluphenazine enanthate,alpha-1b adrenergic receptor,gpcr,,Drug: fluphenazine enanthate | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
5502,fluphenazine enanthate,5-hydroxytryptamine receptor 5a,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
5503,fluphenazine enanthate,5-hydroxytryptamine receptor 1e,gpcr,,Drug: fluphenazine enanthate | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
5504,flupirtine,potassium voltage-gated channel subfamily kqt member 2,ion channel,ACTIVATOR,Drug: flupirtine | Target: potassium voltage-gated channel subfamily kqt member 2 | Type: ion channel | Action: ACTIVATOR
5505,flupirtine,potassium voltage-gated channel subfamily kqt member 3,ion channel,,Drug: flupirtine | Target: potassium voltage-gated channel subfamily kqt member 3 | Type: ion channel | Action: nan
5506,flupirtine,"serine hydroxymethyltransferase, mitochondrial",enzyme,,"Drug: flupirtine | Target: serine hydroxymethyltransferase, mitochondrial | Type: enzyme | Action: nan"
5507,fluprednisolone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fluprednisolone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5508,fludroxycortide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fludroxycortide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5509,fludroxycortide,progesterone receptor,transcription factor,,Drug: fludroxycortide | Target: progesterone receptor | Type: transcription factor | Action: nan
5510,flurazepam,solute carrier family 22 member 2,transporter,,Drug: flurazepam | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
5511,flurazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: flurazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
5512,flurbiprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: flurbiprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
5513,flurbiprofen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: flurbiprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
5514,flurbiprofen,aldo-keto reductase family 1 member c2,enzyme,,Drug: flurbiprofen | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
5515,flurbiprofen,aldo-keto reductase family 1 member c3,enzyme,,Drug: flurbiprofen | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
5516,flurbiprofen,"fatty acid-binding protein, intestinal",cytosolic other,,"Drug: flurbiprofen | Target: fatty acid-binding protein, intestinal | Type: cytosolic other | Action: nan"
5517,flurbiprofen,"fatty acid-binding protein, liver",unclassified,,"Drug: flurbiprofen | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
5518,flurbiprofen,prostaglandin g/h synthase 2,enzyme,,Drug: flurbiprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
5519,flurbiprofen,prostaglandin g/h synthase 1,enzyme,,Drug: flurbiprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
5520,flurbiprofen,prostaglandin g/h synthase 1,enzyme,,Drug: flurbiprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
5521,fluspirilene,beta-1 adrenergic receptor,gpcr,,Drug: fluspirilene | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
5522,fluspirilene,beta-2 adrenergic receptor,gpcr,,Drug: fluspirilene | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
5523,fluspirilene,d(2) dopamine receptor,gpcr,,Drug: fluspirilene | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5524,fluspirilene,alpha-2a adrenergic receptor,gpcr,,Drug: fluspirilene | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5525,fluspirilene,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: fluspirilene | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5526,fluspirilene,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: fluspirilene | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
5527,fluspirilene,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: fluspirilene | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
5528,fluspirilene,5-hydroxytryptamine receptor 2b,gpcr,,Drug: fluspirilene | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
5529,fluspirilene,5-hydroxytryptamine receptor 6,gpcr,,Drug: fluspirilene | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
5530,fluspirilene,alpha-2b adrenergic receptor,gpcr,,Drug: fluspirilene | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
5531,fluspirilene,d(3) dopamine receptor,gpcr,,Drug: fluspirilene | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5532,fluspirilene,histamine h1 receptor,gpcr,ANTAGONIST,Drug: fluspirilene | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
5533,fluspirilene,5-hydroxytryptamine receptor 1b,gpcr,,Drug: fluspirilene | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
5534,fluspirilene,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: fluspirilene | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
5535,fluspirilene,alpha-2c adrenergic receptor,gpcr,,Drug: fluspirilene | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
5536,fluspirilene,d(4) dopamine receptor,gpcr,,Drug: fluspirilene | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
5537,fluspirilene,glycine receptor subunit alpha-1,ion channel,,Drug: fluspirilene | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
5538,fluspirilene,5-hydroxytryptamine receptor 1e,gpcr,ANTAGONIST,Drug: fluspirilene | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: ANTAGONIST
5539,fluspirilene,nociceptin receptor,gpcr,,Drug: fluspirilene | Target: nociceptin receptor | Type: gpcr | Action: nan
5540,flutamide,5-hydroxytryptamine receptor 4,gpcr,,Drug: flutamide | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
5541,flutamide,5-hydroxytryptamine receptor 6,gpcr,,Drug: flutamide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
5542,flutamide,androgen receptor,nuclear hormone receptor,ANTAGONIST,Drug: flutamide | Target: androgen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
5543,flutamide,cytochrome p450 1a2,enzyme,,Drug: flutamide | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
5544,flutamide,androgen receptor,transcription factor,,Drug: flutamide | Target: androgen receptor | Type: transcription factor | Action: nan
5545,flutamide,bile salt export pump,transporter,,Drug: flutamide | Target: bile salt export pump | Type: transporter | Action: nan
5546,fluticasone propionate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fluticasone propionate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5547,fluticasone propionate,mineralocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fluticasone propionate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5548,fluticasone propionate,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: fluticasone propionate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
5549,fluticasone propionate,cytosolic phospholipase a2,enzyme,,Drug: fluticasone propionate | Target: cytosolic phospholipase a2 | Type: enzyme | Action: nan
5550,fluticasone propionate,glucocorticoid receptor,transcription factor,,Drug: fluticasone propionate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
5551,flutrimazole,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: flutrimazole | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
5552,flutrimazole,bile acid receptor,nuclear hormone receptor,,Drug: flutrimazole | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
5553,fluvastatin,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: fluvastatin | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
5554,fluvastatin,cytochrome p450 2c9,enzyme,,Drug: fluvastatin | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
5555,fluvastatin,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: fluvastatin | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
5556,fluvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: fluvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
5557,fluvastatin,sodium/bile acid cotransporter,transporter,,Drug: fluvastatin | Target: sodium/bile acid cotransporter | Type: transporter | Action: nan
5559,fluvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: fluvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
5560,fluvoxamine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: fluvoxamine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5561,fluvoxamine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: fluvoxamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
5562,fluvoxamine,sodium-dependent noradrenaline transporter,transporter,,Drug: fluvoxamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
5563,fluvoxamine,sodium-dependent dopamine transporter,transporter,,Drug: fluvoxamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
5564,fluvoxamine,cytochrome p450 1a2,enzyme,,Drug: fluvoxamine | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
5565,fluvoxamine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: fluvoxamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
5566,fluvoxamine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: fluvoxamine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5567,folic acid,thymidylate synthase,enzyme,,Drug: folic acid | Target: thymidylate synthase | Type: enzyme | Action: nan
5568,folic acid,dihydrofolate reductase,enzyme,,Drug: folic acid | Target: dihydrofolate reductase | Type: enzyme | Action: nan
5569,leucovorin,thymidylate synthase,enzyme,,Drug: leucovorin | Target: thymidylate synthase | Type: enzyme | Action: nan
5570,leucovorin,dihydrofolate reductase,enzyme,,Drug: leucovorin | Target: dihydrofolate reductase | Type: enzyme | Action: nan
5571,fomepizole,alcohol dehydrogenase,enzyme,INHIBITOR,Drug: fomepizole | Target: alcohol dehydrogenase | Type: enzyme | Action: INHIBITOR
5572,fomepizole,alcohol dehydrogenase,enzyme,,Drug: fomepizole | Target: alcohol dehydrogenase | Type: enzyme | Action: nan
5573,fondaparinux,antithrombin-iii,secreted,ACTIVATOR,Drug: fondaparinux | Target: antithrombin-iii | Type: secreted | Action: ACTIVATOR
5574,formestane,aromatase,enzyme,,Drug: formestane | Target: aromatase | Type: enzyme | Action: nan
5575,formoterol,beta-1 adrenergic receptor,gpcr,,Drug: formoterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
5576,formoterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: formoterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
5577,formoterol,d(2) dopamine receptor,gpcr,,Drug: formoterol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5578,formoterol,d(3) dopamine receptor,gpcr,,Drug: formoterol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5579,formoterol,beta-3 adrenergic receptor,gpcr,,Drug: formoterol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
5580,formoterol,beta-2 adrenergic receptor,gpcr,,Drug: formoterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
5581,formoterol,heat shock protein hsp 90-alpha,cytosolic other,,Drug: formoterol | Target: heat shock protein hsp 90-alpha | Type: cytosolic other | Action: nan
5582,fosamprenavir,gag-pol polyprotein,polyprotein,,Drug: fosamprenavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
5583,fosamprenavir,pol polyprotein,enzyme,INHIBITOR,Drug: fosamprenavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
5584,foscarnet,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: foscarnet | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
5585,foscarnet,dna polymerase catalytic subunit,enzyme,,Drug: foscarnet | Target: dna polymerase catalytic subunit | Type: enzyme | Action: nan
5586,foscarnet,reverse transcriptase/rnaseh,enzyme,,Drug: foscarnet | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: nan
5587,foscarnet,reverse transcriptase,enzyme,,Drug: foscarnet | Target: reverse transcriptase | Type: enzyme | Action: nan
5588,fosfluconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: fosfluconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
5589,fosfomycin,udp-n-acetylglucosamine 1-carboxyvinyltransferase 1,enzyme,,Drug: fosfomycin | Target: udp-n-acetylglucosamine 1-carboxyvinyltransferase 1 | Type: enzyme | Action: nan
5590,fosfomycin,udp-n-acetylglucosamine 1-carboxyvinyltransferase 2,enzyme,,Drug: fosfomycin | Target: udp-n-acetylglucosamine 1-carboxyvinyltransferase 2 | Type: enzyme | Action: nan
5591,fosfomycin,udp-n-acetylglucosamine 1-carboxyvinyltransferase,enzyme,INHIBITOR,Drug: fosfomycin | Target: udp-n-acetylglucosamine 1-carboxyvinyltransferase | Type: enzyme | Action: INHIBITOR
5592,fosfomycin,udp-n-acetylglucosamine 1-carboxyvinyltransferase,enzyme,,Drug: fosfomycin | Target: udp-n-acetylglucosamine 1-carboxyvinyltransferase | Type: enzyme | Action: nan
5593,fosinopril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: fosinopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
5594,fosinopril,angiotensin-converting enzyme,enzyme,,Drug: fosinopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
5595,fosphenytoin,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: fosphenytoin | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
5596,frovatriptan,5-hydroxytryptamine receptor 1a,gpcr,,Drug: frovatriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5597,frovatriptan,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: frovatriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
5598,frovatriptan,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: frovatriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
5599,fructose,glycine receptor subunit alpha-1,ion channel,,Drug: fructose | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
5600,ftivazide,myeloperoxidase,enzyme,,Drug: ftivazide | Target: myeloperoxidase | Type: enzyme | Action: nan
5601,fulvestrant,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: fulvestrant | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
5602,fulvestrant,beta-lactamase tem,enzyme,,Drug: fulvestrant | Target: beta-lactamase tem | Type: enzyme | Action: nan
5603,fulvestrant,estrogen receptor,nuclear hormone receptor,ANTAGONIST,Drug: fulvestrant | Target: estrogen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
5604,fulvestrant,progesterone receptor,nuclear hormone receptor,,Drug: fulvestrant | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
5605,fulvestrant,estrogen receptor beta,nuclear hormone receptor,ANTAGONIST,Drug: fulvestrant | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: ANTAGONIST
5606,fulvestrant,g-protein coupled estrogen receptor 1,gpcr,,Drug: fulvestrant | Target: g-protein coupled estrogen receptor 1 | Type: gpcr | Action: nan
5607,fulvestrant,bile acid receptor,nuclear hormone receptor,,Drug: fulvestrant | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
5608,fulvestrant,steroid hormone receptor err1,nuclear hormone receptor,,Drug: fulvestrant | Target: steroid hormone receptor err1 | Type: nuclear hormone receptor | Action: nan
5609,fulvestrant,bifunctional epoxide hydrolase 2,enzyme,,Drug: fulvestrant | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
5610,fulvestrant,estrogen receptor,transcription factor,,Drug: fulvestrant | Target: estrogen receptor | Type: transcription factor | Action: nan
5612,furaltadone,mitogen-activated protein kinase 9,kinase,,Drug: furaltadone | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
5613,furosemide,solute carrier family 12 member 1,transporter,INHIBITOR,Drug: furosemide | Target: solute carrier family 12 member 1 | Type: transporter | Action: INHIBITOR
5614,furosemide,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: furosemide | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
5615,furosemide,carbonic anhydrase 2,enzyme,,Drug: furosemide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
5616,furosemide,carbonic anhydrase 1,enzyme,,Drug: furosemide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
5617,furosemide,carbonic anhydrase 4,enzyme,,Drug: furosemide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
5618,furosemide,carbonic anhydrase 9,enzyme,,Drug: furosemide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
5619,furosemide,carbonic anhydrase 12,enzyme,,Drug: furosemide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
5620,furosemide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: furosemide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
5621,furosemide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: furosemide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
5622,furosemide,carbonic anhydrase 7,enzyme,,Drug: furosemide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
5623,furosemide,carbonic anhydrase 6,enzyme,,Drug: furosemide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
5624,furosemide,carbonic anhydrase 14,enzyme,,Drug: furosemide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
5625,furosemide,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: furosemide | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
5626,furosemide,solute carrier family 12 member 2,transporter,INHIBITOR,Drug: furosemide | Target: solute carrier family 12 member 2 | Type: transporter | Action: INHIBITOR
5627,furosemide,carbonic anhydrase 13,enzyme,,Drug: furosemide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
5628,furosemide,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: furosemide | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
5629,furosemide,g-protein coupled receptor 35,gpcr,,Drug: furosemide | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
5630,furosemide,holo-[acyl-carrieir-protein] synthase,enzyme,,Drug: furosemide | Target: holo-[acyl-carrieir-protein] synthase | Type: enzyme | Action: nan
5631,furosemide,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: furosemide | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
5632,fusidic acid,bile salt export pump,transporter,,Drug: fusidic acid | Target: bile salt export pump | Type: transporter | Action: nan
5633,fusidic acid,bile salt export pump,transporter,,Drug: fusidic acid | Target: bile salt export pump | Type: transporter | Action: nan
5634,aminobutyric acid,sodium- and chloride-dependent gaba transporter 1,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: nan
5635,aminobutyric acid,sodium- and chloride-dependent gaba transporter 1,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: nan
5636,aminobutyric acid,sodium- and chloride-dependent gaba transporter 1,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: nan
5637,aminobutyric acid,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,,Drug: aminobutyric acid | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: nan
5638,aminobutyric acid,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,,Drug: aminobutyric acid | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: nan
5639,aminobutyric acid,gamma-aminobutyric acid receptor subunit rho-1,ion channel,,Drug: aminobutyric acid | Target: gamma-aminobutyric acid receptor subunit rho-1 | Type: ion channel | Action: nan
5640,aminobutyric acid,sodium- and chloride-dependent gaba transporter 3,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent gaba transporter 3 | Type: transporter | Action: nan
5641,aminobutyric acid,sodium- and chloride-dependent betaine transporter,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent betaine transporter | Type: transporter | Action: nan
5642,aminobutyric acid,sodium- and chloride-dependent gaba transporter 3,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent gaba transporter 3 | Type: transporter | Action: nan
5643,aminobutyric acid,sodium- and chloride-dependent gaba transporter 2,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent gaba transporter 2 | Type: transporter | Action: nan
5644,aminobutyric acid,sodium- and chloride-dependent gaba transporter 2,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent gaba transporter 2 | Type: transporter | Action: nan
5645,aminobutyric acid,gamma-aminobutyric acid receptor subunit gamma-1,ion channel,,Drug: aminobutyric acid | Target: gamma-aminobutyric acid receptor subunit gamma-1 | Type: ion channel | Action: nan
5646,aminobutyric acid,gamma-aminobutyric acid type b receptor subunit 1,gpcr,AGONIST,Drug: aminobutyric acid | Target: gamma-aminobutyric acid type b receptor subunit 1 | Type: gpcr | Action: AGONIST
5647,aminobutyric acid,sodium- and chloride-dependent gaba transporter 2,transporter,,Drug: aminobutyric acid | Target: sodium- and chloride-dependent gaba transporter 2 | Type: transporter | Action: nan
5648,gabapentin,sodium channel protein type 5 subunit alpha,ion channel,,Drug: gabapentin | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
5649,gabapentin,alpha-2a adrenergic receptor,gpcr,,Drug: gabapentin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5650,gabapentin,adenosine receptor a1,gpcr,,Drug: gabapentin | Target: adenosine receptor a1 | Type: gpcr | Action: nan
5651,gabapentin,gamma-aminobutyric acid type b receptor subunit 2,gpcr,,Drug: gabapentin | Target: gamma-aminobutyric acid type b receptor subunit 2 | Type: gpcr | Action: nan
5652,gabapentin,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: gabapentin | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
5653,gabapentin,large neutral amino acids transporter small subunit 1,transporter,,Drug: gabapentin | Target: large neutral amino acids transporter small subunit 1 | Type: transporter | Action: nan
5654,gabapentin,voltage-dependent calcium channel subunit alpha-2/delta-1,ion channel,MODULATOR,Drug: gabapentin | Target: voltage-dependent calcium channel subunit alpha-2/delta-1 | Type: ion channel | Action: MODULATOR
5655,gabapentin,potassium voltage-gated channel subfamily kqt member 3,ion channel,ACTIVATOR,Drug: gabapentin | Target: potassium voltage-gated channel subfamily kqt member 3 | Type: ion channel | Action: ACTIVATOR
5656,gabapentin,potassium voltage-gated channel subfamily kqt member 5,ion channel,ACTIVATOR,Drug: gabapentin | Target: potassium voltage-gated channel subfamily kqt member 5 | Type: ion channel | Action: ACTIVATOR
5657,gabapentin,voltage-dependent calcium channel subunit alpha-2/delta-1,ion channel,,Drug: gabapentin | Target: voltage-dependent calcium channel subunit alpha-2/delta-1 | Type: ion channel | Action: nan
5658,gabapentin,uncharacterized protein; voltage-dependent calcium channel alpha-2 delta subunit,ion channel,,Drug: gabapentin | Target: uncharacterized protein; voltage-dependent calcium channel alpha-2 delta subunit | Type: ion channel | Action: nan
5659,gabapentin,voltage-dependent calcium channel subunit alpha-2/delta-2,ion channel,MODULATOR,Drug: gabapentin | Target: voltage-dependent calcium channel subunit alpha-2/delta-2 | Type: ion channel | Action: MODULATOR
5660,galantamine,acetylcholinesterase,enzyme,INHIBITOR,Drug: galantamine | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
5661,galantamine,cholinesterase,enzyme,,Drug: galantamine | Target: cholinesterase | Type: enzyme | Action: nan
5662,galantamine,acetylcholinesterase,enzyme,,Drug: galantamine | Target: acetylcholinesterase | Type: enzyme | Action: nan
5663,galantamine,acetylcholinesterase,enzyme,,Drug: galantamine | Target: acetylcholinesterase | Type: enzyme | Action: nan
5664,galantamine,butyrylcholinesterase; protein bche,enzyme,,Drug: galantamine | Target: butyrylcholinesterase; protein bche | Type: enzyme | Action: nan
5665,galantamine,acetylcholinesterase,enzyme,,Drug: galantamine | Target: acetylcholinesterase | Type: enzyme | Action: nan
5666,galantamine,acetylcholinesterase,enzyme,,Drug: galantamine | Target: acetylcholinesterase | Type: enzyme | Action: nan
5667,galantamine,acetylcholinesterase,enzyme,,Drug: galantamine | Target: acetylcholinesterase | Type: enzyme | Action: nan
5668,galantamine,butyrylcholinesterase,enzyme,,Drug: galantamine | Target: butyrylcholinesterase | Type: enzyme | Action: nan
5669,galantamine,cholinesterase,enzyme,,Drug: galantamine | Target: cholinesterase | Type: enzyme | Action: nan
5670,gallamine,muscarinic acetylcholine receptor m1,gpcr,,Drug: gallamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
5671,gallamine,acetylcholinesterase,enzyme,,Drug: gallamine | Target: acetylcholinesterase | Type: enzyme | Action: nan
5672,gallamine,acetylcholinesterase,enzyme,,Drug: gallamine | Target: acetylcholinesterase | Type: enzyme | Action: nan
5673,gallamine,muscarinic acetylcholine receptor m2,gpcr,ALLOSTERIC MODULATOR,Drug: gallamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ALLOSTERIC MODULATOR
5674,gallamine,muscarinic acetylcholine receptor m2,gpcr,,Drug: gallamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
5675,gallamine,acetylcholine receptor subunit alpha,ion channel,BLOCKER,Drug: gallamine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: BLOCKER
5676,gallamine,muscarinic acetylcholine receptor m2,gpcr,NEGATIVE ALLOSTERIC MODULATOR,Drug: gallamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: NEGATIVE ALLOSTERIC MODULATOR
5677,gallopamil,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: gallopamil | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
5678,gamolenic acid,3-oxo-5-alpha-steroid 4-dehydrogenase 2,enzyme,,Drug: gamolenic acid | Target: 3-oxo-5-alpha-steroid 4-dehydrogenase 2 | Type: enzyme | Action: nan
5679,gamolenic acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: gamolenic acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
5680,gamolenic acid,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: gamolenic acid | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
5681,gamolenic acid,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: gamolenic acid | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
5682,gamolenic acid,free fatty acid receptor 1,gpcr,,Drug: gamolenic acid | Target: free fatty acid receptor 1 | Type: gpcr | Action: nan
5683,gamolenic acid,tissue factor,membrane receptor,,Drug: gamolenic acid | Target: tissue factor | Type: membrane receptor | Action: nan
5684,ganciclovir,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: ganciclovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
5685,ganciclovir,thymidine kinase,kinase,,Drug: ganciclovir | Target: thymidine kinase | Type: kinase | Action: nan
5686,ganciclovir,metabotropic glutamate receptor 1,gpcr,,Drug: ganciclovir | Target: metabotropic glutamate receptor 1 | Type: gpcr | Action: nan
5687,ganciclovir,metabotropic glutamate receptor 5,gpcr,,Drug: ganciclovir | Target: metabotropic glutamate receptor 5 | Type: gpcr | Action: nan
5688,ganciclovir,capsid scaffolding protein,enzyme,,Drug: ganciclovir | Target: capsid scaffolding protein | Type: enzyme | Action: nan
5689,ganciclovir,purine nucleoside phosphorylase,enzyme,,Drug: ganciclovir | Target: purine nucleoside phosphorylase | Type: enzyme | Action: nan
5690,ganirelix,gonadotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: ganirelix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
5691,gatifloxacin,dna topoisomerase 4 subunit a,enzyme,,Drug: gatifloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: nan
5692,gatifloxacin,dna gyrase subunit a,enzyme,,Drug: gatifloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
5693,gatifloxacin,dna topoisomerase 4,enzyme,INHIBITOR,Drug: gatifloxacin | Target: dna topoisomerase 4 | Type: enzyme | Action: INHIBITOR
5694,gatifloxacin,dna gyrase,enzyme,INHIBITOR,Drug: gatifloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
5695,gatifloxacin,dna gyrase,enzyme,,Drug: gatifloxacin | Target: dna gyrase | Type: enzyme | Action: nan
5696,gefitinib,atp-binding cassette sub-family g member 2,transporter,,Drug: gefitinib | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
5697,gefitinib,tyrosine-protein kinase abl1,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
5698,gefitinib,mast/stem cell growth factor receptor kit,kinase,,Drug: gefitinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
5699,gefitinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: gefitinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
5700,gefitinib,tyrosine-protein kinase lck,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
5701,gefitinib,serine/threonine-protein kinase b-raf,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
5702,gefitinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: gefitinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
5703,gefitinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: gefitinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
5704,gefitinib,vascular endothelial growth factor receptor 2,kinase,,Drug: gefitinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
5705,gefitinib,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: gefitinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
5706,gefitinib,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: gefitinib | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
5707,gefitinib,death-associated protein kinase 3,kinase,,Drug: gefitinib | Target: death-associated protein kinase 3 | Type: kinase | Action: nan
5708,gefitinib,tyrosine-protein kinase hck,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
5709,gefitinib,receptor tyrosine-protein kinase erbb-4,kinase,,Drug: gefitinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: nan
5710,gefitinib,mitogen-activated protein kinase 10,kinase,,Drug: gefitinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
5711,gefitinib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: gefitinib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
5712,gefitinib,ephrin type-a receptor 8,kinase,,Drug: gefitinib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
5713,gefitinib,hepatocyte growth factor receptor,kinase,,Drug: gefitinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
5714,gefitinib,tyrosine-protein kinase lyn,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
5715,gefitinib,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: gefitinib | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
5716,gefitinib,serine/threonine-protein kinase 17b,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase 17b | Type: kinase | Action: nan
5717,gefitinib,serine/threonine-protein kinase 10,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
5718,gefitinib,abelson tyrosine-protein kinase 2,kinase,,Drug: gefitinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
5719,gefitinib,ephrin type-a receptor 5,kinase,,Drug: gefitinib | Target: ephrin type-a receptor 5 | Type: kinase | Action: nan
5720,gefitinib,serine/threonine-protein kinase 17a,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
5721,gefitinib,ephrin type-a receptor 6,kinase,,Drug: gefitinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
5722,gefitinib,traf2 and nck-interacting protein kinase,kinase,,Drug: gefitinib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
5723,gefitinib,casein kinase i isoform epsilon,kinase,,Drug: gefitinib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
5724,gefitinib,tyrosine-protein kinase fgr,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
5725,gefitinib,serine/threonine-protein kinase 36,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase 36 | Type: kinase | Action: nan
5726,gefitinib,ephrin type-a receptor 3,kinase,,Drug: gefitinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
5727,gefitinib,tyrosine-protein kinase frk,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
5728,gefitinib,beta-secretase 1,enzyme,,Drug: gefitinib | Target: beta-secretase 1 | Type: enzyme | Action: nan
5729,gefitinib,cyclin-g-associated kinase,kinase,,Drug: gefitinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
5730,gefitinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: gefitinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
5731,gefitinib,ephrin type-b receptor 1,kinase,,Drug: gefitinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
5732,gefitinib,activated cdc42 kinase 1,kinase,,Drug: gefitinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
5733,gefitinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: gefitinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
5734,gefitinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: gefitinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
5735,gefitinib,mitogen-activated protein kinase 9,kinase,,Drug: gefitinib | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
5736,gefitinib,ephrin type-b receptor 4,kinase,,Drug: gefitinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
5737,gefitinib,serine/threonine-protein kinase ulk3,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
5738,gefitinib,protein-tyrosine kinase 6,kinase,,Drug: gefitinib | Target: protein-tyrosine kinase 6 | Type: kinase | Action: nan
5739,gefitinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
5740,gefitinib,cyclin-dependent kinase 7,kinase,,Drug: gefitinib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
5741,gefitinib,serine/threonine-protein kinase d1,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase d1 | Type: kinase | Action: nan
5742,gefitinib,serine/threonine-protein kinase dclk3,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase dclk3 | Type: kinase | Action: nan
5743,gefitinib,nuak family snf1-like kinase 2,kinase,,Drug: gefitinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
5744,gefitinib,casein kinase i isoform delta,kinase,,Drug: gefitinib | Target: casein kinase i isoform delta | Type: kinase | Action: nan
5745,gefitinib,tyrosine-protein kinase txk,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
5746,gefitinib,map kinase-interacting serine/threonine-protein kinase 1,kinase,,Drug: gefitinib | Target: map kinase-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
5747,gefitinib,serine/threonine-protein kinase nlk,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase nlk | Type: kinase | Action: nan
5748,gefitinib,interleukin-1 receptor-associated kinase 3,kinase,,Drug: gefitinib | Target: interleukin-1 receptor-associated kinase 3 | Type: kinase | Action: nan
5749,gefitinib,serine/threonine-protein kinase sik2,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
5750,gefitinib,myotonin-protein kinase,kinase,,Drug: gefitinib | Target: myotonin-protein kinase | Type: kinase | Action: nan
5751,gefitinib,leukocyte tyrosine kinase receptor,kinase,,Drug: gefitinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
5752,gefitinib,serine/threonine-protein kinase pim-3,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase pim-3 | Type: kinase | Action: nan
5753,gefitinib,tyrosine-protein kinase blk,kinase,,Drug: gefitinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
5754,gefitinib,citron rho-interacting kinase,kinase,,Drug: gefitinib | Target: citron rho-interacting kinase | Type: kinase | Action: nan
5755,gefitinib,ephrin type-a receptor 1,kinase,,Drug: gefitinib | Target: ephrin type-a receptor 1 | Type: kinase | Action: nan
5756,gefitinib,tubulin alpha-1a chain,structural,,Drug: gefitinib | Target: tubulin alpha-1a chain | Type: structural | Action: nan
5757,gefitinib,mitogen-activated protein kinase 6,kinase,,Drug: gefitinib | Target: mitogen-activated protein kinase 6 | Type: kinase | Action: nan
5758,gefitinib,mitogen-activated protein kinase 4,kinase,,Drug: gefitinib | Target: mitogen-activated protein kinase 4 | Type: kinase | Action: nan
5759,gefitinib,ribosomal protein s6 kinase alpha-4,kinase,,Drug: gefitinib | Target: ribosomal protein s6 kinase alpha-4 | Type: kinase | Action: nan
5760,gefitinib,cruzipain,enzyme,,Drug: gefitinib | Target: cruzipain | Type: enzyme | Action: nan
5761,gefitinib,misshapen-like kinase 1,kinase,,Drug: gefitinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
5762,gefitinib,interleukin-1 receptor-associated kinase 4,kinase,,Drug: gefitinib | Target: interleukin-1 receptor-associated kinase 4 | Type: kinase | Action: nan
5763,gefitinib,serine/threonine-protein kinase chk2,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase chk2 | Type: kinase | Action: nan
5764,gefitinib,ephrin type-b receptor 6,kinase,,Drug: gefitinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
5765,gefitinib,homeodomain-interacting protein kinase 4,kinase,,Drug: gefitinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
5766,gefitinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: gefitinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
5767,gefitinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: gefitinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
5768,gefitinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: gefitinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
5769,gefitinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: gefitinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
5770,gefitinib,receptor tyrosine-protein kinase erbb-3,kinase,,Drug: gefitinib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: nan
5771,gefitinib,quinolone resistance protein nora,transporter,,Drug: gefitinib | Target: quinolone resistance protein nora | Type: transporter | Action: nan
5772,gefitinib,serine/threonine-protein kinase sbk1,kinase,,Drug: gefitinib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
5773,gefitinib,phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,kinase,,Drug: gefitinib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Type: kinase | Action: nan
5774,gefitinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: gefitinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
5775,gefitinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: gefitinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
5776,gemcitabine,thymidylate synthase,enzyme,,Drug: gemcitabine | Target: thymidylate synthase | Type: enzyme | Action: nan
5777,gemcitabine,deoxycytidine kinase,kinase,,Drug: gemcitabine | Target: deoxycytidine kinase | Type: kinase | Action: nan
5778,gemcitabine,ribonucleoside-diphosphate reductase large subunit,enzyme,INHIBITOR,Drug: gemcitabine | Target: ribonucleoside-diphosphate reductase large subunit | Type: enzyme | Action: INHIBITOR
5779,gemcitabine,ribonucleoside-diphosphate reductase subunit m2,enzyme,INHIBITOR,Drug: gemcitabine | Target: ribonucleoside-diphosphate reductase subunit m2 | Type: enzyme | Action: INHIBITOR
5780,gemcitabine,ump-cmp kinase,kinase,,Drug: gemcitabine | Target: ump-cmp kinase | Type: kinase | Action: nan
5781,gemcitabine,dna polymerase (alpha/delta/epsilon),enzyme,INHIBITOR,Drug: gemcitabine | Target: dna polymerase (alpha/delta/epsilon) | Type: enzyme | Action: INHIBITOR
5782,gemfibrozil,lipoprotein lipase,enzyme,,Drug: gemfibrozil | Target: lipoprotein lipase | Type: enzyme | Action: nan
5783,gemfibrozil,transthyretin,secreted,,Drug: gemfibrozil | Target: transthyretin | Type: secreted | Action: nan
5784,gemfibrozil,cytochrome p450 2c8,enzyme,,Drug: gemfibrozil | Target: cytochrome p450 2c8 | Type: enzyme | Action: nan
5785,gemfibrozil,cytochrome p450 2c9,enzyme,,Drug: gemfibrozil | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
5786,gemfibrozil,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: gemfibrozil | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
5787,gemfibrozil,"fatty acid-binding protein, liver",unclassified,,"Drug: gemfibrozil | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
5788,gemfibrozil,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: gemfibrozil | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
5789,gemifloxacin,dna topoisomerase 4 subunit a,enzyme,,Drug: gemifloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: nan
5790,gemifloxacin,dna gyrase subunit b,enzyme,,Drug: gemifloxacin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
5791,gemifloxacin,dna topoisomerase 4 subunit a,enzyme,INHIBITOR,Drug: gemifloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: INHIBITOR
5792,gestodene,progesterone receptor,nuclear hormone receptor,,Drug: gestodene | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
5793,gestodene,cytochrome p450 3a5,enzyme,,Drug: gestodene | Target: cytochrome p450 3a5 | Type: enzyme | Action: nan
5794,gestrinone,sex hormone-binding globulin,secreted,,Drug: gestrinone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
5795,gimeracil,dihydropyrimidine dehydrogenase [nadp(+)],enzyme,INHIBITOR,Drug: gimeracil | Target: dihydropyrimidine dehydrogenase [nadp(+)] | Type: enzyme | Action: INHIBITOR
5796,glafenine,bile salt export pump,transporter,,Drug: glafenine | Target: bile salt export pump | Type: transporter | Action: nan
5797,glafenine,bile salt export pump,transporter,,Drug: glafenine | Target: bile salt export pump | Type: transporter | Action: nan
5798,glibornuride,"sulfonylurea receptor 2, kir6.2",ion channel,BLOCKER,"Drug: glibornuride | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: BLOCKER"
5799,glibornuride,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: glibornuride | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
5800,gliclazide,"sulfonylurea receptor 2, kir6.2",ion channel,BLOCKER,"Drug: gliclazide | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: BLOCKER"
5801,gliclazide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: gliclazide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
5802,glimepiride,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: glimepiride | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
5803,glimepiride,"sulfonylurea receptor 2, kir6.2",ion channel,BLOCKER,"Drug: glimepiride | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: BLOCKER"
5804,glipizide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: glipizide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
5805,gliquidone,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: gliquidone | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
5806,glisoxepide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: glisoxepide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
5807,glutamic acid,adenosine receptor a3,gpcr,,Drug: glutamic acid | Target: adenosine receptor a3 | Type: gpcr | Action: nan
5808,glutamic acid,"glutathione reductase, mitochondrial",enzyme,,"Drug: glutamic acid | Target: glutathione reductase, mitochondrial | Type: enzyme | Action: nan"
5809,glutamic acid,glutamate receptor 1,ion channel,,Drug: glutamic acid | Target: glutamate receptor 1 | Type: ion channel | Action: nan
5810,glutamic acid,"glutamate receptor ionotropic, kainate 1",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, kainate 1 | Type: ion channel | Action: nan"
5811,glutamic acid,glutamate receptor 2,ion channel,,Drug: glutamic acid | Target: glutamate receptor 2 | Type: ion channel | Action: nan
5812,glutamic acid,metabotropic glutamate receptor 1,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 1 | Type: gpcr | Action: nan
5813,glutamic acid,"glutamate dehydrogenase 1, mitochondrial",enzyme,,"Drug: glutamic acid | Target: glutamate dehydrogenase 1, mitochondrial | Type: enzyme | Action: nan"
5814,glutamic acid,"glutamate dehydrogenase 2, mitochondrial",enzyme,,"Drug: glutamic acid | Target: glutamate dehydrogenase 2, mitochondrial | Type: enzyme | Action: nan"
5815,glutamic acid,"glutamate receptor ionotropic, kainate 5",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, kainate 5 | Type: ion channel | Action: nan"
5816,glutamic acid,metabotropic glutamate receptor 5,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 5 | Type: gpcr | Action: nan
5817,glutamic acid,metabotropic glutamate receptor 4,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 4 | Type: gpcr | Action: nan
5818,glutamic acid,glutamate receptor 4,ion channel,,Drug: glutamic acid | Target: glutamate receptor 4 | Type: ion channel | Action: nan
5819,glutamic acid,"glutamate receptor ionotropic, kainate 2",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, kainate 2 | Type: ion channel | Action: nan"
5820,glutamic acid,"glutamate receptor ionotropic, kainate 3",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, kainate 3 | Type: ion channel | Action: nan"
5821,glutamic acid,metabotropic glutamate receptor 7,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 7 | Type: gpcr | Action: nan
5822,glutamic acid,metabotropic glutamate receptor 6,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 6 | Type: gpcr | Action: nan
5823,glutamic acid,metabotropic glutamate receptor 2,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 2 | Type: gpcr | Action: nan
5824,glutamic acid,excitatory amino acid transporter 1,transporter,,Drug: glutamic acid | Target: excitatory amino acid transporter 1 | Type: transporter | Action: nan
5825,glutamic acid,excitatory amino acid transporter 2,transporter,,Drug: glutamic acid | Target: excitatory amino acid transporter 2 | Type: transporter | Action: nan
5826,glutamic acid,excitatory amino acid transporter 3,transporter,,Drug: glutamic acid | Target: excitatory amino acid transporter 3 | Type: transporter | Action: nan
5827,glutamic acid,glutamate receptor 2,ion channel,,Drug: glutamic acid | Target: glutamate receptor 2 | Type: ion channel | Action: nan
5828,glutamic acid,glutamate receptor 3,ion channel,,Drug: glutamic acid | Target: glutamate receptor 3 | Type: ion channel | Action: nan
5829,glutamic acid,"glutamate receptor ionotropic, kainate 4",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, kainate 4 | Type: ion channel | Action: nan"
5830,glutamic acid,metabotropic glutamate receptor 3,gpcr,AGONIST,Drug: glutamic acid | Target: metabotropic glutamate receptor 3 | Type: gpcr | Action: AGONIST
5831,glutamic acid,metabotropic glutamate receptor 8,gpcr,AGONIST,Drug: glutamic acid | Target: metabotropic glutamate receptor 8 | Type: gpcr | Action: AGONIST
5832,glutamic acid,"glutamate receptor ionotropic, nmda 1",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, nmda 1 | Type: ion channel | Action: nan"
5833,glutamic acid,"glutamate receptor ionotropic, kainate 2",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, kainate 2 | Type: ion channel | Action: nan"
5834,glutamic acid,"glutamate receptor ionotropic, kainate 1",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, kainate 1 | Type: ion channel | Action: nan"
5835,glutamic acid,metabotropic glutamate receptor 4,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 4 | Type: gpcr | Action: nan
5836,glutamic acid,metabotropic glutamate receptor 6,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 6 | Type: gpcr | Action: nan
5837,glutamic acid,glutamate receptor 1,ion channel,,Drug: glutamic acid | Target: glutamate receptor 1 | Type: ion channel | Action: nan
5838,glutamic acid,glutamate receptor 3,ion channel,,Drug: glutamic acid | Target: glutamate receptor 3 | Type: ion channel | Action: nan
5839,glutamic acid,glutamate receptor 4,ion channel,,Drug: glutamic acid | Target: glutamate receptor 4 | Type: ion channel | Action: nan
5840,glutamic acid,"glutamate receptor ionotropic, kainate 3",ion channel,,"Drug: glutamic acid | Target: glutamate receptor ionotropic, kainate 3 | Type: ion channel | Action: nan"
5841,glutamic acid,glutamate racemase,enzyme,,Drug: glutamic acid | Target: glutamate racemase | Type: enzyme | Action: nan
5842,glutamic acid,metabotropic glutamate receptor 8,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 8 | Type: gpcr | Action: nan
5843,glutamic acid,metabotropic glutamate receptor 8,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 8 | Type: gpcr | Action: nan
5844,glutamic acid,metabotropic glutamate receptor 5,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 5 | Type: gpcr | Action: nan
5845,glutamic acid,metabotropic glutamate receptor 1,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 1 | Type: gpcr | Action: nan
5846,glutamic acid,metabotropic glutamate receptor 2,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 2 | Type: gpcr | Action: nan
5847,glutamic acid,metabotropic glutamate receptor 3,gpcr,,Drug: glutamic acid | Target: metabotropic glutamate receptor 3 | Type: gpcr | Action: nan
5848,glutamic acid,glutamate racemase,enzyme,,Drug: glutamic acid | Target: glutamate racemase | Type: enzyme | Action: nan
5849,glutamic acid,excitatory amino acid transporter 4,transporter,,Drug: glutamic acid | Target: excitatory amino acid transporter 4 | Type: transporter | Action: nan
5850,glutamine,amino acid transporter,transporter,,Drug: glutamine | Target: amino acid transporter | Type: transporter | Action: nan
5851,glutathione,glutathione s-transferase kappa 1,enzyme,,Drug: glutathione | Target: glutathione s-transferase kappa 1 | Type: enzyme | Action: nan
5852,glutethimide,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE MODULATOR,Drug: glutethimide | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
5853,glibenclamide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: glibenclamide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5854,glibenclamide,bile salt export pump,transporter,,Drug: glibenclamide | Target: bile salt export pump | Type: transporter | Action: nan
5855,glibenclamide,cytochrome p450 2c9,enzyme,INHIBITOR,Drug: glibenclamide | Target: cytochrome p450 2c9 | Type: enzyme | Action: INHIBITOR
5856,glibenclamide,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: glibenclamide | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
5857,glibenclamide,cystic fibrosis transmembrane conductance regulator,ion channel,BLOCKER,Drug: glibenclamide | Target: cystic fibrosis transmembrane conductance regulator | Type: ion channel | Action: BLOCKER
5858,glibenclamide,"sulfonylurea receptor 2, kir6.2",ion channel,BLOCKER,"Drug: glibenclamide | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: BLOCKER"
5859,glibenclamide,bile salt export pump,transporter,,Drug: glibenclamide | Target: bile salt export pump | Type: transporter | Action: nan
5860,glibenclamide,atp-sensitive inward rectifier potassium channel 11,ion channel,BLOCKER,Drug: glibenclamide | Target: atp-sensitive inward rectifier potassium channel 11 | Type: ion channel | Action: BLOCKER
5861,glibenclamide,"nacht, lrr and pyd domains-containing protein 3",unclassified,,"Drug: glibenclamide | Target: nacht, lrr and pyd domains-containing protein 3 | Type: unclassified | Action: nan"
5862,glibenclamide,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: glibenclamide | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
5863,glibenclamide,peroxisome proliferator-activated receptor gamma,nuclear other,,Drug: glibenclamide | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear other | Action: nan
5864,glibenclamide,sur1-trpm4; sulfonylurea receptor 1 - transient receptor potential melastatin 4,ion channel,INHIBITOR,Drug: glibenclamide | Target: sur1-trpm4; sulfonylurea receptor 1 - transient receptor potential melastatin 4 | Type: ion channel | Action: INHIBITOR
5865,glibenclamide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: glibenclamide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
5866,glycine,"glutamate receptor ionotropic, nmda 1",ion channel,,"Drug: glycine | Target: glutamate receptor ionotropic, nmda 1 | Type: ion channel | Action: nan"
5867,glycine,sodium- and chloride-dependent glycine transporter 1,transporter,,Drug: glycine | Target: sodium- and chloride-dependent glycine transporter 1 | Type: transporter | Action: nan
5868,glycine,glutamate nmda receptor,ion channel,,Drug: glycine | Target: glutamate nmda receptor | Type: ion channel | Action: nan
5869,glycine,olfactory receptor 51e2,gpcr,,Drug: glycine | Target: olfactory receptor 51e2 | Type: gpcr | Action: nan
5870,glycyrrhizic acid,corticosteroid 11-beta-dehydrogenase isozyme 2,enzyme,,Drug: glycyrrhizic acid | Target: corticosteroid 11-beta-dehydrogenase isozyme 2 | Type: enzyme | Action: nan
5871,glycyrrhizic acid,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: glycyrrhizic acid | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
5872,glycyrrhizic acid,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: glycyrrhizic acid | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
5873,glycyrrhizic acid,high mobility group protein b1,nuclear other,,Drug: glycyrrhizic acid | Target: high mobility group protein b1 | Type: nuclear other | Action: nan
5874,goserelin,lutropin-choriogonadotropic hormone receptor,gpcr,,Drug: goserelin | Target: lutropin-choriogonadotropic hormone receptor | Type: gpcr | Action: nan
5875,goserelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: goserelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
5876,gossypol,estrogen receptor,nuclear hormone receptor,,Drug: gossypol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
5877,gossypol,beta-lactamase,enzyme,,Drug: gossypol | Target: beta-lactamase | Type: enzyme | Action: nan
5878,gossypol,aldose reductase,enzyme,,Drug: gossypol | Target: aldose reductase | Type: enzyme | Action: nan
5879,gossypol,apoptosis regulator bcl-2,cytosolic other,,Drug: gossypol | Target: apoptosis regulator bcl-2 | Type: cytosolic other | Action: nan
5880,gossypol,induced myeloid leukemia cell differentiation protein mcl-1,cytosolic other,,Drug: gossypol | Target: induced myeloid leukemia cell differentiation protein mcl-1 | Type: cytosolic other | Action: nan
5881,gossypol,bcl-2-like protein 1,cytosolic other,,Drug: gossypol | Target: bcl-2-like protein 1 | Type: cytosolic other | Action: nan
5882,gossypol,"malate dehydrogenase, mitochondrial",enzyme,,"Drug: gossypol | Target: malate dehydrogenase, mitochondrial | Type: enzyme | Action: nan"
5883,gossypol,lactate dehydrogenase,enzyme,,Drug: gossypol | Target: lactate dehydrogenase | Type: enzyme | Action: nan
5884,gossypol,malate dehydrogenase,enzyme,,Drug: gossypol | Target: malate dehydrogenase | Type: enzyme | Action: nan
5885,gossypol,"malate dehydrogenase, cytoplasmic",enzyme,,"Drug: gossypol | Target: malate dehydrogenase, cytoplasmic | Type: enzyme | Action: nan"
5886,gossypol,l-lactate dehydrogenase a chain,enzyme,,Drug: gossypol | Target: l-lactate dehydrogenase a chain | Type: enzyme | Action: nan
5887,gossypol,apoptosis regulator bcl-w,cytosolic other,,Drug: gossypol | Target: apoptosis regulator bcl-w | Type: cytosolic other | Action: nan
5888,gossypol,kinesin-like protein 1,enzyme,,Drug: gossypol | Target: kinesin-like protein 1 | Type: enzyme | Action: nan
5889,gossypol,"solute carrier family 2, facilitated glucose transporter member 1",transporter,,"Drug: gossypol | Target: solute carrier family 2, facilitated glucose transporter member 1 | Type: transporter | Action: nan"
5890,gossypol,dna-3-methyladenine glycosylase,enzyme,,Drug: gossypol | Target: dna-3-methyladenine glycosylase | Type: enzyme | Action: nan
5891,gossypol,l-lactate dehydrogenase b chain,enzyme,,Drug: gossypol | Target: l-lactate dehydrogenase b chain | Type: enzyme | Action: nan
5892,granisetron,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: granisetron | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5893,granisetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: granisetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
5894,granisetron,solute carrier family 22 member 2,transporter,,Drug: granisetron | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
5895,granisetron,multidrug and toxin extrusion protein 1,transporter,,Drug: granisetron | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
5896,granisetron,serotonin 3 (5-ht3) receptor,ion channel,,Drug: granisetron | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
5897,granisetron,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: granisetron | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
5898,granisetron,5-hydroxytryptamine receptor 3b,ion channel,,Drug: granisetron | Target: 5-hydroxytryptamine receptor 3b | Type: ion channel | Action: nan
5899,granisetron,neuronal acetylcholine receptor subunit alpha-3,ion channel,,Drug: granisetron | Target: neuronal acetylcholine receptor subunit alpha-3 | Type: ion channel | Action: nan
5900,grepafloxacin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: grepafloxacin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5901,grepafloxacin,dna topoisomerase 4,enzyme,INHIBITOR,Drug: grepafloxacin | Target: dna topoisomerase 4 | Type: enzyme | Action: INHIBITOR
5902,grepafloxacin,dna gyrase,enzyme,INHIBITOR,Drug: grepafloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
5903,griseofulvin,tubulin beta chain,structural,,Drug: griseofulvin | Target: tubulin beta chain | Type: structural | Action: nan
5904,griseofulvin,lanosterol 14-alpha demethylase,enzyme,,Drug: griseofulvin | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
5905,griseofulvin,solute carrier family 22 member 1,transporter,,Drug: griseofulvin | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
5906,griseofulvin,tubulin,structural,INHIBITOR,Drug: griseofulvin | Target: tubulin | Type: structural | Action: INHIBITOR
5907,guaiacol,carbonic anhydrase 2,enzyme,,Drug: guaiacol | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
5908,guaiacol,carbonic anhydrase 1,enzyme,,Drug: guaiacol | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
5909,guanadrel,sodium-dependent noradrenaline transporter,transporter,SUBSTRATE,Drug: guanadrel | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: SUBSTRATE
5910,guanadrel,alpha-1a adrenergic receptor,gpcr,,Drug: guanadrel | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5911,guanethidine,alpha-2a adrenergic receptor,gpcr,,Drug: guanethidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5912,guanethidine,sodium-dependent noradrenaline transporter,transporter,SUBSTRATE,Drug: guanethidine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: SUBSTRATE
5913,guanethidine,alpha-1a adrenergic receptor,gpcr,,Drug: guanethidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5914,guanethidine,alpha-2b adrenergic receptor,gpcr,,Drug: guanethidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
5915,guanethidine,alpha-2c adrenergic receptor,gpcr,,Drug: guanethidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
5916,guanethidine,alpha-1d adrenergic receptor,gpcr,,Drug: guanethidine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
5917,guanethidine,alpha-1b adrenergic receptor,gpcr,,Drug: guanethidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
5918,guanfacine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: guanfacine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5919,guanfacine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: guanfacine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
5920,guanfacine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: guanfacine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5921,guanfacine,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: guanfacine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
5922,guanfacine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: guanfacine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
5923,guanfacine,alpha-1d adrenergic receptor,gpcr,,Drug: guanfacine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
5924,guanfacine,nischarin,membrane receptor,,Drug: guanfacine | Target: nischarin | Type: membrane receptor | Action: nan
5925,guanfacine,alpha-1a adrenergic receptor,gpcr,,Drug: guanfacine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5926,guanfacine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: guanfacine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
5927,guanidine,voltage-gated potassium channel,ion channel,BLOCKER,Drug: guanidine | Target: voltage-gated potassium channel | Type: ion channel | Action: BLOCKER
5928,halazepam,gaba-a receptor; anion channel,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: halazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
5929,ulobetasol propionate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: ulobetasol propionate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
5930,halofantrine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: halofantrine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5931,haloperidol,beta-2 adrenergic receptor,gpcr,,Drug: haloperidol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
5932,haloperidol,mu-type opioid receptor,gpcr,,Drug: haloperidol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
5933,haloperidol,d(1a) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5934,haloperidol,d(2) dopamine receptor,gpcr,INVERSE AGONIST,Drug: haloperidol | Target: d(2) dopamine receptor | Type: gpcr | Action: INVERSE AGONIST
5935,haloperidol,alpha-2a adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
5936,haloperidol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: haloperidol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5937,haloperidol,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: haloperidol | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
5938,haloperidol,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: haloperidol | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
5939,haloperidol,multidrug resistance protein 1,transporter,,Drug: haloperidol | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
5940,haloperidol,sodium-dependent serotonin transporter,transporter,,Drug: haloperidol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
5941,haloperidol,sodium-dependent noradrenaline transporter,transporter,,Drug: haloperidol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
5942,haloperidol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5943,haloperidol,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
5944,haloperidol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
5945,haloperidol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
5946,haloperidol,5-hydroxytryptamine receptor 6,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
5947,haloperidol,5-hydroxytryptamine receptor 7,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
5948,haloperidol,alpha-1a adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5949,haloperidol,alpha-2b adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
5950,haloperidol,d(3) dopamine receptor,gpcr,INVERSE AGONIST,Drug: haloperidol | Target: d(3) dopamine receptor | Type: gpcr | Action: INVERSE AGONIST
5951,haloperidol,d(1b) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
5952,haloperidol,histamine h1 receptor,gpcr,,Drug: haloperidol | Target: histamine h1 receptor | Type: gpcr | Action: nan
5953,haloperidol,histamine h2 receptor,gpcr,,Drug: haloperidol | Target: histamine h2 receptor | Type: gpcr | Action: nan
5954,haloperidol,muscarinic acetylcholine receptor m1,gpcr,,Drug: haloperidol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
5955,haloperidol,muscarinic acetylcholine receptor m3,gpcr,,Drug: haloperidol | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
5956,haloperidol,muscarinic acetylcholine receptor m5,gpcr,,Drug: haloperidol | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
5957,haloperidol,5-hydroxytryptamine receptor 1b,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
5958,haloperidol,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
5959,haloperidol,alpha-2c adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
5960,haloperidol,alpha-1d adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
5961,haloperidol,alpha-1b adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
5962,haloperidol,calmodulin,cytosolic other,,Drug: haloperidol | Target: calmodulin | Type: cytosolic other | Action: nan
5963,haloperidol,5-hydroxytryptamine receptor 5a,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
5964,haloperidol,5-hydroxytryptamine receptor 1f,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
5965,haloperidol,5-hydroxytryptamine receptor 1e,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
5966,haloperidol,potassium channel subfamily k member 2,ion channel,,Drug: haloperidol | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
5967,haloperidol,potassium voltage-gated channel subfamily h member 1,ion channel,BLOCKER,Drug: haloperidol | Target: potassium voltage-gated channel subfamily h member 1 | Type: ion channel | Action: BLOCKER
5968,haloperidol,alpha-1b adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
5969,haloperidol,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: haloperidol | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
5970,haloperidol,pol polyprotein,enzyme,,Drug: haloperidol | Target: pol polyprotein | Type: enzyme | Action: nan
5971,haloperidol,alpha-1a adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5972,haloperidol,histamine h1 receptor,gpcr,,Drug: haloperidol | Target: histamine h1 receptor | Type: gpcr | Action: nan
5973,haloperidol,muscarinic acetylcholine receptor m2,gpcr,,Drug: haloperidol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
5974,haloperidol,muscarinic acetylcholine receptor m1,gpcr,,Drug: haloperidol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
5975,haloperidol,d(2) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5976,haloperidol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
5977,haloperidol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5978,haloperidol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: haloperidol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
5979,haloperidol,5-hydroxytryptamine receptor 7,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
5980,haloperidol,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
5981,haloperidol,d(1a) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5982,haloperidol,d(2) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5983,haloperidol,alpha-1a adrenergic receptor,gpcr,,Drug: haloperidol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
5984,haloperidol,histamine h1 receptor,gpcr,,Drug: haloperidol | Target: histamine h1 receptor | Type: gpcr | Action: nan
5985,haloperidol,d(3) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5986,haloperidol,protease,enzyme,,Drug: haloperidol | Target: protease | Type: enzyme | Action: nan
5987,haloperidol,d(2) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
5988,haloperidol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5989,haloperidol,c-8 sterol isomerase,enzyme,,Drug: haloperidol | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
5990,haloperidol,d(1a) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
5991,haloperidol,sigma non-opioid intracellular receptor 1,membrane other,,Drug: haloperidol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
5992,haloperidol,transporter,transporter,,Drug: haloperidol | Target: transporter | Type: transporter | Action: nan
5993,haloperidol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: haloperidol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
5994,haloperidol,d(3) dopamine receptor,gpcr,,Drug: haloperidol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
5995,haloperidol,vesicular acetylcholine transporter,transporter,,Drug: haloperidol | Target: vesicular acetylcholine transporter | Type: transporter | Action: nan
5996,haloperidol,ap-2 complex subunit sigma,unclassified,,Drug: haloperidol | Target: ap-2 complex subunit sigma | Type: unclassified | Action: nan
5997,haloperidol,muscarinic acetylcholine receptor,gpcr,,Drug: haloperidol | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
5998,haloperidol,opioid receptor,gpcr,,Drug: haloperidol | Target: opioid receptor | Type: gpcr | Action: nan
5999,haloperidol,serotonin 1 (5-ht1) receptor,gpcr,,Drug: haloperidol | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
6000,haloperidol,adrenergic receptor alpha-2,gpcr,,Drug: haloperidol | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
6001,haloperidol,dopamine receptor,gpcr,,Drug: haloperidol | Target: dopamine receptor | Type: gpcr | Action: nan
6002,haloperidol,dopamine receptor,gpcr,,Drug: haloperidol | Target: dopamine receptor | Type: gpcr | Action: nan
6003,haloperidol,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: haloperidol | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
6004,haloperidol,serotonin 2 (5-ht2) receptor,gpcr,,Drug: haloperidol | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
6005,haloperidol,adenylate cyclase,enzyme,,Drug: haloperidol | Target: adenylate cyclase | Type: enzyme | Action: nan
6006,haloperidol,serotonin 2 (5-ht2) receptor,gpcr,,Drug: haloperidol | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
6007,haloperidol,g protein-activated inward rectifier potassium channel 2,ion channel,GATING INHIBITOR,Drug: haloperidol | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: GATING INHIBITOR
6008,haloperidol,histone h1.0,nuclear other,,Drug: haloperidol | Target: histone h1.0 | Type: nuclear other | Action: nan
6009,haloperidol,transmembrane protein 97,enzyme,,Drug: haloperidol | Target: transmembrane protein 97 | Type: enzyme | Action: nan
6010,haloperidol,sigma intracellular receptor 2,unclassified,,Drug: haloperidol | Target: sigma intracellular receptor 2 | Type: unclassified | Action: nan
6011,haloperidol,zinc finger protein 664,unclassified,,Drug: haloperidol | Target: zinc finger protein 664 | Type: unclassified | Action: nan
6012,haloperidol,d(4) dopamine receptor,gpcr,INVERSE AGONIST,Drug: haloperidol | Target: d(4) dopamine receptor | Type: gpcr | Action: INVERSE AGONIST
6013,halopredone acetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: halopredone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
6014,haloprogin,d(1a) dopamine receptor,gpcr,,Drug: haloprogin | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
6015,haloprogin,alpha-2a adrenergic receptor,gpcr,,Drug: haloprogin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
6016,haloprogin,sodium-dependent serotonin transporter,transporter,,Drug: haloprogin | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6017,haloprogin,sodium-dependent noradrenaline transporter,transporter,,Drug: haloprogin | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
6018,haloprogin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: haloprogin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
6019,haloprogin,5-hydroxytryptamine receptor 2c,gpcr,,Drug: haloprogin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
6020,haloprogin,5-hydroxytryptamine receptor 6,gpcr,,Drug: haloprogin | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
6021,haloprogin,alpha-2b adrenergic receptor,gpcr,,Drug: haloprogin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
6022,haloprogin,d(3) dopamine receptor,gpcr,,Drug: haloprogin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
6023,haloprogin,alpha-2c adrenergic receptor,gpcr,,Drug: haloprogin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
6024,haloprogin,sodium-dependent dopamine transporter,transporter,,Drug: haloprogin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
6025,haloprogin,adenosine receptor a3,gpcr,,Drug: haloprogin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
6026,haloprogin,kappa-type opioid receptor,gpcr,,Drug: haloprogin | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
6027,haloprogin,substance-k receptor,gpcr,,Drug: haloprogin | Target: substance-k receptor | Type: gpcr | Action: nan
6028,haloprogin,udp-glucose 4-epimerase,enzyme,,Drug: haloprogin | Target: udp-glucose 4-epimerase | Type: enzyme | Action: nan
6029,halothane,potassium channel subfamily k member 2,ion channel,OPENER,Drug: halothane | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: OPENER
6030,halothane,potassium channel subfamily k member 3,ion channel,OPENER,Drug: halothane | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: OPENER
6031,halothane,potassium channel subfamily k member 9,ion channel,OPENER,Drug: halothane | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: OPENER
6032,halothane,potassium channel subfamily k member 10,ion channel,OPENER,Drug: halothane | Target: potassium channel subfamily k member 10 | Type: ion channel | Action: OPENER
6033,halothane,potassium channel subfamily k member 18,ion channel,OPENER,Drug: halothane | Target: potassium channel subfamily k member 18 | Type: ion channel | Action: OPENER
6034,halothane,glycine receptor (alpha-1/beta),ion channel,POSITIVE MODULATOR,Drug: halothane | Target: glycine receptor (alpha-1/beta) | Type: ion channel | Action: POSITIVE MODULATOR
6035,halothane,gaba-a receptor; anion channel,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: halothane | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
6036,heparin,antithrombin-iii,secreted,ACTIVATOR,Drug: heparin | Target: antithrombin-iii | Type: secreted | Action: ACTIVATOR
6037,heparin,spike glycoprotein,glycoprotein,,Drug: heparin | Target: spike glycoprotein | Type: glycoprotein | Action: nan
6038,heparin,spike glycoprotein,unclassified,,Drug: heparin | Target: spike glycoprotein | Type: unclassified | Action: nan
6039,hesperetin,carbonic anhydrase 4,enzyme,,Drug: hesperetin | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
6040,hesperetin,carbonic anhydrase 12,enzyme,,Drug: hesperetin | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
6041,hesperetin,carbonic anhydrase 7,enzyme,,Drug: hesperetin | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
6042,hesperetin,dipeptidyl peptidase 4,enzyme,,Drug: hesperetin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
6043,hesperetin,glycogen synthase kinase-3 beta,kinase,,Drug: hesperetin | Target: glycogen synthase kinase-3 beta | Type: kinase | Action: nan
6044,hesperetin,cytochrome p450 1b1,enzyme,,Drug: hesperetin | Target: cytochrome p450 1b1 | Type: enzyme | Action: nan
6045,hesperetin,replicase polyprotein 1ab,enzyme,,Drug: hesperetin | Target: replicase polyprotein 1ab | Type: enzyme | Action: nan
6046,hesperetin,lysine-specific histone demethylase 1a,enzyme,,Drug: hesperetin | Target: lysine-specific histone demethylase 1a | Type: enzyme | Action: nan
6048,hetacillin,penicillin-binding protein,enzyme,INHIBITOR,Drug: hetacillin | Target: penicillin-binding protein | Type: enzyme | Action: INHIBITOR
6049,hexachlorophene,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: hexachlorophene | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
6050,hexachlorophene,prostaglandin g/h synthase 2,enzyme,,Drug: hexachlorophene | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6051,hexachlorophene,adenosine receptor a2a,gpcr,,Drug: hexachlorophene | Target: adenosine receptor a2a | Type: gpcr | Action: nan
6052,hexachlorophene,alpha-2a adrenergic receptor,gpcr,,Drug: hexachlorophene | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
6053,hexachlorophene,sodium-dependent serotonin transporter,transporter,,Drug: hexachlorophene | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6054,hexachlorophene,5-hydroxytryptamine receptor 2b,gpcr,,Drug: hexachlorophene | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
6055,hexachlorophene,5-hydroxytryptamine receptor 2c,gpcr,,Drug: hexachlorophene | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
6056,hexachlorophene,alpha-2c adrenergic receptor,gpcr,,Drug: hexachlorophene | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
6057,hexachlorophene,adenosine receptor a3,gpcr,,Drug: hexachlorophene | Target: adenosine receptor a3 | Type: gpcr | Action: nan
6058,hexachlorophene,estrogen receptor,nuclear hormone receptor,,Drug: hexachlorophene | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
6059,hexachlorophene,acetylcholinesterase,enzyme,,Drug: hexachlorophene | Target: acetylcholinesterase | Type: enzyme | Action: nan
6060,hexachlorophene,estrogen receptor beta,nuclear hormone receptor,,Drug: hexachlorophene | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
6061,hexachlorophene,cytochrome p450 1a2,enzyme,,Drug: hexachlorophene | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
6062,hexachlorophene,epidermal growth factor receptor,kinase,,Drug: hexachlorophene | Target: epidermal growth factor receptor | Type: kinase | Action: nan
6063,hexachlorophene,cytochrome p450 2c19,enzyme,,Drug: hexachlorophene | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
6064,hexachlorophene,d-lactate dehydrogenase,enzyme,,Drug: hexachlorophene | Target: d-lactate dehydrogenase | Type: enzyme | Action: nan
6065,hexachlorophene,tyrosine-protein kinase lck,kinase,,Drug: hexachlorophene | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
6066,hexachlorophene,tyrosine-protein kinase fyn,kinase,,Drug: hexachlorophene | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
6067,hexachlorophene,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: hexachlorophene | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
6068,hexachlorophene,thromboxane-a synthase,enzyme,,Drug: hexachlorophene | Target: thromboxane-a synthase | Type: enzyme | Action: nan
6069,hexachlorophene,mitogen-activated protein kinase 3,kinase,,Drug: hexachlorophene | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
6070,hexachlorophene,mitogen-activated protein kinase 14,kinase,,Drug: hexachlorophene | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
6071,hexachlorophene,substance-k receptor,gpcr,,Drug: hexachlorophene | Target: substance-k receptor | Type: gpcr | Action: nan
6072,hexachlorophene,androgen receptor,transcription factor,,Drug: hexachlorophene | Target: androgen receptor | Type: transcription factor | Action: nan
6073,hexachlorophene,mitogen-activated protein kinase 1,kinase,,Drug: hexachlorophene | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
6074,hexachlorophene,enoyl-[acyl-carrier-protein] reductase [nadh] fabi,enzyme,INHIBITOR,Drug: hexachlorophene | Target: enoyl-[acyl-carrier-protein] reductase [nadh] fabi | Type: enzyme | Action: INHIBITOR
6075,hexachlorophene,zinc finger protein mex-5,cytosolic other,,Drug: hexachlorophene | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
6076,hexachlorophene,transitional endoplasmic reticulum atpase,enzyme,,Drug: hexachlorophene | Target: transitional endoplasmic reticulum atpase | Type: enzyme | Action: nan
6077,hexachlorophene,heat shock cognate 71 kda protein,unclassified,,Drug: hexachlorophene | Target: heat shock cognate 71 kda protein | Type: unclassified | Action: nan
6078,hexachlorophene,heat shock 70 kda protein 1a,unclassified,,Drug: hexachlorophene | Target: heat shock 70 kda protein 1a | Type: unclassified | Action: nan
6079,hexachlorophene,m1-family alanyl aminopeptidase,enzyme,,Drug: hexachlorophene | Target: m1-family alanyl aminopeptidase | Type: enzyme | Action: nan
6080,hexachlorophene,cytoplasmic zinc-finger protein,unclassified,,Drug: hexachlorophene | Target: cytoplasmic zinc-finger protein | Type: unclassified | Action: nan
6081,hexachlorophene,envelope glycoprotein gp160,viral envelope protein,,Drug: hexachlorophene | Target: envelope glycoprotein gp160 | Type: viral envelope protein | Action: nan
6082,hexachlorophene,macrophage migration inhibitory factor,unclassified,,Drug: hexachlorophene | Target: macrophage migration inhibitory factor | Type: unclassified | Action: nan
6083,hexachlorophene,n-acyl-phosphatidylethanolamine-hydrolyzing phospholipase d,unclassified,INHIBITOR,Drug: hexachlorophene | Target: n-acyl-phosphatidylethanolamine-hydrolyzing phospholipase d | Type: unclassified | Action: INHIBITOR
6084,hexachlorophene,78 kda glucose-regulated protein,unclassified,,Drug: hexachlorophene | Target: 78 kda glucose-regulated protein | Type: unclassified | Action: nan
6085,hexafluronium,acetylcholinesterase,enzyme,INHIBITOR,Drug: hexafluronium | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
6086,hexafluronium,acetylcholinesterase,enzyme,,Drug: hexafluronium | Target: acetylcholinesterase | Type: enzyme | Action: nan
6087,hexafluronium,butyrylcholinesterase,enzyme,,Drug: hexafluronium | Target: butyrylcholinesterase | Type: enzyme | Action: nan
6088,hexamethonium,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: hexamethonium | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
6089,hexamethonium,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: hexamethonium | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
6090,hexamethonium,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: hexamethonium | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
6091,hexamethonium,acetylcholine receptor,ion channel,,Drug: hexamethonium | Target: acetylcholine receptor | Type: ion channel | Action: nan
6092,hexamethonium,neuronal acetylcholine receptor subunit alpha-4,ion channel,BLOCKER,Drug: hexamethonium | Target: neuronal acetylcholine receptor subunit alpha-4 | Type: ion channel | Action: BLOCKER
6093,hexamethonium,neuronal acetylcholine receptor subunit alpha-6,ion channel,BLOCKER,Drug: hexamethonium | Target: neuronal acetylcholine receptor subunit alpha-6 | Type: ion channel | Action: BLOCKER
6094,hexestrol,estrogen receptor,nuclear hormone receptor,ANTAGONIST,Drug: hexestrol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
6095,hexobarbital,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,,Drug: hexobarbital | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: nan
6096,hexobarbital,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,,Drug: hexobarbital | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: nan
6097,hexobarbital,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,,Drug: hexobarbital | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: nan
6098,hexobarbital,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,,Drug: hexobarbital | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: nan
6099,hexobendine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: hexobendine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
6100,hexocyclium,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: hexocyclium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
6101,hexocyclium,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: hexocyclium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
6102,hexocyclium,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: hexocyclium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
6103,hexocyclium,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: hexocyclium | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
6104,hexocyclium,muscarinic acetylcholine receptor m5,gpcr,ANTAGONIST,Drug: hexocyclium | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: ANTAGONIST
6105,hexocyclium,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: hexocyclium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
6106,hexylcaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,BLOCKER,"Drug: hexylcaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: BLOCKER"
6107,hexylresorcinol,arachidonate 5-lipoxygenase,enzyme,,Drug: hexylresorcinol | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
6108,hexylresorcinol,tyrosinase,enzyme,,Drug: hexylresorcinol | Target: tyrosinase | Type: enzyme | Action: nan
6109,hexylresorcinol,polyphenol oxidase 2,enzyme,,Drug: hexylresorcinol | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
6110,histamine,histamine h1 receptor,gpcr,AGONIST,Drug: histamine | Target: histamine h1 receptor | Type: gpcr | Action: AGONIST
6111,histamine,histamine h2 receptor,gpcr,,Drug: histamine | Target: histamine h2 receptor | Type: gpcr | Action: nan
6112,histamine,histamine h4 receptor,gpcr,,Drug: histamine | Target: histamine h4 receptor | Type: gpcr | Action: nan
6113,histamine,trace amine-associated receptor 1,gpcr,,Drug: histamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
6114,histamine,histamine h3 receptor,gpcr,,Drug: histamine | Target: histamine h3 receptor | Type: gpcr | Action: nan
6115,histamine,histamine h1 receptor,gpcr,,Drug: histamine | Target: histamine h1 receptor | Type: gpcr | Action: nan
6116,histamine,histamine h2 receptor,gpcr,,Drug: histamine | Target: histamine h2 receptor | Type: gpcr | Action: nan
6117,histamine,histamine h1 receptor,gpcr,,Drug: histamine | Target: histamine h1 receptor | Type: gpcr | Action: nan
6118,histamine,histamine h3 receptor,gpcr,,Drug: histamine | Target: histamine h3 receptor | Type: gpcr | Action: nan
6119,histamine,histamine h3 receptor,gpcr,,Drug: histamine | Target: histamine h3 receptor | Type: gpcr | Action: nan
6120,histamine,histamine h4 receptor,gpcr,,Drug: histamine | Target: histamine h4 receptor | Type: gpcr | Action: nan
6121,histamine,histamine h4 receptor,gpcr,,Drug: histamine | Target: histamine h4 receptor | Type: gpcr | Action: nan
6122,histamine,histamine h3 receptor,gpcr,,Drug: histamine | Target: histamine h3 receptor | Type: gpcr | Action: nan
6123,histamine,histamine h4 receptor,gpcr,,Drug: histamine | Target: histamine h4 receptor | Type: gpcr | Action: nan
6124,histidine,large neutral amino acids transporter small subunit 1,transporter,,Drug: histidine | Target: large neutral amino acids transporter small subunit 1 | Type: transporter | Action: nan
6125,homatropine,muscarinic acetylcholine receptor m1,gpcr,,Drug: homatropine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
6126,homatropine,muscarinic acetylcholine receptor m2,gpcr,,Drug: homatropine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
6127,homatropine,muscarinic acetylcholine receptor m3,gpcr,,Drug: homatropine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
6128,homatropine,muscarinic acetylcholine receptor m4,gpcr,,Drug: homatropine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
6129,homatropine,muscarinic acetylcholine receptor m5,gpcr,,Drug: homatropine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
6130,hycanthone,dna-(apurinic or apyrimidinic site) lyase,enzyme,,Drug: hycanthone | Target: dna-(apurinic or apyrimidinic site) lyase | Type: enzyme | Action: nan
6131,hydralazine,aldehyde oxidase,enzyme,,Drug: hydralazine | Target: aldehyde oxidase | Type: enzyme | Action: nan
6132,hydralazine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: hydralazine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
6133,hydralazine,dna (cytosine-5)-methyltransferase 1,enzyme,,Drug: hydralazine | Target: dna (cytosine-5)-methyltransferase 1 | Type: enzyme | Action: nan
6134,hydralazine,dna (cytosine-5)-methyltransferase 3a,enzyme,,Drug: hydralazine | Target: dna (cytosine-5)-methyltransferase 3a | Type: enzyme | Action: nan
6135,hydralazine,dna (cytosine-5)-methyltransferase 3b,enzyme,,Drug: hydralazine | Target: dna (cytosine-5)-methyltransferase 3b | Type: enzyme | Action: nan
6136,hydralazine,myeloperoxidase,enzyme,,Drug: hydralazine | Target: myeloperoxidase | Type: enzyme | Action: nan
6137,hydralazine,arachidonate 15-lipoxygenase,enzyme,,Drug: hydralazine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
6138,hydralazine,acetylcholinesterase,enzyme,,Drug: hydralazine | Target: acetylcholinesterase | Type: enzyme | Action: nan
6139,hydralazine,cholinesterase,enzyme,,Drug: hydralazine | Target: cholinesterase | Type: enzyme | Action: nan
6140,hydralazine,lactoperoxidase,enzyme,,Drug: hydralazine | Target: lactoperoxidase | Type: enzyme | Action: nan
6141,hydralazine,ryanodine receptor 2,ion channel,,Drug: hydralazine | Target: ryanodine receptor 2 | Type: ion channel | Action: nan
6142,hydralazine,ryanodine receptor 2,ion channel,BLOCKER,Drug: hydralazine | Target: ryanodine receptor 2 | Type: ion channel | Action: BLOCKER
6143,hydrochlorothiazide,carbonic anhydrase 2,enzyme,,Drug: hydrochlorothiazide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
6144,hydrochlorothiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: hydrochlorothiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
6145,hydrochlorothiazide,carbonic anhydrase 1,enzyme,,Drug: hydrochlorothiazide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
6146,hydrochlorothiazide,carbonic anhydrase 4,enzyme,,Drug: hydrochlorothiazide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
6147,hydrochlorothiazide,calcium-activated potassium channel subunit alpha-1,ion channel,,Drug: hydrochlorothiazide | Target: calcium-activated potassium channel subunit alpha-1 | Type: ion channel | Action: nan
6148,hydrochlorothiazide,astrosclerin-3,enzyme,,Drug: hydrochlorothiazide | Target: astrosclerin-3 | Type: enzyme | Action: nan
6149,hydrochlorothiazide,delta carbonic anhydrase,unclassified,,Drug: hydrochlorothiazide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
6150,hydrochlorothiazide,carbonic anhydrase,enzyme,,Drug: hydrochlorothiazide | Target: carbonic anhydrase | Type: enzyme | Action: nan
6151,hydrochlorothiazide,"carbonic anhydrase, alpha family",unclassified,,"Drug: hydrochlorothiazide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
6152,hydrochlorothiazide,carbonate dehydratase,enzyme,,Drug: hydrochlorothiazide | Target: carbonate dehydratase | Type: enzyme | Action: nan
6153,hydrocodone,mu-type opioid receptor,gpcr,AGONIST,Drug: hydrocodone | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
6154,hydrocodone,kappa-type opioid receptor,gpcr,AGONIST,Drug: hydrocodone | Target: kappa-type opioid receptor | Type: gpcr | Action: AGONIST
6155,hydrocortamate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortamate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
6156,hydrocortisone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortisone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
6157,hydrocortisone,annexin a1,cytosolic other,,Drug: hydrocortisone | Target: annexin a1 | Type: cytosolic other | Action: nan
6158,hydrocortisone,mineralocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortisone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
6159,hydrocortisone,"nitric oxide synthase, inducible",enzyme,,"Drug: hydrocortisone | Target: nitric oxide synthase, inducible | Type: enzyme | Action: nan"
6160,hydrocortisone,corticosteroid-binding globulin,secreted,,Drug: hydrocortisone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
6161,hydrocortisone,sex hormone-binding globulin,secreted,,Drug: hydrocortisone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
6162,hydrocortisone,glucocorticoid receptor,transcription factor,,Drug: hydrocortisone | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
6163,hydrocortisone cypionate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortisone cypionate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
6164,hydroflumethiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: hydroflumethiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
6165,hydromorphone,mu-type opioid receptor,gpcr,AGONIST,Drug: hydromorphone | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
6166,hydromorphone,kappa-type opioid receptor,gpcr,,Drug: hydromorphone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
6167,hydromorphone,delta-type opioid receptor,gpcr,,Drug: hydromorphone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
6168,hydromorphone,opioid receptor,gpcr,,Drug: hydromorphone | Target: opioid receptor | Type: gpcr | Action: nan
6169,hydroxyamfetamine,beta-secretase 1,enzyme,,Drug: hydroxyamfetamine | Target: beta-secretase 1 | Type: enzyme | Action: nan
6170,hydroxyamfetamine,trace amine-associated receptor 1,gpcr,,Drug: hydroxyamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
6171,hydroxyamfetamine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: hydroxyamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
6172,hydroxychloroquine,alpha-2a adrenergic receptor,gpcr,,Drug: hydroxychloroquine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
6173,hydroxychloroquine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: hydroxychloroquine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6174,hydroxychloroquine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: hydroxychloroquine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
6175,hydroxychloroquine,alpha-2b adrenergic receptor,gpcr,,Drug: hydroxychloroquine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
6176,hydroxychloroquine,muscarinic acetylcholine receptor m1,gpcr,,Drug: hydroxychloroquine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
6177,hydroxychloroquine,muscarinic acetylcholine receptor m2,gpcr,,Drug: hydroxychloroquine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
6178,hydroxychloroquine,muscarinic acetylcholine receptor m3,gpcr,,Drug: hydroxychloroquine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
6179,hydroxychloroquine,muscarinic acetylcholine receptor m4,gpcr,,Drug: hydroxychloroquine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
6180,hydroxychloroquine,muscarinic acetylcholine receptor m5,gpcr,,Drug: hydroxychloroquine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
6181,hydroxychloroquine,alpha-2c adrenergic receptor,gpcr,,Drug: hydroxychloroquine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
6182,hydroxychloroquine,hemoglobin subunit alpha,secreted,,Drug: hydroxychloroquine | Target: hemoglobin subunit alpha | Type: secreted | Action: nan
6183,hydroxychloroquine,alpha-1d adrenergic receptor,gpcr,,Drug: hydroxychloroquine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
6184,hydroxychloroquine,toll-like receptor 7,membrane receptor,ANTAGONIST,Drug: hydroxychloroquine | Target: toll-like receptor 7 | Type: membrane receptor | Action: ANTAGONIST
6185,hydroxychloroquine,toll-like receptor 9,membrane receptor,ANTAGONIST,Drug: hydroxychloroquine | Target: toll-like receptor 9 | Type: membrane receptor | Action: ANTAGONIST
6186,hydroxychloroquine,transmembrane protein 97,enzyme,,Drug: hydroxychloroquine | Target: transmembrane protein 97 | Type: enzyme | Action: nan
6187,hydroxystilbamidine,trypsin,enzyme,,Drug: hydroxystilbamidine | Target: trypsin | Type: enzyme | Action: nan
6188,hydroxycarbamide,carbonic anhydrase 2,enzyme,,Drug: hydroxycarbamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
6189,hydroxycarbamide,carbonic anhydrase 9,enzyme,,Drug: hydroxycarbamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
6190,hydroxycarbamide,ribonucleoside-diphosphate reductase large subunit,enzyme,INHIBITOR,Drug: hydroxycarbamide | Target: ribonucleoside-diphosphate reductase large subunit | Type: enzyme | Action: INHIBITOR
6191,hydroxycarbamide,ribonucleoside-diphosphate reductase subunit m2,enzyme,INHIBITOR,Drug: hydroxycarbamide | Target: ribonucleoside-diphosphate reductase subunit m2 | Type: enzyme | Action: INHIBITOR
6192,hydroxycarbamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: hydroxycarbamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
6193,hydroxyzine,d(2) dopamine receptor,gpcr,,Drug: hydroxyzine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
6194,hydroxyzine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: hydroxyzine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
6195,hydroxyzine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: hydroxyzine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
6196,hydroxyzine,cytochrome p450 2d6,enzyme,,Drug: hydroxyzine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
6197,hydroxyzine,envelope glycoprotein gp160,viral envelope protein,,Drug: hydroxyzine | Target: envelope glycoprotein gp160 | Type: viral envelope protein | Action: nan
6198,hymecromone,amine oxidase [flavin-containing] b,enzyme,,Drug: hymecromone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
6199,hymecromone,aldose reductase,enzyme,,Drug: hymecromone | Target: aldose reductase | Type: enzyme | Action: nan
6200,hymecromone,carbonic anhydrase 9,enzyme,,Drug: hymecromone | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
6201,hymecromone,carbonic anhydrase 12,enzyme,,Drug: hymecromone | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
6202,hymecromone,testosterone 17-beta-dehydrogenase 3,enzyme,,Drug: hymecromone | Target: testosterone 17-beta-dehydrogenase 3 | Type: enzyme | Action: nan
6203,hymecromone,aldose reductase,enzyme,,Drug: hymecromone | Target: aldose reductase | Type: enzyme | Action: nan
6204,hyoscyamine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: hyoscyamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
6205,hyoscyamine,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: hyoscyamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
6206,hyoscyamine,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: hyoscyamine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
6207,hyoscyamine,muscarinic acetylcholine receptor m4,gpcr,,Drug: hyoscyamine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
6208,hyoscyamine,muscarinic acetylcholine receptor m5,gpcr,,Drug: hyoscyamine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
6209,ibandronic acid,farnesyl pyrophosphate synthase,enzyme,INHIBITOR,Drug: ibandronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: INHIBITOR
6210,ibandronic acid,geranylgeranyl pyrophosphate synthase,enzyme,,Drug: ibandronic acid | Target: geranylgeranyl pyrophosphate synthase | Type: enzyme | Action: nan
6211,ibandronic acid,squalene synthase,enzyme,,Drug: ibandronic acid | Target: squalene synthase | Type: enzyme | Action: nan
6212,ibandronic acid,farnesyl pyrophosphate synthase,enzyme,INHIBITOR,Drug: ibandronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: INHIBITOR
6213,ibudilast,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,,"Drug: ibudilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: nan"
6214,ibudilast,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: ibudilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
6215,ibudilast,"camp-specific 3',5'-cyclic phosphodiesterase 4d",enzyme,,"Drug: ibudilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4d | Type: enzyme | Action: nan"
6216,ibudilast,"camp-specific 3',5'-cyclic phosphodiesterase 4c",enzyme,,"Drug: ibudilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4c | Type: enzyme | Action: nan"
6217,ibuprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: ibuprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
6218,ibuprofen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: ibuprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
6219,ibuprofen,cytochrome p450 2c9,enzyme,,Drug: ibuprofen | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
6220,ibuprofen,aldo-keto reductase family 1 member c2,enzyme,,Drug: ibuprofen | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
6221,ibuprofen,aldo-keto reductase family 1 member c3,enzyme,,Drug: ibuprofen | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
6222,ibuprofen,arachidonate 5-lipoxygenase,enzyme,,Drug: ibuprofen | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
6223,ibuprofen,"fatty acid-binding protein, liver",unclassified,,"Drug: ibuprofen | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
6224,ibuprofen,interleukin-8,cytokine,,Drug: ibuprofen | Target: interleukin-8 | Type: cytokine | Action: nan
6225,ibuprofen,prostaglandin g/h synthase 2,enzyme,,Drug: ibuprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6226,ibuprofen,prostaglandin g/h synthase 1,enzyme,,Drug: ibuprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6227,ibuprofen,prostaglandin g/h synthase 2,enzyme,,Drug: ibuprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6228,ibuprofen,prostaglandin-h2 d-isomerase,enzyme,,Drug: ibuprofen | Target: prostaglandin-h2 d-isomerase | Type: enzyme | Action: nan
6229,ibuprofen,prostaglandin g/h synthase 2,enzyme,,Drug: ibuprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6230,ibuprofen,serum albumin,secreted,,Drug: ibuprofen | Target: serum albumin | Type: secreted | Action: nan
6231,ibuprofen,solute carrier family 22 member 6,transporter,,Drug: ibuprofen | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
6232,ibuprofen,prostaglandin g/h synthase 1,enzyme,,Drug: ibuprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6233,ibuprofen,solute carrier family 22 member 20,transporter,,Drug: ibuprofen | Target: solute carrier family 22 member 20 | Type: transporter | Action: nan
6234,ibuprofen,cyclooxygenase,enzyme,,Drug: ibuprofen | Target: cyclooxygenase | Type: enzyme | Action: nan
6235,ibuprofen,sodium-coupled monocarboxylate transporter 1,transporter,INHIBITOR,Drug: ibuprofen | Target: sodium-coupled monocarboxylate transporter 1 | Type: transporter | Action: INHIBITOR
6236,ibuprofen,dehydrogenase/reductase sdr family member 9,enzyme,,Drug: ibuprofen | Target: dehydrogenase/reductase sdr family member 9 | Type: enzyme | Action: nan
6237,ibuprofen,acid-sensing ion channel 1,ion channel,BLOCKER,Drug: ibuprofen | Target: acid-sensing ion channel 1 | Type: ion channel | Action: BLOCKER
6238,ibuproxam,arachidonate 5-lipoxygenase,enzyme,,Drug: ibuproxam | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
6239,ibuproxam,cyclooxygenase,enzyme,,Drug: ibuproxam | Target: cyclooxygenase | Type: enzyme | Action: nan
6240,ibutilide,potassium voltage-gated channel subfamily h member 2,ion channel,BLOCKER,Drug: ibutilide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: BLOCKER
6241,icosapent ethyl,diacylglycerol o-acyltransferase 1,enzyme,INHIBITOR,Drug: icosapent ethyl | Target: diacylglycerol o-acyltransferase 1 | Type: enzyme | Action: INHIBITOR
6242,idarubicin,multidrug resistance protein 1,transporter,,Drug: idarubicin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
6243,idarubicin,dna topoisomerase 2-alpha,enzyme,INHIBITOR,Drug: idarubicin | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: INHIBITOR
6244,idarubicin,multidrug resistance-associated protein 1,transporter,,Drug: idarubicin | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
6245,idebenone,cytochrome p450 3a4,enzyme,,Drug: idebenone | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
6246,idebenone,cytochrome p450 2d6,enzyme,,Drug: idebenone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
6247,idebenone,cytochrome p450 2c9,enzyme,,Drug: idebenone | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
6248,idebenone,cytochrome p450 2c19,enzyme,,Drug: idebenone | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
6249,idoxuridine,"thymidine kinase, cytosolic",kinase,,"Drug: idoxuridine | Target: thymidine kinase, cytosolic | Type: kinase | Action: nan"
6250,idoxuridine,thymidine kinase,kinase,,Drug: idoxuridine | Target: thymidine kinase | Type: kinase | Action: nan
6251,ifenprodil,"glutamate receptor ionotropic, nmda 2a",ion channel,,"Drug: ifenprodil | Target: glutamate receptor ionotropic, nmda 2a | Type: ion channel | Action: nan"
6252,ifenprodil,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: ifenprodil | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6253,ifenprodil,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ifenprodil | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
6254,ifenprodil,histamine h1 receptor,gpcr,,Drug: ifenprodil | Target: histamine h1 receptor | Type: gpcr | Action: nan
6255,ifenprodil,"glutamate receptor ionotropic, nmda 2b",ion channel,,"Drug: ifenprodil | Target: glutamate receptor ionotropic, nmda 2b | Type: ion channel | Action: nan"
6256,ifenprodil,"glutamate receptor ionotropic, nmda 2c",ion channel,,"Drug: ifenprodil | Target: glutamate receptor ionotropic, nmda 2c | Type: ion channel | Action: nan"
6257,ifenprodil,"glutamate receptor ionotropic, nmda 2d",ion channel,,"Drug: ifenprodil | Target: glutamate receptor ionotropic, nmda 2d | Type: ion channel | Action: nan"
6258,ifenprodil,"glutamate receptor ionotropic, nmda 1",ion channel,,"Drug: ifenprodil | Target: glutamate receptor ionotropic, nmda 1 | Type: ion channel | Action: nan"
6259,ifenprodil,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: ifenprodil | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6260,ifenprodil,alpha-2a adrenergic receptor,gpcr,,Drug: ifenprodil | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
6261,ifenprodil,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ifenprodil | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
6262,ifenprodil,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ifenprodil | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
6263,ifenprodil,sigma non-opioid intracellular receptor 1,membrane other,,Drug: ifenprodil | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
6264,ifenprodil,glutamate nmda receptor; grin1/grin2b,ion channel,,Drug: ifenprodil | Target: glutamate nmda receptor; grin1/grin2b | Type: ion channel | Action: nan
6265,ifenprodil,adrenergic receptor alpha-1,gpcr,,Drug: ifenprodil | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
6266,ifenprodil,glutamate [nmda] receptor subunit epsilon 2,ion channel,,Drug: ifenprodil | Target: glutamate [nmda] receptor subunit epsilon 2 | Type: ion channel | Action: nan
6267,ifenprodil,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",unclassified,,"Drug: ifenprodil | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: unclassified | Action: nan"
6271,ifenprodil,sigma intracellular receptor 2,unclassified,,Drug: ifenprodil | Target: sigma intracellular receptor 2 | Type: unclassified | Action: nan
6272,iloprost,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: iloprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
6273,iloprost,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: iloprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
6274,iloprost,prostacyclin receptor,gpcr,AGONIST,Drug: iloprost | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
6275,iloprost,thromboxane a2 receptor,gpcr,AGONIST,Drug: iloprost | Target: thromboxane a2 receptor | Type: gpcr | Action: AGONIST
6276,iloprost,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
6277,iloprost,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
6278,iloprost,prostaglandin d2 receptor,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin d2 receptor | Type: gpcr | Action: AGONIST
6279,iloprost,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
6280,iloprost,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
6281,iloprost,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
6282,iloprost,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
6283,iloprost,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
6284,iloprost,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
6285,iloprost,prostacyclin receptor,gpcr,AGONIST,Drug: iloprost | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
6286,iloprost,prostacyclin receptor,gpcr,,Drug: iloprost | Target: prostacyclin receptor | Type: gpcr | Action: nan
6287,iloprost,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
6288,iloprost,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: iloprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
6289,imatinib,multidrug resistance protein 1,transporter,,Drug: imatinib | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
6290,imatinib,sodium-dependent serotonin transporter,transporter,,Drug: imatinib | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6291,imatinib,5-hydroxytryptamine receptor 2a,gpcr,,Drug: imatinib | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
6292,imatinib,histamine h2 receptor,gpcr,,Drug: imatinib | Target: histamine h2 receptor | Type: gpcr | Action: nan
6293,imatinib,carbonic anhydrase 2,enzyme,,Drug: imatinib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
6294,imatinib,multidrug resistance-associated protein 1,transporter,,Drug: imatinib | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
6295,imatinib,atp-binding cassette sub-family g member 2,transporter,,Drug: imatinib | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
6296,imatinib,carbonic anhydrase 1,enzyme,,Drug: imatinib | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
6297,imatinib,carbonic anhydrase 4,enzyme,,Drug: imatinib | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
6298,imatinib,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: imatinib | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
6299,imatinib,carbonic anhydrase 9,enzyme,,Drug: imatinib | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
6300,imatinib,carbonic anhydrase 12,enzyme,,Drug: imatinib | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
6301,imatinib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: imatinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
6302,imatinib,tyrosine-protein kinase abl1,kinase,INHIBITOR,Drug: imatinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: INHIBITOR
6303,imatinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: imatinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
6304,imatinib,epidermal growth factor receptor,kinase,,Drug: imatinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
6305,imatinib,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: imatinib | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
6306,imatinib,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: imatinib | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
6307,imatinib,carbonic anhydrase 7,enzyme,,Drug: imatinib | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
6308,imatinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: imatinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
6309,imatinib,tyrosine-protein kinase lck,kinase,,Drug: imatinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
6310,imatinib,tyrosine-protein kinase fyn,kinase,,Drug: imatinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
6311,imatinib,raf proto-oncogene serine/threonine-protein kinase,kinase,,Drug: imatinib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: nan
6312,imatinib,serine/threonine-protein kinase b-raf,kinase,,Drug: imatinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
6313,imatinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: imatinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
6314,imatinib,vascular endothelial growth factor receptor 2,kinase,,Drug: imatinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
6315,imatinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: imatinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
6316,imatinib,platelet-derived growth factor receptor alpha,kinase,,Drug: imatinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
6317,imatinib,insulin receptor,kinase,AGONIST,Drug: imatinib | Target: insulin receptor | Type: kinase | Action: AGONIST
6318,imatinib,thromboxane-a synthase,enzyme,,Drug: imatinib | Target: thromboxane-a synthase | Type: enzyme | Action: nan
6319,imatinib,mitogen-activated protein kinase 8,kinase,,Drug: imatinib | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
6320,imatinib,carbonic anhydrase 3,enzyme,,Drug: imatinib | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
6321,imatinib,carbonic anhydrase 6,enzyme,,Drug: imatinib | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
6322,imatinib,mitogen-activated protein kinase 10,kinase,,Drug: imatinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
6323,imatinib,tyrosine-protein kinase jak2,kinase,,Drug: imatinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
6324,imatinib,tyrosine-protein kinase syk,kinase,,Drug: imatinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
6325,imatinib,ephrin type-a receptor 8,kinase,,Drug: imatinib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
6326,imatinib,tyrosine-protein kinase lyn,kinase,,Drug: imatinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
6327,imatinib,cytoplasmic tyrosine-protein kinase bmx,kinase,,Drug: imatinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: nan
6328,imatinib,carbonic anhydrase 14,enzyme,,Drug: imatinib | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
6329,imatinib,fibroblast growth factor receptor 1,kinase,,Drug: imatinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
6330,imatinib,serine/threonine-protein kinase plk4,kinase,,Drug: imatinib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
6331,imatinib,abelson tyrosine-protein kinase 2,kinase,,Drug: imatinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
6332,imatinib,fibroblast growth factor receptor 2,kinase,,Drug: imatinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
6333,imatinib,serine/threonine-protein kinase 17a,kinase,,Drug: imatinib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
6334,imatinib,tyrosine-protein kinase fgr,kinase,,Drug: imatinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
6335,imatinib,mitogen-activated protein kinase 14,kinase,,Drug: imatinib | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
6336,imatinib,tyrosine-protein kinase frk,kinase,,Drug: imatinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
6337,imatinib,dual specificity protein kinase clk1,kinase,,Drug: imatinib | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
6338,imatinib,cyclin-g-associated kinase,kinase,,Drug: imatinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
6339,imatinib,ephrin type-b receptor 1,kinase,,Drug: imatinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
6340,imatinib,dual specificity protein kinase clk4,kinase,,Drug: imatinib | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
6341,imatinib,mitogen-activated protein kinase 9,kinase,,Drug: imatinib | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
6342,imatinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: imatinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
6343,imatinib,ephrin type-b receptor 4,kinase,,Drug: imatinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
6344,imatinib,lysine--trna ligase,enzyme,,Drug: imatinib | Target: lysine--trna ligase | Type: enzyme | Action: nan
6345,imatinib,carbonic anhydrase 13,enzyme,,Drug: imatinib | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
6346,imatinib,carbonic anhydrase 15,enzyme,,Drug: imatinib | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
6347,imatinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: imatinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
6348,imatinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: imatinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
6349,imatinib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: imatinib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
6350,imatinib,maternal embryonic leucine zipper kinase,kinase,,Drug: imatinib | Target: maternal embryonic leucine zipper kinase | Type: kinase | Action: nan
6351,imatinib,serine/threonine-protein kinase tnni3k,kinase,,Drug: imatinib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
6352,imatinib,discoidin domain-containing receptor 2,kinase,,Drug: imatinib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
6353,imatinib,tyrosine-protein kinase blk,kinase,,Drug: imatinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
6354,imatinib,cyclin-dependent kinase 19,kinase,,Drug: imatinib | Target: cyclin-dependent kinase 19 | Type: kinase | Action: nan
6355,imatinib,tyrosine-protein kinase abl1,kinase,,Drug: imatinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
6356,imatinib,homeodomain-interacting protein kinase 4,kinase,,Drug: imatinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
6357,imatinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: imatinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
6358,imatinib,phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,kinase,,Drug: imatinib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Type: kinase | Action: nan
6359,imatinib,solute carrier family 22 member 2,transporter,,Drug: imatinib | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
6360,imatinib,multidrug and toxin extrusion protein 1,transporter,,Drug: imatinib | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
6361,imatinib,multidrug and toxin extrusion protein 2,transporter,,Drug: imatinib | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
6362,imatinib,solute carrier family 22 member 3,transporter,,Drug: imatinib | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
6363,imatinib,platelet-derived growth factor receptor,kinase,,Drug: imatinib | Target: platelet-derived growth factor receptor | Type: kinase | Action: nan
6364,imatinib,tyrosine-protein kinase abl,kinase,,Drug: imatinib | Target: tyrosine-protein kinase abl | Type: kinase | Action: nan
6365,imatinib,bcr/abl fusion protein,kinase,,Drug: imatinib | Target: bcr/abl fusion protein | Type: kinase | Action: nan
6366,imatinib,platelet-derived growth factor receptor beta,kinase,,Drug: imatinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
6367,imidapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: imidapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
6368,imipenem,penicillin-binding protein 4,enzyme,,Drug: imipenem | Target: penicillin-binding protein 4 | Type: enzyme | Action: nan
6369,imipenem,penicillin-binding protein 1,enzyme,,Drug: imipenem | Target: penicillin-binding protein 1 | Type: enzyme | Action: nan
6370,imipenem,beta-lactamase,enzyme,,Drug: imipenem | Target: beta-lactamase | Type: enzyme | Action: nan
6371,imipenem,beta-lactamase ges-13,enzyme,,Drug: imipenem | Target: beta-lactamase ges-13 | Type: enzyme | Action: nan
6372,imipenem,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: imipenem | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
6373,imipramine,d(2) dopamine receptor,gpcr,,Drug: imipramine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
6374,imipramine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: imipramine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6375,imipramine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: imipramine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
6376,imipramine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: imipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
6377,imipramine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: imipramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
6378,imipramine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: imipramine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
6379,imipramine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: imipramine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
6380,imipramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: imipramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
6381,imipramine,alpha-1a adrenergic receptor,gpcr,,Drug: imipramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
6382,imipramine,alpha-2b adrenergic receptor,gpcr,,Drug: imipramine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
6383,imipramine,d(3) dopamine receptor,gpcr,,Drug: imipramine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
6384,imipramine,histamine h1 receptor,gpcr,,Drug: imipramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
6385,imipramine,muscarinic acetylcholine receptor m1,gpcr,,Drug: imipramine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
6386,imipramine,muscarinic acetylcholine receptor m2,gpcr,,Drug: imipramine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
6387,imipramine,muscarinic acetylcholine receptor m3,gpcr,,Drug: imipramine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
6388,imipramine,muscarinic acetylcholine receptor m4,gpcr,,Drug: imipramine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
6389,imipramine,muscarinic acetylcholine receptor m5,gpcr,,Drug: imipramine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
6390,imipramine,sodium-dependent dopamine transporter,transporter,,Drug: imipramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
6391,imipramine,adenosine receptor a3,gpcr,,Drug: imipramine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
6392,imipramine,major prion protein,surface antigen,,Drug: imipramine | Target: major prion protein | Type: surface antigen | Action: nan
6393,imipramine,solute carrier family 22 member 1,transporter,,Drug: imipramine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
6394,imipramine,potassium voltage-gated channel subfamily h member 1,ion channel,BLOCKER,Drug: imipramine | Target: potassium voltage-gated channel subfamily h member 1 | Type: ion channel | Action: BLOCKER
6395,imipramine,alpha-1a adrenergic receptor,gpcr,,Drug: imipramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
6396,imipramine,sodium-dependent serotonin transporter,transporter,,Drug: imipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6397,imipramine,transporter,transporter,,Drug: imipramine | Target: transporter | Type: transporter | Action: nan
6398,imipramine,sodium-dependent dopamine transporter,transporter,,Drug: imipramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
6399,imipramine,sodium-dependent noradrenaline transporter,transporter,,Drug: imipramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
6400,imipramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: imipramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
6401,imipramine,d(2) dopamine receptor,gpcr,,Drug: imipramine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
6402,imipramine,sodium-dependent serotonin transporter,transporter,,Drug: imipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6403,imipramine,histamine h1 receptor,gpcr,,Drug: imipramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
6404,imipramine,muscarinic acetylcholine receptor m5,gpcr,,Drug: imipramine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
6405,imipramine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: imipramine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
6406,imipramine,solute carrier family 22 member 2,transporter,,Drug: imipramine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
6407,imipramine,glutamate nmda receptor,ion channel,,Drug: imipramine | Target: glutamate nmda receptor | Type: ion channel | Action: nan
6408,imipramine,muscarinic acetylcholine receptor,gpcr,,Drug: imipramine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
6409,imipramine,serotonin (5-ht) receptor,gpcr,,Drug: imipramine | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
6410,imipramine,adrenergic receptor alpha-2,gpcr,,Drug: imipramine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
6411,imipramine,dopamine receptor,gpcr,,Drug: imipramine | Target: dopamine receptor | Type: gpcr | Action: nan
6412,imipramine,adrenergic receptor alpha-1,gpcr,,Drug: imipramine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
6413,imipramine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: imipramine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
6414,imipramine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: imipramine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
6415,imipramine,g protein-activated inward rectifier potassium channel 4,ion channel,BLOCKER,Drug: imipramine | Target: g protein-activated inward rectifier potassium channel 4 | Type: ion channel | Action: BLOCKER
6416,imipramine,g protein-activated inward rectifier potassium channel 2,ion channel,BLOCKER,Drug: imipramine | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: BLOCKER
6417,imipramine,sphingomyelin phosphodiesterase,enzyme,,Drug: imipramine | Target: sphingomyelin phosphodiesterase | Type: enzyme | Action: nan
6418,imiquimod,adenosine receptor a2a,gpcr,,Drug: imiquimod | Target: adenosine receptor a2a | Type: gpcr | Action: nan
6419,imiquimod,histamine h2 receptor,gpcr,,Drug: imiquimod | Target: histamine h2 receptor | Type: gpcr | Action: nan
6420,imiquimod,alpha-1d adrenergic receptor,gpcr,,Drug: imiquimod | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
6421,imiquimod,toll-like receptor 7,membrane receptor,AGONIST,Drug: imiquimod | Target: toll-like receptor 7 | Type: membrane receptor | Action: AGONIST
6422,incadronic acid,farnesyl pyrophosphate synthase,enzyme,,Drug: incadronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
6423,incadronic acid,vacuolar-type proton translocating pyrophosphatase 1,unclassified,,Drug: incadronic acid | Target: vacuolar-type proton translocating pyrophosphatase 1 | Type: unclassified | Action: nan
6424,incadronic acid,farnesyl pyrophosphate synthase,enzyme,INHIBITOR,Drug: incadronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: INHIBITOR
6425,indalpine,sodium-dependent serotonin transporter,transporter,,Drug: indalpine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6426,indapamide,carbonic anhydrase 2,enzyme,,Drug: indapamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
6427,indapamide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: indapamide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
6428,indapamide,carbonic anhydrase 1,enzyme,,Drug: indapamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
6429,indapamide,carbonic anhydrase 4,enzyme,,Drug: indapamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
6430,indapamide,carbonic anhydrase 9,enzyme,,Drug: indapamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
6431,indapamide,carbonic anhydrase 12,enzyme,,Drug: indapamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
6432,indapamide,potassium voltage-gated channel subfamily kqt member 1,ion channel,,Drug: indapamide | Target: potassium voltage-gated channel subfamily kqt member 1 | Type: ion channel | Action: nan
6433,indapamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: indapamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
6434,indapamide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: indapamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
6435,indapamide,carbonic anhydrase 7,enzyme,,Drug: indapamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
6436,indapamide,carbonic anhydrase 6,enzyme,,Drug: indapamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
6437,indapamide,carbonic anhydrase 14,enzyme,,Drug: indapamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
6438,indapamide,arachidonate 15-lipoxygenase,enzyme,,Drug: indapamide | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
6439,indapamide,carbonic anhydrase 13,enzyme,,Drug: indapamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
6440,indapamide,carbonic anhydrase 13,enzyme,,Drug: indapamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
6441,indecainide,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: indecainide | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
6442,indenolol,beta-1 adrenergic receptor,gpcr,,Drug: indenolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
6443,indenolol,beta-2 adrenergic receptor,gpcr,,Drug: indenolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
6444,indinavir,cytochrome p450 3a4,enzyme,,Drug: indinavir | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
6445,indinavir,gag-pol polyprotein,polyprotein,,Drug: indinavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
6446,indinavir,thromboxane-a synthase,enzyme,,Drug: indinavir | Target: thromboxane-a synthase | Type: enzyme | Action: nan
6447,indinavir,substance-k receptor,gpcr,,Drug: indinavir | Target: substance-k receptor | Type: gpcr | Action: nan
6448,indinavir,pol polyprotein,enzyme,INHIBITOR,Drug: indinavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
6449,indinavir,protease,enzyme,,Drug: indinavir | Target: protease | Type: enzyme | Action: nan
6450,indinavir,multidrug and toxin extrusion protein 1,transporter,,Drug: indinavir | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
6451,indinavir,multidrug and toxin extrusion protein 2,transporter,,Drug: indinavir | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
6452,indinavir,protease,enzyme,,Drug: indinavir | Target: protease | Type: enzyme | Action: nan
6453,indinavir,protease,unclassified,,Drug: indinavir | Target: protease | Type: unclassified | Action: nan
6454,indinavir,protease,unclassified,,Drug: indinavir | Target: protease | Type: unclassified | Action: nan
6455,indisetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: indisetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
6456,indobufen,prostaglandin g/h synthase 2,enzyme,,Drug: indobufen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6457,indobufen,prostaglandin g/h synthase 1,enzyme,,Drug: indobufen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6458,indomethacin,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: indomethacin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
6459,indomethacin,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: indomethacin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
6460,indomethacin,multidrug resistance protein 1,transporter,,Drug: indomethacin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
6461,indomethacin,multidrug resistance-associated protein 1,transporter,,Drug: indomethacin | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
6462,indomethacin,androgen receptor,nuclear hormone receptor,,Drug: indomethacin | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
6463,indomethacin,prostaglandin d2 receptor 2,gpcr,,Drug: indomethacin | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: nan
6464,indomethacin,dehydrogenase/reductase sdr family member 9,enzyme,,Drug: indomethacin | Target: dehydrogenase/reductase sdr family member 9 | Type: enzyme | Action: nan
6465,indomethacin,aldose reductase,enzyme,,Drug: indomethacin | Target: aldose reductase | Type: enzyme | Action: nan
6466,indomethacin,aldo-keto reductase family 1 member c2,enzyme,,Drug: indomethacin | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
6467,indomethacin,aldo-keto reductase family 1 member c3,enzyme,,Drug: indomethacin | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
6468,indomethacin,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: indomethacin | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
6469,indomethacin,prostaglandin e2 receptor ep2 subtype,gpcr,,Drug: indomethacin | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: nan
6470,indomethacin,lactoylglutathione lyase,enzyme,,Drug: indomethacin | Target: lactoylglutathione lyase | Type: enzyme | Action: nan
6471,indomethacin,cytochrome c oxidase subunit 2,enzyme,,Drug: indomethacin | Target: cytochrome c oxidase subunit 2 | Type: enzyme | Action: nan
6472,indomethacin,interleukin-8,cytokine,,Drug: indomethacin | Target: interleukin-8 | Type: cytokine | Action: nan
6473,indomethacin,potassium voltage-gated channel subfamily a member 7,ion channel,,Drug: indomethacin | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: nan
6474,indomethacin,aldose reductase,enzyme,,Drug: indomethacin | Target: aldose reductase | Type: enzyme | Action: nan
6475,indomethacin,prostaglandin g/h synthase 2,enzyme,,Drug: indomethacin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6476,indomethacin,prostaglandin g/h synthase 1,enzyme,,Drug: indomethacin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6477,indomethacin,aldose reductase,enzyme,,Drug: indomethacin | Target: aldose reductase | Type: enzyme | Action: nan
6478,indomethacin,prostaglandin g/h synthase 1,enzyme,,Drug: indomethacin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6479,indomethacin,prostaglandin-h2 d-isomerase,enzyme,,Drug: indomethacin | Target: prostaglandin-h2 d-isomerase | Type: enzyme | Action: nan
6480,indomethacin,prostaglandin g/h synthase 2,enzyme,,Drug: indomethacin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6481,indomethacin,prostaglandin g/h synthase 1,enzyme,,Drug: indomethacin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6482,indomethacin,prostaglandin g/h synthase 2,enzyme,,Drug: indomethacin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6483,indomethacin,prostaglandin g/h synthase 1,enzyme,,Drug: indomethacin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6484,indomethacin,cyclooxygenase,enzyme,,Drug: indomethacin | Target: cyclooxygenase | Type: enzyme | Action: nan
6485,indomethacin,cyclooxygenase,enzyme,,Drug: indomethacin | Target: cyclooxygenase | Type: enzyme | Action: nan
6486,indomethacin,prostaglandin g/h synthase (cyclooxygenase),enzyme,,Drug: indomethacin | Target: prostaglandin g/h synthase (cyclooxygenase) | Type: enzyme | Action: nan
6487,indomethacin,"nitric oxide synthase, inducible",enzyme,,"Drug: indomethacin | Target: nitric oxide synthase, inducible | Type: enzyme | Action: nan"
6488,indomethacin,prostaglandin e synthase,enzyme,,Drug: indomethacin | Target: prostaglandin e synthase | Type: enzyme | Action: nan
6489,indomethacin,aldo-keto reductase family 1 member c4,enzyme,,Drug: indomethacin | Target: aldo-keto reductase family 1 member c4 | Type: enzyme | Action: nan
6490,indomethacin,prostaglandin d2 receptor 2,gpcr,AGONIST,Drug: indomethacin | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: AGONIST
6491,indomethacin,nicotinate phosphoribosyltransferase,enzyme,,Drug: indomethacin | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
6492,indoprofen,"fatty acid-binding protein, liver",unclassified,,"Drug: indoprofen | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
6493,indoprofen,luciferin 4-monooxygenase,unclassified,,Drug: indoprofen | Target: luciferin 4-monooxygenase | Type: unclassified | Action: nan
6494,indoramin,alpha-2a adrenergic receptor,gpcr,,Drug: indoramin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
6495,indoramin,alpha-1a adrenergic receptor,gpcr,,Drug: indoramin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
6496,indoramin,alpha-2b adrenergic receptor,gpcr,,Drug: indoramin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
6497,indoramin,alpha-2c adrenergic receptor,gpcr,,Drug: indoramin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
6498,indoramin,d(4) dopamine receptor,gpcr,,Drug: indoramin | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
6499,indoramin,alpha-1d adrenergic receptor,gpcr,,Drug: indoramin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
6500,indoramin,alpha-1b adrenergic receptor,gpcr,,Drug: indoramin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
6501,indoramin,alpha-1d adrenergic receptor,gpcr,,Drug: indoramin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
6502,indoramin,alpha-1a adrenergic receptor,gpcr,,Drug: indoramin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
6503,indoramin,adrenergic receptor alpha-2,gpcr,,Drug: indoramin | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
6504,indoramin,adrenergic receptor alpha-1,gpcr,,Drug: indoramin | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
6505,intoplicine,dna topoisomerase 2-alpha,enzyme,,Drug: intoplicine | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: nan
6506,intoplicine,"dna topoisomerase i, mitochondrial",enzyme,,"Drug: intoplicine | Target: dna topoisomerase i, mitochondrial | Type: enzyme | Action: nan"
6507,intoplicine,dna topoisomerase 1,enzyme,,Drug: intoplicine | Target: dna topoisomerase 1 | Type: enzyme | Action: nan
6508,diiodohydroxyquinoline,adenosine receptor a3,gpcr,,Drug: diiodohydroxyquinoline | Target: adenosine receptor a3 | Type: gpcr | Action: nan
6509,diiodohydroxyquinoline,epidermal growth factor receptor,kinase,,Drug: diiodohydroxyquinoline | Target: epidermal growth factor receptor | Type: kinase | Action: nan
6510,diiodohydroxyquinoline,tyrosine-protein kinase lck,kinase,,Drug: diiodohydroxyquinoline | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
6511,diiodohydroxyquinoline,tyrosine-protein kinase fyn,kinase,,Drug: diiodohydroxyquinoline | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
6512,diiodohydroxyquinoline,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: diiodohydroxyquinoline | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
6513,diiodohydroxyquinoline,mitogen-activated protein kinase 3,kinase,,Drug: diiodohydroxyquinoline | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
6514,diiodohydroxyquinoline,mitogen-activated protein kinase 14,kinase,,Drug: diiodohydroxyquinoline | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
6515,diiodohydroxyquinoline,angiotensin-converting enzyme,enzyme,,Drug: diiodohydroxyquinoline | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
6516,diiodohydroxyquinoline,mitogen-activated protein kinase 1,kinase,,Drug: diiodohydroxyquinoline | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
6517,diiodohydroxyquinoline,catechol o-methyltransferase,enzyme,,Drug: diiodohydroxyquinoline | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
6518,ipratropium,muscarinic acetylcholine receptor m1,gpcr,,Drug: ipratropium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
6519,ipratropium,muscarinic acetylcholine receptor m2,gpcr,,Drug: ipratropium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
6520,ipratropium,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: ipratropium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
6521,ipratropium,muscarinic acetylcholine receptor m4,gpcr,,Drug: ipratropium | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
6522,ipratropium,muscarinic acetylcholine receptor m5,gpcr,,Drug: ipratropium | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
6523,ipratropium,muscarinic acetylcholine receptor m2,gpcr,,Drug: ipratropium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
6524,ipratropium,muscarinic acetylcholine receptor m1,gpcr,,Drug: ipratropium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
6525,ipratropium,muscarinic acetylcholine receptor m3,gpcr,,Drug: ipratropium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
6526,ipratropium,solute carrier family 22 member 2,transporter,,Drug: ipratropium | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
6527,ipriflavone,prostaglandin g/h synthase 1,enzyme,,Drug: ipriflavone | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6528,ipriflavone,sodium-dependent noradrenaline transporter,transporter,,Drug: ipriflavone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
6529,iprindole,sodium-dependent serotonin transporter,transporter,,Drug: iprindole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6530,iprindole,sodium-dependent noradrenaline transporter,transporter,,Drug: iprindole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
6531,iprindole,histamine h1 receptor,gpcr,,Drug: iprindole | Target: histamine h1 receptor | Type: gpcr | Action: nan
6532,iprindole,sodium-dependent dopamine transporter,transporter,,Drug: iprindole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
6533,iproniazid,amine oxidase [flavin-containing] b,enzyme,,Drug: iproniazid | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
6534,iproniazid,amine oxidase [flavin-containing] a,enzyme,,Drug: iproniazid | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
6535,iproniazid,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: iproniazid | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
6536,iproniazid,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: iproniazid | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
6537,irbesartan,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: irbesartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
6538,irbesartan,endothelin-1 receptor,gpcr,,Drug: irbesartan | Target: endothelin-1 receptor | Type: gpcr | Action: nan
6539,irbesartan,type-1b angiotensin ii receptor,gpcr,,Drug: irbesartan | Target: type-1b angiotensin ii receptor | Type: gpcr | Action: nan
6540,irbesartan,angiotensin ii receptor (at-1) type-1,gpcr,,Drug: irbesartan | Target: angiotensin ii receptor (at-1) type-1 | Type: gpcr | Action: nan
6541,irbesartan,angiotensin ii receptor,gpcr,,Drug: irbesartan | Target: angiotensin ii receptor | Type: gpcr | Action: nan
6542,irbesartan,sodium/bile acid cotransporter,transporter,INHIBITOR,Drug: irbesartan | Target: sodium/bile acid cotransporter | Type: transporter | Action: INHIBITOR
6543,irinotecan,multidrug resistance protein 1,transporter,,Drug: irinotecan | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
6544,irinotecan,muscarinic acetylcholine receptor m4,gpcr,,Drug: irinotecan | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
6545,irinotecan,canalicular multispecific organic anion transporter 1,transporter,,Drug: irinotecan | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
6546,irinotecan,alpha-2c adrenergic receptor,gpcr,,Drug: irinotecan | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
6547,irinotecan,multidrug resistance-associated protein 1,transporter,,Drug: irinotecan | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
6548,irinotecan,atp-binding cassette sub-family g member 2,transporter,,Drug: irinotecan | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
6549,irinotecan,multidrug resistance-associated protein 4,transporter,,Drug: irinotecan | Target: multidrug resistance-associated protein 4 | Type: transporter | Action: nan
6550,irinotecan,acetylcholinesterase,enzyme,,Drug: irinotecan | Target: acetylcholinesterase | Type: enzyme | Action: nan
6551,irinotecan,dna topoisomerase 1,enzyme,INHIBITOR,Drug: irinotecan | Target: dna topoisomerase 1 | Type: enzyme | Action: INHIBITOR
6552,irinotecan,interstitial collagenase,enzyme,,Drug: irinotecan | Target: interstitial collagenase | Type: enzyme | Action: nan
6553,irinotecan,solute carrier family 22 member 1,transporter,,Drug: irinotecan | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
6554,irinotecan,acetylcholinesterase,enzyme,,Drug: irinotecan | Target: acetylcholinesterase | Type: enzyme | Action: nan
6555,irinotecan,solute carrier family 22 member 2,transporter,,Drug: irinotecan | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
6556,irinotecan,multidrug and toxin extrusion protein 1,transporter,,Drug: irinotecan | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
6557,irinotecan,multidrug and toxin extrusion protein 2,transporter,,Drug: irinotecan | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
6558,irinotecan,solute carrier family 22 member 3,transporter,,Drug: irinotecan | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
6559,irofulven,serine/threonine-protein kinase chk2,kinase,,Drug: irofulven | Target: serine/threonine-protein kinase chk2 | Type: kinase | Action: nan
6560,isepamicin,"macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b)",enzyme,,"Drug: isepamicin | Target: macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b) | Type: enzyme | Action: nan"
6561,isocarboxazid,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: isocarboxazid | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
6562,isocarboxazid,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: isocarboxazid | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
6563,isoetarine,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: isoetarine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
6564,isoflurane,5-hydroxytryptamine receptor 2b,gpcr,,Drug: isoflurane | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
6565,isoflurane,potassium channel subfamily k member 2,ion channel,OPENER,Drug: isoflurane | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: OPENER
6566,isoflurane,potassium channel subfamily k member 3,ion channel,OPENER,Drug: isoflurane | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: OPENER
6567,isoflurane,potassium channel subfamily k member 9,ion channel,OPENER,Drug: isoflurane | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: OPENER
6568,isoflurane,potassium channel subfamily k member 10,ion channel,OPENER,Drug: isoflurane | Target: potassium channel subfamily k member 10 | Type: ion channel | Action: OPENER
6569,isoflurane,potassium channel subfamily k member 18,ion channel,OPENER,Drug: isoflurane | Target: potassium channel subfamily k member 18 | Type: ion channel | Action: OPENER
6570,isoflurane,glycine receptor (alpha-1/beta),ion channel,POSITIVE MODULATOR,Drug: isoflurane | Target: glycine receptor (alpha-1/beta) | Type: ion channel | Action: POSITIVE MODULATOR
6571,isoflurane,gaba-a receptor; anion channel,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: isoflurane | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
6572,fluostigmine,prostaglandin g/h synthase 2,enzyme,,Drug: fluostigmine | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6573,fluostigmine,acetylcholinesterase,enzyme,INHIBITOR,Drug: fluostigmine | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
6574,fluostigmine,acetylcholinesterase,enzyme,,Drug: fluostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
6575,fluostigmine,acetylcholinesterase,enzyme,,Drug: fluostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
6576,fluostigmine,lysosomal protective protein,enzyme,,Drug: fluostigmine | Target: lysosomal protective protein | Type: enzyme | Action: nan
6577,fluostigmine,liver carboxylesterase,enzyme,,Drug: fluostigmine | Target: liver carboxylesterase | Type: enzyme | Action: nan
6578,isoniazid,cytochrome p450 3a4,enzyme,,Drug: isoniazid | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
6579,isoniazid,catalase-peroxidase,enzyme,,Drug: isoniazid | Target: catalase-peroxidase | Type: enzyme | Action: nan
6580,isoniazid,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,INHIBITOR,Drug: isoniazid | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: INHIBITOR
6581,isoniazid,myeloperoxidase,enzyme,,Drug: isoniazid | Target: myeloperoxidase | Type: enzyme | Action: nan
6582,isoniazid,cytochrome p450 3a5,enzyme,,Drug: isoniazid | Target: cytochrome p450 3a5 | Type: enzyme | Action: nan
6583,isoniazid,dihydrofolate reductase,enzyme,,Drug: isoniazid | Target: dihydrofolate reductase | Type: enzyme | Action: nan
6584,isoprenaline,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: isoprenaline | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
6585,isoprenaline,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: isoprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
6586,isoprenaline,d(2) dopamine receptor,gpcr,,Drug: isoprenaline | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
6587,isoprenaline,d(3) dopamine receptor,gpcr,,Drug: isoprenaline | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
6588,isoprenaline,beta-3 adrenergic receptor,gpcr,AGONIST,Drug: isoprenaline | Target: beta-3 adrenergic receptor | Type: gpcr | Action: AGONIST
6589,isoprenaline,d(4) dopamine receptor,gpcr,,Drug: isoprenaline | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
6590,isoprenaline,arachidonate 15-lipoxygenase,enzyme,,Drug: isoprenaline | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
6591,isoprenaline,beta-2 adrenergic receptor,gpcr,,Drug: isoprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
6592,isoprenaline,beta-2 adrenergic receptor,gpcr,,Drug: isoprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
6593,isoprenaline,beta-1 adrenergic receptor,gpcr,,Drug: isoprenaline | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
6594,isoprenaline,beta-2 adrenergic receptor,gpcr,,Drug: isoprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
6595,isoprenaline,taste receptor type 2 member 14,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 14 | Type: gpcr | Action: nan
6596,isoprenaline,taste receptor type 2 member 46,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 46 | Type: gpcr | Action: nan
6597,isoprenaline,beta-2 adrenergic receptor,gpcr,,Drug: isoprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
6598,isoprenaline,beta-3 adrenergic receptor,gpcr,AGONIST,Drug: isoprenaline | Target: beta-3 adrenergic receptor | Type: gpcr | Action: AGONIST
6599,isoprenaline,beta-3 adrenergic receptor,gpcr,AGONIST,Drug: isoprenaline | Target: beta-3 adrenergic receptor | Type: gpcr | Action: AGONIST
6600,isoprenaline,beta-1 adrenergic receptor,gpcr,,Drug: isoprenaline | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
6601,isoprenaline,taste receptor type 2 member 38,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 38 | Type: gpcr | Action: nan
6602,isoprenaline,taste receptor type 2 member 39,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 39 | Type: gpcr | Action: nan
6603,isoprenaline,taste receptor type 2 member 40,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 40 | Type: gpcr | Action: nan
6604,isoprenaline,taste receptor type 2 member 41,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 41 | Type: gpcr | Action: nan
6605,isoprenaline,taste receptor type 2 member 43,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 43 | Type: gpcr | Action: nan
6606,isoprenaline,taste receptor type 2 member 31,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 31 | Type: gpcr | Action: nan
6607,isoprenaline,taste receptor type 2 member 45,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 45 | Type: gpcr | Action: nan
6609,isoprenaline,taste receptor type 2 member 30,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 30 | Type: gpcr | Action: nan
6610,isoprenaline,taste receptor type 2 member 19,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 19 | Type: gpcr | Action: nan
6611,isoprenaline,taste receptor type 2 member 20,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 20 | Type: gpcr | Action: nan
6612,isoprenaline,taste receptor type 2 member 50,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 50 | Type: gpcr | Action: nan
6613,isoprenaline,taste receptor type 2 member 60,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 60 | Type: gpcr | Action: nan
6614,isoprenaline,taste receptor type 2 member 42,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 42 | Type: gpcr | Action: nan
6615,isoprenaline,taste receptor type 2 member 16,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 16 | Type: gpcr | Action: nan
6616,isoprenaline,taste receptor type 2 member 14,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 14 | Type: gpcr | Action: nan
6617,isoprenaline,taste receptor type 2 member 13,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 13 | Type: gpcr | Action: nan
6618,isoprenaline,taste receptor type 2 member 10,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 10 | Type: gpcr | Action: nan
6619,isoprenaline,taste receptor type 2 member 9,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 9 | Type: gpcr | Action: nan
6620,isoprenaline,taste receptor type 2 member 8,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 8 | Type: gpcr | Action: nan
6621,isoprenaline,taste receptor type 2 member 7,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 7 | Type: gpcr | Action: nan
6622,isoprenaline,taste receptor type 2 member 5,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 5 | Type: gpcr | Action: nan
6623,isoprenaline,taste receptor type 2 member 4,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 4 | Type: gpcr | Action: nan
6624,isoprenaline,taste receptor type 2 member 3,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 3 | Type: gpcr | Action: nan
6625,isoprenaline,taste receptor type 2 member 1,gpcr,,Drug: isoprenaline | Target: taste receptor type 2 member 1 | Type: gpcr | Action: nan
6626,isopropamide,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: isopropamide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
6627,isopropamide,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: isopropamide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
6628,isosorbide dinitrate,atrial natriuretic peptide receptor 1,enzyme,,Drug: isosorbide dinitrate | Target: atrial natriuretic peptide receptor 1 | Type: enzyme | Action: nan
6629,isosorbide dinitrate,soluble guanylate cyclase,enzyme,ACTIVATOR,Drug: isosorbide dinitrate | Target: soluble guanylate cyclase | Type: enzyme | Action: ACTIVATOR
6630,isosorbide mononitrate,atrial natriuretic peptide receptor 1,enzyme,,Drug: isosorbide mononitrate | Target: atrial natriuretic peptide receptor 1 | Type: enzyme | Action: nan
6631,isosorbide mononitrate,soluble guanylate cyclase,enzyme,ACTIVATOR,Drug: isosorbide mononitrate | Target: soluble guanylate cyclase | Type: enzyme | Action: ACTIVATOR
6632,isotretinoin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: isotretinoin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
6633,isotretinoin,alpha-2b adrenergic receptor,gpcr,,Drug: isotretinoin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
6634,isotretinoin,adenosine receptor a3,gpcr,,Drug: isotretinoin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
6635,isotretinoin,retinoic acid receptor alpha,nuclear hormone receptor,,Drug: isotretinoin | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: nan
6636,isotretinoin,alcohol dehydrogenase 4,enzyme,,Drug: isotretinoin | Target: alcohol dehydrogenase 4 | Type: enzyme | Action: nan
6637,isotretinoin,dehydrogenase/reductase sdr family member 9,enzyme,,Drug: isotretinoin | Target: dehydrogenase/reductase sdr family member 9 | Type: enzyme | Action: nan
6638,isotretinoin,11-cis retinol dehydrogenase,enzyme,,Drug: isotretinoin | Target: 11-cis retinol dehydrogenase | Type: enzyme | Action: nan
6639,isotretinoin,17-beta-hydroxysteroid dehydrogenase type 6,enzyme,,Drug: isotretinoin | Target: 17-beta-hydroxysteroid dehydrogenase type 6 | Type: enzyme | Action: nan
6640,isotretinoin,retinoic acid receptor beta,nuclear hormone receptor,INHIBITOR,Drug: isotretinoin | Target: retinoic acid receptor beta | Type: nuclear hormone receptor | Action: INHIBITOR
6641,isotretinoin,mitogen-activated protein kinase 14,kinase,,Drug: isotretinoin | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
6642,isotretinoin,mitogen-activated protein kinase 1,kinase,,Drug: isotretinoin | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
6643,isotretinoin,cellular retinoic acid-binding protein 1,cytosolic other,,Drug: isotretinoin | Target: cellular retinoic acid-binding protein 1 | Type: cytosolic other | Action: nan
6644,isotretinoin,olfactory receptor 51e2,gpcr,,Drug: isotretinoin | Target: olfactory receptor 51e2 | Type: gpcr | Action: nan
6645,isoxicam,prostaglandin g/h synthase 2,enzyme,,Drug: isoxicam | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6646,isoxicam,prostaglandin g/h synthase 1,enzyme,,Drug: isoxicam | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6647,isradipine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: isradipine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
6648,isradipine,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: isradipine | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
6649,isradipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,GATING INHIBITOR,Drug: isradipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: GATING INHIBITOR
6650,isradipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,GATING INHIBITOR,Drug: isradipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: GATING INHIBITOR
6651,isradipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: isradipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
6652,isradipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: isradipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
6653,isradipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,,Drug: isradipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: nan
6654,isradipine,voltage-dependent l-type calcium channel subunit alpha-1f,ion channel,GATING INHIBITOR,Drug: isradipine | Target: voltage-dependent l-type calcium channel subunit alpha-1f | Type: ion channel | Action: GATING INHIBITOR
6655,isradipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,GATING INHIBITOR,Drug: isradipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: GATING INHIBITOR
6656,itraconazole,beta-2 adrenergic receptor,gpcr,,Drug: itraconazole | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
6657,itraconazole,cytochrome p450 3a4,enzyme,,Drug: itraconazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
6658,itraconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: itraconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
6659,itraconazole,vasopressin v2 receptor,gpcr,,Drug: itraconazole | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
6660,itraconazole,tyrosine-protein kinase fyn,kinase,,Drug: itraconazole | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
6661,itraconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: itraconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
6662,itraconazole,c-c chemokine receptor type 4,gpcr,,Drug: itraconazole | Target: c-c chemokine receptor type 4 | Type: gpcr | Action: nan
6663,itraconazole,c-x-c chemokine receptor type 1,gpcr,,Drug: itraconazole | Target: c-x-c chemokine receptor type 1 | Type: gpcr | Action: nan
6664,itraconazole,cruzipain,enzyme,,Drug: itraconazole | Target: cruzipain | Type: enzyme | Action: nan
6665,itraconazole,14-alpha sterol demethylase cyp51a,enzyme,,Drug: itraconazole | Target: 14-alpha sterol demethylase cyp51a | Type: enzyme | Action: nan
6666,itraconazole,14-alpha sterol demethylase,enzyme,,Drug: itraconazole | Target: 14-alpha sterol demethylase | Type: enzyme | Action: nan
6667,itraconazole,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,enzyme,,Drug: itraconazole | Target: 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase | Type: enzyme | Action: nan
6668,ixabepilone,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: ixabepilone | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
6669,kanamycin,"macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b)",enzyme,,"Drug: kanamycin | Target: macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b) | Type: enzyme | Action: nan"
6670,kanamycin,3-oxoacyl-[acyl-carrier-protein] synthase 3,unclassified,,Drug: kanamycin | Target: 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Type: unclassified | Action: nan
6671,kanamycin,gap junction beta-2 protein,unclassified,,Drug: kanamycin | Target: gap junction beta-2 protein | Type: unclassified | Action: nan
6672,bekanamycin,3-oxoacyl-[acyl-carrier-protein] synthase 3,enzyme,,Drug: bekanamycin | Target: 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Type: enzyme | Action: nan
6673,bekanamycin,3-oxoacyl-[acyl-carrier-protein] synthase 3,unclassified,,Drug: bekanamycin | Target: 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Type: unclassified | Action: nan
6674,ketamine,acetylcholine receptor subunit alpha,ion channel,,Drug: ketamine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
6675,ketamine,glutamate [nmda] receptor,ion channel,BLOCKER,Drug: ketamine | Target: glutamate [nmda] receptor | Type: ion channel | Action: BLOCKER
6676,ketamine,glutamate nmda receptor,ion channel,,Drug: ketamine | Target: glutamate nmda receptor | Type: ion channel | Action: nan
6677,ketamine,glutamate receptor ionotropic ampa,ion channel,OPENER,Drug: ketamine | Target: glutamate receptor ionotropic ampa | Type: ion channel | Action: OPENER
6678,ketanserin,d(1a) dopamine receptor,gpcr,ANTAGONIST,Drug: ketanserin | Target: d(1a) dopamine receptor | Type: gpcr | Action: ANTAGONIST
6679,ketanserin,d(2) dopamine receptor,gpcr,,Drug: ketanserin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
6680,ketanserin,alpha-2a adrenergic receptor,gpcr,,Drug: ketanserin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
6681,ketanserin,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: ketanserin | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6682,ketanserin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ketanserin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
6683,ketanserin,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
6684,ketanserin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
6685,ketanserin,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
6686,ketanserin,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
6687,ketanserin,5-hydroxytryptamine receptor 6,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
6688,ketanserin,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
6689,ketanserin,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: ketanserin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
6690,ketanserin,alpha-2b adrenergic receptor,gpcr,,Drug: ketanserin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
6691,ketanserin,d(1b) dopamine receptor,gpcr,ANTAGONIST,Drug: ketanserin | Target: d(1b) dopamine receptor | Type: gpcr | Action: ANTAGONIST
6692,ketanserin,histamine h1 receptor,gpcr,,Drug: ketanserin | Target: histamine h1 receptor | Type: gpcr | Action: nan
6693,ketanserin,5-hydroxytryptamine receptor 1b,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
6694,ketanserin,5-hydroxytryptamine receptor 1d,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
6695,ketanserin,adenosine receptor a3,gpcr,,Drug: ketanserin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
6696,ketanserin,d(4) dopamine receptor,gpcr,,Drug: ketanserin | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
6697,ketanserin,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: ketanserin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
6698,ketanserin,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: ketanserin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
6699,ketanserin,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
6700,ketanserin,5-hydroxytryptamine receptor 1f,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
6701,ketanserin,synaptic vesicular amine transporter,transporter,,Drug: ketanserin | Target: synaptic vesicular amine transporter | Type: transporter | Action: nan
6702,ketanserin,5-hydroxytryptamine receptor 1b,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
6703,ketanserin,d(2) dopamine receptor,gpcr,,Drug: ketanserin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
6704,ketanserin,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
6705,ketanserin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
6706,ketanserin,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
6707,ketanserin,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
6708,ketanserin,5-hydroxytryptamine receptor 2c,gpcr,,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
6709,ketanserin,chromaffin granule amine transporter,transporter,INHIBITOR,Drug: ketanserin | Target: chromaffin granule amine transporter | Type: transporter | Action: INHIBITOR
6710,ketanserin,adrenergic receptor alpha-1,gpcr,,Drug: ketanserin | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
6711,ketanserin,serotonin 2 (5-ht2) receptor,gpcr,,Drug: ketanserin | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
6712,ketanserin,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: ketanserin | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
6713,ketanserin,synaptic vesicular amine transporter,transporter,,Drug: ketanserin | Target: synaptic vesicular amine transporter | Type: transporter | Action: nan
6714,ketobemidone,mu-type opioid receptor,gpcr,,Drug: ketobemidone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
6715,ketobemidone,kappa-type opioid receptor,gpcr,,Drug: ketobemidone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
6716,ketobemidone,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: ketobemidone | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
6717,ketobemidone,delta-type opioid receptor,gpcr,,Drug: ketobemidone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
6718,ketobemidone,opioid receptor,gpcr,,Drug: ketobemidone | Target: opioid receptor | Type: gpcr | Action: nan
6719,ketobemidone,opioid receptor,gpcr,,Drug: ketobemidone | Target: opioid receptor | Type: gpcr | Action: nan
6720,ketoconazole,sodium/nucleoside cotransporter 1,transporter,,Drug: ketoconazole | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
6721,ketoconazole,alpha-2a adrenergic receptor,gpcr,,Drug: ketoconazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
6722,ketoconazole,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ketoconazole | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
6723,ketoconazole,cytochrome p450 3a4,enzyme,,Drug: ketoconazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
6724,ketoconazole,multidrug resistance protein 1,transporter,,Drug: ketoconazole | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
6725,ketoconazole,sodium-dependent serotonin transporter,transporter,,Drug: ketoconazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6726,ketoconazole,sodium-dependent noradrenaline transporter,transporter,,Drug: ketoconazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
6727,ketoconazole,alpha-2b adrenergic receptor,gpcr,,Drug: ketoconazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
6728,ketoconazole,histamine h2 receptor,gpcr,,Drug: ketoconazole | Target: histamine h2 receptor | Type: gpcr | Action: nan
6729,ketoconazole,muscarinic acetylcholine receptor m2,gpcr,,Drug: ketoconazole | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
6730,ketoconazole,aldehyde oxidase,enzyme,,Drug: ketoconazole | Target: aldehyde oxidase | Type: enzyme | Action: nan
6731,ketoconazole,sodium-dependent dopamine transporter,transporter,,Drug: ketoconazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
6732,ketoconazole,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: ketoconazole | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
6733,ketoconazole,alpha-1d adrenergic receptor,gpcr,,Drug: ketoconazole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
6734,ketoconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: ketoconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
6735,ketoconazole,delta-type opioid receptor,gpcr,,Drug: ketoconazole | Target: delta-type opioid receptor | Type: gpcr | Action: nan
6736,ketoconazole,bile salt export pump,transporter,,Drug: ketoconazole | Target: bile salt export pump | Type: transporter | Action: nan
6737,ketoconazole,cytochrome p450 2c9,enzyme,,Drug: ketoconazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
6738,ketoconazole,aromatase,enzyme,,Drug: ketoconazole | Target: aromatase | Type: enzyme | Action: nan
6739,ketoconazole,"25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial",enzyme,,"Drug: ketoconazole | Target: 25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial | Type: enzyme | Action: nan"
6740,ketoconazole,potassium voltage-gated channel subfamily a member 10,ion channel,BLOCKER,Drug: ketoconazole | Target: potassium voltage-gated channel subfamily a member 10 | Type: ion channel | Action: BLOCKER
6741,ketoconazole,cytochrome p450 2c19,enzyme,,Drug: ketoconazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
6742,ketoconazole,thromboxane-a synthase,enzyme,,Drug: ketoconazole | Target: thromboxane-a synthase | Type: enzyme | Action: nan
6743,ketoconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: ketoconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
6744,ketoconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: ketoconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
6745,ketoconazole,solute carrier family 22 member 1,transporter,,Drug: ketoconazole | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
6746,ketoconazole,substance-k receptor,gpcr,,Drug: ketoconazole | Target: substance-k receptor | Type: gpcr | Action: nan
6747,ketoconazole,cytochrome p450 3a5,enzyme,,Drug: ketoconazole | Target: cytochrome p450 3a5 | Type: enzyme | Action: nan
6748,ketoconazole,arachidonate 15-lipoxygenase,enzyme,,Drug: ketoconazole | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
6749,ketoconazole,alpha-1b adrenergic receptor,gpcr,,Drug: ketoconazole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
6750,ketoconazole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: ketoconazole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
6751,ketoconazole,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: ketoconazole | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
6752,ketoconazole,alpha-1a adrenergic receptor,gpcr,,Drug: ketoconazole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
6753,ketoconazole,gonadotropin-releasing hormone receptor,gpcr,,Drug: ketoconazole | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: nan
6754,ketoconazole,"1,25-dihydroxyvitamin d(3) 24-hydroxylase, mitochondrial",enzyme,,"Drug: ketoconazole | Target: 1,25-dihydroxyvitamin d(3) 24-hydroxylase, mitochondrial | Type: enzyme | Action: nan"
6755,ketoconazole,cytochrome p450 21,enzyme,,Drug: ketoconazole | Target: cytochrome p450 21 | Type: enzyme | Action: nan
6756,ketoconazole,cytochrome p450 11b1,enzyme,,Drug: ketoconazole | Target: cytochrome p450 11b1 | Type: enzyme | Action: nan
6757,ketoconazole,cytochrome p450 11a1,enzyme,,Drug: ketoconazole | Target: cytochrome p450 11a1 | Type: enzyme | Action: nan
6758,ketoconazole,cytochrome p450 24a1,enzyme,,Drug: ketoconazole | Target: cytochrome p450 24a1 | Type: enzyme | Action: nan
6759,ketoconazole,cytochrome p450 7a1,enzyme,,Drug: ketoconazole | Target: cytochrome p450 7a1 | Type: enzyme | Action: nan
6760,ketoconazole,cytochrome p450 51,enzyme,,Drug: ketoconazole | Target: cytochrome p450 51 | Type: enzyme | Action: nan
6761,ketoconazole,cytochrome p450 17a1,enzyme,,Drug: ketoconazole | Target: cytochrome p450 17a1 | Type: enzyme | Action: nan
6762,ketoconazole,bile salt export pump,transporter,,Drug: ketoconazole | Target: bile salt export pump | Type: transporter | Action: nan
6763,ketoconazole,"25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial",enzyme,,"Drug: ketoconazole | Target: 25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial | Type: enzyme | Action: nan"
6764,ketoconazole,"cytochrome p450 11b2, mitochondrial",enzyme,INHIBITOR,"Drug: ketoconazole | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: INHIBITOR"
6765,ketoconazole,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,INHIBITOR,"Drug: ketoconazole | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: INHIBITOR"
6766,ketoconazole,"cytochrome p450 11b1, mitochondrial",enzyme,INHIBITOR,"Drug: ketoconazole | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: INHIBITOR"
6767,ketoprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: ketoprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
6768,ketoprofen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: ketoprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
6769,ketoprofen,prostaglandin g/h synthase 1,enzyme,,Drug: ketoprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
6770,ketoprofen,prostaglandin g/h synthase 2,enzyme,,Drug: ketoprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
6771,ketoprofen,cyclooxygenase,enzyme,,Drug: ketoprofen | Target: cyclooxygenase | Type: enzyme | Action: nan
6772,ketorolac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: ketorolac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
6773,ketorolac,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: ketorolac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
6774,ketorolac,"fatty acid-binding protein, liver",unclassified,,"Drug: ketorolac | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
6775,ketorolac,aldose reductase,enzyme,,Drug: ketorolac | Target: aldose reductase | Type: enzyme | Action: nan
6776,ketorolac,prostaglandin-h2 d-isomerase,enzyme,,Drug: ketorolac | Target: prostaglandin-h2 d-isomerase | Type: enzyme | Action: nan
6777,ketorolac,serine/threonine-protein kinase pak 1,kinase,,Drug: ketorolac | Target: serine/threonine-protein kinase pak 1 | Type: kinase | Action: nan
6778,ketotifen,d(1a) dopamine receptor,gpcr,,Drug: ketotifen | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
6779,ketotifen,alpha-2a adrenergic receptor,gpcr,,Drug: ketotifen | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
6780,ketotifen,multidrug resistance protein 1,transporter,,Drug: ketotifen | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
6781,ketotifen,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ketotifen | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
6782,ketotifen,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ketotifen | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
6783,ketotifen,5-hydroxytryptamine receptor 2b,gpcr,,Drug: ketotifen | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
6784,ketotifen,5-hydroxytryptamine receptor 2c,gpcr,,Drug: ketotifen | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
6785,ketotifen,5-hydroxytryptamine receptor 6,gpcr,,Drug: ketotifen | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
6786,ketotifen,alpha-2b adrenergic receptor,gpcr,,Drug: ketotifen | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
6787,ketotifen,d(3) dopamine receptor,gpcr,,Drug: ketotifen | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
6788,ketotifen,histamine h1 receptor,gpcr,ANTAGONIST,Drug: ketotifen | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
6789,ketotifen,histamine h2 receptor,gpcr,,Drug: ketotifen | Target: histamine h2 receptor | Type: gpcr | Action: nan
6790,ketotifen,histamine h4 receptor,gpcr,,Drug: ketotifen | Target: histamine h4 receptor | Type: gpcr | Action: nan
6791,ketotifen,muscarinic acetylcholine receptor m1,gpcr,,Drug: ketotifen | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
6792,ketotifen,muscarinic acetylcholine receptor m2,gpcr,,Drug: ketotifen | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
6793,ketotifen,muscarinic acetylcholine receptor m3,gpcr,,Drug: ketotifen | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
6794,ketotifen,muscarinic acetylcholine receptor m4,gpcr,,Drug: ketotifen | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
6795,ketotifen,muscarinic acetylcholine receptor m5,gpcr,,Drug: ketotifen | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
6796,ketotifen,alpha-1d adrenergic receptor,gpcr,,Drug: ketotifen | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
6797,ketotifen,histamine h1 receptor,gpcr,,Drug: ketotifen | Target: histamine h1 receptor | Type: gpcr | Action: nan
6798,ketotifen,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ketotifen | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
6799,labetalol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: labetalol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
6800,labetalol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: labetalol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
6801,labetalol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: labetalol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6802,labetalol,sodium-dependent noradrenaline transporter,transporter,,Drug: labetalol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
6803,labetalol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: labetalol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
6804,labetalol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: labetalol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
6805,labetalol,sodium-dependent dopamine transporter,transporter,,Drug: labetalol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
6806,labetalol,cytochrome p450 2d6,enzyme,,Drug: labetalol | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
6807,labetalol,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: labetalol | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
6808,labetalol,alpha-1b adrenergic receptor,gpcr,,Drug: labetalol | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
6809,labetalol,alpha-1a adrenergic receptor,gpcr,,Drug: labetalol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
6810,labetalol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: labetalol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
6811,labetalol,caax prenyl protease 1,enzyme,,Drug: labetalol | Target: caax prenyl protease 1 | Type: enzyme | Action: nan
6812,labetalol,caax prenyl protease 2,enzyme,,Drug: labetalol | Target: caax prenyl protease 2 | Type: enzyme | Action: nan
6813,lacidipine,cytochrome p450 3a4,enzyme,,Drug: lacidipine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
6814,lacidipine,sodium-dependent noradrenaline transporter,transporter,,Drug: lacidipine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
6815,lacidipine,d(3) dopamine receptor,gpcr,,Drug: lacidipine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
6816,lacidipine,adenosine receptor a3,gpcr,,Drug: lacidipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
6817,lacidipine,cytochrome p450 2c9,enzyme,,Drug: lacidipine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
6818,lacidipine,cytochrome p450 2c19,enzyme,,Drug: lacidipine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
6819,lacidipine,thromboxane-a synthase,enzyme,,Drug: lacidipine | Target: thromboxane-a synthase | Type: enzyme | Action: nan
6820,lacidipine,androgen receptor,transcription factor,,Drug: lacidipine | Target: androgen receptor | Type: transcription factor | Action: nan
6821,lacidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: lacidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
6822,lactose,galectin-8,unclassified,,Drug: lactose | Target: galectin-8 | Type: unclassified | Action: nan
6823,lactose,galectin-9,unclassified,,Drug: lactose | Target: galectin-9 | Type: unclassified | Action: nan
6824,lactose,galectin-3,unclassified,,Drug: lactose | Target: galectin-3 | Type: unclassified | Action: nan
6825,lamivudine,deoxycytidine kinase,kinase,,Drug: lamivudine | Target: deoxycytidine kinase | Type: kinase | Action: nan
6826,lamivudine,protein p,polyprotein,INHIBITOR,Drug: lamivudine | Target: protein p | Type: polyprotein | Action: INHIBITOR
6827,lamivudine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: lamivudine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
6828,lamotrigine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: lamotrigine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
6829,lamotrigine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: lamotrigine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6830,lamotrigine,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: lamotrigine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
6831,lamotrigine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: lamotrigine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
6832,lamotrigine,sodium channel protein type 3 subunit alpha,ion channel,BLOCKER,Drug: lamotrigine | Target: sodium channel protein type 3 subunit alpha | Type: ion channel | Action: BLOCKER
6833,lamotrigine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: lamotrigine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
6834,lamotrigine,sodium channel protein type 8 subunit alpha,ion channel,BLOCKER,Drug: lamotrigine | Target: sodium channel protein type 8 subunit alpha | Type: ion channel | Action: BLOCKER
6835,lamotrigine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: lamotrigine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
6836,lamotrigine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: lamotrigine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
6837,lamotrigine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: lamotrigine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
6838,lamotrigine,sodium channel protein type 2 subunit alpha,ion channel,,Drug: lamotrigine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: nan
6839,lamotrigine,dihydrofolate reductase,enzyme,,Drug: lamotrigine | Target: dihydrofolate reductase | Type: enzyme | Action: nan
6840,lamotrigine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: lamotrigine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
6841,lamotrigine,sodium channel protein type x alpha subunit,ion channel,,Drug: lamotrigine | Target: sodium channel protein type x alpha subunit | Type: ion channel | Action: nan
6842,landiolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: landiolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
6843,lanreotide,somatostatin receptor type 2,gpcr,AGONIST,Drug: lanreotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
6844,lanreotide,somatostatin receptor type 3,gpcr,AGONIST,Drug: lanreotide | Target: somatostatin receptor type 3 | Type: gpcr | Action: AGONIST
6845,lanreotide,somatostatin receptor type 5,gpcr,AGONIST,Drug: lanreotide | Target: somatostatin receptor type 5 | Type: gpcr | Action: AGONIST
6846,lanreotide,somatostatin receptor type 2,gpcr,AGONIST,Drug: lanreotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
6847,lanreotide,somatostatin receptor type 3,gpcr,AGONIST,Drug: lanreotide | Target: somatostatin receptor type 3 | Type: gpcr | Action: AGONIST
6848,lanreotide,somatostatin receptor type 4,gpcr,,Drug: lanreotide | Target: somatostatin receptor type 4 | Type: gpcr | Action: nan
6849,lanreotide,somatostatin receptor type 5,gpcr,AGONIST,Drug: lanreotide | Target: somatostatin receptor type 5 | Type: gpcr | Action: AGONIST
6850,lanreotide,somatostatin receptor type 1,gpcr,,Drug: lanreotide | Target: somatostatin receptor type 1 | Type: gpcr | Action: nan
6851,lanreotide,somatostatin receptor type 2,gpcr,AGONIST,Drug: lanreotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
6852,lanreotide,somatostatin receptor type 3,gpcr,AGONIST,Drug: lanreotide | Target: somatostatin receptor type 3 | Type: gpcr | Action: AGONIST
6853,lansoprazole,cytochrome p450 2d6,enzyme,,Drug: lansoprazole | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
6854,lansoprazole,cytochrome p450 2c19,enzyme,,Drug: lansoprazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
6855,lansoprazole,fatty acid synthase,enzyme,,Drug: lansoprazole | Target: fatty acid synthase | Type: enzyme | Action: nan
6856,lansoprazole,phosphoethanolamine/phosphocholine phosphatase,enzyme,,Drug: lansoprazole | Target: phosphoethanolamine/phosphocholine phosphatase | Type: enzyme | Action: nan
6857,lansoprazole,microtubule-associated protein tau,structural,,Drug: lansoprazole | Target: microtubule-associated protein tau | Type: structural | Action: nan
6858,lansoprazole,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: lansoprazole | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
6859,lansoprazole,potassium-transporting atpase,transporter,INHIBITOR,Drug: lansoprazole | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
6860,lansoprazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: lansoprazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
6861,lansoprazole,"n(g),n(g)-dimethylarginine dimethylaminohydrolase 1",enzyme,,"Drug: lansoprazole | Target: n(g),n(g)-dimethylarginine dimethylaminohydrolase 1 | Type: enzyme | Action: nan"
6862,lansoprazole,cytosolic endo-beta-n-acetylglucosaminidase,enzyme,,Drug: lansoprazole | Target: cytosolic endo-beta-n-acetylglucosaminidase | Type: enzyme | Action: nan
6863,lapatinib,multidrug resistance protein 1,transporter,,Drug: lapatinib | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
6864,lapatinib,atp-binding cassette sub-family g member 2,transporter,,Drug: lapatinib | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
6865,lapatinib,platelet-derived growth factor receptor beta,kinase,,Drug: lapatinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
6866,lapatinib,tyrosine-protein kinase abl1,kinase,,Drug: lapatinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
6867,lapatinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: lapatinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
6868,lapatinib,receptor tyrosine-protein kinase erbb-2,kinase,INHIBITOR,Drug: lapatinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: INHIBITOR
6869,lapatinib,solute carrier organic anion transporter family member 1b1,transporter,,Drug: lapatinib | Target: solute carrier organic anion transporter family member 1b1 | Type: transporter | Action: nan
6870,lapatinib,cyclin-dependent kinase 2,kinase,,Drug: lapatinib | Target: cyclin-dependent kinase 2 | Type: kinase | Action: nan
6871,lapatinib,insulin receptor,kinase,AGONIST,Drug: lapatinib | Target: insulin receptor | Type: kinase | Action: AGONIST
6872,lapatinib,receptor tyrosine-protein kinase erbb-4,kinase,,Drug: lapatinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: nan
6873,lapatinib,serine/threonine-protein kinase 10,kinase,,Drug: lapatinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
6874,lapatinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: lapatinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
6875,lapatinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: lapatinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
6876,lapatinib,dual specificity mitogen-activated protein kinase kinase 7,kinase,,Drug: lapatinib | Target: dual specificity mitogen-activated protein kinase kinase 7 | Type: kinase | Action: nan
6877,lapatinib,tubulin alpha-1a chain,structural,,Drug: lapatinib | Target: tubulin alpha-1a chain | Type: structural | Action: nan
6878,lapatinib,receptor tyrosine-protein kinase erbb-3,kinase,,Drug: lapatinib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: nan
6879,lapatinib,phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit beta,kinase,,Drug: lapatinib | Target: phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit beta | Type: kinase | Action: nan
6880,lapatinib,phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit gamma,kinase,,Drug: lapatinib | Target: phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit gamma | Type: kinase | Action: nan
6881,lapatinib,phosphatidylinositol 4-kinase beta,kinase,,Drug: lapatinib | Target: phosphatidylinositol 4-kinase beta | Type: kinase | Action: nan
6882,lapatinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: lapatinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
6883,arginine hydrochloride,"nitric oxide synthase, inducible",enzyme,,"Drug: arginine hydrochloride | Target: nitric oxide synthase, inducible | Type: enzyme | Action: nan"
6884,arginine hydrochloride,g-protein coupled receptor family c group 6 member a,gpcr,AGONIST,Drug: arginine hydrochloride | Target: g-protein coupled receptor family c group 6 member a | Type: gpcr | Action: AGONIST
6885,aspartic acid,calcium-binding mitochondrial carrier protein aralar1,transporter,,Drug: aspartic acid | Target: calcium-binding mitochondrial carrier protein aralar1 | Type: transporter | Action: nan
6886,aspartic acid,"aspartate aminotransferase, cytoplasmic",enzyme,,"Drug: aspartic acid | Target: aspartate aminotransferase, cytoplasmic | Type: enzyme | Action: nan"
6887,aspartic acid,aspartoacylase,enzyme,,Drug: aspartic acid | Target: aspartoacylase | Type: enzyme | Action: nan
6888,aspartic acid,asparagine synthetase [glutamine-hydrolyzing],enzyme,,Drug: aspartic acid | Target: asparagine synthetase [glutamine-hydrolyzing] | Type: enzyme | Action: nan
6889,aspartic acid,argininosuccinate synthase,enzyme,,Drug: aspartic acid | Target: argininosuccinate synthase | Type: enzyme | Action: nan
6890,aspartic acid,aminoacylase-1,enzyme,,Drug: aspartic acid | Target: aminoacylase-1 | Type: enzyme | Action: nan
6891,aspartic acid,"aspartate aminotransferase, mitochondrial",enzyme,,"Drug: aspartic acid | Target: aspartate aminotransferase, mitochondrial | Type: enzyme | Action: nan"
6892,aspartic acid,"aspartate--trna ligase, cytoplasmic",enzyme,,"Drug: aspartic acid | Target: aspartate--trna ligase, cytoplasmic | Type: enzyme | Action: nan"
6893,aspartic acid,aspartyl/asparaginyl beta-hydroxylase,enzyme,,Drug: aspartic acid | Target: aspartyl/asparaginyl beta-hydroxylase | Type: enzyme | Action: nan
6894,aspartic acid,excitatory amino acid transporter 1,transporter,,Drug: aspartic acid | Target: excitatory amino acid transporter 1 | Type: transporter | Action: nan
6895,aspartic acid,excitatory amino acid transporter 2,transporter,,Drug: aspartic acid | Target: excitatory amino acid transporter 2 | Type: transporter | Action: nan
6896,aspartic acid,excitatory amino acid transporter 3,transporter,,Drug: aspartic acid | Target: excitatory amino acid transporter 3 | Type: transporter | Action: nan
6897,aspartic acid,calcium-binding mitochondrial carrier protein aralar2,transporter,,Drug: aspartic acid | Target: calcium-binding mitochondrial carrier protein aralar2 | Type: transporter | Action: nan
6898,aspartic acid,glutamate nmda receptor,ion channel,,Drug: aspartic acid | Target: glutamate nmda receptor | Type: ion channel | Action: nan
6899,aspartic acid,excitatory amino acid transporter 4,transporter,,Drug: aspartic acid | Target: excitatory amino acid transporter 4 | Type: transporter | Action: nan
6900,aspartic acid,glutamate transporter homolog,transporter,,Drug: aspartic acid | Target: glutamate transporter homolog | Type: transporter | Action: nan
6901,latanoprost,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: latanoprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
6902,latanoprost,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: latanoprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
6903,latanoprost,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: latanoprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
6904,latanoprost,prostaglandin f2-alpha receptor,gpcr,,Drug: latanoprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: nan
6905,leflunomide,sodium/nucleoside cotransporter 1,transporter,,Drug: leflunomide | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
6906,leflunomide,sodium-dependent noradrenaline transporter,transporter,,Drug: leflunomide | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
6907,leflunomide,sodium-dependent dopamine transporter,transporter,,Drug: leflunomide | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
6908,leflunomide,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,INHIBITOR,"Drug: leflunomide | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: INHIBITOR"
6909,leflunomide,cytochrome p450 1a2,enzyme,,Drug: leflunomide | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
6910,leflunomide,amine oxidase [flavin-containing] a,enzyme,,Drug: leflunomide | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
6911,leflunomide,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: leflunomide | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
6912,leflunomide,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: leflunomide | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
6913,letrozole,aromatase,enzyme,INHIBITOR,Drug: letrozole | Target: aromatase | Type: enzyme | Action: INHIBITOR
6914,letrozole,"cytochrome p450 11b1, mitochondrial",enzyme,,"Drug: letrozole | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: nan"
6915,letrozole,"cytochrome p450 11b2, mitochondrial",enzyme,,"Drug: letrozole | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: nan"
6916,leucine,large neutral amino acids transporter small subunit 1,transporter,,Drug: leucine | Target: large neutral amino acids transporter small subunit 1 | Type: transporter | Action: nan
6917,leuprorelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: leuprorelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
6918,leuprorelin,gonadotropin-releasing hormone receptor,gpcr,,Drug: leuprorelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: nan
6919,levallorphan,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: levallorphan | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
6920,levallorphan,mu-type opioid receptor,gpcr,,Drug: levallorphan | Target: mu-type opioid receptor | Type: gpcr | Action: nan
6921,levallorphan,acetylcholinesterase,enzyme,,Drug: levallorphan | Target: acetylcholinesterase | Type: enzyme | Action: nan
6922,levallorphan,opioid receptor,gpcr,,Drug: levallorphan | Target: opioid receptor | Type: gpcr | Action: nan
6923,levamisole,acetylcholine receptor subunit alpha-type unc-63,ion channel,,Drug: levamisole | Target: acetylcholine receptor subunit alpha-type unc-63 | Type: ion channel | Action: nan
6924,levamisole,"alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,"Drug: levamisole | Target: alkaline phosphatase, tissue-nonspecific isozyme | Type: enzyme | Action: nan"
6925,levamisole,nicotinic acetylcholine receptor alpha subunit,ion channel,AGONIST,Drug: levamisole | Target: nicotinic acetylcholine receptor alpha subunit | Type: ion channel | Action: AGONIST
6926,levamisole,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: levamisole | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
6927,levamisole,"alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,"Drug: levamisole | Target: alkaline phosphatase, tissue-nonspecific isozyme | Type: enzyme | Action: nan"
6928,levamisole,intestinal-type alkaline phosphatase,enzyme,,Drug: levamisole | Target: intestinal-type alkaline phosphatase | Type: enzyme | Action: nan
6929,levamfetamine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: levamfetamine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6930,levamfetamine,trace amine-associated receptor 1,gpcr,,Drug: levamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
6931,levamfetamine,trace amine-associated receptor 1,gpcr,,Drug: levamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
6932,levamfetamine,trace amine-associated receptor 1,gpcr,,Drug: levamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
6933,levamfetamine,trace amine-associated receptor 1,gpcr,,Drug: levamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
6934,levamfetamine,serotonin (5-ht) receptor,gpcr,,Drug: levamfetamine | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
6935,levetiracetam,sodium channel protein type 1 subunit alpha,ion channel,,Drug: levetiracetam | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: nan
6936,levetiracetam,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,,Drug: levetiracetam | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: nan
6937,levetiracetam,carbonic anhydrase 1,enzyme,,Drug: levetiracetam | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
6938,levetiracetam,synaptic vesicle glycoprotein 2a,unclassified,INHIBITOR,Drug: levetiracetam | Target: synaptic vesicle glycoprotein 2a | Type: unclassified | Action: INHIBITOR
6939,levetiracetam,synaptic vesicle glycoprotein 2a,transporter,MODULATOR,Drug: levetiracetam | Target: synaptic vesicle glycoprotein 2a | Type: transporter | Action: MODULATOR
6940,levocabastine,multidrug resistance protein 1,transporter,,Drug: levocabastine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
6941,levocabastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: levocabastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
6942,levocabastine,neurotensin receptor type 2,gpcr,AGONIST,Drug: levocabastine | Target: neurotensin receptor type 2 | Type: gpcr | Action: AGONIST
6943,levocabastine,neurotensin receptor 2,gpcr,,Drug: levocabastine | Target: neurotensin receptor 2 | Type: gpcr | Action: nan
6944,levocabastine,neurotensin receptor type 2,gpcr,AGONIST,Drug: levocabastine | Target: neurotensin receptor type 2 | Type: gpcr | Action: AGONIST
6945,levocetirizine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: levocetirizine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
6946,levodopa,large neutral amino acids transporter small subunit 1,transporter,,Drug: levodopa | Target: large neutral amino acids transporter small subunit 1 | Type: transporter | Action: nan
6947,levodopa,epidermal growth factor receptor,kinase,,Drug: levodopa | Target: epidermal growth factor receptor | Type: kinase | Action: nan
6948,levodopa,tyrosine-protein kinase lck,kinase,,Drug: levodopa | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
6949,levodopa,tyrosine-protein kinase fyn,kinase,,Drug: levodopa | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
6950,levodopa,arachidonate 15-lipoxygenase,enzyme,,Drug: levodopa | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
6951,levodopa,d(1a) dopamine receptor,gpcr,AGONIST,Drug: levodopa | Target: d(1a) dopamine receptor | Type: gpcr | Action: AGONIST
6952,levodopa,d(2) dopamine receptor,gpcr,AGONIST,Drug: levodopa | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
6953,levofloxacin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: levofloxacin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
6954,levofloxacin,dna gyrase subunit a,enzyme,,Drug: levofloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
6955,levofloxacin,multidrug and toxin extrusion protein 1,transporter,,Drug: levofloxacin | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
6956,levofloxacin,dna topoisomerase 4,enzyme,INHIBITOR,Drug: levofloxacin | Target: dna topoisomerase 4 | Type: enzyme | Action: INHIBITOR
6957,levofloxacin,dna gyrase,enzyme,INHIBITOR,Drug: levofloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
6958,levofloxacin,caax prenyl protease 2,enzyme,,Drug: levofloxacin | Target: caax prenyl protease 2 | Type: enzyme | Action: nan
6959,levomethadyl acetate,mu-type opioid receptor,gpcr,AGONIST,Drug: levomethadyl acetate | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
6960,levomethadyl acetate,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: levomethadyl acetate | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
6961,levonorgestrel,sodium-dependent serotonin transporter,transporter,,Drug: levonorgestrel | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
6962,levonorgestrel,glucocorticoid receptor,nuclear hormone receptor,,Drug: levonorgestrel | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
6963,levonorgestrel,estrogen receptor,nuclear hormone receptor,,Drug: levonorgestrel | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
6964,levonorgestrel,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: levonorgestrel | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
6965,levonorgestrel,sex hormone-binding globulin,secreted,,Drug: levonorgestrel | Target: sex hormone-binding globulin | Type: secreted | Action: nan
6966,levonorgestrel,androgen receptor,transcription factor,,Drug: levonorgestrel | Target: androgen receptor | Type: transcription factor | Action: nan
6967,levonorgestrel,progesterone receptor,transcription factor,,Drug: levonorgestrel | Target: progesterone receptor | Type: transcription factor | Action: nan
6968,levorphanol,mu-type opioid receptor,gpcr,AGONIST,Drug: levorphanol | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
6969,levorphanol,kappa-type opioid receptor,gpcr,,Drug: levorphanol | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
6970,levorphanol,delta-type opioid receptor,gpcr,,Drug: levorphanol | Target: delta-type opioid receptor | Type: gpcr | Action: nan
6971,levorphanol,solute carrier family 22 member 1,transporter,,Drug: levorphanol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
6972,levorphanol,mu-type opioid receptor,gpcr,,Drug: levorphanol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
6973,levorphanol,mu-type opioid receptor,gpcr,,Drug: levorphanol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
6974,levorphanol,kappa-type opioid receptor,gpcr,,Drug: levorphanol | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
6975,levorphanol,acetylcholinesterase,enzyme,,Drug: levorphanol | Target: acetylcholinesterase | Type: enzyme | Action: nan
6976,levorphanol,kappa-type opioid receptor,gpcr,,Drug: levorphanol | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
6977,levorphanol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: levorphanol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
6978,levorphanol,glutamate [nmda] receptor,ion channel,,Drug: levorphanol | Target: glutamate [nmda] receptor | Type: ion channel | Action: nan
6979,levorphanol,glutamate nmda receptor,ion channel,,Drug: levorphanol | Target: glutamate nmda receptor | Type: ion channel | Action: nan
6980,levorphanol,opioid receptor,gpcr,,Drug: levorphanol | Target: opioid receptor | Type: gpcr | Action: nan
6981,levorphanol,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: levorphanol | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
6983,levosalbutamol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: levosalbutamol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
6984,levosimendan,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,,"Drug: levosimendan | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: nan"
6985,levosimendan,atp-sensitive inward rectifier potassium channel 11,ion channel,,Drug: levosimendan | Target: atp-sensitive inward rectifier potassium channel 11 | Type: ion channel | Action: nan
6986,levosimendan,atp-sensitive inward rectifier potassium channel 8,ion channel,,Drug: levosimendan | Target: atp-sensitive inward rectifier potassium channel 8 | Type: ion channel | Action: nan
6987,levosimendan,"troponin c, slow skeletal and cardiac muscles",cytosolic other,OPENER,"Drug: levosimendan | Target: troponin c, slow skeletal and cardiac muscles | Type: cytosolic other | Action: OPENER"
6988,levosulpiride,d(2) dopamine receptor,gpcr,,Drug: levosulpiride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
6989,levosulpiride,d(3) dopamine receptor,gpcr,,Drug: levosulpiride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
6990,levosulpiride,d(4) dopamine receptor,gpcr,,Drug: levosulpiride | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
6991,levosulpiride,myeloperoxidase,enzyme,,Drug: levosulpiride | Target: myeloperoxidase | Type: enzyme | Action: nan
6992,levosulpiride,d(2) dopamine receptor,gpcr,,Drug: levosulpiride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
6993,levosulpiride,d(1a) dopamine receptor,gpcr,,Drug: levosulpiride | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
6994,levosulpiride,dopamine receptor,gpcr,,Drug: levosulpiride | Target: dopamine receptor | Type: gpcr | Action: nan
6995,levosulpiride,adrenergic receptor alpha-1,gpcr,,Drug: levosulpiride | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
6996,levosulpiride,serotonin 2 (5-ht2) receptor,gpcr,,Drug: levosulpiride | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
6997,lidocaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: lidocaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
6998,lidocaine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: lidocaine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
6999,lidocaine,sodium channel protein type 3 subunit alpha,ion channel,BLOCKER,Drug: lidocaine | Target: sodium channel protein type 3 subunit alpha | Type: ion channel | Action: BLOCKER
7000,lidocaine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: lidocaine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
7001,lidocaine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: lidocaine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
7002,lidocaine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: lidocaine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
7003,lidocaine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: lidocaine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
7004,lidocaine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: lidocaine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
7005,lidocaine,acetylcholine receptor,ion channel,,Drug: lidocaine | Target: acetylcholine receptor | Type: ion channel | Action: nan
7006,lidocaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: lidocaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
7007,lidocaine,sodium channel protein type x alpha subunit,ion channel,BLOCKER,Drug: lidocaine | Target: sodium channel protein type x alpha subunit | Type: ion channel | Action: BLOCKER
7008,lidocaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: lidocaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
7009,lidoflazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: lidoflazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7010,lidoflazine,equilibrative nucleoside transporter 1,transporter,,Drug: lidoflazine | Target: equilibrative nucleoside transporter 1 | Type: transporter | Action: nan
7011,lidoflazine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: lidoflazine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
7012,limaprost,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: limaprost | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
7013,lincomycin,50s ribosomal protein l10,ribosomal protein,,Drug: lincomycin | Target: 50s ribosomal protein l10 | Type: ribosomal protein | Action: nan
7014,lindane,gamma-aminobutyric acid receptor subunit beta-3,ion channel,,Drug: lindane | Target: gamma-aminobutyric acid receptor subunit beta-3 | Type: ion channel | Action: nan
7015,lindane,androgen receptor,transcription factor,,Drug: lindane | Target: androgen receptor | Type: transcription factor | Action: nan
7016,lindane,gamma-aminobutyric acid receptor subunit beta,ion channel,,Drug: lindane | Target: gamma-aminobutyric acid receptor subunit beta | Type: ion channel | Action: nan
7017,lindane,gamma-aminobutyric acid receptor subunit rho-1,ion channel,,Drug: lindane | Target: gamma-aminobutyric acid receptor subunit rho-1 | Type: ion channel | Action: nan
7018,lindane,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,,Drug: lindane | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: nan
7019,lindane,gaba-a receptor,ion channel,NEGATIVE ALLOSTERIC MODULATOR,Drug: lindane | Target: gaba-a receptor | Type: ion channel | Action: NEGATIVE ALLOSTERIC MODULATOR
7020,lindane,gaba-a receptor,ion channel,NEGATIVE ALLOSTERIC MODULATOR,Drug: lindane | Target: gaba-a receptor | Type: ion channel | Action: NEGATIVE ALLOSTERIC MODULATOR
7021,lindane,gaba-a receptor alpha-6/beta-3/gamma-2,ion channel,,Drug: lindane | Target: gaba-a receptor alpha-6/beta-3/gamma-2 | Type: ion channel | Action: nan
7022,lindane,gaba a receptor alpha-1/beta-1/gamma-2,ion channel,,Drug: lindane | Target: gaba a receptor alpha-1/beta-1/gamma-2 | Type: ion channel | Action: nan
7023,linezolid,amine oxidase [flavin-containing] b,enzyme,,Drug: linezolid | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
7024,linezolid,amine oxidase [flavin-containing] a,enzyme,,Drug: linezolid | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
7025,linezolid,amine oxidase [flavin-containing] b,enzyme,,Drug: linezolid | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
7026,linezolid,"succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",enzyme,,"Drug: linezolid | Target: succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | Type: enzyme | Action: nan"
7027,liothyronine,thyroid hormone receptor alpha,nuclear hormone receptor,AGONIST,Drug: liothyronine | Target: thyroid hormone receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
7028,liothyronine,thyroid hormone receptor beta,nuclear hormone receptor,AGONIST,Drug: liothyronine | Target: thyroid hormone receptor beta | Type: nuclear hormone receptor | Action: AGONIST
7029,liothyronine,adenosine receptor a1,gpcr,,Drug: liothyronine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
7030,liothyronine,cytochrome p450 2c9,enzyme,,Drug: liothyronine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
7031,liothyronine,thyroid hormone receptor beta,transcription factor,,Drug: liothyronine | Target: thyroid hormone receptor beta | Type: transcription factor | Action: nan
7032,liothyronine,proliferating cell nuclear antigen,nuclear other,,Drug: liothyronine | Target: proliferating cell nuclear antigen | Type: nuclear other | Action: nan
7033,liothyronine,thap domain-containing protein 1,unclassified,,Drug: liothyronine | Target: thap domain-containing protein 1 | Type: unclassified | Action: nan
7034,liothyronine,gaba-a receptor; anion channel,ion channel,,Drug: liothyronine | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
7035,liothyronine,gaba-a receptor; anion channel,ion channel,,Drug: liothyronine | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
7036,lisinopril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: lisinopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
7037,lisinopril,angiotensin-converting enzyme,enzyme,,Drug: lisinopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
7038,lisuride,beta-1 adrenergic receptor,gpcr,,Drug: lisuride | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
7039,lisuride,beta-2 adrenergic receptor,gpcr,,Drug: lisuride | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
7040,lisuride,d(1a) dopamine receptor,gpcr,,Drug: lisuride | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
7041,lisuride,d(2) dopamine receptor,gpcr,,Drug: lisuride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7042,lisuride,alpha-2a adrenergic receptor,gpcr,,Drug: lisuride | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7043,lisuride,5-hydroxytryptamine receptor 1a,gpcr,,Drug: lisuride | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7044,lisuride,5-hydroxytryptamine receptor 2a,gpcr,,Drug: lisuride | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7045,lisuride,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: lisuride | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
7046,lisuride,5-hydroxytryptamine receptor 6,gpcr,,Drug: lisuride | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
7047,lisuride,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: lisuride | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
7048,lisuride,alpha-2b adrenergic receptor,gpcr,,Drug: lisuride | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7049,lisuride,d(3) dopamine receptor,gpcr,,Drug: lisuride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7050,lisuride,d(1b) dopamine receptor,gpcr,AGONIST,Drug: lisuride | Target: d(1b) dopamine receptor | Type: gpcr | Action: AGONIST
7051,lisuride,histamine h1 receptor,gpcr,,Drug: lisuride | Target: histamine h1 receptor | Type: gpcr | Action: nan
7052,lisuride,histamine h2 receptor,gpcr,,Drug: lisuride | Target: histamine h2 receptor | Type: gpcr | Action: nan
7053,lisuride,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: lisuride | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
7054,lisuride,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: lisuride | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
7055,lisuride,alpha-2c adrenergic receptor,gpcr,,Drug: lisuride | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
7056,lisuride,cytochrome p450 2d6,enzyme,,Drug: lisuride | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
7057,lisuride,d(4) dopamine receptor,gpcr,AGONIST,Drug: lisuride | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
7058,lisuride,alpha-1d adrenergic receptor,gpcr,,Drug: lisuride | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
7059,lisuride,alpha-1b adrenergic receptor,gpcr,,Drug: lisuride | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
7060,lisuride,alpha-1b adrenergic receptor,gpcr,,Drug: lisuride | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
7061,lisuride,5-hydroxytryptamine receptor 1b,gpcr,,Drug: lisuride | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
7062,lisuride,alpha-1a adrenergic receptor,gpcr,,Drug: lisuride | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7063,lisuride,d(2) dopamine receptor,gpcr,,Drug: lisuride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7064,lisuride,5-hydroxytryptamine receptor 1a,gpcr,,Drug: lisuride | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7065,lisuride,5-hydroxytryptamine receptor 7,gpcr,AGONIST,Drug: lisuride | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: AGONIST
7066,lisuride,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: lisuride | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
7067,lisuride,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: lisuride | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
7068,lofepramine,d(2) dopamine receptor,gpcr,,Drug: lofepramine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7069,lofepramine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: lofepramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
7070,lofepramine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: lofepramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
7071,lofepramine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: lofepramine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7072,lofepramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: lofepramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7073,lofepramine,alpha-1a adrenergic receptor,gpcr,,Drug: lofepramine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7074,lofepramine,histamine h1 receptor,gpcr,,Drug: lofepramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7075,lofepramine,muscarinic acetylcholine receptor m1,gpcr,,Drug: lofepramine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7076,lofepramine,muscarinic acetylcholine receptor m2,gpcr,,Drug: lofepramine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7077,lofepramine,muscarinic acetylcholine receptor m3,gpcr,,Drug: lofepramine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
7078,lofepramine,muscarinic acetylcholine receptor m4,gpcr,,Drug: lofepramine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7079,lofepramine,muscarinic acetylcholine receptor m5,gpcr,,Drug: lofepramine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
7080,lofexidine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: lofexidine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7081,lofexidine,alpha-2b adrenergic receptor,gpcr,,Drug: lofexidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7082,lofexidine,alpha-2c adrenergic receptor,gpcr,,Drug: lofexidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
7083,lofexidine,nischarin,unclassified,,Drug: lofexidine | Target: nischarin | Type: unclassified | Action: nan
7084,lofexidine,adrenergic receptor alpha-2,gpcr,,Drug: lofexidine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
7085,lofexidine,adrenergic receptor alpha-1,gpcr,,Drug: lofexidine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
7086,lofexidine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: lofexidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
7087,lomefloxacin,dna gyrase subunit a,enzyme,,Drug: lomefloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
7088,lomefloxacin,dna gyrase,enzyme,INHIBITOR,Drug: lomefloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
7089,lomerizine,voltage-dependent n-type calcium channel subunit alpha-1b,ion channel,,Drug: lomerizine | Target: voltage-dependent n-type calcium channel subunit alpha-1b | Type: ion channel | Action: nan
7090,lonazolac,prostaglandin e synthase,enzyme,,Drug: lonazolac | Target: prostaglandin e synthase | Type: enzyme | Action: nan
7091,loperamide,beta-2 adrenergic receptor,gpcr,,Drug: loperamide | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
7092,loperamide,sodium channel protein type 5 subunit alpha,ion channel,,Drug: loperamide | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
7093,loperamide,mu-type opioid receptor,gpcr,AGONIST,Drug: loperamide | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
7094,loperamide,"glutamate receptor ionotropic, nmda 2a",ion channel,,"Drug: loperamide | Target: glutamate receptor ionotropic, nmda 2a | Type: ion channel | Action: nan"
7095,loperamide,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: loperamide | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
7096,loperamide,sodium-dependent serotonin transporter,transporter,,Drug: loperamide | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
7097,loperamide,5-hydroxytryptamine receptor 2b,gpcr,,Drug: loperamide | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7098,loperamide,d(3) dopamine receptor,gpcr,,Drug: loperamide | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7099,loperamide,histamine h1 receptor,gpcr,,Drug: loperamide | Target: histamine h1 receptor | Type: gpcr | Action: nan
7100,loperamide,histamine h2 receptor,gpcr,,Drug: loperamide | Target: histamine h2 receptor | Type: gpcr | Action: nan
7101,loperamide,aldehyde oxidase,enzyme,,Drug: loperamide | Target: aldehyde oxidase | Type: enzyme | Action: nan
7102,loperamide,voltage-dependent p/q-type calcium channel subunit alpha-1a,ion channel,,Drug: loperamide | Target: voltage-dependent p/q-type calcium channel subunit alpha-1a | Type: ion channel | Action: nan
7103,loperamide,cytochrome p450 2d6,enzyme,,Drug: loperamide | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
7104,loperamide,alpha-1d adrenergic receptor,gpcr,,Drug: loperamide | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
7105,loperamide,kappa-type opioid receptor,gpcr,,Drug: loperamide | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
7106,loperamide,calmodulin,cytosolic other,,Drug: loperamide | Target: calmodulin | Type: cytosolic other | Action: nan
7107,loperamide,delta-type opioid receptor,gpcr,,Drug: loperamide | Target: delta-type opioid receptor | Type: gpcr | Action: nan
7108,loperamide,somatostatin receptor type 5,gpcr,,Drug: loperamide | Target: somatostatin receptor type 5 | Type: gpcr | Action: nan
7109,loperamide,"glutamate receptor ionotropic, nmda 2b",ion channel,,"Drug: loperamide | Target: glutamate receptor ionotropic, nmda 2b | Type: ion channel | Action: nan"
7110,loperamide,"glutamate receptor ionotropic, nmda 2c",ion channel,,"Drug: loperamide | Target: glutamate receptor ionotropic, nmda 2c | Type: ion channel | Action: nan"
7111,loperamide,"glutamate receptor ionotropic, nmda 2d",ion channel,,"Drug: loperamide | Target: glutamate receptor ionotropic, nmda 2d | Type: ion channel | Action: nan"
7112,loperamide,angiopoietin-1 receptor,kinase,,Drug: loperamide | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
7113,loperamide,solute carrier family 22 member 1,transporter,,Drug: loperamide | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
7114,loperamide,alpha-1b adrenergic receptor,gpcr,,Drug: loperamide | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
7115,loperamide,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: loperamide | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
7116,loperamide,alpha-1a adrenergic receptor,gpcr,,Drug: loperamide | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7117,loperamide,mu-type opioid receptor,gpcr,,Drug: loperamide | Target: mu-type opioid receptor | Type: gpcr | Action: nan
7118,loperamide,delta-type opioid receptor,gpcr,,Drug: loperamide | Target: delta-type opioid receptor | Type: gpcr | Action: nan
7119,loperamide,cocaine esterase,enzyme,,Drug: loperamide | Target: cocaine esterase | Type: enzyme | Action: nan
7120,loperamide,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: loperamide | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
7121,loperamide,menin,unclassified,,Drug: loperamide | Target: menin | Type: unclassified | Action: nan
7122,loperamide,calmodulin,cytosolic other,,Drug: loperamide | Target: calmodulin | Type: cytosolic other | Action: nan
7123,lopinavir,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: lopinavir | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7124,lopinavir,multidrug resistance protein 1,transporter,,Drug: lopinavir | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
7125,lopinavir,gag-pol polyprotein,polyprotein,,Drug: lopinavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
7126,lopinavir,pol polyprotein,enzyme,INHIBITOR,Drug: lopinavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
7127,lopinavir,caax prenyl protease 1 homolog,enzyme,,Drug: lopinavir | Target: caax prenyl protease 1 homolog | Type: enzyme | Action: nan
7128,lopinavir,protease,enzyme,,Drug: lopinavir | Target: protease | Type: enzyme | Action: nan
7129,lopinavir,protease,unclassified,,Drug: lopinavir | Target: protease | Type: unclassified | Action: nan
7130,lopinavir,protease,unclassified,,Drug: lopinavir | Target: protease | Type: unclassified | Action: nan
7131,loprazolam,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,,Drug: loprazolam | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: nan
7132,loprazolam,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,,Drug: loprazolam | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: nan
7133,loprazolam,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,,Drug: loprazolam | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: nan
7134,loprazolam,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,,Drug: loprazolam | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: nan
7135,loracarbef,penicillin-binding protein 1a,enzyme,,Drug: loracarbef | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
7136,loracarbef,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: loracarbef | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
7137,loratadine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: loratadine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7138,loratadine,multidrug resistance protein 1,transporter,,Drug: loratadine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
7139,loratadine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: loratadine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7140,loratadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: loratadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
7141,loratadine,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: loratadine | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
7142,loratadine,cytochrome p450 2c19,enzyme,,Drug: loratadine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
7143,loratadine,potassium channel subfamily k member 9,ion channel,,Drug: loratadine | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: nan
7144,loratadine,bile acid receptor,nuclear hormone receptor,,Drug: loratadine | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
7145,loratadine,histamine h1 receptor,gpcr,,Drug: loratadine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7146,loratadine,histamine h1 receptor,gpcr,,Drug: loratadine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7147,loratadine,sodium-dependent neutral amino acid transporter b(0)at2,transporter,,Drug: loratadine | Target: sodium-dependent neutral amino acid transporter b(0)at2 | Type: transporter | Action: nan
7149,lorazepam,"fatty acid-binding protein, liver",unclassified,,"Drug: lorazepam | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
7150,lorazepam,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: lorazepam | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7151,lorcainide,sodium channel protein type 5 subunit alpha,ion channel,,Drug: lorcainide | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
7152,lorcainide,sodium channel subunit beta-1,ion channel,,Drug: lorcainide | Target: sodium channel subunit beta-1 | Type: ion channel | Action: nan
7153,lorcainide,sodium channel subunit beta-2,ion channel,,Drug: lorcainide | Target: sodium channel subunit beta-2 | Type: ion channel | Action: nan
7154,lorcainide,sodium channel subunit beta-3,ion channel,,Drug: lorcainide | Target: sodium channel subunit beta-3 | Type: ion channel | Action: nan
7155,lorcainide,sodium channel subunit beta-4,ion channel,,Drug: lorcainide | Target: sodium channel subunit beta-4 | Type: ion channel | Action: nan
7156,losartan,multidrug resistance protein 1,transporter,,Drug: losartan | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
7157,losartan,angiotensin-converting enzyme,enzyme,,Drug: losartan | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
7158,losartan,cytochrome p450 2c9,enzyme,,Drug: losartan | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
7159,losartan,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: losartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
7160,losartan,type-2 angiotensin ii receptor,gpcr,,Drug: losartan | Target: type-2 angiotensin ii receptor | Type: gpcr | Action: nan
7161,losartan,type-1b angiotensin ii receptor,gpcr,,Drug: losartan | Target: type-1b angiotensin ii receptor | Type: gpcr | Action: nan
7162,losartan,type-2 angiotensin ii receptor,gpcr,,Drug: losartan | Target: type-2 angiotensin ii receptor | Type: gpcr | Action: nan
7163,losartan,type-1 angiotensin ii receptor,gpcr,,Drug: losartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
7164,losartan,type-1a angiotensin ii receptor,gpcr,,Drug: losartan | Target: type-1a angiotensin ii receptor | Type: gpcr | Action: nan
7165,losartan,type-1 angiotensin ii receptor,gpcr,,Drug: losartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
7166,losartan,type-1 angiotensin ii receptor,gpcr,,Drug: losartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
7167,losartan,phosphodiesterase 3,enzyme,,Drug: losartan | Target: phosphodiesterase 3 | Type: enzyme | Action: nan
7168,losartan,phosphodiesterase 4,enzyme,,Drug: losartan | Target: phosphodiesterase 4 | Type: enzyme | Action: nan
7169,losartan,angiotensin ii receptor (at-1) type-1,gpcr,,Drug: losartan | Target: angiotensin ii receptor (at-1) type-1 | Type: gpcr | Action: nan
7170,losartan,angiotensin ii receptor,gpcr,,Drug: losartan | Target: angiotensin ii receptor | Type: gpcr | Action: nan
7171,losartan,angiotensin ii receptor,gpcr,,Drug: losartan | Target: angiotensin ii receptor | Type: gpcr | Action: nan
7172,losartan,platelet glycoprotein vi,unclassified,,Drug: losartan | Target: platelet glycoprotein vi | Type: unclassified | Action: nan
7173,loteprednol etabonate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: loteprednol etabonate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
7174,lovastatin,sodium-dependent noradrenaline transporter,transporter,,Drug: lovastatin | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
7175,lovastatin,sodium-dependent dopamine transporter,transporter,,Drug: lovastatin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7176,lovastatin,adenosine receptor a1,gpcr,,Drug: lovastatin | Target: adenosine receptor a1 | Type: gpcr | Action: nan
7177,lovastatin,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,AGONIST,Drug: lovastatin | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: AGONIST
7178,lovastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: lovastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
7179,lovastatin,hydroxycarboxylic acid receptor 2,gpcr,,Drug: lovastatin | Target: hydroxycarboxylic acid receptor 2 | Type: gpcr | Action: nan
7180,lovastatin,hydroxycarboxylic acid receptor 3,gpcr,,Drug: lovastatin | Target: hydroxycarboxylic acid receptor 3 | Type: gpcr | Action: nan
7181,lovastatin,histone deacetylase 2,enzyme,,Drug: lovastatin | Target: histone deacetylase 2 | Type: enzyme | Action: nan
7182,lovastatin,histone deacetylase 1,enzyme,,Drug: lovastatin | Target: histone deacetylase 1 | Type: enzyme | Action: nan
7183,lovastatin,histone deacetylase 6,enzyme,,Drug: lovastatin | Target: histone deacetylase 6 | Type: enzyme | Action: nan
7184,lovastatin,substance-k receptor,gpcr,,Drug: lovastatin | Target: substance-k receptor | Type: gpcr | Action: nan
7185,lovastatin,androgen receptor,transcription factor,,Drug: lovastatin | Target: androgen receptor | Type: transcription factor | Action: nan
7186,lovastatin,acetylcholinesterase,enzyme,,Drug: lovastatin | Target: acetylcholinesterase | Type: enzyme | Action: nan
7187,lovastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: lovastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
7188,lovastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: lovastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
7189,lovastatin,cholinesterase,enzyme,,Drug: lovastatin | Target: cholinesterase | Type: enzyme | Action: nan
7190,lovastatin,leukocyte adhesion glycoprotein lfa-1 alpha,adhesion,,Drug: lovastatin | Target: leukocyte adhesion glycoprotein lfa-1 alpha | Type: adhesion | Action: nan
7191,lovastatin,acyl-coa:cholesterol acyltransferase,enzyme,,Drug: lovastatin | Target: acyl-coa:cholesterol acyltransferase | Type: enzyme | Action: nan
7192,loxapine,d(1a) dopamine receptor,gpcr,,Drug: loxapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
7193,loxapine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: loxapine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
7194,loxapine,alpha-2a adrenergic receptor,gpcr,,Drug: loxapine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7195,loxapine,sodium-dependent noradrenaline transporter,transporter,,Drug: loxapine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
7196,loxapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7197,loxapine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: loxapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
7198,loxapine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: loxapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
7199,loxapine,5-hydroxytryptamine receptor 6,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
7200,loxapine,alpha-1a adrenergic receptor,gpcr,,Drug: loxapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7201,loxapine,alpha-2b adrenergic receptor,gpcr,,Drug: loxapine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7202,loxapine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: loxapine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
7203,loxapine,d(1b) dopamine receptor,gpcr,,Drug: loxapine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
7204,loxapine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: loxapine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
7205,loxapine,histamine h2 receptor,gpcr,,Drug: loxapine | Target: histamine h2 receptor | Type: gpcr | Action: nan
7206,loxapine,histamine h4 receptor,gpcr,,Drug: loxapine | Target: histamine h4 receptor | Type: gpcr | Action: nan
7207,loxapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: loxapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7208,loxapine,muscarinic acetylcholine receptor m2,gpcr,,Drug: loxapine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7209,loxapine,muscarinic acetylcholine receptor m3,gpcr,,Drug: loxapine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
7210,loxapine,muscarinic acetylcholine receptor m4,gpcr,,Drug: loxapine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7211,loxapine,muscarinic acetylcholine receptor m5,gpcr,,Drug: loxapine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
7212,loxapine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
7213,loxapine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
7214,loxapine,alpha-2c adrenergic receptor,gpcr,,Drug: loxapine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
7215,loxapine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: loxapine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
7216,loxapine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
7217,loxapine,alpha-1b adrenergic receptor,gpcr,,Drug: loxapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
7218,loxapine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
7219,loxapine,5-hydroxytryptamine receptor 1e,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
7220,loxapine,potassium channel subfamily k member 2,ion channel,,Drug: loxapine | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
7221,loxapine,potassium channel subfamily t member 1,ion channel,ACTIVATOR,Drug: loxapine | Target: potassium channel subfamily t member 1 | Type: ion channel | Action: ACTIVATOR
7222,loxapine,d(2) dopamine receptor,gpcr,,Drug: loxapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7223,loxapine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7224,loxapine,5-hydroxytryptamine receptor 7,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
7225,loxapine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: loxapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7226,loxapine,histamine h1 receptor,gpcr,,Drug: loxapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7227,loxapine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: loxapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
7228,loxapine,adrenergic receptor alpha-1,gpcr,,Drug: loxapine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
7229,loxiglumide,cholecystokinin receptor type a,gpcr,,Drug: loxiglumide | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
7230,loxiglumide,cholecystokinin receptor type a,gpcr,ANTAGONIST,Drug: loxiglumide | Target: cholecystokinin receptor type a | Type: gpcr | Action: ANTAGONIST
7231,loxoprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: loxoprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
7232,loxoprofen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: loxoprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
7233,lucanthone,dna-(apurinic or apyrimidinic site) lyase,enzyme,,Drug: lucanthone | Target: dna-(apurinic or apyrimidinic site) lyase | Type: enzyme | Action: nan
7234,lumefantrine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: lumefantrine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7235,lumiracoxib,prostaglandin g/h synthase 1,enzyme,,Drug: lumiracoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
7236,lumiracoxib,prostaglandin g/h synthase 2,enzyme,,Drug: lumiracoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
7237,lumiracoxib,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: lumiracoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
7238,lysergide,beta-1 adrenergic receptor,gpcr,,Drug: lysergide | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
7239,lysergide,beta-2 adrenergic receptor,gpcr,,Drug: lysergide | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
7240,lysergide,d(2) dopamine receptor,gpcr,,Drug: lysergide | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7241,lysergide,5-hydroxytryptamine receptor 1a,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7242,lysergide,5-hydroxytryptamine receptor 2a,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7243,lysergide,5-hydroxytryptamine receptor 2b,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7244,lysergide,5-hydroxytryptamine receptor 2c,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7245,lysergide,5-hydroxytryptamine receptor 6,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
7246,lysergide,5-hydroxytryptamine receptor 7,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
7247,lysergide,d(3) dopamine receptor,gpcr,,Drug: lysergide | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7248,lysergide,d(1b) dopamine receptor,gpcr,,Drug: lysergide | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
7249,lysergide,histamine h1 receptor,gpcr,,Drug: lysergide | Target: histamine h1 receptor | Type: gpcr | Action: nan
7250,lysergide,5-hydroxytryptamine receptor 1d,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
7251,lysergide,d(4) dopamine receptor,gpcr,,Drug: lysergide | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
7252,lysergide,5-hydroxytryptamine receptor 5a,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
7253,lysergide,5-hydroxytryptamine receptor 1e,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
7254,lysergide,5-hydroxytryptamine receptor 1a,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7255,lysergide,5-hydroxytryptamine receptor 2a,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7256,lysergide,5-hydroxytryptamine receptor 7,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
7257,lysergide,5-hydroxytryptamine receptor 2c,gpcr,,Drug: lysergide | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7258,lysergide,d(1a) dopamine receptor,gpcr,,Drug: lysergide | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
7259,lysergide,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: lysergide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
7260,lysergide,serotonin 2 (5-ht2) receptor,gpcr,,Drug: lysergide | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
7261,lysine,"glutathione reductase, mitochondrial",enzyme,,"Drug: lysine | Target: glutathione reductase, mitochondrial | Type: enzyme | Action: nan"
7262,mafenide,carbonic anhydrase 2,enzyme,,Drug: mafenide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
7263,mafenide,carbonic anhydrase 1,enzyme,,Drug: mafenide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
7264,mafenide,carbonic anhydrase 4,enzyme,,Drug: mafenide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
7265,mafenide,carbonic anhydrase 9,enzyme,,Drug: mafenide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
7266,mafenide,carbonic anhydrase 12,enzyme,,Drug: mafenide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
7267,mafenide,dihydropteroate synthase,enzyme,INHIBITOR,Drug: mafenide | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
7268,mafenide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: mafenide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
7269,mafenide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: mafenide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
7270,mafenide,carbonic anhydrase 7,enzyme,,Drug: mafenide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
7271,mafenide,carbonic anhydrase,enzyme,,Drug: mafenide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7272,mafenide,carbonic anhydrase 6,enzyme,,Drug: mafenide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
7273,mafenide,carbonic anhydrase 14,enzyme,,Drug: mafenide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
7274,mafenide,carbonic anhydrase 13,enzyme,,Drug: mafenide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
7275,mafenide,carbonic anhydrase 4,enzyme,,Drug: mafenide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
7276,mafenide,carbonic anhydrase,enzyme,,Drug: mafenide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7277,mafenide,carbonic anhydrase,enzyme,,Drug: mafenide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7278,mafenide,carbonic anhydrase 15,enzyme,,Drug: mafenide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
7279,mafenide,carbonic anhydrase,enzyme,,Drug: mafenide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7280,mafenide,carbonic anhydrase,enzyme,,Drug: mafenide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7281,mafenide,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: mafenide | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
7282,mafenide,carbonic anhydrase,enzyme,,Drug: mafenide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7283,mafenide,alpha carbonic anhydrase,enzyme,,Drug: mafenide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
7284,mafenide,carbonic anhydrase,enzyme,,Drug: mafenide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7285,mafenide,carbonic anhydrase 2,enzyme,,Drug: mafenide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
7286,mafenide,astrosclerin-3,enzyme,,Drug: mafenide | Target: astrosclerin-3 | Type: enzyme | Action: nan
7287,mafenide,beta-carbonic anhydrase 1,enzyme,,Drug: mafenide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
7288,mafenide,delta carbonic anhydrase,unclassified,,Drug: mafenide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
7289,mafenide,carbonic anhydrase 2,enzyme,,Drug: mafenide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
7290,mafenide,carbonic anhydrase,enzyme,,Drug: mafenide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7291,mafenide,"carbonic anhydrase, alpha family",unclassified,,"Drug: mafenide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
7292,mafenide,carbonate dehydratase,enzyme,,Drug: mafenide | Target: carbonate dehydratase | Type: enzyme | Action: nan
7293,malathion,melatonin receptor type 1a,gpcr,,Drug: malathion | Target: melatonin receptor type 1a | Type: gpcr | Action: nan
7294,malathion,acetylcholinesterase,enzyme,INHIBITOR,Drug: malathion | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
7295,manidipine,cruzipain,enzyme,,Drug: manidipine | Target: cruzipain | Type: enzyme | Action: nan
7296,manidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: manidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
7297,maprotiline,d(1a) dopamine receptor,gpcr,,Drug: maprotiline | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
7298,maprotiline,d(2) dopamine receptor,gpcr,,Drug: maprotiline | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7299,maprotiline,alpha-2a adrenergic receptor,gpcr,,Drug: maprotiline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7300,maprotiline,cytochrome p450 3a4,enzyme,,Drug: maprotiline | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
7301,maprotiline,sodium-dependent serotonin transporter,transporter,,Drug: maprotiline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
7302,maprotiline,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: maprotiline | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
7303,maprotiline,5-hydroxytryptamine receptor 2a,gpcr,,Drug: maprotiline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7304,maprotiline,5-hydroxytryptamine receptor 2b,gpcr,,Drug: maprotiline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7305,maprotiline,5-hydroxytryptamine receptor 2c,gpcr,,Drug: maprotiline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7306,maprotiline,5-hydroxytryptamine receptor 6,gpcr,,Drug: maprotiline | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
7307,maprotiline,alpha-1a adrenergic receptor,gpcr,,Drug: maprotiline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7308,maprotiline,alpha-2b adrenergic receptor,gpcr,,Drug: maprotiline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7309,maprotiline,d(3) dopamine receptor,gpcr,,Drug: maprotiline | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7310,maprotiline,d(1b) dopamine receptor,gpcr,,Drug: maprotiline | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
7311,maprotiline,histamine h1 receptor,gpcr,,Drug: maprotiline | Target: histamine h1 receptor | Type: gpcr | Action: nan
7312,maprotiline,histamine h2 receptor,gpcr,,Drug: maprotiline | Target: histamine h2 receptor | Type: gpcr | Action: nan
7313,maprotiline,muscarinic acetylcholine receptor m1,gpcr,,Drug: maprotiline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7314,maprotiline,muscarinic acetylcholine receptor m2,gpcr,,Drug: maprotiline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7315,maprotiline,muscarinic acetylcholine receptor m3,gpcr,,Drug: maprotiline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
7316,maprotiline,muscarinic acetylcholine receptor m4,gpcr,,Drug: maprotiline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7317,maprotiline,muscarinic acetylcholine receptor m5,gpcr,,Drug: maprotiline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
7318,maprotiline,aldehyde oxidase,enzyme,,Drug: maprotiline | Target: aldehyde oxidase | Type: enzyme | Action: nan
7319,maprotiline,alpha-2c adrenergic receptor,gpcr,,Drug: maprotiline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
7320,maprotiline,sodium-dependent dopamine transporter,transporter,,Drug: maprotiline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7321,maprotiline,alpha-1d adrenergic receptor,gpcr,,Drug: maprotiline | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
7322,maprotiline,atp-binding cassette sub-family g member 2,transporter,,Drug: maprotiline | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
7323,maprotiline,alpha-1b adrenergic receptor,gpcr,,Drug: maprotiline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
7324,maprotiline,alpha-1a adrenergic receptor,gpcr,,Drug: maprotiline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7325,maprotiline,g protein-activated inward rectifier potassium channel 2,ion channel,BLOCKER,Drug: maprotiline | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: BLOCKER
7326,maprotiline,transient receptor potential cation channel subfamily m member 3,ion channel,BLOCKER,Drug: maprotiline | Target: transient receptor potential cation channel subfamily m member 3 | Type: ion channel | Action: BLOCKER
7327,maraviroc,c-c chemokine receptor type 5,gpcr,ANTAGONIST,Drug: maraviroc | Target: c-c chemokine receptor type 5 | Type: gpcr | Action: ANTAGONIST
7328,maraviroc,c-c chemokine receptor type 5,gpcr,,Drug: maraviroc | Target: c-c chemokine receptor type 5 | Type: gpcr | Action: nan
7329,maraviroc,multidrug and toxin extrusion protein 1,transporter,,Drug: maraviroc | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
7330,maraviroc,c-c chemokine receptor type 5,gpcr,,Drug: maraviroc | Target: c-c chemokine receptor type 5 | Type: gpcr | Action: nan
7331,masoprocol,transthyretin,secreted,,Drug: masoprocol | Target: transthyretin | Type: secreted | Action: nan
7332,masoprocol,estrogen receptor,nuclear hormone receptor,,Drug: masoprocol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
7333,masoprocol,androgen receptor,nuclear hormone receptor,,Drug: masoprocol | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
7334,masoprocol,aromatase,enzyme,,Drug: masoprocol | Target: aromatase | Type: enzyme | Action: nan
7335,masoprocol,arachidonate 5-lipoxygenase,enzyme,,Drug: masoprocol | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
7336,masoprocol,insulin-like growth factor 1 receptor,kinase,,Drug: masoprocol | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: nan
7337,masoprocol,arachidonate 15-lipoxygenase,enzyme,,Drug: masoprocol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
7338,masoprocol,estradiol 17-beta-dehydrogenase 1,enzyme,,Drug: masoprocol | Target: estradiol 17-beta-dehydrogenase 1 | Type: enzyme | Action: nan
7339,masoprocol,estradiol 17-beta-dehydrogenase 2,enzyme,,Drug: masoprocol | Target: estradiol 17-beta-dehydrogenase 2 | Type: enzyme | Action: nan
7340,masoprocol,"arachidonate 12-lipoxygenase, 12s-type",enzyme,,"Drug: masoprocol | Target: arachidonate 12-lipoxygenase, 12s-type | Type: enzyme | Action: nan"
7341,masoprocol,leukotriene b4 receptor 1,gpcr,,Drug: masoprocol | Target: leukotriene b4 receptor 1 | Type: gpcr | Action: nan
7342,masoprocol,transient receptor potential cation channel subfamily a member 1,ion channel,,Drug: masoprocol | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: nan
7343,masoprocol,arachidonate 15-lipoxygenase,enzyme,,Drug: masoprocol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
7344,masoprocol,arachidonate 5-lipoxygenase,enzyme,,Drug: masoprocol | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
7345,masoprocol,seed linoleate 13s-lipoxygenase-1,enzyme,,Drug: masoprocol | Target: seed linoleate 13s-lipoxygenase-1 | Type: enzyme | Action: nan
7346,masoprocol,prostaglandin g/h synthase 1,enzyme,,Drug: masoprocol | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
7347,masoprocol,zinc finger protein mex-5,cytosolic other,,Drug: masoprocol | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
7348,masoprocol,5-lipoxygenase,enzyme,,Drug: masoprocol | Target: 5-lipoxygenase | Type: enzyme | Action: nan
7349,masoprocol,arachidonate 5-lipoxygenase,enzyme,,Drug: masoprocol | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
7350,masoprocol,cyclooxygenase,enzyme,,Drug: masoprocol | Target: cyclooxygenase | Type: enzyme | Action: nan
7351,masoprocol,"arachidonate 15-lipoxygenase, type ii",enzyme,,"Drug: masoprocol | Target: arachidonate 15-lipoxygenase, type ii | Type: enzyme | Action: nan"
7352,masoprocol,lipoxygenase,unclassified,,Drug: masoprocol | Target: lipoxygenase | Type: unclassified | Action: nan
7353,masoprocol,cytoplasmic zinc-finger protein,unclassified,,Drug: masoprocol | Target: cytoplasmic zinc-finger protein | Type: unclassified | Action: nan
7354,masoprocol,"fatty acid hydroperoxide lyase, chloroplastic",enzyme,,"Drug: masoprocol | Target: fatty acid hydroperoxide lyase, chloroplastic | Type: enzyme | Action: nan"
7356,maxacalcitol,vitamin d3 receptor,nuclear hormone receptor,,Drug: maxacalcitol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: nan
7357,maxacalcitol,vitamin d3 receptor,transcription factor,AGONIST,Drug: maxacalcitol | Target: vitamin d3 receptor | Type: transcription factor | Action: AGONIST
7358,mazindol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: mazindol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
7359,mazindol,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: mazindol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
7360,mazindol,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: mazindol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
7361,mazindol,histamine h1 receptor,gpcr,,Drug: mazindol | Target: histamine h1 receptor | Type: gpcr | Action: nan
7362,mazindol,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: mazindol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
7363,mazindol,sodium-dependent serotonin transporter,transporter,,Drug: mazindol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
7364,mazindol,sodium-dependent dopamine transporter,transporter,,Drug: mazindol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7365,mazindol,transporter,transporter,,Drug: mazindol | Target: transporter | Type: transporter | Action: nan
7366,mazindol,sodium-dependent dopamine transporter,transporter,,Drug: mazindol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7367,mebendazole,tyrosine-protein kinase abl1,kinase,,Drug: mebendazole | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
7368,mebendazole,vascular endothelial growth factor receptor 2,kinase,,Drug: mebendazole | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
7369,mebendazole,calmodulin-domain protein kinase 1,kinase,,Drug: mebendazole | Target: calmodulin-domain protein kinase 1 | Type: kinase | Action: nan
7370,mebendazole,tubulin,structural,INHIBITOR,Drug: mebendazole | Target: tubulin | Type: structural | Action: INHIBITOR
7371,mebendazole,tubulin,structural,INHIBITOR,Drug: mebendazole | Target: tubulin | Type: structural | Action: INHIBITOR
7372,mebhydrolin,histamine h1 receptor,gpcr,ANTAGONIST,Drug: mebhydrolin | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
7373,mebhydrolin,histamine h4 receptor,gpcr,,Drug: mebhydrolin | Target: histamine h4 receptor | Type: gpcr | Action: nan
7374,mebhydrolin,muscarinic acetylcholine receptor m1,gpcr,,Drug: mebhydrolin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7375,mebhydrolin,5-hydroxytryptamine receptor 5a,gpcr,,Drug: mebhydrolin | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
7376,mecamylamine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: mecamylamine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
7377,mecamylamine,acetylcholine receptor subunit alpha,ion channel,,Drug: mecamylamine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
7378,mecamylamine,neuronal acetylcholine receptor; alpha2/beta4,ion channel,,Drug: mecamylamine | Target: neuronal acetylcholine receptor; alpha2/beta4 | Type: ion channel | Action: nan
7379,mecamylamine,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: mecamylamine | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
7380,mecamylamine,neuronal acetylcholine receptor; alpha3/beta4,ion channel,NEGATIVE ALLOSTERIC MODULATOR,Drug: mecamylamine | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: NEGATIVE ALLOSTERIC MODULATOR
7381,mecamylamine,neuronal acetylcholine receptor; alpha3/beta2,ion channel,,Drug: mecamylamine | Target: neuronal acetylcholine receptor; alpha3/beta2 | Type: ion channel | Action: nan
7382,mecamylamine,neuronal acetylcholine receptor; alpha4/beta4,ion channel,BLOCKER,Drug: mecamylamine | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: BLOCKER
7383,mecamylamine,neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3,ion channel,,Drug: mecamylamine | Target: neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3 | Type: ion channel | Action: nan
7384,mecamylamine,acetylcholine receptor subunit alpha,ion channel,BLOCKER,Drug: mecamylamine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: BLOCKER
7385,mecamylamine,neuronal acetylcholine receptor subunit alpha-3,ion channel,BLOCKER,Drug: mecamylamine | Target: neuronal acetylcholine receptor subunit alpha-3 | Type: ion channel | Action: BLOCKER
7386,mecamylamine,neuronal acetylcholine receptor subunit alpha-4,ion channel,BLOCKER,Drug: mecamylamine | Target: neuronal acetylcholine receptor subunit alpha-4 | Type: ion channel | Action: BLOCKER
7387,mecamylamine,neuronal acetylcholine receptor subunit alpha-6,ion channel,BLOCKER,Drug: mecamylamine | Target: neuronal acetylcholine receptor subunit alpha-6 | Type: ion channel | Action: BLOCKER
7388,mecillinam,penicillin-binding protein 2,enzyme,INHIBITOR,Drug: mecillinam | Target: penicillin-binding protein 2 | Type: enzyme | Action: INHIBITOR
7389,meclozine,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,ANTAGONIST,Drug: meclozine | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: ANTAGONIST
7390,meclozine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: meclozine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
7391,meclozine,constitutive androstane receptor,nuclear hormone receptor,AGONIST,Drug: meclozine | Target: constitutive androstane receptor | Type: nuclear hormone receptor | Action: AGONIST
7392,meclozine,serine protease hepsin,enzyme,,Drug: meclozine | Target: serine protease hepsin | Type: enzyme | Action: nan
7393,meclofenamic acid,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: meclofenamic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
7394,meclofenamic acid,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: meclofenamic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
7395,meclofenamic acid,transthyretin,secreted,,Drug: meclofenamic acid | Target: transthyretin | Type: secreted | Action: nan
7396,meclofenamic acid,androgen receptor,nuclear hormone receptor,,Drug: meclofenamic acid | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
7397,meclofenamic acid,aldo-keto reductase family 1 member c1,enzyme,,Drug: meclofenamic acid | Target: aldo-keto reductase family 1 member c1 | Type: enzyme | Action: nan
7398,meclofenamic acid,aldo-keto reductase family 1 member c2,enzyme,,Drug: meclofenamic acid | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
7399,meclofenamic acid,aldo-keto reductase family 1 member c3,enzyme,,Drug: meclofenamic acid | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
7400,meclofenamic acid,arachidonate 5-lipoxygenase,enzyme,INHIBITOR,Drug: meclofenamic acid | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: INHIBITOR
7401,meclofenamic acid,"fatty acid-binding protein, intestinal",cytosolic other,,"Drug: meclofenamic acid | Target: fatty acid-binding protein, intestinal | Type: cytosolic other | Action: nan"
7402,meclofenamic acid,"fatty acid-binding protein, liver",unclassified,,"Drug: meclofenamic acid | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
7403,meclofenamic acid,mitogen-activated protein kinase 1,kinase,,Drug: meclofenamic acid | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
7404,meclofenamic acid,prostaglandin g/h synthase 2,enzyme,,Drug: meclofenamic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
7405,meclofenamic acid,prostaglandin g/h synthase 1,enzyme,,Drug: meclofenamic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
7406,meclofenamic acid,arachidonate 5-lipoxygenase,enzyme,,Drug: meclofenamic acid | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
7407,meclofenamic acid,cyclooxygenase,enzyme,,Drug: meclofenamic acid | Target: cyclooxygenase | Type: enzyme | Action: nan
7408,medazepam,gaba-a receptor; anion channel,ion channel,,Drug: medazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
7409,medetomidine,adrenergic receptor alpha-2,gpcr,,Drug: medetomidine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
7410,medetomidine,adrenergic receptor alpha-1,gpcr,,Drug: medetomidine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
7411,medetomidine,adrenergic receptor alpha-2,gpcr,,Drug: medetomidine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
7412,medetomidine,adrenergic receptor alpha-1,gpcr,,Drug: medetomidine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
7413,medroxalol,beta-1 adrenergic receptor,gpcr,,Drug: medroxalol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
7414,medroxalol,alpha-1a adrenergic receptor,gpcr,,Drug: medroxalol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7415,medroxyprogesterone,histamine h2 receptor,gpcr,,Drug: medroxyprogesterone | Target: histamine h2 receptor | Type: gpcr | Action: nan
7416,medroxyprogesterone,glucocorticoid receptor,nuclear hormone receptor,,Drug: medroxyprogesterone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
7417,medroxyprogesterone,mineralocorticoid receptor,nuclear hormone receptor,,Drug: medroxyprogesterone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
7418,medroxyprogesterone,androgen receptor,nuclear hormone receptor,,Drug: medroxyprogesterone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
7419,medroxyprogesterone,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: medroxyprogesterone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
7420,medroxyprogesterone,aldo-keto reductase family 1 member c1,enzyme,,Drug: medroxyprogesterone | Target: aldo-keto reductase family 1 member c1 | Type: enzyme | Action: nan
7421,medroxyprogesterone,aldo-keto reductase family 1 member c2,enzyme,,Drug: medroxyprogesterone | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
7422,medroxyprogesterone,aldo-keto reductase family 1 member c3,enzyme,,Drug: medroxyprogesterone | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
7423,medroxyprogesterone,cytochrome p450 2c19,enzyme,,Drug: medroxyprogesterone | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
7424,medroxyprogesterone,sex hormone-binding globulin,secreted,,Drug: medroxyprogesterone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
7425,medroxyprogesterone,androgen receptor,transcription factor,,Drug: medroxyprogesterone | Target: androgen receptor | Type: transcription factor | Action: nan
7426,medroxyprogesterone,progesterone receptor,transcription factor,,Drug: medroxyprogesterone | Target: progesterone receptor | Type: transcription factor | Action: nan
7427,medroxyprogesterone,androgen receptor,transcription factor,,Drug: medroxyprogesterone | Target: androgen receptor | Type: transcription factor | Action: nan
7428,medroxyprogesterone,estrogen receptor,nuclear hormone receptor,,Drug: medroxyprogesterone | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
7429,medrysone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: medrysone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
7430,mefenamic acid,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: mefenamic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
7431,mefenamic acid,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: mefenamic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
7432,mefenamic acid,cytochrome p450 2c9,enzyme,,Drug: mefenamic acid | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
7433,mefenamic acid,aldose reductase,enzyme,,Drug: mefenamic acid | Target: aldose reductase | Type: enzyme | Action: nan
7434,mefenamic acid,aldo-keto reductase family 1 member c1,enzyme,,Drug: mefenamic acid | Target: aldo-keto reductase family 1 member c1 | Type: enzyme | Action: nan
7435,mefenamic acid,aldo-keto reductase family 1 member c2,enzyme,,Drug: mefenamic acid | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
7436,mefenamic acid,aldo-keto reductase family 1 member c3,enzyme,,Drug: mefenamic acid | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
7437,mefenamic acid,myeloperoxidase,enzyme,,Drug: mefenamic acid | Target: myeloperoxidase | Type: enzyme | Action: nan
7438,mefenamic acid,acetylcholinesterase,enzyme,,Drug: mefenamic acid | Target: acetylcholinesterase | Type: enzyme | Action: nan
7439,mefenamic acid,transient receptor potential cation channel subfamily a member 1,ion channel,,Drug: mefenamic acid | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: nan
7440,mefenamic acid,aldo-keto reductase family 1 member b10,enzyme,,Drug: mefenamic acid | Target: aldo-keto reductase family 1 member b10 | Type: enzyme | Action: nan
7442,mefenamic acid,nicotinate phosphoribosyltransferase,enzyme,,Drug: mefenamic acid | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
7443,mefloquine,adenosine receptor a2a,gpcr,,Drug: mefloquine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
7444,mefloquine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: mefloquine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7445,mefloquine,multidrug resistance protein 1,transporter,,Drug: mefloquine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
7446,mefloquine,adenosine receptor a1,gpcr,,Drug: mefloquine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
7447,mefloquine,hemoglobin subunit alpha,secreted,,Drug: mefloquine | Target: hemoglobin subunit alpha | Type: secreted | Action: nan
7448,mefloquine,glycine receptor subunit alpha-1,ion channel,,Drug: mefloquine | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
7449,mefloquine,protein kinase pfmrk,unclassified,,Drug: mefloquine | Target: protein kinase pfmrk | Type: unclassified | Action: nan
7450,megestrol acetate,multidrug resistance protein 1,transporter,,Drug: megestrol acetate | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
7451,megestrol acetate,glucocorticoid receptor,nuclear hormone receptor,,Drug: megestrol acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
7452,megestrol acetate,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: megestrol acetate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
7453,megestrol acetate,cytochrome p450 2c9,enzyme,,Drug: megestrol acetate | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
7454,megestrol acetate,androgen receptor,transcription factor,,Drug: megestrol acetate | Target: androgen receptor | Type: transcription factor | Action: nan
7455,megestrol acetate,progesterone receptor,transcription factor,,Drug: megestrol acetate | Target: progesterone receptor | Type: transcription factor | Action: nan
7456,meglutol,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: meglutol | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
7457,melatonin,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: melatonin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
7458,melatonin,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: melatonin | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
7459,melatonin,melatonin receptor type 1a,gpcr,AGONIST,Drug: melatonin | Target: melatonin receptor type 1a | Type: gpcr | Action: AGONIST
7460,melatonin,melatonin receptor type 1b,gpcr,AGONIST,Drug: melatonin | Target: melatonin receptor type 1b | Type: gpcr | Action: AGONIST
7461,melatonin,nuclear receptor ror-alpha,nuclear hormone receptor,,Drug: melatonin | Target: nuclear receptor ror-alpha | Type: nuclear hormone receptor | Action: nan
7462,melatonin,myeloperoxidase,enzyme,,Drug: melatonin | Target: myeloperoxidase | Type: enzyme | Action: nan
7463,melatonin,histamine h3 receptor,gpcr,,Drug: melatonin | Target: histamine h3 receptor | Type: gpcr | Action: nan
7464,melatonin,melatonin receptor type 1b,gpcr,,Drug: melatonin | Target: melatonin receptor type 1b | Type: gpcr | Action: nan
7465,melatonin,cytochrome p450 1b1,enzyme,,Drug: melatonin | Target: cytochrome p450 1b1 | Type: enzyme | Action: nan
7466,melatonin,melatonin receptor,gpcr,,Drug: melatonin | Target: melatonin receptor | Type: gpcr | Action: nan
7469,meloxicam,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: meloxicam | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
7470,meloxicam,prostaglandin g/h synthase 1,enzyme,,Drug: meloxicam | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
7471,meloxicam,prostaglandin g/h synthase 2,enzyme,,Drug: meloxicam | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
7472,meloxicam,prostaglandin g/h synthase 1,enzyme,,Drug: meloxicam | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
7473,meloxicam,prostaglandin g/h synthase 2,enzyme,,Drug: meloxicam | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
7474,melperone,d(2) dopamine receptor,gpcr,,Drug: melperone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7475,melperone,alpha-2a adrenergic receptor,gpcr,,Drug: melperone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7476,melperone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: melperone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7477,melperone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: melperone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7478,melperone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: melperone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7479,melperone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: melperone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7480,melperone,alpha-1a adrenergic receptor,gpcr,,Drug: melperone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7481,melperone,d(3) dopamine receptor,gpcr,,Drug: melperone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7482,melperone,histamine h1 receptor,gpcr,,Drug: melperone | Target: histamine h1 receptor | Type: gpcr | Action: nan
7483,melperone,muscarinic acetylcholine receptor m2,gpcr,,Drug: melperone | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7484,melperone,muscarinic acetylcholine receptor m4,gpcr,,Drug: melperone | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7485,melperone,5-hydroxytryptamine receptor 1d,gpcr,,Drug: melperone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
7486,melperone,cytochrome p450 2d6,enzyme,,Drug: melperone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
7487,melperone,d(4) dopamine receptor,gpcr,,Drug: melperone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
7488,melphalan,l-type amino acid transporter 1,transporter,,Drug: melphalan | Target: l-type amino acid transporter 1 | Type: transporter | Action: nan
7489,memantine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: memantine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
7490,memantine,"glutamate receptor ionotropic, nmda 3a",ion channel,NEGATIVE ALLOSTERIC MODULATOR,"Drug: memantine | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: NEGATIVE ALLOSTERIC MODULATOR"
7491,memantine,"glutamate receptor ionotropic, nmda 1",ion channel,NEGATIVE ALLOSTERIC MODULATOR,"Drug: memantine | Target: glutamate receptor ionotropic, nmda 1 | Type: ion channel | Action: NEGATIVE ALLOSTERIC MODULATOR"
7492,memantine,solute carrier family 22 member 1,transporter,,Drug: memantine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
7493,memantine,"glutamate receptor ionotropic, nmda 2c",ion channel,,"Drug: memantine | Target: glutamate receptor ionotropic, nmda 2c | Type: ion channel | Action: nan"
7494,memantine,glutamate nmda receptor; grin1/grin2b,ion channel,NEGATIVE ALLOSTERIC MODULATOR,Drug: memantine | Target: glutamate nmda receptor; grin1/grin2b | Type: ion channel | Action: NEGATIVE ALLOSTERIC MODULATOR
7495,memantine,glutamate nmda receptor; grin1/grin2a,ion channel,NEGATIVE ALLOSTERIC MODULATOR,Drug: memantine | Target: glutamate nmda receptor; grin1/grin2a | Type: ion channel | Action: NEGATIVE ALLOSTERIC MODULATOR
7496,menadione,aldehyde oxidase,enzyme,,Drug: menadione | Target: aldehyde oxidase | Type: enzyme | Action: nan
7497,menadione,"glutathione reductase, mitochondrial",enzyme,,"Drug: menadione | Target: glutathione reductase, mitochondrial | Type: enzyme | Action: nan"
7498,menadione,amine oxidase [flavin-containing] b,enzyme,,Drug: menadione | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
7499,menadione,amine oxidase [flavin-containing] a,enzyme,,Drug: menadione | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
7500,menadione,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: menadione | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
7501,menadione,m-phase inducer phosphatase 2,enzyme,,Drug: menadione | Target: m-phase inducer phosphatase 2 | Type: enzyme | Action: nan
7502,menadione,trypanothione reductase,enzyme,,Drug: menadione | Target: trypanothione reductase | Type: enzyme | Action: nan
7503,menadione,dual specificity phosphatase cdc25c,enzyme,,Drug: menadione | Target: dual specificity phosphatase cdc25c | Type: enzyme | Action: nan
7504,menadione,ubiquitin carboxyl-terminal hydrolase isozyme l3,enzyme,,Drug: menadione | Target: ubiquitin carboxyl-terminal hydrolase isozyme l3 | Type: enzyme | Action: nan
7505,menadione,dual specificity phosphatase cdc25a,enzyme,,Drug: menadione | Target: dual specificity phosphatase cdc25a | Type: enzyme | Action: nan
7506,menadione,dual specificity protein phosphatase 6,enzyme,,Drug: menadione | Target: dual specificity protein phosphatase 6 | Type: enzyme | Action: nan
7507,menadione,dual specificity protein phosphatase 1,enzyme,,Drug: menadione | Target: dual specificity protein phosphatase 1 | Type: enzyme | Action: nan
7508,menadione,m-phase inducer phosphatase 1,enzyme,,Drug: menadione | Target: m-phase inducer phosphatase 1 | Type: enzyme | Action: nan
7510,menadione sodium bisulfite,aldose reductase,enzyme,,Drug: menadione sodium bisulfite | Target: aldose reductase | Type: enzyme | Action: nan
7511,menatetrenone,cruzipain,enzyme,,Drug: menatetrenone | Target: cruzipain | Type: enzyme | Action: nan
7512,pecazine,alpha-2a adrenergic receptor,gpcr,,Drug: pecazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7513,pecazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: pecazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
7514,pecazine,sodium-dependent noradrenaline transporter,transporter,,Drug: pecazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
7515,pecazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: pecazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7516,pecazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: pecazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7517,pecazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: pecazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7518,pecazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: pecazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
7519,pecazine,alpha-2b adrenergic receptor,gpcr,,Drug: pecazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7520,pecazine,d(3) dopamine receptor,gpcr,,Drug: pecazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7521,pecazine,histamine h1 receptor,gpcr,,Drug: pecazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7522,pecazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: pecazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7523,pecazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: pecazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7524,pecazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: pecazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
7525,pecazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: pecazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7526,pecazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: pecazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
7527,pecazine,alpha-1d adrenergic receptor,gpcr,,Drug: pecazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
7528,pecazine,alpha-1b adrenergic receptor,gpcr,,Drug: pecazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
7529,pecazine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: pecazine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
7530,pecazine,alpha-1a adrenergic receptor,gpcr,,Drug: pecazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7531,pecazine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: pecazine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
7532,pecazine,mucosa-associated lymphoid tissue lymphoma translocation protein 1,enzyme,,Drug: pecazine | Target: mucosa-associated lymphoid tissue lymphoma translocation protein 1 | Type: enzyme | Action: nan
7533,mepenzolate,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: mepenzolate | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
7534,mepenzolate,muscarinic acetylcholine receptor m2,gpcr,,Drug: mepenzolate | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7535,mepenzolate,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: mepenzolate | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
7536,mepenzolate,solute carrier family 22 member 1,transporter,,Drug: mepenzolate | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
7537,pethidine,mu-type opioid receptor,gpcr,AGONIST,Drug: pethidine | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
7538,pethidine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: pethidine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7539,pethidine,sodium-dependent dopamine transporter,transporter,,Drug: pethidine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7540,pethidine,kappa-type opioid receptor,gpcr,,Drug: pethidine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
7541,pethidine,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: pethidine | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
7542,pethidine,solute carrier family 22 member 1,transporter,,Drug: pethidine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
7543,pethidine,sodium-dependent serotonin transporter,transporter,,Drug: pethidine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
7544,pethidine,sodium-dependent dopamine transporter,transporter,,Drug: pethidine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7545,pethidine,mu-type opioid receptor,gpcr,,Drug: pethidine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
7546,pethidine,opioid receptor,gpcr,,Drug: pethidine | Target: opioid receptor | Type: gpcr | Action: nan
7547,pethidine,opioid receptor,gpcr,,Drug: pethidine | Target: opioid receptor | Type: gpcr | Action: nan
7549,mephentermine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: mephentermine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
7550,mephenytoin,sodium channel alpha subunit,ion channel,BLOCKER,Drug: mephenytoin | Target: sodium channel alpha subunit | Type: ion channel | Action: BLOCKER
7551,methylphenobarbital,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,,Drug: methylphenobarbital | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: nan
7552,mepivacaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: mepivacaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
7553,mepivacaine,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: mepivacaine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
7554,mepivacaine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: mepivacaine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
7555,mepivacaine,sodium channel protein type 3 subunit alpha,ion channel,BLOCKER,Drug: mepivacaine | Target: sodium channel protein type 3 subunit alpha | Type: ion channel | Action: BLOCKER
7556,mepivacaine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: mepivacaine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
7557,mepivacaine,sodium channel protein type 8 subunit alpha,ion channel,BLOCKER,Drug: mepivacaine | Target: sodium channel protein type 8 subunit alpha | Type: ion channel | Action: BLOCKER
7558,mepivacaine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: mepivacaine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
7559,meprednisone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: meprednisone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
7560,meprobamate,multidrug resistance protein 1,transporter,,Drug: meprobamate | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
7561,meprobamate,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,AGONIST,Drug: meprobamate | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: AGONIST
7562,meprobamate,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,AGONIST,Drug: meprobamate | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: AGONIST
7563,meprobamate,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,AGONIST,Drug: meprobamate | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: AGONIST
7564,meprobamate,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,AGONIST,Drug: meprobamate | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: AGONIST
7565,meproscillarin,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: meproscillarin | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
7566,meptazinol,solute carrier family 22 member 1,transporter,,Drug: meptazinol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
7567,meptazinol,acetylcholinesterase,enzyme,,Drug: meptazinol | Target: acetylcholinesterase | Type: enzyme | Action: nan
7568,meptazinol,cholinesterase,enzyme,,Drug: meptazinol | Target: cholinesterase | Type: enzyme | Action: nan
7570,meptazinol,mu-type opioid receptor,gpcr,PARTIAL AGONIST,Drug: meptazinol | Target: mu-type opioid receptor | Type: gpcr | Action: PARTIAL AGONIST
7571,mequitazine,histamine h1 receptor,gpcr,,Drug: mequitazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7572,mequitazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: mequitazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7573,mequitazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: mequitazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7574,mequitazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: mequitazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
7575,mequitazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: mequitazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7576,mequitazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: mequitazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
7577,mequitazine,trypanothione reductase,enzyme,,Drug: mequitazine | Target: trypanothione reductase | Type: enzyme | Action: nan
7578,mequitazine,histamine h1 receptor,gpcr,,Drug: mequitazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7579,mequitazine,trypanothione reductase,enzyme,,Drug: mequitazine | Target: trypanothione reductase | Type: enzyme | Action: nan
7580,mercaptopurine,prostaglandin g/h synthase 1,enzyme,,Drug: mercaptopurine | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
7581,mercaptopurine,multidrug resistance-associated protein 5,transporter,,Drug: mercaptopurine | Target: multidrug resistance-associated protein 5 | Type: transporter | Action: nan
7582,mercaptopurine,multidrug resistance-associated protein 4,transporter,,Drug: mercaptopurine | Target: multidrug resistance-associated protein 4 | Type: transporter | Action: nan
7583,mercaptopurine,purine nucleoside phosphorylase,enzyme,,Drug: mercaptopurine | Target: purine nucleoside phosphorylase | Type: enzyme | Action: nan
7584,mercaptopurine,amidophosphoribosyltransferase,enzyme,INHIBITOR,Drug: mercaptopurine | Target: amidophosphoribosyltransferase | Type: enzyme | Action: INHIBITOR
7585,mercaptopurine,thiopurine s-methyltransferase,enzyme,,Drug: mercaptopurine | Target: thiopurine s-methyltransferase | Type: enzyme | Action: nan
7586,mercaptopurine,purine nucleoside phosphorylase,enzyme,,Drug: mercaptopurine | Target: purine nucleoside phosphorylase | Type: enzyme | Action: nan
7587,meropenem,penicillin-binding protein 2,enzyme,,Drug: meropenem | Target: penicillin-binding protein 2 | Type: enzyme | Action: nan
7588,meropenem,penicillin-binding protein 4,enzyme,,Drug: meropenem | Target: penicillin-binding protein 4 | Type: enzyme | Action: nan
7589,meropenem,d-ala-d-ala-carboxypeptidase; d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase family protein; penicillin-binding protein 5,enzyme,,Drug: meropenem | Target: d-ala-d-ala-carboxypeptidase; d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase family protein; penicillin-binding protein 5 | Type: enzyme | Action: nan
7590,meropenem,penicillin-binding protein 1,enzyme,,Drug: meropenem | Target: penicillin-binding protein 1 | Type: enzyme | Action: nan
7591,meropenem,d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase penicillin-binding protein 6,enzyme,,Drug: meropenem | Target: d-alanyl-d-alanine carboxypeptidase; d-alanyl-d-alanine carboxypeptidase penicillin-binding protein 6 | Type: enzyme | Action: nan
7592,meropenem,d-alanyl-d-alanine carboxypeptidase dacb,enzyme,INHIBITOR,Drug: meropenem | Target: d-alanyl-d-alanine carboxypeptidase dacb | Type: enzyme | Action: INHIBITOR
7593,meropenem,streptokinase a,enzyme,,Drug: meropenem | Target: streptokinase a | Type: enzyme | Action: nan
7594,meropenem,beta-lactamase class b vim-2,unclassified,,Drug: meropenem | Target: beta-lactamase class b vim-2 | Type: unclassified | Action: nan
7595,meropenem,beta-lactamase ndm-1,enzyme,,Drug: meropenem | Target: beta-lactamase ndm-1 | Type: enzyme | Action: nan
7596,meropenem,beta-lactamase,enzyme,,Drug: meropenem | Target: beta-lactamase | Type: enzyme | Action: nan
7597,mesalazine,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: mesalazine | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
7598,mesalazine,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: mesalazine | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
7599,mesalazine,arachidonate 5-lipoxygenase,enzyme,INHIBITOR,Drug: mesalazine | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: INHIBITOR
7600,mesalazine,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: mesalazine | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
7601,mesalazine,tumor necrosis factor,cytokine,,Drug: mesalazine | Target: tumor necrosis factor | Type: cytokine | Action: nan
7602,mesalazine,prostaglandin g/h synthase 1,enzyme,,Drug: mesalazine | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
7604,mesalazine,hydroxyacid oxidase 1,enzyme,,Drug: mesalazine | Target: hydroxyacid oxidase 1 | Type: enzyme | Action: nan
7605,mesoridazine,d(1a) dopamine receptor,gpcr,ANTAGONIST,Drug: mesoridazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: ANTAGONIST
7606,mesoridazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: mesoridazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
7607,mesoridazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: mesoridazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7608,mesoridazine,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: mesoridazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
7609,mesoridazine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: mesoridazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
7610,mesoridazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: mesoridazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7611,mesoridazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: mesoridazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
7612,mesoridazine,d(3) dopamine receptor,gpcr,,Drug: mesoridazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7613,mesoridazine,histamine h1 receptor,gpcr,,Drug: mesoridazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7614,mesoridazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: mesoridazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7615,mesoridazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: mesoridazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7616,mesoridazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: mesoridazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
7617,mesoridazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: mesoridazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7618,mesoridazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: mesoridazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
7619,mesoridazine,d(4) dopamine receptor,gpcr,,Drug: mesoridazine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
7620,mestranol,cannabinoid receptor 1,gpcr,,Drug: mestranol | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
7621,mestranol,sodium-dependent serotonin transporter,transporter,,Drug: mestranol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
7622,mestranol,sodium-dependent noradrenaline transporter,transporter,,Drug: mestranol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
7623,mestranol,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: mestranol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
7624,mestranol,androgen receptor,transcription factor,,Drug: mestranol | Target: androgen receptor | Type: transcription factor | Action: nan
7625,mestranol,progesterone receptor,transcription factor,,Drug: mestranol | Target: progesterone receptor | Type: transcription factor | Action: nan
7626,orciprenaline,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: orciprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
7627,orciprenaline,beta-2 adrenergic receptor,gpcr,,Drug: orciprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
7628,metaraminol,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: metaraminol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
7629,metergoline,5-hydroxytryptamine receptor 4,gpcr,,Drug: metergoline | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
7630,metergoline,d(1a) dopamine receptor,gpcr,,Drug: metergoline | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
7631,metergoline,d(2) dopamine receptor,gpcr,,Drug: metergoline | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7632,metergoline,alpha-2a adrenergic receptor,gpcr,,Drug: metergoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7633,metergoline,sodium-dependent serotonin transporter,transporter,,Drug: metergoline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
7634,metergoline,sodium-dependent noradrenaline transporter,transporter,,Drug: metergoline | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
7635,metergoline,5-hydroxytryptamine receptor 1a,gpcr,,Drug: metergoline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7636,metergoline,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
7637,metergoline,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
7638,metergoline,5-hydroxytryptamine receptor 2c,gpcr,,Drug: metergoline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7639,metergoline,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
7640,metergoline,5-hydroxytryptamine receptor 7,gpcr,,Drug: metergoline | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
7641,metergoline,alpha-2b adrenergic receptor,gpcr,,Drug: metergoline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7642,metergoline,d(3) dopamine receptor,gpcr,,Drug: metergoline | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7643,metergoline,histamine h1 receptor,gpcr,,Drug: metergoline | Target: histamine h1 receptor | Type: gpcr | Action: nan
7644,metergoline,histamine h2 receptor,gpcr,,Drug: metergoline | Target: histamine h2 receptor | Type: gpcr | Action: nan
7645,metergoline,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
7646,metergoline,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
7647,metergoline,alpha-2c adrenergic receptor,gpcr,,Drug: metergoline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
7648,metergoline,sodium-dependent dopamine transporter,transporter,,Drug: metergoline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7649,metergoline,cytochrome p450 2d6,enzyme,,Drug: metergoline | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
7650,metergoline,alpha-1d adrenergic receptor,gpcr,,Drug: metergoline | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
7651,metergoline,acetylcholinesterase,enzyme,,Drug: metergoline | Target: acetylcholinesterase | Type: enzyme | Action: nan
7652,metergoline,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
7653,metergoline,5-hydroxytryptamine receptor 1f,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: ANTAGONIST
7654,metergoline,5-hydroxytryptamine receptor 1e,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: ANTAGONIST
7655,metergoline,substance-k receptor,gpcr,,Drug: metergoline | Target: substance-k receptor | Type: gpcr | Action: nan
7656,metergoline,alpha-1b adrenergic receptor,gpcr,,Drug: metergoline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
7657,metergoline,5-hydroxytryptamine receptor 1b,gpcr,,Drug: metergoline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
7658,metergoline,alpha-1a adrenergic receptor,gpcr,,Drug: metergoline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
7659,metergoline,5-hydroxytryptamine receptor 1a,gpcr,,Drug: metergoline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7660,metergoline,5-hydroxytryptamine receptor 7,gpcr,,Drug: metergoline | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
7661,metergoline,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
7662,metergoline,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: metergoline | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
7663,metergoline,serotonin 1 (5-ht1) receptor,gpcr,,Drug: metergoline | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
7664,metergoline,serotonin 2 (5-ht2) receptor,gpcr,,Drug: metergoline | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
7665,metformin,5'-amp-activated protein kinase subunit beta-1,kinase,,Drug: metformin | Target: 5'-amp-activated protein kinase subunit beta-1 | Type: kinase | Action: nan
7666,metformin,dipeptidyl peptidase 4,enzyme,,Drug: metformin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
7667,metformin,solute carrier family 22 member 1,transporter,,Drug: metformin | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
7668,metformin,solute carrier family 22 member 2,transporter,,Drug: metformin | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
7669,metformin,solute carrier family 22 member 3,transporter,,Drug: metformin | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
7670,metformin,mitochondrial complex i (nadh dehydrogenase),enzyme,INHIBITOR,Drug: metformin | Target: mitochondrial complex i (nadh dehydrogenase) | Type: enzyme | Action: INHIBITOR
7671,methacholine,muscarinic acetylcholine receptor m1,gpcr,,Drug: methacholine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7672,methacholine,muscarinic acetylcholine receptor m2,gpcr,,Drug: methacholine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7673,methacholine,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: methacholine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
7674,methacholine,muscarinic acetylcholine receptor m4,gpcr,,Drug: methacholine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7675,methacholine,muscarinic acetylcholine receptor m2,gpcr,,Drug: methacholine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7676,methacholine,muscarinic acetylcholine receptor m1,gpcr,AGONIST,Drug: methacholine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: AGONIST
7677,methacholine,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: methacholine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
7678,methacholine,muscarinic acetylcholine receptor m4,gpcr,,Drug: methacholine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7679,metacycline,dna repair protein rad52 homolog,nuclear other,,Drug: metacycline | Target: dna repair protein rad52 homolog | Type: nuclear other | Action: nan
7680,methadone,mu-type opioid receptor,gpcr,AGONIST,Drug: methadone | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
7681,methadone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: methadone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7682,methadone,kappa-type opioid receptor,gpcr,,Drug: methadone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
7683,methadone,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: methadone | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
7684,methadone,neuronal acetylcholine receptor subunit alpha-10,ion channel,,Drug: methadone | Target: neuronal acetylcholine receptor subunit alpha-10 | Type: ion channel | Action: nan
7685,methadone,delta-type opioid receptor,gpcr,,Drug: methadone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
7686,methadone,opioid receptor,gpcr,,Drug: methadone | Target: opioid receptor | Type: gpcr | Action: nan
7687,acetylmethadol,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: acetylmethadol | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7688,acetylmethadol,mu-type opioid receptor,gpcr,AGONIST,Drug: acetylmethadol | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
7689,methamphetamine,alpha-2a adrenergic receptor,gpcr,,Drug: methamphetamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7690,methamphetamine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: methamphetamine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
7691,methamphetamine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: methamphetamine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
7692,methamphetamine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: methamphetamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
7693,methamphetamine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: methamphetamine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7694,methamphetamine,alpha-2b adrenergic receptor,gpcr,,Drug: methamphetamine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7695,methamphetamine,alpha-2c adrenergic receptor,gpcr,,Drug: methamphetamine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
7696,methamphetamine,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: methamphetamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
7697,methamphetamine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: methamphetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
7698,methamphetamine,synaptic vesicular amine transporter,transporter,,Drug: methamphetamine | Target: synaptic vesicular amine transporter | Type: transporter | Action: nan
7699,methamphetamine,trace amine-associated receptor 1,gpcr,,Drug: methamphetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
7700,methamphetamine,trace amine-associated receptor 1,gpcr,,Drug: methamphetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
7701,methamphetamine,trace amine-associated receptor 1,gpcr,,Drug: methamphetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
7702,methanthelinium,muscarinic acetylcholine receptor,gpcr,ANTAGONIST,Drug: methanthelinium | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: ANTAGONIST
7703,methapyrilene,alpha-2a adrenergic receptor,gpcr,,Drug: methapyrilene | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7704,methapyrilene,sodium-dependent serotonin transporter,transporter,,Drug: methapyrilene | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
7705,methapyrilene,sodium-dependent noradrenaline transporter,transporter,,Drug: methapyrilene | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
7706,methapyrilene,5-hydroxytryptamine receptor 2a,gpcr,,Drug: methapyrilene | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7707,methapyrilene,5-hydroxytryptamine receptor 2b,gpcr,,Drug: methapyrilene | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7708,methapyrilene,5-hydroxytryptamine receptor 2c,gpcr,,Drug: methapyrilene | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7709,methapyrilene,5-hydroxytryptamine receptor 6,gpcr,,Drug: methapyrilene | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
7710,methapyrilene,alpha-2b adrenergic receptor,gpcr,,Drug: methapyrilene | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7711,methapyrilene,histamine h1 receptor,gpcr,,Drug: methapyrilene | Target: histamine h1 receptor | Type: gpcr | Action: nan
7712,methapyrilene,muscarinic acetylcholine receptor m1,gpcr,,Drug: methapyrilene | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7713,methapyrilene,muscarinic acetylcholine receptor m2,gpcr,,Drug: methapyrilene | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7714,methapyrilene,muscarinic acetylcholine receptor m5,gpcr,,Drug: methapyrilene | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
7715,methapyrilene,sodium-dependent dopamine transporter,transporter,,Drug: methapyrilene | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7716,methapyrilene,cytochrome p450 2d6,enzyme,,Drug: methapyrilene | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
7717,methaqualone,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7718,methaqualone,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7719,methaqualone,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7720,methaqualone,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7721,methaqualone,gaba a receptor alpha-4/beta-2/delta,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba a receptor alpha-4/beta-2/delta | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7722,methaqualone,gaba a receptor alpha-5/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba a receptor alpha-5/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7723,methaqualone,gaba a receptor alpha-4/beta-3/delta,ion channel,AGONIST,Drug: methaqualone | Target: gaba a receptor alpha-4/beta-3/delta | Type: ion channel | Action: AGONIST
7724,methaqualone,gaba-a receptor alpha-6/beta-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba-a receptor alpha-6/beta-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7725,methaqualone,gaba-a receptor alpha-6/beta-2/delta,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba-a receptor alpha-6/beta-2/delta | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7726,methaqualone,gaba-a receptor alpha-6/beta-3/delta,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methaqualone | Target: gaba-a receptor alpha-6/beta-3/delta | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7727,metharbital,gaba-a receptor; anion channel,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: metharbital | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7728,methazolamide,carbonic anhydrase 2,enzyme,INHIBITOR,Drug: methazolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: INHIBITOR
7729,methazolamide,carbonic anhydrase 1,enzyme,INHIBITOR,Drug: methazolamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: INHIBITOR
7730,methazolamide,carbonic anhydrase 4,enzyme,INHIBITOR,Drug: methazolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: INHIBITOR
7731,methazolamide,carbonic anhydrase 9,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
7732,methazolamide,carbonic anhydrase 12,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
7733,methazolamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: methazolamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
7734,methazolamide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: methazolamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
7735,methazolamide,carbonic anhydrase 7,enzyme,INHIBITOR,Drug: methazolamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: INHIBITOR
7736,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7737,methazolamide,carbonic anhydrase 3,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
7738,methazolamide,carbonic anhydrase 6,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
7739,methazolamide,carbonic anhydrase 14,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
7740,methazolamide,carbonic anhydrase 13,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
7741,methazolamide,carbonic anhydrase 4,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
7742,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7743,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7744,methazolamide,carbonic anhydrase 13,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
7745,methazolamide,carbonic anhydrase 15,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
7746,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7747,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7748,methazolamide,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: methazolamide | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
7749,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7750,methazolamide,alpha carbonic anhydrase,enzyme,,Drug: methazolamide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
7751,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7752,methazolamide,carbonic anhydrase 2,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
7753,methazolamide,astrosclerin-3,enzyme,,Drug: methazolamide | Target: astrosclerin-3 | Type: enzyme | Action: nan
7754,methazolamide,beta-carbonic anhydrase 1,enzyme,,Drug: methazolamide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
7755,methazolamide,delta carbonic anhydrase,unclassified,,Drug: methazolamide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
7756,methazolamide,carbonic anhydrase 2,enzyme,,Drug: methazolamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
7757,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7758,methazolamide,carbonic anhydrase v,enzyme,,Drug: methazolamide | Target: carbonic anhydrase v | Type: enzyme | Action: nan
7759,methazolamide,carbonic anhydrase,enzyme,,Drug: methazolamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
7760,methazolamide,"carbonic anhydrase, alpha family",unclassified,,"Drug: methazolamide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
7761,methazolamide,carbonate dehydratase,enzyme,,Drug: methazolamide | Target: carbonate dehydratase | Type: enzyme | Action: nan
7762,methdilazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: methdilazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
7763,meticillin,beta-lactam-inducible penicillin-binding protein,enzyme,,Drug: meticillin | Target: beta-lactam-inducible penicillin-binding protein | Type: enzyme | Action: nan
7764,meticillin,nh(3)-dependent nad(+) synthetase,enzyme,,Drug: meticillin | Target: nh(3)-dependent nad(+) synthetase | Type: enzyme | Action: nan
7765,meticillin,penicillin-binding protein,enzyme,INHIBITOR,Drug: meticillin | Target: penicillin-binding protein | Type: enzyme | Action: INHIBITOR
7766,thiamazole,thyroid peroxidase,enzyme,INHIBITOR,Drug: thiamazole | Target: thyroid peroxidase | Type: enzyme | Action: INHIBITOR
7767,thiamazole,lactoperoxidase,enzyme,,Drug: thiamazole | Target: lactoperoxidase | Type: enzyme | Action: nan
7768,thiamazole,lactoperoxidase,enzyme,,Drug: thiamazole | Target: lactoperoxidase | Type: enzyme | Action: nan
7769,thiamazole,dopamine beta-hydroxylase,enzyme,,Drug: thiamazole | Target: dopamine beta-hydroxylase | Type: enzyme | Action: nan
7770,methocarbamol,carbonic anhydrase 1,enzyme,INHIBITOR,Drug: methocarbamol | Target: carbonic anhydrase 1 | Type: enzyme | Action: INHIBITOR
7771,methohexital,glycine receptor subunit alpha-1,ion channel,,Drug: methohexital | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
7772,methohexital,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methohexital | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7773,methohexital,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: methohexital | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
7774,methotrexate,multidrug resistance protein 1,transporter,,Drug: methotrexate | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
7775,methotrexate,canalicular multispecific organic anion transporter 1,transporter,,Drug: methotrexate | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
7776,methotrexate,multidrug resistance-associated protein 1,transporter,,Drug: methotrexate | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
7777,methotrexate,atp-binding cassette sub-family g member 2,transporter,,Drug: methotrexate | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
7778,methotrexate,thymidylate synthase,enzyme,,Drug: methotrexate | Target: thymidylate synthase | Type: enzyme | Action: nan
7779,methotrexate,multidrug resistance-associated protein 5,transporter,,Drug: methotrexate | Target: multidrug resistance-associated protein 5 | Type: transporter | Action: nan
7780,methotrexate,"folylpolyglutamate synthase, mitochondrial",enzyme,,"Drug: methotrexate | Target: folylpolyglutamate synthase, mitochondrial | Type: enzyme | Action: nan"
7781,methotrexate,multidrug resistance-associated protein 4,transporter,,Drug: methotrexate | Target: multidrug resistance-associated protein 4 | Type: transporter | Action: nan
7782,methotrexate,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: methotrexate | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
7783,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7784,methotrexate,folate receptor beta,membrane receptor,,Drug: methotrexate | Target: folate receptor beta | Type: membrane receptor | Action: nan
7785,methotrexate,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: methotrexate | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
7786,methotrexate,proton-coupled folate transporter,transporter,,Drug: methotrexate | Target: proton-coupled folate transporter | Type: transporter | Action: nan
7787,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7788,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7789,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7790,methotrexate,thymidylate synthase,enzyme,,Drug: methotrexate | Target: thymidylate synthase | Type: enzyme | Action: nan
7791,methotrexate,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: methotrexate | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
7792,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7793,methotrexate,thymidylate synthase,enzyme,,Drug: methotrexate | Target: thymidylate synthase | Type: enzyme | Action: nan
7794,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7795,methotrexate,thymidylate synthase,enzyme,,Drug: methotrexate | Target: thymidylate synthase | Type: enzyme | Action: nan
7796,methotrexate,pteridine reductase 1,enzyme,,Drug: methotrexate | Target: pteridine reductase 1 | Type: enzyme | Action: nan
7797,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7798,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7799,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7800,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7801,methotrexate,dihydrofolate reductase,enzyme,,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
7802,methotrexate,folate transporter 1,transporter,,Drug: methotrexate | Target: folate transporter 1 | Type: transporter | Action: nan
7803,methotrexate,folate receptor alpha,membrane receptor,,Drug: methotrexate | Target: folate receptor alpha | Type: membrane receptor | Action: nan
7804,methotrexate,high mobility group protein b1,nuclear other,,Drug: methotrexate | Target: high mobility group protein b1 | Type: nuclear other | Action: nan
7805,methotrexate,dihydrofolate reductase,enzyme,INHIBITOR,Drug: methotrexate | Target: dihydrofolate reductase | Type: enzyme | Action: INHIBITOR
7806,levomepromazine,histamine h1 receptor,gpcr,,Drug: levomepromazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7807,levomepromazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: levomepromazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
7808,methoxamine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: methoxamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
7809,methoxamine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: methoxamine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
7810,methoxamine,alpha-1b adrenergic receptor,gpcr,AGONIST,Drug: methoxamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: AGONIST
7811,methoxamine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: methoxamine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
7812,methoxamine,adrenergic receptor alpha-2,gpcr,,Drug: methoxamine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
7813,methoxyflurane,glycine receptor subunit alpha-1,ion channel,AGONIST,Drug: methoxyflurane | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: AGONIST
7814,methoxyflurane,gaba-a receptor; anion channel,ion channel,POSITIVE MODULATOR,Drug: methoxyflurane | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE MODULATOR
7815,methscopolamine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: methscopolamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
7816,methscopolamine,muscarinic acetylcholine receptor m2,gpcr,,Drug: methscopolamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7817,methscopolamine,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: methscopolamine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
7818,methscopolamine,muscarinic acetylcholine receptor m4,gpcr,,Drug: methscopolamine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
7819,methscopolamine,muscarinic acetylcholine receptor m5,gpcr,,Drug: methscopolamine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
7820,methscopolamine,muscarinic acetylcholine receptor m3,gpcr,,Drug: methscopolamine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
7821,methsuximide,voltage-gated t-type calcium channel,ion channel,BLOCKER,Drug: methsuximide | Target: voltage-gated t-type calcium channel | Type: ion channel | Action: BLOCKER
7822,methylclothiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: methylclothiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
7823,metildigoxin,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: metildigoxin | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
7824,methyldopa,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: methyldopa | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
7825,methyldopa,aromatic-l-amino-acid decarboxylase,enzyme,,Drug: methyldopa | Target: aromatic-l-amino-acid decarboxylase | Type: enzyme | Action: nan
7826,methyldopa,epidermal growth factor receptor,kinase,,Drug: methyldopa | Target: epidermal growth factor receptor | Type: kinase | Action: nan
7827,methyldopa,tyrosine-protein kinase fyn,kinase,,Drug: methyldopa | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
7828,methyldopa,arachidonate 15-lipoxygenase,enzyme,,Drug: methyldopa | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
7829,methyldopa,lysine-specific demethylase 4e,enzyme,,Drug: methyldopa | Target: lysine-specific demethylase 4e | Type: enzyme | Action: nan
7830,methylthioninium chloride,"glutathione reductase, mitochondrial",enzyme,,"Drug: methylthioninium chloride | Target: glutathione reductase, mitochondrial | Type: enzyme | Action: nan"
7831,methylthioninium chloride,amine oxidase [flavin-containing] b,enzyme,,Drug: methylthioninium chloride | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
7832,methylthioninium chloride,amine oxidase [flavin-containing] a,enzyme,,Drug: methylthioninium chloride | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
7833,methylthioninium chloride,"thioredoxin reductase 1, cytoplasmic",enzyme,,"Drug: methylthioninium chloride | Target: thioredoxin reductase 1, cytoplasmic | Type: enzyme | Action: nan"
7834,methylthioninium chloride,glutathione reductase,enzyme,,Drug: methylthioninium chloride | Target: glutathione reductase | Type: enzyme | Action: nan
7835,methylthioninium chloride,cruzipain,enzyme,,Drug: methylthioninium chloride | Target: cruzipain | Type: enzyme | Action: nan
7836,methylthioninium chloride,microtubule-associated protein tau,structural,,Drug: methylthioninium chloride | Target: microtubule-associated protein tau | Type: structural | Action: nan
7837,methylthioninium chloride,amyloid beta a4 protein,unclassified,,Drug: methylthioninium chloride | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
7838,methylergometrine,d(1a) dopamine receptor,gpcr,ANTAGONIST,Drug: methylergometrine | Target: d(1a) dopamine receptor | Type: gpcr | Action: ANTAGONIST
7839,methylergometrine,d(2) dopamine receptor,gpcr,,Drug: methylergometrine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7840,methylergometrine,alpha-2a adrenergic receptor,gpcr,,Drug: methylergometrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7841,methylergometrine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7842,methylergometrine,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
7843,methylergometrine,5-hydroxytryptamine receptor 2b,gpcr,PARTIAL AGONIST,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: PARTIAL AGONIST
7844,methylergometrine,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
7845,methylergometrine,5-hydroxytryptamine receptor 6,gpcr,,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
7846,methylergometrine,alpha-2b adrenergic receptor,gpcr,,Drug: methylergometrine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7847,methylergometrine,d(3) dopamine receptor,gpcr,,Drug: methylergometrine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7848,methylergometrine,cytochrome p450 2d6,enzyme,,Drug: methylergometrine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
7849,methylergometrine,5-hydroxytryptamine receptor 1f,gpcr,ANTAGONIST,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: ANTAGONIST
7850,methylergometrine,5-hydroxytryptamine receptor 1e,gpcr,ANTAGONIST,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: ANTAGONIST
7851,methylergometrine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
7852,methylergometrine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7853,methylergometrine,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
7854,methylergometrine,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: methylergometrine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
7855,naltrexone,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: naltrexone | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
7856,naltrexone,cytochrome p450 2d6,enzyme,,Drug: naltrexone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
7857,naltrexone,kappa-type opioid receptor,gpcr,ANTAGONIST,Drug: naltrexone | Target: kappa-type opioid receptor | Type: gpcr | Action: ANTAGONIST
7858,naltrexone,delta-type opioid receptor,gpcr,ANTAGONIST,Drug: naltrexone | Target: delta-type opioid receptor | Type: gpcr | Action: ANTAGONIST
7859,naltrexone,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: naltrexone | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
7860,naltrexone,mu-type opioid receptor,gpcr,,Drug: naltrexone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
7861,naltrexone,mu-type opioid receptor,gpcr,,Drug: naltrexone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
7862,naltrexone,mu-type opioid receptor,gpcr,,Drug: naltrexone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
7863,naltrexone,delta-type opioid receptor,gpcr,,Drug: naltrexone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
7864,naltrexone,delta-type opioid receptor,gpcr,,Drug: naltrexone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
7865,naltrexone,kappa-type opioid receptor,gpcr,,Drug: naltrexone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
7866,naltrexone,neuronal acetylcholine receptor subunit alpha-4,ion channel,,Drug: naltrexone | Target: neuronal acetylcholine receptor subunit alpha-4 | Type: ion channel | Action: nan
7867,naltrexone,kappa-type opioid receptor,gpcr,,Drug: naltrexone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
7868,naltrexone,kappa-type opioid receptor,gpcr,,Drug: naltrexone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
7869,naltrexone,opioid receptor,gpcr,,Drug: naltrexone | Target: opioid receptor | Type: gpcr | Action: nan
7870,naltrexone,opioid receptors; mu and delta,gpcr,,Drug: naltrexone | Target: opioid receptors; mu and delta | Type: gpcr | Action: nan
7871,methylparaben,carbonic anhydrase 2,enzyme,,Drug: methylparaben | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
7872,methylparaben,carbonic anhydrase 1,enzyme,,Drug: methylparaben | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
7873,methylparaben,carbonic anhydrase 9,enzyme,,Drug: methylparaben | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
7874,methylparaben,carbonic anhydrase 12,enzyme,,Drug: methylparaben | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
7875,methylparaben,carbonic anhydrase 7,enzyme,,Drug: methylparaben | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
7876,methylparaben,carbonic anhydrase 14,enzyme,,Drug: methylparaben | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
7877,methylphenidate,alpha-2a adrenergic receptor,gpcr,,Drug: methylphenidate | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7878,methylphenidate,sodium-dependent serotonin transporter,transporter,,Drug: methylphenidate | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
7879,methylphenidate,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: methylphenidate | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
7880,methylphenidate,alpha-2b adrenergic receptor,gpcr,,Drug: methylphenidate | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7881,methylphenidate,alpha-2c adrenergic receptor,gpcr,,Drug: methylphenidate | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
7882,methylphenidate,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: methylphenidate | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
7883,methylphenidate,sodium-dependent dopamine transporter,transporter,,Drug: methylphenidate | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
7884,methylprednisolone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: methylprednisolone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
7885,methylprednisolone,annexin a1,cytosolic other,,Drug: methylprednisolone | Target: annexin a1 | Type: cytosolic other | Action: nan
7886,methylprednisolone,androgen receptor,transcription factor,,Drug: methylprednisolone | Target: androgen receptor | Type: transcription factor | Action: nan
7887,methylprednisolone,short transient receptor potential channel 5,ion channel,ACTIVATOR,Drug: methylprednisolone | Target: short transient receptor potential channel 5 | Type: ion channel | Action: ACTIVATOR
7888,methylprednisolone acetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: methylprednisolone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
7889,methylprednisolone succinate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: methylprednisolone succinate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
7890,methyprylon,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: methyprylon | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
7891,methysergide,d(1a) dopamine receptor,gpcr,,Drug: methysergide | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
7892,methysergide,d(2) dopamine receptor,gpcr,,Drug: methysergide | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7893,methysergide,alpha-2a adrenergic receptor,gpcr,,Drug: methysergide | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7894,methysergide,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: methysergide | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
7895,methysergide,5-hydroxytryptamine receptor 1a,gpcr,PARTIAL AGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: PARTIAL AGONIST
7896,methysergide,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
7897,methysergide,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
7898,methysergide,alpha-2b adrenergic receptor,gpcr,,Drug: methysergide | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
7899,methysergide,d(3) dopamine receptor,gpcr,,Drug: methysergide | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7900,methysergide,histamine h1 receptor,gpcr,,Drug: methysergide | Target: histamine h1 receptor | Type: gpcr | Action: nan
7901,methysergide,muscarinic acetylcholine receptor m1,gpcr,,Drug: methysergide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7902,methysergide,muscarinic acetylcholine receptor m2,gpcr,,Drug: methysergide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
7903,methysergide,muscarinic acetylcholine receptor m3,gpcr,,Drug: methysergide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
7904,methysergide,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
7905,methysergide,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
7906,methysergide,alpha-2c adrenergic receptor,gpcr,,Drug: methysergide | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
7907,methysergide,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
7908,methysergide,5-hydroxytryptamine receptor 1f,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: ANTAGONIST
7909,methysergide,5-hydroxytryptamine receptor 1e,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: ANTAGONIST
7910,methysergide,induced myeloid leukemia cell differentiation protein mcl-1,cytosolic other,,Drug: methysergide | Target: induced myeloid leukemia cell differentiation protein mcl-1 | Type: cytosolic other | Action: nan
7911,methysergide,bcl-2-like protein 1,cytosolic other,,Drug: methysergide | Target: bcl-2-like protein 1 | Type: cytosolic other | Action: nan
7912,methysergide,5-hydroxytryptamine receptor 1b,gpcr,,Drug: methysergide | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
7913,methysergide,5-hydroxytryptamine receptor 1a,gpcr,,Drug: methysergide | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7914,methysergide,5-hydroxytryptamine receptor 2a,gpcr,,Drug: methysergide | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7915,methysergide,5-hydroxytryptamine receptor 7,gpcr,,Drug: methysergide | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
7916,methysergide,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
7917,methysergide,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
7918,methysergide,zinc finger protein mex-5,cytosolic other,,Drug: methysergide | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
7919,methysergide,serotonin 2 (5-ht2) receptor,gpcr,,Drug: methysergide | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
7920,methysergide,cytoplasmic zinc-finger protein,unclassified,,Drug: methysergide | Target: cytoplasmic zinc-finger protein | Type: unclassified | Action: nan
7921,methysergide,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
7922,methysergide,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
7923,methysergide,5-hydroxytryptamine receptor 1f,gpcr,ANTAGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: ANTAGONIST
7924,methysergide,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
7925,methysergide,5-hydroxytryptamine receptor 2b,gpcr,AGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: AGONIST
7926,methysergide,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: methysergide | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
7927,metiazinic acid,prostaglandin g/h synthase 2,enzyme,,Drug: metiazinic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
7928,metipranolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: metipranolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
7929,metipranolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: metipranolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
7930,metixene,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: metixene | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
7931,metixene,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: metixene | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
7932,metixene,cholinesterase,enzyme,,Drug: metixene | Target: cholinesterase | Type: enzyme | Action: nan
7933,metochalcone,atp-binding cassette sub-family g member 2,transporter,,Drug: metochalcone | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
7934,metoclopramide,5-hydroxytryptamine receptor 4,gpcr,,Drug: metoclopramide | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
7935,metoclopramide,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: metoclopramide | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
7936,metoclopramide,alpha-2a adrenergic receptor,gpcr,,Drug: metoclopramide | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
7937,metoclopramide,5-hydroxytryptamine receptor 2a,gpcr,,Drug: metoclopramide | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
7938,metoclopramide,5-hydroxytryptamine receptor 2b,gpcr,,Drug: metoclopramide | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7939,metoclopramide,5-hydroxytryptamine receptor 2c,gpcr,,Drug: metoclopramide | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
7940,metoclopramide,d(3) dopamine receptor,gpcr,,Drug: metoclopramide | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7941,metoclopramide,muscarinic acetylcholine receptor m1,gpcr,,Drug: metoclopramide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
7942,metoclopramide,aldehyde oxidase,enzyme,,Drug: metoclopramide | Target: aldehyde oxidase | Type: enzyme | Action: nan
7943,metoclopramide,cytochrome p450 2d6,enzyme,,Drug: metoclopramide | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
7944,metoclopramide,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: metoclopramide | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
7945,metoclopramide,5-hydroxytryptamine receptor 4,gpcr,AGONIST,Drug: metoclopramide | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: AGONIST
7946,metoclopramide,myeloperoxidase,enzyme,,Drug: metoclopramide | Target: myeloperoxidase | Type: enzyme | Action: nan
7947,metoclopramide,solute carrier family 22 member 1,transporter,,Drug: metoclopramide | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
7948,metoclopramide,d(2) dopamine receptor,gpcr,,Drug: metoclopramide | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7949,metoclopramide,d(2) dopamine receptor,gpcr,,Drug: metoclopramide | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7950,metoclopramide,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: metoclopramide | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
7951,metoclopramide,5-hydroxytryptamine receptor 4,gpcr,,Drug: metoclopramide | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
7952,metoclopramide,d(3) dopamine receptor,gpcr,,Drug: metoclopramide | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7953,metoclopramide,serotonin 3 (5-ht3) receptor,ion channel,,Drug: metoclopramide | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
7954,metoclopramide,serotonin 3 (5-ht3) receptor,ion channel,,Drug: metoclopramide | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
7955,metoclopramide,serotonin 1 (5-ht1) receptor,gpcr,,Drug: metoclopramide | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
7956,metoclopramide,adrenergic receptor alpha-2,gpcr,,Drug: metoclopramide | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
7957,metoclopramide,adrenergic receptor alpha-1,gpcr,,Drug: metoclopramide | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
7958,metoclopramide,serotonin 2 (5-ht2) receptor,gpcr,,Drug: metoclopramide | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
7959,metoclopramide,serotonin 3 receptor (5ht3),ion channel,,Drug: metoclopramide | Target: serotonin 3 receptor (5ht3) | Type: ion channel | Action: nan
7960,metoclopramide,5-hydroxytryptamine receptor 4,gpcr,AGONIST,Drug: metoclopramide | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: AGONIST
7961,metolazone,solute carrier family 12 member 1,transporter,,Drug: metolazone | Target: solute carrier family 12 member 1 | Type: transporter | Action: nan
7962,metolazone,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: metolazone | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
7963,metolazone,carbonic anhydrase 7,enzyme,,Drug: metolazone | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
7964,metopimazine,d(2) dopamine receptor,gpcr,,Drug: metopimazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
7965,metopimazine,d(3) dopamine receptor,gpcr,,Drug: metopimazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
7966,metopimazine,histamine h1 receptor,gpcr,,Drug: metopimazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
7967,metoprolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: metoprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
7968,metoprolol,beta-2 adrenergic receptor,gpcr,,Drug: metoprolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
7969,metoprolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: metoprolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
7970,metoprolol,beta-2 adrenergic receptor,gpcr,,Drug: metoprolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
7971,metoprolol,beta-1 adrenergic receptor,gpcr,,Drug: metoprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
7972,metoprolol,adrenergic receptor beta,gpcr,,Drug: metoprolol | Target: adrenergic receptor beta | Type: gpcr | Action: nan
7973,metoprolol,beta-1 adrenergic receptor,gpcr,,Drug: metoprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
7975,metronidazole,thioredoxin reductase,enzyme,,Drug: metronidazole | Target: thioredoxin reductase | Type: enzyme | Action: nan
7976,metyrapone,cytochrome p450 3a4,enzyme,,Drug: metyrapone | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
7977,metyrapone,"cytochrome p450 11b2, mitochondrial",enzyme,,"Drug: metyrapone | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: nan"
7978,metyrapone,cytochrome p450 11b1,enzyme,,Drug: metyrapone | Target: cytochrome p450 11b1 | Type: enzyme | Action: nan
7979,metyrapone,"cytochrome p450 11b1, mitochondrial",enzyme,,"Drug: metyrapone | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: nan"
7980,metyrapone,"cytochrome p450 11b1, mitochondrial",enzyme,INHIBITOR,"Drug: metyrapone | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: INHIBITOR"
7981,metirosine,tyrosine 3-monooxygenase,enzyme,INHIBITOR,Drug: metirosine | Target: tyrosine 3-monooxygenase | Type: enzyme | Action: INHIBITOR
7982,mexiletine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: mexiletine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
7983,mexiletine,sodium channel subunit beta-1,ion channel,,Drug: mexiletine | Target: sodium channel subunit beta-1 | Type: ion channel | Action: nan
7984,mexiletine,sodium channel subunit beta-2,ion channel,,Drug: mexiletine | Target: sodium channel subunit beta-2 | Type: ion channel | Action: nan
7985,mexiletine,sodium channel subunit beta-3,ion channel,,Drug: mexiletine | Target: sodium channel subunit beta-3 | Type: ion channel | Action: nan
7986,mexiletine,sodium channel subunit beta-4,ion channel,,Drug: mexiletine | Target: sodium channel subunit beta-4 | Type: ion channel | Action: nan
7987,mexiletine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: mexiletine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
7988,mexiletine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: mexiletine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
7989,mexiletine,sodium channel protein type 1 subunit alpha,ion channel,,Drug: mexiletine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: nan
7990,mexiletine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: mexiletine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
7991,mexiletine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: mexiletine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
7992,mexiletine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: mexiletine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
7993,mexiletine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: mexiletine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
7994,mexiletine,potassium channel subfamily k member 3,ion channel,,Drug: mexiletine | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: nan
7995,mexiletine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: mexiletine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
7996,mexiletine,solute carrier family 22 member 2,transporter,,Drug: mexiletine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
7997,mexiletine,sodium channel protein type x alpha subunit,ion channel,,Drug: mexiletine | Target: sodium channel protein type x alpha subunit | Type: ion channel | Action: nan
7998,mexiletine,sodium channel protein type 9 subunit alpha,ion channel,,Drug: mexiletine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: nan
7999,mexiletine,sodium channel protein type 1 subunit alpha,ion channel,,Drug: mexiletine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: nan
8000,mezlocillin,prostaglandin g/h synthase 2,enzyme,,Drug: mezlocillin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8001,mezlocillin,cannabinoid receptor 1,gpcr,,Drug: mezlocillin | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
8002,mezlocillin,prostaglandin g/h synthase 1,enzyme,,Drug: mezlocillin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8003,mezlocillin,cytochrome p450 3a4,enzyme,,Drug: mezlocillin | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8004,mezlocillin,penicillin-binding protein 1a,enzyme,,Drug: mezlocillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
8005,mezlocillin,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: mezlocillin | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
8006,mezlocillin,adenosine receptor a3,gpcr,,Drug: mezlocillin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8007,mezlocillin,carbonic anhydrase 2,enzyme,,Drug: mezlocillin | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
8008,mezlocillin,multidrug resistance-associated protein 1,transporter,,Drug: mezlocillin | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
8009,mezlocillin,cytochrome p450 2c8,enzyme,,Drug: mezlocillin | Target: cytochrome p450 2c8 | Type: enzyme | Action: nan
8010,mezlocillin,prostaglandin d2 receptor 2,gpcr,,Drug: mezlocillin | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: nan
8011,mezlocillin,cytochrome p450 2c9,enzyme,,Drug: mezlocillin | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
8012,mezlocillin,aldose reductase,enzyme,,Drug: mezlocillin | Target: aldose reductase | Type: enzyme | Action: nan
8013,mezlocillin,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: mezlocillin | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
8014,mezlocillin,aldo-keto reductase family 1 member c3,enzyme,,Drug: mezlocillin | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
8015,mezlocillin,arachidonate 5-lipoxygenase,enzyme,,Drug: mezlocillin | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
8016,mezlocillin,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: mezlocillin | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
8017,mezlocillin,"dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a",enzyme,,"Drug: mezlocillin | Target: dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a | Type: enzyme | Action: nan"
8018,mezlocillin,prostaglandin e2 receptor ep2 subtype,gpcr,,Drug: mezlocillin | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: nan
8019,mezlocillin,prostaglandin e2 receptor ep4 subtype,gpcr,,Drug: mezlocillin | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: nan
8020,mezlocillin,prostaglandin d2 receptor,gpcr,,Drug: mezlocillin | Target: prostaglandin d2 receptor | Type: gpcr | Action: nan
8021,mezlocillin,cannabinoid receptor 2,gpcr,,Drug: mezlocillin | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
8022,mezlocillin,thromboxane-a synthase,enzyme,,Drug: mezlocillin | Target: thromboxane-a synthase | Type: enzyme | Action: nan
8023,mezlocillin,serum albumin,secreted,,Drug: mezlocillin | Target: serum albumin | Type: secreted | Action: nan
8024,mezlocillin,interleukin-8,cytokine,,Drug: mezlocillin | Target: interleukin-8 | Type: cytokine | Action: nan
8025,mezlocillin,interleukin-1 receptor type 1,membrane receptor,,Drug: mezlocillin | Target: interleukin-1 receptor type 1 | Type: membrane receptor | Action: nan
8026,mezlocillin,prostaglandin-h2 d-isomerase,enzyme,,Drug: mezlocillin | Target: prostaglandin-h2 d-isomerase | Type: enzyme | Action: nan
8027,mezlocillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: mezlocillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
8028,mianserin,d(1a) dopamine receptor,gpcr,,Drug: mianserin | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
8029,mianserin,d(2) dopamine receptor,gpcr,,Drug: mianserin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8030,mianserin,alpha-2a adrenergic receptor,gpcr,,Drug: mianserin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
8031,mianserin,sodium-dependent serotonin transporter,transporter,,Drug: mianserin | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
8032,mianserin,sodium-dependent noradrenaline transporter,transporter,,Drug: mianserin | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8033,mianserin,5-hydroxytryptamine receptor 1a,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8034,mianserin,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: mianserin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
8035,mianserin,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: mianserin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
8036,mianserin,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: mianserin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
8037,mianserin,5-hydroxytryptamine receptor 6,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
8038,mianserin,5-hydroxytryptamine receptor 7,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
8039,mianserin,alpha-1a adrenergic receptor,gpcr,,Drug: mianserin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
8040,mianserin,alpha-2b adrenergic receptor,gpcr,,Drug: mianserin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
8041,mianserin,d(3) dopamine receptor,gpcr,,Drug: mianserin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
8042,mianserin,histamine h1 receptor,gpcr,,Drug: mianserin | Target: histamine h1 receptor | Type: gpcr | Action: nan
8043,mianserin,histamine h2 receptor,gpcr,,Drug: mianserin | Target: histamine h2 receptor | Type: gpcr | Action: nan
8044,mianserin,histamine h4 receptor,gpcr,,Drug: mianserin | Target: histamine h4 receptor | Type: gpcr | Action: nan
8045,mianserin,muscarinic acetylcholine receptor m1,gpcr,,Drug: mianserin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
8046,mianserin,muscarinic acetylcholine receptor m2,gpcr,,Drug: mianserin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
8047,mianserin,muscarinic acetylcholine receptor m3,gpcr,,Drug: mianserin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
8048,mianserin,muscarinic acetylcholine receptor m4,gpcr,,Drug: mianserin | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
8049,mianserin,muscarinic acetylcholine receptor m5,gpcr,,Drug: mianserin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
8050,mianserin,5-hydroxytryptamine receptor 1b,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
8051,mianserin,5-hydroxytryptamine receptor 1d,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
8052,mianserin,alpha-2c adrenergic receptor,gpcr,,Drug: mianserin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
8053,mianserin,sodium-dependent dopamine transporter,transporter,,Drug: mianserin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8054,mianserin,d(4) dopamine receptor,gpcr,,Drug: mianserin | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
8055,mianserin,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: mianserin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8056,mianserin,5-hydroxytryptamine receptor 3a,ion channel,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
8057,mianserin,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: mianserin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8058,mianserin,5-hydroxytryptamine receptor 1f,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
8059,mianserin,alpha-1b adrenergic receptor,gpcr,,Drug: mianserin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
8060,mianserin,5-hydroxytryptamine receptor 1b,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
8061,mianserin,alpha-1a adrenergic receptor,gpcr,,Drug: mianserin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
8062,mianserin,histamine h1 receptor,gpcr,,Drug: mianserin | Target: histamine h1 receptor | Type: gpcr | Action: nan
8063,mianserin,d(2) dopamine receptor,gpcr,,Drug: mianserin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8064,mianserin,sodium-dependent serotonin transporter,transporter,,Drug: mianserin | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
8065,mianserin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8066,mianserin,transporter,transporter,,Drug: mianserin | Target: transporter | Type: transporter | Action: nan
8067,mianserin,5-hydroxytryptamine receptor 7,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
8068,mianserin,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: mianserin | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
8069,mianserin,d(1a) dopamine receptor,gpcr,,Drug: mianserin | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
8070,mianserin,5-hydroxytryptamine receptor 2c,gpcr,,Drug: mianserin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8071,mianserin,alpha-1a adrenergic receptor,gpcr,,Drug: mianserin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
8072,mianserin,d(3) dopamine receptor,gpcr,,Drug: mianserin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
8073,mianserin,alpha-2a adrenergic receptor,gpcr,,Drug: mianserin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
8074,mianserin,muscarinic acetylcholine receptor m5,gpcr,,Drug: mianserin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
8075,mianserin,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: mianserin | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
8076,mianserin,serotonin 3 (5-ht3) receptor,ion channel,,Drug: mianserin | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
8077,mianserin,serotonin 1 (5-ht1) receptor,gpcr,,Drug: mianserin | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
8078,mianserin,adrenergic receptor alpha-2,gpcr,,Drug: mianserin | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
8079,mianserin,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: mianserin | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
8080,mianserin,cerebral cortex alpha adrenergic receptor,gpcr,,Drug: mianserin | Target: cerebral cortex alpha adrenergic receptor | Type: gpcr | Action: nan
8081,mianserin,serotonin 2 (5-ht2) receptor,gpcr,,Drug: mianserin | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
8082,mianserin,serotonin 3 receptor (5ht3),ion channel,,Drug: mianserin | Target: serotonin 3 receptor (5ht3) | Type: ion channel | Action: nan
8083,mianserin,g-protein coupled receptor,gpcr,,Drug: mianserin | Target: g-protein coupled receptor | Type: gpcr | Action: nan
8084,mianserin,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: mianserin | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
8085,mibefradil,sodium channel protein type 5 subunit alpha,ion channel,,Drug: mibefradil | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
8086,mibefradil,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: mibefradil | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8087,mibefradil,cytochrome p450 3a4,enzyme,,Drug: mibefradil | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8088,mibefradil,multidrug resistance protein 1,transporter,,Drug: mibefradil | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
8089,mibefradil,sodium channel protein type 9 subunit alpha,ion channel,,Drug: mibefradil | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: nan
8090,mibefradil,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: mibefradil | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
8091,mibefradil,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,,Drug: mibefradil | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: nan
8092,mibefradil,voltage-dependent t-type calcium channel subunit alpha-1i,ion channel,,Drug: mibefradil | Target: voltage-dependent t-type calcium channel subunit alpha-1i | Type: ion channel | Action: nan
8093,mibefradil,potassium channel subfamily k member 9,ion channel,,Drug: mibefradil | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: nan
8094,mibefradil,voltage-dependent n-type calcium channel subunit alpha-1b,ion channel,,Drug: mibefradil | Target: voltage-dependent n-type calcium channel subunit alpha-1b | Type: ion channel | Action: nan
8095,mibefradil,sodium channel protein type 2 subunit alpha,ion channel,,Drug: mibefradil | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: nan
8096,mibefradil,cation channel sperm-associated protein 1,ion channel,BLOCKER,Drug: mibefradil | Target: cation channel sperm-associated protein 1 | Type: ion channel | Action: BLOCKER
8097,mibefradil,cation channel sperm-associated protein 2,ion channel,BLOCKER,Drug: mibefradil | Target: cation channel sperm-associated protein 2 | Type: ion channel | Action: BLOCKER
8098,mibefradil,cation channel sperm-associated protein 3,ion channel,BLOCKER,Drug: mibefradil | Target: cation channel sperm-associated protein 3 | Type: ion channel | Action: BLOCKER
8099,mibefradil,cation channel sperm-associated protein 4,ion channel,BLOCKER,Drug: mibefradil | Target: cation channel sperm-associated protein 4 | Type: ion channel | Action: BLOCKER
8100,mibefradil,voltage-dependent r-type calcium channel subunit alpha-1e,ion channel,GATING INHIBITOR,Drug: mibefradil | Target: voltage-dependent r-type calcium channel subunit alpha-1e | Type: ion channel | Action: GATING INHIBITOR
8101,mibefradil,voltage-dependent p/q-type calcium channel subunit alpha-1a,ion channel,GATING INHIBITOR,Drug: mibefradil | Target: voltage-dependent p/q-type calcium channel subunit alpha-1a | Type: ion channel | Action: GATING INHIBITOR
8102,mibefradil,calcium release-activated calcium channel protein 1,ion channel,,Drug: mibefradil | Target: calcium release-activated calcium channel protein 1 | Type: ion channel | Action: nan
8103,mibefradil,sodium channel protein type 4 subunit alpha,ion channel,,Drug: mibefradil | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: nan
8105,mibefradil,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,BLOCKER,Drug: mibefradil | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: BLOCKER
8106,micafungin,"beta-1,3-glucan synthase",unclassified,,"Drug: micafungin | Target: beta-1,3-glucan synthase | Type: unclassified | Action: nan"
8107,micafungin,"beta-1,3-glucan synthase catalytic subunit 1",enzyme,INHIBITOR,"Drug: micafungin | Target: beta-1,3-glucan synthase catalytic subunit 1 | Type: enzyme | Action: INHIBITOR"
8108,miconazole,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: miconazole | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
8109,miconazole,beta-1 adrenergic receptor,gpcr,,Drug: miconazole | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
8110,miconazole,prostaglandin g/h synthase 2,enzyme,,Drug: miconazole | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8111,miconazole,cannabinoid receptor 1,gpcr,,Drug: miconazole | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
8112,miconazole,mu-type opioid receptor,gpcr,,Drug: miconazole | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8113,miconazole,d(1a) dopamine receptor,gpcr,,Drug: miconazole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
8114,miconazole,d(2) dopamine receptor,gpcr,,Drug: miconazole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8115,miconazole,adenosine receptor a2a,gpcr,,Drug: miconazole | Target: adenosine receptor a2a | Type: gpcr | Action: nan
8116,miconazole,alpha-2a adrenergic receptor,gpcr,,Drug: miconazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
8117,miconazole,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: miconazole | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8118,miconazole,cytochrome p450 3a4,enzyme,,Drug: miconazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8119,miconazole,sodium-dependent serotonin transporter,transporter,,Drug: miconazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
8120,miconazole,sodium-dependent noradrenaline transporter,transporter,,Drug: miconazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8121,miconazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: miconazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8122,miconazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: miconazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8123,miconazole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: miconazole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
8124,miconazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: miconazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8125,miconazole,5-hydroxytryptamine receptor 6,gpcr,,Drug: miconazole | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
8126,miconazole,alpha-2b adrenergic receptor,gpcr,,Drug: miconazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
8127,miconazole,d(3) dopamine receptor,gpcr,,Drug: miconazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
8128,miconazole,histamine h2 receptor,gpcr,,Drug: miconazole | Target: histamine h2 receptor | Type: gpcr | Action: nan
8129,miconazole,muscarinic acetylcholine receptor m1,gpcr,,Drug: miconazole | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
8130,miconazole,muscarinic acetylcholine receptor m2,gpcr,,Drug: miconazole | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
8131,miconazole,muscarinic acetylcholine receptor m3,gpcr,,Drug: miconazole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
8132,miconazole,muscarinic acetylcholine receptor m4,gpcr,,Drug: miconazole | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
8133,miconazole,beta-3 adrenergic receptor,gpcr,,Drug: miconazole | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
8134,miconazole,sodium-dependent dopamine transporter,transporter,,Drug: miconazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8135,miconazole,cytochrome p450 2d6,enzyme,,Drug: miconazole | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
8136,miconazole,adenosine receptor a1,gpcr,,Drug: miconazole | Target: adenosine receptor a1 | Type: gpcr | Action: nan
8137,miconazole,adenosine receptor a3,gpcr,,Drug: miconazole | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8138,miconazole,d(4) dopamine receptor,gpcr,,Drug: miconazole | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
8139,miconazole,alpha-1d adrenergic receptor,gpcr,,Drug: miconazole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
8140,miconazole,kappa-type opioid receptor,gpcr,,Drug: miconazole | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8141,miconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: miconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
8142,miconazole,delta-type opioid receptor,gpcr,,Drug: miconazole | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8143,miconazole,beta-lactamase,enzyme,,Drug: miconazole | Target: beta-lactamase | Type: enzyme | Action: nan
8144,miconazole,acetylcholinesterase,enzyme,,Drug: miconazole | Target: acetylcholinesterase | Type: enzyme | Action: nan
8145,miconazole,cytochrome p450 2c9,enzyme,,Drug: miconazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
8146,miconazole,aromatase,enzyme,,Drug: miconazole | Target: aromatase | Type: enzyme | Action: nan
8147,miconazole,epidermal growth factor receptor,kinase,,Drug: miconazole | Target: epidermal growth factor receptor | Type: kinase | Action: nan
8148,miconazole,substance-p receptor,gpcr,,Drug: miconazole | Target: substance-p receptor | Type: gpcr | Action: nan
8149,miconazole,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,,"Drug: miconazole | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: nan"
8150,miconazole,cytochrome p450 2c19,enzyme,,Drug: miconazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
8151,miconazole,"alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,"Drug: miconazole | Target: alkaline phosphatase, tissue-nonspecific isozyme | Type: enzyme | Action: nan"
8152,miconazole,tyrosine-protein kinase fyn,kinase,,Drug: miconazole | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
8153,miconazole,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: miconazole | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
8154,miconazole,thromboxane-a synthase,enzyme,,Drug: miconazole | Target: thromboxane-a synthase | Type: enzyme | Action: nan
8155,miconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: miconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
8156,miconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: miconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
8157,miconazole,type-2 angiotensin ii receptor,gpcr,,Drug: miconazole | Target: type-2 angiotensin ii receptor | Type: gpcr | Action: nan
8158,miconazole,substance-k receptor,gpcr,,Drug: miconazole | Target: substance-k receptor | Type: gpcr | Action: nan
8159,miconazole,androgen receptor,transcription factor,,Drug: miconazole | Target: androgen receptor | Type: transcription factor | Action: nan
8160,miconazole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: miconazole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
8161,miconazole,melanocortin receptor 4,gpcr,,Drug: miconazole | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
8162,miconazole,melanocortin receptor 5,gpcr,,Drug: miconazole | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
8163,miconazole,melanocortin receptor 3,gpcr,,Drug: miconazole | Target: melanocortin receptor 3 | Type: gpcr | Action: nan
8164,miconazole,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: miconazole | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
8165,miconazole,progesterone receptor,transcription factor,,Drug: miconazole | Target: progesterone receptor | Type: transcription factor | Action: nan
8166,miconazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: miconazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8167,miconazole,acetylcholinesterase,enzyme,,Drug: miconazole | Target: acetylcholinesterase | Type: enzyme | Action: nan
8168,miconazole,aromatase,enzyme,,Drug: miconazole | Target: aromatase | Type: enzyme | Action: nan
8169,miconazole,cholinesterase,enzyme,,Drug: miconazole | Target: cholinesterase | Type: enzyme | Action: nan
8170,miconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: miconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
8171,miconazole,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: miconazole | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
8172,miconazole,mycocyclosin synthase,enzyme,,Drug: miconazole | Target: mycocyclosin synthase | Type: enzyme | Action: nan
8173,miconazole,malate dehydrogenase cytoplasmic,enzyme,,Drug: miconazole | Target: malate dehydrogenase cytoplasmic | Type: enzyme | Action: nan
8174,miconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: miconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
8175,miconazole,calcium release-activated calcium channel protein 1,ion channel,,Drug: miconazole | Target: calcium release-activated calcium channel protein 1 | Type: ion channel | Action: nan
8176,miconazole,"fatty acid hydroperoxide lyase, chloroplastic",enzyme,,"Drug: miconazole | Target: fatty acid hydroperoxide lyase, chloroplastic | Type: enzyme | Action: nan"
8177,miconazole,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,enzyme,,Drug: miconazole | Target: 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase | Type: enzyme | Action: nan
8178,midazolam,cytochrome p450 3a4,enzyme,,Drug: midazolam | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8179,midazolam,multidrug resistance protein 1,transporter,,Drug: midazolam | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
8180,midazolam,translocator protein,membrane receptor,,Drug: midazolam | Target: translocator protein | Type: membrane receptor | Action: nan
8181,midazolam,thyrotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: midazolam | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
8182,midazolam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: midazolam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8183,midazolam,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: midazolam | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8184,midazolam,gaba-a receptor alpha-1/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: midazolam | Target: gaba-a receptor alpha-1/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8185,midazolam,gaba-a receptor; anion channel,ion channel,,Drug: midazolam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
8186,midazolam,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: midazolam | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8187,midazolam,gaba a receptor alpha-3/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: midazolam | Target: gaba a receptor alpha-3/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8188,midazolam,gaba a receptor alpha-5/beta-3/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: midazolam | Target: gaba a receptor alpha-5/beta-3/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8189,midazolam,gaba a receptor alpha-5/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: midazolam | Target: gaba a receptor alpha-5/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8190,midazolam,gaba a receptor alpha-5/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: midazolam | Target: gaba a receptor alpha-5/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8191,midodrine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: midodrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
8192,midodrine,heat shock protein hsp 90-alpha,cytosolic other,,Drug: midodrine | Target: heat shock protein hsp 90-alpha | Type: cytosolic other | Action: nan
8193,mifepristone,mu-type opioid receptor,gpcr,,Drug: mifepristone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8194,mifepristone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: mifepristone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
8195,mifepristone,cytochrome p450 3a4,enzyme,,Drug: mifepristone | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8196,mifepristone,alpha-2b adrenergic receptor,gpcr,,Drug: mifepristone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
8197,mifepristone,glucocorticoid receptor,nuclear hormone receptor,ANTAGONIST,Drug: mifepristone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
8198,mifepristone,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,AGONIST,Drug: mifepristone | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: AGONIST
8199,mifepristone,kappa-type opioid receptor,gpcr,,Drug: mifepristone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8200,mifepristone,mineralocorticoid receptor,nuclear hormone receptor,,Drug: mifepristone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
8201,mifepristone,estrogen receptor,nuclear hormone receptor,,Drug: mifepristone | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
8202,mifepristone,androgen receptor,nuclear hormone receptor,,Drug: mifepristone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
8203,mifepristone,progesterone receptor,nuclear hormone receptor,ANTAGONIST,Drug: mifepristone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
8204,mifepristone,estrogen receptor beta,nuclear hormone receptor,,Drug: mifepristone | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
8205,mifepristone,tyrosine-protein kinase fyn,kinase,,Drug: mifepristone | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
8206,mifepristone,mitogen-activated protein kinase 14,kinase,,Drug: mifepristone | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
8207,mifepristone,androgen receptor,transcription factor,,Drug: mifepristone | Target: androgen receptor | Type: transcription factor | Action: nan
8208,mifepristone,arachidonate 15-lipoxygenase,enzyme,,Drug: mifepristone | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
8209,mifepristone,progesterone receptor,transcription factor,,Drug: mifepristone | Target: progesterone receptor | Type: transcription factor | Action: nan
8210,mifepristone,glucocorticoid receptor,transcription factor,,Drug: mifepristone | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
8211,mifepristone,progesterone receptor,transcription factor,,Drug: mifepristone | Target: progesterone receptor | Type: transcription factor | Action: nan
8212,mifepristone,p-glycoprotein 3,transporter,,Drug: mifepristone | Target: p-glycoprotein 3 | Type: transporter | Action: nan
8213,mifepristone,glucocorticoid receptor,nuclear hormone receptor,,Drug: mifepristone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
8214,mifepristone,glucocorticoid receptor,nuclear hormone receptor,,Drug: mifepristone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
8215,miglitol,"maltase-glucoamylase, intestinal",enzyme,INHIBITOR,"Drug: miglitol | Target: maltase-glucoamylase, intestinal | Type: enzyme | Action: INHIBITOR"
8216,miglitol,pancreatic alpha-amylase,enzyme,,Drug: miglitol | Target: pancreatic alpha-amylase | Type: enzyme | Action: nan
8217,miglitol,glucosylceramidase,enzyme,,Drug: miglitol | Target: glucosylceramidase | Type: enzyme | Action: nan
8218,miglitol,lysosomal alpha-glucosidase,enzyme,INHIBITOR,Drug: miglitol | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: INHIBITOR
8219,miglitol,"sucrase-isomaltase, intestinal",enzyme,,"Drug: miglitol | Target: sucrase-isomaltase, intestinal | Type: enzyme | Action: nan"
8220,miglitol,lysosomal alpha-glucosidase,enzyme,,Drug: miglitol | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: nan
8221,miglitol,glycogen debranching enzyme,enzyme,,Drug: miglitol | Target: glycogen debranching enzyme | Type: enzyme | Action: nan
8222,miglitol,"sucrase-isomaltase, intestinal",enzyme,,"Drug: miglitol | Target: sucrase-isomaltase, intestinal | Type: enzyme | Action: nan"
8223,miglitol,lactase-phlorizin hydrolase,enzyme,,Drug: miglitol | Target: lactase-phlorizin hydrolase | Type: enzyme | Action: nan
8224,miglitol,beta-galactosidase,enzyme,,Drug: miglitol | Target: beta-galactosidase | Type: enzyme | Action: nan
8225,miglitol,alpha-mannosidase,enzyme,,Drug: miglitol | Target: alpha-mannosidase | Type: enzyme | Action: nan
8226,miglitol,alpha-glucosidase,enzyme,,Drug: miglitol | Target: alpha-glucosidase | Type: enzyme | Action: nan
8227,miglustat,"maltase-glucoamylase, intestinal",enzyme,,"Drug: miglustat | Target: maltase-glucoamylase, intestinal | Type: enzyme | Action: nan"
8228,miglustat,ceramide glucosyltransferase,enzyme,INHIBITOR,Drug: miglustat | Target: ceramide glucosyltransferase | Type: enzyme | Action: INHIBITOR
8229,miglustat,lysosomal alpha-glucosidase,enzyme,,Drug: miglustat | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: nan
8230,miglustat,"sucrase-isomaltase, intestinal",enzyme,,"Drug: miglustat | Target: sucrase-isomaltase, intestinal | Type: enzyme | Action: nan"
8231,miglustat,non-lysosomal glucosylceramidase,enzyme,,Drug: miglustat | Target: non-lysosomal glucosylceramidase | Type: enzyme | Action: nan
8232,miglustat,lysosomal alpha-glucosidase,enzyme,,Drug: miglustat | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: nan
8233,miglustat,non-lysosomal glucosylceramidase,enzyme,,Drug: miglustat | Target: non-lysosomal glucosylceramidase | Type: enzyme | Action: nan
8234,miglustat,"sucrase-isomaltase, intestinal",enzyme,,"Drug: miglustat | Target: sucrase-isomaltase, intestinal | Type: enzyme | Action: nan"
8235,miglustat,glycogen debranching enzyme,enzyme,,Drug: miglustat | Target: glycogen debranching enzyme | Type: enzyme | Action: nan
8236,miglustat,lysosomal alpha-glucosidase,enzyme,,Drug: miglustat | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: nan
8237,miglustat,sucrase-isomaltase,enzyme,,Drug: miglustat | Target: sucrase-isomaltase | Type: enzyme | Action: nan
8238,miglustat,putative alpha-glucosidase,enzyme,,Drug: miglustat | Target: putative alpha-glucosidase | Type: enzyme | Action: nan
8239,miglustat,trehalase,enzyme,,Drug: miglustat | Target: trehalase | Type: enzyme | Action: nan
8240,miglustat,uncharacterized protein,enzyme,,Drug: miglustat | Target: uncharacterized protein | Type: enzyme | Action: nan
8241,miglustat,ceramide glucosyltransferase,enzyme,,Drug: miglustat | Target: ceramide glucosyltransferase | Type: enzyme | Action: nan
8242,milnacipran,"glutamate receptor ionotropic, nmda 2a",ion channel,,"Drug: milnacipran | Target: glutamate receptor ionotropic, nmda 2a | Type: ion channel | Action: nan"
8243,milnacipran,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: milnacipran | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
8244,milnacipran,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: milnacipran | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
8245,milnacipran,sodium-dependent dopamine transporter,transporter,,Drug: milnacipran | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8246,milnacipran,sodium-dependent serotonin transporter,transporter,,Drug: milnacipran | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
8247,milnacipran,sodium-dependent dopamine transporter,transporter,,Drug: milnacipran | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8248,milnacipran,transporter,transporter,,Drug: milnacipran | Target: transporter | Type: transporter | Action: nan
8249,milrinone,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,INHIBITOR,"Drug: milrinone | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: INHIBITOR"
8250,milrinone,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: milrinone | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
8251,milrinone,"cgmp-inhibited 3',5'-cyclic phosphodiesterase b",enzyme,,"Drug: milrinone | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase b | Type: enzyme | Action: nan"
8252,milrinone,cyclic nucleotide phosphodiesterase pde3a,enzyme,,Drug: milrinone | Target: cyclic nucleotide phosphodiesterase pde3a | Type: enzyme | Action: nan
8253,milrinone,cyclic amp-specific phosphodiesterase sspde4a1a,enzyme,,Drug: milrinone | Target: cyclic amp-specific phosphodiesterase sspde4a1a | Type: enzyme | Action: nan
8254,milrinone,uncharacterized protein,enzyme,,Drug: milrinone | Target: uncharacterized protein | Type: enzyme | Action: nan
8255,milrinone,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: milrinone | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
8256,milrinone,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: milrinone | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
8257,milrinone,phosphodiesterase 3,enzyme,,Drug: milrinone | Target: phosphodiesterase 3 | Type: enzyme | Action: nan
8258,milrinone,phosphodiesterase 4,enzyme,,Drug: milrinone | Target: phosphodiesterase 4 | Type: enzyme | Action: nan
8259,miltefosine,rac-alpha serine/threonine-protein kinase,kinase,,Drug: miltefosine | Target: rac-alpha serine/threonine-protein kinase | Type: kinase | Action: nan
8260,miltefosine,dual specificity phosphatase cdc25a,enzyme,,Drug: miltefosine | Target: dual specificity phosphatase cdc25a | Type: enzyme | Action: nan
8261,mimosine,"serine hydroxymethyltransferase, cytosolic",enzyme,,"Drug: mimosine | Target: serine hydroxymethyltransferase, cytosolic | Type: enzyme | Action: nan"
8262,mimosine,tyrosinase,enzyme,,Drug: mimosine | Target: tyrosinase | Type: enzyme | Action: nan
8263,mimosine,ribonucleoside-diphosphate reductase large subunit,enzyme,,Drug: mimosine | Target: ribonucleoside-diphosphate reductase large subunit | Type: enzyme | Action: nan
8264,mimosine,polyphenol oxidase 2,enzyme,,Drug: mimosine | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
8265,mimosine,deoxyhypusine hydroxylase,enzyme,,Drug: mimosine | Target: deoxyhypusine hydroxylase | Type: enzyme | Action: nan
8266,minaprine,muscarinic acetylcholine receptor m1,gpcr,,Drug: minaprine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
8267,minaprine,acetylcholinesterase,enzyme,,Drug: minaprine | Target: acetylcholinesterase | Type: enzyme | Action: nan
8268,minaprine,muscarinic acetylcholine receptor m1,gpcr,,Drug: minaprine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
8269,minaprine,acetylcholinesterase,enzyme,,Drug: minaprine | Target: acetylcholinesterase | Type: enzyme | Action: nan
8270,minocycline,"tetracycline resistance protein, class b",transporter,,"Drug: minocycline | Target: tetracycline resistance protein, class b | Type: transporter | Action: nan"
8271,minocycline,30s ribosomal protein s4,unclassified,,Drug: minocycline | Target: 30s ribosomal protein s4 | Type: unclassified | Action: nan
8272,minocycline,30s ribosomal protein s9,unclassified,,Drug: minocycline | Target: 30s ribosomal protein s9 | Type: unclassified | Action: nan
8273,minoxidil,atp-sensitive inward rectifier potassium channel 1,ion channel,,Drug: minoxidil | Target: atp-sensitive inward rectifier potassium channel 1 | Type: ion channel | Action: nan
8274,minoxidil,"sulfonylurea receptor 2, kir6.2",ion channel,OPENER,"Drug: minoxidil | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: OPENER"
8275,mirtazapine,d(1a) dopamine receptor,gpcr,,Drug: mirtazapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
8276,mirtazapine,d(2) dopamine receptor,gpcr,,Drug: mirtazapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8277,mirtazapine,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: mirtazapine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8278,mirtazapine,sodium-dependent noradrenaline transporter,transporter,,Drug: mirtazapine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8279,mirtazapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: mirtazapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8280,mirtazapine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: mirtazapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
8281,mirtazapine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: mirtazapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
8282,mirtazapine,5-hydroxytryptamine receptor 7,gpcr,,Drug: mirtazapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
8283,mirtazapine,alpha-1a adrenergic receptor,gpcr,,Drug: mirtazapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
8284,mirtazapine,alpha-2b adrenergic receptor,gpcr,ANTAGONIST,Drug: mirtazapine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8285,mirtazapine,d(3) dopamine receptor,gpcr,,Drug: mirtazapine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
8286,mirtazapine,histamine h1 receptor,gpcr,,Drug: mirtazapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
8287,mirtazapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: mirtazapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
8288,mirtazapine,muscarinic acetylcholine receptor m2,gpcr,,Drug: mirtazapine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
8289,mirtazapine,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: mirtazapine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8290,mirtazapine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: mirtazapine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
8291,mirtazapine,d(2) dopamine receptor,gpcr,,Drug: mirtazapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8292,mirtazapine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: mirtazapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8293,mirtazapine,transporter,transporter,,Drug: mirtazapine | Target: transporter | Type: transporter | Action: nan
8294,mirtazapine,d(1a) dopamine receptor,gpcr,,Drug: mirtazapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
8295,mirtazapine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: mirtazapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8296,mirtazapine,adrenergic receptor alpha-1,gpcr,,Drug: mirtazapine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
8297,misoprostol,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: misoprostol | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
8298,misoprostol,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: misoprostol | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
8299,misoprostol,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: misoprostol | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
8300,misoprostol,prostaglandin f2-alpha receptor,gpcr,,Drug: misoprostol | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: nan
8301,mitiglinide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: mitiglinide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
8302,mitomycin,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: mitomycin | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
8303,mitotane,alpha-2a adrenergic receptor,gpcr,,Drug: mitotane | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
8304,mitotane,sodium-dependent serotonin transporter,transporter,,Drug: mitotane | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
8305,mitotane,sodium-dependent noradrenaline transporter,transporter,,Drug: mitotane | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8306,mitotane,5-hydroxytryptamine receptor 2b,gpcr,,Drug: mitotane | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
8307,mitotane,5-hydroxytryptamine receptor 6,gpcr,,Drug: mitotane | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
8308,mitotane,sodium-dependent dopamine transporter,transporter,,Drug: mitotane | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8309,mitotane,adenosine receptor a3,gpcr,,Drug: mitotane | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8310,mitotane,"cytochrome p450 11b1, mitochondrial",enzyme,INHIBITOR,"Drug: mitotane | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: INHIBITOR"
8311,mitotane,"adrenodoxin, mitochondrial",unclassified,,"Drug: mitotane | Target: adrenodoxin, mitochondrial | Type: unclassified | Action: nan"
8312,mitotane,"cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,INHIBITOR,"Drug: mitotane | Target: cholesterol side-chain cleavage enzyme, mitochondrial | Type: enzyme | Action: INHIBITOR"
8313,mitoxantrone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: mitoxantrone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8314,mitoxantrone,multidrug resistance protein 1,transporter,,Drug: mitoxantrone | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
8315,mitoxantrone,sodium-dependent noradrenaline transporter,transporter,,Drug: mitoxantrone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8316,mitoxantrone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: mitoxantrone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8317,mitoxantrone,muscarinic acetylcholine receptor m1,gpcr,,Drug: mitoxantrone | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
8318,mitoxantrone,muscarinic acetylcholine receptor m2,gpcr,,Drug: mitoxantrone | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
8319,mitoxantrone,muscarinic acetylcholine receptor m4,gpcr,,Drug: mitoxantrone | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
8320,mitoxantrone,canalicular multispecific organic anion transporter 1,transporter,,Drug: mitoxantrone | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
8321,mitoxantrone,dna topoisomerase 2-alpha,enzyme,INHIBITOR,Drug: mitoxantrone | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: INHIBITOR
8322,mitoxantrone,multidrug resistance-associated protein 1,transporter,,Drug: mitoxantrone | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
8323,mitoxantrone,atp-binding cassette sub-family g member 2,transporter,,Drug: mitoxantrone | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
8324,mitoxantrone,epidermal growth factor receptor,kinase,,Drug: mitoxantrone | Target: epidermal growth factor receptor | Type: kinase | Action: nan
8325,mitoxantrone,tyrosine-protein kinase fyn,kinase,,Drug: mitoxantrone | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
8326,mitoxantrone,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: mitoxantrone | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
8327,mitoxantrone,serine/threonine-protein kinase pim-1,kinase,,Drug: mitoxantrone | Target: serine/threonine-protein kinase pim-1 | Type: kinase | Action: nan
8328,mitoxantrone,solute carrier family 22 member 1,transporter,,Drug: mitoxantrone | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
8329,mitoxantrone,dna-(apurinic or apyrimidinic site) lyase,enzyme,,Drug: mitoxantrone | Target: dna-(apurinic or apyrimidinic site) lyase | Type: enzyme | Action: nan
8330,mitoxantrone,arachidonate 15-lipoxygenase,enzyme,,Drug: mitoxantrone | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
8331,mitoxantrone,integrase,enzyme,,Drug: mitoxantrone | Target: integrase | Type: enzyme | Action: nan
8332,mitoxantrone,tyrosine-protein kinase btk,kinase,,Drug: mitoxantrone | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
8333,mitoxantrone,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: mitoxantrone | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
8334,mitoxantrone,solute carrier family 22 member 2,transporter,,Drug: mitoxantrone | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
8335,mitoxantrone,multidrug and toxin extrusion protein 1,transporter,,Drug: mitoxantrone | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
8336,mitoxantrone,multidrug and toxin extrusion protein 2,transporter,,Drug: mitoxantrone | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
8337,mitoxantrone,solute carrier family 22 member 3,transporter,,Drug: mitoxantrone | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
8338,mitoxantrone,dna-3-methyladenine glycosylase,enzyme,,Drug: mitoxantrone | Target: dna-3-methyladenine glycosylase | Type: enzyme | Action: nan
8339,mitoxantrone,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,,Drug: mitoxantrone | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: nan
8340,mivacurium,neuronal acetylcholine receptor subunit alpha-2,ion channel,,Drug: mivacurium | Target: neuronal acetylcholine receptor subunit alpha-2 | Type: ion channel | Action: nan
8341,mivacurium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: mivacurium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
8342,mizolastine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: mizolastine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8343,mizolastine,arachidonate 5-lipoxygenase,enzyme,,Drug: mizolastine | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
8344,mizolastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: mizolastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
8345,moclobemide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: moclobemide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8346,moclobemide,5-hydroxytryptamine receptor 1a,gpcr,,Drug: moclobemide | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8347,moclobemide,amine oxidase [flavin-containing] b,enzyme,,Drug: moclobemide | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
8348,moclobemide,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: moclobemide | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
8349,moclobemide,amine oxidase [flavin-containing] b,enzyme,,Drug: moclobemide | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
8350,moclobemide,amine oxidase [flavin-containing] a,enzyme,,Drug: moclobemide | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
8351,moclobemide,amine oxidase [flavin-containing] a,enzyme,,Drug: moclobemide | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
8352,modafinil,d(2) dopamine receptor,gpcr,,Drug: modafinil | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8353,modafinil,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: modafinil | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
8354,modafinil,alpha-1b adrenergic receptor,gpcr,,Drug: modafinil | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
8355,modafinil,cytochrome p450 1a2,enzyme,,Drug: modafinil | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
8356,modafinil,cytochrome p450 2c19,enzyme,,Drug: modafinil | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
8357,modafinil,sodium-dependent dopamine transporter,transporter,,Drug: modafinil | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8358,modafinil,transporter,transporter,,Drug: modafinil | Target: transporter | Type: transporter | Action: nan
8359,moexipril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: moexipril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
8360,mofezolac,prostaglandin g/h synthase 2,enzyme,,Drug: mofezolac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8361,mofezolac,prostaglandin g/h synthase 1,enzyme,,Drug: mofezolac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8362,mofezolac,prostaglandin g/h synthase 1,enzyme,,Drug: mofezolac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8363,mofezolac,prostaglandin g/h synthase 2,enzyme,,Drug: mofezolac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8364,molindone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: molindone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
8365,molindone,alpha-2a adrenergic receptor,gpcr,,Drug: molindone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
8366,molindone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: molindone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
8367,molindone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: molindone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8368,molindone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: molindone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
8369,molindone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: molindone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8370,molindone,5-hydroxytryptamine receptor 6,gpcr,,Drug: molindone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
8371,molindone,5-hydroxytryptamine receptor 7,gpcr,,Drug: molindone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
8372,molindone,alpha-1a adrenergic receptor,gpcr,,Drug: molindone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
8373,molindone,alpha-2b adrenergic receptor,gpcr,,Drug: molindone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
8374,molindone,d(3) dopamine receptor,gpcr,,Drug: molindone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
8375,molindone,histamine h1 receptor,gpcr,ANTAGONIST,Drug: molindone | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
8376,molindone,muscarinic acetylcholine receptor m3,gpcr,,Drug: molindone | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
8377,molindone,alpha-2c adrenergic receptor,gpcr,,Drug: molindone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
8378,molindone,d(4) dopamine receptor,gpcr,,Drug: molindone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
8379,molindone,d(2) dopamine receptor,gpcr,,Drug: molindone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8380,molindone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: molindone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8381,molindone,d(1a) dopamine receptor,gpcr,,Drug: molindone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
8382,molsidomine,estrogen receptor,nuclear hormone receptor,,Drug: molsidomine | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
8383,mometasone furoate,multidrug resistance protein 1,transporter,,Drug: mometasone furoate | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
8384,mometasone furoate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: mometasone furoate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
8385,mometasone furoate,progesterone receptor,nuclear hormone receptor,,Drug: mometasone furoate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
8386,monobenzone,prostaglandin g/h synthase 2,enzyme,,Drug: monobenzone | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8387,monobenzone,prostaglandin g/h synthase 1,enzyme,,Drug: monobenzone | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8388,monobenzone,sodium-dependent noradrenaline transporter,transporter,,Drug: monobenzone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8389,monobenzone,tyrosinase,enzyme,INHIBITOR,Drug: monobenzone | Target: tyrosinase | Type: enzyme | Action: INHIBITOR
8390,monobenzone,arachidonate 15-lipoxygenase,enzyme,,Drug: monobenzone | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
8391,montelukast,beta-2 adrenergic receptor,gpcr,,Drug: montelukast | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
8392,montelukast,alpha-2a adrenergic receptor,gpcr,,Drug: montelukast | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
8393,montelukast,sodium-dependent noradrenaline transporter,transporter,,Drug: montelukast | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8394,montelukast,5-hydroxytryptamine receptor 2b,gpcr,,Drug: montelukast | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
8395,montelukast,d(3) dopamine receptor,gpcr,,Drug: montelukast | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
8396,montelukast,muscarinic acetylcholine receptor m1,gpcr,,Drug: montelukast | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
8397,montelukast,muscarinic acetylcholine receptor m3,gpcr,,Drug: montelukast | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
8398,montelukast,beta-3 adrenergic receptor,gpcr,,Drug: montelukast | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
8399,montelukast,alpha-2c adrenergic receptor,gpcr,,Drug: montelukast | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
8400,montelukast,sodium-dependent dopamine transporter,transporter,,Drug: montelukast | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8401,montelukast,adenosine receptor a3,gpcr,,Drug: montelukast | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8402,montelukast,cytochrome p450 2c8,enzyme,,Drug: montelukast | Target: cytochrome p450 2c8 | Type: enzyme | Action: nan
8403,montelukast,delta-type opioid receptor,gpcr,,Drug: montelukast | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8404,montelukast,cysteinyl leukotriene receptor 1,gpcr,ANTAGONIST,Drug: montelukast | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: ANTAGONIST
8405,montelukast,arachidonate 5-lipoxygenase,enzyme,,Drug: montelukast | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
8406,montelukast,epidermal growth factor receptor,kinase,,Drug: montelukast | Target: epidermal growth factor receptor | Type: kinase | Action: nan
8407,montelukast,tyrosine-protein kinase fyn,kinase,,Drug: montelukast | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
8408,montelukast,thromboxane-a synthase,enzyme,,Drug: montelukast | Target: thromboxane-a synthase | Type: enzyme | Action: nan
8409,montelukast,cysteinyl leukotriene receptor 2,gpcr,,Drug: montelukast | Target: cysteinyl leukotriene receptor 2 | Type: gpcr | Action: nan
8410,montelukast,mitogen-activated protein kinase 14,kinase,,Drug: montelukast | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
8411,montelukast,substance-k receptor,gpcr,,Drug: montelukast | Target: substance-k receptor | Type: gpcr | Action: nan
8412,montelukast,cysteinyl leukotriene receptor 1,gpcr,,Drug: montelukast | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
8413,montelukast,uracil nucleotide/cysteinyl leukotriene receptor,gpcr,,Drug: montelukast | Target: uracil nucleotide/cysteinyl leukotriene receptor | Type: gpcr | Action: nan
8414,montelukast,uracil nucleotide/cysteinyl leukotriene receptor,gpcr,ANTAGONIST,Drug: montelukast | Target: uracil nucleotide/cysteinyl leukotriene receptor | Type: gpcr | Action: ANTAGONIST
8415,moperone,d(2) dopamine receptor,gpcr,,Drug: moperone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8416,moperone,d(3) dopamine receptor,gpcr,,Drug: moperone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
8417,moperone,d(4) dopamine receptor,gpcr,,Drug: moperone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
8418,moracizine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: moracizine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
8419,morphine,mu-type opioid receptor,gpcr,AGONIST,Drug: morphine | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
8420,morphine,kappa-type opioid receptor,gpcr,,Drug: morphine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8421,morphine,delta-type opioid receptor,gpcr,,Drug: morphine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8422,morphine,solute carrier family 22 member 1,transporter,,Drug: morphine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
8423,morphine,mu-type opioid receptor,gpcr,,Drug: morphine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8424,morphine,mu-type opioid receptor,gpcr,,Drug: morphine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8425,morphine,mu-type opioid receptor,gpcr,,Drug: morphine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8426,morphine,delta-type opioid receptor,gpcr,,Drug: morphine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8427,morphine,delta-type opioid receptor,gpcr,,Drug: morphine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8428,morphine,kappa-type opioid receptor,gpcr,,Drug: morphine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8429,morphine,kappa-type opioid receptor,gpcr,,Drug: morphine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8430,morphine,kappa-type opioid receptor,gpcr,,Drug: morphine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8431,morphine,mu-type opioid receptor,gpcr,,Drug: morphine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8432,morphine,nociceptin receptor,gpcr,,Drug: morphine | Target: nociceptin receptor | Type: gpcr | Action: nan
8433,morphine,opioid receptor,gpcr,,Drug: morphine | Target: opioid receptor | Type: gpcr | Action: nan
8434,morphine,dopamine receptor,gpcr,,Drug: morphine | Target: dopamine receptor | Type: gpcr | Action: nan
8435,morphine,opioid receptor,gpcr,,Drug: morphine | Target: opioid receptor | Type: gpcr | Action: nan
8436,morphine,mu opioid receptor-like or2,gpcr,,Drug: morphine | Target: mu opioid receptor-like or2 | Type: gpcr | Action: nan
8437,morphine,"opioid receptor, delta 1b",gpcr,,"Drug: morphine | Target: opioid receptor, delta 1b | Type: gpcr | Action: nan"
8438,morphine,opioid receptor homologue,gpcr,,Drug: morphine | Target: opioid receptor homologue | Type: gpcr | Action: nan
8439,mosapramine,d(4) dopamine receptor,gpcr,,Drug: mosapramine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
8441,mosapride,5-hydroxytryptamine receptor 4,gpcr,,Drug: mosapride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
8442,mosapride,alpha-2a adrenergic receptor,gpcr,,Drug: mosapride | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
8443,mosapride,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: mosapride | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
8444,mosapride,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: mosapride | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8445,mosapride,cytochrome p450 3a4,enzyme,,Drug: mosapride | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8446,mosapride,sodium-dependent serotonin transporter,transporter,,Drug: mosapride | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
8447,mosapride,5-hydroxytryptamine receptor 2b,gpcr,,Drug: mosapride | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
8448,mosapride,5-hydroxytryptamine receptor 2c,gpcr,,Drug: mosapride | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8449,mosapride,alpha-2b adrenergic receptor,gpcr,,Drug: mosapride | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
8450,mosapride,5-hydroxytryptamine receptor 3a,ion channel,,Drug: mosapride | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
8451,mosapride,cytochrome p450 2c9,enzyme,,Drug: mosapride | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
8452,mosapride,cytochrome p450 1a2,enzyme,,Drug: mosapride | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
8453,mosapride,cytochrome p450 2c19,enzyme,,Drug: mosapride | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
8454,mosapride,serotonin 3 (5-ht3) receptor,ion channel,,Drug: mosapride | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
8455,mosapride,5-hydroxytryptamine receptor 4,gpcr,AGONIST,Drug: mosapride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: AGONIST
8456,latamoxef,peptidoglycan synthase ftsi,enzyme,INHIBITOR,Drug: latamoxef | Target: peptidoglycan synthase ftsi | Type: enzyme | Action: INHIBITOR
8457,latamoxef,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: latamoxef | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
8458,latamoxef,penicillin-binding protein 1b,enzyme,INHIBITOR,Drug: latamoxef | Target: penicillin-binding protein 1b | Type: enzyme | Action: INHIBITOR
8459,moxastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: moxastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
8460,moxifloxacin,dna topoisomerase 4 subunit a,enzyme,,Drug: moxifloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: nan
8461,moxifloxacin,dna gyrase subunit a,enzyme,,Drug: moxifloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
8462,moxifloxacin,topoisomerase iv,enzyme,INHIBITOR,Drug: moxifloxacin | Target: topoisomerase iv | Type: enzyme | Action: INHIBITOR
8463,moxifloxacin,dna gyrase,enzyme,INHIBITOR,Drug: moxifloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
8464,moxonidine,alpha-2a adrenergic receptor,gpcr,,Drug: moxonidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
8465,moxonidine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: moxonidine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8466,moxonidine,alpha-2c adrenergic receptor,gpcr,,Drug: moxonidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
8467,moxonidine,alpha-2b adrenergic receptor,gpcr,,Drug: moxonidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
8468,moxonidine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: moxonidine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8469,moxonidine,nischarin,unclassified,,Drug: moxonidine | Target: nischarin | Type: unclassified | Action: nan
8470,moxonidine,nischarin,membrane receptor,AGONIST,Drug: moxonidine | Target: nischarin | Type: membrane receptor | Action: AGONIST
8471,mupirocin,isoleucine--trna ligase,enzyme,,Drug: mupirocin | Target: isoleucine--trna ligase | Type: enzyme | Action: nan
8472,mupirocin,"isoleucine--trna ligase, cytoplasmic",enzyme,,"Drug: mupirocin | Target: isoleucine--trna ligase, cytoplasmic | Type: enzyme | Action: nan"
8473,mupirocin,isoleucine--trna ligase,enzyme,INHIBITOR,Drug: mupirocin | Target: isoleucine--trna ligase | Type: enzyme | Action: INHIBITOR
8474,mupirocin,isoleucine--trna ligase,enzyme,INHIBITOR,Drug: mupirocin | Target: isoleucine--trna ligase | Type: enzyme | Action: INHIBITOR
8475,mupirocin,isoleucine--trna ligase,enzyme,,Drug: mupirocin | Target: isoleucine--trna ligase | Type: enzyme | Action: nan
8476,mycophenolate mofetil,inosine-5'-monophosphate dehydrogenase 1,enzyme,INHIBITOR,Drug: mycophenolate mofetil | Target: inosine-5'-monophosphate dehydrogenase 1 | Type: enzyme | Action: INHIBITOR
8477,mycophenolate mofetil,inosine-5'-monophosphate dehydrogenase 2,enzyme,INHIBITOR,Drug: mycophenolate mofetil | Target: inosine-5'-monophosphate dehydrogenase 2 | Type: enzyme | Action: INHIBITOR
8478,mycophenolic acid,inosine-5'-monophosphate dehydrogenase 1,enzyme,,Drug: mycophenolic acid | Target: inosine-5'-monophosphate dehydrogenase 1 | Type: enzyme | Action: nan
8479,mycophenolic acid,inosine-5'-monophosphate dehydrogenase 2,enzyme,,Drug: mycophenolic acid | Target: inosine-5'-monophosphate dehydrogenase 2 | Type: enzyme | Action: nan
8480,mycophenolic acid,inosine-5'-monophosphate dehydrogenase (impdh),enzyme,INHIBITOR,Drug: mycophenolic acid | Target: inosine-5'-monophosphate dehydrogenase (impdh) | Type: enzyme | Action: INHIBITOR
8481,mycophenolic acid,inosine-5'-monophosphate dehydrogenase,unclassified,,Drug: mycophenolic acid | Target: inosine-5'-monophosphate dehydrogenase | Type: unclassified | Action: nan
8482,nabilone,cannabinoid receptor 1,gpcr,AGONIST,Drug: nabilone | Target: cannabinoid receptor 1 | Type: gpcr | Action: AGONIST
8483,nabilone,cannabinoid receptor 2,gpcr,,Drug: nabilone | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
8484,nabilone,cannabinoid receptor 1,gpcr,,Drug: nabilone | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
8485,nabilone,cannabinoid receptor 2,gpcr,,Drug: nabilone | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
8486,nabumetone,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: nabumetone | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
8487,nabumetone,prostaglandin g/h synthase 1,enzyme,,Drug: nabumetone | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8488,nabumetone,sodium-dependent noradrenaline transporter,transporter,,Drug: nabumetone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8489,nabumetone,cytochrome p450 1a2,enzyme,,Drug: nabumetone | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
8490,nabumetone,amine oxidase [flavin-containing] a,enzyme,,Drug: nabumetone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
8491,nadolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: nadolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8492,nadolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: nadolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8493,nadolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: nadolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8494,nafamostat,plasminogen,enzyme,,Drug: nafamostat | Target: plasminogen | Type: enzyme | Action: nan
8495,nafamostat,prothrombin,enzyme,,Drug: nafamostat | Target: prothrombin | Type: enzyme | Action: nan
8496,nafamostat,trypsin-1,enzyme,INHIBITOR,Drug: nafamostat | Target: trypsin-1 | Type: enzyme | Action: INHIBITOR
8497,nafamostat,kallikrein-1,enzyme,,Drug: nafamostat | Target: kallikrein-1 | Type: enzyme | Action: nan
8498,nafamostat,coagulation factor x,enzyme,,Drug: nafamostat | Target: coagulation factor x | Type: enzyme | Action: nan
8499,nafamostat,suppressor of tumorigenicity 14 protein,enzyme,,Drug: nafamostat | Target: suppressor of tumorigenicity 14 protein | Type: enzyme | Action: nan
8500,nafamostat,complement c1r subcomponent,enzyme,INHIBITOR,Drug: nafamostat | Target: complement c1r subcomponent | Type: enzyme | Action: INHIBITOR
8501,nafamostat,complement c1s subcomponent,enzyme,,Drug: nafamostat | Target: complement c1s subcomponent | Type: enzyme | Action: nan
8502,nafamostat,acid-sensing ion channel 2,ion channel,BLOCKER,Drug: nafamostat | Target: acid-sensing ion channel 2 | Type: ion channel | Action: BLOCKER
8503,nafamostat,acid-sensing ion channel 1,ion channel,BLOCKER,Drug: nafamostat | Target: acid-sensing ion channel 1 | Type: ion channel | Action: BLOCKER
8504,nafamostat,cationic trypsin,enzyme,,Drug: nafamostat | Target: cationic trypsin | Type: enzyme | Action: nan
8505,nafamostat,acid-sensing ion channel 3,ion channel,BLOCKER,Drug: nafamostat | Target: acid-sensing ion channel 3 | Type: ion channel | Action: BLOCKER
8506,nafamostat,tryptase alpha/beta-1,enzyme,INHIBITOR,Drug: nafamostat | Target: tryptase alpha/beta-1 | Type: enzyme | Action: INHIBITOR
8507,nafamostat,serine protease hepsin,enzyme,,Drug: nafamostat | Target: serine protease hepsin | Type: enzyme | Action: nan
8508,nafamostat,hepatocyte growth factor activator,enzyme,,Drug: nafamostat | Target: hepatocyte growth factor activator | Type: enzyme | Action: nan
8509,nafamostat,transmembrane protease serine 2,enzyme,INHIBITOR,Drug: nafamostat | Target: transmembrane protease serine 2 | Type: enzyme | Action: INHIBITOR
8510,nafarelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: nafarelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
8511,nafcillin,penicillin-binding protein 1a,enzyme,,Drug: nafcillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
8512,nafcillin,penicillin-binding protein,enzyme,INHIBITOR,Drug: nafcillin | Target: penicillin-binding protein | Type: enzyme | Action: INHIBITOR
8513,naftidrofuryl,5-hydroxytryptamine receptor 2a,gpcr,,Drug: naftidrofuryl | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8514,naftifine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: naftifine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
8515,naftifine,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: naftifine | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
8516,naftifine,squalene monooxygenase,enzyme,,Drug: naftifine | Target: squalene monooxygenase | Type: enzyme | Action: nan
8517,naftifine,squalene epoxidase,enzyme,INHIBITOR,Drug: naftifine | Target: squalene epoxidase | Type: enzyme | Action: INHIBITOR
8518,naftifine,c-8 sterol isomerase,enzyme,,Drug: naftifine | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
8519,naftifine,dehydrosqualene desaturase,enzyme,,Drug: naftifine | Target: dehydrosqualene desaturase | Type: enzyme | Action: nan
8520,naftopidil,beta-2 adrenergic receptor,gpcr,,Drug: naftopidil | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
8521,naftopidil,adrenergic receptor alpha-2,gpcr,,Drug: naftopidil | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
8522,naftopidil,adrenergic receptor alpha-1,gpcr,,Drug: naftopidil | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
8523,naftopidil,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: naftopidil | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8524,naftopidil,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: naftopidil | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8525,naftopidil,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: naftopidil | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8526,nalbuphine,mu-type opioid receptor,gpcr,AGONIST,Drug: nalbuphine | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
8527,nalbuphine,kappa-type opioid receptor,gpcr,AGONIST,Drug: nalbuphine | Target: kappa-type opioid receptor | Type: gpcr | Action: AGONIST
8528,nalbuphine,delta-type opioid receptor,gpcr,AGONIST,Drug: nalbuphine | Target: delta-type opioid receptor | Type: gpcr | Action: AGONIST
8529,nalbuphine,kappa-type opioid receptor,gpcr,AGONIST,Drug: nalbuphine | Target: kappa-type opioid receptor | Type: gpcr | Action: AGONIST
8530,nalidixic acid,5-hydroxytryptamine receptor 2b,gpcr,,Drug: nalidixic acid | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
8531,nalidixic acid,dna gyrase,enzyme,INHIBITOR,Drug: nalidixic acid | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
8532,nalmefene,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: nalmefene | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
8533,nalmefene,kappa-type opioid receptor,gpcr,ANTAGONIST,Drug: nalmefene | Target: kappa-type opioid receptor | Type: gpcr | Action: ANTAGONIST
8534,nalmefene,delta-type opioid receptor,gpcr,ANTAGONIST,Drug: nalmefene | Target: delta-type opioid receptor | Type: gpcr | Action: ANTAGONIST
8535,nalmefene,mu-type opioid receptor,gpcr,,Drug: nalmefene | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8536,nalmefene,delta-type opioid receptor,gpcr,,Drug: nalmefene | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8537,nalmefene,kappa-type opioid receptor,gpcr,,Drug: nalmefene | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8538,nalorphine,mu-type opioid receptor,gpcr,,Drug: nalorphine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8539,nalorphine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: nalorphine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
8540,nalorphine,kappa-type opioid receptor,gpcr,,Drug: nalorphine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8541,nalorphine,delta-type opioid receptor,gpcr,,Drug: nalorphine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8542,nalorphine,mu-type opioid receptor,gpcr,,Drug: nalorphine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8543,nalorphine,kappa-type opioid receptor,gpcr,,Drug: nalorphine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8544,nalorphine,opioid receptor,gpcr,,Drug: nalorphine | Target: opioid receptor | Type: gpcr | Action: nan
8545,nalorphine,opioid receptor,gpcr,,Drug: nalorphine | Target: opioid receptor | Type: gpcr | Action: nan
8546,naloxone,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: naloxone | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
8547,naloxone,cytochrome p450 2d6,enzyme,,Drug: naloxone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
8548,naloxone,adenosine receptor a3,gpcr,,Drug: naloxone | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8549,naloxone,kappa-type opioid receptor,gpcr,ANTAGONIST,Drug: naloxone | Target: kappa-type opioid receptor | Type: gpcr | Action: ANTAGONIST
8550,naloxone,delta-type opioid receptor,gpcr,ANTAGONIST,Drug: naloxone | Target: delta-type opioid receptor | Type: gpcr | Action: ANTAGONIST
8551,naloxone,mu-type opioid receptor,gpcr,,Drug: naloxone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8552,naloxone,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: naloxone | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
8553,naloxone,mu-type opioid receptor,gpcr,,Drug: naloxone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8554,naloxone,delta-type opioid receptor,gpcr,,Drug: naloxone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8555,naloxone,delta-type opioid receptor,gpcr,,Drug: naloxone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8556,naloxone,kappa-type opioid receptor,gpcr,,Drug: naloxone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8557,naloxone,kappa-type opioid receptor,gpcr,,Drug: naloxone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8558,naloxone,kappa-type opioid receptor,gpcr,ANTAGONIST,Drug: naloxone | Target: kappa-type opioid receptor | Type: gpcr | Action: ANTAGONIST
8559,naloxone,mu-type opioid receptor,gpcr,,Drug: naloxone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8560,naloxone,c-c chemokine receptor type 5,gpcr,,Drug: naloxone | Target: c-c chemokine receptor type 5 | Type: gpcr | Action: nan
8561,naloxone,opioid receptor,gpcr,,Drug: naloxone | Target: opioid receptor | Type: gpcr | Action: nan
8562,nandrolone,androgen receptor,nuclear hormone receptor,AGONIST,Drug: nandrolone | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
8563,nandrolone,corticosteroid-binding globulin,secreted,,Drug: nandrolone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
8564,nandrolone,sex hormone-binding globulin,secreted,,Drug: nandrolone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
8565,nandrolone,solute carrier family 22 member 1,transporter,,Drug: nandrolone | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
8566,nandrolone,androgen receptor,transcription factor,,Drug: nandrolone | Target: androgen receptor | Type: transcription factor | Action: nan
8567,nandrolone,progesterone receptor,transcription factor,,Drug: nandrolone | Target: progesterone receptor | Type: transcription factor | Action: nan
8568,nandrolone decanoate,androgen receptor,nuclear hormone receptor,AGONIST,Drug: nandrolone decanoate | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
8569,nandrolone decanoate,corticosteroid-binding globulin,secreted,,Drug: nandrolone decanoate | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
8570,nandrolone decanoate,sex hormone-binding globulin,secreted,,Drug: nandrolone decanoate | Target: sex hormone-binding globulin | Type: secreted | Action: nan
8571,nandrolone decanoate,solute carrier family 22 member 1,transporter,,Drug: nandrolone decanoate | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
8572,nandrolone decanoate,androgen receptor,transcription factor,,Drug: nandrolone decanoate | Target: androgen receptor | Type: transcription factor | Action: nan
8573,nandrolone decanoate,progesterone receptor,transcription factor,,Drug: nandrolone decanoate | Target: progesterone receptor | Type: transcription factor | Action: nan
8574,nandrolone phenpropionate,estrogen receptor,nuclear hormone receptor,,Drug: nandrolone phenpropionate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
8575,nandrolone phenpropionate,androgen receptor,nuclear hormone receptor,AGONIST,Drug: nandrolone phenpropionate | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
8576,naproxen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: naproxen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
8577,naproxen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: naproxen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
8578,naproxen,aldo-keto reductase family 1 member c2,enzyme,,Drug: naproxen | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
8579,naproxen,aldo-keto reductase family 1 member c3,enzyme,,Drug: naproxen | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
8580,naproxen,prostaglandin g/h synthase 1,enzyme,,Drug: naproxen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8581,naproxen,prostaglandin-h2 d-isomerase,enzyme,,Drug: naproxen | Target: prostaglandin-h2 d-isomerase | Type: enzyme | Action: nan
8582,naproxen,prostaglandin g/h synthase 2,enzyme,,Drug: naproxen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8583,naproxen,prostaglandin g/h synthase 1,enzyme,,Drug: naproxen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8584,naproxen,hormone-sensitive lipase,enzyme,,Drug: naproxen | Target: hormone-sensitive lipase | Type: enzyme | Action: nan
8585,naproxen,cyclooxygenase,enzyme,,Drug: naproxen | Target: cyclooxygenase | Type: enzyme | Action: nan
8586,naratriptan,5-hydroxytryptamine receptor 1a,gpcr,,Drug: naratriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8587,naratriptan,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: naratriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
8588,naratriptan,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: naratriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
8589,naratriptan,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: naratriptan | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
8590,naratriptan,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: naratriptan | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
8591,nateglinide,solute carrier family 22 member 6,transporter,,Drug: nateglinide | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
8592,nateglinide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: nateglinide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
8593,nateglinide,"sulfonylurea receptor 2, kir6.2",ion channel,BLOCKER,"Drug: nateglinide | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: BLOCKER"
8594,nebivolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: nebivolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8595,nebivolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: nebivolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8596,nebivolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: nebivolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8597,nebivolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: nebivolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
8599,nedocromil,cysteinyl leukotriene receptor 1,gpcr,,Drug: nedocromil | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
8600,nedocromil,g-protein coupled receptor 35,gpcr,AGONIST,Drug: nedocromil | Target: g-protein coupled receptor 35 | Type: gpcr | Action: AGONIST
8601,nefazodone,d(2) dopamine receptor,gpcr,,Drug: nefazodone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8602,nefazodone,cytochrome p450 3a4,enzyme,INHIBITOR,Drug: nefazodone | Target: cytochrome p450 3a4 | Type: enzyme | Action: INHIBITOR
8603,nefazodone,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: nefazodone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
8604,nefazodone,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: nefazodone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
8605,nefazodone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: nefazodone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8606,nefazodone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: nefazodone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
8607,nefazodone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: nefazodone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8608,nefazodone,alpha-1a adrenergic receptor,gpcr,,Drug: nefazodone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
8609,nefazodone,alpha-2b adrenergic receptor,gpcr,,Drug: nefazodone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
8610,nefazodone,histamine h1 receptor,gpcr,,Drug: nefazodone | Target: histamine h1 receptor | Type: gpcr | Action: nan
8611,nefazodone,sodium-dependent dopamine transporter,transporter,,Drug: nefazodone | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8612,nefazodone,acetylcholinesterase,enzyme,,Drug: nefazodone | Target: acetylcholinesterase | Type: enzyme | Action: nan
8613,nefazodone,bile salt export pump,transporter,,Drug: nefazodone | Target: bile salt export pump | Type: transporter | Action: nan
8614,nefazodone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: nefazodone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
8615,nefazodone,sodium-dependent serotonin transporter,transporter,,Drug: nefazodone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
8616,nefazodone,sodium-dependent dopamine transporter,transporter,,Drug: nefazodone | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8617,nefazodone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: nefazodone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8618,nefazodone,transporter,transporter,,Drug: nefazodone | Target: transporter | Type: transporter | Action: nan
8619,nefazodone,bile salt export pump,transporter,,Drug: nefazodone | Target: bile salt export pump | Type: transporter | Action: nan
8622,nefopam,sodium channel protein type 5 subunit alpha,ion channel,,Drug: nefopam | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
8623,nefopam,sodium-dependent serotonin transporter,transporter,,Drug: nefopam | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
8624,nefopam,sodium-dependent noradrenaline transporter,transporter,,Drug: nefopam | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8625,nefopam,5-hydroxytryptamine receptor 2a,gpcr,,Drug: nefopam | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8626,nefopam,5-hydroxytryptamine receptor 2b,gpcr,,Drug: nefopam | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
8627,nefopam,5-hydroxytryptamine receptor 2c,gpcr,,Drug: nefopam | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8628,nefopam,sodium-dependent dopamine transporter,transporter,,Drug: nefopam | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8629,nelfinavir,mu-type opioid receptor,gpcr,,Drug: nelfinavir | Target: mu-type opioid receptor | Type: gpcr | Action: nan
8630,nelfinavir,d(1a) dopamine receptor,gpcr,,Drug: nelfinavir | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
8631,nelfinavir,cytochrome p450 3a4,enzyme,,Drug: nelfinavir | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8632,nelfinavir,multidrug resistance protein 1,transporter,,Drug: nelfinavir | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
8633,nelfinavir,sodium-dependent noradrenaline transporter,transporter,,Drug: nelfinavir | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
8634,nelfinavir,muscarinic acetylcholine receptor m5,gpcr,,Drug: nelfinavir | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
8635,nelfinavir,beta-3 adrenergic receptor,gpcr,,Drug: nelfinavir | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
8636,nelfinavir,sodium-dependent dopamine transporter,transporter,,Drug: nelfinavir | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8637,nelfinavir,adenosine receptor a3,gpcr,,Drug: nelfinavir | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8638,nelfinavir,kappa-type opioid receptor,gpcr,,Drug: nelfinavir | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
8639,nelfinavir,delta-type opioid receptor,gpcr,,Drug: nelfinavir | Target: delta-type opioid receptor | Type: gpcr | Action: nan
8640,nelfinavir,epidermal growth factor receptor,kinase,,Drug: nelfinavir | Target: epidermal growth factor receptor | Type: kinase | Action: nan
8641,nelfinavir,gag-pol polyprotein,polyprotein,,Drug: nelfinavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
8642,nelfinavir,tyrosine-protein kinase lck,kinase,,Drug: nelfinavir | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
8643,nelfinavir,tyrosine-protein kinase fyn,kinase,,Drug: nelfinavir | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
8644,nelfinavir,thromboxane-a synthase,enzyme,,Drug: nelfinavir | Target: thromboxane-a synthase | Type: enzyme | Action: nan
8645,nelfinavir,mitogen-activated protein kinase 3,kinase,,Drug: nelfinavir | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
8646,nelfinavir,mitogen-activated protein kinase 14,kinase,,Drug: nelfinavir | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
8647,nelfinavir,substance-k receptor,gpcr,,Drug: nelfinavir | Target: substance-k receptor | Type: gpcr | Action: nan
8648,nelfinavir,androgen receptor,transcription factor,,Drug: nelfinavir | Target: androgen receptor | Type: transcription factor | Action: nan
8649,nelfinavir,arachidonate 15-lipoxygenase,enzyme,,Drug: nelfinavir | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
8650,nelfinavir,progesterone receptor,transcription factor,,Drug: nelfinavir | Target: progesterone receptor | Type: transcription factor | Action: nan
8651,nelfinavir,pol polyprotein,enzyme,INHIBITOR,Drug: nelfinavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
8652,nelfinavir,protease,enzyme,,Drug: nelfinavir | Target: protease | Type: enzyme | Action: nan
8653,nelfinavir,protease,unclassified,,Drug: nelfinavir | Target: protease | Type: unclassified | Action: nan
8654,nelfinavir,protease,unclassified,,Drug: nelfinavir | Target: protease | Type: unclassified | Action: nan
8655,nemonapride,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: nemonapride | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
8656,nemonapride,d(4) dopamine receptor,gpcr,,Drug: nemonapride | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
8657,nemonapride,alpha-1a adrenergic receptor,gpcr,,Drug: nemonapride | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
8658,nemonapride,d(2) dopamine receptor,gpcr,,Drug: nemonapride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
8659,nemonapride,5-hydroxytryptamine receptor 2a,gpcr,,Drug: nemonapride | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8660,nemonapride,d(3) dopamine receptor,gpcr,,Drug: nemonapride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
8661,framycetin,transient receptor potential cation channel subfamily v member 1,ion channel,,Drug: framycetin | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: nan
8662,framycetin,30s ribosomal protein s12,cytosolic other,,Drug: framycetin | Target: 30s ribosomal protein s12 | Type: cytosolic other | Action: nan
8663,framycetin,phenylalanine--trna ligase alpha subunit,enzyme,,Drug: framycetin | Target: phenylalanine--trna ligase alpha subunit | Type: enzyme | Action: nan
8664,framycetin,phenylalanine--trna ligase beta subunit,enzyme,,Drug: framycetin | Target: phenylalanine--trna ligase beta subunit | Type: enzyme | Action: nan
8665,framycetin,lethal factor,enzyme,,Drug: framycetin | Target: lethal factor | Type: enzyme | Action: nan
8666,framycetin,lecithin retinol acyltransferase,enzyme,,Drug: framycetin | Target: lecithin retinol acyltransferase | Type: enzyme | Action: nan
8667,framycetin,menin,unclassified,,Drug: framycetin | Target: menin | Type: unclassified | Action: nan
8668,framycetin,extracellular calcium-sensing receptor,gpcr,AGONIST,Drug: framycetin | Target: extracellular calcium-sensing receptor | Type: gpcr | Action: AGONIST
8669,neostigmine,acetylcholinesterase,enzyme,INHIBITOR,Drug: neostigmine | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
8670,neostigmine,cholinesterase,enzyme,,Drug: neostigmine | Target: cholinesterase | Type: enzyme | Action: nan
8671,neostigmine,acetylcholinesterase,enzyme,,Drug: neostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
8672,neostigmine,acetylcholinesterase,enzyme,,Drug: neostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
8673,neostigmine,acetylcholinesterase,enzyme,,Drug: neostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
8674,neostigmine,cholinesterase,enzyme,,Drug: neostigmine | Target: cholinesterase | Type: enzyme | Action: nan
8675,nepafenac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: nepafenac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
8676,nepafenac,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: nepafenac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
8677,nepafenac,cyclooxygenase,enzyme,,Drug: nepafenac | Target: cyclooxygenase | Type: enzyme | Action: nan
8678,nepafenac,cyclooxygenase,enzyme,,Drug: nepafenac | Target: cyclooxygenase | Type: enzyme | Action: nan
8679,nepinalone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: nepinalone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
8680,nesiritide,atrial natriuretic peptide receptor 1,enzyme,AGONIST,Drug: nesiritide | Target: atrial natriuretic peptide receptor 1 | Type: enzyme | Action: AGONIST
8681,nevirapine,gag-pol polyprotein,polyprotein,,Drug: nevirapine | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
8682,nevirapine,pol polyprotein,enzyme,,Drug: nevirapine | Target: pol polyprotein | Type: enzyme | Action: nan
8683,nevirapine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: nevirapine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
8684,nevirapine,reverse transcriptase,enzyme,,Drug: nevirapine | Target: reverse transcriptase | Type: enzyme | Action: nan
8685,nevirapine,reverse transcriptase protein,unclassified,,Drug: nevirapine | Target: reverse transcriptase protein | Type: unclassified | Action: nan
8686,nicotinamide,hydroxycarboxylic acid receptor 2,gpcr,,Drug: nicotinamide | Target: hydroxycarboxylic acid receptor 2 | Type: gpcr | Action: nan
8687,nicotinamide,hydroxycarboxylic acid receptor 3,gpcr,,Drug: nicotinamide | Target: hydroxycarboxylic acid receptor 3 | Type: gpcr | Action: nan
8688,nicotinamide,nicotinamide n-methyltransferase,enzyme,,Drug: nicotinamide | Target: nicotinamide n-methyltransferase | Type: enzyme | Action: nan
8689,nicotinamide,nicotinate-nucleotide pyrophosphorylase [carboxylating],enzyme,,Drug: nicotinamide | Target: nicotinate-nucleotide pyrophosphorylase [carboxylating] | Type: enzyme | Action: nan
8690,nicotinamide,nad-dependent protein deacetylase sirtuin-1,enzyme,,Drug: nicotinamide | Target: nad-dependent protein deacetylase sirtuin-1 | Type: enzyme | Action: nan
8691,nicotinamide,nad-dependent protein deacetylase sirtuin-2,enzyme,,Drug: nicotinamide | Target: nad-dependent protein deacetylase sirtuin-2 | Type: enzyme | Action: nan
8692,nicotinamide,fatty-acid amide hydrolase 1,enzyme,,Drug: nicotinamide | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
8693,nicotinamide,nad-dependent deacetylase hst2,enzyme,,Drug: nicotinamide | Target: nad-dependent deacetylase hst2 | Type: enzyme | Action: nan
8694,nicotinamide,nad-dependent deacetylase sirtuin 3,enzyme,,Drug: nicotinamide | Target: nad-dependent deacetylase sirtuin 3 | Type: enzyme | Action: nan
8695,nicotinamide,"nad-dependent protein deacylase sirtuin-5, mitochondrial",enzyme,,"Drug: nicotinamide | Target: nad-dependent protein deacylase sirtuin-5, mitochondrial | Type: enzyme | Action: nan"
8696,nicotinamide,putative silent information regulator 2,unclassified,,Drug: nicotinamide | Target: putative silent information regulator 2 | Type: unclassified | Action: nan
8697,nicotinamide,sterile alpha and tir motif-containing protein 1,unclassified,,Drug: nicotinamide | Target: sterile alpha and tir motif-containing protein 1 | Type: unclassified | Action: nan
8698,nicardipine,cytochrome p450 3a4,enzyme,,Drug: nicardipine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8699,nicardipine,multidrug resistance protein 1,transporter,,Drug: nicardipine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
8700,nicardipine,adenosine receptor a3,gpcr,,Drug: nicardipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8701,nicardipine,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: nicardipine | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
8702,nicardipine,atp-binding cassette sub-family g member 2,transporter,,Drug: nicardipine | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
8703,nicardipine,beta-lactamase,enzyme,,Drug: nicardipine | Target: beta-lactamase | Type: enzyme | Action: nan
8704,nicardipine,cytochrome p450 2c9,enzyme,,Drug: nicardipine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
8705,nicardipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: nicardipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
8706,nicardipine,adenosine receptor a1,gpcr,,Drug: nicardipine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
8707,nicardipine,adenosine receptor a2a,gpcr,,Drug: nicardipine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
8708,nicardipine,adenosine receptor a3,gpcr,,Drug: nicardipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8709,nicardipine,equilibrative nucleoside transporter 1,transporter,,Drug: nicardipine | Target: equilibrative nucleoside transporter 1 | Type: transporter | Action: nan
8710,nicardipine,quinolone resistance protein nora,transporter,,Drug: nicardipine | Target: quinolone resistance protein nora | Type: transporter | Action: nan
8711,nicardipine,adrenergic receptor alpha-2,gpcr,,Drug: nicardipine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
8712,nicardipine,adrenergic receptor alpha-1,gpcr,,Drug: nicardipine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
8713,nicardipine,voltage-gated l-type calcium channel,ion channel,,Drug: nicardipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: nan
8714,nicardipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: nicardipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
8715,nicardipine,malate dehydrogenase cytoplasmic,enzyme,,Drug: nicardipine | Target: malate dehydrogenase cytoplasmic | Type: enzyme | Action: nan
8716,nicardipine,potassium voltage-gated channel subfamily a member 4,ion channel,BLOCKER,Drug: nicardipine | Target: potassium voltage-gated channel subfamily a member 4 | Type: ion channel | Action: BLOCKER
8717,niclosamide,cytochrome p450 2c9,enzyme,,Drug: niclosamide | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
8718,niclosamide,mast/stem cell growth factor receptor kit,kinase,,Drug: niclosamide | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
8719,niclosamide,epidermal growth factor receptor,kinase,,Drug: niclosamide | Target: epidermal growth factor receptor | Type: kinase | Action: nan
8720,niclosamide,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: niclosamide | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
8721,niclosamide,vascular endothelial growth factor receptor 2,kinase,,Drug: niclosamide | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
8722,niclosamide,tyrosine-protein kinase jak2,kinase,,Drug: niclosamide | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
8723,niclosamide,angiopoietin-1 receptor,kinase,,Drug: niclosamide | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
8724,niclosamide,tyrosine-protein kinase lyn,kinase,,Drug: niclosamide | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
8725,niclosamide,fibroblast growth factor receptor 1,kinase,,Drug: niclosamide | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
8726,niclosamide,aurora kinase a,kinase,,Drug: niclosamide | Target: aurora kinase a | Type: kinase | Action: nan
8727,niclosamide,rac-alpha serine/threonine-protein kinase,kinase,,Drug: niclosamide | Target: rac-alpha serine/threonine-protein kinase | Type: kinase | Action: nan
8728,niclosamide,glycogen synthase kinase-3 beta,kinase,,Drug: niclosamide | Target: glycogen synthase kinase-3 beta | Type: kinase | Action: nan
8729,niclosamide,3-phosphoinositide-dependent protein kinase 1,kinase,,Drug: niclosamide | Target: 3-phosphoinositide-dependent protein kinase 1 | Type: kinase | Action: nan
8730,niclosamide,potassium channel subfamily t member 1,ion channel,ACTIVATOR,Drug: niclosamide | Target: potassium channel subfamily t member 1 | Type: ion channel | Action: ACTIVATOR
8731,niclosamide,signal transducer and activator of transcription 3,transcription factor,,Drug: niclosamide | Target: signal transducer and activator of transcription 3 | Type: transcription factor | Action: nan
8732,niclosamide,replicase polyprotein 1ab,enzyme,,Drug: niclosamide | Target: replicase polyprotein 1ab | Type: enzyme | Action: nan
8733,nicorandil,atp-sensitive inward rectifier potassium channel 11,ion channel,,Drug: nicorandil | Target: atp-sensitive inward rectifier potassium channel 11 | Type: ion channel | Action: nan
8734,nicorandil,atp-sensitive inward rectifier potassium channel 1,ion channel,,Drug: nicorandil | Target: atp-sensitive inward rectifier potassium channel 1 | Type: ion channel | Action: nan
8735,nicorandil,atrial natriuretic peptide receptor 1,enzyme,,Drug: nicorandil | Target: atrial natriuretic peptide receptor 1 | Type: enzyme | Action: nan
8736,nicotine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
8737,nicotine,potassium voltage-gated channel subfamily d member 3,ion channel,,Drug: nicotine | Target: potassium voltage-gated channel subfamily d member 3 | Type: ion channel | Action: nan
8738,nicotine,cytochrome p450 2a6,enzyme,,Drug: nicotine | Target: cytochrome p450 2a6 | Type: enzyme | Action: nan
8739,nicotine,acetylcholine-binding protein,unclassified,,Drug: nicotine | Target: acetylcholine-binding protein | Type: unclassified | Action: nan
8740,nicotine,transient receptor potential cation channel subfamily a member 1,ion channel,ACTIVATOR,Drug: nicotine | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: ACTIVATOR
8741,nicotine,acetylcholine receptor subunit delta,ion channel,,Drug: nicotine | Target: acetylcholine receptor subunit delta | Type: ion channel | Action: nan
8742,nicotine,neuronal acetylcholine receptor subunit alpha-4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-4 | Type: ion channel | Action: nan
8743,nicotine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
8744,nicotine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
8745,nicotine,neuronal acetylcholine receptor subunit alpha-9,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-9 | Type: ion channel | Action: nan
8746,nicotine,neuronal acetylcholine receptor subunit beta-4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit beta-4 | Type: ion channel | Action: nan
8747,nicotine,neuronal acetylcholine receptor subunit alpha-3,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-3 | Type: ion channel | Action: nan
8748,nicotine,neuronal acetylcholine receptor subunit alpha-2,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-2 | Type: ion channel | Action: nan
8749,nicotine,soluble acetylcholine receptor,unclassified,,Drug: nicotine | Target: soluble acetylcholine receptor | Type: unclassified | Action: nan
8750,nicotine,acetylcholine receptor subunit alpha,ion channel,,Drug: nicotine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
8751,nicotine,lycopene cyclase,enzyme,,Drug: nicotine | Target: lycopene cyclase | Type: enzyme | Action: nan
8752,nicotine,nicotinic acetylcholine receptor alpha 5 subunit,ion channel,,Drug: nicotine | Target: nicotinic acetylcholine receptor alpha 5 subunit | Type: ion channel | Action: nan
8753,nicotine,acetylcholine receptor subunit beta-like 2,ion channel,,Drug: nicotine | Target: acetylcholine receptor subunit beta-like 2 | Type: ion channel | Action: nan
8754,nicotine,neuronal acetylcholine receptor subunit alpha-4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-4 | Type: ion channel | Action: nan
8755,nicotine,neuronal acetylcholine receptor subunit alpha-4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-4 | Type: ion channel | Action: nan
8756,nicotine,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
8757,nicotine,neuronal acetylcholine receptor; alpha3/beta2,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha3/beta2 | Type: ion channel | Action: nan
8758,nicotine,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
8759,nicotine,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
8760,nicotine,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
8761,nicotine,neuronal acetylcholine receptor; alpha2/beta4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha2/beta4 | Type: ion channel | Action: nan
8762,nicotine,neuronal acetylcholine receptor,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor | Type: ion channel | Action: nan
8763,nicotine,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
8764,nicotine,neuronal acetylcholine receptor; alpha4/beta2,ion channel,AGONIST,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: AGONIST
8765,nicotine,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
8766,nicotine,neuronal acetylcholine receptor; alpha3/beta2,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha3/beta2 | Type: ion channel | Action: nan
8767,nicotine,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
8768,nicotine,serotonin 3 (5-ht3) receptor,ion channel,,Drug: nicotine | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
8769,nicotine,acetylcholine receptor; alpha1/beta1/delta/gamma,ion channel,,Drug: nicotine | Target: acetylcholine receptor; alpha1/beta1/delta/gamma | Type: ion channel | Action: nan
8770,nicotine,neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha3/alpha6/beta2/beta3 | Type: ion channel | Action: nan
8771,nicotine,neuronal acetylcholine receptor; alpha2/beta4,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor; alpha2/beta4 | Type: ion channel | Action: nan
8772,nicotine,acetylcholine receptor,ion channel,,Drug: nicotine | Target: acetylcholine receptor | Type: ion channel | Action: nan
8773,nicotine,muscarinic acetylcholine receptor,gpcr,,Drug: nicotine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
8774,nicotine,acetylcholine receptor subunit alpha,ion channel,,Drug: nicotine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
8775,nicotine,neuronal acetylcholine receptor subunit alpha-3,ion channel,,Drug: nicotine | Target: neuronal acetylcholine receptor subunit alpha-3 | Type: ion channel | Action: nan
8776,nicotine,transient receptor potential cation channel subfamily a member 1,ion channel,,Drug: nicotine | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: nan
8777,nicotine,potassium voltage-gated channel subfamily d member 3,ion channel,BLOCKER,Drug: nicotine | Target: potassium voltage-gated channel subfamily d member 3 | Type: ion channel | Action: BLOCKER
8779,nifedipine,sodium/nucleoside cotransporter 1,transporter,,Drug: nifedipine | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
8780,nifedipine,adenosine receptor a2a,gpcr,,Drug: nifedipine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
8781,nifedipine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: nifedipine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8782,nifedipine,cytochrome p450 3a4,enzyme,,Drug: nifedipine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8783,nifedipine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: nifedipine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
8784,nifedipine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: nifedipine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
8785,nifedipine,adenosine receptor a1,gpcr,,Drug: nifedipine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
8786,nifedipine,adenosine receptor a3,gpcr,,Drug: nifedipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8787,nifedipine,"glutathione reductase, mitochondrial",enzyme,,"Drug: nifedipine | Target: glutathione reductase, mitochondrial | Type: enzyme | Action: nan"
8788,nifedipine,transthyretin,secreted,,Drug: nifedipine | Target: transthyretin | Type: secreted | Action: nan
8789,nifedipine,glycine receptor subunit alpha-1,ion channel,,Drug: nifedipine | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
8790,nifedipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,GATING INHIBITOR,Drug: nifedipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: GATING INHIBITOR
8791,nifedipine,bile salt export pump,transporter,,Drug: nifedipine | Target: bile salt export pump | Type: transporter | Action: nan
8792,nifedipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: nifedipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
8793,nifedipine,cytochrome p450 1a2,enzyme,,Drug: nifedipine | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
8794,nifedipine,potassium voltage-gated channel subfamily a member 1,ion channel,,Drug: nifedipine | Target: potassium voltage-gated channel subfamily a member 1 | Type: ion channel | Action: nan
8795,nifedipine,voltage-dependent l-type calcium channel subunit alpha-1s,ion channel,INHIBITOR,Drug: nifedipine | Target: voltage-dependent l-type calcium channel subunit alpha-1s | Type: ion channel | Action: INHIBITOR
8796,nifedipine,potassium voltage-gated channel subfamily a member 5,ion channel,,Drug: nifedipine | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: nan
8797,nifedipine,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: nifedipine | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
8798,nifedipine,glycine receptor subunit beta,ion channel,ANTAGONIST,Drug: nifedipine | Target: glycine receptor subunit beta | Type: ion channel | Action: ANTAGONIST
8799,nifedipine,potassium voltage-gated channel subfamily a member 2,ion channel,,Drug: nifedipine | Target: potassium voltage-gated channel subfamily a member 2 | Type: ion channel | Action: nan
8800,nifedipine,"myosin light chain kinase, smooth muscle",kinase,,"Drug: nifedipine | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
8801,nifedipine,thromboxane-a synthase,enzyme,,Drug: nifedipine | Target: thromboxane-a synthase | Type: enzyme | Action: nan
8802,nifedipine,c-c chemokine receptor type 2,gpcr,,Drug: nifedipine | Target: c-c chemokine receptor type 2 | Type: gpcr | Action: nan
8803,nifedipine,voltage-dependent l-type calcium channel subunit alpha-1f,ion channel,GATING INHIBITOR,Drug: nifedipine | Target: voltage-dependent l-type calcium channel subunit alpha-1f | Type: ion channel | Action: GATING INHIBITOR
8804,nifedipine,glycine receptor subunit alpha-3,ion channel,ANTAGONIST,Drug: nifedipine | Target: glycine receptor subunit alpha-3 | Type: ion channel | Action: ANTAGONIST
8805,nifedipine,arachidonate 15-lipoxygenase,enzyme,,Drug: nifedipine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
8806,nifedipine,adenosine receptor a1,gpcr,,Drug: nifedipine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
8807,nifedipine,acetylcholinesterase,enzyme,,Drug: nifedipine | Target: acetylcholinesterase | Type: enzyme | Action: nan
8808,nifedipine,adenosine receptor a2a,gpcr,,Drug: nifedipine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
8809,nifedipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: nifedipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
8810,nifedipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: nifedipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
8811,nifedipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,,Drug: nifedipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: nan
8812,nifedipine,cholinesterase,enzyme,,Drug: nifedipine | Target: cholinesterase | Type: enzyme | Action: nan
8813,nifedipine,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: nifedipine | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
8814,nifedipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: nifedipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
8815,nifedipine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: nifedipine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
8816,nifedipine,voltage-gated l-type calcium channel,ion channel,,Drug: nifedipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: nan
8817,nifedipine,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: nifedipine | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
8818,nifedipine,bile salt export pump,transporter,,Drug: nifedipine | Target: bile salt export pump | Type: transporter | Action: nan
8819,nifedipine,potassium voltage-gated channel subfamily a member 7,ion channel,BLOCKER,Drug: nifedipine | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: BLOCKER
8820,nifedipine,potassium voltage-gated channel subfamily a member 1,ion channel,BLOCKER,Drug: nifedipine | Target: potassium voltage-gated channel subfamily a member 1 | Type: ion channel | Action: BLOCKER
8821,nifedipine,potassium voltage-gated channel subfamily a member 2,ion channel,BLOCKER,Drug: nifedipine | Target: potassium voltage-gated channel subfamily a member 2 | Type: ion channel | Action: BLOCKER
8822,nifedipine,potassium channel subfamily k member 2,ion channel,,Drug: nifedipine | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
8823,nifedipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: nifedipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
8824,nifekalant,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: nifekalant | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8825,nifekalant,solute carrier family 22 member 2,transporter,,Drug: nifekalant | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
8826,nifekalant,multidrug and toxin extrusion protein 1,transporter,,Drug: nifekalant | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
8827,nifekalant,multidrug and toxin extrusion protein 2,transporter,,Drug: nifekalant | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
8828,niflumic acid,prostaglandin g/h synthase 2,enzyme,,Drug: niflumic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8829,niflumic acid,prostaglandin g/h synthase 1,enzyme,,Drug: niflumic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8830,niflumic acid,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: niflumic acid | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
8831,niflumic acid,transthyretin,secreted,,Drug: niflumic acid | Target: transthyretin | Type: secreted | Action: nan
8832,niflumic acid,chloride channel protein clc-ka,ion channel,ACTIVATOR,Drug: niflumic acid | Target: chloride channel protein clc-ka | Type: ion channel | Action: ACTIVATOR
8833,niflumic acid,potassium channel subfamily t member 2,ion channel,ACTIVATOR,Drug: niflumic acid | Target: potassium channel subfamily t member 2 | Type: ion channel | Action: ACTIVATOR
8834,niflumic acid,g-protein coupled receptor 35,gpcr,,Drug: niflumic acid | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
8835,niflumic acid,chloride channel protein clc-kb,ion channel,ACTIVATOR,Drug: niflumic acid | Target: chloride channel protein clc-kb | Type: ion channel | Action: ACTIVATOR
8836,niflumic acid,transcriptional enhancer factor tef-3,transcription factor,,Drug: niflumic acid | Target: transcriptional enhancer factor tef-3 | Type: transcription factor | Action: nan
8837,nifuroxazide,signal transducer and activator of transcription 3,transcription factor,,Drug: nifuroxazide | Target: signal transducer and activator of transcription 3 | Type: transcription factor | Action: nan
8838,nilotinib,carbonic anhydrase 2,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
8839,nilotinib,carbonic anhydrase 1,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
8840,nilotinib,carbonic anhydrase 4,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
8841,nilotinib,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: nilotinib | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
8842,nilotinib,carbonic anhydrase 9,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
8843,nilotinib,carbonic anhydrase 12,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
8844,nilotinib,platelet-derived growth factor receptor beta,kinase,,Drug: nilotinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
8845,nilotinib,tyrosine-protein kinase abl1,kinase,INHIBITOR,Drug: nilotinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: INHIBITOR
8846,nilotinib,mast/stem cell growth factor receptor kit,kinase,,Drug: nilotinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
8847,nilotinib,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: nilotinib | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
8848,nilotinib,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: nilotinib | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
8849,nilotinib,carbonic anhydrase 7,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
8850,nilotinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: nilotinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
8851,nilotinib,tyrosine-protein kinase lck,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
8852,nilotinib,tyrosine-protein kinase yes,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
8853,nilotinib,tyrosine-protein kinase fyn,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
8854,nilotinib,ephrin type-a receptor 2,kinase,,Drug: nilotinib | Target: ephrin type-a receptor 2 | Type: kinase | Action: nan
8855,nilotinib,raf proto-oncogene serine/threonine-protein kinase,kinase,,Drug: nilotinib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: nan
8856,nilotinib,serine/threonine-protein kinase b-raf,kinase,,Drug: nilotinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
8857,nilotinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: nilotinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
8858,nilotinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: nilotinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
8859,nilotinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: nilotinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
8860,nilotinib,platelet-derived growth factor receptor alpha,kinase,,Drug: nilotinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
8861,nilotinib,insulin receptor,kinase,,Drug: nilotinib | Target: insulin receptor | Type: kinase | Action: nan
8862,nilotinib,mitogen-activated protein kinase 8,kinase,,Drug: nilotinib | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
8863,nilotinib,tyrosine-protein kinase hck,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
8864,nilotinib,carbonic anhydrase 3,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
8865,nilotinib,carbonic anhydrase 6,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
8866,nilotinib,mitogen-activated protein kinase 10,kinase,,Drug: nilotinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
8867,nilotinib,tyrosine-protein kinase jak2,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
8868,nilotinib,tyrosine-protein kinase csk,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
8869,nilotinib,angiopoietin-1 receptor,kinase,,Drug: nilotinib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
8870,nilotinib,ephrin type-a receptor 8,kinase,,Drug: nilotinib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
8871,nilotinib,tyrosine-protein kinase lyn,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
8872,nilotinib,cytoplasmic tyrosine-protein kinase bmx,kinase,,Drug: nilotinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: nan
8873,nilotinib,carbonic anhydrase 14,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
8874,nilotinib,fibroblast growth factor receptor 1,kinase,,Drug: nilotinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
8875,nilotinib,serine/threonine-protein kinase 10,kinase,,Drug: nilotinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
8876,nilotinib,abelson tyrosine-protein kinase 2,kinase,,Drug: nilotinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
8877,nilotinib,mitogen-activated protein kinase 11,kinase,,Drug: nilotinib | Target: mitogen-activated protein kinase 11 | Type: kinase | Action: nan
8878,nilotinib,ephrin type-a receptor 5,kinase,,Drug: nilotinib | Target: ephrin type-a receptor 5 | Type: kinase | Action: nan
8879,nilotinib,ephrin type-a receptor 4,kinase,,Drug: nilotinib | Target: ephrin type-a receptor 4 | Type: kinase | Action: nan
8880,nilotinib,fibroblast growth factor receptor 2,kinase,,Drug: nilotinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
8881,nilotinib,ephrin type-a receptor 6,kinase,,Drug: nilotinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
8882,nilotinib,tyrosine-protein kinase fgr,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
8883,nilotinib,ephrin type-a receptor 3,kinase,,Drug: nilotinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
8884,nilotinib,mitogen-activated protein kinase 14,kinase,,Drug: nilotinib | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
8885,nilotinib,tyrosine-protein kinase frk,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
8886,nilotinib,dual specificity protein kinase clk1,kinase,,Drug: nilotinib | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
8887,nilotinib,ephrin type-b receptor 1,kinase,,Drug: nilotinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
8888,nilotinib,dual specificity protein kinase clk4,kinase,,Drug: nilotinib | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
8889,nilotinib,mitogen-activated protein kinase 9,kinase,,Drug: nilotinib | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
8890,nilotinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: nilotinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
8891,nilotinib,ephrin type-b receptor 4,kinase,,Drug: nilotinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
8892,nilotinib,carbonic anhydrase 13,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
8893,nilotinib,carbonic anhydrase 15,enzyme,,Drug: nilotinib | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
8894,nilotinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: nilotinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
8895,nilotinib,ephrin type-b receptor 2,kinase,,Drug: nilotinib | Target: ephrin type-b receptor 2 | Type: kinase | Action: nan
8896,nilotinib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: nilotinib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
8897,nilotinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
8898,nilotinib,nt-3 growth factor receptor,kinase,,Drug: nilotinib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
8899,nilotinib,serine/threonine-protein kinase tnni3k,kinase,,Drug: nilotinib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
8900,nilotinib,discoidin domain-containing receptor 2,kinase,,Drug: nilotinib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
8901,nilotinib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: nilotinib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
8902,nilotinib,tyrosine-protein kinase blk,kinase,,Drug: nilotinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
8903,nilotinib,serine/threonine-protein kinase mrck beta,kinase,,Drug: nilotinib | Target: serine/threonine-protein kinase mrck beta | Type: kinase | Action: nan
8904,nilotinib,ephrin type-a receptor 1,kinase,,Drug: nilotinib | Target: ephrin type-a receptor 1 | Type: kinase | Action: nan
8905,nilotinib,ephrin type-b receptor 3,kinase,,Drug: nilotinib | Target: ephrin type-b receptor 3 | Type: kinase | Action: nan
8906,nilotinib,ephrin type-b receptor 6,kinase,,Drug: nilotinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
8907,nilotinib,serine/threonine-protein kinase tao1,kinase,,Drug: nilotinib | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
8908,nilotinib,serine/threonine-protein kinase tao3,kinase,,Drug: nilotinib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
8909,nilotinib,phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,kinase,,Drug: nilotinib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Type: kinase | Action: nan
8910,nilotinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: nilotinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
8911,nilotinib,calcium-dependent protein kinase 1,kinase,,Drug: nilotinib | Target: calcium-dependent protein kinase 1 | Type: kinase | Action: nan
8912,nilotinib,bcr/abl fusion protein,kinase,,Drug: nilotinib | Target: bcr/abl fusion protein | Type: kinase | Action: nan
8913,nilutamide,androgen receptor,nuclear hormone receptor,ANTAGONIST,Drug: nilutamide | Target: androgen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
8914,nilvadipine,voltage-dependent calcium channel gamma-1 subunit,ion channel,,Drug: nilvadipine | Target: voltage-dependent calcium channel gamma-1 subunit | Type: ion channel | Action: nan
8915,nilvadipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: nilvadipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
8916,nilvadipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,,Drug: nilvadipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: nan
8917,nilvadipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: nilvadipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
8918,nimesulide,prostaglandin g/h synthase 2,enzyme,,Drug: nimesulide | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8919,nimesulide,prostaglandin g/h synthase 1,enzyme,,Drug: nimesulide | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8920,nimesulide,sodium-dependent dopamine transporter,transporter,,Drug: nimesulide | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
8921,nimesulide,aromatase,enzyme,,Drug: nimesulide | Target: aromatase | Type: enzyme | Action: nan
8922,nimesulide,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: nimesulide | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
8923,nimesulide,myeloperoxidase,enzyme,,Drug: nimesulide | Target: myeloperoxidase | Type: enzyme | Action: nan
8924,nimesulide,interstitial collagenase,enzyme,,Drug: nimesulide | Target: interstitial collagenase | Type: enzyme | Action: nan
8925,nimesulide,prostaglandin g/h synthase 1,enzyme,,Drug: nimesulide | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
8926,nimesulide,prostaglandin g/h synthase 2,enzyme,,Drug: nimesulide | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8927,nimesulide,sodium-dependent neutral amino acid transporter b(0)at1,transporter,INHIBITOR,Drug: nimesulide | Target: sodium-dependent neutral amino acid transporter b(0)at1 | Type: transporter | Action: INHIBITOR
8928,nimesulide,dipeptidyl peptidase 3,enzyme,,Drug: nimesulide | Target: dipeptidyl peptidase 3 | Type: enzyme | Action: nan
8929,nimodipine,sodium/nucleoside cotransporter 1,transporter,,Drug: nimodipine | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
8930,nimodipine,cannabinoid receptor 1,gpcr,,Drug: nimodipine | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
8931,nimodipine,cytochrome p450 3a4,enzyme,,Drug: nimodipine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
8932,nimodipine,adenosine receptor a3,gpcr,,Drug: nimodipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8933,nimodipine,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: nimodipine | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
8934,nimodipine,voltage-dependent calcium channel gamma-1 subunit,ion channel,,Drug: nimodipine | Target: voltage-dependent calcium channel gamma-1 subunit | Type: ion channel | Action: nan
8935,nimodipine,mineralocorticoid receptor,nuclear hormone receptor,ANTAGONIST,Drug: nimodipine | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
8936,nimodipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: nimodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
8937,nimodipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,BLOCKER,Drug: nimodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: BLOCKER
8938,nimodipine,cytochrome p450 2c9,enzyme,,Drug: nimodipine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
8939,nimodipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: nimodipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
8940,nimodipine,voltage-dependent l-type calcium channel subunit alpha-1s,ion channel,GATING INHIBITOR,Drug: nimodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1s | Type: ion channel | Action: GATING INHIBITOR
8941,nimodipine,cytochrome p450 2c19,enzyme,,Drug: nimodipine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
8942,nimodipine,bile acid receptor,nuclear hormone receptor,,Drug: nimodipine | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
8943,nimodipine,voltage-dependent l-type calcium channel subunit alpha-1f,ion channel,GATING INHIBITOR,Drug: nimodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1f | Type: ion channel | Action: GATING INHIBITOR
8944,nimodipine,adenosine receptor a1,gpcr,,Drug: nimodipine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
8945,nimodipine,adenosine receptor a2a,gpcr,,Drug: nimodipine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
8946,nimodipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,GATING INHIBITOR,Drug: nimodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: GATING INHIBITOR
8947,nimodipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,GATING INHIBITOR,Drug: nimodipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: GATING INHIBITOR
8948,nisoldipine,adenosine receptor a2a,gpcr,,Drug: nisoldipine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
8949,nisoldipine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: nisoldipine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8950,nisoldipine,voltage-dependent p/q-type calcium channel subunit alpha-1a,ion channel,,Drug: nisoldipine | Target: voltage-dependent p/q-type calcium channel subunit alpha-1a | Type: ion channel | Action: nan
8951,nisoldipine,adenosine receptor a3,gpcr,,Drug: nisoldipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8952,nisoldipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,GATING INHIBITOR,Drug: nisoldipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: GATING INHIBITOR
8953,nisoldipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,BLOCKER,Drug: nisoldipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: BLOCKER
8954,nisoldipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: nisoldipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
8955,nisoldipine,cytochrome p450 1a2,enzyme,,Drug: nisoldipine | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
8956,nisoldipine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: nisoldipine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
8957,nisoldipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,GATING INHIBITOR,Drug: nisoldipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: GATING INHIBITOR
8958,nisoldipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,GATING INHIBITOR,Drug: nisoldipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: GATING INHIBITOR
8959,nitazoxanide,aldose reductase,enzyme,,Drug: nitazoxanide | Target: aldose reductase | Type: enzyme | Action: nan
8960,nitazoxanide,pyruvate dehydrogenase [nadp(+)],enzyme,INHIBITOR,Drug: nitazoxanide | Target: pyruvate dehydrogenase [nadp(+)] | Type: enzyme | Action: INHIBITOR
8961,nitazoxanide,pyruvate:ferredoxin oxidoreductase,enzyme,INHIBITOR,Drug: nitazoxanide | Target: pyruvate:ferredoxin oxidoreductase | Type: enzyme | Action: INHIBITOR
8962,nitazoxanide,pyruvate-flavodoxin oxidoreductase,enzyme,,Drug: nitazoxanide | Target: pyruvate-flavodoxin oxidoreductase | Type: enzyme | Action: nan
8963,nitisinone,4-hydroxyphenylpyruvate dioxygenase,enzyme,INHIBITOR,Drug: nitisinone | Target: 4-hydroxyphenylpyruvate dioxygenase | Type: enzyme | Action: INHIBITOR
8964,nitisinone,4-hydroxyphenylpyruvate dioxygenase,enzyme,,Drug: nitisinone | Target: 4-hydroxyphenylpyruvate dioxygenase | Type: enzyme | Action: nan
8965,nitisinone,4-hydroxyphenylpyruvate dioxygenase,unclassified,,Drug: nitisinone | Target: 4-hydroxyphenylpyruvate dioxygenase | Type: unclassified | Action: nan
8966,nitrazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: nitrazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
8967,nitrazepam,gaba-a receptor; anion channel,ion channel,,Drug: nitrazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
8968,nitrendipine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: nitrendipine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
8969,nitrendipine,adenosine receptor a3,gpcr,,Drug: nitrendipine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
8970,nitrendipine,intermediate conductance calcium-activated potassium channel protein 4,ion channel,BLOCKER,Drug: nitrendipine | Target: intermediate conductance calcium-activated potassium channel protein 4 | Type: ion channel | Action: BLOCKER
8971,nitrendipine,voltage-dependent calcium channel gamma-1 subunit,ion channel,,Drug: nitrendipine | Target: voltage-dependent calcium channel gamma-1 subunit | Type: ion channel | Action: nan
8972,nitrendipine,transthyretin,secreted,,Drug: nitrendipine | Target: transthyretin | Type: secreted | Action: nan
8973,nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1d,ion channel,GATING INHIBITOR,Drug: nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1d | Type: ion channel | Action: GATING INHIBITOR
8974,nitrendipine,cytochrome p450 2c9,enzyme,,Drug: nitrendipine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
8975,nitrendipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: nitrendipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
8976,nitrendipine,cytochrome p450 2c19,enzyme,,Drug: nitrendipine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
8977,nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1f,ion channel,GATING INHIBITOR,Drug: nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1f | Type: ion channel | Action: GATING INHIBITOR
8978,nitrendipine,adenosine receptor a1,gpcr,,Drug: nitrendipine | Target: adenosine receptor a1 | Type: gpcr | Action: nan
8979,nitrendipine,adenosine receptor a2a,gpcr,,Drug: nitrendipine | Target: adenosine receptor a2a | Type: gpcr | Action: nan
8980,nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,GATING INHIBITOR,Drug: nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: GATING INHIBITOR
8981,nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1s,ion channel,GATING INHIBITOR,Drug: nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1s | Type: ion channel | Action: GATING INHIBITOR
8982,nitrendipine,platelet-activating factor receptor,gpcr,,Drug: nitrendipine | Target: platelet-activating factor receptor | Type: gpcr | Action: nan
8983,nitrendipine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: nitrendipine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
8984,nitrendipine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: nitrendipine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
8985,nitric oxide,soluble guanylate cyclase,enzyme,ACTIVATOR,Drug: nitric oxide | Target: soluble guanylate cyclase | Type: enzyme | Action: ACTIVATOR
8986,nitrofurantoin,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: nitrofurantoin | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
8987,nitrofurantoin,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: nitrofurantoin | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
8988,nitrofurazone,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: nitrofurazone | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
8989,nitrofurazone,snake venom metalloproteinase bap1,enzyme,,Drug: nitrofurazone | Target: snake venom metalloproteinase bap1 | Type: enzyme | Action: nan
8990,glyceryl trinitrate,atrial natriuretic peptide receptor 1,enzyme,,Drug: glyceryl trinitrate | Target: atrial natriuretic peptide receptor 1 | Type: enzyme | Action: nan
8991,glyceryl trinitrate,soluble guanylate cyclase,enzyme,ACTIVATOR,Drug: glyceryl trinitrate | Target: soluble guanylate cyclase | Type: enzyme | Action: ACTIVATOR
8992,nitroxoline,prostaglandin g/h synthase 2,enzyme,,Drug: nitroxoline | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
8993,nitroxoline,cathepsin b,enzyme,,Drug: nitroxoline | Target: cathepsin b | Type: enzyme | Action: nan
8994,nitroxoline,methionine aminopeptidase 2,enzyme,,Drug: nitroxoline | Target: methionine aminopeptidase 2 | Type: enzyme | Action: nan
8995,nitroxoline,catechol o-methyltransferase,enzyme,,Drug: nitroxoline | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
8996,nitroxoline,bromodomain-containing protein 4,unclassified,,Drug: nitroxoline | Target: bromodomain-containing protein 4 | Type: unclassified | Action: nan
8998,nizatidine,histamine h2 receptor,gpcr,ANTAGONIST,Drug: nizatidine | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
8999,nizatidine,acetylcholinesterase,enzyme,,Drug: nizatidine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9000,nomifensine,sodium-dependent serotonin transporter,transporter,,Drug: nomifensine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
9001,nomifensine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: nomifensine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
9002,nomifensine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: nomifensine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9003,nomifensine,histamine h1 receptor,gpcr,,Drug: nomifensine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9004,nomifensine,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: nomifensine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
9005,nomifensine,amine oxidase [flavin-containing] a,enzyme,,Drug: nomifensine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
9006,nomifensine,myeloperoxidase,enzyme,,Drug: nomifensine | Target: myeloperoxidase | Type: enzyme | Action: nan
9007,nomifensine,sodium-dependent serotonin transporter,transporter,,Drug: nomifensine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
9008,nomifensine,sodium-dependent dopamine transporter,transporter,,Drug: nomifensine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9009,nomifensine,transporter,transporter,,Drug: nomifensine | Target: transporter | Type: transporter | Action: nan
9010,nomifensine,transporter,transporter,,Drug: nomifensine | Target: transporter | Type: transporter | Action: nan
9011,nomifensine,hemoglobin hba,enzyme,,Drug: nomifensine | Target: hemoglobin hba | Type: enzyme | Action: nan
9012,norelgestromin,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: norelgestromin | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
9013,norepinephrine,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: norepinephrine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
9014,norepinephrine,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: norepinephrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
9015,norepinephrine,d(1a) dopamine receptor,gpcr,,Drug: norepinephrine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
9016,norepinephrine,d(2) dopamine receptor,gpcr,,Drug: norepinephrine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9017,norepinephrine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: norepinephrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
9018,norepinephrine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: norepinephrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
9019,norepinephrine,alpha-2b adrenergic receptor,gpcr,,Drug: norepinephrine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9020,norepinephrine,beta-3 adrenergic receptor,gpcr,,Drug: norepinephrine | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
9021,norepinephrine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: norepinephrine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
9022,norepinephrine,sodium-dependent dopamine transporter,transporter,,Drug: norepinephrine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9023,norepinephrine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: norepinephrine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
9024,norepinephrine,alpha-1b adrenergic receptor,gpcr,AGONIST,Drug: norepinephrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: AGONIST
9025,norepinephrine,alpha-2b adrenergic receptor,gpcr,,Drug: norepinephrine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9026,norepinephrine,mu-type opioid receptor,gpcr,,Drug: norepinephrine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9027,norepinephrine,beta-2 adrenergic receptor,gpcr,,Drug: norepinephrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
9028,norepinephrine,beta-1 adrenergic receptor,gpcr,,Drug: norepinephrine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
9029,norepinephrine,beta-2 adrenergic receptor,gpcr,,Drug: norepinephrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
9030,norepinephrine,alpha-1a adrenergic receptor,gpcr,,Drug: norepinephrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9031,norepinephrine,beta-2 adrenergic receptor,gpcr,,Drug: norepinephrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
9032,norepinephrine,alpha-1b adrenergic receptor,gpcr,,Drug: norepinephrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9033,norepinephrine,beta-1 adrenergic receptor,gpcr,,Drug: norepinephrine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
9034,norepinephrine,adrenergic receptor alpha-2,gpcr,,Drug: norepinephrine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
9035,norepinephrine,adrenergic receptor alpha-1,gpcr,,Drug: norepinephrine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
9036,norepinephrine,adrenergic receptor alpha,gpcr,,Drug: norepinephrine | Target: adrenergic receptor alpha | Type: gpcr | Action: nan
9037,norepinephrine,adrenergic receptor beta,gpcr,,Drug: norepinephrine | Target: adrenergic receptor beta | Type: gpcr | Action: nan
9038,norepinephrine,alpha-2c adrenergic receptor,gpcr,,Drug: norepinephrine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
9039,norepinephrine,alpha-2a adrenergic receptor,gpcr,,Drug: norepinephrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9040,norethisterone,sodium-dependent serotonin transporter,transporter,,Drug: norethisterone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
9041,norethisterone,glucocorticoid receptor,nuclear hormone receptor,,Drug: norethisterone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
9042,norethisterone,estrogen receptor,nuclear hormone receptor,,Drug: norethisterone | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
9043,norethisterone,androgen receptor,nuclear hormone receptor,,Drug: norethisterone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
9044,norethisterone,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: norethisterone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
9045,norethisterone,sex hormone-binding globulin,secreted,,Drug: norethisterone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
9046,norethisterone,androgen receptor,transcription factor,,Drug: norethisterone | Target: androgen receptor | Type: transcription factor | Action: nan
9047,norethisterone,progesterone receptor,transcription factor,,Drug: norethisterone | Target: progesterone receptor | Type: transcription factor | Action: nan
9048,norethisterone,estrogen receptor,transcription factor,,Drug: norethisterone | Target: estrogen receptor | Type: transcription factor | Action: nan
9049,norethindrone acetate,sodium-dependent serotonin transporter,transporter,,Drug: norethindrone acetate | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
9050,norethindrone acetate,glucocorticoid receptor,nuclear hormone receptor,,Drug: norethindrone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
9051,norethindrone acetate,estrogen receptor,nuclear hormone receptor,,Drug: norethindrone acetate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
9052,norethindrone acetate,androgen receptor,nuclear hormone receptor,,Drug: norethindrone acetate | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
9053,norethindrone acetate,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: norethindrone acetate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
9054,norethindrone acetate,cytochrome p450 2c19,enzyme,,Drug: norethindrone acetate | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
9055,norethindrone acetate,sex hormone-binding globulin,secreted,,Drug: norethindrone acetate | Target: sex hormone-binding globulin | Type: secreted | Action: nan
9056,norethindrone acetate,androgen receptor,transcription factor,,Drug: norethindrone acetate | Target: androgen receptor | Type: transcription factor | Action: nan
9057,norethindrone acetate,progesterone receptor,transcription factor,,Drug: norethindrone acetate | Target: progesterone receptor | Type: transcription factor | Action: nan
9058,norethynodrel,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: norethynodrel | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
9059,norethynodrel,androgen receptor,transcription factor,,Drug: norethynodrel | Target: androgen receptor | Type: transcription factor | Action: nan
9060,norfloxacin,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,,Drug: norfloxacin | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: nan
9061,norfloxacin,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,,Drug: norfloxacin | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: nan
9062,norfloxacin,gamma-aminobutyric acid receptor subunit alpha-3,ion channel,,Drug: norfloxacin | Target: gamma-aminobutyric acid receptor subunit alpha-3 | Type: ion channel | Action: nan
9063,norfloxacin,gamma-aminobutyric acid receptor subunit alpha-5,ion channel,,Drug: norfloxacin | Target: gamma-aminobutyric acid receptor subunit alpha-5 | Type: ion channel | Action: nan
9064,norfloxacin,dna topoisomerase 4 subunit a,enzyme,INHIBITOR,Drug: norfloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: INHIBITOR
9065,norfloxacin,dna topoisomerase 4 subunit a,enzyme,,Drug: norfloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: nan
9066,norfloxacin,dna gyrase subunit a,enzyme,,Drug: norfloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
9067,norfloxacin,dna gyrase subunit a,enzyme,INHIBITOR,Drug: norfloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: INHIBITOR
9068,norfloxacin,gamma-aminobutyric acid receptor subunit alpha-4,ion channel,,Drug: norfloxacin | Target: gamma-aminobutyric acid receptor subunit alpha-4 | Type: ion channel | Action: nan
9069,norfloxacin,gamma-aminobutyric acid receptor subunit alpha-6,ion channel,,Drug: norfloxacin | Target: gamma-aminobutyric acid receptor subunit alpha-6 | Type: ion channel | Action: nan
9070,norfloxacin,dna topoisomerase 2-beta,enzyme,,Drug: norfloxacin | Target: dna topoisomerase 2-beta | Type: enzyme | Action: nan
9071,norfloxacin,multidrug and toxin extrusion protein 1,transporter,,Drug: norfloxacin | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
9072,norfloxacin,gaba-a receptor; anion channel,ion channel,,Drug: norfloxacin | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
9073,norfloxacin,multidrug resistance protein mdtk,unclassified,,Drug: norfloxacin | Target: multidrug resistance protein mdtk | Type: unclassified | Action: nan
9074,norgestimate,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: norgestimate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
9075,norgestimate,short transient receptor potential channel 3,ion channel,BLOCKER,Drug: norgestimate | Target: short transient receptor potential channel 3 | Type: ion channel | Action: BLOCKER
9076,norgestimate,short transient receptor potential channel 6,ion channel,BLOCKER,Drug: norgestimate | Target: short transient receptor potential channel 6 | Type: ion channel | Action: BLOCKER
9077,nortriptyline,d(1a) dopamine receptor,gpcr,,Drug: nortriptyline | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
9078,nortriptyline,d(2) dopamine receptor,gpcr,,Drug: nortriptyline | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9079,nortriptyline,alpha-2a adrenergic receptor,gpcr,,Drug: nortriptyline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9080,nortriptyline,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: nortriptyline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
9081,nortriptyline,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: nortriptyline | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
9082,nortriptyline,5-hydroxytryptamine receptor 1a,gpcr,,Drug: nortriptyline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9083,nortriptyline,5-hydroxytryptamine receptor 2a,gpcr,,Drug: nortriptyline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9084,nortriptyline,5-hydroxytryptamine receptor 2b,gpcr,,Drug: nortriptyline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9085,nortriptyline,5-hydroxytryptamine receptor 2c,gpcr,,Drug: nortriptyline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9086,nortriptyline,5-hydroxytryptamine receptor 6,gpcr,,Drug: nortriptyline | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9087,nortriptyline,alpha-1a adrenergic receptor,gpcr,,Drug: nortriptyline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9088,nortriptyline,alpha-2b adrenergic receptor,gpcr,,Drug: nortriptyline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9089,nortriptyline,d(3) dopamine receptor,gpcr,,Drug: nortriptyline | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9090,nortriptyline,histamine h1 receptor,gpcr,,Drug: nortriptyline | Target: histamine h1 receptor | Type: gpcr | Action: nan
9091,nortriptyline,histamine h2 receptor,gpcr,,Drug: nortriptyline | Target: histamine h2 receptor | Type: gpcr | Action: nan
9092,nortriptyline,muscarinic acetylcholine receptor m1,gpcr,,Drug: nortriptyline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9093,nortriptyline,muscarinic acetylcholine receptor m2,gpcr,,Drug: nortriptyline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
9094,nortriptyline,muscarinic acetylcholine receptor m3,gpcr,,Drug: nortriptyline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
9095,nortriptyline,muscarinic acetylcholine receptor m4,gpcr,,Drug: nortriptyline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
9096,nortriptyline,muscarinic acetylcholine receptor m5,gpcr,,Drug: nortriptyline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
9097,nortriptyline,aldehyde oxidase,enzyme,,Drug: nortriptyline | Target: aldehyde oxidase | Type: enzyme | Action: nan
9098,nortriptyline,alpha-2c adrenergic receptor,gpcr,,Drug: nortriptyline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
9099,nortriptyline,sodium-dependent dopamine transporter,transporter,,Drug: nortriptyline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9100,nortriptyline,cytochrome p450 2d6,enzyme,,Drug: nortriptyline | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9101,nortriptyline,alpha-1d adrenergic receptor,gpcr,,Drug: nortriptyline | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
9102,nortriptyline,cytochrome p450 2c19,enzyme,,Drug: nortriptyline | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
9103,nortriptyline,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: nortriptyline | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
9104,nortriptyline,alpha-1b adrenergic receptor,gpcr,,Drug: nortriptyline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9105,nortriptyline,5-hydroxytryptamine receptor 1b,gpcr,,Drug: nortriptyline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
9106,nortriptyline,alpha-1a adrenergic receptor,gpcr,,Drug: nortriptyline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9107,nortriptyline,5-hydroxytryptamine receptor 1a,gpcr,,Drug: nortriptyline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9108,nortriptyline,histamine h1 receptor,gpcr,,Drug: nortriptyline | Target: histamine h1 receptor | Type: gpcr | Action: nan
9109,nortriptyline,atp-sensitive inward rectifier potassium channel 10,ion channel,BLOCKER,Drug: nortriptyline | Target: atp-sensitive inward rectifier potassium channel 10 | Type: ion channel | Action: BLOCKER
9110,noscapine,cytochrome p450 2c9,enzyme,,Drug: noscapine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
9111,noscapine,cytochrome p450 2c19,enzyme,,Drug: noscapine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
9112,noscapine,solute carrier family 22 member 2,transporter,,Drug: noscapine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
9113,noscapine,multidrug and toxin extrusion protein 1,transporter,,Drug: noscapine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
9114,novobiocin,atp-binding cassette sub-family g member 2,transporter,,Drug: novobiocin | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
9115,novobiocin,dna gyrase subunit b,enzyme,,Drug: novobiocin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
9116,novobiocin,dna gyrase subunit b,enzyme,,Drug: novobiocin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
9117,novobiocin,pare,enzyme,,Drug: novobiocin | Target: pare | Type: enzyme | Action: nan
9118,novobiocin,dna gyrase subunit b,enzyme,,Drug: novobiocin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
9119,novobiocin,dna gyrase,enzyme,,Drug: novobiocin | Target: dna gyrase | Type: enzyme | Action: nan
9120,novobiocin,dna gyrase,enzyme,INHIBITOR,Drug: novobiocin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
9121,novobiocin,dna gyrase subunit b,enzyme,,Drug: novobiocin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
9122,novobiocin,dna gyrase subunit b,enzyme,,Drug: novobiocin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
9123,novobiocin,dnull gyrase subunit b,enzyme,,Drug: novobiocin | Target: dnull gyrase subunit b | Type: enzyme | Action: nan
9124,novobiocin,dnull gyrase subunit b,enzyme,,Drug: novobiocin | Target: dnull gyrase subunit b | Type: enzyme | Action: nan
9125,buphenine,adrenergic receptor alpha-1,gpcr,,Drug: buphenine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
9126,octreotide,mu-type opioid receptor,gpcr,,Drug: octreotide | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9127,octreotide,somatostatin receptor type 2,gpcr,AGONIST,Drug: octreotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
9128,octreotide,somatostatin receptor type 3,gpcr,AGONIST,Drug: octreotide | Target: somatostatin receptor type 3 | Type: gpcr | Action: AGONIST
9129,octreotide,somatostatin receptor type 5,gpcr,AGONIST,Drug: octreotide | Target: somatostatin receptor type 5 | Type: gpcr | Action: AGONIST
9130,octreotide,somatostatin receptor type 2,gpcr,,Drug: octreotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: nan
9131,octreotide,somatostatin receptor type 3,gpcr,,Drug: octreotide | Target: somatostatin receptor type 3 | Type: gpcr | Action: nan
9132,octreotide,somatostatin receptor type 4,gpcr,AGONIST,Drug: octreotide | Target: somatostatin receptor type 4 | Type: gpcr | Action: AGONIST
9133,octreotide,somatostatin receptor type 5,gpcr,,Drug: octreotide | Target: somatostatin receptor type 5 | Type: gpcr | Action: nan
9134,octreotide,somatostatin receptor type 1,gpcr,AGONIST,Drug: octreotide | Target: somatostatin receptor type 1 | Type: gpcr | Action: AGONIST
9135,octreotide,somatostatin receptor type 2,gpcr,AGONIST,Drug: octreotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
9136,octreotide,somatostatin receptor type 3,gpcr,AGONIST,Drug: octreotide | Target: somatostatin receptor type 3 | Type: gpcr | Action: AGONIST
9137,octreotide,somatostatin receptor type 5,gpcr,AGONIST,Drug: octreotide | Target: somatostatin receptor type 5 | Type: gpcr | Action: AGONIST
9138,ofloxacin,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,,Drug: ofloxacin | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: nan
9139,ofloxacin,sodium-dependent serotonin transporter,transporter,,Drug: ofloxacin | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
9140,ofloxacin,muscarinic acetylcholine receptor m1,gpcr,,Drug: ofloxacin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9141,ofloxacin,dna gyrase subunit a,enzyme,INHIBITOR,Drug: ofloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: INHIBITOR
9142,ofloxacin,dna gyrase subunit b,enzyme,,Drug: ofloxacin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
9143,ofloxacin,histamine h3 receptor,gpcr,,Drug: ofloxacin | Target: histamine h3 receptor | Type: gpcr | Action: nan
9144,ofloxacin,gag-pro-pol polyprotein,polyprotein,,Drug: ofloxacin | Target: gag-pro-pol polyprotein | Type: polyprotein | Action: nan
9145,ofloxacin,gaba-a receptor; anion channel,ion channel,,Drug: ofloxacin | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
9146,ofloxacin,caax prenyl protease 1,enzyme,,Drug: ofloxacin | Target: caax prenyl protease 1 | Type: enzyme | Action: nan
9147,ofloxacin,trypsin,enzyme,,Drug: ofloxacin | Target: trypsin | Type: enzyme | Action: nan
9148,olanzapine,beta-1 adrenergic receptor,gpcr,,Drug: olanzapine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
9149,olanzapine,beta-2 adrenergic receptor,gpcr,,Drug: olanzapine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
9150,olanzapine,d(1a) dopamine receptor,gpcr,,Drug: olanzapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
9151,olanzapine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: olanzapine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9152,olanzapine,alpha-2a adrenergic receptor,gpcr,,Drug: olanzapine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9153,olanzapine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: olanzapine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9154,olanzapine,sodium-dependent serotonin transporter,transporter,,Drug: olanzapine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
9155,olanzapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9156,olanzapine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
9157,olanzapine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9158,olanzapine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
9159,olanzapine,5-hydroxytryptamine receptor 6,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9160,olanzapine,5-hydroxytryptamine receptor 7,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
9161,olanzapine,alpha-1a adrenergic receptor,gpcr,,Drug: olanzapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9162,olanzapine,alpha-2b adrenergic receptor,gpcr,,Drug: olanzapine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9163,olanzapine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: olanzapine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9164,olanzapine,d(1b) dopamine receptor,gpcr,,Drug: olanzapine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
9165,olanzapine,histamine h1 receptor,gpcr,,Drug: olanzapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9166,olanzapine,histamine h2 receptor,gpcr,,Drug: olanzapine | Target: histamine h2 receptor | Type: gpcr | Action: nan
9167,olanzapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: olanzapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9168,olanzapine,muscarinic acetylcholine receptor m2,gpcr,,Drug: olanzapine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
9169,olanzapine,muscarinic acetylcholine receptor m3,gpcr,,Drug: olanzapine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
9170,olanzapine,muscarinic acetylcholine receptor m4,gpcr,,Drug: olanzapine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
9171,olanzapine,muscarinic acetylcholine receptor m5,gpcr,,Drug: olanzapine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
9172,olanzapine,aldehyde oxidase,enzyme,,Drug: olanzapine | Target: aldehyde oxidase | Type: enzyme | Action: nan
9173,olanzapine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
9174,olanzapine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
9175,olanzapine,alpha-2c adrenergic receptor,gpcr,,Drug: olanzapine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
9176,olanzapine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: olanzapine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9177,olanzapine,alpha-1d adrenergic receptor,gpcr,,Drug: olanzapine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
9178,olanzapine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
9179,olanzapine,alpha-1b adrenergic receptor,gpcr,,Drug: olanzapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9180,olanzapine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
9181,olanzapine,5-hydroxytryptamine receptor 1f,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
9182,olanzapine,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
9183,olanzapine,arachidonate 15-lipoxygenase,enzyme,,Drug: olanzapine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
9184,olanzapine,alpha-1b adrenergic receptor,gpcr,,Drug: olanzapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9185,olanzapine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
9186,olanzapine,alpha-1a adrenergic receptor,gpcr,,Drug: olanzapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9187,olanzapine,histamine h1 receptor,gpcr,,Drug: olanzapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9188,olanzapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: olanzapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9189,olanzapine,d(2) dopamine receptor,gpcr,,Drug: olanzapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9190,olanzapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9191,olanzapine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9192,olanzapine,transporter,transporter,,Drug: olanzapine | Target: transporter | Type: transporter | Action: nan
9193,olanzapine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
9194,olanzapine,d(1a) dopamine receptor,gpcr,,Drug: olanzapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
9195,olanzapine,histamine h1 receptor,gpcr,,Drug: olanzapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9196,olanzapine,d(3) dopamine receptor,gpcr,,Drug: olanzapine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9197,olanzapine,d(4) dopamine receptor,gpcr,,Drug: olanzapine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
9198,olanzapine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: olanzapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
9199,olanzapine,transporter,transporter,,Drug: olanzapine | Target: transporter | Type: transporter | Action: nan
9200,olanzapine,adrenergic receptor alpha-2,gpcr,,Drug: olanzapine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
9201,olanzapine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: olanzapine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
9202,olanzapine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: olanzapine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
9203,olanzapine,histone h1.0,nuclear other,,Drug: olanzapine | Target: histone h1.0 | Type: nuclear other | Action: nan
9204,olmesartan medoxomil,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: olmesartan medoxomil | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
9205,olmesartan medoxomil,type-1 angiotensin ii receptor,gpcr,,Drug: olmesartan medoxomil | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
9206,olopatadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: olopatadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
9207,olopatadine,histamine h1 receptor,gpcr,,Drug: olopatadine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9208,olprinone,phosphodiesterase 3,enzyme,INHIBITOR,Drug: olprinone | Target: phosphodiesterase 3 | Type: enzyme | Action: INHIBITOR
9209,olsalazine,arachidonate 5-lipoxygenase,enzyme,INHIBITOR,Drug: olsalazine | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: INHIBITOR
9210,olsalazine,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: olsalazine | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
9211,olsalazine,cyclooxygenase,enzyme,INHIBITOR,Drug: olsalazine | Target: cyclooxygenase | Type: enzyme | Action: INHIBITOR
9212,omapatrilat,angiotensin-converting enzyme,enzyme,,Drug: omapatrilat | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
9213,omapatrilat,neprilysin,enzyme,,Drug: omapatrilat | Target: neprilysin | Type: enzyme | Action: nan
9214,omapatrilat,angiotensin-converting enzyme,enzyme,,Drug: omapatrilat | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
9215,omapatrilat,neprilysin,enzyme,,Drug: omapatrilat | Target: neprilysin | Type: enzyme | Action: nan
9216,omapatrilat,amyloid beta a4 protein,unclassified,,Drug: omapatrilat | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
9217,omapatrilat,amyloid beta a4 protein,unclassified,,Drug: omapatrilat | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
9218,omeprazole,cytochrome p450 3a4,enzyme,,Drug: omeprazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
9219,omeprazole,multidrug resistance protein 1,transporter,,Drug: omeprazole | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
9220,omeprazole,cytochrome p450 2c9,enzyme,,Drug: omeprazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
9221,omeprazole,cytochrome p450 1a2,enzyme,,Drug: omeprazole | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
9222,omeprazole,cytochrome p450 2c19,enzyme,,Drug: omeprazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
9223,omeprazole,fatty acid synthase,enzyme,,Drug: omeprazole | Target: fatty acid synthase | Type: enzyme | Action: nan
9224,omeprazole,potassium-transporting atpase,transporter,INHIBITOR,Drug: omeprazole | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
9225,omeprazole,potassium-transporting atpase,enzyme,,Drug: omeprazole | Target: potassium-transporting atpase | Type: enzyme | Action: nan
9226,omeprazole,"n(g),n(g)-dimethylarginine dimethylaminohydrolase 1",enzyme,,"Drug: omeprazole | Target: n(g),n(g)-dimethylarginine dimethylaminohydrolase 1 | Type: enzyme | Action: nan"
9227,omeprazole,glutathione s-transferase omega-1,unclassified,,Drug: omeprazole | Target: glutathione s-transferase omega-1 | Type: unclassified | Action: nan
9228,omeprazole,cytosolic endo-beta-n-acetylglucosaminidase,enzyme,,Drug: omeprazole | Target: cytosolic endo-beta-n-acetylglucosaminidase | Type: enzyme | Action: nan
9229,omeprazole,potassium-transporting atpase,enzyme,,Drug: omeprazole | Target: potassium-transporting atpase | Type: enzyme | Action: nan
9230,ondansetron,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ondansetron | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9231,ondansetron,5-hydroxytryptamine receptor 2b,gpcr,,Drug: ondansetron | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9232,ondansetron,aldehyde oxidase,enzyme,,Drug: ondansetron | Target: aldehyde oxidase | Type: enzyme | Action: nan
9233,ondansetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: ondansetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
9234,ondansetron,solute carrier family 22 member 1,transporter,,Drug: ondansetron | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
9235,ondansetron,5-hydroxytryptamine receptor 1b,gpcr,,Drug: ondansetron | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
9236,ondansetron,mu-type opioid receptor,gpcr,,Drug: ondansetron | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9237,ondansetron,muscarinic acetylcholine receptor m1,gpcr,,Drug: ondansetron | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9238,ondansetron,gastrin/cholecystokinin type b receptor,gpcr,,Drug: ondansetron | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
9239,ondansetron,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: ondansetron | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9240,ondansetron,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: ondansetron | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
9241,ondansetron,5-hydroxytryptamine receptor 2c,gpcr,,Drug: ondansetron | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9242,ondansetron,5-hydroxytryptamine receptor 4,gpcr,,Drug: ondansetron | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
9243,ondansetron,5-hydroxytryptamine receptor 3a,ion channel,,Drug: ondansetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
9244,ondansetron,5-hydroxytryptamine receptor 1d,gpcr,,Drug: ondansetron | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
9245,ondansetron,solute carrier family 22 member 2,transporter,,Drug: ondansetron | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
9246,ondansetron,multidrug and toxin extrusion protein 1,transporter,,Drug: ondansetron | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
9247,ondansetron,multidrug and toxin extrusion protein 2,transporter,,Drug: ondansetron | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
9248,ondansetron,solute carrier family 22 member 3,transporter,,Drug: ondansetron | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
9249,ondansetron,serotonin 3 (5-ht3) receptor,ion channel,,Drug: ondansetron | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
9250,ondansetron,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: ondansetron | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
9251,ondansetron,serotonin 2 (5-ht2) receptor,gpcr,,Drug: ondansetron | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
9252,ondansetron,serotonin 3 receptor (5ht3),ion channel,,Drug: ondansetron | Target: serotonin 3 receptor (5ht3) | Type: ion channel | Action: nan
9253,ondansetron,5-hydroxytryptamine receptor 3b,ion channel,,Drug: ondansetron | Target: 5-hydroxytryptamine receptor 3b | Type: ion channel | Action: nan
9254,opipramol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: opipramol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9255,opipramol,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: opipramol | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
9256,opipramol,c-8 sterol isomerase,enzyme,,Drug: opipramol | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
9257,orlistat,cannabinoid receptor 1,gpcr,,Drug: orlistat | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
9258,orlistat,lipoprotein lipase,enzyme,,Drug: orlistat | Target: lipoprotein lipase | Type: enzyme | Action: nan
9259,orlistat,fatty acid synthase,enzyme,,Drug: orlistat | Target: fatty acid synthase | Type: enzyme | Action: nan
9260,orlistat,sn1-specific diacylglycerol lipase alpha,enzyme,,Drug: orlistat | Target: sn1-specific diacylglycerol lipase alpha | Type: enzyme | Action: nan
9261,orlistat,fatty-acid amide hydrolase 1,enzyme,,Drug: orlistat | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
9262,orlistat,sn1-specific diacylglycerol lipase beta,enzyme,,Drug: orlistat | Target: sn1-specific diacylglycerol lipase beta | Type: enzyme | Action: nan
9263,orlistat,abhydrolase domain-containing protein 16a,enzyme,,Drug: orlistat | Target: abhydrolase domain-containing protein 16a | Type: enzyme | Action: nan
9264,orlistat,monoacylglycerol lipase abhd12,enzyme,,Drug: orlistat | Target: monoacylglycerol lipase abhd12 | Type: enzyme | Action: nan
9265,orlistat,platelet-activating factor acetylhydrolase,enzyme,,Drug: orlistat | Target: platelet-activating factor acetylhydrolase | Type: enzyme | Action: nan
9266,orlistat,pancreatic triacylglycerol lipase,enzyme,,Drug: orlistat | Target: pancreatic triacylglycerol lipase | Type: enzyme | Action: nan
9267,orlistat,monoacylglycerol lipase abhd6,enzyme,,Drug: orlistat | Target: monoacylglycerol lipase abhd6 | Type: enzyme | Action: nan
9268,orlistat,sn1-specific diacylglycerol lipase alpha,enzyme,,Drug: orlistat | Target: sn1-specific diacylglycerol lipase alpha | Type: enzyme | Action: nan
9270,orlistat,hepatic triacylglycerol lipase,enzyme,,Drug: orlistat | Target: hepatic triacylglycerol lipase | Type: enzyme | Action: nan
9271,orlistat,endothelial lipase,enzyme,,Drug: orlistat | Target: endothelial lipase | Type: enzyme | Action: nan
9272,orlistat,pancreatic triacylglycerol lipase,enzyme,INHIBITOR,Drug: orlistat | Target: pancreatic triacylglycerol lipase | Type: enzyme | Action: INHIBITOR
9273,orlistat,gastric triacylglycerol lipase,enzyme,INHIBITOR,Drug: orlistat | Target: gastric triacylglycerol lipase | Type: enzyme | Action: INHIBITOR
9274,orphenadrine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: orphenadrine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
9275,orphenadrine,alpha-2a adrenergic receptor,gpcr,,Drug: orphenadrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9276,orphenadrine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: orphenadrine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9277,orphenadrine,sodium-dependent serotonin transporter,transporter,,Drug: orphenadrine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
9278,orphenadrine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: orphenadrine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
9279,orphenadrine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: orphenadrine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9280,orphenadrine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: orphenadrine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9281,orphenadrine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: orphenadrine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9282,orphenadrine,5-hydroxytryptamine receptor 6,gpcr,,Drug: orphenadrine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9283,orphenadrine,alpha-2b adrenergic receptor,gpcr,,Drug: orphenadrine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9284,orphenadrine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: orphenadrine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
9285,orphenadrine,histamine h2 receptor,gpcr,,Drug: orphenadrine | Target: histamine h2 receptor | Type: gpcr | Action: nan
9286,orphenadrine,muscarinic acetylcholine receptor m1,gpcr,,Drug: orphenadrine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9287,orphenadrine,muscarinic acetylcholine receptor m2,gpcr,,Drug: orphenadrine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
9288,orphenadrine,muscarinic acetylcholine receptor m3,gpcr,,Drug: orphenadrine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
9289,orphenadrine,muscarinic acetylcholine receptor m4,gpcr,,Drug: orphenadrine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
9290,orphenadrine,muscarinic acetylcholine receptor m5,gpcr,,Drug: orphenadrine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
9291,orphenadrine,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: orphenadrine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
9292,orphenadrine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: orphenadrine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
9293,orphenadrine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: orphenadrine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
9294,orphenadrine,cytochrome p450 2d6,enzyme,,Drug: orphenadrine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9295,orphenadrine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: orphenadrine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
9296,orphenadrine,solute carrier family 22 member 1,transporter,,Drug: orphenadrine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
9297,orphenadrine,histamine h1 receptor,gpcr,,Drug: orphenadrine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9298,orphenadrine,glutamate [nmda] receptor,ion channel,,Drug: orphenadrine | Target: glutamate [nmda] receptor | Type: ion channel | Action: nan
9299,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9300,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9301,oseltamivir,neuraminidase,enzyme,INHIBITOR,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: INHIBITOR
9302,oseltamivir,neuraminidase,enzyme,INHIBITOR,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: INHIBITOR
9303,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9304,oseltamivir,sialidase,enzyme,,Drug: oseltamivir | Target: sialidase | Type: enzyme | Action: nan
9305,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9306,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9307,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9308,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9309,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9310,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9311,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9312,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9313,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9314,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9315,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9316,oseltamivir,neuraminidase,enzyme,,Drug: oseltamivir | Target: neuraminidase | Type: enzyme | Action: nan
9317,oteracil,uridine 5'-monophosphate synthase,enzyme,INHIBITOR,Drug: oteracil | Target: uridine 5'-monophosphate synthase | Type: enzyme | Action: INHIBITOR
9318,ouabain,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: ouabain | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
9319,ouabain,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ouabain | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9320,ouabain,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: ouabain | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
9321,ouabain,signal transducer and activator of transcription 3,transcription factor,,Drug: ouabain | Target: signal transducer and activator of transcription 3 | Type: transcription factor | Action: nan
9322,oxacillin,prostaglandin g/h synthase 2,enzyme,,Drug: oxacillin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
9323,oxacillin,prostaglandin g/h synthase 1,enzyme,,Drug: oxacillin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
9324,oxacillin,penicillin-binding protein 1a,enzyme,,Drug: oxacillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
9325,oxacillin,"dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a",enzyme,,"Drug: oxacillin | Target: dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a | Type: enzyme | Action: nan"
9326,oxacillin,penicillin-binding protein,enzyme,INHIBITOR,Drug: oxacillin | Target: penicillin-binding protein | Type: enzyme | Action: INHIBITOR
9327,oxametacin,prostaglandin g/h synthase 1,enzyme,,Drug: oxametacin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
9328,oxametacin,arachidonate 5-lipoxygenase,enzyme,,Drug: oxametacin | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
9329,oxametacin,cyclooxygenase,enzyme,,Drug: oxametacin | Target: cyclooxygenase | Type: enzyme | Action: nan
9330,oxandrolone,androgen receptor,nuclear hormone receptor,AGONIST,Drug: oxandrolone | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
9331,oxaprozin,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: oxaprozin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
9332,oxaprozin,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: oxaprozin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
9333,oxaprozin,fmet-leu-phe receptor,gpcr,,Drug: oxaprozin | Target: fmet-leu-phe receptor | Type: gpcr | Action: nan
9334,oxaprozin,bifunctional epoxide hydrolase 2,enzyme,INHIBITOR,Drug: oxaprozin | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: INHIBITOR
9335,oxaprozin,complement c5,secreted,,Drug: oxaprozin | Target: complement c5 | Type: secreted | Action: nan
9336,oxaprozin,complement c5,unclassified,,Drug: oxaprozin | Target: complement c5 | Type: unclassified | Action: nan
9337,oxaprozin,"serine hydroxymethyltransferase, mitochondrial",enzyme,,"Drug: oxaprozin | Target: serine hydroxymethyltransferase, mitochondrial | Type: enzyme | Action: nan"
9338,oxatomide,5-hydroxytryptamine receptor 2a,gpcr,,Drug: oxatomide | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9339,oxatomide,5-hydroxytryptamine receptor 2b,gpcr,,Drug: oxatomide | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9340,oxatomide,d(3) dopamine receptor,gpcr,,Drug: oxatomide | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9341,oxatomide,muscarinic acetylcholine receptor m1,gpcr,,Drug: oxatomide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9342,oxatomide,histamine h1 receptor,gpcr,,Drug: oxatomide | Target: histamine h1 receptor | Type: gpcr | Action: nan
9343,oxatomide,histamine h1 receptor,gpcr,ANTAGONIST,Drug: oxatomide | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
9344,oxazepam,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: oxazepam | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
9345,oxcarbazepine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: oxcarbazepine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
9346,oxyphencyclimine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: oxyphencyclimine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
9347,oxyphencyclimine,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: oxyphencyclimine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
9348,oxprenolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: oxprenolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9349,oxprenolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: oxprenolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9350,oxprenolol,solute carrier family 22 member 1,transporter,,Drug: oxprenolol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
9351,oxprenolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: oxprenolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9352,oxybutynin,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: oxybutynin | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9353,oxybutynin,sodium-dependent noradrenaline transporter,transporter,,Drug: oxybutynin | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
9354,oxybutynin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: oxybutynin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9355,oxybutynin,d(3) dopamine receptor,gpcr,,Drug: oxybutynin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9356,oxybutynin,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: oxybutynin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
9357,oxybutynin,muscarinic acetylcholine receptor m4,gpcr,,Drug: oxybutynin | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
9358,oxybutynin,muscarinic acetylcholine receptor m5,gpcr,,Drug: oxybutynin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
9359,oxybutynin,sodium-dependent dopamine transporter,transporter,,Drug: oxybutynin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9360,oxybutynin,cytochrome p450 2c19,enzyme,,Drug: oxybutynin | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
9361,oxybutynin,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: oxybutynin | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
9362,oxybutynin,muscarinic acetylcholine receptor m2,gpcr,,Drug: oxybutynin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
9363,oxybutynin,muscarinic acetylcholine receptor m1,gpcr,,Drug: oxybutynin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9364,oxybutynin,muscarinic acetylcholine receptor m3,gpcr,,Drug: oxybutynin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
9365,oxybutynin,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: oxybutynin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
9366,oxybutynin,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: oxybutynin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
9367,oxycodone,mu-type opioid receptor,gpcr,AGONIST,Drug: oxycodone | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
9368,oxycodone,kappa-type opioid receptor,gpcr,,Drug: oxycodone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9369,oxycodone,delta-type opioid receptor,gpcr,,Drug: oxycodone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
9370,oxycodone,mu-type opioid receptor,gpcr,,Drug: oxycodone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9371,oxycodone,mu-type opioid receptor,gpcr,,Drug: oxycodone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9372,oxycodone,delta-type opioid receptor,gpcr,,Drug: oxycodone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
9373,oxycodone,kappa-type opioid receptor,gpcr,,Drug: oxycodone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9374,oxycodone,acetylcholinesterase,enzyme,,Drug: oxycodone | Target: acetylcholinesterase | Type: enzyme | Action: nan
9375,oxycodone,kappa-type opioid receptor,gpcr,,Drug: oxycodone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9376,oxycodone,kappa-type opioid receptor,gpcr,,Drug: oxycodone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9378,oxymetazoline,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: oxymetazoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
9379,oxymetazoline,5-hydroxytryptamine receptor 1a,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9380,oxymetazoline,5-hydroxytryptamine receptor 2a,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9381,oxymetazoline,5-hydroxytryptamine receptor 2b,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9382,oxymetazoline,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
9383,oxymetazoline,5-hydroxytryptamine receptor 6,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9384,oxymetazoline,muscarinic acetylcholine receptor m4,gpcr,,Drug: oxymetazoline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
9385,oxymetazoline,muscarinic acetylcholine receptor m5,gpcr,,Drug: oxymetazoline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
9386,oxymetazoline,5-hydroxytryptamine receptor 1b,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
9387,oxymetazoline,5-hydroxytryptamine receptor 1d,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
9388,oxymetazoline,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: oxymetazoline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
9389,oxymetazoline,cytochrome p450 2d6,enzyme,,Drug: oxymetazoline | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9390,oxymetazoline,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: oxymetazoline | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
9391,oxymetazoline,alpha-1b adrenergic receptor,gpcr,AGONIST,Drug: oxymetazoline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: AGONIST
9392,oxymetazoline,5-hydroxytryptamine receptor 1e,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
9393,oxymetazoline,nischarin,membrane receptor,,Drug: oxymetazoline | Target: nischarin | Type: membrane receptor | Action: nan
9394,oxymetazoline,alpha-1b adrenergic receptor,gpcr,,Drug: oxymetazoline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9395,oxymetazoline,5-hydroxytryptamine receptor 1b,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
9396,oxymetazoline,alpha-1a adrenergic receptor,gpcr,,Drug: oxymetazoline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9397,oxymetazoline,alpha-1d adrenergic receptor,gpcr,,Drug: oxymetazoline | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
9398,oxymetazoline,5-hydroxytryptamine receptor 1a,gpcr,,Drug: oxymetazoline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9399,oxymetazoline,alpha-1a adrenergic receptor,gpcr,,Drug: oxymetazoline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9400,oxymetazoline,alpha-2a adrenergic receptor,gpcr,,Drug: oxymetazoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9401,oxymetazoline,alpha-2a adrenergic receptor,gpcr,,Drug: oxymetazoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9402,oxymetazoline,alpha-1b adrenergic receptor,gpcr,,Drug: oxymetazoline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9403,oxymetazoline,adrenergic receptor alpha-2,gpcr,,Drug: oxymetazoline | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
9404,oxymetazoline,alpha-2 adrenergic receptor,gpcr,,Drug: oxymetazoline | Target: alpha-2 adrenergic receptor | Type: gpcr | Action: nan
9405,oxymetazoline,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: oxymetazoline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
9406,oxymetazoline,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: oxymetazoline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
9407,oxymetholone,estrogen receptor,nuclear hormone receptor,,Drug: oxymetholone | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
9408,oxymetholone,androgen receptor,nuclear hormone receptor,AGONIST,Drug: oxymetholone | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
9409,oxymetholone,androgen receptor,transcription factor,,Drug: oxymetholone | Target: androgen receptor | Type: transcription factor | Action: nan
9410,oxymorphone,mu-type opioid receptor,gpcr,AGONIST,Drug: oxymorphone | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
9411,oxymorphone,kappa-type opioid receptor,gpcr,AGONIST,Drug: oxymorphone | Target: kappa-type opioid receptor | Type: gpcr | Action: AGONIST
9412,oxymorphone,delta-type opioid receptor,gpcr,AGONIST,Drug: oxymorphone | Target: delta-type opioid receptor | Type: gpcr | Action: AGONIST
9413,oxymorphone,mu-type opioid receptor,gpcr,,Drug: oxymorphone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9414,oxymorphone,mu-type opioid receptor,gpcr,,Drug: oxymorphone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9415,oxymorphone,mu-type opioid receptor,gpcr,,Drug: oxymorphone | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9416,oxymorphone,delta-type opioid receptor,gpcr,,Drug: oxymorphone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
9417,oxymorphone,delta-type opioid receptor,gpcr,,Drug: oxymorphone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
9418,oxymorphone,kappa-type opioid receptor,gpcr,,Drug: oxymorphone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9419,oxymorphone,kappa-type opioid receptor,gpcr,,Drug: oxymorphone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9420,oxymorphone,opioid receptor,gpcr,,Drug: oxymorphone | Target: opioid receptor | Type: gpcr | Action: nan
9421,oxymorphone,opioid receptors; mu and delta,gpcr,,Drug: oxymorphone | Target: opioid receptors; mu and delta | Type: gpcr | Action: nan
9422,oxyphenbutazone,fmet-leu-phe receptor,gpcr,,Drug: oxyphenbutazone | Target: fmet-leu-phe receptor | Type: gpcr | Action: nan
9423,oxyphenbutazone,prostacyclin synthase,enzyme,,Drug: oxyphenbutazone | Target: prostacyclin synthase | Type: enzyme | Action: nan
9424,oxyphenbutazone,cyclooxygenase,enzyme,INHIBITOR,Drug: oxyphenbutazone | Target: cyclooxygenase | Type: enzyme | Action: INHIBITOR
9425,oxyphenbutazone,nicotinate phosphoribosyltransferase,enzyme,,Drug: oxyphenbutazone | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
9426,oxyphenonium,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: oxyphenonium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
9427,oxyphenonium,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: oxyphenonium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
9428,oxyphenonium,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: oxyphenonium | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
9429,oxytetracycline,30s ribosomal protein s4,ribosomal protein,,Drug: oxytetracycline | Target: 30s ribosomal protein s4 | Type: ribosomal protein | Action: nan
9430,oxytetracycline,30s ribosomal protein s9,ribosomal protein,,Drug: oxytetracycline | Target: 30s ribosomal protein s9 | Type: ribosomal protein | Action: nan
9431,oxytocin,vasopressin v1a receptor,gpcr,,Drug: oxytocin | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
9432,oxytocin,vasopressin v1b receptor,gpcr,,Drug: oxytocin | Target: vasopressin v1b receptor | Type: gpcr | Action: nan
9433,oxytocin,vasopressin v2 receptor,gpcr,,Drug: oxytocin | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
9434,oxytocin,oxytocin receptor,gpcr,AGONIST,Drug: oxytocin | Target: oxytocin receptor | Type: gpcr | Action: AGONIST
9435,oxytocin,oxytocin-neurophysin 1,secreted,,Drug: oxytocin | Target: oxytocin-neurophysin 1 | Type: secreted | Action: nan
9436,oxytocin,oxytocin receptor,gpcr,,Drug: oxytocin | Target: oxytocin receptor | Type: gpcr | Action: nan
9437,oxytocin,vasopressin v2 receptor,gpcr,,Drug: oxytocin | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
9438,oxytocin,vasopressin v1a receptor,gpcr,AGONIST,Drug: oxytocin | Target: vasopressin v1a receptor | Type: gpcr | Action: AGONIST
9439,ozagrel,thromboxane-a synthase,enzyme,,Drug: ozagrel | Target: thromboxane-a synthase | Type: enzyme | Action: nan
9440,ozagrel,thromboxane-a synthase,enzyme,,Drug: ozagrel | Target: thromboxane-a synthase | Type: enzyme | Action: nan
9441,paclitaxel,multidrug resistance protein 1,transporter,,Drug: paclitaxel | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
9442,paclitaxel,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,AGONIST,Drug: paclitaxel | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: AGONIST
9443,paclitaxel,delta-type opioid receptor,gpcr,,Drug: paclitaxel | Target: delta-type opioid receptor | Type: gpcr | Action: nan
9444,paclitaxel,bile salt export pump,transporter,,Drug: paclitaxel | Target: bile salt export pump | Type: transporter | Action: nan
9445,paclitaxel,multidrug resistance-associated protein 7,transporter,,Drug: paclitaxel | Target: multidrug resistance-associated protein 7 | Type: transporter | Action: nan
9446,paclitaxel,tubulin beta chain,structural,INHIBITOR,Drug: paclitaxel | Target: tubulin beta chain | Type: structural | Action: INHIBITOR
9447,paclitaxel,tyrosine-protein kinase fyn,kinase,,Drug: paclitaxel | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
9448,paclitaxel,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: paclitaxel | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
9449,paclitaxel,cholecystokinin receptor type a,gpcr,,Drug: paclitaxel | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
9450,paclitaxel,substance-k receptor,gpcr,,Drug: paclitaxel | Target: substance-k receptor | Type: gpcr | Action: nan
9451,paclitaxel,melanocortin receptor 5,gpcr,,Drug: paclitaxel | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
9452,paclitaxel,botulinum neurotoxin type a,enzyme,,Drug: paclitaxel | Target: botulinum neurotoxin type a | Type: enzyme | Action: nan
9453,paclitaxel,tyrosine-protein kinase mer,kinase,,Drug: paclitaxel | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
9454,paclitaxel,tubulin beta-3 chain,structural,,Drug: paclitaxel | Target: tubulin beta-3 chain | Type: structural | Action: nan
9455,paclitaxel,nucleotide-binding oligomerization domain-containing protein 2,cytosolic other,,Drug: paclitaxel | Target: nucleotide-binding oligomerization domain-containing protein 2 | Type: cytosolic other | Action: nan
9456,paclitaxel,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: paclitaxel | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
9457,palmidrol,cannabinoid receptor 1,gpcr,,Drug: palmidrol | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
9458,palmidrol,cannabinoid receptor 2,gpcr,,Drug: palmidrol | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
9459,palmidrol,fatty-acid amide hydrolase 1,enzyme,,Drug: palmidrol | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
9460,palmidrol,g-protein coupled receptor 55,gpcr,AGONIST,Drug: palmidrol | Target: g-protein coupled receptor 55 | Type: gpcr | Action: AGONIST
9461,palonosetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: palonosetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
9462,palonosetron,serotonin 3 receptor (5ht3),ion channel,,Drug: palonosetron | Target: serotonin 3 receptor (5ht3) | Type: ion channel | Action: nan
9463,pamabrom,adenosine receptor a1,gpcr,,Drug: pamabrom | Target: adenosine receptor a1 | Type: gpcr | Action: nan
9464,pamidronic acid,farnesyl pyrophosphate synthase,enzyme,INHIBITOR,Drug: pamidronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: INHIBITOR
9465,pamidronic acid,farnesyl pyrophosphate synthase,enzyme,,Drug: pamidronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
9466,pamidronic acid,hypoxanthine-guanine phosphoribosyltransferase,enzyme,,Drug: pamidronic acid | Target: hypoxanthine-guanine phosphoribosyltransferase | Type: enzyme | Action: nan
9467,aminobenzoic acid,carbonic anhydrase 2,enzyme,,Drug: aminobenzoic acid | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
9468,aminobenzoic acid,carbonic anhydrase 1,enzyme,,Drug: aminobenzoic acid | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
9469,aminobenzoic acid,acetylcholinesterase,enzyme,,Drug: aminobenzoic acid | Target: acetylcholinesterase | Type: enzyme | Action: nan
9470,aminobenzoic acid,polyphenol oxidase 2,enzyme,,Drug: aminobenzoic acid | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
9471,aminobenzoic acid,dihydropteroate synthase,enzyme,,Drug: aminobenzoic acid | Target: dihydropteroate synthase | Type: enzyme | Action: nan
9473,aminosalicylic acid,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,kinase,,Drug: aminosalicylic acid | Target: 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | Type: kinase | Action: nan
9474,aminosalicylic acid,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: aminosalicylic acid | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
9475,aminosalicylic acid,cyclooxygenase,enzyme,INHIBITOR,Drug: aminosalicylic acid | Target: cyclooxygenase | Type: enzyme | Action: INHIBITOR
9476,pancuronium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: pancuronium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
9477,pancuronium,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: pancuronium | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
9478,pancuronium,acetylcholine receptor; alpha1/beta1/delta/gamma,ion channel,,Drug: pancuronium | Target: acetylcholine receptor; alpha1/beta1/delta/gamma | Type: ion channel | Action: nan
9479,pantoprazole,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: pantoprazole | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
9480,pantoprazole,fatty acid synthase,enzyme,,Drug: pantoprazole | Target: fatty acid synthase | Type: enzyme | Action: nan
9481,pantoprazole,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: pantoprazole | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
9482,pantoprazole,solute carrier family 22 member 2,transporter,,Drug: pantoprazole | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
9483,pantoprazole,multidrug and toxin extrusion protein 1,transporter,,Drug: pantoprazole | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
9484,pantoprazole,multidrug and toxin extrusion protein 2,transporter,,Drug: pantoprazole | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
9485,pantoprazole,potassium-transporting atpase,transporter,INHIBITOR,Drug: pantoprazole | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
9486,pantoprazole,"n(g),n(g)-dimethylarginine dimethylaminohydrolase 1",enzyme,,"Drug: pantoprazole | Target: n(g),n(g)-dimethylarginine dimethylaminohydrolase 1 | Type: enzyme | Action: nan"
9487,pantoprazole,potassium-transporting atpase,enzyme,,Drug: pantoprazole | Target: potassium-transporting atpase | Type: enzyme | Action: nan
9488,papaverine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: papaverine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9489,papaverine,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,,"Drug: papaverine | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: nan"
9490,papaverine,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,,"Drug: papaverine | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: nan"
9491,papaverine,acetylcholinesterase,enzyme,,Drug: papaverine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9492,papaverine,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: papaverine | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
9493,papaverine,"camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a",enzyme,,"Drug: papaverine | Target: camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | Type: enzyme | Action: nan"
9494,papaverine,cytochrome p450 2c19,enzyme,,Drug: papaverine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
9495,papaverine,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: papaverine | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
9496,papaverine,"camp-specific 3',5'-cyclic phosphodiesterase 4d",enzyme,,"Drug: papaverine | Target: camp-specific 3',5'-cyclic phosphodiesterase 4d | Type: enzyme | Action: nan"
9497,papaverine,"cgmp-dependent 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: papaverine | Target: cgmp-dependent 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
9498,papaverine,"cgmp-inhibited 3',5'-cyclic phosphodiesterase b",enzyme,,"Drug: papaverine | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase b | Type: enzyme | Action: nan"
9499,papaverine,protein-arginine deiminase type-4,enzyme,,Drug: papaverine | Target: protein-arginine deiminase type-4 | Type: enzyme | Action: nan
9500,papaverine,acetylcholinesterase,enzyme,,Drug: papaverine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9501,papaverine,cyclic nucleotide phosphodiesterase pde3a,enzyme,,Drug: papaverine | Target: cyclic nucleotide phosphodiesterase pde3a | Type: enzyme | Action: nan
9502,papaverine,cyclic amp-specific phosphodiesterase sspde4a1a,enzyme,,Drug: papaverine | Target: cyclic amp-specific phosphodiesterase sspde4a1a | Type: enzyme | Action: nan
9503,papaverine,"camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a",enzyme,,"Drug: papaverine | Target: camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | Type: enzyme | Action: nan"
9504,papaverine,phosphodiesterase 1,enzyme,,Drug: papaverine | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
9505,papaverine,phosphodiesterase 1,enzyme,,Drug: papaverine | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
9506,papaverine,phosphodiesterase 1,enzyme,,Drug: papaverine | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
9507,papaverine,"serine hydroxymethyltransferase, mitochondrial",enzyme,,"Drug: papaverine | Target: serine hydroxymethyltransferase, mitochondrial | Type: enzyme | Action: nan"
9509,paramethadione,voltage-gated t-type calcium channel,ion channel,BLOCKER,Drug: paramethadione | Target: voltage-gated t-type calcium channel | Type: ion channel | Action: BLOCKER
9510,parecoxib,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: parecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
9511,parecoxib,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: parecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
9512,pargyline,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: pargyline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
9513,pargyline,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: pargyline | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
9514,pargyline,amine oxidase [flavin-containing] b,enzyme,,Drug: pargyline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
9515,pargyline,amine oxidase [flavin-containing] a,enzyme,,Drug: pargyline | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
9516,pargyline,"aldehyde dehydrogenase, mitochondrial",enzyme,,"Drug: pargyline | Target: aldehyde dehydrogenase, mitochondrial | Type: enzyme | Action: nan"
9517,paricalcitol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: paricalcitol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
9518,paroxetine,beta-1 adrenergic receptor,gpcr,,Drug: paroxetine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
9519,paroxetine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: paroxetine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9520,paroxetine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: paroxetine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9521,paroxetine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: paroxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
9522,paroxetine,sodium-dependent noradrenaline transporter,transporter,,Drug: paroxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
9523,paroxetine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: paroxetine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9524,paroxetine,d(3) dopamine receptor,gpcr,,Drug: paroxetine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9525,paroxetine,muscarinic acetylcholine receptor m1,gpcr,,Drug: paroxetine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9526,paroxetine,muscarinic acetylcholine receptor m2,gpcr,,Drug: paroxetine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
9527,paroxetine,muscarinic acetylcholine receptor m3,gpcr,,Drug: paroxetine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
9528,paroxetine,muscarinic acetylcholine receptor m4,gpcr,,Drug: paroxetine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
9529,paroxetine,muscarinic acetylcholine receptor m5,gpcr,,Drug: paroxetine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
9530,paroxetine,sodium-dependent dopamine transporter,transporter,,Drug: paroxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9531,paroxetine,cytochrome p450 2d6,enzyme,,Drug: paroxetine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9532,paroxetine,cytochrome p450 1a2,enzyme,,Drug: paroxetine | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
9533,paroxetine,substance-p receptor,gpcr,,Drug: paroxetine | Target: substance-p receptor | Type: gpcr | Action: nan
9534,paroxetine,myeloperoxidase,enzyme,,Drug: paroxetine | Target: myeloperoxidase | Type: enzyme | Action: nan
9535,paroxetine,beta-adrenergic receptor kinase 1,kinase,,Drug: paroxetine | Target: beta-adrenergic receptor kinase 1 | Type: kinase | Action: nan
9536,paroxetine,sodium-dependent serotonin transporter,transporter,,Drug: paroxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
9537,paroxetine,sodium-dependent dopamine transporter,transporter,,Drug: paroxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9538,paroxetine,transporter,transporter,,Drug: paroxetine | Target: transporter | Type: transporter | Action: nan
9539,paroxetine,sodium-dependent dopamine transporter,transporter,,Drug: paroxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9540,paroxetine,sodium-dependent noradrenaline transporter,transporter,,Drug: paroxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
9541,paroxetine,transporter,transporter,,Drug: paroxetine | Target: transporter | Type: transporter | Action: nan
9542,paroxetine,quinolone resistance protein nora,transporter,,Drug: paroxetine | Target: quinolone resistance protein nora | Type: transporter | Action: nan
9543,paroxetine,p2x purinoceptor 4,ion channel,,Drug: paroxetine | Target: p2x purinoceptor 4 | Type: ion channel | Action: nan
9544,paroxetine,adrenergic receptor alpha-2,gpcr,,Drug: paroxetine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
9545,paroxetine,adrenergic receptor alpha-1,gpcr,,Drug: paroxetine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
9546,paroxetine,p2x purinoceptor 4,unclassified,,Drug: paroxetine | Target: p2x purinoceptor 4 | Type: unclassified | Action: nan
9548,paroxetine,beta-adrenergic receptor kinase 1,kinase,,Drug: paroxetine | Target: beta-adrenergic receptor kinase 1 | Type: kinase | Action: nan
9550,pefloxacin,dna gyrase subunit a,enzyme,,Drug: pefloxacin | Target: dna gyrase subunit a | Type: enzyme | Action: nan
9551,pefloxacin,cytochrome p450 1a2,enzyme,,Drug: pefloxacin | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
9552,pefloxacin,dna gyrase subunit b,enzyme,,Drug: pefloxacin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
9553,pemetrexed,thymidylate synthase,enzyme,INHIBITOR,Drug: pemetrexed | Target: thymidylate synthase | Type: enzyme | Action: INHIBITOR
9554,pemetrexed,dihydrofolate reductase,enzyme,INHIBITOR,Drug: pemetrexed | Target: dihydrofolate reductase | Type: enzyme | Action: INHIBITOR
9555,pemetrexed,"folylpolyglutamate synthase, mitochondrial",enzyme,,"Drug: pemetrexed | Target: folylpolyglutamate synthase, mitochondrial | Type: enzyme | Action: nan"
9556,pemetrexed,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: pemetrexed | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
9557,pemetrexed,"serine hydroxymethyltransferase, cytosolic",enzyme,,"Drug: pemetrexed | Target: serine hydroxymethyltransferase, cytosolic | Type: enzyme | Action: nan"
9558,pemetrexed,folate receptor beta,membrane receptor,,Drug: pemetrexed | Target: folate receptor beta | Type: membrane receptor | Action: nan
9559,pemetrexed,proton-coupled folate transporter,transporter,,Drug: pemetrexed | Target: proton-coupled folate transporter | Type: transporter | Action: nan
9560,pemetrexed,dihydrofolate reductase,enzyme,,Drug: pemetrexed | Target: dihydrofolate reductase | Type: enzyme | Action: nan
9561,pemetrexed,thymidylate synthase,enzyme,,Drug: pemetrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
9562,pemetrexed,dihydrofolate reductase,enzyme,,Drug: pemetrexed | Target: dihydrofolate reductase | Type: enzyme | Action: nan
9563,pemetrexed,thymidylate synthase,enzyme,,Drug: pemetrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
9564,pemetrexed,thymidylate synthase,enzyme,,Drug: pemetrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
9565,pemetrexed,thymidylate synthase,enzyme,,Drug: pemetrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
9566,pemetrexed,dihydrofolate reductase,enzyme,,Drug: pemetrexed | Target: dihydrofolate reductase | Type: enzyme | Action: nan
9567,pemetrexed,thymidylate synthase,enzyme,,Drug: pemetrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
9568,pemetrexed,thymidylate synthase (ec 2.1.1.45) (ts) (tsase),enzyme,,Drug: pemetrexed | Target: thymidylate synthase (ec 2.1.1.45) (ts) (tsase) | Type: enzyme | Action: nan
9569,pemetrexed,folate transporter 1,transporter,,Drug: pemetrexed | Target: folate transporter 1 | Type: transporter | Action: nan
9570,pemetrexed,folate receptor alpha,membrane receptor,,Drug: pemetrexed | Target: folate receptor alpha | Type: membrane receptor | Action: nan
9571,pemetrexed,trifunctional purine biosynthetic protein adenosine-3,enzyme,INHIBITOR,Drug: pemetrexed | Target: trifunctional purine biosynthetic protein adenosine-3 | Type: enzyme | Action: INHIBITOR
9572,pemetrexed,trifunctional purine biosynthetic protein adenosine-3,enzyme,INHIBITOR,Drug: pemetrexed | Target: trifunctional purine biosynthetic protein adenosine-3 | Type: enzyme | Action: INHIBITOR
9573,pemoline,sodium-dependent dopamine transporter,transporter,,Drug: pemoline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9574,penbutolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: penbutolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9575,penbutolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: penbutolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9576,penbutolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: penbutolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9577,penbutolol,alpha-1-acid glycoprotein 1,secreted,,Drug: penbutolol | Target: alpha-1-acid glycoprotein 1 | Type: secreted | Action: nan
9578,penbutolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: penbutolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9579,penciclovir,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: penciclovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
9580,penciclovir,thymidine kinase,kinase,,Drug: penciclovir | Target: thymidine kinase | Type: kinase | Action: nan
9581,penciclovir,thymidine kinase,kinase,,Drug: penciclovir | Target: thymidine kinase | Type: kinase | Action: nan
9582,penfluridol,mu-type opioid receptor,gpcr,,Drug: penfluridol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9583,penfluridol,d(1a) dopamine receptor,gpcr,,Drug: penfluridol | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
9584,penfluridol,d(2) dopamine receptor,gpcr,,Drug: penfluridol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9585,penfluridol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: penfluridol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9586,penfluridol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: penfluridol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9587,penfluridol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: penfluridol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9588,penfluridol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: penfluridol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9589,penfluridol,5-hydroxytryptamine receptor 6,gpcr,,Drug: penfluridol | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9590,penfluridol,alpha-2b adrenergic receptor,gpcr,,Drug: penfluridol | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9591,penfluridol,d(3) dopamine receptor,gpcr,,Drug: penfluridol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9592,penfluridol,d(1b) dopamine receptor,gpcr,,Drug: penfluridol | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
9593,penfluridol,histamine h1 receptor,gpcr,,Drug: penfluridol | Target: histamine h1 receptor | Type: gpcr | Action: nan
9594,penfluridol,histamine h2 receptor,gpcr,,Drug: penfluridol | Target: histamine h2 receptor | Type: gpcr | Action: nan
9595,penfluridol,beta-3 adrenergic receptor,gpcr,,Drug: penfluridol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
9596,penfluridol,5-hydroxytryptamine receptor 1d,gpcr,,Drug: penfluridol | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
9597,penfluridol,alpha-2c adrenergic receptor,gpcr,,Drug: penfluridol | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
9598,penfluridol,d(4) dopamine receptor,gpcr,,Drug: penfluridol | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
9599,penfluridol,alpha-1d adrenergic receptor,gpcr,,Drug: penfluridol | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
9600,penfluridol,kappa-type opioid receptor,gpcr,,Drug: penfluridol | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9601,penfluridol,delta-type opioid receptor,gpcr,,Drug: penfluridol | Target: delta-type opioid receptor | Type: gpcr | Action: nan
9602,penfluridol,5-hydroxytryptamine receptor 5a,gpcr,,Drug: penfluridol | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
9603,penfluridol,dopamine receptor,gpcr,,Drug: penfluridol | Target: dopamine receptor | Type: gpcr | Action: nan
9604,penicillamine,succinyl-diaminopimelate desuccinylase,enzyme,,Drug: penicillamine | Target: succinyl-diaminopimelate desuccinylase | Type: enzyme | Action: nan
9605,benzylpenicillin,penicillin-binding protein 1a,enzyme,,Drug: benzylpenicillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
9606,benzylpenicillin,beta-lactamase tem,enzyme,,Drug: benzylpenicillin | Target: beta-lactamase tem | Type: enzyme | Action: nan
9607,benzylpenicillin,beta-lactamase,enzyme,,Drug: benzylpenicillin | Target: beta-lactamase | Type: enzyme | Action: nan
9608,benzylpenicillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: benzylpenicillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
9610,phenoxymethylpenicillin,penicillin-binding protein 1a,enzyme,,Drug: phenoxymethylpenicillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
9611,phenoxymethylpenicillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: phenoxymethylpenicillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
9612,pentagastrin,gastrin/cholecystokinin type b receptor,gpcr,,Drug: pentagastrin | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
9613,pentagastrin,cholecystokinin receptor type a,gpcr,,Drug: pentagastrin | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
9614,pentagastrin,gastrin/cholecystokinin type b receptor,gpcr,,Drug: pentagastrin | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
9615,pentagastrin,gastrin/cholecystokinin type b receptor,gpcr,,Drug: pentagastrin | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
9616,pentamidine,alpha-2a adrenergic receptor,gpcr,,Drug: pentamidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9617,pentamidine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: pentamidine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9618,pentamidine,sodium-dependent noradrenaline transporter,transporter,,Drug: pentamidine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
9619,pentamidine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: pentamidine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9620,pentamidine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: pentamidine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9621,pentamidine,d(3) dopamine receptor,gpcr,,Drug: pentamidine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9622,pentamidine,muscarinic acetylcholine receptor m2,gpcr,,Drug: pentamidine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
9623,pentamidine,muscarinic acetylcholine receptor m4,gpcr,,Drug: pentamidine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
9624,pentamidine,muscarinic acetylcholine receptor m5,gpcr,,Drug: pentamidine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
9625,pentamidine,sodium-dependent dopamine transporter,transporter,,Drug: pentamidine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9626,pentamidine,alpha-1d adrenergic receptor,gpcr,,Drug: pentamidine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
9627,pentamidine,amine oxidase [flavin-containing] a,enzyme,,Drug: pentamidine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
9628,pentamidine,plasminogen,enzyme,,Drug: pentamidine | Target: plasminogen | Type: enzyme | Action: nan
9629,pentamidine,trypsin-1,enzyme,,Drug: pentamidine | Target: trypsin-1 | Type: enzyme | Action: nan
9630,pentamidine,coagulation factor x,enzyme,,Drug: pentamidine | Target: coagulation factor x | Type: enzyme | Action: nan
9631,pentamidine,suppressor of tumorigenicity 14 protein,enzyme,,Drug: pentamidine | Target: suppressor of tumorigenicity 14 protein | Type: enzyme | Action: nan
9632,pentamidine,protein s100-b,cytosolic other,,Drug: pentamidine | Target: protein s100-b | Type: cytosolic other | Action: nan
9633,pentamidine,protein arginine n-methyltransferase 1,enzyme,,Drug: pentamidine | Target: protein arginine n-methyltransferase 1 | Type: enzyme | Action: nan
9634,pentamidine,solute carrier family 22 member 1,transporter,,Drug: pentamidine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
9635,pentamidine,amiloride-sensitive amine oxidase [copper-containing],enzyme,,Drug: pentamidine | Target: amiloride-sensitive amine oxidase [copper-containing] | Type: enzyme | Action: nan
9636,pentamidine,alpha-1b adrenergic receptor,gpcr,,Drug: pentamidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9637,pentamidine,alpha-1a adrenergic receptor,gpcr,,Drug: pentamidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9638,pentamidine,solute carrier family 22 member 2,transporter,,Drug: pentamidine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
9639,pentamidine,multidrug and toxin extrusion protein 1,transporter,,Drug: pentamidine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
9640,pentamidine,multidrug and toxin extrusion protein 2,transporter,,Drug: pentamidine | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
9641,pentamidine,solute carrier family 22 member 3,transporter,,Drug: pentamidine | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
9642,pentamidine,glutamate nmda receptor,ion channel,,Drug: pentamidine | Target: glutamate nmda receptor | Type: ion channel | Action: nan
9643,pentamidine,glutamate nmda receptor; grin1/grin2a,ion channel,,Drug: pentamidine | Target: glutamate nmda receptor; grin1/grin2a | Type: ion channel | Action: nan
9644,pentamidine,spermidine/spermine n(1)-acetyltransferase 1,enzyme,,Drug: pentamidine | Target: spermidine/spermine n(1)-acetyltransferase 1 | Type: enzyme | Action: nan
9645,pentamidine,protein-tyrosine phosphatase 4a3,enzyme,,Drug: pentamidine | Target: protein-tyrosine phosphatase 4a3 | Type: enzyme | Action: nan
9646,pentamidine,acrosin,enzyme,,Drug: pentamidine | Target: acrosin | Type: enzyme | Action: nan
9647,pentamidine,protein s100-b,unclassified,,Drug: pentamidine | Target: protein s100-b | Type: unclassified | Action: nan
9650,pentamidine,protein tyrosine phosphatase type iva 2,enzyme,,Drug: pentamidine | Target: protein tyrosine phosphatase type iva 2 | Type: enzyme | Action: nan
9651,pentamidine,protein tyrosine phosphatase type iva 1,enzyme,,Drug: pentamidine | Target: protein tyrosine phosphatase type iva 1 | Type: enzyme | Action: nan
9652,pentobarbital,gamma-aminobutyric acid receptor subunit beta-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: pentobarbital | Target: gamma-aminobutyric acid receptor subunit beta-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
9653,pentobarbital,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: pentobarbital | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9654,pentobarbital,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: pentobarbital | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
9655,pentobarbital,gaba-a receptor; anion channel,ion channel,,Drug: pentobarbital | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
9656,pentobarbital,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,,Drug: pentobarbital | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: nan
9657,pentolonium,neuronal acetylcholine receptor subunit alpha-10,ion channel,,Drug: pentolonium | Target: neuronal acetylcholine receptor subunit alpha-10 | Type: ion channel | Action: nan
9658,pentolonium,neuronal acetylcholine receptor; alpha3/beta4,ion channel,ANTAGONIST,Drug: pentolonium | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: ANTAGONIST
9659,pentostatin,adenosine deaminase,enzyme,INHIBITOR,Drug: pentostatin | Target: adenosine deaminase | Type: enzyme | Action: INHIBITOR
9660,pentostatin,adenosine deaminase,enzyme,,Drug: pentostatin | Target: adenosine deaminase | Type: enzyme | Action: nan
9661,pentoxifylline,adenosine receptor a2b,gpcr,ANTAGONIST,Drug: pentoxifylline | Target: adenosine receptor a2b | Type: gpcr | Action: ANTAGONIST
9662,pentoxifylline,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,INHIBITOR,"Drug: pentoxifylline | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: INHIBITOR"
9663,pentoxifylline,acetylcholinesterase,enzyme,,Drug: pentoxifylline | Target: acetylcholinesterase | Type: enzyme | Action: nan
9664,pentoxifylline,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: pentoxifylline | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
9665,pergolide,alpha-2a adrenergic receptor,gpcr,,Drug: pergolide | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9666,pergolide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: pergolide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9667,pergolide,5-hydroxytryptamine receptor 1a,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9668,pergolide,5-hydroxytryptamine receptor 2a,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9669,pergolide,5-hydroxytryptamine receptor 2b,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9670,pergolide,5-hydroxytryptamine receptor 2c,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9671,pergolide,5-hydroxytryptamine receptor 6,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9672,pergolide,alpha-1a adrenergic receptor,gpcr,,Drug: pergolide | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9673,pergolide,alpha-2b adrenergic receptor,gpcr,,Drug: pergolide | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9674,pergolide,d(3) dopamine receptor,gpcr,AGONIST,Drug: pergolide | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
9675,pergolide,d(1b) dopamine receptor,gpcr,AGONIST,Drug: pergolide | Target: d(1b) dopamine receptor | Type: gpcr | Action: AGONIST
9676,pergolide,5-hydroxytryptamine receptor 1b,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
9677,pergolide,5-hydroxytryptamine receptor 1d,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
9678,pergolide,alpha-2c adrenergic receptor,gpcr,,Drug: pergolide | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
9679,pergolide,cytochrome p450 2d6,enzyme,,Drug: pergolide | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9680,pergolide,d(4) dopamine receptor,gpcr,AGONIST,Drug: pergolide | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
9681,pergolide,alpha-1d adrenergic receptor,gpcr,,Drug: pergolide | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
9682,pergolide,alpha-1b adrenergic receptor,gpcr,,Drug: pergolide | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9683,pergolide,alpha-1b adrenergic receptor,gpcr,,Drug: pergolide | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9684,pergolide,5-hydroxytryptamine receptor 1b,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
9685,pergolide,alpha-1a adrenergic receptor,gpcr,,Drug: pergolide | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9686,pergolide,d(2) dopamine receptor,gpcr,,Drug: pergolide | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9687,pergolide,5-hydroxytryptamine receptor 1a,gpcr,,Drug: pergolide | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9688,pergolide,5-hydroxytryptamine receptor 7,gpcr,AGONIST,Drug: pergolide | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: AGONIST
9689,pergolide,d(2) dopamine receptor,gpcr,,Drug: pergolide | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9690,pergolide,d(3) dopamine receptor,gpcr,,Drug: pergolide | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9691,pergolide,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: pergolide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
9692,pergolide,adrenergic receptor alpha-2,gpcr,,Drug: pergolide | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
9693,pergolide,dopamine receptor,gpcr,,Drug: pergolide | Target: dopamine receptor | Type: gpcr | Action: nan
9694,pergolide,dopamine receptor,gpcr,,Drug: pergolide | Target: dopamine receptor | Type: gpcr | Action: nan
9695,pergolide,cerebral cortex alpha adrenergic receptor,gpcr,,Drug: pergolide | Target: cerebral cortex alpha adrenergic receptor | Type: gpcr | Action: nan
9696,pergolide,d(2) dopamine receptor,gpcr,AGONIST,Drug: pergolide | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
9697,pergolide,d(1a) dopamine receptor,gpcr,AGONIST,Drug: pergolide | Target: d(1a) dopamine receptor | Type: gpcr | Action: AGONIST
9698,perhexiline,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: perhexiline | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9699,perhexiline,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: perhexiline | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9700,perhexiline,sodium-dependent noradrenaline transporter,transporter,,Drug: perhexiline | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
9701,perhexiline,muscarinic acetylcholine receptor m1,gpcr,,Drug: perhexiline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9702,perhexiline,muscarinic acetylcholine receptor m3,gpcr,,Drug: perhexiline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
9703,perhexiline,muscarinic acetylcholine receptor m4,gpcr,,Drug: perhexiline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
9704,perhexiline,muscarinic acetylcholine receptor m5,gpcr,,Drug: perhexiline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
9705,perhexiline,cytochrome p450 2d6,enzyme,,Drug: perhexiline | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9706,perhexiline,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,,Drug: perhexiline | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: nan
9707,perhexiline,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,,Drug: perhexiline | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: nan
9708,perhexiline,voltage-dependent t-type calcium channel subunit alpha-1i,ion channel,,Drug: perhexiline | Target: voltage-dependent t-type calcium channel subunit alpha-1i | Type: ion channel | Action: nan
9709,perhexiline,"carnitine o-palmitoyltransferase 1, liver isoform",enzyme,,"Drug: perhexiline | Target: carnitine o-palmitoyltransferase 1, liver isoform | Type: enzyme | Action: nan"
9710,perhexiline,"carnitine o-palmitoyltransferase 2, mitochondrial",enzyme,,"Drug: perhexiline | Target: carnitine o-palmitoyltransferase 2, mitochondrial | Type: enzyme | Action: nan"
9711,perhexiline,epidermal growth factor receptor,kinase,,Drug: perhexiline | Target: epidermal growth factor receptor | Type: kinase | Action: nan
9712,perhexiline,tyrosine-protein kinase fyn,kinase,,Drug: perhexiline | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
9713,perhexiline,"carnitine o-palmitoyltransferase 1, muscle isoform",enzyme,,"Drug: perhexiline | Target: carnitine o-palmitoyltransferase 1, muscle isoform | Type: enzyme | Action: nan"
9714,perhexiline,adrenergic receptor alpha-1,gpcr,,Drug: perhexiline | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
9715,perhexiline,carnitine palmitoyltransferase 2,enzyme,,Drug: perhexiline | Target: carnitine palmitoyltransferase 2 | Type: enzyme | Action: nan
9716,perhexiline,carnitine palmitoyltransferase 1a,enzyme,,Drug: perhexiline | Target: carnitine palmitoyltransferase 1a | Type: enzyme | Action: nan
9717,periciazine,d(1a) dopamine receptor,gpcr,ANTAGONIST,Drug: periciazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9718,periciazine,androgen receptor,transcription factor,,Drug: periciazine | Target: androgen receptor | Type: transcription factor | Action: nan
9719,periciazine,acetylcholinesterase,enzyme,,Drug: periciazine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9720,periciazine,cholinesterase,enzyme,,Drug: periciazine | Target: cholinesterase | Type: enzyme | Action: nan
9721,perindopril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: perindopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
9722,perlapine,d(2) dopamine receptor,gpcr,,Drug: perlapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9723,perlapine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: perlapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9724,perlapine,5-hydroxytryptamine receptor 6,gpcr,,Drug: perlapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9725,perlapine,d(3) dopamine receptor,gpcr,,Drug: perlapine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9726,perlapine,histamine h4 receptor,gpcr,,Drug: perlapine | Target: histamine h4 receptor | Type: gpcr | Action: nan
9727,perlapine,d(4) dopamine receptor,gpcr,,Drug: perlapine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
9728,perlapine,d(2) dopamine receptor,gpcr,,Drug: perlapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9729,perospirone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: perospirone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9730,perospirone,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: perospirone | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9731,perospirone,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: perospirone | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9732,perospirone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: perospirone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
9733,perphenazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: perphenazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9734,perphenazine,alpha-2a adrenergic receptor,gpcr,,Drug: perphenazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9735,perphenazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: perphenazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9736,perphenazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: perphenazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9737,perphenazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: perphenazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9738,perphenazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: perphenazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9739,perphenazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: perphenazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9740,perphenazine,5-hydroxytryptamine receptor 7,gpcr,,Drug: perphenazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
9741,perphenazine,alpha-1a adrenergic receptor,gpcr,,Drug: perphenazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9742,perphenazine,alpha-2b adrenergic receptor,gpcr,,Drug: perphenazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9743,perphenazine,d(3) dopamine receptor,gpcr,,Drug: perphenazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
9744,perphenazine,histamine h1 receptor,gpcr,,Drug: perphenazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9745,perphenazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: perphenazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
9746,perphenazine,aldehyde oxidase,enzyme,,Drug: perphenazine | Target: aldehyde oxidase | Type: enzyme | Action: nan
9747,perphenazine,alpha-2c adrenergic receptor,gpcr,,Drug: perphenazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
9748,perphenazine,d(4) dopamine receptor,gpcr,,Drug: perphenazine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
9749,perphenazine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: perphenazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
9750,perphenazine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: perphenazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
9751,perphenazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: perphenazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
9752,phenacemide,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: phenacemide | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
9753,phenacetin,prostaglandin g/h synthase 1,enzyme,,Drug: phenacetin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
9754,phenazocine,mu-type opioid receptor,gpcr,,Drug: phenazocine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9755,phenazocine,kappa-type opioid receptor,gpcr,,Drug: phenazocine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9756,phenazocine,delta-type opioid receptor,gpcr,,Drug: phenazocine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
9757,phenazocine,mu-type opioid receptor,gpcr,,Drug: phenazocine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9758,phenazocine,mu-type opioid receptor,gpcr,,Drug: phenazocine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9759,phenazopyridine,sodium channel alpha subunit,ion channel,BLOCKER,Drug: phenazopyridine | Target: sodium channel alpha subunit | Type: ion channel | Action: BLOCKER
9760,phenazopyridine,snake venom metalloproteinase bap1,enzyme,,Drug: phenazopyridine | Target: snake venom metalloproteinase bap1 | Type: enzyme | Action: nan
9761,phencyclidine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: phencyclidine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9762,phencyclidine,lysosomal pro-x carboxypeptidase,enzyme,,Drug: phencyclidine | Target: lysosomal pro-x carboxypeptidase | Type: enzyme | Action: nan
9763,phencyclidine,"glutamate receptor ionotropic, nmda 1",ion channel,,"Drug: phencyclidine | Target: glutamate receptor ionotropic, nmda 1 | Type: ion channel | Action: nan"
9764,phencyclidine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: phencyclidine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9765,phencyclidine,"glutamate receptor ionotropic, nmda 2c",ion channel,,"Drug: phencyclidine | Target: glutamate receptor ionotropic, nmda 2c | Type: ion channel | Action: nan"
9766,phencyclidine,cholinesterase,enzyme,,Drug: phencyclidine | Target: cholinesterase | Type: enzyme | Action: nan
9767,phencyclidine,acetylcholine receptor subunit alpha,ion channel,,Drug: phencyclidine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
9768,phencyclidine,glutamate [nmda] receptor,ion channel,,Drug: phencyclidine | Target: glutamate [nmda] receptor | Type: ion channel | Action: nan
9769,phencyclidine,glutamate nmda receptor,ion channel,,Drug: phencyclidine | Target: glutamate nmda receptor | Type: ion channel | Action: nan
9770,phencyclidine,glutamate nmda receptor; grin1/grin2b,ion channel,,Drug: phencyclidine | Target: glutamate nmda receptor; grin1/grin2b | Type: ion channel | Action: nan
9771,phencyclidine,glutamate nmda receptor; grin1/grin2a,ion channel,,Drug: phencyclidine | Target: glutamate nmda receptor; grin1/grin2a | Type: ion channel | Action: nan
9772,phencyclidine,muscarinic acetylcholine receptor,gpcr,,Drug: phencyclidine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
9773,phendimetrazine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: phendimetrazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
9774,phendimetrazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: phendimetrazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9775,phendimetrazine,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: phendimetrazine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
9776,phenelzine,cytochrome p450 3a4,enzyme,,Drug: phenelzine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
9777,phenelzine,sodium-dependent dopamine transporter,transporter,,Drug: phenelzine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9778,phenelzine,cytochrome p450 2d6,enzyme,,Drug: phenelzine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9779,phenelzine,cytochrome p450 2c8,enzyme,INHIBITOR,Drug: phenelzine | Target: cytochrome p450 2c8 | Type: enzyme | Action: INHIBITOR
9780,phenelzine,cytochrome p450 2c9,enzyme,,Drug: phenelzine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
9781,phenelzine,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: phenelzine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
9782,phenelzine,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: phenelzine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
9783,phenelzine,cytochrome p450 2c19,enzyme,,Drug: phenelzine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
9784,phenelzine,membrane primary amine oxidase,enzyme,,Drug: phenelzine | Target: membrane primary amine oxidase | Type: enzyme | Action: nan
9785,phenelzine,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: phenelzine | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
9786,phenelzine,amine oxidase [flavin-containing] b,enzyme,,Drug: phenelzine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
9787,phenelzine,amine oxidase [flavin-containing] a,enzyme,,Drug: phenelzine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
9788,phenelzine,lysine-specific histone demethylase 1a,enzyme,,Drug: phenelzine | Target: lysine-specific histone demethylase 1a | Type: enzyme | Action: nan
9789,phenelzine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: phenelzine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
9790,phenformin,5'-amp-activated protein kinase subunit beta-1,kinase,,Drug: phenformin | Target: 5'-amp-activated protein kinase subunit beta-1 | Type: kinase | Action: nan
9791,phenindamine,histamine h1 receptor,gpcr,,Drug: phenindamine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9792,phenindione,vitamin k epoxide reductase complex subunit 1,enzyme,INHIBITOR,Drug: phenindione | Target: vitamin k epoxide reductase complex subunit 1 | Type: enzyme | Action: INHIBITOR
9793,phenindione,prothrombin,enzyme,,Drug: phenindione | Target: prothrombin | Type: enzyme | Action: nan
9794,phenindione,arachidonate 5-lipoxygenase,enzyme,,Drug: phenindione | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
9795,pheniprazine,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: pheniprazine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
9796,pheniprazine,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: pheniprazine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
9797,pheniramine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: pheniramine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
9798,pheniramine,histamine h4 receptor,gpcr,,Drug: pheniramine | Target: histamine h4 receptor | Type: gpcr | Action: nan
9799,pheniramine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: pheniramine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
9800,phenmetrazine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: phenmetrazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
9801,phenmetrazine,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: phenmetrazine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
9802,phenmetrazine,amine oxidase [flavin-containing] a,enzyme,,Drug: phenmetrazine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
9803,phenobarbital,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: phenobarbital | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
9804,phenobarbital,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: phenobarbital | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
9805,phenobarbital,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: phenobarbital | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
9806,phenobarbital,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: phenobarbital | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
9807,phenolphthalein,thymidylate synthase,enzyme,,Drug: phenolphthalein | Target: thymidylate synthase | Type: enzyme | Action: nan
9808,phenolphthalein,thymidylate synthase,enzyme,,Drug: phenolphthalein | Target: thymidylate synthase | Type: enzyme | Action: nan
9809,phenolphthalein,thymidylate synthase,enzyme,,Drug: phenolphthalein | Target: thymidylate synthase | Type: enzyme | Action: nan
9810,phenolphthalein,thymidylate synthase,enzyme,,Drug: phenolphthalein | Target: thymidylate synthase | Type: enzyme | Action: nan
9811,phenoxybenzamine,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: phenoxybenzamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9812,phenoxybenzamine,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: phenoxybenzamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9813,phenoxybenzamine,alpha-2b adrenergic receptor,gpcr,ANTAGONIST,Drug: phenoxybenzamine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9814,phenoxybenzamine,solute carrier family 22 member 1,transporter,,Drug: phenoxybenzamine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
9815,phenoxybenzamine,dopamine receptor,gpcr,,Drug: phenoxybenzamine | Target: dopamine receptor | Type: gpcr | Action: nan
9816,phenoxybenzamine,adrenergic receptor alpha-1,gpcr,,Drug: phenoxybenzamine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
9817,phenoxybenzamine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: phenoxybenzamine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
9818,phenprocoumon,pol polyprotein,enzyme,,Drug: phenprocoumon | Target: pol polyprotein | Type: enzyme | Action: nan
9819,phenprocoumon,vitamin k epoxide reductase complex subunit 1,unclassified,,Drug: phenprocoumon | Target: vitamin k epoxide reductase complex subunit 1 | Type: unclassified | Action: nan
9821,phenprocoumon,vitamin k epoxide reductase complex subunit 1,enzyme,INHIBITOR,Drug: phenprocoumon | Target: vitamin k epoxide reductase complex subunit 1 | Type: enzyme | Action: INHIBITOR
9822,phensuximide,voltage-gated t-type calcium channel,ion channel,BLOCKER,Drug: phensuximide | Target: voltage-gated t-type calcium channel | Type: ion channel | Action: BLOCKER
9823,phentermine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: phentermine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
9824,phentermine,sodium-dependent dopamine transporter,transporter,,Drug: phentermine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9825,phentolamine,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: phentolamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9826,phentolamine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: phentolamine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9827,phentolamine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: phentolamine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9828,phentolamine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: phentolamine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9829,phentolamine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: phentolamine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9830,phentolamine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: phentolamine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
9831,phentolamine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: phentolamine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9832,phentolamine,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: phentolamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9833,phentolamine,alpha-2b adrenergic receptor,gpcr,ANTAGONIST,Drug: phentolamine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9834,phentolamine,histamine h1 receptor,gpcr,,Drug: phentolamine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9835,phentolamine,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: phentolamine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9836,phentolamine,cytochrome p450 2d6,enzyme,,Drug: phentolamine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9837,phentolamine,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: phentolamine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9838,phentolamine,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: phentolamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
9839,phentolamine,nischarin,membrane receptor,,Drug: phentolamine | Target: nischarin | Type: membrane receptor | Action: nan
9840,phentolamine,alpha-1b adrenergic receptor,gpcr,,Drug: phentolamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9841,phentolamine,alpha-1a adrenergic receptor,gpcr,,Drug: phentolamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9842,phentolamine,alpha-1d adrenergic receptor,gpcr,,Drug: phentolamine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
9843,phentolamine,alpha-2a adrenergic receptor,gpcr,,Drug: phentolamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9844,phentolamine,alpha-1a adrenergic receptor,gpcr,,Drug: phentolamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9845,phentolamine,histamine h1 receptor,gpcr,,Drug: phentolamine | Target: histamine h1 receptor | Type: gpcr | Action: nan
9846,phentolamine,alpha-2a adrenergic receptor,gpcr,,Drug: phentolamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9847,phentolamine,alpha-1b adrenergic receptor,gpcr,,Drug: phentolamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9848,phentolamine,adrenergic receptor alpha-2,gpcr,,Drug: phentolamine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
9849,phentolamine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: phentolamine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
9850,phenylalanine,large neutral amino acids transporter small subunit 1,transporter,,Drug: phenylalanine | Target: large neutral amino acids transporter small subunit 1 | Type: transporter | Action: nan
9851,phenylalanine,voltage-dependent calcium channel subunit alpha-2/delta-1,ion channel,,Drug: phenylalanine | Target: voltage-dependent calcium channel subunit alpha-2/delta-1 | Type: ion channel | Action: nan
9852,phenylalanine,l-type amino acid transporter 1,transporter,,Drug: phenylalanine | Target: l-type amino acid transporter 1 | Type: transporter | Action: nan
9853,phenylalanine,intestinal alkaline phosphatase,enzyme,,Drug: phenylalanine | Target: intestinal alkaline phosphatase | Type: enzyme | Action: nan
9854,phenylalanine,probable g-protein coupled receptor 139,gpcr,AGONIST,Drug: phenylalanine | Target: probable g-protein coupled receptor 139 | Type: gpcr | Action: AGONIST
9855,phenylalanine,intestinal-type alkaline phosphatase,enzyme,,Drug: phenylalanine | Target: intestinal-type alkaline phosphatase | Type: enzyme | Action: nan
9856,phenylalanine,e3 ubiquitin-protein ligase xiap,unclassified,,Drug: phenylalanine | Target: e3 ubiquitin-protein ligase xiap | Type: unclassified | Action: nan
9857,phenylbutazone,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: phenylbutazone | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
9858,phenylbutazone,fmet-leu-phe receptor,gpcr,,Drug: phenylbutazone | Target: fmet-leu-phe receptor | Type: gpcr | Action: nan
9859,phenylbutazone,prostacyclin synthase,enzyme,,Drug: phenylbutazone | Target: prostacyclin synthase | Type: enzyme | Action: nan
9860,phenylbutazone,cytochrome p450 2c9,enzyme,,Drug: phenylbutazone | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
9861,phenylbutazone,cyclooxygenase 2; prostaglandin g/h synthase-2; uncharacterized protein,enzyme,,Drug: phenylbutazone | Target: cyclooxygenase 2; prostaglandin g/h synthase-2; uncharacterized protein | Type: enzyme | Action: nan
9862,phenylbutazone,cyclooxygenase,enzyme,,Drug: phenylbutazone | Target: cyclooxygenase | Type: enzyme | Action: nan
9863,phenylbutazone,nicotinate phosphoribosyltransferase,enzyme,,Drug: phenylbutazone | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
9864,phenylephrine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: phenylephrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
9865,phenylephrine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: phenylephrine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
9866,phenylephrine,alpha-1b adrenergic receptor,gpcr,AGONIST,Drug: phenylephrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: AGONIST
9867,phenylephrine,beta-1 adrenergic receptor,gpcr,,Drug: phenylephrine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
9868,phenylephrine,alpha-1a adrenergic receptor,gpcr,,Drug: phenylephrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9869,phenylephrine,alpha-1b adrenergic receptor,gpcr,,Drug: phenylephrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9870,phenylephrine,adrenergic receptor alpha-2,gpcr,,Drug: phenylephrine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
9871,phenylephrine,adrenergic receptor alpha-1,gpcr,,Drug: phenylephrine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
9872,phenylephrine,adrenergic receptor alpha-2,gpcr,,Drug: phenylephrine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
9873,phenylephrine,alpha-1b adrenergic receptor,gpcr,,Drug: phenylephrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9874,phenylpropanolamine,alpha-2a adrenergic receptor,gpcr,,Drug: phenylpropanolamine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9875,phenylpropanolamine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: phenylpropanolamine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9876,phenylpropanolamine,sodium-dependent noradrenaline transporter,transporter,,Drug: phenylpropanolamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
9877,phenylpropanolamine,5-hydroxytryptamine receptor 7,gpcr,,Drug: phenylpropanolamine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
9878,phenylpropanolamine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: phenylpropanolamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
9879,phenylpropanolamine,alpha-2b adrenergic receptor,gpcr,,Drug: phenylpropanolamine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9880,phenylpropanolamine,muscarinic acetylcholine receptor m1,gpcr,,Drug: phenylpropanolamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9881,phenylpropanolamine,alpha-2c adrenergic receptor,gpcr,,Drug: phenylpropanolamine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
9882,phenylpropanolamine,sodium-dependent dopamine transporter,transporter,,Drug: phenylpropanolamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
9883,phenylpropanolamine,alpha-1a adrenergic receptor,gpcr,,Drug: phenylpropanolamine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9884,phenylpropanolamine,alpha-2b adrenergic receptor,gpcr,,Drug: phenylpropanolamine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9885,phenylpropanolamine,alpha-1d adrenergic receptor,gpcr,,Drug: phenylpropanolamine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
9886,phenylpropanolamine,alpha-1b adrenergic receptor,gpcr,,Drug: phenylpropanolamine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
9887,phenyltoloxamine,d(1a) dopamine receptor,gpcr,,Drug: phenyltoloxamine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
9888,phenyltoloxamine,d(2) dopamine receptor,gpcr,,Drug: phenyltoloxamine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9889,phenyltoloxamine,d(1b) dopamine receptor,gpcr,,Drug: phenyltoloxamine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
9890,phenyltoloxamine,d(4) dopamine receptor,gpcr,,Drug: phenyltoloxamine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
9891,phenyltoloxamine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: phenyltoloxamine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
9892,phenytoin,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: phenytoin | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
9893,phenytoin,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: phenytoin | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
9894,phenytoin,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: phenytoin | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
9895,phenytoin,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: phenytoin | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
9896,phenytoin,sodium channel protein type 3 subunit alpha,ion channel,BLOCKER,Drug: phenytoin | Target: sodium channel protein type 3 subunit alpha | Type: ion channel | Action: BLOCKER
9897,phenytoin,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: phenytoin | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
9898,phenytoin,sodium channel protein type 8 subunit alpha,ion channel,BLOCKER,Drug: phenytoin | Target: sodium channel protein type 8 subunit alpha | Type: ion channel | Action: BLOCKER
9899,phenytoin,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: phenytoin | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
9900,phenytoin,sodium channel protein type 2 subunit alpha,ion channel,,Drug: phenytoin | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: nan
9901,phenytoin,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: phenytoin | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
9902,phloroglucinol,beta-secretase 1,enzyme,,Drug: phloroglucinol | Target: beta-secretase 1 | Type: enzyme | Action: nan
9903,oxagrelate,phosphodiesterase 3,enzyme,,Drug: oxagrelate | Target: phosphodiesterase 3 | Type: enzyme | Action: nan
9904,oxagrelate,phosphodiesterase 1,enzyme,,Drug: oxagrelate | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
9905,physostigmine,cytochrome p450 2d6,enzyme,,Drug: physostigmine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
9906,physostigmine,acetylcholinesterase,enzyme,INHIBITOR,Drug: physostigmine | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
9907,physostigmine,cholinesterase,enzyme,,Drug: physostigmine | Target: cholinesterase | Type: enzyme | Action: nan
9908,physostigmine,acetylcholinesterase,enzyme,,Drug: physostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9909,physostigmine,acetylcholinesterase,enzyme,,Drug: physostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9910,physostigmine,butyrylcholinesterase; protein bche,enzyme,,Drug: physostigmine | Target: butyrylcholinesterase; protein bche | Type: enzyme | Action: nan
9911,physostigmine,acetylcholinesterase,enzyme,,Drug: physostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9912,physostigmine,acetylcholinesterase,enzyme,,Drug: physostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9913,physostigmine,acetylcholinesterase,enzyme,,Drug: physostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9914,physostigmine,muscarinic acetylcholine receptor m1,gpcr,,Drug: physostigmine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9915,physostigmine,cholinesterase,enzyme,,Drug: physostigmine | Target: cholinesterase | Type: enzyme | Action: nan
9916,physostigmine,butyrylcholinesterase,enzyme,,Drug: physostigmine | Target: butyrylcholinesterase | Type: enzyme | Action: nan
9917,physostigmine,cholinesterase,enzyme,,Drug: physostigmine | Target: cholinesterase | Type: enzyme | Action: nan
9918,physostigmine,acetylcholinesterase,enzyme,,Drug: physostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
9919,picrotoxin,glycine receptor subunit alpha-1,ion channel,BLOCKER,Drug: picrotoxin | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: BLOCKER
9920,picrotoxin,glycine receptor subunit alpha-2,ion channel,BLOCKER,Drug: picrotoxin | Target: glycine receptor subunit alpha-2 | Type: ion channel | Action: BLOCKER
9921,picrotoxin,glycine receptor subunit beta,ion channel,BLOCKER,Drug: picrotoxin | Target: glycine receptor subunit beta | Type: ion channel | Action: BLOCKER
9922,picrotoxin,5-hydroxytryptamine receptor 3a,ion channel,BLOCKER,Drug: picrotoxin | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: BLOCKER
9923,picrotoxin,gaba-a receptor; anion channel,ion channel,,Drug: picrotoxin | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
9924,picrotin,glycine receptor subunit alpha-1,ion channel,,Drug: picrotin | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
9925,picrotin,glycine receptor subunit alpha-2,ion channel,BLOCKER,Drug: picrotin | Target: glycine receptor subunit alpha-2 | Type: ion channel | Action: BLOCKER
9926,picrotin,glycine receptor subunit beta,ion channel,BLOCKER,Drug: picrotin | Target: glycine receptor subunit beta | Type: ion channel | Action: BLOCKER
9927,picrotin,glycine receptor subunit alpha-3,ion channel,,Drug: picrotin | Target: glycine receptor subunit alpha-3 | Type: ion channel | Action: nan
9928,piketoprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: piketoprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
9929,piketoprofen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: piketoprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
9930,pilocarpine,muscarinic acetylcholine receptor m2,gpcr,,Drug: pilocarpine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
9931,pilocarpine,muscarinic acetylcholine receptor m1,gpcr,,Drug: pilocarpine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9932,pilocarpine,muscarinic acetylcholine receptor m1,gpcr,,Drug: pilocarpine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
9933,pilocarpine,muscarinic acetylcholine receptor dm1,gpcr,,Drug: pilocarpine | Target: muscarinic acetylcholine receptor dm1 | Type: gpcr | Action: nan
9934,pilocarpine,muscarinic acetylcholine receptor,gpcr,,Drug: pilocarpine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
9935,pilocarpine,muscarinic acetylcholine receptor m1,gpcr,AGONIST,Drug: pilocarpine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: AGONIST
9936,pilocarpine,muscarinic acetylcholine receptor m2,gpcr,AGONIST,Drug: pilocarpine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: AGONIST
9937,pilocarpine,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: pilocarpine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
9938,pilocarpine,muscarinic acetylcholine receptor m4,gpcr,AGONIST,Drug: pilocarpine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: AGONIST
9939,pilocarpine,muscarinic acetylcholine receptor m5,gpcr,AGONIST,Drug: pilocarpine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: AGONIST
9940,pilsicainide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: pilsicainide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9941,pilsicainide,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: pilsicainide | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
9942,pimecrolimus,interleukin-5,cytokine,,Drug: pimecrolimus | Target: interleukin-5 | Type: cytokine | Action: nan
9943,pimecrolimus,interferon gamma,cytokine,,Drug: pimecrolimus | Target: interferon gamma | Type: cytokine | Action: nan
9944,pimecrolimus,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,INHIBITOR,Drug: pimecrolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: INHIBITOR
9945,pimecrolimus,interleukin-2,cytokine,,Drug: pimecrolimus | Target: interleukin-2 | Type: cytokine | Action: nan
9946,pimecrolimus,serine/threonine-protein phosphatase 2b catalytic subunit gamma isoform,enzyme,,Drug: pimecrolimus | Target: serine/threonine-protein phosphatase 2b catalytic subunit gamma isoform | Type: enzyme | Action: nan
9947,pimecrolimus,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,INHIBITOR,Drug: pimecrolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: INHIBITOR
9948,pimethixene,5-hydroxytryptamine receptor 2a,gpcr,,Drug: pimethixene | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
9949,pimethixene,transcriptional activator protein luxr,unclassified,,Drug: pimethixene | Target: transcriptional activator protein luxr | Type: unclassified | Action: nan
9950,pimethixene,histone-lysine n-methyltransferase setd7,enzyme,,Drug: pimethixene | Target: histone-lysine n-methyltransferase setd7 | Type: enzyme | Action: nan
9951,pimobendan,type-1 angiotensin ii receptor,gpcr,,Drug: pimobendan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
9952,pimobendan,phosphodiesterase 3,enzyme,INHIBITOR,Drug: pimobendan | Target: phosphodiesterase 3 | Type: enzyme | Action: INHIBITOR
9953,pimozide,mu-type opioid receptor,gpcr,,Drug: pimozide | Target: mu-type opioid receptor | Type: gpcr | Action: nan
9954,pimozide,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: pimozide | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9955,pimozide,alpha-2a adrenergic receptor,gpcr,,Drug: pimozide | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
9956,pimozide,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: pimozide | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
9957,pimozide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: pimozide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
9958,pimozide,multidrug resistance protein 1,transporter,,Drug: pimozide | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
9959,pimozide,5-hydroxytryptamine receptor 1a,gpcr,,Drug: pimozide | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9960,pimozide,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: pimozide | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
9961,pimozide,5-hydroxytryptamine receptor 2c,gpcr,,Drug: pimozide | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
9962,pimozide,5-hydroxytryptamine receptor 6,gpcr,,Drug: pimozide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
9963,pimozide,5-hydroxytryptamine receptor 7,gpcr,,Drug: pimozide | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
9964,pimozide,alpha-1a adrenergic receptor,gpcr,,Drug: pimozide | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
9965,pimozide,alpha-2b adrenergic receptor,gpcr,,Drug: pimozide | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
9966,pimozide,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: pimozide | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9967,pimozide,histamine h1 receptor,gpcr,,Drug: pimozide | Target: histamine h1 receptor | Type: gpcr | Action: nan
9968,pimozide,histamine h4 receptor,gpcr,,Drug: pimozide | Target: histamine h4 receptor | Type: gpcr | Action: nan
9969,pimozide,muscarinic acetylcholine receptor m3,gpcr,,Drug: pimozide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
9970,pimozide,5-hydroxytryptamine receptor 1d,gpcr,,Drug: pimozide | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
9971,pimozide,alpha-2c adrenergic receptor,gpcr,,Drug: pimozide | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
9972,pimozide,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: pimozide | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
9973,pimozide,kappa-type opioid receptor,gpcr,,Drug: pimozide | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
9974,pimozide,multidrug resistance-associated protein 1,transporter,,Drug: pimozide | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
9975,pimozide,glycine receptor subunit alpha-1,ion channel,,Drug: pimozide | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
9976,pimozide,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,,Drug: pimozide | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: nan
9977,pimozide,calmodulin,cytosolic other,,Drug: pimozide | Target: calmodulin | Type: cytosolic other | Action: nan
9978,pimozide,delta-type opioid receptor,gpcr,,Drug: pimozide | Target: delta-type opioid receptor | Type: gpcr | Action: nan
9979,pimozide,voltage-dependent t-type calcium channel subunit alpha-1i,ion channel,BLOCKER,Drug: pimozide | Target: voltage-dependent t-type calcium channel subunit alpha-1i | Type: ion channel | Action: BLOCKER
9980,pimozide,potassium channel subfamily k member 2,ion channel,,Drug: pimozide | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
9981,pimozide,potassium voltage-gated channel subfamily a member 10,ion channel,BLOCKER,Drug: pimozide | Target: potassium voltage-gated channel subfamily a member 10 | Type: ion channel | Action: BLOCKER
9982,pimozide,5-hydroxytryptamine receptor 7,gpcr,,Drug: pimozide | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
9983,pimozide,sodium channel protein type 2 subunit alpha,ion channel,,Drug: pimozide | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: nan
9984,pimozide,d(2) dopamine receptor,gpcr,,Drug: pimozide | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
9985,pimozide,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: pimozide | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
9986,pimozide,solute carrier family 22 member 2,transporter,,Drug: pimozide | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
9987,pimozide,dopamine receptor,gpcr,,Drug: pimozide | Target: dopamine receptor | Type: gpcr | Action: nan
9988,pimozide,ubiquitin carboxyl-terminal hydrolase 1,enzyme,,Drug: pimozide | Target: ubiquitin carboxyl-terminal hydrolase 1 | Type: enzyme | Action: nan
9989,pimozide,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,BLOCKER,Drug: pimozide | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: BLOCKER
9990,pimozide,g protein-activated inward rectifier potassium channel 2,ion channel,GATING INHIBITOR,Drug: pimozide | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: GATING INHIBITOR
9991,pimozide,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,BLOCKER,Drug: pimozide | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: BLOCKER
9992,pinacidil,atp-binding cassette sub-family c member 9,ion channel,,Drug: pinacidil | Target: atp-binding cassette sub-family c member 9 | Type: ion channel | Action: nan
9993,pinacidil,calcium-activated potassium channel subunit alpha-1,ion channel,,Drug: pinacidil | Target: calcium-activated potassium channel subunit alpha-1 | Type: ion channel | Action: nan
9994,pinacidil,"sulfonylurea receptor 2, kir6.2",ion channel,OPENER,"Drug: pinacidil | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: OPENER"
9995,pindolol,beta-1 adrenergic receptor,gpcr,PARTIAL AGONIST,Drug: pindolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: PARTIAL AGONIST
9996,pindolol,beta-2 adrenergic receptor,gpcr,PARTIAL AGONIST,Drug: pindolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: PARTIAL AGONIST
9997,pindolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: pindolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
9998,pindolol,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: pindolol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
9999,pindolol,5-hydroxytryptamine receptor 2b,gpcr,AGONIST,Drug: pindolol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: AGONIST
10000,pindolol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: pindolol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10001,pindolol,beta-3 adrenergic receptor,gpcr,,Drug: pindolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
10002,pindolol,5-hydroxytryptamine receptor 1b,gpcr,,Drug: pindolol | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10003,pindolol,5-hydroxytryptamine receptor 1d,gpcr,,Drug: pindolol | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
10004,pindolol,5-hydroxytryptamine receptor 1b,gpcr,,Drug: pindolol | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10005,pindolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: pindolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10006,pindolol,serotonin 1 (5-ht1) receptor,gpcr,,Drug: pindolol | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
10007,pindolol,serotonin 2 (5-ht2) receptor,gpcr,,Drug: pindolol | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
10008,pioglitazone,carbonic anhydrase 2,enzyme,,Drug: pioglitazone | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
10009,pioglitazone,bile salt export pump,transporter,,Drug: pioglitazone | Target: bile salt export pump | Type: transporter | Action: nan
10010,pioglitazone,amine oxidase [flavin-containing] b,enzyme,,Drug: pioglitazone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
10011,pioglitazone,amine oxidase [flavin-containing] a,enzyme,,Drug: pioglitazone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
10012,pioglitazone,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: pioglitazone | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
10013,pioglitazone,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: pioglitazone | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
10014,pioglitazone,aldose reductase,enzyme,,Drug: pioglitazone | Target: aldose reductase | Type: enzyme | Action: nan
10015,pioglitazone,amine oxidase [flavin-containing] b,enzyme,,Drug: pioglitazone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
10016,pioglitazone,peroxisome proliferator-activated receptor alpha,transcription factor,,Drug: pioglitazone | Target: peroxisome proliferator-activated receptor alpha | Type: transcription factor | Action: nan
10017,pioglitazone,peroxisome proliferator-activated receptor gamma,transcription factor,,Drug: pioglitazone | Target: peroxisome proliferator-activated receptor gamma | Type: transcription factor | Action: nan
10018,pioglitazone,peroxisome proliferator-activated receptor gamma,transcription factor,,Drug: pioglitazone | Target: peroxisome proliferator-activated receptor gamma | Type: transcription factor | Action: nan
10019,pioglitazone,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,,Drug: pioglitazone | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: nan
10020,pioglitazone,bile salt export pump,transporter,,Drug: pioglitazone | Target: bile salt export pump | Type: transporter | Action: nan
10021,pioglitazone,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: pioglitazone | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
10022,pioglitazone,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: pioglitazone | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
10023,pioglitazone,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: pioglitazone | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
10024,pioglitazone,cdgsh iron-sulfur domain-containing protein 2,unclassified,,Drug: pioglitazone | Target: cdgsh iron-sulfur domain-containing protein 2 | Type: unclassified | Action: nan
10025,pipamazine,d(1a) dopamine receptor,gpcr,,Drug: pipamazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10026,pipamazine,d(2) dopamine receptor,gpcr,,Drug: pipamazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10027,pipamazine,alpha-2a adrenergic receptor,gpcr,,Drug: pipamazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10028,pipamazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: pipamazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10029,pipamazine,sodium-dependent serotonin transporter,transporter,,Drug: pipamazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10030,pipamazine,sodium-dependent noradrenaline transporter,transporter,,Drug: pipamazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10031,pipamazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: pipamazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10032,pipamazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: pipamazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10033,pipamazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: pipamazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10034,pipamazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: pipamazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10035,pipamazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: pipamazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10036,pipamazine,alpha-2b adrenergic receptor,gpcr,,Drug: pipamazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10037,pipamazine,d(3) dopamine receptor,gpcr,,Drug: pipamazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10038,pipamazine,histamine h1 receptor,gpcr,,Drug: pipamazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10039,pipamazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: pipamazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10040,pipamazine,alpha-2c adrenergic receptor,gpcr,,Drug: pipamazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10041,pipamazine,cytochrome p450 2d6,enzyme,,Drug: pipamazine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10042,pipamazine,alpha-1d adrenergic receptor,gpcr,,Drug: pipamazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10043,pipamazine,alpha-1b adrenergic receptor,gpcr,,Drug: pipamazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10044,pipamazine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: pipamazine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10045,pipamazine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: pipamazine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
10046,pipamazine,alpha-1a adrenergic receptor,gpcr,,Drug: pipamazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10047,pipamazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: pipamazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10048,pipamperone,beta-1 adrenergic receptor,gpcr,,Drug: pipamperone | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10049,pipamperone,beta-2 adrenergic receptor,gpcr,,Drug: pipamperone | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10050,pipamperone,d(2) dopamine receptor,gpcr,,Drug: pipamperone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10051,pipamperone,alpha-2a adrenergic receptor,gpcr,,Drug: pipamperone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10052,pipamperone,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: pipamperone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
10053,pipamperone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: pipamperone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
10054,pipamperone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: pipamperone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10055,pipamperone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: pipamperone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10056,pipamperone,alpha-2b adrenergic receptor,gpcr,,Drug: pipamperone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10057,pipamperone,d(3) dopamine receptor,gpcr,,Drug: pipamperone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10058,pipamperone,histamine h1 receptor,gpcr,ANTAGONIST,Drug: pipamperone | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
10059,pipamperone,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: pipamperone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
10060,pipamperone,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: pipamperone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
10061,pipamperone,alpha-2c adrenergic receptor,gpcr,,Drug: pipamperone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10062,pipamperone,5-hydroxytryptamine receptor 1f,gpcr,,Drug: pipamperone | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
10063,pipamperone,5-hydroxytryptamine receptor 1e,gpcr,,Drug: pipamperone | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
10064,pipecuronium,neuronal acetylcholine receptor; alpha2/beta4,ion channel,,Drug: pipecuronium | Target: neuronal acetylcholine receptor; alpha2/beta4 | Type: ion channel | Action: nan
10065,pipecuronium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: pipecuronium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
10066,pipecuronium,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: pipecuronium | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
10067,pipecuronium,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: pipecuronium | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
10068,piperacillin,penicillin-binding protein 1a,enzyme,,Drug: piperacillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
10069,piperacillin,beta-lactamase,enzyme,,Drug: piperacillin | Target: beta-lactamase | Type: enzyme | Action: nan
10070,piperacillin,streptokinase a,enzyme,,Drug: piperacillin | Target: streptokinase a | Type: enzyme | Action: nan
10071,piperacillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: piperacillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
10072,piperazine,gamma-aminobutyric acid receptor subunit beta,ion channel,,Drug: piperazine | Target: gamma-aminobutyric acid receptor subunit beta | Type: ion channel | Action: nan
10073,pipotiazine palmitate,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: pipotiazine palmitate | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10074,pipotiazine palmitate,d(3) dopamine receptor,gpcr,,Drug: pipotiazine palmitate | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10075,pirbuterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: pirbuterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
10076,pirenzepine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
10077,pirenzepine,muscarinic acetylcholine receptor m2,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10078,pirenzepine,muscarinic acetylcholine receptor m3,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10079,pirenzepine,muscarinic acetylcholine receptor m4,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10080,pirenzepine,muscarinic acetylcholine receptor m5,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10081,pirenzepine,adenosine receptor a3,gpcr,,Drug: pirenzepine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
10082,pirenzepine,muscarinic acetylcholine receptor m2,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10083,pirenzepine,muscarinic acetylcholine receptor m1,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10084,pirenzepine,muscarinic acetylcholine receptor m3,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10085,pirenzepine,muscarinic receptor m1,gpcr,,Drug: pirenzepine | Target: muscarinic receptor m1 | Type: gpcr | Action: nan
10086,pirenzepine,muscarinic acetylcholine receptor m4,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10087,pirenzepine,muscarinic acetylcholine receptor,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
10088,pirenzepine,muscarinic acetylcholine receptor dm1,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor dm1 | Type: gpcr | Action: nan
10089,pirenzepine,muscarinic acetylcholine receptor,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
10090,pirenzepine,muscarinic acetylcholine receptor,gpcr,,Drug: pirenzepine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
10091,piretanide,solute carrier family 12 member 1,transporter,INHIBITOR,Drug: piretanide | Target: solute carrier family 12 member 1 | Type: transporter | Action: INHIBITOR
10092,piretanide,solute carrier family 12 member 2,transporter,INHIBITOR,Drug: piretanide | Target: solute carrier family 12 member 2 | Type: transporter | Action: INHIBITOR
10093,piribedil,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: piribedil | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10094,piribedil,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: piribedil | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
10095,piribedil,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: piribedil | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
10096,piribedil,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: piribedil | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10097,piribedil,alpha-2b adrenergic receptor,gpcr,,Drug: piribedil | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10098,piribedil,d(3) dopamine receptor,gpcr,AGONIST,Drug: piribedil | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
10099,piribedil,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: piribedil | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10100,piribedil,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: piribedil | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10101,piribedil,alpha-1d adrenergic receptor,gpcr,,Drug: piribedil | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10102,piribedil,alpha-1b adrenergic receptor,gpcr,,Drug: piribedil | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10103,piribedil,d(2) dopamine receptor,gpcr,AGONIST,Drug: piribedil | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
10104,pirlindole,transcriptional enhancer factor tef-3,transcription factor,,Drug: pirlindole | Target: transcriptional enhancer factor tef-3 | Type: transcription factor | Action: nan
10105,pirlindole,transcriptional enhancer factor tef-1,transcription factor,,Drug: pirlindole | Target: transcriptional enhancer factor tef-1 | Type: transcription factor | Action: nan
10107,pirlindole,transcriptional enhancer factor tef-4,transcription factor,,Drug: pirlindole | Target: transcriptional enhancer factor tef-4 | Type: transcription factor | Action: nan
10108,pirlindole,transcriptional enhancer factor tef-5,transcription factor,,Drug: pirlindole | Target: transcriptional enhancer factor tef-5 | Type: transcription factor | Action: nan
10109,pirlindole,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: pirlindole | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
10110,pirmenol,sodium channel protein type 5 subunit alpha,ion channel,,Drug: pirmenol | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
10111,piroxicam,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: piroxicam | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
10112,piroxicam,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: piroxicam | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
10113,piroxicam,prostaglandin g/h synthase 1,enzyme,,Drug: piroxicam | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
10114,piroxicam,cyclooxygenase,enzyme,,Drug: piroxicam | Target: cyclooxygenase | Type: enzyme | Action: nan
10115,piroxicam,cyclooxygenase,enzyme,,Drug: piroxicam | Target: cyclooxygenase | Type: enzyme | Action: nan
10116,pirprofen,prostaglandin g/h synthase 2,enzyme,,Drug: pirprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
10117,pirprofen,prostaglandin g/h synthase 1,enzyme,,Drug: pirprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
10118,pitavastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: pitavastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
10119,pitavastatin,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: pitavastatin | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
10120,pitavastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: pitavastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
10121,pizotifen,d(2) dopamine receptor,gpcr,,Drug: pizotifen | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10122,pizotifen,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: pizotifen | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
10123,pizotifen,5-hydroxytryptamine receptor 2a,gpcr,,Drug: pizotifen | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10124,pizotifen,5-hydroxytryptamine receptor 2b,gpcr,,Drug: pizotifen | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10125,pizotifen,5-hydroxytryptamine receptor 2c,gpcr,,Drug: pizotifen | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10126,pizotifen,5-hydroxytryptamine receptor 7,gpcr,,Drug: pizotifen | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
10127,pizotifen,muscarinic acetylcholine receptor m1,gpcr,,Drug: pizotifen | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10128,polythiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: polythiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
10129,pralidoxime,acetylcholinesterase,enzyme,ACTIVATOR,Drug: pralidoxime | Target: acetylcholinesterase | Type: enzyme | Action: ACTIVATOR
10130,pralmorelin,growth hormone secretagogue receptor type 1,gpcr,AGONIST,Drug: pralmorelin | Target: growth hormone secretagogue receptor type 1 | Type: gpcr | Action: AGONIST
10131,pralmorelin,growth hormone secretagogue receptor type 1,gpcr,AGONIST,Drug: pralmorelin | Target: growth hormone secretagogue receptor type 1 | Type: gpcr | Action: AGONIST
10132,pramipexole,beta-2 adrenergic receptor,gpcr,,Drug: pramipexole | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10133,pramipexole,d(2) dopamine receptor,gpcr,AGONIST,Drug: pramipexole | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
10134,pramipexole,alpha-2a adrenergic receptor,gpcr,,Drug: pramipexole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10135,pramipexole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: pramipexole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10136,pramipexole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: pramipexole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10137,pramipexole,5-hydroxytryptamine receptor 7,gpcr,,Drug: pramipexole | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
10138,pramipexole,alpha-2b adrenergic receptor,gpcr,,Drug: pramipexole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10139,pramipexole,d(3) dopamine receptor,gpcr,AGONIST,Drug: pramipexole | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
10140,pramipexole,histamine h2 receptor,gpcr,,Drug: pramipexole | Target: histamine h2 receptor | Type: gpcr | Action: nan
10141,pramipexole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: pramipexole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10142,pramipexole,5-hydroxytryptamine receptor 1d,gpcr,,Drug: pramipexole | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
10143,pramipexole,alpha-2c adrenergic receptor,gpcr,,Drug: pramipexole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10144,pramipexole,d(4) dopamine receptor,gpcr,AGONIST,Drug: pramipexole | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
10145,pramipexole,d(2) dopamine receptor,gpcr,,Drug: pramipexole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10146,pramipexole,d(2) dopamine receptor,gpcr,,Drug: pramipexole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10147,pramipexole,d(3) dopamine receptor,gpcr,,Drug: pramipexole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10148,pramlintide,amylin receptor amy2,gpcr,AGONIST,Drug: pramlintide | Target: amylin receptor amy2 | Type: gpcr | Action: AGONIST
10149,pramlintide,amylin receptor amy1,gpcr,AGONIST,Drug: pramlintide | Target: amylin receptor amy1 | Type: gpcr | Action: AGONIST
10150,pramlintide,amylin receptor amy3,gpcr,AGONIST,Drug: pramlintide | Target: amylin receptor amy3 | Type: gpcr | Action: AGONIST
10151,pranlukast,bile acid receptor,nuclear hormone receptor,,Drug: pranlukast | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
10152,pranlukast,cysteinyl leukotriene receptor 2,gpcr,ANTAGONIST,Drug: pranlukast | Target: cysteinyl leukotriene receptor 2 | Type: gpcr | Action: ANTAGONIST
10153,pranlukast,cysteinyl leukotriene receptor 1,gpcr,,Drug: pranlukast | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
10154,pranlukast,cruzipain,enzyme,,Drug: pranlukast | Target: cruzipain | Type: enzyme | Action: nan
10155,pranlukast,uracil nucleotide/cysteinyl leukotriene receptor,gpcr,,Drug: pranlukast | Target: uracil nucleotide/cysteinyl leukotriene receptor | Type: gpcr | Action: nan
10156,pranlukast,bile acid receptor,nuclear other,,Drug: pranlukast | Target: bile acid receptor | Type: nuclear other | Action: nan
10157,pranlukast,cysteinyl leukotriene receptor 1,gpcr,ANTAGONIST,Drug: pranlukast | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: ANTAGONIST
10158,pranoprofen,prostaglandin g/h synthase 1,enzyme,,Drug: pranoprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
10159,pranoprofen,prostaglandin g/h synthase 1,enzyme,,Drug: pranoprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
10160,pravastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: pravastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
10161,pravastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: pravastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
10162,pravastatin,solute carrier family 22 member 6,transporter,,Drug: pravastatin | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
10163,prazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: prazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
10164,praziquantel,bile salt export pump,transporter,,Drug: praziquantel | Target: bile salt export pump | Type: transporter | Action: nan
10165,praziquantel,glutathione s-transferase class-mu 26 kda isozyme,enzyme,,Drug: praziquantel | Target: glutathione s-transferase class-mu 26 kda isozyme | Type: enzyme | Action: nan
10166,praziquantel,high voltage-activated calcium channel beta subunit cavb1,ion channel,BLOCKER,Drug: praziquantel | Target: high voltage-activated calcium channel beta subunit cavb1 | Type: ion channel | Action: BLOCKER
10167,praziquantel,high voltage-activated calcium channel beta subunit cavb2,ion channel,BLOCKER,Drug: praziquantel | Target: high voltage-activated calcium channel beta subunit cavb2 | Type: ion channel | Action: BLOCKER
10168,prednicarbate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: prednicarbate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
10169,prednisolone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: prednisolone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
10170,prednisolone,annexin a1,cytosolic other,,Drug: prednisolone | Target: annexin a1 | Type: cytosolic other | Action: nan
10171,prednisolone,mineralocorticoid receptor,nuclear hormone receptor,,Drug: prednisolone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
10172,prednisolone,androgen receptor,nuclear hormone receptor,,Drug: prednisolone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
10173,prednisolone,progesterone receptor,nuclear hormone receptor,,Drug: prednisolone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
10174,prednisolone,corticosteroid-binding globulin,secreted,,Drug: prednisolone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
10175,prednisolone,interleukin-6,cytokine,,Drug: prednisolone | Target: interleukin-6 | Type: cytokine | Action: nan
10176,prednisolone,g-protein coupled bile acid receptor 1,gpcr,,Drug: prednisolone | Target: g-protein coupled bile acid receptor 1 | Type: gpcr | Action: nan
10177,prednisolone,"fatty acid-binding protein, liver",unclassified,,"Drug: prednisolone | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
10178,prednisolone,glutamine synthetase,enzyme,,Drug: prednisolone | Target: glutamine synthetase | Type: enzyme | Action: nan
10179,prednisolone,glucocorticoid receptor,transcription factor,,Drug: prednisolone | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
10180,prednisolone,glucocorticoid receptor,transcription factor,,Drug: prednisolone | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
10181,prednisolone,disintegrin and metalloproteinase domain-containing protein 17,unclassified,,Drug: prednisolone | Target: disintegrin and metalloproteinase domain-containing protein 17 | Type: unclassified | Action: nan
10183,prednisolone acetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: prednisolone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
10184,prednisolone tebutate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: prednisolone tebutate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
10185,prednisolone tebutate,mineralocorticoid receptor,nuclear hormone receptor,,Drug: prednisolone tebutate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
10186,prednisolone tebutate,androgen receptor,nuclear hormone receptor,,Drug: prednisolone tebutate | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
10187,prednisolone tebutate,progesterone receptor,nuclear hormone receptor,,Drug: prednisolone tebutate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
10188,prednisolone tebutate,corticosteroid-binding globulin,secreted,,Drug: prednisolone tebutate | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
10189,prednisolone tebutate,interleukin-6,cytokine,,Drug: prednisolone tebutate | Target: interleukin-6 | Type: cytokine | Action: nan
10190,prednisolone tebutate,g-protein coupled bile acid receptor 1,gpcr,,Drug: prednisolone tebutate | Target: g-protein coupled bile acid receptor 1 | Type: gpcr | Action: nan
10191,prednisolone tebutate,"fatty acid-binding protein, liver",unclassified,,"Drug: prednisolone tebutate | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
10192,prednisolone tebutate,glutamine synthetase,enzyme,,Drug: prednisolone tebutate | Target: glutamine synthetase | Type: enzyme | Action: nan
10193,prednisolone tebutate,glucocorticoid receptor,transcription factor,,Drug: prednisolone tebutate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
10194,prednisolone tebutate,glucocorticoid receptor,transcription factor,,Drug: prednisolone tebutate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
10195,prednisolone tebutate,disintegrin and metalloproteinase domain-containing protein 17,unclassified,,Drug: prednisolone tebutate | Target: disintegrin and metalloproteinase domain-containing protein 17 | Type: unclassified | Action: nan
10197,prednisone,sodium/nucleoside cotransporter 1,transporter,,Drug: prednisone | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
10198,prednisone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: prednisone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
10199,prednisone,annexin a1,cytosolic other,,Drug: prednisone | Target: annexin a1 | Type: cytosolic other | Action: nan
10200,pregabalin,large neutral amino acids transporter small subunit 1,transporter,,Drug: pregabalin | Target: large neutral amino acids transporter small subunit 1 | Type: transporter | Action: nan
10201,pregabalin,voltage-dependent calcium channel subunit alpha-2/delta-1,ion channel,MODULATOR,Drug: pregabalin | Target: voltage-dependent calcium channel subunit alpha-2/delta-1 | Type: ion channel | Action: MODULATOR
10202,pregabalin,uncharacterized protein; voltage-dependent calcium channel alpha-2 delta subunit,ion channel,,Drug: pregabalin | Target: uncharacterized protein; voltage-dependent calcium channel alpha-2 delta subunit | Type: ion channel | Action: nan
10203,pregabalin,voltage-dependent calcium channel subunit alpha-2/delta-2,ion channel,MODULATOR,Drug: pregabalin | Target: voltage-dependent calcium channel subunit alpha-2/delta-2 | Type: ion channel | Action: MODULATOR
10204,pregnenolone succinate,corticosteroid-binding globulin,secreted,,Drug: pregnenolone succinate | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
10205,pregnenolone succinate,sex hormone-binding globulin,secreted,,Drug: pregnenolone succinate | Target: sex hormone-binding globulin | Type: secreted | Action: nan
10206,pregnenolone succinate,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: pregnenolone succinate | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
10207,prenalterol,beta-1 adrenergic receptor,gpcr,,Drug: prenalterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10208,prenalterol,beta-2 adrenergic receptor,gpcr,,Drug: prenalterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10209,prenylamine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: prenylamine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
10210,prenylamine,voltage-gated l-type calcium channel,ion channel,,Drug: prenylamine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: nan
10211,prenylamine,calmodulin,cytosolic other,,Drug: prenylamine | Target: calmodulin | Type: cytosolic other | Action: nan
10212,pridinol,muscarinic acetylcholine receptor m1,gpcr,,Drug: pridinol | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10213,pridinol,muscarinic acetylcholine receptor m2,gpcr,,Drug: pridinol | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10214,pridinol,muscarinic acetylcholine receptor m3,gpcr,,Drug: pridinol | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10215,pridinol,muscarinic acetylcholine receptor m4,gpcr,,Drug: pridinol | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10216,pridinol,muscarinic acetylcholine receptor m5,gpcr,,Drug: pridinol | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10217,prilocaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,BLOCKER,"Drug: prilocaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: BLOCKER"
10218,primaquine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: primaquine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10219,primaquine,sodium-dependent serotonin transporter,transporter,,Drug: primaquine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10220,primaquine,hemoglobin subunit alpha,secreted,,Drug: primaquine | Target: hemoglobin subunit alpha | Type: secreted | Action: nan
10221,primaquine,amine oxidase [flavin-containing] b,enzyme,,Drug: primaquine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
10222,primaquine,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: primaquine | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
10223,primaquine,cytochrome p450 1a2,enzyme,,Drug: primaquine | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
10224,primaquine,amine oxidase [flavin-containing] a,enzyme,,Drug: primaquine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
10225,primaquine,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: primaquine | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
10226,primaquine,heat shock protein hsp 90-alpha,cytosolic other,,Drug: primaquine | Target: heat shock protein hsp 90-alpha | Type: cytosolic other | Action: nan
10227,primaquine,reverse transcriptase,enzyme,,Drug: primaquine | Target: reverse transcriptase | Type: enzyme | Action: nan
10228,primaquine,aryl hydrocarbon receptor,transcription factor,,Drug: primaquine | Target: aryl hydrocarbon receptor | Type: transcription factor | Action: nan
10229,primaquine,chloroquine resistance transporter,transporter,,Drug: primaquine | Target: chloroquine resistance transporter | Type: transporter | Action: nan
10230,primaquine,"serine hydroxymethyltransferase, mitochondrial",enzyme,,"Drug: primaquine | Target: serine hydroxymethyltransferase, mitochondrial | Type: enzyme | Action: nan"
10231,primaquine,reverse transcriptase,unclassified,,Drug: primaquine | Target: reverse transcriptase | Type: unclassified | Action: nan
10232,primidone,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: primidone | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
10233,primidone,transient receptor potential cation channel subfamily m member 3,ion channel,BLOCKER,Drug: primidone | Target: transient receptor potential cation channel subfamily m member 3 | Type: ion channel | Action: BLOCKER
10234,probenecid,carbonic anhydrase 2,enzyme,,Drug: probenecid | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
10235,probenecid,carbonic anhydrase 9,enzyme,,Drug: probenecid | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
10236,probenecid,carbonic anhydrase 12,enzyme,,Drug: probenecid | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
10237,probenecid,solute carrier family 22 member 6,transporter,INHIBITOR,Drug: probenecid | Target: solute carrier family 22 member 6 | Type: transporter | Action: INHIBITOR
10238,probenecid,solute carrier family 22 member 8,transporter,INHIBITOR,Drug: probenecid | Target: solute carrier family 22 member 8 | Type: transporter | Action: INHIBITOR
10239,probenecid,solute carrier family 22 member 11,transporter,INHIBITOR,Drug: probenecid | Target: solute carrier family 22 member 11 | Type: transporter | Action: INHIBITOR
10240,probenecid,solute carrier family 22 member 12,transporter,,Drug: probenecid | Target: solute carrier family 22 member 12 | Type: transporter | Action: nan
10241,probenecid,solute carrier family 22 member 6,transporter,,Drug: probenecid | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
10242,probenecid,solute carrier family 22 member 20,transporter,,Drug: probenecid | Target: solute carrier family 22 member 20 | Type: transporter | Action: nan
10243,probenecid,udp-glucuronosyltransferase 1-7,enzyme,,Drug: probenecid | Target: udp-glucuronosyltransferase 1-7 | Type: enzyme | Action: nan
10244,probenecid,transient receptor potential cation channel subfamily v member 2,ion channel,ACTIVATOR,Drug: probenecid | Target: transient receptor potential cation channel subfamily v member 2 | Type: ion channel | Action: ACTIVATOR
10245,probucol,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: probucol | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10246,probucol,arachidonate 15-lipoxygenase,enzyme,,Drug: probucol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
10247,probucol,atp-binding cassette sub-family a member 1,transporter,INHIBITOR,Drug: probucol | Target: atp-binding cassette sub-family a member 1 | Type: transporter | Action: INHIBITOR
10248,probucol,serine protease hepsin,enzyme,,Drug: probucol | Target: serine protease hepsin | Type: enzyme | Action: nan
10249,probucol,trypsin,enzyme,,Drug: probucol | Target: trypsin | Type: enzyme | Action: nan
10250,procainamide,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: procainamide | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10251,procainamide,muscarinic acetylcholine receptor m2,gpcr,,Drug: procainamide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10252,procainamide,acetylcholinesterase,enzyme,,Drug: procainamide | Target: acetylcholinesterase | Type: enzyme | Action: nan
10253,procainamide,dna (cytosine-5)-methyltransferase 1,enzyme,,Drug: procainamide | Target: dna (cytosine-5)-methyltransferase 1 | Type: enzyme | Action: nan
10254,procainamide,dna (cytosine-5)-methyltransferase 3a,enzyme,,Drug: procainamide | Target: dna (cytosine-5)-methyltransferase 3a | Type: enzyme | Action: nan
10255,procainamide,dna (cytosine-5)-methyltransferase 3b,enzyme,,Drug: procainamide | Target: dna (cytosine-5)-methyltransferase 3b | Type: enzyme | Action: nan
10256,procainamide,acetylcholinesterase,enzyme,,Drug: procainamide | Target: acetylcholinesterase | Type: enzyme | Action: nan
10257,procainamide,sodium channel alpha subunit,ion channel,BLOCKER,Drug: procainamide | Target: sodium channel alpha subunit | Type: ion channel | Action: BLOCKER
10258,procaine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: procaine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
10259,procaine,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: procaine | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
10260,procaine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: procaine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
10261,procaine,ryanodine receptor 1,ion channel,,Drug: procaine | Target: ryanodine receptor 1 | Type: ion channel | Action: nan
10262,procaine,acetylcholine receptor,ion channel,,Drug: procaine | Target: acetylcholine receptor | Type: ion channel | Action: nan
10263,procaterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: procaterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
10264,procaterol,d(2) dopamine receptor,gpcr,,Drug: procaterol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10265,prochlorperazine,5-hydroxytryptamine receptor 4,gpcr,,Drug: prochlorperazine | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
10266,prochlorperazine,d(1a) dopamine receptor,gpcr,,Drug: prochlorperazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10267,prochlorperazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: prochlorperazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10268,prochlorperazine,alpha-2a adrenergic receptor,gpcr,,Drug: prochlorperazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10269,prochlorperazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: prochlorperazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10270,prochlorperazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: prochlorperazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10271,prochlorperazine,sodium-dependent serotonin transporter,transporter,,Drug: prochlorperazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10272,prochlorperazine,sodium-dependent noradrenaline transporter,transporter,,Drug: prochlorperazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10273,prochlorperazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: prochlorperazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10274,prochlorperazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: prochlorperazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10275,prochlorperazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: prochlorperazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10276,prochlorperazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: prochlorperazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10277,prochlorperazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: prochlorperazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10278,prochlorperazine,alpha-1a adrenergic receptor,gpcr,,Drug: prochlorperazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10279,prochlorperazine,alpha-2b adrenergic receptor,gpcr,,Drug: prochlorperazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10280,prochlorperazine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: prochlorperazine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10281,prochlorperazine,histamine h1 receptor,gpcr,,Drug: prochlorperazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10282,prochlorperazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: prochlorperazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10283,prochlorperazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: prochlorperazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10284,prochlorperazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: prochlorperazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10285,prochlorperazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: prochlorperazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10286,prochlorperazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: prochlorperazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10287,prochlorperazine,alpha-2c adrenergic receptor,gpcr,,Drug: prochlorperazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10288,prochlorperazine,sodium-dependent dopamine transporter,transporter,,Drug: prochlorperazine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
10289,prochlorperazine,cytochrome p450 2d6,enzyme,,Drug: prochlorperazine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10290,prochlorperazine,d(4) dopamine receptor,gpcr,,Drug: prochlorperazine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
10291,prochlorperazine,alpha-1d adrenergic receptor,gpcr,,Drug: prochlorperazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10292,prochlorperazine,cytochrome p450 1a2,enzyme,,Drug: prochlorperazine | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
10293,prochlorperazine,tyrosine-protein kinase fyn,kinase,,Drug: prochlorperazine | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
10294,prochlorperazine,solute carrier family 22 member 1,transporter,,Drug: prochlorperazine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10295,prochlorperazine,alpha-1b adrenergic receptor,gpcr,,Drug: prochlorperazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10296,prochlorperazine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: prochlorperazine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10297,prochlorperazine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: prochlorperazine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
10298,prochlorperazine,alpha-1a adrenergic receptor,gpcr,,Drug: prochlorperazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10299,prochlorperazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: prochlorperazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10300,prochlorperazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: prochlorperazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
10301,procyclidine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: procyclidine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
10302,procyclidine,muscarinic acetylcholine receptor m2,gpcr,,Drug: procyclidine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10303,procyclidine,muscarinic acetylcholine receptor m3,gpcr,,Drug: procyclidine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10304,procyclidine,muscarinic acetylcholine receptor m4,gpcr,,Drug: procyclidine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10305,procyclidine,muscarinic acetylcholine receptor m5,gpcr,,Drug: procyclidine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10306,procyclidine,histamine h1 receptor,gpcr,,Drug: procyclidine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10307,procyclidine,glutamate [nmda] receptor,ion channel,,Drug: procyclidine | Target: glutamate [nmda] receptor | Type: ion channel | Action: nan
10308,progabide,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,,Drug: progabide | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
10309,progabide,gaba-a receptor; anion channel,ion channel,,Drug: progabide | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
10310,progabide,gaba-a receptor; anion channel,ion channel,,Drug: progabide | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
10311,progesterone,sodium/nucleoside cotransporter 1,transporter,,Drug: progesterone | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
10312,progesterone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: progesterone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10313,progesterone,multidrug resistance protein 1,transporter,,Drug: progesterone | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
10314,progesterone,glucocorticoid receptor,nuclear hormone receptor,,Drug: progesterone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
10315,progesterone,mineralocorticoid receptor,nuclear hormone receptor,,Drug: progesterone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
10316,progesterone,estrogen receptor,nuclear hormone receptor,,Drug: progesterone | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
10317,progesterone,androgen receptor,nuclear hormone receptor,,Drug: progesterone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
10318,progesterone,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: progesterone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
10319,progesterone,corticosteroid-binding globulin,secreted,,Drug: progesterone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
10320,progesterone,sex hormone-binding globulin,secreted,,Drug: progesterone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
10321,progesterone,sterol o-acyltransferase 1,enzyme,,Drug: progesterone | Target: sterol o-acyltransferase 1 | Type: enzyme | Action: nan
10322,progesterone,"fatty acid-binding protein, intestinal",cytosolic other,,"Drug: progesterone | Target: fatty acid-binding protein, intestinal | Type: cytosolic other | Action: nan"
10323,progesterone,androgen receptor,transcription factor,,Drug: progesterone | Target: androgen receptor | Type: transcription factor | Action: nan
10324,progesterone,"fatty acid-binding protein, liver",unclassified,,"Drug: progesterone | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
10325,progesterone,progesterone receptor,transcription factor,,Drug: progesterone | Target: progesterone receptor | Type: transcription factor | Action: nan
10326,progesterone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: progesterone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10327,progesterone,androgen receptor,transcription factor,,Drug: progesterone | Target: androgen receptor | Type: transcription factor | Action: nan
10328,progesterone,progesterone receptor,transcription factor,,Drug: progesterone | Target: progesterone receptor | Type: transcription factor | Action: nan
10329,progesterone,c-8 sterol isomerase,enzyme,,Drug: progesterone | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
10330,progesterone,sigma non-opioid intracellular receptor 1,membrane other,,Drug: progesterone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
10331,progesterone,steroid 5-alpha-reductase,enzyme,,Drug: progesterone | Target: steroid 5-alpha-reductase | Type: enzyme | Action: nan
10332,progesterone,estrogen receptor,transcription factor,,Drug: progesterone | Target: estrogen receptor | Type: transcription factor | Action: nan
10333,progesterone,cation channel sperm-associated protein 1,ion channel,ACTIVATOR,Drug: progesterone | Target: cation channel sperm-associated protein 1 | Type: ion channel | Action: ACTIVATOR
10334,progesterone,cation channel sperm-associated protein 2,ion channel,ACTIVATOR,Drug: progesterone | Target: cation channel sperm-associated protein 2 | Type: ion channel | Action: ACTIVATOR
10335,progesterone,cation channel sperm-associated protein 3,ion channel,ACTIVATOR,Drug: progesterone | Target: cation channel sperm-associated protein 3 | Type: ion channel | Action: ACTIVATOR
10336,progesterone,cation channel sperm-associated protein 4,ion channel,ACTIVATOR,Drug: progesterone | Target: cation channel sperm-associated protein 4 | Type: ion channel | Action: ACTIVATOR
10337,progesterone,short transient receptor potential channel 5,ion channel,BLOCKER,Drug: progesterone | Target: short transient receptor potential channel 5 | Type: ion channel | Action: BLOCKER
10338,progesterone,p2x purinoceptor 3,ion channel,,Drug: progesterone | Target: p2x purinoceptor 3 | Type: ion channel | Action: nan
10339,proglumide,histamine h2 receptor,gpcr,,Drug: proglumide | Target: histamine h2 receptor | Type: gpcr | Action: nan
10340,proglumide,gastrin/cholecystokinin type b receptor,gpcr,ANTAGONIST,Drug: proglumide | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: ANTAGONIST
10341,proguanil,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: proguanil | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
10342,proguanil,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: proguanil | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
10343,proguanil,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,INHIBITOR,Drug: proguanil | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: INHIBITOR
10344,proguanil,trace amine-associated receptor 1,gpcr,,Drug: proguanil | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
10345,promazine,d(1a) dopamine receptor,gpcr,,Drug: promazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10346,promazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: promazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10347,promazine,alpha-2a adrenergic receptor,gpcr,,Drug: promazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10348,promazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: promazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10349,promazine,sodium-dependent serotonin transporter,transporter,,Drug: promazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10350,promazine,sodium-dependent noradrenaline transporter,transporter,,Drug: promazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10351,promazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: promazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10352,promazine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: promazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
10353,promazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: promazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10354,promazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: promazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10355,promazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: promazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10356,promazine,alpha-1a adrenergic receptor,gpcr,,Drug: promazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10357,promazine,alpha-2b adrenergic receptor,gpcr,,Drug: promazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10358,promazine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: promazine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10359,promazine,histamine h1 receptor,gpcr,,Drug: promazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10360,promazine,histamine h2 receptor,gpcr,,Drug: promazine | Target: histamine h2 receptor | Type: gpcr | Action: nan
10361,promazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: promazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10362,promazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: promazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10363,promazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: promazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10364,promazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: promazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10365,promazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: promazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10366,promazine,aldehyde oxidase,enzyme,,Drug: promazine | Target: aldehyde oxidase | Type: enzyme | Action: nan
10367,promazine,alpha-2c adrenergic receptor,gpcr,,Drug: promazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10368,promazine,cytochrome p450 2d6,enzyme,,Drug: promazine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10369,promazine,alpha-1d adrenergic receptor,gpcr,,Drug: promazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10370,promazine,major prion protein,surface antigen,,Drug: promazine | Target: major prion protein | Type: surface antigen | Action: nan
10371,promazine,solute carrier family 22 member 1,transporter,,Drug: promazine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10372,promazine,trypanothione reductase,enzyme,,Drug: promazine | Target: trypanothione reductase | Type: enzyme | Action: nan
10373,promazine,alpha-1b adrenergic receptor,gpcr,,Drug: promazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10374,promazine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: promazine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
10375,promazine,alpha-1a adrenergic receptor,gpcr,,Drug: promazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10376,promazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: promazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10377,promazine,histamine h1 receptor,gpcr,,Drug: promazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10378,promazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: promazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
10379,promazine,dopamine receptor,gpcr,,Drug: promazine | Target: dopamine receptor | Type: gpcr | Action: nan
10380,promazine,dopamine receptor,gpcr,,Drug: promazine | Target: dopamine receptor | Type: gpcr | Action: nan
10381,promazine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: promazine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
10382,promazine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: promazine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
10383,promegestone,progesterone receptor,nuclear hormone receptor,,Drug: promegestone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
10384,promegestone,androgen receptor,transcription factor,,Drug: promegestone | Target: androgen receptor | Type: transcription factor | Action: nan
10385,promethazine,d(1a) dopamine receptor,gpcr,,Drug: promethazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10386,promethazine,d(2) dopamine receptor,gpcr,,Drug: promethazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10387,promethazine,alpha-2a adrenergic receptor,gpcr,,Drug: promethazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10388,promethazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: promethazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10389,promethazine,sodium-dependent serotonin transporter,transporter,,Drug: promethazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10390,promethazine,sodium-dependent noradrenaline transporter,transporter,,Drug: promethazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10391,promethazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: promethazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10392,promethazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: promethazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10393,promethazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: promethazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10394,promethazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: promethazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10395,promethazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: promethazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10396,promethazine,alpha-1a adrenergic receptor,gpcr,,Drug: promethazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10397,promethazine,alpha-2b adrenergic receptor,gpcr,,Drug: promethazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10398,promethazine,d(3) dopamine receptor,gpcr,,Drug: promethazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10399,promethazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: promethazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
10400,promethazine,histamine h2 receptor,gpcr,,Drug: promethazine | Target: histamine h2 receptor | Type: gpcr | Action: nan
10401,promethazine,histamine h4 receptor,gpcr,,Drug: promethazine | Target: histamine h4 receptor | Type: gpcr | Action: nan
10402,promethazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: promethazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10403,promethazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: promethazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10404,promethazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: promethazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10405,promethazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: promethazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10406,promethazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: promethazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10407,promethazine,aldehyde oxidase,enzyme,,Drug: promethazine | Target: aldehyde oxidase | Type: enzyme | Action: nan
10408,promethazine,alpha-2c adrenergic receptor,gpcr,,Drug: promethazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10409,promethazine,cytochrome p450 2d6,enzyme,,Drug: promethazine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10410,promethazine,alpha-1d adrenergic receptor,gpcr,,Drug: promethazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10411,promethazine,cholinesterase,enzyme,,Drug: promethazine | Target: cholinesterase | Type: enzyme | Action: nan
10412,promethazine,major prion protein,surface antigen,,Drug: promethazine | Target: major prion protein | Type: surface antigen | Action: nan
10413,promethazine,solute carrier family 22 member 1,transporter,,Drug: promethazine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10414,promethazine,alpha-1b adrenergic receptor,gpcr,,Drug: promethazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10415,promethazine,alpha-1a adrenergic receptor,gpcr,,Drug: promethazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10416,promethazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: promethazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10417,promethazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: promethazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
10418,promethazine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: promethazine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
10419,promethazine,chloroquine resistance transporter,transporter,,Drug: promethazine | Target: chloroquine resistance transporter | Type: transporter | Action: nan
10420,promethazine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: promethazine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
10421,promethazine,calmodulin,cytosolic other,,Drug: promethazine | Target: calmodulin | Type: cytosolic other | Action: nan
10422,promethazine,calmodulin-1,cytosolic other,,Drug: promethazine | Target: calmodulin-1 | Type: cytosolic other | Action: nan
10423,pronetalol,beta-2 adrenergic receptor,gpcr,,Drug: pronetalol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10424,propafenone,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: propafenone | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10425,propafenone,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: propafenone | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10426,propafenone,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: propafenone | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
10427,propafenone,sodium channel subunit beta-1,ion channel,,Drug: propafenone | Target: sodium channel subunit beta-1 | Type: ion channel | Action: nan
10428,propafenone,sodium channel subunit beta-2,ion channel,,Drug: propafenone | Target: sodium channel subunit beta-2 | Type: ion channel | Action: nan
10429,propafenone,sodium channel subunit beta-3,ion channel,,Drug: propafenone | Target: sodium channel subunit beta-3 | Type: ion channel | Action: nan
10430,propafenone,sodium channel subunit beta-4,ion channel,,Drug: propafenone | Target: sodium channel subunit beta-4 | Type: ion channel | Action: nan
10431,propafenone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: propafenone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10432,propafenone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: propafenone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10433,propafenone,multidrug resistance protein 1,transporter,,Drug: propafenone | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
10434,propafenone,sodium-dependent noradrenaline transporter,transporter,,Drug: propafenone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10435,propafenone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: propafenone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10436,propafenone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: propafenone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10437,propafenone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: propafenone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10438,propafenone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: propafenone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10439,propafenone,5-hydroxytryptamine receptor 6,gpcr,,Drug: propafenone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10440,propafenone,aldehyde oxidase,enzyme,,Drug: propafenone | Target: aldehyde oxidase | Type: enzyme | Action: nan
10441,propafenone,beta-3 adrenergic receptor,gpcr,,Drug: propafenone | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
10442,propafenone,sodium-dependent dopamine transporter,transporter,,Drug: propafenone | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
10443,propafenone,cytochrome p450 2d6,enzyme,,Drug: propafenone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10444,propafenone,alpha-1d adrenergic receptor,gpcr,,Drug: propafenone | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10445,propafenone,cytochrome p450 1a2,enzyme,,Drug: propafenone | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
10446,propafenone,potassium channel subfamily k member 2,ion channel,,Drug: propafenone | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: nan
10447,propafenone,potassium voltage-gated channel subfamily a member 5,ion channel,BLOCKER,Drug: propafenone | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: BLOCKER
10448,propafenone,potassium channel subfamily k member 3,ion channel,,Drug: propafenone | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: nan
10449,propafenone,solute carrier family 22 member 1,transporter,,Drug: propafenone | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10450,propafenone,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: propafenone | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
10451,propafenone,alpha-1b adrenergic receptor,gpcr,,Drug: propafenone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10452,propafenone,alpha-1a adrenergic receptor,gpcr,,Drug: propafenone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10453,propafenone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: propafenone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10454,propafenone,solute carrier family 22 member 2,transporter,,Drug: propafenone | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
10455,propafenone,"sulfonylurea receptor 2, kir6.2",ion channel,,"Drug: propafenone | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: nan"
10456,propantheline,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: propantheline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
10457,propantheline,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: propantheline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
10458,propantheline,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: propantheline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
10459,propantheline,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: propantheline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
10460,proparacaine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: proparacaine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10461,proparacaine,amine oxidase [flavin-containing] a,enzyme,,Drug: proparacaine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
10462,proparacaine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: proparacaine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
10463,proparacaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,BLOCKER,"Drug: proparacaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: BLOCKER"
10464,propentofylline,acetylcholinesterase,enzyme,,Drug: propentofylline | Target: acetylcholinesterase | Type: enzyme | Action: nan
10465,propiomazine,d(1a) dopamine receptor,gpcr,,Drug: propiomazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10466,propiomazine,d(2) dopamine receptor,gpcr,,Drug: propiomazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10467,propiomazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: propiomazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10468,propiomazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: propiomazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10469,propiomazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: propiomazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
10470,propiomazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: propiomazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10471,propiomazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: propiomazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10472,propiomazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: propiomazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10473,propiomazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: propiomazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10474,propiomazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: propiomazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10475,propiomazine,d(4) dopamine receptor,gpcr,,Drug: propiomazine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
10476,propiomazine,alpha-1b adrenergic receptor,gpcr,,Drug: propiomazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10477,propiram,mu-type opioid receptor,gpcr,AGONIST,Drug: propiram | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
10478,propofol,fatty-acid amide hydrolase 1,enzyme,,Drug: propofol | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
10479,propofol,prostaglandin g/h synthase 1,enzyme,,Drug: propofol | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
10480,propofol,sodium-dependent noradrenaline transporter,transporter,,Drug: propofol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10481,propofol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: propofol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10482,propofol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: propofol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10483,propofol,carbonic anhydrase 2,enzyme,,Drug: propofol | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
10484,propofol,carbonic anhydrase 1,enzyme,,Drug: propofol | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
10485,propofol,cytochrome p450 2c9,enzyme,,Drug: propofol | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
10486,propofol,arachidonate 15-lipoxygenase,enzyme,,Drug: propofol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
10487,propofol,fatty-acid amide hydrolase 1,enzyme,,Drug: propofol | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
10488,propofol,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,ion channel,BLOCKER,Drug: propofol | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | Type: ion channel | Action: BLOCKER
10489,propofol,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: propofol | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
10490,propofol,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: propofol | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
10491,propofol,gaba-a receptor; anion channel,ion channel,,Drug: propofol | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
10492,propofol,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: propofol | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
10493,propranolol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: propranolol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10494,propranolol,multidrug resistance protein 1,transporter,,Drug: propranolol | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
10495,propranolol,sodium-dependent serotonin transporter,transporter,,Drug: propranolol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10496,propranolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10497,propranolol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10498,propranolol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10499,propranolol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10500,propranolol,5-hydroxytryptamine receptor 6,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10501,propranolol,histamine h1 receptor,gpcr,,Drug: propranolol | Target: histamine h1 receptor | Type: gpcr | Action: nan
10502,propranolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: propranolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10503,propranolol,5-hydroxytryptamine receptor 1b,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10504,propranolol,5-hydroxytryptamine receptor 1d,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
10505,propranolol,cytochrome p450 2d6,enzyme,,Drug: propranolol | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10506,propranolol,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: propranolol | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
10507,propranolol,cytochrome p450 1a2,enzyme,,Drug: propranolol | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
10508,propranolol,solute carrier family 22 member 1,transporter,,Drug: propranolol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10509,propranolol,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: propranolol | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
10510,propranolol,5-hydroxytryptamine receptor 1b,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10511,propranolol,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: propranolol | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
10512,propranolol,d(2) dopamine receptor,gpcr,,Drug: propranolol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10513,propranolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: propranolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10514,propranolol,beta-2 adrenergic receptor,gpcr,,Drug: propranolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10515,propranolol,beta-2 adrenergic receptor,gpcr,,Drug: propranolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10516,propranolol,beta-1 adrenergic receptor,gpcr,,Drug: propranolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10517,propranolol,beta-2 adrenergic receptor,gpcr,,Drug: propranolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10518,propranolol,beta-1 adrenergic receptor,gpcr,,Drug: propranolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10519,propranolol,adrenergic receptor beta,gpcr,,Drug: propranolol | Target: adrenergic receptor beta | Type: gpcr | Action: nan
10520,propranolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: propranolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10521,propranolol,beta-1 adrenergic receptor,gpcr,,Drug: propranolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10523,propranolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: propranolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10524,propranolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: propranolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10525,propylthiouracil,thyroid peroxidase,enzyme,INHIBITOR,Drug: propylthiouracil | Target: thyroid peroxidase | Type: enzyme | Action: INHIBITOR
10526,propylthiouracil,myeloperoxidase,enzyme,,Drug: propylthiouracil | Target: myeloperoxidase | Type: enzyme | Action: nan
10527,propylthiouracil,type i iodothyronine deiodinase,enzyme,INHIBITOR,Drug: propylthiouracil | Target: type i iodothyronine deiodinase | Type: enzyme | Action: INHIBITOR
10528,propylthiouracil,taste receptor type 2 member 38,gpcr,,Drug: propylthiouracil | Target: taste receptor type 2 member 38 | Type: gpcr | Action: nan
10529,propyphenazone,transient receptor potential cation channel subfamily a member 1,ion channel,BLOCKER,Drug: propyphenazone | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: BLOCKER
10530,proquazone,prostaglandin g/h synthase 2,enzyme,,Drug: proquazone | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
10531,proquazone,prostaglandin g/h synthase 1,enzyme,,Drug: proquazone | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
10532,proquazone,cyclooxygenase,enzyme,,Drug: proquazone | Target: cyclooxygenase | Type: enzyme | Action: nan
10533,proscillaridin,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: proscillaridin | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
10534,proscillaridin,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: proscillaridin | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
10535,protionamide,polyphenol oxidase 2,enzyme,,Drug: protionamide | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
10536,protirelin,thyrotropin-releasing hormone receptor,gpcr,AGONIST,Drug: protirelin | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
10537,protirelin,thyrotropin-releasing hormone receptor,gpcr,,Drug: protirelin | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: nan
10538,protirelin,protein trhr2; thyrotropin releasing hormone receptor 2; thyrotropin-releasing hormone receptor 2,gpcr,,Drug: protirelin | Target: protein trhr2; thyrotropin releasing hormone receptor 2; thyrotropin-releasing hormone receptor 2 | Type: gpcr | Action: nan
10539,protirelin,thyrotropin-releasing hormone receptor,gpcr,,Drug: protirelin | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: nan
10540,protirelin,thyrotropin-releasing hormone receptor 2,gpcr,,Drug: protirelin | Target: thyrotropin-releasing hormone receptor 2 | Type: gpcr | Action: nan
10541,protokylol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: protokylol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
10542,protriptyline,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: protriptyline | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10543,protriptyline,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: protriptyline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
10544,protriptyline,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: protriptyline | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
10545,protriptyline,5-hydroxytryptamine receptor 2a,gpcr,,Drug: protriptyline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10546,protriptyline,5-hydroxytryptamine receptor 2b,gpcr,,Drug: protriptyline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10547,protriptyline,5-hydroxytryptamine receptor 2c,gpcr,,Drug: protriptyline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10548,protriptyline,histamine h1 receptor,gpcr,,Drug: protriptyline | Target: histamine h1 receptor | Type: gpcr | Action: nan
10549,protriptyline,muscarinic acetylcholine receptor m1,gpcr,,Drug: protriptyline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10550,protriptyline,muscarinic acetylcholine receptor m2,gpcr,,Drug: protriptyline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10551,protriptyline,muscarinic acetylcholine receptor m3,gpcr,,Drug: protriptyline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10552,protriptyline,muscarinic acetylcholine receptor m4,gpcr,,Drug: protriptyline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10553,protriptyline,muscarinic acetylcholine receptor m5,gpcr,,Drug: protriptyline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10554,protriptyline,sodium-dependent dopamine transporter,transporter,,Drug: protriptyline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
10555,protriptyline,adenosine receptor a3,gpcr,,Drug: protriptyline | Target: adenosine receptor a3 | Type: gpcr | Action: nan
10556,pseudoephedrine,beta-2 adrenergic receptor,gpcr,,Drug: pseudoephedrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10557,pseudoephedrine,alpha-2a adrenergic receptor,gpcr,,Drug: pseudoephedrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10558,pseudoephedrine,sodium-dependent noradrenaline transporter,transporter,RELEASING AGENT,Drug: pseudoephedrine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: RELEASING AGENT
10559,pseudoephedrine,alpha-1a adrenergic receptor,gpcr,,Drug: pseudoephedrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10560,pyrazinamide,cytochrome p450 3a4,enzyme,,Drug: pyrazinamide | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
10561,pyrazinamide,carbonic anhydrase 2,enzyme,,Drug: pyrazinamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
10562,pyrazinamide,cyclopropane mycolic acid synthase 1,enzyme,,Drug: pyrazinamide | Target: cyclopropane mycolic acid synthase 1 | Type: enzyme | Action: nan
10563,pyrazinamide,amidase; nicotinamidase; nicotinamidase/pyrazinamidase; pyrazinamidase; pyrazinamidase/nicotinamidase; pyrazinamidase/nicotinamidase pnca,enzyme,,Drug: pyrazinamide | Target: amidase; nicotinamidase; nicotinamidase/pyrazinamidase; pyrazinamidase; pyrazinamidase/nicotinamidase; pyrazinamidase/nicotinamidase pnca | Type: enzyme | Action: nan
10564,pyrazinamide,cytochrome p450 3a5,enzyme,,Drug: pyrazinamide | Target: cytochrome p450 3a5 | Type: enzyme | Action: nan
10565,pyrazinamide,3-oxoacyl-acp synthase; fatty acid synthase fas; probable fatty acid synthase fas (fatty acid synthetase),enzyme,INHIBITOR,Drug: pyrazinamide | Target: 3-oxoacyl-acp synthase; fatty acid synthase fas; probable fatty acid synthase fas (fatty acid synthetase) | Type: enzyme | Action: INHIBITOR
10566,pyridostigmine,acetylcholinesterase,enzyme,INHIBITOR,Drug: pyridostigmine | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
10567,pyridostigmine,cholinesterase,enzyme,,Drug: pyridostigmine | Target: cholinesterase | Type: enzyme | Action: nan
10568,pyridostigmine,acetylcholinesterase,enzyme,,Drug: pyridostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
10569,pyridostigmine,acetylcholinesterase,enzyme,,Drug: pyridostigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
10570,mepyramine,alpha-2a adrenergic receptor,gpcr,,Drug: mepyramine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10571,mepyramine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: mepyramine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10572,mepyramine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: mepyramine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10573,mepyramine,sodium-dependent serotonin transporter,transporter,,Drug: mepyramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10574,mepyramine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: mepyramine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10575,mepyramine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: mepyramine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10576,mepyramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: mepyramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10577,mepyramine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: mepyramine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
10578,mepyramine,sodium-dependent dopamine transporter,transporter,,Drug: mepyramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
10579,mepyramine,cytochrome p450 2d6,enzyme,,Drug: mepyramine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10580,mepyramine,adenosine receptor a3,gpcr,,Drug: mepyramine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
10581,mepyramine,histamine h1 receptor,gpcr,,Drug: mepyramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10582,mepyramine,histamine h1 receptor,gpcr,,Drug: mepyramine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10583,pyrimethamine,muscarinic acetylcholine receptor m1,gpcr,,Drug: pyrimethamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10584,pyrimethamine,dihydrofolate reductase,enzyme,,Drug: pyrimethamine | Target: dihydrofolate reductase | Type: enzyme | Action: nan
10585,pyrimethamine,cytochrome p450 2c9,enzyme,,Drug: pyrimethamine | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
10586,pyrimethamine,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: pyrimethamine | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
10587,pyrimethamine,dihydrofolate reductase,enzyme,,Drug: pyrimethamine | Target: dihydrofolate reductase | Type: enzyme | Action: nan
10588,pyrimethamine,solute carrier family 22 member 1,transporter,,Drug: pyrimethamine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10589,pyrimethamine,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,INHIBITOR,Drug: pyrimethamine | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: INHIBITOR
10590,pyrimethamine,dihydrofolate reductase,enzyme,,Drug: pyrimethamine | Target: dihydrofolate reductase | Type: enzyme | Action: nan
10591,pyrimethamine,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: pyrimethamine | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
10592,pyrimethamine,dihydrofolate reductase,enzyme,,Drug: pyrimethamine | Target: dihydrofolate reductase | Type: enzyme | Action: nan
10593,pyrimethamine,dihydrofolate reductase,enzyme,,Drug: pyrimethamine | Target: dihydrofolate reductase | Type: enzyme | Action: nan
10594,pyrimethamine,pteridine reductase 1,enzyme,,Drug: pyrimethamine | Target: pteridine reductase 1 | Type: enzyme | Action: nan
10595,pyrimethamine,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: pyrimethamine | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
10596,pyrimethamine,multidrug and toxin extrusion protein 1,transporter,INHIBITOR,Drug: pyrimethamine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: INHIBITOR
10597,pyrimethamine,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: pyrimethamine | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
10598,pyrimethamine,solute carrier family 22 member 1,transporter,,Drug: pyrimethamine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10599,pyrimethamine,multidrug and toxin extrusion protein 1,unclassified,,Drug: pyrimethamine | Target: multidrug and toxin extrusion protein 1 | Type: unclassified | Action: nan
10600,pyrimethamine,dihydrofolate reductase,enzyme,,Drug: pyrimethamine | Target: dihydrofolate reductase | Type: enzyme | Action: nan
10601,pyrimethamine,beta-hexosaminidase subunit alpha,enzyme,,Drug: pyrimethamine | Target: beta-hexosaminidase subunit alpha | Type: enzyme | Action: nan
10602,pyrimethamine,beta-hexosaminidase subunit beta,enzyme,,Drug: pyrimethamine | Target: beta-hexosaminidase subunit beta | Type: enzyme | Action: nan
10603,pyrimethamine,multidrug and toxin extrusion protein 2,unclassified,INHIBITOR,Drug: pyrimethamine | Target: multidrug and toxin extrusion protein 2 | Type: unclassified | Action: INHIBITOR
10605,pyrimethamine,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: pyrimethamine | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
10606,pyrvinium,fumarate reductase,unclassified,,Drug: pyrvinium | Target: fumarate reductase | Type: unclassified | Action: nan
10607,pyrvinium,synaptojanin-2,enzyme,,Drug: pyrvinium | Target: synaptojanin-2 | Type: enzyme | Action: nan
10608,pyrvinium,synaptojanin-1,enzyme,,Drug: pyrvinium | Target: synaptojanin-1 | Type: enzyme | Action: nan
10609,pyrvinium,"serine hydroxymethyltransferase, mitochondrial",enzyme,,"Drug: pyrvinium | Target: serine hydroxymethyltransferase, mitochondrial | Type: enzyme | Action: nan"
10610,quazepam,gaba a receptor alpha-1/beta-1/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: quazepam | Target: gaba a receptor alpha-1/beta-1/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
10611,quazepam,gaba a receptor alpha-3/beta-1/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: quazepam | Target: gaba a receptor alpha-3/beta-1/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
10612,quazepam,gaba a receptor alpha-2/beta-1/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: quazepam | Target: gaba a receptor alpha-2/beta-1/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
10613,quetiapine,beta-1 adrenergic receptor,gpcr,,Drug: quetiapine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10614,quetiapine,beta-2 adrenergic receptor,gpcr,,Drug: quetiapine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10615,quetiapine,d(1a) dopamine receptor,gpcr,,Drug: quetiapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10616,quetiapine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: quetiapine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10617,quetiapine,alpha-2a adrenergic receptor,gpcr,,Drug: quetiapine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10618,quetiapine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: quetiapine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10619,quetiapine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: quetiapine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10620,quetiapine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: quetiapine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
10621,quetiapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10622,quetiapine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
10623,quetiapine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10624,quetiapine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
10625,quetiapine,5-hydroxytryptamine receptor 6,gpcr,,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10626,quetiapine,5-hydroxytryptamine receptor 7,gpcr,,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
10627,quetiapine,alpha-1a adrenergic receptor,gpcr,,Drug: quetiapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10628,quetiapine,alpha-2b adrenergic receptor,gpcr,,Drug: quetiapine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10629,quetiapine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: quetiapine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10630,quetiapine,d(1b) dopamine receptor,gpcr,,Drug: quetiapine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
10631,quetiapine,histamine h1 receptor,gpcr,,Drug: quetiapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10632,quetiapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: quetiapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10633,quetiapine,muscarinic acetylcholine receptor m2,gpcr,,Drug: quetiapine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10634,quetiapine,muscarinic acetylcholine receptor m3,gpcr,,Drug: quetiapine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10635,quetiapine,muscarinic acetylcholine receptor m4,gpcr,,Drug: quetiapine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10636,quetiapine,muscarinic acetylcholine receptor m5,gpcr,,Drug: quetiapine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10637,quetiapine,aldehyde oxidase,enzyme,,Drug: quetiapine | Target: aldehyde oxidase | Type: enzyme | Action: nan
10638,quetiapine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10639,quetiapine,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
10640,quetiapine,alpha-2c adrenergic receptor,gpcr,,Drug: quetiapine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10641,quetiapine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: quetiapine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10642,quetiapine,alpha-1d adrenergic receptor,gpcr,,Drug: quetiapine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10643,quetiapine,alpha-1b adrenergic receptor,gpcr,,Drug: quetiapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10644,quetiapine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
10645,quetiapine,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
10646,quetiapine,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
10647,quetiapine,alpha-1b adrenergic receptor,gpcr,,Drug: quetiapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10648,quetiapine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: quetiapine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
10649,quetiapine,alpha-1a adrenergic receptor,gpcr,,Drug: quetiapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10650,quetiapine,histamine h1 receptor,gpcr,,Drug: quetiapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10651,quetiapine,d(2) dopamine receptor,gpcr,,Drug: quetiapine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10652,quetiapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10653,quetiapine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: quetiapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10654,quetiapine,histamine h1 receptor,gpcr,,Drug: quetiapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
10655,quetiapine,transporter,transporter,,Drug: quetiapine | Target: transporter | Type: transporter | Action: nan
10656,quetiapine,histone h1.0,nuclear other,,Drug: quetiapine | Target: histone h1.0 | Type: nuclear other | Action: nan
10657,mepacrine,alpha-2a adrenergic receptor,gpcr,,Drug: mepacrine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10658,mepacrine,sodium-dependent noradrenaline transporter,transporter,,Drug: mepacrine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10659,mepacrine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: mepacrine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10660,mepacrine,alpha-2b adrenergic receptor,gpcr,,Drug: mepacrine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10661,mepacrine,d(3) dopamine receptor,gpcr,,Drug: mepacrine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10662,mepacrine,histamine h2 receptor,gpcr,,Drug: mepacrine | Target: histamine h2 receptor | Type: gpcr | Action: nan
10663,mepacrine,muscarinic acetylcholine receptor m1,gpcr,,Drug: mepacrine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10664,mepacrine,muscarinic acetylcholine receptor m2,gpcr,,Drug: mepacrine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10665,mepacrine,muscarinic acetylcholine receptor m3,gpcr,,Drug: mepacrine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10666,mepacrine,muscarinic acetylcholine receptor m4,gpcr,,Drug: mepacrine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10667,mepacrine,muscarinic acetylcholine receptor m5,gpcr,,Drug: mepacrine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
10668,mepacrine,aldehyde oxidase,enzyme,,Drug: mepacrine | Target: aldehyde oxidase | Type: enzyme | Action: nan
10669,mepacrine,alpha-2c adrenergic receptor,gpcr,,Drug: mepacrine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10670,mepacrine,alpha-1d adrenergic receptor,gpcr,,Drug: mepacrine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10671,mepacrine,acetylcholinesterase,enzyme,,Drug: mepacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
10672,mepacrine,major prion protein,surface antigen,,Drug: mepacrine | Target: major prion protein | Type: surface antigen | Action: nan
10673,mepacrine,trypanothione reductase,enzyme,,Drug: mepacrine | Target: trypanothione reductase | Type: enzyme | Action: nan
10674,mepacrine,alpha-1b adrenergic receptor,gpcr,,Drug: mepacrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10675,mepacrine,cholinesterase,enzyme,,Drug: mepacrine | Target: cholinesterase | Type: enzyme | Action: nan
10676,mepacrine,riboflavin-binding protein,unclassified,,Drug: mepacrine | Target: riboflavin-binding protein | Type: unclassified | Action: nan
10677,mepacrine,cyclooxygenase,enzyme,,Drug: mepacrine | Target: cyclooxygenase | Type: enzyme | Action: nan
10678,mepacrine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: mepacrine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
10679,mepacrine,bacterial dna-directed rna polymerase,enzyme,,Drug: mepacrine | Target: bacterial dna-directed rna polymerase | Type: enzyme | Action: nan
10680,mepacrine,phospholipase a2 group 1b,enzyme,,Drug: mepacrine | Target: phospholipase a2 group 1b | Type: enzyme | Action: nan
10681,mepacrine,phospholipase a2 group 1b,enzyme,,Drug: mepacrine | Target: phospholipase a2 group 1b | Type: enzyme | Action: nan
10682,quinagolide,serotonin (5-ht) receptor,gpcr,,Drug: quinagolide | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
10683,quinagolide,adrenergic receptor alpha-2,gpcr,,Drug: quinagolide | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
10684,quinagolide,dopamine receptor,gpcr,,Drug: quinagolide | Target: dopamine receptor | Type: gpcr | Action: nan
10685,quinagolide,adrenergic receptor alpha-1,gpcr,,Drug: quinagolide | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
10686,quinapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: quinapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
10687,quinapril,angiotensin-converting enzyme,enzyme,,Drug: quinapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
10688,quinestrol,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: quinestrol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
10689,quinethazone,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: quinethazone | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
10690,quingestanol acetate,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: quingestanol acetate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
10691,quinidine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: quinidine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
10692,quinidine,sodium channel subunit beta-1,ion channel,,Drug: quinidine | Target: sodium channel subunit beta-1 | Type: ion channel | Action: nan
10693,quinidine,sodium channel subunit beta-2,ion channel,,Drug: quinidine | Target: sodium channel subunit beta-2 | Type: ion channel | Action: nan
10694,quinidine,sodium channel subunit beta-3,ion channel,,Drug: quinidine | Target: sodium channel subunit beta-3 | Type: ion channel | Action: nan
10695,quinidine,sodium channel subunit beta-4,ion channel,,Drug: quinidine | Target: sodium channel subunit beta-4 | Type: ion channel | Action: nan
10696,quinidine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: quinidine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10697,quinidine,multidrug resistance protein 1,transporter,,Drug: quinidine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
10698,quinidine,muscarinic acetylcholine receptor m2,gpcr,,Drug: quinidine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10699,quinidine,cholinesterase,enzyme,,Drug: quinidine | Target: cholinesterase | Type: enzyme | Action: nan
10700,quinidine,potassium voltage-gated channel subfamily a member 5,ion channel,BLOCKER,Drug: quinidine | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: BLOCKER
10701,quinidine,potassium voltage-gated channel subfamily h member 1,ion channel,BLOCKER,Drug: quinidine | Target: potassium voltage-gated channel subfamily h member 1 | Type: ion channel | Action: BLOCKER
10702,quinidine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: quinidine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
10703,quinidine,potassium voltage-gated channel subfamily a member 7,ion channel,BLOCKER,Drug: quinidine | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: BLOCKER
10704,quinidine,cholinesterase,enzyme,,Drug: quinidine | Target: cholinesterase | Type: enzyme | Action: nan
10705,quinidine,solute carrier family 22 member 2,transporter,,Drug: quinidine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
10706,quinidine,multidrug and toxin extrusion protein 1,transporter,,Drug: quinidine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
10707,quinidine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,BLOCKER,"Drug: quinidine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: BLOCKER"
10708,quinidine,equilibrative nucleoside transporter 4,transporter,INHIBITOR,Drug: quinidine | Target: equilibrative nucleoside transporter 4 | Type: transporter | Action: INHIBITOR
10709,quinidine,potassium voltage-gated channel subfamily d member 2,ion channel,,Drug: quinidine | Target: potassium voltage-gated channel subfamily d member 2 | Type: ion channel | Action: nan
10710,quinidine,potassium channel subfamily t member 1,ion channel,BLOCKER,Drug: quinidine | Target: potassium channel subfamily t member 1 | Type: ion channel | Action: BLOCKER
10711,quinidine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: quinidine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
10712,quinidine,cytochrome p450 2d6,enzyme,INHIBITOR,Drug: quinidine | Target: cytochrome p450 2d6 | Type: enzyme | Action: INHIBITOR
10713,rabeprazole,alpha-2b adrenergic receptor,gpcr,,Drug: rabeprazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10714,rabeprazole,d(3) dopamine receptor,gpcr,,Drug: rabeprazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10715,rabeprazole,5-hydroxytryptamine receptor 1d,gpcr,,Drug: rabeprazole | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
10716,rabeprazole,sodium/potassium-transporting atpase subunit alpha-1,transporter,,Drug: rabeprazole | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: transporter | Action: nan
10717,rabeprazole,adenosine receptor a3,gpcr,,Drug: rabeprazole | Target: adenosine receptor a3 | Type: gpcr | Action: nan
10718,rabeprazole,fatty acid synthase,enzyme,,Drug: rabeprazole | Target: fatty acid synthase | Type: enzyme | Action: nan
10719,rabeprazole,potassium-transporting atpase,transporter,INHIBITOR,Drug: rabeprazole | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
10720,rabeprazole,insulin-degrading enzyme,enzyme,,Drug: rabeprazole | Target: insulin-degrading enzyme | Type: enzyme | Action: nan
10721,rabeprazole,"n(g),n(g)-dimethylarginine dimethylaminohydrolase 1",enzyme,,"Drug: rabeprazole | Target: n(g),n(g)-dimethylarginine dimethylaminohydrolase 1 | Type: enzyme | Action: nan"
10722,rabeprazole,cytosolic endo-beta-n-acetylglucosaminidase,enzyme,,Drug: rabeprazole | Target: cytosolic endo-beta-n-acetylglucosaminidase | Type: enzyme | Action: nan
10725,rabeprazole,sterile alpha and tir motif-containing protein 1,unclassified,,Drug: rabeprazole | Target: sterile alpha and tir motif-containing protein 1 | Type: unclassified | Action: nan
10726,raloxifene,mu-type opioid receptor,gpcr,,Drug: raloxifene | Target: mu-type opioid receptor | Type: gpcr | Action: nan
10727,raloxifene,d(1a) dopamine receptor,gpcr,,Drug: raloxifene | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10728,raloxifene,d(2) dopamine receptor,gpcr,,Drug: raloxifene | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10729,raloxifene,adenosine receptor a2a,gpcr,,Drug: raloxifene | Target: adenosine receptor a2a | Type: gpcr | Action: nan
10730,raloxifene,alpha-2a adrenergic receptor,gpcr,,Drug: raloxifene | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10731,raloxifene,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: raloxifene | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10732,raloxifene,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: raloxifene | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
10733,raloxifene,sodium-dependent serotonin transporter,transporter,,Drug: raloxifene | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10734,raloxifene,sodium-dependent noradrenaline transporter,transporter,,Drug: raloxifene | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10735,raloxifene,5-hydroxytryptamine receptor 2a,gpcr,,Drug: raloxifene | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10736,raloxifene,5-hydroxytryptamine receptor 2b,gpcr,,Drug: raloxifene | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10737,raloxifene,5-hydroxytryptamine receptor 2c,gpcr,,Drug: raloxifene | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10738,raloxifene,5-hydroxytryptamine receptor 6,gpcr,,Drug: raloxifene | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10739,raloxifene,alpha-2b adrenergic receptor,gpcr,,Drug: raloxifene | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10740,raloxifene,d(3) dopamine receptor,gpcr,,Drug: raloxifene | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10741,raloxifene,aldehyde oxidase,enzyme,,Drug: raloxifene | Target: aldehyde oxidase | Type: enzyme | Action: nan
10742,raloxifene,5-hydroxytryptamine receptor 1d,gpcr,,Drug: raloxifene | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
10743,raloxifene,alpha-2c adrenergic receptor,gpcr,,Drug: raloxifene | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10744,raloxifene,sodium-dependent dopamine transporter,transporter,,Drug: raloxifene | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
10745,raloxifene,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: raloxifene | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
10746,raloxifene,alpha-1d adrenergic receptor,gpcr,,Drug: raloxifene | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
10747,raloxifene,kappa-type opioid receptor,gpcr,,Drug: raloxifene | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
10748,raloxifene,estrogen receptor,nuclear hormone receptor,ANTAGONIST,Drug: raloxifene | Target: estrogen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
10749,raloxifene,delta-type opioid receptor,gpcr,,Drug: raloxifene | Target: delta-type opioid receptor | Type: gpcr | Action: nan
10750,raloxifene,acetylcholinesterase,enzyme,,Drug: raloxifene | Target: acetylcholinesterase | Type: enzyme | Action: nan
10751,raloxifene,cytochrome p450 2c9,enzyme,,Drug: raloxifene | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
10752,raloxifene,estrogen receptor beta,nuclear hormone receptor,MODULATOR,Drug: raloxifene | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: MODULATOR
10753,raloxifene,g-protein coupled estrogen receptor 1,gpcr,,Drug: raloxifene | Target: g-protein coupled estrogen receptor 1 | Type: gpcr | Action: nan
10754,raloxifene,interleukin-6,cytokine,,Drug: raloxifene | Target: interleukin-6 | Type: cytokine | Action: nan
10755,raloxifene,tyrosine-protein kinase fyn,kinase,,Drug: raloxifene | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
10756,raloxifene,bile acid receptor,nuclear hormone receptor,,Drug: raloxifene | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
10757,raloxifene,substance-k receptor,gpcr,,Drug: raloxifene | Target: substance-k receptor | Type: gpcr | Action: nan
10758,raloxifene,phospholipase d1,enzyme,,Drug: raloxifene | Target: phospholipase d1 | Type: enzyme | Action: nan
10759,raloxifene,phospholipase d2,enzyme,,Drug: raloxifene | Target: phospholipase d2 | Type: enzyme | Action: nan
10760,raloxifene,alpha-1b adrenergic receptor,gpcr,,Drug: raloxifene | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10761,raloxifene,5-hydroxytryptamine receptor 1b,gpcr,,Drug: raloxifene | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
10762,raloxifene,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: raloxifene | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
10763,raloxifene,alpha-1a adrenergic receptor,gpcr,,Drug: raloxifene | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10764,raloxifene,estrogen receptor,transcription factor,,Drug: raloxifene | Target: estrogen receptor | Type: transcription factor | Action: nan
10765,raloxifene,estrogen receptor beta,transcription factor,,Drug: raloxifene | Target: estrogen receptor beta | Type: transcription factor | Action: nan
10766,raloxifene,c-8 sterol isomerase,enzyme,,Drug: raloxifene | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
10767,raloxifene,cruzipain,enzyme,,Drug: raloxifene | Target: cruzipain | Type: enzyme | Action: nan
10768,raloxifene,estrogen receptor,transcription factor,,Drug: raloxifene | Target: estrogen receptor | Type: transcription factor | Action: nan
10769,raloxifene,complement c5,secreted,,Drug: raloxifene | Target: complement c5 | Type: secreted | Action: nan
10770,raloxifene,"hla class i histocompatibility antigen, a-3 alpha chain",unclassified,,"Drug: raloxifene | Target: hla class i histocompatibility antigen, a-3 alpha chain | Type: unclassified | Action: nan"
10771,raloxifene,complement c5,unclassified,,Drug: raloxifene | Target: complement c5 | Type: unclassified | Action: nan
10772,raltegravir,gag-pol polyprotein,polyprotein,INHIBITOR,Drug: raltegravir | Target: gag-pol polyprotein | Type: polyprotein | Action: INHIBITOR
10773,raltegravir,integrase,enzyme,INHIBITOR,Drug: raltegravir | Target: integrase | Type: enzyme | Action: INHIBITOR
10774,raltegravir,c-c chemokine receptor type 1,gpcr,,Drug: raltegravir | Target: c-c chemokine receptor type 1 | Type: gpcr | Action: nan
10775,raltegravir,integrase,enzyme,,Drug: raltegravir | Target: integrase | Type: enzyme | Action: nan
10776,raltitrexed,thymidylate synthase,enzyme,,Drug: raltitrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
10777,raltitrexed,dihydrofolate reductase,enzyme,,Drug: raltitrexed | Target: dihydrofolate reductase | Type: enzyme | Action: nan
10778,raltitrexed,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: raltitrexed | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
10779,raltitrexed,folate receptor beta,membrane receptor,,Drug: raltitrexed | Target: folate receptor beta | Type: membrane receptor | Action: nan
10780,raltitrexed,proton-coupled folate transporter,transporter,,Drug: raltitrexed | Target: proton-coupled folate transporter | Type: transporter | Action: nan
10781,raltitrexed,thymidylate synthase,enzyme,,Drug: raltitrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
10782,raltitrexed,thymidylate synthase,enzyme,,Drug: raltitrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
10783,raltitrexed,thymidylate synthase,enzyme,,Drug: raltitrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
10784,raltitrexed,thymidylate synthase,enzyme,,Drug: raltitrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
10785,raltitrexed,dihydrofolate reductase,enzyme,,Drug: raltitrexed | Target: dihydrofolate reductase | Type: enzyme | Action: nan
10786,raltitrexed,thymidylate synthase,enzyme,,Drug: raltitrexed | Target: thymidylate synthase | Type: enzyme | Action: nan
10787,raltitrexed,folate transporter 1,transporter,,Drug: raltitrexed | Target: folate transporter 1 | Type: transporter | Action: nan
10788,raltitrexed,folate receptor alpha,membrane receptor,,Drug: raltitrexed | Target: folate receptor alpha | Type: membrane receptor | Action: nan
10789,ramatroban,prostaglandin d2 receptor 2,gpcr,,Drug: ramatroban | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: nan
10790,ramatroban,thromboxane a2 receptor,gpcr,INVERSE AGONIST,Drug: ramatroban | Target: thromboxane a2 receptor | Type: gpcr | Action: INVERSE AGONIST
10791,ramatroban,prostaglandin d2 receptor,gpcr,,Drug: ramatroban | Target: prostaglandin d2 receptor | Type: gpcr | Action: nan
10792,ramatroban,prostaglandin d2 receptor 2,gpcr,ANTAGONIST,Drug: ramatroban | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: ANTAGONIST
10793,ramatroban,prostaglandin d2 receptor 2,gpcr,ANTAGONIST,Drug: ramatroban | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: ANTAGONIST
10794,ramelteon,melatonin receptor type 1a,gpcr,AGONIST,Drug: ramelteon | Target: melatonin receptor type 1a | Type: gpcr | Action: AGONIST
10795,ramelteon,melatonin receptor type 1b,gpcr,AGONIST,Drug: ramelteon | Target: melatonin receptor type 1b | Type: gpcr | Action: AGONIST
10796,ramipril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: ramipril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
10797,ramipril,angiotensin-converting enzyme,enzyme,,Drug: ramipril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
10798,ramosetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: ramosetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
10799,ranitidine,histamine h2 receptor,gpcr,ANTAGONIST,Drug: ranitidine | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
10800,ranitidine,acetylcholinesterase,enzyme,,Drug: ranitidine | Target: acetylcholinesterase | Type: enzyme | Action: nan
10801,ranitidine,histamine h2 receptor,gpcr,,Drug: ranitidine | Target: histamine h2 receptor | Type: gpcr | Action: nan
10802,ranitidine,multidrug and toxin extrusion protein 1,transporter,,Drug: ranitidine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
10803,ranitidine,histamine h2 receptor,gpcr,ANTAGONIST,Drug: ranitidine | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
10804,ranolazine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: ranolazine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
10805,ranolazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ranolazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10806,ranolazine,multidrug resistance protein 1,transporter,,Drug: ranolazine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
10807,ranolazine,voltage-gated sodium channel nav1.5 cardiac isoform,unclassified,,Drug: ranolazine | Target: voltage-gated sodium channel nav1.5 cardiac isoform | Type: unclassified | Action: nan
10808,rebamipide,cholecystokinin receptor type a,gpcr,AGONIST,Drug: rebamipide | Target: cholecystokinin receptor type a | Type: gpcr | Action: AGONIST
10809,reboxetine,sodium-dependent serotonin transporter,transporter,,Drug: reboxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10810,reboxetine,sodium-dependent noradrenaline transporter,transporter,,Drug: reboxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10811,reboxetine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: reboxetine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10812,reboxetine,5-hydroxytryptamine receptor 6,gpcr,,Drug: reboxetine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10813,reboxetine,sodium-dependent dopamine transporter,transporter,,Drug: reboxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
10814,reboxetine,g protein-activated inward rectifier potassium channel 2,ion channel,,Drug: reboxetine | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: nan
10815,reboxetine,sodium-dependent serotonin transporter,transporter,,Drug: reboxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10816,reboxetine,transporter,transporter,,Drug: reboxetine | Target: transporter | Type: transporter | Action: nan
10817,reboxetine,transporter,transporter,,Drug: reboxetine | Target: transporter | Type: transporter | Action: nan
10818,reboxetine,kir3.1/kir3.2,ion channel,,Drug: reboxetine | Target: kir3.1/kir3.2 | Type: ion channel | Action: nan
10819,reboxetine,kir3.1/kir3.4,ion channel,,Drug: reboxetine | Target: kir3.1/kir3.4 | Type: ion channel | Action: nan
10820,regadenoson,adenosine receptor a2a,gpcr,AGONIST,Drug: regadenoson | Target: adenosine receptor a2a | Type: gpcr | Action: AGONIST
10821,regadenoson,adenosine receptor a1,gpcr,,Drug: regadenoson | Target: adenosine receptor a1 | Type: gpcr | Action: nan
10822,regadenoson,adenosine receptor a2b,gpcr,,Drug: regadenoson | Target: adenosine receptor a2b | Type: gpcr | Action: nan
10823,regadenoson,adenosine receptor a3,gpcr,,Drug: regadenoson | Target: adenosine receptor a3 | Type: gpcr | Action: nan
10824,regadenoson,adenosine receptor a2a,gpcr,,Drug: regadenoson | Target: adenosine receptor a2a | Type: gpcr | Action: nan
10825,remifentanil,mu-type opioid receptor,gpcr,AGONIST,Drug: remifentanil | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
10826,remifentanil,mu-type opioid receptor,gpcr,,Drug: remifentanil | Target: mu-type opioid receptor | Type: gpcr | Action: nan
10828,remoxipride,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: remoxipride | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10829,remoxipride,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: remoxipride | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10830,remoxipride,5-hydroxytryptamine receptor 1a,gpcr,,Drug: remoxipride | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10831,remoxipride,5-hydroxytryptamine receptor 2a,gpcr,,Drug: remoxipride | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10832,remoxipride,d(3) dopamine receptor,gpcr,,Drug: remoxipride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10833,remoxipride,d(4) dopamine receptor,gpcr,,Drug: remoxipride | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
10834,remoxipride,d(2) dopamine receptor,gpcr,,Drug: remoxipride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10835,remoxipride,d(2) dopamine receptor,gpcr,,Drug: remoxipride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10836,remoxipride,d(3) dopamine receptor,gpcr,,Drug: remoxipride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10837,remoxipride,dopamine receptor,gpcr,,Drug: remoxipride | Target: dopamine receptor | Type: gpcr | Action: nan
10838,repaglinide,atp-binding cassette sub-family c member 8,ion channel,,Drug: repaglinide | Target: atp-binding cassette sub-family c member 8 | Type: ion channel | Action: nan
10839,repaglinide,solute carrier organic anion transporter family member 1b1,transporter,,Drug: repaglinide | Target: solute carrier organic anion transporter family member 1b1 | Type: transporter | Action: nan
10840,repaglinide,solute carrier family 22 member 1,transporter,,Drug: repaglinide | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10841,repaglinide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: repaglinide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
10842,repaglinide,"sulfonylurea receptor 2, kir6.2",ion channel,BLOCKER,"Drug: repaglinide | Target: sulfonylurea receptor 2, kir6.2 | Type: ion channel | Action: BLOCKER"
10843,reproterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: reproterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
10844,rescinnamine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: rescinnamine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
10845,reserpine,mu-type opioid receptor,gpcr,,Drug: reserpine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
10846,reserpine,d(1a) dopamine receptor,gpcr,,Drug: reserpine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10847,reserpine,d(2) dopamine receptor,gpcr,,Drug: reserpine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10848,reserpine,multidrug resistance protein 1,transporter,,Drug: reserpine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
10849,reserpine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: reserpine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10850,reserpine,d(3) dopamine receptor,gpcr,,Drug: reserpine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10851,reserpine,atp-binding cassette sub-family g member 2,transporter,,Drug: reserpine | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
10852,reserpine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: reserpine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
10853,reserpine,synaptic vesicular amine transporter,transporter,,Drug: reserpine | Target: synaptic vesicular amine transporter | Type: transporter | Action: nan
10854,reserpine,quinolone resistance protein nora,transporter,,Drug: reserpine | Target: quinolone resistance protein nora | Type: transporter | Action: nan
10855,reserpine,chromaffin granule amine transporter,transporter,INHIBITOR,Drug: reserpine | Target: chromaffin granule amine transporter | Type: transporter | Action: INHIBITOR
10856,reserpine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: reserpine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
10857,reserpine,synaptic vesicular amine transporter,transporter,,Drug: reserpine | Target: synaptic vesicular amine transporter | Type: transporter | Action: nan
10858,reserpine,sodium-dependent serotonin transporter,transporter,,Drug: reserpine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10859,retinol acetate,retinol-binding protein 4,secreted,,Drug: retinol acetate | Target: retinol-binding protein 4 | Type: secreted | Action: nan
10860,retinol acetate,beta-lactoglobulin,unclassified,,Drug: retinol acetate | Target: beta-lactoglobulin | Type: unclassified | Action: nan
10861,ribavirin,adenosine receptor a1,gpcr,,Drug: ribavirin | Target: adenosine receptor a1 | Type: gpcr | Action: nan
10862,ribavirin,adenosine kinase,kinase,,Drug: ribavirin | Target: adenosine kinase | Type: kinase | Action: nan
10863,ribavirin,ectonucleotide pyrophosphatase/phosphodiesterase family member 1,enzyme,,Drug: ribavirin | Target: ectonucleotide pyrophosphatase/phosphodiesterase family member 1 | Type: enzyme | Action: nan
10864,ribavirin,cytosolic purine 5'-nucleotidase,enzyme,,Drug: ribavirin | Target: cytosolic purine 5'-nucleotidase | Type: enzyme | Action: nan
10865,ribavirin,inosine-5'-monophosphate dehydrogenase 1,enzyme,INHIBITOR,Drug: ribavirin | Target: inosine-5'-monophosphate dehydrogenase 1 | Type: enzyme | Action: INHIBITOR
10866,ribavirin,inosine-5'-monophosphate dehydrogenase 2,enzyme,INHIBITOR,Drug: ribavirin | Target: inosine-5'-monophosphate dehydrogenase 2 | Type: enzyme | Action: INHIBITOR
10867,ribavirin,dna topoisomerase 1,enzyme,,Drug: ribavirin | Target: dna topoisomerase 1 | Type: enzyme | Action: nan
10868,ribavirin,ns5b protein,enzyme,INHIBITOR,Drug: ribavirin | Target: ns5b protein | Type: enzyme | Action: INHIBITOR
10870,rifabutin,dna-directed rna polymerase subunit beta,enzyme,,Drug: rifabutin | Target: dna-directed rna polymerase subunit beta | Type: enzyme | Action: nan
10871,rifabutin,bacterial dna-directed rna polymerase,enzyme,INHIBITOR,Drug: rifabutin | Target: bacterial dna-directed rna polymerase | Type: enzyme | Action: INHIBITOR
10872,rifampicin,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: rifampicin | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
10873,rifampicin,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,,Drug: rifampicin | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: nan
10874,rifampicin,bile salt export pump,transporter,,Drug: rifampicin | Target: bile salt export pump | Type: transporter | Action: nan
10875,rifampicin,caspase-1,enzyme,,Drug: rifampicin | Target: caspase-1 | Type: enzyme | Action: nan
10876,rifampicin,solute carrier organic anion transporter family member 1b1,transporter,INHIBITOR,Drug: rifampicin | Target: solute carrier organic anion transporter family member 1b1 | Type: transporter | Action: INHIBITOR
10877,rifampicin,lanosterol 14-alpha demethylase,enzyme,,Drug: rifampicin | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
10878,rifampicin,dna-directed rna polymerase subunit beta,enzyme,INHIBITOR,Drug: rifampicin | Target: dna-directed rna polymerase subunit beta | Type: enzyme | Action: INHIBITOR
10879,rifampicin,arachidonate 15-lipoxygenase,enzyme,,Drug: rifampicin | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
10880,rifampicin,solute carrier organic anion transporter family member 1a2,transporter,INHIBITOR,Drug: rifampicin | Target: solute carrier organic anion transporter family member 1a2 | Type: transporter | Action: INHIBITOR
10881,rifampicin,solute carrier organic anion transporter family member 1b3,transporter,INHIBITOR,Drug: rifampicin | Target: solute carrier organic anion transporter family member 1b3 | Type: transporter | Action: INHIBITOR
10882,rifampicin,bile salt export pump,transporter,,Drug: rifampicin | Target: bile salt export pump | Type: transporter | Action: nan
10883,rifampicin,glutathione s-transferase omega-1,unclassified,,Drug: rifampicin | Target: glutathione s-transferase omega-1 | Type: unclassified | Action: nan
10884,rifapentine,bacterial dna-directed rna polymerase,enzyme,INHIBITOR,Drug: rifapentine | Target: bacterial dna-directed rna polymerase | Type: enzyme | Action: INHIBITOR
10885,rifaximin,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: rifaximin | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
10886,rifaximin,bacterial dna-directed rna polymerase,enzyme,INHIBITOR,Drug: rifaximin | Target: bacterial dna-directed rna polymerase | Type: enzyme | Action: INHIBITOR
10887,rilmenidine,alpha-2a adrenergic receptor,gpcr,,Drug: rilmenidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10888,rilmenidine,alpha-1a adrenergic receptor,gpcr,,Drug: rilmenidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10889,rilmenidine,alpha-2b adrenergic receptor,gpcr,,Drug: rilmenidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10890,rilmenidine,alpha-2c adrenergic receptor,gpcr,,Drug: rilmenidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10891,rilmenidine,nischarin,membrane receptor,,Drug: rilmenidine | Target: nischarin | Type: membrane receptor | Action: nan
10892,rilmenidine,nischarin,unclassified,,Drug: rilmenidine | Target: nischarin | Type: unclassified | Action: nan
10893,riluzole,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: riluzole | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
10894,riluzole,potassium voltage-gated channel subfamily h member 2,ion channel,BLOCKER,Drug: riluzole | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: BLOCKER
10895,riluzole,sodium-dependent noradrenaline transporter,transporter,,Drug: riluzole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
10896,riluzole,intermediate conductance calcium-activated potassium channel protein 4,ion channel,ACTIVATOR,Drug: riluzole | Target: intermediate conductance calcium-activated potassium channel protein 4 | Type: ion channel | Action: ACTIVATOR
10897,riluzole,"glutamate receptor ionotropic, nmda 3a",ion channel,,"Drug: riluzole | Target: glutamate receptor ionotropic, nmda 3a | Type: ion channel | Action: nan"
10898,riluzole,small conductance calcium-activated potassium channel protein 3,ion channel,ACTIVATOR,Drug: riluzole | Target: small conductance calcium-activated potassium channel protein 3 | Type: ion channel | Action: ACTIVATOR
10899,riluzole,pteridine reductase 1,enzyme,,Drug: riluzole | Target: pteridine reductase 1 | Type: enzyme | Action: nan
10900,riluzole,small conductance calcium-activated potassium channel protein 1,ion channel,ACTIVATOR,Drug: riluzole | Target: small conductance calcium-activated potassium channel protein 1 | Type: ion channel | Action: ACTIVATOR
10901,riluzole,short transient receptor potential channel 5,ion channel,ACTIVATOR,Drug: riluzole | Target: short transient receptor potential channel 5 | Type: ion channel | Action: ACTIVATOR
10902,riluzole,small conductance calcium-activated potassium channel protein 2,ion channel,ACTIVATOR,Drug: riluzole | Target: small conductance calcium-activated potassium channel protein 2 | Type: ion channel | Action: ACTIVATOR
10903,rimantadine,matrix protein 2,ion channel,,Drug: rimantadine | Target: matrix protein 2 | Type: ion channel | Action: nan
10904,rimantadine,solute carrier family 22 member 2,transporter,,Drug: rimantadine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
10905,rimantadine,multidrug and toxin extrusion protein 1,transporter,,Drug: rimantadine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
10906,rimantadine,matrix protein 2,ion channel,INHIBITOR,Drug: rimantadine | Target: matrix protein 2 | Type: ion channel | Action: INHIBITOR
10907,rimantadine,polymerase acidic protein,enzyme,,Drug: rimantadine | Target: polymerase acidic protein | Type: enzyme | Action: nan
10908,rimantadine,polymerase acidic protein,unclassified,,Drug: rimantadine | Target: polymerase acidic protein | Type: unclassified | Action: nan
10909,rimantadine,matrix protein 2,unclassified,,Drug: rimantadine | Target: matrix protein 2 | Type: unclassified | Action: nan
10910,rimantadine,matrix protein 2,unclassified,,Drug: rimantadine | Target: matrix protein 2 | Type: unclassified | Action: nan
10911,rimexolone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: rimexolone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
10912,ripazepam,gaba-a receptor; anion channel,ion channel,,Drug: ripazepam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
10913,risedronic acid,farnesyl pyrophosphate synthase,enzyme,INHIBITOR,Drug: risedronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: INHIBITOR
10914,risedronic acid,farnesyl pyrophosphate synthase,enzyme,,Drug: risedronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
10915,risedronic acid,farnesyl diphosphate synthase,enzyme,,Drug: risedronic acid | Target: farnesyl diphosphate synthase | Type: enzyme | Action: nan
10916,risedronic acid,farnesyl diphosphate synthase,enzyme,,Drug: risedronic acid | Target: farnesyl diphosphate synthase | Type: enzyme | Action: nan
10917,levisoprenaline,beta-1 adrenergic receptor,gpcr,,Drug: levisoprenaline | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10918,levisoprenaline,beta-2 adrenergic receptor,gpcr,,Drug: levisoprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10919,levisoprenaline,beta-3 adrenergic receptor,gpcr,,Drug: levisoprenaline | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
10920,levisoprenaline,beta-2 adrenergic receptor,gpcr,,Drug: levisoprenaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10921,levisoprenaline,beta-1 adrenergic receptor,gpcr,,Drug: levisoprenaline | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10923,risperidone,beta-1 adrenergic receptor,gpcr,,Drug: risperidone | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10924,risperidone,beta-2 adrenergic receptor,gpcr,,Drug: risperidone | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
10925,risperidone,d(1a) dopamine receptor,gpcr,,Drug: risperidone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10926,risperidone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: risperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10927,risperidone,alpha-2a adrenergic receptor,gpcr,,Drug: risperidone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10928,risperidone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: risperidone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
10929,risperidone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: risperidone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
10930,risperidone,sodium-dependent serotonin transporter,transporter,,Drug: risperidone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
10931,risperidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10932,risperidone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: risperidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
10933,risperidone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
10934,risperidone,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: risperidone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
10935,risperidone,5-hydroxytryptamine receptor 6,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
10936,risperidone,5-hydroxytryptamine receptor 7,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
10937,risperidone,alpha-1a adrenergic receptor,gpcr,,Drug: risperidone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10938,risperidone,alpha-2b adrenergic receptor,gpcr,,Drug: risperidone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
10939,risperidone,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: risperidone | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10940,risperidone,d(1b) dopamine receptor,gpcr,,Drug: risperidone | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
10941,risperidone,histamine h1 receptor,gpcr,,Drug: risperidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
10942,risperidone,histamine h2 receptor,gpcr,,Drug: risperidone | Target: histamine h2 receptor | Type: gpcr | Action: nan
10943,risperidone,muscarinic acetylcholine receptor m1,gpcr,,Drug: risperidone | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
10944,risperidone,muscarinic acetylcholine receptor m2,gpcr,,Drug: risperidone | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
10945,risperidone,muscarinic acetylcholine receptor m3,gpcr,,Drug: risperidone | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
10946,risperidone,muscarinic acetylcholine receptor m4,gpcr,,Drug: risperidone | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
10947,risperidone,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: risperidone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
10948,risperidone,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: risperidone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
10949,risperidone,alpha-2c adrenergic receptor,gpcr,,Drug: risperidone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
10950,risperidone,cytochrome p450 2d6,enzyme,,Drug: risperidone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10951,risperidone,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: risperidone | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
10952,risperidone,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: risperidone | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
10953,risperidone,alpha-1b adrenergic receptor,gpcr,,Drug: risperidone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10954,risperidone,glycine receptor subunit alpha-1,ion channel,,Drug: risperidone | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
10955,risperidone,5-hydroxytryptamine receptor 5a,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
10956,risperidone,5-hydroxytryptamine receptor 1f,gpcr,ANTAGONIST,Drug: risperidone | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: ANTAGONIST
10957,risperidone,5-hydroxytryptamine receptor 1e,gpcr,ANTAGONIST,Drug: risperidone | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: ANTAGONIST
10958,risperidone,alpha-1b adrenergic receptor,gpcr,,Drug: risperidone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
10959,risperidone,alpha-1a adrenergic receptor,gpcr,,Drug: risperidone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
10960,risperidone,histamine h1 receptor,gpcr,,Drug: risperidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
10961,risperidone,d(2) dopamine receptor,gpcr,,Drug: risperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10962,risperidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10963,risperidone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
10964,risperidone,5-hydroxytryptamine receptor 7,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
10965,risperidone,beta-1 adrenergic receptor,gpcr,,Drug: risperidone | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
10966,risperidone,d(1a) dopamine receptor,gpcr,,Drug: risperidone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
10967,risperidone,alpha-2a adrenergic receptor,gpcr,,Drug: risperidone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
10968,risperidone,d(2) dopamine receptor,gpcr,,Drug: risperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
10969,risperidone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
10970,risperidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: risperidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
10971,risperidone,histamine h1 receptor,gpcr,,Drug: risperidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
10972,risperidone,d(3) dopamine receptor,gpcr,,Drug: risperidone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
10973,risperidone,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: risperidone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
10974,risperidone,transporter,transporter,,Drug: risperidone | Target: transporter | Type: transporter | Action: nan
10975,risperidone,solute carrier family 22 member 2,transporter,,Drug: risperidone | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
10976,risperidone,multidrug and toxin extrusion protein 1,transporter,,Drug: risperidone | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
10977,risperidone,serotonin 1 (5-ht1) receptor,gpcr,,Drug: risperidone | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
10978,risperidone,serotonin 2 (5-ht2) receptor,gpcr,,Drug: risperidone | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
10979,risperidone,serotonin 2 (5-ht2) receptor,gpcr,,Drug: risperidone | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
10980,risperidone,histone h1.0,nuclear other,,Drug: risperidone | Target: histone h1.0 | Type: nuclear other | Action: nan
10981,ritodrine,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: ritodrine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
10982,ritodrine,beta-3 adrenergic receptor,gpcr,,Drug: ritodrine | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
10983,ritonavir,mu-type opioid receptor,gpcr,,Drug: ritonavir | Target: mu-type opioid receptor | Type: gpcr | Action: nan
10984,ritonavir,cytochrome p450 3a4,enzyme,,Drug: ritonavir | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
10985,ritonavir,multidrug resistance protein 1,transporter,,Drug: ritonavir | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
10986,ritonavir,cytochrome p450 2d6,enzyme,,Drug: ritonavir | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
10987,ritonavir,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: ritonavir | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
10988,ritonavir,kappa-type opioid receptor,gpcr,,Drug: ritonavir | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
10989,ritonavir,cytochrome p450 2c9,enzyme,,Drug: ritonavir | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
10990,ritonavir,vasopressin v1a receptor,gpcr,,Drug: ritonavir | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
10991,ritonavir,gag-pol polyprotein,polyprotein,,Drug: ritonavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
10992,ritonavir,thromboxane-a synthase,enzyme,,Drug: ritonavir | Target: thromboxane-a synthase | Type: enzyme | Action: nan
10993,ritonavir,solute carrier family 22 member 1,transporter,,Drug: ritonavir | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
10994,ritonavir,substance-k receptor,gpcr,,Drug: ritonavir | Target: substance-k receptor | Type: gpcr | Action: nan
10995,ritonavir,cytochrome p450 3a5,enzyme,INHIBITOR,Drug: ritonavir | Target: cytochrome p450 3a5 | Type: enzyme | Action: INHIBITOR
10996,ritonavir,pol polyprotein,enzyme,INHIBITOR,Drug: ritonavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
10997,ritonavir,udp-glucuronosyltransferase 1-1,enzyme,INHIBITOR,Drug: ritonavir | Target: udp-glucuronosyltransferase 1-1 | Type: enzyme | Action: INHIBITOR
10998,ritonavir,solute carrier family 22 member 2,transporter,,Drug: ritonavir | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
10999,ritonavir,multidrug and toxin extrusion protein 1,transporter,,Drug: ritonavir | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
11000,ritonavir,multidrug and toxin extrusion protein 2,transporter,,Drug: ritonavir | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
11001,ritonavir,protease,enzyme,,Drug: ritonavir | Target: protease | Type: enzyme | Action: nan
11002,rivastigmine,acetylcholinesterase,enzyme,INHIBITOR,Drug: rivastigmine | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
11003,rivastigmine,cholinesterase,enzyme,INHIBITOR,Drug: rivastigmine | Target: cholinesterase | Type: enzyme | Action: INHIBITOR
11004,rivastigmine,acetylcholinesterase,enzyme,,Drug: rivastigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
11005,rivastigmine,butyrylcholinesterase; protein bche,enzyme,,Drug: rivastigmine | Target: butyrylcholinesterase; protein bche | Type: enzyme | Action: nan
11006,rivastigmine,acetylcholinesterase,enzyme,,Drug: rivastigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
11007,rivastigmine,acetylcholinesterase,enzyme,,Drug: rivastigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
11008,rivastigmine,acetylcholinesterase,enzyme,,Drug: rivastigmine | Target: acetylcholinesterase | Type: enzyme | Action: nan
11009,rivastigmine,cholinesterase,enzyme,,Drug: rivastigmine | Target: cholinesterase | Type: enzyme | Action: nan
11010,rivastigmine,butyrylcholinesterase,enzyme,,Drug: rivastigmine | Target: butyrylcholinesterase | Type: enzyme | Action: nan
11011,rivastigmine,cholinesterase,enzyme,,Drug: rivastigmine | Target: cholinesterase | Type: enzyme | Action: nan
11012,rizatriptan,5-hydroxytryptamine receptor 1a,gpcr,,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11013,rizatriptan,5-hydroxytryptamine receptor 2a,gpcr,,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11014,rizatriptan,5-hydroxytryptamine receptor 2c,gpcr,,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
11015,rizatriptan,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
11016,rizatriptan,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
11017,rizatriptan,cytochrome p450 2d6,enzyme,,Drug: rizatriptan | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
11018,rizatriptan,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
11019,rizatriptan,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
11020,rizatriptan,5-hydroxytryptamine receptor 2a,gpcr,,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11021,rizatriptan,5-hydroxytryptamine receptor 1d,gpcr,,Drug: rizatriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
11022,rizatriptan,serotonin 3 (5-ht3) receptor,ion channel,,Drug: rizatriptan | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
11023,rocuronium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: rocuronium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
11024,rocuronium,acetylcholine receptor; alpha1/beta1/delta/gamma,ion channel,,Drug: rocuronium | Target: acetylcholine receptor; alpha1/beta1/delta/gamma | Type: ion channel | Action: nan
11025,rofecoxib,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: rofecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
11026,rofecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: rofecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
11027,rofecoxib,prostaglandin e2 receptor ep2 subtype,gpcr,,Drug: rofecoxib | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: nan
11028,rofecoxib,cytochrome c oxidase subunit 2,enzyme,,Drug: rofecoxib | Target: cytochrome c oxidase subunit 2 | Type: enzyme | Action: nan
11029,rofecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: rofecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
11030,rofecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: rofecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
11031,rofecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: rofecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
11032,rofecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: rofecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
11033,rofecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: rofecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
11034,rofecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: rofecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
11035,rolitetracycline,insulin-degrading enzyme,enzyme,,Drug: rolitetracycline | Target: insulin-degrading enzyme | Type: enzyme | Action: nan
11036,rolitetracycline,integrase,enzyme,,Drug: rolitetracycline | Target: integrase | Type: enzyme | Action: nan
11038,rolitetracycline,dna repair protein rad52 homolog,nuclear other,,Drug: rolitetracycline | Target: dna repair protein rad52 homolog | Type: nuclear other | Action: nan
11039,ropinirole,d(1a) dopamine receptor,gpcr,,Drug: ropinirole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
11040,ropinirole,d(2) dopamine receptor,gpcr,AGONIST,Drug: ropinirole | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
11041,ropinirole,alpha-2a adrenergic receptor,gpcr,,Drug: ropinirole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
11042,ropinirole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ropinirole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11043,ropinirole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ropinirole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11044,ropinirole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: ropinirole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
11045,ropinirole,5-hydroxytryptamine receptor 7,gpcr,,Drug: ropinirole | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
11046,ropinirole,alpha-2b adrenergic receptor,gpcr,,Drug: ropinirole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
11047,ropinirole,d(3) dopamine receptor,gpcr,AGONIST,Drug: ropinirole | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
11048,ropinirole,d(1b) dopamine receptor,gpcr,,Drug: ropinirole | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
11049,ropinirole,5-hydroxytryptamine receptor 1d,gpcr,,Drug: ropinirole | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
11050,ropinirole,alpha-2c adrenergic receptor,gpcr,,Drug: ropinirole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
11051,ropinirole,d(4) dopamine receptor,gpcr,AGONIST,Drug: ropinirole | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
11052,ropinirole,d(2) dopamine receptor,gpcr,,Drug: ropinirole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11053,ropinirole,d(2) dopamine receptor,gpcr,,Drug: ropinirole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11054,ropinirole,d(3) dopamine receptor,gpcr,,Drug: ropinirole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11055,ropivacaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: ropivacaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
11056,ropivacaine,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: ropivacaine | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
11057,ropivacaine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: ropivacaine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
11058,ropivacaine,sodium channel protein type 3 subunit alpha,ion channel,BLOCKER,Drug: ropivacaine | Target: sodium channel protein type 3 subunit alpha | Type: ion channel | Action: BLOCKER
11059,ropivacaine,sodium channel protein type 4 subunit alpha,ion channel,BLOCKER,Drug: ropivacaine | Target: sodium channel protein type 4 subunit alpha | Type: ion channel | Action: BLOCKER
11060,ropivacaine,sodium channel protein type 8 subunit alpha,ion channel,BLOCKER,Drug: ropivacaine | Target: sodium channel protein type 8 subunit alpha | Type: ion channel | Action: BLOCKER
11061,ropivacaine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: ropivacaine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
11062,ropivacaine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: ropivacaine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
11063,ropivacaine,potassium channel subfamily k member 3,ion channel,,Drug: ropivacaine | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: nan
11065,rosiglitazone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: rosiglitazone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
11066,rosiglitazone,carbonic anhydrase 2,enzyme,,Drug: rosiglitazone | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11067,rosiglitazone,bile salt export pump,transporter,,Drug: rosiglitazone | Target: bile salt export pump | Type: transporter | Action: nan
11068,rosiglitazone,amine oxidase [flavin-containing] b,enzyme,,Drug: rosiglitazone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
11069,rosiglitazone,amine oxidase [flavin-containing] a,enzyme,,Drug: rosiglitazone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
11070,rosiglitazone,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: rosiglitazone | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
11071,rosiglitazone,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: rosiglitazone | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
11072,rosiglitazone,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: rosiglitazone | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
11073,rosiglitazone,retinoic acid receptor gamma,nuclear hormone receptor,,Drug: rosiglitazone | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: nan
11074,rosiglitazone,thromboxane-a synthase,enzyme,,Drug: rosiglitazone | Target: thromboxane-a synthase | Type: enzyme | Action: nan
11075,rosiglitazone,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: rosiglitazone | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
11076,rosiglitazone,free fatty acid receptor 1,gpcr,AGONIST,Drug: rosiglitazone | Target: free fatty acid receptor 1 | Type: gpcr | Action: AGONIST
11077,rosiglitazone,amine oxidase [flavin-containing] b,enzyme,,Drug: rosiglitazone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
11078,rosiglitazone,amine oxidase [flavin-containing] a,enzyme,,Drug: rosiglitazone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
11079,rosiglitazone,peroxisome proliferator-activated receptor alpha,transcription factor,,Drug: rosiglitazone | Target: peroxisome proliferator-activated receptor alpha | Type: transcription factor | Action: nan
11080,rosiglitazone,peroxisome proliferator-activated receptor gamma,transcription factor,,Drug: rosiglitazone | Target: peroxisome proliferator-activated receptor gamma | Type: transcription factor | Action: nan
11081,rosiglitazone,type-1a angiotensin ii receptor,gpcr,,Drug: rosiglitazone | Target: type-1a angiotensin ii receptor | Type: gpcr | Action: nan
11082,rosiglitazone,short transient receptor potential channel 5,ion channel,ACTIVATOR,Drug: rosiglitazone | Target: short transient receptor potential channel 5 | Type: ion channel | Action: ACTIVATOR
11083,rosiglitazone,sodium/bile acid cotransporter,transporter,,Drug: rosiglitazone | Target: sodium/bile acid cotransporter | Type: transporter | Action: nan
11084,rosiglitazone,bile salt export pump,transporter,,Drug: rosiglitazone | Target: bile salt export pump | Type: transporter | Action: nan
11085,rosiglitazone,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: rosiglitazone | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
11086,rosiglitazone,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: rosiglitazone | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
11087,rosiglitazone,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: rosiglitazone | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
11090,rosiglitazone,cdgsh iron-sulfur domain-containing protein 2,unclassified,,Drug: rosiglitazone | Target: cdgsh iron-sulfur domain-containing protein 2 | Type: unclassified | Action: nan
11091,rosuvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: rosuvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
11092,rosuvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: rosuvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
11093,rosuvastatin,phosphodiesterase 6d,enzyme,,Drug: rosuvastatin | Target: phosphodiesterase 6d | Type: enzyme | Action: nan
11094,rotigotine,d(1a) dopamine receptor,gpcr,AGONIST,Drug: rotigotine | Target: d(1a) dopamine receptor | Type: gpcr | Action: AGONIST
11095,rotigotine,d(2) dopamine receptor,gpcr,AGONIST,Drug: rotigotine | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
11096,rotigotine,d(3) dopamine receptor,gpcr,AGONIST,Drug: rotigotine | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
11097,rotigotine,d(1b) dopamine receptor,gpcr,AGONIST,Drug: rotigotine | Target: d(1b) dopamine receptor | Type: gpcr | Action: AGONIST
11098,rotigotine,d(4) dopamine receptor,gpcr,AGONIST,Drug: rotigotine | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
11099,rotigotine,d(1a) dopamine receptor,gpcr,,Drug: rotigotine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
11100,rotigotine,d(2) dopamine receptor,gpcr,,Drug: rotigotine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11101,roxatidine acetate,histamine h2 receptor,gpcr,ANTAGONIST,Drug: roxatidine acetate | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
11102,roxithromycin,50s ribosomal protein l10,ribosomal protein,,Drug: roxithromycin | Target: 50s ribosomal protein l10 | Type: ribosomal protein | Action: nan
11103,roxithromycin,motilin receptor,gpcr,AGONIST,Drug: roxithromycin | Target: motilin receptor | Type: gpcr | Action: AGONIST
11104,roxithromycin,alpha-1b adrenergic receptor,gpcr,,Drug: roxithromycin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
11105,rupatadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: rupatadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
11106,rupatadine,platelet-activating factor receptor,gpcr,,Drug: rupatadine | Target: platelet-activating factor receptor | Type: gpcr | Action: nan
11107,ademetionine,protein arginine n-methyltransferase 1,enzyme,,Drug: ademetionine | Target: protein arginine n-methyltransferase 1 | Type: enzyme | Action: nan
11108,ademetionine,s-adenosylmethionine decarboxylase proenzyme,enzyme,,Drug: ademetionine | Target: s-adenosylmethionine decarboxylase proenzyme | Type: enzyme | Action: nan
11109,ademetionine,met repressor,unclassified,,Drug: ademetionine | Target: met repressor | Type: unclassified | Action: nan
11110,ademetionine,phenylethanolamine n-methyltransferase,enzyme,,Drug: ademetionine | Target: phenylethanolamine n-methyltransferase | Type: enzyme | Action: nan
11111,ademetionine,protein-beta-aspartate methyltransferase,enzyme,,Drug: ademetionine | Target: protein-beta-aspartate methyltransferase | Type: enzyme | Action: nan
11112,salicylic acid,carbonic anhydrase 2,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11113,salicylic acid,carbonic anhydrase 1,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
11114,salicylic acid,carbonic anhydrase 4,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
11115,salicylic acid,salicylic acid-binding protein 2,enzyme,,Drug: salicylic acid | Target: salicylic acid-binding protein 2 | Type: enzyme | Action: nan
11116,salicylic acid,carbonic anhydrase 9,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
11117,salicylic acid,carbonic anhydrase 12,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
11118,salicylic acid,carbonic anhydrase 7,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
11119,salicylic acid,carbonic anhydrase 6,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
11120,salicylic acid,carbonic anhydrase 14,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
11121,salicylic acid,carbonic anhydrase 13,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
11122,salicylic acid,polyphenol oxidase 2,enzyme,,Drug: salicylic acid | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
11123,salicylic acid,carbonic anhydrase 15,enzyme,,Drug: salicylic acid | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
11124,salicylic acid,solute carrier family 22 member 20,transporter,,Drug: salicylic acid | Target: solute carrier family 22 member 20 | Type: transporter | Action: nan
11125,salicylic acid,high mobility group protein b1,nuclear other,,Drug: salicylic acid | Target: high mobility group protein b1 | Type: nuclear other | Action: nan
11126,salicylic acid,nicotinate phosphoribosyltransferase,enzyme,,Drug: salicylic acid | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
11127,salmeterol,beta-1 adrenergic receptor,gpcr,,Drug: salmeterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
11128,salmeterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: salmeterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
11129,salmeterol,d(2) dopamine receptor,gpcr,,Drug: salmeterol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11130,salmeterol,d(3) dopamine receptor,gpcr,,Drug: salmeterol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11131,salmeterol,aldehyde oxidase,enzyme,,Drug: salmeterol | Target: aldehyde oxidase | Type: enzyme | Action: nan
11132,salmeterol,beta-3 adrenergic receptor,gpcr,,Drug: salmeterol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
11133,salmeterol,beta-2 adrenergic receptor,gpcr,,Drug: salmeterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
11134,salmeterol,beta-1 adrenergic receptor,gpcr,,Drug: salmeterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
11136,saquinavir,mu-type opioid receptor,gpcr,,Drug: saquinavir | Target: mu-type opioid receptor | Type: gpcr | Action: nan
11137,saquinavir,cytochrome p450 3a4,enzyme,,Drug: saquinavir | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
11138,saquinavir,multidrug resistance protein 1,transporter,,Drug: saquinavir | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
11139,saquinavir,5-hydroxytryptamine receptor 1a,gpcr,,Drug: saquinavir | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11140,saquinavir,d(3) dopamine receptor,gpcr,,Drug: saquinavir | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11141,saquinavir,canalicular multispecific organic anion transporter 1,transporter,,Drug: saquinavir | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
11142,saquinavir,sodium-dependent dopamine transporter,transporter,,Drug: saquinavir | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
11143,saquinavir,kappa-type opioid receptor,gpcr,,Drug: saquinavir | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
11144,saquinavir,multidrug resistance-associated protein 1,transporter,,Drug: saquinavir | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
11145,saquinavir,delta-type opioid receptor,gpcr,,Drug: saquinavir | Target: delta-type opioid receptor | Type: gpcr | Action: nan
11146,saquinavir,vasopressin v1a receptor,gpcr,,Drug: saquinavir | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
11147,saquinavir,gag-pol polyprotein,polyprotein,,Drug: saquinavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
11148,saquinavir,thromboxane-a synthase,enzyme,,Drug: saquinavir | Target: thromboxane-a synthase | Type: enzyme | Action: nan
11149,saquinavir,substance-k receptor,gpcr,,Drug: saquinavir | Target: substance-k receptor | Type: gpcr | Action: nan
11150,saquinavir,pol polyprotein,enzyme,INHIBITOR,Drug: saquinavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
11151,saquinavir,5-hydroxytryptamine receptor 1a,gpcr,,Drug: saquinavir | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11152,saquinavir,protease,enzyme,,Drug: saquinavir | Target: protease | Type: enzyme | Action: nan
11153,saquinavir,protease,enzyme,,Drug: saquinavir | Target: protease | Type: enzyme | Action: nan
11154,saquinavir,chloroquine resistance transporter,transporter,,Drug: saquinavir | Target: chloroquine resistance transporter | Type: transporter | Action: nan
11155,saquinavir,protease,unclassified,,Drug: saquinavir | Target: protease | Type: unclassified | Action: nan
11156,saquinavir,protease,unclassified,,Drug: saquinavir | Target: protease | Type: unclassified | Action: nan
11157,sarpogrelate,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: sarpogrelate | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
11158,sarpogrelate,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: sarpogrelate | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
11159,sarpogrelate,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: sarpogrelate | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
11160,sarpogrelate,serotonin 2 (5-ht2) receptor,gpcr,,Drug: sarpogrelate | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
11161,scopolamine,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: scopolamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
11162,scopolamine,muscarinic acetylcholine receptor m2,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
11163,scopolamine,muscarinic acetylcholine receptor m3,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
11164,scopolamine,muscarinic acetylcholine receptor m4,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
11165,scopolamine,muscarinic acetylcholine receptor m5,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
11166,scopolamine,muscarinic acetylcholine receptor m2,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
11167,scopolamine,muscarinic acetylcholine receptor m1,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
11168,scopolamine,muscarinic acetylcholine receptor m3,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
11169,scopolamine,muscarinic receptor m1,gpcr,,Drug: scopolamine | Target: muscarinic receptor m1 | Type: gpcr | Action: nan
11170,scopolamine,muscarinic acetylcholine receptor dm1,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor dm1 | Type: gpcr | Action: nan
11171,scopolamine,muscarinic acetylcholine receptor,gpcr,,Drug: scopolamine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
11172,secnidazole,3-oxoacyl-[acyl-carrier-protein] synthase 3,enzyme,,Drug: secnidazole | Target: 3-oxoacyl-[acyl-carrier-protein] synthase 3 | Type: enzyme | Action: nan
11173,secobarbital,matrix metalloproteinase-9,enzyme,,Drug: secobarbital | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
11174,secobarbital,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: secobarbital | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
11175,selegiline,alpha-2a adrenergic receptor,gpcr,,Drug: selegiline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
11176,selegiline,alpha-2b adrenergic receptor,gpcr,,Drug: selegiline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
11177,selegiline,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: selegiline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
11178,selegiline,amine oxidase [flavin-containing] a,enzyme,,Drug: selegiline | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
11179,selegiline,amine oxidase [flavin-containing] b,enzyme,,Drug: selegiline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
11180,selegiline,amine oxidase [flavin-containing] a,enzyme,,Drug: selegiline | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
11181,selegiline,amine oxidase [flavin-containing] a,enzyme,,Drug: selegiline | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
11182,selegiline,amine oxidase [flavin-containing] b,enzyme,,Drug: selegiline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
11183,selegiline,monoamine oxidase,enzyme,,Drug: selegiline | Target: monoamine oxidase | Type: enzyme | Action: nan
11184,seratrodast,thromboxane a2 receptor,gpcr,,Drug: seratrodast | Target: thromboxane a2 receptor | Type: gpcr | Action: nan
11185,sermorelin,growth hormone-releasing hormone receptor,gpcr,AGONIST,Drug: sermorelin | Target: growth hormone-releasing hormone receptor | Type: gpcr | Action: AGONIST
11186,sertaconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: sertaconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
11187,sertaconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: sertaconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
11188,sertindole,beta-1 adrenergic receptor,gpcr,,Drug: sertindole | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
11189,sertindole,beta-2 adrenergic receptor,gpcr,,Drug: sertindole | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
11190,sertindole,d(1a) dopamine receptor,gpcr,,Drug: sertindole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
11191,sertindole,alpha-2a adrenergic receptor,gpcr,,Drug: sertindole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
11192,sertindole,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: sertindole | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
11193,sertindole,multidrug resistance protein 1,transporter,,Drug: sertindole | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
11194,sertindole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: sertindole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11195,sertindole,5-hydroxytryptamine receptor 6,gpcr,,Drug: sertindole | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
11196,sertindole,5-hydroxytryptamine receptor 7,gpcr,,Drug: sertindole | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
11197,sertindole,alpha-1a adrenergic receptor,gpcr,,Drug: sertindole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
11198,sertindole,alpha-2b adrenergic receptor,gpcr,,Drug: sertindole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
11199,sertindole,d(3) dopamine receptor,gpcr,,Drug: sertindole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11200,sertindole,histamine h1 receptor,gpcr,,Drug: sertindole | Target: histamine h1 receptor | Type: gpcr | Action: nan
11201,sertindole,muscarinic acetylcholine receptor m3,gpcr,,Drug: sertindole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
11202,sertindole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: sertindole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
11203,sertindole,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: sertindole | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
11204,sertindole,alpha-2c adrenergic receptor,gpcr,,Drug: sertindole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
11205,sertindole,d(4) dopamine receptor,gpcr,,Drug: sertindole | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
11206,sertindole,5-hydroxytryptamine receptor 1f,gpcr,ANTAGONIST,Drug: sertindole | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: ANTAGONIST
11207,sertindole,5-hydroxytryptamine receptor 1e,gpcr,ANTAGONIST,Drug: sertindole | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: ANTAGONIST
11208,sertindole,alpha-1a adrenergic receptor,gpcr,,Drug: sertindole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
11209,sertindole,alpha-1d adrenergic receptor,gpcr,,Drug: sertindole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
11210,sertindole,d(2) dopamine receptor,gpcr,,Drug: sertindole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11211,sertindole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: sertindole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11212,sertindole,d(1a) dopamine receptor,gpcr,,Drug: sertindole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
11213,sertindole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: sertindole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
11214,sertindole,alpha-1a adrenergic receptor,gpcr,,Drug: sertindole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
11215,sertindole,alpha-1b adrenergic receptor,gpcr,,Drug: sertindole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
11216,sertindole,adrenergic receptor alpha-1,gpcr,,Drug: sertindole | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
11217,sertindole,serotonin 2 (5-ht2) receptor,gpcr,,Drug: sertindole | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
11218,sertindole,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: sertindole | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
11219,sertindole,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: sertindole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
11220,sertindole,5-hydroxytryptamine receptor 2c,gpcr,INVERSE AGONIST,Drug: sertindole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: INVERSE AGONIST
11221,sertraline,alpha-2a adrenergic receptor,gpcr,,Drug: sertraline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
11222,sertraline,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: sertraline | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
11223,sertraline,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: sertraline | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
11224,sertraline,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: sertraline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
11225,sertraline,sodium-dependent noradrenaline transporter,transporter,,Drug: sertraline | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
11226,sertraline,5-hydroxytryptamine receptor 2a,gpcr,,Drug: sertraline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11227,sertraline,5-hydroxytryptamine receptor 2b,gpcr,,Drug: sertraline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
11228,sertraline,5-hydroxytryptamine receptor 2c,gpcr,,Drug: sertraline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
11229,sertraline,alpha-1a adrenergic receptor,gpcr,,Drug: sertraline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
11230,sertraline,alpha-2b adrenergic receptor,gpcr,,Drug: sertraline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
11231,sertraline,muscarinic acetylcholine receptor m1,gpcr,,Drug: sertraline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
11232,sertraline,muscarinic acetylcholine receptor m2,gpcr,,Drug: sertraline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
11233,sertraline,muscarinic acetylcholine receptor m3,gpcr,,Drug: sertraline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
11234,sertraline,muscarinic acetylcholine receptor m4,gpcr,,Drug: sertraline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
11235,sertraline,muscarinic acetylcholine receptor m5,gpcr,,Drug: sertraline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
11236,sertraline,alpha-2c adrenergic receptor,gpcr,,Drug: sertraline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
11237,sertraline,sodium-dependent dopamine transporter,transporter,,Drug: sertraline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
11238,sertraline,cytochrome p450 2c19,enzyme,,Drug: sertraline | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
11239,sertraline,alpha-1b adrenergic receptor,gpcr,,Drug: sertraline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
11240,sertraline,melanocortin receptor 5,gpcr,,Drug: sertraline | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
11241,sertraline,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: sertraline | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
11242,sertraline,sodium-dependent serotonin transporter,transporter,,Drug: sertraline | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
11243,sertraline,sodium-dependent dopamine transporter,transporter,,Drug: sertraline | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
11244,sertraline,transporter,transporter,,Drug: sertraline | Target: transporter | Type: transporter | Action: nan
11245,sertraline,transcriptional activator protein luxr,unclassified,,Drug: sertraline | Target: transcriptional activator protein luxr | Type: unclassified | Action: nan
11246,setastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: setastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
11247,sevoflurane,glycine receptor subunit alpha-1,ion channel,POSITIVE MODULATOR,Drug: sevoflurane | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: POSITIVE MODULATOR
11248,sevoflurane,potassium channel subfamily k member 2,ion channel,OPENER,Drug: sevoflurane | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: OPENER
11249,sevoflurane,potassium channel subfamily k member 3,ion channel,OPENER,Drug: sevoflurane | Target: potassium channel subfamily k member 3 | Type: ion channel | Action: OPENER
11250,sevoflurane,potassium channel subfamily k member 9,ion channel,OPENER,Drug: sevoflurane | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: OPENER
11251,sevoflurane,potassium channel subfamily k member 10,ion channel,OPENER,Drug: sevoflurane | Target: potassium channel subfamily k member 10 | Type: ion channel | Action: OPENER
11252,sevoflurane,potassium channel subfamily k member 18,ion channel,OPENER,Drug: sevoflurane | Target: potassium channel subfamily k member 18 | Type: ion channel | Action: OPENER
11253,sevoflurane,gaba-a receptor; anion channel,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: sevoflurane | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
11254,sibutramine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: sibutramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
11255,sibutramine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: sibutramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
11256,sibutramine,alpha-2b adrenergic receptor,gpcr,,Drug: sibutramine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
11257,sibutramine,alpha-2c adrenergic receptor,gpcr,,Drug: sibutramine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
11258,sibutramine,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: sibutramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
11259,sibutramine,potassium voltage-gated channel subfamily d member 3,ion channel,,Drug: sibutramine | Target: potassium voltage-gated channel subfamily d member 3 | Type: ion channel | Action: nan
11260,sibutramine,cytochrome p450 2b6,enzyme,INHIBITOR,Drug: sibutramine | Target: cytochrome p450 2b6 | Type: enzyme | Action: INHIBITOR
11261,sibutramine,solute carrier family 22 member 2,transporter,,Drug: sibutramine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
11262,sibutramine,potassium voltage-gated channel subfamily d member 3,ion channel,BLOCKER,Drug: sibutramine | Target: potassium voltage-gated channel subfamily d member 3 | Type: ion channel | Action: BLOCKER
11263,sildenafil,adenosine receptor a2a,gpcr,,Drug: sildenafil | Target: adenosine receptor a2a | Type: gpcr | Action: nan
11264,sildenafil,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: sildenafil | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
11265,sildenafil,adenosine receptor a1,gpcr,,Drug: sildenafil | Target: adenosine receptor a1 | Type: gpcr | Action: nan
11266,sildenafil,multidrug resistance-associated protein 5,transporter,,Drug: sildenafil | Target: multidrug resistance-associated protein 5 | Type: transporter | Action: nan
11267,sildenafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: sildenafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
11268,sildenafil,"rod cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha",enzyme,,"Drug: sildenafil | Target: rod cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha | Type: enzyme | Action: nan"
11269,sildenafil,"dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a",enzyme,,"Drug: sildenafil | Target: dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a | Type: enzyme | Action: nan"
11270,sildenafil,"camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a",enzyme,,"Drug: sildenafil | Target: camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | Type: enzyme | Action: nan"
11271,sildenafil,"camp-specific 3',5'-cyclic phosphodiesterase 4d",enzyme,,"Drug: sildenafil | Target: camp-specific 3',5'-cyclic phosphodiesterase 4d | Type: enzyme | Action: nan"
11272,sildenafil,"cgmp-dependent 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: sildenafil | Target: cgmp-dependent 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
11273,sildenafil,"high affinity camp-specific 3',5'-cyclic phosphodiesterase 7a",enzyme,,"Drug: sildenafil | Target: high affinity camp-specific 3',5'-cyclic phosphodiesterase 7a | Type: enzyme | Action: nan"
11274,sildenafil,"cone cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha'",enzyme,,"Drug: sildenafil | Target: cone cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha' | Type: enzyme | Action: nan"
11275,sildenafil,"high affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9a",enzyme,,"Drug: sildenafil | Target: high affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9a | Type: enzyme | Action: nan"
11276,sildenafil,"high affinity camp-specific and ibmx-insensitive 3',5'-cyclic phosphodiesterase 8a",enzyme,,"Drug: sildenafil | Target: high affinity camp-specific and ibmx-insensitive 3',5'-cyclic phosphodiesterase 8a | Type: enzyme | Action: nan"
11277,sildenafil,alpha-1b adrenergic receptor,gpcr,,Drug: sildenafil | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
11278,sildenafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: sildenafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
11279,sildenafil,uncharacterized protein,enzyme,,Drug: sildenafil | Target: uncharacterized protein | Type: enzyme | Action: nan
11280,sildenafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: sildenafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
11281,sildenafil,"cone cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha'",enzyme,,"Drug: sildenafil | Target: cone cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha' | Type: enzyme | Action: nan"
11282,sildenafil,"rod cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha",enzyme,,"Drug: sildenafil | Target: rod cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha | Type: enzyme | Action: nan"
11283,sildenafil,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: sildenafil | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
11284,sildenafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: sildenafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
11285,sildenafil,phosphodiesterase 3,enzyme,,Drug: sildenafil | Target: phosphodiesterase 3 | Type: enzyme | Action: nan
11286,sildenafil,phosphodiesterase 4,enzyme,,Drug: sildenafil | Target: phosphodiesterase 4 | Type: enzyme | Action: nan
11287,sildenafil,phosphodiesterase 4,enzyme,,Drug: sildenafil | Target: phosphodiesterase 4 | Type: enzyme | Action: nan
11288,sildenafil,phosphodiesterase 1,enzyme,,Drug: sildenafil | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
11289,sildenafil,phosphodiesterase 1,enzyme,,Drug: sildenafil | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
11290,sildenafil,phosphodiesterase 6,enzyme,,Drug: sildenafil | Target: phosphodiesterase 6 | Type: enzyme | Action: nan
11291,sildenafil,phosphodiesterase 1,enzyme,,Drug: sildenafil | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
11292,sildenafil,solute carrier organic anion transporter family member 1b3,transporter,INHIBITOR,Drug: sildenafil | Target: solute carrier organic anion transporter family member 1b3 | Type: transporter | Action: INHIBITOR
11293,sildenafil,phosphodiesterase 2a,enzyme,,Drug: sildenafil | Target: phosphodiesterase 2a | Type: enzyme | Action: nan
11294,silymarin,urokinase-type plasminogen activator,enzyme,,Drug: silymarin | Target: urokinase-type plasminogen activator | Type: enzyme | Action: nan
11295,silymarin,carbonic anhydrase 2,enzyme,,Drug: silymarin | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11296,silymarin,carbonic anhydrase 1,enzyme,,Drug: silymarin | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
11297,silymarin,carbonic anhydrase 4,enzyme,,Drug: silymarin | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
11298,silymarin,carbonic anhydrase 9,enzyme,,Drug: silymarin | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
11299,silymarin,carbonic anhydrase 12,enzyme,,Drug: silymarin | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
11300,silymarin,prothrombin,enzyme,,Drug: silymarin | Target: prothrombin | Type: enzyme | Action: nan
11301,silymarin,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: silymarin | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
11302,silymarin,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: silymarin | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
11303,silymarin,carbonic anhydrase 7,enzyme,,Drug: silymarin | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
11304,silymarin,carbonic anhydrase 3,enzyme,,Drug: silymarin | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
11305,silymarin,carbonic anhydrase 6,enzyme,,Drug: silymarin | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
11306,silymarin,carbonic anhydrase 14,enzyme,,Drug: silymarin | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
11307,silymarin,polyphenol oxidase 2,enzyme,,Drug: silymarin | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
11308,silymarin,carbonic anhydrase 13,enzyme,,Drug: silymarin | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
11309,silymarin,carbonic anhydrase 15,enzyme,,Drug: silymarin | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
11310,silymarin,xanthine dehydrogenase/oxidase,enzyme,,Drug: silymarin | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
11311,silymarin,p-glycoprotein 3,transporter,,Drug: silymarin | Target: p-glycoprotein 3 | Type: transporter | Action: nan
11313,silymarin,"solute carrier family 2, facilitated glucose transporter member 4",transporter,,"Drug: silymarin | Target: solute carrier family 2, facilitated glucose transporter member 4 | Type: transporter | Action: nan"
11314,simvastatin,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: simvastatin | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
11315,simvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,INHIBITOR,Drug: simvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: INHIBITOR
11316,simvastatin,acetylcholinesterase,enzyme,,Drug: simvastatin | Target: acetylcholinesterase | Type: enzyme | Action: nan
11317,simvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: simvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
11318,simvastatin,cholinesterase,enzyme,,Drug: simvastatin | Target: cholinesterase | Type: enzyme | Action: nan
11319,simvastatin,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: simvastatin | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
11320,sirolimus,sodium/nucleoside cotransporter 1,transporter,,Drug: sirolimus | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
11321,sirolimus,cytochrome p450 3a4,enzyme,,Drug: sirolimus | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
11322,sirolimus,multidrug resistance protein 1,transporter,,Drug: sirolimus | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
11323,sirolimus,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,INHIBITOR,Drug: sirolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: INHIBITOR
11324,sirolimus,cytochrome p450 2c9,enzyme,,Drug: sirolimus | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
11325,sirolimus,serine/threonine-protein kinase mtor,kinase,,Drug: sirolimus | Target: serine/threonine-protein kinase mtor | Type: kinase | Action: nan
11326,sirolimus,peptidyl-prolyl cis-trans isomerase fkbp3,enzyme,,Drug: sirolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp3 | Type: enzyme | Action: nan
11327,sirolimus,cytochrome p450 2c19,enzyme,,Drug: sirolimus | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
11328,sirolimus,peptidyl-prolyl cis-trans isomerase fkbp1b,enzyme,,Drug: sirolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1b | Type: enzyme | Action: nan
11329,sirolimus,peptidyl-prolyl cis-trans isomerase fkbp5,enzyme,,Drug: sirolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp5 | Type: enzyme | Action: nan
11330,sirolimus,programmed cell death protein 4,nuclear other,,Drug: sirolimus | Target: programmed cell death protein 4 | Type: nuclear other | Action: nan
11331,sirolimus,eukaryotic translation initiation factor 4e,nuclear other,,Drug: sirolimus | Target: eukaryotic translation initiation factor 4e | Type: nuclear other | Action: nan
11332,sirolimus,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,,Drug: sirolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: nan
11333,sisomicin,30s ribosomal protein s12,cytosolic other,,Drug: sisomicin | Target: 30s ribosomal protein s12 | Type: cytosolic other | Action: nan
11334,sitagliptin,dipeptidyl peptidase 4,enzyme,,Drug: sitagliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
11335,sitagliptin,angiotensin-converting enzyme,enzyme,,Drug: sitagliptin | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
11336,sitagliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: sitagliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
11337,sitagliptin,dipeptidyl peptidase 4,enzyme,,Drug: sitagliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
11338,sitagliptin,prolyl endopeptidase fap,enzyme,,Drug: sitagliptin | Target: prolyl endopeptidase fap | Type: enzyme | Action: nan
11339,sitagliptin,dipeptidyl peptidase 8,enzyme,,Drug: sitagliptin | Target: dipeptidyl peptidase 8 | Type: enzyme | Action: nan
11340,sitagliptin,dipeptidyl peptidase 9,enzyme,,Drug: sitagliptin | Target: dipeptidyl peptidase 9 | Type: enzyme | Action: nan
11341,sitagliptin,dipeptidyl peptidase 2,enzyme,,Drug: sitagliptin | Target: dipeptidyl peptidase 2 | Type: enzyme | Action: nan
11342,sitagliptin,dipeptidyl peptidase iv,unclassified,,Drug: sitagliptin | Target: dipeptidyl peptidase iv | Type: unclassified | Action: nan
11343,sitafloxacin,dna gyrase subunit b,enzyme,,Drug: sitafloxacin | Target: dna gyrase subunit b | Type: enzyme | Action: nan
11344,sitafloxacin,dna topoisomerase 4 subunit a,enzyme,,Drug: sitafloxacin | Target: dna topoisomerase 4 subunit a | Type: enzyme | Action: nan
11345,sitosterol,amine oxidase [flavin-containing] b,enzyme,,Drug: sitosterol | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
11346,sitosterol,amine oxidase [flavin-containing] a,enzyme,,Drug: sitosterol | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
11347,sitosterol,prothrombin,enzyme,,Drug: sitosterol | Target: prothrombin | Type: enzyme | Action: nan
11348,sitosterol,dipeptidyl peptidase 4,enzyme,,Drug: sitosterol | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
11349,sitosterol,nuclear factor nf-kappa-b p105 subunit,cytosolic other,,Drug: sitosterol | Target: nuclear factor nf-kappa-b p105 subunit | Type: cytosolic other | Action: nan
11350,sitosterol,acetylcholinesterase,enzyme,,Drug: sitosterol | Target: acetylcholinesterase | Type: enzyme | Action: nan
11351,sitosterol,amine oxidase [flavin-containing] a,enzyme,,Drug: sitosterol | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
11352,sitosterol,dna polymerase beta,enzyme,,Drug: sitosterol | Target: dna polymerase beta | Type: enzyme | Action: nan
11357,sivelestat,neutrophil elastase,enzyme,,Drug: sivelestat | Target: neutrophil elastase | Type: enzyme | Action: nan
11358,sivelestat,myeloblastin,enzyme,,Drug: sivelestat | Target: myeloblastin | Type: enzyme | Action: nan
11359,sivelestat,neutrophil elastase,enzyme,,Drug: sivelestat | Target: neutrophil elastase | Type: enzyme | Action: nan
11360,solifenacin,muscarinic acetylcholine receptor m1,gpcr,,Drug: solifenacin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
11361,solifenacin,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: solifenacin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
11362,solifenacin,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: solifenacin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
11363,solifenacin,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: solifenacin | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
11364,solifenacin,muscarinic acetylcholine receptor m5,gpcr,ANTAGONIST,Drug: solifenacin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: ANTAGONIST
11365,solifenacin,muscarinic acetylcholine receptor m2,gpcr,,Drug: solifenacin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
11366,solifenacin,muscarinic acetylcholine receptor m1,gpcr,,Drug: solifenacin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
11367,solifenacin,muscarinic acetylcholine receptor m3,gpcr,,Drug: solifenacin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
11368,sorafenib,tyrosine-protein kinase jak3,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
11369,sorafenib,5-hydroxytryptamine receptor 1a,gpcr,,Drug: sorafenib | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11370,sorafenib,5-hydroxytryptamine receptor 2a,gpcr,,Drug: sorafenib | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11371,sorafenib,5-hydroxytryptamine receptor 2b,gpcr,,Drug: sorafenib | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
11372,sorafenib,5-hydroxytryptamine receptor 2c,gpcr,,Drug: sorafenib | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
11373,sorafenib,5-hydroxytryptamine receptor 6,gpcr,,Drug: sorafenib | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
11374,sorafenib,5-hydroxytryptamine receptor 7,gpcr,,Drug: sorafenib | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
11375,sorafenib,5-hydroxytryptamine receptor 5a,gpcr,,Drug: sorafenib | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
11376,sorafenib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: sorafenib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
11377,sorafenib,tyrosine-protein kinase abl1,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
11378,sorafenib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: sorafenib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
11379,sorafenib,epidermal growth factor receptor,kinase,,Drug: sorafenib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
11380,sorafenib,carbonic anhydrase 7,enzyme,,Drug: sorafenib | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
11381,sorafenib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: sorafenib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
11382,sorafenib,tyrosine-protein kinase lck,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
11383,sorafenib,tyrosine-protein kinase fyn,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
11384,sorafenib,ephrin type-a receptor 2,kinase,,Drug: sorafenib | Target: ephrin type-a receptor 2 | Type: kinase | Action: nan
11385,sorafenib,raf proto-oncogene serine/threonine-protein kinase,kinase,INHIBITOR,Drug: sorafenib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: INHIBITOR
11386,sorafenib,serine/threonine-protein kinase b-raf,kinase,INHIBITOR,Drug: sorafenib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: INHIBITOR
11387,sorafenib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: sorafenib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
11388,sorafenib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: sorafenib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
11389,sorafenib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: sorafenib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
11390,sorafenib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: sorafenib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
11391,sorafenib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: sorafenib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
11392,sorafenib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: sorafenib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
11393,sorafenib,platelet-derived growth factor receptor alpha,kinase,,Drug: sorafenib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
11394,sorafenib,cyclin-dependent kinase 2,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase 2 | Type: kinase | Action: nan
11395,sorafenib,insulin receptor,kinase,AGONIST,Drug: sorafenib | Target: insulin receptor | Type: kinase | Action: AGONIST
11396,sorafenib,fibroblast growth factor receptor 3,kinase,,Drug: sorafenib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
11397,sorafenib,tyrosine-protein kinase hck,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
11398,sorafenib,high affinity nerve growth factor receptor,kinase,,Drug: sorafenib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
11399,sorafenib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: sorafenib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
11400,sorafenib,tyrosine-protein kinase csk,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
11401,sorafenib,angiopoietin-1 receptor,kinase,,Drug: sorafenib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
11402,sorafenib,ephrin type-a receptor 8,kinase,,Drug: sorafenib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
11403,sorafenib,hepatocyte growth factor receptor,kinase,,Drug: sorafenib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
11404,sorafenib,tyrosine-protein kinase lyn,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
11405,sorafenib,lim domain kinase 1,kinase,,Drug: sorafenib | Target: lim domain kinase 1 | Type: kinase | Action: nan
11406,sorafenib,fibroblast growth factor receptor 1,kinase,,Drug: sorafenib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
11407,sorafenib,cyclin-dependent-like kinase 5,kinase,,Drug: sorafenib | Target: cyclin-dependent-like kinase 5 | Type: kinase | Action: nan
11408,sorafenib,serine/threonine-protein kinase 10,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
11409,sorafenib,serine/threonine-protein kinase plk4,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
11410,sorafenib,aurora kinase c,kinase,,Drug: sorafenib | Target: aurora kinase c | Type: kinase | Action: nan
11411,sorafenib,dual specificity protein kinase ttk,kinase,,Drug: sorafenib | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
11412,sorafenib,abelson tyrosine-protein kinase 2,kinase,,Drug: sorafenib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
11413,sorafenib,mitogen-activated protein kinase 11,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase 11 | Type: kinase | Action: nan
11414,sorafenib,ephrin type-a receptor 5,kinase,,Drug: sorafenib | Target: ephrin type-a receptor 5 | Type: kinase | Action: nan
11415,sorafenib,ephrin type-a receptor 4,kinase,,Drug: sorafenib | Target: ephrin type-a receptor 4 | Type: kinase | Action: nan
11416,sorafenib,fibroblast growth factor receptor 2,kinase,,Drug: sorafenib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
11417,sorafenib,mitogen-activated protein kinase 3,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
11418,sorafenib,ephrin type-a receptor 6,kinase,,Drug: sorafenib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
11419,sorafenib,traf2 and nck-interacting protein kinase,kinase,,Drug: sorafenib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
11420,sorafenib,mitogen-activated protein kinase 12,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase 12 | Type: kinase | Action: nan
11421,sorafenib,tyrosine-protein kinase fgr,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
11422,sorafenib,aurora kinase a,kinase,,Drug: sorafenib | Target: aurora kinase a | Type: kinase | Action: nan
11423,sorafenib,serine/threonine-protein kinase 36,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase 36 | Type: kinase | Action: nan
11424,sorafenib,ephrin type-a receptor 3,kinase,,Drug: sorafenib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
11425,sorafenib,mitogen-activated protein kinase 14,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
11426,sorafenib,tyrosine-protein kinase frk,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
11427,sorafenib,dual specificity protein kinase clk1,kinase,,Drug: sorafenib | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
11428,sorafenib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
11429,sorafenib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: sorafenib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
11430,sorafenib,ephrin type-b receptor 1,kinase,,Drug: sorafenib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
11431,sorafenib,ephrin type-a receptor 7,kinase,,Drug: sorafenib | Target: ephrin type-a receptor 7 | Type: kinase | Action: nan
11432,sorafenib,ste20-like serine/threonine-protein kinase,kinase,,Drug: sorafenib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
11433,sorafenib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: sorafenib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
11434,sorafenib,mitogen-activated protein kinase 9,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
11435,sorafenib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: sorafenib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
11436,sorafenib,ephrin type-b receptor 4,kinase,,Drug: sorafenib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
11437,sorafenib,cyclin-dependent kinase 15,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase 15 | Type: kinase | Action: nan
11438,sorafenib,bifunctional epoxide hydrolase 2,enzyme,,Drug: sorafenib | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
11439,sorafenib,tgf-beta receptor type-2,kinase,,Drug: sorafenib | Target: tgf-beta receptor type-2 | Type: kinase | Action: nan
11440,sorafenib,mitogen-activated protein kinase 1,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
11441,sorafenib,tyrosine-protein kinase receptor ufo,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
11442,sorafenib,bdnf/nt-3 growth factors receptor,kinase,,Drug: sorafenib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
11443,sorafenib,ephrin type-b receptor 2,kinase,,Drug: sorafenib | Target: ephrin type-b receptor 2 | Type: kinase | Action: nan
11444,sorafenib,cyclin-dependent kinase 7,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
11445,sorafenib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: sorafenib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
11446,sorafenib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: sorafenib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
11447,sorafenib,mitogen-activated protein kinase 13,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase 13 | Type: kinase | Action: nan
11448,sorafenib,cyclin-dependent kinase 17,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase 17 | Type: kinase | Action: nan
11449,sorafenib,cyclin-dependent kinase 14,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase 14 | Type: kinase | Action: nan
11450,sorafenib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
11451,sorafenib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
11452,sorafenib,nt-3 growth factor receptor,kinase,,Drug: sorafenib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
11453,sorafenib,lim domain kinase 2,kinase,,Drug: sorafenib | Target: lim domain kinase 2 | Type: kinase | Action: nan
11454,sorafenib,map kinase-interacting serine/threonine-protein kinase 1,kinase,,Drug: sorafenib | Target: map kinase-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
11455,sorafenib,serine/threonine-protein kinase nlk,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase nlk | Type: kinase | Action: nan
11456,sorafenib,serine/threonine-protein kinase 33,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
11457,sorafenib,serine/threonine-protein kinase tnni3k,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
11458,sorafenib,discoidin domain-containing receptor 2,kinase,,Drug: sorafenib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
11459,sorafenib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
11460,sorafenib,aurora kinase b,kinase,,Drug: sorafenib | Target: aurora kinase b | Type: kinase | Action: nan
11461,sorafenib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
11462,sorafenib,tyrosine-protein kinase mer,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
11463,sorafenib,cyclin-dependent kinase 19,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase 19 | Type: kinase | Action: nan
11464,sorafenib,cyclin-dependent kinase 8,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase 8 | Type: kinase | Action: nan
11465,sorafenib,"muscle, skeletal receptor tyrosine-protein kinase",kinase,,"Drug: sorafenib | Target: muscle, skeletal receptor tyrosine-protein kinase | Type: kinase | Action: nan"
11466,sorafenib,citron rho-interacting kinase,kinase,,Drug: sorafenib | Target: citron rho-interacting kinase | Type: kinase | Action: nan
11467,sorafenib,myosin-iiib,kinase,,Drug: sorafenib | Target: myosin-iiib | Type: kinase | Action: nan
11468,sorafenib,cyclin-dependent kinase 3,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase 3 | Type: kinase | Action: nan
11469,sorafenib,tyrosine-protein kinase srms,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase srms | Type: kinase | Action: nan
11470,sorafenib,ephrin type-a receptor 1,kinase,,Drug: sorafenib | Target: ephrin type-a receptor 1 | Type: kinase | Action: nan
11471,sorafenib,mitogen-activated protein kinase 15,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase 15 | Type: kinase | Action: nan
11472,sorafenib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: sorafenib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
11473,sorafenib,tyrosine-protein kinase abl1,kinase,,Drug: sorafenib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
11474,sorafenib,casein kinase i isoform alpha,kinase,,Drug: sorafenib | Target: casein kinase i isoform alpha | Type: kinase | Action: nan
11475,sorafenib,cyclin-dependent kinase-like 2,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase-like 2 | Type: kinase | Action: nan
11476,sorafenib,cyclin-dependent kinase-like 3,kinase,,Drug: sorafenib | Target: cyclin-dependent kinase-like 3 | Type: kinase | Action: nan
11477,sorafenib,ephrin type-b receptor 6,kinase,,Drug: sorafenib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
11478,sorafenib,homeodomain-interacting protein kinase 2,kinase,,Drug: sorafenib | Target: homeodomain-interacting protein kinase 2 | Type: kinase | Action: nan
11479,sorafenib,homeodomain-interacting protein kinase 3,kinase,,Drug: sorafenib | Target: homeodomain-interacting protein kinase 3 | Type: kinase | Action: nan
11480,sorafenib,homeodomain-interacting protein kinase 4,kinase,,Drug: sorafenib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
11481,sorafenib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
11482,sorafenib,serine/threonine-protein kinase tao1,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
11483,sorafenib,serine/threonine-protein kinase tao3,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
11484,sorafenib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: sorafenib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
11485,sorafenib,homeodomain-interacting protein kinase 1,kinase,,Drug: sorafenib | Target: homeodomain-interacting protein kinase 1 | Type: kinase | Action: nan
11486,sorafenib,serine/threonine-protein kinase tao2,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase tao2 | Type: kinase | Action: nan
11487,sorafenib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: sorafenib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
11488,sorafenib,myosin light chain kinase 3,kinase,,Drug: sorafenib | Target: myosin light chain kinase 3 | Type: kinase | Action: nan
11489,sorafenib,calcium-dependent protein kinase 1,kinase,,Drug: sorafenib | Target: calcium-dependent protein kinase 1 | Type: kinase | Action: nan
11490,sorafenib,vascular endothelial growth factor receptor 2,kinase,,Drug: sorafenib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
11491,sorafenib,vascular endothelial growth factor receptor 2,kinase,,Drug: sorafenib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
11492,sorafenib,serine/threonine-protein kinase a-raf,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase a-raf | Type: kinase | Action: nan
11493,sorafenib,purine nucleoside phosphorylase,enzyme,,Drug: sorafenib | Target: purine nucleoside phosphorylase | Type: enzyme | Action: nan
11494,sorafenib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: sorafenib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
11495,sorafenib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: sorafenib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
11496,sorafenib,receptor-interacting serine/threonine-protein kinase 3,kinase,,Drug: sorafenib | Target: receptor-interacting serine/threonine-protein kinase 3 | Type: kinase | Action: nan
11498,sorafenib,serine/threonine-protein kinase b-raf,kinase,,Drug: sorafenib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
11502,sorivudine,thymidine kinase,kinase,,Drug: sorivudine | Target: thymidine kinase | Type: kinase | Action: nan
11503,sorivudine,thymidine kinase,kinase,,Drug: sorivudine | Target: thymidine kinase | Type: kinase | Action: nan
11504,sorivudine,deoxynucleoside kinase,kinase,,Drug: sorivudine | Target: deoxynucleoside kinase | Type: kinase | Action: nan
11505,sorivudine,"thymidine kinase, mitochondrial",kinase,,"Drug: sorivudine | Target: thymidine kinase, mitochondrial | Type: kinase | Action: nan"
11506,sotalol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: sotalol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
11507,sotalol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: sotalol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
11508,sotalol,potassium voltage-gated channel subfamily h member 2,ion channel,BLOCKER,Drug: sotalol | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: BLOCKER
11509,sotalol,beta-2 adrenergic receptor,gpcr,,Drug: sotalol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
11510,sotalol,beta-2 adrenergic receptor,gpcr,,Drug: sotalol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
11511,sparfloxacin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: sparfloxacin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
11512,sparfloxacin,topoisomerase iv,enzyme,INHIBITOR,Drug: sparfloxacin | Target: topoisomerase iv | Type: enzyme | Action: INHIBITOR
11513,sparfloxacin,dna gyrase,enzyme,INHIBITOR,Drug: sparfloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
11514,spectinomycin,30s ribosomal protein s12,cytosolic other,,Drug: spectinomycin | Target: 30s ribosomal protein s12 | Type: cytosolic other | Action: nan
11515,spiclomazine,beta-secretase 1,enzyme,,Drug: spiclomazine | Target: beta-secretase 1 | Type: enzyme | Action: nan
11516,spiperone,d(1a) dopamine receptor,gpcr,,Drug: spiperone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
11517,spiperone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: spiperone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
11518,spiperone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: spiperone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
11519,spiperone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11520,spiperone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: spiperone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
11521,spiperone,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: spiperone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
11522,spiperone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
11523,spiperone,5-hydroxytryptamine receptor 6,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
11524,spiperone,5-hydroxytryptamine receptor 7,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
11525,spiperone,alpha-1a adrenergic receptor,gpcr,,Drug: spiperone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
11526,spiperone,d(3) dopamine receptor,gpcr,,Drug: spiperone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11527,spiperone,d(1b) dopamine receptor,gpcr,ANTAGONIST,Drug: spiperone | Target: d(1b) dopamine receptor | Type: gpcr | Action: ANTAGONIST
11528,spiperone,histamine h1 receptor,gpcr,,Drug: spiperone | Target: histamine h1 receptor | Type: gpcr | Action: nan
11529,spiperone,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: spiperone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
11530,spiperone,d(4) dopamine receptor,gpcr,,Drug: spiperone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
11531,spiperone,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: spiperone | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
11532,spiperone,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: spiperone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
11533,spiperone,5-hydroxytryptamine receptor 5a,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
11534,spiperone,5-hydroxytryptamine receptor 1f,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
11535,spiperone,5-hydroxytryptamine receptor 1e,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
11536,spiperone,alpha-1b adrenergic receptor,gpcr,,Drug: spiperone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
11537,spiperone,5-hydroxytryptamine receptor 1b,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
11538,spiperone,alpha-1a adrenergic receptor,gpcr,,Drug: spiperone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
11539,spiperone,alpha-1d adrenergic receptor,gpcr,,Drug: spiperone | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
11540,spiperone,d(2) dopamine receptor,gpcr,,Drug: spiperone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11541,spiperone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11542,spiperone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11543,spiperone,5-hydroxytryptamine receptor 7,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
11544,spiperone,5-hydroxytryptamine receptor 7,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
11545,spiperone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: spiperone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
11546,spiperone,alpha-1a adrenergic receptor,gpcr,,Drug: spiperone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
11547,spiperone,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: spiperone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
11548,spiperone,vesicular acetylcholine transporter,transporter,,Drug: spiperone | Target: vesicular acetylcholine transporter | Type: transporter | Action: nan
11549,spiperone,muscarinic acetylcholine receptor,gpcr,,Drug: spiperone | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
11550,spiperone,serotonin 1 (5-ht1) receptor,gpcr,,Drug: spiperone | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
11551,spiperone,dopamine receptor,gpcr,,Drug: spiperone | Target: dopamine receptor | Type: gpcr | Action: nan
11552,spiperone,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: spiperone | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
11553,spiperone,serotonin 2 (5-ht2) receptor,gpcr,,Drug: spiperone | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
11554,spiperone,dopamine receptor,gpcr,,Drug: spiperone | Target: dopamine receptor | Type: gpcr | Action: nan
11555,spiperone,beta-casein,unclassified,,Drug: spiperone | Target: beta-casein | Type: unclassified | Action: nan
11556,spiperone,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: spiperone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
11557,spiperone,"hla class i histocompatibility antigen, a-3 alpha chain",unclassified,,"Drug: spiperone | Target: hla class i histocompatibility antigen, a-3 alpha chain | Type: unclassified | Action: nan"
11558,spirapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: spirapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
11559,spirapril,angiotensin-converting enzyme,enzyme,,Drug: spirapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
11560,spironolactone,glucocorticoid receptor,nuclear hormone receptor,,Drug: spironolactone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
11561,spironolactone,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: spironolactone | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
11562,spironolactone,mineralocorticoid receptor,nuclear hormone receptor,ANTAGONIST,Drug: spironolactone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
11563,spironolactone,androgen receptor,nuclear hormone receptor,,Drug: spironolactone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
11564,spironolactone,progesterone receptor,nuclear hormone receptor,,Drug: spironolactone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
11565,spironolactone,estrogen receptor beta,nuclear hormone receptor,,Drug: spironolactone | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
11566,spironolactone,cytochrome p450 2c19,enzyme,,Drug: spironolactone | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
11567,spironolactone,androgen receptor,transcription factor,,Drug: spironolactone | Target: androgen receptor | Type: transcription factor | Action: nan
11568,spironolactone,progesterone receptor,transcription factor,,Drug: spironolactone | Target: progesterone receptor | Type: transcription factor | Action: nan
11569,spironolactone,multidrug and toxin extrusion protein 1,transporter,,Drug: spironolactone | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
11570,stanozolol,cytochrome p450 2d6,enzyme,,Drug: stanozolol | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
11571,stanozolol,adenosine receptor a3,gpcr,,Drug: stanozolol | Target: adenosine receptor a3 | Type: gpcr | Action: nan
11572,stanozolol,estrogen receptor,nuclear hormone receptor,,Drug: stanozolol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
11573,stanozolol,androgen receptor,nuclear hormone receptor,AGONIST,Drug: stanozolol | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
11574,stanozolol,cytochrome p450 2c9,enzyme,,Drug: stanozolol | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
11575,stanozolol,cytochrome p450 2c19,enzyme,,Drug: stanozolol | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
11576,stanozolol,androgen receptor,transcription factor,,Drug: stanozolol | Target: androgen receptor | Type: transcription factor | Action: nan
11577,stanozolol,progesterone receptor,transcription factor,,Drug: stanozolol | Target: progesterone receptor | Type: transcription factor | Action: nan
11578,stavudine,gag-pol polyprotein,polyprotein,,Drug: stavudine | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
11579,stavudine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: stavudine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
11580,stavudine,reverse transcriptase,enzyme,,Drug: stavudine | Target: reverse transcriptase | Type: enzyme | Action: nan
11581,stiripentol,cytochrome p450 3a4,enzyme,,Drug: stiripentol | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
11582,stiripentol,sodium- and chloride-dependent gaba transporter 1,transporter,,Drug: stiripentol | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: nan
11583,stiripentol,cytochrome p450 1a2,enzyme,,Drug: stiripentol | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
11584,stiripentol,cytochrome p450 2c19,enzyme,,Drug: stiripentol | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
11585,streptomycin,30s ribosomal protein s12,ribosomal protein,,Drug: streptomycin | Target: 30s ribosomal protein s12 | Type: ribosomal protein | Action: nan
11586,strychnine,muscarinic acetylcholine receptor m1,gpcr,ALLOSTERIC MODULATOR,Drug: strychnine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ALLOSTERIC MODULATOR
11587,strychnine,muscarinic acetylcholine receptor m2,gpcr,ALLOSTERIC MODULATOR,Drug: strychnine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ALLOSTERIC MODULATOR
11588,strychnine,muscarinic acetylcholine receptor m3,gpcr,ALLOSTERIC MODULATOR,Drug: strychnine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ALLOSTERIC MODULATOR
11589,strychnine,muscarinic acetylcholine receptor m4,gpcr,ALLOSTERIC MODULATOR,Drug: strychnine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ALLOSTERIC MODULATOR
11590,strychnine,glycine receptor subunit alpha-1,ion channel,,Drug: strychnine | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
11591,strychnine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: strychnine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
11592,strychnine,glycine receptor subunit alpha-1,ion channel,,Drug: strychnine | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
11593,strychnine,taste receptor type 2 member 10,gpcr,,Drug: strychnine | Target: taste receptor type 2 member 10 | Type: gpcr | Action: nan
11594,strychnine,taste receptor type 2 member 46,gpcr,AGONIST,Drug: strychnine | Target: taste receptor type 2 member 46 | Type: gpcr | Action: AGONIST
11595,succinic acid,egl nine homolog 1,enzyme,,Drug: succinic acid | Target: egl nine homolog 1 | Type: enzyme | Action: nan
11596,succinic acid,succinate receptor 1,gpcr,AGONIST,Drug: succinic acid | Target: succinate receptor 1 | Type: gpcr | Action: AGONIST
11597,suxamethonium,acetylcholinesterase,enzyme,,Drug: suxamethonium | Target: acetylcholinesterase | Type: enzyme | Action: nan
11598,suxamethonium,muscle-type nicotinic acetylcholine receptor,ion channel,AGONIST,Drug: suxamethonium | Target: muscle-type nicotinic acetylcholine receptor | Type: ion channel | Action: AGONIST
11599,sufentanil,mu-type opioid receptor,gpcr,AGONIST,Drug: sufentanil | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
11600,sufentanil,kappa-type opioid receptor,gpcr,,Drug: sufentanil | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
11601,sufentanil,delta-type opioid receptor,gpcr,,Drug: sufentanil | Target: delta-type opioid receptor | Type: gpcr | Action: nan
11602,sufentanil,solute carrier family 22 member 1,transporter,,Drug: sufentanil | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
11603,sufentanil,mu-type opioid receptor,gpcr,,Drug: sufentanil | Target: mu-type opioid receptor | Type: gpcr | Action: nan
11604,sufentanil,sigma non-opioid intracellular receptor 1,membrane other,,Drug: sufentanil | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
11605,sufentanil,opioid receptor,gpcr,,Drug: sufentanil | Target: opioid receptor | Type: gpcr | Action: nan
11607,sufentanil,sigma non-opioid intracellular receptor 1,unclassified,,Drug: sufentanil | Target: sigma non-opioid intracellular receptor 1 | Type: unclassified | Action: nan
11608,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11609,sulbactam,beta-lactamase tem,enzyme,INHIBITOR,Drug: sulbactam | Target: beta-lactamase tem | Type: enzyme | Action: INHIBITOR
11610,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11611,sulbactam,beta-lactamase shv-1,enzyme,,Drug: sulbactam | Target: beta-lactamase shv-1 | Type: enzyme | Action: nan
11612,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11613,sulbactam,beta-lactamase oxa-1,enzyme,,Drug: sulbactam | Target: beta-lactamase oxa-1 | Type: enzyme | Action: nan
11614,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11615,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11616,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11617,sulbactam,carbapenem-hydrolizing beta-lactamase sfc-1,enzyme,,Drug: sulbactam | Target: carbapenem-hydrolizing beta-lactamase sfc-1 | Type: enzyme | Action: nan
11618,sulbactam,beta-lactamase ges-13,enzyme,,Drug: sulbactam | Target: beta-lactamase ges-13 | Type: enzyme | Action: nan
11619,sulbactam,class d beta-lactamase,unclassified,,Drug: sulbactam | Target: class d beta-lactamase | Type: unclassified | Action: nan
11620,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11621,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11622,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11623,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11624,sulbactam,"serine beta-lactamase-like protein lactb, mitochondrial",enzyme,,"Drug: sulbactam | Target: serine beta-lactamase-like protein lactb, mitochondrial | Type: enzyme | Action: nan"
11625,sulbactam,beta-lactamase tem,enzyme,,Drug: sulbactam | Target: beta-lactamase tem | Type: enzyme | Action: nan
11626,sulbactam,adc-18 protein,enzyme,,Drug: sulbactam | Target: adc-18 protein | Type: enzyme | Action: nan
11627,sulbactam,beta-lactamase 1,enzyme,,Drug: sulbactam | Target: beta-lactamase 1 | Type: enzyme | Action: nan
11628,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11629,sulbactam,beta-lactamase,enzyme,,Drug: sulbactam | Target: beta-lactamase | Type: enzyme | Action: nan
11630,sulconazole,alpha-2a adrenergic receptor,gpcr,,Drug: sulconazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
11631,sulconazole,cytochrome p450 3a4,enzyme,,Drug: sulconazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
11632,sulconazole,sodium-dependent serotonin transporter,transporter,,Drug: sulconazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
11633,sulconazole,sodium-dependent noradrenaline transporter,transporter,,Drug: sulconazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
11634,sulconazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: sulconazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11635,sulconazole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: sulconazole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
11636,sulconazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: sulconazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
11637,sulconazole,alpha-2b adrenergic receptor,gpcr,,Drug: sulconazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
11638,sulconazole,d(3) dopamine receptor,gpcr,,Drug: sulconazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11639,sulconazole,muscarinic acetylcholine receptor m1,gpcr,,Drug: sulconazole | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
11640,sulconazole,muscarinic acetylcholine receptor m3,gpcr,,Drug: sulconazole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
11641,sulconazole,muscarinic acetylcholine receptor m4,gpcr,,Drug: sulconazole | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
11642,sulconazole,muscarinic acetylcholine receptor m5,gpcr,,Drug: sulconazole | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
11643,sulconazole,alpha-2c adrenergic receptor,gpcr,,Drug: sulconazole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
11644,sulconazole,sodium-dependent dopamine transporter,transporter,,Drug: sulconazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
11645,sulconazole,cytochrome p450 2d6,enzyme,,Drug: sulconazole | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
11646,sulconazole,adenosine receptor a3,gpcr,,Drug: sulconazole | Target: adenosine receptor a3 | Type: gpcr | Action: nan
11647,sulconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: sulconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
11648,sulconazole,beta-lactamase,enzyme,,Drug: sulconazole | Target: beta-lactamase | Type: enzyme | Action: nan
11649,sulconazole,cytochrome p450 2c9,enzyme,,Drug: sulconazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
11650,sulconazole,cytochrome p450 1a2,enzyme,,Drug: sulconazole | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
11651,sulconazole,cytochrome p450 2c19,enzyme,,Drug: sulconazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
11652,sulconazole,"alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,"Drug: sulconazole | Target: alkaline phosphatase, tissue-nonspecific isozyme | Type: enzyme | Action: nan"
11653,sulconazole,tyrosine-protein kinase fyn,kinase,,Drug: sulconazole | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
11654,sulconazole,thromboxane-a synthase,enzyme,,Drug: sulconazole | Target: thromboxane-a synthase | Type: enzyme | Action: nan
11655,sulconazole,bile acid receptor,nuclear hormone receptor,,Drug: sulconazole | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
11656,sulconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: sulconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
11657,sulconazole,substance-k receptor,gpcr,,Drug: sulconazole | Target: substance-k receptor | Type: gpcr | Action: nan
11658,sulconazole,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: sulconazole | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
11659,sulconazole,malate dehydrogenase cytoplasmic,enzyme,,Drug: sulconazole | Target: malate dehydrogenase cytoplasmic | Type: enzyme | Action: nan
11660,sulconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: sulconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
11661,sulfacetamide,dihydrofolate reductase,enzyme,,Drug: sulfacetamide | Target: dihydrofolate reductase | Type: enzyme | Action: nan
11662,sulfacetamide,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfacetamide | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11663,sulfacetamide,dihydrofolate reductase,enzyme,,Drug: sulfacetamide | Target: dihydrofolate reductase | Type: enzyme | Action: nan
11664,sulfacytine,"7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; dihydropteroate synthetase",kinase,INHIBITOR,"Drug: sulfacytine | Target: 7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; dihydropteroate synthetase | Type: kinase | Action: INHIBITOR"
11665,sulfadiazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: sulfadiazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11666,sulfadiazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: sulfadiazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
11667,sulfadiazine,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: sulfadiazine | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
11668,sulfadiazine,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfadiazine | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11669,sulfadiazine,aurora kinase a,kinase,,Drug: sulfadiazine | Target: aurora kinase a | Type: kinase | Action: nan
11670,sulfadiazine,high affinity choline transporter 1,transporter,,Drug: sulfadiazine | Target: high affinity choline transporter 1 | Type: transporter | Action: nan
11671,sulfadimethoxine,5-hydroxytryptamine receptor 6,gpcr,,Drug: sulfadimethoxine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
11672,sulfadimidine,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfadimidine | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11673,sulfadimidine,lactoylglutathione lyase,enzyme,,Drug: sulfadimidine | Target: lactoylglutathione lyase | Type: enzyme | Action: nan
11674,sulfadoxine,"7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; dihydropteroate synthetase",kinase,INHIBITOR,"Drug: sulfadoxine | Target: 7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase-dihydropteroate synthase; dihydropteroate synthetase | Type: kinase | Action: INHIBITOR"
11675,sulfadoxine,"6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase",unclassified,,"Drug: sulfadoxine | Target: 6-hydroxymethyl-7,8-dihydropterin pyrophosphokinase | Type: unclassified | Action: nan"
11676,sulfaethidole,rac-alpha serine/threonine-protein kinase,kinase,,Drug: sulfaethidole | Target: rac-alpha serine/threonine-protein kinase | Type: kinase | Action: nan
11677,sulfaguanidine,prothrombin,enzyme,,Drug: sulfaguanidine | Target: prothrombin | Type: enzyme | Action: nan
11678,sulfaguanidine,trypsin,enzyme,,Drug: sulfaguanidine | Target: trypsin | Type: enzyme | Action: nan
11679,sulfamerazine,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfamerazine | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11680,sulfameter,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfameter | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11681,sulfamethizole,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfamethizole | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11682,sulfamethoxazole,bifunctional protein folc,enzyme,,Drug: sulfamethoxazole | Target: bifunctional protein folc | Type: enzyme | Action: nan
11683,sulfamethoxazole,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfamethoxazole | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11684,sulfamethoxazole,dihydrofolate reductase,enzyme,,Drug: sulfamethoxazole | Target: dihydrofolate reductase | Type: enzyme | Action: nan
11685,sulfamethoxazole,pol polyprotein,enzyme,,Drug: sulfamethoxazole | Target: pol polyprotein | Type: enzyme | Action: nan
11686,sulfamethoxazole,endothelin-1 receptor,gpcr,,Drug: sulfamethoxazole | Target: endothelin-1 receptor | Type: gpcr | Action: nan
11687,sulfalene,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfalene | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11688,sulfanilamide,carbonic anhydrase 2,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11689,sulfanilamide,carbonic anhydrase 1,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
11690,sulfanilamide,carbonic anhydrase 4,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
11691,sulfanilamide,carbonic anhydrase 9,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
11692,sulfanilamide,carbonic anhydrase 12,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
11693,sulfanilamide,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfanilamide | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11694,sulfanilamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: sulfanilamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
11695,sulfanilamide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: sulfanilamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
11696,sulfanilamide,carbonic anhydrase 7,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
11697,sulfanilamide,carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
11698,sulfanilamide,carbonic anhydrase 3,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
11699,sulfanilamide,carbonic anhydrase 6,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
11700,sulfanilamide,carbonic anhydrase 14,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
11701,sulfanilamide,carbonic anhydrase 13,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
11702,sulfanilamide,carbonic anhydrase 4,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
11703,sulfanilamide,carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
11704,sulfanilamide,carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
11705,sulfanilamide,carbonic anhydrase 13,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
11706,sulfanilamide,carbonic anhydrase 15,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
11707,sulfanilamide,carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
11708,sulfanilamide,carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
11709,sulfanilamide,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
11710,sulfanilamide,carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
11711,sulfanilamide,alpha carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
11712,sulfanilamide,carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
11713,sulfanilamide,carbonic anhydrase 2,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11714,sulfanilamide,astrosclerin-3,enzyme,,Drug: sulfanilamide | Target: astrosclerin-3 | Type: enzyme | Action: nan
11715,sulfanilamide,beta-carbonic anhydrase 1,enzyme,,Drug: sulfanilamide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
11716,sulfanilamide,delta carbonic anhydrase,unclassified,,Drug: sulfanilamide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
11717,sulfanilamide,carbonic anhydrase 2,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11718,sulfanilamide,carbonic anhydrase 2,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11719,sulfanilamide,carbonic anhydrase,enzyme,,Drug: sulfanilamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
11720,sulfanilamide,"carbonic anhydrase, alpha family",unclassified,,"Drug: sulfanilamide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
11721,sulfanilamide,carbonate dehydratase,enzyme,,Drug: sulfanilamide | Target: carbonate dehydratase | Type: enzyme | Action: nan
11722,sulfaphenazole,cytochrome p450 2c9,enzyme,,Drug: sulfaphenazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
11723,sulfaphenazole,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfaphenazole | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11724,sulfapyridine,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfapyridine | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11725,sulfapyridine,dihydropteroate synthase type-1,enzyme,,Drug: sulfapyridine | Target: dihydropteroate synthase type-1 | Type: enzyme | Action: nan
11726,sulfasalazine,carbonic anhydrase 2,enzyme,,Drug: sulfasalazine | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11727,sulfasalazine,carbonic anhydrase 1,enzyme,,Drug: sulfasalazine | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
11728,sulfasalazine,"acetyl-coa acetyltransferase, mitochondrial",enzyme,,"Drug: sulfasalazine | Target: acetyl-coa acetyltransferase, mitochondrial | Type: enzyme | Action: nan"
11729,sulfasalazine,arachidonate 5-lipoxygenase,enzyme,INHIBITOR,Drug: sulfasalazine | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: INHIBITOR
11730,sulfasalazine,cystine/glutamate transporter,transporter,,Drug: sulfasalazine | Target: cystine/glutamate transporter | Type: transporter | Action: nan
11731,sulfasalazine,caspase-1,enzyme,,Drug: sulfasalazine | Target: caspase-1 | Type: enzyme | Action: nan
11732,sulfasalazine,thromboxane-a synthase,enzyme,,Drug: sulfasalazine | Target: thromboxane-a synthase | Type: enzyme | Action: nan
11733,sulfasalazine,interstitial collagenase,enzyme,,Drug: sulfasalazine | Target: interstitial collagenase | Type: enzyme | Action: nan
11734,sulfasalazine,androgen receptor,transcription factor,,Drug: sulfasalazine | Target: androgen receptor | Type: transcription factor | Action: nan
11735,sulfasalazine,proton-coupled folate transporter,transporter,INHIBITOR,Drug: sulfasalazine | Target: proton-coupled folate transporter | Type: transporter | Action: INHIBITOR
11736,sulfasalazine,aldose reductase,enzyme,,Drug: sulfasalazine | Target: aldose reductase | Type: enzyme | Action: nan
11737,sulfasalazine,mitogen-activated protein kinase 1,kinase,,Drug: sulfasalazine | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
11738,sulfasalazine,cyclooxygenase,enzyme,INHIBITOR,Drug: sulfasalazine | Target: cyclooxygenase | Type: enzyme | Action: INHIBITOR
11739,sulfasalazine,sodium/bile acid cotransporter,transporter,,Drug: sulfasalazine | Target: sodium/bile acid cotransporter | Type: transporter | Action: nan
11741,sulfathiazole,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfathiazole | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11742,sulfathiazole,endothelin-1 receptor,gpcr,,Drug: sulfathiazole | Target: endothelin-1 receptor | Type: gpcr | Action: nan
11743,sulfathiazole,endothelin-1 receptor,gpcr,,Drug: sulfathiazole | Target: endothelin-1 receptor | Type: gpcr | Action: nan
11744,sulfathiazole,transcriptional activator protein lasr,unclassified,,Drug: sulfathiazole | Target: transcriptional activator protein lasr | Type: unclassified | Action: nan
11745,sulfinpyrazone,multidrug resistance-associated protein 1,transporter,,Drug: sulfinpyrazone | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
11746,sulfinpyrazone,fmet-leu-phe receptor,gpcr,,Drug: sulfinpyrazone | Target: fmet-leu-phe receptor | Type: gpcr | Action: nan
11747,sulfinpyrazone,solute carrier family 22 member 12,transporter,INHIBITOR,Drug: sulfinpyrazone | Target: solute carrier family 22 member 12 | Type: transporter | Action: INHIBITOR
11748,sulfinpyrazone,nicotinate phosphoribosyltransferase,enzyme,,Drug: sulfinpyrazone | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
11749,sulfafurazole,histamine h4 receptor,gpcr,,Drug: sulfafurazole | Target: histamine h4 receptor | Type: gpcr | Action: nan
11750,sulfafurazole,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: sulfafurazole | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
11751,sulfafurazole,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfafurazole | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
11752,sulfafurazole,endothelin-1 receptor,gpcr,,Drug: sulfafurazole | Target: endothelin-1 receptor | Type: gpcr | Action: nan
11753,sulfafurazole,endothelin b receptor,gpcr,,Drug: sulfafurazole | Target: endothelin b receptor | Type: gpcr | Action: nan
11754,sulfafurazole,endothelin-1 receptor,gpcr,,Drug: sulfafurazole | Target: endothelin-1 receptor | Type: gpcr | Action: nan
11755,sulfobromophthalein,hematopoietic prostaglandin d synthase,enzyme,,Drug: sulfobromophthalein | Target: hematopoietic prostaglandin d synthase | Type: enzyme | Action: nan
11756,sulforidazine,d(2) dopamine receptor,gpcr,,Drug: sulforidazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11757,sulforidazine,d(3) dopamine receptor,gpcr,,Drug: sulforidazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11758,aldesulfone,dihydropteroate synthase 1,enzyme,INHIBITOR,Drug: aldesulfone | Target: dihydropteroate synthase 1 | Type: enzyme | Action: INHIBITOR
11759,aldesulfone,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: aldesulfone | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
11760,sulindac,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: sulindac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
11761,sulindac,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: sulindac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
11762,sulindac,glycine receptor subunit alpha-1,ion channel,,Drug: sulindac | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
11763,sulindac,aldose reductase,enzyme,,Drug: sulindac | Target: aldose reductase | Type: enzyme | Action: nan
11764,sulindac,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: sulindac | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
11765,sulindac,72 kda type iv collagenase,enzyme,,Drug: sulindac | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
11766,sulindac,lactoylglutathione lyase,enzyme,,Drug: sulindac | Target: lactoylglutathione lyase | Type: enzyme | Action: nan
11767,sulindac,aldose reductase,enzyme,,Drug: sulindac | Target: aldose reductase | Type: enzyme | Action: nan
11768,sulindac,prostaglandin g/h synthase 1,enzyme,,Drug: sulindac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
11769,sulindac,prostaglandin e synthase,enzyme,,Drug: sulindac | Target: prostaglandin e synthase | Type: enzyme | Action: nan
11770,sulindac,complement c5,secreted,,Drug: sulindac | Target: complement c5 | Type: secreted | Action: nan
11771,sulindac,bile salt export pump,transporter,,Drug: sulindac | Target: bile salt export pump | Type: transporter | Action: nan
11772,sulindac,complement c5,unclassified,,Drug: sulindac | Target: complement c5 | Type: unclassified | Action: nan
11773,suloctidil,alpha-2a adrenergic receptor,gpcr,,Drug: suloctidil | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
11774,suloctidil,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: suloctidil | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
11775,suloctidil,sodium-dependent serotonin transporter,transporter,,Drug: suloctidil | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
11776,suloctidil,sodium-dependent noradrenaline transporter,transporter,,Drug: suloctidil | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
11777,suloctidil,5-hydroxytryptamine receptor 1a,gpcr,,Drug: suloctidil | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11778,suloctidil,5-hydroxytryptamine receptor 2b,gpcr,,Drug: suloctidil | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
11779,suloctidil,d(3) dopamine receptor,gpcr,,Drug: suloctidil | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11780,suloctidil,histamine h1 receptor,gpcr,,Drug: suloctidil | Target: histamine h1 receptor | Type: gpcr | Action: nan
11781,suloctidil,histamine h2 receptor,gpcr,,Drug: suloctidil | Target: histamine h2 receptor | Type: gpcr | Action: nan
11782,suloctidil,muscarinic acetylcholine receptor m1,gpcr,,Drug: suloctidil | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
11783,suloctidil,muscarinic acetylcholine receptor m3,gpcr,,Drug: suloctidil | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
11784,suloctidil,muscarinic acetylcholine receptor m4,gpcr,,Drug: suloctidil | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
11785,suloctidil,muscarinic acetylcholine receptor m5,gpcr,,Drug: suloctidil | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
11786,suloctidil,beta-3 adrenergic receptor,gpcr,,Drug: suloctidil | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
11787,suloctidil,alpha-2c adrenergic receptor,gpcr,,Drug: suloctidil | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
11788,suloctidil,sodium-dependent dopamine transporter,transporter,,Drug: suloctidil | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
11789,suloctidil,adenosine receptor a3,gpcr,,Drug: suloctidil | Target: adenosine receptor a3 | Type: gpcr | Action: nan
11790,suloctidil,epidermal growth factor receptor,kinase,,Drug: suloctidil | Target: epidermal growth factor receptor | Type: kinase | Action: nan
11791,suloctidil,tyrosine-protein kinase fyn,kinase,,Drug: suloctidil | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
11792,suloctidil,substance-k receptor,gpcr,,Drug: suloctidil | Target: substance-k receptor | Type: gpcr | Action: nan
11793,suloctidil,5-hydroxytryptamine receptor 1a,gpcr,,Drug: suloctidil | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11794,sulpiride,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: sulpiride | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
11795,sulpiride,alpha-2a adrenergic receptor,gpcr,,Drug: sulpiride | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
11796,sulpiride,d(3) dopamine receptor,gpcr,,Drug: sulpiride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11797,sulpiride,d(4) dopamine receptor,gpcr,,Drug: sulpiride | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
11798,sulpiride,carbonic anhydrase 2,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11799,sulpiride,carbonic anhydrase 1,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
11800,sulpiride,carbonic anhydrase 9,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
11801,sulpiride,carbonic anhydrase 12,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
11802,sulpiride,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: sulpiride | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
11803,sulpiride,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: sulpiride | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
11804,sulpiride,carbonic anhydrase 7,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
11805,sulpiride,carbonic anhydrase,enzyme,,Drug: sulpiride | Target: carbonic anhydrase | Type: enzyme | Action: nan
11806,sulpiride,carbonic anhydrase 3,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
11807,sulpiride,carbonic anhydrase 6,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
11808,sulpiride,d(2) dopamine receptor,gpcr,,Drug: sulpiride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11809,sulpiride,d(2) dopamine receptor,gpcr,,Drug: sulpiride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11810,sulpiride,carbonic anhydrase 15,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
11811,sulpiride,carbonic anhydrase,enzyme,,Drug: sulpiride | Target: carbonic anhydrase | Type: enzyme | Action: nan
11812,sulpiride,carbonic anhydrase,enzyme,,Drug: sulpiride | Target: carbonic anhydrase | Type: enzyme | Action: nan
11813,sulpiride,carbonic anhydrase,enzyme,,Drug: sulpiride | Target: carbonic anhydrase | Type: enzyme | Action: nan
11814,sulpiride,alpha carbonic anhydrase,enzyme,,Drug: sulpiride | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
11815,sulpiride,carbonic anhydrase,enzyme,,Drug: sulpiride | Target: carbonic anhydrase | Type: enzyme | Action: nan
11816,sulpiride,carbonic anhydrase 2,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11817,sulpiride,astrosclerin-3,enzyme,,Drug: sulpiride | Target: astrosclerin-3 | Type: enzyme | Action: nan
11818,sulpiride,beta-carbonic anhydrase 1,enzyme,,Drug: sulpiride | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
11819,sulpiride,delta carbonic anhydrase,unclassified,,Drug: sulpiride | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
11820,sulpiride,carbonic anhydrase 2,enzyme,,Drug: sulpiride | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11821,sulpiride,dopamine receptor,gpcr,,Drug: sulpiride | Target: dopamine receptor | Type: gpcr | Action: nan
11822,sulpiride,carbonic anhydrase,enzyme,,Drug: sulpiride | Target: carbonic anhydrase | Type: enzyme | Action: nan
11823,sulpiride,"carbonic anhydrase, alpha family",unclassified,,"Drug: sulpiride | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
11824,sulpiride,carbonate dehydratase,enzyme,,Drug: sulpiride | Target: carbonate dehydratase | Type: enzyme | Action: nan
11825,sulprostone,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: sulprostone | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
11826,sulprostone,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: sulprostone | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
11827,sulprostone,prostaglandin e2 receptor ep4 subtype,gpcr,,Drug: sulprostone | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: nan
11828,sulprostone,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: sulprostone | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
11829,sulprostone,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: sulprostone | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
11830,sulprostone,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: sulprostone | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
11831,sulprostone,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: sulprostone | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
11832,sulprostone,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: sulprostone | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
11833,sultiame,carbonic anhydrase 2,enzyme,,Drug: sultiame | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11834,sultiame,carbonic anhydrase 1,enzyme,,Drug: sultiame | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
11835,sultiame,carbonic anhydrase 9,enzyme,,Drug: sultiame | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
11836,sultiame,carbonic anhydrase 6,enzyme,,Drug: sultiame | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
11837,sultiame,carbonic anhydrase 15,enzyme,,Drug: sultiame | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
11838,sultiame,carbonic anhydrase,enzyme,,Drug: sultiame | Target: carbonic anhydrase | Type: enzyme | Action: nan
11839,sultiame,carbonic anhydrase,enzyme,,Drug: sultiame | Target: carbonic anhydrase | Type: enzyme | Action: nan
11840,sultiame,alpha carbonic anhydrase,enzyme,,Drug: sultiame | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
11841,sultiame,carbonic anhydrase,enzyme,,Drug: sultiame | Target: carbonic anhydrase | Type: enzyme | Action: nan
11842,sultiame,astrosclerin-3,enzyme,,Drug: sultiame | Target: astrosclerin-3 | Type: enzyme | Action: nan
11843,sultiame,beta-carbonic anhydrase 1,enzyme,,Drug: sultiame | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
11844,sultiame,delta carbonic anhydrase,unclassified,,Drug: sultiame | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
11845,sultiame,carbonic anhydrase 2,enzyme,,Drug: sultiame | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
11846,sultiame,carbonic anhydrase,enzyme,,Drug: sultiame | Target: carbonic anhydrase | Type: enzyme | Action: nan
11847,sultiame,"carbonic anhydrase, alpha family",unclassified,,"Drug: sultiame | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
11848,sultiame,carbonate dehydratase,enzyme,,Drug: sultiame | Target: carbonate dehydratase | Type: enzyme | Action: nan
11849,sultopride,d(2) dopamine receptor,gpcr,,Drug: sultopride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
11850,sultopride,d(3) dopamine receptor,gpcr,,Drug: sultopride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
11851,sumatriptan,5-hydroxytryptamine receptor 1a,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11852,sumatriptan,5-hydroxytryptamine receptor 2a,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
11853,sumatriptan,5-hydroxytryptamine receptor 2c,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
11854,sumatriptan,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
11855,sumatriptan,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
11856,sumatriptan,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
11857,sumatriptan,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
11858,sumatriptan,5-hydroxytryptamine receptor 3a,ion channel,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
11859,sumatriptan,5-hydroxytryptamine receptor 5a,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
11860,sumatriptan,5-hydroxytryptamine receptor 1f,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
11861,sumatriptan,5-hydroxytryptamine receptor 1e,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
11862,sumatriptan,5-hydroxytryptamine receptor 1b,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
11863,sumatriptan,5-hydroxytryptamine receptor 1a,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11864,sumatriptan,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
11865,sumatriptan,5-hydroxytryptamine receptor 1d,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
11866,sumatriptan,5-hydroxytryptamine receptor 1a,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
11867,sumatriptan,5-hydroxytryptamine receptor 1d,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
11868,sumatriptan,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
11869,sumatriptan,multidrug and toxin extrusion protein 1,transporter,,Drug: sumatriptan | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
11870,sumatriptan,5-hydroxytryptamine receptor 1b,gpcr,,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
11871,sumatriptan,5-hydroxytryptamine 1d receptor,unclassified,,Drug: sumatriptan | Target: 5-hydroxytryptamine 1d receptor | Type: unclassified | Action: nan
11872,sumatriptan,5-hydroxytryptamine receptor 5a,gpcr,AGONIST,Drug: sumatriptan | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: AGONIST
11873,sunitinib,tyrosine-protein kinase jak3,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
11874,sunitinib,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: sunitinib | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
11875,sunitinib,acetylcholinesterase,enzyme,,Drug: sunitinib | Target: acetylcholinesterase | Type: enzyme | Action: nan
11876,sunitinib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: sunitinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
11877,sunitinib,tyrosine-protein kinase abl1,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
11878,sunitinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: sunitinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
11879,sunitinib,epidermal growth factor receptor,kinase,,Drug: sunitinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
11880,sunitinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: sunitinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
11881,sunitinib,tyrosine-protein kinase lck,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
11882,sunitinib,tyrosine-protein kinase yes,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
11883,sunitinib,tyrosine-protein kinase fyn,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
11884,sunitinib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: sunitinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
11885,sunitinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: sunitinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
11886,sunitinib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: sunitinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
11887,sunitinib,macrophage colony-stimulating factor 1 receptor,kinase,INHIBITOR,Drug: sunitinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: INHIBITOR
11888,sunitinib,ribosomal protein s6 kinase alpha-3,kinase,,Drug: sunitinib | Target: ribosomal protein s6 kinase alpha-3 | Type: kinase | Action: nan
11889,sunitinib,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: sunitinib | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
11890,sunitinib,insulin-like growth factor 1 receptor,kinase,,Drug: sunitinib | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: nan
11891,sunitinib,"myosin light chain kinase, smooth muscle",kinase,,"Drug: sunitinib | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
11892,sunitinib,insulin receptor,kinase,AGONIST,Drug: sunitinib | Target: insulin receptor | Type: kinase | Action: AGONIST
11893,sunitinib,death-associated protein kinase 3,kinase,,Drug: sunitinib | Target: death-associated protein kinase 3 | Type: kinase | Action: nan
11894,sunitinib,calcium/calmodulin-dependent protein kinase type 1,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase type 1 | Type: kinase | Action: nan
11895,sunitinib,fibroblast growth factor receptor 3,kinase,,Drug: sunitinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
11896,sunitinib,rho-associated protein kinase 1,kinase,,Drug: sunitinib | Target: rho-associated protein kinase 1 | Type: kinase | Action: nan
11897,sunitinib,focal adhesion kinase 1,kinase,,Drug: sunitinib | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
11898,sunitinib,tyrosine-protein kinase hck,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
11899,sunitinib,tyrosine-protein kinase jak1,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: nan
11900,sunitinib,mitogen-activated protein kinase 10,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
11901,sunitinib,death-associated protein kinase 2,kinase,,Drug: sunitinib | Target: death-associated protein kinase 2 | Type: kinase | Action: nan
11902,sunitinib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,,"Drug: sunitinib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: nan"
11903,sunitinib,high affinity nerve growth factor receptor,kinase,,Drug: sunitinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
11904,sunitinib,tyrosine-protein kinase jak2,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
11905,sunitinib,rho-associated protein kinase 2,kinase,,Drug: sunitinib | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
11906,sunitinib,protein kinase c alpha type,kinase,,Drug: sunitinib | Target: protein kinase c alpha type | Type: kinase | Action: nan
11907,sunitinib,calcium/calmodulin-dependent protein kinase type ii subunit delta,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit delta | Type: kinase | Action: nan
11908,sunitinib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: sunitinib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
11909,sunitinib,calcium/calmodulin-dependent protein kinase type ii subunit gamma,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit gamma | Type: kinase | Action: nan
11910,sunitinib,ap2-associated protein kinase 1,kinase,,Drug: sunitinib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
11911,sunitinib,serine/threonine-protein kinase mark2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase mark2 | Type: kinase | Action: nan
11912,sunitinib,hepatocyte growth factor receptor,kinase,,Drug: sunitinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
11913,sunitinib,tyrosine-protein kinase lyn,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
11914,sunitinib,serine/threonine-protein kinase nek2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase nek2 | Type: kinase | Action: nan
11915,sunitinib,ribosomal protein s6 kinase alpha-2,kinase,,Drug: sunitinib | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
11916,sunitinib,5'-amp-activated protein kinase catalytic subunit alpha-1,kinase,,Drug: sunitinib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-1 | Type: kinase | Action: nan
11917,sunitinib,calcium/calmodulin-dependent protein kinase type ii subunit beta,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit beta | Type: kinase | Action: nan
11918,sunitinib,fibroblast growth factor receptor 1,kinase,,Drug: sunitinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
11919,sunitinib,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: sunitinib | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
11920,sunitinib,cyclin-dependent-like kinase 5,kinase,,Drug: sunitinib | Target: cyclin-dependent-like kinase 5 | Type: kinase | Action: nan
11921,sunitinib,calcium/calmodulin-dependent protein kinase type ii subunit alpha,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit alpha | Type: kinase | Action: nan
11922,sunitinib,serine/threonine-protein kinase 17b,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 17b | Type: kinase | Action: nan
11923,sunitinib,serine/threonine-protein kinase 10,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
11924,sunitinib,tyrosine-protein kinase fer,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
11925,sunitinib,serine/threonine-protein kinase plk4,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
11926,sunitinib,aurora kinase c,kinase,,Drug: sunitinib | Target: aurora kinase c | Type: kinase | Action: nan
11927,sunitinib,serine/threonine-protein kinase 16,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 16 | Type: kinase | Action: nan
11928,sunitinib,dual specificity protein kinase ttk,kinase,,Drug: sunitinib | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
11929,sunitinib,abelson tyrosine-protein kinase 2,kinase,,Drug: sunitinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
11930,sunitinib,ephrin type-a receptor 5,kinase,,Drug: sunitinib | Target: ephrin type-a receptor 5 | Type: kinase | Action: nan
11931,sunitinib,fibroblast growth factor receptor 2,kinase,,Drug: sunitinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
11932,sunitinib,serine/threonine-protein kinase n1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
11933,sunitinib,protein kinase c theta type,kinase,,Drug: sunitinib | Target: protein kinase c theta type | Type: kinase | Action: nan
11934,sunitinib,serine/threonine-protein kinase 17a,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
11935,sunitinib,ephrin type-a receptor 6,kinase,,Drug: sunitinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
11936,sunitinib,traf2 and nck-interacting protein kinase,kinase,,Drug: sunitinib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
11937,sunitinib,casein kinase i isoform epsilon,kinase,,Drug: sunitinib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
11938,sunitinib,tyrosine-protein kinase fgr,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
11939,sunitinib,aurora kinase a,kinase,,Drug: sunitinib | Target: aurora kinase a | Type: kinase | Action: nan
11940,sunitinib,alk tyrosine kinase receptor,kinase,,Drug: sunitinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
11941,sunitinib,ephrin type-a receptor 3,kinase,,Drug: sunitinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
11942,sunitinib,bmp-2-inducible protein kinase,kinase,,Drug: sunitinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
11943,sunitinib,serine/threonine-protein kinase pim-2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase pim-2 | Type: kinase | Action: nan
11944,sunitinib,tyrosine-protein kinase frk,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
11945,sunitinib,dual specificity protein kinase clk1,kinase,,Drug: sunitinib | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
11946,sunitinib,dual specificity protein kinase clk2,kinase,,Drug: sunitinib | Target: dual specificity protein kinase clk2 | Type: kinase | Action: nan
11947,sunitinib,serine/threonine-protein kinase 38-like,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 38-like | Type: kinase | Action: nan
11948,sunitinib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
11949,sunitinib,mitogen-activated protein kinase kinase kinase 4,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 4 | Type: kinase | Action: nan
11950,sunitinib,cyclin-g-associated kinase,kinase,,Drug: sunitinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
11951,sunitinib,ephrin type-b receptor 1,kinase,,Drug: sunitinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
11952,sunitinib,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
11953,sunitinib,cyclin-dependent kinase 16,kinase,,Drug: sunitinib | Target: cyclin-dependent kinase 16 | Type: kinase | Action: nan
11954,sunitinib,serine/threonine-protein kinase 4,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
11955,sunitinib,activated cdc42 kinase 1,kinase,,Drug: sunitinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
11956,sunitinib,ribosomal protein s6 kinase alpha-5,kinase,,Drug: sunitinib | Target: ribosomal protein s6 kinase alpha-5 | Type: kinase | Action: nan
11957,sunitinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: sunitinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
11958,sunitinib,dual specificity protein kinase clk4,kinase,,Drug: sunitinib | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
11959,sunitinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: sunitinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
11960,sunitinib,mitogen-activated protein kinase 9,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
11961,sunitinib,calcium/calmodulin-dependent protein kinase kinase 2,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase kinase 2 | Type: kinase | Action: nan
11962,sunitinib,map/microtubule affinity-regulating kinase 3,kinase,,Drug: sunitinib | Target: map/microtubule affinity-regulating kinase 3 | Type: kinase | Action: nan
11963,sunitinib,calcium/calmodulin-dependent protein kinase kinase 1,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase kinase 1 | Type: kinase | Action: nan
11964,sunitinib,calcium/calmodulin-dependent protein kinase type 1g,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase type 1g | Type: kinase | Action: nan
11965,sunitinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: sunitinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
11966,sunitinib,solute carrier family 22 member 1,transporter,,Drug: sunitinib | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
11967,sunitinib,testis-specific serine/threonine-protein kinase 1,kinase,,Drug: sunitinib | Target: testis-specific serine/threonine-protein kinase 1 | Type: kinase | Action: nan
11968,sunitinib,3-phosphoinositide-dependent protein kinase 1,kinase,,Drug: sunitinib | Target: 3-phosphoinositide-dependent protein kinase 1 | Type: kinase | Action: nan
11969,sunitinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: sunitinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
11970,sunitinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: sunitinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
11971,sunitinib,tyrosine-protein kinase itk/tsk,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: nan
11972,sunitinib,serine/threonine-protein kinase 3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
11973,sunitinib,serine/threonine-protein kinase ulk3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
11974,sunitinib,protein-tyrosine kinase 6,kinase,,Drug: sunitinib | Target: protein-tyrosine kinase 6 | Type: kinase | Action: nan
11975,sunitinib,tyrosine-protein kinase btk,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
11976,sunitinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
11977,sunitinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: sunitinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
11978,sunitinib,tyrosine-protein kinase receptor tyro3,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase receptor tyro3 | Type: kinase | Action: nan
11979,sunitinib,cyclin-dependent kinase 7,kinase,,Drug: sunitinib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
11980,sunitinib,serine/threonine-protein kinase d1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase d1 | Type: kinase | Action: nan
11981,sunitinib,ribosomal protein s6 kinase beta-1,kinase,,Drug: sunitinib | Target: ribosomal protein s6 kinase beta-1 | Type: kinase | Action: nan
11982,sunitinib,serine/threonine-protein kinase n2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase n2 | Type: kinase | Action: nan
11983,sunitinib,rac-beta serine/threonine-protein kinase,kinase,,Drug: sunitinib | Target: rac-beta serine/threonine-protein kinase | Type: kinase | Action: nan
11984,sunitinib,serine/threonine-protein kinase dclk3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase dclk3 | Type: kinase | Action: nan
11985,sunitinib,serine/threonine-protein kinase 3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
11986,sunitinib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: sunitinib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
11987,sunitinib,nuak family snf1-like kinase 2,kinase,,Drug: sunitinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
11988,sunitinib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: sunitinib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
11989,sunitinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: sunitinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
11990,sunitinib,serine/threonine-protein kinase chk1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase chk1 | Type: kinase | Action: nan
11991,sunitinib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,,"Drug: sunitinib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: nan"
11992,sunitinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: sunitinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
11993,sunitinib,serine/threonine-protein kinase pak 3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase pak 3 | Type: kinase | Action: nan
11994,sunitinib,cyclin-dependent kinase 17,kinase,,Drug: sunitinib | Target: cyclin-dependent kinase 17 | Type: kinase | Action: nan
11995,sunitinib,cyclin-dependent kinase 18,kinase,,Drug: sunitinib | Target: cyclin-dependent kinase 18 | Type: kinase | Action: nan
11996,sunitinib,cyclin-dependent kinase 14,kinase,,Drug: sunitinib | Target: cyclin-dependent kinase 14 | Type: kinase | Action: nan
11997,sunitinib,phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,kinase,,Drug: sunitinib | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Type: kinase | Action: nan
11998,sunitinib,phosphatidylinositol 5-phosphate 4-kinase type-2 beta,kinase,,Drug: sunitinib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Type: kinase | Action: nan
11999,sunitinib,myosin light chain kinase family member 4,kinase,,Drug: sunitinib | Target: myosin light chain kinase family member 4 | Type: kinase | Action: nan
12000,sunitinib,wee1-like protein kinase,kinase,,Drug: sunitinib | Target: wee1-like protein kinase | Type: kinase | Action: nan
12001,sunitinib,serine/threonine-protein kinase 25,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 25 | Type: kinase | Action: nan
12002,sunitinib,protein-tyrosine kinase 2-beta,kinase,,Drug: sunitinib | Target: protein-tyrosine kinase 2-beta | Type: kinase | Action: nan
12003,sunitinib,serine/threonine-protein kinase rio1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
12004,sunitinib,casein kinase i isoform alpha-like,kinase,,Drug: sunitinib | Target: casein kinase i isoform alpha-like | Type: kinase | Action: nan
12005,sunitinib,casein kinase i isoform delta,kinase,,Drug: sunitinib | Target: casein kinase i isoform delta | Type: kinase | Action: nan
12006,sunitinib,casein kinase i isoform gamma-2,kinase,,Drug: sunitinib | Target: casein kinase i isoform gamma-2 | Type: kinase | Action: nan
12007,sunitinib,casein kinase i isoform gamma-3,kinase,,Drug: sunitinib | Target: casein kinase i isoform gamma-3 | Type: kinase | Action: nan
12008,sunitinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
12009,sunitinib,serine/threonine-protein kinase tousled-like 1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase tousled-like 1 | Type: kinase | Action: nan
12010,sunitinib,serine/threonine-protein kinase tousled-like 2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase tousled-like 2 | Type: kinase | Action: nan
12011,sunitinib,nt-3 growth factor receptor,kinase,,Drug: sunitinib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
12012,sunitinib,casein kinase ii subunit alpha,kinase,,Drug: sunitinib | Target: casein kinase ii subunit alpha | Type: kinase | Action: nan
12013,sunitinib,casein kinase ii subunit alpha',kinase,,Drug: sunitinib | Target: casein kinase ii subunit alpha' | Type: kinase | Action: nan
12014,sunitinib,dual specificity tyrosine-phosphorylation-regulated kinase 1b,kinase,,Drug: sunitinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1b | Type: kinase | Action: nan
12015,sunitinib,inhibitor of nuclear factor kappa-b kinase subunit epsilon,kinase,,Drug: sunitinib | Target: inhibitor of nuclear factor kappa-b kinase subunit epsilon | Type: kinase | Action: nan
12016,sunitinib,serine/threonine-protein kinase stk11,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase stk11 | Type: kinase | Action: nan
12017,sunitinib,dual specificity mitogen-activated protein kinase kinase 3,kinase,,Drug: sunitinib | Target: dual specificity mitogen-activated protein kinase kinase 3 | Type: kinase | Action: nan
12018,sunitinib,maternal embryonic leucine zipper kinase,kinase,,Drug: sunitinib | Target: maternal embryonic leucine zipper kinase | Type: kinase | Action: nan
12019,sunitinib,map kinase-interacting serine/threonine-protein kinase 1,kinase,,Drug: sunitinib | Target: map kinase-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
12020,sunitinib,serine/threonine-protein kinase 26,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 26 | Type: kinase | Action: nan
12021,sunitinib,serine/threonine-protein kinase nek7,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase nek7 | Type: kinase | Action: nan
12022,sunitinib,eukaryotic translation initiation factor 2-alpha kinase 4,kinase,,Drug: sunitinib | Target: eukaryotic translation initiation factor 2-alpha kinase 4 | Type: kinase | Action: nan
12023,sunitinib,insulin receptor-related protein,kinase,,Drug: sunitinib | Target: insulin receptor-related protein | Type: kinase | Action: nan
12024,sunitinib,interleukin-1 receptor-associated kinase 3,kinase,,Drug: sunitinib | Target: interleukin-1 receptor-associated kinase 3 | Type: kinase | Action: nan
12025,sunitinib,serine/threonine-protein kinase rio3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
12026,sunitinib,serine/threonine-protein kinase sik2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
12027,sunitinib,srsf protein kinase 1,kinase,,Drug: sunitinib | Target: srsf protein kinase 1 | Type: kinase | Action: nan
12028,sunitinib,srsf protein kinase 2,kinase,,Drug: sunitinib | Target: srsf protein kinase 2 | Type: kinase | Action: nan
12029,sunitinib,serine/threonine-protein kinase 33,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
12030,sunitinib,5'-amp-activated protein kinase catalytic subunit alpha-2,kinase,,Drug: sunitinib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-2 | Type: kinase | Action: nan
12031,sunitinib,ankyrin repeat and protein kinase domain-containing protein 1,kinase,,Drug: sunitinib | Target: ankyrin repeat and protein kinase domain-containing protein 1 | Type: kinase | Action: nan
12032,sunitinib,discoidin domain-containing receptor 2,kinase,,Drug: sunitinib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
12033,sunitinib,serine/threonine-protein kinase lats1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase lats1 | Type: kinase | Action: nan
12034,sunitinib,serine/threonine-protein kinase lats2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase lats2 | Type: kinase | Action: nan
12035,sunitinib,leukocyte tyrosine kinase receptor,kinase,,Drug: sunitinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
12036,sunitinib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
12037,sunitinib,serine/threonine-protein kinase pak 6,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase pak 6 | Type: kinase | Action: nan
12038,sunitinib,serine/threonine-protein kinase pak 7,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase pak 7 | Type: kinase | Action: nan
12039,sunitinib,nuak family snf1-like kinase 1,kinase,,Drug: sunitinib | Target: nuak family snf1-like kinase 1 | Type: kinase | Action: nan
12040,sunitinib,serine/threonine-protein kinase pim-3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase pim-3 | Type: kinase | Action: nan
12041,sunitinib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
12042,sunitinib,aurora kinase b,kinase,,Drug: sunitinib | Target: aurora kinase b | Type: kinase | Action: nan
12043,sunitinib,tyrosine-protein kinase blk,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
12044,sunitinib,bone morphogenetic protein receptor type-2,kinase,,Drug: sunitinib | Target: bone morphogenetic protein receptor type-2 | Type: kinase | Action: nan
12045,sunitinib,serine/threonine-protein kinase brsk1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase brsk1 | Type: kinase | Action: nan
12046,sunitinib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
12047,sunitinib,serine/threonine-protein kinase mark1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase mark1 | Type: kinase | Action: nan
12048,sunitinib,map/microtubule affinity-regulating kinase 4,kinase,,Drug: sunitinib | Target: map/microtubule affinity-regulating kinase 4 | Type: kinase | Action: nan
12049,sunitinib,dual specificity mitogen-activated protein kinase kinase 4,kinase,,Drug: sunitinib | Target: dual specificity mitogen-activated protein kinase kinase 4 | Type: kinase | Action: nan
12050,sunitinib,dual specificity mitogen-activated protein kinase kinase 6,kinase,,Drug: sunitinib | Target: dual specificity mitogen-activated protein kinase kinase 6 | Type: kinase | Action: nan
12051,sunitinib,tyrosine-protein kinase mer,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
12052,sunitinib,calcium/calmodulin-dependent protein kinase type iv,kinase,,Drug: sunitinib | Target: calcium/calmodulin-dependent protein kinase type iv | Type: kinase | Action: nan
12053,sunitinib,"myosin light chain kinase, smooth muscle",kinase,,"Drug: sunitinib | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
12054,sunitinib,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
12055,sunitinib,mitogen-activated protein kinase kinase kinase 11,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 11 | Type: kinase | Action: nan
12056,sunitinib,serine/threonine-protein kinase 24,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 24 | Type: kinase | Action: nan
12057,sunitinib,"muscle, skeletal receptor tyrosine-protein kinase",kinase,,"Drug: sunitinib | Target: muscle, skeletal receptor tyrosine-protein kinase | Type: kinase | Action: nan"
12058,sunitinib,citron rho-interacting kinase,kinase,,Drug: sunitinib | Target: citron rho-interacting kinase | Type: kinase | Action: nan
12059,sunitinib,casein kinase i isoform gamma-1,kinase,,Drug: sunitinib | Target: casein kinase i isoform gamma-1 | Type: kinase | Action: nan
12060,sunitinib,death-associated protein kinase 1,kinase,,Drug: sunitinib | Target: death-associated protein kinase 1 | Type: kinase | Action: nan
12061,sunitinib,serine/threonine-protein kinase dclk1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase dclk1 | Type: kinase | Action: nan
12062,sunitinib,serine/threonine-protein kinase dclk2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase dclk2 | Type: kinase | Action: nan
12063,sunitinib,myosin-iiia,kinase,,Drug: sunitinib | Target: myosin-iiia | Type: kinase | Action: nan
12064,sunitinib,myosin-iiib,kinase,,Drug: sunitinib | Target: myosin-iiib | Type: kinase | Action: nan
12065,sunitinib,serine/threonine-protein kinase pak 4,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase pak 4 | Type: kinase | Action: nan
12066,sunitinib,serine/threonine-protein kinase brsk2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase brsk2 | Type: kinase | Action: nan
12067,sunitinib,serine/threonine-protein kinase sik1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
12068,sunitinib,mitogen-activated protein kinase 7,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase 7 | Type: kinase | Action: nan
12069,sunitinib,serine/threonine-protein kinase d2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase d2 | Type: kinase | Action: nan
12070,sunitinib,serine/threonine-protein kinase d3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase d3 | Type: kinase | Action: nan
12071,sunitinib,"interferon-induced, double-stranded rna-activated protein kinase",kinase,,"Drug: sunitinib | Target: interferon-induced, double-stranded rna-activated protein kinase | Type: kinase | Action: nan"
12072,sunitinib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: sunitinib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
12073,sunitinib,tyrosine-protein kinase fes/fps,kinase,,Drug: sunitinib | Target: tyrosine-protein kinase fes/fps | Type: kinase | Action: nan
12074,sunitinib,fibroblast growth factor receptor 4,kinase,,Drug: sunitinib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: nan
12075,sunitinib,ribosomal protein s6 kinase alpha-1,kinase,,Drug: sunitinib | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
12076,sunitinib,ribosomal protein s6 kinase alpha-4,kinase,,Drug: sunitinib | Target: ribosomal protein s6 kinase alpha-4 | Type: kinase | Action: nan
12077,sunitinib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,,"Drug: sunitinib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: nan"
12078,sunitinib,casein kinase i isoform alpha,kinase,,Drug: sunitinib | Target: casein kinase i isoform alpha | Type: kinase | Action: nan
12079,sunitinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
12080,sunitinib,misshapen-like kinase 1,kinase,,Drug: sunitinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
12081,sunitinib,serine/threonine-protein kinase tbk1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
12082,sunitinib,interleukin-1 receptor-associated kinase 4,kinase,,Drug: sunitinib | Target: interleukin-1 receptor-associated kinase 4 | Type: kinase | Action: nan
12083,sunitinib,cyclin-dependent kinase 4,kinase,,Drug: sunitinib | Target: cyclin-dependent kinase 4 | Type: kinase | Action: nan
12084,sunitinib,cyclin-dependent kinase-like 2,kinase,,Drug: sunitinib | Target: cyclin-dependent kinase-like 2 | Type: kinase | Action: nan
12085,sunitinib,serine/threonine-protein kinase chk2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase chk2 | Type: kinase | Action: nan
12086,sunitinib,protein delta homolog 1,unclassified,,Drug: sunitinib | Target: protein delta homolog 1 | Type: unclassified | Action: nan
12087,sunitinib,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,,Drug: sunitinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: nan
12088,sunitinib,dual specificity tyrosine-phosphorylation-regulated kinase 2,kinase,,Drug: sunitinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 2 | Type: kinase | Action: nan
12089,sunitinib,ephrin type-b receptor 6,kinase,,Drug: sunitinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
12090,sunitinib,serine/threonine-protein kinase/endoribonuclease ire1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase/endoribonuclease ire1 | Type: kinase | Action: nan
12091,sunitinib,rhodopsin kinase,kinase,,Drug: sunitinib | Target: rhodopsin kinase | Type: kinase | Action: nan
12092,sunitinib,g protein-coupled receptor kinase 4,kinase,,Drug: sunitinib | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
12093,sunitinib,g protein-coupled receptor kinase 7,kinase,,Drug: sunitinib | Target: g protein-coupled receptor kinase 7 | Type: kinase | Action: nan
12094,sunitinib,homeodomain-interacting protein kinase 2,kinase,,Drug: sunitinib | Target: homeodomain-interacting protein kinase 2 | Type: kinase | Action: nan
12095,sunitinib,homeodomain-interacting protein kinase 3,kinase,,Drug: sunitinib | Target: homeodomain-interacting protein kinase 3 | Type: kinase | Action: nan
12096,sunitinib,homeodomain-interacting protein kinase 4,kinase,,Drug: sunitinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
12097,sunitinib,hormonally up-regulated neu tumor-associated kinase,kinase,,Drug: sunitinib | Target: hormonally up-regulated neu tumor-associated kinase | Type: kinase | Action: nan
12098,sunitinib,serine/threonine-protein kinase ick,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase ick | Type: kinase | Action: nan
12099,sunitinib,inhibitor of nuclear factor kappa-b kinase subunit alpha,kinase,,Drug: sunitinib | Target: inhibitor of nuclear factor kappa-b kinase subunit alpha | Type: kinase | Action: nan
12100,sunitinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: sunitinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
12101,sunitinib,mitogen-activated protein kinase kinase kinase 13,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 13 | Type: kinase | Action: nan
12102,sunitinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
12103,sunitinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
12104,sunitinib,microtubule-associated serine/threonine-protein kinase 1,kinase,,Drug: sunitinib | Target: microtubule-associated serine/threonine-protein kinase 1 | Type: kinase | Action: nan
12105,sunitinib,serine/threonine-protein kinase 38,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 38 | Type: kinase | Action: nan
12106,sunitinib,serine/threonine-protein kinase nim1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase nim1 | Type: kinase | Action: nan
12107,sunitinib,serine/threonine-protein kinase osr1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase osr1 | Type: kinase | Action: nan
12108,sunitinib,u4/u6 small nuclear ribonucleoprotein prp4,nuclear other,,Drug: sunitinib | Target: u4/u6 small nuclear ribonucleoprotein prp4 | Type: nuclear other | Action: nan
12109,sunitinib,serine/threonine-protein kinase rio2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase rio2 | Type: kinase | Action: nan
12110,sunitinib,srsf protein kinase 3,kinase,,Drug: sunitinib | Target: srsf protein kinase 3 | Type: kinase | Action: nan
12111,sunitinib,ste20/sps1-related proline-alanine-rich protein kinase,kinase,,Drug: sunitinib | Target: ste20/sps1-related proline-alanine-rich protein kinase | Type: kinase | Action: nan
12112,sunitinib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
12113,sunitinib,serine/threonine-protein kinase tao1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
12114,sunitinib,serine/threonine-protein kinase tao3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
12115,sunitinib,serine/threonine-protein kinase ulk1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase ulk1 | Type: kinase | Action: nan
12116,sunitinib,serine/threonine-protein kinase ulk2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase ulk2 | Type: kinase | Action: nan
12117,sunitinib,serine/threonine-protein kinase ulk3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
12118,sunitinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
12119,sunitinib,homeodomain-interacting protein kinase 1,kinase,,Drug: sunitinib | Target: homeodomain-interacting protein kinase 1 | Type: kinase | Action: nan
12120,sunitinib,mitogen-activated protein kinase kinase kinase 15,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 15 | Type: kinase | Action: nan
12121,sunitinib,serine/threonine-protein kinase plk2,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase plk2 | Type: kinase | Action: nan
12122,sunitinib,receptor-interacting serine/threonine-protein kinase 4,kinase,,Drug: sunitinib | Target: receptor-interacting serine/threonine-protein kinase 4 | Type: kinase | Action: nan
12123,sunitinib,uncharacterized serine/threonine-protein kinase sbk3,kinase,,Drug: sunitinib | Target: uncharacterized serine/threonine-protein kinase sbk3 | Type: kinase | Action: nan
12124,sunitinib,serine/threonine-protein kinase 35,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase 35 | Type: kinase | Action: nan
12125,sunitinib,tankyrase-2,enzyme,,Drug: sunitinib | Target: tankyrase-2 | Type: enzyme | Action: nan
12126,sunitinib,megakaryocyte-associated tyrosine-protein kinase,kinase,,Drug: sunitinib | Target: megakaryocyte-associated tyrosine-protein kinase | Type: kinase | Action: nan
12127,sunitinib,bone morphogenetic protein receptor type-1b,kinase,,Drug: sunitinib | Target: bone morphogenetic protein receptor type-1b | Type: kinase | Action: nan
12128,sunitinib,serine/threonine-protein kinase sbk1,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
12129,sunitinib,serine/threonine-protein kinase prp4 homolog,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase prp4 homolog | Type: kinase | Action: nan
12130,sunitinib,mitogen-activated protein kinase kinase kinase 12,kinase,,Drug: sunitinib | Target: mitogen-activated protein kinase kinase kinase 12 | Type: kinase | Action: nan
12131,sunitinib,serine/threonine-protein kinase sgk3,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase sgk3 | Type: kinase | Action: nan
12132,sunitinib,snf-related serine/threonine-protein kinase,kinase,,Drug: sunitinib | Target: snf-related serine/threonine-protein kinase | Type: kinase | Action: nan
12133,sunitinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: sunitinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
12134,sunitinib,myosin light chain kinase 3,kinase,,Drug: sunitinib | Target: myosin light chain kinase 3 | Type: kinase | Action: nan
12135,sunitinib,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: sunitinib | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
12136,sunitinib,dual serine/threonine and tyrosine protein kinase,kinase,,Drug: sunitinib | Target: dual serine/threonine and tyrosine protein kinase | Type: kinase | Action: nan
12137,sunitinib,calcium-dependent protein kinase 1,kinase,,Drug: sunitinib | Target: calcium-dependent protein kinase 1 | Type: kinase | Action: nan
12138,sunitinib,serine/threonine-protein kinase pknb,kinase,,Drug: sunitinib | Target: serine/threonine-protein kinase pknb | Type: kinase | Action: nan
12139,sunitinib,bromodomain-containing protein 9,unclassified,,Drug: sunitinib | Target: bromodomain-containing protein 9 | Type: unclassified | Action: nan
12140,sunitinib,ephrin type-a receptor 7,kinase,,Drug: sunitinib | Target: ephrin type-a receptor 7 | Type: kinase | Action: nan
12141,sunitinib,ephrin type-b receptor 4,kinase,,Drug: sunitinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
12142,sunitinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: sunitinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
12143,sunitinib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: sunitinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
12144,sunitinib,platelet-derived growth factor receptor alpha,kinase,INHIBITOR,Drug: sunitinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: INHIBITOR
12145,suprofen,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: suprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
12146,suprofen,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: suprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
12147,suprofen,cytochrome p450 2c9,enzyme,,Drug: suprofen | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
12148,secretin human,secretin receptor,gpcr,AGONIST,Drug: secretin human | Target: secretin receptor | Type: gpcr | Action: AGONIST
12149,tacrine,sodium-dependent noradrenaline transporter,transporter,,Drug: tacrine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12150,tacrine,aldehyde oxidase,enzyme,,Drug: tacrine | Target: aldehyde oxidase | Type: enzyme | Action: nan
12151,tacrine,cytochrome p450 2d6,enzyme,,Drug: tacrine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
12152,tacrine,alpha-1d adrenergic receptor,gpcr,,Drug: tacrine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12153,tacrine,acetylcholinesterase,enzyme,INHIBITOR,Drug: tacrine | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
12154,tacrine,acetylcholine receptor subunit epsilon,ion channel,,Drug: tacrine | Target: acetylcholine receptor subunit epsilon | Type: ion channel | Action: nan
12155,tacrine,solute carrier family 22 member 1,transporter,,Drug: tacrine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
12156,tacrine,acetylcholinesterase,enzyme,,Drug: tacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
12157,tacrine,alpha-1a adrenergic receptor,gpcr,,Drug: tacrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12158,tacrine,muscarinic acetylcholine receptor m2,gpcr,,Drug: tacrine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12159,tacrine,acetylcholinesterase,enzyme,,Drug: tacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
12160,tacrine,butyrylcholinesterase; protein bche,enzyme,,Drug: tacrine | Target: butyrylcholinesterase; protein bche | Type: enzyme | Action: nan
12161,tacrine,acetylcholinesterase,enzyme,,Drug: tacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
12162,tacrine,acetylcholinesterase,enzyme,,Drug: tacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
12163,tacrine,acetylcholinesterase,enzyme,,Drug: tacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
12164,tacrine,choline o-acetyltransferase,enzyme,,Drug: tacrine | Target: choline o-acetyltransferase | Type: enzyme | Action: nan
12165,tacrine,muscarinic acetylcholine receptor m1,gpcr,,Drug: tacrine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12166,tacrine,muscarinic acetylcholine receptor m2,gpcr,,Drug: tacrine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12167,tacrine,amine oxidase [flavin-containing] a,enzyme,,Drug: tacrine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
12168,tacrine,cholinesterase,enzyme,,Drug: tacrine | Target: cholinesterase | Type: enzyme | Action: nan
12169,tacrine,histamine n-methyltransferase,enzyme,,Drug: tacrine | Target: histamine n-methyltransferase | Type: enzyme | Action: nan
12170,tacrine,butyrylcholinesterase,enzyme,,Drug: tacrine | Target: butyrylcholinesterase | Type: enzyme | Action: nan
12171,tacrine,muscarinic acetylcholine receptor m2,gpcr,,Drug: tacrine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12172,tacrine,cholinesterase,enzyme,,Drug: tacrine | Target: cholinesterase | Type: enzyme | Action: nan
12173,tacrine,glutamate nmda receptor; grin1/grin2b,ion channel,,Drug: tacrine | Target: glutamate nmda receptor; grin1/grin2b | Type: ion channel | Action: nan
12174,tacrine,glutamate nmda receptor; grin1/grin2a,ion channel,,Drug: tacrine | Target: glutamate nmda receptor; grin1/grin2a | Type: ion channel | Action: nan
12175,tacrine,muscarinic acetylcholine receptor,gpcr,,Drug: tacrine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
12176,tacrine,amyloid beta a4 protein,unclassified,,Drug: tacrine | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
12177,tacrine,cholinesterase,enzyme,INHIBITOR,Drug: tacrine | Target: cholinesterase | Type: enzyme | Action: INHIBITOR
12178,tacrolimus,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: tacrolimus | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12179,tacrolimus,cytochrome p450 3a4,enzyme,,Drug: tacrolimus | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
12180,tacrolimus,interleukin-5,cytokine,,Drug: tacrolimus | Target: interleukin-5 | Type: cytokine | Action: nan
12181,tacrolimus,interferon gamma,cytokine,,Drug: tacrolimus | Target: interferon gamma | Type: cytokine | Action: nan
12182,tacrolimus,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,INHIBITOR,Drug: tacrolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: INHIBITOR
12183,tacrolimus,interleukin-2,cytokine,,Drug: tacrolimus | Target: interleukin-2 | Type: cytokine | Action: nan
12184,tacrolimus,serine/threonine-protein phosphatase 2b catalytic subunit gamma isoform,enzyme,,Drug: tacrolimus | Target: serine/threonine-protein phosphatase 2b catalytic subunit gamma isoform | Type: enzyme | Action: nan
12185,tacrolimus,serine/threonine-protein kinase mtor,kinase,,Drug: tacrolimus | Target: serine/threonine-protein kinase mtor | Type: kinase | Action: nan
12186,tacrolimus,serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform,enzyme,,Drug: tacrolimus | Target: serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform | Type: enzyme | Action: nan
12187,tacrolimus,peptidyl-prolyl cis-trans isomerase fkbp1b,enzyme,,Drug: tacrolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1b | Type: enzyme | Action: nan
12188,tacrolimus,peptidyl-prolyl cis-trans isomerase fkbp5,enzyme,,Drug: tacrolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp5 | Type: enzyme | Action: nan
12189,tacrolimus,splicing factor 3b subunit 3,nuclear other,,Drug: tacrolimus | Target: splicing factor 3b subunit 3 | Type: nuclear other | Action: nan
12190,tacrolimus,peptidyl-prolyl cis-trans isomerase fkbp10,enzyme,,Drug: tacrolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp10 | Type: enzyme | Action: nan
12191,tadalafil,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: tadalafil | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12192,tadalafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: tadalafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
12193,tadalafil,"dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a",enzyme,,"Drug: tadalafil | Target: dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a | Type: enzyme | Action: nan"
12194,tadalafil,acetylcholinesterase,enzyme,,Drug: tadalafil | Target: acetylcholinesterase | Type: enzyme | Action: nan
12195,tadalafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: tadalafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
12196,tadalafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: tadalafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
12197,tadalafil,"rod cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha",enzyme,,"Drug: tadalafil | Target: rod cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha | Type: enzyme | Action: nan"
12198,tadalafil,phosphodiesterase 6,enzyme,,Drug: tadalafil | Target: phosphodiesterase 6 | Type: enzyme | Action: nan
12199,tadalafil,phosphodiesterase 6,enzyme,,Drug: tadalafil | Target: phosphodiesterase 6 | Type: enzyme | Action: nan
12201,talbutal,gaba-a receptor; anion channel,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: talbutal | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12202,talinolol,beta-1 adrenergic receptor,gpcr,,Drug: talinolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
12203,talinolol,beta-2 adrenergic receptor,gpcr,,Drug: talinolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
12204,talinolol,multidrug resistance protein 1,transporter,,Drug: talinolol | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
12205,talinolol,bifunctional epoxide hydrolase 2,enzyme,,Drug: talinolol | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
12208,talipexole,d(2) dopamine receptor,gpcr,,Drug: talipexole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12209,talipexole,alpha-2a adrenergic receptor,gpcr,,Drug: talipexole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12210,talipexole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: talipexole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12211,talipexole,alpha-2b adrenergic receptor,gpcr,,Drug: talipexole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12212,talipexole,d(3) dopamine receptor,gpcr,,Drug: talipexole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12213,talipexole,d(1b) dopamine receptor,gpcr,,Drug: talipexole | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
12214,talipexole,alpha-2c adrenergic receptor,gpcr,,Drug: talipexole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12215,talipexole,d(4) dopamine receptor,gpcr,,Drug: talipexole | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
12216,talipexole,alpha-1d adrenergic receptor,gpcr,,Drug: talipexole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12217,talipexole,alpha-1b adrenergic receptor,gpcr,,Drug: talipexole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12218,talipexole,d(2) dopamine receptor,gpcr,,Drug: talipexole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12219,talipexole,adrenergic receptor alpha-2,gpcr,,Drug: talipexole | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
12220,taltirelin,thyrotropin-releasing hormone receptor,gpcr,AGONIST,Drug: taltirelin | Target: thyrotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
12221,tamoxifen,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: tamoxifen | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
12222,tamoxifen,beta-1 adrenergic receptor,gpcr,,Drug: tamoxifen | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
12223,tamoxifen,prostaglandin g/h synthase 2,enzyme,,Drug: tamoxifen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
12224,tamoxifen,prostaglandin g/h synthase 1,enzyme,,Drug: tamoxifen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
12225,tamoxifen,mu-type opioid receptor,gpcr,,Drug: tamoxifen | Target: mu-type opioid receptor | Type: gpcr | Action: nan
12226,tamoxifen,d(1a) dopamine receptor,gpcr,,Drug: tamoxifen | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12227,tamoxifen,d(2) dopamine receptor,gpcr,,Drug: tamoxifen | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12228,tamoxifen,adenosine receptor a2a,gpcr,,Drug: tamoxifen | Target: adenosine receptor a2a | Type: gpcr | Action: nan
12229,tamoxifen,alpha-2a adrenergic receptor,gpcr,,Drug: tamoxifen | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12230,tamoxifen,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: tamoxifen | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12231,tamoxifen,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: tamoxifen | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12232,tamoxifen,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: tamoxifen | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
12233,tamoxifen,multidrug resistance protein 1,transporter,,Drug: tamoxifen | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
12234,tamoxifen,sodium-dependent serotonin transporter,transporter,,Drug: tamoxifen | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
12235,tamoxifen,sodium-dependent noradrenaline transporter,transporter,,Drug: tamoxifen | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12236,tamoxifen,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tamoxifen | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12237,tamoxifen,5-hydroxytryptamine receptor 2a,gpcr,,Drug: tamoxifen | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
12238,tamoxifen,5-hydroxytryptamine receptor 2b,gpcr,,Drug: tamoxifen | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
12239,tamoxifen,5-hydroxytryptamine receptor 2c,gpcr,,Drug: tamoxifen | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
12240,tamoxifen,5-hydroxytryptamine receptor 6,gpcr,,Drug: tamoxifen | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
12241,tamoxifen,alpha-2b adrenergic receptor,gpcr,,Drug: tamoxifen | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12242,tamoxifen,d(3) dopamine receptor,gpcr,,Drug: tamoxifen | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12243,tamoxifen,histamine h2 receptor,gpcr,,Drug: tamoxifen | Target: histamine h2 receptor | Type: gpcr | Action: nan
12244,tamoxifen,muscarinic acetylcholine receptor m1,gpcr,,Drug: tamoxifen | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12245,tamoxifen,muscarinic acetylcholine receptor m2,gpcr,,Drug: tamoxifen | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12246,tamoxifen,muscarinic acetylcholine receptor m3,gpcr,,Drug: tamoxifen | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
12247,tamoxifen,muscarinic acetylcholine receptor m4,gpcr,,Drug: tamoxifen | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
12248,tamoxifen,muscarinic acetylcholine receptor m5,gpcr,,Drug: tamoxifen | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
12249,tamoxifen,aldehyde oxidase,enzyme,,Drug: tamoxifen | Target: aldehyde oxidase | Type: enzyme | Action: nan
12250,tamoxifen,beta-3 adrenergic receptor,gpcr,,Drug: tamoxifen | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
12251,tamoxifen,sodium-dependent dopamine transporter,transporter,,Drug: tamoxifen | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
12252,tamoxifen,adenosine receptor a1,gpcr,,Drug: tamoxifen | Target: adenosine receptor a1 | Type: gpcr | Action: nan
12253,tamoxifen,adenosine receptor a3,gpcr,,Drug: tamoxifen | Target: adenosine receptor a3 | Type: gpcr | Action: nan
12254,tamoxifen,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: tamoxifen | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
12255,tamoxifen,d(4) dopamine receptor,gpcr,,Drug: tamoxifen | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
12256,tamoxifen,alpha-1d adrenergic receptor,gpcr,,Drug: tamoxifen | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12257,tamoxifen,kappa-type opioid receptor,gpcr,,Drug: tamoxifen | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
12258,tamoxifen,estrogen receptor,nuclear hormone receptor,MODULATOR,Drug: tamoxifen | Target: estrogen receptor | Type: nuclear hormone receptor | Action: MODULATOR
12259,tamoxifen,progesterone receptor,nuclear hormone receptor,,Drug: tamoxifen | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
12260,tamoxifen,delta-type opioid receptor,gpcr,,Drug: tamoxifen | Target: delta-type opioid receptor | Type: gpcr | Action: nan
12261,tamoxifen,estrogen receptor beta,nuclear hormone receptor,,Drug: tamoxifen | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
12262,tamoxifen,g-protein coupled estrogen receptor 1,gpcr,,Drug: tamoxifen | Target: g-protein coupled estrogen receptor 1 | Type: gpcr | Action: nan
12263,tamoxifen,estrogen-related receptor gamma,nuclear hormone receptor,,Drug: tamoxifen | Target: estrogen-related receptor gamma | Type: nuclear hormone receptor | Action: nan
12264,tamoxifen,epidermal growth factor receptor,kinase,,Drug: tamoxifen | Target: epidermal growth factor receptor | Type: kinase | Action: nan
12265,tamoxifen,substance-p receptor,gpcr,,Drug: tamoxifen | Target: substance-p receptor | Type: gpcr | Action: nan
12266,tamoxifen,tyrosine-protein kinase lck,kinase,,Drug: tamoxifen | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
12267,tamoxifen,tyrosine-protein kinase fyn,kinase,,Drug: tamoxifen | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
12268,tamoxifen,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: tamoxifen | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
12269,tamoxifen,thromboxane-a synthase,enzyme,,Drug: tamoxifen | Target: thromboxane-a synthase | Type: enzyme | Action: nan
12270,tamoxifen,steroid hormone receptor err1,nuclear hormone receptor,,Drug: tamoxifen | Target: steroid hormone receptor err1 | Type: nuclear hormone receptor | Action: nan
12271,tamoxifen,substance-k receptor,gpcr,,Drug: tamoxifen | Target: substance-k receptor | Type: gpcr | Action: nan
12272,tamoxifen,androgen receptor,transcription factor,,Drug: tamoxifen | Target: androgen receptor | Type: transcription factor | Action: nan
12273,tamoxifen,b2 bradykinin receptor,gpcr,,Drug: tamoxifen | Target: b2 bradykinin receptor | Type: gpcr | Action: nan
12274,tamoxifen,melanocortin receptor 4,gpcr,,Drug: tamoxifen | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
12275,tamoxifen,melanocortin receptor 5,gpcr,,Drug: tamoxifen | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
12276,tamoxifen,melanocortin receptor 3,gpcr,,Drug: tamoxifen | Target: melanocortin receptor 3 | Type: gpcr | Action: nan
12277,tamoxifen,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: tamoxifen | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
12278,tamoxifen,serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform,enzyme,,Drug: tamoxifen | Target: serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform | Type: enzyme | Action: nan
12279,tamoxifen,progesterone receptor,transcription factor,,Drug: tamoxifen | Target: progesterone receptor | Type: transcription factor | Action: nan
12280,tamoxifen,alpha-1a adrenergic receptor,gpcr,,Drug: tamoxifen | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12281,tamoxifen,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tamoxifen | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12282,tamoxifen,c-8 sterol isomerase,enzyme,,Drug: tamoxifen | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
12283,tamoxifen,solute carrier family 22 member 2,transporter,,Drug: tamoxifen | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
12284,tamoxifen,emopamil-binding protein-like,enzyme,,Drug: tamoxifen | Target: emopamil-binding protein-like | Type: enzyme | Action: nan
12285,tamoxifen,anti-estrogen binding site (aebs),enzyme,,Drug: tamoxifen | Target: anti-estrogen binding site (aebs) | Type: enzyme | Action: nan
12286,tamoxifen,transcriptional activator protein luxr,unclassified,,Drug: tamoxifen | Target: transcriptional activator protein luxr | Type: unclassified | Action: nan
12287,tamsulosin,d(2) dopamine receptor,gpcr,,Drug: tamsulosin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12288,tamsulosin,alpha-2a adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12289,tamsulosin,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tamsulosin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12290,tamsulosin,5-hydroxytryptamine receptor 7,gpcr,,Drug: tamsulosin | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
12291,tamsulosin,alpha-1a adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12292,tamsulosin,d(3) dopamine receptor,gpcr,,Drug: tamsulosin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12293,tamsulosin,alpha-2c adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12294,tamsulosin,alpha-1d adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12295,tamsulosin,alpha-1b adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12296,tamsulosin,alpha-1a adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12297,tamsulosin,alpha-2b adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12298,tamsulosin,alpha-1d adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12299,tamsulosin,alpha-1a adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12300,tamsulosin,alpha-1b adrenergic receptor,gpcr,,Drug: tamsulosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12301,tamsulosin,serotonin 1 (5-ht1) receptor,gpcr,,Drug: tamsulosin | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
12302,tandospirone,d(2) dopamine receptor,gpcr,,Drug: tandospirone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12303,tandospirone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tandospirone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12304,tandospirone,d(4) dopamine receptor,gpcr,,Drug: tandospirone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
12305,tazarotene,retinoic acid receptor alpha,nuclear hormone receptor,AGONIST,Drug: tazarotene | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
12306,tazarotene,retinoic acid receptor beta,nuclear hormone receptor,AGONIST,Drug: tazarotene | Target: retinoic acid receptor beta | Type: nuclear hormone receptor | Action: AGONIST
12307,tazarotene,retinoic acid receptor gamma,nuclear hormone receptor,AGONIST,Drug: tazarotene | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
12308,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12309,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12310,tazobactam,beta-lactamase tem,enzyme,INHIBITOR,Drug: tazobactam | Target: beta-lactamase tem | Type: enzyme | Action: INHIBITOR
12311,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12312,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12313,tazobactam,beta-lactamase shv-1,enzyme,,Drug: tazobactam | Target: beta-lactamase shv-1 | Type: enzyme | Action: nan
12314,tazobactam,beta-lactamase 1,enzyme,,Drug: tazobactam | Target: beta-lactamase 1 | Type: enzyme | Action: nan
12315,tazobactam,imi-1; imi-1 carbapenemase,enzyme,,Drug: tazobactam | Target: imi-1; imi-1 carbapenemase | Type: enzyme | Action: nan
12316,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12317,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12318,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12319,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12320,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12321,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12322,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12323,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12324,tazobactam,carbapenem-hydrolizing beta-lactamase sfc-1,enzyme,,Drug: tazobactam | Target: carbapenem-hydrolizing beta-lactamase sfc-1 | Type: enzyme | Action: nan
12325,tazobactam,carbepenem-hydrolyzing beta-lactamase kpc,enzyme,,Drug: tazobactam | Target: carbepenem-hydrolyzing beta-lactamase kpc | Type: enzyme | Action: nan
12326,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12327,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12328,tazobactam,beta-lactamase shv-1,enzyme,,Drug: tazobactam | Target: beta-lactamase shv-1 | Type: enzyme | Action: nan
12329,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12330,tazobactam,beta-lactamase ges-13,enzyme,,Drug: tazobactam | Target: beta-lactamase ges-13 | Type: enzyme | Action: nan
12331,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12332,tazobactam,class d beta-lactamase,unclassified,,Drug: tazobactam | Target: class d beta-lactamase | Type: unclassified | Action: nan
12333,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12334,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12335,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12336,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12337,tazobactam,beta-lactamase,enzyme,,Drug: tazobactam | Target: beta-lactamase | Type: enzyme | Action: nan
12338,tegaserod,5-hydroxytryptamine receptor 4,gpcr,,Drug: tegaserod | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
12339,tegaserod,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tegaserod | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12340,tegaserod,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: tegaserod | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
12341,tegaserod,5-hydroxytryptamine receptor 1d,gpcr,,Drug: tegaserod | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
12342,tegaserod,5-hydroxytryptamine receptor 3a,ion channel,,Drug: tegaserod | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
12343,tegaserod,5-hydroxytryptamine receptor 4,gpcr,PARTIAL AGONIST,Drug: tegaserod | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: PARTIAL AGONIST
12344,teicoplanin aglycone,cathepsin l1,enzyme,INHIBITOR,Drug: teicoplanin aglycone | Target: cathepsin l1 | Type: enzyme | Action: INHIBITOR
12345,telithromycin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: telithromycin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12346,telmisartan,angiotensin-converting enzyme,enzyme,,Drug: telmisartan | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
12347,telmisartan,glycine receptor subunit alpha-1,ion channel,,Drug: telmisartan | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
12348,telmisartan,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: telmisartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
12349,telmisartan,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: telmisartan | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
12350,telmisartan,type-2 angiotensin ii receptor,gpcr,,Drug: telmisartan | Target: type-2 angiotensin ii receptor | Type: gpcr | Action: nan
12351,telmisartan,type-1b angiotensin ii receptor,gpcr,,Drug: telmisartan | Target: type-1b angiotensin ii receptor | Type: gpcr | Action: nan
12352,telmisartan,type-1a angiotensin ii receptor,gpcr,,Drug: telmisartan | Target: type-1a angiotensin ii receptor | Type: gpcr | Action: nan
12353,telmisartan,multidrug and toxin extrusion protein 1,transporter,,Drug: telmisartan | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
12354,temazepam,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: temazepam | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
12355,temazepam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: temazepam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12356,temocapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: temocapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
12357,temocapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: temocapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
12358,teniposide,multidrug resistance protein 1,transporter,,Drug: teniposide | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
12359,teniposide,dna topoisomerase 2-alpha,enzyme,INHIBITOR,Drug: teniposide | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: INHIBITOR
12360,teniposide,atp-binding cassette sub-family g member 2,transporter,,Drug: teniposide | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
12361,teniposide,multidrug resistance-associated protein 6,transporter,,Drug: teniposide | Target: multidrug resistance-associated protein 6 | Type: transporter | Action: nan
12362,teniposide,canalicular multispecific organic anion transporter 2,transporter,,Drug: teniposide | Target: canalicular multispecific organic anion transporter 2 | Type: transporter | Action: nan
12363,tenofovir,reverse transcriptase,enzyme,,Drug: tenofovir | Target: reverse transcriptase | Type: enzyme | Action: nan
12364,tenofovir,capsid protein,unclassified,,Drug: tenofovir | Target: capsid protein | Type: unclassified | Action: nan
12365,tenofovir disoproxil,gag-pol polyprotein,polyprotein,,Drug: tenofovir disoproxil | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
12366,tenofovir disoproxil,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: tenofovir disoproxil | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
12367,tenoxicam,prostaglandin g/h synthase 2,enzyme,,Drug: tenoxicam | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
12368,tenoxicam,prostaglandin g/h synthase 1,enzyme,,Drug: tenoxicam | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
12369,terbinafine,alpha-2a adrenergic receptor,gpcr,,Drug: terbinafine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12370,terbinafine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: terbinafine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12371,terbinafine,sodium-dependent noradrenaline transporter,transporter,,Drug: terbinafine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12372,terbinafine,cytochrome p450 2d6,enzyme,,Drug: terbinafine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
12373,terbinafine,squalene monooxygenase,enzyme,,Drug: terbinafine | Target: squalene monooxygenase | Type: enzyme | Action: nan
12374,terbinafine,squalene epoxidase,enzyme,INHIBITOR,Drug: terbinafine | Target: squalene epoxidase | Type: enzyme | Action: INHIBITOR
12375,terbinafine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: terbinafine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
12376,terbinafine,squalene monooxygenase,enzyme,,Drug: terbinafine | Target: squalene monooxygenase | Type: enzyme | Action: nan
12377,terbutaline,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: terbutaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
12378,terbutaline,beta-2 adrenergic receptor,gpcr,,Drug: terbutaline | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
12379,terconazole,sodium/nucleoside cotransporter 1,transporter,,Drug: terconazole | Target: sodium/nucleoside cotransporter 1 | Type: transporter | Action: nan
12380,terconazole,5-hydroxytryptamine receptor 4,gpcr,,Drug: terconazole | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
12381,terconazole,d(1a) dopamine receptor,gpcr,,Drug: terconazole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12382,terconazole,alpha-2a adrenergic receptor,gpcr,,Drug: terconazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12383,terconazole,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: terconazole | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12384,terconazole,sodium-dependent serotonin transporter,transporter,,Drug: terconazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
12385,terconazole,sodium-dependent noradrenaline transporter,transporter,,Drug: terconazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12386,terconazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: terconazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
12387,terconazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: terconazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
12388,terconazole,alpha-2b adrenergic receptor,gpcr,,Drug: terconazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12389,terconazole,d(3) dopamine receptor,gpcr,,Drug: terconazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12390,terconazole,muscarinic acetylcholine receptor m1,gpcr,,Drug: terconazole | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12391,terconazole,muscarinic acetylcholine receptor m2,gpcr,,Drug: terconazole | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12392,terconazole,muscarinic acetylcholine receptor m3,gpcr,,Drug: terconazole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
12393,terconazole,muscarinic acetylcholine receptor m4,gpcr,,Drug: terconazole | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
12394,terconazole,muscarinic acetylcholine receptor m5,gpcr,,Drug: terconazole | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
12395,terconazole,alpha-2c adrenergic receptor,gpcr,,Drug: terconazole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12396,terconazole,sodium-dependent dopamine transporter,transporter,,Drug: terconazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
12397,terconazole,alpha-1d adrenergic receptor,gpcr,,Drug: terconazole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12398,terconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: terconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
12399,terconazole,acetylcholinesterase,enzyme,,Drug: terconazole | Target: acetylcholinesterase | Type: enzyme | Action: nan
12400,terconazole,tyrosine-protein kinase fyn,kinase,,Drug: terconazole | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
12401,terconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: terconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
12402,terconazole,heme oxygenase 2,enzyme,,Drug: terconazole | Target: heme oxygenase 2 | Type: enzyme | Action: nan
12403,terconazole,arachidonate 15-lipoxygenase,enzyme,,Drug: terconazole | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
12404,terconazole,alpha-1b adrenergic receptor,gpcr,,Drug: terconazole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12405,terconazole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: terconazole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
12406,terconazole,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: terconazole | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
12407,terconazole,alpha-1a adrenergic receptor,gpcr,,Drug: terconazole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12409,terfenadine,d(1a) dopamine receptor,gpcr,,Drug: terfenadine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12410,terfenadine,d(2) dopamine receptor,gpcr,,Drug: terfenadine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12411,terfenadine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: terfenadine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12412,terfenadine,multidrug resistance protein 1,transporter,,Drug: terfenadine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
12413,terfenadine,sodium-dependent noradrenaline transporter,transporter,,Drug: terfenadine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12414,terfenadine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: terfenadine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
12415,terfenadine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: terfenadine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
12416,terfenadine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: terfenadine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
12417,terfenadine,5-hydroxytryptamine receptor 6,gpcr,,Drug: terfenadine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
12418,terfenadine,d(3) dopamine receptor,gpcr,,Drug: terfenadine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12419,terfenadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: terfenadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
12420,terfenadine,muscarinic acetylcholine receptor m1,gpcr,,Drug: terfenadine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12421,terfenadine,alpha-2c adrenergic receptor,gpcr,,Drug: terfenadine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12422,terfenadine,sodium-dependent dopamine transporter,transporter,,Drug: terfenadine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
12423,terfenadine,epidermal growth factor receptor,kinase,,Drug: terfenadine | Target: epidermal growth factor receptor | Type: kinase | Action: nan
12424,terfenadine,c-c chemokine receptor type 5,gpcr,,Drug: terfenadine | Target: c-c chemokine receptor type 5 | Type: gpcr | Action: nan
12425,terfenadine,tyrosine-protein kinase fyn,kinase,,Drug: terfenadine | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
12426,terfenadine,cytochrome p450 2j2,enzyme,,Drug: terfenadine | Target: cytochrome p450 2j2 | Type: enzyme | Action: nan
12427,terfenadine,substance-k receptor,gpcr,,Drug: terfenadine | Target: substance-k receptor | Type: gpcr | Action: nan
12428,terfenadine,potassium voltage-gated channel subfamily h member 1,ion channel,BLOCKER,Drug: terfenadine | Target: potassium voltage-gated channel subfamily h member 1 | Type: ion channel | Action: BLOCKER
12429,terfenadine,alpha-1b adrenergic receptor,gpcr,,Drug: terfenadine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12430,terfenadine,histamine h1 receptor,gpcr,,Drug: terfenadine | Target: histamine h1 receptor | Type: gpcr | Action: nan
12431,terfenadine,heat shock protein hsp 90-alpha,cytosolic other,,Drug: terfenadine | Target: heat shock protein hsp 90-alpha | Type: cytosolic other | Action: nan
12432,terfenadine,adrenergic receptor alpha-1,gpcr,,Drug: terfenadine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
12433,terfenadine,transcriptional activator protein luxr,unclassified,,Drug: terfenadine | Target: transcriptional activator protein luxr | Type: unclassified | Action: nan
12434,terguride,beta-1 adrenergic receptor,gpcr,,Drug: terguride | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
12435,terguride,beta-2 adrenergic receptor,gpcr,,Drug: terguride | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
12436,terguride,d(1a) dopamine receptor,gpcr,,Drug: terguride | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12437,terguride,d(2) dopamine receptor,gpcr,AGONIST,Drug: terguride | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
12438,terguride,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: terguride | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12439,terguride,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: terguride | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
12440,terguride,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: terguride | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
12441,terguride,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: terguride | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12442,terguride,alpha-2b adrenergic receptor,gpcr,ANTAGONIST,Drug: terguride | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12443,terguride,d(3) dopamine receptor,gpcr,AGONIST,Drug: terguride | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
12444,terguride,d(1b) dopamine receptor,gpcr,,Drug: terguride | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
12445,terguride,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: terguride | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
12446,terguride,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: terguride | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
12447,terguride,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: terguride | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12448,terguride,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: terguride | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
12449,terguride,alpha-1d adrenergic receptor,gpcr,,Drug: terguride | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12450,terguride,alpha-1b adrenergic receptor,gpcr,,Drug: terguride | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12451,terguride,d(2) dopamine receptor,gpcr,,Drug: terguride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12452,terguride,5-hydroxytryptamine receptor 1a,gpcr,,Drug: terguride | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12453,terguride,d(1a) dopamine receptor,gpcr,,Drug: terguride | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12454,terguride,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: terguride | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
12455,terguride,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: terguride | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
12456,terodiline,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: terodiline | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12457,tertatolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tertatolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12458,tertatolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: tertatolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12459,tertatolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tertatolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12460,tertatolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: tertatolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12461,tertatolol,beta-3 adrenergic receptor,gpcr,ANTAGONIST,Drug: tertatolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12462,testolactone,aromatase,enzyme,INHIBITOR,Drug: testolactone | Target: aromatase | Type: enzyme | Action: INHIBITOR
12463,testosterone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: testosterone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12464,testosterone,glucocorticoid receptor,nuclear hormone receptor,,Drug: testosterone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
12465,testosterone,androgen receptor,nuclear hormone receptor,AGONIST,Drug: testosterone | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
12466,testosterone,aromatase,enzyme,,Drug: testosterone | Target: aromatase | Type: enzyme | Action: nan
12467,testosterone,corticosteroid-binding globulin,secreted,,Drug: testosterone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
12468,testosterone,sex hormone-binding globulin,secreted,,Drug: testosterone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
12469,testosterone,lanosterol 14-alpha demethylase,enzyme,,Drug: testosterone | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
12470,testosterone,androgen receptor,transcription factor,,Drug: testosterone | Target: androgen receptor | Type: transcription factor | Action: nan
12471,testosterone,progesterone receptor,transcription factor,,Drug: testosterone | Target: progesterone receptor | Type: transcription factor | Action: nan
12472,testosterone,c-8 sterol isomerase,enzyme,,Drug: testosterone | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
12473,testosterone,steroid 5-alpha-reductase,enzyme,,Drug: testosterone | Target: steroid 5-alpha-reductase | Type: enzyme | Action: nan
12474,testosterone,constitutive androstane receptor,nuclear hormone receptor,,Drug: testosterone | Target: constitutive androstane receptor | Type: nuclear hormone receptor | Action: nan
12475,testosterone undecanoate,androgen receptor,nuclear hormone receptor,AGONIST,Drug: testosterone undecanoate | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
12476,tetrabenazine,d(2) dopamine receptor,gpcr,,Drug: tetrabenazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12477,tetrabenazine,alpha-2a adrenergic receptor,gpcr,,Drug: tetrabenazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12478,tetrabenazine,alpha-2c adrenergic receptor,gpcr,,Drug: tetrabenazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12479,tetrabenazine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: tetrabenazine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
12480,tetrabenazine,synaptic vesicular amine transporter,transporter,,Drug: tetrabenazine | Target: synaptic vesicular amine transporter | Type: transporter | Action: nan
12481,tetrabenazine,synaptic vesicular amine transporter,transporter,,Drug: tetrabenazine | Target: synaptic vesicular amine transporter | Type: transporter | Action: nan
12482,tetrabenazine,chromaffin granule amine transporter,transporter,INHIBITOR,Drug: tetrabenazine | Target: chromaffin granule amine transporter | Type: transporter | Action: INHIBITOR
12483,tetrabenazine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: tetrabenazine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
12484,tetracaine,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: tetracaine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
12485,tetracaine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: tetracaine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12486,tetracaine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: tetracaine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
12487,tetracaine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: tetracaine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
12488,tetracaine,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: tetracaine | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
12489,tetracaine,sodium channel protein type 8 subunit alpha,ion channel,,Drug: tetracaine | Target: sodium channel protein type 8 subunit alpha | Type: ion channel | Action: nan
12490,tetracaine,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: tetracaine | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
12491,tetracaine,amine oxidase [flavin-containing] a,enzyme,,Drug: tetracaine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
12492,tetracaine,cgmp-gated cation channel alpha-1,ion channel,,Drug: tetracaine | Target: cgmp-gated cation channel alpha-1 | Type: ion channel | Action: nan
12493,tetracaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,BLOCKER,"Drug: tetracaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: BLOCKER"
12494,tetracaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: tetracaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
12495,tetracycline,30s ribosomal protein s4,ribosomal protein,,Drug: tetracycline | Target: 30s ribosomal protein s4 | Type: ribosomal protein | Action: nan
12496,tetracycline,30s ribosomal protein s9,ribosomal protein,,Drug: tetracycline | Target: 30s ribosomal protein s9 | Type: ribosomal protein | Action: nan
12497,sapropterin,"nitric oxide synthase, brain",enzyme,,"Drug: sapropterin | Target: nitric oxide synthase, brain | Type: enzyme | Action: nan"
12498,sapropterin,phenylalanine-4-hydroxylase,enzyme,ACTIVATOR,Drug: sapropterin | Target: phenylalanine-4-hydroxylase | Type: enzyme | Action: ACTIVATOR
12499,tetroxoprim,dihydrofolate reductase,enzyme,,Drug: tetroxoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
12500,tetroxoprim,dihydrofolate reductase,enzyme,,Drug: tetroxoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
12501,tetroxoprim,dihydrofolate reductase,enzyme,,Drug: tetroxoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
12502,tetroxoprim,dihydrofolate reductase,enzyme,,Drug: tetroxoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
12503,thalidomide,prostaglandin g/h synthase 2,enzyme,,Drug: thalidomide | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
12504,thalidomide,prostaglandin g/h synthase 1,enzyme,,Drug: thalidomide | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
12505,thalidomide,tumor necrosis factor,cytokine,,Drug: thalidomide | Target: tumor necrosis factor | Type: cytokine | Action: nan
12506,thalidomide,prostaglandin g/h synthase 1,enzyme,,Drug: thalidomide | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
12507,thalidomide,prostaglandin g/h synthase 2,enzyme,,Drug: thalidomide | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
12508,thalidomide,cereblon isoform 4,unclassified,,Drug: thalidomide | Target: cereblon isoform 4 | Type: unclassified | Action: nan
12509,thalidomide,protein cereblon,cytosolic other,MODULATOR,Drug: thalidomide | Target: protein cereblon | Type: cytosolic other | Action: MODULATOR
12510,theophylline,adenosine receptor a2a,gpcr,ANTAGONIST,Drug: theophylline | Target: adenosine receptor a2a | Type: gpcr | Action: ANTAGONIST
12511,theophylline,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,INHIBITOR,"Drug: theophylline | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: INHIBITOR"
12512,theophylline,adenosine receptor a1,gpcr,ANTAGONIST,Drug: theophylline | Target: adenosine receptor a1 | Type: gpcr | Action: ANTAGONIST
12513,theophylline,adenosine receptor a2b,gpcr,ANTAGONIST,Drug: theophylline | Target: adenosine receptor a2b | Type: gpcr | Action: ANTAGONIST
12514,theophylline,adenosine receptor a3,gpcr,ANTAGONIST,Drug: theophylline | Target: adenosine receptor a3 | Type: gpcr | Action: ANTAGONIST
12515,theophylline,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,INHIBITOR,"Drug: theophylline | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: INHIBITOR"
12516,theophylline,"alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,"Drug: theophylline | Target: alkaline phosphatase, tissue-nonspecific isozyme | Type: enzyme | Action: nan"
12517,theophylline,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,,"Drug: theophylline | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: nan"
12518,theophylline,adenosine receptor a1,gpcr,,Drug: theophylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
12519,theophylline,adenosine receptor a2a,gpcr,,Drug: theophylline | Target: adenosine receptor a2a | Type: gpcr | Action: nan
12520,theophylline,uncharacterized protein,enzyme,,Drug: theophylline | Target: uncharacterized protein | Type: enzyme | Action: nan
12521,theophylline,adenosine receptor a3,gpcr,,Drug: theophylline | Target: adenosine receptor a3 | Type: gpcr | Action: nan
12522,theophylline,adenosine receptor a1,gpcr,,Drug: theophylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
12523,theophylline,adenosine receptor a1,gpcr,,Drug: theophylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
12524,theophylline,adenosine a2 receptor,gpcr,,Drug: theophylline | Target: adenosine a2 receptor | Type: gpcr | Action: nan
12525,theophylline,adenosine a2b receptor,gpcr,,Drug: theophylline | Target: adenosine a2b receptor | Type: gpcr | Action: nan
12526,theophylline,adenosine receptor,gpcr,,Drug: theophylline | Target: adenosine receptor | Type: gpcr | Action: nan
12527,theophylline,heart phosphodiesterase,enzyme,,Drug: theophylline | Target: heart phosphodiesterase | Type: enzyme | Action: nan
12528,theophylline,adenosine a2a receptor,gpcr,,Drug: theophylline | Target: adenosine a2a receptor | Type: gpcr | Action: nan
12529,theophylline,adenosine receptor a2b,gpcr,ANTAGONIST,Drug: theophylline | Target: adenosine receptor a2b | Type: gpcr | Action: ANTAGONIST
12530,theophylline,transmembrane domain-containing protein tmigd3,unclassified,,Drug: theophylline | Target: transmembrane domain-containing protein tmigd3 | Type: unclassified | Action: nan
12531,thiabendazole,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,,Drug: thiabendazole | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: nan
12532,thiabendazole,cytochrome p450 1a2,enzyme,,Drug: thiabendazole | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
12533,thiabendazole,"succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial",enzyme,,"Drug: thiabendazole | Target: succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial | Type: enzyme | Action: nan"
12534,thiabendazole,methionine aminopeptidase 2,enzyme,,Drug: thiabendazole | Target: methionine aminopeptidase 2 | Type: enzyme | Action: nan
12535,thiabendazole,reverse transcriptase/rnaseh,enzyme,,Drug: thiabendazole | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: nan
12536,thiabendazole,methionine aminopeptidase,enzyme,,Drug: thiabendazole | Target: methionine aminopeptidase | Type: enzyme | Action: nan
12537,thiabendazole,methionine aminopeptidase 1,enzyme,,Drug: thiabendazole | Target: methionine aminopeptidase 1 | Type: enzyme | Action: nan
12538,thiabendazole,tubulin,structural,INHIBITOR,Drug: thiabendazole | Target: tubulin | Type: structural | Action: INHIBITOR
12539,thiabendazole,tubulin,structural,INHIBITOR,Drug: thiabendazole | Target: tubulin | Type: structural | Action: INHIBITOR
12540,thiamphenicol,50s ribosomal protein l10,ribosomal protein,,Drug: thiamphenicol | Target: 50s ribosomal protein l10 | Type: ribosomal protein | Action: nan
12541,thiamphenicol,cytochrome p450 2c19,enzyme,,Drug: thiamphenicol | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
12542,thiamphenicol,streptokinase a,enzyme,,Drug: thiamphenicol | Target: streptokinase a | Type: enzyme | Action: nan
12543,thiamylal,gaba-a receptor; anion channel,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: thiamylal | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12544,thiethylperazine,d(1a) dopamine receptor,gpcr,,Drug: thiethylperazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12545,thiethylperazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: thiethylperazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
12546,thiethylperazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: thiethylperazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12547,thiethylperazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: thiethylperazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12548,thiethylperazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: thiethylperazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
12549,thiethylperazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: thiethylperazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
12550,thiethylperazine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: thiethylperazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
12551,thiethylperazine,alpha-1a adrenergic receptor,gpcr,,Drug: thiethylperazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12552,thiethylperazine,d(3) dopamine receptor,gpcr,,Drug: thiethylperazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12553,thiethylperazine,histamine h1 receptor,gpcr,,Drug: thiethylperazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
12554,thiethylperazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: thiethylperazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12555,thiethylperazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: thiethylperazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12556,thiethylperazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: thiethylperazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
12557,thiethylperazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: thiethylperazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
12558,thiethylperazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: thiethylperazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
12559,thiethylperazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: thiethylperazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
12560,thiethylperazine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: thiethylperazine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
12561,thioguanine,prostaglandin g/h synthase 1,enzyme,,Drug: thioguanine | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
12562,thioguanine,adenosine receptor a3,gpcr,,Drug: thioguanine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
12563,thioguanine,multidrug resistance-associated protein 5,transporter,,Drug: thioguanine | Target: multidrug resistance-associated protein 5 | Type: transporter | Action: nan
12564,thioguanine,multidrug resistance-associated protein 4,transporter,,Drug: thioguanine | Target: multidrug resistance-associated protein 4 | Type: transporter | Action: nan
12565,thioguanine,inosine-5'-monophosphate dehydrogenase 1,enzyme,INHIBITOR,Drug: thioguanine | Target: inosine-5'-monophosphate dehydrogenase 1 | Type: enzyme | Action: INHIBITOR
12566,thioguanine,xanthine dehydrogenase/oxidase,enzyme,,Drug: thioguanine | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
12567,thioguanine,inosine-5'-monophosphate dehydrogenase 2,enzyme,INHIBITOR,Drug: thioguanine | Target: inosine-5'-monophosphate dehydrogenase 2 | Type: enzyme | Action: INHIBITOR
12568,thioguanine,hypoxanthine-guanine phosphoribosyltransferase,enzyme,,Drug: thioguanine | Target: hypoxanthine-guanine phosphoribosyltransferase | Type: enzyme | Action: nan
12569,thioguanine,mitogen-activated protein kinase 3,kinase,,Drug: thioguanine | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
12570,thioguanine,arachidonate 15-lipoxygenase,enzyme,,Drug: thioguanine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
12571,thioguanine,2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase,kinase,,Drug: thioguanine | Target: 2-amino-4-hydroxy-6-hydroxymethyldihydropteridine pyrophosphokinase | Type: kinase | Action: nan
12572,thiopental,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: thiopental | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12573,thiopental,gaba-a receptor; anion channel,ion channel,,Drug: thiopental | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
12574,thiopental,potassium voltage-gated channel subfamily c member 4,ion channel,GATING INHIBITOR,Drug: thiopental | Target: potassium voltage-gated channel subfamily c member 4 | Type: ion channel | Action: GATING INHIBITOR
12575,thioproperazine,d(2) dopamine receptor,gpcr,,Drug: thioproperazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12576,thioproperazine,d(3) dopamine receptor,gpcr,,Drug: thioproperazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12577,thioridazine,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: thioridazine | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
12578,thioridazine,d(1a) dopamine receptor,gpcr,,Drug: thioridazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12579,thioridazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: thioridazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
12580,thioridazine,alpha-2a adrenergic receptor,gpcr,,Drug: thioridazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12581,thioridazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: thioridazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12582,thioridazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: thioridazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12583,thioridazine,sodium-dependent serotonin transporter,transporter,,Drug: thioridazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
12584,thioridazine,sodium-dependent noradrenaline transporter,transporter,,Drug: thioridazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12585,thioridazine,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
12586,thioridazine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
12587,thioridazine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
12588,thioridazine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
12589,thioridazine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
12590,thioridazine,5-hydroxytryptamine receptor 7,gpcr,,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
12591,thioridazine,alpha-1a adrenergic receptor,gpcr,,Drug: thioridazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12592,thioridazine,alpha-2b adrenergic receptor,gpcr,,Drug: thioridazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12593,thioridazine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: thioridazine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
12594,thioridazine,d(1b) dopamine receptor,gpcr,ANTAGONIST,Drug: thioridazine | Target: d(1b) dopamine receptor | Type: gpcr | Action: ANTAGONIST
12595,thioridazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: thioridazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
12596,thioridazine,histamine h2 receptor,gpcr,,Drug: thioridazine | Target: histamine h2 receptor | Type: gpcr | Action: nan
12597,thioridazine,histamine h4 receptor,gpcr,,Drug: thioridazine | Target: histamine h4 receptor | Type: gpcr | Action: nan
12598,thioridazine,muscarinic acetylcholine receptor m1,gpcr,,Drug: thioridazine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12599,thioridazine,muscarinic acetylcholine receptor m2,gpcr,,Drug: thioridazine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12600,thioridazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: thioridazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
12601,thioridazine,muscarinic acetylcholine receptor m4,gpcr,,Drug: thioridazine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
12602,thioridazine,muscarinic acetylcholine receptor m5,gpcr,,Drug: thioridazine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
12603,thioridazine,aldehyde oxidase,enzyme,,Drug: thioridazine | Target: aldehyde oxidase | Type: enzyme | Action: nan
12604,thioridazine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
12605,thioridazine,5-hydroxytryptamine receptor 1d,gpcr,,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
12606,thioridazine,alpha-2c adrenergic receptor,gpcr,,Drug: thioridazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12607,thioridazine,sodium-dependent dopamine transporter,transporter,,Drug: thioridazine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
12608,thioridazine,cytochrome p450 2d6,enzyme,,Drug: thioridazine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
12609,thioridazine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: thioridazine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
12610,thioridazine,alpha-1d adrenergic receptor,gpcr,,Drug: thioridazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12611,thioridazine,alpha-1b adrenergic receptor,gpcr,,Drug: thioridazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12612,thioridazine,kappa-type opioid receptor,gpcr,,Drug: thioridazine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
12613,thioridazine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
12614,thioridazine,cytochrome p450 1a2,enzyme,,Drug: thioridazine | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
12615,thioridazine,5-hydroxytryptamine receptor 1e,gpcr,,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
12616,thioridazine,epidermal growth factor receptor,kinase,,Drug: thioridazine | Target: epidermal growth factor receptor | Type: kinase | Action: nan
12617,thioridazine,cytochrome p450 2c19,enzyme,,Drug: thioridazine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
12618,thioridazine,tyrosine-protein kinase fyn,kinase,,Drug: thioridazine | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
12619,thioridazine,serine/threonine-protein kinase pim-1,kinase,,Drug: thioridazine | Target: serine/threonine-protein kinase pim-1 | Type: kinase | Action: nan
12620,thioridazine,alpha-1b adrenergic receptor,gpcr,,Drug: thioridazine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12621,thioridazine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: thioridazine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
12622,thioridazine,alpha-1a adrenergic receptor,gpcr,,Drug: thioridazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12623,thioridazine,d(2) dopamine receptor,gpcr,,Drug: thioridazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12624,thioridazine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
12625,thioridazine,d(1a) dopamine receptor,gpcr,,Drug: thioridazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12626,thioridazine,histamine h1 receptor,gpcr,,Drug: thioridazine | Target: histamine h1 receptor | Type: gpcr | Action: nan
12627,thioridazine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: thioridazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
12628,thioridazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: thioridazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
12629,thioridazine,muscarinic acetylcholine receptor,gpcr,,Drug: thioridazine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
12630,thioridazine,serotonin 1 (5-ht1) receptor,gpcr,,Drug: thioridazine | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
12631,thioridazine,adrenergic receptor alpha-2,gpcr,,Drug: thioridazine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
12632,thioridazine,dopamine receptor,gpcr,,Drug: thioridazine | Target: dopamine receptor | Type: gpcr | Action: nan
12633,thioridazine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: thioridazine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
12634,thioridazine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: thioridazine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
12635,thioridazine,g protein-activated inward rectifier potassium channel 2,ion channel,GATING INHIBITOR,Drug: thioridazine | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: GATING INHIBITOR
12636,thiotepa,cytochrome p450 2b6,enzyme,INHIBITOR,Drug: thiotepa | Target: cytochrome p450 2b6 | Type: enzyme | Action: INHIBITOR
12637,thiothixene,d(1a) dopamine receptor,gpcr,,Drug: thiothixene | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12638,thiothixene,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: thiothixene | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
12639,thiothixene,alpha-2a adrenergic receptor,gpcr,,Drug: thiothixene | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12640,thiothixene,sodium-dependent serotonin transporter,transporter,,Drug: thiothixene | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
12641,thiothixene,5-hydroxytryptamine receptor 1a,gpcr,,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12642,thiothixene,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
12643,thiothixene,5-hydroxytryptamine receptor 2c,gpcr,,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
12644,thiothixene,5-hydroxytryptamine receptor 6,gpcr,,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
12645,thiothixene,5-hydroxytryptamine receptor 7,gpcr,,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
12646,thiothixene,alpha-1a adrenergic receptor,gpcr,,Drug: thiothixene | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12647,thiothixene,alpha-2b adrenergic receptor,gpcr,,Drug: thiothixene | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12648,thiothixene,d(3) dopamine receptor,gpcr,,Drug: thiothixene | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12649,thiothixene,d(1b) dopamine receptor,gpcr,,Drug: thiothixene | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
12650,thiothixene,histamine h1 receptor,gpcr,ANTAGONIST,Drug: thiothixene | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
12651,thiothixene,histamine h2 receptor,gpcr,,Drug: thiothixene | Target: histamine h2 receptor | Type: gpcr | Action: nan
12652,thiothixene,muscarinic acetylcholine receptor m1,gpcr,,Drug: thiothixene | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12653,thiothixene,muscarinic acetylcholine receptor m2,gpcr,,Drug: thiothixene | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12654,thiothixene,muscarinic acetylcholine receptor m3,gpcr,,Drug: thiothixene | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
12655,thiothixene,muscarinic acetylcholine receptor m4,gpcr,,Drug: thiothixene | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
12656,thiothixene,muscarinic acetylcholine receptor m5,gpcr,,Drug: thiothixene | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
12657,thiothixene,5-hydroxytryptamine receptor 1b,gpcr,,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
12658,thiothixene,5-hydroxytryptamine receptor 1d,gpcr,,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
12659,thiothixene,alpha-2c adrenergic receptor,gpcr,,Drug: thiothixene | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12660,thiothixene,d(4) dopamine receptor,gpcr,,Drug: thiothixene | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
12661,thiothixene,5-hydroxytryptamine receptor 3a,ion channel,,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
12662,thiothixene,alpha-1b adrenergic receptor,gpcr,,Drug: thiothixene | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12663,thiothixene,5-hydroxytryptamine receptor 5a,gpcr,,Drug: thiothixene | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
12664,levothyroxine,thyroid hormone receptor alpha,nuclear hormone receptor,AGONIST,Drug: levothyroxine | Target: thyroid hormone receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
12665,levothyroxine,thyroid hormone receptor beta,nuclear hormone receptor,AGONIST,Drug: levothyroxine | Target: thyroid hormone receptor beta | Type: nuclear hormone receptor | Action: AGONIST
12666,levothyroxine,transthyretin,secreted,,Drug: levothyroxine | Target: transthyretin | Type: secreted | Action: nan
12667,levothyroxine,bile acid receptor,nuclear hormone receptor,,Drug: levothyroxine | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
12668,levothyroxine,thyroid hormone receptor beta,transcription factor,,Drug: levothyroxine | Target: thyroid hormone receptor beta | Type: transcription factor | Action: nan
12669,levothyroxine,thap domain-containing protein 1,unclassified,,Drug: levothyroxine | Target: thap domain-containing protein 1 | Type: unclassified | Action: nan
12670,levothyroxine,macrophage migration inhibitory factor,unclassified,,Drug: levothyroxine | Target: macrophage migration inhibitory factor | Type: unclassified | Action: nan
12671,levothyroxine,"malate dehydrogenase, mitochondrial",enzyme,,"Drug: levothyroxine | Target: malate dehydrogenase, mitochondrial | Type: enzyme | Action: nan"
12672,tiagabine,sodium- and chloride-dependent gaba transporter 1,transporter,INHIBITOR,Drug: tiagabine | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: INHIBITOR
12673,tiagabine,sodium- and chloride-dependent gaba transporter 1,transporter,,Drug: tiagabine | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: nan
12674,tiagabine,sodium- and chloride-dependent gaba transporter 1,transporter,,Drug: tiagabine | Target: sodium- and chloride-dependent gaba transporter 1 | Type: transporter | Action: nan
12675,tiagabine,sodium- and chloride-dependent betaine transporter,transporter,,Drug: tiagabine | Target: sodium- and chloride-dependent betaine transporter | Type: transporter | Action: nan
12676,tiamenidine,adrenergic receptor alpha-2,gpcr,,Drug: tiamenidine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
12677,tiamenidine,adrenergic receptor alpha-1,gpcr,,Drug: tiamenidine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
12678,tianeptine,mu-type opioid receptor,gpcr,,Drug: tianeptine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
12679,tiapride,d(2) dopamine receptor,gpcr,,Drug: tiapride | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12680,tiapride,alpha-2a adrenergic receptor,gpcr,,Drug: tiapride | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12681,tiapride,d(3) dopamine receptor,gpcr,,Drug: tiapride | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12682,tiapride,d(4) dopamine receptor,gpcr,,Drug: tiapride | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
12683,tiaprofenic acid,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: tiaprofenic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
12684,tiaprofenic acid,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: tiaprofenic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
12685,tibolone,sodium-dependent serotonin transporter,transporter,,Drug: tibolone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
12686,tibolone,estrogen receptor,nuclear hormone receptor,,Drug: tibolone | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
12687,tibolone,androgen receptor,nuclear hormone receptor,,Drug: tibolone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
12688,tibolone,progesterone receptor,nuclear hormone receptor,,Drug: tibolone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
12689,tibolone,cytochrome p450 2c19,enzyme,,Drug: tibolone | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
12690,tibolone,steryl-sulfatase,enzyme,,Drug: tibolone | Target: steryl-sulfatase | Type: enzyme | Action: nan
12691,tibolone,androgen receptor,transcription factor,,Drug: tibolone | Target: androgen receptor | Type: transcription factor | Action: nan
12692,tibolone,progesterone receptor,transcription factor,,Drug: tibolone | Target: progesterone receptor | Type: transcription factor | Action: nan
12693,ticarcillin,penicillin-binding protein 1a,enzyme,,Drug: ticarcillin | Target: penicillin-binding protein 1a | Type: enzyme | Action: nan
12694,ticarcillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: ticarcillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
12695,ticlopidine,prostaglandin g/h synthase 2,enzyme,,Drug: ticlopidine | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
12696,ticlopidine,prostaglandin g/h synthase 1,enzyme,,Drug: ticlopidine | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
12697,ticlopidine,alpha-2a adrenergic receptor,gpcr,,Drug: ticlopidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12698,ticlopidine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: ticlopidine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12699,ticlopidine,alpha-2b adrenergic receptor,gpcr,,Drug: ticlopidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12700,ticlopidine,alpha-2c adrenergic receptor,gpcr,,Drug: ticlopidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12701,ticlopidine,cytochrome p450 2d6,enzyme,,Drug: ticlopidine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
12702,ticlopidine,cytochrome p450 2a6,enzyme,,Drug: ticlopidine | Target: cytochrome p450 2a6 | Type: enzyme | Action: nan
12703,ticlopidine,bile salt export pump,transporter,,Drug: ticlopidine | Target: bile salt export pump | Type: transporter | Action: nan
12704,ticlopidine,p2y purinoceptor 12,gpcr,ANTAGONIST,Drug: ticlopidine | Target: p2y purinoceptor 12 | Type: gpcr | Action: ANTAGONIST
12705,ticlopidine,cytochrome p450 2c19,enzyme,,Drug: ticlopidine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
12706,ticlopidine,cytochrome p450 2b6,enzyme,INHIBITOR,Drug: ticlopidine | Target: cytochrome p450 2b6 | Type: enzyme | Action: INHIBITOR
12707,ticlopidine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: ticlopidine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
12708,ticlopidine,bile salt export pump,transporter,,Drug: ticlopidine | Target: bile salt export pump | Type: transporter | Action: nan
12709,tienilic acid,aldose reductase,enzyme,,Drug: tienilic acid | Target: aldose reductase | Type: enzyme | Action: nan
12710,tilidine,mu-type opioid receptor,gpcr,AGONIST,Drug: tilidine | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
12711,tiliquinol,catechol o-methyltransferase,enzyme,,Drug: tiliquinol | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
12712,tiludronic acid,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: tiludronic acid | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
12713,tiludronic acid,v-type proton atpase 116 kda subunit a isoform 3,enzyme,,Drug: tiludronic acid | Target: v-type proton atpase 116 kda subunit a isoform 3 | Type: enzyme | Action: nan
12714,tiludronic acid,72 kda type iv collagenase,enzyme,,Drug: tiludronic acid | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
12715,tiludronic acid,matrix metalloproteinase-14,enzyme,,Drug: tiludronic acid | Target: matrix metalloproteinase-14 | Type: enzyme | Action: nan
12716,tiludronic acid,neutrophil collagenase,enzyme,,Drug: tiludronic acid | Target: neutrophil collagenase | Type: enzyme | Action: nan
12717,tinoridine,adenosine receptor a1,gpcr,ANTAGONIST,Drug: tinoridine | Target: adenosine receptor a1 | Type: gpcr | Action: ANTAGONIST
12718,tiocarlide,"epoxide hydrolase ephe; hydrolase, alpha/beta hydrolase fold family",enzyme,,"Drug: tiocarlide | Target: epoxide hydrolase ephe; hydrolase, alpha/beta hydrolase fold family | Type: enzyme | Action: nan"
12719,tioconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: tioconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
12720,tioconazole,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,,"Drug: tioconazole | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: nan"
12721,tiopronin,angiotensin-converting enzyme,enzyme,,Drug: tiopronin | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
12722,tiotropium bromide,muscarinic acetylcholine receptor m1,gpcr,,Drug: tiotropium bromide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12723,tiotropium bromide,muscarinic acetylcholine receptor m2,gpcr,,Drug: tiotropium bromide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12724,tiotropium bromide,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: tiotropium bromide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
12725,tiotropium bromide,muscarinic acetylcholine receptor m4,gpcr,,Drug: tiotropium bromide | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
12726,tiotropium bromide,muscarinic acetylcholine receptor m5,gpcr,,Drug: tiotropium bromide | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
12727,tiotropium bromide,muscarinic acetylcholine receptor m2,gpcr,,Drug: tiotropium bromide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12728,tiotropium bromide,muscarinic acetylcholine receptor m1,gpcr,,Drug: tiotropium bromide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12729,tiotropium bromide,muscarinic acetylcholine receptor m3,gpcr,,Drug: tiotropium bromide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
12730,tiquizium,muscarinic acetylcholine receptor,gpcr,,Drug: tiquizium | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
12731,tiquizium,muscarinic acetylcholine receptor,gpcr,,Drug: tiquizium | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
12732,tiquizium,muscarinic acetylcholine receptor,gpcr,,Drug: tiquizium | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
12733,tiracizine,nuclear receptor subfamily 1 group i member 3,nuclear hormone receptor,,Drug: tiracizine | Target: nuclear receptor subfamily 1 group i member 3 | Type: nuclear hormone receptor | Action: nan
12734,tirofiban,integrin alpha-iib/beta-3,adhesion,INHIBITOR,Drug: tirofiban | Target: integrin alpha-iib/beta-3 | Type: adhesion | Action: INHIBITOR
12735,tizanidine,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: tizanidine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
12736,tizanidine,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: tizanidine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
12737,tizanidine,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: tizanidine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
12738,tizanidine,nischarin,membrane receptor,,Drug: tizanidine | Target: nischarin | Type: membrane receptor | Action: nan
12739,tizanidine,alpha-1a adrenergic receptor,gpcr,,Drug: tizanidine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12740,tizanidine,alpha-1b adrenergic receptor,gpcr,,Drug: tizanidine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12741,tobramycin,"macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b)",enzyme,,"Drug: tobramycin | Target: macrolide 2'-phosphotransferase ii; macrolide 2'-phosphotransferase ii protein mphb; macrolide 2-phosphotransferase, mph(b) | Type: enzyme | Action: nan"
12742,tocainide,sodium channel alpha subunit,ion channel,BLOCKER,Drug: tocainide | Target: sodium channel alpha subunit | Type: ion channel | Action: BLOCKER
12743,tofisopam,"camp-specific 3',5'-cyclic phosphodiesterase 4d",enzyme,,"Drug: tofisopam | Target: camp-specific 3',5'-cyclic phosphodiesterase 4d | Type: enzyme | Action: nan"
12745,tolazamide,arachidonate 15-lipoxygenase,enzyme,,Drug: tolazamide | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
12746,tolazamide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: tolazamide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
12747,tolazoline,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: tolazoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12748,tolazoline,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: tolazoline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12749,tolazoline,alpha-2b adrenergic receptor,gpcr,ANTAGONIST,Drug: tolazoline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12750,tolazoline,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: tolazoline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
12751,tolazoline,trace amine-associated receptor 1,gpcr,,Drug: tolazoline | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
12752,tolazoline,adrenergic receptor alpha-2,gpcr,,Drug: tolazoline | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
12753,tolazoline,adrenergic receptor alpha-1,gpcr,,Drug: tolazoline | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
12754,tolbutamide,solute carrier family 22 member 6,transporter,,Drug: tolbutamide | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
12755,tolbutamide,atp-sensitive inward rectifier potassium channel 11,ion channel,BLOCKER,Drug: tolbutamide | Target: atp-sensitive inward rectifier potassium channel 11 | Type: ion channel | Action: BLOCKER
12756,tolbutamide,"sulfonylurea receptor 1, kir6.2",ion channel,BLOCKER,"Drug: tolbutamide | Target: sulfonylurea receptor 1, kir6.2 | Type: ion channel | Action: BLOCKER"
12757,tolcapone,transthyretin,secreted,,Drug: tolcapone | Target: transthyretin | Type: secreted | Action: nan
12758,tolcapone,catechol o-methyltransferase,enzyme,,Drug: tolcapone | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
12759,tolcapone,g-protein coupled receptor 35,gpcr,,Drug: tolcapone | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
12760,tolcapone,krueppel-like factor 10,nuclear other,,Drug: tolcapone | Target: krueppel-like factor 10 | Type: nuclear other | Action: nan
12761,tolcapone,bile salt export pump,transporter,,Drug: tolcapone | Target: bile salt export pump | Type: transporter | Action: nan
12762,tolcapone,catechol o-methyltransferase,enzyme,INHIBITOR,Drug: tolcapone | Target: catechol o-methyltransferase | Type: enzyme | Action: INHIBITOR
12763,tolfenamic acid,prostaglandin g/h synthase 2,enzyme,,Drug: tolfenamic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
12764,tolfenamic acid,prostaglandin g/h synthase 1,enzyme,,Drug: tolfenamic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
12765,tolfenamic acid,transthyretin,secreted,,Drug: tolfenamic acid | Target: transthyretin | Type: secreted | Action: nan
12766,tolfenamic acid,androgen receptor,nuclear hormone receptor,,Drug: tolfenamic acid | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
12767,tolfenamic acid,aldo-keto reductase family 1 member c3,enzyme,,Drug: tolfenamic acid | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
12768,tolmetin,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: tolmetin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
12769,tolmetin,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: tolmetin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
12770,tolmetin,aldose reductase,enzyme,,Drug: tolmetin | Target: aldose reductase | Type: enzyme | Action: nan
12771,tolmetin,lactoylglutathione lyase,enzyme,,Drug: tolmetin | Target: lactoylglutathione lyase | Type: enzyme | Action: nan
12772,tolmetin,interleukin-8,cytokine,,Drug: tolmetin | Target: interleukin-8 | Type: cytokine | Action: nan
12773,tolmetin,aldose reductase,enzyme,,Drug: tolmetin | Target: aldose reductase | Type: enzyme | Action: nan
12774,tolonium,microtubule-associated protein tau,structural,,Drug: tolonium | Target: microtubule-associated protein tau | Type: structural | Action: nan
12775,tolonium,zinc finger protein mex-5,cytosolic other,,Drug: tolonium | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
12776,toloxatone,amine oxidase [flavin-containing] b,enzyme,,Drug: toloxatone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
12777,toloxatone,amine oxidase [flavin-containing] a,enzyme,,Drug: toloxatone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
12778,toloxatone,amine oxidase [flavin-containing] a,enzyme,,Drug: toloxatone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
12779,toloxatone,amine oxidase [flavin-containing] b,enzyme,,Drug: toloxatone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
12780,toloxatone,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: toloxatone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
12781,tolperisone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: tolperisone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12782,tolperisone,alpha-2b adrenergic receptor,gpcr,,Drug: tolperisone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12783,tolperisone,smr1-alpha3,unclassified,,Drug: tolperisone | Target: smr1-alpha3 | Type: unclassified | Action: nan
12784,tolperisone,betab2-crystallin,unclassified,,Drug: tolperisone | Target: betab2-crystallin | Type: unclassified | Action: nan
12785,tolrestat,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: tolrestat | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
12786,tolrestat,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: tolrestat | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
12787,tolrestat,aldose reductase,enzyme,,Drug: tolrestat | Target: aldose reductase | Type: enzyme | Action: nan
12788,tolrestat,aldose reductase,enzyme,,Drug: tolrestat | Target: aldose reductase | Type: enzyme | Action: nan
12789,tolrestat,aldose reductase,enzyme,,Drug: tolrestat | Target: aldose reductase | Type: enzyme | Action: nan
12790,tolrestat,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: tolrestat | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
12791,tolrestat,aldo-keto reductase family 1 member c21,enzyme,,Drug: tolrestat | Target: aldo-keto reductase family 1 member c21 | Type: enzyme | Action: nan
12792,tolrestat,aldo-keto reductase family 1 member b10,enzyme,,Drug: tolrestat | Target: aldo-keto reductase family 1 member b10 | Type: enzyme | Action: nan
12793,tolrestat,aldose reductase,enzyme,INHIBITOR,Drug: tolrestat | Target: aldose reductase | Type: enzyme | Action: INHIBITOR
12794,tolterodine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: tolterodine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12795,tolterodine,muscarinic acetylcholine receptor m1,gpcr,,Drug: tolterodine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12796,tolterodine,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: tolterodine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
12797,tolterodine,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: tolterodine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
12798,tolterodine,muscarinic acetylcholine receptor m4,gpcr,,Drug: tolterodine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
12799,tolterodine,muscarinic acetylcholine receptor m5,gpcr,,Drug: tolterodine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
12800,tolterodine,muscarinic acetylcholine receptor m2,gpcr,,Drug: tolterodine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
12801,tolterodine,muscarinic acetylcholine receptor m1,gpcr,,Drug: tolterodine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
12802,tolterodine,muscarinic acetylcholine receptor m3,gpcr,,Drug: tolterodine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
12803,tolterodine,muscarinic acetylcholine receptor m5,gpcr,,Drug: tolterodine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
12804,tolterodine,muscarinic acetylcholine receptor m4,gpcr,,Drug: tolterodine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
12805,topiramate,sodium channel protein type 5 subunit alpha,ion channel,BLOCKER,Drug: topiramate | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: BLOCKER
12806,topiramate,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: topiramate | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
12807,topiramate,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: topiramate | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
12808,topiramate,carbonic anhydrase 2,enzyme,INHIBITOR,Drug: topiramate | Target: carbonic anhydrase 2 | Type: enzyme | Action: INHIBITOR
12809,topiramate,carbonic anhydrase 1,enzyme,,Drug: topiramate | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
12810,topiramate,carbonic anhydrase 4,enzyme,INHIBITOR,Drug: topiramate | Target: carbonic anhydrase 4 | Type: enzyme | Action: INHIBITOR
12811,topiramate,carbonic anhydrase 9,enzyme,,Drug: topiramate | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
12812,topiramate,carbonic anhydrase 12,enzyme,,Drug: topiramate | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
12813,topiramate,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: topiramate | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
12814,topiramate,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: topiramate | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
12815,topiramate,carbonic anhydrase 7,enzyme,,Drug: topiramate | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
12816,topiramate,carbonic anhydrase,enzyme,,Drug: topiramate | Target: carbonic anhydrase | Type: enzyme | Action: nan
12817,topiramate,carbonic anhydrase 6,enzyme,,Drug: topiramate | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
12818,topiramate,carbonic anhydrase 14,enzyme,,Drug: topiramate | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
12819,topiramate,carbonic anhydrase 13,enzyme,,Drug: topiramate | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
12820,topiramate,carbonic anhydrase 4,enzyme,,Drug: topiramate | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
12821,topiramate,sodium channel protein type 2 subunit alpha,ion channel,,Drug: topiramate | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: nan
12822,topiramate,carbonic anhydrase 2,enzyme,,Drug: topiramate | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
12823,topiramate,carbonic anhydrase,enzyme,,Drug: topiramate | Target: carbonic anhydrase | Type: enzyme | Action: nan
12824,topiramate,carbonic anhydrase,enzyme,,Drug: topiramate | Target: carbonic anhydrase | Type: enzyme | Action: nan
12825,topiramate,carbonic anhydrase 13,enzyme,,Drug: topiramate | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
12826,topiramate,carbonic anhydrase 15,enzyme,,Drug: topiramate | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
12827,topiramate,carbonic anhydrase,enzyme,,Drug: topiramate | Target: carbonic anhydrase | Type: enzyme | Action: nan
12828,topiramate,carbonic anhydrase,enzyme,,Drug: topiramate | Target: carbonic anhydrase | Type: enzyme | Action: nan
12829,topiramate,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: topiramate | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
12830,topiramate,carbonic anhydrase,enzyme,,Drug: topiramate | Target: carbonic anhydrase | Type: enzyme | Action: nan
12831,topiramate,alpha carbonic anhydrase,enzyme,,Drug: topiramate | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
12832,topiramate,carbonic anhydrase,enzyme,,Drug: topiramate | Target: carbonic anhydrase | Type: enzyme | Action: nan
12833,topiramate,carbonic anhydrase 2,enzyme,,Drug: topiramate | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
12834,topiramate,astrosclerin-3,enzyme,,Drug: topiramate | Target: astrosclerin-3 | Type: enzyme | Action: nan
12835,topiramate,beta-carbonic anhydrase 1,enzyme,,Drug: topiramate | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
12836,topiramate,delta carbonic anhydrase,unclassified,,Drug: topiramate | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
12837,topiramate,carbonic anhydrase 2,enzyme,,Drug: topiramate | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
12838,topiramate,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE MODULATOR,Drug: topiramate | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
12839,topiramate,carbonic anhydrase v,enzyme,,Drug: topiramate | Target: carbonic anhydrase v | Type: enzyme | Action: nan
12840,topiramate,glutamate receptor ionotropic kainate,ion channel,ANTAGONIST,Drug: topiramate | Target: glutamate receptor ionotropic kainate | Type: ion channel | Action: ANTAGONIST
12841,topiramate,glutamate receptor ionotropic ampa,ion channel,ANTAGONIST,Drug: topiramate | Target: glutamate receptor ionotropic ampa | Type: ion channel | Action: ANTAGONIST
12842,topiramate,"carbonic anhydrase, alpha family",unclassified,,"Drug: topiramate | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
12843,topiramate,carbonate dehydratase,enzyme,,Drug: topiramate | Target: carbonate dehydratase | Type: enzyme | Action: nan
12844,topotecan,cytochrome p450 3a4,enzyme,,Drug: topotecan | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
12845,topotecan,multidrug resistance protein 1,transporter,,Drug: topotecan | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
12846,topotecan,canalicular multispecific organic anion transporter 1,transporter,,Drug: topotecan | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
12847,topotecan,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: topotecan | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
12848,topotecan,atp-binding cassette sub-family g member 2,transporter,,Drug: topotecan | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
12849,topotecan,multidrug resistance-associated protein 4,transporter,,Drug: topotecan | Target: multidrug resistance-associated protein 4 | Type: transporter | Action: nan
12850,topotecan,"dna topoisomerase i, mitochondrial",enzyme,INHIBITOR,"Drug: topotecan | Target: dna topoisomerase i, mitochondrial | Type: enzyme | Action: INHIBITOR"
12851,topotecan,dna topoisomerase 1,enzyme,,Drug: topotecan | Target: dna topoisomerase 1 | Type: enzyme | Action: nan
12852,topotecan,hypoxia-inducible factor 1-alpha,transcription factor,,Drug: topotecan | Target: hypoxia-inducible factor 1-alpha | Type: transcription factor | Action: nan
12853,topotecan,solute carrier family 22 member 2,transporter,,Drug: topotecan | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
12854,topotecan,multidrug and toxin extrusion protein 1,transporter,,Drug: topotecan | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
12855,topotecan,multidrug and toxin extrusion protein 2,transporter,,Drug: topotecan | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
12856,topotecan,dna topoisomerase i,enzyme,,Drug: topotecan | Target: dna topoisomerase i | Type: enzyme | Action: nan
12857,topotecan,orf 73,unclassified,,Drug: topotecan | Target: orf 73 | Type: unclassified | Action: nan
12858,topotecan,udp-galactopyranose mutase,enzyme,,Drug: topotecan | Target: udp-galactopyranose mutase | Type: enzyme | Action: nan
12859,torsemide,solute carrier family 12 member 1,transporter,INHIBITOR,Drug: torsemide | Target: solute carrier family 12 member 1 | Type: transporter | Action: INHIBITOR
12860,toremifene,5-hydroxytryptamine receptor 6,gpcr,,Drug: toremifene | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
12861,toremifene,estrogen receptor,nuclear hormone receptor,MODULATOR,Drug: toremifene | Target: estrogen receptor | Type: nuclear hormone receptor | Action: MODULATOR
12862,toremifene,estrogen-related receptor gamma,nuclear hormone receptor,,Drug: toremifene | Target: estrogen-related receptor gamma | Type: nuclear hormone receptor | Action: nan
12863,toremifene,envelope glycoprotein,unclassified,,Drug: toremifene | Target: envelope glycoprotein | Type: unclassified | Action: nan
12864,tramadol,mu-type opioid receptor,gpcr,AGONIST,Drug: tramadol | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
12865,tramadol,sodium-dependent serotonin transporter,transporter,,Drug: tramadol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
12866,tramadol,sodium-dependent noradrenaline transporter,transporter,,Drug: tramadol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12867,tramadol,kappa-type opioid receptor,gpcr,,Drug: tramadol | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
12868,tramadol,delta-type opioid receptor,gpcr,,Drug: tramadol | Target: delta-type opioid receptor | Type: gpcr | Action: nan
12869,tramadol,solute carrier family 22 member 1,transporter,,Drug: tramadol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
12870,tramadol,mu-type opioid receptor,gpcr,,Drug: tramadol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
12871,trandolapril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: trandolapril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
12872,tranexamic acid,plasminogen,enzyme,INHIBITOR,Drug: tranexamic acid | Target: plasminogen | Type: enzyme | Action: INHIBITOR
12873,tranilast,hematopoietic prostaglandin d synthase,enzyme,,Drug: tranilast | Target: hematopoietic prostaglandin d synthase | Type: enzyme | Action: nan
12874,tranylcypromine,sodium-dependent noradrenaline transporter,transporter,,Drug: tranylcypromine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12875,tranylcypromine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tranylcypromine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12876,tranylcypromine,sodium-dependent dopamine transporter,transporter,,Drug: tranylcypromine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
12877,tranylcypromine,cytochrome p450 2a6,enzyme,,Drug: tranylcypromine | Target: cytochrome p450 2a6 | Type: enzyme | Action: nan
12878,tranylcypromine,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: tranylcypromine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
12879,tranylcypromine,amine oxidase [flavin-containing] a,enzyme,,Drug: tranylcypromine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
12880,tranylcypromine,cytochrome p450 2c19,enzyme,,Drug: tranylcypromine | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
12881,tranylcypromine,cytochrome p450 2b6,enzyme,,Drug: tranylcypromine | Target: cytochrome p450 2b6 | Type: enzyme | Action: nan
12882,tranylcypromine,cationic trypsin,enzyme,,Drug: tranylcypromine | Target: cationic trypsin | Type: enzyme | Action: nan
12883,tranylcypromine,d(2) dopamine receptor,gpcr,,Drug: tranylcypromine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12884,tranylcypromine,amine oxidase [flavin-containing] b,enzyme,,Drug: tranylcypromine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
12885,tranylcypromine,amine oxidase [flavin-containing] a,enzyme,,Drug: tranylcypromine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
12886,tranylcypromine,d(3) dopamine receptor,gpcr,,Drug: tranylcypromine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12887,tranylcypromine,lysine-specific histone demethylase 1a,enzyme,,Drug: tranylcypromine | Target: lysine-specific histone demethylase 1a | Type: enzyme | Action: nan
12888,tranylcypromine,lysine-specific histone demethylase 1b,enzyme,,Drug: tranylcypromine | Target: lysine-specific histone demethylase 1b | Type: enzyme | Action: nan
12889,tranylcypromine,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,enzyme,,Drug: tranylcypromine | Target: 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase | Type: enzyme | Action: nan
12890,travoprost,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: travoprost | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
12891,travoprost,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: travoprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
12892,trazodone,d(1a) dopamine receptor,gpcr,,Drug: trazodone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
12893,trazodone,d(2) dopamine receptor,gpcr,,Drug: trazodone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
12894,trazodone,alpha-2a adrenergic receptor,gpcr,,Drug: trazodone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
12895,trazodone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: trazodone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
12896,trazodone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: trazodone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
12897,trazodone,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: trazodone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
12898,trazodone,sodium-dependent noradrenaline transporter,transporter,,Drug: trazodone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
12899,trazodone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: trazodone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12900,trazodone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: trazodone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
12901,trazodone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: trazodone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
12902,trazodone,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: trazodone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
12903,trazodone,5-hydroxytryptamine receptor 7,gpcr,,Drug: trazodone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
12904,trazodone,alpha-1a adrenergic receptor,gpcr,,Drug: trazodone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12905,trazodone,alpha-2b adrenergic receptor,gpcr,,Drug: trazodone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
12906,trazodone,d(3) dopamine receptor,gpcr,,Drug: trazodone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
12907,trazodone,histamine h1 receptor,gpcr,,Drug: trazodone | Target: histamine h1 receptor | Type: gpcr | Action: nan
12908,trazodone,histamine h2 receptor,gpcr,,Drug: trazodone | Target: histamine h2 receptor | Type: gpcr | Action: nan
12909,trazodone,5-hydroxytryptamine receptor 1d,gpcr,,Drug: trazodone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
12910,trazodone,alpha-2c adrenergic receptor,gpcr,,Drug: trazodone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
12911,trazodone,sodium-dependent dopamine transporter,transporter,,Drug: trazodone | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
12912,trazodone,d(4) dopamine receptor,gpcr,,Drug: trazodone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
12913,trazodone,alpha-1d adrenergic receptor,gpcr,,Drug: trazodone | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
12914,trazodone,alpha-1b adrenergic receptor,gpcr,,Drug: trazodone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
12915,trazodone,5-hydroxytryptamine receptor 1b,gpcr,,Drug: trazodone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
12916,trazodone,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: trazodone | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
12917,trazodone,alpha-1a adrenergic receptor,gpcr,,Drug: trazodone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
12918,trazodone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: trazodone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
12919,trazodone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: trazodone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
12920,trazodone,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: trazodone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
12921,trazodone,"hla class i histocompatibility antigen, a-3 alpha chain",unclassified,,"Drug: trazodone | Target: hla class i histocompatibility antigen, a-3 alpha chain | Type: unclassified | Action: nan"
12922,treprostinil,prostaglandin e2 receptor ep1 subtype,gpcr,AGONIST,Drug: treprostinil | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: AGONIST
12923,treprostinil,prostaglandin e2 receptor ep3 subtype,gpcr,AGONIST,Drug: treprostinil | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: AGONIST
12924,treprostinil,prostacyclin receptor,gpcr,AGONIST,Drug: treprostinil | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
12925,treprostinil,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: treprostinil | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
12926,treprostinil,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: treprostinil | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
12927,treprostinil,prostaglandin d2 receptor,gpcr,AGONIST,Drug: treprostinil | Target: prostaglandin d2 receptor | Type: gpcr | Action: AGONIST
12928,tretinoin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: tretinoin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
12929,tretinoin,adenosine receptor a3,gpcr,,Drug: tretinoin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
12930,tretinoin,retinoic acid receptor alpha,nuclear hormone receptor,AGONIST,Drug: tretinoin | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
12931,tretinoin,11-cis retinol dehydrogenase,enzyme,,Drug: tretinoin | Target: 11-cis retinol dehydrogenase | Type: enzyme | Action: nan
12932,tretinoin,nuclear receptor ror-alpha,nuclear hormone receptor,,Drug: tretinoin | Target: nuclear receptor ror-alpha | Type: nuclear hormone receptor | Action: nan
12933,tretinoin,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: tretinoin | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
12934,tretinoin,retinoic acid receptor rxr-beta,nuclear hormone receptor,,Drug: tretinoin | Target: retinoic acid receptor rxr-beta | Type: nuclear hormone receptor | Action: nan
12935,tretinoin,retinoic acid receptor rxr-gamma,nuclear hormone receptor,,Drug: tretinoin | Target: retinoic acid receptor rxr-gamma | Type: nuclear hormone receptor | Action: nan
12936,tretinoin,retinoic acid receptor beta,nuclear hormone receptor,AGONIST,Drug: tretinoin | Target: retinoic acid receptor beta | Type: nuclear hormone receptor | Action: AGONIST
12937,tretinoin,retinoic acid receptor gamma,nuclear hormone receptor,AGONIST,Drug: tretinoin | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
12938,tretinoin,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,AGONIST,Drug: tretinoin | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: AGONIST
12939,tretinoin,nuclear receptor ror-beta,nuclear hormone receptor,ANTAGONIST,Drug: tretinoin | Target: nuclear receptor ror-beta | Type: nuclear hormone receptor | Action: ANTAGONIST
12940,tretinoin,nuclear receptor ror-gamma,nuclear hormone receptor,,Drug: tretinoin | Target: nuclear receptor ror-gamma | Type: nuclear hormone receptor | Action: nan
12941,tretinoin,mitogen-activated protein kinase 1,kinase,,Drug: tretinoin | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
12942,tretinoin,cellular retinoic acid-binding protein 1,cytosolic other,,Drug: tretinoin | Target: cellular retinoic acid-binding protein 1 | Type: cytosolic other | Action: nan
12943,tretinoin,retinoic acid receptor rxr-beta,transcription factor,,Drug: tretinoin | Target: retinoic acid receptor rxr-beta | Type: transcription factor | Action: nan
12944,tretinoin,retinoic acid receptor rxr-gamma,transcription factor,,Drug: tretinoin | Target: retinoic acid receptor rxr-gamma | Type: transcription factor | Action: nan
12945,tretinoin,cellular retinoic acid-binding protein 1,cytosolic other,,Drug: tretinoin | Target: cellular retinoic acid-binding protein 1 | Type: cytosolic other | Action: nan
12946,tretinoin,cellular retinoic acid-binding protein 2,cytosolic other,,Drug: tretinoin | Target: cellular retinoic acid-binding protein 2 | Type: cytosolic other | Action: nan
12947,tretinoin,retinoic acid receptor alpha,transcription factor,,Drug: tretinoin | Target: retinoic acid receptor alpha | Type: transcription factor | Action: nan
12948,tretinoin,retinoic acid receptor rxr-alpha,transcription factor,,Drug: tretinoin | Target: retinoic acid receptor rxr-alpha | Type: transcription factor | Action: nan
12949,tretinoin,retinoic acid receptor beta,transcription factor,,Drug: tretinoin | Target: retinoic acid receptor beta | Type: transcription factor | Action: nan
12950,tretinoin,retinoic acid receptor gamma,transcription factor,,Drug: tretinoin | Target: retinoic acid receptor gamma | Type: transcription factor | Action: nan
12951,tretinoin,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: tretinoin | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
12952,tretinoin,nuclear receptor subfamily 2 group e member 1,nuclear hormone receptor,AGONIST,Drug: tretinoin | Target: nuclear receptor subfamily 2 group e member 1 | Type: nuclear hormone receptor | Action: AGONIST
12953,tretinoin,nuclear receptor subfamily 2 group c member 2,nuclear other,AGONIST,Drug: tretinoin | Target: nuclear receptor subfamily 2 group c member 2 | Type: nuclear other | Action: AGONIST
12954,tretinoin,peptidyl-prolyl cis-trans isomerase nima-interacting 1,unclassified,,Drug: tretinoin | Target: peptidyl-prolyl cis-trans isomerase nima-interacting 1 | Type: unclassified | Action: nan
12955,tretinoin,nuclear receptor subfamily 2 group e member 1,nuclear other,AGONIST,Drug: tretinoin | Target: nuclear receptor subfamily 2 group e member 1 | Type: nuclear other | Action: AGONIST
12956,tretoquinol,beta-1 adrenergic receptor,gpcr,,Drug: tretoquinol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
12957,tretoquinol,beta-2 adrenergic receptor,gpcr,,Drug: tretoquinol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
12958,tretoquinol,thromboxane a2 receptor,gpcr,,Drug: tretoquinol | Target: thromboxane a2 receptor | Type: gpcr | Action: nan
12959,tretoquinol,beta-2 adrenergic receptor,gpcr,,Drug: tretoquinol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
12960,tretoquinol,beta-1 adrenergic receptor,gpcr,,Drug: tretoquinol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
12961,tretoquinol,adrenergic receptor beta,gpcr,,Drug: tretoquinol | Target: adrenergic receptor beta | Type: gpcr | Action: nan
12962,tretoquinol,dopamine receptor,gpcr,,Drug: tretoquinol | Target: dopamine receptor | Type: gpcr | Action: nan
12963,tretoquinol,adrenergic receptor alpha,gpcr,,Drug: tretoquinol | Target: adrenergic receptor alpha | Type: gpcr | Action: nan
12964,tretoquinol,adrenergic receptor beta,gpcr,,Drug: tretoquinol | Target: adrenergic receptor beta | Type: gpcr | Action: nan
12965,triamcinolone,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: triamcinolone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
12966,triamcinolone,annexin a1,cytosolic other,,Drug: triamcinolone | Target: annexin a1 | Type: cytosolic other | Action: nan
12967,triamcinolone,progesterone receptor,nuclear hormone receptor,,Drug: triamcinolone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
12968,triamcinolone acetonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: triamcinolone acetonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
12969,triamcinolone acetonide,annexin a1,cytosolic other,,Drug: triamcinolone acetonide | Target: annexin a1 | Type: cytosolic other | Action: nan
12970,triamcinolone acetonide,progesterone receptor,transcription factor,,Drug: triamcinolone acetonide | Target: progesterone receptor | Type: transcription factor | Action: nan
12971,triamcinolone diacetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: triamcinolone diacetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
12972,triamterene,solute carrier family 12 member 1,transporter,,Drug: triamterene | Target: solute carrier family 12 member 1 | Type: transporter | Action: nan
12973,triamterene,cytochrome p450 2d6,enzyme,,Drug: triamterene | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
12974,triamterene,caspase-1,enzyme,,Drug: triamterene | Target: caspase-1 | Type: enzyme | Action: nan
12975,triamterene,cathepsin g,enzyme,,Drug: triamterene | Target: cathepsin g | Type: enzyme | Action: nan
12976,triamterene,pteridine reductase 1,enzyme,,Drug: triamterene | Target: pteridine reductase 1 | Type: enzyme | Action: nan
12977,triamterene,"amiloride-sensitive sodium channel, enac",ion channel,BLOCKER,"Drug: triamterene | Target: amiloride-sensitive sodium channel, enac | Type: ion channel | Action: BLOCKER"
12978,triazolam,cytochrome p450 3a4,enzyme,,Drug: triazolam | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
12979,triazolam,platelet-activating factor receptor,gpcr,,Drug: triazolam | Target: platelet-activating factor receptor | Type: gpcr | Action: nan
12980,triazolam,cholecystokinin receptor type a,gpcr,,Drug: triazolam | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
12981,triazolam,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12982,triazolam,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12983,triazolam,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12984,triazolam,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12985,triazolam,gaba-a receptor alpha-1/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba-a receptor alpha-1/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12986,triazolam,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12987,triazolam,gaba-a receptor; anion channel,ion channel,,Drug: triazolam | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
12988,triazolam,gaba-a receptor,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba-a receptor | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12989,triazolam,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12990,triazolam,gaba a receptor alpha-3/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba a receptor alpha-3/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12991,triazolam,gaba a receptor alpha-5/beta-3/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba a receptor alpha-5/beta-3/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12992,triazolam,gaba a receptor alpha-5/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba a receptor alpha-5/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12993,triazolam,gaba a receptor alpha-5/beta-2/gamma-3,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: triazolam | Target: gaba a receptor alpha-5/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
12994,trichlormethiazide,carbonic anhydrase 2,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
12995,trichlormethiazide,solute carrier family 12 member 3,transporter,INHIBITOR,Drug: trichlormethiazide | Target: solute carrier family 12 member 3 | Type: transporter | Action: INHIBITOR
12996,trichlormethiazide,carbonic anhydrase 1,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
12997,trichlormethiazide,carbonic anhydrase 4,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
12998,trichlormethiazide,carbonic anhydrase 9,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
12999,trichlormethiazide,carbonic anhydrase 12,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
13000,trichlormethiazide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: trichlormethiazide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
13001,trichlormethiazide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: trichlormethiazide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
13002,trichlormethiazide,carbonic anhydrase 7,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
13003,trichlormethiazide,carbonic anhydrase 6,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
13004,trichlormethiazide,carbonic anhydrase 14,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
13005,trichlormethiazide,carbonic anhydrase 13,enzyme,,Drug: trichlormethiazide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
13006,triclabendazole,cruzipain,enzyme,,Drug: triclabendazole | Target: cruzipain | Type: enzyme | Action: nan
13007,triclofos,gaba-a receptor; anion channel,ion channel,POSITIVE MODULATOR,Drug: triclofos | Target: gaba-a receptor; anion channel | Type: ion channel | Action: POSITIVE MODULATOR
13008,tridihexethyl,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: tridihexethyl | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
13009,tridihexethyl,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: tridihexethyl | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
13010,trientine,carbonic anhydrase 2,enzyme,,Drug: trientine | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13011,trientine,carbonic anhydrase 1,enzyme,,Drug: trientine | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
13012,trientine,carbonic anhydrase 4,enzyme,,Drug: trientine | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
13013,trientine,carbonic anhydrase 9,enzyme,,Drug: trientine | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
13014,trientine,carbonic anhydrase 12,enzyme,,Drug: trientine | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
13015,trientine,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: trientine | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
13016,trientine,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: trientine | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
13017,trientine,carbonic anhydrase 7,enzyme,,Drug: trientine | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
13018,trientine,carbonic anhydrase 3,enzyme,,Drug: trientine | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
13019,trientine,carbonic anhydrase 6,enzyme,,Drug: trientine | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
13020,trientine,carbonic anhydrase 14,enzyme,,Drug: trientine | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
13021,trientine,carbonic anhydrase 13,enzyme,,Drug: trientine | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
13022,trientine,carbonic anhydrase 15,enzyme,,Drug: trientine | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
13023,trifluoperazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: trifluoperazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13024,trifluoperazine,alpha-2a adrenergic receptor,gpcr,,Drug: trifluoperazine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
13025,trifluoperazine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: trifluoperazine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
13026,trifluoperazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: trifluoperazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
13027,trifluoperazine,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: trifluoperazine | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
13028,trifluoperazine,multidrug resistance protein 1,transporter,,Drug: trifluoperazine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
13029,trifluoperazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: trifluoperazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13030,trifluoperazine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: trifluoperazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
13031,trifluoperazine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: trifluoperazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
13032,trifluoperazine,5-hydroxytryptamine receptor 6,gpcr,,Drug: trifluoperazine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
13033,trifluoperazine,5-hydroxytryptamine receptor 7,gpcr,,Drug: trifluoperazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
13034,trifluoperazine,alpha-1a adrenergic receptor,gpcr,,Drug: trifluoperazine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
13035,trifluoperazine,alpha-2b adrenergic receptor,gpcr,,Drug: trifluoperazine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
13036,trifluoperazine,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: trifluoperazine | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13037,trifluoperazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: trifluoperazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
13038,trifluoperazine,muscarinic acetylcholine receptor m3,gpcr,,Drug: trifluoperazine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
13039,trifluoperazine,alpha-2c adrenergic receptor,gpcr,,Drug: trifluoperazine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
13040,trifluoperazine,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: trifluoperazine | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13041,trifluoperazine,calmodulin,cytosolic other,,Drug: trifluoperazine | Target: calmodulin | Type: cytosolic other | Action: nan
13042,trifluoperazine,trypanothione reductase,enzyme,,Drug: trifluoperazine | Target: trypanothione reductase | Type: enzyme | Action: nan
13043,trifluoperazine,d(2) dopamine receptor,gpcr,,Drug: trifluoperazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
13044,trifluoperazine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: trifluoperazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13045,trifluoperazine,dna-dependent protein kinase catalytic subunit,kinase,,Drug: trifluoperazine | Target: dna-dependent protein kinase catalytic subunit | Type: kinase | Action: nan
13046,trifluoperazine,ns3,enzyme,,Drug: trifluoperazine | Target: ns3 | Type: enzyme | Action: nan
13047,trifluoperazine,beta-glucuronidase,enzyme,,Drug: trifluoperazine | Target: beta-glucuronidase | Type: enzyme | Action: nan
13048,trifluoperazine,lysozyme c-1,enzyme,,Drug: trifluoperazine | Target: lysozyme c-1 | Type: enzyme | Action: nan
13049,trifluoperazine,c-8 sterol isomerase,enzyme,,Drug: trifluoperazine | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
13050,trifluoperazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: trifluoperazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
13051,trifluoperazine,emopamil-binding protein-like,enzyme,,Drug: trifluoperazine | Target: emopamil-binding protein-like | Type: enzyme | Action: nan
13052,trifluoperazine,adrenergic receptor alpha-1,gpcr,,Drug: trifluoperazine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
13053,trifluoperazine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: trifluoperazine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
13054,trifluoperazine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: trifluoperazine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
13055,trifluoperazine,calmodulin,cytosolic other,,Drug: trifluoperazine | Target: calmodulin | Type: cytosolic other | Action: nan
13056,trifluperidol,d(2) dopamine receptor,gpcr,,Drug: trifluperidol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
13057,trifluperidol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: trifluperidol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
13058,trifluperidol,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: trifluperidol | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
13059,trifluperidol,d(3) dopamine receptor,gpcr,,Drug: trifluperidol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
13060,trifluperidol,d(4) dopamine receptor,gpcr,,Drug: trifluperidol | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
13061,trifluperidol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: trifluperidol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
13062,trifluperidol,c-8 sterol isomerase,enzyme,,Drug: trifluperidol | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
13063,triflupromazine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: triflupromazine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13064,triflupromazine,multidrug resistance protein 1,transporter,,Drug: triflupromazine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
13065,triflupromazine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: triflupromazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
13066,triflupromazine,trypanothione reductase,enzyme,,Drug: triflupromazine | Target: trypanothione reductase | Type: enzyme | Action: nan
13067,triflupromazine,cholinesterase,enzyme,,Drug: triflupromazine | Target: cholinesterase | Type: enzyme | Action: nan
13068,triflupromazine,pleiotropic abc efflux transporter of multiple drugs,transporter,,Drug: triflupromazine | Target: pleiotropic abc efflux transporter of multiple drugs | Type: transporter | Action: nan
13069,trifluridine,thymidine kinase,kinase,,Drug: trifluridine | Target: thymidine kinase | Type: kinase | Action: nan
13070,trifluridine,thymidylate kinase,kinase,,Drug: trifluridine | Target: thymidylate kinase | Type: kinase | Action: nan
13071,trihexyphenidyl,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: trihexyphenidyl | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
13072,trihexyphenidyl,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: trihexyphenidyl | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
13073,trihexyphenidyl,muscarinic acetylcholine receptor m2,gpcr,,Drug: trihexyphenidyl | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13074,trihexyphenidyl,muscarinic acetylcholine receptor m3,gpcr,,Drug: trihexyphenidyl | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
13075,trihexyphenidyl,muscarinic acetylcholine receptor m4,gpcr,,Drug: trihexyphenidyl | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
13076,trihexyphenidyl,muscarinic acetylcholine receptor m5,gpcr,,Drug: trihexyphenidyl | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
13077,trihexyphenidyl,cytochrome p450 2d6,enzyme,,Drug: trihexyphenidyl | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
13078,trilostane,3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type 2,enzyme,INHIBITOR,Drug: trilostane | Target: 3 beta-hydroxysteroid dehydrogenase/delta 5-->4-isomerase type 2 | Type: enzyme | Action: INHIBITOR
13079,alimemazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: alimemazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
13080,alimemazine,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: alimemazine | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
13081,trimetazidine,"carnitine o-palmitoyltransferase 1, muscle isoform",enzyme,,"Drug: trimetazidine | Target: carnitine o-palmitoyltransferase 1, muscle isoform | Type: enzyme | Action: nan"
13082,trimethadione,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,BLOCKER,Drug: trimethadione | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: BLOCKER
13083,trimetaphan,neuronal acetylcholine receptor subunit alpha-10,ion channel,,Drug: trimetaphan | Target: neuronal acetylcholine receptor subunit alpha-10 | Type: ion channel | Action: nan
13084,trimetaphan,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: trimetaphan | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
13085,trimetaphan,acetylcholine receptor subunit alpha,ion channel,,Drug: trimetaphan | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
13086,trimetaphan,nicotinic acetylcholine receptor alpha 5 subunit,ion channel,,Drug: trimetaphan | Target: nicotinic acetylcholine receptor alpha 5 subunit | Type: ion channel | Action: nan
13087,trimetaphan,neuronal acetylcholine receptor; alpha3/beta4,ion channel,ANTAGONIST,Drug: trimetaphan | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: ANTAGONIST
13088,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13089,trimethoprim,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimethoprim | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13090,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13091,trimethoprim,solute carrier family 22 member 1,transporter,,Drug: trimethoprim | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
13092,trimethoprim,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimethoprim | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13093,trimethoprim,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimethoprim | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13094,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13095,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13096,trimethoprim,dihydrofolate reductase,enzyme,INHIBITOR,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: INHIBITOR
13097,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13098,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13099,trimethoprim,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimethoprim | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13100,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13101,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13102,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13103,trimethoprim,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimethoprim | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13104,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13105,trimethoprim,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimethoprim | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13106,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13107,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13108,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13109,trimethoprim,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimethoprim | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13110,trimethoprim,dihydrofolate reductase type 1,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase type 1 | Type: enzyme | Action: nan
13111,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13112,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13113,trimethoprim,dihydrofolate reductase,enzyme,,Drug: trimethoprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13114,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13115,trimetrexate,"folylpolyglutamate synthase, mitochondrial",enzyme,,"Drug: trimetrexate | Target: folylpolyglutamate synthase, mitochondrial | Type: enzyme | Action: nan"
13116,trimetrexate,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimetrexate | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13117,trimetrexate,dihydrofolate reductase,enzyme,INHIBITOR,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: INHIBITOR
13118,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13119,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13120,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13121,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13122,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13123,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13124,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13125,trimetrexate,dihydrofolate reductase,enzyme,,Drug: trimetrexate | Target: dihydrofolate reductase | Type: enzyme | Action: nan
13126,trimetrexate,bifunctional dihydrofolate reductase-thymidylate synthase,enzyme,,Drug: trimetrexate | Target: bifunctional dihydrofolate reductase-thymidylate synthase | Type: enzyme | Action: nan
13127,trimipramine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: trimipramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
13128,trimipramine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: trimipramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
13129,trimipramine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: trimipramine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
13130,trimipramine,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: trimipramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
13131,trimipramine,solute carrier family 22 member 1,transporter,,Drug: trimipramine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
13132,trioxsalen,adenosine receptor a2a,gpcr,,Drug: trioxsalen | Target: adenosine receptor a2a | Type: gpcr | Action: nan
13133,trioxsalen,5-hydroxytryptamine receptor 2c,gpcr,,Drug: trioxsalen | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
13134,trioxsalen,amine oxidase [flavin-containing] a,enzyme,,Drug: trioxsalen | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
13135,triparanol,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: triparanol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
13136,triparanol,"3-beta-hydroxysteroid-delta(8),delta(7)-isomerase",enzyme,,"Drug: triparanol | Target: 3-beta-hydroxysteroid-delta(8),delta(7)-isomerase | Type: enzyme | Action: nan"
13137,triparanol,c-8 sterol isomerase,enzyme,,Drug: triparanol | Target: c-8 sterol isomerase | Type: enzyme | Action: nan
13138,tripelennamine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: tripelennamine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
13139,triprolidine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: triprolidine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
13140,triprolidine,histamine h1 receptor,gpcr,,Drug: triprolidine | Target: histamine h1 receptor | Type: gpcr | Action: nan
13141,troglitazone,cytochrome p450 3a4,enzyme,,Drug: troglitazone | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
13142,troglitazone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: troglitazone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
13143,troglitazone,adenosine receptor a3,gpcr,,Drug: troglitazone | Target: adenosine receptor a3 | Type: gpcr | Action: nan
13144,troglitazone,carbonic anhydrase 2,enzyme,,Drug: troglitazone | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13145,troglitazone,bile salt export pump,transporter,,Drug: troglitazone | Target: bile salt export pump | Type: transporter | Action: nan
13146,troglitazone,cytochrome p450 2c9,enzyme,,Drug: troglitazone | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
13147,troglitazone,amine oxidase [flavin-containing] b,enzyme,,Drug: troglitazone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
13148,troglitazone,amine oxidase [flavin-containing] a,enzyme,,Drug: troglitazone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
13149,troglitazone,aldose reductase,enzyme,,Drug: troglitazone | Target: aldose reductase | Type: enzyme | Action: nan
13150,troglitazone,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: troglitazone | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
13151,troglitazone,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: troglitazone | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
13152,troglitazone,"glycogen [starch] synthase, liver",enzyme,,"Drug: troglitazone | Target: glycogen [starch] synthase, liver | Type: enzyme | Action: nan"
13153,troglitazone,thromboxane-a synthase,enzyme,,Drug: troglitazone | Target: thromboxane-a synthase | Type: enzyme | Action: nan
13154,troglitazone,aldose reductase,enzyme,,Drug: troglitazone | Target: aldose reductase | Type: enzyme | Action: nan
13155,troglitazone,mitogen-activated protein kinase 1,kinase,,Drug: troglitazone | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
13156,troglitazone,amine oxidase [flavin-containing] b,enzyme,,Drug: troglitazone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
13157,troglitazone,amine oxidase [flavin-containing] a,enzyme,,Drug: troglitazone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
13158,troglitazone,"indoleamine 2,3-dioxygenase 2",enzyme,,"Drug: troglitazone | Target: indoleamine 2,3-dioxygenase 2 | Type: enzyme | Action: nan"
13159,troglitazone,udp-glucuronosyltransferase 1-6,enzyme,,Drug: troglitazone | Target: udp-glucuronosyltransferase 1-6 | Type: enzyme | Action: nan
13160,troglitazone,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: troglitazone | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
13161,troglitazone,bile salt export pump,transporter,,Drug: troglitazone | Target: bile salt export pump | Type: transporter | Action: nan
13162,troglitazone,polyunsaturated fatty acid lipoxygenase alox15,enzyme,,Drug: troglitazone | Target: polyunsaturated fatty acid lipoxygenase alox15 | Type: enzyme | Action: nan
13163,troleandomycin,cytochrome p450 3a4,enzyme,INHIBITOR,Drug: troleandomycin | Target: cytochrome p450 3a4 | Type: enzyme | Action: INHIBITOR
13164,tropicamide,muscarinic acetylcholine receptor m1,gpcr,,Drug: tropicamide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
13165,tropicamide,muscarinic acetylcholine receptor m2,gpcr,,Drug: tropicamide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13166,tropicamide,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: tropicamide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
13167,tropicamide,muscarinic acetylcholine receptor m4,gpcr,,Drug: tropicamide | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
13168,tropicamide,muscarinic acetylcholine receptor m5,gpcr,,Drug: tropicamide | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
13169,tropicamide,cytochrome p450 2c9,enzyme,,Drug: tropicamide | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
13170,tropicamide,cytochrome p450 2c19,enzyme,,Drug: tropicamide | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
13171,tropisetron,5-hydroxytryptamine receptor 4,gpcr,,Drug: tropisetron | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
13172,tropisetron,sodium-dependent serotonin transporter,transporter,,Drug: tropisetron | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13173,tropisetron,5-hydroxytryptamine receptor 1a,gpcr,,Drug: tropisetron | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13174,tropisetron,muscarinic acetylcholine receptor m5,gpcr,,Drug: tropisetron | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
13175,tropisetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: tropisetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
13176,tropisetron,glycine receptor subunit alpha-1,ion channel,ANTAGONIST,Drug: tropisetron | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: ANTAGONIST
13177,tropisetron,glycine receptor subunit alpha-2,ion channel,ANTAGONIST,Drug: tropisetron | Target: glycine receptor subunit alpha-2 | Type: ion channel | Action: ANTAGONIST
13178,tropisetron,5-hydroxytryptamine receptor 4,gpcr,,Drug: tropisetron | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
13179,tropisetron,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: tropisetron | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
13180,tropisetron,glycine receptor subunit beta,ion channel,ANTAGONIST,Drug: tropisetron | Target: glycine receptor subunit beta | Type: ion channel | Action: ANTAGONIST
13181,tropisetron,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: tropisetron | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
13182,tropisetron,5-hydroxytryptamine receptor 4,gpcr,,Drug: tropisetron | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
13183,tropisetron,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: tropisetron | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
13184,tropisetron,5-hydroxytryptamine receptor 3a,ion channel,,Drug: tropisetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
13185,tropisetron,serotonin 3 (5-ht3) receptor,ion channel,,Drug: tropisetron | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
13186,tropisetron,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: tropisetron | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
13187,tropisetron,acetylcholine receptor; alpha1/beta1/delta/gamma,ion channel,,Drug: tropisetron | Target: acetylcholine receptor; alpha1/beta1/delta/gamma | Type: ion channel | Action: nan
13188,tropisetron,serotonin 3 receptor (5ht3),ion channel,,Drug: tropisetron | Target: serotonin 3 receptor (5ht3) | Type: ion channel | Action: nan
13189,tropisetron,5-hydroxytryptamine receptor 3b,ion channel,,Drug: tropisetron | Target: 5-hydroxytryptamine receptor 3b | Type: ion channel | Action: nan
13190,tropisetron,neuronal acetylcholine receptor subunit alpha-3,ion channel,,Drug: tropisetron | Target: neuronal acetylcholine receptor subunit alpha-3 | Type: ion channel | Action: nan
13191,tropisetron,5-hydroxytryptamine receptor 4,gpcr,ANTAGONIST,Drug: tropisetron | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: ANTAGONIST
13192,trospium,muscarinic acetylcholine receptor m1,gpcr,,Drug: trospium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
13193,trospium,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: trospium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
13194,trospium,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: trospium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
13195,trospium,muscarinic acetylcholine receptor m5,gpcr,,Drug: trospium | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
13196,trovafloxacin,sodium-dependent dopamine transporter,transporter,,Drug: trovafloxacin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13197,trovafloxacin,thromboxane-a synthase,enzyme,,Drug: trovafloxacin | Target: thromboxane-a synthase | Type: enzyme | Action: nan
13198,trovafloxacin,topoisomerase iv,enzyme,INHIBITOR,Drug: trovafloxacin | Target: topoisomerase iv | Type: enzyme | Action: INHIBITOR
13199,trovafloxacin,dna gyrase,enzyme,INHIBITOR,Drug: trovafloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
13200,tryptophan,extracellular calcium-sensing receptor,gpcr,ALLOSTERIC MODULATOR,Drug: tryptophan | Target: extracellular calcium-sensing receptor | Type: gpcr | Action: ALLOSTERIC MODULATOR
13201,tryptophan,myeloperoxidase,enzyme,,Drug: tryptophan | Target: myeloperoxidase | Type: enzyme | Action: nan
13202,tryptophan,probable g-protein coupled receptor 139,gpcr,AGONIST,Drug: tryptophan | Target: probable g-protein coupled receptor 139 | Type: gpcr | Action: AGONIST
13204,tubocurarine,muscarinic acetylcholine receptor m2,gpcr,,Drug: tubocurarine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13205,tubocurarine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: tubocurarine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
13206,tubocurarine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: tubocurarine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
13207,tubocurarine,small conductance calcium-activated potassium channel protein 3,ion channel,BLOCKER,Drug: tubocurarine | Target: small conductance calcium-activated potassium channel protein 3 | Type: ion channel | Action: BLOCKER
13208,tubocurarine,small conductance calcium-activated potassium channel protein 2,ion channel,BLOCKER,Drug: tubocurarine | Target: small conductance calcium-activated potassium channel protein 2 | Type: ion channel | Action: BLOCKER
13209,tubocurarine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: tubocurarine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
13210,tubocurarine,small conductance calcium-activated potassium channel protein 3,ion channel,,Drug: tubocurarine | Target: small conductance calcium-activated potassium channel protein 3 | Type: ion channel | Action: nan
13211,tubocurarine,zinc-activated ligand-gated ion channel,ion channel,,Drug: tubocurarine | Target: zinc-activated ligand-gated ion channel | Type: ion channel | Action: nan
13212,tubocurarine,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: tubocurarine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
13213,tubocurarine,solute carrier family 22 member 2,transporter,,Drug: tubocurarine | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
13214,tubocurarine,multidrug and toxin extrusion protein 1,transporter,,Drug: tubocurarine | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
13215,tubocurarine,multidrug and toxin extrusion protein 2,transporter,,Drug: tubocurarine | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
13216,tubocurarine,acetylcholine receptor subunit alpha,ion channel,,Drug: tubocurarine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
13217,tubocurarine,nicotinic acetylcholine receptor alpha 5 subunit,ion channel,,Drug: tubocurarine | Target: nicotinic acetylcholine receptor alpha 5 subunit | Type: ion channel | Action: nan
13218,tubocurarine,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: tubocurarine | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
13219,tubocurarine,acetylcholine receptor,ion channel,ANTAGONIST,Drug: tubocurarine | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
13220,tubocurarine,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: tubocurarine | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
13221,tubocurarine,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: tubocurarine | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
13222,tubocurarine,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: tubocurarine | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
13223,tubocurarine,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: tubocurarine | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
13224,tubocurarine,acetylcholine receptor; alpha1/beta1/delta/gamma,ion channel,,Drug: tubocurarine | Target: acetylcholine receptor; alpha1/beta1/delta/gamma | Type: ion channel | Action: nan
13225,tubocurarine,serotonin 3 receptor (5ht3),ion channel,ANTAGONIST,Drug: tubocurarine | Target: serotonin 3 receptor (5ht3) | Type: ion channel | Action: ANTAGONIST
13226,tubocurarine,small conductance calcium-activated potassium channel protein 1,ion channel,BLOCKER,Drug: tubocurarine | Target: small conductance calcium-activated potassium channel protein 1 | Type: ion channel | Action: BLOCKER
13227,tubocurarine,gaba-a receptor; anion channel,ion channel,,Drug: tubocurarine | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
13228,tubocurarine,small conductance calcium-activated potassium channel protein 2,ion channel,BLOCKER,Drug: tubocurarine | Target: small conductance calcium-activated potassium channel protein 2 | Type: ion channel | Action: BLOCKER
13229,tulobuterol,beta-2 adrenergic receptor,gpcr,,Drug: tulobuterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
13230,tulobuterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: tulobuterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
13231,tyramine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: tyramine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
13232,tyramine,beta-secretase 1,enzyme,,Drug: tyramine | Target: beta-secretase 1 | Type: enzyme | Action: nan
13233,tyramine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: tyramine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
13234,tyramine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: tyramine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
13235,tyramine,tyr1,gpcr,,Drug: tyramine | Target: tyr1 | Type: gpcr | Action: nan
13236,tyramine,serotonin (5-ht) receptor,gpcr,,Drug: tyramine | Target: serotonin (5-ht) receptor | Type: gpcr | Action: nan
13237,tyramine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: tyramine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
13238,tyrosine,large neutral amino acids transporter small subunit 1,transporter,,Drug: tyrosine | Target: large neutral amino acids transporter small subunit 1 | Type: transporter | Action: nan
13239,ubenimex,72 kda type iv collagenase,enzyme,,Drug: ubenimex | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
13240,ubenimex,aminopeptidase n,enzyme,,Drug: ubenimex | Target: aminopeptidase n | Type: enzyme | Action: nan
13241,ubenimex,cytosol aminopeptidase,enzyme,,Drug: ubenimex | Target: cytosol aminopeptidase | Type: enzyme | Action: nan
13242,ubenimex,leukotriene a-4 hydrolase,enzyme,,Drug: ubenimex | Target: leukotriene a-4 hydrolase | Type: enzyme | Action: nan
13243,ubenimex,aminopeptidase n,enzyme,,Drug: ubenimex | Target: aminopeptidase n | Type: enzyme | Action: nan
13244,ubenimex,m1 family aminopeptidase,enzyme,,Drug: ubenimex | Target: m1 family aminopeptidase | Type: enzyme | Action: nan
13245,ubenimex,aminopeptidase b,enzyme,,Drug: ubenimex | Target: aminopeptidase b | Type: enzyme | Action: nan
13246,ubenimex,leucyl-cystinyl aminopeptidase,enzyme,,Drug: ubenimex | Target: leucyl-cystinyl aminopeptidase | Type: enzyme | Action: nan
13247,ubenimex,aminopeptidase b,enzyme,,Drug: ubenimex | Target: aminopeptidase b | Type: enzyme | Action: nan
13248,ubenimex,cytosol aminopeptidase,enzyme,,Drug: ubenimex | Target: cytosol aminopeptidase | Type: enzyme | Action: nan
13249,ubenimex,aminopeptidase n,enzyme,,Drug: ubenimex | Target: aminopeptidase n | Type: enzyme | Action: nan
13250,ubenimex,bacterial leucyl aminopeptidase,enzyme,,Drug: ubenimex | Target: bacterial leucyl aminopeptidase | Type: enzyme | Action: nan
13251,ubenimex,cytosol aminopeptidase,enzyme,,Drug: ubenimex | Target: cytosol aminopeptidase | Type: enzyme | Action: nan
13252,ubenimex,aminopeptidase n,enzyme,,Drug: ubenimex | Target: aminopeptidase n | Type: enzyme | Action: nan
13253,ubenimex,puromycin-sensitive aminopeptidase,enzyme,,Drug: ubenimex | Target: puromycin-sensitive aminopeptidase | Type: enzyme | Action: nan
13255,ubenimex,endoplasmic reticulum aminopeptidase 1,enzyme,,Drug: ubenimex | Target: endoplasmic reticulum aminopeptidase 1 | Type: enzyme | Action: nan
13256,urapidil,5-hydroxytryptamine receptor 1a,gpcr,,Drug: urapidil | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13257,urapidil,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: urapidil | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
13258,urapidil,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: urapidil | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
13259,urapidil,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: urapidil | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
13260,ursodiol,aldo-keto reductase family 1 member c2,enzyme,,Drug: ursodiol | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
13261,ursodiol,bile acid receptor,nuclear hormone receptor,AGONIST,Drug: ursodiol | Target: bile acid receptor | Type: nuclear hormone receptor | Action: AGONIST
13262,ursodiol,g-protein coupled bile acid receptor 1,gpcr,,Drug: ursodiol | Target: g-protein coupled bile acid receptor 1 | Type: gpcr | Action: nan
13263,ursodiol,m1-family alanyl aminopeptidase,enzyme,,Drug: ursodiol | Target: m1-family alanyl aminopeptidase | Type: enzyme | Action: nan
13264,ursodiol,cdgsh iron-sulfur domain-containing protein 1,unclassified,,Drug: ursodiol | Target: cdgsh iron-sulfur domain-containing protein 1 | Type: unclassified | Action: nan
13265,valaciclovir,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: valaciclovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
13266,valdecoxib,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: valdecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
13267,valdecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: valdecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
13268,valdecoxib,sodium-dependent noradrenaline transporter,transporter,,Drug: valdecoxib | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
13269,valdecoxib,5-hydroxytryptamine receptor 2b,gpcr,,Drug: valdecoxib | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
13270,valdecoxib,carbonic anhydrase 2,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13271,valdecoxib,carbonic anhydrase 1,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
13272,valdecoxib,carbonic anhydrase 4,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
13273,valdecoxib,carbonic anhydrase 9,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
13274,valdecoxib,carbonic anhydrase 12,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
13275,valdecoxib,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: valdecoxib | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
13276,valdecoxib,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: valdecoxib | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
13277,valdecoxib,carbonic anhydrase 7,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
13278,valdecoxib,carbonic anhydrase 3,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
13279,valdecoxib,carbonic anhydrase 6,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
13280,valdecoxib,carbonic anhydrase 14,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
13281,valdecoxib,cytochrome c oxidase subunit 2,enzyme,,Drug: valdecoxib | Target: cytochrome c oxidase subunit 2 | Type: enzyme | Action: nan
13282,valdecoxib,carbonic anhydrase 13,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
13283,valdecoxib,carbonic anhydrase 4,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
13284,valdecoxib,carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
13285,valdecoxib,carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
13286,valdecoxib,carbonic anhydrase 13,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
13287,valdecoxib,carbonic anhydrase 15,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
13288,valdecoxib,carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
13289,valdecoxib,carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
13290,valdecoxib,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
13291,valdecoxib,carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
13292,valdecoxib,alpha carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
13293,valdecoxib,carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
13294,valdecoxib,carbonic anhydrase 2,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13295,valdecoxib,astrosclerin-3,enzyme,,Drug: valdecoxib | Target: astrosclerin-3 | Type: enzyme | Action: nan
13296,valdecoxib,beta-carbonic anhydrase 1,enzyme,,Drug: valdecoxib | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
13297,valdecoxib,delta carbonic anhydrase,unclassified,,Drug: valdecoxib | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
13298,valdecoxib,carbonic anhydrase 2,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13299,valdecoxib,cytochrome c oxidase subunit 1,enzyme,,Drug: valdecoxib | Target: cytochrome c oxidase subunit 1 | Type: enzyme | Action: nan
13300,valdecoxib,carbonic anhydrase,enzyme,,Drug: valdecoxib | Target: carbonic anhydrase | Type: enzyme | Action: nan
13301,valdecoxib,"carbonic anhydrase, alpha family",unclassified,,"Drug: valdecoxib | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
13302,valdecoxib,carbonate dehydratase,enzyme,,Drug: valdecoxib | Target: carbonate dehydratase | Type: enzyme | Action: nan
13303,valethamate,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: valethamate | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
13304,valethamate,muscarinic acetylcholine receptor m1,gpcr,,Drug: valethamate | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
13305,valethamate,muscarinic acetylcholine receptor m2,gpcr,,Drug: valethamate | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13306,valethamate,muscarinic acetylcholine receptor m3,gpcr,,Drug: valethamate | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
13307,valethamate,muscarinic acetylcholine receptor m4,gpcr,,Drug: valethamate | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
13308,valethamate,muscarinic acetylcholine receptor m5,gpcr,,Drug: valethamate | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
13309,valethamate,cytochrome p450 2d6,enzyme,,Drug: valethamate | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
13310,valganciclovir,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: valganciclovir | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
13311,valproic acid,"succinate-semialdehyde dehydrogenase, mitochondrial",enzyme,INHIBITOR,"Drug: valproic acid | Target: succinate-semialdehyde dehydrogenase, mitochondrial | Type: enzyme | Action: INHIBITOR"
13312,valproic acid,histone deacetylase 2,enzyme,,Drug: valproic acid | Target: histone deacetylase 2 | Type: enzyme | Action: nan
13313,valproic acid,histone deacetylase 1,enzyme,INHIBITOR,Drug: valproic acid | Target: histone deacetylase 1 | Type: enzyme | Action: INHIBITOR
13314,valproic acid,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: valproic acid | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
13315,valproic acid,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: valproic acid | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
13316,valproic acid,aldose reductase,enzyme,,Drug: valproic acid | Target: aldose reductase | Type: enzyme | Action: nan
13317,valproic acid,aldose reductase,enzyme,,Drug: valproic acid | Target: aldose reductase | Type: enzyme | Action: nan
13318,valproic acid,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: valproic acid | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
13319,valproic acid,udp-glucuronosyltransferase 1-5,enzyme,,Drug: valproic acid | Target: udp-glucuronosyltransferase 1-5 | Type: enzyme | Action: nan
13320,valproic acid,aldose reductase-related protein 1,enzyme,,Drug: valproic acid | Target: aldose reductase-related protein 1 | Type: enzyme | Action: nan
13321,valrubicin,dna topoisomerase 2-alpha,enzyme,INHIBITOR,Drug: valrubicin | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: INHIBITOR
13322,valsartan,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: valsartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
13323,valsartan,type-1b angiotensin ii receptor,gpcr,,Drug: valsartan | Target: type-1b angiotensin ii receptor | Type: gpcr | Action: nan
13324,valsartan,type-1a angiotensin ii receptor,gpcr,,Drug: valsartan | Target: type-1a angiotensin ii receptor | Type: gpcr | Action: nan
13325,valsartan,angiotensin ii receptor (at-1) type-1,gpcr,,Drug: valsartan | Target: angiotensin ii receptor (at-1) type-1 | Type: gpcr | Action: nan
13326,vancomycin,alpha-2a adrenergic receptor,gpcr,,Drug: vancomycin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
13327,vancomycin,d-alanyl-d-alanine dipeptidase,enzyme,,Drug: vancomycin | Target: d-alanyl-d-alanine dipeptidase | Type: enzyme | Action: nan
13328,vancomycin,udp-n-acetylglucosamine--n-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol n-acetylglucosamine transferase,enzyme,,Drug: vancomycin | Target: udp-n-acetylglucosamine--n-acetylmuramyl-(pentapeptide) pyrophosphoryl-undecaprenol n-acetylglucosamine transferase | Type: enzyme | Action: nan
13329,varenicline,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
13330,varenicline,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
13331,varenicline,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
13332,varenicline,neuronal acetylcholine receptor; alpha3/beta2,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha3/beta2 | Type: ion channel | Action: nan
13333,varenicline,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
13334,varenicline,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
13335,varenicline,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
13336,varenicline,neuronal acetylcholine receptor; alpha4/beta2,ion channel,AGONIST,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: AGONIST
13337,varenicline,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
13338,varenicline,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
13339,varenicline,acetylcholine receptor; alpha1/beta1/delta/gamma,ion channel,,Drug: varenicline | Target: acetylcholine receptor; alpha1/beta1/delta/gamma | Type: ion channel | Action: nan
13340,varenicline,neuronal acetylcholine receptor; alpha2/beta4,ion channel,,Drug: varenicline | Target: neuronal acetylcholine receptor; alpha2/beta4 | Type: ion channel | Action: nan
13341,varenicline,acetylcholine receptor,ion channel,,Drug: varenicline | Target: acetylcholine receptor | Type: ion channel | Action: nan
13342,vardenafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: vardenafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
13343,vardenafil,"rod cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha",enzyme,,"Drug: vardenafil | Target: rod cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha | Type: enzyme | Action: nan"
13344,vardenafil,"dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a",enzyme,,"Drug: vardenafil | Target: dual 3',5'-cyclic-amp and -gmp phosphodiesterase 11a | Type: enzyme | Action: nan"
13345,vardenafil,"calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1a",enzyme,,"Drug: vardenafil | Target: calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1a | Type: enzyme | Action: nan"
13346,vardenafil,"camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a",enzyme,,"Drug: vardenafil | Target: camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | Type: enzyme | Action: nan"
13347,vardenafil,"cgmp-dependent 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: vardenafil | Target: cgmp-dependent 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
13348,vardenafil,"high affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9a",enzyme,,"Drug: vardenafil | Target: high affinity cgmp-specific 3',5'-cyclic phosphodiesterase 9a | Type: enzyme | Action: nan"
13349,vardenafil,phosphodiesterase 3,enzyme,,Drug: vardenafil | Target: phosphodiesterase 3 | Type: enzyme | Action: nan
13350,vardenafil,phosphodiesterase 4,enzyme,,Drug: vardenafil | Target: phosphodiesterase 4 | Type: enzyme | Action: nan
13351,vardenafil,phosphodiesterase 1,enzyme,,Drug: vardenafil | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
13352,vasopressin,vasopressin v1a receptor,gpcr,AGONIST,Drug: vasopressin | Target: vasopressin v1a receptor | Type: gpcr | Action: AGONIST
13353,vasopressin,vasopressin v1b receptor,gpcr,AGONIST,Drug: vasopressin | Target: vasopressin v1b receptor | Type: gpcr | Action: AGONIST
13354,vasopressin,vasopressin v2 receptor,gpcr,AGONIST,Drug: vasopressin | Target: vasopressin v2 receptor | Type: gpcr | Action: AGONIST
13355,vasopressin,oxytocin receptor,gpcr,,Drug: vasopressin | Target: oxytocin receptor | Type: gpcr | Action: nan
13356,vasopressin,vasopressin v2 receptor,gpcr,,Drug: vasopressin | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
13357,vasopressin,oxytocin receptor,gpcr,,Drug: vasopressin | Target: oxytocin receptor | Type: gpcr | Action: nan
13358,vasopressin,vasopressin v2 receptor,gpcr,,Drug: vasopressin | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
13359,vasopressin,vasopressin v2 receptor,gpcr,,Drug: vasopressin | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
13360,vasopressin,vasopressin v1a receptor,gpcr,,Drug: vasopressin | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
13361,vasopressin,vasopressin v1b receptor,gpcr,,Drug: vasopressin | Target: vasopressin v1b receptor | Type: gpcr | Action: nan
13362,vasopressin,vasopressin v1 receptor,gpcr,,Drug: vasopressin | Target: vasopressin v1 receptor | Type: gpcr | Action: nan
13363,vecuronium,solute carrier family 22 member 2,transporter,,Drug: vecuronium | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
13364,vecuronium,multidrug and toxin extrusion protein 1,transporter,,Drug: vecuronium | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
13365,vecuronium,multidrug and toxin extrusion protein 2,transporter,,Drug: vecuronium | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
13366,vecuronium,neuronal acetylcholine receptor; alpha2/beta4,ion channel,,Drug: vecuronium | Target: neuronal acetylcholine receptor; alpha2/beta4 | Type: ion channel | Action: nan
13367,vecuronium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: vecuronium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
13368,vecuronium,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: vecuronium | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
13369,vecuronium,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: vecuronium | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
13370,vecuronium,acetylcholine receptor; alpha1/beta1/delta/gamma,ion channel,,Drug: vecuronium | Target: acetylcholine receptor; alpha1/beta1/delta/gamma | Type: ion channel | Action: nan
13371,venlafaxine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: venlafaxine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
13372,venlafaxine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: venlafaxine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
13373,venlafaxine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: venlafaxine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
13374,venlafaxine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: venlafaxine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
13375,venlafaxine,5-hydroxytryptamine receptor 6,gpcr,,Drug: venlafaxine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
13376,venlafaxine,sodium-dependent dopamine transporter,transporter,,Drug: venlafaxine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13377,venlafaxine,alpha-1a adrenergic receptor,gpcr,,Drug: venlafaxine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
13378,venlafaxine,sodium-dependent serotonin transporter,transporter,,Drug: venlafaxine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13379,venlafaxine,sodium-dependent dopamine transporter,transporter,,Drug: venlafaxine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13380,venlafaxine,transporter,transporter,,Drug: venlafaxine | Target: transporter | Type: transporter | Action: nan
13381,venlafaxine,transporter,transporter,,Drug: venlafaxine | Target: transporter | Type: transporter | Action: nan
13382,verapamil,sodium channel protein type 5 subunit alpha,ion channel,,Drug: verapamil | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
13383,verapamil,alpha-2a adrenergic receptor,gpcr,,Drug: verapamil | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
13384,verapamil,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: verapamil | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
13385,verapamil,cytochrome p450 3a4,enzyme,INHIBITOR,Drug: verapamil | Target: cytochrome p450 3a4 | Type: enzyme | Action: INHIBITOR
13386,verapamil,multidrug resistance protein 1,transporter,,Drug: verapamil | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
13387,verapamil,sodium-dependent serotonin transporter,transporter,,Drug: verapamil | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13388,verapamil,5-hydroxytryptamine receptor 1a,gpcr,,Drug: verapamil | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13389,verapamil,5-hydroxytryptamine receptor 2a,gpcr,,Drug: verapamil | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
13390,verapamil,5-hydroxytryptamine receptor 2b,gpcr,,Drug: verapamil | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
13391,verapamil,5-hydroxytryptamine receptor 2c,gpcr,,Drug: verapamil | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
13392,verapamil,d(3) dopamine receptor,gpcr,,Drug: verapamil | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
13393,verapamil,histamine h2 receptor,gpcr,,Drug: verapamil | Target: histamine h2 receptor | Type: gpcr | Action: nan
13394,verapamil,aldehyde oxidase,enzyme,,Drug: verapamil | Target: aldehyde oxidase | Type: enzyme | Action: nan
13395,verapamil,alpha-1d adrenergic receptor,gpcr,,Drug: verapamil | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
13396,verapamil,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,BLOCKER,Drug: verapamil | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: BLOCKER
13397,verapamil,multidrug resistance-associated protein 1,transporter,,Drug: verapamil | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
13398,verapamil,atp-binding cassette sub-family g member 2,transporter,,Drug: verapamil | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
13399,verapamil,carbonic anhydrase 1,enzyme,,Drug: verapamil | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
13400,verapamil,g protein-activated inward rectifier potassium channel 2,ion channel,,Drug: verapamil | Target: g protein-activated inward rectifier potassium channel 2 | Type: ion channel | Action: nan
13401,verapamil,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,BLOCKER,Drug: verapamil | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: BLOCKER
13402,verapamil,voltage-dependent l-type calcium channel subunit alpha-1s,ion channel,BLOCKER,Drug: verapamil | Target: voltage-dependent l-type calcium channel subunit alpha-1s | Type: ion channel | Action: BLOCKER
13403,verapamil,potassium voltage-gated channel subfamily a member 10,ion channel,BLOCKER,Drug: verapamil | Target: potassium voltage-gated channel subfamily a member 10 | Type: ion channel | Action: BLOCKER
13404,verapamil,potassium voltage-gated channel subfamily a member 3,ion channel,,Drug: verapamil | Target: potassium voltage-gated channel subfamily a member 3 | Type: ion channel | Action: nan
13405,verapamil,potassium voltage-gated channel subfamily c member 2,ion channel,,Drug: verapamil | Target: potassium voltage-gated channel subfamily c member 2 | Type: ion channel | Action: nan
13406,verapamil,solute carrier family 22 member 1,transporter,,Drug: verapamil | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
13407,verapamil,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: verapamil | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
13408,verapamil,potassium voltage-gated channel subfamily a member 7,ion channel,,Drug: verapamil | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: nan
13409,verapamil,alpha-1b adrenergic receptor,gpcr,,Drug: verapamil | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
13410,verapamil,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: verapamil | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
13411,verapamil,alpha-1a adrenergic receptor,gpcr,,Drug: verapamil | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
13412,verapamil,5-hydroxytryptamine receptor 1a,gpcr,,Drug: verapamil | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13413,verapamil,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: verapamil | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
13414,verapamil,translocator protein,membrane receptor,,Drug: verapamil | Target: translocator protein | Type: membrane receptor | Action: nan
13415,verapamil,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: verapamil | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
13416,verapamil,voltage-dependent l-type calcium channel subunit alpha-1s,ion channel,,Drug: verapamil | Target: voltage-dependent l-type calcium channel subunit alpha-1s | Type: ion channel | Action: nan
13417,verapamil,muscarinic acetylcholine receptor m2,gpcr,,Drug: verapamil | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13418,verapamil,solute carrier family 22 member 2,transporter,,Drug: verapamil | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
13419,verapamil,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: verapamil | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
13420,verapamil,voltage-gated l-type calcium channel,ion channel,,Drug: verapamil | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: nan
13421,verapamil,equilibrative nucleoside transporter 4,transporter,INHIBITOR,Drug: verapamil | Target: equilibrative nucleoside transporter 4 | Type: transporter | Action: INHIBITOR
13422,verapamil,chloroquine resistance transporter,transporter,,Drug: verapamil | Target: chloroquine resistance transporter | Type: transporter | Action: nan
13423,verapamil,potassium voltage-gated channel subfamily c member 2,ion channel,BLOCKER,Drug: verapamil | Target: potassium voltage-gated channel subfamily c member 2 | Type: ion channel | Action: BLOCKER
13424,verapamil,two pore calcium channel protein 1,ion channel,BLOCKER,Drug: verapamil | Target: two pore calcium channel protein 1 | Type: ion channel | Action: BLOCKER
13425,verapamil,two pore calcium channel protein 2,ion channel,BLOCKER,Drug: verapamil | Target: two pore calcium channel protein 2 | Type: ion channel | Action: BLOCKER
13426,vesnarinone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: vesnarinone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
13427,vesnarinone,"cgmp-inhibited 3',5'-cyclic phosphodiesterase a",enzyme,,"Drug: vesnarinone | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase a | Type: enzyme | Action: nan"
13428,vesnarinone,"cgmp-inhibited 3',5'-cyclic phosphodiesterase b",enzyme,,"Drug: vesnarinone | Target: cgmp-inhibited 3',5'-cyclic phosphodiesterase b | Type: enzyme | Action: nan"
13429,vesnarinone,phosphodiesterase 3,enzyme,,Drug: vesnarinone | Target: phosphodiesterase 3 | Type: enzyme | Action: nan
13430,vesnarinone,transitional endoplasmic reticulum atpase,enzyme,,Drug: vesnarinone | Target: transitional endoplasmic reticulum atpase | Type: enzyme | Action: nan
13431,vidarabine,dna polymerase catalytic subunit,enzyme,INHIBITOR,Drug: vidarabine | Target: dna polymerase catalytic subunit | Type: enzyme | Action: INHIBITOR
13432,vidarabine,deoxycytidine kinase,kinase,,Drug: vidarabine | Target: deoxycytidine kinase | Type: kinase | Action: nan
13433,vidarabine,dna polymerase alpha catalytic subunit,enzyme,,Drug: vidarabine | Target: dna polymerase alpha catalytic subunit | Type: enzyme | Action: nan
13434,vidarabine,ribonucleoside-diphosphate reductase large subunit,enzyme,,Drug: vidarabine | Target: ribonucleoside-diphosphate reductase large subunit | Type: enzyme | Action: nan
13435,vidarabine,ribonucleoside-diphosphate reductase subunit m2,enzyme,,Drug: vidarabine | Target: ribonucleoside-diphosphate reductase subunit m2 | Type: enzyme | Action: nan
13436,vidarabine,"deoxyguanosine kinase, mitochondrial",kinase,,"Drug: vidarabine | Target: deoxyguanosine kinase, mitochondrial | Type: kinase | Action: nan"
13437,vidarabine,ribose-phosphate pyrophosphokinase 1,kinase,,Drug: vidarabine | Target: ribose-phosphate pyrophosphokinase 1 | Type: kinase | Action: nan
13438,vidarabine,dipeptidyl peptidase 4,enzyme,,Drug: vidarabine | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
13439,vidarabine,adenylate cyclase type v,enzyme,,Drug: vidarabine | Target: adenylate cyclase type v | Type: enzyme | Action: nan
13440,vidarabine,adenosylhomocysteinase,enzyme,,Drug: vidarabine | Target: adenosylhomocysteinase | Type: enzyme | Action: nan
13441,vigabatrin,"4-aminobutyrate aminotransferase, mitochondrial",enzyme,INHIBITOR,"Drug: vigabatrin | Target: 4-aminobutyrate aminotransferase, mitochondrial | Type: enzyme | Action: INHIBITOR"
13442,vigabatrin,gamma-amino-n-butyrate transaminase,enzyme,,Drug: vigabatrin | Target: gamma-amino-n-butyrate transaminase | Type: enzyme | Action: nan
13443,viloxazine,sodium-dependent serotonin transporter,transporter,,Drug: viloxazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13444,viloxazine,sodium-dependent dopamine transporter,transporter,,Drug: viloxazine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13445,viloxazine,sodium-dependent serotonin transporter,transporter,,Drug: viloxazine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13446,viloxazine,sodium-dependent dopamine transporter,transporter,,Drug: viloxazine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13447,viloxazine,transporter,transporter,,Drug: viloxazine | Target: transporter | Type: transporter | Action: nan
13448,viloxazine,sodium-dependent noradrenaline transporter,transporter,ANTAGONIST,Drug: viloxazine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: ANTAGONIST
13449,vinblastine,multidrug resistance protein 1,transporter,,Drug: vinblastine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
13450,vinblastine,canalicular multispecific organic anion transporter 1,transporter,,Drug: vinblastine | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
13451,vinblastine,multidrug resistance-associated protein 1,transporter,,Drug: vinblastine | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
13452,vinblastine,multidrug resistance-associated protein 7,transporter,,Drug: vinblastine | Target: multidrug resistance-associated protein 7 | Type: transporter | Action: nan
13453,vinblastine,thromboxane-a synthase,enzyme,,Drug: vinblastine | Target: thromboxane-a synthase | Type: enzyme | Action: nan
13454,vinblastine,arachidonate 15-lipoxygenase,enzyme,,Drug: vinblastine | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
13455,vinblastine,amine oxidase [flavin-containing] b,enzyme,,Drug: vinblastine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
13456,vinblastine,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: vinblastine | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
13457,vinburnine,muscarinic acetylcholine receptor m1,gpcr,ALLOSTERIC MODULATOR,Drug: vinburnine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ALLOSTERIC MODULATOR
13458,vinburnine,muscarinic acetylcholine receptor m2,gpcr,ALLOSTERIC MODULATOR,Drug: vinburnine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ALLOSTERIC MODULATOR
13459,vinburnine,muscarinic acetylcholine receptor m3,gpcr,ALLOSTERIC MODULATOR,Drug: vinburnine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ALLOSTERIC MODULATOR
13460,vinburnine,muscarinic acetylcholine receptor m4,gpcr,ALLOSTERIC MODULATOR,Drug: vinburnine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ALLOSTERIC MODULATOR
13461,vincristine,multidrug resistance protein 1,transporter,,Drug: vincristine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
13462,vincristine,canalicular multispecific organic anion transporter 1,transporter,,Drug: vincristine | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
13463,vincristine,multidrug resistance-associated protein 1,transporter,,Drug: vincristine | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
13464,vincristine,multidrug resistance-associated protein 7,transporter,,Drug: vincristine | Target: multidrug resistance-associated protein 7 | Type: transporter | Action: nan
13465,vincristine,tubulin,structural,,Drug: vincristine | Target: tubulin | Type: structural | Action: nan
13466,vincristine,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: vincristine | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
13467,vindesine,cytochrome p450 3a4,enzyme,,Drug: vindesine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
13468,vinorelbine,cytochrome p450 3a4,enzyme,,Drug: vinorelbine | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
13469,vinorelbine,substance-k receptor,gpcr,,Drug: vinorelbine | Target: substance-k receptor | Type: gpcr | Action: nan
13470,vinorelbine,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: vinorelbine | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
13471,vinpocetine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: vinpocetine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
13472,vinpocetine,"calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1a",enzyme,,"Drug: vinpocetine | Target: calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1a | Type: enzyme | Action: nan"
13473,vinpocetine,"calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1c",enzyme,INHIBITOR,"Drug: vinpocetine | Target: calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1c | Type: enzyme | Action: INHIBITOR"
13474,vinpocetine,phosphodiesterase 1,enzyme,,Drug: vinpocetine | Target: phosphodiesterase 1 | Type: enzyme | Action: nan
13475,retinol,11-cis retinol dehydrogenase,enzyme,,Drug: retinol | Target: 11-cis retinol dehydrogenase | Type: enzyme | Action: nan
13476,retinol,retinol dehydrogenase 12,enzyme,,Drug: retinol | Target: retinol dehydrogenase 12 | Type: enzyme | Action: nan
13477,retinol,retinol dehydrogenase 13,enzyme,,Drug: retinol | Target: retinol dehydrogenase 13 | Type: enzyme | Action: nan
13478,retinol,retinol-binding protein 3,surface antigen,,Drug: retinol | Target: retinol-binding protein 3 | Type: surface antigen | Action: nan
13479,retinol,retinol-binding protein 5,cytosolic other,,Drug: retinol | Target: retinol-binding protein 5 | Type: cytosolic other | Action: nan
13480,retinol,retinoid-binding protein 7,cytosolic other,,Drug: retinol | Target: retinoid-binding protein 7 | Type: cytosolic other | Action: nan
13481,retinol,retinol-binding protein 4,secreted,,Drug: retinol | Target: retinol-binding protein 4 | Type: secreted | Action: nan
13482,retinol,retinol-binding protein 2,cytosolic other,,Drug: retinol | Target: retinol-binding protein 2 | Type: cytosolic other | Action: nan
13483,retinol,retinal dehydrogenase 2,enzyme,,Drug: retinol | Target: retinal dehydrogenase 2 | Type: enzyme | Action: nan
13484,retinol,retinal dehydrogenase 1,enzyme,,Drug: retinol | Target: retinal dehydrogenase 1 | Type: enzyme | Action: nan
13485,retinol,retinaldehyde-binding protein 1,transporter,,Drug: retinol | Target: retinaldehyde-binding protein 1 | Type: transporter | Action: nan
13486,retinol,beta-lactoglobulin,unclassified,,Drug: retinol | Target: beta-lactoglobulin | Type: unclassified | Action: nan
13487,retinol,retinol-binding protein 1,cytosolic other,,Drug: retinol | Target: retinol-binding protein 1 | Type: cytosolic other | Action: nan
13488,retinol,nuclear receptor subfamily 2 group c member 2,nuclear other,AGONIST,Drug: retinol | Target: nuclear receptor subfamily 2 group c member 2 | Type: nuclear other | Action: AGONIST
13489,thiamine,thiamine transporter 1,transporter,,Drug: thiamine | Target: thiamine transporter 1 | Type: transporter | Action: nan
13490,thiamine,transketolase,enzyme,,Drug: thiamine | Target: transketolase | Type: enzyme | Action: nan
13491,thiamine,thiamin pyrophosphokinase 1,kinase,,Drug: thiamine | Target: thiamin pyrophosphokinase 1 | Type: kinase | Action: nan
13492,thiamine,thiamine-triphosphatase,enzyme,,Drug: thiamine | Target: thiamine-triphosphatase | Type: enzyme | Action: nan
13493,thiamine,transketolase-like protein 1,enzyme,,Drug: thiamine | Target: transketolase-like protein 1 | Type: enzyme | Action: nan
13494,thiamine,heat shock protein hsp 90-alpha,cytosolic other,,Drug: thiamine | Target: heat shock protein hsp 90-alpha | Type: cytosolic other | Action: nan
13495,thiamine,thiamine transporter thit,transporter,,Drug: thiamine | Target: thiamine transporter thit | Type: transporter | Action: nan
13496,riboflavin,flavin reductase (nadph),enzyme,,Drug: riboflavin | Target: flavin reductase (nadph) | Type: enzyme | Action: nan
13497,riboflavin,riboflavin kinase,kinase,,Drug: riboflavin | Target: riboflavin kinase | Type: kinase | Action: nan
13498,riboflavin,riboflavin-binding protein,unclassified,,Drug: riboflavin | Target: riboflavin-binding protein | Type: unclassified | Action: nan
13499,nicotinic acid,hydroxycarboxylic acid receptor 3,gpcr,AGONIST,Drug: nicotinic acid | Target: hydroxycarboxylic acid receptor 3 | Type: gpcr | Action: AGONIST
13500,nicotinic acid,nicotinamide n-methyltransferase,enzyme,,Drug: nicotinic acid | Target: nicotinamide n-methyltransferase | Type: enzyme | Action: nan
13501,nicotinic acid,nicotinate-nucleotide pyrophosphorylase [carboxylating],enzyme,,Drug: nicotinic acid | Target: nicotinate-nucleotide pyrophosphorylase [carboxylating] | Type: enzyme | Action: nan
13502,nicotinic acid,nicotinamide phosphoribosyltransferase,enzyme,,Drug: nicotinic acid | Target: nicotinamide phosphoribosyltransferase | Type: enzyme | Action: nan
13503,nicotinic acid,hydroxycarboxylic acid receptor 2,gpcr,,Drug: nicotinic acid | Target: hydroxycarboxylic acid receptor 2 | Type: gpcr | Action: nan
13504,nicotinic acid,hydroxycarboxylic acid receptor 2,gpcr,,Drug: nicotinic acid | Target: hydroxycarboxylic acid receptor 2 | Type: gpcr | Action: nan
13505,nicotinic acid,amyloid beta a4 protein,unclassified,,Drug: nicotinic acid | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
13506,nicotinic acid,hydroxycarboxylic acid receptor 2,gpcr,AGONIST,Drug: nicotinic acid | Target: hydroxycarboxylic acid receptor 2 | Type: gpcr | Action: AGONIST
13507,pyridoxine,"serine hydroxymethyltransferase, cytosolic",enzyme,,"Drug: pyridoxine | Target: serine hydroxymethyltransferase, cytosolic | Type: enzyme | Action: nan"
13508,pyridoxine,pyridoxine-5'-phosphate oxidase,enzyme,,Drug: pyridoxine | Target: pyridoxine-5'-phosphate oxidase | Type: enzyme | Action: nan
13509,pyridoxine,pyridoxal phosphate phosphatase,enzyme,,Drug: pyridoxine | Target: pyridoxal phosphate phosphatase | Type: enzyme | Action: nan
13510,pyridoxine,pyridoxal kinase,kinase,,Drug: pyridoxine | Target: pyridoxal kinase | Type: kinase | Action: nan
13511,pyridoxine,cystathionine beta-synthase,enzyme,,Drug: pyridoxine | Target: cystathionine beta-synthase | Type: enzyme | Action: nan
13512,pyridoxine,phosphoserine aminotransferase,enzyme,,Drug: pyridoxine | Target: phosphoserine aminotransferase | Type: enzyme | Action: nan
13513,ergocalciferol,"25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial",enzyme,,"Drug: ergocalciferol | Target: 25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial | Type: enzyme | Action: nan"
13514,ergocalciferol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: ergocalciferol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
13515,ergocalciferol,vitamin d 25-hydroxylase,enzyme,,Drug: ergocalciferol | Target: vitamin d 25-hydroxylase | Type: enzyme | Action: nan
13516,colecalciferol,glycine receptor subunit alpha-1,ion channel,,Drug: colecalciferol | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
13517,colecalciferol,"25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial",enzyme,,"Drug: colecalciferol | Target: 25-hydroxyvitamin d-1 alpha hydroxylase, mitochondrial | Type: enzyme | Action: nan"
13518,colecalciferol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: colecalciferol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
13519,colecalciferol,vitamin d 25-hydroxylase,enzyme,,Drug: colecalciferol | Target: vitamin d 25-hydroxylase | Type: enzyme | Action: nan
13520,colecalciferol,"sterol 26-hydroxylase, mitochondrial",enzyme,,"Drug: colecalciferol | Target: sterol 26-hydroxylase, mitochondrial | Type: enzyme | Action: nan"
13521,dihydrotachysterol,vitamin d3 receptor,nuclear hormone receptor,,Drug: dihydrotachysterol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: nan
13522,voglibose,"maltase-glucoamylase, intestinal",enzyme,,"Drug: voglibose | Target: maltase-glucoamylase, intestinal | Type: enzyme | Action: nan"
13523,voglibose,"sucrase-isomaltase, intestinal",enzyme,,"Drug: voglibose | Target: sucrase-isomaltase, intestinal | Type: enzyme | Action: nan"
13524,voglibose,lysosomal alpha-glucosidase,enzyme,,Drug: voglibose | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: nan
13525,voglibose,glycogen debranching enzyme,enzyme,,Drug: voglibose | Target: glycogen debranching enzyme | Type: enzyme | Action: nan
13526,voglibose,lysosomal alpha-glucosidase,enzyme,INHIBITOR,Drug: voglibose | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: INHIBITOR
13527,voriconazole,cytochrome p450 3a4,enzyme,,Drug: voriconazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
13528,voriconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: voriconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
13529,voriconazole,cytochrome p450 2c9,enzyme,,Drug: voriconazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
13530,voriconazole,cytochrome p450 2c19,enzyme,,Drug: voriconazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
13531,voriconazole,lanosterol 14-alpha demethylase,enzyme,,Drug: voriconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
13532,voriconazole,14-alpha sterol demethylase cyp51a,enzyme,,Drug: voriconazole | Target: 14-alpha sterol demethylase cyp51a | Type: enzyme | Action: nan
13533,voriconazole,14-alpha sterol demethylase,enzyme,,Drug: voriconazole | Target: 14-alpha sterol demethylase | Type: enzyme | Action: nan
13534,voriconazole,cytochrome p450 11a1,enzyme,,Drug: voriconazole | Target: cytochrome p450 11a1 | Type: enzyme | Action: nan
13535,voriconazole,"cholesterol side-chain cleavage enzyme, mitochondrial",enzyme,,"Drug: voriconazole | Target: cholesterol side-chain cleavage enzyme, mitochondrial | Type: enzyme | Action: nan"
13536,voriconazole,cholesterol 24-hydroxylase,enzyme,,Drug: voriconazole | Target: cholesterol 24-hydroxylase | Type: enzyme | Action: nan
13537,warfarin,cytochrome p450 3a4,enzyme,,Drug: warfarin | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
13538,warfarin,cytochrome p450 2c9,enzyme,,Drug: warfarin | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
13539,warfarin,vitamin k epoxide reductase complex subunit 1,enzyme,INHIBITOR,Drug: warfarin | Target: vitamin k epoxide reductase complex subunit 1 | Type: enzyme | Action: INHIBITOR
13540,warfarin,proprotein convertase subtilisin/kexin type 7,enzyme,,Drug: warfarin | Target: proprotein convertase subtilisin/kexin type 7 | Type: enzyme | Action: nan
13541,warfarin,vitamin k epoxide reductase complex subunit 1-like protein 1,enzyme,,Drug: warfarin | Target: vitamin k epoxide reductase complex subunit 1-like protein 1 | Type: enzyme | Action: nan
13542,xamoterol,beta-1 adrenergic receptor,gpcr,,Drug: xamoterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
13543,xamoterol,beta-2 adrenergic receptor,gpcr,,Drug: xamoterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
13544,xamoterol,beta-3 adrenergic receptor,gpcr,,Drug: xamoterol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
13545,ximelagatran,urokinase-type plasminogen activator,enzyme,,Drug: ximelagatran | Target: urokinase-type plasminogen activator | Type: enzyme | Action: nan
13546,ximelagatran,plasminogen,enzyme,,Drug: ximelagatran | Target: plasminogen | Type: enzyme | Action: nan
13547,ximelagatran,coagulation factor x,enzyme,,Drug: ximelagatran | Target: coagulation factor x | Type: enzyme | Action: nan
13548,ximelagatran,tissue-type plasminogen activator,enzyme,,Drug: ximelagatran | Target: tissue-type plasminogen activator | Type: enzyme | Action: nan
13549,ximelagatran,coagulation factor vii,enzyme,,Drug: ximelagatran | Target: coagulation factor vii | Type: enzyme | Action: nan
13550,ximelagatran,vitamin k-dependent protein c,enzyme,,Drug: ximelagatran | Target: vitamin k-dependent protein c | Type: enzyme | Action: nan
13551,ximelagatran,cationic trypsin,enzyme,,Drug: ximelagatran | Target: cationic trypsin | Type: enzyme | Action: nan
13552,ximelagatran,coagulation factor xi,enzyme,,Drug: ximelagatran | Target: coagulation factor xi | Type: enzyme | Action: nan
13554,ximelagatran,prothrombin,enzyme,INHIBITOR,Drug: ximelagatran | Target: prothrombin | Type: enzyme | Action: INHIBITOR
13555,zafirlukast,cytochrome p450 3a4,enzyme,,Drug: zafirlukast | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
13556,zafirlukast,adenosine receptor a3,gpcr,,Drug: zafirlukast | Target: adenosine receptor a3 | Type: gpcr | Action: nan
13557,zafirlukast,cytochrome p450 2c9,enzyme,,Drug: zafirlukast | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
13558,zafirlukast,cysteinyl leukotriene receptor 1,gpcr,ANTAGONIST,Drug: zafirlukast | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: ANTAGONIST
13559,zafirlukast,cytosolic phospholipase a2,enzyme,,Drug: zafirlukast | Target: cytosolic phospholipase a2 | Type: enzyme | Action: nan
13560,zafirlukast,epidermal growth factor receptor,kinase,,Drug: zafirlukast | Target: epidermal growth factor receptor | Type: kinase | Action: nan
13561,zafirlukast,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: zafirlukast | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
13562,zafirlukast,thromboxane-a synthase,enzyme,,Drug: zafirlukast | Target: thromboxane-a synthase | Type: enzyme | Action: nan
13563,zafirlukast,mitogen-activated protein kinase 3,kinase,,Drug: zafirlukast | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
13564,zafirlukast,cysteinyl leukotriene receptor 2,gpcr,ANTAGONIST,Drug: zafirlukast | Target: cysteinyl leukotriene receptor 2 | Type: gpcr | Action: ANTAGONIST
13565,zafirlukast,mitogen-activated protein kinase 14,kinase,,Drug: zafirlukast | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
13566,zafirlukast,leukotriene b4 receptor 1,gpcr,,Drug: zafirlukast | Target: leukotriene b4 receptor 1 | Type: gpcr | Action: nan
13567,zafirlukast,bifunctional epoxide hydrolase 2,enzyme,,Drug: zafirlukast | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
13568,zafirlukast,mitogen-activated protein kinase 1,kinase,,Drug: zafirlukast | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
13569,zafirlukast,cysteinyl leukotriene receptor 1,gpcr,,Drug: zafirlukast | Target: cysteinyl leukotriene receptor 1 | Type: gpcr | Action: nan
13570,zafirlukast,solute carrier family 22 member 2,transporter,,Drug: zafirlukast | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
13571,zafirlukast,multidrug and toxin extrusion protein 1,transporter,,Drug: zafirlukast | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
13572,zafirlukast,multidrug and toxin extrusion protein 2,transporter,,Drug: zafirlukast | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
13573,zafirlukast,sodium/bile acid cotransporter,transporter,,Drug: zafirlukast | Target: sodium/bile acid cotransporter | Type: transporter | Action: nan
13574,zafirlukast,prostaglandin e synthase,enzyme,,Drug: zafirlukast | Target: prostaglandin e synthase | Type: enzyme | Action: nan
13576,zalcitabine,deoxycytidine kinase,kinase,,Drug: zalcitabine | Target: deoxycytidine kinase | Type: kinase | Action: nan
13577,zalcitabine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: zalcitabine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
13578,zaleplon,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: zaleplon | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
13579,zaleplon,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: zaleplon | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
13580,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13581,zanamivir,neuraminidase,enzyme,INHIBITOR,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: INHIBITOR
13582,zanamivir,neuraminidase,enzyme,INHIBITOR,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: INHIBITOR
13583,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13584,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13585,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13586,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13587,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13588,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13589,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13590,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13591,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13592,zanamivir,sialidase 3,enzyme,,Drug: zanamivir | Target: sialidase 3 | Type: enzyme | Action: nan
13593,zanamivir,sialidase 2,enzyme,,Drug: zanamivir | Target: sialidase 2 | Type: enzyme | Action: nan
13594,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13595,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13596,zanamivir,sialidase-4,enzyme,,Drug: zanamivir | Target: sialidase-4 | Type: enzyme | Action: nan
13597,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13598,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13599,zanamivir,neuraminidase,enzyme,,Drug: zanamivir | Target: neuraminidase | Type: enzyme | Action: nan
13600,zidovudine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: zidovudine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
13601,zidovudine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: zidovudine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
13602,zidovudine,"thymidine kinase, cytosolic",kinase,,"Drug: zidovudine | Target: thymidine kinase, cytosolic | Type: kinase | Action: nan"
13603,zidovudine,thymidylate kinase,kinase,,Drug: zidovudine | Target: thymidylate kinase | Type: kinase | Action: nan
13604,zidovudine,pol polyprotein,enzyme,,Drug: zidovudine | Target: pol polyprotein | Type: enzyme | Action: nan
13605,zidovudine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: zidovudine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
13606,zidovudine,gag-pro-pol polyprotein,polyprotein,,Drug: zidovudine | Target: gag-pro-pol polyprotein | Type: polyprotein | Action: nan
13607,zidovudine,reverse transcriptase/rnaseh,enzyme,,Drug: zidovudine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: nan
13608,zidovudine,reverse transcriptase,enzyme,,Drug: zidovudine | Target: reverse transcriptase | Type: enzyme | Action: nan
13609,zidovudine,thymidylate kinase,kinase,,Drug: zidovudine | Target: thymidylate kinase | Type: kinase | Action: nan
13610,zidovudine,thymidine kinase,kinase,,Drug: zidovudine | Target: thymidine kinase | Type: kinase | Action: nan
13611,zidovudine,reverse transcriptase protein,unclassified,,Drug: zidovudine | Target: reverse transcriptase protein | Type: unclassified | Action: nan
13612,zileuton,arachidonate 5-lipoxygenase,enzyme,INHIBITOR,Drug: zileuton | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: INHIBITOR
13613,zileuton,arachidonate 15-lipoxygenase,enzyme,,Drug: zileuton | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
13614,zileuton,cysteinyl leukotriene receptor 2,gpcr,,Drug: zileuton | Target: cysteinyl leukotriene receptor 2 | Type: gpcr | Action: nan
13615,zileuton,leukotriene a-4 hydrolase,enzyme,,Drug: zileuton | Target: leukotriene a-4 hydrolase | Type: enzyme | Action: nan
13616,zileuton,leukotriene b4 receptor 1,gpcr,,Drug: zileuton | Target: leukotriene b4 receptor 1 | Type: gpcr | Action: nan
13617,zileuton,arachidonate 5-lipoxygenase-activating protein,cytosolic other,,Drug: zileuton | Target: arachidonate 5-lipoxygenase-activating protein | Type: cytosolic other | Action: nan
13618,zileuton,bifunctional epoxide hydrolase 2,enzyme,,Drug: zileuton | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
13619,zileuton,arachidonate 5-lipoxygenase,enzyme,,Drug: zileuton | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
13620,zileuton,arachidonate 5-lipoxygenase,enzyme,,Drug: zileuton | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
13621,zileuton,prostaglandin e synthase,enzyme,,Drug: zileuton | Target: prostaglandin e synthase | Type: enzyme | Action: nan
13622,zimeldine,d(2) dopamine receptor,gpcr,,Drug: zimeldine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
13623,zimeldine,sodium-dependent serotonin transporter,transporter,,Drug: zimeldine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13624,zimeldine,sodium-dependent noradrenaline transporter,transporter,,Drug: zimeldine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
13625,ziprasidone,beta-1 adrenergic receptor,gpcr,,Drug: ziprasidone | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
13626,ziprasidone,beta-2 adrenergic receptor,gpcr,,Drug: ziprasidone | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
13627,ziprasidone,d(1a) dopamine receptor,gpcr,,Drug: ziprasidone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
13628,ziprasidone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: ziprasidone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13629,ziprasidone,alpha-2a adrenergic receptor,gpcr,,Drug: ziprasidone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
13630,ziprasidone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ziprasidone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
13631,ziprasidone,sodium-dependent serotonin transporter,transporter,,Drug: ziprasidone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13632,ziprasidone,sodium-dependent noradrenaline transporter,transporter,,Drug: ziprasidone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
13633,ziprasidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13634,ziprasidone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
13635,ziprasidone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
13636,ziprasidone,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
13637,ziprasidone,5-hydroxytryptamine receptor 6,gpcr,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
13638,ziprasidone,5-hydroxytryptamine receptor 7,gpcr,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
13639,ziprasidone,alpha-1a adrenergic receptor,gpcr,,Drug: ziprasidone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
13640,ziprasidone,alpha-2b adrenergic receptor,gpcr,,Drug: ziprasidone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
13641,ziprasidone,d(3) dopamine receptor,gpcr,ANTAGONIST,Drug: ziprasidone | Target: d(3) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13642,ziprasidone,d(1b) dopamine receptor,gpcr,,Drug: ziprasidone | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
13643,ziprasidone,histamine h1 receptor,gpcr,,Drug: ziprasidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
13644,ziprasidone,histamine h2 receptor,gpcr,,Drug: ziprasidone | Target: histamine h2 receptor | Type: gpcr | Action: nan
13645,ziprasidone,muscarinic acetylcholine receptor m1,gpcr,,Drug: ziprasidone | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
13646,ziprasidone,muscarinic acetylcholine receptor m2,gpcr,,Drug: ziprasidone | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13647,ziprasidone,muscarinic acetylcholine receptor m3,gpcr,,Drug: ziprasidone | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
13648,ziprasidone,muscarinic acetylcholine receptor m4,gpcr,,Drug: ziprasidone | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
13649,ziprasidone,muscarinic acetylcholine receptor m5,gpcr,,Drug: ziprasidone | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
13650,ziprasidone,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
13651,ziprasidone,5-hydroxytryptamine receptor 1d,gpcr,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
13652,ziprasidone,alpha-2c adrenergic receptor,gpcr,,Drug: ziprasidone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
13653,ziprasidone,sodium-dependent dopamine transporter,transporter,,Drug: ziprasidone | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13654,ziprasidone,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: ziprasidone | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13655,ziprasidone,5-hydroxytryptamine receptor 3a,ion channel,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
13656,ziprasidone,alpha-1b adrenergic receptor,gpcr,,Drug: ziprasidone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
13657,ziprasidone,5-hydroxytryptamine receptor 5a,gpcr,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
13658,ziprasidone,5-hydroxytryptamine receptor 1e,gpcr,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
13659,ziprasidone,alpha-1a adrenergic receptor,gpcr,,Drug: ziprasidone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
13660,ziprasidone,histamine h1 receptor,gpcr,,Drug: ziprasidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
13661,ziprasidone,d(2) dopamine receptor,gpcr,,Drug: ziprasidone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
13662,ziprasidone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: ziprasidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
13663,ziprasidone,histamine h1 receptor,gpcr,,Drug: ziprasidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
13664,ziprasidone,transporter,transporter,,Drug: ziprasidone | Target: transporter | Type: transporter | Action: nan
13665,ziprasidone,adrenergic receptor alpha-1,gpcr,,Drug: ziprasidone | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
13666,ziprasidone,histone h1.0,nuclear other,,Drug: ziprasidone | Target: histone h1.0 | Type: nuclear other | Action: nan
13667,zofenopril,angiotensin-converting enzyme,enzyme,,Drug: zofenopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
13668,zofenopril,angiotensin-converting enzyme,enzyme,,Drug: zofenopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
13669,zofenopril,angiotensin-converting enzyme,enzyme,INHIBITOR,Drug: zofenopril | Target: angiotensin-converting enzyme | Type: enzyme | Action: INHIBITOR
13670,zoledronic acid,carbonic anhydrase 2,enzyme,,Drug: zoledronic acid | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13671,zoledronic acid,carbonic anhydrase 9,enzyme,,Drug: zoledronic acid | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
13672,zoledronic acid,carbonic anhydrase 12,enzyme,,Drug: zoledronic acid | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
13673,zoledronic acid,farnesyl pyrophosphate synthase,enzyme,INHIBITOR,Drug: zoledronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: INHIBITOR
13674,zoledronic acid,72 kda type iv collagenase,enzyme,,Drug: zoledronic acid | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
13675,zoledronic acid,carbonic anhydrase 14,enzyme,,Drug: zoledronic acid | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
13676,zoledronic acid,matrix metalloproteinase-14,enzyme,,Drug: zoledronic acid | Target: matrix metalloproteinase-14 | Type: enzyme | Action: nan
13677,zoledronic acid,matrix metalloproteinase-9,enzyme,,Drug: zoledronic acid | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
13678,zoledronic acid,neutrophil collagenase,enzyme,,Drug: zoledronic acid | Target: neutrophil collagenase | Type: enzyme | Action: nan
13679,zoledronic acid,geranylgeranyl pyrophosphate synthase,enzyme,,Drug: zoledronic acid | Target: geranylgeranyl pyrophosphate synthase | Type: enzyme | Action: nan
13680,zoledronic acid,farnesyl diphosphate synthase,enzyme,,Drug: zoledronic acid | Target: farnesyl diphosphate synthase | Type: enzyme | Action: nan
13681,zoledronic acid,farnesyl pyrophosphate synthase,enzyme,,Drug: zoledronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
13682,zoledronic acid,geranylgeranyl pyrophosphate synthase,enzyme,,Drug: zoledronic acid | Target: geranylgeranyl pyrophosphate synthase | Type: enzyme | Action: nan
13683,zoledronic acid,farnesyl pyrophosphate synthase,enzyme,INHIBITOR,Drug: zoledronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: INHIBITOR
13684,zoledronic acid,butyrophilin subfamily 3 member a1,unclassified,,Drug: zoledronic acid | Target: butyrophilin subfamily 3 member a1 | Type: unclassified | Action: nan
13685,zolmitriptan,5-hydroxytryptamine receptor 1a,gpcr,,Drug: zolmitriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13686,zolmitriptan,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: zolmitriptan | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
13687,zolmitriptan,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: zolmitriptan | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
13688,zolmitriptan,5-hydroxytryptamine receptor 1f,gpcr,,Drug: zolmitriptan | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: nan
13689,zolmitriptan,5-hydroxytryptamine receptor 1e,gpcr,,Drug: zolmitriptan | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
13690,zolmitriptan,d(2) dopamine receptor,gpcr,,Drug: zolmitriptan | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
13691,zolmitriptan,d(1a) dopamine receptor,gpcr,,Drug: zolmitriptan | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
13692,zolmitriptan,adrenergic receptor alpha-2,gpcr,,Drug: zolmitriptan | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
13693,zolpidem,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,ALLOSTERIC MODULATOR,Drug: zolpidem | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: ALLOSTERIC MODULATOR
13694,zolpidem,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,,Drug: zolpidem | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: nan
13695,zolpidem,gamma-aminobutyric acid receptor subunit alpha-3,ion channel,,Drug: zolpidem | Target: gamma-aminobutyric acid receptor subunit alpha-3 | Type: ion channel | Action: nan
13696,zolpidem,multidrug resistance protein 1,transporter,,Drug: zolpidem | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
13697,zolpidem,translocator protein,membrane receptor,,Drug: zolpidem | Target: translocator protein | Type: membrane receptor | Action: nan
13698,zolpidem,gamma-aminobutyric acid receptor subunit alpha-1,ion channel,,Drug: zolpidem | Target: gamma-aminobutyric acid receptor subunit alpha-1 | Type: ion channel | Action: nan
13699,zolpidem,gamma-aminobutyric acid receptor subunit alpha-2,ion channel,,Drug: zolpidem | Target: gamma-aminobutyric acid receptor subunit alpha-2 | Type: ion channel | Action: nan
13700,zolpidem,gamma-aminobutyric acid receptor subunit alpha-5,ion channel,,Drug: zolpidem | Target: gamma-aminobutyric acid receptor subunit alpha-5 | Type: ion channel | Action: nan
13701,zolpidem,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: zolpidem | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
13702,zolpidem,gaba-a receptor alpha-2/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: zolpidem | Target: gaba-a receptor alpha-2/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
13703,zolpidem,gaba-a receptor alpha-3/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: zolpidem | Target: gaba-a receptor alpha-3/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
13704,zolpidem,gaba-a receptor alpha-1/beta-3/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: zolpidem | Target: gaba-a receptor alpha-1/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
13705,zolpidem,gaba-a receptor; anion channel,ion channel,,Drug: zolpidem | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
13706,zolpidem,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,,Drug: zolpidem | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: nan
13707,zolpidem,gaba a receptor alpha-6/beta-2/gamma-2,ion channel,,Drug: zolpidem | Target: gaba a receptor alpha-6/beta-2/gamma-2 | Type: ion channel | Action: nan
13708,zolpidem,gaba-a receptor; alpha-1/beta-2/gamma-2,ion channel,,Drug: zolpidem | Target: gaba-a receptor; alpha-1/beta-2/gamma-2 | Type: ion channel | Action: nan
13709,zolpidem,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,,Drug: zolpidem | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: nan
13710,zolpidem,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: zolpidem | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
13711,zolpidem,caax prenyl protease 2,enzyme,,Drug: zolpidem | Target: caax prenyl protease 2 | Type: enzyme | Action: nan
13712,zomepirac,prostaglandin g/h synthase 2,enzyme,,Drug: zomepirac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
13713,zomepirac,prostaglandin g/h synthase 1,enzyme,,Drug: zomepirac | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
13714,zomepirac,cyclooxygenase,enzyme,,Drug: zomepirac | Target: cyclooxygenase | Type: enzyme | Action: nan
13715,zonisamide,sodium channel protein type 1 subunit alpha,ion channel,BLOCKER,Drug: zonisamide | Target: sodium channel protein type 1 subunit alpha | Type: ion channel | Action: BLOCKER
13716,zonisamide,carbonic anhydrase 2,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13717,zonisamide,voltage-dependent t-type calcium channel subunit alpha-1g,ion channel,,Drug: zonisamide | Target: voltage-dependent t-type calcium channel subunit alpha-1g | Type: ion channel | Action: nan
13718,zonisamide,carbonic anhydrase 1,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
13719,zonisamide,carbonic anhydrase 4,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
13720,zonisamide,amine oxidase [flavin-containing] b,enzyme,,Drug: zonisamide | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
13721,zonisamide,carbonic anhydrase 9,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
13722,zonisamide,carbonic anhydrase 12,enzyme,INHIBITOR,Drug: zonisamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: INHIBITOR
13723,zonisamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: zonisamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
13724,zonisamide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: zonisamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
13725,zonisamide,carbonic anhydrase 7,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
13726,zonisamide,carbonic anhydrase,enzyme,,Drug: zonisamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
13727,zonisamide,carbonic anhydrase 6,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
13728,zonisamide,carbonic anhydrase 14,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
13729,zonisamide,amine oxidase [flavin-containing] b,enzyme,,Drug: zonisamide | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
13730,zonisamide,carbonic anhydrase 13,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
13731,zonisamide,carbonic anhydrase 15,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
13732,zonisamide,carbonic anhydrase,enzyme,,Drug: zonisamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
13733,zonisamide,carbonic anhydrase,enzyme,,Drug: zonisamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
13734,zonisamide,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: zonisamide | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
13735,zonisamide,carbonic anhydrase,enzyme,,Drug: zonisamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
13736,zonisamide,alpha carbonic anhydrase,enzyme,,Drug: zonisamide | Target: alpha carbonic anhydrase | Type: enzyme | Action: nan
13737,zonisamide,carbonic anhydrase,enzyme,,Drug: zonisamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
13738,zonisamide,carbonic anhydrase 2,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13739,zonisamide,astrosclerin-3,enzyme,,Drug: zonisamide | Target: astrosclerin-3 | Type: enzyme | Action: nan
13740,zonisamide,beta-carbonic anhydrase 1,enzyme,,Drug: zonisamide | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
13741,zonisamide,delta carbonic anhydrase,unclassified,,Drug: zonisamide | Target: delta carbonic anhydrase | Type: unclassified | Action: nan
13742,zonisamide,carbonic anhydrase 2,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
13743,zonisamide,carbonic anhydrase v,enzyme,,Drug: zonisamide | Target: carbonic anhydrase v | Type: enzyme | Action: nan
13744,zonisamide,carbonic anhydrase 3,enzyme,,Drug: zonisamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
13745,zonisamide,amine oxidase [flavin-containing],enzyme,,Drug: zonisamide | Target: amine oxidase [flavin-containing] | Type: enzyme | Action: nan
13746,zonisamide,carbonic anhydrase,enzyme,,Drug: zonisamide | Target: carbonic anhydrase | Type: enzyme | Action: nan
13747,zonisamide,"carbonic anhydrase, alpha family",unclassified,,"Drug: zonisamide | Target: carbonic anhydrase, alpha family | Type: unclassified | Action: nan"
13748,zonisamide,carbonate dehydratase,enzyme,,Drug: zonisamide | Target: carbonate dehydratase | Type: enzyme | Action: nan
13749,zopiclone,gaba-a receptor; anion channel,ion channel,,Drug: zopiclone | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
13750,zopiclone,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE MODULATOR,Drug: zopiclone | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
13751,zopiclone,gaba-a receptor alpha-5/beta-3/gamma-2,ion channel,POSITIVE MODULATOR,Drug: zopiclone | Target: gaba-a receptor alpha-5/beta-3/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
13752,zopiclone,gaba-a receptor alpha-1/beta-2/gamma-3,ion channel,POSITIVE MODULATOR,Drug: zopiclone | Target: gaba-a receptor alpha-1/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE MODULATOR
13753,zopiclone,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,POSITIVE MODULATOR,Drug: zopiclone | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
13754,zopiclone,gaba a receptor alpha-3/beta-2/gamma-3,ion channel,POSITIVE MODULATOR,Drug: zopiclone | Target: gaba a receptor alpha-3/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE MODULATOR
13755,zopiclone,gaba a receptor alpha-5/beta-3/gamma-3,ion channel,POSITIVE MODULATOR,Drug: zopiclone | Target: gaba a receptor alpha-5/beta-3/gamma-3 | Type: ion channel | Action: POSITIVE MODULATOR
13756,zopiclone,gaba a receptor alpha-5/beta-2/gamma-2,ion channel,POSITIVE MODULATOR,Drug: zopiclone | Target: gaba a receptor alpha-5/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE MODULATOR
13757,zopiclone,gaba a receptor alpha-5/beta-2/gamma-3,ion channel,POSITIVE MODULATOR,Drug: zopiclone | Target: gaba a receptor alpha-5/beta-2/gamma-3 | Type: ion channel | Action: POSITIVE MODULATOR
13758,zotepine,beta-1 adrenergic receptor,gpcr,,Drug: zotepine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
13759,zotepine,beta-2 adrenergic receptor,gpcr,,Drug: zotepine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
13760,zotepine,d(1a) dopamine receptor,gpcr,,Drug: zotepine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
13761,zotepine,d(2) dopamine receptor,gpcr,,Drug: zotepine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
13762,zotepine,alpha-2a adrenergic receptor,gpcr,,Drug: zotepine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
13763,zotepine,sodium-dependent serotonin transporter,transporter,,Drug: zotepine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13764,zotepine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: zotepine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
13765,zotepine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: zotepine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13766,zotepine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: zotepine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
13767,zotepine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: zotepine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
13768,zotepine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: zotepine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
13769,zotepine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: zotepine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
13770,zotepine,alpha-1a adrenergic receptor,gpcr,,Drug: zotepine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
13771,zotepine,alpha-2b adrenergic receptor,gpcr,,Drug: zotepine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
13772,zotepine,d(3) dopamine receptor,gpcr,,Drug: zotepine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
13773,zotepine,d(1b) dopamine receptor,gpcr,,Drug: zotepine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
13774,zotepine,histamine h1 receptor,gpcr,,Drug: zotepine | Target: histamine h1 receptor | Type: gpcr | Action: nan
13775,zotepine,histamine h2 receptor,gpcr,,Drug: zotepine | Target: histamine h2 receptor | Type: gpcr | Action: nan
13776,zotepine,histamine h4 receptor,gpcr,,Drug: zotepine | Target: histamine h4 receptor | Type: gpcr | Action: nan
13777,zotepine,muscarinic acetylcholine receptor m1,gpcr,,Drug: zotepine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
13778,zotepine,muscarinic acetylcholine receptor m2,gpcr,,Drug: zotepine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13779,zotepine,muscarinic acetylcholine receptor m3,gpcr,,Drug: zotepine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
13780,zotepine,muscarinic acetylcholine receptor m4,gpcr,,Drug: zotepine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
13781,zotepine,muscarinic acetylcholine receptor m5,gpcr,,Drug: zotepine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
13782,zotepine,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: zotepine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
13783,zotepine,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: zotepine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
13784,zotepine,alpha-2c adrenergic receptor,gpcr,,Drug: zotepine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
13785,zotepine,sodium-dependent dopamine transporter,transporter,,Drug: zotepine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13786,zotepine,d(4) dopamine receptor,gpcr,,Drug: zotepine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
13787,zotepine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: zotepine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
13788,zotepine,alpha-1b adrenergic receptor,gpcr,,Drug: zotepine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
13789,zotepine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: zotepine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
13790,zotepine,5-hydroxytryptamine receptor 1e,gpcr,ANTAGONIST,Drug: zotepine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: ANTAGONIST
13791,zotepine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: zotepine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
13792,zotepine,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: zotepine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
13793,zuclopenthixol,5-hydroxytryptamine receptor 2a,gpcr,,Drug: zuclopenthixol | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
13794,zuclopenthixol,5-hydroxytryptamine receptor 6,gpcr,,Drug: zuclopenthixol | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
13795,zuclopenthixol,alpha-1a adrenergic receptor,gpcr,,Drug: zuclopenthixol | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
13796,zuclopenthixol,d(1a) dopamine receptor,gpcr,ANTAGONIST,Drug: zuclopenthixol | Target: d(1a) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13797,zuclopenthixol,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: zuclopenthixol | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
13798,ziconotide,voltage-dependent n-type calcium channel subunit alpha-1b,ion channel,BLOCKER,Drug: ziconotide | Target: voltage-dependent n-type calcium channel subunit alpha-1b | Type: ion channel | Action: BLOCKER
13799,ziconotide,voltage-dependent n-type calcium channel subunit alpha-1b,ion channel,BLOCKER,Drug: ziconotide | Target: voltage-dependent n-type calcium channel subunit alpha-1b | Type: ion channel | Action: BLOCKER
13800,ziconotide,voltage-dependent p/q-type calcium channel subunit alpha-1a,ion channel,BLOCKER,Drug: ziconotide | Target: voltage-dependent p/q-type calcium channel subunit alpha-1a | Type: ion channel | Action: BLOCKER
13801,zotarolimus,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,INHIBITOR,Drug: zotarolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: INHIBITOR
13802,zotarolimus,serine/threonine-protein kinase mtor,kinase,,Drug: zotarolimus | Target: serine/threonine-protein kinase mtor | Type: kinase | Action: nan
13803,eledoisin,substance-p receptor,gpcr,AGONIST,Drug: eledoisin | Target: substance-p receptor | Type: gpcr | Action: AGONIST
13804,eledoisin,neuromedin-k receptor,gpcr,,Drug: eledoisin | Target: neuromedin-k receptor | Type: gpcr | Action: nan
13805,gonadorelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: gonadorelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
13806,gonadorelin,gonadotropin-releasing hormone receptor,gpcr,,Drug: gonadorelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: nan
13807,gonadorelin,lutropin-choriogonadotropic hormone receptor,gpcr,,Drug: gonadorelin | Target: lutropin-choriogonadotropic hormone receptor | Type: gpcr | Action: nan
13808,lypressin,vasopressin receptor,gpcr,AGONIST,Drug: lypressin | Target: vasopressin receptor | Type: gpcr | Action: AGONIST
13809,mifamurtide,nucleotide-binding oligomerization domain-containing protein 2,cytosolic other,ACTIVATOR,Drug: mifamurtide | Target: nucleotide-binding oligomerization domain-containing protein 2 | Type: cytosolic other | Action: ACTIVATOR
13810,suramin,nad-dependent protein deacetylase sirtuin-1,enzyme,,Drug: suramin | Target: nad-dependent protein deacetylase sirtuin-1 | Type: enzyme | Action: nan
13811,suramin,p2y purinoceptor 6,gpcr,ANTAGONIST,Drug: suramin | Target: p2y purinoceptor 6 | Type: gpcr | Action: ANTAGONIST
13812,suramin,p2y purinoceptor 1,gpcr,ANTAGONIST,Drug: suramin | Target: p2y purinoceptor 1 | Type: gpcr | Action: ANTAGONIST
13813,suramin,nad-dependent protein deacetylase sirtuin-2,enzyme,,Drug: suramin | Target: nad-dependent protein deacetylase sirtuin-2 | Type: enzyme | Action: nan
13814,suramin,p2y purinoceptor 2,gpcr,ANTAGONIST,Drug: suramin | Target: p2y purinoceptor 2 | Type: gpcr | Action: ANTAGONIST
13815,suramin,p2y purinoceptor 11,gpcr,ANTAGONIST,Drug: suramin | Target: p2y purinoceptor 11 | Type: gpcr | Action: ANTAGONIST
13816,suramin,protein arginine n-methyltransferase 1,enzyme,,Drug: suramin | Target: protein arginine n-methyltransferase 1 | Type: enzyme | Action: nan
13817,suramin,p2y purinoceptor 13,gpcr,ANTAGONIST,Drug: suramin | Target: p2y purinoceptor 13 | Type: gpcr | Action: ANTAGONIST
13818,suramin,reverse transcriptase/rnaseh,enzyme,,Drug: suramin | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: nan
13819,suramin,dna-dependent protein kinase catalytic subunit,kinase,,Drug: suramin | Target: dna-dependent protein kinase catalytic subunit | Type: kinase | Action: nan
13820,suramin,rmta,enzyme,,Drug: suramin | Target: rmta | Type: enzyme | Action: nan
13821,suramin,p2x purinoceptor 4,ion channel,,Drug: suramin | Target: p2x purinoceptor 4 | Type: ion channel | Action: nan
13822,suramin,atp-dependent 6-phosphofructokinase,kinase,,Drug: suramin | Target: atp-dependent 6-phosphofructokinase | Type: kinase | Action: nan
13823,suramin,protein kinase c (pkc),kinase,,Drug: suramin | Target: protein kinase c (pkc) | Type: kinase | Action: nan
13824,suramin,p2x purinoceptor 3,ion channel,,Drug: suramin | Target: p2x purinoceptor 3 | Type: ion channel | Action: nan
13825,suramin,"nad-dependent protein deacylase sirtuin-5, mitochondrial",enzyme,,"Drug: suramin | Target: nad-dependent protein deacylase sirtuin-5, mitochondrial | Type: enzyme | Action: nan"
13826,suramin,nucleoside triphosphate diphosphohydrolase 3,enzyme,,Drug: suramin | Target: nucleoside triphosphate diphosphohydrolase 3 | Type: enzyme | Action: nan
13827,suramin,ectonucleoside triphosphate diphosphohydrolase 2,enzyme,,Drug: suramin | Target: ectonucleoside triphosphate diphosphohydrolase 2 | Type: enzyme | Action: nan
13828,suramin,p2x purinoceptor 3,unclassified,ANTAGONIST,Drug: suramin | Target: p2x purinoceptor 3 | Type: unclassified | Action: ANTAGONIST
13829,suramin,p2x purinoceptor 2,unclassified,ANTAGONIST,Drug: suramin | Target: p2x purinoceptor 2 | Type: unclassified | Action: ANTAGONIST
13830,suramin,p2x purinoceptor 1,unclassified,ANTAGONIST,Drug: suramin | Target: p2x purinoceptor 1 | Type: unclassified | Action: ANTAGONIST
13831,suramin,p2x purinoceptor 5,unclassified,ANTAGONIST,Drug: suramin | Target: p2x purinoceptor 5 | Type: unclassified | Action: ANTAGONIST
13832,suramin,signal transducer and activator of transcription 1-alpha/beta,unclassified,,Drug: suramin | Target: signal transducer and activator of transcription 1-alpha/beta | Type: unclassified | Action: nan
13833,suramin,signal transducer and activator of transcription 5a,unclassified,,Drug: suramin | Target: signal transducer and activator of transcription 5a | Type: unclassified | Action: nan
13834,suramin,signal transducer and activator of transcription 5b,unclassified,,Drug: suramin | Target: signal transducer and activator of transcription 5b | Type: unclassified | Action: nan
13835,triptorelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: triptorelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
13836,triptorelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: triptorelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
13837,doxacurium,muscarinic acetylcholine receptor m2,gpcr,,Drug: doxacurium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13838,doxacurium,neuronal acetylcholine receptor subunit alpha-2,ion channel,,Drug: doxacurium | Target: neuronal acetylcholine receptor subunit alpha-2 | Type: ion channel | Action: nan
13839,doxacurium,acetylcholine receptor,ion channel,ANTAGONIST,Drug: doxacurium | Target: acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
13840,histrelin,gonadotropin-releasing hormone receptor,gpcr,AGONIST,Drug: histrelin | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: AGONIST
13841,caspofungin,"beta-1,3-glucan synthase catalytic subunit 1",enzyme,INHIBITOR,"Drug: caspofungin | Target: beta-1,3-glucan synthase catalytic subunit 1 | Type: enzyme | Action: INHIBITOR"
13842,caspofungin,"1,3-beta-glucan synthase catalytic subunit fksp",enzyme,INHIBITOR,"Drug: caspofungin | Target: 1,3-beta-glucan synthase catalytic subunit fksp | Type: enzyme | Action: INHIBITOR"
13843,caspofungin,"1,3-beta-d-glucan synthase catalytic subunit",unclassified,,"Drug: caspofungin | Target: 1,3-beta-d-glucan synthase catalytic subunit | Type: unclassified | Action: nan"
13844,calcitonin (salmon synthetic),amylin receptor amy1,gpcr,AGONIST,Drug: calcitonin (salmon synthetic) | Target: amylin receptor amy1 | Type: gpcr | Action: AGONIST
13845,calcitonin (salmon synthetic),amylin receptor amy2,gpcr,AGONIST,Drug: calcitonin (salmon synthetic) | Target: amylin receptor amy2 | Type: gpcr | Action: AGONIST
13846,calcitonin (salmon synthetic),amylin receptor amy3,gpcr,AGONIST,Drug: calcitonin (salmon synthetic) | Target: amylin receptor amy3 | Type: gpcr | Action: AGONIST
13847,calcitonin (salmon synthetic),calcitonin receptor,gpcr,AGONIST,Drug: calcitonin (salmon synthetic) | Target: calcitonin receptor | Type: gpcr | Action: AGONIST
13848,desirudin,prothrombin,enzyme,INHIBITOR,Drug: desirudin | Target: prothrombin | Type: enzyme | Action: INHIBITOR
13849,glucagon,glucagon-like peptide 1 receptor,gpcr,AGONIST,Drug: glucagon | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: AGONIST
13850,glucagon,glucagon receptor,gpcr,AGONIST,Drug: glucagon | Target: glucagon receptor | Type: gpcr | Action: AGONIST
13851,glucagon,glucagon receptor,gpcr,,Drug: glucagon | Target: glucagon receptor | Type: gpcr | Action: nan
13852,glucagon,adenylate cyclase,enzyme,,Drug: glucagon | Target: adenylate cyclase | Type: enzyme | Action: nan
13853,glucagon,glucagon-like peptide 1 receptor,gpcr,,Drug: glucagon | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: nan
13854,glucagon,glucagon-like peptide 1 receptor,gpcr,,Drug: glucagon | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: nan
13855,lepirudin,prothrombin,enzyme,INHIBITOR,Drug: lepirudin | Target: prothrombin | Type: enzyme | Action: INHIBITOR
13856,somatostatin,mu-type opioid receptor,gpcr,,Drug: somatostatin | Target: mu-type opioid receptor | Type: gpcr | Action: nan
13857,somatostatin,delta-type opioid receptor,gpcr,,Drug: somatostatin | Target: delta-type opioid receptor | Type: gpcr | Action: nan
13858,somatostatin,somatostatin receptor type 2,gpcr,,Drug: somatostatin | Target: somatostatin receptor type 2 | Type: gpcr | Action: nan
13859,somatostatin,somatostatin receptor type 3,gpcr,,Drug: somatostatin | Target: somatostatin receptor type 3 | Type: gpcr | Action: nan
13860,somatostatin,somatostatin receptor type 5,gpcr,,Drug: somatostatin | Target: somatostatin receptor type 5 | Type: gpcr | Action: nan
13861,somatostatin,somatostatin receptor,gpcr,,Drug: somatostatin | Target: somatostatin receptor | Type: gpcr | Action: nan
13862,somatostatin,somatostatin receptor,gpcr,,Drug: somatostatin | Target: somatostatin receptor | Type: gpcr | Action: nan
13863,somatostatin,somatostatin receptor type 2,gpcr,AGONIST,Drug: somatostatin | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
13864,somatostatin,somatostatin receptor type 3,gpcr,AGONIST,Drug: somatostatin | Target: somatostatin receptor type 3 | Type: gpcr | Action: AGONIST
13865,somatostatin,somatostatin receptor type 5,gpcr,AGONIST,Drug: somatostatin | Target: somatostatin receptor type 5 | Type: gpcr | Action: AGONIST
13866,somatostatin,somatostatin receptor type 4,gpcr,AGONIST,Drug: somatostatin | Target: somatostatin receptor type 4 | Type: gpcr | Action: AGONIST
13867,somatostatin,somatostatin receptor type 1,gpcr,AGONIST,Drug: somatostatin | Target: somatostatin receptor type 1 | Type: gpcr | Action: AGONIST
13868,pyrantel,acetylcholinesterase,enzyme,,Drug: pyrantel | Target: acetylcholinesterase | Type: enzyme | Action: nan
13869,atosiban,vasopressin v1a receptor,gpcr,,Drug: atosiban | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
13870,atosiban,vasopressin v1b receptor,gpcr,,Drug: atosiban | Target: vasopressin v1b receptor | Type: gpcr | Action: nan
13871,atosiban,vasopressin v2 receptor,gpcr,,Drug: atosiban | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
13872,atosiban,oxytocin receptor,gpcr,,Drug: atosiban | Target: oxytocin receptor | Type: gpcr | Action: nan
13873,atosiban,oxytocin receptor,gpcr,ANTAGONIST,Drug: atosiban | Target: oxytocin receptor | Type: gpcr | Action: ANTAGONIST
13874,oxybuprocaine,sodium channel protein type 10 subunit alpha,ion channel,BLOCKER,Drug: oxybuprocaine | Target: sodium channel protein type 10 subunit alpha | Type: ion channel | Action: BLOCKER
13875,oxybuprocaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,BLOCKER,"Drug: oxybuprocaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: BLOCKER"
13876,benzethonium,alpha-2a adrenergic receptor,gpcr,,Drug: benzethonium | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
13877,benzethonium,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: benzethonium | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
13878,benzethonium,sodium-dependent serotonin transporter,transporter,,Drug: benzethonium | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
13879,benzethonium,sodium-dependent noradrenaline transporter,transporter,,Drug: benzethonium | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
13880,benzethonium,5-hydroxytryptamine receptor 2a,gpcr,,Drug: benzethonium | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
13881,benzethonium,5-hydroxytryptamine receptor 2c,gpcr,,Drug: benzethonium | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
13882,benzethonium,alpha-2b adrenergic receptor,gpcr,,Drug: benzethonium | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
13883,benzethonium,muscarinic acetylcholine receptor m1,gpcr,,Drug: benzethonium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
13884,benzethonium,muscarinic acetylcholine receptor m2,gpcr,,Drug: benzethonium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13885,benzethonium,muscarinic acetylcholine receptor m3,gpcr,,Drug: benzethonium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
13886,benzethonium,muscarinic acetylcholine receptor m4,gpcr,,Drug: benzethonium | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
13887,benzethonium,muscarinic acetylcholine receptor m5,gpcr,,Drug: benzethonium | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
13888,benzethonium,alpha-2c adrenergic receptor,gpcr,,Drug: benzethonium | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
13889,benzethonium,sodium-dependent dopamine transporter,transporter,,Drug: benzethonium | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13890,benzethonium,acetylcholinesterase,enzyme,,Drug: benzethonium | Target: acetylcholinesterase | Type: enzyme | Action: nan
13891,benzethonium,tyrosine-protein kinase fyn,kinase,,Drug: benzethonium | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
13892,benzethonium,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: benzethonium | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
13893,benzethonium,substance-k receptor,gpcr,,Drug: benzethonium | Target: substance-k receptor | Type: gpcr | Action: nan
13894,benzethonium,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: benzethonium | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
13895,benzethonium,kiss-1 receptor,gpcr,,Drug: benzethonium | Target: kiss-1 receptor | Type: gpcr | Action: nan
13896,bergapten,amine oxidase [flavin-containing] a,enzyme,,Drug: bergapten | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
13897,bergapten,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,,Drug: bergapten | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: nan
13898,bergapten,cytochrome p450 1a1,enzyme,,Drug: bergapten | Target: cytochrome p450 1a1 | Type: enzyme | Action: nan
13899,bietamiverine,muscarinic acetylcholine receptor m1,gpcr,,Drug: bietamiverine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
13900,bietamiverine,muscarinic acetylcholine receptor m2,gpcr,,Drug: bietamiverine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
13901,bietamiverine,muscarinic acetylcholine receptor m3,gpcr,,Drug: bietamiverine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
13902,bithionol,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: bithionol | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
13903,bithionol,mu-type opioid receptor,gpcr,,Drug: bithionol | Target: mu-type opioid receptor | Type: gpcr | Action: nan
13904,bithionol,adenosine receptor a2a,gpcr,,Drug: bithionol | Target: adenosine receptor a2a | Type: gpcr | Action: nan
13905,bithionol,alpha-2a adrenergic receptor,gpcr,,Drug: bithionol | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
13906,bithionol,sodium-dependent noradrenaline transporter,transporter,,Drug: bithionol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
13907,bithionol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: bithionol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13908,bithionol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: bithionol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
13909,bithionol,5-hydroxytryptamine receptor 2c,gpcr,,Drug: bithionol | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
13910,bithionol,alpha-2b adrenergic receptor,gpcr,,Drug: bithionol | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
13911,bithionol,d(3) dopamine receptor,gpcr,,Drug: bithionol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
13912,bithionol,alpha-2c adrenergic receptor,gpcr,,Drug: bithionol | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
13913,bithionol,sodium-dependent dopamine transporter,transporter,,Drug: bithionol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
13914,bithionol,adenosine receptor a3,gpcr,,Drug: bithionol | Target: adenosine receptor a3 | Type: gpcr | Action: nan
13915,bithionol,estrogen receptor,nuclear hormone receptor,,Drug: bithionol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
13916,bithionol,estrogen receptor beta,nuclear hormone receptor,,Drug: bithionol | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
13917,bithionol,epidermal growth factor receptor,kinase,,Drug: bithionol | Target: epidermal growth factor receptor | Type: kinase | Action: nan
13918,bithionol,tyrosine-protein kinase lck,kinase,,Drug: bithionol | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
13919,bithionol,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: bithionol | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
13920,bithionol,thromboxane-a synthase,enzyme,,Drug: bithionol | Target: thromboxane-a synthase | Type: enzyme | Action: nan
13921,bithionol,mitogen-activated protein kinase 14,kinase,,Drug: bithionol | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
13922,bithionol,solute carrier family 22 member 1,transporter,,Drug: bithionol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
13923,bithionol,substance-k receptor,gpcr,,Drug: bithionol | Target: substance-k receptor | Type: gpcr | Action: nan
13924,bithionol,mitogen-activated protein kinase 1,kinase,,Drug: bithionol | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
13925,bithionol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: bithionol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
13926,bithionol,solute carrier family 22 member 2,transporter,,Drug: bithionol | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
13927,bithionol,multidrug and toxin extrusion protein 1,transporter,,Drug: bithionol | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
13928,bithionol,multidrug and toxin extrusion protein 2,transporter,,Drug: bithionol | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
13929,bithionol,solute carrier family 22 member 3,transporter,,Drug: bithionol | Target: solute carrier family 22 member 3 | Type: transporter | Action: nan
13930,bithionol,m1-family alanyl aminopeptidase,enzyme,,Drug: bithionol | Target: m1-family alanyl aminopeptidase | Type: enzyme | Action: nan
13931,bithionol,envelope glycoprotein gp160,viral envelope protein,,Drug: bithionol | Target: envelope glycoprotein gp160 | Type: viral envelope protein | Action: nan
13932,bithionol,potassium channel subfamily t member 1,ion channel,ACTIVATOR,Drug: bithionol | Target: potassium channel subfamily t member 1 | Type: ion channel | Action: ACTIVATOR
13933,bithionol,n-acyl-phosphatidylethanolamine-hydrolyzing phospholipase d,unclassified,INHIBITOR,Drug: bithionol | Target: n-acyl-phosphatidylethanolamine-hydrolyzing phospholipase d | Type: unclassified | Action: INHIBITOR
13934,broxuridine,"thymidine kinase, cytosolic",kinase,,"Drug: broxuridine | Target: thymidine kinase, cytosolic | Type: kinase | Action: nan"
13935,broxuridine,thymidylate kinase,kinase,,Drug: broxuridine | Target: thymidylate kinase | Type: kinase | Action: nan
13936,bufexamac,histone deacetylase 6,enzyme,INHIBITOR,Drug: bufexamac | Target: histone deacetylase 6 | Type: enzyme | Action: INHIBITOR
13937,bufexamac,histone deacetylase 10,enzyme,INHIBITOR,Drug: bufexamac | Target: histone deacetylase 10 | Type: enzyme | Action: INHIBITOR
13938,bufexamac,arachidonate 5-lipoxygenase,enzyme,,Drug: bufexamac | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
13939,bufexamac,m1-family alanyl aminopeptidase,enzyme,,Drug: bufexamac | Target: m1-family alanyl aminopeptidase | Type: enzyme | Action: nan
13940,butacaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: butacaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
13941,butethamine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: butethamine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
13942,capsaicin,transient receptor potential cation channel subfamily v member 1,ion channel,OPENER,Drug: capsaicin | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: OPENER
13943,capsaicin,prostaglandin g/h synthase 1,enzyme,,Drug: capsaicin | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
13944,capsaicin,cytochrome p450 1a2,enzyme,,Drug: capsaicin | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
13945,capsaicin,arachidonate 5-lipoxygenase,enzyme,,Drug: capsaicin | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
13946,capsaicin,potassium voltage-gated channel subfamily a member 1,ion channel,,Drug: capsaicin | Target: potassium voltage-gated channel subfamily a member 1 | Type: ion channel | Action: nan
13947,capsaicin,"tyrosine--trna ligase, cytoplasmic",enzyme,,"Drug: capsaicin | Target: tyrosine--trna ligase, cytoplasmic | Type: enzyme | Action: nan"
13948,capsaicin,transient receptor potential cation channel subfamily v member 1,ion channel,,Drug: capsaicin | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: nan
13949,capsaicin,nadh-ubiquinone oxidoreductase chain 1,unclassified,,Drug: capsaicin | Target: nadh-ubiquinone oxidoreductase chain 1 | Type: unclassified | Action: nan
13950,capsaicin,transient receptor potential cation channel subfamily m member 8,ion channel,,Drug: capsaicin | Target: transient receptor potential cation channel subfamily m member 8 | Type: ion channel | Action: nan
13951,capsaicin,transient receptor potential cation channel subfamily v member 1,ion channel,ACTIVATOR,Drug: capsaicin | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: ACTIVATOR
13952,capsaicin,potassium voltage-gated channel subfamily a member 7,ion channel,BLOCKER,Drug: capsaicin | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: BLOCKER
13953,capsaicin,potassium voltage-gated channel subfamily a member 1,ion channel,BLOCKER,Drug: capsaicin | Target: potassium voltage-gated channel subfamily a member 1 | Type: ion channel | Action: BLOCKER
13954,capsaicin,potassium voltage-gated channel subfamily a member 2,ion channel,BLOCKER,Drug: capsaicin | Target: potassium voltage-gated channel subfamily a member 2 | Type: ion channel | Action: BLOCKER
13956,carbaryl,acetylcholinesterase,enzyme,,Drug: carbaryl | Target: acetylcholinesterase | Type: enzyme | Action: nan
13957,carbaryl,acetylcholinesterase,enzyme,,Drug: carbaryl | Target: acetylcholinesterase | Type: enzyme | Action: nan
13958,carbaryl,ace-orthologous acetylcholinesterase; acetylcholinesterase,unclassified,,Drug: carbaryl | Target: ace-orthologous acetylcholinesterase; acetylcholinesterase | Type: unclassified | Action: nan
13959,carbaryl,acetylcholinesterase,enzyme,,Drug: carbaryl | Target: acetylcholinesterase | Type: enzyme | Action: nan
13960,carbaryl,acetylcholinesterase,enzyme,,Drug: carbaryl | Target: acetylcholinesterase | Type: enzyme | Action: nan
13961,carbon tetrachloride,cytochrome p450 2e1,enzyme,,Drug: carbon tetrachloride | Target: cytochrome p450 2e1 | Type: enzyme | Action: nan
13962,carglumic acid,"carbamoyl-phosphate synthase [ammonia], mitochondrial",enzyme,POSITIVE ALLOSTERIC MODULATOR,"Drug: carglumic acid | Target: carbamoyl-phosphate synthase [ammonia], mitochondrial | Type: enzyme | Action: POSITIVE ALLOSTERIC MODULATOR"
13963,articaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,BLOCKER,"Drug: articaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: BLOCKER"
13964,cetrimonium,dynamin-1,structural,,Drug: cetrimonium | Target: dynamin-1 | Type: structural | Action: nan
13965,cetylpyridinium,high affinity choline transporter 1,transporter,,Drug: cetylpyridinium | Target: high affinity choline transporter 1 | Type: transporter | Action: nan
13966,cetylpyridinium,caspase-2,enzyme,,Drug: cetylpyridinium | Target: caspase-2 | Type: enzyme | Action: nan
13967,chloroxylenol,5-hydroxytryptamine receptor 2b,gpcr,,Drug: chloroxylenol | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
13968,chloroxylenol,amine oxidase [flavin-containing] a,enzyme,,Drug: chloroxylenol | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
13969,chlorquinaldol,botulinum neurotoxin type a,enzyme,,Drug: chlorquinaldol | Target: botulinum neurotoxin type a | Type: enzyme | Action: nan
13970,cholic acid,bile acid receptor,nuclear hormone receptor,,Drug: cholic acid | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
13971,cholic acid,g-protein coupled bile acid receptor 1,gpcr,AGONIST,Drug: cholic acid | Target: g-protein coupled bile acid receptor 1 | Type: gpcr | Action: AGONIST
13972,choline,acetylcholine receptor subunit delta,ion channel,,Drug: choline | Target: acetylcholine receptor subunit delta | Type: ion channel | Action: nan
13973,choline,high affinity choline transporter 1,transporter,,Drug: choline | Target: high affinity choline transporter 1 | Type: transporter | Action: nan
13974,choline,neuronal acetylcholine receptor; alpha2/beta2,ion channel,,Drug: choline | Target: neuronal acetylcholine receptor; alpha2/beta2 | Type: ion channel | Action: nan
13975,choline,neuronal acetylcholine receptor; alpha3/beta2,ion channel,,Drug: choline | Target: neuronal acetylcholine receptor; alpha3/beta2 | Type: ion channel | Action: nan
13976,choline,neuronal acetylcholine receptor; alpha3/beta4,ion channel,,Drug: choline | Target: neuronal acetylcholine receptor; alpha3/beta4 | Type: ion channel | Action: nan
13977,choline,neuronal acetylcholine receptor; alpha4/beta2,ion channel,,Drug: choline | Target: neuronal acetylcholine receptor; alpha4/beta2 | Type: ion channel | Action: nan
13978,choline,neuronal acetylcholine receptor; alpha4/beta4,ion channel,,Drug: choline | Target: neuronal acetylcholine receptor; alpha4/beta4 | Type: ion channel | Action: nan
13979,choline,creatine transporter,transporter,,Drug: choline | Target: creatine transporter | Type: transporter | Action: nan
13980,cinchophen,"camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a",enzyme,,"Drug: cinchophen | Target: camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | Type: enzyme | Action: nan"
13981,cinromide,sodium-dependent neutral amino acid transporter b(0)at1,transporter,INHIBITOR,Drug: cinromide | Target: sodium-dependent neutral amino acid transporter b(0)at1 | Type: transporter | Action: INHIBITOR
13982,clorindione,arachidonate 5-lipoxygenase,enzyme,,Drug: clorindione | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
13983,cloxiquine,methionine aminopeptidase 2,enzyme,,Drug: cloxiquine | Target: methionine aminopeptidase 2 | Type: enzyme | Action: nan
13984,cloxiquine,catechol o-methyltransferase,enzyme,,Drug: cloxiquine | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
13985,cloxiquine,methionine aminopeptidase 1,enzyme,,Drug: cloxiquine | Target: methionine aminopeptidase 1 | Type: enzyme | Action: nan
13986,cyclomethycaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: cyclomethycaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
13987,cynarine,integrase,enzyme,,Drug: cynarine | Target: integrase | Type: enzyme | Action: nan
13988,demoxytocin,oxytocin receptor,gpcr,,Drug: demoxytocin | Target: oxytocin receptor | Type: gpcr | Action: nan
13989,desomorphine,opioid receptor,gpcr,,Drug: desomorphine | Target: opioid receptor | Type: gpcr | Action: nan
13990,desonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: desonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
13991,dibrompropamidine,urokinase-type plasminogen activator,enzyme,,Drug: dibrompropamidine | Target: urokinase-type plasminogen activator | Type: enzyme | Action: nan
13992,dibrompropamidine,prothrombin,enzyme,,Drug: dibrompropamidine | Target: prothrombin | Type: enzyme | Action: nan
13993,dibrompropamidine,suppressor of tumorigenicity 14 protein,enzyme,,Drug: dibrompropamidine | Target: suppressor of tumorigenicity 14 protein | Type: enzyme | Action: nan
13994,dibrompropamidine,acrosin,enzyme,,Drug: dibrompropamidine | Target: acrosin | Type: enzyme | Action: nan
13995,difluprednate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: difluprednate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
13996,quinisocaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: quinisocaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
13997,diosmin,lysine-specific histone demethylase 1a,enzyme,,Drug: diosmin | Target: lysine-specific histone demethylase 1a | Type: enzyme | Action: nan
13999,dioxadrol,sigma non-opioid intracellular receptor 1,membrane other,,Drug: dioxadrol | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
14000,disufenton,lipoxygenase,unclassified,,Drug: disufenton | Target: lipoxygenase | Type: unclassified | Action: nan
14002,domitroban,thromboxane a2 receptor,gpcr,ANTAGONIST,Drug: domitroban | Target: thromboxane a2 receptor | Type: gpcr | Action: ANTAGONIST
14003,domitroban,thromboxane a2 receptor,gpcr,ANTAGONIST,Drug: domitroban | Target: thromboxane a2 receptor | Type: gpcr | Action: ANTAGONIST
14004,eburnamonine,muscarinic acetylcholine receptor m1,gpcr,ALLOSTERIC MODULATOR,Drug: eburnamonine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ALLOSTERIC MODULATOR
14005,eburnamonine,muscarinic acetylcholine receptor m2,gpcr,ALLOSTERIC MODULATOR,Drug: eburnamonine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ALLOSTERIC MODULATOR
14006,eburnamonine,muscarinic acetylcholine receptor m3,gpcr,ALLOSTERIC MODULATOR,Drug: eburnamonine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ALLOSTERIC MODULATOR
14007,eburnamonine,muscarinic acetylcholine receptor m4,gpcr,ALLOSTERIC MODULATOR,Drug: eburnamonine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ALLOSTERIC MODULATOR
14008,edoxudine,thymidine kinase,kinase,,Drug: edoxudine | Target: thymidine kinase | Type: kinase | Action: nan
14009,eicosapentaenoic acid,aromatase,enzyme,,Drug: eicosapentaenoic acid | Target: aromatase | Type: enzyme | Action: nan
14010,eicosapentaenoic acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: eicosapentaenoic acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
14011,eicosapentaenoic acid,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: eicosapentaenoic acid | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
14012,eicosapentaenoic acid,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: eicosapentaenoic acid | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
14013,eicosapentaenoic acid,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: eicosapentaenoic acid | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
14014,eicosapentaenoic acid,tissue factor,membrane receptor,,Drug: eicosapentaenoic acid | Target: tissue factor | Type: membrane receptor | Action: nan
14015,eicosapentaenoic acid,prostaglandin g/h synthase 2,enzyme,,Drug: eicosapentaenoic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
14016,eicosapentaenoic acid,prostaglandin g/h synthase 1,enzyme,,Drug: eicosapentaenoic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
14017,eicosapentaenoic acid,oxoeicosanoid receptor 1,gpcr,,Drug: eicosapentaenoic acid | Target: oxoeicosanoid receptor 1 | Type: gpcr | Action: nan
14018,eicosapentaenoic acid,retinoic acid receptor rxr-alpha,nuclear other,,Drug: eicosapentaenoic acid | Target: retinoic acid receptor rxr-alpha | Type: nuclear other | Action: nan
14019,enilconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: enilconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
14020,enoxolone,arachidonate 5-lipoxygenase,enzyme,,Drug: enoxolone | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
14021,enoxolone,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: enoxolone | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
14022,enoxolone,liver carboxylesterase 1,enzyme,,Drug: enoxolone | Target: liver carboxylesterase 1 | Type: enzyme | Action: nan
14023,enoxolone,protein kinase c eta type,kinase,,Drug: enoxolone | Target: protein kinase c eta type | Type: kinase | Action: nan
14024,enoxolone,corticosteroid 11-beta-dehydrogenase isozyme 2,enzyme,,Drug: enoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 2 | Type: enzyme | Action: nan
14025,enoxolone,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: enoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
14026,enoxolone,"glycogen phosphorylase, muscle form",enzyme,,"Drug: enoxolone | Target: glycogen phosphorylase, muscle form | Type: enzyme | Action: nan"
14027,enoxolone,cocaine esterase,enzyme,,Drug: enoxolone | Target: cocaine esterase | Type: enzyme | Action: nan
14028,enoxolone,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: enoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
14029,enoxolone,aldo-keto reductase family 1 member b10,enzyme,,Drug: enoxolone | Target: aldo-keto reductase family 1 member b10 | Type: enzyme | Action: nan
14030,enoxolone,corticosteroid 11-beta-dehydrogenase isozyme 1,enzyme,,Drug: enoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 1 | Type: enzyme | Action: nan
14031,enoxolone,corticosteroid 11-beta-dehydrogenase isozyme 2,enzyme,,Drug: enoxolone | Target: corticosteroid 11-beta-dehydrogenase isozyme 2 | Type: enzyme | Action: nan
14032,enoxolone,tyrosine-protein phosphatase non-receptor type 11,enzyme,,Drug: enoxolone | Target: tyrosine-protein phosphatase non-receptor type 11 | Type: enzyme | Action: nan
14033,enoxolone,protein-tyrosine phosphatase 1c,enzyme,,Drug: enoxolone | Target: protein-tyrosine phosphatase 1c | Type: enzyme | Action: nan
14034,enoxolone,high mobility group protein b1,nuclear other,,Drug: enoxolone | Target: high mobility group protein b1 | Type: nuclear other | Action: nan
14036,enoxolone,lactoylglutathione lyase,enzyme,,Drug: enoxolone | Target: lactoylglutathione lyase | Type: enzyme | Action: nan
14037,eseridine,acetylcholinesterase,enzyme,,Drug: eseridine | Target: acetylcholinesterase | Type: enzyme | Action: nan
14038,eseridine,cholinesterase,enzyme,,Drug: eseridine | Target: cholinesterase | Type: enzyme | Action: nan
14039,eseridine,acetylcholinesterase,enzyme,,Drug: eseridine | Target: acetylcholinesterase | Type: enzyme | Action: nan
14040,estriol,sodium-dependent serotonin transporter,transporter,,Drug: estriol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
14041,estriol,glucocorticoid receptor,nuclear hormone receptor,,Drug: estriol | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
14042,estriol,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: estriol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
14043,estriol,estrogen receptor beta,nuclear hormone receptor,AGONIST,Drug: estriol | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: AGONIST
14044,estriol,corticosteroid-binding globulin,secreted,,Drug: estriol | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
14045,estriol,sex hormone-binding globulin,secreted,,Drug: estriol | Target: sex hormone-binding globulin | Type: secreted | Action: nan
14046,estriol,arachidonate 15-lipoxygenase,enzyme,,Drug: estriol | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
14047,estriol,lanosterol 14-alpha demethylase,enzyme,,Drug: estriol | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
14048,estriol,olfactory receptor 51e2,gpcr,,Drug: estriol | Target: olfactory receptor 51e2 | Type: gpcr | Action: nan
14049,estrone,sodium-dependent serotonin transporter,transporter,,Drug: estrone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
14050,estrone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: estrone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
14051,estrone,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: estrone | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
14052,estrone,estrogen receptor beta,nuclear hormone receptor,,Drug: estrone | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
14053,estrone,aromatase,enzyme,,Drug: estrone | Target: aromatase | Type: enzyme | Action: nan
14054,estrone,corticosteroid-binding globulin,secreted,,Drug: estrone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
14055,estrone,steryl-sulfatase,enzyme,,Drug: estrone | Target: steryl-sulfatase | Type: enzyme | Action: nan
14056,estrone,sex hormone-binding globulin,secreted,,Drug: estrone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
14057,estrone,estradiol 17-beta-dehydrogenase 1,enzyme,,Drug: estrone | Target: estradiol 17-beta-dehydrogenase 1 | Type: enzyme | Action: nan
14058,estrone,androgen receptor,transcription factor,,Drug: estrone | Target: androgen receptor | Type: transcription factor | Action: nan
14059,estrone,arachidonate 15-lipoxygenase,enzyme,,Drug: estrone | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
14060,estrone,progesterone receptor,transcription factor,,Drug: estrone | Target: progesterone receptor | Type: transcription factor | Action: nan
14061,ethacridine,telomerase reverse transcriptase,enzyme,,Drug: ethacridine | Target: telomerase reverse transcriptase | Type: enzyme | Action: nan
14062,ethacridine,reverse transcriptase,enzyme,,Drug: ethacridine | Target: reverse transcriptase | Type: enzyme | Action: nan
14063,kainic acid,adenosine receptor a3,gpcr,,Drug: kainic acid | Target: adenosine receptor a3 | Type: gpcr | Action: nan
14064,kainic acid,glutamate receptor 1,ion channel,,Drug: kainic acid | Target: glutamate receptor 1 | Type: ion channel | Action: nan
14065,kainic acid,"glutamate receptor ionotropic, kainate 1",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 1 | Type: ion channel | Action: nan"
14066,kainic acid,glutamate receptor 2,ion channel,,Drug: kainic acid | Target: glutamate receptor 2 | Type: ion channel | Action: nan
14067,kainic acid,"glutamate receptor ionotropic, kainate 5",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 5 | Type: ion channel | Action: nan"
14068,kainic acid,glutamate receptor 4,ion channel,,Drug: kainic acid | Target: glutamate receptor 4 | Type: ion channel | Action: nan
14069,kainic acid,"glutamate receptor ionotropic, kainate 2",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 2 | Type: ion channel | Action: nan"
14070,kainic acid,"glutamate receptor ionotropic, kainate 3",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 3 | Type: ion channel | Action: nan"
14071,kainic acid,glutamate receptor 2,ion channel,,Drug: kainic acid | Target: glutamate receptor 2 | Type: ion channel | Action: nan
14072,kainic acid,glutamate receptor 3,ion channel,,Drug: kainic acid | Target: glutamate receptor 3 | Type: ion channel | Action: nan
14073,kainic acid,"glutamate receptor ionotropic, kainate 4",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 4 | Type: ion channel | Action: nan"
14074,kainic acid,"glutamate receptor ionotropic, kainate 2",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 2 | Type: ion channel | Action: nan"
14075,kainic acid,"glutamate receptor ionotropic, kainate 1",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 1 | Type: ion channel | Action: nan"
14076,kainic acid,glutamate receptor 1,ion channel,,Drug: kainic acid | Target: glutamate receptor 1 | Type: ion channel | Action: nan
14077,kainic acid,glutamate receptor 3,ion channel,,Drug: kainic acid | Target: glutamate receptor 3 | Type: ion channel | Action: nan
14078,kainic acid,glutamate receptor 4,ion channel,,Drug: kainic acid | Target: glutamate receptor 4 | Type: ion channel | Action: nan
14079,kainic acid,"glutamate receptor ionotropic, kainate 4",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 4 | Type: ion channel | Action: nan"
14080,kainic acid,"glutamate receptor ionotropic, kainate 5",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 5 | Type: ion channel | Action: nan"
14081,kainic acid,"glutamate receptor ionotropic, kainate 3",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate 3 | Type: ion channel | Action: nan"
14082,kainic acid,"glutamate receptor ionotropic, ampa",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, ampa | Type: ion channel | Action: nan"
14083,kainic acid,"glutamate receptor ionotropic, kainate",ion channel,,"Drug: kainic acid | Target: glutamate receptor ionotropic, kainate | Type: ion channel | Action: nan"
14084,nordefrin,adrenergic receptor alpha-2,gpcr,,Drug: nordefrin | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
14085,etoxadrol,glutamate nmda receptor,ion channel,,Drug: etoxadrol | Target: glutamate nmda receptor | Type: ion channel | Action: nan
14086,evans blue,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: evans blue | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
14087,evans blue,tyrosine-protein phosphatase 1,enzyme,,Drug: evans blue | Target: tyrosine-protein phosphatase 1 | Type: enzyme | Action: nan
14088,evans blue,vesicular glutamate transporter 3,transporter,,Drug: evans blue | Target: vesicular glutamate transporter 3 | Type: transporter | Action: nan
14089,evans blue,ectonucleotide pyrophosphatase/phosphodiesterase family member 2,enzyme,,Drug: evans blue | Target: ectonucleotide pyrophosphatase/phosphodiesterase family member 2 | Type: enzyme | Action: nan
14090,evans blue,luciferin 4-monooxygenase,unclassified,,Drug: evans blue | Target: luciferin 4-monooxygenase | Type: unclassified | Action: nan
14091,exisulind,endothelin-1 receptor,gpcr,,Drug: exisulind | Target: endothelin-1 receptor | Type: gpcr | Action: nan
14092,exisulind,aldose reductase,enzyme,,Drug: exisulind | Target: aldose reductase | Type: enzyme | Action: nan
14093,exisulind,mitogen-activated protein kinase 1,kinase,,Drug: exisulind | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
14094,femoxetine,d(2) dopamine receptor,gpcr,,Drug: femoxetine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
14095,femoxetine,sodium-dependent serotonin transporter,transporter,,Drug: femoxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
14096,femoxetine,sodium-dependent noradrenaline transporter,transporter,,Drug: femoxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
14097,femoxetine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: femoxetine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14098,femoxetine,histamine h1 receptor,gpcr,,Drug: femoxetine | Target: histamine h1 receptor | Type: gpcr | Action: nan
14099,femoxetine,muscarinic acetylcholine receptor m1,gpcr,,Drug: femoxetine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
14100,femoxetine,muscarinic acetylcholine receptor m2,gpcr,,Drug: femoxetine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
14101,femoxetine,muscarinic acetylcholine receptor m3,gpcr,,Drug: femoxetine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
14102,femoxetine,muscarinic acetylcholine receptor m4,gpcr,,Drug: femoxetine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
14103,femoxetine,muscarinic acetylcholine receptor m5,gpcr,,Drug: femoxetine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
14104,femoxetine,sodium-dependent dopamine transporter,transporter,,Drug: femoxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
14105,femoxetine,sodium-dependent dopamine transporter,transporter,,Drug: femoxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
14106,femoxetine,sodium-dependent noradrenaline transporter,transporter,,Drug: femoxetine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
14107,fendosal,plasminogen activator inhibitor 1,secreted,INHIBITOR,Drug: fendosal | Target: plasminogen activator inhibitor 1 | Type: secreted | Action: INHIBITOR
14108,fenoxazoline,nischarin,membrane receptor,,Drug: fenoxazoline | Target: nischarin | Type: membrane receptor | Action: nan
14109,fenticlor,uracil-dna glycosylase,enzyme,,Drug: fenticlor | Target: uracil-dna glycosylase | Type: enzyme | Action: nan
14110,fumaric acid,egl nine homolog 1,enzyme,,Drug: fumaric acid | Target: egl nine homolog 1 | Type: enzyme | Action: nan
14111,flusalan,kappa-type opioid receptor,gpcr,,Drug: flusalan | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
14112,flusalan,mu-type opioid receptor,gpcr,,Drug: flusalan | Target: mu-type opioid receptor | Type: gpcr | Action: nan
14113,flusalan,mu-type opioid receptor,gpcr,,Drug: flusalan | Target: mu-type opioid receptor | Type: gpcr | Action: nan
14114,fosfestrol,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: fosfestrol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
14115,fospropofol,gaba-a receptor,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: fospropofol | Target: gaba-a receptor | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
14116,fumagillin,methionine aminopeptidase 2,enzyme,,Drug: fumagillin | Target: methionine aminopeptidase 2 | Type: enzyme | Action: nan
14117,furtrethonium,muscarinic acetylcholine receptor m1,gpcr,AGONIST,Drug: furtrethonium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: AGONIST
14118,furtrethonium,muscarinic acetylcholine receptor m2,gpcr,AGONIST,Drug: furtrethonium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: AGONIST
14119,furtrethonium,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: furtrethonium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
14120,furtrethonium,muscarinic acetylcholine receptor m4,gpcr,AGONIST,Drug: furtrethonium | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: AGONIST
14121,gabexate,urokinase-type plasminogen activator,enzyme,,Drug: gabexate | Target: urokinase-type plasminogen activator | Type: enzyme | Action: nan
14122,gabexate,plasminogen,enzyme,,Drug: gabexate | Target: plasminogen | Type: enzyme | Action: nan
14123,gabexate,prothrombin,enzyme,,Drug: gabexate | Target: prothrombin | Type: enzyme | Action: nan
14124,gabexate,coagulation factor x,enzyme,,Drug: gabexate | Target: coagulation factor x | Type: enzyme | Action: nan
14125,gabexate,tissue-type plasminogen activator,enzyme,,Drug: gabexate | Target: tissue-type plasminogen activator | Type: enzyme | Action: nan
14126,gabexate,plasma kallikrein,enzyme,,Drug: gabexate | Target: plasma kallikrein | Type: enzyme | Action: nan
14127,gabexate,membrane primary amine oxidase,enzyme,,Drug: gabexate | Target: membrane primary amine oxidase | Type: enzyme | Action: nan
14128,gabexate,solute carrier family 22 member 2,transporter,,Drug: gabexate | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
14129,gabexate,multidrug and toxin extrusion protein 1,transporter,,Drug: gabexate | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
14130,gabexate,multidrug and toxin extrusion protein 2,transporter,,Drug: gabexate | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
14131,gabexate,tryptase alpha/beta-1,enzyme,INHIBITOR,Drug: gabexate | Target: tryptase alpha/beta-1 | Type: enzyme | Action: INHIBITOR
14132,gabexate,serine protease hepsin,enzyme,,Drug: gabexate | Target: serine protease hepsin | Type: enzyme | Action: nan
14133,gentisic acid,carbonic anhydrase 2,enzyme,,Drug: gentisic acid | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
14134,gentisic acid,carbonic anhydrase 1,enzyme,,Drug: gentisic acid | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
14135,gentisic acid,carbonic anhydrase 9,enzyme,,Drug: gentisic acid | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
14136,gentisic acid,carbonic anhydrase 12,enzyme,,Drug: gentisic acid | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
14137,gentisic acid,arachidonate 5-lipoxygenase,enzyme,,Drug: gentisic acid | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
14138,gentisic acid,carbonic anhydrase 7,enzyme,,Drug: gentisic acid | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
14139,gentisic acid,carbonic anhydrase 14,enzyme,,Drug: gentisic acid | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
14140,hexamidine,urokinase-type plasminogen activator,enzyme,,Drug: hexamidine | Target: urokinase-type plasminogen activator | Type: enzyme | Action: nan
14141,hexamidine,prothrombin,enzyme,,Drug: hexamidine | Target: prothrombin | Type: enzyme | Action: nan
14142,hexamidine,trypsin-1,enzyme,,Drug: hexamidine | Target: trypsin-1 | Type: enzyme | Action: nan
14143,hexamidine,suppressor of tumorigenicity 14 protein,enzyme,,Drug: hexamidine | Target: suppressor of tumorigenicity 14 protein | Type: enzyme | Action: nan
14144,hexamidine,protein arginine n-methyltransferase 1,enzyme,,Drug: hexamidine | Target: protein arginine n-methyltransferase 1 | Type: enzyme | Action: nan
14145,hydroquinone,carbonic anhydrase 2,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
14146,hydroquinone,carbonic anhydrase 1,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
14147,hydroquinone,carbonic anhydrase 4,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
14148,hydroquinone,carbonic anhydrase 9,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
14149,hydroquinone,carbonic anhydrase 12,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
14150,hydroquinone,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: hydroquinone | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
14151,hydroquinone,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: hydroquinone | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
14152,hydroquinone,carbonic anhydrase 3,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
14153,hydroquinone,carbonic anhydrase 14,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
14154,hydroquinone,carbonic anhydrase 13,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
14155,hydroquinone,acetylcholinesterase,enzyme,,Drug: hydroquinone | Target: acetylcholinesterase | Type: enzyme | Action: nan
14156,hydroquinone,polyphenol oxidase 2,enzyme,,Drug: hydroquinone | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
14157,hydroquinone,carbonic anhydrase 15,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
14158,hydroquinone,carbonic anhydrase,enzyme,,Drug: hydroquinone | Target: carbonic anhydrase | Type: enzyme | Action: nan
14159,oxyquinoline,72 kda type iv collagenase,enzyme,,Drug: oxyquinoline | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
14160,oxyquinoline,catechol o-methyltransferase,enzyme,,Drug: oxyquinoline | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
14161,oxyquinoline,methionine aminopeptidase 2,enzyme,,Drug: oxyquinoline | Target: methionine aminopeptidase 2 | Type: enzyme | Action: nan
14162,oxyquinoline,catechol o-methyltransferase,enzyme,,Drug: oxyquinoline | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
14163,oxyquinoline,methionine aminopeptidase 1,enzyme,,Drug: oxyquinoline | Target: methionine aminopeptidase 1 | Type: enzyme | Action: nan
14164,oxyquinoline,bacterial leucyl aminopeptidase,enzyme,,Drug: oxyquinoline | Target: bacterial leucyl aminopeptidase | Type: enzyme | Action: nan
14165,ibufenac,prostaglandin g/h synthase 2,enzyme,,Drug: ibufenac | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
14166,iloperidone,d(1a) dopamine receptor,gpcr,,Drug: iloperidone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
14167,iloperidone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: iloperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
14168,iloperidone,alpha-2a adrenergic receptor,gpcr,,Drug: iloperidone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14169,iloperidone,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: iloperidone | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
14170,iloperidone,sodium-dependent noradrenaline transporter,transporter,,Drug: iloperidone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
14171,iloperidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14172,iloperidone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
14173,iloperidone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
14174,iloperidone,5-hydroxytryptamine receptor 6,gpcr,,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
14175,iloperidone,5-hydroxytryptamine receptor 7,gpcr,,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
14176,iloperidone,alpha-1a adrenergic receptor,gpcr,,Drug: iloperidone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14177,iloperidone,alpha-2b adrenergic receptor,gpcr,,Drug: iloperidone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
14178,iloperidone,d(3) dopamine receptor,gpcr,,Drug: iloperidone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
14179,iloperidone,d(1b) dopamine receptor,gpcr,,Drug: iloperidone | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
14180,iloperidone,histamine h1 receptor,gpcr,,Drug: iloperidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
14181,iloperidone,muscarinic acetylcholine receptor m1,gpcr,,Drug: iloperidone | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
14182,iloperidone,muscarinic acetylcholine receptor m2,gpcr,,Drug: iloperidone | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
14183,iloperidone,muscarinic acetylcholine receptor m4,gpcr,,Drug: iloperidone | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
14184,iloperidone,5-hydroxytryptamine receptor 1b,gpcr,,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
14185,iloperidone,5-hydroxytryptamine receptor 1d,gpcr,,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
14186,iloperidone,alpha-2c adrenergic receptor,gpcr,,Drug: iloperidone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
14187,iloperidone,sodium-dependent dopamine transporter,transporter,,Drug: iloperidone | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
14188,iloperidone,d(4) dopamine receptor,gpcr,,Drug: iloperidone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
14189,iloperidone,gastrin/cholecystokinin type b receptor,gpcr,,Drug: iloperidone | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
14190,iloperidone,d(2) dopamine receptor,gpcr,,Drug: iloperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
14191,iloperidone,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
14192,iloperidone,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
14193,iloperidone,alpha-2a adrenergic receptor,gpcr,,Drug: iloperidone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14194,iloperidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14195,iloperidone,d(1a) dopamine receptor,gpcr,,Drug: iloperidone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
14196,iloperidone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
14197,iloperidone,5-hydroxytryptamine receptor 6,gpcr,ANTAGONIST,Drug: iloperidone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: ANTAGONIST
14198,iloperidone,serotonin 2 (5-ht2) receptor,gpcr,,Drug: iloperidone | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
14199,isoconazole,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,,"Drug: isoconazole | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: nan"
14200,isoconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: isoconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
14201,ivabradine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,,Drug: ivabradine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: nan
14202,ivabradine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,ion channel,,Drug: ivabradine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | Type: ion channel | Action: nan
14203,ivabradine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,ion channel,,Drug: ivabradine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | Type: ion channel | Action: nan
14204,ivabradine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,ion channel,BLOCKER,Drug: ivabradine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | Type: ion channel | Action: BLOCKER
14205,ivabradine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,ion channel,BLOCKER,Drug: ivabradine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | Type: ion channel | Action: BLOCKER
14206,ivabradine,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,ion channel,BLOCKER,Drug: ivabradine | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 | Type: ion channel | Action: BLOCKER
14207,khellin,cytochrome p450 1a1,enzyme,,Drug: khellin | Target: cytochrome p450 1a1 | Type: enzyme | Action: nan
14208,lenalidomide,tumor necrosis factor,cytokine,,Drug: lenalidomide | Target: tumor necrosis factor | Type: cytokine | Action: nan
14209,lenalidomide,cereblon isoform 4,unclassified,,Drug: lenalidomide | Target: cereblon isoform 4 | Type: unclassified | Action: nan
14211,lenalidomide,protein cereblon,cytosolic other,MODULATOR,Drug: lenalidomide | Target: protein cereblon | Type: cytosolic other | Action: MODULATOR
14212,linoleic acid,prostaglandin g/h synthase 1,enzyme,,Drug: linoleic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
14213,linoleic acid,aromatase,enzyme,,Drug: linoleic acid | Target: aromatase | Type: enzyme | Action: nan
14214,linoleic acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: linoleic acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
14215,linoleic acid,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: linoleic acid | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
14216,linoleic acid,"fatty acid-binding protein, adipocyte",cytosolic other,,"Drug: linoleic acid | Target: fatty acid-binding protein, adipocyte | Type: cytosolic other | Action: nan"
14217,linoleic acid,"fatty acid-binding protein, heart",cytosolic other,,"Drug: linoleic acid | Target: fatty acid-binding protein, heart | Type: cytosolic other | Action: nan"
14218,linoleic acid,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: linoleic acid | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
14219,linoleic acid,free fatty acid receptor 1,gpcr,AGONIST,Drug: linoleic acid | Target: free fatty acid receptor 1 | Type: gpcr | Action: AGONIST
14220,linoleic acid,potassium voltage-gated channel subfamily b member 1,ion channel,ACTIVATOR,Drug: linoleic acid | Target: potassium voltage-gated channel subfamily b member 1 | Type: ion channel | Action: ACTIVATOR
14221,linoleic acid,adenosine receptor a1,gpcr,,Drug: linoleic acid | Target: adenosine receptor a1 | Type: gpcr | Action: nan
14222,linoleic acid,seed linoleate 13s-lipoxygenase-1,enzyme,,Drug: linoleic acid | Target: seed linoleate 13s-lipoxygenase-1 | Type: enzyme | Action: nan
14223,linoleic acid,tissue factor,membrane receptor,,Drug: linoleic acid | Target: tissue factor | Type: membrane receptor | Action: nan
14224,linoleic acid,prostaglandin g/h synthase 2,enzyme,,Drug: linoleic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
14225,linoleic acid,free fatty acid receptor 4,gpcr,AGONIST,Drug: linoleic acid | Target: free fatty acid receptor 4 | Type: gpcr | Action: AGONIST
14226,lodoxamide,g-protein coupled receptor 35,gpcr,AGONIST,Drug: lodoxamide | Target: g-protein coupled receptor 35 | Type: gpcr | Action: AGONIST
14227,lubeluzole,sodium channel protein type 2 subunit alpha,ion channel,,Drug: lubeluzole | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: nan
14228,lubeluzole,calmodulin,cytosolic other,,Drug: lubeluzole | Target: calmodulin | Type: cytosolic other | Action: nan
14229,mestanolone,androgen receptor,nuclear hormone receptor,AGONIST,Drug: mestanolone | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
14230,mestanolone,sex hormone-binding globulin,secreted,,Drug: mestanolone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
14231,mesterolone,sex hormone-binding globulin,secreted,,Drug: mesterolone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
14232,mesterolone,androgen receptor,transcription factor,,Drug: mesterolone | Target: androgen receptor | Type: transcription factor | Action: nan
14233,methionine,s-ribosylhomocysteine lyase,unclassified,,Drug: methionine | Target: s-ribosylhomocysteine lyase | Type: unclassified | Action: nan
14234,methyltestosterone,glucocorticoid receptor,nuclear hormone receptor,,Drug: methyltestosterone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
14235,methyltestosterone,androgen receptor,nuclear hormone receptor,AGONIST,Drug: methyltestosterone | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
14236,methyltestosterone,sex hormone-binding globulin,secreted,,Drug: methyltestosterone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
14237,methyltestosterone,androgen receptor,transcription factor,,Drug: methyltestosterone | Target: androgen receptor | Type: transcription factor | Action: nan
14238,methyltestosterone,progesterone receptor,transcription factor,,Drug: methyltestosterone | Target: progesterone receptor | Type: transcription factor | Action: nan
14239,mitoguazone,s-adenosylmethionine decarboxylase proenzyme,enzyme,,Drug: mitoguazone | Target: s-adenosylmethionine decarboxylase proenzyme | Type: enzyme | Action: nan
14240,mitoguazone,amiloride-sensitive amine oxidase [copper-containing],enzyme,,Drug: mitoguazone | Target: amiloride-sensitive amine oxidase [copper-containing] | Type: enzyme | Action: nan
14241,moxestrol,estrogen receptor,nuclear hormone receptor,,Drug: moxestrol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
14242,naphazoline,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: naphazoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
14243,naphazoline,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: naphazoline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
14244,naphazoline,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: naphazoline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
14245,naphazoline,nischarin,membrane receptor,,Drug: naphazoline | Target: nischarin | Type: membrane receptor | Action: nan
14246,naphazoline,nischarin,unclassified,,Drug: naphazoline | Target: nischarin | Type: unclassified | Action: nan
14247,naphazoline,adrenergic receptor alpha-2,gpcr,,Drug: naphazoline | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
14248,naphazoline,adrenergic receptor alpha-1,gpcr,,Drug: naphazoline | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
14249,naphazoline,adrenergic receptor alpha,gpcr,,Drug: naphazoline | Target: adrenergic receptor alpha | Type: gpcr | Action: nan
14250,neridronic acid,farnesyl pyrophosphate synthase,enzyme,,Drug: neridronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
14251,nifenalol,beta-2 adrenergic receptor,gpcr,,Drug: nifenalol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
14252,octopamine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: octopamine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
14253,octopamine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: octopamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
14254,octopamine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: octopamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
14255,octopamine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: octopamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
14256,octopamine,tyr1,gpcr,,Drug: octopamine | Target: tyr1 | Type: gpcr | Action: nan
14257,oleandrin,neurogenic locus notch homolog protein 1,unclassified,,Drug: oleandrin | Target: neurogenic locus notch homolog protein 1 | Type: unclassified | Action: nan
14258,oleic acid,fatty-acid amide hydrolase 1,enzyme,,Drug: oleic acid | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
14259,oleic acid,aromatase,enzyme,,Drug: oleic acid | Target: aromatase | Type: enzyme | Action: nan
14260,oleic acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: oleic acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
14261,oleic acid,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: oleic acid | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
14262,oleic acid,"fatty acid-binding protein, adipocyte",cytosolic other,,"Drug: oleic acid | Target: fatty acid-binding protein, adipocyte | Type: cytosolic other | Action: nan"
14263,oleic acid,dna topoisomerase 1,enzyme,,Drug: oleic acid | Target: dna topoisomerase 1 | Type: enzyme | Action: nan
14264,oleic acid,telomerase reverse transcriptase,enzyme,,Drug: oleic acid | Target: telomerase reverse transcriptase | Type: enzyme | Action: nan
14265,oleic acid,"fatty acid-binding protein, epidermal",cytosolic other,,"Drug: oleic acid | Target: fatty acid-binding protein, epidermal | Type: cytosolic other | Action: nan"
14266,oleic acid,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: oleic acid | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
14267,oleic acid,free fatty acid receptor 1,gpcr,AGONIST,Drug: oleic acid | Target: free fatty acid receptor 1 | Type: gpcr | Action: AGONIST
14268,oleic acid,"fatty acid-binding protein, liver",unclassified,,"Drug: oleic acid | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
14269,oleic acid,"fatty acid-binding protein, liver",unclassified,,"Drug: oleic acid | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
14270,oleic acid,seed linoleate 13s-lipoxygenase-1,enzyme,,Drug: oleic acid | Target: seed linoleate 13s-lipoxygenase-1 | Type: enzyme | Action: nan
14271,oleic acid,tissue factor,membrane receptor,,Drug: oleic acid | Target: tissue factor | Type: membrane receptor | Action: nan
14272,oleic acid,free fatty acid receptor 4,gpcr,AGONIST,Drug: oleic acid | Target: free fatty acid receptor 4 | Type: gpcr | Action: AGONIST
14273,ornithine,g-protein coupled receptor family c group 6 member a,gpcr,AGONIST,Drug: ornithine | Target: g-protein coupled receptor family c group 6 member a | Type: gpcr | Action: AGONIST
14274,oxetacaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: oxetacaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
14275,oxiconazole,d(1a) dopamine receptor,gpcr,,Drug: oxiconazole | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
14276,oxiconazole,alpha-2a adrenergic receptor,gpcr,,Drug: oxiconazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14277,oxiconazole,cytochrome p450 3a4,enzyme,,Drug: oxiconazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
14278,oxiconazole,sodium-dependent serotonin transporter,transporter,,Drug: oxiconazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
14279,oxiconazole,sodium-dependent noradrenaline transporter,transporter,,Drug: oxiconazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
14280,oxiconazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: oxiconazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14281,oxiconazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: oxiconazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
14282,oxiconazole,5-hydroxytryptamine receptor 2b,gpcr,,Drug: oxiconazole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
14283,oxiconazole,alpha-2b adrenergic receptor,gpcr,,Drug: oxiconazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
14284,oxiconazole,d(3) dopamine receptor,gpcr,,Drug: oxiconazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
14285,oxiconazole,muscarinic acetylcholine receptor m1,gpcr,,Drug: oxiconazole | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
14286,oxiconazole,muscarinic acetylcholine receptor m3,gpcr,,Drug: oxiconazole | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
14287,oxiconazole,beta-3 adrenergic receptor,gpcr,,Drug: oxiconazole | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
14288,oxiconazole,alpha-2c adrenergic receptor,gpcr,,Drug: oxiconazole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
14289,oxiconazole,sodium-dependent dopamine transporter,transporter,,Drug: oxiconazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
14290,oxiconazole,cytochrome p450 2d6,enzyme,,Drug: oxiconazole | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
14291,oxiconazole,adenosine receptor a3,gpcr,,Drug: oxiconazole | Target: adenosine receptor a3 | Type: gpcr | Action: nan
14292,oxiconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: oxiconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
14293,oxiconazole,delta-type opioid receptor,gpcr,,Drug: oxiconazole | Target: delta-type opioid receptor | Type: gpcr | Action: nan
14294,oxiconazole,acetylcholinesterase,enzyme,,Drug: oxiconazole | Target: acetylcholinesterase | Type: enzyme | Action: nan
14295,oxiconazole,cytochrome p450 2c9,enzyme,,Drug: oxiconazole | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
14296,oxiconazole,cytochrome p450 2c19,enzyme,,Drug: oxiconazole | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
14297,oxiconazole,thromboxane-a synthase,enzyme,,Drug: oxiconazole | Target: thromboxane-a synthase | Type: enzyme | Action: nan
14298,oxiconazole,"indoleamine 2,3-dioxygenase 1",enzyme,,"Drug: oxiconazole | Target: indoleamine 2,3-dioxygenase 1 | Type: enzyme | Action: nan"
14299,oxiconazole,substance-k receptor,gpcr,,Drug: oxiconazole | Target: substance-k receptor | Type: gpcr | Action: nan
14300,oxiconazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: oxiconazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14301,oxybenzone,hormone-sensitive lipase,enzyme,,Drug: oxybenzone | Target: hormone-sensitive lipase | Type: enzyme | Action: nan
14302,oxycinchophen,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: oxycinchophen | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
14303,oxycinchophen,"camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a",enzyme,,"Drug: oxycinchophen | Target: camp and camp-inhibited cgmp 3',5'-cyclic phosphodiesterase 10a | Type: enzyme | Action: nan"
14304,pentazocine,mu-type opioid receptor,gpcr,,Drug: pentazocine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
14305,pentazocine,sigma non-opioid intracellular receptor 1,membrane receptor,MODULATOR,Drug: pentazocine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: MODULATOR
14306,pentazocine,kappa-type opioid receptor,gpcr,,Drug: pentazocine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
14307,pentazocine,delta-type opioid receptor,gpcr,,Drug: pentazocine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
14308,pentazocine,mu-type opioid receptor,gpcr,,Drug: pentazocine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
14309,pentazocine,kappa-type opioid receptor,gpcr,,Drug: pentazocine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
14310,pentazocine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: pentazocine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
14311,pentazocine,sigma non-opioid intracellular receptor 1,membrane other,,Drug: pentazocine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
14312,pentazocine,opioid receptor,gpcr,,Drug: pentazocine | Target: opioid receptor | Type: gpcr | Action: nan
14313,phenacaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: phenacaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
14314,picloxydine,acetylcholinesterase,enzyme,,Drug: picloxydine | Target: acetylcholinesterase | Type: enzyme | Action: nan
14315,picloxydine,cholinesterase,enzyme,,Drug: picloxydine | Target: cholinesterase | Type: enzyme | Action: nan
14316,adipic acid,solute carrier family 22 member 6,transporter,,Drug: adipic acid | Target: solute carrier family 22 member 6 | Type: transporter | Action: nan
14317,podophyllotoxin,cytochrome p450 3a4,enzyme,,Drug: podophyllotoxin | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
14318,podophyllotoxin,glucocorticoid receptor,nuclear hormone receptor,,Drug: podophyllotoxin | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
14319,podophyllotoxin,cytochrome p450 2c9,enzyme,,Drug: podophyllotoxin | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
14320,podophyllotoxin,cytochrome p450 2c19,enzyme,,Drug: podophyllotoxin | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
14321,podophyllotoxin,regulatory protein e2,unclassified,,Drug: podophyllotoxin | Target: regulatory protein e2 | Type: unclassified | Action: nan
14322,podophyllotoxin,tubulin alpha-1a chain,structural,,Drug: podophyllotoxin | Target: tubulin alpha-1a chain | Type: structural | Action: nan
14323,podophyllotoxin,regulatory protein e2,unclassified,,Drug: podophyllotoxin | Target: regulatory protein e2 | Type: unclassified | Action: nan
14324,podophyllotoxin,tubulin,structural,,Drug: podophyllotoxin | Target: tubulin | Type: structural | Action: nan
14325,podophyllotoxin,tubulin,structural,,Drug: podophyllotoxin | Target: tubulin | Type: structural | Action: nan
14326,podophyllotoxin,tubulin,structural,,Drug: podophyllotoxin | Target: tubulin | Type: structural | Action: nan
14327,podophyllotoxin,human papillomavirus regulatory protein e2,unclassified,,Drug: podophyllotoxin | Target: human papillomavirus regulatory protein e2 | Type: unclassified | Action: nan
14328,polyestradiol phosphate,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: polyestradiol phosphate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
14329,posaconazole,cytochrome p450 3a4,enzyme,,Drug: posaconazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
14330,posaconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: posaconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
14331,posaconazole,14-alpha sterol demethylase cyp51a,enzyme,,Drug: posaconazole | Target: 14-alpha sterol demethylase cyp51a | Type: enzyme | Action: nan
14332,posaconazole,14-alpha sterol demethylase,enzyme,,Drug: posaconazole | Target: 14-alpha sterol demethylase | Type: enzyme | Action: nan
14333,posaconazole,sterol 14-alpha demethylase,enzyme,,Drug: posaconazole | Target: sterol 14-alpha demethylase | Type: enzyme | Action: nan
14334,posaconazole,7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase,enzyme,,Drug: posaconazole | Target: 7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase | Type: enzyme | Action: nan
14335,practolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: practolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
14336,practolol,beta-2 adrenergic receptor,gpcr,,Drug: practolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
14337,practolol,beta-2 adrenergic receptor,gpcr,,Drug: practolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
14338,practolol,beta-1 adrenergic receptor,gpcr,,Drug: practolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
14339,practolol,beta-1 adrenergic receptor,gpcr,,Drug: practolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
14340,practolol,beta-2 adrenergic receptor,gpcr,,Drug: practolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
14341,pramocaine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: pramocaine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
14342,pramocaine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: pramocaine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
14343,pramocaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: pramocaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
14344,propamidine,trypsin-1,enzyme,,Drug: propamidine | Target: trypsin-1 | Type: enzyme | Action: nan
14345,propamidine,acrosin,enzyme,,Drug: propamidine | Target: acrosin | Type: enzyme | Action: nan
14346,propoxycaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,BLOCKER,"Drug: propoxycaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: BLOCKER"
14347,protoporphyrin,zinc finger protein mex-5,cytosolic other,,Drug: protoporphyrin | Target: zinc finger protein mex-5 | Type: cytosolic other | Action: nan
14348,protoporphyrin,cytoplasmic zinc-finger protein,unclassified,,Drug: protoporphyrin | Target: cytoplasmic zinc-finger protein | Type: unclassified | Action: nan
14349,prucalopride,d(4) dopamine receptor,gpcr,,Drug: prucalopride | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
14350,prucalopride,5-hydroxytryptamine receptor 3a,ion channel,,Drug: prucalopride | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
14351,prucalopride,5-hydroxytryptamine receptor 4,gpcr,,Drug: prucalopride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
14352,prucalopride,5-hydroxytryptamine receptor 4,gpcr,AGONIST,Drug: prucalopride | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: AGONIST
14353,homonicotinic acid,hydroxycarboxylic acid receptor 2,gpcr,AGONIST,Drug: homonicotinic acid | Target: hydroxycarboxylic acid receptor 2 | Type: gpcr | Action: AGONIST
14354,pyridoxal phosphate,p2x purinoceptor 1,ion channel,,Drug: pyridoxal phosphate | Target: p2x purinoceptor 1 | Type: ion channel | Action: nan
14355,pyrithione,carbonic anhydrase 4,enzyme,,Drug: pyrithione | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
14356,pyrithione,carbonic anhydrase 9,enzyme,,Drug: pyrithione | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
14357,pyrithione,carbonic anhydrase 12,enzyme,,Drug: pyrithione | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
14358,pyrithione,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: pyrithione | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
14359,pyrithione,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: pyrithione | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
14360,pyrithione,carbonic anhydrase 7,enzyme,,Drug: pyrithione | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
14361,pyrithione,carbonic anhydrase 3,enzyme,,Drug: pyrithione | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
14362,pyrithione,carbonic anhydrase 6,enzyme,,Drug: pyrithione | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
14363,pyrithione,carbonic anhydrase 14,enzyme,,Drug: pyrithione | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
14364,pyrithione,carbonic anhydrase 13,enzyme,,Drug: pyrithione | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
14365,pyrithione,fad-linked sulfhydryl oxidase alr,enzyme,,Drug: pyrithione | Target: fad-linked sulfhydryl oxidase alr | Type: enzyme | Action: nan
14366,pyrithione,protein-lysine 6-oxidase,enzyme,,Drug: pyrithione | Target: protein-lysine 6-oxidase | Type: enzyme | Action: nan
14367,pyrithione,lysyl oxidase homolog 3,enzyme,,Drug: pyrithione | Target: lysyl oxidase homolog 3 | Type: enzyme | Action: nan
14368,pyrithione,lysyl oxidase homolog 4,enzyme,,Drug: pyrithione | Target: lysyl oxidase homolog 4 | Type: enzyme | Action: nan
14369,pyrithione,lysyl oxidase homolog 2,enzyme,,Drug: pyrithione | Target: lysyl oxidase homolog 2 | Type: enzyme | Action: nan
14370,pyrovalerone,sodium-dependent serotonin transporter,transporter,,Drug: pyrovalerone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
14371,pyrovalerone,sodium-dependent noradrenaline transporter,transporter,,Drug: pyrovalerone | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
14372,pyrovalerone,sodium-dependent dopamine transporter,transporter,,Drug: pyrovalerone | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
14373,quercetin,prostaglandin g/h synthase 2,enzyme,,Drug: quercetin | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
14374,quercetin,urokinase-type plasminogen activator,enzyme,,Drug: quercetin | Target: urokinase-type plasminogen activator | Type: enzyme | Action: nan
14375,quercetin,multidrug resistance protein 1,transporter,,Drug: quercetin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
14376,quercetin,adenosine receptor a3,gpcr,,Drug: quercetin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
14377,quercetin,d(4) dopamine receptor,gpcr,,Drug: quercetin | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
14378,quercetin,carbonic anhydrase 2,enzyme,,Drug: quercetin | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
14379,quercetin,multidrug resistance-associated protein 1,transporter,,Drug: quercetin | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
14380,quercetin,atp-binding cassette sub-family g member 2,transporter,,Drug: quercetin | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
14381,quercetin,carbonic anhydrase 1,enzyme,,Drug: quercetin | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
14382,quercetin,cytochrome p450 2c8,enzyme,,Drug: quercetin | Target: cytochrome p450 2c8 | Type: enzyme | Action: nan
14383,quercetin,calmodulin,cytosolic other,,Drug: quercetin | Target: calmodulin | Type: cytosolic other | Action: nan
14384,quercetin,carbonic anhydrase 4,enzyme,,Drug: quercetin | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
14385,quercetin,beta-lactamase,enzyme,,Drug: quercetin | Target: beta-lactamase | Type: enzyme | Action: nan
14386,quercetin,acetylcholinesterase,enzyme,,Drug: quercetin | Target: acetylcholinesterase | Type: enzyme | Action: nan
14387,quercetin,amine oxidase [flavin-containing] b,enzyme,,Drug: quercetin | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
14388,quercetin,cholinesterase,enzyme,,Drug: quercetin | Target: cholinesterase | Type: enzyme | Action: nan
14389,quercetin,xanthine dehydrogenase/oxidase,enzyme,,Drug: quercetin | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
14390,quercetin,amine oxidase [flavin-containing] a,enzyme,,Drug: quercetin | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
14391,quercetin,aldose reductase,enzyme,,Drug: quercetin | Target: aldose reductase | Type: enzyme | Action: nan
14392,quercetin,carbonic anhydrase 9,enzyme,,Drug: quercetin | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
14393,quercetin,aromatase,enzyme,,Drug: quercetin | Target: aromatase | Type: enzyme | Action: nan
14394,quercetin,carbonic anhydrase 12,enzyme,,Drug: quercetin | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
14395,quercetin,arachidonate 5-lipoxygenase,enzyme,,Drug: quercetin | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
14396,quercetin,prothrombin,enzyme,,Drug: quercetin | Target: prothrombin | Type: enzyme | Action: nan
14397,quercetin,epidermal growth factor receptor,kinase,,Drug: quercetin | Target: epidermal growth factor receptor | Type: kinase | Action: nan
14398,quercetin,vasopressin v2 receptor,gpcr,,Drug: quercetin | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
14399,quercetin,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: quercetin | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
14400,quercetin,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: quercetin | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
14401,quercetin,carbonic anhydrase 7,enzyme,,Drug: quercetin | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
14402,quercetin,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: quercetin | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
14403,quercetin,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: quercetin | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
14404,quercetin,tyrosine-protein kinase lck,kinase,,Drug: quercetin | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
14405,quercetin,serine/threonine-protein kinase b-raf,kinase,,Drug: quercetin | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
14406,quercetin,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: quercetin | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
14407,quercetin,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: quercetin | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
14408,quercetin,vascular endothelial growth factor receptor 2,kinase,,Drug: quercetin | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
14409,quercetin,dipeptidyl peptidase 4,enzyme,,Drug: quercetin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
14410,quercetin,myeloperoxidase,enzyme,,Drug: quercetin | Target: myeloperoxidase | Type: enzyme | Action: nan
14411,quercetin,72 kda type iv collagenase,enzyme,,Drug: quercetin | Target: 72 kda type iv collagenase | Type: enzyme | Action: nan
14412,quercetin,cyclin-dependent kinase 1,kinase,,Drug: quercetin | Target: cyclin-dependent kinase 1 | Type: kinase | Action: nan
14413,quercetin,cyclin-dependent kinase 2,kinase,,Drug: quercetin | Target: cyclin-dependent kinase 2 | Type: kinase | Action: nan
14414,quercetin,serine/threonine-protein kinase pim-1,kinase,,Drug: quercetin | Target: serine/threonine-protein kinase pim-1 | Type: kinase | Action: nan
14415,quercetin,insulin-like growth factor 1 receptor,kinase,,Drug: quercetin | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: nan
14416,quercetin,lactoylglutathione lyase,enzyme,,Drug: quercetin | Target: lactoylglutathione lyase | Type: enzyme | Action: nan
14417,quercetin,alpha-amylase 1,enzyme,,Drug: quercetin | Target: alpha-amylase 1 | Type: enzyme | Action: nan
14418,quercetin,neutrophil elastase,enzyme,,Drug: quercetin | Target: neutrophil elastase | Type: enzyme | Action: nan
14419,quercetin,focal adhesion kinase 1,kinase,,Drug: quercetin | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
14420,quercetin,arachidonate 15-lipoxygenase,enzyme,,Drug: quercetin | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
14421,quercetin,carbonic anhydrase 3,enzyme,,Drug: quercetin | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
14422,quercetin,stromelysin-1,enzyme,,Drug: quercetin | Target: stromelysin-1 | Type: enzyme | Action: nan
14423,quercetin,serine/threonine-protein kinase plk1,kinase,,Drug: quercetin | Target: serine/threonine-protein kinase plk1 | Type: kinase | Action: nan
14424,quercetin,carbonic anhydrase 6,enzyme,,Drug: quercetin | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
14425,quercetin,estradiol 17-beta-dehydrogenase 2,enzyme,,Drug: quercetin | Target: estradiol 17-beta-dehydrogenase 2 | Type: enzyme | Action: nan
14426,quercetin,tyrosine-protein kinase syk,kinase,,Drug: quercetin | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
14427,quercetin,prolyl endopeptidase,enzyme,,Drug: quercetin | Target: prolyl endopeptidase | Type: enzyme | Action: nan
14428,quercetin,"arachidonate 12-lipoxygenase, 12s-type",enzyme,,"Drug: quercetin | Target: arachidonate 12-lipoxygenase, 12s-type | Type: enzyme | Action: nan"
14429,quercetin,hepatocyte growth factor receptor,kinase,,Drug: quercetin | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
14430,quercetin,serine/threonine-protein kinase nek2,kinase,,Drug: quercetin | Target: serine/threonine-protein kinase nek2 | Type: kinase | Action: nan
14431,quercetin,carbonic anhydrase 14,enzyme,,Drug: quercetin | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
14432,quercetin,calcium/calmodulin-dependent protein kinase type ii subunit beta,kinase,,Drug: quercetin | Target: calcium/calmodulin-dependent protein kinase type ii subunit beta | Type: kinase | Action: nan
14433,quercetin,matrix metalloproteinase-9,enzyme,,Drug: quercetin | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
14434,quercetin,serine/threonine-protein kinase n1,kinase,,Drug: quercetin | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
14435,quercetin,phospholipase a2,enzyme,,Drug: quercetin | Target: phospholipase a2 | Type: enzyme | Action: nan
14436,quercetin,alk tyrosine kinase receptor,kinase,,Drug: quercetin | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
14437,quercetin,rac-alpha serine/threonine-protein kinase,kinase,,Drug: quercetin | Target: rac-alpha serine/threonine-protein kinase | Type: kinase | Action: nan
14438,quercetin,macrophage metalloelastase,enzyme,,Drug: quercetin | Target: macrophage metalloelastase | Type: enzyme | Action: nan
14439,quercetin,collagenase 3,enzyme,,Drug: quercetin | Target: collagenase 3 | Type: enzyme | Action: nan
14440,quercetin,chymotrypsinogen b,enzyme,,Drug: quercetin | Target: chymotrypsinogen b | Type: enzyme | Action: nan
14441,quercetin,beta-secretase 1,enzyme,,Drug: quercetin | Target: beta-secretase 1 | Type: enzyme | Action: nan
14442,quercetin,glycogen synthase kinase-3 beta,kinase,,Drug: quercetin | Target: glycogen synthase kinase-3 beta | Type: kinase | Action: nan
14443,quercetin,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: quercetin | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
14444,quercetin,aldose reductase,enzyme,,Drug: quercetin | Target: aldose reductase | Type: enzyme | Action: nan
14445,quercetin,bifunctional epoxide hydrolase 2,enzyme,,Drug: quercetin | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
14446,quercetin,"glycogen phosphorylase, liver form",enzyme,,"Drug: quercetin | Target: glycogen phosphorylase, liver form | Type: enzyme | Action: nan"
14447,quercetin,lysine--trna ligase,enzyme,,Drug: quercetin | Target: lysine--trna ligase | Type: enzyme | Action: nan
14448,quercetin,cationic trypsin,enzyme,,Drug: quercetin | Target: cationic trypsin | Type: enzyme | Action: nan
14449,quercetin,xanthine dehydrogenase/oxidase,enzyme,,Drug: quercetin | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
14450,quercetin,aldose reductase,enzyme,,Drug: quercetin | Target: aldose reductase | Type: enzyme | Action: nan
14451,quercetin,arachidonate 15-lipoxygenase,enzyme,,Drug: quercetin | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
14452,quercetin,c-c chemokine receptor type 4,gpcr,,Drug: quercetin | Target: c-c chemokine receptor type 4 | Type: gpcr | Action: nan
14453,quercetin,integrase,enzyme,,Drug: quercetin | Target: integrase | Type: enzyme | Action: nan
14454,quercetin,carbonic anhydrase 13,enzyme,,Drug: quercetin | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
14455,quercetin,aldose reductase,enzyme,,Drug: quercetin | Target: aldose reductase | Type: enzyme | Action: nan
14456,quercetin,adenosine receptor a1,gpcr,,Drug: quercetin | Target: adenosine receptor a1 | Type: gpcr | Action: nan
14457,quercetin,alcohol dehydrogenase [nadp(+)],enzyme,,Drug: quercetin | Target: alcohol dehydrogenase [nadp(+)] | Type: enzyme | Action: nan
14458,quercetin,arachidonate 5-lipoxygenase,enzyme,,Drug: quercetin | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
14459,quercetin,adenosine receptor a2a,gpcr,,Drug: quercetin | Target: adenosine receptor a2a | Type: gpcr | Action: nan
14460,quercetin,beta-lactamase,enzyme,,Drug: quercetin | Target: beta-lactamase | Type: enzyme | Action: nan
14461,quercetin,amine oxidase [flavin-containing] a,enzyme,,Drug: quercetin | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
14462,quercetin,amine oxidase [flavin-containing] b,enzyme,,Drug: quercetin | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
14463,quercetin,cyclin-dependent kinase 6,kinase,,Drug: quercetin | Target: cyclin-dependent kinase 6 | Type: kinase | Action: nan
14464,quercetin,enoyl-[acyl-carrier-protein] reductase [nadh] fabi,enzyme,,Drug: quercetin | Target: enoyl-[acyl-carrier-protein] reductase [nadh] fabi | Type: enzyme | Action: nan
14465,quercetin,enoyl-acyl-carrier protein reductase,enzyme,,Drug: quercetin | Target: enoyl-acyl-carrier protein reductase | Type: enzyme | Action: nan
14466,quercetin,polyphenol oxidase 2,enzyme,,Drug: quercetin | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
14467,quercetin,aldo-keto reductase family 1 member c21,enzyme,,Drug: quercetin | Target: aldo-keto reductase family 1 member c21 | Type: enzyme | Action: nan
14468,quercetin,tyrosine-protein kinase receptor ufo,kinase,,Drug: quercetin | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
14469,quercetin,neuraminidase,enzyme,,Drug: quercetin | Target: neuraminidase | Type: enzyme | Action: nan
14470,quercetin,c-x-c chemokine receptor type 1,gpcr,,Drug: quercetin | Target: c-x-c chemokine receptor type 1 | Type: gpcr | Action: nan
14471,quercetin,casein kinase ii subunit alpha,kinase,,Drug: quercetin | Target: casein kinase ii subunit alpha | Type: kinase | Action: nan
14472,quercetin,nuak family snf1-like kinase 1,kinase,,Drug: quercetin | Target: nuak family snf1-like kinase 1 | Type: kinase | Action: nan
14473,quercetin,aurora kinase b,kinase,,Drug: quercetin | Target: aurora kinase b | Type: kinase | Action: nan
14474,quercetin,death-associated protein kinase 1,kinase,,Drug: quercetin | Target: death-associated protein kinase 1 | Type: kinase | Action: nan
14475,quercetin,sialidase,enzyme,,Drug: quercetin | Target: sialidase | Type: enzyme | Action: nan
14476,quercetin,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,,"Drug: quercetin | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: nan"
14477,quercetin,g-protein coupled receptor 35,gpcr,,Drug: quercetin | Target: g-protein coupled receptor 35 | Type: gpcr | Action: nan
14478,quercetin,proteasome subunit beta type-5,enzyme,,Drug: quercetin | Target: proteasome subunit beta type-5 | Type: enzyme | Action: nan
14479,quercetin,cytochrome p450 1b1,enzyme,,Drug: quercetin | Target: cytochrome p450 1b1 | Type: enzyme | Action: nan
14480,quercetin,malate dehydrogenase,enzyme,,Drug: quercetin | Target: malate dehydrogenase | Type: enzyme | Action: nan
14481,quercetin,5'-nucleotidase,enzyme,,Drug: quercetin | Target: 5'-nucleotidase | Type: enzyme | Action: nan
14482,quercetin,3-oxoacyl-acyl-carrier protein reductase,enzyme,,Drug: quercetin | Target: 3-oxoacyl-acyl-carrier protein reductase | Type: enzyme | Action: nan
14483,quercetin,beta-hydroxyacyl-acp dehydratase; fatty acid synthesis protein,enzyme,,Drug: quercetin | Target: beta-hydroxyacyl-acp dehydratase; fatty acid synthesis protein | Type: enzyme | Action: nan
14484,quercetin,phosphatidylinositol 3-kinase regulatory subunit alpha,kinase,,Drug: quercetin | Target: phosphatidylinositol 3-kinase regulatory subunit alpha | Type: kinase | Action: nan
14485,quercetin,nadph oxidase 4,enzyme,,Drug: quercetin | Target: nadph oxidase 4 | Type: enzyme | Action: nan
14486,quercetin,replicase polyprotein 1ab,enzyme,,Drug: quercetin | Target: replicase polyprotein 1ab | Type: enzyme | Action: nan
14487,quercetin,lactoperoxidase,enzyme,,Drug: quercetin | Target: lactoperoxidase | Type: enzyme | Action: nan
14488,quercetin,lysine-specific histone demethylase 1a,enzyme,,Drug: quercetin | Target: lysine-specific histone demethylase 1a | Type: enzyme | Action: nan
14489,quercetin,d-alanine--d-alanine ligase,enzyme,,Drug: quercetin | Target: d-alanine--d-alanine ligase | Type: enzyme | Action: nan
14490,quercetin,serine/threonine-protein kinase nek6,kinase,,Drug: quercetin | Target: serine/threonine-protein kinase nek6 | Type: kinase | Action: nan
14491,quercetin,arginase,enzyme,,Drug: quercetin | Target: arginase | Type: enzyme | Action: nan
14492,quercetin,cyclin-dependent kinase 1/cyclin b1,kinase,,Drug: quercetin | Target: cyclin-dependent kinase 1/cyclin b1 | Type: kinase | Action: nan
14493,quercetin,cyclin-dependent kinase 5/cdk5 activator 1,kinase,,Drug: quercetin | Target: cyclin-dependent kinase 5/cdk5 activator 1 | Type: kinase | Action: nan
14494,quercetin,cyclin-dependent kinase 1/cyclin b,kinase,,Drug: quercetin | Target: cyclin-dependent kinase 1/cyclin b | Type: kinase | Action: nan
14495,quercetin,cyclin-dependent kinase 4/cyclin d1,kinase,,Drug: quercetin | Target: cyclin-dependent kinase 4/cyclin d1 | Type: kinase | Action: nan
14496,quercetin,glycogen synthase kinase-3,kinase,,Drug: quercetin | Target: glycogen synthase kinase-3 | Type: kinase | Action: nan
14497,quercetin,short transient receptor potential channel 5,ion channel,,Drug: quercetin | Target: short transient receptor potential channel 5 | Type: ion channel | Action: nan
14498,quercetin,"nitric oxide synthase, inducible",enzyme,,"Drug: quercetin | Target: nitric oxide synthase, inducible | Type: enzyme | Action: nan"
14499,quercetin,sorbitol dehydrogenase,enzyme,,Drug: quercetin | Target: sorbitol dehydrogenase | Type: enzyme | Action: nan
14500,quercetin,chymotrypsin c,enzyme,,Drug: quercetin | Target: chymotrypsin c | Type: enzyme | Action: nan
14501,quercetin,cell division protein kinase 5,kinase,,Drug: quercetin | Target: cell division protein kinase 5 | Type: kinase | Action: nan
14502,quercetin,hypoxia-inducible factor 1-alpha inhibitor,enzyme,,Drug: quercetin | Target: hypoxia-inducible factor 1-alpha inhibitor | Type: enzyme | Action: nan
14503,quercetin,d-alanylalanine synthetase,enzyme,,Drug: quercetin | Target: d-alanylalanine synthetase | Type: enzyme | Action: nan
14504,quercetin,lymphocyte differentiation antigen cd38,tumour-associated antigen,,Drug: quercetin | Target: lymphocyte differentiation antigen cd38 | Type: tumour-associated antigen | Action: nan
14505,quercetin,phosphodiesterase 2a,enzyme,,Drug: quercetin | Target: phosphodiesterase 2a | Type: enzyme | Action: nan
14506,quercetin,cytosol aminopeptidase,enzyme,,Drug: quercetin | Target: cytosol aminopeptidase | Type: enzyme | Action: nan
14507,quercetin,glutathione reductase,enzyme,,Drug: quercetin | Target: glutathione reductase | Type: enzyme | Action: nan
14508,quercetin,amyloid beta a4 protein,unclassified,,Drug: quercetin | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
14509,quercetin,cytochrome p450 1a1,enzyme,,Drug: quercetin | Target: cytochrome p450 1a1 | Type: enzyme | Action: nan
14510,quercetin,"solute carrier family 2, facilitated glucose transporter member 2",transporter,,"Drug: quercetin | Target: solute carrier family 2, facilitated glucose transporter member 2 | Type: transporter | Action: nan"
14511,quercetin,elav-like protein 3,unclassified,,Drug: quercetin | Target: elav-like protein 3 | Type: unclassified | Action: nan
14512,quercetin,elav-like protein 1,unclassified,,Drug: quercetin | Target: elav-like protein 1 | Type: unclassified | Action: nan
14515,quercetin,"solute carrier family 2, facilitated glucose transporter member 4",transporter,,"Drug: quercetin | Target: solute carrier family 2, facilitated glucose transporter member 4 | Type: transporter | Action: nan"
14517,quercetin,inositol polyphosphate multikinase,kinase,,Drug: quercetin | Target: inositol polyphosphate multikinase | Type: kinase | Action: nan
14518,quercetin,inositol hexakisphosphate kinase 2,kinase,,Drug: quercetin | Target: inositol hexakisphosphate kinase 2 | Type: kinase | Action: nan
14520,rapacuronium,muscle-type nicotinic acetylcholine receptor,ion channel,ANTAGONIST,Drug: rapacuronium | Target: muscle-type nicotinic acetylcholine receptor | Type: ion channel | Action: ANTAGONIST
14521,rasagiline,acetylcholinesterase,enzyme,,Drug: rasagiline | Target: acetylcholinesterase | Type: enzyme | Action: nan
14522,rasagiline,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: rasagiline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
14523,rasagiline,cholinesterase,enzyme,,Drug: rasagiline | Target: cholinesterase | Type: enzyme | Action: nan
14524,rasagiline,amine oxidase [flavin-containing] a,enzyme,,Drug: rasagiline | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
14525,rasagiline,amine oxidase [flavin-containing] b,enzyme,,Drug: rasagiline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
14526,rasagiline,amine oxidase [flavin-containing] a,enzyme,,Drug: rasagiline | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
14527,resorcinol,carbonic anhydrase 2,enzyme,,Drug: resorcinol | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
14528,resorcinol,carbonic anhydrase 9,enzyme,,Drug: resorcinol | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
14529,resorcinol,carbonic anhydrase 12,enzyme,,Drug: resorcinol | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
14530,resorcinol,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: resorcinol | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
14531,resorcinol,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: resorcinol | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
14532,resorcinol,carbonic anhydrase 14,enzyme,,Drug: resorcinol | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
14533,resorcinol,carbonic anhydrase 13,enzyme,,Drug: resorcinol | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
14534,resorcinol,prostaglandin g/h synthase 1,enzyme,,Drug: resorcinol | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
14535,resorcinol,carbonic anhydrase,enzyme,,Drug: resorcinol | Target: carbonic anhydrase | Type: enzyme | Action: nan
14536,revaprazan,potassium-transporting atpase,transporter,INHIBITOR,Drug: revaprazan | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
14537,rioprostil,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: rioprostil | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
14538,roflumilast,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,,"Drug: roflumilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: nan"
14539,roflumilast,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,,"Drug: roflumilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: nan"
14540,roflumilast,"camp-specific 3',5'-cyclic phosphodiesterase 4d",enzyme,,"Drug: roflumilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4d | Type: enzyme | Action: nan"
14541,roflumilast,phosphodiesterase 4,enzyme,INHIBITOR,Drug: roflumilast | Target: phosphodiesterase 4 | Type: enzyme | Action: INHIBITOR
14542,roflumilast,phosphodiesterase,enzyme,,Drug: roflumilast | Target: phosphodiesterase | Type: enzyme | Action: nan
14543,ruboxistaurin,tyrosine-protein kinase jak3,kinase,,Drug: ruboxistaurin | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
14544,ruboxistaurin,platelet-derived growth factor receptor beta,kinase,,Drug: ruboxistaurin | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
14545,ruboxistaurin,mast/stem cell growth factor receptor kit,kinase,,Drug: ruboxistaurin | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
14546,ruboxistaurin,epidermal growth factor receptor,kinase,,Drug: ruboxistaurin | Target: epidermal growth factor receptor | Type: kinase | Action: nan
14547,ruboxistaurin,tyrosine-protein kinase lck,kinase,,Drug: ruboxistaurin | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
14548,ruboxistaurin,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: ruboxistaurin | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
14549,ruboxistaurin,ribosomal protein s6 kinase alpha-3,kinase,,Drug: ruboxistaurin | Target: ribosomal protein s6 kinase alpha-3 | Type: kinase | Action: nan
14550,ruboxistaurin,serine/threonine-protein kinase pim-1,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase pim-1 | Type: kinase | Action: nan
14551,ruboxistaurin,"myosin light chain kinase, smooth muscle",kinase,,"Drug: ruboxistaurin | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
14552,ruboxistaurin,death-associated protein kinase 3,kinase,,Drug: ruboxistaurin | Target: death-associated protein kinase 3 | Type: kinase | Action: nan
14553,ruboxistaurin,tyrosine-protein kinase hck,kinase,,Drug: ruboxistaurin | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
14554,ruboxistaurin,protein kinase c beta type,kinase,,Drug: ruboxistaurin | Target: protein kinase c beta type | Type: kinase | Action: nan
14555,ruboxistaurin,death-associated protein kinase 2,kinase,,Drug: ruboxistaurin | Target: death-associated protein kinase 2 | Type: kinase | Action: nan
14556,ruboxistaurin,protein kinase c delta type,kinase,,Drug: ruboxistaurin | Target: protein kinase c delta type | Type: kinase | Action: nan
14557,ruboxistaurin,camp-dependent protein kinase catalytic subunit beta,kinase,,Drug: ruboxistaurin | Target: camp-dependent protein kinase catalytic subunit beta | Type: kinase | Action: nan
14558,ruboxistaurin,protein kinase c alpha type,kinase,,Drug: ruboxistaurin | Target: protein kinase c alpha type | Type: kinase | Action: nan
14559,ruboxistaurin,calcium/calmodulin-dependent protein kinase type ii subunit delta,kinase,,Drug: ruboxistaurin | Target: calcium/calmodulin-dependent protein kinase type ii subunit delta | Type: kinase | Action: nan
14560,ruboxistaurin,protein kinase c gamma type,kinase,,Drug: ruboxistaurin | Target: protein kinase c gamma type | Type: kinase | Action: nan
14561,ruboxistaurin,calcium/calmodulin-dependent protein kinase type ii subunit gamma,kinase,,Drug: ruboxistaurin | Target: calcium/calmodulin-dependent protein kinase type ii subunit gamma | Type: kinase | Action: nan
14562,ruboxistaurin,ap2-associated protein kinase 1,kinase,,Drug: ruboxistaurin | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
14563,ruboxistaurin,serine/threonine-protein kinase mark2,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase mark2 | Type: kinase | Action: nan
14564,ruboxistaurin,ribosomal protein s6 kinase alpha-2,kinase,,Drug: ruboxistaurin | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
14565,ruboxistaurin,protein kinase c eta type,kinase,,Drug: ruboxistaurin | Target: protein kinase c eta type | Type: kinase | Action: nan
14566,ruboxistaurin,fibroblast growth factor receptor 1,kinase,,Drug: ruboxistaurin | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
14567,ruboxistaurin,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: ruboxistaurin | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
14568,ruboxistaurin,calcium/calmodulin-dependent protein kinase type ii subunit alpha,kinase,,Drug: ruboxistaurin | Target: calcium/calmodulin-dependent protein kinase type ii subunit alpha | Type: kinase | Action: nan
14569,ruboxistaurin,serine/threonine-protein kinase 10,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
14570,ruboxistaurin,protein kinase c epsilon type,kinase,,Drug: ruboxistaurin | Target: protein kinase c epsilon type | Type: kinase | Action: nan
14571,ruboxistaurin,serine/threonine-protein kinase plk4,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
14572,ruboxistaurin,aurora kinase c,kinase,,Drug: ruboxistaurin | Target: aurora kinase c | Type: kinase | Action: nan
14573,ruboxistaurin,serine/threonine-protein kinase n1,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
14574,ruboxistaurin,protein kinase c theta type,kinase,,Drug: ruboxistaurin | Target: protein kinase c theta type | Type: kinase | Action: nan
14575,ruboxistaurin,traf2 and nck-interacting protein kinase,kinase,,Drug: ruboxistaurin | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
14576,ruboxistaurin,bmp-2-inducible protein kinase,kinase,,Drug: ruboxistaurin | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
14577,ruboxistaurin,serine/threonine-protein kinase pim-2,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase pim-2 | Type: kinase | Action: nan
14578,ruboxistaurin,dual specificity protein kinase clk1,kinase,,Drug: ruboxistaurin | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
14579,ruboxistaurin,dual specificity protein kinase clk2,kinase,,Drug: ruboxistaurin | Target: dual specificity protein kinase clk2 | Type: kinase | Action: nan
14580,ruboxistaurin,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
14581,ruboxistaurin,cyclin-g-associated kinase,kinase,,Drug: ruboxistaurin | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
14582,ruboxistaurin,glycogen synthase kinase-3 beta,kinase,,Drug: ruboxistaurin | Target: glycogen synthase kinase-3 beta | Type: kinase | Action: nan
14583,ruboxistaurin,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: ruboxistaurin | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
14584,ruboxistaurin,cyclin-dependent kinase 16,kinase,,Drug: ruboxistaurin | Target: cyclin-dependent kinase 16 | Type: kinase | Action: nan
14585,ruboxistaurin,serine/threonine-protein kinase 4,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
14586,ruboxistaurin,ribosomal protein s6 kinase alpha-5,kinase,,Drug: ruboxistaurin | Target: ribosomal protein s6 kinase alpha-5 | Type: kinase | Action: nan
14587,ruboxistaurin,ste20-like serine/threonine-protein kinase,kinase,,Drug: ruboxistaurin | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
14588,ruboxistaurin,dual specificity protein kinase clk4,kinase,,Drug: ruboxistaurin | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
14589,ruboxistaurin,calcium/calmodulin-dependent protein kinase kinase 2,kinase,,Drug: ruboxistaurin | Target: calcium/calmodulin-dependent protein kinase kinase 2 | Type: kinase | Action: nan
14590,ruboxistaurin,calcium/calmodulin-dependent protein kinase kinase 1,kinase,,Drug: ruboxistaurin | Target: calcium/calmodulin-dependent protein kinase kinase 1 | Type: kinase | Action: nan
14591,ruboxistaurin,3-phosphoinositide-dependent protein kinase 1,kinase,,Drug: ruboxistaurin | Target: 3-phosphoinositide-dependent protein kinase 1 | Type: kinase | Action: nan
14592,ruboxistaurin,serine/threonine-protein kinase 3,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
14593,ruboxistaurin,cyclin-dependent kinase 7,kinase,,Drug: ruboxistaurin | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
14594,ruboxistaurin,ribosomal protein s6 kinase beta-1,kinase,,Drug: ruboxistaurin | Target: ribosomal protein s6 kinase beta-1 | Type: kinase | Action: nan
14595,ruboxistaurin,serine/threonine-protein kinase n2,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase n2 | Type: kinase | Action: nan
14596,ruboxistaurin,rac-beta serine/threonine-protein kinase,kinase,,Drug: ruboxistaurin | Target: rac-beta serine/threonine-protein kinase | Type: kinase | Action: nan
14597,ruboxistaurin,serine/threonine-protein kinase 3,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
14598,ruboxistaurin,ribosomal protein s6 kinase alpha-6,kinase,,Drug: ruboxistaurin | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
14599,ruboxistaurin,nuak family snf1-like kinase 2,kinase,,Drug: ruboxistaurin | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
14600,ruboxistaurin,serine/threonine-protein kinase chk1,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase chk1 | Type: kinase | Action: nan
14601,ruboxistaurin,phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,kinase,,Drug: ruboxistaurin | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Type: kinase | Action: nan
14602,ruboxistaurin,phosphatidylinositol 5-phosphate 4-kinase type-2 beta,kinase,,Drug: ruboxistaurin | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Type: kinase | Action: nan
14603,ruboxistaurin,serine/threonine-protein kinase rio1,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
14604,ruboxistaurin,serine/threonine-protein kinase tousled-like 1,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase tousled-like 1 | Type: kinase | Action: nan
14605,ruboxistaurin,casein kinase ii subunit alpha,kinase,,Drug: ruboxistaurin | Target: casein kinase ii subunit alpha | Type: kinase | Action: nan
14606,ruboxistaurin,casein kinase ii subunit alpha',kinase,,Drug: ruboxistaurin | Target: casein kinase ii subunit alpha' | Type: kinase | Action: nan
14607,ruboxistaurin,dual specificity tyrosine-phosphorylation-regulated kinase 1b,kinase,,Drug: ruboxistaurin | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1b | Type: kinase | Action: nan
14608,ruboxistaurin,serine/threonine-protein kinase stk11,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase stk11 | Type: kinase | Action: nan
14609,ruboxistaurin,map kinase-interacting serine/threonine-protein kinase 1,kinase,,Drug: ruboxistaurin | Target: map kinase-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
14610,ruboxistaurin,serine/threonine-protein kinase rio3,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
14611,ruboxistaurin,srsf protein kinase 1,kinase,,Drug: ruboxistaurin | Target: srsf protein kinase 1 | Type: kinase | Action: nan
14612,ruboxistaurin,srsf protein kinase 2,kinase,,Drug: ruboxistaurin | Target: srsf protein kinase 2 | Type: kinase | Action: nan
14613,ruboxistaurin,serine/threonine-protein kinase 33,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
14614,ruboxistaurin,myotonin-protein kinase,kinase,,Drug: ruboxistaurin | Target: myotonin-protein kinase | Type: kinase | Action: nan
14615,ruboxistaurin,rac-gamma serine/threonine-protein kinase,kinase,,Drug: ruboxistaurin | Target: rac-gamma serine/threonine-protein kinase | Type: kinase | Action: nan
14616,ruboxistaurin,serine/threonine-protein kinase lats1,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase lats1 | Type: kinase | Action: nan
14617,ruboxistaurin,serine/threonine-protein kinase lats2,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase lats2 | Type: kinase | Action: nan
14618,ruboxistaurin,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
14619,ruboxistaurin,nuak family snf1-like kinase 1,kinase,,Drug: ruboxistaurin | Target: nuak family snf1-like kinase 1 | Type: kinase | Action: nan
14620,ruboxistaurin,serine/threonine-protein kinase pim-3,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase pim-3 | Type: kinase | Action: nan
14621,ruboxistaurin,camp-dependent protein kinase catalytic subunit alpha,kinase,,Drug: ruboxistaurin | Target: camp-dependent protein kinase catalytic subunit alpha | Type: kinase | Action: nan
14622,ruboxistaurin,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
14623,ruboxistaurin,dual specificity mitogen-activated protein kinase kinase 4,kinase,,Drug: ruboxistaurin | Target: dual specificity mitogen-activated protein kinase kinase 4 | Type: kinase | Action: nan
14624,ruboxistaurin,dual specificity mitogen-activated protein kinase kinase 6,kinase,,Drug: ruboxistaurin | Target: dual specificity mitogen-activated protein kinase kinase 6 | Type: kinase | Action: nan
14625,ruboxistaurin,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
14626,ruboxistaurin,citron rho-interacting kinase,kinase,,Drug: ruboxistaurin | Target: citron rho-interacting kinase | Type: kinase | Action: nan
14627,ruboxistaurin,death-associated protein kinase 1,kinase,,Drug: ruboxistaurin | Target: death-associated protein kinase 1 | Type: kinase | Action: nan
14628,ruboxistaurin,mitogen-activated protein kinase 15,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase 15 | Type: kinase | Action: nan
14629,ruboxistaurin,serine/threonine-protein kinase d2,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase d2 | Type: kinase | Action: nan
14630,ruboxistaurin,cgmp-dependent protein kinase 2,kinase,,Drug: ruboxistaurin | Target: cgmp-dependent protein kinase 2 | Type: kinase | Action: nan
14631,ruboxistaurin,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: ruboxistaurin | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
14632,ruboxistaurin,ribosomal protein s6 kinase alpha-1,kinase,,Drug: ruboxistaurin | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
14633,ruboxistaurin,ribosomal protein s6 kinase alpha-4,kinase,,Drug: ruboxistaurin | Target: ribosomal protein s6 kinase alpha-4 | Type: kinase | Action: nan
14634,ruboxistaurin,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
14635,ruboxistaurin,misshapen-like kinase 1,kinase,,Drug: ruboxistaurin | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
14636,ruboxistaurin,serine/threonine-protein kinase tbk1,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
14637,ruboxistaurin,cyclin-dependent kinase 4,kinase,,Drug: ruboxistaurin | Target: cyclin-dependent kinase 4 | Type: kinase | Action: nan
14638,ruboxistaurin,serine/threonine-protein kinase chk2,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase chk2 | Type: kinase | Action: nan
14639,ruboxistaurin,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,,Drug: ruboxistaurin | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: nan
14640,ruboxistaurin,rhodopsin kinase,kinase,,Drug: ruboxistaurin | Target: rhodopsin kinase | Type: kinase | Action: nan
14641,ruboxistaurin,g protein-coupled receptor kinase 4,kinase,,Drug: ruboxistaurin | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
14642,ruboxistaurin,g protein-coupled receptor kinase 7,kinase,,Drug: ruboxistaurin | Target: g protein-coupled receptor kinase 7 | Type: kinase | Action: nan
14643,ruboxistaurin,homeodomain-interacting protein kinase 2,kinase,,Drug: ruboxistaurin | Target: homeodomain-interacting protein kinase 2 | Type: kinase | Action: nan
14644,ruboxistaurin,homeodomain-interacting protein kinase 3,kinase,,Drug: ruboxistaurin | Target: homeodomain-interacting protein kinase 3 | Type: kinase | Action: nan
14645,ruboxistaurin,serine/threonine-protein kinase ick,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase ick | Type: kinase | Action: nan
14646,ruboxistaurin,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
14647,ruboxistaurin,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
14648,ruboxistaurin,srsf protein kinase 3,kinase,,Drug: ruboxistaurin | Target: srsf protein kinase 3 | Type: kinase | Action: nan
14649,ruboxistaurin,serine/threonine-protein kinase tao1,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
14650,ruboxistaurin,serine/threonine-protein kinase tao3,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
14651,ruboxistaurin,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: ruboxistaurin | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
14652,ruboxistaurin,homeodomain-interacting protein kinase 1,kinase,,Drug: ruboxistaurin | Target: homeodomain-interacting protein kinase 1 | Type: kinase | Action: nan
14653,ruboxistaurin,cyclin-dependent kinase-like 5,kinase,,Drug: ruboxistaurin | Target: cyclin-dependent kinase-like 5 | Type: kinase | Action: nan
14654,ruboxistaurin,protein kinase c iota type,kinase,,Drug: ruboxistaurin | Target: protein kinase c iota type | Type: kinase | Action: nan
14655,ruboxistaurin,serine/threonine-protein kinase prp4 homolog,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase prp4 homolog | Type: kinase | Action: nan
14656,ruboxistaurin,phosphatidylinositol 4-phosphate 5-kinase type-1 gamma,kinase,,Drug: ruboxistaurin | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 gamma | Type: kinase | Action: nan
14657,ruboxistaurin,serine/threonine-protein kinase sgk3,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase sgk3 | Type: kinase | Action: nan
14658,ruboxistaurin,serine/threonine-protein kinase tao2,kinase,,Drug: ruboxistaurin | Target: serine/threonine-protein kinase tao2 | Type: kinase | Action: nan
14659,ruboxistaurin,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: ruboxistaurin | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
14660,ruboxistaurin,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: ruboxistaurin | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
14661,ruboxistaurin,protein kinase c (pkc),kinase,,Drug: ruboxistaurin | Target: protein kinase c (pkc) | Type: kinase | Action: nan
14662,ruboxistaurin,cam kinase ii,kinase,,Drug: ruboxistaurin | Target: cam kinase ii | Type: kinase | Action: nan
14663,rufinamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: rufinamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
14664,rufinamide,sodium channel alpha subunit,ion channel,BLOCKER,Drug: rufinamide | Target: sodium channel alpha subunit | Type: ion channel | Action: BLOCKER
14666,rutoside,alpha-2a adrenergic receptor,gpcr,,Drug: rutoside | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14667,rutoside,muscarinic acetylcholine receptor m5,gpcr,,Drug: rutoside | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
14668,rutoside,alpha-2c adrenergic receptor,gpcr,,Drug: rutoside | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
14669,rutoside,acetylcholinesterase,enzyme,,Drug: rutoside | Target: acetylcholinesterase | Type: enzyme | Action: nan
14670,rutoside,xanthine dehydrogenase/oxidase,enzyme,,Drug: rutoside | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
14671,rutoside,bifunctional epoxide hydrolase 2,enzyme,,Drug: rutoside | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
14672,rutoside,aldose reductase,enzyme,,Drug: rutoside | Target: aldose reductase | Type: enzyme | Action: nan
14673,rutoside,polyphenol oxidase 2,enzyme,,Drug: rutoside | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
14674,rutoside,serum albumin,secreted,,Drug: rutoside | Target: serum albumin | Type: secreted | Action: nan
14675,rutoside,neuraminidase,enzyme,,Drug: rutoside | Target: neuraminidase | Type: enzyme | Action: nan
14676,rutoside,sialidase,enzyme,,Drug: rutoside | Target: sialidase | Type: enzyme | Action: nan
14677,rutoside,lysine-specific histone demethylase 1a,enzyme,,Drug: rutoside | Target: lysine-specific histone demethylase 1a | Type: enzyme | Action: nan
14678,rutoside,neuromedin-u receptor 2,gpcr,,Drug: rutoside | Target: neuromedin-u receptor 2 | Type: gpcr | Action: nan
14679,rutoside,neuraminidase,enzyme,,Drug: rutoside | Target: neuraminidase | Type: enzyme | Action: nan
14681,sabcomeline,muscarinic acetylcholine receptor m1,gpcr,,Drug: sabcomeline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
14682,sabcomeline,muscarinic acetylcholine receptor m2,gpcr,,Drug: sabcomeline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
14683,sabcomeline,muscarinic acetylcholine receptor m3,gpcr,,Drug: sabcomeline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
14684,sabcomeline,muscarinic acetylcholine receptor m4,gpcr,,Drug: sabcomeline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
14685,sabcomeline,muscarinic acetylcholine receptor m5,gpcr,AGONIST,Drug: sabcomeline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: AGONIST
14686,sabcomeline,muscarinic acetylcholine receptor,gpcr,,Drug: sabcomeline | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
14687,saralasin,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: saralasin | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
14688,saralasin,type-2 angiotensin ii receptor,gpcr,,Drug: saralasin | Target: type-2 angiotensin ii receptor | Type: gpcr | Action: nan
14689,saralasin,type-1b angiotensin ii receptor,gpcr,,Drug: saralasin | Target: type-1b angiotensin ii receptor | Type: gpcr | Action: nan
14690,saralasin,type-2 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: saralasin | Target: type-2 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
14691,saralasin,angiotensin ii receptor (at-1) type-1,gpcr,,Drug: saralasin | Target: angiotensin ii receptor (at-1) type-1 | Type: gpcr | Action: nan
14692,sitaxentan,endothelin-1 receptor,gpcr,ANTAGONIST,Drug: sitaxentan | Target: endothelin-1 receptor | Type: gpcr | Action: ANTAGONIST
14693,sitaxentan,endothelin b receptor,gpcr,ANTAGONIST,Drug: sitaxentan | Target: endothelin b receptor | Type: gpcr | Action: ANTAGONIST
14694,sitaxentan,endothelin-1 receptor,gpcr,ANTAGONIST,Drug: sitaxentan | Target: endothelin-1 receptor | Type: gpcr | Action: ANTAGONIST
14695,stallimycin,dna topoisomerase 1,enzyme,,Drug: stallimycin | Target: dna topoisomerase 1 | Type: enzyme | Action: nan
14696,stallimycin,gtpase hras,cytosolic other,,Drug: stallimycin | Target: gtpase hras | Type: cytosolic other | Action: nan
14697,stallimycin,estrogen receptor,nuclear hormone receptor,,Drug: stallimycin | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
14698,sulbentine,mu-type opioid receptor,gpcr,,Drug: sulbentine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
14699,sulbentine,delta-type opioid receptor,gpcr,,Drug: sulbentine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
14700,sulmazole,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: sulmazole | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
14701,sulmazole,phosphodiesterase 3,enzyme,,Drug: sulmazole | Target: phosphodiesterase 3 | Type: enzyme | Action: nan
14702,oxedrine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: oxedrine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14703,oxedrine,neuromedin-u receptor 2,gpcr,,Drug: oxedrine | Target: neuromedin-u receptor 2 | Type: gpcr | Action: nan
14704,talastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: talastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
14705,tamibarotene,retinoic acid receptor alpha,nuclear hormone receptor,,Drug: tamibarotene | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: nan
14706,tamibarotene,retinoic acid receptor beta,nuclear hormone receptor,AGONIST,Drug: tamibarotene | Target: retinoic acid receptor beta | Type: nuclear hormone receptor | Action: AGONIST
14707,tamibarotene,retinoic acid receptor gamma,nuclear hormone receptor,AGONIST,Drug: tamibarotene | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
14708,terazosin,alpha-2a adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14709,terazosin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: terazosin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
14710,terazosin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: terazosin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
14711,terazosin,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: terazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
14712,terazosin,alpha-2b adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
14713,terazosin,alpha-2c adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
14714,terazosin,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: terazosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
14715,terazosin,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: terazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
14716,terazosin,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: terazosin | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
14717,terazosin,solute carrier family 22 member 1,transporter,,Drug: terazosin | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
14718,terazosin,alpha-1b adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
14719,terazosin,alpha-1a adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14720,terazosin,alpha-2b adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
14721,terazosin,alpha-1d adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
14722,terazosin,alpha-1a adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14723,terazosin,alpha-1b adrenergic receptor,gpcr,,Drug: terazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
14724,tetryzoline,adrenergic receptor alpha-2,gpcr,,Drug: tetryzoline | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
14725,tetryzoline,adrenergic receptor alpha-1,gpcr,,Drug: tetryzoline | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
14726,tetryzoline,adrenergic receptor alpha,gpcr,,Drug: tetryzoline | Target: adrenergic receptor alpha | Type: gpcr | Action: nan
14727,tetryzoline,adrenergic receptor alpha,gpcr,AGONIST,Drug: tetryzoline | Target: adrenergic receptor alpha | Type: gpcr | Action: AGONIST
14728,thiram,fatty-acid amide hydrolase 1,enzyme,,Drug: thiram | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
14729,thiram,gamma-butyrobetaine dioxygenase,enzyme,,Drug: thiram | Target: gamma-butyrobetaine dioxygenase | Type: enzyme | Action: nan
14730,thiram,monoglyceride lipase,enzyme,,Drug: thiram | Target: monoglyceride lipase | Type: enzyme | Action: nan
14731,thiram,bifunctional protein glmu,enzyme,,Drug: thiram | Target: bifunctional protein glmu | Type: enzyme | Action: nan
14732,thiram,protein-lysine 6-oxidase,enzyme,,Drug: thiram | Target: protein-lysine 6-oxidase | Type: enzyme | Action: nan
14733,thiram,lysyl oxidase homolog 3,enzyme,,Drug: thiram | Target: lysyl oxidase homolog 3 | Type: enzyme | Action: nan
14734,thiram,lysyl oxidase homolog 4,enzyme,,Drug: thiram | Target: lysyl oxidase homolog 4 | Type: enzyme | Action: nan
14735,thiram,histone-lysine n-methyltransferase ehmt2,enzyme,,Drug: thiram | Target: histone-lysine n-methyltransferase ehmt2 | Type: enzyme | Action: nan
14736,thiram,histone-lysine n-methyltransferase ehmt1,enzyme,,Drug: thiram | Target: histone-lysine n-methyltransferase ehmt1 | Type: enzyme | Action: nan
14737,thiram,lysyl oxidase homolog 2,enzyme,,Drug: thiram | Target: lysyl oxidase homolog 2 | Type: enzyme | Action: nan
14738,thyropropic acid,thyroid hormone receptor alpha,nuclear hormone receptor,,Drug: thyropropic acid | Target: thyroid hormone receptor alpha | Type: nuclear hormone receptor | Action: nan
14739,thyropropic acid,thyroid hormone receptor beta,nuclear hormone receptor,,Drug: thyropropic acid | Target: thyroid hormone receptor beta | Type: nuclear hormone receptor | Action: nan
14740,thyropropic acid,proliferating cell nuclear antigen,nuclear other,,Drug: thyropropic acid | Target: proliferating cell nuclear antigen | Type: nuclear other | Action: nan
14741,tioxolone,carbonic anhydrase 2,enzyme,,Drug: tioxolone | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
14742,tioxolone,amine oxidase [flavin-containing] b,enzyme,,Drug: tioxolone | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
14743,tioxolone,amine oxidase [flavin-containing] a,enzyme,,Drug: tioxolone | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
14744,tipranavir,multidrug resistance protein 1,transporter,,Drug: tipranavir | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
14745,tipranavir,cathepsin d,enzyme,,Drug: tipranavir | Target: cathepsin d | Type: enzyme | Action: nan
14746,tipranavir,pol polyprotein,enzyme,INHIBITOR,Drug: tipranavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
14747,tipranavir,caax prenyl protease 1 homolog,enzyme,,Drug: tipranavir | Target: caax prenyl protease 1 homolog | Type: enzyme | Action: nan
14748,tipranavir,cathepsin e,enzyme,,Drug: tipranavir | Target: cathepsin e | Type: enzyme | Action: nan
14749,tipranavir,pepsin a-5,enzyme,,Drug: tipranavir | Target: pepsin a-5 | Type: enzyme | Action: nan
14750,tiratricol,thyroid hormone receptor alpha,nuclear hormone receptor,,Drug: tiratricol | Target: thyroid hormone receptor alpha | Type: nuclear hormone receptor | Action: nan
14751,tiratricol,thyroid hormone receptor beta,nuclear hormone receptor,,Drug: tiratricol | Target: thyroid hormone receptor beta | Type: nuclear hormone receptor | Action: nan
14752,tiratricol,androgen receptor,nuclear hormone receptor,,Drug: tiratricol | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
14753,tiratricol,thyroid hormone receptor beta,transcription factor,,Drug: tiratricol | Target: thyroid hormone receptor beta | Type: transcription factor | Action: nan
14754,tiratricol,proliferating cell nuclear antigen,nuclear other,,Drug: tiratricol | Target: proliferating cell nuclear antigen | Type: nuclear other | Action: nan
14755,tiratricol,sodium/bile acid cotransporter,transporter,,Drug: tiratricol | Target: sodium/bile acid cotransporter | Type: transporter | Action: nan
14757,vitamin e,glutathione s-transferase p,enzyme,,Drug: vitamin e | Target: glutathione s-transferase p | Type: enzyme | Action: nan
14758,vitamin e,alpha-tocopherol transfer protein,transporter,,Drug: vitamin e | Target: alpha-tocopherol transfer protein | Type: transporter | Action: nan
14759,toliprolol,beta-1 adrenergic receptor,gpcr,,Drug: toliprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
14760,toliprolol,beta-2 adrenergic receptor,gpcr,,Drug: toliprolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
14761,toliprolol,beta-2 adrenergic receptor,gpcr,,Drug: toliprolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
14762,toliprolol,beta-1 adrenergic receptor,gpcr,,Drug: toliprolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
14763,tolnaftate,5-hydroxytryptamine receptor 2b,gpcr,,Drug: tolnaftate | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
14764,tolnaftate,cytochrome p450 2c19,enzyme,,Drug: tolnaftate | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
14765,tolnaftate,lanosterol 14-alpha demethylase,enzyme,,Drug: tolnaftate | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: nan
14766,tramazoline,alpha-2a adrenergic receptor,gpcr,,Drug: tramazoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14767,tramazoline,alpha-2b adrenergic receptor,gpcr,,Drug: tramazoline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
14768,tramazoline,alpha-2c adrenergic receptor,gpcr,,Drug: tramazoline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
14769,tramazoline,adrenergic receptor alpha-2,gpcr,,Drug: tramazoline | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
14770,tramazoline,adrenergic receptor alpha-1,gpcr,,Drug: tramazoline | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
14771,triclocarban,bifunctional epoxide hydrolase 2,enzyme,,Drug: triclocarban | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
14772,triclocarban,epoxide hydrolase; epoxide hydrolase ephb,enzyme,,Drug: triclocarban | Target: epoxide hydrolase; epoxide hydrolase ephb | Type: enzyme | Action: nan
14773,triclocarban,epoxide hydrolase 1,enzyme,,Drug: triclocarban | Target: epoxide hydrolase 1 | Type: enzyme | Action: nan
14774,triclocarban,epoxide hydrolase 1,enzyme,,Drug: triclocarban | Target: epoxide hydrolase 1 | Type: enzyme | Action: nan
14775,triclosan,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,,Drug: triclosan | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: nan
14776,triclosan,carbonyl reductase [nadph] 1,enzyme,,Drug: triclosan | Target: carbonyl reductase [nadph] 1 | Type: enzyme | Action: nan
14777,triclosan,enoyl-[acyl-carrier-protein] reductase [nadph] fabi,enzyme,,Drug: triclosan | Target: enoyl-[acyl-carrier-protein] reductase [nadph] fabi | Type: enzyme | Action: nan
14778,triclosan,enoyl-[acyl-carrier-protein] reductase [nadh] fabi,enzyme,INHIBITOR,Drug: triclosan | Target: enoyl-[acyl-carrier-protein] reductase [nadh] fabi | Type: enzyme | Action: INHIBITOR
14779,triclosan,enoyl-acyl-carrier protein reductase,enzyme,,Drug: triclosan | Target: enoyl-acyl-carrier protein reductase | Type: enzyme | Action: nan
14780,triclosan,enoyl-[acyl-carrier-protein] reductase [nadh] fabi,enzyme,,Drug: triclosan | Target: enoyl-[acyl-carrier-protein] reductase [nadh] fabi | Type: enzyme | Action: nan
14781,triclosan,enoyl-acyl carrier reductase; enoyl-acyl carrier reductase enr,enzyme,,Drug: triclosan | Target: enoyl-acyl carrier reductase; enoyl-acyl carrier reductase enr | Type: enzyme | Action: nan
14782,triclosan,enoyl-acp reductase,enzyme,,Drug: triclosan | Target: enoyl-acp reductase | Type: enzyme | Action: nan
14783,triclosan,enoyl-[acyl-carrier-protein] reductase [nadph],enzyme,,Drug: triclosan | Target: enoyl-[acyl-carrier-protein] reductase [nadph] | Type: enzyme | Action: nan
14784,triclosan,enoyl-[acyl-carrier-protein] reductase [nadh],enzyme,,Drug: triclosan | Target: enoyl-[acyl-carrier-protein] reductase [nadh] | Type: enzyme | Action: nan
14785,triclosan,enoyl-[acyl-carrier-protein] reductase [nulldh],enzyme,,Drug: triclosan | Target: enoyl-[acyl-carrier-protein] reductase [nulldh] | Type: enzyme | Action: nan
14786,triclosan,78 kda glucose-regulated protein,unclassified,,Drug: triclosan | Target: 78 kda glucose-regulated protein | Type: unclassified | Action: nan
14787,uridine triphosphate,p2y purinoceptor 4,gpcr,AGONIST,Drug: uridine triphosphate | Target: p2y purinoceptor 4 | Type: gpcr | Action: AGONIST
14788,uridine triphosphate,p2y purinoceptor 6,gpcr,AGONIST,Drug: uridine triphosphate | Target: p2y purinoceptor 6 | Type: gpcr | Action: AGONIST
14789,uridine triphosphate,p2y purinoceptor 2,gpcr,AGONIST,Drug: uridine triphosphate | Target: p2y purinoceptor 2 | Type: gpcr | Action: AGONIST
14790,uridine triphosphate,p2y purinoceptor 11,gpcr,AGONIST,Drug: uridine triphosphate | Target: p2y purinoceptor 11 | Type: gpcr | Action: AGONIST
14791,uridine triphosphate,p2x purinoceptor 3,ion channel,,Drug: uridine triphosphate | Target: p2x purinoceptor 3 | Type: ion channel | Action: nan
14792,uridine triphosphate,p2y purinoceptor 4,gpcr,AGONIST,Drug: uridine triphosphate | Target: p2y purinoceptor 4 | Type: gpcr | Action: AGONIST
14793,vildagliptin,prolyl endopeptidase fap,enzyme,,Drug: vildagliptin | Target: prolyl endopeptidase fap | Type: enzyme | Action: nan
14794,vildagliptin,dipeptidyl peptidase 8,enzyme,,Drug: vildagliptin | Target: dipeptidyl peptidase 8 | Type: enzyme | Action: nan
14795,vildagliptin,dipeptidyl peptidase 9,enzyme,,Drug: vildagliptin | Target: dipeptidyl peptidase 9 | Type: enzyme | Action: nan
14796,vildagliptin,prolyl endopeptidase fap,enzyme,,Drug: vildagliptin | Target: prolyl endopeptidase fap | Type: enzyme | Action: nan
14797,vildagliptin,dipeptidyl peptidase 9,unclassified,,Drug: vildagliptin | Target: dipeptidyl peptidase 9 | Type: unclassified | Action: nan
14798,vildagliptin,dipeptidyl peptidase iv,unclassified,,Drug: vildagliptin | Target: dipeptidyl peptidase iv | Type: unclassified | Action: nan
14799,vildagliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: vildagliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
14800,vincamine,muscarinic acetylcholine receptor m1,gpcr,ALLOSTERIC MODULATOR,Drug: vincamine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ALLOSTERIC MODULATOR
14801,vincamine,muscarinic acetylcholine receptor m2,gpcr,ALLOSTERIC MODULATOR,Drug: vincamine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ALLOSTERIC MODULATOR
14802,vincamine,muscarinic acetylcholine receptor m3,gpcr,ALLOSTERIC MODULATOR,Drug: vincamine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ALLOSTERIC MODULATOR
14803,vincamine,muscarinic acetylcholine receptor m4,gpcr,ALLOSTERIC MODULATOR,Drug: vincamine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ALLOSTERIC MODULATOR
14804,vinflunine,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: vinflunine | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
14805,vorozole,aromatase,enzyme,INHIBITOR,Drug: vorozole | Target: aromatase | Type: enzyme | Action: INHIBITOR
14806,xanomeline,d(2) dopamine receptor,gpcr,,Drug: xanomeline | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
14807,xanomeline,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
14808,xanomeline,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
14809,xanomeline,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
14810,xanomeline,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
14811,xanomeline,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
14812,xanomeline,5-hydroxytryptamine receptor 7,gpcr,AGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: AGONIST
14813,xanomeline,d(3) dopamine receptor,gpcr,,Drug: xanomeline | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
14814,xanomeline,muscarinic acetylcholine receptor m1,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
14815,xanomeline,muscarinic acetylcholine receptor m2,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
14816,xanomeline,muscarinic acetylcholine receptor m3,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
14817,xanomeline,muscarinic acetylcholine receptor m4,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
14818,xanomeline,muscarinic acetylcholine receptor m5,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
14819,xanomeline,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
14820,xanomeline,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
14821,xanomeline,alpha-1b adrenergic receptor,gpcr,,Drug: xanomeline | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
14822,xanomeline,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
14823,xanomeline,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: xanomeline | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
14824,xanomeline,muscarinic acetylcholine receptor m2,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
14825,xanomeline,muscarinic acetylcholine receptor m1,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
14826,xanomeline,muscarinic acetylcholine receptor m1,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
14827,xanomeline,muscarinic acetylcholine receptor,gpcr,,Drug: xanomeline | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
14828,xylometazoline,alpha-2a adrenergic receptor,gpcr,,Drug: xylometazoline | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14829,xylometazoline,alpha-1a adrenergic receptor,gpcr,,Drug: xylometazoline | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14830,xylometazoline,5-hydroxytryptamine receptor 1b,gpcr,,Drug: xylometazoline | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
14831,xylometazoline,5-hydroxytryptamine receptor 1d,gpcr,,Drug: xylometazoline | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
14832,xylometazoline,alpha-2c adrenergic receptor,gpcr,,Drug: xylometazoline | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
14833,xylometazoline,adrenergic receptor alpha-2,gpcr,,Drug: xylometazoline | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
14834,xylometazoline,adrenergic receptor alpha-1,gpcr,,Drug: xylometazoline | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
14835,xylometazoline,adrenergic receptor alpha,gpcr,,Drug: xylometazoline | Target: adrenergic receptor alpha | Type: gpcr | Action: nan
14836,xylometazoline,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: xylometazoline | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
14837,yohimbine,d(2) dopamine receptor,gpcr,,Drug: yohimbine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
14838,yohimbine,alpha-2a adrenergic receptor,gpcr,ANTAGONIST,Drug: yohimbine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
14839,yohimbine,5-hydroxytryptamine receptor 1a,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: ANTAGONIST
14840,yohimbine,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
14841,yohimbine,5-hydroxytryptamine receptor 6,gpcr,,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
14842,yohimbine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
14843,yohimbine,alpha-1a adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14844,yohimbine,alpha-2b adrenergic receptor,gpcr,ANTAGONIST,Drug: yohimbine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
14845,yohimbine,d(3) dopamine receptor,gpcr,,Drug: yohimbine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
14846,yohimbine,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
14847,yohimbine,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
14848,yohimbine,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: yohimbine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
14849,yohimbine,cytochrome p450 2d6,enzyme,,Drug: yohimbine | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
14850,yohimbine,adenosine receptor a3,gpcr,,Drug: yohimbine | Target: adenosine receptor a3 | Type: gpcr | Action: nan
14851,yohimbine,alpha-1d adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
14852,yohimbine,alpha-1b adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
14853,yohimbine,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
14854,yohimbine,5-hydroxytryptamine receptor 1f,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: ANTAGONIST
14855,yohimbine,5-hydroxytryptamine receptor 1e,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: ANTAGONIST
14856,yohimbine,dna topoisomerase 1,enzyme,,Drug: yohimbine | Target: dna topoisomerase 1 | Type: enzyme | Action: nan
14857,yohimbine,alpha-1b adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
14858,yohimbine,alpha-1a adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14859,yohimbine,alpha-2b adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
14860,yohimbine,alpha-1d adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
14861,yohimbine,d(2) dopamine receptor,gpcr,,Drug: yohimbine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
14862,yohimbine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14863,yohimbine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
14864,yohimbine,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
14865,yohimbine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: yohimbine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
14866,yohimbine,alpha-1a adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14867,yohimbine,alpha-2a adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14868,yohimbine,d(3) dopamine receptor,gpcr,,Drug: yohimbine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
14869,yohimbine,alpha-2a adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
14870,yohimbine,adrenergic receptor alpha-2,gpcr,,Drug: yohimbine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
14871,yohimbine,dopamine receptor,gpcr,,Drug: yohimbine | Target: dopamine receptor | Type: gpcr | Action: nan
14872,yohimbine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: yohimbine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
14873,yohimbine,alpha-2 adrenergic receptor,gpcr,,Drug: yohimbine | Target: alpha-2 adrenergic receptor | Type: gpcr | Action: nan
14874,yohimbine,dual specificity phosphatase cdc25a,enzyme,,Drug: yohimbine | Target: dual specificity phosphatase cdc25a | Type: enzyme | Action: nan
14875,yohimbine,5-hydroxytryptamine receptor 1b,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: ANTAGONIST
14876,yohimbine,5-hydroxytryptamine receptor 5a,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: ANTAGONIST
14877,yohimbine,5-hydroxytryptamine receptor 1f,gpcr,ANTAGONIST,Drug: yohimbine | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: ANTAGONIST
14878,azacyclonol,histamine h1 receptor,gpcr,,Drug: azacyclonol | Target: histamine h1 receptor | Type: gpcr | Action: nan
14879,azacyclonol,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: azacyclonol | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
14880,benzylsulfamide,carbonic anhydrase 2,enzyme,,Drug: benzylsulfamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
14881,benzylsulfamide,carbonic anhydrase 1,enzyme,,Drug: benzylsulfamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
14882,benzylsulfamide,carbonic anhydrase 9,enzyme,,Drug: benzylsulfamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
14883,benzylsulfamide,carbonic anhydrase 12,enzyme,,Drug: benzylsulfamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
14884,bropirimine,xanthine dehydrogenase/oxidase,enzyme,,Drug: bropirimine | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
14885,chlorthenoxazine,poly [adp-ribose] polymerase 1,enzyme,,Drug: chlorthenoxazine | Target: poly [adp-ribose] polymerase 1 | Type: enzyme | Action: nan
14886,ciramadol,mu-type opioid receptor,gpcr,MODULATOR,Drug: ciramadol | Target: mu-type opioid receptor | Type: gpcr | Action: MODULATOR
14887,clobenztropine,sodium-dependent dopamine transporter,transporter,,Drug: clobenztropine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
14888,diperodon,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: diperodon | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
14889,meprylcaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: meprylcaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
14890,myrtecaine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: myrtecaine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
14891,parethoxycaine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: parethoxycaine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
14892,tasosartan,angiotensin ii receptor (at-1) type-1,gpcr,,Drug: tasosartan | Target: angiotensin ii receptor (at-1) type-1 | Type: gpcr | Action: nan
14893,tasosartan,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: tasosartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
14894,velnacrine,acetylcholinesterase,enzyme,,Drug: velnacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
14895,velnacrine,acetylcholinesterase,enzyme,,Drug: velnacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
14896,velnacrine,acetylcholinesterase,enzyme,,Drug: velnacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
14897,velnacrine,acetylcholinesterase,enzyme,,Drug: velnacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
14898,velnacrine,butyrylcholinesterase,enzyme,,Drug: velnacrine | Target: butyrylcholinesterase | Type: enzyme | Action: nan
14899,dexibuprofen,prostaglandin g/h synthase 2,enzyme,,Drug: dexibuprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
14900,dexibuprofen,prostaglandin g/h synthase 1,enzyme,,Drug: dexibuprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
14901,dexibuprofen,aldo-keto reductase family 1 member c2,enzyme,,Drug: dexibuprofen | Target: aldo-keto reductase family 1 member c2 | Type: enzyme | Action: nan
14902,dexibuprofen,aldo-keto reductase family 1 member c3,enzyme,,Drug: dexibuprofen | Target: aldo-keto reductase family 1 member c3 | Type: enzyme | Action: nan
14903,dexibuprofen,prostaglandin g/h synthase 1,enzyme,,Drug: dexibuprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
14904,dexibuprofen,prostaglandin g/h synthase 2,enzyme,,Drug: dexibuprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
14905,docosanoic acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: docosanoic acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
14906,docosanoic acid,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: docosanoic acid | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
14907,docosanoic acid,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: docosanoic acid | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
14908,alitretinoin,retinoic acid receptor alpha,nuclear hormone receptor,AGONIST,Drug: alitretinoin | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
14909,alitretinoin,retinoic acid receptor rxr-alpha,nuclear hormone receptor,AGONIST,Drug: alitretinoin | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: AGONIST
14910,alitretinoin,retinoic acid receptor rxr-beta,nuclear hormone receptor,AGONIST,Drug: alitretinoin | Target: retinoic acid receptor rxr-beta | Type: nuclear hormone receptor | Action: AGONIST
14911,alitretinoin,retinoic acid receptor rxr-gamma,nuclear hormone receptor,AGONIST,Drug: alitretinoin | Target: retinoic acid receptor rxr-gamma | Type: nuclear hormone receptor | Action: AGONIST
14912,alitretinoin,retinoic acid receptor beta,nuclear hormone receptor,AGONIST,Drug: alitretinoin | Target: retinoic acid receptor beta | Type: nuclear hormone receptor | Action: AGONIST
14913,alitretinoin,retinoic acid receptor gamma,nuclear hormone receptor,AGONIST,Drug: alitretinoin | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
14914,alitretinoin,nuclear receptor ror-gamma,nuclear hormone receptor,,Drug: alitretinoin | Target: nuclear receptor ror-gamma | Type: nuclear hormone receptor | Action: nan
14915,alitretinoin,retinoic acid receptor rxr-beta,transcription factor,,Drug: alitretinoin | Target: retinoic acid receptor rxr-beta | Type: transcription factor | Action: nan
14916,alitretinoin,retinoic acid receptor rxr-gamma,transcription factor,,Drug: alitretinoin | Target: retinoic acid receptor rxr-gamma | Type: transcription factor | Action: nan
14917,alitretinoin,retinoic acid receptor alpha,transcription factor,,Drug: alitretinoin | Target: retinoic acid receptor alpha | Type: transcription factor | Action: nan
14918,alitretinoin,retinoic acid receptor rxr-alpha,transcription factor,,Drug: alitretinoin | Target: retinoic acid receptor rxr-alpha | Type: transcription factor | Action: nan
14919,alitretinoin,retinoic acid receptor beta,transcription factor,,Drug: alitretinoin | Target: retinoic acid receptor beta | Type: transcription factor | Action: nan
14920,alitretinoin,retinoic acid receptor gamma,transcription factor,,Drug: alitretinoin | Target: retinoic acid receptor gamma | Type: transcription factor | Action: nan
14921,alitretinoin,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: alitretinoin | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
14922,alitretinoin,nuclear receptor subfamily 4 group a member 1,nuclear other,,Drug: alitretinoin | Target: nuclear receptor subfamily 4 group a member 1 | Type: nuclear other | Action: nan
14923,alitretinoin,oxysterols receptor lxr-beta,nuclear other,,Drug: alitretinoin | Target: oxysterols receptor lxr-beta | Type: nuclear other | Action: nan
14924,alitretinoin,oxysterols receptor lxr-alpha,nuclear other,,Drug: alitretinoin | Target: oxysterols receptor lxr-alpha | Type: nuclear other | Action: nan
14925,artemisinin,cytochrome p450 1a2,enzyme,,Drug: artemisinin | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
14926,benzamycin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: benzamycin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
14927,benzamycin,aldehyde oxidase,enzyme,,Drug: benzamycin | Target: aldehyde oxidase | Type: enzyme | Action: nan
14928,benzamycin,motilin receptor,gpcr,,Drug: benzamycin | Target: motilin receptor | Type: gpcr | Action: nan
14929,benzamycin,cytochrome p450 1b1,enzyme,,Drug: benzamycin | Target: cytochrome p450 1b1 | Type: enzyme | Action: nan
14931,benidipine,voltage-dependent t-type calcium channel subunit alpha-1h,ion channel,BLOCKER,Drug: benidipine | Target: voltage-dependent t-type calcium channel subunit alpha-1h | Type: ion channel | Action: BLOCKER
14932,benidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: benidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
14933,benzydamine,soluble guanylate cyclase,enzyme,,Drug: benzydamine | Target: soluble guanylate cyclase | Type: enzyme | Action: nan
14934,biriperone,d(3) dopamine receptor,gpcr,,Drug: biriperone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
14935,biriperone,d(2) dopamine receptor,gpcr,,Drug: biriperone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
14936,biriperone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: biriperone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
14937,biriperone,d(1a) dopamine receptor,gpcr,,Drug: biriperone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
14938,clobetasone butyrate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: clobetasone butyrate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
14939,clorotepine,d(2) dopamine receptor,gpcr,,Drug: clorotepine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
14940,clorotepine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: clorotepine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
14941,clorotepine,5-hydroxytryptamine receptor 6,gpcr,,Drug: clorotepine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
14942,clorotepine,d(3) dopamine receptor,gpcr,,Drug: clorotepine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
14943,clorotepine,histamine h1 receptor,gpcr,,Drug: clorotepine | Target: histamine h1 receptor | Type: gpcr | Action: nan
14944,clorotepine,d(4) dopamine receptor,gpcr,,Drug: clorotepine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
14945,clorotepine,trace amine-associated receptor 1,gpcr,,Drug: clorotepine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
14946,clorotepine,potassium channel subfamily k member 9,ion channel,,Drug: clorotepine | Target: potassium channel subfamily k member 9 | Type: ion channel | Action: nan
14947,clorotepine,alpha-1d adrenergic receptor,gpcr,,Drug: clorotepine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
14948,clorotepine,d(2) dopamine receptor,gpcr,,Drug: clorotepine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
14949,clorotepine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: clorotepine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
14950,clorotepine,d(1a) dopamine receptor,gpcr,,Drug: clorotepine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
14951,clorotepine,alpha-1a adrenergic receptor,gpcr,,Drug: clorotepine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14952,clorotepine,d(3) dopamine receptor,gpcr,,Drug: clorotepine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
14953,clorotepine,alpha-1b adrenergic receptor,gpcr,,Drug: clorotepine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
14954,clorotepine,dopamine receptor,gpcr,,Drug: clorotepine | Target: dopamine receptor | Type: gpcr | Action: nan
14955,clorotepine,adrenergic receptor alpha-1,gpcr,,Drug: clorotepine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
14956,clorotepine,serotonin 2 (5-ht2) receptor,gpcr,,Drug: clorotepine | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
14958,dexamethasone phosphate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: dexamethasone phosphate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
14959,dexamethasone phosphate,mineralocorticoid receptor,nuclear hormone receptor,,Drug: dexamethasone phosphate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
14960,dexamethasone phosphate,androgen receptor,nuclear hormone receptor,,Drug: dexamethasone phosphate | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
14961,dexamethasone phosphate,progesterone receptor,nuclear hormone receptor,,Drug: dexamethasone phosphate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
14962,dexamethasone phosphate,androgen receptor,transcription factor,,Drug: dexamethasone phosphate | Target: androgen receptor | Type: transcription factor | Action: nan
14963,dexamethasone phosphate,"fatty acid-binding protein, liver",unclassified,,"Drug: dexamethasone phosphate | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
14964,dexamethasone phosphate,progesterone receptor,transcription factor,,Drug: dexamethasone phosphate | Target: progesterone receptor | Type: transcription factor | Action: nan
14965,dexamethasone phosphate,glucocorticoid receptor,transcription factor,,Drug: dexamethasone phosphate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
14966,androstanolone,glucocorticoid receptor,nuclear hormone receptor,,Drug: androstanolone | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
14967,androstanolone,mineralocorticoid receptor,nuclear hormone receptor,,Drug: androstanolone | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
14968,androstanolone,androgen receptor,nuclear hormone receptor,,Drug: androstanolone | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
14969,androstanolone,progesterone receptor,nuclear hormone receptor,,Drug: androstanolone | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
14970,androstanolone,aromatase,enzyme,,Drug: androstanolone | Target: aromatase | Type: enzyme | Action: nan
14971,androstanolone,corticosteroid-binding globulin,secreted,,Drug: androstanolone | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
14972,androstanolone,sex hormone-binding globulin,secreted,,Drug: androstanolone | Target: sex hormone-binding globulin | Type: secreted | Action: nan
14973,androstanolone,androgen receptor,transcription factor,,Drug: androstanolone | Target: androgen receptor | Type: transcription factor | Action: nan
14974,androstanolone,progesterone receptor,transcription factor,,Drug: androstanolone | Target: progesterone receptor | Type: transcription factor | Action: nan
14975,androstanolone,glucocorticoid receptor,transcription factor,,Drug: androstanolone | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
14976,androstanolone,androgen receptor,transcription factor,,Drug: androstanolone | Target: androgen receptor | Type: transcription factor | Action: nan
14977,androstanolone,progesterone receptor,transcription factor,,Drug: androstanolone | Target: progesterone receptor | Type: transcription factor | Action: nan
14978,androstanolone,mineralocorticoid receptor,transcription factor,,Drug: androstanolone | Target: mineralocorticoid receptor | Type: transcription factor | Action: nan
14980,dolasetron,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: dolasetron | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
14981,dolasetron,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: dolasetron | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
14982,etoposide phosphate,dna topoisomerase 2-alpha,enzyme,INHIBITOR,Drug: etoposide phosphate | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: INHIBITOR
14983,guanabenz,alpha-2a adrenergic receptor,gpcr,AGONIST,Drug: guanabenz | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: AGONIST
14984,guanabenz,5-hydroxytryptamine receptor 1a,gpcr,,Drug: guanabenz | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14985,guanabenz,5-hydroxytryptamine receptor 2a,gpcr,,Drug: guanabenz | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
14986,guanabenz,5-hydroxytryptamine receptor 2b,gpcr,,Drug: guanabenz | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
14987,guanabenz,5-hydroxytryptamine receptor 2c,gpcr,,Drug: guanabenz | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
14988,guanabenz,alpha-2b adrenergic receptor,gpcr,AGONIST,Drug: guanabenz | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: AGONIST
14989,guanabenz,alpha-2c adrenergic receptor,gpcr,AGONIST,Drug: guanabenz | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: AGONIST
14990,guanabenz,alpha-1d adrenergic receptor,gpcr,,Drug: guanabenz | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
14991,guanabenz,amine oxidase [flavin-containing] a,enzyme,,Drug: guanabenz | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
14992,guanabenz,trace amine-associated receptor 1,gpcr,,Drug: guanabenz | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
14993,guanabenz,nischarin,membrane receptor,,Drug: guanabenz | Target: nischarin | Type: membrane receptor | Action: nan
14994,guanabenz,solute carrier family 22 member 1,transporter,,Drug: guanabenz | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
14995,guanabenz,alpha-1b adrenergic receptor,gpcr,,Drug: guanabenz | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
14996,guanabenz,alpha-1a adrenergic receptor,gpcr,,Drug: guanabenz | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
14997,guanabenz,5-hydroxytryptamine receptor 1a,gpcr,,Drug: guanabenz | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
14998,guanabenz,adrenergic receptor alpha-2,gpcr,,Drug: guanabenz | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
14999,hydrocortisone butyrate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortisone butyrate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
15000,ilaprazole,potassium-transporting atpase,transporter,INHIBITOR,Drug: ilaprazole | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
15001,ivermectin,d(1a) dopamine receptor,gpcr,,Drug: ivermectin | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
15002,ivermectin,alpha-2a adrenergic receptor,gpcr,,Drug: ivermectin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15003,ivermectin,multidrug resistance protein 1,transporter,,Drug: ivermectin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
15004,ivermectin,sodium-dependent noradrenaline transporter,transporter,,Drug: ivermectin | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
15005,ivermectin,d(3) dopamine receptor,gpcr,,Drug: ivermectin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
15006,ivermectin,muscarinic acetylcholine receptor m1,gpcr,,Drug: ivermectin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
15007,ivermectin,muscarinic acetylcholine receptor m3,gpcr,,Drug: ivermectin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
15008,ivermectin,muscarinic acetylcholine receptor m5,gpcr,,Drug: ivermectin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
15009,ivermectin,alpha-2c adrenergic receptor,gpcr,,Drug: ivermectin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
15010,ivermectin,sodium-dependent dopamine transporter,transporter,,Drug: ivermectin | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
15011,ivermectin,adenosine receptor a3,gpcr,,Drug: ivermectin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
15012,ivermectin,neuronal acetylcholine receptor subunit alpha-7,ion channel,ALLOSTERIC MODULATOR,Drug: ivermectin | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: ALLOSTERIC MODULATOR
15013,ivermectin,bile acid receptor,nuclear hormone receptor,,Drug: ivermectin | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
15014,ivermectin,glycine receptor,ion channel,AGONIST,Drug: ivermectin | Target: glycine receptor | Type: ion channel | Action: AGONIST
15015,ivermectin,glutamate-gated chloride channel,ion channel,MODULATOR,Drug: ivermectin | Target: glutamate-gated chloride channel | Type: ion channel | Action: MODULATOR
15016,ivermectin,glutamate-gated chloride channel,ion channel,MODULATOR,Drug: ivermectin | Target: glutamate-gated chloride channel | Type: ion channel | Action: MODULATOR
15017,ivermectin,sarcoplasmic/endoplasmic reticulum calcium atpase 2,enzyme,,Drug: ivermectin | Target: sarcoplasmic/endoplasmic reticulum calcium atpase 2 | Type: enzyme | Action: nan
15018,ivermectin,sodium/potassium-transporting atpase subunit alpha-1,enzyme,,Drug: ivermectin | Target: sodium/potassium-transporting atpase subunit alpha-1 | Type: enzyme | Action: nan
15019,ivermectin,sarcoplasmic/endoplasmic reticulum calcium atpase 1,enzyme,,Drug: ivermectin | Target: sarcoplasmic/endoplasmic reticulum calcium atpase 1 | Type: enzyme | Action: nan
15020,ivermectin,p2x purinoceptor 4,unclassified,ALLOSTERIC MODULATOR,Drug: ivermectin | Target: p2x purinoceptor 4 | Type: unclassified | Action: ALLOSTERIC MODULATOR
15021,kinetin,endochitinase,enzyme,,Drug: kinetin | Target: endochitinase | Type: enzyme | Action: nan
15022,kojic acid,tyrosinase,enzyme,,Drug: kojic acid | Target: tyrosinase | Type: enzyme | Action: nan
15023,kojic acid,polyphenol oxidase 2,enzyme,,Drug: kojic acid | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
15024,kojic acid,d-amino-acid oxidase,enzyme,,Drug: kojic acid | Target: d-amino-acid oxidase | Type: enzyme | Action: nan
15025,kojic acid,d-amino-acid oxidase,unclassified,,Drug: kojic acid | Target: d-amino-acid oxidase | Type: unclassified | Action: nan
15026,kojic acid,tyrosinase,enzyme,,Drug: kojic acid | Target: tyrosinase | Type: enzyme | Action: nan
15027,kojic acid,polymerase acidic protein,enzyme,,Drug: kojic acid | Target: polymerase acidic protein | Type: enzyme | Action: nan
15028,kojic acid,tyrosinase,unclassified,,Drug: kojic acid | Target: tyrosinase | Type: unclassified | Action: nan
15029,kojic acid,polymerase acidic protein,unclassified,,Drug: kojic acid | Target: polymerase acidic protein | Type: unclassified | Action: nan
15030,kojic acid,polyphenol oxidase 1,enzyme,,Drug: kojic acid | Target: polyphenol oxidase 1 | Type: enzyme | Action: nan
15031,meldonium,gamma-butyrobetaine dioxygenase,enzyme,,Drug: meldonium | Target: gamma-butyrobetaine dioxygenase | Type: enzyme | Action: nan
15032,octanoic acid,g-protein coupled receptor 84,gpcr,,Drug: octanoic acid | Target: g-protein coupled receptor 84 | Type: gpcr | Action: nan
15033,octanoic acid,g-protein coupled receptor 84,gpcr,,Drug: octanoic acid | Target: g-protein coupled receptor 84 | Type: gpcr | Action: nan
15034,niperotidine,histamine h2 receptor,gpcr,ANTAGONIST,Drug: niperotidine | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
15035,mozavaptan,vasopressin v1a receptor,gpcr,,Drug: mozavaptan | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
15036,mozavaptan,vasopressin v1b receptor,gpcr,ANTAGONIST,Drug: mozavaptan | Target: vasopressin v1b receptor | Type: gpcr | Action: ANTAGONIST
15037,mozavaptan,oxytocin receptor,gpcr,,Drug: mozavaptan | Target: oxytocin receptor | Type: gpcr | Action: nan
15038,mozavaptan,vasopressin v2 receptor,gpcr,,Drug: mozavaptan | Target: vasopressin v2 receptor | Type: gpcr | Action: nan
15039,mozavaptan,vasopressin v1a receptor,gpcr,,Drug: mozavaptan | Target: vasopressin v1a receptor | Type: gpcr | Action: nan
15040,mozavaptan,vasopressin v1 receptor,gpcr,,Drug: mozavaptan | Target: vasopressin v1 receptor | Type: gpcr | Action: nan
15041,mozavaptan,vasopressin v2 receptor,gpcr,ANTAGONIST,Drug: mozavaptan | Target: vasopressin v2 receptor | Type: gpcr | Action: ANTAGONIST
15042,oxitriptan,5-hydroxytryptamine receptor 1a,gpcr,,Drug: oxitriptan | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
15043,oxitriptan,5-hydroxytryptamine receptor 2a,gpcr,,Drug: oxitriptan | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
15044,oxitriptan,5-hydroxytryptamine receptor 2b,gpcr,,Drug: oxitriptan | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
15045,oxitriptan,5-hydroxytryptamine receptor 2c,gpcr,,Drug: oxitriptan | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
15046,oxitriptan,5-hydroxytryptamine receptor 7,gpcr,,Drug: oxitriptan | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
15047,spaglumic acid,metabotropic glutamate receptor 3,gpcr,AGONIST,Drug: spaglumic acid | Target: metabotropic glutamate receptor 3 | Type: gpcr | Action: AGONIST
15048,baicalin,cyclin-dependent kinase 1,kinase,,Drug: baicalin | Target: cyclin-dependent kinase 1 | Type: kinase | Action: nan
15049,baicalin,prolyl endopeptidase,enzyme,,Drug: baicalin | Target: prolyl endopeptidase | Type: enzyme | Action: nan
15050,baicalin,lysine-specific histone demethylase 1a,enzyme,,Drug: baicalin | Target: lysine-specific histone demethylase 1a | Type: enzyme | Action: nan
15051,baicalin,gaba-a receptor; anion channel,ion channel,,Drug: baicalin | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
15053,timolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: timolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
15054,timolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: timolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
15055,timolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: timolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
15056,timolol,beta-3 adrenergic receptor,gpcr,,Drug: timolol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
15057,timolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: timolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
15058,timolol,beta-2 adrenergic receptor,gpcr,,Drug: timolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
15059,timolol,beta-1 adrenergic receptor,gpcr,,Drug: timolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
15060,tirilazad,beta-2 adrenergic receptor,gpcr,,Drug: tirilazad | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
15061,tirilazad,5-hydroxytryptamine receptor 2a,gpcr,,Drug: tirilazad | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
15062,tirilazad,5-hydroxytryptamine receptor 2b,gpcr,,Drug: tirilazad | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
15063,tirilazad,5-hydroxytryptamine receptor 2c,gpcr,,Drug: tirilazad | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
15064,tirilazad,histamine h2 receptor,gpcr,,Drug: tirilazad | Target: histamine h2 receptor | Type: gpcr | Action: nan
15065,tirilazad,alpha-2c adrenergic receptor,gpcr,,Drug: tirilazad | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
15066,tirilazad,epidermal growth factor receptor,kinase,,Drug: tirilazad | Target: epidermal growth factor receptor | Type: kinase | Action: nan
15067,tirilazad,tyrosine-protein kinase lck,kinase,,Drug: tirilazad | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
15068,tirilazad,tyrosine-protein kinase fyn,kinase,,Drug: tirilazad | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
15069,tirilazad,mitogen-activated protein kinase 3,kinase,,Drug: tirilazad | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
15070,tirilazad,mitogen-activated protein kinase 14,kinase,,Drug: tirilazad | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
15071,ascorbic acid,tyrosinase,enzyme,,Drug: ascorbic acid | Target: tyrosinase | Type: enzyme | Action: nan
15072,ascorbic acid,prolyl 4-hydroxylase subunit alpha-1,enzyme,,Drug: ascorbic acid | Target: prolyl 4-hydroxylase subunit alpha-1 | Type: enzyme | Action: nan
15073,ascorbic acid,"procollagen-lysine,2-oxoglutarate 5-dioxygenase 1",enzyme,,"Drug: ascorbic acid | Target: procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 | Type: enzyme | Action: nan"
15074,ascorbic acid,solute carrier family 23 member 2,transporter,,Drug: ascorbic acid | Target: solute carrier family 23 member 2 | Type: transporter | Action: nan
15075,ascorbic acid,solute carrier family 23 member 1,transporter,,Drug: ascorbic acid | Target: solute carrier family 23 member 1 | Type: transporter | Action: nan
15076,ascorbic acid,pancreatic alpha-amylase,enzyme,,Drug: ascorbic acid | Target: pancreatic alpha-amylase | Type: enzyme | Action: nan
15077,minodronic acid,farnesyl pyrophosphate synthase,enzyme,,Drug: minodronic acid | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
15078,minodronic acid,geranylgeranyl pyrophosphate synthase,enzyme,,Drug: minodronic acid | Target: geranylgeranyl pyrophosphate synthase | Type: enzyme | Action: nan
15079,minodronic acid,farnesyl diphosphate synthase,enzyme,,Drug: minodronic acid | Target: farnesyl diphosphate synthase | Type: enzyme | Action: nan
15080,minodronic acid,geranylgeranyl pyrophosphate synthase,enzyme,,Drug: minodronic acid | Target: geranylgeranyl pyrophosphate synthase | Type: enzyme | Action: nan
15081,levamlodipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: levamlodipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
15082,sucralfate,pepsin a-5,enzyme,INHIBITOR,Drug: sucralfate | Target: pepsin a-5 | Type: enzyme | Action: INHIBITOR
15083,dronabinol,cannabinoid receptor 1,gpcr,AGONIST,Drug: dronabinol | Target: cannabinoid receptor 1 | Type: gpcr | Action: AGONIST
15084,dronabinol,d(3) dopamine receptor,gpcr,,Drug: dronabinol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
15085,dronabinol,glycine receptor subunit alpha-1,ion channel,,Drug: dronabinol | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
15086,dronabinol,glycine receptor subunit alpha-2,ion channel,ALLOSTERIC MODULATOR,Drug: dronabinol | Target: glycine receptor subunit alpha-2 | Type: ion channel | Action: ALLOSTERIC MODULATOR
15087,dronabinol,cannabinoid receptor 2,gpcr,,Drug: dronabinol | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
15088,dronabinol,glycine receptor subunit alpha-3,ion channel,ALLOSTERIC MODULATOR,Drug: dronabinol | Target: glycine receptor subunit alpha-3 | Type: ion channel | Action: ALLOSTERIC MODULATOR
15089,dronabinol,n-arachidonyl glycine receptor,gpcr,,Drug: dronabinol | Target: n-arachidonyl glycine receptor | Type: gpcr | Action: nan
15090,dronabinol,transient receptor potential cation channel subfamily a member 1,ion channel,ACTIVATOR,Drug: dronabinol | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: ACTIVATOR
15091,dronabinol,cannabinoid receptor 1,gpcr,,Drug: dronabinol | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
15092,dronabinol,cannabinoid receptor 2,gpcr,,Drug: dronabinol | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
15093,dronabinol,cannabinoid receptor 1,gpcr,,Drug: dronabinol | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
15094,dronabinol,g-protein coupled receptor 55,gpcr,,Drug: dronabinol | Target: g-protein coupled receptor 55 | Type: gpcr | Action: nan
15095,dronabinol,cannabinoid receptor,gpcr,,Drug: dronabinol | Target: cannabinoid receptor | Type: gpcr | Action: nan
15096,dronabinol,cannabinoid receptor,gpcr,,Drug: dronabinol | Target: cannabinoid receptor | Type: gpcr | Action: nan
15097,dronabinol,transient receptor potential cation channel subfamily v member 2,ion channel,ACTIVATOR,Drug: dronabinol | Target: transient receptor potential cation channel subfamily v member 2 | Type: ion channel | Action: ACTIVATOR
15098,tolvaptan,vasopressin v1a receptor,gpcr,ANTAGONIST,Drug: tolvaptan | Target: vasopressin v1a receptor | Type: gpcr | Action: ANTAGONIST
15099,tolvaptan,vasopressin v2 receptor,gpcr,ANTAGONIST,Drug: tolvaptan | Target: vasopressin v2 receptor | Type: gpcr | Action: ANTAGONIST
15100,tolvaptan,vasopressin v1a receptor,gpcr,ANTAGONIST,Drug: tolvaptan | Target: vasopressin v1a receptor | Type: gpcr | Action: ANTAGONIST
15101,tolvaptan,vasopressin v2 receptor,gpcr,ANTAGONIST,Drug: tolvaptan | Target: vasopressin v2 receptor | Type: gpcr | Action: ANTAGONIST
15102,besifloxacin,topoisomerase iv,enzyme,INHIBITOR,Drug: besifloxacin | Target: topoisomerase iv | Type: enzyme | Action: INHIBITOR
15103,besifloxacin,dna gyrase,enzyme,INHIBITOR,Drug: besifloxacin | Target: dna gyrase | Type: enzyme | Action: INHIBITOR
15104,dronedarone,thyroid hormone receptor alpha,nuclear hormone receptor,,Drug: dronedarone | Target: thyroid hormone receptor alpha | Type: nuclear hormone receptor | Action: nan
15105,dronedarone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: dronedarone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
15106,dronedarone,voltage-dependent calcium channel gamma-1 subunit,ion channel,,Drug: dronedarone | Target: voltage-dependent calcium channel gamma-1 subunit | Type: ion channel | Action: nan
15107,dronedarone,potassium voltage-gated channel subfamily kqt member 2,ion channel,BLOCKER,Drug: dronedarone | Target: potassium voltage-gated channel subfamily kqt member 2 | Type: ion channel | Action: BLOCKER
15108,dronedarone,potassium voltage-gated channel subfamily a member 5,ion channel,,Drug: dronedarone | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: nan
15109,dronedarone,thap domain-containing protein 1,unclassified,,Drug: dronedarone | Target: thap domain-containing protein 1 | Type: unclassified | Action: nan
15110,dronedarone,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1,ion channel,BLOCKER,Drug: dronedarone | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1 | Type: ion channel | Action: BLOCKER
15111,dronedarone,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2,ion channel,BLOCKER,Drug: dronedarone | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 2 | Type: ion channel | Action: BLOCKER
15112,dronedarone,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3,ion channel,BLOCKER,Drug: dronedarone | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 3 | Type: ion channel | Action: BLOCKER
15113,dronedarone,potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4,ion channel,BLOCKER,Drug: dronedarone | Target: potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 | Type: ion channel | Action: BLOCKER
15114,prasugrel,p2y purinoceptor 12,gpcr,ANTAGONIST,Drug: prasugrel | Target: p2y purinoceptor 12 | Type: gpcr | Action: ANTAGONIST
15115,saxagliptin,cytochrome p450 3a4,enzyme,,Drug: saxagliptin | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
15116,saxagliptin,multidrug resistance protein 1,transporter,,Drug: saxagliptin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
15117,saxagliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: saxagliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
15118,saxagliptin,dipeptidyl peptidase 8,enzyme,,Drug: saxagliptin | Target: dipeptidyl peptidase 8 | Type: enzyme | Action: nan
15119,saxagliptin,dipeptidyl peptidase 9,enzyme,,Drug: saxagliptin | Target: dipeptidyl peptidase 9 | Type: enzyme | Action: nan
15120,asenapine,beta-1 adrenergic receptor,gpcr,,Drug: asenapine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
15121,asenapine,beta-2 adrenergic receptor,gpcr,,Drug: asenapine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
15122,asenapine,d(1a) dopamine receptor,gpcr,,Drug: asenapine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
15123,asenapine,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: asenapine | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
15124,asenapine,alpha-2a adrenergic receptor,gpcr,,Drug: asenapine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15125,asenapine,5-hydroxytryptamine receptor 1a,gpcr,,Drug: asenapine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
15126,asenapine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: asenapine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
15127,asenapine,5-hydroxytryptamine receptor 2b,gpcr,,Drug: asenapine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
15128,asenapine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: asenapine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
15129,asenapine,5-hydroxytryptamine receptor 6,gpcr,,Drug: asenapine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
15130,asenapine,5-hydroxytryptamine receptor 7,gpcr,,Drug: asenapine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
15131,asenapine,alpha-1a adrenergic receptor,gpcr,,Drug: asenapine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
15132,asenapine,alpha-2b adrenergic receptor,gpcr,,Drug: asenapine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
15133,asenapine,d(3) dopamine receptor,gpcr,,Drug: asenapine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
15134,asenapine,d(1b) dopamine receptor,gpcr,,Drug: asenapine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
15135,asenapine,histamine h1 receptor,gpcr,,Drug: asenapine | Target: histamine h1 receptor | Type: gpcr | Action: nan
15136,asenapine,histamine h2 receptor,gpcr,,Drug: asenapine | Target: histamine h2 receptor | Type: gpcr | Action: nan
15137,asenapine,muscarinic acetylcholine receptor m1,gpcr,,Drug: asenapine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
15138,asenapine,muscarinic acetylcholine receptor m2,gpcr,,Drug: asenapine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
15139,asenapine,muscarinic acetylcholine receptor m3,gpcr,,Drug: asenapine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
15140,asenapine,muscarinic acetylcholine receptor m5,gpcr,,Drug: asenapine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
15141,asenapine,5-hydroxytryptamine receptor 1b,gpcr,,Drug: asenapine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
15142,asenapine,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: asenapine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
15143,asenapine,alpha-2c adrenergic receptor,gpcr,,Drug: asenapine | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
15144,asenapine,sodium-dependent dopamine transporter,transporter,,Drug: asenapine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
15145,asenapine,d(4) dopamine receptor,gpcr,,Drug: asenapine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
15146,asenapine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: asenapine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
15147,asenapine,alpha-1b adrenergic receptor,gpcr,,Drug: asenapine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
15148,asenapine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: asenapine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
15149,asenapine,5-hydroxytryptamine receptor 1e,gpcr,AGONIST,Drug: asenapine | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: AGONIST
15150,pralatrexate,dihydrofolate reductase,enzyme,INHIBITOR,Drug: pralatrexate | Target: dihydrofolate reductase | Type: enzyme | Action: INHIBITOR
15151,pralatrexate,proton-coupled folate transporter,transporter,,Drug: pralatrexate | Target: proton-coupled folate transporter | Type: transporter | Action: nan
15152,pralatrexate,folate transporter 1,transporter,,Drug: pralatrexate | Target: folate transporter 1 | Type: transporter | Action: nan
15153,pralatrexate,folate receptor alpha,membrane receptor,,Drug: pralatrexate | Target: folate receptor alpha | Type: membrane receptor | Action: nan
15154,pazopanib,tyrosine-protein kinase jak3,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
15155,pazopanib,acetylcholinesterase,enzyme,,Drug: pazopanib | Target: acetylcholinesterase | Type: enzyme | Action: nan
15156,pazopanib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: pazopanib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
15157,pazopanib,tyrosine-protein kinase abl1,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
15158,pazopanib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: pazopanib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
15159,pazopanib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: pazopanib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
15160,pazopanib,tyrosine-protein kinase lck,kinase,INHIBITOR,Drug: pazopanib | Target: tyrosine-protein kinase lck | Type: kinase | Action: INHIBITOR
15161,pazopanib,tyrosine-protein kinase yes,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
15162,pazopanib,tyrosine-protein kinase fyn,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
15163,pazopanib,raf proto-oncogene serine/threonine-protein kinase,kinase,,Drug: pazopanib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: nan
15164,pazopanib,serine/threonine-protein kinase b-raf,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
15165,pazopanib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: pazopanib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
15166,pazopanib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: pazopanib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
15167,pazopanib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: pazopanib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
15168,pazopanib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: pazopanib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
15169,pazopanib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: pazopanib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
15170,pazopanib,macrophage colony-stimulating factor 1 receptor,kinase,INHIBITOR,Drug: pazopanib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: INHIBITOR
15171,pazopanib,platelet-derived growth factor receptor alpha,kinase,INHIBITOR,Drug: pazopanib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: INHIBITOR
15172,pazopanib,calcium/calmodulin-dependent protein kinase type 1,kinase,,Drug: pazopanib | Target: calcium/calmodulin-dependent protein kinase type 1 | Type: kinase | Action: nan
15173,pazopanib,mitogen-activated protein kinase 8,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
15174,pazopanib,fibroblast growth factor receptor 3,kinase,INHIBITOR,Drug: pazopanib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: INHIBITOR
15175,pazopanib,tyrosine-protein kinase hck,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
15176,pazopanib,mitogen-activated protein kinase 10,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
15177,pazopanib,tyrosine-protein kinase jak2,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
15178,pazopanib,tyrosine-protein kinase syk,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
15179,pazopanib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: pazopanib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
15180,pazopanib,angiopoietin-1 receptor,kinase,,Drug: pazopanib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
15181,pazopanib,ap2-associated protein kinase 1,kinase,,Drug: pazopanib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
15182,pazopanib,hepatocyte growth factor receptor,kinase,,Drug: pazopanib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
15183,pazopanib,tyrosine-protein kinase lyn,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
15184,pazopanib,serine/threonine-protein kinase nek2,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase nek2 | Type: kinase | Action: nan
15185,pazopanib,lim domain kinase 1,kinase,,Drug: pazopanib | Target: lim domain kinase 1 | Type: kinase | Action: nan
15186,pazopanib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: pazopanib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
15187,pazopanib,serine/threonine-protein kinase 10,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
15188,pazopanib,tyrosine-protein kinase fer,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
15189,pazopanib,serine/threonine-protein kinase plk4,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
15190,pazopanib,aurora kinase c,kinase,,Drug: pazopanib | Target: aurora kinase c | Type: kinase | Action: nan
15191,pazopanib,serine/threonine-protein kinase 16,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase 16 | Type: kinase | Action: nan
15192,pazopanib,dual specificity protein kinase ttk,kinase,,Drug: pazopanib | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
15193,pazopanib,abelson tyrosine-protein kinase 2,kinase,,Drug: pazopanib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
15194,pazopanib,fibroblast growth factor receptor 2,kinase,,Drug: pazopanib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
15195,pazopanib,traf2 and nck-interacting protein kinase,kinase,,Drug: pazopanib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
15196,pazopanib,tyrosine-protein kinase fgr,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
15197,pazopanib,aurora kinase a,kinase,,Drug: pazopanib | Target: aurora kinase a | Type: kinase | Action: nan
15198,pazopanib,alk tyrosine kinase receptor,kinase,,Drug: pazopanib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
15199,pazopanib,serine/threonine-protein kinase 36,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase 36 | Type: kinase | Action: nan
15200,pazopanib,bmp-2-inducible protein kinase,kinase,,Drug: pazopanib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
15201,pazopanib,tyrosine-protein kinase frk,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
15202,pazopanib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
15203,pazopanib,cyclin-g-associated kinase,kinase,,Drug: pazopanib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
15204,pazopanib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: pazopanib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
15205,pazopanib,cyclin-dependent kinase 16,kinase,,Drug: pazopanib | Target: cyclin-dependent kinase 16 | Type: kinase | Action: nan
15206,pazopanib,ste20-like serine/threonine-protein kinase,kinase,,Drug: pazopanib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
15207,pazopanib,map/microtubule affinity-regulating kinase 3,kinase,,Drug: pazopanib | Target: map/microtubule affinity-regulating kinase 3 | Type: kinase | Action: nan
15208,pazopanib,calcium/calmodulin-dependent protein kinase type 1g,kinase,,Drug: pazopanib | Target: calcium/calmodulin-dependent protein kinase type 1g | Type: kinase | Action: nan
15209,pazopanib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: pazopanib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
15210,pazopanib,tgf-beta receptor type-2,kinase,,Drug: pazopanib | Target: tgf-beta receptor type-2 | Type: kinase | Action: nan
15211,pazopanib,tyrosine-protein kinase itk/tsk,kinase,INHIBITOR,Drug: pazopanib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: INHIBITOR
15212,pazopanib,protein-tyrosine kinase 6,kinase,,Drug: pazopanib | Target: protein-tyrosine kinase 6 | Type: kinase | Action: nan
15213,pazopanib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: pazopanib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
15214,pazopanib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: pazopanib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
15215,pazopanib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
15216,pazopanib,tyrosine-protein kinase txk,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
15217,pazopanib,lim domain kinase 2,kinase,,Drug: pazopanib | Target: lim domain kinase 2 | Type: kinase | Action: nan
15218,pazopanib,serine/threonine-protein kinase nlk,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase nlk | Type: kinase | Action: nan
15219,pazopanib,interleukin-1 receptor-associated kinase 3,kinase,,Drug: pazopanib | Target: interleukin-1 receptor-associated kinase 3 | Type: kinase | Action: nan
15220,pazopanib,serine/threonine-protein kinase sik2,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
15221,pazopanib,activin receptor type-2b,kinase,,Drug: pazopanib | Target: activin receptor type-2b | Type: kinase | Action: nan
15222,pazopanib,discoidin domain-containing receptor 2,kinase,,Drug: pazopanib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
15223,pazopanib,leukocyte tyrosine kinase receptor,kinase,,Drug: pazopanib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
15224,pazopanib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
15225,pazopanib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
15226,pazopanib,tyrosine-protein kinase blk,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
15227,pazopanib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
15228,pazopanib,dual specificity mitogen-activated protein kinase kinase 4,kinase,,Drug: pazopanib | Target: dual specificity mitogen-activated protein kinase kinase 4 | Type: kinase | Action: nan
15229,pazopanib,dual specificity mitogen-activated protein kinase kinase 6,kinase,,Drug: pazopanib | Target: dual specificity mitogen-activated protein kinase kinase 6 | Type: kinase | Action: nan
15230,pazopanib,tyrosine-protein kinase mer,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
15231,pazopanib,cyclin-dependent kinase 11b,kinase,,Drug: pazopanib | Target: cyclin-dependent kinase 11b | Type: kinase | Action: nan
15232,pazopanib,cyclin-dependent kinase 11a,kinase,,Drug: pazopanib | Target: cyclin-dependent kinase 11a | Type: kinase | Action: nan
15233,pazopanib,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
15234,pazopanib,mitogen-activated protein kinase kinase kinase 10,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase 10 | Type: kinase | Action: nan
15235,pazopanib,mitogen-activated protein kinase kinase kinase 11,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase 11 | Type: kinase | Action: nan
15236,pazopanib,serine/threonine-protein kinase nek5,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase nek5 | Type: kinase | Action: nan
15237,pazopanib,serine/threonine-protein kinase sik1,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
15238,pazopanib,tyrosine-protein kinase srms,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase srms | Type: kinase | Action: nan
15239,pazopanib,"interferon-induced, double-stranded rna-activated protein kinase",kinase,,"Drug: pazopanib | Target: interferon-induced, double-stranded rna-activated protein kinase | Type: kinase | Action: nan"
15240,pazopanib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: pazopanib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
15241,pazopanib,tyrosine-protein kinase fes/fps,kinase,,Drug: pazopanib | Target: tyrosine-protein kinase fes/fps | Type: kinase | Action: nan
15242,pazopanib,fibroblast growth factor receptor 4,kinase,,Drug: pazopanib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: nan
15243,pazopanib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: pazopanib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
15244,pazopanib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
15245,pazopanib,ephrin type-b receptor 6,kinase,,Drug: pazopanib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
15246,pazopanib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: pazopanib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
15247,pazopanib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
15248,pazopanib,serine/threonine-protein kinase rio2,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase rio2 | Type: kinase | Action: nan
15249,pazopanib,serine/threonine-protein kinase tao1,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
15250,pazopanib,serine/threonine-protein kinase tao3,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
15251,pazopanib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
15252,pazopanib,mitogen-activated protein kinase kinase kinase 1,kinase,,Drug: pazopanib | Target: mitogen-activated protein kinase kinase kinase 1 | Type: kinase | Action: nan
15253,pazopanib,phosphatidylinositol 4-kinase beta,kinase,,Drug: pazopanib | Target: phosphatidylinositol 4-kinase beta | Type: kinase | Action: nan
15254,pazopanib,bone morphogenetic protein receptor type-1b,kinase,,Drug: pazopanib | Target: bone morphogenetic protein receptor type-1b | Type: kinase | Action: nan
15255,pazopanib,phosphatidylinositol 4-phosphate 5-kinase type-1 gamma,kinase,,Drug: pazopanib | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 gamma | Type: kinase | Action: nan
15256,pazopanib,serine/threonine-protein kinase tao2,kinase,,Drug: pazopanib | Target: serine/threonine-protein kinase tao2 | Type: kinase | Action: nan
15257,pazopanib,phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,kinase,,Drug: pazopanib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Type: kinase | Action: nan
15258,pazopanib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: pazopanib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
15259,pazopanib,calcium-dependent protein kinase 1,kinase,,Drug: pazopanib | Target: calcium-dependent protein kinase 1 | Type: kinase | Action: nan
15260,romidepsin,histone deacetylase 5,enzyme,INHIBITOR,Drug: romidepsin | Target: histone deacetylase 5 | Type: enzyme | Action: INHIBITOR
15261,romidepsin,histone deacetylase 2,enzyme,,Drug: romidepsin | Target: histone deacetylase 2 | Type: enzyme | Action: nan
15262,romidepsin,histone deacetylase 1,enzyme,,Drug: romidepsin | Target: histone deacetylase 1 | Type: enzyme | Action: nan
15263,romidepsin,histone deacetylase 3,enzyme,,Drug: romidepsin | Target: histone deacetylase 3 | Type: enzyme | Action: nan
15264,romidepsin,histone deacetylase 6,enzyme,,Drug: romidepsin | Target: histone deacetylase 6 | Type: enzyme | Action: nan
15265,romidepsin,histone deacetylase 7,enzyme,INHIBITOR,Drug: romidepsin | Target: histone deacetylase 7 | Type: enzyme | Action: INHIBITOR
15266,romidepsin,histone deacetylase 8,enzyme,INHIBITOR,Drug: romidepsin | Target: histone deacetylase 8 | Type: enzyme | Action: INHIBITOR
15267,romidepsin,histone deacetylase 4,enzyme,,Drug: romidepsin | Target: histone deacetylase 4 | Type: enzyme | Action: nan
15268,romidepsin,histone deacetylase 9,enzyme,INHIBITOR,Drug: romidepsin | Target: histone deacetylase 9 | Type: enzyme | Action: INHIBITOR
15269,romidepsin,bromodomain-containing protein 4,unclassified,,Drug: romidepsin | Target: bromodomain-containing protein 4 | Type: unclassified | Action: nan
15270,romidepsin,histone deacetylase 3/nuclear receptor corepressor 2 (hdac3/ncor2),transcription factor,,Drug: romidepsin | Target: histone deacetylase 3/nuclear receptor corepressor 2 (hdac3/ncor2) | Type: transcription factor | Action: nan
15271,romidepsin,histone deacetylase 3/ncor1,transcription factor,,Drug: romidepsin | Target: histone deacetylase 3/ncor1 | Type: transcription factor | Action: nan
15272,romidepsin,histone deacetylase 6,enzyme,,Drug: romidepsin | Target: histone deacetylase 6 | Type: enzyme | Action: nan
15273,romidepsin,histone deacetylase,enzyme,INHIBITOR,Drug: romidepsin | Target: histone deacetylase | Type: enzyme | Action: INHIBITOR
15274,dexfosfoserine,metabotropic glutamate receptor 4,gpcr,,Drug: dexfosfoserine | Target: metabotropic glutamate receptor 4 | Type: gpcr | Action: nan
15275,dexfosfoserine,metabotropic glutamate receptor 7,gpcr,AGONIST,Drug: dexfosfoserine | Target: metabotropic glutamate receptor 7 | Type: gpcr | Action: AGONIST
15276,dexfosfoserine,metabotropic glutamate receptor 6,gpcr,AGONIST,Drug: dexfosfoserine | Target: metabotropic glutamate receptor 6 | Type: gpcr | Action: AGONIST
15277,dexfosfoserine,metabotropic glutamate receptor 8,gpcr,AGONIST,Drug: dexfosfoserine | Target: metabotropic glutamate receptor 8 | Type: gpcr | Action: AGONIST
15278,dexfosfoserine,metabotropic glutamate receptor 4,gpcr,,Drug: dexfosfoserine | Target: metabotropic glutamate receptor 4 | Type: gpcr | Action: nan
15279,dexfosfoserine,metabotropic glutamate receptor 6,gpcr,,Drug: dexfosfoserine | Target: metabotropic glutamate receptor 6 | Type: gpcr | Action: nan
15280,auranofin,alpha-2a adrenergic receptor,gpcr,,Drug: auranofin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15281,auranofin,alpha-2b adrenergic receptor,gpcr,,Drug: auranofin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
15282,auranofin,d(3) dopamine receptor,gpcr,,Drug: auranofin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
15283,auranofin,glucocorticoid receptor,nuclear hormone receptor,,Drug: auranofin | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
15284,auranofin,adenosine receptor a3,gpcr,,Drug: auranofin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
15285,auranofin,d(4) dopamine receptor,gpcr,,Drug: auranofin | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
15286,auranofin,arachidonate 5-lipoxygenase,enzyme,,Drug: auranofin | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
15287,auranofin,"thioredoxin reductase 1, cytoplasmic",enzyme,,"Drug: auranofin | Target: thioredoxin reductase 1, cytoplasmic | Type: enzyme | Action: nan"
15288,auranofin,tyrosine-protein kinase fyn,kinase,,Drug: auranofin | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
15289,auranofin,transient receptor potential cation channel subfamily a member 1,ion channel,ACTIVATOR,Drug: auranofin | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: ACTIVATOR
15290,lubiprostone,chloride channel protein 2,ion channel,OPENER,Drug: lubiprostone | Target: chloride channel protein 2 | Type: ion channel | Action: OPENER
15291,vorinostat,histone deacetylase 5,enzyme,,Drug: vorinostat | Target: histone deacetylase 5 | Type: enzyme | Action: nan
15292,vorinostat,histone deacetylase 2,enzyme,INHIBITOR,Drug: vorinostat | Target: histone deacetylase 2 | Type: enzyme | Action: INHIBITOR
15293,vorinostat,histone deacetylase 1,enzyme,INHIBITOR,Drug: vorinostat | Target: histone deacetylase 1 | Type: enzyme | Action: INHIBITOR
15294,vorinostat,histone deacetylase 3,enzyme,INHIBITOR,Drug: vorinostat | Target: histone deacetylase 3 | Type: enzyme | Action: INHIBITOR
15295,vorinostat,histone deacetylase 6,enzyme,INHIBITOR,Drug: vorinostat | Target: histone deacetylase 6 | Type: enzyme | Action: INHIBITOR
15296,vorinostat,histone deacetylase 7,enzyme,,Drug: vorinostat | Target: histone deacetylase 7 | Type: enzyme | Action: nan
15297,vorinostat,histone deacetylase 8,enzyme,,Drug: vorinostat | Target: histone deacetylase 8 | Type: enzyme | Action: nan
15298,vorinostat,histone deacetylase 4,enzyme,,Drug: vorinostat | Target: histone deacetylase 4 | Type: enzyme | Action: nan
15299,vorinostat,histone deacetylase 9,enzyme,,Drug: vorinostat | Target: histone deacetylase 9 | Type: enzyme | Action: nan
15300,vorinostat,leukotriene a-4 hydrolase,enzyme,,Drug: vorinostat | Target: leukotriene a-4 hydrolase | Type: enzyme | Action: nan
15301,vorinostat,histone deacetylase 10,enzyme,,Drug: vorinostat | Target: histone deacetylase 10 | Type: enzyme | Action: nan
15302,vorinostat,hd2 type histone deacetylase hda106; histone deacetylase 2b; uncharacterized protein,enzyme,,Drug: vorinostat | Target: hd2 type histone deacetylase hda106; histone deacetylase 2b; uncharacterized protein | Type: enzyme | Action: nan
15303,vorinostat,histone deacetylase 1,enzyme,,Drug: vorinostat | Target: histone deacetylase 1 | Type: enzyme | Action: nan
15304,vorinostat,histone deacetylase,enzyme,,Drug: vorinostat | Target: histone deacetylase | Type: enzyme | Action: nan
15305,vorinostat,histone deacetylase,enzyme,,Drug: vorinostat | Target: histone deacetylase | Type: enzyme | Action: nan
15306,vorinostat,histone deacetylase-like amidohydrolase,enzyme,,Drug: vorinostat | Target: histone deacetylase-like amidohydrolase | Type: enzyme | Action: nan
15307,vorinostat,histone deacetylase 11,enzyme,,Drug: vorinostat | Target: histone deacetylase 11 | Type: enzyme | Action: nan
15308,vorinostat,histone deacetylase,enzyme,,Drug: vorinostat | Target: histone deacetylase | Type: enzyme | Action: nan
15309,vorinostat,lysine-specific demethylase 4e,enzyme,,Drug: vorinostat | Target: lysine-specific demethylase 4e | Type: enzyme | Action: nan
15310,vorinostat,bromodomain-containing protein 4,unclassified,,Drug: vorinostat | Target: bromodomain-containing protein 4 | Type: unclassified | Action: nan
15311,vorinostat,histone deacetylase 3/nuclear receptor corepressor 2 (hdac3/ncor2),transcription factor,,Drug: vorinostat | Target: histone deacetylase 3/nuclear receptor corepressor 2 (hdac3/ncor2) | Type: transcription factor | Action: nan
15312,vorinostat,histone deacetylase 3/ncor1,transcription factor,,Drug: vorinostat | Target: histone deacetylase 3/ncor1 | Type: transcription factor | Action: nan
15313,vorinostat,histone deacetylase,enzyme,,Drug: vorinostat | Target: histone deacetylase | Type: enzyme | Action: nan
15314,vorinostat,histone deacetylase 1/3/5/8,enzyme,,Drug: vorinostat | Target: histone deacetylase 1/3/5/8 | Type: enzyme | Action: nan
15315,vorinostat,histone deacetylase (hdac1 and hdac2),enzyme,,Drug: vorinostat | Target: histone deacetylase (hdac1 and hdac2) | Type: enzyme | Action: nan
15316,vorinostat,histone deacetylase,enzyme,,Drug: vorinostat | Target: histone deacetylase | Type: enzyme | Action: nan
15317,vorinostat,histone deacetylase 8,unclassified,,Drug: vorinostat | Target: histone deacetylase 8 | Type: unclassified | Action: nan
15318,vorinostat,leukotriene a-4 hydrolase,enzyme,,Drug: vorinostat | Target: leukotriene a-4 hydrolase | Type: enzyme | Action: nan
15319,proline,angiotensin-converting enzyme,enzyme,,Drug: proline | Target: angiotensin-converting enzyme | Type: enzyme | Action: nan
15320,proline,"glutamate receptor ionotropic, nmda 1",ion channel,,"Drug: proline | Target: glutamate receptor ionotropic, nmda 1 | Type: ion channel | Action: nan"
15321,asparagine,amino acid transporter,transporter,,Drug: asparagine | Target: amino acid transporter | Type: transporter | Action: nan
15322,serine,acetylcholinesterase,enzyme,,Drug: serine | Target: acetylcholinesterase | Type: enzyme | Action: nan
15323,serine,cholinesterase,enzyme,,Drug: serine | Target: cholinesterase | Type: enzyme | Action: nan
15324,serine,gamma-glutamyltranspeptidase 1,enzyme,,Drug: serine | Target: gamma-glutamyltranspeptidase 1 | Type: enzyme | Action: nan
15325,serine,asc-type amino acid transporter 1,unclassified,,Drug: serine | Target: asc-type amino acid transporter 1 | Type: unclassified | Action: nan
15326,serine,amino acid transporter,transporter,,Drug: serine | Target: amino acid transporter | Type: transporter | Action: nan
15327,valine,large neutral amino acids transporter small subunit 1,transporter,,Drug: valine | Target: large neutral amino acids transporter small subunit 1 | Type: transporter | Action: nan
15328,pyridoxal,aldehyde oxidase,enzyme,,Drug: pyridoxal | Target: aldehyde oxidase | Type: enzyme | Action: nan
15329,lisdexamfetamine,sodium-dependent noradrenaline transporter,transporter,RELEASING AGENT,Drug: lisdexamfetamine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: RELEASING AGENT
15330,lisdexamfetamine,sodium-dependent dopamine transporter,transporter,RELEASING AGENT,Drug: lisdexamfetamine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: RELEASING AGENT
15331,lisdexamfetamine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: lisdexamfetamine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
15332,paliperidone,beta-1 adrenergic receptor,gpcr,,Drug: paliperidone | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
15333,paliperidone,beta-2 adrenergic receptor,gpcr,,Drug: paliperidone | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
15334,paliperidone,d(1a) dopamine receptor,gpcr,,Drug: paliperidone | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
15335,paliperidone,alpha-2a adrenergic receptor,gpcr,,Drug: paliperidone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15336,paliperidone,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: paliperidone | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
15337,paliperidone,sodium-dependent serotonin transporter,transporter,,Drug: paliperidone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
15338,paliperidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
15339,paliperidone,5-hydroxytryptamine receptor 2b,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
15340,paliperidone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
15341,paliperidone,5-hydroxytryptamine receptor 6,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
15342,paliperidone,5-hydroxytryptamine receptor 7,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
15343,paliperidone,alpha-1a adrenergic receptor,gpcr,,Drug: paliperidone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
15344,paliperidone,alpha-2b adrenergic receptor,gpcr,,Drug: paliperidone | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
15345,paliperidone,d(3) dopamine receptor,gpcr,,Drug: paliperidone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
15346,paliperidone,d(1b) dopamine receptor,gpcr,,Drug: paliperidone | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
15347,paliperidone,histamine h1 receptor,gpcr,,Drug: paliperidone | Target: histamine h1 receptor | Type: gpcr | Action: nan
15348,paliperidone,histamine h2 receptor,gpcr,,Drug: paliperidone | Target: histamine h2 receptor | Type: gpcr | Action: nan
15349,paliperidone,histamine h4 receptor,gpcr,,Drug: paliperidone | Target: histamine h4 receptor | Type: gpcr | Action: nan
15350,paliperidone,5-hydroxytryptamine receptor 1b,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
15351,paliperidone,5-hydroxytryptamine receptor 1d,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
15352,paliperidone,alpha-2c adrenergic receptor,gpcr,,Drug: paliperidone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
15353,paliperidone,d(4) dopamine receptor,gpcr,,Drug: paliperidone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
15354,paliperidone,alpha-1b adrenergic receptor,gpcr,,Drug: paliperidone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
15355,paliperidone,5-hydroxytryptamine receptor 5a,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
15356,paliperidone,5-hydroxytryptamine receptor 1e,gpcr,,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 1e | Type: gpcr | Action: nan
15357,paliperidone,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: paliperidone | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
15358,paliperidone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: paliperidone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
15359,paliperidone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: paliperidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
15360,gentian violet,mu-type opioid receptor,gpcr,,Drug: gentian violet | Target: mu-type opioid receptor | Type: gpcr | Action: nan
15361,gentian violet,d(1a) dopamine receptor,gpcr,,Drug: gentian violet | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
15362,gentian violet,d(2) dopamine receptor,gpcr,,Drug: gentian violet | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
15363,gentian violet,adenosine receptor a2a,gpcr,,Drug: gentian violet | Target: adenosine receptor a2a | Type: gpcr | Action: nan
15364,gentian violet,alpha-2a adrenergic receptor,gpcr,,Drug: gentian violet | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15365,gentian violet,cytochrome p450 3a4,enzyme,,Drug: gentian violet | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
15366,gentian violet,5-hydroxytryptamine receptor 2a,gpcr,,Drug: gentian violet | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
15367,gentian violet,alpha-2b adrenergic receptor,gpcr,,Drug: gentian violet | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
15368,gentian violet,d(3) dopamine receptor,gpcr,,Drug: gentian violet | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
15369,gentian violet,histamine h2 receptor,gpcr,,Drug: gentian violet | Target: histamine h2 receptor | Type: gpcr | Action: nan
15370,gentian violet,muscarinic acetylcholine receptor m1,gpcr,,Drug: gentian violet | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
15371,gentian violet,muscarinic acetylcholine receptor m2,gpcr,,Drug: gentian violet | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
15372,gentian violet,muscarinic acetylcholine receptor m3,gpcr,,Drug: gentian violet | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
15373,gentian violet,muscarinic acetylcholine receptor m4,gpcr,,Drug: gentian violet | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
15374,gentian violet,muscarinic acetylcholine receptor m5,gpcr,,Drug: gentian violet | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
15375,gentian violet,alpha-2c adrenergic receptor,gpcr,,Drug: gentian violet | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
15376,gentian violet,sodium-dependent dopamine transporter,transporter,,Drug: gentian violet | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
15377,gentian violet,cytochrome p450 2d6,enzyme,,Drug: gentian violet | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
15378,gentian violet,adenosine receptor a3,gpcr,,Drug: gentian violet | Target: adenosine receptor a3 | Type: gpcr | Action: nan
15379,gentian violet,alpha-1d adrenergic receptor,gpcr,,Drug: gentian violet | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
15380,gentian violet,kappa-type opioid receptor,gpcr,,Drug: gentian violet | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
15381,gentian violet,acetylcholinesterase,enzyme,,Drug: gentian violet | Target: acetylcholinesterase | Type: enzyme | Action: nan
15382,gentian violet,epidermal growth factor receptor,kinase,,Drug: gentian violet | Target: epidermal growth factor receptor | Type: kinase | Action: nan
15383,gentian violet,tyrosine-protein kinase fyn,kinase,,Drug: gentian violet | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
15384,gentian violet,substance-k receptor,gpcr,,Drug: gentian violet | Target: substance-k receptor | Type: gpcr | Action: nan
15385,gentian violet,androgen receptor,transcription factor,,Drug: gentian violet | Target: androgen receptor | Type: transcription factor | Action: nan
15386,gentian violet,alpha-1b adrenergic receptor,gpcr,,Drug: gentian violet | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
15387,udenafil,multidrug resistance protein 1,transporter,,Drug: udenafil | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
15388,udenafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: udenafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
15389,sulfadiazine silver,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfadiazine silver | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
15390,sulfadiazine silver,aurora kinase a,kinase,,Drug: sulfadiazine silver | Target: aurora kinase a | Type: kinase | Action: nan
15391,darunavir,multidrug resistance protein 1,transporter,,Drug: darunavir | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
15392,darunavir,gag-pol polyprotein,polyprotein,,Drug: darunavir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
15393,darunavir,pol polyprotein,enzyme,INHIBITOR,Drug: darunavir | Target: pol polyprotein | Type: enzyme | Action: INHIBITOR
15394,darunavir,protease,enzyme,,Drug: darunavir | Target: protease | Type: enzyme | Action: nan
15395,darunavir,protease,unclassified,,Drug: darunavir | Target: protease | Type: unclassified | Action: nan
15397,darunavir,protease,unclassified,,Drug: darunavir | Target: protease | Type: unclassified | Action: nan
15398,sodium lauryl sulfate,bifunctional epoxide hydrolase 2,enzyme,,Drug: sodium lauryl sulfate | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: nan
15400,testosterone propionate,androgen receptor,nuclear hormone receptor,AGONIST,Drug: testosterone propionate | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
15401,testosterone propionate,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,,"Drug: testosterone propionate | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: nan"
15402,testosterone propionate,androgen receptor,transcription factor,,Drug: testosterone propionate | Target: androgen receptor | Type: transcription factor | Action: nan
15403,doripenem,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: doripenem | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
15404,rimonabant,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: rimonabant | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
15405,rimonabant,acetylcholinesterase,enzyme,,Drug: rimonabant | Target: acetylcholinesterase | Type: enzyme | Action: nan
15406,rimonabant,cannabinoid receptor 2,gpcr,,Drug: rimonabant | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
15407,rimonabant,n-arachidonyl glycine receptor,gpcr,,Drug: rimonabant | Target: n-arachidonyl glycine receptor | Type: gpcr | Action: nan
15408,rimonabant,cannabinoid receptor 1,gpcr,,Drug: rimonabant | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
15409,rimonabant,cannabinoid receptor 2,gpcr,,Drug: rimonabant | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
15410,rimonabant,cannabinoid receptor 1,gpcr,,Drug: rimonabant | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
15411,rimonabant,g-protein coupled receptor 55,gpcr,,Drug: rimonabant | Target: g-protein coupled receptor 55 | Type: gpcr | Action: nan
15412,rimonabant,cannabinoid receptor 1,gpcr,ANTAGONIST,Drug: rimonabant | Target: cannabinoid receptor 1 | Type: gpcr | Action: ANTAGONIST
15413,silodosin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: silodosin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
15414,silodosin,multidrug resistance protein 1,transporter,,Drug: silodosin | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
15415,silodosin,alpha-1a adrenergic receptor,gpcr,ANTAGONIST,Drug: silodosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: ANTAGONIST
15416,silodosin,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: silodosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
15417,silodosin,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: silodosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
15418,silodosin,alpha-1a adrenergic receptor,gpcr,,Drug: silodosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
15419,permethrin,sodium channel protein,ion channel,BLOCKER,Drug: permethrin | Target: sodium channel protein | Type: ion channel | Action: BLOCKER
15420,cabazitaxel,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: cabazitaxel | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
15421,edaravone,polyunsaturated fatty acid lipoxygenase alox15,enzyme,,Drug: edaravone | Target: polyunsaturated fatty acid lipoxygenase alox15 | Type: enzyme | Action: nan
15422,lercanidipine,voltage-gated l-type calcium channel,ion channel,BLOCKER,Drug: lercanidipine | Target: voltage-gated l-type calcium channel | Type: ion channel | Action: BLOCKER
15423,temsirolimus,multidrug resistance protein 1,transporter,,Drug: temsirolimus | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
15424,temsirolimus,peptidyl-prolyl cis-trans isomerase fkbp1a,enzyme,INHIBITOR,Drug: temsirolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp1a | Type: enzyme | Action: INHIBITOR
15425,temsirolimus,serine/threonine-protein kinase mtor,kinase,,Drug: temsirolimus | Target: serine/threonine-protein kinase mtor | Type: kinase | Action: nan
15426,temsirolimus,peptidyl-prolyl cis-trans isomerase fkbp3,enzyme,,Drug: temsirolimus | Target: peptidyl-prolyl cis-trans isomerase fkbp3 | Type: enzyme | Action: nan
15427,dexlansoprazole,potassium-transporting atpase,transporter,INHIBITOR,Drug: dexlansoprazole | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
15428,dexlansoprazole,cytosolic endo-beta-n-acetylglucosaminidase,enzyme,,Drug: dexlansoprazole | Target: cytosolic endo-beta-n-acetylglucosaminidase | Type: enzyme | Action: nan
15429,dexlansoprazole,sterile alpha and tir motif-containing protein 1,unclassified,,Drug: dexlansoprazole | Target: sterile alpha and tir motif-containing protein 1 | Type: unclassified | Action: nan
15430,fampridine,voltage-gated potassium channel,ion channel,BLOCKER,Drug: fampridine | Target: voltage-gated potassium channel | Type: ion channel | Action: BLOCKER
15431,fampridine,potassium voltage-gated channel subfamily c member 1,ion channel,BLOCKER,Drug: fampridine | Target: potassium voltage-gated channel subfamily c member 1 | Type: ion channel | Action: BLOCKER
15432,fampridine,potassium voltage-gated channel subfamily c member 2,ion channel,BLOCKER,Drug: fampridine | Target: potassium voltage-gated channel subfamily c member 2 | Type: ion channel | Action: BLOCKER
15433,liraglutide,glucagon-like peptide 1 receptor,gpcr,AGONIST,Drug: liraglutide | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: AGONIST
15434,alcaftadine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: alcaftadine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
15435,ulipristal,progesterone receptor,nuclear hormone receptor,ANTAGONIST,Drug: ulipristal | Target: progesterone receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
15436,fingolimod,sphingosine-1-phosphate lyase 1,enzyme,,Drug: fingolimod | Target: sphingosine-1-phosphate lyase 1 | Type: enzyme | Action: nan
15437,fingolimod,sphingosine 1-phosphate receptor 1,gpcr,AGONIST,Drug: fingolimod | Target: sphingosine 1-phosphate receptor 1 | Type: gpcr | Action: AGONIST
15438,fingolimod,sphingosine 1-phosphate receptor 5,gpcr,AGONIST,Drug: fingolimod | Target: sphingosine 1-phosphate receptor 5 | Type: gpcr | Action: AGONIST
15439,fingolimod,sphingosine 1-phosphate receptor 4,gpcr,AGONIST,Drug: fingolimod | Target: sphingosine 1-phosphate receptor 4 | Type: gpcr | Action: AGONIST
15440,fingolimod,sphingosine 1-phosphate receptor 3,gpcr,AGONIST,Drug: fingolimod | Target: sphingosine 1-phosphate receptor 3 | Type: gpcr | Action: AGONIST
15441,fingolimod,transient receptor potential cation channel subfamily m member 7,ion channel,BLOCKER,Drug: fingolimod | Target: transient receptor potential cation channel subfamily m member 7 | Type: ion channel | Action: BLOCKER
15442,lurasidone,alpha-2a adrenergic receptor,gpcr,,Drug: lurasidone | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15443,lurasidone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: lurasidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
15444,lurasidone,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: lurasidone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
15445,lurasidone,alpha-2c adrenergic receptor,gpcr,,Drug: lurasidone | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
15446,lurasidone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: lurasidone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
15447,lurasidone,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: lurasidone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
15448,lurasidone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: lurasidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
15449,lurasidone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: lurasidone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
15450,lurasidone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: lurasidone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
15451,ceftaroline fosamil,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: ceftaroline fosamil | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
15452,tesamorelin,growth hormone-releasing hormone receptor,gpcr,AGONIST,Drug: tesamorelin | Target: growth hormone-releasing hormone receptor | Type: gpcr | Action: AGONIST
15453,eribulin,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: eribulin | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
15454,boceprevir,neutrophil elastase,enzyme,,Drug: boceprevir | Target: neutrophil elastase | Type: enzyme | Action: nan
15455,boceprevir,cathepsin b,enzyme,,Drug: boceprevir | Target: cathepsin b | Type: enzyme | Action: nan
15456,boceprevir,cathepsin l1,enzyme,,Drug: boceprevir | Target: cathepsin l1 | Type: enzyme | Action: nan
15457,boceprevir,chymase,enzyme,,Drug: boceprevir | Target: chymase | Type: enzyme | Action: nan
15458,boceprevir,lysosomal protective protein,enzyme,INHIBITOR,Drug: boceprevir | Target: lysosomal protective protein | Type: enzyme | Action: INHIBITOR
15459,boceprevir,cathepsin l2,enzyme,,Drug: boceprevir | Target: cathepsin l2 | Type: enzyme | Action: nan
15460,boceprevir,cathepsin k,enzyme,,Drug: boceprevir | Target: cathepsin k | Type: enzyme | Action: nan
15461,boceprevir,cathepsin s,enzyme,,Drug: boceprevir | Target: cathepsin s | Type: enzyme | Action: nan
15462,boceprevir,cathepsin f,enzyme,,Drug: boceprevir | Target: cathepsin f | Type: enzyme | Action: nan
15463,boceprevir,"hepatitis c virus serine protease, ns3/ns4a",enzyme,INHIBITOR,"Drug: boceprevir | Target: hepatitis c virus serine protease, ns3/ns4a | Type: enzyme | Action: INHIBITOR"
15464,boceprevir,nonstructural protein ns3-4a,unclassified,,Drug: boceprevir | Target: nonstructural protein ns3-4a | Type: unclassified | Action: nan
15465,telaprevir,plasminogen,enzyme,,Drug: telaprevir | Target: plasminogen | Type: enzyme | Action: nan
15466,telaprevir,neutrophil elastase,enzyme,,Drug: telaprevir | Target: neutrophil elastase | Type: enzyme | Action: nan
15467,telaprevir,chymotrypsin-like elastase family member 1,enzyme,,Drug: telaprevir | Target: chymotrypsin-like elastase family member 1 | Type: enzyme | Action: nan
15468,telaprevir,cathepsin b,enzyme,,Drug: telaprevir | Target: cathepsin b | Type: enzyme | Action: nan
15469,telaprevir,cathepsin l1,enzyme,,Drug: telaprevir | Target: cathepsin l1 | Type: enzyme | Action: nan
15470,telaprevir,chymase,enzyme,,Drug: telaprevir | Target: chymase | Type: enzyme | Action: nan
15471,telaprevir,lysosomal protective protein,enzyme,INHIBITOR,Drug: telaprevir | Target: lysosomal protective protein | Type: enzyme | Action: INHIBITOR
15472,telaprevir,cathepsin l2,enzyme,,Drug: telaprevir | Target: cathepsin l2 | Type: enzyme | Action: nan
15473,telaprevir,cathepsin k,enzyme,,Drug: telaprevir | Target: cathepsin k | Type: enzyme | Action: nan
15474,telaprevir,cathepsin s,enzyme,,Drug: telaprevir | Target: cathepsin s | Type: enzyme | Action: nan
15475,telaprevir,"hepatitis c virus serine protease, ns3/ns4a",enzyme,INHIBITOR,"Drug: telaprevir | Target: hepatitis c virus serine protease, ns3/ns4a | Type: enzyme | Action: INHIBITOR"
15476,telaprevir,ns3 protease,unclassified,,Drug: telaprevir | Target: ns3 protease | Type: unclassified | Action: nan
15477,telaprevir,ns3 protease,unclassified,,Drug: telaprevir | Target: ns3 protease | Type: unclassified | Action: nan
15478,telaprevir,ns3 protease,unclassified,,Drug: telaprevir | Target: ns3 protease | Type: unclassified | Action: nan
15479,rilpivirine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: rilpivirine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
15480,rilpivirine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: rilpivirine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
15481,rilpivirine,reverse transcriptase,enzyme,,Drug: rilpivirine | Target: reverse transcriptase | Type: enzyme | Action: nan
15483,rilpivirine,reverse transcriptase protein,unclassified,,Drug: rilpivirine | Target: reverse transcriptase protein | Type: unclassified | Action: nan
15484,linagliptin,muscarinic acetylcholine receptor m1,gpcr,,Drug: linagliptin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
15485,linagliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: linagliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
15486,linagliptin,prolyl endopeptidase fap,enzyme,,Drug: linagliptin | Target: prolyl endopeptidase fap | Type: enzyme | Action: nan
15487,linagliptin,dipeptidyl peptidase 9,enzyme,,Drug: linagliptin | Target: dipeptidyl peptidase 9 | Type: enzyme | Action: nan
15488,linagliptin,prolyl endopeptidase fap,enzyme,,Drug: linagliptin | Target: prolyl endopeptidase fap | Type: enzyme | Action: nan
15489,linagliptin,dipeptidyl peptidase iv,unclassified,,Drug: linagliptin | Target: dipeptidyl peptidase iv | Type: unclassified | Action: nan
15490,abiraterone acetate,cytochrome p450 3a4,enzyme,,Drug: abiraterone acetate | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
15491,abiraterone acetate,androgen receptor,nuclear hormone receptor,,Drug: abiraterone acetate | Target: androgen receptor | Type: nuclear hormone receptor | Action: nan
15492,abiraterone acetate,"steroid 17-alpha-hydroxylase/17,20 lyase",enzyme,INHIBITOR,"Drug: abiraterone acetate | Target: steroid 17-alpha-hydroxylase/17,20 lyase | Type: enzyme | Action: INHIBITOR"
15493,abiraterone acetate,"cytochrome p450 11b1, mitochondrial",enzyme,,"Drug: abiraterone acetate | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: nan"
15494,abiraterone acetate,"cytochrome p450 11b2, mitochondrial",enzyme,,"Drug: abiraterone acetate | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: nan"
15495,abiraterone acetate,cytochrome p450 17a1,enzyme,,Drug: abiraterone acetate | Target: cytochrome p450 17a1 | Type: enzyme | Action: nan
15496,gabapentin enacarbil,voltage-dependent calcium channel subunit alpha-2/delta-1,ion channel,MODULATOR,Drug: gabapentin enacarbil | Target: voltage-dependent calcium channel subunit alpha-2/delta-1 | Type: ion channel | Action: MODULATOR
15497,gabapentin enacarbil,voltage-dependent calcium channel subunit alpha-2/delta-2,ion channel,MODULATOR,Drug: gabapentin enacarbil | Target: voltage-dependent calcium channel subunit alpha-2/delta-2 | Type: ion channel | Action: MODULATOR
15498,vandetanib,macrophage-stimulating protein receptor,kinase,,Drug: vandetanib | Target: macrophage-stimulating protein receptor | Type: kinase | Action: nan
15499,vandetanib,platelet-derived growth factor receptor beta,kinase,,Drug: vandetanib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
15500,vandetanib,tyrosine-protein kinase abl1,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
15501,vandetanib,mast/stem cell growth factor receptor kit,kinase,,Drug: vandetanib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
15502,vandetanib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: vandetanib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
15503,vandetanib,proto-oncogene tyrosine-protein kinase src,kinase,INHIBITOR,Drug: vandetanib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: INHIBITOR
15504,vandetanib,tyrosine-protein kinase lck,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
15505,vandetanib,tyrosine-protein kinase yes,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
15506,vandetanib,tyrosine-protein kinase fyn,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
15507,vandetanib,ephrin type-a receptor 2,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-a receptor 2 | Type: kinase | Action: INHIBITOR
15508,vandetanib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: vandetanib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
15509,vandetanib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: vandetanib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
15510,vandetanib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: vandetanib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
15511,vandetanib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: vandetanib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
15512,vandetanib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: vandetanib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
15513,vandetanib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: vandetanib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
15514,vandetanib,platelet-derived growth factor receptor alpha,kinase,,Drug: vandetanib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
15515,vandetanib,receptor tyrosine-protein kinase erbb-2,kinase,INHIBITOR,Drug: vandetanib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: INHIBITOR
15516,vandetanib,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: vandetanib | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
15517,vandetanib,fibroblast growth factor receptor 3,kinase,,Drug: vandetanib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
15518,vandetanib,tyrosine-protein kinase hck,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
15519,vandetanib,receptor tyrosine-protein kinase erbb-4,kinase,INHIBITOR,Drug: vandetanib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: INHIBITOR
15520,vandetanib,rho-associated protein kinase 2,kinase,,Drug: vandetanib | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
15521,vandetanib,tyrosine-protein kinase csk,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
15522,vandetanib,angiopoietin-1 receptor,kinase,INHIBITOR,Drug: vandetanib | Target: angiopoietin-1 receptor | Type: kinase | Action: INHIBITOR
15523,vandetanib,ephrin type-a receptor 8,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-a receptor 8 | Type: kinase | Action: INHIBITOR
15524,vandetanib,hepatocyte growth factor receptor,kinase,,Drug: vandetanib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
15525,vandetanib,tyrosine-protein kinase lyn,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
15526,vandetanib,5'-amp-activated protein kinase catalytic subunit alpha-1,kinase,,Drug: vandetanib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-1 | Type: kinase | Action: nan
15527,vandetanib,fibroblast growth factor receptor 1,kinase,,Drug: vandetanib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
15528,vandetanib,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: vandetanib | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
15529,vandetanib,serine/threonine-protein kinase 10,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
15530,vandetanib,serine/threonine-protein kinase plk4,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
15531,vandetanib,aurora kinase c,kinase,,Drug: vandetanib | Target: aurora kinase c | Type: kinase | Action: nan
15532,vandetanib,abelson tyrosine-protein kinase 2,kinase,,Drug: vandetanib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
15533,vandetanib,ephrin type-a receptor 5,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-a receptor 5 | Type: kinase | Action: INHIBITOR
15534,vandetanib,ephrin type-a receptor 4,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-a receptor 4 | Type: kinase | Action: INHIBITOR
15535,vandetanib,fibroblast growth factor receptor 2,kinase,,Drug: vandetanib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
15536,vandetanib,ephrin type-a receptor 6,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-a receptor 6 | Type: kinase | Action: INHIBITOR
15537,vandetanib,traf2 and nck-interacting protein kinase,kinase,,Drug: vandetanib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
15538,vandetanib,casein kinase i isoform epsilon,kinase,,Drug: vandetanib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
15539,vandetanib,tyrosine-protein kinase fgr,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
15540,vandetanib,alk tyrosine kinase receptor,kinase,,Drug: vandetanib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
15541,vandetanib,ephrin type-a receptor 3,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-a receptor 3 | Type: kinase | Action: INHIBITOR
15542,vandetanib,tyrosine-protein kinase frk,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
15543,vandetanib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
15544,vandetanib,mitogen-activated protein kinase kinase kinase 4,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase kinase kinase 4 | Type: kinase | Action: nan
15545,vandetanib,cyclin-g-associated kinase,kinase,,Drug: vandetanib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
15546,vandetanib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: vandetanib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
15547,vandetanib,ephrin type-b receptor 1,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-b receptor 1 | Type: kinase | Action: INHIBITOR
15548,vandetanib,ephrin type-a receptor 7,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-a receptor 7 | Type: kinase | Action: INHIBITOR
15549,vandetanib,ste20-like serine/threonine-protein kinase,kinase,,Drug: vandetanib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
15550,vandetanib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: vandetanib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
15551,vandetanib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: vandetanib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
15552,vandetanib,ephrin type-b receptor 4,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-b receptor 4 | Type: kinase | Action: INHIBITOR
15553,vandetanib,serine/threonine-protein kinase receptor r3,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase receptor r3 | Type: kinase | Action: nan
15554,vandetanib,activin receptor type-1,kinase,,Drug: vandetanib | Target: activin receptor type-1 | Type: kinase | Action: nan
15555,vandetanib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: vandetanib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
15556,vandetanib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: vandetanib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
15557,vandetanib,protein-tyrosine kinase 6,kinase,INHIBITOR,Drug: vandetanib | Target: protein-tyrosine kinase 6 | Type: kinase | Action: INHIBITOR
15558,vandetanib,tyrosine-protein kinase btk,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
15559,vandetanib,tyrosine-protein kinase receptor ufo,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
15560,vandetanib,tyrosine-protein kinase receptor tyro3,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase receptor tyro3 | Type: kinase | Action: nan
15561,vandetanib,ephrin type-b receptor 2,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-b receptor 2 | Type: kinase | Action: INHIBITOR
15562,vandetanib,cyclin-dependent kinase 7,kinase,,Drug: vandetanib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
15563,vandetanib,ribosomal protein s6 kinase beta-1,kinase,,Drug: vandetanib | Target: ribosomal protein s6 kinase beta-1 | Type: kinase | Action: nan
15564,vandetanib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: vandetanib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
15565,vandetanib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
15566,vandetanib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
15567,vandetanib,tyrosine-protein kinase txk,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
15568,vandetanib,map kinase-interacting serine/threonine-protein kinase 1,kinase,,Drug: vandetanib | Target: map kinase-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
15569,vandetanib,serine/threonine-protein kinase sik2,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
15570,vandetanib,serine/threonine-protein kinase 33,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
15571,vandetanib,serine/threonine-protein kinase tnni3k,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
15572,vandetanib,discoidin domain-containing receptor 2,kinase,,Drug: vandetanib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
15573,vandetanib,"chaperone activity of bc1 complex-like, mitochondrial",kinase,,"Drug: vandetanib | Target: chaperone activity of bc1 complex-like, mitochondrial | Type: kinase | Action: nan"
15574,vandetanib,serine/threonine-protein kinase mrck gamma,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase mrck gamma | Type: kinase | Action: nan
15575,vandetanib,leukocyte tyrosine kinase receptor,kinase,,Drug: vandetanib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
15576,vandetanib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
15577,vandetanib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
15578,vandetanib,tyrosine-protein kinase blk,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
15579,vandetanib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
15580,vandetanib,tyrosine-protein kinase mer,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
15581,vandetanib,serine/threonine-protein kinase mrck alpha,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase mrck alpha | Type: kinase | Action: nan
15582,vandetanib,serine/threonine-protein kinase mrck beta,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase mrck beta | Type: kinase | Action: nan
15583,vandetanib,citron rho-interacting kinase,kinase,,Drug: vandetanib | Target: citron rho-interacting kinase | Type: kinase | Action: nan
15584,vandetanib,aarf domain-containing protein kinase 4,kinase,,Drug: vandetanib | Target: aarf domain-containing protein kinase 4 | Type: kinase | Action: nan
15585,vandetanib,serine/threonine-protein kinase sik1,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
15586,vandetanib,tyrosine-protein kinase srms,kinase,,Drug: vandetanib | Target: tyrosine-protein kinase srms | Type: kinase | Action: nan
15587,vandetanib,dual specificity testis-specific protein kinase 1,kinase,,Drug: vandetanib | Target: dual specificity testis-specific protein kinase 1 | Type: kinase | Action: nan
15588,vandetanib,ephrin type-a receptor 1,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-a receptor 1 | Type: kinase | Action: INHIBITOR
15589,vandetanib,tubulin alpha-1a chain,structural,,Drug: vandetanib | Target: tubulin alpha-1a chain | Type: structural | Action: nan
15590,vandetanib,mitogen-activated protein kinase 6,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase 6 | Type: kinase | Action: nan
15591,vandetanib,fibroblast growth factor receptor 4,kinase,,Drug: vandetanib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: nan
15592,vandetanib,ribosomal protein s6 kinase alpha-1,kinase,,Drug: vandetanib | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
15593,vandetanib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
15594,vandetanib,misshapen-like kinase 1,kinase,,Drug: vandetanib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
15595,vandetanib,interleukin-1 receptor-associated kinase 4,kinase,,Drug: vandetanib | Target: interleukin-1 receptor-associated kinase 4 | Type: kinase | Action: nan
15596,vandetanib,ephrin type-b receptor 6,kinase,INHIBITOR,Drug: vandetanib | Target: ephrin type-b receptor 6 | Type: kinase | Action: INHIBITOR
15597,vandetanib,hormonally up-regulated neu tumor-associated kinase,kinase,,Drug: vandetanib | Target: hormonally up-regulated neu tumor-associated kinase | Type: kinase | Action: nan
15598,vandetanib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: vandetanib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
15599,vandetanib,serine/threonine-protein kinase ulk3,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
15600,vandetanib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: vandetanib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
15601,vandetanib,receptor-interacting serine/threonine-protein kinase 4,kinase,,Drug: vandetanib | Target: receptor-interacting serine/threonine-protein kinase 4 | Type: kinase | Action: nan
15602,vandetanib,serine/threonine-protein kinase 35,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase 35 | Type: kinase | Action: nan
15603,vandetanib,receptor tyrosine-protein kinase erbb-3,kinase,INHIBITOR,Drug: vandetanib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: INHIBITOR
15604,vandetanib,serine/threonine-protein kinase sik3,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase sik3 | Type: kinase | Action: nan
15605,vandetanib,bone morphogenetic protein receptor type-1b,kinase,,Drug: vandetanib | Target: bone morphogenetic protein receptor type-1b | Type: kinase | Action: nan
15606,vandetanib,serine/threonine-protein kinase 32a,kinase,,Drug: vandetanib | Target: serine/threonine-protein kinase 32a | Type: kinase | Action: nan
15607,vandetanib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: vandetanib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
15608,fidaxomicin,dna-directed rna polymerase,enzyme,INHIBITOR,Drug: fidaxomicin | Target: dna-directed rna polymerase | Type: enzyme | Action: INHIBITOR
15609,retigabine,potassium voltage-gated channel subfamily kqt member 2,ion channel,ACTIVATOR,Drug: retigabine | Target: potassium voltage-gated channel subfamily kqt member 2 | Type: ion channel | Action: ACTIVATOR
15610,retigabine,potassium voltage-gated channel subfamily kqt member 3,ion channel,ACTIVATOR,Drug: retigabine | Target: potassium voltage-gated channel subfamily kqt member 3 | Type: ion channel | Action: ACTIVATOR
15611,retigabine,potassium voltage-gated channel subfamily kqt member 5,ion channel,ACTIVATOR,Drug: retigabine | Target: potassium voltage-gated channel subfamily kqt member 5 | Type: ion channel | Action: ACTIVATOR
15612,retigabine,potassium voltage-gated channel subfamily kqt member 4,ion channel,ACTIVATOR,Drug: retigabine | Target: potassium voltage-gated channel subfamily kqt member 4 | Type: ion channel | Action: ACTIVATOR
15613,retigabine,potassium voltage-gated channel subfamily kqt member 2,ion channel,,Drug: retigabine | Target: potassium voltage-gated channel subfamily kqt member 2 | Type: ion channel | Action: nan
15614,rivaroxaban,coagulation factor x,enzyme,INHIBITOR,Drug: rivaroxaban | Target: coagulation factor x | Type: enzyme | Action: INHIBITOR
15615,rivaroxaban,suppressor of tumorigenicity 14 protein,enzyme,,Drug: rivaroxaban | Target: suppressor of tumorigenicity 14 protein | Type: enzyme | Action: nan
15616,rivaroxaban,coagulation factor x,enzyme,,Drug: rivaroxaban | Target: coagulation factor x | Type: enzyme | Action: nan
15617,indacaterol,beta-1 adrenergic receptor,gpcr,,Drug: indacaterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
15618,indacaterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: indacaterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
15619,indacaterol,d(2) dopamine receptor,gpcr,,Drug: indacaterol | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
15620,indacaterol,d(3) dopamine receptor,gpcr,,Drug: indacaterol | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
15621,indacaterol,beta-2 adrenergic receptor,gpcr,,Drug: indacaterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
15622,ticagrelor,p2y purinoceptor 12,gpcr,NEGATIVE ALLOSTERIC MODULATOR,Drug: ticagrelor | Target: p2y purinoceptor 12 | Type: gpcr | Action: NEGATIVE ALLOSTERIC MODULATOR
15623,ticagrelor,equilibrative nucleoside transporter 1,transporter,INHIBITOR,Drug: ticagrelor | Target: equilibrative nucleoside transporter 1 | Type: transporter | Action: INHIBITOR
15624,ticagrelor,p2y purinoceptor 12,gpcr,,Drug: ticagrelor | Target: p2y purinoceptor 12 | Type: gpcr | Action: nan
15625,vemurafenib,raf proto-oncogene serine/threonine-protein kinase,kinase,,Drug: vemurafenib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: nan
15626,vemurafenib,serine/threonine-protein kinase b-raf,kinase,INHIBITOR,Drug: vemurafenib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: INHIBITOR
15627,vemurafenib,vascular endothelial growth factor receptor 2,kinase,,Drug: vemurafenib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
15628,vemurafenib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: vemurafenib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
15629,vemurafenib,serine/threonine-protein kinase a-raf,kinase,,Drug: vemurafenib | Target: serine/threonine-protein kinase a-raf | Type: kinase | Action: nan
15630,vemurafenib,gtpase kras,enzyme,,Drug: vemurafenib | Target: gtpase kras | Type: enzyme | Action: nan
15631,vemurafenib,"ferrochelatase, mitochondrial",enzyme,,"Drug: vemurafenib | Target: ferrochelatase, mitochondrial | Type: enzyme | Action: nan"
15632,vemurafenib,serine/threonine-protein kinase b-raf,kinase,,Drug: vemurafenib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
15633,icatibant,b2 bradykinin receptor,gpcr,ANTAGONIST,Drug: icatibant | Target: b2 bradykinin receptor | Type: gpcr | Action: ANTAGONIST
15634,icatibant,b2 bradykinin receptor,gpcr,,Drug: icatibant | Target: b2 bradykinin receptor | Type: gpcr | Action: nan
15635,icatibant,b2 bradykinin receptor,gpcr,,Drug: icatibant | Target: b2 bradykinin receptor | Type: gpcr | Action: nan
15636,icatibant,b1 bradykinin receptor,gpcr,ANTAGONIST,Drug: icatibant | Target: b1 bradykinin receptor | Type: gpcr | Action: ANTAGONIST
15637,icatibant,b2 bradykinin receptor,gpcr,ANTAGONIST,Drug: icatibant | Target: b2 bradykinin receptor | Type: gpcr | Action: ANTAGONIST
15638,icatibant,b1 bradykinin receptor,gpcr,ANTAGONIST,Drug: icatibant | Target: b1 bradykinin receptor | Type: gpcr | Action: ANTAGONIST
15639,crizotinib,tyrosine-protein kinase jak3,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
15640,crizotinib,macrophage-stimulating protein receptor,kinase,,Drug: crizotinib | Target: macrophage-stimulating protein receptor | Type: kinase | Action: nan
15641,crizotinib,tyrosine-protein kinase abl1,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
15642,crizotinib,mast/stem cell growth factor receptor kit,kinase,,Drug: crizotinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
15643,crizotinib,epidermal growth factor receptor,kinase,,Drug: crizotinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
15644,crizotinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: crizotinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
15645,crizotinib,tyrosine-protein kinase lck,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
15646,crizotinib,tyrosine-protein kinase yes,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
15647,crizotinib,tyrosine-protein kinase fyn,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
15648,crizotinib,ephrin type-a receptor 2,kinase,,Drug: crizotinib | Target: ephrin type-a receptor 2 | Type: kinase | Action: nan
15649,crizotinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: crizotinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
15650,crizotinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: crizotinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
15651,crizotinib,vascular endothelial growth factor receptor 1,kinase,,Drug: crizotinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
15652,crizotinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: crizotinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
15653,crizotinib,insulin-like growth factor 1 receptor,kinase,,Drug: crizotinib | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: nan
15654,crizotinib,insulin receptor,kinase,AGONIST,Drug: crizotinib | Target: insulin receptor | Type: kinase | Action: AGONIST
15655,crizotinib,fibroblast growth factor receptor 3,kinase,,Drug: crizotinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
15656,crizotinib,rho-associated protein kinase 1,kinase,,Drug: crizotinib | Target: rho-associated protein kinase 1 | Type: kinase | Action: nan
15657,crizotinib,focal adhesion kinase 1,kinase,,Drug: crizotinib | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
15658,crizotinib,tyrosine-protein kinase jak1,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: nan
15659,crizotinib,high affinity nerve growth factor receptor,kinase,,Drug: crizotinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
15660,crizotinib,tyrosine-protein kinase jak2,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
15661,crizotinib,rho-associated protein kinase 2,kinase,,Drug: crizotinib | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
15662,crizotinib,tyrosine-protein kinase syk,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
15663,crizotinib,angiopoietin-1 receptor,kinase,,Drug: crizotinib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
15664,crizotinib,ephrin type-a receptor 8,kinase,,Drug: crizotinib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
15665,crizotinib,ap2-associated protein kinase 1,kinase,,Drug: crizotinib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
15666,crizotinib,hepatocyte growth factor receptor,kinase,INHIBITOR,Drug: crizotinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: INHIBITOR
15667,crizotinib,tyrosine-protein kinase lyn,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
15668,crizotinib,cytoplasmic tyrosine-protein kinase bmx,kinase,,Drug: crizotinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: nan
15669,crizotinib,lim domain kinase 1,kinase,,Drug: crizotinib | Target: lim domain kinase 1 | Type: kinase | Action: nan
15670,crizotinib,5'-amp-activated protein kinase catalytic subunit alpha-1,kinase,,Drug: crizotinib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-1 | Type: kinase | Action: nan
15671,crizotinib,serine/threonine-protein kinase 10,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
15672,crizotinib,tyrosine-protein kinase fer,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
15673,crizotinib,serine/threonine-protein kinase plk4,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
15674,crizotinib,aurora kinase c,kinase,,Drug: crizotinib | Target: aurora kinase c | Type: kinase | Action: nan
15675,crizotinib,abelson tyrosine-protein kinase 2,kinase,,Drug: crizotinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
15676,crizotinib,ephrin type-a receptor 5,kinase,,Drug: crizotinib | Target: ephrin type-a receptor 5 | Type: kinase | Action: nan
15677,crizotinib,ephrin type-a receptor 4,kinase,,Drug: crizotinib | Target: ephrin type-a receptor 4 | Type: kinase | Action: nan
15678,crizotinib,ephrin type-a receptor 6,kinase,,Drug: crizotinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
15679,crizotinib,tyrosine-protein kinase fgr,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
15680,crizotinib,aurora kinase a,kinase,,Drug: crizotinib | Target: aurora kinase a | Type: kinase | Action: nan
15681,crizotinib,alk tyrosine kinase receptor,kinase,INHIBITOR,Drug: crizotinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: INHIBITOR
15682,crizotinib,ephrin type-a receptor 3,kinase,,Drug: crizotinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
15683,crizotinib,bmp-2-inducible protein kinase,kinase,,Drug: crizotinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
15684,crizotinib,tyrosine-protein kinase frk,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
15685,crizotinib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
15686,crizotinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: crizotinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
15687,crizotinib,ephrin type-b receptor 1,kinase,,Drug: crizotinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
15688,crizotinib,serine/threonine-protein kinase 4,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
15689,crizotinib,activated cdc42 kinase 1,kinase,,Drug: crizotinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
15690,crizotinib,ephrin type-a receptor 7,kinase,,Drug: crizotinib | Target: ephrin type-a receptor 7 | Type: kinase | Action: nan
15691,crizotinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: crizotinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
15692,crizotinib,calcium/calmodulin-dependent protein kinase kinase 2,kinase,,Drug: crizotinib | Target: calcium/calmodulin-dependent protein kinase kinase 2 | Type: kinase | Action: nan
15693,crizotinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: crizotinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
15694,crizotinib,ephrin type-b receptor 4,kinase,,Drug: crizotinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
15695,crizotinib,activin receptor type-1b,kinase,,Drug: crizotinib | Target: activin receptor type-1b | Type: kinase | Action: nan
15696,crizotinib,activin receptor type-1,kinase,,Drug: crizotinib | Target: activin receptor type-1 | Type: kinase | Action: nan
15697,crizotinib,inhibitor of nuclear factor kappa-b kinase subunit beta,kinase,,Drug: crizotinib | Target: inhibitor of nuclear factor kappa-b kinase subunit beta | Type: kinase | Action: nan
15698,crizotinib,tyrosine-protein kinase itk/tsk,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: nan
15699,crizotinib,tyrosine-protein kinase zap-70,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase zap-70 | Type: kinase | Action: nan
15700,crizotinib,tyrosine-protein kinase btk,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
15701,crizotinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
15702,crizotinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: crizotinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
15703,crizotinib,tyrosine-protein kinase receptor tyro3,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase receptor tyro3 | Type: kinase | Action: nan
15704,crizotinib,cyclin-dependent kinase 7,kinase,,Drug: crizotinib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
15705,crizotinib,serine/threonine-protein kinase d1,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase d1 | Type: kinase | Action: nan
15706,crizotinib,ribosomal protein s6 kinase beta-1,kinase,,Drug: crizotinib | Target: ribosomal protein s6 kinase beta-1 | Type: kinase | Action: nan
15707,crizotinib,serine/threonine-protein kinase 3,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
15708,crizotinib,nuak family snf1-like kinase 2,kinase,,Drug: crizotinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
15709,crizotinib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: crizotinib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
15710,crizotinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: crizotinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
15711,crizotinib,phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,kinase,,Drug: crizotinib | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Type: kinase | Action: nan
15712,crizotinib,protein-tyrosine kinase 2-beta,kinase,,Drug: crizotinib | Target: protein-tyrosine kinase 2-beta | Type: kinase | Action: nan
15713,crizotinib,serine/threonine-protein kinase rio1,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
15714,crizotinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
15715,crizotinib,nt-3 growth factor receptor,kinase,,Drug: crizotinib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
15716,crizotinib,tyrosine-protein kinase txk,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
15717,crizotinib,inhibitor of nuclear factor kappa-b kinase subunit epsilon,kinase,,Drug: crizotinib | Target: inhibitor of nuclear factor kappa-b kinase subunit epsilon | Type: kinase | Action: nan
15718,crizotinib,lim domain kinase 2,kinase,,Drug: crizotinib | Target: lim domain kinase 2 | Type: kinase | Action: nan
15719,crizotinib,dual specificity mitogen-activated protein kinase kinase 3,kinase,,Drug: crizotinib | Target: dual specificity mitogen-activated protein kinase kinase 3 | Type: kinase | Action: nan
15720,crizotinib,serine/threonine-protein kinase 26,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase 26 | Type: kinase | Action: nan
15721,crizotinib,serine/threonine-protein kinase nek7,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase nek7 | Type: kinase | Action: nan
15722,crizotinib,insulin receptor-related protein,kinase,,Drug: crizotinib | Target: insulin receptor-related protein | Type: kinase | Action: nan
15723,crizotinib,interleukin-1 receptor-associated kinase 3,kinase,,Drug: crizotinib | Target: interleukin-1 receptor-associated kinase 3 | Type: kinase | Action: nan
15724,crizotinib,serine/threonine-protein kinase rio3,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
15725,crizotinib,serine/threonine-protein kinase sik2,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
15726,crizotinib,srsf protein kinase 1,kinase,,Drug: crizotinib | Target: srsf protein kinase 1 | Type: kinase | Action: nan
15727,crizotinib,serine/threonine-protein kinase tnni3k,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
15728,crizotinib,ankyrin repeat and protein kinase domain-containing protein 1,kinase,,Drug: crizotinib | Target: ankyrin repeat and protein kinase domain-containing protein 1 | Type: kinase | Action: nan
15729,crizotinib,myotonin-protein kinase,kinase,,Drug: crizotinib | Target: myotonin-protein kinase | Type: kinase | Action: nan
15730,crizotinib,leukocyte tyrosine kinase receptor,kinase,,Drug: crizotinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
15731,crizotinib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
15732,crizotinib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
15733,crizotinib,aurora kinase b,kinase,,Drug: crizotinib | Target: aurora kinase b | Type: kinase | Action: nan
15734,crizotinib,tyrosine-protein kinase blk,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
15735,crizotinib,tyrosine-protein kinase mer,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
15736,crizotinib,cyclin-dependent kinase 11b,kinase,,Drug: crizotinib | Target: cyclin-dependent kinase 11b | Type: kinase | Action: nan
15737,crizotinib,cyclin-dependent kinase 11a,kinase,,Drug: crizotinib | Target: cyclin-dependent kinase 11a | Type: kinase | Action: nan
15738,crizotinib,"muscle, skeletal receptor tyrosine-protein kinase",kinase,,"Drug: crizotinib | Target: muscle, skeletal receptor tyrosine-protein kinase | Type: kinase | Action: nan"
15739,crizotinib,serine/threonine-protein kinase dclk1,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase dclk1 | Type: kinase | Action: nan
15740,crizotinib,serine/threonine-protein kinase dclk2,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase dclk2 | Type: kinase | Action: nan
15741,crizotinib,serine/threonine-protein kinase nek9,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase nek9 | Type: kinase | Action: nan
15742,crizotinib,aarf domain-containing protein kinase 4,kinase,,Drug: crizotinib | Target: aarf domain-containing protein kinase 4 | Type: kinase | Action: nan
15743,crizotinib,dual specificity testis-specific protein kinase 1,kinase,,Drug: crizotinib | Target: dual specificity testis-specific protein kinase 1 | Type: kinase | Action: nan
15744,crizotinib,tgf-beta receptor type-1,kinase,,Drug: crizotinib | Target: tgf-beta receptor type-1 | Type: kinase | Action: nan
15745,crizotinib,ephrin type-a receptor 1,kinase,,Drug: crizotinib | Target: ephrin type-a receptor 1 | Type: kinase | Action: nan
15746,crizotinib,mitogen-activated protein kinase 7,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase 7 | Type: kinase | Action: nan
15747,crizotinib,serine/threonine-protein kinase d3,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase d3 | Type: kinase | Action: nan
15748,crizotinib,"interferon-induced, double-stranded rna-activated protein kinase",kinase,,"Drug: crizotinib | Target: interferon-induced, double-stranded rna-activated protein kinase | Type: kinase | Action: nan"
15749,crizotinib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: crizotinib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
15750,crizotinib,tyrosine-protein kinase fes/fps,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase fes/fps | Type: kinase | Action: nan
15751,crizotinib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: crizotinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
15752,crizotinib,tyrosine-protein kinase abl1,kinase,,Drug: crizotinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
15753,crizotinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
15754,crizotinib,misshapen-like kinase 1,kinase,,Drug: crizotinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
15755,crizotinib,serine/threonine-protein kinase tbk1,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
15756,crizotinib,interleukin-1 receptor-associated kinase 4,kinase,,Drug: crizotinib | Target: interleukin-1 receptor-associated kinase 4 | Type: kinase | Action: nan
15757,crizotinib,cyclin-dependent kinase-like 2,kinase,,Drug: crizotinib | Target: cyclin-dependent kinase-like 2 | Type: kinase | Action: nan
15758,crizotinib,dual specificity tyrosine-phosphorylation-regulated kinase 2,kinase,,Drug: crizotinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 2 | Type: kinase | Action: nan
15759,crizotinib,ephrin type-b receptor 6,kinase,,Drug: crizotinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
15760,crizotinib,g protein-coupled receptor kinase 4,kinase,,Drug: crizotinib | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
15761,crizotinib,homeodomain-interacting protein kinase 4,kinase,,Drug: crizotinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
15762,crizotinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: crizotinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
15763,crizotinib,mitogen-activated protein kinase kinase kinase 13,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase 13 | Type: kinase | Action: nan
15764,crizotinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
15765,crizotinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
15766,crizotinib,serine/threonine-protein kinase nim1,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase nim1 | Type: kinase | Action: nan
15767,crizotinib,srsf protein kinase 3,kinase,,Drug: crizotinib | Target: srsf protein kinase 3 | Type: kinase | Action: nan
15768,crizotinib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
15769,crizotinib,serine/threonine-protein kinase tao1,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
15770,crizotinib,serine/threonine-protein kinase tao3,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
15771,crizotinib,serine/threonine-protein kinase ulk1,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase ulk1 | Type: kinase | Action: nan
15772,crizotinib,serine/threonine-protein kinase ulk2,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase ulk2 | Type: kinase | Action: nan
15773,crizotinib,serine/threonine-protein kinase ulk3,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
15774,crizotinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
15775,crizotinib,mitogen-activated protein kinase kinase kinase 15,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase 15 | Type: kinase | Action: nan
15776,crizotinib,receptor-interacting serine/threonine-protein kinase 4,kinase,,Drug: crizotinib | Target: receptor-interacting serine/threonine-protein kinase 4 | Type: kinase | Action: nan
15777,crizotinib,uncharacterized serine/threonine-protein kinase sbk3,kinase,,Drug: crizotinib | Target: uncharacterized serine/threonine-protein kinase sbk3 | Type: kinase | Action: nan
15778,crizotinib,serine/threonine-protein kinase 35,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase 35 | Type: kinase | Action: nan
15779,crizotinib,mitogen-activated protein kinase kinase kinase 1,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase 1 | Type: kinase | Action: nan
15780,crizotinib,bone morphogenetic protein receptor type-1b,kinase,,Drug: crizotinib | Target: bone morphogenetic protein receptor type-1b | Type: kinase | Action: nan
15781,crizotinib,macrophage-stimulating protein receptor,kinase,,Drug: crizotinib | Target: macrophage-stimulating protein receptor | Type: kinase | Action: nan
15782,crizotinib,angiopoietin-1 receptor,kinase,,Drug: crizotinib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
15783,crizotinib,serine/threonine-protein kinase sbk1,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
15784,crizotinib,peripheral plasma membrane protein cask,kinase,,Drug: crizotinib | Target: peripheral plasma membrane protein cask | Type: kinase | Action: nan
15785,crizotinib,mitogen-activated protein kinase kinase kinase 12,kinase,,Drug: crizotinib | Target: mitogen-activated protein kinase kinase kinase 12 | Type: kinase | Action: nan
15786,crizotinib,serine/threonine-protein kinase tao2,kinase,,Drug: crizotinib | Target: serine/threonine-protein kinase tao2 | Type: kinase | Action: nan
15787,crizotinib,dual serine/threonine and tyrosine protein kinase,kinase,,Drug: crizotinib | Target: dual serine/threonine and tyrosine protein kinase | Type: kinase | Action: nan
15788,crizotinib,npm/alk (nucleophosmin/alk tyrosine kinase receptor),kinase,,Drug: crizotinib | Target: npm/alk (nucleophosmin/alk tyrosine kinase receptor) | Type: kinase | Action: nan
15789,crizotinib,"phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",enzyme,,"Drug: crizotinib | Target: phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | Type: enzyme | Action: nan"
15790,crizotinib,receptor-interacting serine/threonine-protein kinase 3,kinase,,Drug: crizotinib | Target: receptor-interacting serine/threonine-protein kinase 3 | Type: kinase | Action: nan
15791,crizotinib,mixed lineage kinase domain-like protein,kinase,,Drug: crizotinib | Target: mixed lineage kinase domain-like protein | Type: kinase | Action: nan
15793,deferiprone,deoxyhypusine hydroxylase,enzyme,,Drug: deferiprone | Target: deoxyhypusine hydroxylase | Type: enzyme | Action: nan
15794,hydroxyprogesterone caproate,glucocorticoid receptor,nuclear hormone receptor,,Drug: hydroxyprogesterone caproate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: nan
15795,hydroxyprogesterone caproate,sodium-dependent dopamine transporter,transporter,,Drug: hydroxyprogesterone caproate | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
15796,hydroxyprogesterone caproate,adenosine receptor a3,gpcr,,Drug: hydroxyprogesterone caproate | Target: adenosine receptor a3 | Type: gpcr | Action: nan
15797,hydroxyprogesterone caproate,corticosteroid-binding globulin,secreted,,Drug: hydroxyprogesterone caproate | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
15798,hydroxyprogesterone caproate,sex hormone-binding globulin,secreted,,Drug: hydroxyprogesterone caproate | Target: sex hormone-binding globulin | Type: secreted | Action: nan
15799,hydroxyprogesterone caproate,mitogen-activated protein kinase 3,kinase,,Drug: hydroxyprogesterone caproate | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
15800,hydroxyprogesterone caproate,androgen receptor,transcription factor,,Drug: hydroxyprogesterone caproate | Target: androgen receptor | Type: transcription factor | Action: nan
15801,hydroxyprogesterone caproate,progesterone receptor,transcription factor,,Drug: hydroxyprogesterone caproate | Target: progesterone receptor | Type: transcription factor | Action: nan
15802,hydroxyprogesterone caproate,progesterone receptor,nuclear hormone receptor,AGONIST,Drug: hydroxyprogesterone caproate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: AGONIST
15803,ruxolitinib,tyrosine-protein kinase jak3,kinase,,Drug: ruxolitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
15804,ruxolitinib,tyrosine-protein kinase abl1,kinase,,Drug: ruxolitinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
15805,ruxolitinib,mast/stem cell growth factor receptor kit,kinase,,Drug: ruxolitinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
15806,ruxolitinib,serine/threonine-protein kinase b-raf,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
15807,ruxolitinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: ruxolitinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
15808,ruxolitinib,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: ruxolitinib | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
15809,ruxolitinib,"myosin light chain kinase, smooth muscle",kinase,,"Drug: ruxolitinib | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
15810,ruxolitinib,death-associated protein kinase 3,kinase,,Drug: ruxolitinib | Target: death-associated protein kinase 3 | Type: kinase | Action: nan
15811,ruxolitinib,histone deacetylase 6,enzyme,,Drug: ruxolitinib | Target: histone deacetylase 6 | Type: enzyme | Action: nan
15812,ruxolitinib,calcium/calmodulin-dependent protein kinase type 1,kinase,,Drug: ruxolitinib | Target: calcium/calmodulin-dependent protein kinase type 1 | Type: kinase | Action: nan
15813,ruxolitinib,mitogen-activated protein kinase 8,kinase,,Drug: ruxolitinib | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
15814,ruxolitinib,rho-associated protein kinase 1,kinase,,Drug: ruxolitinib | Target: rho-associated protein kinase 1 | Type: kinase | Action: nan
15815,ruxolitinib,tyrosine-protein kinase jak1,kinase,INHIBITOR,Drug: ruxolitinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: INHIBITOR
15816,ruxolitinib,serine/threonine-protein kinase plk1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase plk1 | Type: kinase | Action: nan
15817,ruxolitinib,death-associated protein kinase 2,kinase,,Drug: ruxolitinib | Target: death-associated protein kinase 2 | Type: kinase | Action: nan
15818,ruxolitinib,high affinity nerve growth factor receptor,kinase,,Drug: ruxolitinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
15819,ruxolitinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: ruxolitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
15820,ruxolitinib,rho-associated protein kinase 2,kinase,,Drug: ruxolitinib | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
15821,ruxolitinib,calcium/calmodulin-dependent protein kinase type ii subunit delta,kinase,,Drug: ruxolitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit delta | Type: kinase | Action: nan
15822,ruxolitinib,calcium/calmodulin-dependent protein kinase type ii subunit gamma,kinase,,Drug: ruxolitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit gamma | Type: kinase | Action: nan
15823,ruxolitinib,ap2-associated protein kinase 1,kinase,,Drug: ruxolitinib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
15824,ruxolitinib,serine/threonine-protein kinase mark2,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase mark2 | Type: kinase | Action: nan
15825,ruxolitinib,ribosomal protein s6 kinase alpha-2,kinase,,Drug: ruxolitinib | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
15826,ruxolitinib,calcium/calmodulin-dependent protein kinase type ii subunit beta,kinase,,Drug: ruxolitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit beta | Type: kinase | Action: nan
15827,ruxolitinib,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: ruxolitinib | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
15828,ruxolitinib,calcium/calmodulin-dependent protein kinase type ii subunit alpha,kinase,,Drug: ruxolitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit alpha | Type: kinase | Action: nan
15829,ruxolitinib,serine/threonine-protein kinase 17b,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase 17b | Type: kinase | Action: nan
15830,ruxolitinib,protein kinase c epsilon type,kinase,,Drug: ruxolitinib | Target: protein kinase c epsilon type | Type: kinase | Action: nan
15831,ruxolitinib,serine/threonine-protein kinase plk4,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
15832,ruxolitinib,aurora kinase c,kinase,,Drug: ruxolitinib | Target: aurora kinase c | Type: kinase | Action: nan
15833,ruxolitinib,serine/threonine-protein kinase 16,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase 16 | Type: kinase | Action: nan
15834,ruxolitinib,dual specificity protein kinase ttk,kinase,,Drug: ruxolitinib | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
15835,ruxolitinib,serine/threonine-protein kinase 17a,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
15836,ruxolitinib,alk tyrosine kinase receptor,kinase,,Drug: ruxolitinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
15837,ruxolitinib,ephrin type-a receptor 3,kinase,,Drug: ruxolitinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
15838,ruxolitinib,bmp-2-inducible protein kinase,kinase,,Drug: ruxolitinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
15839,ruxolitinib,dual specificity protein kinase clk2,kinase,,Drug: ruxolitinib | Target: dual specificity protein kinase clk2 | Type: kinase | Action: nan
15840,ruxolitinib,cyclin-g-associated kinase,kinase,,Drug: ruxolitinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
15841,ruxolitinib,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: ruxolitinib | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
15842,ruxolitinib,activated cdc42 kinase 1,kinase,,Drug: ruxolitinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
15843,ruxolitinib,ribosomal protein s6 kinase alpha-5,kinase,,Drug: ruxolitinib | Target: ribosomal protein s6 kinase alpha-5 | Type: kinase | Action: nan
15844,ruxolitinib,dual specificity protein kinase clk4,kinase,,Drug: ruxolitinib | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
15845,ruxolitinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: ruxolitinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
15846,ruxolitinib,calcium/calmodulin-dependent protein kinase type 1g,kinase,,Drug: ruxolitinib | Target: calcium/calmodulin-dependent protein kinase type 1g | Type: kinase | Action: nan
15847,ruxolitinib,inhibitor of nuclear factor kappa-b kinase subunit beta,kinase,,Drug: ruxolitinib | Target: inhibitor of nuclear factor kappa-b kinase subunit beta | Type: kinase | Action: nan
15848,ruxolitinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: ruxolitinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
15849,ruxolitinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: ruxolitinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
15850,ruxolitinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: ruxolitinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
15851,ruxolitinib,cyclin-dependent kinase 7,kinase,,Drug: ruxolitinib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
15852,ruxolitinib,serine/threonine-protein kinase dclk3,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase dclk3 | Type: kinase | Action: nan
15853,ruxolitinib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: ruxolitinib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
15854,ruxolitinib,nuak family snf1-like kinase 2,kinase,,Drug: ruxolitinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
15855,ruxolitinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: ruxolitinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
15856,ruxolitinib,serine/threonine-protein kinase 25,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase 25 | Type: kinase | Action: nan
15857,ruxolitinib,serine/threonine-protein kinase rio1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
15858,ruxolitinib,nt-3 growth factor receptor,kinase,,Drug: ruxolitinib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
15859,ruxolitinib,casein kinase ii subunit alpha,kinase,,Drug: ruxolitinib | Target: casein kinase ii subunit alpha | Type: kinase | Action: nan
15860,ruxolitinib,casein kinase ii subunit alpha',kinase,,Drug: ruxolitinib | Target: casein kinase ii subunit alpha' | Type: kinase | Action: nan
15861,ruxolitinib,inhibitor of nuclear factor kappa-b kinase subunit epsilon,kinase,,Drug: ruxolitinib | Target: inhibitor of nuclear factor kappa-b kinase subunit epsilon | Type: kinase | Action: nan
15862,ruxolitinib,dual specificity mitogen-activated protein kinase kinase 3,kinase,,Drug: ruxolitinib | Target: dual specificity mitogen-activated protein kinase kinase 3 | Type: kinase | Action: nan
15863,ruxolitinib,maternal embryonic leucine zipper kinase,kinase,,Drug: ruxolitinib | Target: maternal embryonic leucine zipper kinase | Type: kinase | Action: nan
15864,ruxolitinib,serine/threonine-protein kinase 26,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase 26 | Type: kinase | Action: nan
15865,ruxolitinib,serine/threonine-protein kinase nek7,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase nek7 | Type: kinase | Action: nan
15866,ruxolitinib,serine/threonine-protein kinase rio3,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
15867,ruxolitinib,srsf protein kinase 1,kinase,,Drug: ruxolitinib | Target: srsf protein kinase 1 | Type: kinase | Action: nan
15868,ruxolitinib,ankyrin repeat and protein kinase domain-containing protein 1,kinase,,Drug: ruxolitinib | Target: ankyrin repeat and protein kinase domain-containing protein 1 | Type: kinase | Action: nan
15869,ruxolitinib,myotonin-protein kinase,kinase,,Drug: ruxolitinib | Target: myotonin-protein kinase | Type: kinase | Action: nan
15870,ruxolitinib,leukocyte tyrosine kinase receptor,kinase,,Drug: ruxolitinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
15871,ruxolitinib,serine/threonine-protein kinase pak 6,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase pak 6 | Type: kinase | Action: nan
15872,ruxolitinib,serine/threonine-protein kinase pak 7,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase pak 7 | Type: kinase | Action: nan
15873,ruxolitinib,bone morphogenetic protein receptor type-2,kinase,,Drug: ruxolitinib | Target: bone morphogenetic protein receptor type-2 | Type: kinase | Action: nan
15874,ruxolitinib,dual specificity mitogen-activated protein kinase kinase 4,kinase,,Drug: ruxolitinib | Target: dual specificity mitogen-activated protein kinase kinase 4 | Type: kinase | Action: nan
15875,ruxolitinib,death-associated protein kinase 1,kinase,,Drug: ruxolitinib | Target: death-associated protein kinase 1 | Type: kinase | Action: nan
15876,ruxolitinib,serine/threonine-protein kinase dclk1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase dclk1 | Type: kinase | Action: nan
15877,ruxolitinib,serine/threonine-protein kinase dclk2,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase dclk2 | Type: kinase | Action: nan
15878,ruxolitinib,serine/threonine-protein kinase pak 4,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase pak 4 | Type: kinase | Action: nan
15879,ruxolitinib,serine/threonine-protein kinase plk3,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase plk3 | Type: kinase | Action: nan
15880,ruxolitinib,cgmp-dependent protein kinase 2,kinase,,Drug: ruxolitinib | Target: cgmp-dependent protein kinase 2 | Type: kinase | Action: nan
15881,ruxolitinib,ribosomal protein s6 kinase alpha-1,kinase,,Drug: ruxolitinib | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
15882,ruxolitinib,ribosomal protein s6 kinase alpha-4,kinase,,Drug: ruxolitinib | Target: ribosomal protein s6 kinase alpha-4 | Type: kinase | Action: nan
15883,ruxolitinib,casein kinase i isoform alpha,kinase,,Drug: ruxolitinib | Target: casein kinase i isoform alpha | Type: kinase | Action: nan
15884,ruxolitinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: ruxolitinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
15885,ruxolitinib,serine/threonine-protein kinase tbk1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
15886,ruxolitinib,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,,Drug: ruxolitinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: nan
15887,ruxolitinib,dual specificity tyrosine-phosphorylation-regulated kinase 2,kinase,,Drug: ruxolitinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 2 | Type: kinase | Action: nan
15888,ruxolitinib,ephrin type-b receptor 6,kinase,,Drug: ruxolitinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
15889,ruxolitinib,serine/threonine-protein kinase/endoribonuclease ire1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase/endoribonuclease ire1 | Type: kinase | Action: nan
15890,ruxolitinib,rhodopsin kinase,kinase,,Drug: ruxolitinib | Target: rhodopsin kinase | Type: kinase | Action: nan
15891,ruxolitinib,g protein-coupled receptor kinase 4,kinase,,Drug: ruxolitinib | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
15892,ruxolitinib,g protein-coupled receptor kinase 7,kinase,,Drug: ruxolitinib | Target: g protein-coupled receptor kinase 7 | Type: kinase | Action: nan
15893,ruxolitinib,homeodomain-interacting protein kinase 2,kinase,,Drug: ruxolitinib | Target: homeodomain-interacting protein kinase 2 | Type: kinase | Action: nan
15894,ruxolitinib,homeodomain-interacting protein kinase 3,kinase,,Drug: ruxolitinib | Target: homeodomain-interacting protein kinase 3 | Type: kinase | Action: nan
15895,ruxolitinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: ruxolitinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
15896,ruxolitinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: ruxolitinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
15897,ruxolitinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: ruxolitinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
15898,ruxolitinib,microtubule-associated serine/threonine-protein kinase 1,kinase,,Drug: ruxolitinib | Target: microtubule-associated serine/threonine-protein kinase 1 | Type: kinase | Action: nan
15899,ruxolitinib,serine/threonine-protein kinase osr1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase osr1 | Type: kinase | Action: nan
15900,ruxolitinib,serine/threonine-protein kinase rio2,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase rio2 | Type: kinase | Action: nan
15901,ruxolitinib,srsf protein kinase 3,kinase,,Drug: ruxolitinib | Target: srsf protein kinase 3 | Type: kinase | Action: nan
15902,ruxolitinib,ste20/sps1-related proline-alanine-rich protein kinase,kinase,,Drug: ruxolitinib | Target: ste20/sps1-related proline-alanine-rich protein kinase | Type: kinase | Action: nan
15903,ruxolitinib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: ruxolitinib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
15904,ruxolitinib,serine/threonine-protein kinase tao1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
15905,ruxolitinib,serine/threonine-protein kinase tao3,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
15906,ruxolitinib,serine/threonine-protein kinase ulk1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase ulk1 | Type: kinase | Action: nan
15907,ruxolitinib,serine/threonine-protein kinase ulk2,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase ulk2 | Type: kinase | Action: nan
15908,ruxolitinib,serine/threonine-protein kinase ulk3,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
15909,ruxolitinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: ruxolitinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
15910,ruxolitinib,homeodomain-interacting protein kinase 1,kinase,,Drug: ruxolitinib | Target: homeodomain-interacting protein kinase 1 | Type: kinase | Action: nan
15911,ruxolitinib,mitogen-activated protein kinase kinase kinase 15,kinase,,Drug: ruxolitinib | Target: mitogen-activated protein kinase kinase kinase 15 | Type: kinase | Action: nan
15912,ruxolitinib,serine/threonine-protein kinase plk2,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase plk2 | Type: kinase | Action: nan
15913,ruxolitinib,receptor-interacting serine/threonine-protein kinase 4,kinase,,Drug: ruxolitinib | Target: receptor-interacting serine/threonine-protein kinase 4 | Type: kinase | Action: nan
15914,ruxolitinib,uncharacterized serine/threonine-protein kinase sbk3,kinase,,Drug: ruxolitinib | Target: uncharacterized serine/threonine-protein kinase sbk3 | Type: kinase | Action: nan
15915,ruxolitinib,mitogen-activated protein kinase kinase kinase 1,kinase,,Drug: ruxolitinib | Target: mitogen-activated protein kinase kinase kinase 1 | Type: kinase | Action: nan
15916,ruxolitinib,phosphatidylinositol 4-kinase beta,kinase,,Drug: ruxolitinib | Target: phosphatidylinositol 4-kinase beta | Type: kinase | Action: nan
15917,ruxolitinib,serine/threonine-protein kinase sik3,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase sik3 | Type: kinase | Action: nan
15918,ruxolitinib,bone morphogenetic protein receptor type-1b,kinase,,Drug: ruxolitinib | Target: bone morphogenetic protein receptor type-1b | Type: kinase | Action: nan
15919,ruxolitinib,serine/threonine-protein kinase sbk1,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
15920,ruxolitinib,serine/threonine-protein kinase nek3,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase nek3 | Type: kinase | Action: nan
15921,ruxolitinib,peripheral plasma membrane protein cask,kinase,,Drug: ruxolitinib | Target: peripheral plasma membrane protein cask | Type: kinase | Action: nan
15922,ruxolitinib,serine/threonine-protein kinase vrk2,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase vrk2 | Type: kinase | Action: nan
15923,ruxolitinib,serine/threonine-protein kinase tao2,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase tao2 | Type: kinase | Action: nan
15924,ruxolitinib,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: ruxolitinib | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
15925,ruxolitinib,tyrosine-protein kinase jak2,kinase,,Drug: ruxolitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
15926,ruxolitinib,serine/threonine-protein kinase pknb,kinase,,Drug: ruxolitinib | Target: serine/threonine-protein kinase pknb | Type: kinase | Action: nan
15927,ruxolitinib,jak2/jak1,kinase,,Drug: ruxolitinib | Target: jak2/jak1 | Type: kinase | Action: nan
15928,ruxolitinib,jak3/jak1,kinase,,Drug: ruxolitinib | Target: jak3/jak1 | Type: kinase | Action: nan
15929,ruxolitinib,jak1/tyk2,kinase,,Drug: ruxolitinib | Target: jak1/tyk2 | Type: kinase | Action: nan
15930,ruxolitinib,jak1/jak2/tyk2,kinase,,Drug: ruxolitinib | Target: jak1/jak2/tyk2 | Type: kinase | Action: nan
15931,ruxolitinib,jak2/tyk2,kinase,,Drug: ruxolitinib | Target: jak2/tyk2 | Type: kinase | Action: nan
15932,ruxolitinib,oxysterols receptor lxr-beta,nuclear other,,Drug: ruxolitinib | Target: oxysterols receptor lxr-beta | Type: nuclear other | Action: nan
15936,fesoterodine,muscarinic acetylcholine receptor m1,gpcr,,Drug: fesoterodine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
15937,fesoterodine,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: fesoterodine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
15938,fesoterodine,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: fesoterodine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
15939,fesoterodine,muscarinic acetylcholine receptor m4,gpcr,,Drug: fesoterodine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
15940,fesoterodine,muscarinic acetylcholine receptor m5,gpcr,,Drug: fesoterodine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
15941,tafamidis,atp-binding cassette sub-family g member 2,transporter,INHIBITOR,Drug: tafamidis | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: INHIBITOR
15942,tafamidis,solute carrier family 22 member 6,transporter,INHIBITOR,Drug: tafamidis | Target: solute carrier family 22 member 6 | Type: transporter | Action: INHIBITOR
15943,tafamidis,solute carrier family 22 member 8,transporter,INHIBITOR,Drug: tafamidis | Target: solute carrier family 22 member 8 | Type: transporter | Action: INHIBITOR
15944,tafamidis,transthyretin,secreted,BINDING AGENT,Drug: tafamidis | Target: transthyretin | Type: secreted | Action: BINDING AGENT
15945,cyanocobalamin,methionine synthase,enzyme,,Drug: cyanocobalamin | Target: methionine synthase | Type: enzyme | Action: nan
15946,cyanocobalamin,methionine synthase reductase,enzyme,,Drug: cyanocobalamin | Target: methionine synthase reductase | Type: enzyme | Action: nan
15947,cyanocobalamin,protein amnionless,unclassified,,Drug: cyanocobalamin | Target: protein amnionless | Type: unclassified | Action: nan
15948,cyanocobalamin,"cob(i)yrinic acid a,c-diamide adenosyltransferase, mitochondrial",enzyme,,"Drug: cyanocobalamin | Target: cob(i)yrinic acid a,c-diamide adenosyltransferase, mitochondrial | Type: enzyme | Action: nan"
15949,cyanocobalamin,"methylmalonic aciduria type a protein, mitochondrial",enzyme,,"Drug: cyanocobalamin | Target: methylmalonic aciduria type a protein, mitochondrial | Type: enzyme | Action: nan"
15950,cyanocobalamin,transcobalamin-2,secreted,,Drug: cyanocobalamin | Target: transcobalamin-2 | Type: secreted | Action: nan
15951,cyanocobalamin,transcobalamin-1,secreted,,Drug: cyanocobalamin | Target: transcobalamin-1 | Type: secreted | Action: nan
15952,vitamin a palmitate,retinol-binding protein 4,secreted,,Drug: vitamin a palmitate | Target: retinol-binding protein 4 | Type: secreted | Action: nan
15953,vitamin a palmitate,beta-lactoglobulin,unclassified,,Drug: vitamin a palmitate | Target: beta-lactoglobulin | Type: unclassified | Action: nan
15954,potassium chloride,carbonic anhydrase 4,enzyme,,Drug: potassium chloride | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
15955,sodium acetate,carbonic anhydrase 1,enzyme,,Drug: sodium acetate | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
15956,sodium acetate,carbonic anhydrase,enzyme,,Drug: sodium acetate | Target: carbonic anhydrase | Type: enzyme | Action: nan
15957,lithium carbonate,glycogen synthase kinase-3,kinase,INHIBITOR,Drug: lithium carbonate | Target: glycogen synthase kinase-3 | Type: kinase | Action: INHIBITOR
15958,lithium carbonate,inositol-1(or 4)-monophosphatase 1,enzyme,INHIBITOR,Drug: lithium carbonate | Target: inositol-1(or 4)-monophosphatase 1 | Type: enzyme | Action: INHIBITOR
15959,prazosin,alpha-2a adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15960,prazosin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: prazosin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
15961,prazosin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: prazosin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
15962,prazosin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: prazosin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
15963,prazosin,alpha-1a adrenergic receptor,gpcr,INVERSE AGONIST,Drug: prazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: INVERSE AGONIST
15964,prazosin,alpha-2b adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
15965,prazosin,5-hydroxytryptamine receptor 1d,gpcr,,Drug: prazosin | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
15966,prazosin,alpha-2c adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
15967,prazosin,adenosine receptor a3,gpcr,,Drug: prazosin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
15968,prazosin,d(4) dopamine receptor,gpcr,,Drug: prazosin | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
15969,prazosin,alpha-1d adrenergic receptor,gpcr,INVERSE AGONIST,Drug: prazosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: INVERSE AGONIST
15970,prazosin,alpha-1b adrenergic receptor,gpcr,INVERSE AGONIST,Drug: prazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: INVERSE AGONIST
15971,prazosin,ribosyldihydronicotinamide dehydrogenase [quinone],enzyme,,Drug: prazosin | Target: ribosyldihydronicotinamide dehydrogenase [quinone] | Type: enzyme | Action: nan
15972,prazosin,matrix metalloproteinase-9,enzyme,,Drug: prazosin | Target: matrix metalloproteinase-9 | Type: enzyme | Action: nan
15973,prazosin,interstitial collagenase,enzyme,,Drug: prazosin | Target: interstitial collagenase | Type: enzyme | Action: nan
15974,prazosin,solute carrier family 22 member 1,transporter,,Drug: prazosin | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
15975,prazosin,alpha-1b adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
15976,prazosin,alpha-1a adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
15977,prazosin,alpha-1d adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
15978,prazosin,mu-type opioid receptor,gpcr,,Drug: prazosin | Target: mu-type opioid receptor | Type: gpcr | Action: nan
15979,prazosin,d(2) dopamine receptor,gpcr,,Drug: prazosin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
15980,prazosin,5-hydroxytryptamine receptor 1a,gpcr,,Drug: prazosin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
15981,prazosin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: prazosin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
15982,prazosin,alpha-2a adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15983,prazosin,alpha-1a adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
15984,prazosin,alpha-2a adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15985,prazosin,alpha-2a adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
15986,prazosin,alpha-1b adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
15987,prazosin,solute carrier family 22 member 2,transporter,,Drug: prazosin | Target: solute carrier family 22 member 2 | Type: transporter | Action: nan
15988,prazosin,multidrug and toxin extrusion protein 1,transporter,,Drug: prazosin | Target: multidrug and toxin extrusion protein 1 | Type: transporter | Action: nan
15989,prazosin,multidrug and toxin extrusion protein 2,transporter,,Drug: prazosin | Target: multidrug and toxin extrusion protein 2 | Type: transporter | Action: nan
15990,prazosin,adrenergic receptor alpha-2,gpcr,,Drug: prazosin | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
15991,prazosin,adrenergic receptor alpha-1,gpcr,,Drug: prazosin | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
15992,prazosin,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: prazosin | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
15993,prazosin,serotonin 2 (5-ht2) receptor,gpcr,,Drug: prazosin | Target: serotonin 2 (5-ht2) receptor | Type: gpcr | Action: nan
15994,prazosin,alpha-2 adrenergic receptor,gpcr,,Drug: prazosin | Target: alpha-2 adrenergic receptor | Type: gpcr | Action: nan
15995,prazosin,beta-casein,unclassified,,Drug: prazosin | Target: beta-casein | Type: unclassified | Action: nan
15996,acetic acid,tyrosine-protein kinase lck,kinase,,Drug: acetic acid | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
15997,acetic acid,tyrosine-protein kinase fyn,kinase,,Drug: acetic acid | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
15998,acetic acid,free fatty acid receptor 2,gpcr,AGONIST,Drug: acetic acid | Target: free fatty acid receptor 2 | Type: gpcr | Action: AGONIST
15999,acetic acid,free fatty acid receptor 3,gpcr,,Drug: acetic acid | Target: free fatty acid receptor 3 | Type: gpcr | Action: nan
16000,hydrocortisone acetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortisone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16001,hydrocortisone acetate,corticosteroid-binding globulin,secreted,,Drug: hydrocortisone acetate | Target: corticosteroid-binding globulin | Type: secreted | Action: nan
16002,methyldopate,adrenergic receptor alpha-2,gpcr,AGONIST,Drug: methyldopate | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: AGONIST
16003,sodium phosphate,carbonic anhydrase 4,enzyme,,Drug: sodium phosphate | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16004,telbivudine,capsid protein,unclassified,,Drug: telbivudine | Target: capsid protein | Type: unclassified | Action: nan
16005,telbivudine,protein p,polyprotein,INHIBITOR,Drug: telbivudine | Target: protein p | Type: polyprotein | Action: INHIBITOR
16006,mequinol,tyrosinase,enzyme,INHIBITOR,Drug: mequinol | Target: tyrosinase | Type: enzyme | Action: INHIBITOR
16007,vilazodone,d(2) dopamine receptor,gpcr,AGONIST,Drug: vilazodone | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
16008,vilazodone,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: vilazodone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
16009,vilazodone,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
16010,vilazodone,5-hydroxytryptamine receptor 7,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
16011,vilazodone,d(3) dopamine receptor,gpcr,AGONIST,Drug: vilazodone | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
16012,vilazodone,histamine h1 receptor,gpcr,AGONIST,Drug: vilazodone | Target: histamine h1 receptor | Type: gpcr | Action: AGONIST
16013,vilazodone,5-hydroxytryptamine receptor 4,gpcr,AGONIST,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: AGONIST
16014,vilazodone,5-hydroxytryptamine receptor 1b,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
16015,vilazodone,d(2) dopamine receptor,gpcr,,Drug: vilazodone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
16016,vilazodone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
16017,vilazodone,sodium-dependent serotonin transporter,transporter,,Drug: vilazodone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
16018,vilazodone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
16019,vilazodone,5-hydroxytryptamine receptor 7,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
16020,vilazodone,acetylcholinesterase,enzyme,,Drug: vilazodone | Target: acetylcholinesterase | Type: enzyme | Action: nan
16021,vilazodone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
16022,vilazodone,5-hydroxytryptamine receptor 4,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 4 | Type: gpcr | Action: nan
16023,vilazodone,d(3) dopamine receptor,gpcr,,Drug: vilazodone | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
16024,vilazodone,5-hydroxytryptamine receptor 1d,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: nan
16025,vilazodone,d(4) dopamine receptor,gpcr,,Drug: vilazodone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
16026,vilazodone,5-hydroxytryptamine receptor 6,gpcr,,Drug: vilazodone | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
16027,vilazodone,serotonin 3 (5-ht3) receptor,ion channel,,Drug: vilazodone | Target: serotonin 3 (5-ht3) receptor | Type: ion channel | Action: nan
16028,vilazodone,adrenergic receptor alpha-2,gpcr,,Drug: vilazodone | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
16029,vilazodone,adrenergic receptor alpha-1,gpcr,,Drug: vilazodone | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
16031,axitinib,tyrosine-protein kinase jak3,kinase,,Drug: axitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
16032,axitinib,platelet-derived growth factor receptor beta,kinase,,Drug: axitinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
16033,axitinib,tyrosine-protein kinase abl1,kinase,,Drug: axitinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
16034,axitinib,mast/stem cell growth factor receptor kit,kinase,,Drug: axitinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
16035,axitinib,epidermal growth factor receptor,kinase,,Drug: axitinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
16036,axitinib,tyrosine-protein kinase lck,kinase,,Drug: axitinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
16037,axitinib,tyrosine-protein kinase yes,kinase,,Drug: axitinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
16038,axitinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: axitinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
16039,axitinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: axitinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
16040,axitinib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: axitinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
16041,axitinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: axitinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
16042,axitinib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: axitinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
16043,axitinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: axitinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
16044,axitinib,platelet-derived growth factor receptor alpha,kinase,,Drug: axitinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
16045,axitinib,mitogen-activated protein kinase 8,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
16046,axitinib,fibroblast growth factor receptor 3,kinase,,Drug: axitinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
16047,axitinib,mitogen-activated protein kinase 10,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
16048,axitinib,high affinity nerve growth factor receptor,kinase,,Drug: axitinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
16049,axitinib,tyrosine-protein kinase jak2,kinase,,Drug: axitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
16050,axitinib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: axitinib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
16051,axitinib,tyrosine-protein kinase csk,kinase,,Drug: axitinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
16052,axitinib,angiopoietin-1 receptor,kinase,,Drug: axitinib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
16053,axitinib,ap2-associated protein kinase 1,kinase,,Drug: axitinib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
16054,axitinib,hepatocyte growth factor receptor,kinase,,Drug: axitinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
16055,axitinib,fibroblast growth factor receptor 1,kinase,,Drug: axitinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
16056,axitinib,serine/threonine-protein kinase 10,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
16057,axitinib,serine/threonine-protein kinase plk4,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
16058,axitinib,aurora kinase c,kinase,,Drug: axitinib | Target: aurora kinase c | Type: kinase | Action: nan
16059,axitinib,serine/threonine-protein kinase 16,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase 16 | Type: kinase | Action: nan
16060,axitinib,dual specificity protein kinase ttk,kinase,,Drug: axitinib | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
16061,axitinib,abelson tyrosine-protein kinase 2,kinase,,Drug: axitinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
16062,axitinib,fibroblast growth factor receptor 2,kinase,,Drug: axitinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
16063,axitinib,traf2 and nck-interacting protein kinase,kinase,,Drug: axitinib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
16064,axitinib,tyrosine-protein kinase fgr,kinase,,Drug: axitinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
16065,axitinib,aurora kinase a,kinase,,Drug: axitinib | Target: aurora kinase a | Type: kinase | Action: nan
16066,axitinib,bmp-2-inducible protein kinase,kinase,,Drug: axitinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
16067,axitinib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
16068,axitinib,mitogen-activated protein kinase kinase kinase 4,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase 4 | Type: kinase | Action: nan
16069,axitinib,cyclin-g-associated kinase,kinase,,Drug: axitinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
16070,axitinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: axitinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
16071,axitinib,cyclin-dependent kinase 16,kinase,,Drug: axitinib | Target: cyclin-dependent kinase 16 | Type: kinase | Action: nan
16072,axitinib,serine/threonine-protein kinase 4,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
16073,axitinib,activated cdc42 kinase 1,kinase,,Drug: axitinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
16074,axitinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: axitinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
16075,axitinib,calcium/calmodulin-dependent protein kinase kinase 2,kinase,,Drug: axitinib | Target: calcium/calmodulin-dependent protein kinase kinase 2 | Type: kinase | Action: nan
16076,axitinib,calcium/calmodulin-dependent protein kinase kinase 1,kinase,,Drug: axitinib | Target: calcium/calmodulin-dependent protein kinase kinase 1 | Type: kinase | Action: nan
16077,axitinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: axitinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
16078,axitinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: axitinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
16079,axitinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: axitinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
16080,axitinib,tyrosine-protein kinase itk/tsk,kinase,,Drug: axitinib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: nan
16081,axitinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: axitinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
16082,axitinib,serine/threonine-protein kinase n2,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase n2 | Type: kinase | Action: nan
16083,axitinib,serine/threonine-protein kinase 3,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
16084,axitinib,nuak family snf1-like kinase 2,kinase,,Drug: axitinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
16085,axitinib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: axitinib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
16086,axitinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: axitinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
16087,axitinib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
16088,axitinib,serine/threonine-protein kinase rio1,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
16089,axitinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: axitinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
16090,axitinib,tyrosine-protein kinase txk,kinase,,Drug: axitinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
16091,axitinib,casein kinase ii subunit alpha',kinase,,Drug: axitinib | Target: casein kinase ii subunit alpha' | Type: kinase | Action: nan
16092,axitinib,serine/threonine-protein kinase rio3,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
16093,axitinib,srsf protein kinase 1,kinase,,Drug: axitinib | Target: srsf protein kinase 1 | Type: kinase | Action: nan
16094,axitinib,activin receptor type-2b,kinase,,Drug: axitinib | Target: activin receptor type-2b | Type: kinase | Action: nan
16095,axitinib,ankyrin repeat and protein kinase domain-containing protein 1,kinase,,Drug: axitinib | Target: ankyrin repeat and protein kinase domain-containing protein 1 | Type: kinase | Action: nan
16096,axitinib,discoidin domain-containing receptor 2,kinase,,Drug: axitinib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
16097,axitinib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
16098,axitinib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
16099,axitinib,aurora kinase b,kinase,,Drug: axitinib | Target: aurora kinase b | Type: kinase | Action: nan
16100,axitinib,tyrosine-protein kinase blk,kinase,,Drug: axitinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
16101,axitinib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
16102,axitinib,tyrosine-protein kinase mer,kinase,,Drug: axitinib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
16103,axitinib,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
16104,axitinib,serine/threonine-protein kinase mrck beta,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase mrck beta | Type: kinase | Action: nan
16105,axitinib,myosin-iiia,kinase,,Drug: axitinib | Target: myosin-iiia | Type: kinase | Action: nan
16106,axitinib,serine/threonine-protein kinase pak 4,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase pak 4 | Type: kinase | Action: nan
16107,axitinib,serine/threonine-protein kinase sik1,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
16108,axitinib,dual specificity testis-specific protein kinase 1,kinase,,Drug: axitinib | Target: dual specificity testis-specific protein kinase 1 | Type: kinase | Action: nan
16109,axitinib,"interferon-induced, double-stranded rna-activated protein kinase",kinase,,"Drug: axitinib | Target: interferon-induced, double-stranded rna-activated protein kinase | Type: kinase | Action: nan"
16110,axitinib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: axitinib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
16111,axitinib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: axitinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
16112,axitinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
16113,axitinib,misshapen-like kinase 1,kinase,,Drug: axitinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
16114,axitinib,cyclin-dependent kinase-like 2,kinase,,Drug: axitinib | Target: cyclin-dependent kinase-like 2 | Type: kinase | Action: nan
16115,axitinib,ephrin type-b receptor 6,kinase,,Drug: axitinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
16116,axitinib,g protein-coupled receptor kinase 4,kinase,,Drug: axitinib | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
16117,axitinib,hormonally up-regulated neu tumor-associated kinase,kinase,,Drug: axitinib | Target: hormonally up-regulated neu tumor-associated kinase | Type: kinase | Action: nan
16118,axitinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: axitinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
16119,axitinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
16120,axitinib,srsf protein kinase 3,kinase,,Drug: axitinib | Target: srsf protein kinase 3 | Type: kinase | Action: nan
16121,axitinib,serine/threonine-protein kinase ulk2,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase ulk2 | Type: kinase | Action: nan
16122,axitinib,serine/threonine-protein kinase ulk3,kinase,,Drug: axitinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
16123,axitinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
16124,axitinib,receptor-interacting serine/threonine-protein kinase 4,kinase,,Drug: axitinib | Target: receptor-interacting serine/threonine-protein kinase 4 | Type: kinase | Action: nan
16125,axitinib,bone morphogenetic protein receptor type-1b,kinase,,Drug: axitinib | Target: bone morphogenetic protein receptor type-1b | Type: kinase | Action: nan
16126,axitinib,mitogen-activated protein kinase kinase kinase 12,kinase,,Drug: axitinib | Target: mitogen-activated protein kinase kinase kinase 12 | Type: kinase | Action: nan
16127,axitinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: axitinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
16128,axitinib,myosin light chain kinase 3,kinase,,Drug: axitinib | Target: myosin light chain kinase 3 | Type: kinase | Action: nan
16129,axitinib,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: axitinib | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
16130,ingenol mebutate,protein kinase c gamma type,kinase,ACTIVATOR,Drug: ingenol mebutate | Target: protein kinase c gamma type | Type: kinase | Action: ACTIVATOR
16131,ingenol mebutate,protein kinase c beta type,kinase,,Drug: ingenol mebutate | Target: protein kinase c beta type | Type: kinase | Action: nan
16132,ingenol mebutate,protein kinase c alpha type,kinase,,Drug: ingenol mebutate | Target: protein kinase c alpha type | Type: kinase | Action: nan
16133,ingenol mebutate,protein kinase c epsilon type,kinase,,Drug: ingenol mebutate | Target: protein kinase c epsilon type | Type: kinase | Action: nan
16134,ingenol mebutate,serine/threonine-protein kinase d1,kinase,,Drug: ingenol mebutate | Target: serine/threonine-protein kinase d1 | Type: kinase | Action: nan
16135,ingenol mebutate,protein kinase c delta type,kinase,ACTIVATOR,Drug: ingenol mebutate | Target: protein kinase c delta type | Type: kinase | Action: ACTIVATOR
16136,vismodegib,sonic hedgehog protein,enzyme,,Drug: vismodegib | Target: sonic hedgehog protein | Type: enzyme | Action: nan
16137,vismodegib,sonic hedgehog protein,enzyme,,Drug: vismodegib | Target: sonic hedgehog protein | Type: enzyme | Action: nan
16138,vismodegib,smoothened homolog,gpcr,INHIBITOR,Drug: vismodegib | Target: smoothened homolog | Type: gpcr | Action: INHIBITOR
16139,vismodegib,smoothened homolog,gpcr,,Drug: vismodegib | Target: smoothened homolog | Type: gpcr | Action: nan
16140,ivacaftor,cystic fibrosis transmembrane conductance regulator,ion channel,POSITIVE MODULATOR,Drug: ivacaftor | Target: cystic fibrosis transmembrane conductance regulator | Type: ion channel | Action: POSITIVE MODULATOR
16141,tafluprost,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: tafluprost | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
16142,peginesatide,erythropoietin receptor,membrane receptor,AGONIST,Drug: peginesatide | Target: erythropoietin receptor | Type: membrane receptor | Action: AGONIST
16143,avobenzone,tyrosinase,enzyme,INHIBITOR,Drug: avobenzone | Target: tyrosinase | Type: enzyme | Action: INHIBITOR
16144,neomycin,transient receptor potential cation channel subfamily v member 1,ion channel,,Drug: neomycin | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: nan
16145,neomycin,lethal factor,enzyme,,Drug: neomycin | Target: lethal factor | Type: enzyme | Action: nan
16146,neomycin,lecithin retinol acyltransferase,enzyme,,Drug: neomycin | Target: lecithin retinol acyltransferase | Type: enzyme | Action: nan
16147,neomycin,menin,unclassified,,Drug: neomycin | Target: menin | Type: unclassified | Action: nan
16148,neomycin,extracellular calcium-sensing receptor,gpcr,AGONIST,Drug: neomycin | Target: extracellular calcium-sensing receptor | Type: gpcr | Action: AGONIST
16149,pyrithione zinc,carbonic anhydrase 4,enzyme,,Drug: pyrithione zinc | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16150,pyrithione zinc,potassium voltage-gated channel subfamily kqt member 2,ion channel,ACTIVATOR,Drug: pyrithione zinc | Target: potassium voltage-gated channel subfamily kqt member 2 | Type: ion channel | Action: ACTIVATOR
16151,pyrithione zinc,carbonic anhydrase 9,enzyme,,Drug: pyrithione zinc | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
16152,pyrithione zinc,carbonic anhydrase 12,enzyme,,Drug: pyrithione zinc | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
16153,pyrithione zinc,potassium voltage-gated channel subfamily kqt member 1,ion channel,ACTIVATOR,Drug: pyrithione zinc | Target: potassium voltage-gated channel subfamily kqt member 1 | Type: ion channel | Action: ACTIVATOR
16154,pyrithione zinc,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: pyrithione zinc | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
16155,pyrithione zinc,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: pyrithione zinc | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
16156,pyrithione zinc,carbonic anhydrase 7,enzyme,,Drug: pyrithione zinc | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
16157,pyrithione zinc,potassium voltage-gated channel subfamily kqt member 5,ion channel,ACTIVATOR,Drug: pyrithione zinc | Target: potassium voltage-gated channel subfamily kqt member 5 | Type: ion channel | Action: ACTIVATOR
16158,pyrithione zinc,carbonic anhydrase 3,enzyme,,Drug: pyrithione zinc | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
16159,pyrithione zinc,carbonic anhydrase 6,enzyme,,Drug: pyrithione zinc | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
16160,pyrithione zinc,carbonic anhydrase 14,enzyme,,Drug: pyrithione zinc | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
16161,pyrithione zinc,potassium voltage-gated channel subfamily kqt member 4,ion channel,ACTIVATOR,Drug: pyrithione zinc | Target: potassium voltage-gated channel subfamily kqt member 4 | Type: ion channel | Action: ACTIVATOR
16162,pyrithione zinc,carbonic anhydrase 13,enzyme,,Drug: pyrithione zinc | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
16163,bismuth subsalicylate,cyclooxygenase,enzyme,INHIBITOR,Drug: bismuth subsalicylate | Target: cyclooxygenase | Type: enzyme | Action: INHIBITOR
16164,thymol,transient receptor potential cation channel subfamily a member 1,ion channel,,Drug: thymol | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: nan
16165,thymol,transient receptor potential cation channel subfamily m member 8,ion channel,,Drug: thymol | Target: transient receptor potential cation channel subfamily m member 8 | Type: ion channel | Action: nan
16166,thymol,heat sensitive channel trpv3,unclassified,,Drug: thymol | Target: heat sensitive channel trpv3 | Type: unclassified | Action: nan
16167,sulfur,carbonic anhydrase 2,enzyme,,Drug: sulfur | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
16168,sulfur,carbonic anhydrase 1,enzyme,,Drug: sulfur | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
16169,carbamide,olfactory receptor 51e2,gpcr,,Drug: carbamide | Target: olfactory receptor 51e2 | Type: gpcr | Action: nan
16170,gentamicin,dihydrofolate reductase,enzyme,,Drug: gentamicin | Target: dihydrofolate reductase | Type: enzyme | Action: nan
16171,gentamicin,dihydrofolate reductase,enzyme,,Drug: gentamicin | Target: dihydrofolate reductase | Type: enzyme | Action: nan
16172,gentamicin,transient receptor potential cation channel subfamily a member 1,ion channel,GATING INHIBITOR,Drug: gentamicin | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: GATING INHIBITOR
16173,phenol,carbonic anhydrase 2,enzyme,,Drug: phenol | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
16174,phenol,carbonic anhydrase 1,enzyme,,Drug: phenol | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
16175,phenol,carbonic anhydrase 4,enzyme,,Drug: phenol | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16176,phenol,carbonic anhydrase 9,enzyme,,Drug: phenol | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
16177,phenol,carbonic anhydrase 12,enzyme,,Drug: phenol | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
16178,phenol,carbonic anhydrase 3,enzyme,,Drug: phenol | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
16179,phenol,carbonic anhydrase 14,enzyme,,Drug: phenol | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
16180,phenol,endolysin,enzyme,,Drug: phenol | Target: endolysin | Type: enzyme | Action: nan
16181,phenol,carbonic anhydrase 15,enzyme,,Drug: phenol | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
16182,phenol,carbonic anhydrase,enzyme,,Drug: phenol | Target: carbonic anhydrase | Type: enzyme | Action: nan
16183,phenol,probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase,enzyme,,Drug: phenol | Target: probable transmembrane carbonic anhydrase (carbonate dehydratase) (carbonic dehydratase); transmembrane carbonic anhydrase | Type: enzyme | Action: nan
16184,phenol,carbonic anhydrase 2,enzyme,,Drug: phenol | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
16185,phenol,carbonic anhydrase,enzyme,,Drug: phenol | Target: carbonic anhydrase | Type: enzyme | Action: nan
16186,phenol,beta-carbonic anhydrase 1,enzyme,,Drug: phenol | Target: beta-carbonic anhydrase 1 | Type: enzyme | Action: nan
16187,arbutin,tyrosinase,enzyme,,Drug: arbutin | Target: tyrosinase | Type: enzyme | Action: nan
16188,arbutin,polyphenol oxidase 2,enzyme,,Drug: arbutin | Target: polyphenol oxidase 2 | Type: enzyme | Action: nan
16189,arbutin,tyrosinase,enzyme,,Drug: arbutin | Target: tyrosinase | Type: enzyme | Action: nan
16190,piperonyl butoxide,cytochrome p450 3a4,enzyme,,Drug: piperonyl butoxide | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
16191,piperonyl butoxide,cytochrome p450,enzyme,INHIBITOR,Drug: piperonyl butoxide | Target: cytochrome p450 | Type: enzyme | Action: INHIBITOR
16192,tapentadol,mu-type opioid receptor,gpcr,AGONIST,Drug: tapentadol | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
16193,tapentadol,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: tapentadol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
16194,tapentadol,solute carrier family 22 member 1,transporter,,Drug: tapentadol | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
16196,florbetapir f-18,amyloid beta a4 protein,unclassified,,Drug: florbetapir f-18 | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
16197,doconexent,aromatase,enzyme,,Drug: doconexent | Target: aromatase | Type: enzyme | Action: nan
16198,doconexent,retinoic acid receptor rxr-alpha,nuclear hormone receptor,,Drug: doconexent | Target: retinoic acid receptor rxr-alpha | Type: nuclear hormone receptor | Action: nan
16199,doconexent,free fatty acid receptor 1,gpcr,AGONIST,Drug: doconexent | Target: free fatty acid receptor 1 | Type: gpcr | Action: AGONIST
16200,doconexent,prostaglandin g/h synthase 2,enzyme,,Drug: doconexent | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
16201,doconexent,prostaglandin g/h synthase 1,enzyme,,Drug: doconexent | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
16202,doconexent,oxoeicosanoid receptor 1,gpcr,,Drug: doconexent | Target: oxoeicosanoid receptor 1 | Type: gpcr | Action: nan
16203,doconexent,transient receptor potential cation channel subfamily a member 1,ion channel,ACTIVATOR,Drug: doconexent | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: ACTIVATOR
16204,doconexent,retinoic acid receptor rxr-alpha,nuclear other,,Drug: doconexent | Target: retinoic acid receptor rxr-alpha | Type: nuclear other | Action: nan
16205,potassium iodide,carbonic anhydrase 4,enzyme,,Drug: potassium iodide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16206,apixaban,prothrombin,enzyme,,Drug: apixaban | Target: prothrombin | Type: enzyme | Action: nan
16207,apixaban,coagulation factor x,enzyme,INHIBITOR,Drug: apixaban | Target: coagulation factor x | Type: enzyme | Action: INHIBITOR
16208,apixaban,coagulation factor x,enzyme,,Drug: apixaban | Target: coagulation factor x | Type: enzyme | Action: nan
16209,cobicistat,cytochrome p450 3a,enzyme,INHIBITOR,Drug: cobicistat | Target: cytochrome p450 3a | Type: enzyme | Action: INHIBITOR
16210,elvitegravir,gag-pol polyprotein,polyprotein,,Drug: elvitegravir | Target: gag-pol polyprotein | Type: polyprotein | Action: nan
16211,elvitegravir,integrase,enzyme,INHIBITOR,Drug: elvitegravir | Target: integrase | Type: enzyme | Action: INHIBITOR
16212,elvitegravir,reverse transcriptase,enzyme,,Drug: elvitegravir | Target: reverse transcriptase | Type: enzyme | Action: nan
16213,elvitegravir,integrase,enzyme,,Drug: elvitegravir | Target: integrase | Type: enzyme | Action: nan
16214,flutemetamol (18f),amyloid beta a4 protein,unclassified,,Drug: flutemetamol (18f) | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
16215,glycopyrronium bromide,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: glycopyrronium bromide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
16216,glycopyrronium bromide,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: glycopyrronium bromide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
16217,glycopyrronium bromide,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: glycopyrronium bromide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
16218,glycopyrronium bromide,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: glycopyrronium bromide | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
16219,glycopyrronium bromide,muscarinic acetylcholine receptor m5,gpcr,ANTAGONIST,Drug: glycopyrronium bromide | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: ANTAGONIST
16220,eslicarbazepine acetate,sodium channel alpha subunit,ion channel,BLOCKER,Drug: eslicarbazepine acetate | Target: sodium channel alpha subunit | Type: ion channel | Action: BLOCKER
16221,dapagliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: dapagliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
16222,dapagliflozin,sodium/glucose cotransporter 1,transporter,,Drug: dapagliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: nan
16223,dapagliflozin,sodium/glucose cotransporter 2,transporter,,Drug: dapagliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: nan
16224,dapagliflozin,sodium/myo-inositol cotransporter 2,transporter,,Drug: dapagliflozin | Target: sodium/myo-inositol cotransporter 2 | Type: transporter | Action: nan
16225,dapagliflozin,low affinity sodium-glucose cotransporter,transporter,,Drug: dapagliflozin | Target: low affinity sodium-glucose cotransporter | Type: transporter | Action: nan
16226,avanafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: avanafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
16227,avanafil,"cone cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha'",enzyme,,"Drug: avanafil | Target: cone cgmp-specific 3',5'-cyclic phosphodiesterase subunit alpha' | Type: enzyme | Action: nan"
16228,avanafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: avanafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
16229,lasofoxifene,estrogen receptor,transcription factor,,Drug: lasofoxifene | Target: estrogen receptor | Type: transcription factor | Action: nan
16230,lasofoxifene,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: lasofoxifene | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
16231,lasofoxifene,estrogen receptor beta,nuclear hormone receptor,AGONIST,Drug: lasofoxifene | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: AGONIST
16232,lacosamide,sodium channel protein type 9 subunit alpha,ion channel,BLOCKER,Drug: lacosamide | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: BLOCKER
16233,lacosamide,carbonic anhydrase 2,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
16234,lacosamide,carbonic anhydrase 1,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
16235,lacosamide,carbonic anhydrase 4,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16236,lacosamide,carbonic anhydrase 9,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
16237,lacosamide,carbonic anhydrase 12,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
16238,lacosamide,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: lacosamide | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
16239,lacosamide,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: lacosamide | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
16240,lacosamide,carbonic anhydrase 7,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
16241,lacosamide,carbonic anhydrase 3,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
16242,lacosamide,carbonic anhydrase 6,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
16243,lacosamide,carbonic anhydrase 14,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
16244,lacosamide,sodium channel protein type 2 subunit alpha,ion channel,BLOCKER,Drug: lacosamide | Target: sodium channel protein type 2 subunit alpha | Type: ion channel | Action: BLOCKER
16245,lacosamide,carbonic anhydrase 13,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
16246,lacosamide,carbonic anhydrase 15,enzyme,,Drug: lacosamide | Target: carbonic anhydrase 15 | Type: enzyme | Action: nan
16247,lacosamide,sodium channel protein type 3 subunit alpha,ion channel,,Drug: lacosamide | Target: sodium channel protein type 3 subunit alpha | Type: ion channel | Action: nan
16248,lacosamide,dihydropyrimidinase-related protein 2,enzyme,,Drug: lacosamide | Target: dihydropyrimidinase-related protein 2 | Type: enzyme | Action: nan
16249,lacosamide,sodium channel protein type x alpha subunit,ion channel,,Drug: lacosamide | Target: sodium channel protein type x alpha subunit | Type: ion channel | Action: nan
16250,aceclidine,muscarinic acetylcholine receptor m1,gpcr,AGONIST,Drug: aceclidine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: AGONIST
16251,aceclidine,muscarinic acetylcholine receptor m2,gpcr,AGONIST,Drug: aceclidine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: AGONIST
16252,aceclidine,muscarinic acetylcholine receptor m3,gpcr,AGONIST,Drug: aceclidine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: AGONIST
16253,aceclidine,muscarinic acetylcholine receptor m4,gpcr,AGONIST,Drug: aceclidine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: AGONIST
16254,aceclidine,muscarinic acetylcholine receptor m5,gpcr,AGONIST,Drug: aceclidine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: AGONIST
16255,aceclidine,muscarinic acetylcholine receptor m1,gpcr,,Drug: aceclidine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
16256,aceclidine,muscarinic acetylcholine receptor,gpcr,,Drug: aceclidine | Target: muscarinic acetylcholine receptor | Type: gpcr | Action: nan
16257,euflavine,hypoxia-inducible factor 1-alpha,transcription factor,,Drug: euflavine | Target: hypoxia-inducible factor 1-alpha | Type: transcription factor | Action: nan
16258,euflavine,orf 73,unclassified,,Drug: euflavine | Target: orf 73 | Type: unclassified | Action: nan
16260,afatinib,tyrosine-protein kinase abl1,kinase,,Drug: afatinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
16261,afatinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: afatinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
16262,afatinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: afatinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
16263,afatinib,tyrosine-protein kinase lck,kinase,,Drug: afatinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
16264,afatinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: afatinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
16265,afatinib,receptor tyrosine-protein kinase erbb-2,kinase,INHIBITOR,Drug: afatinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: INHIBITOR
16266,afatinib,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: afatinib | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
16267,afatinib,tyrosine-protein kinase hck,kinase,,Drug: afatinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
16268,afatinib,receptor tyrosine-protein kinase erbb-4,kinase,INHIBITOR,Drug: afatinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: INHIBITOR
16269,afatinib,mitogen-activated protein kinase 10,kinase,,Drug: afatinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
16270,afatinib,hepatocyte growth factor receptor,kinase,,Drug: afatinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
16271,afatinib,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: afatinib | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
16272,afatinib,serine/threonine-protein kinase 10,kinase,,Drug: afatinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
16273,afatinib,serine/threonine-protein kinase 17a,kinase,,Drug: afatinib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
16274,afatinib,ephrin type-a receptor 6,kinase,,Drug: afatinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
16275,afatinib,casein kinase i isoform epsilon,kinase,,Drug: afatinib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
16276,afatinib,mitogen-activated protein kinase 14,kinase,,Drug: afatinib | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
16277,afatinib,tyrosine-protein kinase frk,kinase,,Drug: afatinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
16278,afatinib,cyclin-g-associated kinase,kinase,,Drug: afatinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
16279,afatinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: afatinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
16280,afatinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: afatinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
16281,afatinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: afatinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
16282,afatinib,mitogen-activated protein kinase 9,kinase,,Drug: afatinib | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
16283,afatinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: afatinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
16284,afatinib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: afatinib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
16285,afatinib,tyrosine-protein kinase txk,kinase,,Drug: afatinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
16286,afatinib,dual specificity tyrosine-phosphorylation-regulated kinase 1b,kinase,,Drug: afatinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1b | Type: kinase | Action: nan
16287,afatinib,map kinase-interacting serine/threonine-protein kinase 1,kinase,,Drug: afatinib | Target: map kinase-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
16288,afatinib,tyrosine-protein kinase blk,kinase,,Drug: afatinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
16289,afatinib,citron rho-interacting kinase,kinase,,Drug: afatinib | Target: citron rho-interacting kinase | Type: kinase | Action: nan
16290,afatinib,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,,Drug: afatinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: nan
16291,afatinib,dual specificity tyrosine-phosphorylation-regulated kinase 2,kinase,,Drug: afatinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 2 | Type: kinase | Action: nan
16292,afatinib,ephrin type-b receptor 6,kinase,,Drug: afatinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
16293,afatinib,homeodomain-interacting protein kinase 4,kinase,,Drug: afatinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
16294,afatinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: afatinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
16295,afatinib,receptor tyrosine-protein kinase erbb-3,kinase,,Drug: afatinib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: nan
16296,afatinib,serine/threonine-protein kinase sbk1,kinase,,Drug: afatinib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
16297,afatinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: afatinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
16298,azilsartan medoxomil,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: azilsartan medoxomil | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
16299,azilsartan medoxomil,type-1 angiotensin ii receptor,gpcr,,Drug: azilsartan medoxomil | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
16300,laropiprant,prostaglandin e2 receptor ep1 subtype,gpcr,,Drug: laropiprant | Target: prostaglandin e2 receptor ep1 subtype | Type: gpcr | Action: nan
16301,laropiprant,prostaglandin d2 receptor 2,gpcr,,Drug: laropiprant | Target: prostaglandin d2 receptor 2 | Type: gpcr | Action: nan
16302,laropiprant,prostaglandin e2 receptor ep3 subtype,gpcr,,Drug: laropiprant | Target: prostaglandin e2 receptor ep3 subtype | Type: gpcr | Action: nan
16303,laropiprant,prostacyclin receptor,gpcr,,Drug: laropiprant | Target: prostacyclin receptor | Type: gpcr | Action: nan
16304,laropiprant,thromboxane a2 receptor,gpcr,,Drug: laropiprant | Target: thromboxane a2 receptor | Type: gpcr | Action: nan
16305,laropiprant,prostaglandin e2 receptor ep2 subtype,gpcr,,Drug: laropiprant | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: nan
16306,laropiprant,prostaglandin f2-alpha receptor,gpcr,,Drug: laropiprant | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: nan
16307,laropiprant,prostaglandin d2 receptor,gpcr,ANTAGONIST,Drug: laropiprant | Target: prostaglandin d2 receptor | Type: gpcr | Action: ANTAGONIST
16308,pasireotide,somatostatin receptor type 2,gpcr,AGONIST,Drug: pasireotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
16309,pasireotide,somatostatin receptor type 3,gpcr,AGONIST,Drug: pasireotide | Target: somatostatin receptor type 3 | Type: gpcr | Action: AGONIST
16310,pasireotide,somatostatin receptor type 5,gpcr,AGONIST,Drug: pasireotide | Target: somatostatin receptor type 5 | Type: gpcr | Action: AGONIST
16311,pasireotide,somatostatin receptor type 1,gpcr,AGONIST,Drug: pasireotide | Target: somatostatin receptor type 1 | Type: gpcr | Action: AGONIST
16312,pasireotide,somatostatin receptor type 2,gpcr,AGONIST,Drug: pasireotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
16313,bazedoxifene,estrogen receptor,nuclear hormone receptor,MODULATOR,Drug: bazedoxifene | Target: estrogen receptor | Type: nuclear hormone receptor | Action: MODULATOR
16314,bazedoxifene,estrogen receptor beta,nuclear hormone receptor,MODULATOR,Drug: bazedoxifene | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: MODULATOR
16315,amifampridine,voltage-gated potassium channel,ion channel,BLOCKER,Drug: amifampridine | Target: voltage-gated potassium channel | Type: ion channel | Action: BLOCKER
16316,ambrisentan,endothelin b receptor,gpcr,ANTAGONIST,Drug: ambrisentan | Target: endothelin b receptor | Type: gpcr | Action: ANTAGONIST
16317,ambrisentan,endothelin-1 receptor,gpcr,ANTAGONIST,Drug: ambrisentan | Target: endothelin-1 receptor | Type: gpcr | Action: ANTAGONIST
16318,alogliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: alogliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
16319,zucapsaicin,transient receptor potential cation channel subfamily v member 1,ion channel,OPENER,Drug: zucapsaicin | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: OPENER
16320,zinc chloride,sodium-dependent noradrenaline transporter,transporter,,Drug: zinc chloride | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
16321,zinc chloride,carbonic anhydrase 2,enzyme,,Drug: zinc chloride | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
16322,zinc chloride,epidermal growth factor receptor,kinase,,Drug: zinc chloride | Target: epidermal growth factor receptor | Type: kinase | Action: nan
16323,zinc chloride,tyrosine-protein kinase fyn,kinase,,Drug: zinc chloride | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
16324,zinc chloride,androgen receptor,transcription factor,,Drug: zinc chloride | Target: androgen receptor | Type: transcription factor | Action: nan
16325,zinc chloride,serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform,enzyme,,Drug: zinc chloride | Target: serine/threonine-protein phosphatase 2b catalytic subunit alpha isoform | Type: enzyme | Action: nan
16326,zinc chloride,g-protein coupled receptor 39,gpcr,,Drug: zinc chloride | Target: g-protein coupled receptor 39 | Type: gpcr | Action: nan
16327,zinc chloride,g protein-coupled receptor 39-1b,gpcr,,Drug: zinc chloride | Target: g protein-coupled receptor 39-1b | Type: gpcr | Action: nan
16328,zinc chloride,ubiquitin-conjugating enzyme e2 t,unclassified,,Drug: zinc chloride | Target: ubiquitin-conjugating enzyme e2 t | Type: unclassified | Action: nan
16329,benzathine benzylpenicillin,beta-lactamase tem,enzyme,,Drug: benzathine benzylpenicillin | Target: beta-lactamase tem | Type: enzyme | Action: nan
16330,benzathine benzylpenicillin,bacterial penicillin-binding protein,enzyme,INHIBITOR,Drug: benzathine benzylpenicillin | Target: bacterial penicillin-binding protein | Type: enzyme | Action: INHIBITOR
16331,aurothioglucose,5-hydroxytryptamine receptor 3a,ion channel,,Drug: aurothioglucose | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
16332,aurothioglucose,"thioredoxin reductase 1, cytoplasmic",enzyme,,"Drug: aurothioglucose | Target: thioredoxin reductase 1, cytoplasmic | Type: enzyme | Action: nan"
16333,aurothioglucose,5-hydroxytryptamine receptor 3b,ion channel,,Drug: aurothioglucose | Target: 5-hydroxytryptamine receptor 3b | Type: ion channel | Action: nan
16335,aurothioglucose,"sulfide:quinone oxidoreductase, mitochondrial",unclassified,,"Drug: aurothioglucose | Target: sulfide:quinone oxidoreductase, mitochondrial | Type: unclassified | Action: nan"
16336,bilastine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: bilastine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
16337,anidulafungin,"beta-1,3-glucan synthase catalytic subunit 1",enzyme,INHIBITOR,"Drug: anidulafungin | Target: beta-1,3-glucan synthase catalytic subunit 1 | Type: enzyme | Action: INHIBITOR"
16338,arginine glutamate,"nitric oxide synthase, inducible",enzyme,,"Drug: arginine glutamate | Target: nitric oxide synthase, inducible | Type: enzyme | Action: nan"
16339,bosutinib,tyrosine-protein kinase jak3,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
16340,bosutinib,macrophage-stimulating protein receptor,kinase,,Drug: bosutinib | Target: macrophage-stimulating protein receptor | Type: kinase | Action: nan
16341,bosutinib,platelet-derived growth factor receptor beta,kinase,,Drug: bosutinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
16342,bosutinib,tyrosine-protein kinase abl1,kinase,INHIBITOR,Drug: bosutinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: INHIBITOR
16343,bosutinib,mast/stem cell growth factor receptor kit,kinase,,Drug: bosutinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
16344,bosutinib,epidermal growth factor receptor,kinase,,Drug: bosutinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
16345,bosutinib,proto-oncogene tyrosine-protein kinase src,kinase,INHIBITOR,Drug: bosutinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: INHIBITOR
16346,bosutinib,tyrosine-protein kinase lck,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
16347,bosutinib,tyrosine-protein kinase yes,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
16348,bosutinib,tyrosine-protein kinase fyn,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
16349,bosutinib,ephrin type-a receptor 2,kinase,,Drug: bosutinib | Target: ephrin type-a receptor 2 | Type: kinase | Action: nan
16350,bosutinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: bosutinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
16351,bosutinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: bosutinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
16352,bosutinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: bosutinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
16353,bosutinib,platelet-derived growth factor receptor alpha,kinase,,Drug: bosutinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
16354,bosutinib,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: bosutinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
16355,bosutinib,ribosomal protein s6 kinase alpha-3,kinase,,Drug: bosutinib | Target: ribosomal protein s6 kinase alpha-3 | Type: kinase | Action: nan
16356,bosutinib,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: bosutinib | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
16357,bosutinib,"myosin light chain kinase, smooth muscle",kinase,,"Drug: bosutinib | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
16358,bosutinib,rho-associated protein kinase 1,kinase,,Drug: bosutinib | Target: rho-associated protein kinase 1 | Type: kinase | Action: nan
16359,bosutinib,focal adhesion kinase 1,kinase,,Drug: bosutinib | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
16360,bosutinib,tyrosine-protein kinase hck,kinase,INHIBITOR,Drug: bosutinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: INHIBITOR
16361,bosutinib,serine/threonine-protein kinase plk1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase plk1 | Type: kinase | Action: nan
16362,bosutinib,receptor tyrosine-protein kinase erbb-4,kinase,,Drug: bosutinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: nan
16363,bosutinib,high affinity nerve growth factor receptor,kinase,,Drug: bosutinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
16364,bosutinib,protein kinase c delta type,kinase,,Drug: bosutinib | Target: protein kinase c delta type | Type: kinase | Action: nan
16365,bosutinib,tyrosine-protein kinase jak2,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
16366,bosutinib,rho-associated protein kinase 2,kinase,,Drug: bosutinib | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
16367,bosutinib,tyrosine-protein kinase syk,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
16368,bosutinib,tyrosine-protein kinase csk,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
16369,bosutinib,angiopoietin-1 receptor,kinase,,Drug: bosutinib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
16370,bosutinib,ephrin type-a receptor 8,kinase,,Drug: bosutinib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
16371,bosutinib,calcium/calmodulin-dependent protein kinase type ii subunit gamma,kinase,,Drug: bosutinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit gamma | Type: kinase | Action: nan
16372,bosutinib,ap2-associated protein kinase 1,kinase,,Drug: bosutinib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
16373,bosutinib,hepatocyte growth factor receptor,kinase,,Drug: bosutinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
16374,bosutinib,tyrosine-protein kinase lyn,kinase,INHIBITOR,Drug: bosutinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: INHIBITOR
16375,bosutinib,cytoplasmic tyrosine-protein kinase bmx,kinase,,Drug: bosutinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: nan
16376,bosutinib,serine/threonine-protein kinase nek2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase nek2 | Type: kinase | Action: nan
16377,bosutinib,ribosomal protein s6 kinase alpha-2,kinase,,Drug: bosutinib | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
16378,bosutinib,5'-amp-activated protein kinase catalytic subunit alpha-1,kinase,,Drug: bosutinib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-1 | Type: kinase | Action: nan
16379,bosutinib,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: bosutinib | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
16380,bosutinib,calcium/calmodulin-dependent protein kinase type ii subunit alpha,kinase,,Drug: bosutinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit alpha | Type: kinase | Action: nan
16381,bosutinib,serine/threonine-protein kinase 10,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
16382,bosutinib,tyrosine-protein kinase fer,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
16383,bosutinib,protein kinase c epsilon type,kinase,,Drug: bosutinib | Target: protein kinase c epsilon type | Type: kinase | Action: nan
16384,bosutinib,abelson tyrosine-protein kinase 2,kinase,,Drug: bosutinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
16385,bosutinib,ephrin type-a receptor 5,kinase,,Drug: bosutinib | Target: ephrin type-a receptor 5 | Type: kinase | Action: nan
16386,bosutinib,ephrin type-a receptor 4,kinase,,Drug: bosutinib | Target: ephrin type-a receptor 4 | Type: kinase | Action: nan
16387,bosutinib,serine/threonine-protein kinase n1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
16388,bosutinib,protein kinase c theta type,kinase,,Drug: bosutinib | Target: protein kinase c theta type | Type: kinase | Action: nan
16389,bosutinib,ephrin type-a receptor 6,kinase,,Drug: bosutinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
16390,bosutinib,traf2 and nck-interacting protein kinase,kinase,,Drug: bosutinib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
16391,bosutinib,casein kinase i isoform epsilon,kinase,,Drug: bosutinib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
16392,bosutinib,tyrosine-protein kinase fgr,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
16393,bosutinib,alk tyrosine kinase receptor,kinase,,Drug: bosutinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
16394,bosutinib,serine/threonine-protein kinase 36,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 36 | Type: kinase | Action: nan
16395,bosutinib,ephrin type-a receptor 3,kinase,,Drug: bosutinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
16396,bosutinib,bmp-2-inducible protein kinase,kinase,,Drug: bosutinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
16397,bosutinib,tyrosine-protein kinase frk,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
16398,bosutinib,dual specificity protein kinase clk1,kinase,,Drug: bosutinib | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
16399,bosutinib,dual specificity protein kinase clk2,kinase,,Drug: bosutinib | Target: dual specificity protein kinase clk2 | Type: kinase | Action: nan
16400,bosutinib,dual specificity protein kinase clk3,kinase,,Drug: bosutinib | Target: dual specificity protein kinase clk3 | Type: kinase | Action: nan
16401,bosutinib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
16402,bosutinib,mitogen-activated protein kinase kinase kinase 4,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 4 | Type: kinase | Action: nan
16403,bosutinib,cyclin-g-associated kinase,kinase,,Drug: bosutinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
16404,bosutinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: bosutinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
16405,bosutinib,ephrin type-b receptor 1,kinase,,Drug: bosutinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
16406,bosutinib,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: bosutinib | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
16407,bosutinib,cyclin-dependent kinase 16,kinase,,Drug: bosutinib | Target: cyclin-dependent kinase 16 | Type: kinase | Action: nan
16408,bosutinib,serine/threonine-protein kinase 4,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
16409,bosutinib,activated cdc42 kinase 1,kinase,,Drug: bosutinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
16410,bosutinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: bosutinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
16411,bosutinib,dual specificity protein kinase clk4,kinase,,Drug: bosutinib | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
16412,bosutinib,calcium/calmodulin-dependent protein kinase kinase 2,kinase,,Drug: bosutinib | Target: calcium/calmodulin-dependent protein kinase kinase 2 | Type: kinase | Action: nan
16413,bosutinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: bosutinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
16414,bosutinib,ephrin type-b receptor 4,kinase,,Drug: bosutinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
16415,bosutinib,testis-specific serine/threonine-protein kinase 1,kinase,,Drug: bosutinib | Target: testis-specific serine/threonine-protein kinase 1 | Type: kinase | Action: nan
16416,bosutinib,cyclin-dependent kinase 15,kinase,,Drug: bosutinib | Target: cyclin-dependent kinase 15 | Type: kinase | Action: nan
16417,bosutinib,dual specificity mitogen-activated protein kinase kinase 7,kinase,,Drug: bosutinib | Target: dual specificity mitogen-activated protein kinase kinase 7 | Type: kinase | Action: nan
16418,bosutinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: bosutinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
16419,bosutinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: bosutinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
16420,bosutinib,tyrosine-protein kinase itk/tsk,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: nan
16421,bosutinib,tyrosine-protein kinase zap-70,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase zap-70 | Type: kinase | Action: nan
16422,bosutinib,tyrosine-protein kinase btk,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
16423,bosutinib,tyrosine-protein kinase tec,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase tec | Type: kinase | Action: nan
16424,bosutinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
16425,bosutinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: bosutinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
16426,bosutinib,tyrosine-protein kinase receptor tyro3,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase receptor tyro3 | Type: kinase | Action: nan
16427,bosutinib,ephrin type-b receptor 2,kinase,,Drug: bosutinib | Target: ephrin type-b receptor 2 | Type: kinase | Action: nan
16428,bosutinib,cyclin-dependent kinase 7,kinase,,Drug: bosutinib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
16429,bosutinib,ribosomal protein s6 kinase beta-1,kinase,,Drug: bosutinib | Target: ribosomal protein s6 kinase beta-1 | Type: kinase | Action: nan
16430,bosutinib,serine/threonine-protein kinase n2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase n2 | Type: kinase | Action: nan
16431,bosutinib,serine/threonine-protein kinase dclk3,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase dclk3 | Type: kinase | Action: nan
16432,bosutinib,serine/threonine-protein kinase 3,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
16433,bosutinib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: bosutinib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
16434,bosutinib,nuak family snf1-like kinase 2,kinase,,Drug: bosutinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
16435,bosutinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: bosutinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
16436,bosutinib,serine/threonine-protein kinase chk1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase chk1 | Type: kinase | Action: nan
16437,bosutinib,serine/threonine-protein kinase pak 3,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase pak 3 | Type: kinase | Action: nan
16438,bosutinib,cyclin-dependent kinase 14,kinase,,Drug: bosutinib | Target: cyclin-dependent kinase 14 | Type: kinase | Action: nan
16439,bosutinib,phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,kinase,,Drug: bosutinib | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Type: kinase | Action: nan
16440,bosutinib,wee1-like protein kinase,kinase,,Drug: bosutinib | Target: wee1-like protein kinase | Type: kinase | Action: nan
16441,bosutinib,serine/threonine-protein kinase 25,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 25 | Type: kinase | Action: nan
16442,bosutinib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
16443,bosutinib,protein-tyrosine kinase 2-beta,kinase,,Drug: bosutinib | Target: protein-tyrosine kinase 2-beta | Type: kinase | Action: nan
16444,bosutinib,serine/threonine-protein kinase rio1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
16445,bosutinib,casein kinase i isoform alpha-like,kinase,,Drug: bosutinib | Target: casein kinase i isoform alpha-like | Type: kinase | Action: nan
16446,bosutinib,casein kinase i isoform delta,kinase,,Drug: bosutinib | Target: casein kinase i isoform delta | Type: kinase | Action: nan
16447,bosutinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
16448,bosutinib,serine/threonine-protein kinase tousled-like 1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase tousled-like 1 | Type: kinase | Action: nan
16449,bosutinib,serine/threonine-protein kinase tousled-like 2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase tousled-like 2 | Type: kinase | Action: nan
16450,bosutinib,nt-3 growth factor receptor,kinase,,Drug: bosutinib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
16451,bosutinib,tyrosine-protein kinase txk,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
16452,bosutinib,inhibitor of nuclear factor kappa-b kinase subunit epsilon,kinase,,Drug: bosutinib | Target: inhibitor of nuclear factor kappa-b kinase subunit epsilon | Type: kinase | Action: nan
16453,bosutinib,dual specificity mitogen-activated protein kinase kinase 3,kinase,,Drug: bosutinib | Target: dual specificity mitogen-activated protein kinase kinase 3 | Type: kinase | Action: nan
16454,bosutinib,serine/threonine-protein kinase 26,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 26 | Type: kinase | Action: nan
16455,bosutinib,serine/threonine-protein kinase nlk,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase nlk | Type: kinase | Action: nan
16456,bosutinib,eukaryotic translation initiation factor 2-alpha kinase 4,kinase,,Drug: bosutinib | Target: eukaryotic translation initiation factor 2-alpha kinase 4 | Type: kinase | Action: nan
16457,bosutinib,serine/threonine-protein kinase rio3,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
16458,bosutinib,serine/threonine-protein kinase sik2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
16459,bosutinib,serine/threonine-protein kinase 33,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
16460,bosutinib,serine/threonine-protein kinase tnni3k,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
16461,bosutinib,ankyrin repeat and protein kinase domain-containing protein 1,kinase,,Drug: bosutinib | Target: ankyrin repeat and protein kinase domain-containing protein 1 | Type: kinase | Action: nan
16462,bosutinib,discoidin domain-containing receptor 2,kinase,,Drug: bosutinib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
16463,bosutinib,myotonin-protein kinase,kinase,,Drug: bosutinib | Target: myotonin-protein kinase | Type: kinase | Action: nan
16464,bosutinib,leukocyte tyrosine kinase receptor,kinase,,Drug: bosutinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
16465,bosutinib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
16466,bosutinib,nuak family snf1-like kinase 1,kinase,,Drug: bosutinib | Target: nuak family snf1-like kinase 1 | Type: kinase | Action: nan
16467,bosutinib,membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase,kinase,,Drug: bosutinib | Target: membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | Type: kinase | Action: nan
16468,bosutinib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
16469,bosutinib,tyrosine-protein kinase blk,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
16470,bosutinib,bone morphogenetic protein receptor type-2,kinase,,Drug: bosutinib | Target: bone morphogenetic protein receptor type-2 | Type: kinase | Action: nan
16471,bosutinib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
16472,bosutinib,dual specificity mitogen-activated protein kinase kinase 4,kinase,,Drug: bosutinib | Target: dual specificity mitogen-activated protein kinase kinase 4 | Type: kinase | Action: nan
16473,bosutinib,dual specificity mitogen-activated protein kinase kinase 6,kinase,,Drug: bosutinib | Target: dual specificity mitogen-activated protein kinase kinase 6 | Type: kinase | Action: nan
16474,bosutinib,tyrosine-protein kinase mer,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
16475,bosutinib,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
16476,bosutinib,mitogen-activated protein kinase kinase kinase 11,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 11 | Type: kinase | Action: nan
16477,bosutinib,serine/threonine-protein kinase 24,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 24 | Type: kinase | Action: nan
16478,bosutinib,citron rho-interacting kinase,kinase,,Drug: bosutinib | Target: citron rho-interacting kinase | Type: kinase | Action: nan
16479,bosutinib,myosin-iiia,kinase,,Drug: bosutinib | Target: myosin-iiia | Type: kinase | Action: nan
16480,bosutinib,myosin-iiib,kinase,,Drug: bosutinib | Target: myosin-iiib | Type: kinase | Action: nan
16481,bosutinib,serine/threonine-protein kinase pak 1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase pak 1 | Type: kinase | Action: nan
16482,bosutinib,serine/threonine-protein kinase pak 2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase pak 2 | Type: kinase | Action: nan
16483,bosutinib,serine/threonine-protein kinase sik1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
16484,bosutinib,tyrosine-protein kinase srms,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase srms | Type: kinase | Action: nan
16485,bosutinib,ephrin type-a receptor 1,kinase,,Drug: bosutinib | Target: ephrin type-a receptor 1 | Type: kinase | Action: nan
16486,bosutinib,ephrin type-b receptor 3,kinase,,Drug: bosutinib | Target: ephrin type-b receptor 3 | Type: kinase | Action: nan
16487,bosutinib,mitogen-activated protein kinase 7,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase 7 | Type: kinase | Action: nan
16488,bosutinib,serine/threonine-protein kinase d3,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase d3 | Type: kinase | Action: nan
16489,bosutinib,tyrosine-protein kinase fes/fps,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase fes/fps | Type: kinase | Action: nan
16490,bosutinib,casein kinase i isoform alpha,kinase,,Drug: bosutinib | Target: casein kinase i isoform alpha | Type: kinase | Action: nan
16491,bosutinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
16492,bosutinib,misshapen-like kinase 1,kinase,,Drug: bosutinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
16493,bosutinib,serine/threonine-protein kinase tbk1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
16494,bosutinib,tyrosine-protein kinase blk,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
16495,bosutinib,interleukin-1 receptor-associated kinase 4,kinase,,Drug: bosutinib | Target: interleukin-1 receptor-associated kinase 4 | Type: kinase | Action: nan
16496,bosutinib,serine/threonine-protein kinase chk2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase chk2 | Type: kinase | Action: nan
16497,bosutinib,ephrin type-b receptor 6,kinase,,Drug: bosutinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
16498,bosutinib,g protein-coupled receptor kinase 4,kinase,,Drug: bosutinib | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
16499,bosutinib,g protein-coupled receptor kinase 7,kinase,,Drug: bosutinib | Target: g protein-coupled receptor kinase 7 | Type: kinase | Action: nan
16500,bosutinib,homeodomain-interacting protein kinase 2,kinase,,Drug: bosutinib | Target: homeodomain-interacting protein kinase 2 | Type: kinase | Action: nan
16501,bosutinib,homeodomain-interacting protein kinase 3,kinase,,Drug: bosutinib | Target: homeodomain-interacting protein kinase 3 | Type: kinase | Action: nan
16502,bosutinib,homeodomain-interacting protein kinase 4,kinase,,Drug: bosutinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
16503,bosutinib,hormonally up-regulated neu tumor-associated kinase,kinase,,Drug: bosutinib | Target: hormonally up-regulated neu tumor-associated kinase | Type: kinase | Action: nan
16504,bosutinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: bosutinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
16505,bosutinib,mitogen-activated protein kinase kinase kinase 13,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 13 | Type: kinase | Action: nan
16506,bosutinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
16507,bosutinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
16508,bosutinib,microtubule-associated serine/threonine-protein kinase 1,kinase,,Drug: bosutinib | Target: microtubule-associated serine/threonine-protein kinase 1 | Type: kinase | Action: nan
16509,bosutinib,serine/threonine-protein kinase nim1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase nim1 | Type: kinase | Action: nan
16510,bosutinib,srsf protein kinase 3,kinase,,Drug: bosutinib | Target: srsf protein kinase 3 | Type: kinase | Action: nan
16511,bosutinib,ste20/sps1-related proline-alanine-rich protein kinase,kinase,,Drug: bosutinib | Target: ste20/sps1-related proline-alanine-rich protein kinase | Type: kinase | Action: nan
16512,bosutinib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
16513,bosutinib,serine/threonine-protein kinase tao1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
16514,bosutinib,serine/threonine-protein kinase tao3,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
16515,bosutinib,serine/threonine-protein kinase ulk1,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase ulk1 | Type: kinase | Action: nan
16516,bosutinib,serine/threonine-protein kinase ulk2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase ulk2 | Type: kinase | Action: nan
16517,bosutinib,serine/threonine-protein kinase ulk3,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
16518,bosutinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
16519,bosutinib,homeodomain-interacting protein kinase 1,kinase,,Drug: bosutinib | Target: homeodomain-interacting protein kinase 1 | Type: kinase | Action: nan
16520,bosutinib,serine/threonine-protein kinase plk2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase plk2 | Type: kinase | Action: nan
16521,bosutinib,serine/threonine-protein kinase 35,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 35 | Type: kinase | Action: nan
16522,bosutinib,megakaryocyte-associated tyrosine-protein kinase,kinase,,Drug: bosutinib | Target: megakaryocyte-associated tyrosine-protein kinase | Type: kinase | Action: nan
16523,bosutinib,receptor tyrosine-protein kinase erbb-3,kinase,,Drug: bosutinib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: nan
16524,bosutinib,mitogen-activated protein kinase kinase kinase 1,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 1 | Type: kinase | Action: nan
16525,bosutinib,serine/threonine-protein kinase sik3,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase sik3 | Type: kinase | Action: nan
16526,bosutinib,wee1-like protein kinase 2,kinase,,Drug: bosutinib | Target: wee1-like protein kinase 2 | Type: kinase | Action: nan
16527,bosutinib,serine/threonine-protein kinase 32a,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase 32a | Type: kinase | Action: nan
16528,bosutinib,peripheral plasma membrane protein cask,kinase,,Drug: bosutinib | Target: peripheral plasma membrane protein cask | Type: kinase | Action: nan
16529,bosutinib,serine/threonine-protein kinase vrk2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase vrk2 | Type: kinase | Action: nan
16530,bosutinib,mitogen-activated protein kinase kinase kinase 12,kinase,,Drug: bosutinib | Target: mitogen-activated protein kinase kinase kinase 12 | Type: kinase | Action: nan
16531,bosutinib,eukaryotic translation initiation factor 2-alpha kinase 1,kinase,,Drug: bosutinib | Target: eukaryotic translation initiation factor 2-alpha kinase 1 | Type: kinase | Action: nan
16532,bosutinib,serine/threonine-protein kinase tao2,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase tao2 | Type: kinase | Action: nan
16533,bosutinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: bosutinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
16534,bosutinib,serine/threonine-protein kinase nek11,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase nek11 | Type: kinase | Action: nan
16535,bosutinib,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: bosutinib | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
16536,bosutinib,dual serine/threonine and tyrosine protein kinase,kinase,,Drug: bosutinib | Target: dual serine/threonine and tyrosine protein kinase | Type: kinase | Action: nan
16537,bosutinib,serine/threonine-protein kinase pknb,kinase,,Drug: bosutinib | Target: serine/threonine-protein kinase pknb | Type: kinase | Action: nan
16538,bosutinib,npm/alk (nucleophosmin/alk tyrosine kinase receptor),kinase,,Drug: bosutinib | Target: npm/alk (nucleophosmin/alk tyrosine kinase receptor) | Type: kinase | Action: nan
16539,bosutinib,tyrosine-protein kinase abl,kinase,,Drug: bosutinib | Target: tyrosine-protein kinase abl | Type: kinase | Action: nan
16540,bosutinib,bcr/abl fusion protein,kinase,,Drug: bosutinib | Target: bcr/abl fusion protein | Type: kinase | Action: nan
16541,cetrimide,dynamin-1,structural,,Drug: cetrimide | Target: dynamin-1 | Type: structural | Action: nan
16542,chenodiol,fmet-leu-phe receptor,gpcr,ANTAGONIST,Drug: chenodiol | Target: fmet-leu-phe receptor | Type: gpcr | Action: ANTAGONIST
16543,chenodiol,bile acid receptor,nuclear hormone receptor,AGONIST,Drug: chenodiol | Target: bile acid receptor | Type: nuclear hormone receptor | Action: AGONIST
16544,chenodiol,g-protein coupled bile acid receptor 1,gpcr,AGONIST,Drug: chenodiol | Target: g-protein coupled bile acid receptor 1 | Type: gpcr | Action: AGONIST
16545,chiniofon,catechol o-methyltransferase,enzyme,,Drug: chiniofon | Target: catechol o-methyltransferase | Type: enzyme | Action: nan
16546,vernakalant,sodium channel protein type 5 subunit alpha,ion channel,,Drug: vernakalant | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
16547,vernakalant,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: vernakalant | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
16548,vernakalant,potassium voltage-gated channel subfamily d member 2,ion channel,,Drug: vernakalant | Target: potassium voltage-gated channel subfamily d member 2 | Type: ion channel | Action: nan
16549,vernakalant,potassium voltage-gated channel subfamily a member 5,ion channel,BLOCKER,Drug: vernakalant | Target: potassium voltage-gated channel subfamily a member 5 | Type: ion channel | Action: BLOCKER
16550,voclosporin,peptidyl-prolyl cis-trans isomerase a,enzyme,INHIBITOR,Drug: voclosporin | Target: peptidyl-prolyl cis-trans isomerase a | Type: enzyme | Action: INHIBITOR
16552,sodium benzoate,carbonic anhydrase 2,enzyme,,Drug: sodium benzoate | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
16553,sodium benzoate,carbonic anhydrase 4,enzyme,,Drug: sodium benzoate | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16554,sodium benzoate,carbonic anhydrase,enzyme,,Drug: sodium benzoate | Target: carbonic anhydrase | Type: enzyme | Action: nan
16555,lorcaserin,sodium-dependent serotonin transporter,transporter,,Drug: lorcaserin | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
16556,lorcaserin,5-hydroxytryptamine receptor 2a,gpcr,,Drug: lorcaserin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
16557,lorcaserin,5-hydroxytryptamine receptor 2b,gpcr,,Drug: lorcaserin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: nan
16558,lorcaserin,5-hydroxytryptamine receptor 2c,gpcr,AGONIST,Drug: lorcaserin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: AGONIST
16559,dequalinium,protein kinase c alpha type,kinase,,Drug: dequalinium | Target: protein kinase c alpha type | Type: kinase | Action: nan
16560,dequalinium,small conductance calcium-activated potassium channel protein 3,ion channel,,Drug: dequalinium | Target: small conductance calcium-activated potassium channel protein 3 | Type: ion channel | Action: nan
16561,dequalinium,small conductance calcium-activated potassium channel protein 3,ion channel,,Drug: dequalinium | Target: small conductance calcium-activated potassium channel protein 3 | Type: ion channel | Action: nan
16562,dequalinium,small conductance calcium-activated potassium channel protein 1,ion channel,BLOCKER,Drug: dequalinium | Target: small conductance calcium-activated potassium channel protein 1 | Type: ion channel | Action: BLOCKER
16563,dequalinium,small conductance calcium-activated potassium channel protein 2,ion channel,BLOCKER,Drug: dequalinium | Target: small conductance calcium-activated potassium channel protein 2 | Type: ion channel | Action: BLOCKER
16564,dequalinium,cgmp-gated cation channel alpha-1,ion channel,BLOCKER,Drug: dequalinium | Target: cgmp-gated cation channel alpha-1 | Type: ion channel | Action: BLOCKER
16565,dequalinium,cyclic nucleotide-gated olfactory channel,ion channel,BLOCKER,Drug: dequalinium | Target: cyclic nucleotide-gated olfactory channel | Type: ion channel | Action: BLOCKER
16566,degarelix,gonadotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: degarelix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
16567,desvenlafaxine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: desvenlafaxine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
16568,desvenlafaxine,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: desvenlafaxine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
16569,desvenlafaxine,alpha-1a adrenergic receptor,gpcr,,Drug: desvenlafaxine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
16570,dapoxetine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: dapoxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
16571,mirabegron,beta-3 adrenergic receptor,gpcr,AGONIST,Drug: mirabegron | Target: beta-3 adrenergic receptor | Type: gpcr | Action: AGONIST
16572,choline theophyllinate,adenosine receptor a2a,gpcr,ANTAGONIST,Drug: choline theophyllinate | Target: adenosine receptor a2a | Type: gpcr | Action: ANTAGONIST
16573,choline theophyllinate,adenosine receptor a1,gpcr,ANTAGONIST,Drug: choline theophyllinate | Target: adenosine receptor a1 | Type: gpcr | Action: ANTAGONIST
16574,choline theophyllinate,adenosine receptor a2b,gpcr,ANTAGONIST,Drug: choline theophyllinate | Target: adenosine receptor a2b | Type: gpcr | Action: ANTAGONIST
16575,choline theophyllinate,adenosine receptor a3,gpcr,ANTAGONIST,Drug: choline theophyllinate | Target: adenosine receptor a3 | Type: gpcr | Action: ANTAGONIST
16576,choline theophyllinate,"alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,"Drug: choline theophyllinate | Target: alkaline phosphatase, tissue-nonspecific isozyme | Type: enzyme | Action: nan"
16577,choline theophyllinate,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,,"Drug: choline theophyllinate | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: nan"
16578,choline theophyllinate,adenosine receptor a1,gpcr,,Drug: choline theophyllinate | Target: adenosine receptor a1 | Type: gpcr | Action: nan
16579,choline theophyllinate,adenosine receptor a2a,gpcr,,Drug: choline theophyllinate | Target: adenosine receptor a2a | Type: gpcr | Action: nan
16580,choline theophyllinate,uncharacterized protein,enzyme,,Drug: choline theophyllinate | Target: uncharacterized protein | Type: enzyme | Action: nan
16581,choline theophyllinate,adenosine receptor a3,gpcr,,Drug: choline theophyllinate | Target: adenosine receptor a3 | Type: gpcr | Action: nan
16582,choline theophyllinate,adenosine receptor a1,gpcr,,Drug: choline theophyllinate | Target: adenosine receptor a1 | Type: gpcr | Action: nan
16583,choline theophyllinate,adenosine receptor a1,gpcr,,Drug: choline theophyllinate | Target: adenosine receptor a1 | Type: gpcr | Action: nan
16584,choline theophyllinate,adenosine a2 receptor,gpcr,,Drug: choline theophyllinate | Target: adenosine a2 receptor | Type: gpcr | Action: nan
16585,choline theophyllinate,phosphodiesterase 3,enzyme,INHIBITOR,Drug: choline theophyllinate | Target: phosphodiesterase 3 | Type: enzyme | Action: INHIBITOR
16586,choline theophyllinate,phosphodiesterase 4,enzyme,INHIBITOR,Drug: choline theophyllinate | Target: phosphodiesterase 4 | Type: enzyme | Action: INHIBITOR
16587,choline theophyllinate,adenosine a2b receptor,gpcr,,Drug: choline theophyllinate | Target: adenosine a2b receptor | Type: gpcr | Action: nan
16588,choline theophyllinate,adenosine receptor,gpcr,,Drug: choline theophyllinate | Target: adenosine receptor | Type: gpcr | Action: nan
16589,choline theophyllinate,adenosine a2 receptor,gpcr,ANTAGONIST,Drug: choline theophyllinate | Target: adenosine a2 receptor | Type: gpcr | Action: ANTAGONIST
16590,choline theophyllinate,heart phosphodiesterase,enzyme,,Drug: choline theophyllinate | Target: heart phosphodiesterase | Type: enzyme | Action: nan
16591,choline theophyllinate,adenosine a2a receptor,gpcr,,Drug: choline theophyllinate | Target: adenosine a2a receptor | Type: gpcr | Action: nan
16592,cisplatin,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: cisplatin | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
16593,cisplatin,d(3) dopamine receptor,gpcr,,Drug: cisplatin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
16594,cisplatin,muscarinic acetylcholine receptor m5,gpcr,,Drug: cisplatin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
16595,cisplatin,canalicular multispecific organic anion transporter 1,transporter,,Drug: cisplatin | Target: canalicular multispecific organic anion transporter 1 | Type: transporter | Action: nan
16596,cisplatin,adenosine receptor a3,gpcr,,Drug: cisplatin | Target: adenosine receptor a3 | Type: gpcr | Action: nan
16597,cisplatin,multidrug resistance-associated protein 6,transporter,,Drug: cisplatin | Target: multidrug resistance-associated protein 6 | Type: transporter | Action: nan
16598,cisplatin,multidrug resistance-associated protein 5,transporter,,Drug: cisplatin | Target: multidrug resistance-associated protein 5 | Type: transporter | Action: nan
16599,cisplatin,epidermal growth factor receptor,kinase,,Drug: cisplatin | Target: epidermal growth factor receptor | Type: kinase | Action: nan
16600,cisplatin,tyrosine-protein kinase lck,kinase,,Drug: cisplatin | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
16601,cisplatin,tyrosine-protein kinase fyn,kinase,,Drug: cisplatin | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
16602,cisplatin,c-x-c chemokine receptor type 2,gpcr,,Drug: cisplatin | Target: c-x-c chemokine receptor type 2 | Type: gpcr | Action: nan
16603,cisplatin,thromboxane-a synthase,enzyme,,Drug: cisplatin | Target: thromboxane-a synthase | Type: enzyme | Action: nan
16604,cisplatin,c-c chemokine receptor type 2,gpcr,,Drug: cisplatin | Target: c-c chemokine receptor type 2 | Type: gpcr | Action: nan
16605,cisplatin,mitogen-activated protein kinase 3,kinase,,Drug: cisplatin | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
16606,cisplatin,melanocortin receptor 5,gpcr,,Drug: cisplatin | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
16607,clofenotane,androgen receptor,transcription factor,,Drug: clofenotane | Target: androgen receptor | Type: transcription factor | Action: nan
16608,clopenthixol,5-hydroxytryptamine receptor 6,gpcr,,Drug: clopenthixol | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
16609,eltrombopag,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: eltrombopag | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
16610,eltrombopag,thrombopoietin receptor,membrane receptor,AGONIST,Drug: eltrombopag | Target: thrombopoietin receptor | Type: membrane receptor | Action: AGONIST
16611,casopitant,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: casopitant | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
16612,casopitant,substance-p receptor,gpcr,ANTAGONIST,Drug: casopitant | Target: substance-p receptor | Type: gpcr | Action: ANTAGONIST
16613,ceftobiprole medocaril,meca,enzyme,,Drug: ceftobiprole medocaril | Target: meca | Type: enzyme | Action: nan
16614,plerixafor,c-x-c chemokine receptor type 4,gpcr,PARTIAL AGONIST,Drug: plerixafor | Target: c-x-c chemokine receptor type 4 | Type: gpcr | Action: PARTIAL AGONIST
16615,plerixafor,c-c chemokine receptor type 2,gpcr,,Drug: plerixafor | Target: c-c chemokine receptor type 2 | Type: gpcr | Action: nan
16616,plerixafor,stromal cell-derived factor 1,cytokine,,Drug: plerixafor | Target: stromal cell-derived factor 1 | Type: cytokine | Action: nan
16617,plerixafor,c-c chemokine receptor type 4,gpcr,ANTAGONIST,Drug: plerixafor | Target: c-c chemokine receptor type 4 | Type: gpcr | Action: ANTAGONIST
16618,plerixafor,c-x-c chemokine receptor type 4,gpcr,,Drug: plerixafor | Target: c-x-c chemokine receptor type 4 | Type: gpcr | Action: nan
16619,plerixafor,atypical chemokine receptor 3,gpcr,AGONIST,Drug: plerixafor | Target: atypical chemokine receptor 3 | Type: gpcr | Action: AGONIST
16620,dexchlorpheniramine,alpha-2a adrenergic receptor,gpcr,,Drug: dexchlorpheniramine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
16621,dexchlorpheniramine,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: dexchlorpheniramine | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
16622,dexchlorpheniramine,sodium-dependent serotonin transporter,transporter,,Drug: dexchlorpheniramine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
16623,dexchlorpheniramine,sodium-dependent noradrenaline transporter,transporter,,Drug: dexchlorpheniramine | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
16624,dexchlorpheniramine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: dexchlorpheniramine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
16625,dexchlorpheniramine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: dexchlorpheniramine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
16626,dexchlorpheniramine,alpha-2b adrenergic receptor,gpcr,,Drug: dexchlorpheniramine | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
16627,dexchlorpheniramine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: dexchlorpheniramine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
16628,dexchlorpheniramine,histamine h2 receptor,gpcr,,Drug: dexchlorpheniramine | Target: histamine h2 receptor | Type: gpcr | Action: nan
16629,dexchlorpheniramine,muscarinic acetylcholine receptor m1,gpcr,,Drug: dexchlorpheniramine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
16630,dexchlorpheniramine,muscarinic acetylcholine receptor m2,gpcr,,Drug: dexchlorpheniramine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
16631,dexchlorpheniramine,muscarinic acetylcholine receptor m3,gpcr,,Drug: dexchlorpheniramine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
16632,dexchlorpheniramine,muscarinic acetylcholine receptor m4,gpcr,,Drug: dexchlorpheniramine | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
16633,dexchlorpheniramine,muscarinic acetylcholine receptor m5,gpcr,,Drug: dexchlorpheniramine | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
16634,dexchlorpheniramine,sodium-dependent dopamine transporter,transporter,,Drug: dexchlorpheniramine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
16635,dexchlorpheniramine,alpha-1d adrenergic receptor,gpcr,,Drug: dexchlorpheniramine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
16636,dexchlorpheniramine,alpha-1b adrenergic receptor,gpcr,,Drug: dexchlorpheniramine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
16637,dexchlorpheniramine,membrane-associated progesterone receptor component 1,membrane receptor,,Drug: dexchlorpheniramine | Target: membrane-associated progesterone receptor component 1 | Type: membrane receptor | Action: nan
16638,diamorphine,d(2) dopamine receptor,gpcr,,Drug: diamorphine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
16639,diamorphine,d(1a) dopamine receptor,gpcr,,Drug: diamorphine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
16640,diamorphine,d(3) dopamine receptor,gpcr,,Drug: diamorphine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
16641,dibutylphthalate,transient receptor potential cation channel subfamily a member 1,ion channel,ACTIVATOR,Drug: dibutylphthalate | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: ACTIVATOR
16642,dihydroergocryptine,5-hydroxytryptamine receptor 2b,gpcr,AGONIST,Drug: dihydroergocryptine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: AGONIST
16643,dihydroergocryptine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: dihydroergocryptine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
16644,dihydroergocryptine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: dihydroergocryptine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
16645,colistin,epidermal growth factor receptor,kinase,,Drug: colistin | Target: epidermal growth factor receptor | Type: kinase | Action: nan
16646,colistin,tyrosine-protein kinase fyn,kinase,,Drug: colistin | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
16647,colistin,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: colistin | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
16648,colistin,melanocortin receptor 4,gpcr,,Drug: colistin | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
16649,colistin,melanocortin receptor 5,gpcr,,Drug: colistin | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
16650,colistin,melanocortin receptor 3,gpcr,,Drug: colistin | Target: melanocortin receptor 3 | Type: gpcr | Action: nan
16651,bufylline,adenosine receptor a2a,gpcr,ANTAGONIST,Drug: bufylline | Target: adenosine receptor a2a | Type: gpcr | Action: ANTAGONIST
16652,bufylline,adenosine receptor a1,gpcr,ANTAGONIST,Drug: bufylline | Target: adenosine receptor a1 | Type: gpcr | Action: ANTAGONIST
16653,bufylline,adenosine receptor a2b,gpcr,ANTAGONIST,Drug: bufylline | Target: adenosine receptor a2b | Type: gpcr | Action: ANTAGONIST
16654,bufylline,adenosine receptor a3,gpcr,ANTAGONIST,Drug: bufylline | Target: adenosine receptor a3 | Type: gpcr | Action: ANTAGONIST
16655,bufylline,"alkaline phosphatase, tissue-nonspecific isozyme",enzyme,,"Drug: bufylline | Target: alkaline phosphatase, tissue-nonspecific isozyme | Type: enzyme | Action: nan"
16656,bufylline,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,,"Drug: bufylline | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: nan"
16657,bufylline,adenosine receptor a1,gpcr,,Drug: bufylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
16658,bufylline,adenosine receptor a2a,gpcr,,Drug: bufylline | Target: adenosine receptor a2a | Type: gpcr | Action: nan
16659,bufylline,uncharacterized protein,enzyme,,Drug: bufylline | Target: uncharacterized protein | Type: enzyme | Action: nan
16660,bufylline,adenosine receptor a3,gpcr,,Drug: bufylline | Target: adenosine receptor a3 | Type: gpcr | Action: nan
16661,bufylline,adenosine receptor a1,gpcr,,Drug: bufylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
16662,bufylline,adenosine receptor a1,gpcr,,Drug: bufylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
16663,bufylline,adenosine a2 receptor,gpcr,,Drug: bufylline | Target: adenosine a2 receptor | Type: gpcr | Action: nan
16664,bufylline,phosphodiesterase 3,enzyme,INHIBITOR,Drug: bufylline | Target: phosphodiesterase 3 | Type: enzyme | Action: INHIBITOR
16665,bufylline,phosphodiesterase 4,enzyme,INHIBITOR,Drug: bufylline | Target: phosphodiesterase 4 | Type: enzyme | Action: INHIBITOR
16666,bufylline,adenosine a2b receptor,gpcr,,Drug: bufylline | Target: adenosine a2b receptor | Type: gpcr | Action: nan
16667,bufylline,adenosine receptor,gpcr,,Drug: bufylline | Target: adenosine receptor | Type: gpcr | Action: nan
16668,bufylline,adenosine a2 receptor,gpcr,ANTAGONIST,Drug: bufylline | Target: adenosine a2 receptor | Type: gpcr | Action: ANTAGONIST
16669,bufylline,heart phosphodiesterase,enzyme,,Drug: bufylline | Target: heart phosphodiesterase | Type: enzyme | Action: nan
16670,bufylline,adenosine a2a receptor,gpcr,,Drug: bufylline | Target: adenosine a2a receptor | Type: gpcr | Action: nan
16671,calcitonin human,calcitonin receptor,gpcr,AGONIST,Drug: calcitonin human | Target: calcitonin receptor | Type: gpcr | Action: AGONIST
16672,calcitonin human,amylin receptor amy1,gpcr,AGONIST,Drug: calcitonin human | Target: amylin receptor amy1 | Type: gpcr | Action: AGONIST
16673,calcitonin human,amylin receptor amy2,gpcr,AGONIST,Drug: calcitonin human | Target: amylin receptor amy2 | Type: gpcr | Action: AGONIST
16674,calcitonin human,amylin receptor amy3,gpcr,AGONIST,Drug: calcitonin human | Target: amylin receptor amy3 | Type: gpcr | Action: AGONIST
16675,prednisolone sodium phosphate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: prednisolone sodium phosphate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16676,clobetasol propionate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: clobetasol propionate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16677,clobetasol propionate,annexin a1,cytosolic other,,Drug: clobetasol propionate | Target: annexin a1 | Type: cytosolic other | Action: nan
16678,clobetasol propionate,bile salt export pump,transporter,,Drug: clobetasol propionate | Target: bile salt export pump | Type: transporter | Action: nan
16679,clobetasol propionate,androgen receptor,transcription factor,,Drug: clobetasol propionate | Target: androgen receptor | Type: transcription factor | Action: nan
16680,clobetasol propionate,cytochrome p450 3a5,enzyme,,Drug: clobetasol propionate | Target: cytochrome p450 3a5 | Type: enzyme | Action: nan
16681,clobetasol propionate,progesterone receptor,transcription factor,,Drug: clobetasol propionate | Target: progesterone receptor | Type: transcription factor | Action: nan
16682,clobetasol propionate,glucocorticoid receptor,transcription factor,,Drug: clobetasol propionate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
16683,clobetasol propionate,bile salt export pump,transporter,,Drug: clobetasol propionate | Target: bile salt export pump | Type: transporter | Action: nan
16685,testosterone cypionate,androgen receptor,nuclear hormone receptor,AGONIST,Drug: testosterone cypionate | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
16686,hydrocortisone succinate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortisone succinate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16687,hydrocortisone succinate,glucocorticoid receptor,transcription factor,,Drug: hydrocortisone succinate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
16688,sulfisoxazole acetyl,dihydropteroate synthase,enzyme,INHIBITOR,Drug: sulfisoxazole acetyl | Target: dihydropteroate synthase | Type: enzyme | Action: INHIBITOR
16689,sulfisoxazole acetyl,endothelin-1 receptor,gpcr,,Drug: sulfisoxazole acetyl | Target: endothelin-1 receptor | Type: gpcr | Action: nan
16690,sulfisoxazole acetyl,endothelin b receptor,gpcr,,Drug: sulfisoxazole acetyl | Target: endothelin b receptor | Type: gpcr | Action: nan
16691,sulfisoxazole acetyl,endothelin-1 receptor,gpcr,,Drug: sulfisoxazole acetyl | Target: endothelin-1 receptor | Type: gpcr | Action: nan
16692,eosin,protein arginine n-methyltransferase 1,enzyme,,Drug: eosin | Target: protein arginine n-methyltransferase 1 | Type: enzyme | Action: nan
16693,eosin,rmta,enzyme,,Drug: eosin | Target: rmta | Type: enzyme | Action: nan
16694,esketamine,glutamate nmda receptor,ion channel,ANTAGONIST,Drug: esketamine | Target: glutamate nmda receptor | Type: ion channel | Action: ANTAGONIST
16695,fosaprepitant,substance-p receptor,gpcr,ANTAGONIST,Drug: fosaprepitant | Target: substance-p receptor | Type: gpcr | Action: ANTAGONIST
16696,trisodium citrate dihydrate,carbonic anhydrase 4,enzyme,,Drug: trisodium citrate dihydrate | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16697,trisodium citrate dihydrate,carbonic anhydrase,enzyme,,Drug: trisodium citrate dihydrate | Target: carbonic anhydrase | Type: enzyme | Action: nan
16698,sodium citrate,carbonic anhydrase 4,enzyme,,Drug: sodium citrate | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16699,sodium citrate,carbonic anhydrase,enzyme,,Drug: sodium citrate | Target: carbonic anhydrase | Type: enzyme | Action: nan
16700,"potassium phosphate, monobasic",intestinal alkaline phosphatase,enzyme,,"Drug: potassium phosphate, monobasic | Target: intestinal alkaline phosphatase | Type: enzyme | Action: nan"
16701,corbadrine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: corbadrine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
16702,corbadrine,adrenergic receptor alpha-2,gpcr,,Drug: corbadrine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: nan
16703,corbadrine,adrenergic receptor alpha-1,gpcr,,Drug: corbadrine | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
16704,corbadrine,adrenergic receptor alpha-2,gpcr,AGONIST,Drug: corbadrine | Target: adrenergic receptor alpha-2 | Type: gpcr | Action: AGONIST
16705,carfilzomib,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: carfilzomib | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
16706,carfilzomib,cathepsin b,enzyme,,Drug: carfilzomib | Target: cathepsin b | Type: enzyme | Action: nan
16707,carfilzomib,proteasome subunit beta type-8,enzyme,,Drug: carfilzomib | Target: proteasome subunit beta type-8 | Type: enzyme | Action: nan
16708,carfilzomib,proteasome subunit beta type-1,enzyme,,Drug: carfilzomib | Target: proteasome subunit beta type-1 | Type: enzyme | Action: nan
16709,carfilzomib,proteasome subunit beta type-2,enzyme,,Drug: carfilzomib | Target: proteasome subunit beta type-2 | Type: enzyme | Action: nan
16710,carfilzomib,glutathione s-transferase omega-1,unclassified,,Drug: carfilzomib | Target: glutathione s-transferase omega-1 | Type: unclassified | Action: nan
16712,carfilzomib,proteasome subunit beta type-9,enzyme,,Drug: carfilzomib | Target: proteasome subunit beta type-9 | Type: enzyme | Action: nan
16713,carfilzomib,proteasome subunit beta type-10,enzyme,,Drug: carfilzomib | Target: proteasome subunit beta type-10 | Type: enzyme | Action: nan
16715,carfilzomib,proteasome subunit beta type-5,enzyme,INHIBITOR,Drug: carfilzomib | Target: proteasome subunit beta type-5 | Type: enzyme | Action: INHIBITOR
16716,aclidinium bromide,muscarinic acetylcholine receptor m1,gpcr,,Drug: aclidinium bromide | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
16717,aclidinium bromide,muscarinic acetylcholine receptor m2,gpcr,,Drug: aclidinium bromide | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
16718,aclidinium bromide,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: aclidinium bromide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
16719,aclidinium bromide,muscarinic acetylcholine receptor m4,gpcr,,Drug: aclidinium bromide | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
16720,aclidinium bromide,muscarinic acetylcholine receptor m5,gpcr,,Drug: aclidinium bromide | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
16721,diflorasone diacetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: diflorasone diacetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16722,diflorasone diacetate,progesterone receptor,transcription factor,,Drug: diflorasone diacetate | Target: progesterone receptor | Type: transcription factor | Action: nan
16723,alclometasone dipropionate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: alclometasone dipropionate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16724,haloperidol decanoate,d(2) dopamine receptor,gpcr,INVERSE AGONIST,Drug: haloperidol decanoate | Target: d(2) dopamine receptor | Type: gpcr | Action: INVERSE AGONIST
16725,haloperidol decanoate,d(3) dopamine receptor,gpcr,,Drug: haloperidol decanoate | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
16726,haloperidol decanoate,d(4) dopamine receptor,gpcr,,Drug: haloperidol decanoate | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
16727,haloperidol decanoate,d(1a) dopamine receptor,gpcr,,Drug: haloperidol decanoate | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
16728,estradiol acetate,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: estradiol acetate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
16729,paliperidone palmitate,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: paliperidone palmitate | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
16730,paliperidone palmitate,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: paliperidone palmitate | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
16731,paliperidone palmitate,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: paliperidone palmitate | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
16732,armodafinil,d(2) dopamine receptor,gpcr,,Drug: armodafinil | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
16733,armodafinil,d(3) dopamine receptor,gpcr,,Drug: armodafinil | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
16734,armodafinil,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: armodafinil | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
16735,armodafinil,alpha-1b adrenergic receptor,gpcr,,Drug: armodafinil | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
16736,armodafinil,cytochrome p450 1a2,enzyme,,Drug: armodafinil | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
16737,armodafinil,cytochrome p450 2c19,enzyme,,Drug: armodafinil | Target: cytochrome p450 2c19 | Type: enzyme | Action: nan
16738,armodafinil,sodium-dependent dopamine transporter,transporter,,Drug: armodafinil | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
16739,hydrocortisone valerate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortisone valerate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16740,choline fenofibrate,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: choline fenofibrate | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
16741,choline fenofibrate,"fatty acid-binding protein, intestinal",cytosolic other,,"Drug: choline fenofibrate | Target: fatty acid-binding protein, intestinal | Type: cytosolic other | Action: nan"
16742,choline fenofibrate,"fatty acid-binding protein, liver",unclassified,,"Drug: choline fenofibrate | Target: fatty acid-binding protein, liver | Type: unclassified | Action: nan"
16743,choline fenofibrate,solute carrier family 22 member 12,transporter,,Drug: choline fenofibrate | Target: solute carrier family 22 member 12 | Type: transporter | Action: nan
16744,halcinonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: halcinonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16745,halcinonide,androgen receptor,transcription factor,,Drug: halcinonide | Target: androgen receptor | Type: transcription factor | Action: nan
16746,halcinonide,progesterone receptor,transcription factor,,Drug: halcinonide | Target: progesterone receptor | Type: transcription factor | Action: nan
16747,racepinefrine,alpha-1a adrenergic receptor,gpcr,AGONIST,Drug: racepinefrine | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: AGONIST
16748,racepinefrine,alpha-1d adrenergic receptor,gpcr,AGONIST,Drug: racepinefrine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: AGONIST
16749,racepinefrine,alpha-1b adrenergic receptor,gpcr,AGONIST,Drug: racepinefrine | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: AGONIST
16750,lithium citrate,glycogen synthase kinase-3,kinase,INHIBITOR,Drug: lithium citrate | Target: glycogen synthase kinase-3 | Type: kinase | Action: INHIBITOR
16751,lithium citrate,inositol-1(or 4)-monophosphatase 1,enzyme,INHIBITOR,Drug: lithium citrate | Target: inositol-1(or 4)-monophosphatase 1 | Type: enzyme | Action: INHIBITOR
16752,teriparatide,parathyroid hormone/parathyroid hormone-related peptide receptor,gpcr,AGONIST,Drug: teriparatide | Target: parathyroid hormone/parathyroid hormone-related peptide receptor | Type: gpcr | Action: AGONIST
16753,teriparatide,parathyroid hormone 2 receptor,gpcr,AGONIST,Drug: teriparatide | Target: parathyroid hormone 2 receptor | Type: gpcr | Action: AGONIST
16754,teriparatide,parathyroid hormone 2 receptor,gpcr,AGONIST,Drug: teriparatide | Target: parathyroid hormone 2 receptor | Type: gpcr | Action: AGONIST
16755,teriparatide,parathyroid hormone/parathyroid hormone-related peptide receptor,gpcr,AGONIST,Drug: teriparatide | Target: parathyroid hormone/parathyroid hormone-related peptide receptor | Type: gpcr | Action: AGONIST
16756,tetracosactide,melanocortin receptor 4,gpcr,,Drug: tetracosactide | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
16757,tetracosactide,adrenocorticotropic hormone receptor,gpcr,AGONIST,Drug: tetracosactide | Target: adrenocorticotropic hormone receptor | Type: gpcr | Action: AGONIST
16758,quinine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: quinine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
16759,quinine,multidrug resistance protein 1,transporter,,Drug: quinine | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
16760,quinine,hemoglobin subunit alpha,secreted,,Drug: quinine | Target: hemoglobin subunit alpha | Type: secreted | Action: nan
16761,quinine,potassium voltage-gated channel subfamily b member 2,ion channel,BLOCKER,Drug: quinine | Target: potassium voltage-gated channel subfamily b member 2 | Type: ion channel | Action: BLOCKER
16762,quinine,solute carrier family 22 member 1,transporter,,Drug: quinine | Target: solute carrier family 22 member 1 | Type: transporter | Action: nan
16763,quinine,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: quinine | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
16764,quinine,equilibrative nucleoside transporter 4,transporter,INHIBITOR,Drug: quinine | Target: equilibrative nucleoside transporter 4 | Type: transporter | Action: INHIBITOR
16765,fenbendazole,mitogen-activated protein kinase 14,kinase,,Drug: fenbendazole | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
16766,fenbendazole,beta-lactamase 1,enzyme,,Drug: fenbendazole | Target: beta-lactamase 1 | Type: enzyme | Action: nan
16767,fluticasone furoate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fluticasone furoate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16768,fluticasone furoate,mineralocorticoid receptor,nuclear hormone receptor,,Drug: fluticasone furoate | Target: mineralocorticoid receptor | Type: nuclear hormone receptor | Action: nan
16769,fluticasone furoate,progesterone receptor,nuclear hormone receptor,,Drug: fluticasone furoate | Target: progesterone receptor | Type: nuclear hormone receptor | Action: nan
16770,fluticasone furoate,androgen receptor,transcription factor,,Drug: fluticasone furoate | Target: androgen receptor | Type: transcription factor | Action: nan
16771,fluticasone furoate,glucocorticoid receptor,transcription factor,,Drug: fluticasone furoate | Target: glucocorticoid receptor | Type: transcription factor | Action: nan
16773,gepirone,d(2) dopamine receptor,gpcr,,Drug: gepirone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
16774,gepirone,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: gepirone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
16775,gepirone,5-hydroxytryptamine receptor 2a,gpcr,,Drug: gepirone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
16776,gepirone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: gepirone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
16777,gepirone,serotonin 1 (5-ht1) receptor,gpcr,,Drug: gepirone | Target: serotonin 1 (5-ht1) receptor | Type: gpcr | Action: nan
16778,gepirone,adrenergic receptor alpha-1,gpcr,,Drug: gepirone | Target: adrenergic receptor alpha-1 | Type: gpcr | Action: nan
16779,sodium oxybate,gaba-b receptor,gpcr,AGONIST,Drug: sodium oxybate | Target: gaba-b receptor | Type: gpcr | Action: AGONIST
16780,sodium oxybate,gamma-hydroxybutyrate receptor,unclassified,,Drug: sodium oxybate | Target: gamma-hydroxybutyrate receptor | Type: unclassified | Action: nan
16781,hydrochloric acid,carbonic anhydrase 4,enzyme,,Drug: hydrochloric acid | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
16782,hydrocortisone probutate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: hydrocortisone probutate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16783,iclaprim,dihydrofolate reductase,enzyme,,Drug: iclaprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
16784,iclaprim,dihydrofolate reductase,enzyme,,Drug: iclaprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
16785,iclaprim,dihydrofolate reductase,enzyme,,Drug: iclaprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
16786,iclaprim,dihydrofolate reductase,enzyme,,Drug: iclaprim | Target: dihydrofolate reductase | Type: enzyme | Action: nan
16787,levomethadone,opioid receptor,gpcr,,Drug: levomethadone | Target: opioid receptor | Type: gpcr | Action: nan
16788,linopirdine,potassium voltage-gated channel subfamily kqt member 2,ion channel,BLOCKER,Drug: linopirdine | Target: potassium voltage-gated channel subfamily kqt member 2 | Type: ion channel | Action: BLOCKER
16789,linopirdine,potassium voltage-gated channel subfamily kqt member 5,ion channel,BLOCKER,Drug: linopirdine | Target: potassium voltage-gated channel subfamily kqt member 5 | Type: ion channel | Action: BLOCKER
16790,linopirdine,potassium voltage-gated channel subfamily kqt member 4,ion channel,BLOCKER,Drug: linopirdine | Target: potassium voltage-gated channel subfamily kqt member 4 | Type: ion channel | Action: BLOCKER
16791,linopirdine,potassium voltage-gated channel subfamily kqt member 3,ion channel,INHIBITOR,Drug: linopirdine | Target: potassium voltage-gated channel subfamily kqt member 3 | Type: ion channel | Action: INHIBITOR
16792,linopirdine,potassium voltage-gated channel subfamily kqt member 1,ion channel,INHIBITOR,Drug: linopirdine | Target: potassium voltage-gated channel subfamily kqt member 1 | Type: ion channel | Action: INHIBITOR
16793,diosmetin,multidrug resistance-associated protein 1,transporter,,Drug: diosmetin | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
16794,diosmetin,cytochrome p450 1b1,enzyme,,Drug: diosmetin | Target: cytochrome p450 1b1 | Type: enzyme | Action: nan
16795,diosmetin,lysine-specific histone demethylase 1a,enzyme,,Drug: diosmetin | Target: lysine-specific histone demethylase 1a | Type: enzyme | Action: nan
16797,diosmetin,inositol polyphosphate multikinase,kinase,,Drug: diosmetin | Target: inositol polyphosphate multikinase | Type: kinase | Action: nan
16798,diosmetin,inositol hexakisphosphate kinase 2,kinase,,Drug: diosmetin | Target: inositol hexakisphosphate kinase 2 | Type: kinase | Action: nan
16799,tonzonium,insulin-degrading enzyme,enzyme,,Drug: tonzonium | Target: insulin-degrading enzyme | Type: enzyme | Action: nan
16800,tonzonium,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,,Drug: tonzonium | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: nan
16801,clocortolone pivalate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: clocortolone pivalate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16802,trypan blue,tyrosine-protein phosphatase non-receptor type 1,enzyme,,Drug: trypan blue | Target: tyrosine-protein phosphatase non-receptor type 1 | Type: enzyme | Action: nan
16803,trypan blue,tyrosine-protein phosphatase 1,enzyme,,Drug: trypan blue | Target: tyrosine-protein phosphatase 1 | Type: enzyme | Action: nan
16804,testosterone enantate,androgen receptor,nuclear hormone receptor,AGONIST,Drug: testosterone enantate | Target: androgen receptor | Type: nuclear hormone receptor | Action: AGONIST
16805,stearic acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: stearic acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
16806,stearic acid,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: stearic acid | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
16807,stearic acid,"fatty acid-binding protein, adipocyte",cytosolic other,,"Drug: stearic acid | Target: fatty acid-binding protein, adipocyte | Type: cytosolic other | Action: nan"
16808,stearic acid,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: stearic acid | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
16809,stearic acid,acetylcholinesterase,enzyme,,Drug: stearic acid | Target: acetylcholinesterase | Type: enzyme | Action: nan
16810,n-acetylglucosamine,killer cell lectin-like receptor subfamily b member 1a,unclassified,,Drug: n-acetylglucosamine | Target: killer cell lectin-like receptor subfamily b member 1a | Type: unclassified | Action: nan
16811,methylnaltrexone,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: methylnaltrexone | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
16812,methylnaltrexone,cytochrome p450 2d6,enzyme,,Drug: methylnaltrexone | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
16813,methylnaltrexone,kappa-type opioid receptor,gpcr,,Drug: methylnaltrexone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
16814,methylnaltrexone,delta-type opioid receptor,gpcr,,Drug: methylnaltrexone | Target: delta-type opioid receptor | Type: gpcr | Action: nan
16815,methylnaltrexone,kappa-type opioid receptor,gpcr,,Drug: methylnaltrexone | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
16816,linolenic acid,prostaglandin g/h synthase 1,enzyme,,Drug: linolenic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
16817,linolenic acid,aromatase,enzyme,,Drug: linolenic acid | Target: aromatase | Type: enzyme | Action: nan
16818,linolenic acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: linolenic acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
16819,linolenic acid,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: linolenic acid | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
16820,linolenic acid,"fatty acid-binding protein, heart",cytosolic other,,"Drug: linolenic acid | Target: fatty acid-binding protein, heart | Type: cytosolic other | Action: nan"
16821,linolenic acid,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: linolenic acid | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
16822,linolenic acid,free fatty acid receptor 1,gpcr,,Drug: linolenic acid | Target: free fatty acid receptor 1 | Type: gpcr | Action: nan
16823,linolenic acid,tissue factor,membrane receptor,,Drug: linolenic acid | Target: tissue factor | Type: membrane receptor | Action: nan
16824,linolenic acid,prostaglandin g/h synthase 2,enzyme,,Drug: linolenic acid | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
16825,linolenic acid,prostaglandin g/h synthase 1,enzyme,,Drug: linolenic acid | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
16826,levomenol,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: levomenol | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
16827,levomenol,signal transducer and activator of transcription 3,transcription factor,,Drug: levomenol | Target: signal transducer and activator of transcription 3 | Type: transcription factor | Action: nan
16829,levomefolic acid,thymidylate synthase,enzyme,,Drug: levomefolic acid | Target: thymidylate synthase | Type: enzyme | Action: nan
16830,linaclotide,heat-stable enterotoxin receptor,enzyme,AGONIST,Drug: linaclotide | Target: heat-stable enterotoxin receptor | Type: enzyme | Action: AGONIST
16831,linaclotide,heat-stable enterotoxin receptor,enzyme,AGONIST,Drug: linaclotide | Target: heat-stable enterotoxin receptor | Type: enzyme | Action: AGONIST
16832,spinosad,nicotinic acetylcholine receptor,ion channel,AGONIST,Drug: spinosad | Target: nicotinic acetylcholine receptor | Type: ion channel | Action: AGONIST
16833,phenylacetic acid,aldose reductase,enzyme,,Drug: phenylacetic acid | Target: aldose reductase | Type: enzyme | Action: nan
16834,sincalide,cholecystokinin receptor type a,gpcr,,Drug: sincalide | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
16835,sincalide,gastrin/cholecystokinin type b receptor,gpcr,,Drug: sincalide | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
16836,sincalide,cholecystokinin receptor type a,gpcr,,Drug: sincalide | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
16837,sincalide,gastrin/cholecystokinin type b receptor,gpcr,,Drug: sincalide | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
16838,sincalide,gastrin/cholecystokinin type b receptor,gpcr,,Drug: sincalide | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
16839,sincalide,cholecystokinin receptor type a,gpcr,,Drug: sincalide | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
16840,sincalide,cholecystokinin receptor,gpcr,,Drug: sincalide | Target: cholecystokinin receptor | Type: gpcr | Action: nan
16841,enzalutamide,androgen receptor,nuclear hormone receptor,ANTAGONIST,Drug: enzalutamide | Target: androgen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
16842,enzalutamide,androgen receptor,transcription factor,,Drug: enzalutamide | Target: androgen receptor | Type: transcription factor | Action: nan
16843,sodium pyrophosphate,farnesyl pyrophosphate synthase,enzyme,,Drug: sodium pyrophosphate | Target: farnesyl pyrophosphate synthase | Type: enzyme | Action: nan
16844,nitroprusside,atrial natriuretic peptide receptor 1,enzyme,,Drug: nitroprusside | Target: atrial natriuretic peptide receptor 1 | Type: enzyme | Action: nan
16845,nitroprusside,soluble guanylate cyclase,enzyme,ACTIVATOR,Drug: nitroprusside | Target: soluble guanylate cyclase | Type: enzyme | Action: ACTIVATOR
16846,trabectedin,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: trabectedin | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
16847,trabectedin,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,ANTAGONIST,Drug: trabectedin | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: ANTAGONIST
16848,teriflunomide,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,INHIBITOR,"Drug: teriflunomide | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: INHIBITOR"
16849,teriflunomide,dihydrofolate reductase,enzyme,,Drug: teriflunomide | Target: dihydrofolate reductase | Type: enzyme | Action: nan
16850,teriflunomide,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: teriflunomide | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
16851,teriflunomide,"dihydroorotate dehydrogenase (quinone), mitochondrial",enzyme,,"Drug: teriflunomide | Target: dihydroorotate dehydrogenase (quinone), mitochondrial | Type: enzyme | Action: nan"
16852,teriflunomide,dihydroorotate dehydrogenase,enzyme,,Drug: teriflunomide | Target: dihydroorotate dehydrogenase | Type: enzyme | Action: nan
16853,choline c-11,high affinity choline transporter 1,transporter,,Drug: choline c-11 | Target: high affinity choline transporter 1 | Type: transporter | Action: nan
16854,rose bengal,beta-lactamase,enzyme,,Drug: rose bengal | Target: beta-lactamase | Type: enzyme | Action: nan
16855,rose bengal,vesicular acetylcholine transporter,transporter,,Drug: rose bengal | Target: vesicular acetylcholine transporter | Type: transporter | Action: nan
16856,rose bengal,chymotrypsin c,enzyme,,Drug: rose bengal | Target: chymotrypsin c | Type: enzyme | Action: nan
16857,rose bengal,beta-galactosidase,enzyme,,Drug: rose bengal | Target: beta-galactosidase | Type: enzyme | Action: nan
16858,rose bengal,protein translocase subunit seca 1,unclassified,,Drug: rose bengal | Target: protein translocase subunit seca 1 | Type: unclassified | Action: nan
16859,rose bengal,protein translocase subunit seca 2,unclassified,,Drug: rose bengal | Target: protein translocase subunit seca 2 | Type: unclassified | Action: nan
16860,levmetamfetamine,trace amine-associated receptor 1,gpcr,,Drug: levmetamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
16861,levmetamfetamine,trace amine-associated receptor 1,gpcr,,Drug: levmetamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
16862,levmetamfetamine,trace amine-associated receptor 1,gpcr,,Drug: levmetamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: nan
16863,levmetamfetamine,trace amine-associated receptor 1,gpcr,AGONIST,Drug: levmetamfetamine | Target: trace amine-associated receptor 1 | Type: gpcr | Action: AGONIST
16864,dodecanoic acid,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,,Drug: dodecanoic acid | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: nan
16865,dodecanoic acid,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,,Drug: dodecanoic acid | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: nan
16866,dodecanoic acid,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,,Drug: dodecanoic acid | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: nan
16867,dodecanoic acid,free fatty acid receptor 1,gpcr,,Drug: dodecanoic acid | Target: free fatty acid receptor 1 | Type: gpcr | Action: nan
16868,dodecanoic acid,g-protein coupled receptor 84,gpcr,AGONIST,Drug: dodecanoic acid | Target: g-protein coupled receptor 84 | Type: gpcr | Action: AGONIST
16869,fluorometholone acetate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: fluorometholone acetate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16870,eugenol,prostaglandin g/h synthase 1,enzyme,,Drug: eugenol | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
16871,eugenol,arachidonate 5-lipoxygenase,enzyme,,Drug: eugenol | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
16873,regorafenib,glycine receptor subunit alpha-1,ion channel,,Drug: regorafenib | Target: glycine receptor subunit alpha-1 | Type: ion channel | Action: nan
16874,regorafenib,platelet-derived growth factor receptor beta,kinase,,Drug: regorafenib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
16875,regorafenib,mast/stem cell growth factor receptor kit,kinase,,Drug: regorafenib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
16876,regorafenib,raf proto-oncogene serine/threonine-protein kinase,kinase,,Drug: regorafenib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: nan
16877,regorafenib,serine/threonine-protein kinase b-raf,kinase,INHIBITOR,Drug: regorafenib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: INHIBITOR
16878,regorafenib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: regorafenib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
16879,regorafenib,vascular endothelial growth factor receptor 1,kinase,,Drug: regorafenib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
16880,regorafenib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: regorafenib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
16881,regorafenib,angiopoietin-1 receptor,kinase,,Drug: regorafenib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
16882,regorafenib,fibroblast growth factor receptor 1,kinase,,Drug: regorafenib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
16883,regorafenib,bifunctional epoxide hydrolase 2,enzyme,INHIBITOR,Drug: regorafenib | Target: bifunctional epoxide hydrolase 2 | Type: enzyme | Action: INHIBITOR
16884,regorafenib,vascular endothelial growth factor receptor 2,kinase,,Drug: regorafenib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
16885,regorafenib,vascular endothelial growth factor receptor 3,kinase,,Drug: regorafenib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: nan
16894,tedisamil,potassium voltage-gated channel subfamily a member 7,ion channel,BLOCKER,Drug: tedisamil | Target: potassium voltage-gated channel subfamily a member 7 | Type: ion channel | Action: BLOCKER
16895,metamizole,transient receptor potential cation channel subfamily a member 1,ion channel,BLOCKER,Drug: metamizole | Target: transient receptor potential cation channel subfamily a member 1 | Type: ion channel | Action: BLOCKER
16896,methylatropine,muscarinic acetylcholine receptor m2,gpcr,,Drug: methylatropine | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
16897,methylatropine,muscarinic acetylcholine receptor m1,gpcr,,Drug: methylatropine | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
16898,methylatropine,muscarinic acetylcholine receptor m3,gpcr,,Drug: methylatropine | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
16899,methylatropine,muscarinic acetylcholine receptor dm1,gpcr,,Drug: methylatropine | Target: muscarinic acetylcholine receptor dm1 | Type: gpcr | Action: nan
16900,benzoin,liver carboxylesterase 1,enzyme,,Drug: benzoin | Target: liver carboxylesterase 1 | Type: enzyme | Action: nan
16901,benzoin,cocaine esterase,enzyme,,Drug: benzoin | Target: cocaine esterase | Type: enzyme | Action: nan
16902,benzoic acid,solute carrier family 22 member 20,transporter,,Drug: benzoic acid | Target: solute carrier family 22 member 20 | Type: transporter | Action: nan
16903,benzoic acid,d-amino-acid oxidase,enzyme,,Drug: benzoic acid | Target: d-amino-acid oxidase | Type: enzyme | Action: nan
16904,benzoic acid,nicotinate phosphoribosyltransferase,enzyme,,Drug: benzoic acid | Target: nicotinate phosphoribosyltransferase | Type: enzyme | Action: nan
16905,betamethasone phosphate,histamine h1 receptor,gpcr,,Drug: betamethasone phosphate | Target: histamine h1 receptor | Type: gpcr | Action: nan
16906,betamethasone phosphate,muscarinic acetylcholine receptor m1,gpcr,,Drug: betamethasone phosphate | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
16907,betamethasone phosphate,muscarinic acetylcholine receptor m3,gpcr,,Drug: betamethasone phosphate | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: nan
16908,betamethasone phosphate,muscarinic acetylcholine receptor m4,gpcr,,Drug: betamethasone phosphate | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: nan
16909,betamethasone phosphate,muscarinic acetylcholine receptor m5,gpcr,,Drug: betamethasone phosphate | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: nan
16910,betamethasone phosphate,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: betamethasone phosphate | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
16911,metizoline,nischarin,membrane receptor,,Drug: metizoline | Target: nischarin | Type: membrane receptor | Action: nan
16912,metizoline,amine oxidase [flavin-containing] b,enzyme,,Drug: metizoline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
16913,metizoline,amine oxidase [flavin-containing] a,enzyme,,Drug: metizoline | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
16914,metizoline,nischarin,unclassified,,Drug: metizoline | Target: nischarin | Type: unclassified | Action: nan
16915,nalfurafine,orexin receptor type 1,gpcr,,Drug: nalfurafine | Target: orexin receptor type 1 | Type: gpcr | Action: nan
16916,nalfurafine,mu-type opioid receptor,gpcr,,Drug: nalfurafine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
16917,nalfurafine,delta-type opioid receptor,gpcr,,Drug: nalfurafine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
16918,nalfurafine,nociceptin receptor,gpcr,,Drug: nalfurafine | Target: nociceptin receptor | Type: gpcr | Action: nan
16919,nalfurafine,mitogen-activated protein kinase 3,kinase,,Drug: nalfurafine | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
16920,nalfurafine,mitogen-activated protein kinase 1,kinase,,Drug: nalfurafine | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
16921,nalfurafine,mu-type opioid receptor,gpcr,,Drug: nalfurafine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
16922,nalfurafine,mu-type opioid receptor,gpcr,,Drug: nalfurafine | Target: mu-type opioid receptor | Type: gpcr | Action: nan
16923,nalfurafine,delta-type opioid receptor,gpcr,,Drug: nalfurafine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
16924,nalfurafine,delta-type opioid receptor,gpcr,,Drug: nalfurafine | Target: delta-type opioid receptor | Type: gpcr | Action: nan
16925,nalfurafine,kappa-type opioid receptor,gpcr,,Drug: nalfurafine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
16926,nalfurafine,kappa-type opioid receptor,gpcr,,Drug: nalfurafine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
16927,nalfurafine,kappa-type opioid receptor,gpcr,,Drug: nalfurafine | Target: kappa-type opioid receptor | Type: gpcr | Action: nan
16931,nalfurafine,kappa-type opioid receptor,gpcr,AGONIST,Drug: nalfurafine | Target: kappa-type opioid receptor | Type: gpcr | Action: AGONIST
16932,obidoxime,acetylcholinesterase,enzyme,,Drug: obidoxime | Target: acetylcholinesterase | Type: enzyme | Action: nan
16933,panobinostat,histone deacetylase,enzyme,,Drug: panobinostat | Target: histone deacetylase | Type: enzyme | Action: nan
16934,panobinostat,bromodomain-containing protein 4,unclassified,,Drug: panobinostat | Target: bromodomain-containing protein 4 | Type: unclassified | Action: nan
16935,panobinostat,histone deacetylase 8,unclassified,,Drug: panobinostat | Target: histone deacetylase 8 | Type: unclassified | Action: nan
16936,panobinostat,histone deacetylase 5,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 5 | Type: enzyme | Action: INHIBITOR
16937,panobinostat,histone deacetylase 2,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 2 | Type: enzyme | Action: INHIBITOR
16938,panobinostat,histone deacetylase 1,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 1 | Type: enzyme | Action: INHIBITOR
16939,panobinostat,histone deacetylase 3,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 3 | Type: enzyme | Action: INHIBITOR
16940,panobinostat,histone deacetylase 6,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 6 | Type: enzyme | Action: INHIBITOR
16941,panobinostat,histone deacetylase 7,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 7 | Type: enzyme | Action: INHIBITOR
16942,panobinostat,histone deacetylase 8,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 8 | Type: enzyme | Action: INHIBITOR
16943,panobinostat,histone deacetylase 4,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 4 | Type: enzyme | Action: INHIBITOR
16944,panobinostat,histone deacetylase 9,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 9 | Type: enzyme | Action: INHIBITOR
16945,panobinostat,histone deacetylase 10,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 10 | Type: enzyme | Action: INHIBITOR
16946,panobinostat,histone deacetylase 11,enzyme,INHIBITOR,Drug: panobinostat | Target: histone deacetylase 11 | Type: enzyme | Action: INHIBITOR
16947,paraoxon,carbonic anhydrase 2,enzyme,,Drug: paraoxon | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
16948,paraoxon,carbonic anhydrase 1,enzyme,,Drug: paraoxon | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
16949,paraoxon,acetylcholinesterase,enzyme,,Drug: paraoxon | Target: acetylcholinesterase | Type: enzyme | Action: nan
16950,paraoxon,cholinesterase,enzyme,,Drug: paraoxon | Target: cholinesterase | Type: enzyme | Action: nan
16951,paraoxon,carbonic anhydrase 13,enzyme,,Drug: paraoxon | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
16952,paraoxon,acetylcholinesterase,enzyme,,Drug: paraoxon | Target: acetylcholinesterase | Type: enzyme | Action: nan
16953,paraoxon,cannabinoid receptor 1,gpcr,,Drug: paraoxon | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
16954,paraoxon,monoglyceride lipase,enzyme,,Drug: paraoxon | Target: monoglyceride lipase | Type: enzyme | Action: nan
16955,paraoxon,fatty-acid amide hydrolase 1,enzyme,,Drug: paraoxon | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
16956,perampanel,glutamate receptor ionotropic ampa,ion channel,ANTAGONIST,Drug: perampanel | Target: glutamate receptor ionotropic ampa | Type: ion channel | Action: ANTAGONIST
16957,pleconaril,nuclear receptor subfamily 1 group i member 2,nuclear hormone receptor,,Drug: pleconaril | Target: nuclear receptor subfamily 1 group i member 2 | Type: nuclear hormone receptor | Action: nan
16958,pleconaril,protease,enzyme,,Drug: pleconaril | Target: protease | Type: enzyme | Action: nan
16959,pleconaril,genome polyprotein,unclassified,,Drug: pleconaril | Target: genome polyprotein | Type: unclassified | Action: nan
16960,remikiren,renin,enzyme,INHIBITOR,Drug: remikiren | Target: renin | Type: enzyme | Action: INHIBITOR
16961,esatenolol,beta-1 adrenergic receptor,gpcr,,Drug: esatenolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
16962,esatenolol,beta-2 adrenergic receptor,gpcr,,Drug: esatenolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
16963,esatenolol,adenosine receptor a3,gpcr,,Drug: esatenolol | Target: adenosine receptor a3 | Type: gpcr | Action: nan
16964,esatenolol,5-hydroxytryptamine receptor 1a,gpcr,,Drug: esatenolol | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
16965,esatenolol,beta-2 adrenergic receptor,gpcr,,Drug: esatenolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
16966,esatenolol,beta-1 adrenergic receptor,gpcr,,Drug: esatenolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
16967,semustine,alpha-2a adrenergic receptor,gpcr,,Drug: semustine | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
16968,sodium aurothiomalate,adenosine receptor a3,gpcr,,Drug: sodium aurothiomalate | Target: adenosine receptor a3 | Type: gpcr | Action: nan
16969,sodium aurothiomalate,"thioredoxin reductase 1, cytoplasmic",enzyme,,"Drug: sodium aurothiomalate | Target: thioredoxin reductase 1, cytoplasmic | Type: enzyme | Action: nan"
16970,sodium aurothiomalate,epidermal growth factor receptor,kinase,,Drug: sodium aurothiomalate | Target: epidermal growth factor receptor | Type: kinase | Action: nan
16971,sodium aurothiomalate,tyrosine-protein kinase fyn,kinase,,Drug: sodium aurothiomalate | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
16972,sodium aurothiomalate,cathepsin l1,enzyme,,Drug: sodium aurothiomalate | Target: cathepsin l1 | Type: enzyme | Action: nan
16973,somatorelin,vasoactive intestinal polypeptide receptor 1,gpcr,AGONIST,Drug: somatorelin | Target: vasoactive intestinal polypeptide receptor 1 | Type: gpcr | Action: AGONIST
16974,tofacitinib,tyrosine-protein kinase jak3,kinase,INHIBITOR,Drug: tofacitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: INHIBITOR
16975,tofacitinib,tyrosine-protein kinase abl1,kinase,,Drug: tofacitinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
16976,tofacitinib,tyrosine-protein kinase lck,kinase,,Drug: tofacitinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
16977,tofacitinib,tyrosine-protein kinase fyn,kinase,,Drug: tofacitinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
16978,tofacitinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: tofacitinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
16979,tofacitinib,calcium/calmodulin-dependent protein kinase type 1,kinase,,Drug: tofacitinib | Target: calcium/calmodulin-dependent protein kinase type 1 | Type: kinase | Action: nan
16980,tofacitinib,rho-associated protein kinase 1,kinase,,Drug: tofacitinib | Target: rho-associated protein kinase 1 | Type: kinase | Action: nan
16981,tofacitinib,tyrosine-protein kinase jak1,kinase,INHIBITOR,Drug: tofacitinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: INHIBITOR
16982,tofacitinib,protein kinase c delta type,kinase,,Drug: tofacitinib | Target: protein kinase c delta type | Type: kinase | Action: nan
16983,tofacitinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: tofacitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
16984,tofacitinib,rho-associated protein kinase 2,kinase,,Drug: tofacitinib | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
16985,tofacitinib,calcium/calmodulin-dependent protein kinase type ii subunit delta,kinase,,Drug: tofacitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit delta | Type: kinase | Action: nan
16986,tofacitinib,ribosomal protein s6 kinase alpha-2,kinase,,Drug: tofacitinib | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
16987,tofacitinib,calcium/calmodulin-dependent protein kinase type ii subunit alpha,kinase,,Drug: tofacitinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit alpha | Type: kinase | Action: nan
16988,tofacitinib,serine/threonine-protein kinase n1,kinase,,Drug: tofacitinib | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
16989,tofacitinib,bmp-2-inducible protein kinase,kinase,,Drug: tofacitinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
16990,tofacitinib,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: tofacitinib | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
16991,tofacitinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: tofacitinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
16992,tofacitinib,serine/threonine-protein kinase n2,kinase,,Drug: tofacitinib | Target: serine/threonine-protein kinase n2 | Type: kinase | Action: nan
16993,tofacitinib,serine/threonine-protein kinase dclk3,kinase,,Drug: tofacitinib | Target: serine/threonine-protein kinase dclk3 | Type: kinase | Action: nan
16994,tofacitinib,serine/threonine-protein kinase 3,kinase,,Drug: tofacitinib | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
16995,tofacitinib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: tofacitinib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
16996,tofacitinib,nuak family snf1-like kinase 2,kinase,,Drug: tofacitinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
16997,tofacitinib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: tofacitinib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
16998,tofacitinib,non-receptor tyrosine-protein kinase tyk2,kinase,INHIBITOR,Drug: tofacitinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: INHIBITOR
16999,tofacitinib,myotonin-protein kinase,kinase,,Drug: tofacitinib | Target: myotonin-protein kinase | Type: kinase | Action: nan
17000,tofacitinib,serine/threonine-protein kinase dclk1,kinase,,Drug: tofacitinib | Target: serine/threonine-protein kinase dclk1 | Type: kinase | Action: nan
17001,tofacitinib,ribosomal protein s6 kinase alpha-1,kinase,,Drug: tofacitinib | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
17002,tofacitinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: tofacitinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
17003,tofacitinib,g protein-coupled receptor kinase 7,kinase,,Drug: tofacitinib | Target: g protein-coupled receptor kinase 7 | Type: kinase | Action: nan
17004,tofacitinib,serine/threonine-protein kinase ulk3,kinase,,Drug: tofacitinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
17005,tofacitinib,tyrosine-protein kinase jak3,kinase,,Drug: tofacitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
17006,tofacitinib,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: tofacitinib | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
17007,tofacitinib,tyrosine-protein kinase jak2,kinase,,Drug: tofacitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
17008,tofacitinib,serine/threonine-protein kinase pknb,kinase,,Drug: tofacitinib | Target: serine/threonine-protein kinase pknb | Type: kinase | Action: nan
17009,tofacitinib,jak1/tyk2,kinase,INHIBITOR,Drug: tofacitinib | Target: jak1/tyk2 | Type: kinase | Action: INHIBITOR
17010,tofacitinib,jak1/jak2/tyk2,kinase,INHIBITOR,Drug: tofacitinib | Target: jak1/jak2/tyk2 | Type: kinase | Action: INHIBITOR
17011,tofacitinib,jak2/tyk2,kinase,INHIBITOR,Drug: tofacitinib | Target: jak2/tyk2 | Type: kinase | Action: INHIBITOR
17012,tofacitinib,tyrosine-protein kinase jak3,kinase,,Drug: tofacitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
17013,tofacitinib,jak2/jak1,kinase,INHIBITOR,Drug: tofacitinib | Target: jak2/jak1 | Type: kinase | Action: INHIBITOR
17014,tofacitinib,jak3/jak1,kinase,INHIBITOR,Drug: tofacitinib | Target: jak3/jak1 | Type: kinase | Action: INHIBITOR
17015,cabozantinib,macrophage-stimulating protein receptor,kinase,INHIBITOR,Drug: cabozantinib | Target: macrophage-stimulating protein receptor | Type: kinase | Action: INHIBITOR
17016,cabozantinib,epidermal growth factor receptor,kinase,,Drug: cabozantinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
17017,cabozantinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: cabozantinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
17018,cabozantinib,vascular endothelial growth factor receptor 1,kinase,,Drug: cabozantinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
17019,cabozantinib,vascular endothelial growth factor receptor 3,kinase,,Drug: cabozantinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: nan
17020,cabozantinib,fibroblast growth factor receptor 1,kinase,,Drug: cabozantinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
17021,cabozantinib,aurora kinase a,kinase,,Drug: cabozantinib | Target: aurora kinase a | Type: kinase | Action: nan
17022,cabozantinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: cabozantinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
17024,cabozantinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: cabozantinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
17025,cabozantinib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: cabozantinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
17026,cabozantinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: cabozantinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
17027,cabozantinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: cabozantinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
17028,cabozantinib,angiopoietin-1 receptor,kinase,INHIBITOR,Drug: cabozantinib | Target: angiopoietin-1 receptor | Type: kinase | Action: INHIBITOR
17029,cabozantinib,hepatocyte growth factor receptor,kinase,INHIBITOR,Drug: cabozantinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: INHIBITOR
17030,ponatinib,platelet-derived growth factor receptor beta,kinase,,Drug: ponatinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
17031,ponatinib,tyrosine-protein kinase abl1,kinase,INHIBITOR,Drug: ponatinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: INHIBITOR
17032,ponatinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: ponatinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
17033,ponatinib,breakpoint cluster region protein,kinase,INHIBITOR,Drug: ponatinib | Target: breakpoint cluster region protein | Type: kinase | Action: INHIBITOR
17034,ponatinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: ponatinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
17035,ponatinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: ponatinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
17036,ponatinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: ponatinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
17037,ponatinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: ponatinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
17038,ponatinib,platelet-derived growth factor receptor alpha,kinase,INHIBITOR,Drug: ponatinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: INHIBITOR
17039,ponatinib,fibroblast growth factor receptor 3,kinase,,Drug: ponatinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
17040,ponatinib,tyrosine-protein kinase csk,kinase,INHIBITOR,Drug: ponatinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: INHIBITOR
17041,ponatinib,tyrosine-protein kinase lyn,kinase,INHIBITOR,Drug: ponatinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: INHIBITOR
17042,ponatinib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: ponatinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
17043,ponatinib,fibroblast growth factor receptor 2,kinase,,Drug: ponatinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
17044,ponatinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: ponatinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
17045,ponatinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: ponatinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
17046,ponatinib,cyclin-dependent kinase 19,kinase,INHIBITOR,Drug: ponatinib | Target: cyclin-dependent kinase 19 | Type: kinase | Action: INHIBITOR
17047,ponatinib,cyclin-dependent kinase 8,kinase,INHIBITOR,Drug: ponatinib | Target: cyclin-dependent kinase 8 | Type: kinase | Action: INHIBITOR
17048,ponatinib,receptor-interacting serine/threonine-protein kinase 1,kinase,INHIBITOR,Drug: ponatinib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: INHIBITOR
17049,ponatinib,fibroblast growth factor receptor 4,kinase,,Drug: ponatinib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: nan
17050,ponatinib,bcr/abl fusion protein,kinase,,Drug: ponatinib | Target: bcr/abl fusion protein | Type: kinase | Action: nan
17051,ponatinib,receptor-interacting serine/threonine-protein kinase 3,kinase,INHIBITOR,Drug: ponatinib | Target: receptor-interacting serine/threonine-protein kinase 3 | Type: kinase | Action: INHIBITOR
17052,teduglutide,glucagon-like peptide 2 receptor,gpcr,AGONIST,Drug: teduglutide | Target: glucagon-like peptide 2 receptor | Type: gpcr | Action: AGONIST
17053,teduglutide,glucagon-like peptide 2 receptor,gpcr,,Drug: teduglutide | Target: glucagon-like peptide 2 receptor | Type: gpcr | Action: nan
17054,daunorubicinol,multidrug resistance protein 1,transporter,,Drug: daunorubicinol | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
17055,daunorubicinol,dna topoisomerase 2-alpha,enzyme,,Drug: daunorubicinol | Target: dna topoisomerase 2-alpha | Type: enzyme | Action: nan
17056,daunorubicinol,multidrug resistance-associated protein 1,transporter,,Drug: daunorubicinol | Target: multidrug resistance-associated protein 1 | Type: transporter | Action: nan
17057,daunorubicinol,atp-binding cassette sub-family g member 2,transporter,,Drug: daunorubicinol | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: nan
17058,daunorubicinol,multidrug resistance-associated protein 6,transporter,,Drug: daunorubicinol | Target: multidrug resistance-associated protein 6 | Type: transporter | Action: nan
17059,lomitapide,microsomal triglyceride transfer protein large subunit,cytosolic other,INHIBITOR,Drug: lomitapide | Target: microsomal triglyceride transfer protein large subunit | Type: cytosolic other | Action: INHIBITOR
17060,succinimide,protein cereblon,cytosolic other,,Drug: succinimide | Target: protein cereblon | Type: cytosolic other | Action: nan
17061,succinimide,cereblon isoform 4,unclassified,,Drug: succinimide | Target: cereblon isoform 4 | Type: unclassified | Action: nan
17062,tacalcitol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: tacalcitol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
17063,tenidap,prostaglandin g/h synthase 2,enzyme,,Drug: tenidap | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
17064,tenidap,prostaglandin g/h synthase 1,enzyme,,Drug: tenidap | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
17065,tenidap,cytochrome p450 2c9,enzyme,,Drug: tenidap | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
17066,tenidap,cytochrome p450 1a2,enzyme,,Drug: tenidap | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
17067,tenidap,arachidonate 5-lipoxygenase,enzyme,,Drug: tenidap | Target: arachidonate 5-lipoxygenase | Type: enzyme | Action: nan
17068,tenidap,prostaglandin g/h synthase 1,enzyme,,Drug: tenidap | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
17069,tenidap,prostaglandin g/h synthase 2,enzyme,,Drug: tenidap | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
17070,tenidap,cyclooxygenase,enzyme,,Drug: tenidap | Target: cyclooxygenase | Type: enzyme | Action: nan
17071,tenidap,inward rectifier potassium channel 4,ion channel,ACTIVATOR,Drug: tenidap | Target: inward rectifier potassium channel 4 | Type: ion channel | Action: ACTIVATOR
17072,thiocolchicoside,gaba-a receptor; anion channel,ion channel,,Drug: thiocolchicoside | Target: gaba-a receptor; anion channel | Type: ion channel | Action: nan
17073,thiocolchicoside,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,NEGATIVE MODULATOR,Drug: thiocolchicoside | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: NEGATIVE MODULATOR
17074,thiocolchicoside,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,NEGATIVE MODULATOR,Drug: thiocolchicoside | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: NEGATIVE MODULATOR
17075,thiocolchicoside,gaba a receptor alpha-1/beta-1/gamma-2,ion channel,NEGATIVE MODULATOR,Drug: thiocolchicoside | Target: gaba a receptor alpha-1/beta-1/gamma-2 | Type: ion channel | Action: NEGATIVE MODULATOR
17076,thioctic acid,acetylcholinesterase,enzyme,,Drug: thioctic acid | Target: acetylcholinesterase | Type: enzyme | Action: nan
17077,thioctic acid,sumo-activating enzyme,enzyme,,Drug: thioctic acid | Target: sumo-activating enzyme | Type: enzyme | Action: nan
17078,thioctic acid,bifunctional protein glmu,enzyme,,Drug: thioctic acid | Target: bifunctional protein glmu | Type: enzyme | Action: nan
17079,thiomersal,alpha-2a adrenergic receptor,gpcr,,Drug: thiomersal | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
17080,thiomersal,sodium-dependent serotonin transporter,transporter,,Drug: thiomersal | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
17081,thiomersal,sodium-dependent noradrenaline transporter,transporter,,Drug: thiomersal | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: nan
17082,thiomersal,5-hydroxytryptamine receptor 6,gpcr,,Drug: thiomersal | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
17083,thiomersal,alpha-2b adrenergic receptor,gpcr,,Drug: thiomersal | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
17084,thiomersal,d(3) dopamine receptor,gpcr,,Drug: thiomersal | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
17085,thiomersal,alpha-2c adrenergic receptor,gpcr,,Drug: thiomersal | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: nan
17086,thiomersal,cytochrome p450 2d6,enzyme,,Drug: thiomersal | Target: cytochrome p450 2d6 | Type: enzyme | Action: nan
17087,thiomersal,adenosine receptor a3,gpcr,,Drug: thiomersal | Target: adenosine receptor a3 | Type: gpcr | Action: nan
17088,thiomersal,carbonic anhydrase 4,enzyme,,Drug: thiomersal | Target: carbonic anhydrase 4 | Type: enzyme | Action: nan
17089,thiomersal,carbonic anhydrase 12,enzyme,,Drug: thiomersal | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
17090,thiomersal,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: thiomersal | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
17091,thiomersal,"carbonic anhydrase 5b, mitochondrial",enzyme,,"Drug: thiomersal | Target: carbonic anhydrase 5b, mitochondrial | Type: enzyme | Action: nan"
17092,thiomersal,carbonic anhydrase 7,enzyme,,Drug: thiomersal | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
17093,thiomersal,toll-like receptor 9,membrane receptor,,Drug: thiomersal | Target: toll-like receptor 9 | Type: membrane receptor | Action: nan
17094,thiomersal,carbonic anhydrase 3,enzyme,,Drug: thiomersal | Target: carbonic anhydrase 3 | Type: enzyme | Action: nan
17095,thiomersal,carbonic anhydrase 6,enzyme,,Drug: thiomersal | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
17096,thiomersal,carbonic anhydrase 14,enzyme,,Drug: thiomersal | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
17097,thiomersal,mitogen-activated protein kinase 3,kinase,,Drug: thiomersal | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
17098,thiomersal,carbonic anhydrase 13,enzyme,,Drug: thiomersal | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
17099,thiomersal,beta-lactamase,enzyme,,Drug: thiomersal | Target: beta-lactamase | Type: enzyme | Action: nan
17100,bedaquiline,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: bedaquiline | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17101,bedaquiline,atp synthase,enzyme,INHIBITOR,Drug: bedaquiline | Target: atp synthase | Type: enzyme | Action: INHIBITOR
17102,bedaquiline,atp synthase subunit c,enzyme,,Drug: bedaquiline | Target: atp synthase subunit c | Type: enzyme | Action: nan
17103,bedaquiline,atp synthase subunit c,enzyme,,Drug: bedaquiline | Target: atp synthase subunit c | Type: enzyme | Action: nan
17104,crofelemer,cystic fibrosis transmembrane conductance regulator,ion channel,INHIBITOR,Drug: crofelemer | Target: cystic fibrosis transmembrane conductance regulator | Type: ion channel | Action: INHIBITOR
17105,crofelemer,anoctamin-1,ion channel,INHIBITOR,Drug: crofelemer | Target: anoctamin-1 | Type: ion channel | Action: INHIBITOR
17106,pomalidomide,cereblon isoform 4,unclassified,,Drug: pomalidomide | Target: cereblon isoform 4 | Type: unclassified | Action: nan
17108,pomalidomide,protein cereblon,cytosolic other,MODULATOR,Drug: pomalidomide | Target: protein cereblon | Type: cytosolic other | Action: MODULATOR
17109,ospemifene,estrogen receptor,nuclear hormone receptor,MODULATOR,Drug: ospemifene | Target: estrogen receptor | Type: nuclear hormone receptor | Action: MODULATOR
17110,levobetaxolol,beta-1 adrenergic receptor,gpcr,ANTAGONIST,Drug: levobetaxolol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
17111,levobetaxolol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: levobetaxolol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
17112,dimethyl fumarate,hydroxycarboxylic acid receptor 2,gpcr,,Drug: dimethyl fumarate | Target: hydroxycarboxylic acid receptor 2 | Type: gpcr | Action: nan
17113,dimethyl fumarate,kelch-like ech-associated protein 1,cytosolic other,INHIBITOR,Drug: dimethyl fumarate | Target: kelch-like ech-associated protein 1 | Type: cytosolic other | Action: INHIBITOR
17114,canagliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: canagliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
17115,canagliflozin,sodium/glucose cotransporter 1,transporter,,Drug: canagliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: nan
17116,canagliflozin,protease,enzyme,,Drug: canagliflozin | Target: protease | Type: enzyme | Action: nan
17117,ethyl hydroxybenzoate,carbonic anhydrase 2,enzyme,,Drug: ethyl hydroxybenzoate | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
17118,ethyl hydroxybenzoate,estrogen receptor,nuclear hormone receptor,,Drug: ethyl hydroxybenzoate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: nan
17119,ethyl hydroxybenzoate,carbonic anhydrase 1,enzyme,,Drug: ethyl hydroxybenzoate | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
17120,ethyl hydroxybenzoate,estrogen receptor beta,nuclear hormone receptor,,Drug: ethyl hydroxybenzoate | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: nan
17121,ethyl hydroxybenzoate,carbonic anhydrase 9,enzyme,,Drug: ethyl hydroxybenzoate | Target: carbonic anhydrase 9 | Type: enzyme | Action: nan
17122,ethyl hydroxybenzoate,carbonic anhydrase 12,enzyme,,Drug: ethyl hydroxybenzoate | Target: carbonic anhydrase 12 | Type: enzyme | Action: nan
17123,ethyl hydroxybenzoate,carbonic anhydrase 7,enzyme,,Drug: ethyl hydroxybenzoate | Target: carbonic anhydrase 7 | Type: enzyme | Action: nan
17124,ethyl hydroxybenzoate,carbonic anhydrase 14,enzyme,,Drug: ethyl hydroxybenzoate | Target: carbonic anhydrase 14 | Type: enzyme | Action: nan
17125,ridaforolimus,serine/threonine-protein kinase mtor,kinase,INHIBITOR,Drug: ridaforolimus | Target: serine/threonine-protein kinase mtor | Type: kinase | Action: INHIBITOR
17126,gramicidin,sodium/potassium-transporting atpase subunit alpha-2,ion channel,,Drug: gramicidin | Target: sodium/potassium-transporting atpase subunit alpha-2 | Type: ion channel | Action: nan
17127,gramicidin,endothelin-1 receptor,gpcr,,Drug: gramicidin | Target: endothelin-1 receptor | Type: gpcr | Action: nan
17128,gramicidin,tyrosine-protein kinase lck,kinase,,Drug: gramicidin | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
17129,gramicidin,tyrosine-protein kinase fyn,kinase,,Drug: gramicidin | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
17130,gramicidin,thromboxane-a synthase,enzyme,,Drug: gramicidin | Target: thromboxane-a synthase | Type: enzyme | Action: nan
17131,gramicidin,substance-k receptor,gpcr,,Drug: gramicidin | Target: substance-k receptor | Type: gpcr | Action: nan
17132,gramicidin,melanocortin receptor 4,gpcr,,Drug: gramicidin | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
17133,gramicidin,melanocortin receptor 5,gpcr,,Drug: gramicidin | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
17134,sodium propionate,carbonic anhydrase,enzyme,,Drug: sodium propionate | Target: carbonic anhydrase | Type: enzyme | Action: nan
17135,sodium propionate,free fatty acid receptor 3,gpcr,,Drug: sodium propionate | Target: free fatty acid receptor 3 | Type: gpcr | Action: nan
17136,sodium nitrite,carbonic anhydrase 2,enzyme,,Drug: sodium nitrite | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
17137,sodium nitrite,carbonic anhydrase 1,enzyme,,Drug: sodium nitrite | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
17138,sodium nitrite,carbonic anhydrase 13,enzyme,,Drug: sodium nitrite | Target: carbonic anhydrase 13 | Type: enzyme | Action: nan
17139,vilanterol,beta-1 adrenergic receptor,gpcr,,Drug: vilanterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
17140,vilanterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: vilanterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
17141,vilanterol,beta-3 adrenergic receptor,gpcr,,Drug: vilanterol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
17142,dabrafenib,raf proto-oncogene serine/threonine-protein kinase,kinase,,Drug: dabrafenib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: nan
17143,dabrafenib,serine/threonine-protein kinase b-raf,kinase,INHIBITOR,Drug: dabrafenib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: INHIBITOR
17144,dabrafenib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: dabrafenib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
17145,dabrafenib,tgf-beta receptor type-1,kinase,,Drug: dabrafenib | Target: tgf-beta receptor type-1 | Type: kinase | Action: nan
17146,dabrafenib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: dabrafenib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
17147,dabrafenib,dual serine/threonine and tyrosine protein kinase,kinase,,Drug: dabrafenib | Target: dual serine/threonine and tyrosine protein kinase | Type: kinase | Action: nan
17148,dabrafenib,serine/threonine-protein kinase a-raf,kinase,,Drug: dabrafenib | Target: serine/threonine-protein kinase a-raf | Type: kinase | Action: nan
17149,dabrafenib,gtpase kras,enzyme,,Drug: dabrafenib | Target: gtpase kras | Type: enzyme | Action: nan
17150,dabrafenib,receptor-interacting serine/threonine-protein kinase 3,kinase,,Drug: dabrafenib | Target: receptor-interacting serine/threonine-protein kinase 3 | Type: kinase | Action: nan
17153,dabrafenib,dual serine/threonine and tyrosine protein kinase,kinase,,Drug: dabrafenib | Target: dual serine/threonine and tyrosine protein kinase | Type: kinase | Action: nan
17155,trametinib,multidrug resistance protein 1,transporter,,Drug: trametinib | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
17156,trametinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,INHIBITOR,Drug: trametinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: INHIBITOR
17157,trametinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,INHIBITOR,Drug: trametinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: INHIBITOR
17159,palifermin,fibroblast growth factor receptor 2,kinase,AGONIST,Drug: palifermin | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: AGONIST
17160,dolutegravir,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: dolutegravir | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
17161,dolutegravir,sigma non-opioid intracellular receptor 1,membrane other,,Drug: dolutegravir | Target: sigma non-opioid intracellular receptor 1 | Type: membrane other | Action: nan
17162,dolutegravir,vesicular acetylcholine transporter,transporter,,Drug: dolutegravir | Target: vesicular acetylcholine transporter | Type: transporter | Action: nan
17163,dolutegravir,integrase,enzyme,,Drug: dolutegravir | Target: integrase | Type: enzyme | Action: nan
17164,dolutegravir,sigma intracellular receptor 2,unclassified,,Drug: dolutegravir | Target: sigma intracellular receptor 2 | Type: unclassified | Action: nan
17165,dolutegravir,integrase,enzyme,INHIBITOR,Drug: dolutegravir | Target: integrase | Type: enzyme | Action: INHIBITOR
17166,vortioxetine,beta-1 adrenergic receptor,gpcr,,Drug: vortioxetine | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
17167,vortioxetine,beta-2 adrenergic receptor,gpcr,,Drug: vortioxetine | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
17168,vortioxetine,5-hydroxytryptamine receptor 2a,gpcr,,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
17169,vortioxetine,5-hydroxytryptamine receptor 2c,gpcr,,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
17170,vortioxetine,5-hydroxytryptamine receptor 6,gpcr,,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
17171,vortioxetine,histamine h1 receptor,gpcr,,Drug: vortioxetine | Target: histamine h1 receptor | Type: gpcr | Action: nan
17172,vortioxetine,histamine h2 receptor,gpcr,,Drug: vortioxetine | Target: histamine h2 receptor | Type: gpcr | Action: nan
17173,vortioxetine,5-hydroxytryptamine receptor 5a,gpcr,,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
17174,vortioxetine,sodium-dependent serotonin transporter,transporter,,Drug: vortioxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
17175,vortioxetine,sodium-dependent dopamine transporter,transporter,,Drug: vortioxetine | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
17176,vortioxetine,5-hydroxytryptamine receptor 3a,ion channel,,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: nan
17177,vortioxetine,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
17178,vortioxetine,5-hydroxytryptamine receptor 7,gpcr,,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
17179,vortioxetine,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: vortioxetine | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
17180,vortioxetine,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
17181,vortioxetine,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
17182,vortioxetine,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
17183,vortioxetine,5-hydroxytryptamine receptor 3a,ion channel,ANTAGONIST,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 3a | Type: ion channel | Action: ANTAGONIST
17184,vortioxetine,5-hydroxytryptamine receptor 1d,gpcr,ANTAGONIST,Drug: vortioxetine | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: ANTAGONIST
17185,riociguat,"camp-specific 3',5'-cyclic phosphodiesterase 7b",enzyme,,"Drug: riociguat | Target: camp-specific 3',5'-cyclic phosphodiesterase 7b | Type: enzyme | Action: nan"
17186,riociguat,guanylate cyclase soluble subunit beta-1,enzyme,POSITIVE ALLOSTERIC MODULATOR,Drug: riociguat | Target: guanylate cyclase soluble subunit beta-1 | Type: enzyme | Action: POSITIVE ALLOSTERIC MODULATOR
17187,ipidacrine,acetylcholinesterase,enzyme,,Drug: ipidacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
17188,ipidacrine,acetylcholinesterase,enzyme,,Drug: ipidacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
17189,ipidacrine,cholinesterase,enzyme,,Drug: ipidacrine | Target: cholinesterase | Type: enzyme | Action: nan
17190,ipidacrine,butyrylcholinesterase; protein bche,enzyme,,Drug: ipidacrine | Target: butyrylcholinesterase; protein bche | Type: enzyme | Action: nan
17191,ipidacrine,acetylcholinesterase,enzyme,,Drug: ipidacrine | Target: acetylcholinesterase | Type: enzyme | Action: nan
17192,macitentan,endothelin-1 receptor,gpcr,ANTAGONIST,Drug: macitentan | Target: endothelin-1 receptor | Type: gpcr | Action: ANTAGONIST
17193,macitentan,endothelin b receptor,gpcr,ANTAGONIST,Drug: macitentan | Target: endothelin b receptor | Type: gpcr | Action: ANTAGONIST
17194,ibrutinib,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ibrutinib | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17195,ibrutinib,tyrosine-protein kinase abl1,kinase,,Drug: ibrutinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
17196,ibrutinib,epidermal growth factor receptor,kinase,,Drug: ibrutinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
17197,ibrutinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: ibrutinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
17198,ibrutinib,tyrosine-protein kinase csk,kinase,,Drug: ibrutinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
17199,ibrutinib,cytoplasmic tyrosine-protein kinase bmx,kinase,,Drug: ibrutinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: nan
17200,ibrutinib,tyrosine-protein kinase fer,kinase,,Drug: ibrutinib | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
17201,ibrutinib,fibroblast growth factor receptor 2,kinase,,Drug: ibrutinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
17202,ibrutinib,protein-tyrosine kinase 6,kinase,,Drug: ibrutinib | Target: protein-tyrosine kinase 6 | Type: kinase | Action: nan
17203,ibrutinib,redox-regulatory protein fam213a,unclassified,,Drug: ibrutinib | Target: redox-regulatory protein fam213a | Type: unclassified | Action: nan
17204,ibrutinib,tyrosine-protein kinase lyn,kinase,,Drug: ibrutinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
17205,ibrutinib,tyrosine-protein kinase jak3,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: INHIBITOR
17206,ibrutinib,proto-oncogene tyrosine-protein kinase src,kinase,INHIBITOR,Drug: ibrutinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: INHIBITOR
17207,ibrutinib,tyrosine-protein kinase lck,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: INHIBITOR
17208,ibrutinib,tyrosine-protein kinase yes,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: INHIBITOR
17209,ibrutinib,tyrosine-protein kinase fyn,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: INHIBITOR
17210,ibrutinib,receptor tyrosine-protein kinase erbb-2,kinase,INHIBITOR,Drug: ibrutinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: INHIBITOR
17211,ibrutinib,tyrosine-protein kinase hck,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: INHIBITOR
17212,ibrutinib,receptor tyrosine-protein kinase erbb-4,kinase,INHIBITOR,Drug: ibrutinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: INHIBITOR
17213,ibrutinib,tyrosine-protein kinase fgr,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: INHIBITOR
17214,ibrutinib,tyrosine-protein kinase itk/tsk,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: INHIBITOR
17215,ibrutinib,tyrosine-protein kinase tec,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase tec | Type: kinase | Action: INHIBITOR
17216,ibrutinib,tyrosine-protein kinase txk,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: INHIBITOR
17217,ibrutinib,tyrosine-protein kinase blk,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: INHIBITOR
17218,ibrutinib,tyrosine-protein kinase btk,kinase,INHIBITOR,Drug: ibrutinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: INHIBITOR
17219,sofosbuvir,ns5b protein,enzyme,INHIBITOR,Drug: sofosbuvir | Target: ns5b protein | Type: enzyme | Action: INHIBITOR
17220,sofosbuvir,genome polyprotein,polyprotein,INHIBITOR,Drug: sofosbuvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17221,simeprevir,cathepsin s,enzyme,,Drug: simeprevir | Target: cathepsin s | Type: enzyme | Action: nan
17222,simeprevir,"hepatitis c virus serine protease, ns3/ns4a",enzyme,INHIBITOR,"Drug: simeprevir | Target: hepatitis c virus serine protease, ns3/ns4a | Type: enzyme | Action: INHIBITOR"
17223,simeprevir,nonstructural protein ns3-4a,unclassified,,Drug: simeprevir | Target: nonstructural protein ns3-4a | Type: unclassified | Action: nan
17224,simeprevir,polyprotein,polyprotein,INHIBITOR,Drug: simeprevir | Target: polyprotein | Type: polyprotein | Action: INHIBITOR
17225,simeprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: simeprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17226,luliconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: luliconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
17227,olodaterol,beta-1 adrenergic receptor,gpcr,,Drug: olodaterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
17228,olodaterol,beta-3 adrenergic receptor,gpcr,,Drug: olodaterol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
17229,olodaterol,beta-2 adrenergic receptor,gpcr,ANTAGONIST,Drug: olodaterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: ANTAGONIST
17230,lixisenatide,glucagon-like peptide 1 receptor,gpcr,AGONIST,Drug: lixisenatide | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: AGONIST
17231,umeclidinium,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: umeclidinium | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
17232,umeclidinium,muscarinic acetylcholine receptor m5,gpcr,ANTAGONIST,Drug: umeclidinium | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: ANTAGONIST
17233,umeclidinium,muscarinic acetylcholine receptor m1,gpcr,,Drug: umeclidinium | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
17234,umeclidinium,muscarinic acetylcholine receptor m2,gpcr,,Drug: umeclidinium | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: nan
17235,umeclidinium,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: umeclidinium | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
17236,rifamycin,bile salt export pump,transporter,,Drug: rifamycin | Target: bile salt export pump | Type: transporter | Action: nan
17237,rifamycin,solute carrier organic anion transporter family member 1b1,transporter,INHIBITOR,Drug: rifamycin | Target: solute carrier organic anion transporter family member 1b1 | Type: transporter | Action: INHIBITOR
17238,rifamycin,solute carrier organic anion transporter family member 1a2,transporter,INHIBITOR,Drug: rifamycin | Target: solute carrier organic anion transporter family member 1a2 | Type: transporter | Action: INHIBITOR
17239,rifamycin,bile salt export pump,transporter,,Drug: rifamycin | Target: bile salt export pump | Type: transporter | Action: nan
17240,rifamycin,dna-directed rna polymerase subunit beta,enzyme,INHIBITOR,Drug: rifamycin | Target: dna-directed rna polymerase subunit beta | Type: enzyme | Action: INHIBITOR
17241,florbetaben f18,amyloid beta a4 protein,unclassified,,Drug: florbetaben f18 | Target: amyloid beta a4 protein | Type: unclassified | Action: nan
17242,tasimelteon,melatonin receptor type 1a,gpcr,AGONIST,Drug: tasimelteon | Target: melatonin receptor type 1a | Type: gpcr | Action: AGONIST
17243,tasimelteon,melatonin receptor type 1b,gpcr,AGONIST,Drug: tasimelteon | Target: melatonin receptor type 1b | Type: gpcr | Action: AGONIST
17244,seractide,adrenocorticotropic hormone receptor,gpcr,AGONIST,Drug: seractide | Target: adrenocorticotropic hormone receptor | Type: gpcr | Action: AGONIST
17245,laninamivir octanoate hydrate,neuraminidase,enzyme,,Drug: laninamivir octanoate hydrate | Target: neuraminidase | Type: enzyme | Action: nan
17246,laninamivir octanoate hydrate,neuraminidase,enzyme,,Drug: laninamivir octanoate hydrate | Target: neuraminidase | Type: enzyme | Action: nan
17247,peramivir,neuraminidase,enzyme,,Drug: peramivir | Target: neuraminidase | Type: enzyme | Action: nan
17248,peramivir,sialidase,enzyme,,Drug: peramivir | Target: sialidase | Type: enzyme | Action: nan
17249,peramivir,neuraminidase,enzyme,,Drug: peramivir | Target: neuraminidase | Type: enzyme | Action: nan
17250,peramivir,neuraminidase,enzyme,,Drug: peramivir | Target: neuraminidase | Type: enzyme | Action: nan
17251,peramivir,sialidase 2,enzyme,,Drug: peramivir | Target: sialidase 2 | Type: enzyme | Action: nan
17252,peramivir,neuraminidase,enzyme,,Drug: peramivir | Target: neuraminidase | Type: enzyme | Action: nan
17253,peramivir,neuraminidase,enzyme,,Drug: peramivir | Target: neuraminidase | Type: enzyme | Action: nan
17254,peramivir,neuraminidase,enzyme,INHIBITOR,Drug: peramivir | Target: neuraminidase | Type: enzyme | Action: INHIBITOR
17255,peramivir,neuraminidase,enzyme,INHIBITOR,Drug: peramivir | Target: neuraminidase | Type: enzyme | Action: INHIBITOR
17256,peramivir,neuraminidase,enzyme,INHIBITOR,Drug: peramivir | Target: neuraminidase | Type: enzyme | Action: INHIBITOR
17257,etilefrine pivalate,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: etilefrine pivalate | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
17258,metreleptin,leptin receptor,membrane receptor,AGONIST,Drug: metreleptin | Target: leptin receptor | Type: membrane receptor | Action: AGONIST
17259,apremilast,"camp-specific 3',5'-cyclic phosphodiesterase 4b",enzyme,INHIBITOR,"Drug: apremilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4b | Type: enzyme | Action: INHIBITOR"
17260,apremilast,"camp-specific 3',5'-cyclic phosphodiesterase 4a",enzyme,INHIBITOR,"Drug: apremilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4a | Type: enzyme | Action: INHIBITOR"
17261,apremilast,"camp-specific 3',5'-cyclic phosphodiesterase 4c",enzyme,INHIBITOR,"Drug: apremilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4c | Type: enzyme | Action: INHIBITOR"
17262,apremilast,"camp-specific 3',5'-cyclic phosphodiesterase 4d",enzyme,INHIBITOR,"Drug: apremilast | Target: camp-specific 3',5'-cyclic phosphodiesterase 4d | Type: enzyme | Action: INHIBITOR"
17263,empagliflozin,sodium/glucose cotransporter 4,transporter,,Drug: empagliflozin | Target: sodium/glucose cotransporter 4 | Type: transporter | Action: nan
17264,empagliflozin,sodium/glucose cotransporter 5,transporter,,Drug: empagliflozin | Target: sodium/glucose cotransporter 5 | Type: transporter | Action: nan
17265,empagliflozin,sodium/glucose cotransporter 1,transporter,,Drug: empagliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: nan
17266,empagliflozin,sodium/myo-inositol cotransporter 2,transporter,,Drug: empagliflozin | Target: sodium/myo-inositol cotransporter 2 | Type: transporter | Action: nan
17267,empagliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: empagliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
17268,naloxegol,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: naloxegol | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
17269,gemigliptin,dipeptidyl peptidase 9,enzyme,,Drug: gemigliptin | Target: dipeptidyl peptidase 9 | Type: enzyme | Action: nan
17270,gemigliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: gemigliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
17271,eliglustat,ceramide glucosyltransferase,enzyme,INHIBITOR,Drug: eliglustat | Target: ceramide glucosyltransferase | Type: enzyme | Action: INHIBITOR
17272,afamelanotide,adenosine deaminase,enzyme,,Drug: afamelanotide | Target: adenosine deaminase | Type: enzyme | Action: nan
17273,afamelanotide,melanocortin receptor 4,gpcr,AGONIST,Drug: afamelanotide | Target: melanocortin receptor 4 | Type: gpcr | Action: AGONIST
17274,afamelanotide,melanocortin receptor 5,gpcr,AGONIST,Drug: afamelanotide | Target: melanocortin receptor 5 | Type: gpcr | Action: AGONIST
17275,afamelanotide,melanocortin receptor 3,gpcr,AGONIST,Drug: afamelanotide | Target: melanocortin receptor 3 | Type: gpcr | Action: AGONIST
17276,afamelanotide,melanocortin receptor 3,gpcr,,Drug: afamelanotide | Target: melanocortin receptor 3 | Type: gpcr | Action: nan
17277,afamelanotide,melanocortin receptor 5,gpcr,,Drug: afamelanotide | Target: melanocortin receptor 5 | Type: gpcr | Action: nan
17278,afamelanotide,melanocortin receptor 4,gpcr,,Drug: afamelanotide | Target: melanocortin receptor 4 | Type: gpcr | Action: nan
17279,afamelanotide,melanocyte-stimulating hormone receptor,gpcr,,Drug: afamelanotide | Target: melanocyte-stimulating hormone receptor | Type: gpcr | Action: nan
17280,afamelanotide,melanocyte-stimulating hormone receptor,gpcr,AGONIST,Drug: afamelanotide | Target: melanocyte-stimulating hormone receptor | Type: gpcr | Action: AGONIST
17281,aprotinin,plasminogen,enzyme,INHIBITOR,Drug: aprotinin | Target: plasminogen | Type: enzyme | Action: INHIBITOR
17282,aprotinin,plasma kallikrein,enzyme,INHIBITOR,Drug: aprotinin | Target: plasma kallikrein | Type: enzyme | Action: INHIBITOR
17283,ecallantide,plasma kallikrein,enzyme,INHIBITOR,Drug: ecallantide | Target: plasma kallikrein | Type: enzyme | Action: INHIBITOR
17284,somatropin,growth hormone receptor,gpcr,AGONIST,Drug: somatropin | Target: growth hormone receptor | Type: gpcr | Action: AGONIST
17285,cridanimod,trypsin,enzyme,,Drug: cridanimod | Target: trypsin | Type: enzyme | Action: nan
17286,cridanimod,stimulator of interferon genes protein,unclassified,,Drug: cridanimod | Target: stimulator of interferon genes protein | Type: unclassified | Action: nan
17287,conjugated estrogens,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: conjugated estrogens | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
17288,conjugated estrogens,estrogen receptor beta,nuclear hormone receptor,AGONIST,Drug: conjugated estrogens | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: AGONIST
17289,estrone sulphate,steryl-sulfatase,enzyme,,Drug: estrone sulphate | Target: steryl-sulfatase | Type: enzyme | Action: nan
17290,estrone sulphate,solute carrier family 22 member 20,transporter,,Drug: estrone sulphate | Target: solute carrier family 22 member 20 | Type: transporter | Action: nan
17291,estrone sulphate,estrogen receptor,nuclear hormone receptor,AGONIST,Drug: estrone sulphate | Target: estrogen receptor | Type: nuclear hormone receptor | Action: AGONIST
17292,estrone sulphate,estrogen receptor beta,nuclear hormone receptor,AGONIST,Drug: estrone sulphate | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: AGONIST
17293,corticorelin,corticotropin-releasing factor receptor 2,gpcr,AGONIST,Drug: corticorelin | Target: corticotropin-releasing factor receptor 2 | Type: gpcr | Action: AGONIST
17294,corticorelin,corticotropin-releasing factor receptor 2,gpcr,AGONIST,Drug: corticorelin | Target: corticotropin-releasing factor receptor 2 | Type: gpcr | Action: AGONIST
17295,corticorelin,corticotropin-releasing factor receptor 2,gpcr,AGONIST,Drug: corticorelin | Target: corticotropin-releasing factor receptor 2 | Type: gpcr | Action: AGONIST
17296,corticorelin,corticotropin-releasing factor receptor 1,gpcr,AGONIST,Drug: corticorelin | Target: corticotropin-releasing factor receptor 1 | Type: gpcr | Action: AGONIST
17297,phenibut,gaba-b receptor,gpcr,AGONIST,Drug: phenibut | Target: gaba-b receptor | Type: gpcr | Action: AGONIST
17298,levomilnacipran,sodium-dependent dopamine transporter,transporter,,Drug: levomilnacipran | Target: sodium-dependent dopamine transporter | Type: transporter | Action: nan
17299,levomilnacipran,sodium-dependent serotonin transporter,transporter,,Drug: levomilnacipran | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
17300,levomilnacipran,glutamate nmda receptor,ion channel,,Drug: levomilnacipran | Target: glutamate nmda receptor | Type: ion channel | Action: nan
17301,levomilnacipran,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: levomilnacipran | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
17302,levomilnacipran,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: levomilnacipran | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
17303,mebanazine,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: mebanazine | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
17304,mebanazine,amine oxidase [flavin-containing] a,enzyme,INHIBITOR,Drug: mebanazine | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: INHIBITOR
17305,ceritinib,tyrosine-protein kinase jak3,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
17306,ceritinib,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: ceritinib | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17307,ceritinib,multidrug resistance protein 1,transporter,,Drug: ceritinib | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
17308,ceritinib,tyrosine-protein kinase abl1,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
17309,ceritinib,mast/stem cell growth factor receptor kit,kinase,,Drug: ceritinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
17310,ceritinib,epidermal growth factor receptor,kinase,,Drug: ceritinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
17311,ceritinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: ceritinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
17312,ceritinib,tyrosine-protein kinase lck,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
17313,ceritinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: ceritinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
17314,ceritinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: ceritinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
17315,ceritinib,vascular endothelial growth factor receptor 2,kinase,,Drug: ceritinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
17316,ceritinib,platelet-derived growth factor receptor alpha,kinase,,Drug: ceritinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
17317,ceritinib,cyclin-dependent kinase 2,kinase,,Drug: ceritinib | Target: cyclin-dependent kinase 2 | Type: kinase | Action: nan
17318,ceritinib,fibroblast growth factor receptor 3,kinase,,Drug: ceritinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
17319,ceritinib,tyrosine-protein kinase jak1,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: nan
17320,ceritinib,high affinity nerve growth factor receptor,kinase,,Drug: ceritinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
17321,ceritinib,tyrosine-protein kinase jak2,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
17322,ceritinib,rho-associated protein kinase 2,kinase,,Drug: ceritinib | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
17323,ceritinib,tyrosine-protein kinase syk,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
17324,ceritinib,hepatocyte growth factor receptor,kinase,,Drug: ceritinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
17325,ceritinib,tyrosine-protein kinase lyn,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
17326,ceritinib,fibroblast growth factor receptor 2,kinase,,Drug: ceritinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
17327,ceritinib,tyrosine-protein kinase fgr,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
17328,ceritinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: ceritinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
17329,ceritinib,tyrosine-protein kinase zap-70,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase zap-70 | Type: kinase | Action: nan
17330,ceritinib,tyrosine-protein kinase btk,kinase,,Drug: ceritinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
17331,ceritinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: ceritinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
17332,ceritinib,fibroblast growth factor receptor 4,kinase,,Drug: ceritinib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: nan
17333,ceritinib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: ceritinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
17334,ceritinib,cyclin-dependent kinase 4,kinase,,Drug: ceritinib | Target: cyclin-dependent kinase 4 | Type: kinase | Action: nan
17335,ceritinib,transcription factor etv6,transcription factor,,Drug: ceritinib | Target: transcription factor etv6 | Type: transcription factor | Action: nan
17337,ceritinib,insulin-like growth factor 1 receptor,kinase,,Drug: ceritinib | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: nan
17338,ceritinib,insulin receptor,kinase,AGONIST,Drug: ceritinib | Target: insulin receptor | Type: kinase | Action: AGONIST
17339,ceritinib,testis-specific serine/threonine-protein kinase 1,kinase,,Drug: ceritinib | Target: testis-specific serine/threonine-protein kinase 1 | Type: kinase | Action: nan
17340,ceritinib,alk tyrosine kinase receptor,kinase,INHIBITOR,Drug: ceritinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: INHIBITOR
17341,dexrabeprazole,alpha-2b adrenergic receptor,gpcr,,Drug: dexrabeprazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
17342,dexrabeprazole,d(3) dopamine receptor,gpcr,,Drug: dexrabeprazole | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
17343,dexrabeprazole,adenosine receptor a3,gpcr,,Drug: dexrabeprazole | Target: adenosine receptor a3 | Type: gpcr | Action: nan
17344,dexrabeprazole,fatty acid synthase,enzyme,,Drug: dexrabeprazole | Target: fatty acid synthase | Type: enzyme | Action: nan
17345,dexrabeprazole,insulin-degrading enzyme,enzyme,,Drug: dexrabeprazole | Target: insulin-degrading enzyme | Type: enzyme | Action: nan
17346,dexrabeprazole,"n(g),n(g)-dimethylarginine dimethylaminohydrolase 1",enzyme,,"Drug: dexrabeprazole | Target: n(g),n(g)-dimethylarginine dimethylaminohydrolase 1 | Type: enzyme | Action: nan"
17347,dexrabeprazole,cytosolic endo-beta-n-acetylglucosaminidase,enzyme,,Drug: dexrabeprazole | Target: cytosolic endo-beta-n-acetylglucosaminidase | Type: enzyme | Action: nan
17350,dexrabeprazole,sterile alpha and tir motif-containing protein 1,unclassified,,Drug: dexrabeprazole | Target: sterile alpha and tir motif-containing protein 1 | Type: unclassified | Action: nan
17351,dexrabeprazole,potassium-transporting atpase,transporter,INHIBITOR,Drug: dexrabeprazole | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
17352,vorapaxar,proteinase-activated receptor 1,gpcr,ANTAGONIST,Drug: vorapaxar | Target: proteinase-activated receptor 1 | Type: gpcr | Action: ANTAGONIST
17353,tedizolid phosphate,amine oxidase [flavin-containing] b,enzyme,,Drug: tedizolid phosphate | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
17354,tedizolid phosphate,amine oxidase [flavin-containing] a,enzyme,,Drug: tedizolid phosphate | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
17355,efinaconazole,lanosterol 14-alpha demethylase,enzyme,INHIBITOR,Drug: efinaconazole | Target: lanosterol 14-alpha demethylase | Type: enzyme | Action: INHIBITOR
17356,daclatasvir,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: daclatasvir | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17357,daclatasvir,nonstructural protein 5a,unclassified,,Drug: daclatasvir | Target: nonstructural protein 5a | Type: unclassified | Action: nan
17359,daclatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: daclatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17360,daclatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: daclatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17361,belinostat,histone deacetylase 5,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 5 | Type: enzyme | Action: INHIBITOR
17362,belinostat,histone deacetylase 2,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 2 | Type: enzyme | Action: INHIBITOR
17363,belinostat,histone deacetylase 1,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 1 | Type: enzyme | Action: INHIBITOR
17364,belinostat,histone deacetylase 3,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 3 | Type: enzyme | Action: INHIBITOR
17365,belinostat,histone deacetylase 6,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 6 | Type: enzyme | Action: INHIBITOR
17366,belinostat,histone deacetylase 7,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 7 | Type: enzyme | Action: INHIBITOR
17367,belinostat,histone deacetylase 8,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 8 | Type: enzyme | Action: INHIBITOR
17368,belinostat,histone deacetylase 9,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 9 | Type: enzyme | Action: INHIBITOR
17369,belinostat,histone deacetylase 10,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 10 | Type: enzyme | Action: INHIBITOR
17370,belinostat,histone deacetylase,enzyme,,Drug: belinostat | Target: histone deacetylase | Type: enzyme | Action: nan
17371,belinostat,histone deacetylase 11,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 11 | Type: enzyme | Action: INHIBITOR
17372,belinostat,bromodomain-containing protein 4,unclassified,,Drug: belinostat | Target: bromodomain-containing protein 4 | Type: unclassified | Action: nan
17373,belinostat,histone deacetylase 4,enzyme,INHIBITOR,Drug: belinostat | Target: histone deacetylase 4 | Type: enzyme | Action: INHIBITOR
17374,tavaborole,carbonic anhydrase 2,enzyme,,Drug: tavaborole | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
17375,tavaborole,carbonic anhydrase 1,enzyme,,Drug: tavaborole | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
17376,tavaborole,carbonic anhydrase,enzyme,,Drug: tavaborole | Target: carbonic anhydrase | Type: enzyme | Action: nan
17377,tavaborole,carbonic anhydrase 2,enzyme,,Drug: tavaborole | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
17378,tavaborole,"leucine--trna ligase, cytoplasmic",enzyme,,"Drug: tavaborole | Target: leucine--trna ligase, cytoplasmic | Type: enzyme | Action: nan"
17379,tavaborole,leucine-trna ligase,enzyme,INHIBITOR,Drug: tavaborole | Target: leucine-trna ligase | Type: enzyme | Action: INHIBITOR
17380,idelalisib,dna-dependent protein kinase catalytic subunit,kinase,,Drug: idelalisib | Target: dna-dependent protein kinase catalytic subunit | Type: kinase | Action: nan
17381,idelalisib,phosphatidylinositol 3-kinase catalytic subunit type 3,kinase,,Drug: idelalisib | Target: phosphatidylinositol 3-kinase catalytic subunit type 3 | Type: kinase | Action: nan
17382,idelalisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,,"Drug: idelalisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: nan"
17383,idelalisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",kinase,,"Drug: idelalisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Type: kinase | Action: nan"
17384,idelalisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,,"Drug: idelalisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: nan"
17385,idelalisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,INHIBITOR,"Drug: idelalisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: INHIBITOR"
17386,enoxaparin sodium,antithrombin-iii,secreted,ACTIVATOR,Drug: enoxaparin sodium | Target: antithrombin-iii | Type: secreted | Action: ACTIVATOR
17387,suvorexant,orexin receptor type 2,gpcr,,Drug: suvorexant | Target: orexin receptor type 2 | Type: gpcr | Action: nan
17388,suvorexant,orexin receptor type 1,gpcr,,Drug: suvorexant | Target: orexin receptor type 1 | Type: gpcr | Action: nan
17389,suvorexant,orexin receptor type 1,gpcr,ANTAGONIST,Drug: suvorexant | Target: orexin receptor type 1 | Type: gpcr | Action: ANTAGONIST
17390,suvorexant,orexin receptor type 2,gpcr,ANTAGONIST,Drug: suvorexant | Target: orexin receptor type 2 | Type: gpcr | Action: ANTAGONIST
17391,istradefylline,adenosine receptor a1,gpcr,,Drug: istradefylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
17392,istradefylline,adenosine receptor a2b,gpcr,,Drug: istradefylline | Target: adenosine receptor a2b | Type: gpcr | Action: nan
17393,istradefylline,adenosine receptor a3,gpcr,,Drug: istradefylline | Target: adenosine receptor a3 | Type: gpcr | Action: nan
17394,istradefylline,amine oxidase [flavin-containing] b,enzyme,,Drug: istradefylline | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
17395,istradefylline,adenosine receptor a1,gpcr,,Drug: istradefylline | Target: adenosine receptor a1 | Type: gpcr | Action: nan
17396,istradefylline,adenosine receptor a2a,gpcr,,Drug: istradefylline | Target: adenosine receptor a2a | Type: gpcr | Action: nan
17398,istradefylline,adenosine receptor a2a,gpcr,ANTAGONIST,Drug: istradefylline | Target: adenosine receptor a2a | Type: gpcr | Action: ANTAGONIST
17399,dulaglutide,glucagon-like peptide 1 receptor,gpcr,AGONIST,Drug: dulaglutide | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: AGONIST
17400,cetilistat,pancreatic triacylglycerol lipase,enzyme,INHIBITOR,Drug: cetilistat | Target: pancreatic triacylglycerol lipase | Type: enzyme | Action: INHIBITOR
17401,topiroxostat,xanthine dehydrogenase/oxidase,enzyme,,Drug: topiroxostat | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: nan
17402,topiroxostat,xanthine dehydrogenase/oxidase,enzyme,INHIBITOR,Drug: topiroxostat | Target: xanthine dehydrogenase/oxidase | Type: enzyme | Action: INHIBITOR
17403,asunaprevir,ns3,enzyme,,Drug: asunaprevir | Target: ns3 | Type: enzyme | Action: nan
17404,asunaprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: asunaprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17405,ipragliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: ipragliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
17406,ipragliflozin,sodium/glucose cotransporter 1,transporter,INHIBITOR,Drug: ipragliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: INHIBITOR
17407,ipragliflozin,sodium/glucose cotransporter 1,transporter,INHIBITOR,Drug: ipragliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: INHIBITOR
17408,ipragliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: ipragliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
17409,ipragliflozin,sodium/glucose cotransporter 1,transporter,,Drug: ipragliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: nan
17410,ipragliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: ipragliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
17411,luseogliflozin,sodium/glucose cotransporter 1,transporter,,Drug: luseogliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: nan
17412,luseogliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: luseogliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
17413,tofogliflozin,sodium/glucose cotransporter 1,transporter,,Drug: tofogliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: nan
17414,tofogliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: tofogliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
17415,tipiracil,thymidine phosphorylase,enzyme,,Drug: tipiracil | Target: thymidine phosphorylase | Type: enzyme | Action: nan
17416,tipiracil,thymidine phosphorylase,enzyme,INHIBITOR,Drug: tipiracil | Target: thymidine phosphorylase | Type: enzyme | Action: INHIBITOR
17417,iguratimod,macrophage migration inhibitory factor,unclassified,,Drug: iguratimod | Target: macrophage migration inhibitory factor | Type: unclassified | Action: nan
17418,teneligliptin,dipeptidyl peptidase 4,enzyme,,Drug: teneligliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
17419,teneligliptin,dipeptidyl peptidase 8,enzyme,,Drug: teneligliptin | Target: dipeptidyl peptidase 8 | Type: enzyme | Action: nan
17420,teneligliptin,dipeptidyl peptidase 9,enzyme,,Drug: teneligliptin | Target: dipeptidyl peptidase 9 | Type: enzyme | Action: nan
17421,teneligliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: teneligliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
17422,anagliptin,prolyl endopeptidase fap,enzyme,,Drug: anagliptin | Target: prolyl endopeptidase fap | Type: enzyme | Action: nan
17423,anagliptin,dipeptidyl peptidase 8,enzyme,,Drug: anagliptin | Target: dipeptidyl peptidase 8 | Type: enzyme | Action: nan
17424,anagliptin,dipeptidyl peptidase 9,enzyme,,Drug: anagliptin | Target: dipeptidyl peptidase 9 | Type: enzyme | Action: nan
17425,anagliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: anagliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
17426,edoxaban,coagulation factor x,enzyme,INHIBITOR,Drug: edoxaban | Target: coagulation factor x | Type: enzyme | Action: INHIBITOR
17427,netupitant,substance-p receptor,gpcr,ANTAGONIST,Drug: netupitant | Target: substance-p receptor | Type: gpcr | Action: ANTAGONIST
17428,ledipasvir,nonstructural protein 5a,unclassified,,Drug: ledipasvir | Target: nonstructural protein 5a | Type: unclassified | Action: nan
17430,ledipasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: ledipasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17431,ledipasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: ledipasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17432,diquafosol,p2y purinoceptor 4,gpcr,AGONIST,Drug: diquafosol | Target: p2y purinoceptor 4 | Type: gpcr | Action: AGONIST
17433,diquafosol,p2y purinoceptor 2,gpcr,AGONIST,Drug: diquafosol | Target: p2y purinoceptor 2 | Type: gpcr | Action: AGONIST
17434,insulin glargine,insulin receptor,kinase,AGONIST,Drug: insulin glargine | Target: insulin receptor | Type: kinase | Action: AGONIST
17435,imidafenacin,muscarinic acetylcholine receptor m1,gpcr,,Drug: imidafenacin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: nan
17436,imidafenacin,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: imidafenacin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
17437,nintedanib,tyrosine-protein kinase jak3,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
17438,nintedanib,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: nintedanib | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17439,nintedanib,multidrug resistance protein 1,transporter,,Drug: nintedanib | Target: multidrug resistance protein 1 | Type: transporter | Action: nan
17440,nintedanib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: nintedanib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
17441,nintedanib,tyrosine-protein kinase abl1,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
17442,nintedanib,mast/stem cell growth factor receptor kit,kinase,,Drug: nintedanib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
17443,nintedanib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: nintedanib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
17444,nintedanib,tyrosine-protein kinase lck,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
17445,nintedanib,tyrosine-protein kinase yes,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
17446,nintedanib,tyrosine-protein kinase fyn,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
17447,nintedanib,ephrin type-a receptor 2,kinase,,Drug: nintedanib | Target: ephrin type-a receptor 2 | Type: kinase | Action: nan
17448,nintedanib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: nintedanib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
17449,nintedanib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: nintedanib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
17450,nintedanib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: nintedanib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
17451,nintedanib,ribosomal protein s6 kinase alpha-3,kinase,,Drug: nintedanib | Target: ribosomal protein s6 kinase alpha-3 | Type: kinase | Action: nan
17452,nintedanib,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: nintedanib | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
17453,nintedanib,cyclin-dependent kinase 2,kinase,,Drug: nintedanib | Target: cyclin-dependent kinase 2 | Type: kinase | Action: nan
17454,nintedanib,insulin-like growth factor 1 receptor,kinase,,Drug: nintedanib | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: nan
17455,nintedanib,"myosin light chain kinase, smooth muscle",kinase,,"Drug: nintedanib | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
17456,nintedanib,insulin receptor,kinase,AGONIST,Drug: nintedanib | Target: insulin receptor | Type: kinase | Action: AGONIST
17457,nintedanib,death-associated protein kinase 3,kinase,,Drug: nintedanib | Target: death-associated protein kinase 3 | Type: kinase | Action: nan
17458,nintedanib,calcium/calmodulin-dependent protein kinase type 1,kinase,,Drug: nintedanib | Target: calcium/calmodulin-dependent protein kinase type 1 | Type: kinase | Action: nan
17459,nintedanib,mitogen-activated protein kinase 8,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
17460,nintedanib,fibroblast growth factor receptor 3,kinase,INHIBITOR,Drug: nintedanib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: INHIBITOR
17461,nintedanib,focal adhesion kinase 1,kinase,,Drug: nintedanib | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
17462,nintedanib,tyrosine-protein kinase hck,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
17463,nintedanib,tyrosine-protein kinase jak1,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: nan
17464,nintedanib,mitogen-activated protein kinase 10,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
17465,nintedanib,death-associated protein kinase 2,kinase,,Drug: nintedanib | Target: death-associated protein kinase 2 | Type: kinase | Action: nan
17466,nintedanib,high affinity nerve growth factor receptor,kinase,,Drug: nintedanib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
17467,nintedanib,tyrosine-protein kinase jak2,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
17468,nintedanib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: nintedanib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
17469,nintedanib,angiopoietin-1 receptor,kinase,,Drug: nintedanib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
17470,nintedanib,ap2-associated protein kinase 1,kinase,,Drug: nintedanib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
17471,nintedanib,serine/threonine-protein kinase mark2,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase mark2 | Type: kinase | Action: nan
17472,nintedanib,hepatocyte growth factor receptor,kinase,,Drug: nintedanib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
17473,nintedanib,tyrosine-protein kinase lyn,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
17474,nintedanib,ribosomal protein s6 kinase alpha-2,kinase,,Drug: nintedanib | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
17475,nintedanib,5'-amp-activated protein kinase catalytic subunit alpha-1,kinase,,Drug: nintedanib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-1 | Type: kinase | Action: nan
17476,nintedanib,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: nintedanib | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
17477,nintedanib,calcium/calmodulin-dependent protein kinase type ii subunit alpha,kinase,,Drug: nintedanib | Target: calcium/calmodulin-dependent protein kinase type ii subunit alpha | Type: kinase | Action: nan
17478,nintedanib,serine/threonine-protein kinase 17b,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 17b | Type: kinase | Action: nan
17479,nintedanib,serine/threonine-protein kinase 10,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
17480,nintedanib,tyrosine-protein kinase fer,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
17481,nintedanib,serine/threonine-protein kinase plk4,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
17482,nintedanib,aurora kinase c,kinase,,Drug: nintedanib | Target: aurora kinase c | Type: kinase | Action: nan
17483,nintedanib,serine/threonine-protein kinase 16,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 16 | Type: kinase | Action: nan
17484,nintedanib,dual specificity protein kinase ttk,kinase,,Drug: nintedanib | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
17485,nintedanib,abelson tyrosine-protein kinase 2,kinase,,Drug: nintedanib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
17486,nintedanib,fibroblast growth factor receptor 2,kinase,INHIBITOR,Drug: nintedanib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: INHIBITOR
17487,nintedanib,serine/threonine-protein kinase n1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
17488,nintedanib,protein kinase c theta type,kinase,,Drug: nintedanib | Target: protein kinase c theta type | Type: kinase | Action: nan
17489,nintedanib,serine/threonine-protein kinase 17a,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
17490,nintedanib,ephrin type-a receptor 6,kinase,,Drug: nintedanib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
17491,nintedanib,traf2 and nck-interacting protein kinase,kinase,,Drug: nintedanib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
17492,nintedanib,casein kinase i isoform epsilon,kinase,,Drug: nintedanib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
17493,nintedanib,tyrosine-protein kinase fgr,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
17494,nintedanib,alk tyrosine kinase receptor,kinase,,Drug: nintedanib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
17495,nintedanib,ephrin type-a receptor 3,kinase,,Drug: nintedanib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
17496,nintedanib,bmp-2-inducible protein kinase,kinase,,Drug: nintedanib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
17497,nintedanib,tyrosine-protein kinase frk,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
17498,nintedanib,dual specificity protein kinase clk1,kinase,,Drug: nintedanib | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
17499,nintedanib,dual specificity protein kinase clk2,kinase,,Drug: nintedanib | Target: dual specificity protein kinase clk2 | Type: kinase | Action: nan
17500,nintedanib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
17501,nintedanib,glycogen synthase kinase-3 beta,kinase,,Drug: nintedanib | Target: glycogen synthase kinase-3 beta | Type: kinase | Action: nan
17502,nintedanib,ephrin type-b receptor 1,kinase,,Drug: nintedanib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
17503,nintedanib,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: nintedanib | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
17504,nintedanib,cyclin-dependent kinase 16,kinase,,Drug: nintedanib | Target: cyclin-dependent kinase 16 | Type: kinase | Action: nan
17505,nintedanib,serine/threonine-protein kinase 4,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
17506,nintedanib,activated cdc42 kinase 1,kinase,,Drug: nintedanib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
17507,nintedanib,ribosomal protein s6 kinase alpha-5,kinase,,Drug: nintedanib | Target: ribosomal protein s6 kinase alpha-5 | Type: kinase | Action: nan
17508,nintedanib,ste20-like serine/threonine-protein kinase,kinase,,Drug: nintedanib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
17509,nintedanib,dual specificity protein kinase clk4,kinase,,Drug: nintedanib | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
17510,nintedanib,calcium/calmodulin-dependent protein kinase kinase 2,kinase,,Drug: nintedanib | Target: calcium/calmodulin-dependent protein kinase kinase 2 | Type: kinase | Action: nan
17511,nintedanib,map/microtubule affinity-regulating kinase 3,kinase,,Drug: nintedanib | Target: map/microtubule affinity-regulating kinase 3 | Type: kinase | Action: nan
17512,nintedanib,calcium/calmodulin-dependent protein kinase kinase 1,kinase,,Drug: nintedanib | Target: calcium/calmodulin-dependent protein kinase kinase 1 | Type: kinase | Action: nan
17513,nintedanib,calcium/calmodulin-dependent protein kinase type 1g,kinase,,Drug: nintedanib | Target: calcium/calmodulin-dependent protein kinase type 1g | Type: kinase | Action: nan
17514,nintedanib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: nintedanib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
17515,nintedanib,ephrin type-b receptor 4,kinase,,Drug: nintedanib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
17516,nintedanib,testis-specific serine/threonine-protein kinase 1,kinase,,Drug: nintedanib | Target: testis-specific serine/threonine-protein kinase 1 | Type: kinase | Action: nan
17517,nintedanib,activin receptor type-1b,kinase,,Drug: nintedanib | Target: activin receptor type-1b | Type: kinase | Action: nan
17518,nintedanib,serine/threonine-protein kinase receptor r3,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase receptor r3 | Type: kinase | Action: nan
17519,nintedanib,activin receptor type-1,kinase,,Drug: nintedanib | Target: activin receptor type-1 | Type: kinase | Action: nan
17520,nintedanib,3-phosphoinositide-dependent protein kinase 1,kinase,,Drug: nintedanib | Target: 3-phosphoinositide-dependent protein kinase 1 | Type: kinase | Action: nan
17521,nintedanib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: nintedanib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
17522,nintedanib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: nintedanib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
17523,nintedanib,tyrosine-protein kinase itk/tsk,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: nan
17524,nintedanib,tyrosine-protein kinase zap-70,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase zap-70 | Type: kinase | Action: nan
17525,nintedanib,glycogen synthase kinase-3 alpha,kinase,,Drug: nintedanib | Target: glycogen synthase kinase-3 alpha | Type: kinase | Action: nan
17526,nintedanib,tyrosine-protein kinase btk,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
17527,nintedanib,tyrosine-protein kinase receptor ufo,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
17528,nintedanib,bdnf/nt-3 growth factors receptor,kinase,,Drug: nintedanib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
17529,nintedanib,tyrosine-protein kinase receptor tyro3,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase receptor tyro3 | Type: kinase | Action: nan
17530,nintedanib,cyclin-dependent kinase 7,kinase,,Drug: nintedanib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
17531,nintedanib,serine/threonine-protein kinase d1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase d1 | Type: kinase | Action: nan
17532,nintedanib,ribosomal protein s6 kinase beta-1,kinase,,Drug: nintedanib | Target: ribosomal protein s6 kinase beta-1 | Type: kinase | Action: nan
17533,nintedanib,serine/threonine-protein kinase n2,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase n2 | Type: kinase | Action: nan
17534,nintedanib,serine/threonine-protein kinase dclk3,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase dclk3 | Type: kinase | Action: nan
17535,nintedanib,serine/threonine-protein kinase 3,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
17536,nintedanib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: nintedanib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
17537,nintedanib,nuak family snf1-like kinase 2,kinase,,Drug: nintedanib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
17538,nintedanib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: nintedanib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
17539,nintedanib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: nintedanib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
17540,nintedanib,serine/threonine-protein kinase chk1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase chk1 | Type: kinase | Action: nan
17541,nintedanib,serine/threonine-protein kinase pak 3,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase pak 3 | Type: kinase | Action: nan
17542,nintedanib,cyclin-dependent kinase 17,kinase,,Drug: nintedanib | Target: cyclin-dependent kinase 17 | Type: kinase | Action: nan
17543,nintedanib,cyclin-dependent kinase 18,kinase,,Drug: nintedanib | Target: cyclin-dependent kinase 18 | Type: kinase | Action: nan
17544,nintedanib,cyclin-dependent kinase 14,kinase,,Drug: nintedanib | Target: cyclin-dependent kinase 14 | Type: kinase | Action: nan
17545,nintedanib,phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,kinase,,Drug: nintedanib | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Type: kinase | Action: nan
17546,nintedanib,phosphatidylinositol 5-phosphate 4-kinase type-2 beta,kinase,,Drug: nintedanib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Type: kinase | Action: nan
17547,nintedanib,myosin light chain kinase family member 4,kinase,,Drug: nintedanib | Target: myosin light chain kinase family member 4 | Type: kinase | Action: nan
17548,nintedanib,wee1-like protein kinase,kinase,,Drug: nintedanib | Target: wee1-like protein kinase | Type: kinase | Action: nan
17549,nintedanib,protein-tyrosine kinase 2-beta,kinase,,Drug: nintedanib | Target: protein-tyrosine kinase 2-beta | Type: kinase | Action: nan
17550,nintedanib,serine/threonine-protein kinase rio1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
17551,nintedanib,casein kinase i isoform delta,kinase,,Drug: nintedanib | Target: casein kinase i isoform delta | Type: kinase | Action: nan
17552,nintedanib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
17553,nintedanib,nt-3 growth factor receptor,kinase,,Drug: nintedanib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
17554,nintedanib,tyrosine-protein kinase txk,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
17555,nintedanib,casein kinase ii subunit alpha,kinase,,Drug: nintedanib | Target: casein kinase ii subunit alpha | Type: kinase | Action: nan
17556,nintedanib,casein kinase ii subunit alpha',kinase,,Drug: nintedanib | Target: casein kinase ii subunit alpha' | Type: kinase | Action: nan
17557,nintedanib,dual specificity tyrosine-phosphorylation-regulated kinase 1b,kinase,,Drug: nintedanib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1b | Type: kinase | Action: nan
17558,nintedanib,inhibitor of nuclear factor kappa-b kinase subunit epsilon,kinase,,Drug: nintedanib | Target: inhibitor of nuclear factor kappa-b kinase subunit epsilon | Type: kinase | Action: nan
17559,nintedanib,serine/threonine-protein kinase stk11,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase stk11 | Type: kinase | Action: nan
17560,nintedanib,dual specificity mitogen-activated protein kinase kinase 3,kinase,,Drug: nintedanib | Target: dual specificity mitogen-activated protein kinase kinase 3 | Type: kinase | Action: nan
17561,nintedanib,maternal embryonic leucine zipper kinase,kinase,,Drug: nintedanib | Target: maternal embryonic leucine zipper kinase | Type: kinase | Action: nan
17562,nintedanib,serine/threonine-protein kinase 26,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 26 | Type: kinase | Action: nan
17563,nintedanib,eukaryotic translation initiation factor 2-alpha kinase 4,kinase,,Drug: nintedanib | Target: eukaryotic translation initiation factor 2-alpha kinase 4 | Type: kinase | Action: nan
17564,nintedanib,insulin receptor-related protein,kinase,,Drug: nintedanib | Target: insulin receptor-related protein | Type: kinase | Action: nan
17565,nintedanib,interleukin-1 receptor-associated kinase 3,kinase,,Drug: nintedanib | Target: interleukin-1 receptor-associated kinase 3 | Type: kinase | Action: nan
17566,nintedanib,serine/threonine-protein kinase rio3,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
17567,nintedanib,serine/threonine-protein kinase sik2,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
17568,nintedanib,srsf protein kinase 1,kinase,,Drug: nintedanib | Target: srsf protein kinase 1 | Type: kinase | Action: nan
17569,nintedanib,srsf protein kinase 2,kinase,,Drug: nintedanib | Target: srsf protein kinase 2 | Type: kinase | Action: nan
17570,nintedanib,serine/threonine-protein kinase 33,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
17571,nintedanib,5'-amp-activated protein kinase catalytic subunit alpha-2,kinase,,Drug: nintedanib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-2 | Type: kinase | Action: nan
17572,nintedanib,discoidin domain-containing receptor 2,kinase,,Drug: nintedanib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
17573,nintedanib,serine/threonine-protein kinase lats1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase lats1 | Type: kinase | Action: nan
17574,nintedanib,serine/threonine-protein kinase lats2,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase lats2 | Type: kinase | Action: nan
17575,nintedanib,leukocyte tyrosine kinase receptor,kinase,,Drug: nintedanib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
17576,nintedanib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
17577,nintedanib,serine/threonine-protein kinase pak 7,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase pak 7 | Type: kinase | Action: nan
17578,nintedanib,nuak family snf1-like kinase 1,kinase,,Drug: nintedanib | Target: nuak family snf1-like kinase 1 | Type: kinase | Action: nan
17579,nintedanib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
17580,nintedanib,aurora kinase b,kinase,,Drug: nintedanib | Target: aurora kinase b | Type: kinase | Action: nan
17581,nintedanib,tyrosine-protein kinase blk,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
17582,nintedanib,bone morphogenetic protein receptor type-2,kinase,,Drug: nintedanib | Target: bone morphogenetic protein receptor type-2 | Type: kinase | Action: nan
17583,nintedanib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
17584,nintedanib,serine/threonine-protein kinase mark1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase mark1 | Type: kinase | Action: nan
17585,nintedanib,map/microtubule affinity-regulating kinase 4,kinase,,Drug: nintedanib | Target: map/microtubule affinity-regulating kinase 4 | Type: kinase | Action: nan
17586,nintedanib,dual specificity mitogen-activated protein kinase kinase 4,kinase,,Drug: nintedanib | Target: dual specificity mitogen-activated protein kinase kinase 4 | Type: kinase | Action: nan
17587,nintedanib,tyrosine-protein kinase mer,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
17588,nintedanib,calcium/calmodulin-dependent protein kinase type iv,kinase,,Drug: nintedanib | Target: calcium/calmodulin-dependent protein kinase type iv | Type: kinase | Action: nan
17589,nintedanib,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
17590,nintedanib,mitogen-activated protein kinase kinase kinase 10,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 10 | Type: kinase | Action: nan
17591,nintedanib,mitogen-activated protein kinase kinase kinase 11,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 11 | Type: kinase | Action: nan
17592,nintedanib,serine/threonine-protein kinase 24,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 24 | Type: kinase | Action: nan
17593,nintedanib,"muscle, skeletal receptor tyrosine-protein kinase",kinase,,"Drug: nintedanib | Target: muscle, skeletal receptor tyrosine-protein kinase | Type: kinase | Action: nan"
17594,nintedanib,serine/threonine-protein kinase dclk1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase dclk1 | Type: kinase | Action: nan
17595,nintedanib,myosin-iiib,kinase,,Drug: nintedanib | Target: myosin-iiib | Type: kinase | Action: nan
17596,nintedanib,serine/threonine-protein kinase pak 2,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase pak 2 | Type: kinase | Action: nan
17597,nintedanib,serine/threonine-protein kinase pak 4,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase pak 4 | Type: kinase | Action: nan
17598,nintedanib,serine/threonine-protein kinase sik1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
17599,nintedanib,tgf-beta receptor type-1,kinase,,Drug: nintedanib | Target: tgf-beta receptor type-1 | Type: kinase | Action: nan
17600,nintedanib,ephrin type-a receptor 1,kinase,,Drug: nintedanib | Target: ephrin type-a receptor 1 | Type: kinase | Action: nan
17601,nintedanib,mitogen-activated protein kinase 7,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase 7 | Type: kinase | Action: nan
17602,nintedanib,serine/threonine-protein kinase d2,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase d2 | Type: kinase | Action: nan
17603,nintedanib,serine/threonine-protein kinase d3,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase d3 | Type: kinase | Action: nan
17604,nintedanib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: nintedanib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
17605,nintedanib,tyrosine-protein kinase fes/fps,kinase,,Drug: nintedanib | Target: tyrosine-protein kinase fes/fps | Type: kinase | Action: nan
17606,nintedanib,fibroblast growth factor receptor 4,kinase,INHIBITOR,Drug: nintedanib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: INHIBITOR
17607,nintedanib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: nintedanib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
17608,nintedanib,ribosomal protein s6 kinase alpha-1,kinase,,Drug: nintedanib | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
17609,nintedanib,ribosomal protein s6 kinase alpha-4,kinase,,Drug: nintedanib | Target: ribosomal protein s6 kinase alpha-4 | Type: kinase | Action: nan
17610,nintedanib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
17611,nintedanib,misshapen-like kinase 1,kinase,,Drug: nintedanib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
17612,nintedanib,serine/threonine-protein kinase tbk1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
17613,nintedanib,interleukin-1 receptor-associated kinase 4,kinase,,Drug: nintedanib | Target: interleukin-1 receptor-associated kinase 4 | Type: kinase | Action: nan
17614,nintedanib,cyclin-dependent kinase 4,kinase,,Drug: nintedanib | Target: cyclin-dependent kinase 4 | Type: kinase | Action: nan
17615,nintedanib,cyclin-dependent kinase-like 2,kinase,,Drug: nintedanib | Target: cyclin-dependent kinase-like 2 | Type: kinase | Action: nan
17616,nintedanib,ephrin type-b receptor 6,kinase,,Drug: nintedanib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
17617,nintedanib,serine/threonine-protein kinase/endoribonuclease ire1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase/endoribonuclease ire1 | Type: kinase | Action: nan
17618,nintedanib,rhodopsin kinase,kinase,,Drug: nintedanib | Target: rhodopsin kinase | Type: kinase | Action: nan
17619,nintedanib,g protein-coupled receptor kinase 4,kinase,,Drug: nintedanib | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
17620,nintedanib,g protein-coupled receptor kinase 7,kinase,,Drug: nintedanib | Target: g protein-coupled receptor kinase 7 | Type: kinase | Action: nan
17621,nintedanib,homeodomain-interacting protein kinase 2,kinase,,Drug: nintedanib | Target: homeodomain-interacting protein kinase 2 | Type: kinase | Action: nan
17622,nintedanib,homeodomain-interacting protein kinase 3,kinase,,Drug: nintedanib | Target: homeodomain-interacting protein kinase 3 | Type: kinase | Action: nan
17623,nintedanib,homeodomain-interacting protein kinase 4,kinase,,Drug: nintedanib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
17624,nintedanib,serine/threonine-protein kinase ick,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase ick | Type: kinase | Action: nan
17625,nintedanib,inhibitor of nuclear factor kappa-b kinase subunit alpha,kinase,,Drug: nintedanib | Target: inhibitor of nuclear factor kappa-b kinase subunit alpha | Type: kinase | Action: nan
17626,nintedanib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: nintedanib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
17627,nintedanib,mitogen-activated protein kinase kinase kinase 13,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 13 | Type: kinase | Action: nan
17628,nintedanib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
17629,nintedanib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
17630,nintedanib,microtubule-associated serine/threonine-protein kinase 1,kinase,,Drug: nintedanib | Target: microtubule-associated serine/threonine-protein kinase 1 | Type: kinase | Action: nan
17631,nintedanib,serine/threonine-protein kinase osr1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase osr1 | Type: kinase | Action: nan
17632,nintedanib,srsf protein kinase 3,kinase,,Drug: nintedanib | Target: srsf protein kinase 3 | Type: kinase | Action: nan
17633,nintedanib,ste20/sps1-related proline-alanine-rich protein kinase,kinase,,Drug: nintedanib | Target: ste20/sps1-related proline-alanine-rich protein kinase | Type: kinase | Action: nan
17634,nintedanib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
17635,nintedanib,serine/threonine-protein kinase ulk1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase ulk1 | Type: kinase | Action: nan
17636,nintedanib,serine/threonine-protein kinase ulk2,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase ulk2 | Type: kinase | Action: nan
17637,nintedanib,serine/threonine-protein kinase ulk3,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
17638,nintedanib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
17639,nintedanib,homeodomain-interacting protein kinase 1,kinase,,Drug: nintedanib | Target: homeodomain-interacting protein kinase 1 | Type: kinase | Action: nan
17640,nintedanib,mitogen-activated protein kinase kinase kinase 15,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 15 | Type: kinase | Action: nan
17641,nintedanib,receptor-interacting serine/threonine-protein kinase 4,kinase,,Drug: nintedanib | Target: receptor-interacting serine/threonine-protein kinase 4 | Type: kinase | Action: nan
17642,nintedanib,uncharacterized serine/threonine-protein kinase sbk3,kinase,,Drug: nintedanib | Target: uncharacterized serine/threonine-protein kinase sbk3 | Type: kinase | Action: nan
17643,nintedanib,serine/threonine-protein kinase 35,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase 35 | Type: kinase | Action: nan
17644,nintedanib,serine/threonine-protein kinase sbk1,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
17645,nintedanib,serine/threonine-protein kinase prp4 homolog,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase prp4 homolog | Type: kinase | Action: nan
17646,nintedanib,mitogen-activated protein kinase kinase kinase 12,kinase,,Drug: nintedanib | Target: mitogen-activated protein kinase kinase kinase 12 | Type: kinase | Action: nan
17647,nintedanib,serine/threonine-protein kinase sgk3,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase sgk3 | Type: kinase | Action: nan
17648,nintedanib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: nintedanib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
17649,nintedanib,myosin light chain kinase 3,kinase,,Drug: nintedanib | Target: myosin light chain kinase 3 | Type: kinase | Action: nan
17650,nintedanib,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: nintedanib | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
17651,nintedanib,calcium-dependent protein kinase 1,kinase,,Drug: nintedanib | Target: calcium-dependent protein kinase 1 | Type: kinase | Action: nan
17652,nintedanib,vascular endothelial growth factor receptor 2,kinase,,Drug: nintedanib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
17653,nintedanib,serine/threonine-protein kinase pknb,kinase,,Drug: nintedanib | Target: serine/threonine-protein kinase pknb | Type: kinase | Action: nan
17654,nintedanib,cgmp-dependent protein kinase 1,kinase,,Drug: nintedanib | Target: cgmp-dependent protein kinase 1 | Type: kinase | Action: nan
17656,nintedanib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: nintedanib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
17657,nintedanib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: nintedanib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
17658,nintedanib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: nintedanib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
17659,nintedanib,platelet-derived growth factor receptor alpha,kinase,INHIBITOR,Drug: nintedanib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: INHIBITOR
17660,nintedanib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: nintedanib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
17661,adalimumab,tumor necrosis factor,cytokine,ANTIBODY BINDING,Drug: adalimumab | Target: tumor necrosis factor | Type: cytokine | Action: ANTIBODY BINDING
17662,pegaptanib,vascular endothelial growth factor a,secreted,ANTAGONIST,Drug: pegaptanib | Target: vascular endothelial growth factor a | Type: secreted | Action: ANTAGONIST
17663,fimasartan,type-1 angiotensin ii receptor,gpcr,ANTAGONIST,Drug: fimasartan | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: ANTAGONIST
17664,olaparib,tankyrase-2,enzyme,,Drug: olaparib | Target: tankyrase-2 | Type: enzyme | Action: nan
17665,olaparib,poly [adp-ribose] polymerase 4,enzyme,,Drug: olaparib | Target: poly [adp-ribose] polymerase 4 | Type: enzyme | Action: nan
17666,olaparib,poly [adp-ribose] polymerase 10,enzyme,,Drug: olaparib | Target: poly [adp-ribose] polymerase 10 | Type: enzyme | Action: nan
17667,olaparib,poly [adp-ribose] polymerase 12,enzyme,,Drug: olaparib | Target: poly [adp-ribose] polymerase 12 | Type: enzyme | Action: nan
17668,olaparib,poly [adp-ribose] polymerase 15,enzyme,,Drug: olaparib | Target: poly [adp-ribose] polymerase 15 | Type: enzyme | Action: nan
17669,olaparib,poly [adp-ribose] polymerase 6,unclassified,,Drug: olaparib | Target: poly [adp-ribose] polymerase 6 | Type: unclassified | Action: nan
17670,olaparib,mono [adp-ribose] polymerase parp16,unclassified,,Drug: olaparib | Target: mono [adp-ribose] polymerase parp16 | Type: unclassified | Action: nan
17671,olaparib,tankyrase-1,enzyme,,Drug: olaparib | Target: tankyrase-1 | Type: enzyme | Action: nan
17672,olaparib,poly [adp-ribose] polymerase 2,enzyme,INHIBITOR,Drug: olaparib | Target: poly [adp-ribose] polymerase 2 | Type: enzyme | Action: INHIBITOR
17673,olaparib,poly [adp-ribose] polymerase 1,enzyme,INHIBITOR,Drug: olaparib | Target: poly [adp-ribose] polymerase 1 | Type: enzyme | Action: INHIBITOR
17674,olaparib,poly [adp-ribose] polymerase 3,enzyme,INHIBITOR,Drug: olaparib | Target: poly [adp-ribose] polymerase 3 | Type: enzyme | Action: INHIBITOR
17675,acotiamide,acetylcholinesterase,enzyme,INHIBITOR,Drug: acotiamide | Target: acetylcholinesterase | Type: enzyme | Action: INHIBITOR
17676,alemtuzumab,campath-1 antigen,surface antigen,ANTIBODY BINDING,Drug: alemtuzumab | Target: campath-1 antigen | Type: surface antigen | Action: ANTIBODY BINDING
17677,felypressin,vasopressin v1a receptor,gpcr,AGONIST,Drug: felypressin | Target: vasopressin v1a receptor | Type: gpcr | Action: AGONIST
17678,ombitasvir,nonstructural protein 5a,unclassified,,Drug: ombitasvir | Target: nonstructural protein 5a | Type: unclassified | Action: nan
17679,ombitasvir,genome polyprotein [cleaved into: core protein p21,unclassified,,Drug: ombitasvir | Target: genome polyprotein [cleaved into: core protein p21 | Type: unclassified | Action: nan
17680,ombitasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: ombitasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17681,ombitasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: ombitasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17682,dasabuvir,ns5b protein,enzyme,,Drug: dasabuvir | Target: ns5b protein | Type: enzyme | Action: nan
17683,dasabuvir,ns5b protein,unclassified,,Drug: dasabuvir | Target: ns5b protein | Type: unclassified | Action: nan
17684,blinatumomab,b-lymphocyte antigen cd19,surface antigen,ANTIBODY BINDING,Drug: blinatumomab | Target: b-lymphocyte antigen cd19 | Type: surface antigen | Action: ANTIBODY BINDING
17685,blinatumomab,t-cell surface glycoprotein cd3,surface antigen,ANTIBODY BINDING,Drug: blinatumomab | Target: t-cell surface glycoprotein cd3 | Type: surface antigen | Action: ANTIBODY BINDING
17686,aflibercept,vascular endothelial growth factor a,secreted,INHIBITOR,Drug: aflibercept | Target: vascular endothelial growth factor a | Type: secreted | Action: INHIBITOR
17687,aflibercept,placenta growth factor,secreted,INHIBITOR,Drug: aflibercept | Target: placenta growth factor | Type: secreted | Action: INHIBITOR
17688,aflibercept,vascular endothelial growth factor b,secreted,INHIBITOR,Drug: aflibercept | Target: vascular endothelial growth factor b | Type: secreted | Action: INHIBITOR
17689,ramucirumab,vascular endothelial growth factor receptor 2,kinase,ANTIBODY BINDING,Drug: ramucirumab | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: ANTIBODY BINDING
17690,safinamide,sodium channel protein type 9 subunit alpha,ion channel,,Drug: safinamide | Target: sodium channel protein type 9 subunit alpha | Type: ion channel | Action: nan
17691,safinamide,amine oxidase [flavin-containing] a,enzyme,,Drug: safinamide | Target: amine oxidase [flavin-containing] a | Type: enzyme | Action: nan
17692,safinamide,sigma non-opioid intracellular receptor 1,membrane receptor,,Drug: safinamide | Target: sigma non-opioid intracellular receptor 1 | Type: membrane receptor | Action: nan
17693,safinamide,amine oxidase [flavin-containing] b,enzyme,,Drug: safinamide | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: nan
17694,safinamide,"sodium channel alpha subunits; brain (types i, ii, iii)",ion channel,,"Drug: safinamide | Target: sodium channel alpha subunits; brain (types i, ii, iii) | Type: ion channel | Action: nan"
17695,safinamide,amine oxidase [flavin-containing] b,enzyme,INHIBITOR,Drug: safinamide | Target: amine oxidase [flavin-containing] b | Type: enzyme | Action: INHIBITOR
17696,nivolumab,programmed cell death protein 1,membrane receptor,ANTIBODY BINDING,Drug: nivolumab | Target: programmed cell death protein 1 | Type: membrane receptor | Action: ANTIBODY BINDING
17697,pembrolizumab,programmed cell death protein 1,membrane receptor,ANTIBODY BINDING,Drug: pembrolizumab | Target: programmed cell death protein 1 | Type: membrane receptor | Action: ANTIBODY BINDING
17698,becaplermin,platelet-derived growth factor receptor,kinase,AGONIST,Drug: becaplermin | Target: platelet-derived growth factor receptor | Type: kinase | Action: AGONIST
17699,albiglutide,glucagon-like peptide 1 receptor,gpcr,AGONIST,Drug: albiglutide | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: AGONIST
17700,albiglutide,glucagon-like peptide 1 receptor,gpcr,AGONIST,Drug: albiglutide | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: AGONIST
17701,follitropin,follicle-stimulating hormone receptor,gpcr,AGONIST,Drug: follitropin | Target: follicle-stimulating hormone receptor | Type: gpcr | Action: AGONIST
17702,lutropin alfa,lutropin-choriogonadotropic hormone receptor,gpcr,AGONIST,Drug: lutropin alfa | Target: lutropin-choriogonadotropic hormone receptor | Type: gpcr | Action: AGONIST
17703,thyrotropin alfa,thyrotropin receptor,gpcr,AGONIST,Drug: thyrotropin alfa | Target: thyrotropin receptor | Type: gpcr | Action: AGONIST
17704,corticotropin,melanocortin receptor 4,gpcr,AGONIST,Drug: corticotropin | Target: melanocortin receptor 4 | Type: gpcr | Action: AGONIST
17705,corticotropin,melanocortin receptor 3,gpcr,AGONIST,Drug: corticotropin | Target: melanocortin receptor 3 | Type: gpcr | Action: AGONIST
17706,corticotropin,melanocyte-stimulating hormone receptor,gpcr,AGONIST,Drug: corticotropin | Target: melanocyte-stimulating hormone receptor | Type: gpcr | Action: AGONIST
17707,corticotropin,adrenocorticotropic hormone receptor,gpcr,AGONIST,Drug: corticotropin | Target: adrenocorticotropic hormone receptor | Type: gpcr | Action: AGONIST
17708,corticotropin,adrenocorticotropic hormone receptor,gpcr,AGONIST,Drug: corticotropin | Target: adrenocorticotropic hormone receptor | Type: gpcr | Action: AGONIST
17709,tocilizumab,interleukin-6 receptor,membrane receptor,ANTIBODY BINDING,Drug: tocilizumab | Target: interleukin-6 receptor | Type: membrane receptor | Action: ANTIBODY BINDING
17710,secukinumab,interleukin-17a,cytokine,ANTIBODY BINDING,Drug: secukinumab | Target: interleukin-17a | Type: cytokine | Action: ANTIBODY BINDING
17711,palivizumab,fusion glycoprotein f0,surface antigen,ANTIBODY BINDING,Drug: palivizumab | Target: fusion glycoprotein f0 | Type: surface antigen | Action: ANTIBODY BINDING
17712,parathyroid hormone,parathyroid hormone/parathyroid hormone-related peptide receptor,gpcr,AGONIST,Drug: parathyroid hormone | Target: parathyroid hormone/parathyroid hormone-related peptide receptor | Type: gpcr | Action: AGONIST
17713,alectinib,vascular endothelial growth factor receptor 2,kinase,,Drug: alectinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
17714,alectinib,srsf protein kinase 1,kinase,,Drug: alectinib | Target: srsf protein kinase 1 | Type: kinase | Action: nan
17715,alectinib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: alectinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
17717,alectinib,alk tyrosine kinase receptor,kinase,INHIBITOR,Drug: alectinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: INHIBITOR
17718,alectinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: alectinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
17719,ripasudil,camp-dependent protein kinase catalytic subunit alpha,kinase,INHIBITOR,Drug: ripasudil | Target: camp-dependent protein kinase catalytic subunit alpha | Type: kinase | Action: INHIBITOR
17720,ripasudil,rho-associated protein kinase 1,kinase,INHIBITOR,Drug: ripasudil | Target: rho-associated protein kinase 1 | Type: kinase | Action: INHIBITOR
17721,ripasudil,rho-associated protein kinase 2,kinase,INHIBITOR,Drug: ripasudil | Target: rho-associated protein kinase 2 | Type: kinase | Action: INHIBITOR
17722,vaniprevir,cathepsin s,enzyme,,Drug: vaniprevir | Target: cathepsin s | Type: enzyme | Action: nan
17723,vaniprevir,nonstructural protein ns3-4a,unclassified,,Drug: vaniprevir | Target: nonstructural protein ns3-4a | Type: unclassified | Action: nan
17724,vaniprevir,genome polyprotein,unclassified,,Drug: vaniprevir | Target: genome polyprotein | Type: unclassified | Action: nan
17725,vaniprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: vaniprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17726,vaniprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: vaniprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17727,basiliximab,interleukin-2 receptor subunit alpha,membrane receptor,ANTIBODY BINDING,Drug: basiliximab | Target: interleukin-2 receptor subunit alpha | Type: membrane receptor | Action: ANTIBODY BINDING
17728,palbociclib,tyrosine-protein kinase jak3,kinase,,Drug: palbociclib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
17729,palbociclib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: palbociclib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
17730,palbociclib,cyclin-dependent kinase 9,kinase,,Drug: palbociclib | Target: cyclin-dependent kinase 9 | Type: kinase | Action: nan
17731,palbociclib,cyclin-dependent kinase 4/cyclin d1,kinase,,Drug: palbociclib | Target: cyclin-dependent kinase 4/cyclin d1 | Type: kinase | Action: nan
17732,palbociclib,cdk2/cyclin a,kinase,,Drug: palbociclib | Target: cdk2/cyclin a | Type: kinase | Action: nan
17733,palbociclib,cdk6/cyclin d1,kinase,,Drug: palbociclib | Target: cdk6/cyclin d1 | Type: kinase | Action: nan
17734,palbociclib,ribosomal protein s6 kinase alpha-1,kinase,INHIBITOR,Drug: palbociclib | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: INHIBITOR
17735,palbociclib,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,INHIBITOR,Drug: palbociclib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: INHIBITOR
17736,palbociclib,cyclin-dependent kinase 6,kinase,INHIBITOR,Drug: palbociclib | Target: cyclin-dependent kinase 6 | Type: kinase | Action: INHIBITOR
17737,palbociclib,cyclin-dependent kinase 4,kinase,INHIBITOR,Drug: palbociclib | Target: cyclin-dependent kinase 4 | Type: kinase | Action: INHIBITOR
17738,lenvatinib,"carbonic anhydrase 5a, mitochondrial",enzyme,,"Drug: lenvatinib | Target: carbonic anhydrase 5a, mitochondrial | Type: enzyme | Action: nan"
17740,lenvatinib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: lenvatinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
17741,lenvatinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: lenvatinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
17742,lenvatinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: lenvatinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
17743,lenvatinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: lenvatinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
17744,lenvatinib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: lenvatinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
17745,lenvatinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: lenvatinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
17746,lenvatinib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: lenvatinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
17747,lenvatinib,platelet-derived growth factor receptor alpha,kinase,INHIBITOR,Drug: lenvatinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: INHIBITOR
17748,lenvatinib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: lenvatinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
17749,arformoterol,beta-3 adrenergic receptor,gpcr,,Drug: arformoterol | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
17750,arformoterol,beta-2 adrenergic receptor,gpcr,,Drug: arformoterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
17751,arformoterol,beta-1 adrenergic receptor,gpcr,AGONIST,Drug: arformoterol | Target: beta-1 adrenergic receptor | Type: gpcr | Action: AGONIST
17752,arformoterol,beta-2 adrenergic receptor,gpcr,AGONIST,Drug: arformoterol | Target: beta-2 adrenergic receptor | Type: gpcr | Action: AGONIST
17753,pancreozymin,cholecystokinin receptor type a,gpcr,,Drug: pancreozymin | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
17754,pancreozymin,gastrin/cholecystokinin type b receptor,gpcr,AGONIST,Drug: pancreozymin | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: AGONIST
17755,pancreozymin,cholecystokinin receptor type a,gpcr,AGONIST,Drug: pancreozymin | Target: cholecystokinin receptor type a | Type: gpcr | Action: AGONIST
17756,pancreozymin,gastrin/cholecystokinin type b receptor,gpcr,,Drug: pancreozymin | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
17757,pancreozymin,gastrin/cholecystokinin type b receptor,gpcr,,Drug: pancreozymin | Target: gastrin/cholecystokinin type b receptor | Type: gpcr | Action: nan
17758,pancreozymin,cholecystokinin receptor type a,gpcr,,Drug: pancreozymin | Target: cholecystokinin receptor type a | Type: gpcr | Action: nan
17759,avibactam,penicillin-binding protein 2,enzyme,,Drug: avibactam | Target: penicillin-binding protein 2 | Type: enzyme | Action: nan
17761,avibactam,beta-lactamase,enzyme,INHIBITOR,Drug: avibactam | Target: beta-lactamase | Type: enzyme | Action: INHIBITOR
17762,avibactam,beta-lactamase,enzyme,INHIBITOR,Drug: avibactam | Target: beta-lactamase | Type: enzyme | Action: INHIBITOR
17763,avibactam,beta-lactamase,enzyme,INHIBITOR,Drug: avibactam | Target: beta-lactamase | Type: enzyme | Action: INHIBITOR
17764,belimumab,tumor necrosis factor ligand superfamily member 13b,cytokine,ANTIBODY BINDING,Drug: belimumab | Target: tumor necrosis factor ligand superfamily member 13b | Type: cytokine | Action: ANTIBODY BINDING
17765,abciximab,integrin alpha-iib/beta-3,adhesion,ANTIBODY BINDING,Drug: abciximab | Target: integrin alpha-iib/beta-3 | Type: adhesion | Action: ANTIBODY BINDING
17766,ofatumumab,b-lymphocyte antigen cd20,surface antigen,ANTIBODY BINDING,Drug: ofatumumab | Target: b-lymphocyte antigen cd20 | Type: surface antigen | Action: ANTIBODY BINDING
17767,canakinumab,interleukin-1 beta,cytokine,ANTIBODY BINDING,Drug: canakinumab | Target: interleukin-1 beta | Type: cytokine | Action: ANTIBODY BINDING
17768,daclizumab,interleukin-2 receptor,membrane receptor,ANTIBODY BINDING,Drug: daclizumab | Target: interleukin-2 receptor | Type: membrane receptor | Action: ANTIBODY BINDING
17769,cetuximab,epidermal growth factor receptor,kinase,ANTIBODY BINDING,Drug: cetuximab | Target: epidermal growth factor receptor | Type: kinase | Action: ANTIBODY BINDING
17770,panitumumab,epidermal growth factor receptor,kinase,AGONIST,Drug: panitumumab | Target: epidermal growth factor receptor | Type: kinase | Action: AGONIST
17771,bevacizumab,vascular endothelial growth factor a,secreted,ANTIBODY BINDING,Drug: bevacizumab | Target: vascular endothelial growth factor a | Type: secreted | Action: ANTIBODY BINDING
17772,pertuzumab,receptor tyrosine-protein kinase erbb-2,kinase,ANTIBODY BINDING,Drug: pertuzumab | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: ANTIBODY BINDING
17773,ipilimumab,cytotoxic t-lymphocyte protein 4,surface antigen,ANTIBODY BINDING,Drug: ipilimumab | Target: cytotoxic t-lymphocyte protein 4 | Type: surface antigen | Action: ANTIBODY BINDING
17774,efalizumab,leukocyte adhesion glycoprotein lfa-1 alpha,adhesion,ANTIBODY BINDING,Drug: efalizumab | Target: leukocyte adhesion glycoprotein lfa-1 alpha | Type: adhesion | Action: ANTIBODY BINDING
17775,insulin degludec,insulin receptor,kinase,AGONIST,Drug: insulin degludec | Target: insulin receptor | Type: kinase | Action: AGONIST
17776,raxibacumab,protective antigen,secreted,ANTIBODY BINDING,Drug: raxibacumab | Target: protective antigen | Type: secreted | Action: ANTIBODY BINDING
17777,brentuximab vedotin,tumor necrosis factor receptor superfamily member 8,membrane receptor,BINDING AGENT,Drug: brentuximab vedotin | Target: tumor necrosis factor receptor superfamily member 8 | Type: membrane receptor | Action: BINDING AGENT
17778,brentuximab vedotin,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: brentuximab vedotin | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
17779,denosumab,tumor necrosis factor ligand superfamily member 11,cytokine,ANTIBODY BINDING,Drug: denosumab | Target: tumor necrosis factor ligand superfamily member 11 | Type: cytokine | Action: ANTIBODY BINDING
17780,ustekinumab,interleukin-12,cytokine,ANTIBODY BINDING,Drug: ustekinumab | Target: interleukin-12 | Type: cytokine | Action: ANTIBODY BINDING
17781,ustekinumab,interleukin-23,cytokine,ANTIBODY BINDING,Drug: ustekinumab | Target: interleukin-23 | Type: cytokine | Action: ANTIBODY BINDING
17782,golimumab,tumor necrosis factor,cytokine,ANTIBODY BINDING,Drug: golimumab | Target: tumor necrosis factor | Type: cytokine | Action: ANTIBODY BINDING
17783,certolizumab pegol,tumor necrosis factor,cytokine,ANTIBODY BINDING,Drug: certolizumab pegol | Target: tumor necrosis factor | Type: cytokine | Action: ANTIBODY BINDING
17784,eculizumab,complement c5,secreted,ANTIBODY BINDING,Drug: eculizumab | Target: complement c5 | Type: secreted | Action: ANTIBODY BINDING
17785,natalizumab,integrin alpha-4/beta-1,adhesion,ANTIBODY BINDING,Drug: natalizumab | Target: integrin alpha-4/beta-1 | Type: adhesion | Action: ANTIBODY BINDING
17786,natalizumab,integrin alpha-4/beta-7,adhesion,ANTIBODY BINDING,Drug: natalizumab | Target: integrin alpha-4/beta-7 | Type: adhesion | Action: ANTIBODY BINDING
17787,ranibizumab,vascular endothelial growth factor a,secreted,ANTIBODY BINDING,Drug: ranibizumab | Target: vascular endothelial growth factor a | Type: secreted | Action: ANTIBODY BINDING
17788,omalizumab,ig epsilon chain c region,antibody,ANTIBODY BINDING,Drug: omalizumab | Target: ig epsilon chain c region | Type: antibody | Action: ANTIBODY BINDING
17789,chidamide,nicotinamide phosphoribosyltransferase,enzyme,,Drug: chidamide | Target: nicotinamide phosphoribosyltransferase | Type: enzyme | Action: nan
17790,chidamide,nicotinamide phosphoribosyltransferase,cytokine,,Drug: chidamide | Target: nicotinamide phosphoribosyltransferase | Type: cytokine | Action: nan
17791,chidamide,histone deacetylase 8,enzyme,INHIBITOR,Drug: chidamide | Target: histone deacetylase 8 | Type: enzyme | Action: INHIBITOR
17792,chidamide,histone deacetylase 11,enzyme,INHIBITOR,Drug: chidamide | Target: histone deacetylase 11 | Type: enzyme | Action: INHIBITOR
17793,chidamide,histone deacetylase 2,enzyme,INHIBITOR,Drug: chidamide | Target: histone deacetylase 2 | Type: enzyme | Action: INHIBITOR
17794,chidamide,histone deacetylase 1,enzyme,INHIBITOR,Drug: chidamide | Target: histone deacetylase 1 | Type: enzyme | Action: INHIBITOR
17795,chidamide,histone deacetylase 3,enzyme,INHIBITOR,Drug: chidamide | Target: histone deacetylase 3 | Type: enzyme | Action: INHIBITOR
17796,chidamide,histone deacetylase 10,enzyme,INHIBITOR,Drug: chidamide | Target: histone deacetylase 10 | Type: enzyme | Action: INHIBITOR
17797,infliximab,tumor necrosis factor,cytokine,ANTIBODY BINDING,Drug: infliximab | Target: tumor necrosis factor | Type: cytokine | Action: ANTIBODY BINDING
17798,rituximab,b-lymphocyte antigen cd20,surface antigen,ANTIBODY BINDING,Drug: rituximab | Target: b-lymphocyte antigen cd20 | Type: surface antigen | Action: ANTIBODY BINDING
17799,triamcinolone hexacetonide,glucocorticoid receptor,nuclear hormone receptor,AGONIST,Drug: triamcinolone hexacetonide | Target: glucocorticoid receptor | Type: nuclear hormone receptor | Action: AGONIST
17800,siltuximab,interleukin-6,cytokine,ANTIBODY BINDING,Drug: siltuximab | Target: interleukin-6 | Type: cytokine | Action: ANTIBODY BINDING
17801,etanercept,tumor necrosis factor,cytokine,INHIBITOR,Drug: etanercept | Target: tumor necrosis factor | Type: cytokine | Action: INHIBITOR
17802,trastuzumab,receptor tyrosine-protein kinase erbb-2,kinase,ANTIBODY BINDING,Drug: trastuzumab | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: ANTIBODY BINDING
17803,gemtuzumab ozogamicin,myeloid cell surface antigen cd33,surface antigen,ANTIBODY BINDING,Drug: gemtuzumab ozogamicin | Target: myeloid cell surface antigen cd33 | Type: surface antigen | Action: ANTIBODY BINDING
17804,insulin aspart,insulin receptor,kinase,AGONIST,Drug: insulin aspart | Target: insulin receptor | Type: kinase | Action: AGONIST
17805,vedolizumab,integrin alpha-4/beta-7,adhesion,ANTIBODY BINDING,Drug: vedolizumab | Target: integrin alpha-4/beta-7 | Type: adhesion | Action: ANTIBODY BINDING
17806,obinutuzumab,b-lymphocyte antigen cd20,surface antigen,ANTIBODY BINDING,Drug: obinutuzumab | Target: b-lymphocyte antigen cd20 | Type: surface antigen | Action: ANTIBODY BINDING
17807,ibritumomab tiuxetan,b-lymphocyte antigen cd20,surface antigen,ANTIBODY BINDING,Drug: ibritumomab tiuxetan | Target: b-lymphocyte antigen cd20 | Type: surface antigen | Action: ANTIBODY BINDING
17808,insulin detemir,insulin receptor,kinase,AGONIST,Drug: insulin detemir | Target: insulin receptor | Type: kinase | Action: AGONIST
17809,pegfilgrastim,granulocyte colony-stimulating factor receptor,membrane receptor,ACTIVATOR,Drug: pegfilgrastim | Target: granulocyte colony-stimulating factor receptor | Type: membrane receptor | Action: ACTIVATOR
17810,filgrastim,granulocyte colony-stimulating factor receptor,membrane receptor,ACTIVATOR,Drug: filgrastim | Target: granulocyte colony-stimulating factor receptor | Type: membrane receptor | Action: ACTIVATOR
17811,deoxycholic acid,fmet-leu-phe receptor,gpcr,ANTAGONIST,Drug: deoxycholic acid | Target: fmet-leu-phe receptor | Type: gpcr | Action: ANTAGONIST
17812,deoxycholic acid,bile acid receptor,nuclear hormone receptor,,Drug: deoxycholic acid | Target: bile acid receptor | Type: nuclear hormone receptor | Action: nan
17813,deoxycholic acid,g-protein coupled bile acid receptor 1,gpcr,AGONIST,Drug: deoxycholic acid | Target: g-protein coupled bile acid receptor 1 | Type: gpcr | Action: AGONIST
17814,deoxycholic acid,steroid delta-isomerase,unclassified,,Drug: deoxycholic acid | Target: steroid delta-isomerase | Type: unclassified | Action: nan
17815,trastuzumab emtansine,receptor tyrosine-protein kinase erbb-2,kinase,ANTIBODY BINDING,Drug: trastuzumab emtansine | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: ANTIBODY BINDING
17816,trastuzumab emtansine,tubulin beta,tumour-associated antigen,INHIBITOR,Drug: trastuzumab emtansine | Target: tubulin beta | Type: tumour-associated antigen | Action: INHIBITOR
17817,lipegfilgrastim,granulocyte colony-stimulating factor receptor,membrane receptor,ACTIVATOR,Drug: lipegfilgrastim | Target: granulocyte colony-stimulating factor receptor | Type: membrane receptor | Action: ACTIVATOR
17818,vonoprazan,potassium-transporting atpase,transporter,INHIBITOR,Drug: vonoprazan | Target: potassium-transporting atpase | Type: transporter | Action: INHIBITOR
17819,epoetin alfa,erythropoietin receptor,membrane receptor,AGONIST,Drug: epoetin alfa | Target: erythropoietin receptor | Type: membrane receptor | Action: AGONIST
17820,romiplostim,thrombopoietin receptor,membrane receptor,AGONIST,Drug: romiplostim | Target: thrombopoietin receptor | Type: membrane receptor | Action: AGONIST
17821,evolocumab,proprotein convertase subtilisin/kexin type 9,enzyme,INHIBITOR,Drug: evolocumab | Target: proprotein convertase subtilisin/kexin type 9 | Type: enzyme | Action: INHIBITOR
17822,eluxadoline,mu-type opioid receptor,gpcr,,Drug: eluxadoline | Target: mu-type opioid receptor | Type: gpcr | Action: nan
17823,eluxadoline,delta-type opioid receptor,gpcr,,Drug: eluxadoline | Target: delta-type opioid receptor | Type: gpcr | Action: nan
17824,eluxadoline,kappa-type opioid receptor,gpcr,AGONIST,Drug: eluxadoline | Target: kappa-type opioid receptor | Type: gpcr | Action: AGONIST
17825,eluxadoline,kappa-type opioid receptor,gpcr,AGONIST,Drug: eluxadoline | Target: kappa-type opioid receptor | Type: gpcr | Action: AGONIST
17826,eluxadoline,mu-type opioid receptor,gpcr,AGONIST,Drug: eluxadoline | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
17827,eluxadoline,delta-type opioid receptor,gpcr,ANTAGONIST,Drug: eluxadoline | Target: delta-type opioid receptor | Type: gpcr | Action: ANTAGONIST
17828,insulin lispro,insulin receptor,kinase,AGONIST,Drug: insulin lispro | Target: insulin receptor | Type: kinase | Action: AGONIST
17829,insulin human,tyrosine-protein kinase lck,kinase,,Drug: insulin human | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
17830,insulin human,insulin receptor,kinase,,Drug: insulin human | Target: insulin receptor | Type: kinase | Action: nan
17831,insulin human,insulin receptor,kinase,AGONIST,Drug: insulin human | Target: insulin receptor | Type: kinase | Action: AGONIST
17832,mirodenafil,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,INHIBITOR,"Drug: mirodenafil | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: INHIBITOR"
17833,cangrelor,p2y purinoceptor 13,gpcr,ANTAGONIST,Drug: cangrelor | Target: p2y purinoceptor 13 | Type: gpcr | Action: ANTAGONIST
17834,cangrelor,uracil nucleotide/cysteinyl leukotriene receptor,gpcr,ANTAGONIST,Drug: cangrelor | Target: uracil nucleotide/cysteinyl leukotriene receptor | Type: gpcr | Action: ANTAGONIST
17835,cangrelor,p2y purinoceptor 12,gpcr,ANTAGONIST,Drug: cangrelor | Target: p2y purinoceptor 12 | Type: gpcr | Action: ANTAGONIST
17836,epoetin theta,erythropoietin receptor,membrane receptor,AGONIST,Drug: epoetin theta | Target: erythropoietin receptor | Type: membrane receptor | Action: AGONIST
17837,sonidegib,sonic hedgehog protein,enzyme,,Drug: sonidegib | Target: sonic hedgehog protein | Type: enzyme | Action: nan
17838,sonidegib,smoothened homolog,gpcr,ANTAGONIST,Drug: sonidegib | Target: smoothened homolog | Type: gpcr | Action: ANTAGONIST
17839,mecasermin,insulin receptor,kinase,,Drug: mecasermin | Target: insulin receptor | Type: kinase | Action: nan
17840,mecasermin,insulin-like growth factor 1 receptor,kinase,AGONIST,Drug: mecasermin | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: AGONIST
17841,lumacaftor,cystic fibrosis transmembrane conductance regulator,ion channel,PHARMACOLOGICAL CHAPERONE,Drug: lumacaftor | Target: cystic fibrosis transmembrane conductance regulator | Type: ion channel | Action: PHARMACOLOGICAL CHAPERONE
17842,aldesleukin,interleukin-2 receptor,membrane receptor,AGONIST,Drug: aldesleukin | Target: interleukin-2 receptor | Type: membrane receptor | Action: AGONIST
17843,sacubitril,neprilysin,enzyme,INHIBITOR,Drug: sacubitril | Target: neprilysin | Type: enzyme | Action: INHIBITOR
17844,trelagliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: trelagliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
17845,brexpiprazole,d(2) dopamine receptor,gpcr,,Drug: brexpiprazole | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
17846,brexpiprazole,5-hydroxytryptamine receptor 1a,gpcr,,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
17847,brexpiprazole,5-hydroxytryptamine receptor 2a,gpcr,,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: nan
17849,brexpiprazole,beta-1 adrenergic receptor,gpcr,,Drug: brexpiprazole | Target: beta-1 adrenergic receptor | Type: gpcr | Action: nan
17850,brexpiprazole,beta-2 adrenergic receptor,gpcr,,Drug: brexpiprazole | Target: beta-2 adrenergic receptor | Type: gpcr | Action: nan
17851,brexpiprazole,d(1a) dopamine receptor,gpcr,AGONIST,Drug: brexpiprazole | Target: d(1a) dopamine receptor | Type: gpcr | Action: AGONIST
17852,brexpiprazole,alpha-2a adrenergic receptor,gpcr,,Drug: brexpiprazole | Target: alpha-2a adrenergic receptor | Type: gpcr | Action: nan
17853,brexpiprazole,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: brexpiprazole | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
17854,brexpiprazole,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: brexpiprazole | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
17855,brexpiprazole,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
17856,brexpiprazole,5-hydroxytryptamine receptor 2c,gpcr,,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
17857,brexpiprazole,5-hydroxytryptamine receptor 6,gpcr,,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: nan
17858,brexpiprazole,5-hydroxytryptamine receptor 7,gpcr,ANTAGONIST,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: ANTAGONIST
17859,brexpiprazole,alpha-1a adrenergic receptor,gpcr,,Drug: brexpiprazole | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
17860,brexpiprazole,alpha-2b adrenergic receptor,gpcr,,Drug: brexpiprazole | Target: alpha-2b adrenergic receptor | Type: gpcr | Action: nan
17861,brexpiprazole,d(3) dopamine receptor,gpcr,AGONIST,Drug: brexpiprazole | Target: d(3) dopamine receptor | Type: gpcr | Action: AGONIST
17862,brexpiprazole,histamine h1 receptor,gpcr,ANTAGONIST,Drug: brexpiprazole | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
17863,brexpiprazole,5-hydroxytryptamine receptor 1b,gpcr,,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: nan
17864,brexpiprazole,alpha-2c adrenergic receptor,gpcr,ANTAGONIST,Drug: brexpiprazole | Target: alpha-2c adrenergic receptor | Type: gpcr | Action: ANTAGONIST
17865,brexpiprazole,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: brexpiprazole | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
17866,brexpiprazole,d(4) dopamine receptor,gpcr,AGONIST,Drug: brexpiprazole | Target: d(4) dopamine receptor | Type: gpcr | Action: AGONIST
17867,brexpiprazole,alpha-1d adrenergic receptor,gpcr,ANTAGONIST,Drug: brexpiprazole | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: ANTAGONIST
17868,brexpiprazole,alpha-1b adrenergic receptor,gpcr,ANTAGONIST,Drug: brexpiprazole | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: ANTAGONIST
17869,brexpiprazole,5-hydroxytryptamine receptor 5a,gpcr,,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
17870,brexpiprazole,d(2) dopamine receptor,gpcr,AGONIST,Drug: brexpiprazole | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
17871,brexpiprazole,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
17872,brexpiprazole,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: brexpiprazole | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
17873,pegvisomant,growth hormone receptor,gpcr,ANTAGONIST,Drug: pegvisomant | Target: growth hormone receptor | Type: gpcr | Action: ANTAGONIST
17874,alirocumab,proprotein convertase subtilisin/kexin type 9,enzyme,INHIBITOR,Drug: alirocumab | Target: proprotein convertase subtilisin/kexin type 9 | Type: enzyme | Action: INHIBITOR
17875,anakinra,"interleukin-1 receptor, type i",membrane receptor,ANTAGONIST,"Drug: anakinra | Target: interleukin-1 receptor, type i | Type: membrane receptor | Action: ANTAGONIST"
17876,flibanserin,5-hydroxytryptamine receptor 1a,gpcr,,Drug: flibanserin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
17877,flibanserin,d(2) dopamine receptor,gpcr,,Drug: flibanserin | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
17878,flibanserin,d(3) dopamine receptor,gpcr,,Drug: flibanserin | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
17879,flibanserin,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: flibanserin | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
17880,flibanserin,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: flibanserin | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
17881,flibanserin,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: flibanserin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
17882,flibanserin,5-hydroxytryptamine receptor 5a,gpcr,,Drug: flibanserin | Target: 5-hydroxytryptamine receptor 5a | Type: gpcr | Action: nan
17883,flibanserin,5-hydroxytryptamine receptor 1a,gpcr,AGONIST,Drug: flibanserin | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: AGONIST
17884,flibanserin,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: flibanserin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
17885,sargramostim,granulocyte macrophage colony-stimulating factor receptor,membrane receptor,AGONIST,Drug: sargramostim | Target: granulocyte macrophage colony-stimulating factor receptor | Type: membrane receptor | Action: AGONIST
17886,oprelvekin,interleukin-11 receptor,membrane receptor,AGONIST,Drug: oprelvekin | Target: interleukin-11 receptor | Type: membrane receptor | Action: AGONIST
17887,rolapitant,substance-p receptor,gpcr,ANTAGONIST,Drug: rolapitant | Target: substance-p receptor | Type: gpcr | Action: ANTAGONIST
17888,mogamulizumab,c-c chemokine receptor type 4,gpcr,ANTIBODY BINDING,Drug: mogamulizumab | Target: c-c chemokine receptor type 4 | Type: gpcr | Action: ANTIBODY BINDING
17889,cariprazine,d(1a) dopamine receptor,gpcr,,Drug: cariprazine | Target: d(1a) dopamine receptor | Type: gpcr | Action: nan
17890,cariprazine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: cariprazine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17891,cariprazine,d(1b) dopamine receptor,gpcr,,Drug: cariprazine | Target: d(1b) dopamine receptor | Type: gpcr | Action: nan
17892,cariprazine,d(4) dopamine receptor,gpcr,,Drug: cariprazine | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
17893,cariprazine,d(2) dopamine receptor,gpcr,,Drug: cariprazine | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
17894,cariprazine,d(3) dopamine receptor,gpcr,,Drug: cariprazine | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
17895,cariprazine,5-hydroxytryptamine receptor 2b,gpcr,ANTAGONIST,Drug: cariprazine | Target: 5-hydroxytryptamine receptor 2b | Type: gpcr | Action: ANTAGONIST
17896,cariprazine,5-hydroxytryptamine receptor 2c,gpcr,ANTAGONIST,Drug: cariprazine | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: ANTAGONIST
17897,cariprazine,5-hydroxytryptamine receptor 7,gpcr,,Drug: cariprazine | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
17898,cariprazine,d(3) dopamine receptor,gpcr,PARTIAL AGONIST,Drug: cariprazine | Target: d(3) dopamine receptor | Type: gpcr | Action: PARTIAL AGONIST
17899,cariprazine,histamine h1 receptor,gpcr,ANTAGONIST,Drug: cariprazine | Target: histamine h1 receptor | Type: gpcr | Action: ANTAGONIST
17900,cariprazine,alpha-1d adrenergic receptor,gpcr,,Drug: cariprazine | Target: alpha-1d adrenergic receptor | Type: gpcr | Action: nan
17901,cariprazine,d(2) dopamine receptor,gpcr,PARTIAL AGONIST,Drug: cariprazine | Target: d(2) dopamine receptor | Type: gpcr | Action: PARTIAL AGONIST
17902,cariprazine,5-hydroxytryptamine receptor 1a,gpcr,PARTIAL AGONIST,Drug: cariprazine | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: PARTIAL AGONIST
17903,cariprazine,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: cariprazine | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
17904,tannic acid,carbonic anhydrase 2,enzyme,,Drug: tannic acid | Target: carbonic anhydrase 2 | Type: enzyme | Action: nan
17905,tannic acid,carbonic anhydrase 1,enzyme,,Drug: tannic acid | Target: carbonic anhydrase 1 | Type: enzyme | Action: nan
17906,tannic acid,3-hydroxy-3-methylglutaryl-coenzyme a reductase,enzyme,,Drug: tannic acid | Target: 3-hydroxy-3-methylglutaryl-coenzyme a reductase | Type: enzyme | Action: nan
17907,tannic acid,cytochrome p450 2c9,enzyme,,Drug: tannic acid | Target: cytochrome p450 2c9 | Type: enzyme | Action: nan
17908,tannic acid,cytochrome p450 1a2,enzyme,,Drug: tannic acid | Target: cytochrome p450 1a2 | Type: enzyme | Action: nan
17909,tannic acid,"cgmp-specific 3',5'-cyclic phosphodiesterase",enzyme,,"Drug: tannic acid | Target: cgmp-specific 3',5'-cyclic phosphodiesterase | Type: enzyme | Action: nan"
17910,tannic acid,tyrosine-protein kinase lck,kinase,,Drug: tannic acid | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
17911,tannic acid,tyrosine-protein kinase fyn,kinase,,Drug: tannic acid | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
17912,tannic acid,thromboxane-a synthase,enzyme,,Drug: tannic acid | Target: thromboxane-a synthase | Type: enzyme | Action: nan
17913,tannic acid,carbonic anhydrase 6,enzyme,,Drug: tannic acid | Target: carbonic anhydrase 6 | Type: enzyme | Action: nan
17914,tannic acid,mitogen-activated protein kinase 3,kinase,,Drug: tannic acid | Target: mitogen-activated protein kinase 3 | Type: kinase | Action: nan
17915,tannic acid,mitogen-activated protein kinase 14,kinase,,Drug: tannic acid | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
17916,tannic acid,aldose reductase,enzyme,,Drug: tannic acid | Target: aldose reductase | Type: enzyme | Action: nan
17917,tannic acid,arachidonate 15-lipoxygenase,enzyme,,Drug: tannic acid | Target: arachidonate 15-lipoxygenase | Type: enzyme | Action: nan
17918,tannic acid,mitogen-activated protein kinase 1,kinase,,Drug: tannic acid | Target: mitogen-activated protein kinase 1 | Type: kinase | Action: nan
17919,tannic acid,carbonic anhydrase,enzyme,,Drug: tannic acid | Target: carbonic anhydrase | Type: enzyme | Action: nan
17920,tannic acid,leukotriene c4 synthase,unclassified,,Drug: tannic acid | Target: leukotriene c4 synthase | Type: unclassified | Action: nan
17921,somatrem,growth hormone receptor,gpcr,AGONIST,Drug: somatrem | Target: growth hormone receptor | Type: gpcr | Action: AGONIST
17922,reteplase,plasminogen,enzyme,ACTIVATOR,Drug: reteplase | Target: plasminogen | Type: enzyme | Action: ACTIVATOR
17923,cobimetinib,serine/threonine-protein kinase b-raf,kinase,,Drug: cobimetinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
17924,cobimetinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,ALLOSTERIC MODULATOR,Drug: cobimetinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: ALLOSTERIC MODULATOR
17925,cobimetinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,INHIBITOR,Drug: cobimetinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: INHIBITOR
17926,saroglitazar,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: saroglitazar | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
17927,saroglitazar,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: saroglitazar | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
17928,pitolisant,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: pitolisant | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17929,pitolisant,histamine h1 receptor,gpcr,,Drug: pitolisant | Target: histamine h1 receptor | Type: gpcr | Action: nan
17930,pitolisant,histamine h2 receptor,gpcr,ANTAGONIST,Drug: pitolisant | Target: histamine h2 receptor | Type: gpcr | Action: ANTAGONIST
17931,pitolisant,histamine h3 receptor,gpcr,,Drug: pitolisant | Target: histamine h3 receptor | Type: gpcr | Action: nan
17932,pitolisant,cholinesterase,enzyme,,Drug: pitolisant | Target: cholinesterase | Type: enzyme | Action: nan
17933,pitolisant,histamine h3 receptor,gpcr,,Drug: pitolisant | Target: histamine h3 receptor | Type: gpcr | Action: nan
17934,pitolisant,histamine h3 receptor,gpcr,,Drug: pitolisant | Target: histamine h3 receptor | Type: gpcr | Action: nan
17938,pitolisant,histamine h3 receptor,gpcr,INVERSE AGONIST,Drug: pitolisant | Target: histamine h3 receptor | Type: gpcr | Action: INVERSE AGONIST
17939,aripiprazole lauroxil,5-hydroxytryptamine receptor 1b,gpcr,AGONIST,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 1b | Type: gpcr | Action: AGONIST
17940,aripiprazole lauroxil,5-hydroxytryptamine receptor 1d,gpcr,AGONIST,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 1d | Type: gpcr | Action: AGONIST
17941,aripiprazole lauroxil,d(2) dopamine receptor,gpcr,AGONIST,Drug: aripiprazole lauroxil | Target: d(2) dopamine receptor | Type: gpcr | Action: AGONIST
17942,aripiprazole lauroxil,5-hydroxytryptamine receptor 2a,gpcr,AGONIST,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: AGONIST
17943,aripiprazole lauroxil,5-hydroxytryptamine receptor 7,gpcr,AGONIST,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: AGONIST
17944,aripiprazole lauroxil,d(4) dopamine receptor,gpcr,ANTAGONIST,Drug: aripiprazole lauroxil | Target: d(4) dopamine receptor | Type: gpcr | Action: ANTAGONIST
17945,aripiprazole lauroxil,5-hydroxytryptamine receptor 6,gpcr,AGONIST,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 6 | Type: gpcr | Action: AGONIST
17946,aripiprazole lauroxil,5-hydroxytryptamine receptor 2c,gpcr,,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
17947,aripiprazole lauroxil,5-hydroxytryptamine receptor 7,gpcr,,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 7 | Type: gpcr | Action: nan
17948,aripiprazole lauroxil,d(3) dopamine receptor,gpcr,,Drug: aripiprazole lauroxil | Target: d(3) dopamine receptor | Type: gpcr | Action: nan
17949,aripiprazole lauroxil,histamine h1 receptor,gpcr,,Drug: aripiprazole lauroxil | Target: histamine h1 receptor | Type: gpcr | Action: nan
17950,aripiprazole lauroxil,d(4) dopamine receptor,gpcr,,Drug: aripiprazole lauroxil | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
17951,aripiprazole lauroxil,d(2) dopamine receptor,gpcr,PARTIAL AGONIST,Drug: aripiprazole lauroxil | Target: d(2) dopamine receptor | Type: gpcr | Action: PARTIAL AGONIST
17952,aripiprazole lauroxil,5-hydroxytryptamine receptor 1a,gpcr,PARTIAL AGONIST,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: PARTIAL AGONIST
17953,aripiprazole lauroxil,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: aripiprazole lauroxil | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
17954,omarigliptin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: omarigliptin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17955,omarigliptin,dipeptidyl peptidase 4,enzyme,,Drug: omarigliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: nan
17956,omarigliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: omarigliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
17957,insulin glulisine,insulin receptor,kinase,AGONIST,Drug: insulin glulisine | Target: insulin receptor | Type: kinase | Action: AGONIST
17958,lusutrombopag,thrombopoietin receptor,membrane receptor,AGONIST,Drug: lusutrombopag | Target: thrombopoietin receptor | Type: membrane receptor | Action: AGONIST
17959,esflurbiprofen,prostaglandin g/h synthase 2,enzyme,,Drug: esflurbiprofen | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
17960,esflurbiprofen,prostaglandin g/h synthase 1,enzyme,,Drug: esflurbiprofen | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
17961,mepolizumab,interleukin-5,cytokine,ANTIBODY BINDING,Drug: mepolizumab | Target: interleukin-5 | Type: cytokine | Action: ANTIBODY BINDING
17962,osimertinib,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: osimertinib | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
17963,osimertinib,insulin receptor,kinase,,Drug: osimertinib | Target: insulin receptor | Type: kinase | Action: nan
17964,osimertinib,alk tyrosine kinase receptor,kinase,,Drug: osimertinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
17965,osimertinib,receptor tyrosine-protein kinase erbb-3,kinase,,Drug: osimertinib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: nan
17966,osimertinib,dipeptidyl peptidase 1,enzyme,,Drug: osimertinib | Target: dipeptidyl peptidase 1 | Type: enzyme | Action: nan
17968,osimertinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: osimertinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
17969,daratumumab,lymphocyte differentiation antigen cd38,tumour-associated antigen,ANTIBODY BINDING,Drug: daratumumab | Target: lymphocyte differentiation antigen cd38 | Type: tumour-associated antigen | Action: ANTIBODY BINDING
17970,climbazole,cytochrome p450 3a4,enzyme,,Drug: climbazole | Target: cytochrome p450 3a4 | Type: enzyme | Action: nan
17971,trenbolone hexahydrobenzylcarbonate,androgen receptor,transcription factor,,Drug: trenbolone hexahydrobenzylcarbonate | Target: androgen receptor | Type: transcription factor | Action: nan
17972,trenbolone hexahydrobenzylcarbonate,polymerase acidic protein,enzyme,,Drug: trenbolone hexahydrobenzylcarbonate | Target: polymerase acidic protein | Type: enzyme | Action: nan
17973,tenecteplase,plasminogen,enzyme,ACTIVATOR,Drug: tenecteplase | Target: plasminogen | Type: enzyme | Action: ACTIVATOR
17974,ixazomib,proteasome subunit beta type-1,enzyme,INHIBITOR,Drug: ixazomib | Target: proteasome subunit beta type-1 | Type: enzyme | Action: INHIBITOR
17975,ixazomib,proteasome subunit beta type-2,enzyme,INHIBITOR,Drug: ixazomib | Target: proteasome subunit beta type-2 | Type: enzyme | Action: INHIBITOR
17976,ixazomib,proteasome subunit beta type-5,enzyme,INHIBITOR,Drug: ixazomib | Target: proteasome subunit beta type-5 | Type: enzyme | Action: INHIBITOR
17977,brivaracetam,synaptic vesicle glycoprotein 2a,unclassified,INHIBITOR,Drug: brivaracetam | Target: synaptic vesicle glycoprotein 2a | Type: unclassified | Action: INHIBITOR
17978,brivaracetam,synaptic vesicle glycoprotein 2a,transporter,MODULATOR,Drug: brivaracetam | Target: synaptic vesicle glycoprotein 2a | Type: transporter | Action: MODULATOR
17979,necitumumab,epidermal growth factor receptor,kinase,ANTIBODY BINDING,Drug: necitumumab | Target: epidermal growth factor receptor | Type: kinase | Action: ANTIBODY BINDING
17980,elotuzumab,slam family member 7,membrane receptor,ANTIBODY BINDING,Drug: elotuzumab | Target: slam family member 7 | Type: membrane receptor | Action: ANTIBODY BINDING
17981,lesinurad,solute carrier family 22 member 11,transporter,INHIBITOR,Drug: lesinurad | Target: solute carrier family 22 member 11 | Type: transporter | Action: INHIBITOR
17982,lesinurad,solute carrier family 22 member 12,transporter,INHIBITOR,Drug: lesinurad | Target: solute carrier family 22 member 12 | Type: transporter | Action: INHIBITOR
17983,selexipag,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: selexipag | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
17984,selexipag,prostaglandin e2 receptor ep4 subtype,gpcr,AGONIST,Drug: selexipag | Target: prostaglandin e2 receptor ep4 subtype | Type: gpcr | Action: AGONIST
17985,selexipag,prostaglandin d2 receptor,gpcr,,Drug: selexipag | Target: prostaglandin d2 receptor | Type: gpcr | Action: nan
17986,selexipag,prostacyclin receptor,gpcr,AGONIST,Drug: selexipag | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
17989,selexipag,prostacyclin receptor,gpcr,AGONIST,Drug: selexipag | Target: prostacyclin receptor | Type: gpcr | Action: AGONIST
17990,lobeglitazone,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: lobeglitazone | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
17991,lobeglitazone,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: lobeglitazone | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
17992,elbasvir,nonstructural protein 5a,unclassified,,Drug: elbasvir | Target: nonstructural protein 5a | Type: unclassified | Action: nan
17994,elbasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: elbasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17995,elbasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: elbasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17996,elbasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: elbasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
17997,grazoprevir,ns3,enzyme,,Drug: grazoprevir | Target: ns3 | Type: enzyme | Action: nan
17998,grazoprevir,genome polyprotein,unclassified,,Drug: grazoprevir | Target: genome polyprotein | Type: unclassified | Action: nan
17999,grazoprevir,ns3 protease,unclassified,,Drug: grazoprevir | Target: ns3 protease | Type: unclassified | Action: nan
18000,grazoprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: grazoprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18001,grazoprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: grazoprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18002,grazoprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: grazoprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18003,ixekizumab,interleukin-17a,cytokine,ANTIBODY BINDING,Drug: ixekizumab | Target: interleukin-17a | Type: cytokine | Action: ANTIBODY BINDING
18004,denileukin diftitox,interleukin-2 receptor,membrane receptor,ANTIBODY BINDING,Drug: denileukin diftitox | Target: interleukin-2 receptor | Type: membrane receptor | Action: ANTIBODY BINDING
18005,alefacept,t-cell surface antigen cd2,surface antigen,INHIBITOR,Drug: alefacept | Target: t-cell surface antigen cd2 | Type: surface antigen | Action: INHIBITOR
18006,abatacept,t-lymphocyte activation antigen cd80,surface antigen,INHIBITOR,Drug: abatacept | Target: t-lymphocyte activation antigen cd80 | Type: surface antigen | Action: INHIBITOR
18007,abatacept,t-lymphocyte activation antigen cd86,surface antigen,INHIBITOR,Drug: abatacept | Target: t-lymphocyte activation antigen cd86 | Type: surface antigen | Action: INHIBITOR
18008,belatacept,t-lymphocyte activation antigen cd80,surface antigen,INHIBITOR,Drug: belatacept | Target: t-lymphocyte activation antigen cd80 | Type: surface antigen | Action: INHIBITOR
18009,belatacept,t-lymphocyte activation antigen cd86,surface antigen,INHIBITOR,Drug: belatacept | Target: t-lymphocyte activation antigen cd86 | Type: surface antigen | Action: INHIBITOR
18010,reslizumab,interleukin-5,cytokine,ANTIBODY BINDING,Drug: reslizumab | Target: interleukin-5 | Type: cytokine | Action: ANTIBODY BINDING
18011,obiltoxaximab,protective antigen,secreted,ANTIBODY BINDING,Drug: obiltoxaximab | Target: protective antigen | Type: secreted | Action: ANTIBODY BINDING
18012,rilonacept,interleukin-1 alpha,cytokine,INHIBITOR,Drug: rilonacept | Target: interleukin-1 alpha | Type: cytokine | Action: INHIBITOR
18013,rilonacept,interleukin-1 receptor antagonist protein,unclassified,INHIBITOR,Drug: rilonacept | Target: interleukin-1 receptor antagonist protein | Type: unclassified | Action: INHIBITOR
18014,rilonacept,interleukin-1 beta,cytokine,INHIBITOR,Drug: rilonacept | Target: interleukin-1 beta | Type: cytokine | Action: INHIBITOR
18015,urokinase,plasminogen,enzyme,ACTIVATOR,Drug: urokinase | Target: plasminogen | Type: enzyme | Action: ACTIVATOR
18016,migalastat,"maltase-glucoamylase, intestinal",enzyme,,"Drug: migalastat | Target: maltase-glucoamylase, intestinal | Type: enzyme | Action: nan"
18017,migalastat,lysosomal alpha-glucosidase,enzyme,,Drug: migalastat | Target: lysosomal alpha-glucosidase | Type: enzyme | Action: nan
18018,migalastat,non-lysosomal glucosylceramidase,enzyme,,Drug: migalastat | Target: non-lysosomal glucosylceramidase | Type: enzyme | Action: nan
18019,migalastat,"sucrase-isomaltase, intestinal",enzyme,,"Drug: migalastat | Target: sucrase-isomaltase, intestinal | Type: enzyme | Action: nan"
18020,migalastat,glycogen debranching enzyme,enzyme,,Drug: migalastat | Target: glycogen debranching enzyme | Type: enzyme | Action: nan
18021,migalastat,lactase-phlorizin hydrolase,enzyme,,Drug: migalastat | Target: lactase-phlorizin hydrolase | Type: enzyme | Action: nan
18022,migalastat,beta-galactosidase,enzyme,,Drug: migalastat | Target: beta-galactosidase | Type: enzyme | Action: nan
18023,migalastat,beta-galactosidase,enzyme,,Drug: migalastat | Target: beta-galactosidase | Type: enzyme | Action: nan
18024,migalastat,lactase-phlorizin hydrolase,enzyme,,Drug: migalastat | Target: lactase-phlorizin hydrolase | Type: enzyme | Action: nan
18025,migalastat,alpha-galactosidase c,enzyme,,Drug: migalastat | Target: alpha-galactosidase c | Type: enzyme | Action: nan
18026,migalastat,alpha-galactosidase,enzyme,,Drug: migalastat | Target: alpha-galactosidase | Type: enzyme | Action: nan
18027,migalastat,beta-galactosidase,enzyme,,Drug: migalastat | Target: beta-galactosidase | Type: enzyme | Action: nan
18028,migalastat,beta-galactosidase,enzyme,,Drug: migalastat | Target: beta-galactosidase | Type: enzyme | Action: nan
18029,migalastat,alpha-galactosidase a,enzyme,PHARMACOLOGICAL CHAPERONE,Drug: migalastat | Target: alpha-galactosidase a | Type: enzyme | Action: PHARMACOLOGICAL CHAPERONE
18030,chromic chloride,epidermal growth factor receptor,kinase,,Drug: chromic chloride | Target: epidermal growth factor receptor | Type: kinase | Action: nan
18031,chromic chloride,tyrosine-protein kinase fyn,kinase,,Drug: chromic chloride | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
18032,venetoclax,bcl-2-like protein 1,cytosolic other,INHIBITOR,Drug: venetoclax | Target: bcl-2-like protein 1 | Type: cytosolic other | Action: INHIBITOR
18033,venetoclax,apoptosis regulator bcl-w,cytosolic other,INHIBITOR,Drug: venetoclax | Target: apoptosis regulator bcl-w | Type: cytosolic other | Action: INHIBITOR
18034,venetoclax,apoptosis regulator bcl-2,cytosolic other,INHIBITOR,Drug: venetoclax | Target: apoptosis regulator bcl-2 | Type: cytosolic other | Action: INHIBITOR
18035,peginterferon beta-1a,interferon alpha/beta receptor,membrane receptor,AGONIST,Drug: peginterferon beta-1a | Target: interferon alpha/beta receptor | Type: membrane receptor | Action: AGONIST
18036,interferon beta-1a,interferon alpha/beta receptor,membrane receptor,AGONIST,Drug: interferon beta-1a | Target: interferon alpha/beta receptor | Type: membrane receptor | Action: AGONIST
18037,interferon beta-1b,interferon alpha/beta receptor,membrane receptor,AGONIST,Drug: interferon beta-1b | Target: interferon alpha/beta receptor | Type: membrane receptor | Action: AGONIST
18038,alteplase,plasminogen,enzyme,ACTIVATOR,Drug: alteplase | Target: plasminogen | Type: enzyme | Action: ACTIVATOR
18039,pimavanserin,5-hydroxytryptamine receptor 2c,gpcr,INVERSE AGONIST,Drug: pimavanserin | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: INVERSE AGONIST
18040,pimavanserin,5-hydroxytryptamine receptor 2a,gpcr,INVERSE AGONIST,Drug: pimavanserin | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: INVERSE AGONIST
18041,opicapone,catechol o-methyltransferase,enzyme,INHIBITOR,Drug: opicapone | Target: catechol o-methyltransferase | Type: enzyme | Action: INHIBITOR
18042,opicapone,catechol o-methyltransferase,enzyme,INHIBITOR,Drug: opicapone | Target: catechol o-methyltransferase | Type: enzyme | Action: INHIBITOR
18043,opicapone,catechol o-methyltransferase,enzyme,INHIBITOR,Drug: opicapone | Target: catechol o-methyltransferase | Type: enzyme | Action: INHIBITOR
18044,gluconolactone,glucosylceramidase,enzyme,,Drug: gluconolactone | Target: glucosylceramidase | Type: enzyme | Action: nan
18045,choriogonadotropin alfa,lutropin-choriogonadotropic hormone receptor,gpcr,AGONIST,Drug: choriogonadotropin alfa | Target: lutropin-choriogonadotropic hormone receptor | Type: gpcr | Action: AGONIST
18046,atezolizumab,programmed cell death 1 ligand 1,cd molecules,ANTIBODY BINDING,Drug: atezolizumab | Target: programmed cell death 1 ligand 1 | Type: cd molecules | Action: ANTIBODY BINDING
18047,velpatasvir,nonstructural protein 5a,unclassified,,Drug: velpatasvir | Target: nonstructural protein 5a | Type: unclassified | Action: nan
18049,velpatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: velpatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18050,velpatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: velpatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18051,velpatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: velpatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18052,velpatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: velpatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18053,velpatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: velpatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18054,velpatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: velpatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18055,velpatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: velpatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18056,velpatasvir,genome polyprotein,polyprotein,INHIBITOR,Drug: velpatasvir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18057,obeticholic acid,g-protein coupled bile acid receptor 1,gpcr,,Drug: obeticholic acid | Target: g-protein coupled bile acid receptor 1 | Type: gpcr | Action: nan
18058,obeticholic acid,bile acid receptor,nuclear hormone receptor,AGONIST,Drug: obeticholic acid | Target: bile acid receptor | Type: nuclear hormone receptor | Action: AGONIST
18059,darbepoetin alfa,erythropoietin receptor,membrane receptor,AGONIST,Drug: darbepoetin alfa | Target: erythropoietin receptor | Type: membrane receptor | Action: AGONIST
18060,peginterferon alfa-2a,interferon alpha/beta receptor,membrane receptor,AGONIST,Drug: peginterferon alfa-2a | Target: interferon alpha/beta receptor | Type: membrane receptor | Action: AGONIST
18061,epoetin beta,erythropoietin receptor,membrane receptor,AGONIST,Drug: epoetin beta | Target: erythropoietin receptor | Type: membrane receptor | Action: AGONIST
18062,peginterferon alfa-2b,interferon alpha/beta receptor,membrane receptor,AGONIST,Drug: peginterferon alfa-2b | Target: interferon alpha/beta receptor | Type: membrane receptor | Action: AGONIST
18063,methoxy polyethylene glycol-epoetin beta,erythropoietin receptor,membrane receptor,AGONIST,Drug: methoxy polyethylene glycol-epoetin beta | Target: erythropoietin receptor | Type: membrane receptor | Action: AGONIST
18064,lenograstim,granulocyte colony-stimulating factor receptor,membrane receptor,ACTIVATOR,Drug: lenograstim | Target: granulocyte colony-stimulating factor receptor | Type: membrane receptor | Action: ACTIVATOR
18065,eldecalcitol,vitamin d3 receptor,nuclear hormone receptor,AGONIST,Drug: eldecalcitol | Target: vitamin d3 receptor | Type: nuclear hormone receptor | Action: AGONIST
18066,eldecalcitol,vitamin d3 receptor,transcription factor,AGONIST,Drug: eldecalcitol | Target: vitamin d3 receptor | Type: transcription factor | Action: AGONIST
18067,epoetin zeta,erythropoietin receptor,membrane receptor,AGONIST,Drug: epoetin zeta | Target: erythropoietin receptor | Type: membrane receptor | Action: AGONIST
18068,lifitegrast,intercellular adhesion molecule 1,unclassified,,Drug: lifitegrast | Target: intercellular adhesion molecule 1 | Type: unclassified | Action: nan
18069,lifitegrast,integrin alpha-l/beta-2,adhesion,ANTAGONIST,Drug: lifitegrast | Target: integrin alpha-l/beta-2 | Type: adhesion | Action: ANTAGONIST
18070,muromonab-cd3,t-cell surface glycoprotein cd3,surface antigen,ANTIBODY BINDING,Drug: muromonab-cd3 | Target: t-cell surface glycoprotein cd3 | Type: surface antigen | Action: ANTIBODY BINDING
18071,brodalumab,interleukin-17 receptor,membrane receptor,ANTIBODY BINDING,Drug: brodalumab | Target: interleukin-17 receptor | Type: membrane receptor | Action: ANTIBODY BINDING
18072,etelcalcetide,extracellular calcium-sensing receptor,gpcr,AGONIST,Drug: etelcalcetide | Target: extracellular calcium-sensing receptor | Type: gpcr | Action: AGONIST
18073,eteplirsen,exon 51 of dystrophin pre-mrna,rna,BINDING AGENT,Drug: eteplirsen | Target: exon 51 of dystrophin pre-mrna | Type: rna | Action: BINDING AGENT
18074,olaratumab,platelet-derived growth factor receptor alpha,kinase,ANTIBODY BINDING,Drug: olaratumab | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: ANTIBODY BINDING
18075,gallium (68ga) edotreotide,somatostatin receptor type 2,gpcr,ANTAGONIST,Drug: gallium (68ga) edotreotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: ANTAGONIST
18076,bezlotoxumab,toxin b,enzyme,ANTIBODY BINDING,Drug: bezlotoxumab | Target: toxin b | Type: enzyme | Action: ANTIBODY BINDING
18077,radotinib,tyrosine-protein kinase abl1,kinase,INHIBITOR,Drug: radotinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: INHIBITOR
18078,crisaborole,"calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1a",enzyme,,"Drug: crisaborole | Target: calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1a | Type: enzyme | Action: nan"
18079,crisaborole,"high affinity camp-specific 3',5'-cyclic phosphodiesterase 7a",enzyme,,"Drug: crisaborole | Target: high affinity camp-specific 3',5'-cyclic phosphodiesterase 7a | Type: enzyme | Action: nan"
18080,crisaborole,phosphodiesterase 4,enzyme,INHIBITOR,Drug: crisaborole | Target: phosphodiesterase 4 | Type: enzyme | Action: INHIBITOR
18081,baricitinib,tyrosine-protein kinase jak3,kinase,,Drug: baricitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
18082,baricitinib,ap2-associated protein kinase 1,kinase,INHIBITOR,Drug: baricitinib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: INHIBITOR
18083,baricitinib,bmp-2-inducible protein kinase,kinase,INHIBITOR,Drug: baricitinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: INHIBITOR
18084,baricitinib,cyclin-g-associated kinase,kinase,INHIBITOR,Drug: baricitinib | Target: cyclin-g-associated kinase | Type: kinase | Action: INHIBITOR
18085,baricitinib,non-receptor tyrosine-protein kinase tyk2,kinase,INHIBITOR,Drug: baricitinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: INHIBITOR
18086,baricitinib,tyrosine-protein kinase jak1,kinase,INHIBITOR,Drug: baricitinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: INHIBITOR
18087,baricitinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: baricitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
18088,rucaparib,tankyrase-2,enzyme,INHIBITOR,Drug: rucaparib | Target: tankyrase-2 | Type: enzyme | Action: INHIBITOR
18089,rucaparib,tankyrase-1,enzyme,INHIBITOR,Drug: rucaparib | Target: tankyrase-1 | Type: enzyme | Action: INHIBITOR
18090,rucaparib,poly [adp-ribose] polymerase 4,enzyme,INHIBITOR,Drug: rucaparib | Target: poly [adp-ribose] polymerase 4 | Type: enzyme | Action: INHIBITOR
18091,rucaparib,poly [adp-ribose] polymerase 10,enzyme,INHIBITOR,Drug: rucaparib | Target: poly [adp-ribose] polymerase 10 | Type: enzyme | Action: INHIBITOR
18092,rucaparib,poly [adp-ribose] polymerase 12,enzyme,INHIBITOR,Drug: rucaparib | Target: poly [adp-ribose] polymerase 12 | Type: enzyme | Action: INHIBITOR
18093,rucaparib,poly [adp-ribose] polymerase 14,enzyme,INHIBITOR,Drug: rucaparib | Target: poly [adp-ribose] polymerase 14 | Type: enzyme | Action: INHIBITOR
18094,rucaparib,poly [adp-ribose] polymerase 15,enzyme,INHIBITOR,Drug: rucaparib | Target: poly [adp-ribose] polymerase 15 | Type: enzyme | Action: INHIBITOR
18095,rucaparib,poly [adp-ribose] polymerase 2,enzyme,INHIBITOR,Drug: rucaparib | Target: poly [adp-ribose] polymerase 2 | Type: enzyme | Action: INHIBITOR
18096,rucaparib,poly [adp-ribose] polymerase 1,enzyme,INHIBITOR,Drug: rucaparib | Target: poly [adp-ribose] polymerase 1 | Type: enzyme | Action: INHIBITOR
18097,rucaparib,poly [adp-ribose] polymerase 3,enzyme,INHIBITOR,Drug: rucaparib | Target: poly [adp-ribose] polymerase 3 | Type: enzyme | Action: INHIBITOR
18098,plecanatide,tumor necrosis factor,cytokine,,Drug: plecanatide | Target: tumor necrosis factor | Type: cytokine | Action: nan
18099,plecanatide,tumor necrosis factor receptor superfamily member 1a,unclassified,,Drug: plecanatide | Target: tumor necrosis factor receptor superfamily member 1a | Type: unclassified | Action: nan
18100,plecanatide,heat-stable enterotoxin receptor,enzyme,AGONIST,Drug: plecanatide | Target: heat-stable enterotoxin receptor | Type: enzyme | Action: AGONIST
18101,icotinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: icotinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
18102,olmutinib,tyrosine-protein kinase btk,kinase,,Drug: olmutinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
18103,olmutinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: olmutinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
18104,apatinib,tyrosine-protein kinase csk,kinase,INHIBITOR,Drug: apatinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: INHIBITOR
18105,apatinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: apatinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
18106,apatinib,proto-oncogene tyrosine-protein kinase src,kinase,INHIBITOR,Drug: apatinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: INHIBITOR
18107,apatinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: apatinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
18108,apatinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: apatinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
18109,telotristat ethyl,tryptophan 5-hydroxylase 1,enzyme,INHIBITOR,Drug: telotristat ethyl | Target: tryptophan 5-hydroxylase 1 | Type: enzyme | Action: INHIBITOR
18110,beclabuvir,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: beclabuvir | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
18111,beclabuvir,rna-directed rna polymerase,unclassified,,Drug: beclabuvir | Target: rna-directed rna polymerase | Type: unclassified | Action: nan
18112,cytisine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: cytisine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
18113,cytisine,acetylcholine receptor subunit delta,ion channel,,Drug: cytisine | Target: acetylcholine receptor subunit delta | Type: ion channel | Action: nan
18114,cytisine,neuronal acetylcholine receptor subunit alpha-4,ion channel,,Drug: cytisine | Target: neuronal acetylcholine receptor subunit alpha-4 | Type: ion channel | Action: nan
18115,cytisine,neuronal acetylcholine receptor subunit alpha-7,ion channel,,Drug: cytisine | Target: neuronal acetylcholine receptor subunit alpha-7 | Type: ion channel | Action: nan
18116,cytisine,acetylcholine receptor subunit alpha,ion channel,,Drug: cytisine | Target: acetylcholine receptor subunit alpha | Type: ion channel | Action: nan
18117,cytisine,nicotinic acetylcholine receptor alpha 5 subunit,ion channel,,Drug: cytisine | Target: nicotinic acetylcholine receptor alpha 5 subunit | Type: ion channel | Action: nan
18118,ribociclib,cyclin-dependent kinase 2,kinase,,Drug: ribociclib | Target: cyclin-dependent kinase 2 | Type: kinase | Action: nan
18119,ribociclib,cyclin-dependent kinase 6,kinase,INHIBITOR,Drug: ribociclib | Target: cyclin-dependent kinase 6 | Type: kinase | Action: INHIBITOR
18120,ribociclib,cyclin-dependent kinase 4,kinase,INHIBITOR,Drug: ribociclib | Target: cyclin-dependent kinase 4 | Type: kinase | Action: INHIBITOR
18121,naldemedine,delta-type opioid receptor,gpcr,ANTAGONIST,Drug: naldemedine | Target: delta-type opioid receptor | Type: gpcr | Action: ANTAGONIST
18122,naldemedine,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: naldemedine | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
18123,avelumab,programmed cell death 1 ligand 1,cd molecules,ANTIBODY BINDING,Drug: avelumab | Target: programmed cell death 1 ligand 1 | Type: cd molecules | Action: ANTIBODY BINDING
18124,niraparib,tankyrase-2,enzyme,,Drug: niraparib | Target: tankyrase-2 | Type: enzyme | Action: nan
18125,niraparib,tankyrase-1,enzyme,,Drug: niraparib | Target: tankyrase-1 | Type: enzyme | Action: nan
18126,niraparib,poly [adp-ribose] polymerase 3,enzyme,,Drug: niraparib | Target: poly [adp-ribose] polymerase 3 | Type: enzyme | Action: nan
18127,niraparib,poly [adp-ribose] polymerase 4,enzyme,,Drug: niraparib | Target: poly [adp-ribose] polymerase 4 | Type: enzyme | Action: nan
18128,niraparib,poly [adp-ribose] polymerase 10,enzyme,,Drug: niraparib | Target: poly [adp-ribose] polymerase 10 | Type: enzyme | Action: nan
18129,niraparib,poly [adp-ribose] polymerase 12,enzyme,,Drug: niraparib | Target: poly [adp-ribose] polymerase 12 | Type: enzyme | Action: nan
18130,niraparib,poly [adp-ribose] polymerase 14,enzyme,,Drug: niraparib | Target: poly [adp-ribose] polymerase 14 | Type: enzyme | Action: nan
18131,niraparib,poly [adp-ribose] polymerase 15,enzyme,,Drug: niraparib | Target: poly [adp-ribose] polymerase 15 | Type: enzyme | Action: nan
18132,niraparib,poly [adp-ribose] polymerase 2,enzyme,INHIBITOR,Drug: niraparib | Target: poly [adp-ribose] polymerase 2 | Type: enzyme | Action: INHIBITOR
18133,niraparib,poly [adp-ribose] polymerase 1,enzyme,INHIBITOR,Drug: niraparib | Target: poly [adp-ribose] polymerase 1 | Type: enzyme | Action: INHIBITOR
18134,ocrelizumab,b-lymphocyte antigen cd20,surface antigen,ANTIBODY BINDING,Drug: ocrelizumab | Target: b-lymphocyte antigen cd20 | Type: surface antigen | Action: ANTIBODY BINDING
18135,dupilumab,interleukin-4 receptor subunit alpha,membrane receptor,ANTIBODY BINDING,Drug: dupilumab | Target: interleukin-4 receptor subunit alpha | Type: membrane receptor | Action: ANTIBODY BINDING
18136,deutetrabenazine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: deutetrabenazine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
18137,valbenazine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: valbenazine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
18138,valbenazine,synaptic vesicular amine transporter,transporter,INHIBITOR,Drug: valbenazine | Target: synaptic vesicular amine transporter | Type: transporter | Action: INHIBITOR
18139,forodesine,purine nucleoside phosphorylase,enzyme,,Drug: forodesine | Target: purine nucleoside phosphorylase | Type: enzyme | Action: nan
18140,forodesine,purine nucleoside phosphorylase,enzyme,,Drug: forodesine | Target: purine nucleoside phosphorylase | Type: enzyme | Action: nan
18141,forodesine,purine nucleoside phosphorylase,enzyme,INHIBITOR,Drug: forodesine | Target: purine nucleoside phosphorylase | Type: enzyme | Action: INHIBITOR
18142,midostaurin,tyrosine-protein kinase jak3,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
18143,midostaurin,platelet-derived growth factor receptor beta,kinase,,Drug: midostaurin | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
18144,midostaurin,tyrosine-protein kinase abl1,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
18145,midostaurin,mast/stem cell growth factor receptor kit,kinase,,Drug: midostaurin | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
18146,midostaurin,epidermal growth factor receptor,kinase,,Drug: midostaurin | Target: epidermal growth factor receptor | Type: kinase | Action: nan
18147,midostaurin,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: midostaurin | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
18148,midostaurin,tyrosine-protein kinase lck,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
18149,midostaurin,tyrosine-protein kinase yes,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
18150,midostaurin,tyrosine-protein kinase fyn,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
18151,midostaurin,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: midostaurin | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
18152,midostaurin,vascular endothelial growth factor receptor 1,kinase,,Drug: midostaurin | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
18153,midostaurin,vascular endothelial growth factor receptor 2,kinase,,Drug: midostaurin | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
18154,midostaurin,vascular endothelial growth factor receptor 3,kinase,,Drug: midostaurin | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: nan
18155,midostaurin,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: midostaurin | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
18156,midostaurin,platelet-derived growth factor receptor alpha,kinase,,Drug: midostaurin | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
18157,midostaurin,ribosomal protein s6 kinase alpha-3,kinase,,Drug: midostaurin | Target: ribosomal protein s6 kinase alpha-3 | Type: kinase | Action: nan
18158,midostaurin,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: midostaurin | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
18159,midostaurin,serine/threonine-protein kinase pim-1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase pim-1 | Type: kinase | Action: nan
18160,midostaurin,"myosin light chain kinase, smooth muscle",kinase,,"Drug: midostaurin | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
18161,midostaurin,death-associated protein kinase 3,kinase,,Drug: midostaurin | Target: death-associated protein kinase 3 | Type: kinase | Action: nan
18162,midostaurin,calcium/calmodulin-dependent protein kinase type 1,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase type 1 | Type: kinase | Action: nan
18163,midostaurin,mitogen-activated protein kinase 8,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
18164,midostaurin,fibroblast growth factor receptor 3,kinase,,Drug: midostaurin | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
18165,midostaurin,rho-associated protein kinase 1,kinase,,Drug: midostaurin | Target: rho-associated protein kinase 1 | Type: kinase | Action: nan
18166,midostaurin,tyrosine-protein kinase hck,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
18167,midostaurin,tyrosine-protein kinase jak1,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: nan
18168,midostaurin,receptor tyrosine-protein kinase erbb-4,kinase,,Drug: midostaurin | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: nan
18169,midostaurin,mitogen-activated protein kinase 10,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
18170,midostaurin,death-associated protein kinase 2,kinase,,Drug: midostaurin | Target: death-associated protein kinase 2 | Type: kinase | Action: nan
18171,midostaurin,high affinity nerve growth factor receptor,kinase,,Drug: midostaurin | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
18172,midostaurin,protein kinase c delta type,kinase,,Drug: midostaurin | Target: protein kinase c delta type | Type: kinase | Action: nan
18173,midostaurin,camp-dependent protein kinase catalytic subunit beta,kinase,,Drug: midostaurin | Target: camp-dependent protein kinase catalytic subunit beta | Type: kinase | Action: nan
18174,midostaurin,tyrosine-protein kinase jak2,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
18175,midostaurin,rho-associated protein kinase 2,kinase,,Drug: midostaurin | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
18176,midostaurin,protein kinase c alpha type,kinase,,Drug: midostaurin | Target: protein kinase c alpha type | Type: kinase | Action: nan
18177,midostaurin,tyrosine-protein kinase syk,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
18178,midostaurin,calcium/calmodulin-dependent protein kinase type ii subunit delta,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase type ii subunit delta | Type: kinase | Action: nan
18179,midostaurin,tyrosine-protein kinase csk,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
18180,midostaurin,angiopoietin-1 receptor,kinase,,Drug: midostaurin | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
18181,midostaurin,calcium/calmodulin-dependent protein kinase type ii subunit gamma,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase type ii subunit gamma | Type: kinase | Action: nan
18182,midostaurin,ap2-associated protein kinase 1,kinase,,Drug: midostaurin | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
18183,midostaurin,serine/threonine-protein kinase mark2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase mark2 | Type: kinase | Action: nan
18184,midostaurin,hepatocyte growth factor receptor,kinase,,Drug: midostaurin | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
18185,midostaurin,tyrosine-protein kinase lyn,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
18186,midostaurin,ribosomal protein s6 kinase alpha-2,kinase,,Drug: midostaurin | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
18187,midostaurin,5'-amp-activated protein kinase catalytic subunit alpha-1,kinase,,Drug: midostaurin | Target: 5'-amp-activated protein kinase catalytic subunit alpha-1 | Type: kinase | Action: nan
18188,midostaurin,calcium/calmodulin-dependent protein kinase type ii subunit beta,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase type ii subunit beta | Type: kinase | Action: nan
18189,midostaurin,protein kinase c eta type,kinase,,Drug: midostaurin | Target: protein kinase c eta type | Type: kinase | Action: nan
18190,midostaurin,fibroblast growth factor receptor 1,kinase,,Drug: midostaurin | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
18191,midostaurin,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: midostaurin | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
18192,midostaurin,calcium/calmodulin-dependent protein kinase type ii subunit alpha,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase type ii subunit alpha | Type: kinase | Action: nan
18193,midostaurin,serine/threonine-protein kinase 17b,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 17b | Type: kinase | Action: nan
18194,midostaurin,serine/threonine-protein kinase 10,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
18195,midostaurin,tyrosine-protein kinase fer,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
18196,midostaurin,protein kinase c epsilon type,kinase,,Drug: midostaurin | Target: protein kinase c epsilon type | Type: kinase | Action: nan
18197,midostaurin,serine/threonine-protein kinase plk4,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
18198,midostaurin,aurora kinase c,kinase,,Drug: midostaurin | Target: aurora kinase c | Type: kinase | Action: nan
18199,midostaurin,serine/threonine-protein kinase 16,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 16 | Type: kinase | Action: nan
18200,midostaurin,dual specificity protein kinase ttk,kinase,,Drug: midostaurin | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
18201,midostaurin,fibroblast growth factor receptor 2,kinase,,Drug: midostaurin | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
18202,midostaurin,serine/threonine-protein kinase n1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
18203,midostaurin,protein kinase c theta type,kinase,,Drug: midostaurin | Target: protein kinase c theta type | Type: kinase | Action: nan
18204,midostaurin,serine/threonine-protein kinase 17a,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
18205,midostaurin,traf2 and nck-interacting protein kinase,kinase,,Drug: midostaurin | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
18206,midostaurin,tyrosine-protein kinase fgr,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
18207,midostaurin,aurora kinase a,kinase,,Drug: midostaurin | Target: aurora kinase a | Type: kinase | Action: nan
18208,midostaurin,alk tyrosine kinase receptor,kinase,,Drug: midostaurin | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
18209,midostaurin,rac-alpha serine/threonine-protein kinase,kinase,,Drug: midostaurin | Target: rac-alpha serine/threonine-protein kinase | Type: kinase | Action: nan
18210,midostaurin,bmp-2-inducible protein kinase,kinase,,Drug: midostaurin | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
18211,midostaurin,serine/threonine-protein kinase pim-2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase pim-2 | Type: kinase | Action: nan
18212,midostaurin,tyrosine-protein kinase frk,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
18213,midostaurin,dual specificity protein kinase clk1,kinase,,Drug: midostaurin | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
18214,midostaurin,dual specificity protein kinase clk2,kinase,,Drug: midostaurin | Target: dual specificity protein kinase clk2 | Type: kinase | Action: nan
18215,midostaurin,dual specificity protein kinase clk3,kinase,,Drug: midostaurin | Target: dual specificity protein kinase clk3 | Type: kinase | Action: nan
18216,midostaurin,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
18217,midostaurin,cyclin-g-associated kinase,kinase,,Drug: midostaurin | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
18218,midostaurin,glycogen synthase kinase-3 beta,kinase,,Drug: midostaurin | Target: glycogen synthase kinase-3 beta | Type: kinase | Action: nan
18219,midostaurin,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
18220,midostaurin,serine/threonine-protein kinase 4,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
18221,midostaurin,activated cdc42 kinase 1,kinase,,Drug: midostaurin | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
18222,midostaurin,ribosomal protein s6 kinase alpha-5,kinase,,Drug: midostaurin | Target: ribosomal protein s6 kinase alpha-5 | Type: kinase | Action: nan
18223,midostaurin,ste20-like serine/threonine-protein kinase,kinase,,Drug: midostaurin | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
18224,midostaurin,dual specificity protein kinase clk4,kinase,,Drug: midostaurin | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
18225,midostaurin,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: midostaurin | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
18226,midostaurin,mitogen-activated protein kinase 9,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
18227,midostaurin,calcium/calmodulin-dependent protein kinase kinase 2,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase kinase 2 | Type: kinase | Action: nan
18228,midostaurin,map/microtubule affinity-regulating kinase 3,kinase,,Drug: midostaurin | Target: map/microtubule affinity-regulating kinase 3 | Type: kinase | Action: nan
18229,midostaurin,calcium/calmodulin-dependent protein kinase kinase 1,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase kinase 1 | Type: kinase | Action: nan
18230,midostaurin,calcium/calmodulin-dependent protein kinase type 1g,kinase,,Drug: midostaurin | Target: calcium/calmodulin-dependent protein kinase type 1g | Type: kinase | Action: nan
18231,midostaurin,epithelial discoidin domain-containing receptor 1,kinase,,Drug: midostaurin | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
18232,midostaurin,testis-specific serine/threonine-protein kinase 1,kinase,,Drug: midostaurin | Target: testis-specific serine/threonine-protein kinase 1 | Type: kinase | Action: nan
18233,midostaurin,inhibitor of nuclear factor kappa-b kinase subunit beta,kinase,,Drug: midostaurin | Target: inhibitor of nuclear factor kappa-b kinase subunit beta | Type: kinase | Action: nan
18234,midostaurin,3-phosphoinositide-dependent protein kinase 1,kinase,,Drug: midostaurin | Target: 3-phosphoinositide-dependent protein kinase 1 | Type: kinase | Action: nan
18235,midostaurin,tyrosine-protein kinase zap-70,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase zap-70 | Type: kinase | Action: nan
18236,midostaurin,glycogen synthase kinase-3 alpha,kinase,,Drug: midostaurin | Target: glycogen synthase kinase-3 alpha | Type: kinase | Action: nan
18237,midostaurin,tyrosine-protein kinase receptor ufo,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
18238,midostaurin,bdnf/nt-3 growth factors receptor,kinase,,Drug: midostaurin | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
18239,midostaurin,tyrosine-protein kinase receptor tyro3,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase receptor tyro3 | Type: kinase | Action: nan
18240,midostaurin,ribosomal protein s6 kinase beta-1,kinase,,Drug: midostaurin | Target: ribosomal protein s6 kinase beta-1 | Type: kinase | Action: nan
18241,midostaurin,serine/threonine-protein kinase n2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase n2 | Type: kinase | Action: nan
18242,midostaurin,rac-beta serine/threonine-protein kinase,kinase,,Drug: midostaurin | Target: rac-beta serine/threonine-protein kinase | Type: kinase | Action: nan
18243,midostaurin,serine/threonine-protein kinase 3,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
18244,midostaurin,ribosomal protein s6 kinase alpha-6,kinase,,Drug: midostaurin | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
18245,midostaurin,nuak family snf1-like kinase 2,kinase,,Drug: midostaurin | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
18246,midostaurin,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: midostaurin | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
18247,midostaurin,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: midostaurin | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
18248,midostaurin,serine/threonine-protein kinase chk1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase chk1 | Type: kinase | Action: nan
18249,midostaurin,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,,"Drug: midostaurin | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: nan"
18250,midostaurin,serine/threonine-protein kinase pak 3,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase pak 3 | Type: kinase | Action: nan
18251,midostaurin,phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,kinase,,Drug: midostaurin | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Type: kinase | Action: nan
18252,midostaurin,phosphatidylinositol 5-phosphate 4-kinase type-2 beta,kinase,,Drug: midostaurin | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Type: kinase | Action: nan
18253,midostaurin,myosin light chain kinase family member 4,kinase,,Drug: midostaurin | Target: myosin light chain kinase family member 4 | Type: kinase | Action: nan
18254,midostaurin,wee1-like protein kinase,kinase,,Drug: midostaurin | Target: wee1-like protein kinase | Type: kinase | Action: nan
18255,midostaurin,serine/threonine-protein kinase 25,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 25 | Type: kinase | Action: nan
18256,midostaurin,protein-tyrosine kinase 2-beta,kinase,,Drug: midostaurin | Target: protein-tyrosine kinase 2-beta | Type: kinase | Action: nan
18257,midostaurin,serine/threonine-protein kinase rio1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
18258,midostaurin,tyrosine-protein kinase receptor tie-1,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
18259,midostaurin,nt-3 growth factor receptor,kinase,,Drug: midostaurin | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
18260,midostaurin,casein kinase ii subunit alpha,kinase,,Drug: midostaurin | Target: casein kinase ii subunit alpha | Type: kinase | Action: nan
18261,midostaurin,dual specificity tyrosine-phosphorylation-regulated kinase 1b,kinase,,Drug: midostaurin | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1b | Type: kinase | Action: nan
18262,midostaurin,inhibitor of nuclear factor kappa-b kinase subunit epsilon,kinase,,Drug: midostaurin | Target: inhibitor of nuclear factor kappa-b kinase subunit epsilon | Type: kinase | Action: nan
18263,midostaurin,serine/threonine-protein kinase stk11,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase stk11 | Type: kinase | Action: nan
18264,midostaurin,dual specificity mitogen-activated protein kinase kinase 3,kinase,,Drug: midostaurin | Target: dual specificity mitogen-activated protein kinase kinase 3 | Type: kinase | Action: nan
18265,midostaurin,maternal embryonic leucine zipper kinase,kinase,,Drug: midostaurin | Target: maternal embryonic leucine zipper kinase | Type: kinase | Action: nan
18266,midostaurin,eukaryotic translation initiation factor 2-alpha kinase 4,kinase,,Drug: midostaurin | Target: eukaryotic translation initiation factor 2-alpha kinase 4 | Type: kinase | Action: nan
18267,midostaurin,interleukin-1 receptor-associated kinase 3,kinase,,Drug: midostaurin | Target: interleukin-1 receptor-associated kinase 3 | Type: kinase | Action: nan
18268,midostaurin,serine/threonine-protein kinase rio3,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
18269,midostaurin,serine/threonine-protein kinase sik2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
18270,midostaurin,srsf protein kinase 1,kinase,,Drug: midostaurin | Target: srsf protein kinase 1 | Type: kinase | Action: nan
18271,midostaurin,srsf protein kinase 2,kinase,,Drug: midostaurin | Target: srsf protein kinase 2 | Type: kinase | Action: nan
18272,midostaurin,serine/threonine-protein kinase 33,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
18273,midostaurin,5'-amp-activated protein kinase catalytic subunit alpha-2,kinase,,Drug: midostaurin | Target: 5'-amp-activated protein kinase catalytic subunit alpha-2 | Type: kinase | Action: nan
18274,midostaurin,myotonin-protein kinase,kinase,,Drug: midostaurin | Target: myotonin-protein kinase | Type: kinase | Action: nan
18275,midostaurin,rac-gamma serine/threonine-protein kinase,kinase,,Drug: midostaurin | Target: rac-gamma serine/threonine-protein kinase | Type: kinase | Action: nan
18276,midostaurin,serine/threonine-protein kinase lats1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase lats1 | Type: kinase | Action: nan
18277,midostaurin,serine/threonine-protein kinase lats2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase lats2 | Type: kinase | Action: nan
18278,midostaurin,leukocyte tyrosine kinase receptor,kinase,,Drug: midostaurin | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
18279,midostaurin,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
18280,midostaurin,nuak family snf1-like kinase 1,kinase,,Drug: midostaurin | Target: nuak family snf1-like kinase 1 | Type: kinase | Action: nan
18281,midostaurin,serine/threonine-protein kinase pim-3,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase pim-3 | Type: kinase | Action: nan
18282,midostaurin,camp-dependent protein kinase catalytic subunit alpha,kinase,,Drug: midostaurin | Target: camp-dependent protein kinase catalytic subunit alpha | Type: kinase | Action: nan
18283,midostaurin,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
18284,midostaurin,aurora kinase b,kinase,,Drug: midostaurin | Target: aurora kinase b | Type: kinase | Action: nan
18285,midostaurin,tyrosine-protein kinase blk,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
18286,midostaurin,serine/threonine-protein kinase brsk1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase brsk1 | Type: kinase | Action: nan
18287,midostaurin,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
18288,midostaurin,serine/threonine-protein kinase mark1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase mark1 | Type: kinase | Action: nan
18289,midostaurin,map/microtubule affinity-regulating kinase 4,kinase,,Drug: midostaurin | Target: map/microtubule affinity-regulating kinase 4 | Type: kinase | Action: nan
18290,midostaurin,dual specificity mitogen-activated protein kinase kinase 4,kinase,,Drug: midostaurin | Target: dual specificity mitogen-activated protein kinase kinase 4 | Type: kinase | Action: nan
18291,midostaurin,dual specificity mitogen-activated protein kinase kinase 6,kinase,,Drug: midostaurin | Target: dual specificity mitogen-activated protein kinase kinase 6 | Type: kinase | Action: nan
18292,midostaurin,tyrosine-protein kinase mer,kinase,,Drug: midostaurin | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
18293,midostaurin,cyclin-dependent kinase 19,kinase,,Drug: midostaurin | Target: cyclin-dependent kinase 19 | Type: kinase | Action: nan
18294,midostaurin,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
18295,midostaurin,mitogen-activated protein kinase kinase kinase 10,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase 10 | Type: kinase | Action: nan
18296,midostaurin,mitogen-activated protein kinase kinase kinase 11,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase 11 | Type: kinase | Action: nan
18297,midostaurin,death-associated protein kinase 1,kinase,,Drug: midostaurin | Target: death-associated protein kinase 1 | Type: kinase | Action: nan
18298,midostaurin,serine/threonine-protein kinase pak 1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase pak 1 | Type: kinase | Action: nan
18299,midostaurin,serine/threonine-protein kinase pak 2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase pak 2 | Type: kinase | Action: nan
18300,midostaurin,serine/threonine-protein kinase brsk2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase brsk2 | Type: kinase | Action: nan
18301,midostaurin,serine/threonine-protein kinase sik1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
18302,midostaurin,tubulin alpha-1a chain,structural,,Drug: midostaurin | Target: tubulin alpha-1a chain | Type: structural | Action: nan
18303,midostaurin,serine/threonine-protein kinase d2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase d2 | Type: kinase | Action: nan
18304,midostaurin,serine/threonine-protein kinase d3,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase d3 | Type: kinase | Action: nan
18305,midostaurin,cgmp-dependent protein kinase 2,kinase,,Drug: midostaurin | Target: cgmp-dependent protein kinase 2 | Type: kinase | Action: nan
18306,midostaurin,"interferon-induced, double-stranded rna-activated protein kinase",kinase,,"Drug: midostaurin | Target: interferon-induced, double-stranded rna-activated protein kinase | Type: kinase | Action: nan"
18307,midostaurin,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: midostaurin | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
18308,midostaurin,ribosomal protein s6 kinase alpha-1,kinase,,Drug: midostaurin | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
18309,midostaurin,ribosomal protein s6 kinase alpha-4,kinase,,Drug: midostaurin | Target: ribosomal protein s6 kinase alpha-4 | Type: kinase | Action: nan
18310,midostaurin,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
18311,midostaurin,misshapen-like kinase 1,kinase,,Drug: midostaurin | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
18312,midostaurin,serine/threonine-protein kinase tbk1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
18313,midostaurin,dual specificity tyrosine-phosphorylation-regulated kinase 1a,kinase,,Drug: midostaurin | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1a | Type: kinase | Action: nan
18314,midostaurin,ephrin type-b receptor 6,kinase,,Drug: midostaurin | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
18315,midostaurin,serine/threonine-protein kinase/endoribonuclease ire1,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase/endoribonuclease ire1 | Type: kinase | Action: nan
18316,midostaurin,rhodopsin kinase,kinase,,Drug: midostaurin | Target: rhodopsin kinase | Type: kinase | Action: nan
18317,midostaurin,g protein-coupled receptor kinase 4,kinase,,Drug: midostaurin | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
18318,midostaurin,g protein-coupled receptor kinase 7,kinase,,Drug: midostaurin | Target: g protein-coupled receptor kinase 7 | Type: kinase | Action: nan
18319,midostaurin,homeodomain-interacting protein kinase 2,kinase,,Drug: midostaurin | Target: homeodomain-interacting protein kinase 2 | Type: kinase | Action: nan
18320,midostaurin,homeodomain-interacting protein kinase 3,kinase,,Drug: midostaurin | Target: homeodomain-interacting protein kinase 3 | Type: kinase | Action: nan
18321,midostaurin,homeodomain-interacting protein kinase 4,kinase,,Drug: midostaurin | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
18322,midostaurin,hormonally up-regulated neu tumor-associated kinase,kinase,,Drug: midostaurin | Target: hormonally up-regulated neu tumor-associated kinase | Type: kinase | Action: nan
18323,midostaurin,serine/threonine-protein kinase ick,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase ick | Type: kinase | Action: nan
18324,midostaurin,inhibitor of nuclear factor kappa-b kinase subunit alpha,kinase,,Drug: midostaurin | Target: inhibitor of nuclear factor kappa-b kinase subunit alpha | Type: kinase | Action: nan
18325,midostaurin,mitogen-activated protein kinase kinase kinase 13,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase 13 | Type: kinase | Action: nan
18326,midostaurin,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
18327,midostaurin,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
18328,midostaurin,microtubule-associated serine/threonine-protein kinase 1,kinase,,Drug: midostaurin | Target: microtubule-associated serine/threonine-protein kinase 1 | Type: kinase | Action: nan
18329,midostaurin,u4/u6 small nuclear ribonucleoprotein prp4,nuclear other,,Drug: midostaurin | Target: u4/u6 small nuclear ribonucleoprotein prp4 | Type: nuclear other | Action: nan
18330,midostaurin,serine/threonine-protein kinase rio2,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase rio2 | Type: kinase | Action: nan
18331,midostaurin,srsf protein kinase 3,kinase,,Drug: midostaurin | Target: srsf protein kinase 3 | Type: kinase | Action: nan
18332,midostaurin,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
18333,midostaurin,serine/threonine-protein kinase ulk3,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
18334,midostaurin,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: midostaurin | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
18335,midostaurin,tankyrase-2,enzyme,,Drug: midostaurin | Target: tankyrase-2 | Type: enzyme | Action: nan
18336,midostaurin,phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit beta,kinase,,Drug: midostaurin | Target: phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit beta | Type: kinase | Action: nan
18337,midostaurin,phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit gamma,kinase,,Drug: midostaurin | Target: phosphatidylinositol 4-phosphate 3-kinase c2 domain-containing subunit gamma | Type: kinase | Action: nan
18338,midostaurin,serine/threonine-protein kinase sik3,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase sik3 | Type: kinase | Action: nan
18339,midostaurin,serine/threonine-protein kinase 32a,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase 32a | Type: kinase | Action: nan
18340,midostaurin,serine/threonine-protein kinase prp4 homolog,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase prp4 homolog | Type: kinase | Action: nan
18341,midostaurin,serine/threonine-protein kinase sgk3,kinase,,Drug: midostaurin | Target: serine/threonine-protein kinase sgk3 | Type: kinase | Action: nan
18342,midostaurin,myosin light chain kinase 3,kinase,,Drug: midostaurin | Target: myosin light chain kinase 3 | Type: kinase | Action: nan
18343,midostaurin,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: midostaurin | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
18344,midostaurin,dual serine/threonine and tyrosine protein kinase,kinase,,Drug: midostaurin | Target: dual serine/threonine and tyrosine protein kinase | Type: kinase | Action: nan
18345,midostaurin,calcium-dependent protein kinase 1,kinase,,Drug: midostaurin | Target: calcium-dependent protein kinase 1 | Type: kinase | Action: nan
18346,midostaurin,cgmp-dependent protein kinase 1,kinase,,Drug: midostaurin | Target: cgmp-dependent protein kinase 1 | Type: kinase | Action: nan
18347,midostaurin,camp-dependent protein kinase catalytic subunit prkx,kinase,,Drug: midostaurin | Target: camp-dependent protein kinase catalytic subunit prkx | Type: kinase | Action: nan
18349,midostaurin,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: midostaurin | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
18350,abaloparatide,parathyroid hormone/parathyroid hormone-related peptide receptor,gpcr,AGONIST,Drug: abaloparatide | Target: parathyroid hormone/parathyroid hormone-related peptide receptor | Type: gpcr | Action: AGONIST
18351,brigatinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: brigatinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
18352,brigatinib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: brigatinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
18353,brigatinib,insulin-like growth factor 1 receptor,kinase,INHIBITOR,Drug: brigatinib | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: INHIBITOR
18354,brigatinib,insulin receptor,kinase,INHIBITOR,Drug: brigatinib | Target: insulin receptor | Type: kinase | Action: INHIBITOR
18355,brigatinib,proto-oncogene tyrosine-protein kinase ros,kinase,INHIBITOR,Drug: brigatinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: INHIBITOR
18356,brigatinib,alk tyrosine kinase receptor,kinase,INHIBITOR,Drug: brigatinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: INHIBITOR
18357,durvalumab,programmed cell death 1 ligand 1,cd molecules,ANTIBODY BINDING,Drug: durvalumab | Target: programmed cell death 1 ligand 1 | Type: cd molecules | Action: ANTIBODY BINDING
18358,cenegermin,high affinity nerve growth factor receptor,kinase,AGONIST,Drug: cenegermin | Target: high affinity nerve growth factor receptor | Type: kinase | Action: AGONIST
18359,cenegermin,tumor necrosis factor receptor superfamily member 16,membrane receptor,AGONIST,Drug: cenegermin | Target: tumor necrosis factor receptor superfamily member 16 | Type: membrane receptor | Action: AGONIST
18360,sarilumab,interleukin-6 receptor,membrane receptor,ANTIBODY BINDING,Drug: sarilumab | Target: interleukin-6 receptor | Type: membrane receptor | Action: ANTIBODY BINDING
18361,evogliptin,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: evogliptin | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
18362,evogliptin,dipeptidyl peptidase 4,enzyme,INHIBITOR,Drug: evogliptin | Target: dipeptidyl peptidase 4 | Type: enzyme | Action: INHIBITOR
18363,polmacoxib,prostaglandin g/h synthase 1,enzyme,,Drug: polmacoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
18365,polmacoxib,prostaglandin g/h synthase 1,enzyme,INHIBITOR,Drug: polmacoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: INHIBITOR
18366,polmacoxib,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: polmacoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
18367,betrixaban,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: betrixaban | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
18368,betrixaban,prothrombin,enzyme,,Drug: betrixaban | Target: prothrombin | Type: enzyme | Action: nan
18369,betrixaban,coagulation factor x,enzyme,INHIBITOR,Drug: betrixaban | Target: coagulation factor x | Type: enzyme | Action: INHIBITOR
18370,voxilaprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: voxilaprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18371,voxilaprevir,genome polyprotein,polyprotein,INHIBITOR,Drug: voxilaprevir | Target: genome polyprotein | Type: polyprotein | Action: INHIBITOR
18372,pibrentasvir,nonstructural protein 5a,unclassified,,Drug: pibrentasvir | Target: nonstructural protein 5a | Type: unclassified | Action: nan
18373,pibrentasvir,genome polyprotein [cleaved into: core protein p21,unclassified,,Drug: pibrentasvir | Target: genome polyprotein [cleaved into: core protein p21 | Type: unclassified | Action: nan
18374,corifollitropin alfa,follicle-stimulating hormone receptor,gpcr,AGONIST,Drug: corifollitropin alfa | Target: follicle-stimulating hormone receptor | Type: gpcr | Action: AGONIST
18375,guselkumab,interleukin-23,cytokine,ANTIBODY BINDING,Drug: guselkumab | Target: interleukin-23 | Type: cytokine | Action: ANTIBODY BINDING
18376,inotuzumab ozogamicin,b-cell receptor cd22,membrane receptor,ANTIBODY BINDING,Drug: inotuzumab ozogamicin | Target: b-cell receptor cd22 | Type: membrane receptor | Action: ANTIBODY BINDING
18377,pemafibrate,peroxisome proliferator-activated receptor gamma,nuclear hormone receptor,AGONIST,Drug: pemafibrate | Target: peroxisome proliferator-activated receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
18378,pemafibrate,peroxisome proliferator-activated receptor delta,nuclear hormone receptor,AGONIST,Drug: pemafibrate | Target: peroxisome proliferator-activated receptor delta | Type: nuclear hormone receptor | Action: AGONIST
18379,pemafibrate,peroxisome proliferator-activated receptor alpha,nuclear hormone receptor,AGONIST,Drug: pemafibrate | Target: peroxisome proliferator-activated receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
18380,imrecoxib,prostaglandin g/h synthase 2,enzyme,,Drug: imrecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: nan
18381,imrecoxib,prostaglandin g/h synthase 1,enzyme,,Drug: imrecoxib | Target: prostaglandin g/h synthase 1 | Type: enzyme | Action: nan
18382,imrecoxib,prostaglandin g/h synthase 2,enzyme,INHIBITOR,Drug: imrecoxib | Target: prostaglandin g/h synthase 2 | Type: enzyme | Action: INHIBITOR
18383,enasidenib,isocitrate dehydrogenase [nadp] cytoplasmic,enzyme,,Drug: enasidenib | Target: isocitrate dehydrogenase [nadp] cytoplasmic | Type: enzyme | Action: nan
18385,enasidenib,"isocitrate dehydrogenase [nadp], mitochondrial",enzyme,INHIBITOR,"Drug: enasidenib | Target: isocitrate dehydrogenase [nadp], mitochondrial | Type: enzyme | Action: INHIBITOR"
18386,neratinib,tyrosine-protein kinase jak3,kinase,,Drug: neratinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
18387,neratinib,macrophage-stimulating protein receptor,kinase,,Drug: neratinib | Target: macrophage-stimulating protein receptor | Type: kinase | Action: nan
18388,neratinib,tyrosine-protein kinase abl1,kinase,,Drug: neratinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
18389,neratinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: neratinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
18390,neratinib,tyrosine-protein kinase lck,kinase,,Drug: neratinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
18391,neratinib,tyrosine-protein kinase yes,kinase,,Drug: neratinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
18392,neratinib,tyrosine-protein kinase fyn,kinase,,Drug: neratinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
18393,neratinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: neratinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
18394,neratinib,vascular endothelial growth factor receptor 2,kinase,,Drug: neratinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
18395,neratinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: neratinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
18396,neratinib,insulin receptor,kinase,,Drug: neratinib | Target: insulin receptor | Type: kinase | Action: nan
18397,neratinib,mitogen-activated protein kinase 8,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
18398,neratinib,focal adhesion kinase 1,kinase,,Drug: neratinib | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
18399,neratinib,tyrosine-protein kinase hck,kinase,,Drug: neratinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
18400,neratinib,mitogen-activated protein kinase 10,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
18401,neratinib,tyrosine-protein kinase syk,kinase,,Drug: neratinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
18402,neratinib,tyrosine-protein kinase csk,kinase,,Drug: neratinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
18403,neratinib,angiopoietin-1 receptor,kinase,,Drug: neratinib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
18404,neratinib,hepatocyte growth factor receptor,kinase,,Drug: neratinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
18405,neratinib,tyrosine-protein kinase lyn,kinase,,Drug: neratinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
18406,neratinib,serine/threonine-protein kinase nek2,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase nek2 | Type: kinase | Action: nan
18407,neratinib,ribosomal protein s6 kinase alpha-2,kinase,,Drug: neratinib | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
18408,neratinib,serine/threonine-protein kinase 17b,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 17b | Type: kinase | Action: nan
18409,neratinib,serine/threonine-protein kinase 10,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
18410,neratinib,tyrosine-protein kinase fer,kinase,,Drug: neratinib | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
18411,neratinib,serine/threonine-protein kinase 17a,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
18412,neratinib,traf2 and nck-interacting protein kinase,kinase,,Drug: neratinib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
18413,neratinib,casein kinase i isoform epsilon,kinase,,Drug: neratinib | Target: casein kinase i isoform epsilon | Type: kinase | Action: nan
18414,neratinib,tyrosine-protein kinase fgr,kinase,,Drug: neratinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
18415,neratinib,serine/threonine-protein kinase 36,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 36 | Type: kinase | Action: nan
18416,neratinib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
18417,neratinib,mitogen-activated protein kinase kinase kinase 4,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 4 | Type: kinase | Action: nan
18418,neratinib,cyclin-g-associated kinase,kinase,,Drug: neratinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
18419,neratinib,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: neratinib | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
18420,neratinib,cyclin-dependent kinase 16,kinase,,Drug: neratinib | Target: cyclin-dependent kinase 16 | Type: kinase | Action: nan
18421,neratinib,serine/threonine-protein kinase 4,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 4 | Type: kinase | Action: nan
18422,neratinib,activated cdc42 kinase 1,kinase,,Drug: neratinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
18423,neratinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: neratinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
18424,neratinib,dual specificity mitogen-activated protein kinase kinase 7,kinase,,Drug: neratinib | Target: dual specificity mitogen-activated protein kinase kinase 7 | Type: kinase | Action: nan
18425,neratinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: neratinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
18426,neratinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: neratinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
18427,neratinib,tyrosine-protein kinase btk,kinase,,Drug: neratinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
18428,neratinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: neratinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
18429,neratinib,cyclin-dependent kinase 7,kinase,,Drug: neratinib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
18430,neratinib,serine/threonine-protein kinase d1,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase d1 | Type: kinase | Action: nan
18431,neratinib,serine/threonine-protein kinase 3,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 3 | Type: kinase | Action: nan
18432,neratinib,nuak family snf1-like kinase 2,kinase,,Drug: neratinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
18433,neratinib,serine/threonine-protein kinase chk1,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase chk1 | Type: kinase | Action: nan
18434,neratinib,wee1-like protein kinase,kinase,,Drug: neratinib | Target: wee1-like protein kinase | Type: kinase | Action: nan
18435,neratinib,serine/threonine-protein kinase 25,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 25 | Type: kinase | Action: nan
18436,neratinib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
18437,neratinib,protein-tyrosine kinase 2-beta,kinase,,Drug: neratinib | Target: protein-tyrosine kinase 2-beta | Type: kinase | Action: nan
18438,neratinib,casein kinase i isoform gamma-2,kinase,,Drug: neratinib | Target: casein kinase i isoform gamma-2 | Type: kinase | Action: nan
18439,neratinib,casein kinase i isoform gamma-3,kinase,,Drug: neratinib | Target: casein kinase i isoform gamma-3 | Type: kinase | Action: nan
18440,neratinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: neratinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
18441,neratinib,tyrosine-protein kinase txk,kinase,,Drug: neratinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
18442,neratinib,maternal embryonic leucine zipper kinase,kinase,,Drug: neratinib | Target: maternal embryonic leucine zipper kinase | Type: kinase | Action: nan
18443,neratinib,serine/threonine-protein kinase 26,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 26 | Type: kinase | Action: nan
18444,neratinib,eukaryotic translation initiation factor 2-alpha kinase 4,kinase,,Drug: neratinib | Target: eukaryotic translation initiation factor 2-alpha kinase 4 | Type: kinase | Action: nan
18445,neratinib,insulin receptor-related protein,kinase,,Drug: neratinib | Target: insulin receptor-related protein | Type: kinase | Action: nan
18446,neratinib,serine/threonine-protein kinase sik2,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
18447,neratinib,serine/threonine-protein kinase 33,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
18448,neratinib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
18449,neratinib,serine/threonine-protein kinase pak 6,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase pak 6 | Type: kinase | Action: nan
18450,neratinib,nuak family snf1-like kinase 1,kinase,,Drug: neratinib | Target: nuak family snf1-like kinase 1 | Type: kinase | Action: nan
18451,neratinib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
18452,neratinib,tyrosine-protein kinase blk,kinase,,Drug: neratinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
18453,neratinib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
18454,neratinib,tyrosine-protein kinase mer,kinase,,Drug: neratinib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
18455,neratinib,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
18456,neratinib,mitogen-activated protein kinase kinase kinase 10,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 10 | Type: kinase | Action: nan
18457,neratinib,mitogen-activated protein kinase kinase kinase 11,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 11 | Type: kinase | Action: nan
18458,neratinib,serine/threonine-protein kinase 24,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 24 | Type: kinase | Action: nan
18459,neratinib,serine/threonine-protein kinase pak 1,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase pak 1 | Type: kinase | Action: nan
18460,neratinib,serine/threonine-protein kinase pak 2,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase pak 2 | Type: kinase | Action: nan
18461,neratinib,serine/threonine-protein kinase sik1,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
18462,neratinib,serine/threonine-protein kinase d2,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase d2 | Type: kinase | Action: nan
18463,neratinib,serine/threonine-protein kinase d3,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase d3 | Type: kinase | Action: nan
18464,neratinib,tyrosine-protein kinase fes/fps,kinase,,Drug: neratinib | Target: tyrosine-protein kinase fes/fps | Type: kinase | Action: nan
18465,neratinib,ribosomal protein s6 kinase alpha-1,kinase,,Drug: neratinib | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
18466,neratinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
18467,neratinib,misshapen-like kinase 1,kinase,,Drug: neratinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
18468,neratinib,serine/threonine-protein kinase chk2,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase chk2 | Type: kinase | Action: nan
18469,neratinib,ephrin type-b receptor 6,kinase,,Drug: neratinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
18470,neratinib,homeodomain-interacting protein kinase 4,kinase,,Drug: neratinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
18471,neratinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: neratinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
18472,neratinib,mitogen-activated protein kinase kinase kinase 13,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 13 | Type: kinase | Action: nan
18473,neratinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
18474,neratinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
18475,neratinib,microtubule-associated serine/threonine-protein kinase 1,kinase,,Drug: neratinib | Target: microtubule-associated serine/threonine-protein kinase 1 | Type: kinase | Action: nan
18476,neratinib,serine/threonine-protein kinase tao3,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
18477,neratinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
18478,neratinib,serine/threonine-protein kinase 35,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 35 | Type: kinase | Action: nan
18479,neratinib,receptor tyrosine-protein kinase erbb-3,kinase,,Drug: neratinib | Target: receptor tyrosine-protein kinase erbb-3 | Type: kinase | Action: nan
18480,neratinib,wee1-like protein kinase 2,kinase,,Drug: neratinib | Target: wee1-like protein kinase 2 | Type: kinase | Action: nan
18481,neratinib,serine/threonine-protein kinase nek3,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase nek3 | Type: kinase | Action: nan
18482,neratinib,mitogen-activated protein kinase kinase kinase 12,kinase,,Drug: neratinib | Target: mitogen-activated protein kinase kinase kinase 12 | Type: kinase | Action: nan
18483,neratinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: neratinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
18484,neratinib,dual serine/threonine and tyrosine protein kinase,kinase,,Drug: neratinib | Target: dual serine/threonine and tyrosine protein kinase | Type: kinase | Action: nan
18485,neratinib,serine/threonine-protein kinase 32b,kinase,,Drug: neratinib | Target: serine/threonine-protein kinase 32b | Type: kinase | Action: nan
18486,neratinib,receptor tyrosine-protein kinase erbb-4,kinase,INHIBITOR,Drug: neratinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: INHIBITOR
18487,neratinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: neratinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
18488,neratinib,receptor tyrosine-protein kinase erbb-2,kinase,INHIBITOR,Drug: neratinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: INHIBITOR
18489,copanlisib,serine/threonine-protein kinase mtor,kinase,INHIBITOR,Drug: copanlisib | Target: serine/threonine-protein kinase mtor | Type: kinase | Action: INHIBITOR
18490,copanlisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",kinase,INHIBITOR,"Drug: copanlisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Type: kinase | Action: INHIBITOR"
18491,copanlisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,INHIBITOR,"Drug: copanlisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: INHIBITOR"
18492,copanlisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,INHIBITOR,"Drug: copanlisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: INHIBITOR"
18493,copanlisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,INHIBITOR,"Drug: copanlisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: INHIBITOR"
18494,butylphthalide,potassium channel subfamily k member 2,ion channel,BLOCKER,Drug: butylphthalide | Target: potassium channel subfamily k member 2 | Type: ion channel | Action: BLOCKER
18495,tivozanib,platelet-derived growth factor receptor alpha,kinase,,Drug: tivozanib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
18496,tivozanib,ephrin type-b receptor 2,kinase,,Drug: tivozanib | Target: ephrin type-b receptor 2 | Type: kinase | Action: nan
18497,tivozanib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: tivozanib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
18498,tivozanib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: tivozanib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
18499,tivozanib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: tivozanib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
18500,tivozanib,hepatocyte growth factor receptor,kinase,INHIBITOR,Drug: tivozanib | Target: hepatocyte growth factor receptor | Type: kinase | Action: INHIBITOR
18501,tivozanib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: tivozanib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
18502,tivozanib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: tivozanib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
18503,tivozanib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: tivozanib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
18504,tivozanib,vascular endothelial growth factor receptor 3,kinase,INHIBITOR,Drug: tivozanib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: INHIBITOR
18505,abemaciclib,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: abemaciclib | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
18506,abemaciclib,cyclin-dependent kinase 1,kinase,,Drug: abemaciclib | Target: cyclin-dependent kinase 1 | Type: kinase | Action: nan
18507,abemaciclib,cyclin-dependent kinase 9,kinase,,Drug: abemaciclib | Target: cyclin-dependent kinase 9 | Type: kinase | Action: nan
18508,abemaciclib,cyclin-dependent kinase 7,kinase,,Drug: abemaciclib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
18510,abemaciclib,cyclin-dependent kinase 9,kinase,,Drug: abemaciclib | Target: cyclin-dependent kinase 9 | Type: kinase | Action: nan
18511,abemaciclib,cyclin-dependent kinase 6,kinase,INHIBITOR,Drug: abemaciclib | Target: cyclin-dependent kinase 6 | Type: kinase | Action: INHIBITOR
18512,abemaciclib,cyclin-dependent kinase 4,kinase,INHIBITOR,Drug: abemaciclib | Target: cyclin-dependent kinase 4 | Type: kinase | Action: INHIBITOR
18513,acalabrutinib,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: acalabrutinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
18514,acalabrutinib,tyrosine-protein kinase lyn,kinase,INHIBITOR,Drug: acalabrutinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: INHIBITOR
18516,acalabrutinib,receptor tyrosine-protein kinase erbb-4,kinase,INHIBITOR,Drug: acalabrutinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: INHIBITOR
18517,acalabrutinib,cytoplasmic tyrosine-protein kinase bmx,kinase,INHIBITOR,Drug: acalabrutinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: INHIBITOR
18518,acalabrutinib,tyrosine-protein kinase tec,kinase,INHIBITOR,Drug: acalabrutinib | Target: tyrosine-protein kinase tec | Type: kinase | Action: INHIBITOR
18519,acalabrutinib,tyrosine-protein kinase txk,kinase,INHIBITOR,Drug: acalabrutinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: INHIBITOR
18520,acalabrutinib,tyrosine-protein kinase btk,kinase,INHIBITOR,Drug: acalabrutinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: INHIBITOR
18521,latanoprostene bunod,prostaglandin f2-alpha receptor,gpcr,,Drug: latanoprostene bunod | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: nan
18522,latanoprostene bunod,prostaglandin f2-alpha receptor,gpcr,AGONIST,Drug: latanoprostene bunod | Target: prostaglandin f2-alpha receptor | Type: gpcr | Action: AGONIST
18523,letermovir,dna terminase complex,enzyme,INHIBITOR,Drug: letermovir | Target: dna terminase complex | Type: enzyme | Action: INHIBITOR
18524,benralizumab,interleukin-5 receptor subunit alpha,membrane receptor,ANTIBODY BINDING,Drug: benralizumab | Target: interleukin-5 receptor subunit alpha | Type: membrane receptor | Action: ANTIBODY BINDING
18525,semaglutide,glucagon-like peptide 1 receptor,gpcr,AGONIST,Drug: semaglutide | Target: glucagon-like peptide 1 receptor | Type: gpcr | Action: AGONIST
18526,emicizumab,coagulation factor x,enzyme,ANTIBODY BINDING,Drug: emicizumab | Target: coagulation factor x | Type: enzyme | Action: ANTIBODY BINDING
18527,emicizumab,coagulation factor ix,enzyme,ANTIBODY BINDING,Drug: emicizumab | Target: coagulation factor ix | Type: enzyme | Action: ANTIBODY BINDING
18528,netarsudil,rho-associated protein kinase 1,kinase,INHIBITOR,Drug: netarsudil | Target: rho-associated protein kinase 1 | Type: kinase | Action: INHIBITOR
18529,netarsudil,rho-associated protein kinase 2,kinase,INHIBITOR,Drug: netarsudil | Target: rho-associated protein kinase 2 | Type: kinase | Action: INHIBITOR
18530,ertugliflozin,sodium/glucose cotransporter 2,transporter,,Drug: ertugliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: nan
18531,ertugliflozin,low affinity sodium-glucose cotransporter,transporter,,Drug: ertugliflozin | Target: low affinity sodium-glucose cotransporter | Type: transporter | Action: nan
18532,ertugliflozin,sodium/glucose cotransporter 1,transporter,INHIBITOR,Drug: ertugliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: INHIBITOR
18533,ertugliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: ertugliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
18534,macimorelin,growth hormone secretagogue receptor type 1,gpcr,AGONIST,Drug: macimorelin | Target: growth hormone secretagogue receptor type 1 | Type: gpcr | Action: AGONIST
18535,angiotensin ii,type-2 angiotensin ii receptor,gpcr,AGONIST,Drug: angiotensin ii | Target: type-2 angiotensin ii receptor | Type: gpcr | Action: AGONIST
18536,angiotensin ii,type-1b angiotensin ii receptor,gpcr,,Drug: angiotensin ii | Target: type-1b angiotensin ii receptor | Type: gpcr | Action: nan
18537,angiotensin ii,type-1 angiotensin ii receptor,gpcr,,Drug: angiotensin ii | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: nan
18538,angiotensin ii,type-1a angiotensin ii receptor,gpcr,,Drug: angiotensin ii | Target: type-1a angiotensin ii receptor | Type: gpcr | Action: nan
18539,angiotensin ii,type-1 angiotensin ii receptor,gpcr,AGONIST,Drug: angiotensin ii | Target: type-1 angiotensin ii receptor | Type: gpcr | Action: AGONIST
18540,bictegravir,integrase,enzyme,,Drug: bictegravir | Target: integrase | Type: enzyme | Action: nan
18541,bictegravir,integrase,unclassified,,Drug: bictegravir | Target: integrase | Type: unclassified | Action: nan
18542,bictegravir,integrase,enzyme,INHIBITOR,Drug: bictegravir | Target: integrase | Type: enzyme | Action: INHIBITOR
18543,lutetium (177lu) oxodotreotide,somatostatin receptor type 2,gpcr,AGONIST,Drug: lutetium (177lu) oxodotreotide | Target: somatostatin receptor type 2 | Type: gpcr | Action: AGONIST
18544,tezacaftor,cystic fibrosis transmembrane conductance regulator,ion channel,PHARMACOLOGICAL CHAPERONE,Drug: tezacaftor | Target: cystic fibrosis transmembrane conductance regulator | Type: ion channel | Action: PHARMACOLOGICAL CHAPERONE
18545,elobixibat,ileal sodium/bile acid cotransporter,transporter,INHIBITOR,Drug: elobixibat | Target: ileal sodium/bile acid cotransporter | Type: transporter | Action: INHIBITOR
18546,apalutamide,androgen receptor,transcription factor,ANTAGONIST,Drug: apalutamide | Target: androgen receptor | Type: transcription factor | Action: ANTAGONIST
18547,apalutamide,androgen receptor,nuclear hormone receptor,INHIBITOR,Drug: apalutamide | Target: androgen receptor | Type: nuclear hormone receptor | Action: INHIBITOR
18548,ibalizumab,t-cell surface glycoprotein cd4,membrane receptor,ANTIBODY BINDING,Drug: ibalizumab | Target: t-cell surface glycoprotein cd4 | Type: membrane receptor | Action: ANTIBODY BINDING
18549,fostamatinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: fostamatinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
18550,fostamatinib,vascular endothelial growth factor receptor 2,kinase,,Drug: fostamatinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
18552,fostamatinib,adenosine receptor a3,gpcr,INHIBITOR,Drug: fostamatinib | Target: adenosine receptor a3 | Type: gpcr | Action: INHIBITOR
18553,fostamatinib,tyrosine-protein kinase syk,kinase,INHIBITOR,Drug: fostamatinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: INHIBITOR
18554,tildrakizumab,interleukin-23,cytokine,ANTIBODY BINDING,Drug: tildrakizumab | Target: interleukin-23 | Type: cytokine | Action: ANTIBODY BINDING
18555,burosumab,fibroblast growth factor 23,secreted,ANTIBODY BINDING,Drug: burosumab | Target: fibroblast growth factor 23 | Type: secreted | Action: ANTIBODY BINDING
18556,fosnetupitant,substance-p receptor,gpcr,ANTAGONIST,Drug: fosnetupitant | Target: substance-p receptor | Type: gpcr | Action: ANTAGONIST
18557,erenumab,calcitonin-gene-related peptide receptor,gpcr,ANTIBODY BINDING,Drug: erenumab | Target: calcitonin-gene-related peptide receptor | Type: gpcr | Action: ANTIBODY BINDING
18558,avatrombopag,thrombopoietin receptor,membrane receptor,AGONIST,Drug: avatrombopag | Target: thrombopoietin receptor | Type: membrane receptor | Action: AGONIST
18559,moxidectin,glutamate-gated chloride channel,ion channel,INHIBITOR,Drug: moxidectin | Target: glutamate-gated chloride channel | Type: ion channel | Action: INHIBITOR
18560,cannabidiol,cannabinoid receptor 1,gpcr,,Drug: cannabidiol | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
18561,cannabidiol,cannabinoid receptor 2,gpcr,,Drug: cannabidiol | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
18562,cannabidiol,n-arachidonyl glycine receptor,gpcr,AGONIST,Drug: cannabidiol | Target: n-arachidonyl glycine receptor | Type: gpcr | Action: AGONIST
18563,cannabidiol,cannabinoid receptor 1,gpcr,,Drug: cannabidiol | Target: cannabinoid receptor 1 | Type: gpcr | Action: nan
18564,cannabidiol,cannabinoid receptor 2,gpcr,,Drug: cannabidiol | Target: cannabinoid receptor 2 | Type: gpcr | Action: nan
18565,cannabidiol,fatty-acid amide hydrolase 1,enzyme,,Drug: cannabidiol | Target: fatty-acid amide hydrolase 1 | Type: enzyme | Action: nan
18566,cannabidiol,transient receptor potential cation channel subfamily v member 2,ion channel,ACTIVATOR,Drug: cannabidiol | Target: transient receptor potential cation channel subfamily v member 2 | Type: ion channel | Action: ACTIVATOR
18567,cannabidiol,transient receptor potential cation channel subfamily v member 2,ion channel,ACTIVATOR,Drug: cannabidiol | Target: transient receptor potential cation channel subfamily v member 2 | Type: ion channel | Action: ACTIVATOR
18569,cannabidiol,transient receptor potential cation channel subfamily v member 1,ion channel,INHIBITOR,Drug: cannabidiol | Target: transient receptor potential cation channel subfamily v member 1 | Type: ion channel | Action: INHIBITOR
18570,cannabidiol,g-protein coupled receptor 55,gpcr,ANTAGONIST,Drug: cannabidiol | Target: g-protein coupled receptor 55 | Type: gpcr | Action: ANTAGONIST
18571,encorafenib,mitogen-activated protein kinase 14,kinase,,Drug: encorafenib | Target: mitogen-activated protein kinase 14 | Type: kinase | Action: nan
18572,encorafenib,raf proto-oncogene serine/threonine-protein kinase,kinase,INHIBITOR,Drug: encorafenib | Target: raf proto-oncogene serine/threonine-protein kinase | Type: kinase | Action: INHIBITOR
18573,encorafenib,serine/threonine-protein kinase b-raf,kinase,INHIBITOR,Drug: encorafenib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: INHIBITOR
18574,binimetinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,INHIBITOR,Drug: binimetinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: INHIBITOR
18575,binimetinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,INHIBITOR,Drug: binimetinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: INHIBITOR
18576,tecovirimat,envelope protein f13,viral envelope protein,INHIBITOR,Drug: tecovirimat | Target: envelope protein f13 | Type: viral envelope protein | Action: INHIBITOR
18577,ivosidenib,isocitrate dehydrogenase [nadp] cytoplasmic,enzyme,INHIBITOR,Drug: ivosidenib | Target: isocitrate dehydrogenase [nadp] cytoplasmic | Type: enzyme | Action: INHIBITOR
18578,elagolix,gonadotropin-releasing hormone receptor,gpcr,,Drug: elagolix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: nan
18579,elagolix,gonadotropin-releasing hormone receptor,gpcr,,Drug: elagolix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: nan
18580,elagolix,gonadotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: elagolix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
18581,doravirine,reverse transcriptase,enzyme,,Drug: doravirine | Target: reverse transcriptase | Type: enzyme | Action: nan
18582,doravirine,reverse transcriptase,unclassified,,Drug: doravirine | Target: reverse transcriptase | Type: unclassified | Action: nan
18583,doravirine,reverse transcriptase/rnaseh,enzyme,INHIBITOR,Drug: doravirine | Target: reverse transcriptase/rnaseh | Type: enzyme | Action: INHIBITOR
18584,duvelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,INHIBITOR,"Drug: duvelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: INHIBITOR"
18585,duvelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",kinase,INHIBITOR,"Drug: duvelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Type: kinase | Action: INHIBITOR"
18586,duvelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,INHIBITOR,"Drug: duvelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: INHIBITOR"
18587,duvelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,INHIBITOR,"Drug: duvelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: INHIBITOR"
18588,dacomitinib,tyrosine-protein kinase jak3,kinase,,Drug: dacomitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
18589,dacomitinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: dacomitinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
18590,dacomitinib,tyrosine-protein kinase lck,kinase,,Drug: dacomitinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
18591,dacomitinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: dacomitinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
18592,dacomitinib,receptor tyrosine-protein kinase erbb-2,kinase,INHIBITOR,Drug: dacomitinib | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: INHIBITOR
18593,dacomitinib,receptor tyrosine-protein kinase erbb-4,kinase,INHIBITOR,Drug: dacomitinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: INHIBITOR
18594,talazoparib tosylate,poly [adp-ribose] polymerase 2,enzyme,INHIBITOR,Drug: talazoparib tosylate | Target: poly [adp-ribose] polymerase 2 | Type: enzyme | Action: INHIBITOR
18595,talazoparib tosylate,poly [adp-ribose] polymerase 1,enzyme,INHIBITOR,Drug: talazoparib tosylate | Target: poly [adp-ribose] polymerase 1 | Type: enzyme | Action: INHIBITOR
18596,baloxavir marboxil,polymerase acidic protein,enzyme,INHIBITOR,Drug: baloxavir marboxil | Target: polymerase acidic protein | Type: enzyme | Action: INHIBITOR
18597,lorlatinib,tyrosine-protein kinase frk,kinase,,Drug: lorlatinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
18598,lorlatinib,alk tyrosine kinase receptor,kinase,INHIBITOR,Drug: lorlatinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: INHIBITOR
18599,lorlatinib,proto-oncogene tyrosine-protein kinase ros,kinase,INHIBITOR,Drug: lorlatinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: INHIBITOR
18600,lorlatinib,focal adhesion kinase 1,kinase,INHIBITOR,Drug: lorlatinib | Target: focal adhesion kinase 1 | Type: kinase | Action: INHIBITOR
18601,lorlatinib,high affinity nerve growth factor receptor,kinase,INHIBITOR,Drug: lorlatinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: INHIBITOR
18602,lorlatinib,tyrosine-protein kinase fer,kinase,INHIBITOR,Drug: lorlatinib | Target: tyrosine-protein kinase fer | Type: kinase | Action: INHIBITOR
18603,lorlatinib,activated cdc42 kinase 1,kinase,INHIBITOR,Drug: lorlatinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: INHIBITOR
18604,lorlatinib,bdnf/nt-3 growth factors receptor,kinase,INHIBITOR,Drug: lorlatinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: INHIBITOR
18605,lorlatinib,protein-tyrosine kinase 2-beta,kinase,INHIBITOR,Drug: lorlatinib | Target: protein-tyrosine kinase 2-beta | Type: kinase | Action: INHIBITOR
18606,lorlatinib,nt-3 growth factor receptor,kinase,INHIBITOR,Drug: lorlatinib | Target: nt-3 growth factor receptor | Type: kinase | Action: INHIBITOR
18607,lorlatinib,leukocyte tyrosine kinase receptor,kinase,INHIBITOR,Drug: lorlatinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: INHIBITOR
18608,lorlatinib,tyrosine-protein kinase fes/fps,kinase,INHIBITOR,Drug: lorlatinib | Target: tyrosine-protein kinase fes/fps | Type: kinase | Action: INHIBITOR
18609,revefenacin,muscarinic acetylcholine receptor m1,gpcr,ANTAGONIST,Drug: revefenacin | Target: muscarinic acetylcholine receptor m1 | Type: gpcr | Action: ANTAGONIST
18610,revefenacin,muscarinic acetylcholine receptor m2,gpcr,ANTAGONIST,Drug: revefenacin | Target: muscarinic acetylcholine receptor m2 | Type: gpcr | Action: ANTAGONIST
18611,revefenacin,muscarinic acetylcholine receptor m3,gpcr,ANTAGONIST,Drug: revefenacin | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: ANTAGONIST
18612,revefenacin,muscarinic acetylcholine receptor m4,gpcr,ANTAGONIST,Drug: revefenacin | Target: muscarinic acetylcholine receptor m4 | Type: gpcr | Action: ANTAGONIST
18613,revefenacin,muscarinic acetylcholine receptor m5,gpcr,ANTAGONIST,Drug: revefenacin | Target: muscarinic acetylcholine receptor m5 | Type: gpcr | Action: ANTAGONIST
18614,glasdegib,smoothened homolog,gpcr,,Drug: glasdegib | Target: smoothened homolog | Type: gpcr | Action: nan
18615,glasdegib,smoothened homolog,gpcr,ANTAGONIST,Drug: glasdegib | Target: smoothened homolog | Type: gpcr | Action: ANTAGONIST
18616,larotrectinib,high affinity nerve growth factor receptor,kinase,INHIBITOR,Drug: larotrectinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: INHIBITOR
18617,larotrectinib,bdnf/nt-3 growth factors receptor,kinase,INHIBITOR,Drug: larotrectinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: INHIBITOR
18618,larotrectinib,nt-3 growth factor receptor,kinase,INHIBITOR,Drug: larotrectinib | Target: nt-3 growth factor receptor | Type: kinase | Action: INHIBITOR
18619,gilteritinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: gilteritinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
18620,gilteritinib,high affinity nerve growth factor receptor,kinase,INHIBITOR,Drug: gilteritinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: INHIBITOR
18621,gilteritinib,alk tyrosine kinase receptor,kinase,,Drug: gilteritinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
18622,gilteritinib,tyrosine-protein kinase receptor ufo,kinase,INHIBITOR,Drug: gilteritinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: INHIBITOR
18623,gilteritinib,leukocyte tyrosine kinase receptor,kinase,INHIBITOR,Drug: gilteritinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: INHIBITOR
18624,gilteritinib,tyrosine-protein kinase mer,kinase,INHIBITOR,Drug: gilteritinib | Target: tyrosine-protein kinase mer | Type: kinase | Action: INHIBITOR
18625,gilteritinib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: gilteritinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
18626,gilteritinib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: gilteritinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
18627,evocalcet,extracellular calcium-sensing receptor,gpcr,AGONIST,Drug: evocalcet | Target: extracellular calcium-sensing receptor | Type: gpcr | Action: AGONIST
18628,caplacizumab,von willebrand factor,unclassified,ANTIBODY BINDING,Drug: caplacizumab | Target: von willebrand factor | Type: unclassified | Action: ANTIBODY BINDING
18629,lanadelumab,plasma kallikrein,enzyme,ANTIBODY BINDING,Drug: lanadelumab | Target: plasma kallikrein | Type: enzyme | Action: ANTIBODY BINDING
18630,vibegron,beta-3 adrenergic receptor,gpcr,,Drug: vibegron | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
18631,vibegron,beta-3 adrenergic receptor,gpcr,,Drug: vibegron | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
18632,vibegron,beta-3 adrenergic receptor,gpcr,,Drug: vibegron | Target: beta-3 adrenergic receptor | Type: gpcr | Action: nan
18633,vibegron,beta-3 adrenergic receptor,gpcr,AGONIST,Drug: vibegron | Target: beta-3 adrenergic receptor | Type: gpcr | Action: AGONIST
18634,omidenepag isopropyl,prostaglandin e2 receptor ep2 subtype,gpcr,AGONIST,Drug: omidenepag isopropyl | Target: prostaglandin e2 receptor ep2 subtype | Type: gpcr | Action: AGONIST
18635,patisiran,transthyretin (ttr) mrna,rna,ANTISENSE INHIBITOR,Drug: patisiran | Target: transthyretin (ttr) mrna | Type: rna | Action: ANTISENSE INHIBITOR
18636,moxetumomab pasudotox,b-cell receptor cd22,membrane receptor,BINDING AGENT,Drug: moxetumomab pasudotox | Target: b-cell receptor cd22 | Type: membrane receptor | Action: BINDING AGENT
18637,fremanezumab,calcitonin gene-related peptide 1,gpcr,ANTIBODY BINDING,Drug: fremanezumab | Target: calcitonin gene-related peptide 1 | Type: gpcr | Action: ANTIBODY BINDING
18638,galcanezumab,calcitonin gene-related peptide 1,gpcr,ANTIBODY BINDING,Drug: galcanezumab | Target: calcitonin gene-related peptide 1 | Type: gpcr | Action: ANTIBODY BINDING
18639,cemiplimab,programmed cell death protein 1,membrane receptor,ANTIBODY BINDING,Drug: cemiplimab | Target: programmed cell death protein 1 | Type: membrane receptor | Action: ANTIBODY BINDING
18640,inotersen,transthyretin (ttr) mrna,rna,ANTISENSE INHIBITOR,Drug: inotersen | Target: transthyretin (ttr) mrna | Type: rna | Action: ANTISENSE INHIBITOR
18641,emapalumab,interferon gamma,cytokine,ANTIBODY BINDING,Drug: emapalumab | Target: interferon gamma | Type: cytokine | Action: ANTIBODY BINDING
18642,ravulizumab,complement c5,secreted,ANTIBODY BINDING,Drug: ravulizumab | Target: complement c5 | Type: secreted | Action: ANTIBODY BINDING
18643,tagraxofusp,interleukin-3 receptor,membrane receptor,BINDING AGENT,Drug: tagraxofusp | Target: interleukin-3 receptor | Type: membrane receptor | Action: BINDING AGENT
18644,brexanolone,glucose-6-phosphate 1-dehydrogenase,enzyme,,Drug: brexanolone | Target: glucose-6-phosphate 1-dehydrogenase | Type: enzyme | Action: nan
18645,brexanolone,gaba-a receptor alpha-1/beta-2/gamma-2,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: brexanolone | Target: gaba-a receptor alpha-1/beta-2/gamma-2 | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
18646,brexanolone,gaba a receptor alpha-4/beta-3/delta,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: brexanolone | Target: gaba a receptor alpha-4/beta-3/delta | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
18647,brexanolone,gaba-a receptor alpha-6/beta-3/delta,ion channel,POSITIVE ALLOSTERIC MODULATOR,Drug: brexanolone | Target: gaba-a receptor alpha-6/beta-3/delta | Type: ion channel | Action: POSITIVE ALLOSTERIC MODULATOR
18648,solriamfetol,sodium-dependent serotonin transporter,transporter,INHIBITOR,Drug: solriamfetol | Target: sodium-dependent serotonin transporter | Type: transporter | Action: INHIBITOR
18649,solriamfetol,sodium-dependent noradrenaline transporter,transporter,INHIBITOR,Drug: solriamfetol | Target: sodium-dependent noradrenaline transporter | Type: transporter | Action: INHIBITOR
18650,solriamfetol,sodium-dependent dopamine transporter,transporter,INHIBITOR,Drug: solriamfetol | Target: sodium-dependent dopamine transporter | Type: transporter | Action: INHIBITOR
18651,siponimod,sphingosine 1-phosphate receptor 4,gpcr,MODULATOR,Drug: siponimod | Target: sphingosine 1-phosphate receptor 4 | Type: gpcr | Action: MODULATOR
18652,siponimod,sphingosine 1-phosphate receptor 3,gpcr,MODULATOR,Drug: siponimod | Target: sphingosine 1-phosphate receptor 3 | Type: gpcr | Action: MODULATOR
18653,siponimod,sphingosine 1-phosphate receptor 2,gpcr,MODULATOR,Drug: siponimod | Target: sphingosine 1-phosphate receptor 2 | Type: gpcr | Action: MODULATOR
18654,siponimod,sphingosine 1-phosphate receptor 1,gpcr,MODULATOR,Drug: siponimod | Target: sphingosine 1-phosphate receptor 1 | Type: gpcr | Action: MODULATOR
18655,siponimod,sphingosine 1-phosphate receptor 5,gpcr,MODULATOR,Drug: siponimod | Target: sphingosine 1-phosphate receptor 5 | Type: gpcr | Action: MODULATOR
18656,erdafitinib,vascular endothelial growth factor receptor 2,kinase,,Drug: erdafitinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
18658,erdafitinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: erdafitinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
18659,erdafitinib,fibroblast growth factor receptor 3,kinase,INHIBITOR,Drug: erdafitinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: INHIBITOR
18660,erdafitinib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: erdafitinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
18661,erdafitinib,fibroblast growth factor receptor 2,kinase,INHIBITOR,Drug: erdafitinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: INHIBITOR
18662,erdafitinib,fibroblast growth factor receptor 4,kinase,INHIBITOR,Drug: erdafitinib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: INHIBITOR
18663,alpelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,,"Drug: alpelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: nan"
18664,alpelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",kinase,,"Drug: alpelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Type: kinase | Action: nan"
18665,alpelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,,"Drug: alpelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: nan"
18666,alpelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",kinase,,"Drug: alpelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Type: kinase | Action: nan"
18667,alpelisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,INHIBITOR,"Drug: alpelisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: INHIBITOR"
18668,bremelanotide,melanocortin receptor 5,gpcr,AGONIST,Drug: bremelanotide | Target: melanocortin receptor 5 | Type: gpcr | Action: AGONIST
18669,bremelanotide,melanocortin receptor 3,gpcr,AGONIST,Drug: bremelanotide | Target: melanocortin receptor 3 | Type: gpcr | Action: AGONIST
18670,bremelanotide,melanocyte-stimulating hormone receptor,gpcr,AGONIST,Drug: bremelanotide | Target: melanocyte-stimulating hormone receptor | Type: gpcr | Action: AGONIST
18671,bremelanotide,adrenocorticotropic hormone receptor,gpcr,AGONIST,Drug: bremelanotide | Target: adrenocorticotropic hormone receptor | Type: gpcr | Action: AGONIST
18672,bremelanotide,melanocortin receptor 4,gpcr,AGONIST,Drug: bremelanotide | Target: melanocortin receptor 4 | Type: gpcr | Action: AGONIST
18673,selinexor,exportin-1,nuclear other,INHIBITOR,Drug: selinexor | Target: exportin-1 | Type: nuclear other | Action: INHIBITOR
18674,prabotulinumtoxina,synaptosomal-associated protein 25,cytosolic other,BLOCKER,Drug: prabotulinumtoxina | Target: synaptosomal-associated protein 25 | Type: cytosolic other | Action: BLOCKER
18675,polatuzumab vedotin,tubulin beta,tumour-associated antigen,BINDING AGENT,Drug: polatuzumab vedotin | Target: tubulin beta | Type: tumour-associated antigen | Action: BINDING AGENT
18676,polatuzumab vedotin,b-cell antigen receptor complex-associated protein beta chain,tumour-associated antigen,ANTIBODY BINDING,Drug: polatuzumab vedotin | Target: b-cell antigen receptor complex-associated protein beta chain | Type: tumour-associated antigen | Action: ANTIBODY BINDING
18677,darolutamide,androgen receptor,transcription factor,ANTAGONIST,Drug: darolutamide | Target: androgen receptor | Type: transcription factor | Action: ANTAGONIST
18678,darolutamide,progesterone receptor,nuclear hormone receptor,ANTAGONIST,Drug: darolutamide | Target: progesterone receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
18679,darolutamide,androgen receptor,nuclear hormone receptor,INHIBITOR,Drug: darolutamide | Target: androgen receptor | Type: nuclear hormone receptor | Action: INHIBITOR
18680,volanesorsen,apolipoprotein c-iii (apoc-iii) mrna,rna,ANTISENSE INHIBITOR,Drug: volanesorsen | Target: apolipoprotein c-iii (apoc-iii) mrna | Type: rna | Action: ANTISENSE INHIBITOR
18681,risankizumab,interleukin-23 subunit alpha,cytokine,INHIBITOR,Drug: risankizumab | Target: interleukin-23 subunit alpha | Type: cytokine | Action: INHIBITOR
18682,ropeginterferon alfa-2b,interferon alpha/beta receptor,membrane receptor,BINDING AGENT,Drug: ropeginterferon alfa-2b | Target: interferon alpha/beta receptor | Type: membrane receptor | Action: BINDING AGENT
18683,sotagliflozin,sodium/glucose cotransporter 2,transporter,INHIBITOR,Drug: sotagliflozin | Target: sodium/glucose cotransporter 2 | Type: transporter | Action: INHIBITOR
18684,sotagliflozin,sodium/glucose cotransporter 1,transporter,INHIBITOR,Drug: sotagliflozin | Target: sodium/glucose cotransporter 1 | Type: transporter | Action: INHIBITOR
18685,quizartinib,platelet-derived growth factor receptor beta,kinase,,Drug: quizartinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
18686,quizartinib,tyrosine-protein kinase abl1,kinase,,Drug: quizartinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
18687,quizartinib,mast/stem cell growth factor receptor kit,kinase,,Drug: quizartinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
18688,quizartinib,tyrosine-protein kinase lck,kinase,,Drug: quizartinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
18689,quizartinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: quizartinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
18690,quizartinib,vascular endothelial growth factor receptor 1,kinase,,Drug: quizartinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
18691,quizartinib,vascular endothelial growth factor receptor 2,kinase,,Drug: quizartinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
18692,quizartinib,vascular endothelial growth factor receptor 3,kinase,,Drug: quizartinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: nan
18693,quizartinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: quizartinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
18694,quizartinib,platelet-derived growth factor receptor alpha,kinase,,Drug: quizartinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
18695,quizartinib,"myosin light chain kinase, smooth muscle",kinase,,"Drug: quizartinib | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
18696,quizartinib,high affinity nerve growth factor receptor,kinase,,Drug: quizartinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
18697,quizartinib,tyrosine-protein kinase lyn,kinase,,Drug: quizartinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
18698,quizartinib,serine/threonine-protein kinase 10,kinase,,Drug: quizartinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
18699,quizartinib,ephrin type-a receptor 6,kinase,,Drug: quizartinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
18700,quizartinib,traf2 and nck-interacting protein kinase,kinase,,Drug: quizartinib | Target: traf2 and nck-interacting protein kinase | Type: kinase | Action: nan
18701,quizartinib,ephrin type-a receptor 3,kinase,,Drug: quizartinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
18702,quizartinib,tyrosine-protein kinase frk,kinase,,Drug: quizartinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
18703,quizartinib,mitogen-activated protein kinase kinase kinase kinase 5,kinase,,Drug: quizartinib | Target: mitogen-activated protein kinase kinase kinase kinase 5 | Type: kinase | Action: nan
18704,quizartinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: quizartinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
18705,quizartinib,ephrin type-a receptor 7,kinase,,Drug: quizartinib | Target: ephrin type-a receptor 7 | Type: kinase | Action: nan
18706,quizartinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: quizartinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
18707,quizartinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: quizartinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
18708,quizartinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: quizartinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
18709,quizartinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: quizartinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
18710,quizartinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: quizartinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
18711,quizartinib,nt-3 growth factor receptor,kinase,,Drug: quizartinib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
18712,quizartinib,discoidin domain-containing receptor 2,kinase,,Drug: quizartinib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
18713,quizartinib,mitogen-activated protein kinase kinase kinase kinase 4,kinase,,Drug: quizartinib | Target: mitogen-activated protein kinase kinase kinase kinase 4 | Type: kinase | Action: nan
18714,quizartinib,"muscle, skeletal receptor tyrosine-protein kinase",kinase,,"Drug: quizartinib | Target: muscle, skeletal receptor tyrosine-protein kinase | Type: kinase | Action: nan"
18715,quizartinib,mitogen-activated protein kinase 15,kinase,,Drug: quizartinib | Target: mitogen-activated protein kinase 15 | Type: kinase | Action: nan
18716,quizartinib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: quizartinib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
18717,quizartinib,ephrin type-b receptor 6,kinase,,Drug: quizartinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
18718,quizartinib,homeodomain-interacting protein kinase 4,kinase,,Drug: quizartinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
18719,quizartinib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: quizartinib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
18720,quizartinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: quizartinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
18721,quizartinib,myosin light chain kinase 3,kinase,,Drug: quizartinib | Target: myosin light chain kinase 3 | Type: kinase | Action: nan
18722,quizartinib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: quizartinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
18723,relebactam,beta-lactamase,enzyme,,Drug: relebactam | Target: beta-lactamase | Type: enzyme | Action: nan
18724,relebactam,beta-lactamase,enzyme,INHIBITOR,Drug: relebactam | Target: beta-lactamase | Type: enzyme | Action: INHIBITOR
18725,relebactam,beta-lactamase,enzyme,INHIBITOR,Drug: relebactam | Target: beta-lactamase | Type: enzyme | Action: INHIBITOR
18726,relebactam,beta-lactamase,enzyme,INHIBITOR,Drug: relebactam | Target: beta-lactamase | Type: enzyme | Action: INHIBITOR
18727,relebactam,beta-lactamase,enzyme,INHIBITOR,Drug: relebactam | Target: beta-lactamase | Type: enzyme | Action: INHIBITOR
18728,relebactam,beta-lactamase,enzyme,INHIBITOR,Drug: relebactam | Target: beta-lactamase | Type: enzyme | Action: INHIBITOR
18729,pexidartinib,tyrosine-protein kinase lck,kinase,INHIBITOR,Drug: pexidartinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: INHIBITOR
18730,pexidartinib,vascular endothelial growth factor receptor 1,kinase,INHIBITOR,Drug: pexidartinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: INHIBITOR
18731,pexidartinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: pexidartinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
18732,pexidartinib,nt-3 growth factor receptor,kinase,INHIBITOR,Drug: pexidartinib | Target: nt-3 growth factor receptor | Type: kinase | Action: INHIBITOR
18733,pexidartinib,cyclin-dependent kinase 19,kinase,INHIBITOR,Drug: pexidartinib | Target: cyclin-dependent kinase 19 | Type: kinase | Action: INHIBITOR
18734,pexidartinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: pexidartinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
18735,pexidartinib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: pexidartinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
18736,pexidartinib,macrophage colony-stimulating factor 1 receptor,kinase,INHIBITOR,Drug: pexidartinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: INHIBITOR
18737,entrectinib,tyrosine-protein kinase jak3,kinase,,Drug: entrectinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: nan
18738,entrectinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: entrectinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
18739,entrectinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: entrectinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
18740,entrectinib,insulin-like growth factor 1 receptor,kinase,,Drug: entrectinib | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: nan
18741,entrectinib,insulin receptor,kinase,,Drug: entrectinib | Target: insulin receptor | Type: kinase | Action: nan
18742,entrectinib,focal adhesion kinase 1,kinase,,Drug: entrectinib | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
18743,entrectinib,tyrosine-protein kinase jak1,kinase,,Drug: entrectinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: nan
18744,entrectinib,aurora kinase a,kinase,,Drug: entrectinib | Target: aurora kinase a | Type: kinase | Action: nan
18745,entrectinib,protein-tyrosine kinase 6,kinase,,Drug: entrectinib | Target: protein-tyrosine kinase 6 | Type: kinase | Action: nan
18746,entrectinib,aurora kinase b,kinase,,Drug: entrectinib | Target: aurora kinase b | Type: kinase | Action: nan
18747,entrectinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: entrectinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
18748,entrectinib,activated cdc42 kinase 1,kinase,INHIBITOR,Drug: entrectinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: INHIBITOR
18749,entrectinib,high affinity nerve growth factor receptor,kinase,INHIBITOR,Drug: entrectinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: INHIBITOR
18750,entrectinib,alk tyrosine kinase receptor,kinase,INHIBITOR,Drug: entrectinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: INHIBITOR
18751,entrectinib,bdnf/nt-3 growth factors receptor,kinase,INHIBITOR,Drug: entrectinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: INHIBITOR
18752,entrectinib,nt-3 growth factor receptor,kinase,INHIBITOR,Drug: entrectinib | Target: nt-3 growth factor receptor | Type: kinase | Action: INHIBITOR
18753,entrectinib,proto-oncogene tyrosine-protein kinase ros,kinase,INHIBITOR,Drug: entrectinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: INHIBITOR
18754,upadacitinib,non-receptor tyrosine-protein kinase tyk2,kinase,INHIBITOR,Drug: upadacitinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: INHIBITOR
18755,upadacitinib,tyrosine-protein kinase jak3,kinase,INHIBITOR,Drug: upadacitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: INHIBITOR
18756,upadacitinib,tyrosine-protein kinase jak1,kinase,INHIBITOR,Drug: upadacitinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: INHIBITOR
18757,upadacitinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: upadacitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
18758,fedratinib,platelet-derived growth factor receptor beta,kinase,,Drug: fedratinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: nan
18759,fedratinib,tyrosine-protein kinase abl1,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
18760,fedratinib,mast/stem cell growth factor receptor kit,kinase,,Drug: fedratinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
18761,fedratinib,epidermal growth factor receptor,kinase,,Drug: fedratinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
18762,fedratinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: fedratinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
18763,fedratinib,tyrosine-protein kinase lck,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
18764,fedratinib,tyrosine-protein kinase yes,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
18765,fedratinib,tyrosine-protein kinase fyn,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
18766,fedratinib,ephrin type-a receptor 2,kinase,,Drug: fedratinib | Target: ephrin type-a receptor 2 | Type: kinase | Action: nan
18767,fedratinib,serine/threonine-protein kinase b-raf,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
18768,fedratinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: fedratinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
18769,fedratinib,vascular endothelial growth factor receptor 1,kinase,,Drug: fedratinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
18770,fedratinib,vascular endothelial growth factor receptor 2,kinase,,Drug: fedratinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: nan
18771,fedratinib,vascular endothelial growth factor receptor 3,kinase,,Drug: fedratinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: nan
18772,fedratinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: fedratinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
18773,fedratinib,platelet-derived growth factor receptor alpha,kinase,,Drug: fedratinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
18774,fedratinib,ribosomal protein s6 kinase alpha-3,kinase,,Drug: fedratinib | Target: ribosomal protein s6 kinase alpha-3 | Type: kinase | Action: nan
18775,fedratinib,"phosphorylase b kinase gamma catalytic chain, liver/testis isoform",kinase,,"Drug: fedratinib | Target: phosphorylase b kinase gamma catalytic chain, liver/testis isoform | Type: kinase | Action: nan"
18776,fedratinib,insulin-like growth factor 1 receptor,kinase,,Drug: fedratinib | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: nan
18777,fedratinib,"myosin light chain kinase, smooth muscle",kinase,,"Drug: fedratinib | Target: myosin light chain kinase, smooth muscle | Type: kinase | Action: nan"
18778,fedratinib,insulin receptor,kinase,,Drug: fedratinib | Target: insulin receptor | Type: kinase | Action: nan
18779,fedratinib,death-associated protein kinase 3,kinase,,Drug: fedratinib | Target: death-associated protein kinase 3 | Type: kinase | Action: nan
18780,fedratinib,calcium/calmodulin-dependent protein kinase type 1,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase type 1 | Type: kinase | Action: nan
18781,fedratinib,mitogen-activated protein kinase 8,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase 8 | Type: kinase | Action: nan
18782,fedratinib,fibroblast growth factor receptor 3,kinase,,Drug: fedratinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: nan
18783,fedratinib,rho-associated protein kinase 1,kinase,,Drug: fedratinib | Target: rho-associated protein kinase 1 | Type: kinase | Action: nan
18784,fedratinib,focal adhesion kinase 1,kinase,,Drug: fedratinib | Target: focal adhesion kinase 1 | Type: kinase | Action: nan
18785,fedratinib,tyrosine-protein kinase hck,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase hck | Type: kinase | Action: nan
18786,fedratinib,serine/threonine-protein kinase plk1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase plk1 | Type: kinase | Action: nan
18787,fedratinib,receptor tyrosine-protein kinase erbb-4,kinase,,Drug: fedratinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: nan
18788,fedratinib,mitogen-activated protein kinase 10,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase 10 | Type: kinase | Action: nan
18789,fedratinib,death-associated protein kinase 2,kinase,,Drug: fedratinib | Target: death-associated protein kinase 2 | Type: kinase | Action: nan
18790,fedratinib,high affinity nerve growth factor receptor,kinase,,Drug: fedratinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: nan
18791,fedratinib,rho-associated protein kinase 2,kinase,,Drug: fedratinib | Target: rho-associated protein kinase 2 | Type: kinase | Action: nan
18792,fedratinib,tyrosine-protein kinase syk,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
18793,fedratinib,calcium/calmodulin-dependent protein kinase type ii subunit delta,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit delta | Type: kinase | Action: nan
18794,fedratinib,"myosin light chain kinase 2, skeletal/cardiac muscle",kinase,,"Drug: fedratinib | Target: myosin light chain kinase 2, skeletal/cardiac muscle | Type: kinase | Action: nan"
18795,fedratinib,tyrosine-protein kinase csk,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase csk | Type: kinase | Action: nan
18796,fedratinib,angiopoietin-1 receptor,kinase,,Drug: fedratinib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
18797,fedratinib,ephrin type-a receptor 8,kinase,,Drug: fedratinib | Target: ephrin type-a receptor 8 | Type: kinase | Action: nan
18798,fedratinib,calcium/calmodulin-dependent protein kinase type ii subunit gamma,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit gamma | Type: kinase | Action: nan
18799,fedratinib,ap2-associated protein kinase 1,kinase,,Drug: fedratinib | Target: ap2-associated protein kinase 1 | Type: kinase | Action: nan
18800,fedratinib,serine/threonine-protein kinase mark2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase mark2 | Type: kinase | Action: nan
18801,fedratinib,hepatocyte growth factor receptor,kinase,,Drug: fedratinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
18802,fedratinib,tyrosine-protein kinase lyn,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
18803,fedratinib,cytoplasmic tyrosine-protein kinase bmx,kinase,,Drug: fedratinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: nan
18804,fedratinib,serine/threonine-protein kinase nek2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek2 | Type: kinase | Action: nan
18805,fedratinib,lim domain kinase 1,kinase,,Drug: fedratinib | Target: lim domain kinase 1 | Type: kinase | Action: nan
18806,fedratinib,ribosomal protein s6 kinase alpha-2,kinase,,Drug: fedratinib | Target: ribosomal protein s6 kinase alpha-2 | Type: kinase | Action: nan
18807,fedratinib,5'-amp-activated protein kinase catalytic subunit alpha-1,kinase,,Drug: fedratinib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-1 | Type: kinase | Action: nan
18808,fedratinib,calcium/calmodulin-dependent protein kinase type ii subunit beta,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit beta | Type: kinase | Action: nan
18809,fedratinib,fibroblast growth factor receptor 1,kinase,,Drug: fedratinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: nan
18810,fedratinib,"phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform",kinase,,"Drug: fedratinib | Target: phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | Type: kinase | Action: nan"
18811,fedratinib,calcium/calmodulin-dependent protein kinase type ii subunit alpha,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase type ii subunit alpha | Type: kinase | Action: nan
18812,fedratinib,serine/threonine-protein kinase 17b,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 17b | Type: kinase | Action: nan
18813,fedratinib,serine/threonine-protein kinase 10,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 10 | Type: kinase | Action: nan
18814,fedratinib,tyrosine-protein kinase fer,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase fer | Type: kinase | Action: nan
18815,fedratinib,protein kinase c epsilon type,kinase,,Drug: fedratinib | Target: protein kinase c epsilon type | Type: kinase | Action: nan
18816,fedratinib,serine/threonine-protein kinase plk4,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase plk4 | Type: kinase | Action: nan
18817,fedratinib,aurora kinase c,kinase,,Drug: fedratinib | Target: aurora kinase c | Type: kinase | Action: nan
18818,fedratinib,serine/threonine-protein kinase 16,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 16 | Type: kinase | Action: nan
18819,fedratinib,dual specificity protein kinase ttk,kinase,,Drug: fedratinib | Target: dual specificity protein kinase ttk | Type: kinase | Action: nan
18820,fedratinib,abelson tyrosine-protein kinase 2,kinase,,Drug: fedratinib | Target: abelson tyrosine-protein kinase 2 | Type: kinase | Action: nan
18821,fedratinib,ephrin type-a receptor 4,kinase,,Drug: fedratinib | Target: ephrin type-a receptor 4 | Type: kinase | Action: nan
18822,fedratinib,fibroblast growth factor receptor 2,kinase,,Drug: fedratinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: nan
18823,fedratinib,serine/threonine-protein kinase n1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase n1 | Type: kinase | Action: nan
18824,fedratinib,serine/threonine-protein kinase 17a,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 17a | Type: kinase | Action: nan
18825,fedratinib,ephrin type-a receptor 6,kinase,,Drug: fedratinib | Target: ephrin type-a receptor 6 | Type: kinase | Action: nan
18826,fedratinib,tyrosine-protein kinase fgr,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase fgr | Type: kinase | Action: nan
18827,fedratinib,aurora kinase a,kinase,,Drug: fedratinib | Target: aurora kinase a | Type: kinase | Action: nan
18828,fedratinib,alk tyrosine kinase receptor,kinase,,Drug: fedratinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
18829,fedratinib,serine/threonine-protein kinase 36,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 36 | Type: kinase | Action: nan
18830,fedratinib,ephrin type-a receptor 3,kinase,,Drug: fedratinib | Target: ephrin type-a receptor 3 | Type: kinase | Action: nan
18831,fedratinib,bmp-2-inducible protein kinase,kinase,,Drug: fedratinib | Target: bmp-2-inducible protein kinase | Type: kinase | Action: nan
18832,fedratinib,tyrosine-protein kinase frk,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase frk | Type: kinase | Action: nan
18833,fedratinib,dual specificity protein kinase clk1,kinase,,Drug: fedratinib | Target: dual specificity protein kinase clk1 | Type: kinase | Action: nan
18834,fedratinib,dual specificity protein kinase clk2,kinase,,Drug: fedratinib | Target: dual specificity protein kinase clk2 | Type: kinase | Action: nan
18835,fedratinib,mitogen-activated protein kinase kinase kinase 4,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 4 | Type: kinase | Action: nan
18836,fedratinib,cyclin-g-associated kinase,kinase,,Drug: fedratinib | Target: cyclin-g-associated kinase | Type: kinase | Action: nan
18837,fedratinib,receptor-interacting serine/threonine-protein kinase 2,kinase,,Drug: fedratinib | Target: receptor-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
18838,fedratinib,ephrin type-b receptor 1,kinase,,Drug: fedratinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
18839,fedratinib,calcium/calmodulin-dependent protein kinase type 1d,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase type 1d | Type: kinase | Action: nan
18840,fedratinib,cyclin-dependent kinase 16,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase 16 | Type: kinase | Action: nan
18841,fedratinib,activated cdc42 kinase 1,kinase,,Drug: fedratinib | Target: activated cdc42 kinase 1 | Type: kinase | Action: nan
18842,fedratinib,ephrin type-a receptor 7,kinase,,Drug: fedratinib | Target: ephrin type-a receptor 7 | Type: kinase | Action: nan
18843,fedratinib,ribosomal protein s6 kinase alpha-5,kinase,,Drug: fedratinib | Target: ribosomal protein s6 kinase alpha-5 | Type: kinase | Action: nan
18844,fedratinib,ste20-like serine/threonine-protein kinase,kinase,,Drug: fedratinib | Target: ste20-like serine/threonine-protein kinase | Type: kinase | Action: nan
18845,fedratinib,dual specificity protein kinase clk4,kinase,,Drug: fedratinib | Target: dual specificity protein kinase clk4 | Type: kinase | Action: nan
18846,fedratinib,map kinase-interacting serine/threonine-protein kinase 2,kinase,,Drug: fedratinib | Target: map kinase-interacting serine/threonine-protein kinase 2 | Type: kinase | Action: nan
18847,fedratinib,mitogen-activated protein kinase 9,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase 9 | Type: kinase | Action: nan
18848,fedratinib,calcium/calmodulin-dependent protein kinase kinase 2,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase kinase 2 | Type: kinase | Action: nan
18849,fedratinib,map/microtubule affinity-regulating kinase 3,kinase,,Drug: fedratinib | Target: map/microtubule affinity-regulating kinase 3 | Type: kinase | Action: nan
18850,fedratinib,calcium/calmodulin-dependent protein kinase kinase 1,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase kinase 1 | Type: kinase | Action: nan
18851,fedratinib,calcium/calmodulin-dependent protein kinase type 1g,kinase,,Drug: fedratinib | Target: calcium/calmodulin-dependent protein kinase type 1g | Type: kinase | Action: nan
18852,fedratinib,epithelial discoidin domain-containing receptor 1,kinase,,Drug: fedratinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: nan
18853,fedratinib,ephrin type-b receptor 4,kinase,,Drug: fedratinib | Target: ephrin type-b receptor 4 | Type: kinase | Action: nan
18854,fedratinib,testis-specific serine/threonine-protein kinase 1,kinase,,Drug: fedratinib | Target: testis-specific serine/threonine-protein kinase 1 | Type: kinase | Action: nan
18855,fedratinib,activin receptor type-1b,kinase,,Drug: fedratinib | Target: activin receptor type-1b | Type: kinase | Action: nan
18856,fedratinib,serine/threonine-protein kinase receptor r3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase receptor r3 | Type: kinase | Action: nan
18857,fedratinib,activin receptor type-1,kinase,,Drug: fedratinib | Target: activin receptor type-1 | Type: kinase | Action: nan
18858,fedratinib,cyclin-dependent kinase 15,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase 15 | Type: kinase | Action: nan
18859,fedratinib,inhibitor of nuclear factor kappa-b kinase subunit beta,kinase,,Drug: fedratinib | Target: inhibitor of nuclear factor kappa-b kinase subunit beta | Type: kinase | Action: nan
18860,fedratinib,tgf-beta receptor type-2,kinase,,Drug: fedratinib | Target: tgf-beta receptor type-2 | Type: kinase | Action: nan
18861,fedratinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,,Drug: fedratinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: nan
18862,fedratinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,,Drug: fedratinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: nan
18863,fedratinib,tyrosine-protein kinase itk/tsk,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase itk/tsk | Type: kinase | Action: nan
18864,fedratinib,tyrosine-protein kinase zap-70,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase zap-70 | Type: kinase | Action: nan
18865,fedratinib,cyclin-dependent kinase 9,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase 9 | Type: kinase | Action: nan
18866,fedratinib,protein-tyrosine kinase 6,kinase,,Drug: fedratinib | Target: protein-tyrosine kinase 6 | Type: kinase | Action: nan
18867,fedratinib,tyrosine-protein kinase btk,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: nan
18868,fedratinib,tyrosine-protein kinase receptor ufo,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase receptor ufo | Type: kinase | Action: nan
18869,fedratinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: fedratinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
18870,fedratinib,ephrin type-b receptor 2,kinase,,Drug: fedratinib | Target: ephrin type-b receptor 2 | Type: kinase | Action: nan
18871,fedratinib,cyclin-dependent kinase 7,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: nan
18872,fedratinib,ribosomal protein s6 kinase beta-1,kinase,,Drug: fedratinib | Target: ribosomal protein s6 kinase beta-1 | Type: kinase | Action: nan
18873,fedratinib,serine/threonine-protein kinase dclk3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase dclk3 | Type: kinase | Action: nan
18874,fedratinib,ribosomal protein s6 kinase alpha-6,kinase,,Drug: fedratinib | Target: ribosomal protein s6 kinase alpha-6 | Type: kinase | Action: nan
18875,fedratinib,nuak family snf1-like kinase 2,kinase,,Drug: fedratinib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: nan
18876,fedratinib,non-receptor tyrosine-protein kinase tnk1,kinase,,Drug: fedratinib | Target: non-receptor tyrosine-protein kinase tnk1 | Type: kinase | Action: nan
18877,fedratinib,serine/threonine-protein kinase chk1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase chk1 | Type: kinase | Action: nan
18878,fedratinib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,,"Drug: fedratinib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: nan"
18879,fedratinib,cyclin-dependent kinase 17,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase 17 | Type: kinase | Action: nan
18880,fedratinib,cyclin-dependent kinase 18,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase 18 | Type: kinase | Action: nan
18881,fedratinib,cyclin-dependent kinase 14,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase 14 | Type: kinase | Action: nan
18882,fedratinib,phosphatidylinositol 4-phosphate 5-kinase type-1 alpha,kinase,,Drug: fedratinib | Target: phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | Type: kinase | Action: nan
18883,fedratinib,phosphatidylinositol 5-phosphate 4-kinase type-2 beta,kinase,,Drug: fedratinib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 beta | Type: kinase | Action: nan
18884,fedratinib,myosin light chain kinase family member 4,kinase,,Drug: fedratinib | Target: myosin light chain kinase family member 4 | Type: kinase | Action: nan
18885,fedratinib,wee1-like protein kinase,kinase,,Drug: fedratinib | Target: wee1-like protein kinase | Type: kinase | Action: nan
18886,fedratinib,serine/threonine-protein kinase 25,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 25 | Type: kinase | Action: nan
18887,fedratinib,mitogen-activated protein kinase kinase kinase mlt,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase mlt | Type: kinase | Action: nan
18888,fedratinib,protein-tyrosine kinase 2-beta,kinase,,Drug: fedratinib | Target: protein-tyrosine kinase 2-beta | Type: kinase | Action: nan
18889,fedratinib,serine/threonine-protein kinase rio1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase rio1 | Type: kinase | Action: nan
18890,fedratinib,tyrosine-protein kinase receptor tie-1,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase receptor tie-1 | Type: kinase | Action: nan
18891,fedratinib,serine/threonine-protein kinase tousled-like 1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase tousled-like 1 | Type: kinase | Action: nan
18892,fedratinib,serine/threonine-protein kinase tousled-like 2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase tousled-like 2 | Type: kinase | Action: nan
18893,fedratinib,nt-3 growth factor receptor,kinase,,Drug: fedratinib | Target: nt-3 growth factor receptor | Type: kinase | Action: nan
18894,fedratinib,tyrosine-protein kinase txk,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase txk | Type: kinase | Action: nan
18895,fedratinib,casein kinase ii subunit alpha,kinase,,Drug: fedratinib | Target: casein kinase ii subunit alpha | Type: kinase | Action: nan
18896,fedratinib,casein kinase ii subunit alpha',kinase,,Drug: fedratinib | Target: casein kinase ii subunit alpha' | Type: kinase | Action: nan
18897,fedratinib,dual specificity tyrosine-phosphorylation-regulated kinase 1b,kinase,,Drug: fedratinib | Target: dual specificity tyrosine-phosphorylation-regulated kinase 1b | Type: kinase | Action: nan
18898,fedratinib,inhibitor of nuclear factor kappa-b kinase subunit epsilon,kinase,,Drug: fedratinib | Target: inhibitor of nuclear factor kappa-b kinase subunit epsilon | Type: kinase | Action: nan
18899,fedratinib,lim domain kinase 2,kinase,,Drug: fedratinib | Target: lim domain kinase 2 | Type: kinase | Action: nan
18900,fedratinib,serine/threonine-protein kinase stk11,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase stk11 | Type: kinase | Action: nan
18901,fedratinib,dual specificity mitogen-activated protein kinase kinase 3,kinase,,Drug: fedratinib | Target: dual specificity mitogen-activated protein kinase kinase 3 | Type: kinase | Action: nan
18902,fedratinib,maternal embryonic leucine zipper kinase,kinase,,Drug: fedratinib | Target: maternal embryonic leucine zipper kinase | Type: kinase | Action: nan
18903,fedratinib,map kinase-interacting serine/threonine-protein kinase 1,kinase,,Drug: fedratinib | Target: map kinase-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
18904,fedratinib,serine/threonine-protein kinase 26,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 26 | Type: kinase | Action: nan
18905,fedratinib,serine/threonine-protein kinase nek7,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek7 | Type: kinase | Action: nan
18906,fedratinib,eukaryotic translation initiation factor 2-alpha kinase 4,kinase,,Drug: fedratinib | Target: eukaryotic translation initiation factor 2-alpha kinase 4 | Type: kinase | Action: nan
18907,fedratinib,insulin receptor-related protein,kinase,,Drug: fedratinib | Target: insulin receptor-related protein | Type: kinase | Action: nan
18908,fedratinib,interleukin-1 receptor-associated kinase 3,kinase,,Drug: fedratinib | Target: interleukin-1 receptor-associated kinase 3 | Type: kinase | Action: nan
18909,fedratinib,serine/threonine-protein kinase rio3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase rio3 | Type: kinase | Action: nan
18910,fedratinib,serine/threonine-protein kinase sik2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase sik2 | Type: kinase | Action: nan
18911,fedratinib,srsf protein kinase 1,kinase,,Drug: fedratinib | Target: srsf protein kinase 1 | Type: kinase | Action: nan
18912,fedratinib,srsf protein kinase 2,kinase,,Drug: fedratinib | Target: srsf protein kinase 2 | Type: kinase | Action: nan
18913,fedratinib,serine/threonine-protein kinase 33,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 33 | Type: kinase | Action: nan
18914,fedratinib,serine/threonine-protein kinase tnni3k,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase tnni3k | Type: kinase | Action: nan
18915,fedratinib,5'-amp-activated protein kinase catalytic subunit alpha-2,kinase,,Drug: fedratinib | Target: 5'-amp-activated protein kinase catalytic subunit alpha-2 | Type: kinase | Action: nan
18916,fedratinib,ankyrin repeat and protein kinase domain-containing protein 1,kinase,,Drug: fedratinib | Target: ankyrin repeat and protein kinase domain-containing protein 1 | Type: kinase | Action: nan
18917,fedratinib,discoidin domain-containing receptor 2,kinase,,Drug: fedratinib | Target: discoidin domain-containing receptor 2 | Type: kinase | Action: nan
18918,fedratinib,myotonin-protein kinase,kinase,,Drug: fedratinib | Target: myotonin-protein kinase | Type: kinase | Action: nan
18919,fedratinib,"chaperone activity of bc1 complex-like, mitochondrial",kinase,,"Drug: fedratinib | Target: chaperone activity of bc1 complex-like, mitochondrial | Type: kinase | Action: nan"
18920,fedratinib,serine/threonine-protein kinase lats2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase lats2 | Type: kinase | Action: nan
18921,fedratinib,leukocyte tyrosine kinase receptor,kinase,,Drug: fedratinib | Target: leukocyte tyrosine kinase receptor | Type: kinase | Action: nan
18922,fedratinib,mitogen-activated protein kinase kinase kinase kinase 1,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase kinase 1 | Type: kinase | Action: nan
18923,fedratinib,serine/threonine-protein kinase pak 6,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase pak 6 | Type: kinase | Action: nan
18924,fedratinib,serine/threonine-protein kinase pak 7,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase pak 7 | Type: kinase | Action: nan
18925,fedratinib,nuak family snf1-like kinase 1,kinase,,Drug: fedratinib | Target: nuak family snf1-like kinase 1 | Type: kinase | Action: nan
18926,fedratinib,mitogen-activated protein kinase kinase kinase kinase 3,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase kinase 3 | Type: kinase | Action: nan
18927,fedratinib,aurora kinase b,kinase,,Drug: fedratinib | Target: aurora kinase b | Type: kinase | Action: nan
18928,fedratinib,tyrosine-protein kinase blk,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase blk | Type: kinase | Action: nan
18929,fedratinib,bone morphogenetic protein receptor type-2,kinase,,Drug: fedratinib | Target: bone morphogenetic protein receptor type-2 | Type: kinase | Action: nan
18930,fedratinib,serine/threonine-protein kinase mark1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase mark1 | Type: kinase | Action: nan
18931,fedratinib,map/microtubule affinity-regulating kinase 4,kinase,,Drug: fedratinib | Target: map/microtubule affinity-regulating kinase 4 | Type: kinase | Action: nan
18932,fedratinib,dual specificity mitogen-activated protein kinase kinase 4,kinase,,Drug: fedratinib | Target: dual specificity mitogen-activated protein kinase kinase 4 | Type: kinase | Action: nan
18933,fedratinib,tyrosine-protein kinase mer,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase mer | Type: kinase | Action: nan
18934,fedratinib,mitogen-activated protein kinase kinase kinase 9,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 9 | Type: kinase | Action: nan
18935,fedratinib,mitogen-activated protein kinase kinase kinase 10,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 10 | Type: kinase | Action: nan
18936,fedratinib,mitogen-activated protein kinase kinase kinase 11,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 11 | Type: kinase | Action: nan
18937,fedratinib,"muscle, skeletal receptor tyrosine-protein kinase",kinase,,"Drug: fedratinib | Target: muscle, skeletal receptor tyrosine-protein kinase | Type: kinase | Action: nan"
18938,fedratinib,citron rho-interacting kinase,kinase,,Drug: fedratinib | Target: citron rho-interacting kinase | Type: kinase | Action: nan
18939,fedratinib,death-associated protein kinase 1,kinase,,Drug: fedratinib | Target: death-associated protein kinase 1 | Type: kinase | Action: nan
18940,fedratinib,serine/threonine-protein kinase dclk1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase dclk1 | Type: kinase | Action: nan
18941,fedratinib,serine/threonine-protein kinase dclk2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase dclk2 | Type: kinase | Action: nan
18942,fedratinib,serine/threonine-protein kinase nek5,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek5 | Type: kinase | Action: nan
18943,fedratinib,serine/threonine-protein kinase nek9,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek9 | Type: kinase | Action: nan
18944,fedratinib,serine/threonine-protein kinase pak 1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase pak 1 | Type: kinase | Action: nan
18945,fedratinib,serine/threonine-protein kinase pak 2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase pak 2 | Type: kinase | Action: nan
18946,fedratinib,serine/threonine-protein kinase pak 4,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase pak 4 | Type: kinase | Action: nan
18947,fedratinib,aarf domain-containing protein kinase 4,kinase,,Drug: fedratinib | Target: aarf domain-containing protein kinase 4 | Type: kinase | Action: nan
18948,fedratinib,serine/threonine-protein kinase sik1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase sik1 | Type: kinase | Action: nan
18949,fedratinib,tyrosine-protein kinase srms,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase srms | Type: kinase | Action: nan
18950,fedratinib,dual specificity testis-specific protein kinase 1,kinase,,Drug: fedratinib | Target: dual specificity testis-specific protein kinase 1 | Type: kinase | Action: nan
18951,fedratinib,ephrin type-a receptor 1,kinase,,Drug: fedratinib | Target: ephrin type-a receptor 1 | Type: kinase | Action: nan
18952,fedratinib,serine/threonine-protein kinase plk3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase plk3 | Type: kinase | Action: nan
18953,fedratinib,mitogen-activated protein kinase 6,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase 6 | Type: kinase | Action: nan
18954,fedratinib,mitogen-activated protein kinase 7,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase 7 | Type: kinase | Action: nan
18955,fedratinib,mitogen-activated protein kinase 15,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase 15 | Type: kinase | Action: nan
18956,fedratinib,serine/threonine-protein kinase d3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase d3 | Type: kinase | Action: nan
18957,fedratinib,cgmp-dependent protein kinase 2,kinase,,Drug: fedratinib | Target: cgmp-dependent protein kinase 2 | Type: kinase | Action: nan
18958,fedratinib,"interferon-induced, double-stranded rna-activated protein kinase",kinase,,"Drug: fedratinib | Target: interferon-induced, double-stranded rna-activated protein kinase | Type: kinase | Action: nan"
18959,fedratinib,receptor-interacting serine/threonine-protein kinase 1,kinase,,Drug: fedratinib | Target: receptor-interacting serine/threonine-protein kinase 1 | Type: kinase | Action: nan
18960,fedratinib,tyrosine-protein kinase fes/fps,kinase,,Drug: fedratinib | Target: tyrosine-protein kinase fes/fps | Type: kinase | Action: nan
18961,fedratinib,fibroblast growth factor receptor 4,kinase,,Drug: fedratinib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: nan
18962,fedratinib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: fedratinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
18963,fedratinib,ribosomal protein s6 kinase alpha-1,kinase,,Drug: fedratinib | Target: ribosomal protein s6 kinase alpha-1 | Type: kinase | Action: nan
18964,fedratinib,ribosomal protein s6 kinase alpha-4,kinase,,Drug: fedratinib | Target: ribosomal protein s6 kinase alpha-4 | Type: kinase | Action: nan
18965,fedratinib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,,"Drug: fedratinib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: nan"
18966,fedratinib,mitogen-activated protein kinase kinase kinase kinase 2,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase kinase 2 | Type: kinase | Action: nan
18967,fedratinib,misshapen-like kinase 1,kinase,,Drug: fedratinib | Target: misshapen-like kinase 1 | Type: kinase | Action: nan
18968,fedratinib,serine/threonine-protein kinase tbk1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase tbk1 | Type: kinase | Action: nan
18969,fedratinib,interleukin-1 receptor-associated kinase 4,kinase,,Drug: fedratinib | Target: interleukin-1 receptor-associated kinase 4 | Type: kinase | Action: nan
18970,fedratinib,cyclin-dependent kinase 4,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase 4 | Type: kinase | Action: nan
18971,fedratinib,cyclin-dependent kinase-like 2,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase-like 2 | Type: kinase | Action: nan
18972,fedratinib,ephrin type-b receptor 6,kinase,,Drug: fedratinib | Target: ephrin type-b receptor 6 | Type: kinase | Action: nan
18973,fedratinib,serine/threonine-protein kinase/endoribonuclease ire1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase/endoribonuclease ire1 | Type: kinase | Action: nan
18974,fedratinib,g protein-coupled receptor kinase 4,kinase,,Drug: fedratinib | Target: g protein-coupled receptor kinase 4 | Type: kinase | Action: nan
18975,fedratinib,g protein-coupled receptor kinase 7,kinase,,Drug: fedratinib | Target: g protein-coupled receptor kinase 7 | Type: kinase | Action: nan
18976,fedratinib,homeodomain-interacting protein kinase 2,kinase,,Drug: fedratinib | Target: homeodomain-interacting protein kinase 2 | Type: kinase | Action: nan
18977,fedratinib,homeodomain-interacting protein kinase 3,kinase,,Drug: fedratinib | Target: homeodomain-interacting protein kinase 3 | Type: kinase | Action: nan
18978,fedratinib,homeodomain-interacting protein kinase 4,kinase,,Drug: fedratinib | Target: homeodomain-interacting protein kinase 4 | Type: kinase | Action: nan
18979,fedratinib,serine/threonine-protein kinase ick,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase ick | Type: kinase | Action: nan
18980,fedratinib,inhibitor of nuclear factor kappa-b kinase subunit alpha,kinase,,Drug: fedratinib | Target: inhibitor of nuclear factor kappa-b kinase subunit alpha | Type: kinase | Action: nan
18981,fedratinib,interleukin-1 receptor-associated kinase 1,kinase,,Drug: fedratinib | Target: interleukin-1 receptor-associated kinase 1 | Type: kinase | Action: nan
18982,fedratinib,mitogen-activated protein kinase kinase kinase 13,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 13 | Type: kinase | Action: nan
18983,fedratinib,mitogen-activated protein kinase kinase kinase 2,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 2 | Type: kinase | Action: nan
18984,fedratinib,mitogen-activated protein kinase kinase kinase 3,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 3 | Type: kinase | Action: nan
18985,fedratinib,serine/threonine-protein kinase 38,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase 38 | Type: kinase | Action: nan
18986,fedratinib,serine/threonine-protein kinase nim1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nim1 | Type: kinase | Action: nan
18987,fedratinib,serine/threonine-protein kinase rio2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase rio2 | Type: kinase | Action: nan
18988,fedratinib,srsf protein kinase 3,kinase,,Drug: fedratinib | Target: srsf protein kinase 3 | Type: kinase | Action: nan
18989,fedratinib,ste20/sps1-related proline-alanine-rich protein kinase,kinase,,Drug: fedratinib | Target: ste20/sps1-related proline-alanine-rich protein kinase | Type: kinase | Action: nan
18990,fedratinib,mitogen-activated protein kinase kinase kinase 7,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 7 | Type: kinase | Action: nan
18991,fedratinib,serine/threonine-protein kinase tao1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase tao1 | Type: kinase | Action: nan
18992,fedratinib,serine/threonine-protein kinase tao3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase tao3 | Type: kinase | Action: nan
18993,fedratinib,serine/threonine-protein kinase ulk1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase ulk1 | Type: kinase | Action: nan
18994,fedratinib,serine/threonine-protein kinase ulk2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase ulk2 | Type: kinase | Action: nan
18995,fedratinib,serine/threonine-protein kinase ulk3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase ulk3 | Type: kinase | Action: nan
18996,fedratinib,mitogen-activated protein kinase kinase kinase 19,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 19 | Type: kinase | Action: nan
18997,fedratinib,homeodomain-interacting protein kinase 1,kinase,,Drug: fedratinib | Target: homeodomain-interacting protein kinase 1 | Type: kinase | Action: nan
18998,fedratinib,serine/threonine-protein kinase plk2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase plk2 | Type: kinase | Action: nan
18999,fedratinib,receptor-interacting serine/threonine-protein kinase 4,kinase,,Drug: fedratinib | Target: receptor-interacting serine/threonine-protein kinase 4 | Type: kinase | Action: nan
19000,fedratinib,uncharacterized serine/threonine-protein kinase sbk3,kinase,,Drug: fedratinib | Target: uncharacterized serine/threonine-protein kinase sbk3 | Type: kinase | Action: nan
19001,fedratinib,cyclin-dependent kinase-like 5,kinase,,Drug: fedratinib | Target: cyclin-dependent kinase-like 5 | Type: kinase | Action: nan
19002,fedratinib,megakaryocyte-associated tyrosine-protein kinase,kinase,,Drug: fedratinib | Target: megakaryocyte-associated tyrosine-protein kinase | Type: kinase | Action: nan
19003,fedratinib,phosphatidylinositol 4-kinase beta,kinase,,Drug: fedratinib | Target: phosphatidylinositol 4-kinase beta | Type: kinase | Action: nan
19004,fedratinib,serine/threonine-protein kinase sik3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase sik3 | Type: kinase | Action: nan
19005,fedratinib,wee1-like protein kinase 2,kinase,,Drug: fedratinib | Target: wee1-like protein kinase 2 | Type: kinase | Action: nan
19006,fedratinib,bone morphogenetic protein receptor type-1b,kinase,,Drug: fedratinib | Target: bone morphogenetic protein receptor type-1b | Type: kinase | Action: nan
19007,fedratinib,serine/threonine-protein kinase sbk1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase sbk1 | Type: kinase | Action: nan
19008,fedratinib,serine/threonine-protein kinase nek3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek3 | Type: kinase | Action: nan
19009,fedratinib,peripheral plasma membrane protein cask,kinase,,Drug: fedratinib | Target: peripheral plasma membrane protein cask | Type: kinase | Action: nan
19010,fedratinib,serine/threonine-protein kinase prp4 homolog,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase prp4 homolog | Type: kinase | Action: nan
19011,fedratinib,mitogen-activated protein kinase kinase kinase 12,kinase,,Drug: fedratinib | Target: mitogen-activated protein kinase kinase kinase 12 | Type: kinase | Action: nan
19012,fedratinib,serine/threonine-protein kinase sgk3,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase sgk3 | Type: kinase | Action: nan
19013,fedratinib,eukaryotic translation initiation factor 2-alpha kinase 1,kinase,,Drug: fedratinib | Target: eukaryotic translation initiation factor 2-alpha kinase 1 | Type: kinase | Action: nan
19014,fedratinib,serine/threonine-protein kinase tao2,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase tao2 | Type: kinase | Action: nan
19015,fedratinib,snf-related serine/threonine-protein kinase,kinase,,Drug: fedratinib | Target: snf-related serine/threonine-protein kinase | Type: kinase | Action: nan
19016,fedratinib,phosphatidylinositol 5-phosphate 4-kinase type-2 gamma,kinase,,Drug: fedratinib | Target: phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | Type: kinase | Action: nan
19017,fedratinib,dual specificity mitogen-activated protein kinase kinase 5,kinase,,Drug: fedratinib | Target: dual specificity mitogen-activated protein kinase kinase 5 | Type: kinase | Action: nan
19018,fedratinib,serine/threonine-protein kinase nek11,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek11 | Type: kinase | Action: nan
19019,fedratinib,myosin light chain kinase 3,kinase,,Drug: fedratinib | Target: myosin light chain kinase 3 | Type: kinase | Action: nan
19020,fedratinib,leucine-rich repeat serine/threonine-protein kinase 2,kinase,,Drug: fedratinib | Target: leucine-rich repeat serine/threonine-protein kinase 2 | Type: kinase | Action: nan
19021,fedratinib,dual serine/threonine and tyrosine protein kinase,kinase,,Drug: fedratinib | Target: dual serine/threonine and tyrosine protein kinase | Type: kinase | Action: nan
19022,fedratinib,calcium-dependent protein kinase 1,kinase,,Drug: fedratinib | Target: calcium-dependent protein kinase 1 | Type: kinase | Action: nan
19023,fedratinib,bromodomain-containing protein 4,unclassified,,Drug: fedratinib | Target: bromodomain-containing protein 4 | Type: unclassified | Action: nan
19024,fedratinib,serine/threonine-protein kinase pknb,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase pknb | Type: kinase | Action: nan
19025,fedratinib,serine/threonine-protein kinase nek6,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek6 | Type: kinase | Action: nan
19026,fedratinib,cgmp-dependent protein kinase 1,kinase,,Drug: fedratinib | Target: cgmp-dependent protein kinase 1 | Type: kinase | Action: nan
19027,fedratinib,serine/threonine-protein kinase nek4,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek4 | Type: kinase | Action: nan
19028,fedratinib,bromodomain testis-specific protein,unclassified,,Drug: fedratinib | Target: bromodomain testis-specific protein | Type: unclassified | Action: nan
19029,fedratinib,serine/threonine-protein kinase nek1,kinase,,Drug: fedratinib | Target: serine/threonine-protein kinase nek1 | Type: kinase | Action: nan
19030,fedratinib,tyrosine-protein kinase jak3,kinase,INHIBITOR,Drug: fedratinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: INHIBITOR
19031,fedratinib,tyrosine-protein kinase jak1,kinase,INHIBITOR,Drug: fedratinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: INHIBITOR
19032,fedratinib,non-receptor tyrosine-protein kinase tyk2,kinase,INHIBITOR,Drug: fedratinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: INHIBITOR
19033,fedratinib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: fedratinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
19034,fedratinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: fedratinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
19035,tenapanor,sodium/hydrogen exchanger 3,transporter,,Drug: tenapanor | Target: sodium/hydrogen exchanger 3 | Type: transporter | Action: nan
19036,tenapanor,sodium/hydrogen exchanger 3,transporter,INHIBITOR,Drug: tenapanor | Target: sodium/hydrogen exchanger 3 | Type: transporter | Action: INHIBITOR
19037,trifarotene,retinoic acid receptor alpha,nuclear hormone receptor,AGONIST,Drug: trifarotene | Target: retinoic acid receptor alpha | Type: nuclear hormone receptor | Action: AGONIST
19038,trifarotene,retinoic acid receptor beta,nuclear hormone receptor,AGONIST,Drug: trifarotene | Target: retinoic acid receptor beta | Type: nuclear hormone receptor | Action: AGONIST
19039,trifarotene,retinoic acid receptor gamma,nuclear hormone receptor,AGONIST,Drug: trifarotene | Target: retinoic acid receptor gamma | Type: nuclear hormone receptor | Action: AGONIST
19040,lasmiditan,5-hydroxytryptamine receptor 1f,gpcr,AGONIST,Drug: lasmiditan | Target: 5-hydroxytryptamine receptor 1f | Type: gpcr | Action: AGONIST
19041,cefiderocol,peptidoglycan synthase ftsi,enzyme,INHIBITOR,Drug: cefiderocol | Target: peptidoglycan synthase ftsi | Type: enzyme | Action: INHIBITOR
19042,cefiderocol,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: cefiderocol | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
19043,cefiderocol,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: cefiderocol | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
19044,cefiderocol,penicillin-binding protein 1b,enzyme,INHIBITOR,Drug: cefiderocol | Target: penicillin-binding protein 1b | Type: enzyme | Action: INHIBITOR
19045,cefiderocol,penicillin-binding protein 1a,enzyme,INHIBITOR,Drug: cefiderocol | Target: penicillin-binding protein 1a | Type: enzyme | Action: INHIBITOR
19046,cefiderocol,penicillin-binding protein 1b,enzyme,INHIBITOR,Drug: cefiderocol | Target: penicillin-binding protein 1b | Type: enzyme | Action: INHIBITOR
19047,cefiderocol,"peptidoglycan d,d-transpeptidase mrda",enzyme,INHIBITOR,"Drug: cefiderocol | Target: peptidoglycan d,d-transpeptidase mrda | Type: enzyme | Action: INHIBITOR"
19048,cefiderocol,"peptidoglycan d,d-transpeptidase mrda",enzyme,INHIBITOR,"Drug: cefiderocol | Target: peptidoglycan d,d-transpeptidase mrda | Type: enzyme | Action: INHIBITOR"
19049,cefiderocol,"peptidoglycan d,d-transpeptidase ftsi",enzyme,INHIBITOR,"Drug: cefiderocol | Target: peptidoglycan d,d-transpeptidase ftsi | Type: enzyme | Action: INHIBITOR"
19050,cefiderocol,"peptidoglycan d,d-transpeptidase ftsi",enzyme,INHIBITOR,"Drug: cefiderocol | Target: peptidoglycan d,d-transpeptidase ftsi | Type: enzyme | Action: INHIBITOR"
19051,cefiderocol,"peptidoglycan d,d-transpeptidase ftsi",enzyme,INHIBITOR,"Drug: cefiderocol | Target: peptidoglycan d,d-transpeptidase ftsi | Type: enzyme | Action: INHIBITOR"
19052,cefiderocol,penicillin-binding protein 4,enzyme,INHIBITOR,Drug: cefiderocol | Target: penicillin-binding protein 4 | Type: enzyme | Action: INHIBITOR
19053,zanubrutinib,tyrosine-protein kinase btk,kinase,INHIBITOR,Drug: zanubrutinib | Target: tyrosine-protein kinase btk | Type: kinase | Action: INHIBITOR
19054,givosiran,aminolevulinate synthase1 (alas1) mrna,rna,ANTISENSE INHIBITOR,Drug: givosiran | Target: aminolevulinate synthase1 (alas1) mrna | Type: rna | Action: ANTISENSE INHIBITOR
19055,cenobamate,gamma-aminobutyric acid receptor subunit alpha-4,ion channel,ALLOSTERIC MODULATOR,Drug: cenobamate | Target: gamma-aminobutyric acid receptor subunit alpha-4 | Type: ion channel | Action: ALLOSTERIC MODULATOR
19056,cenobamate,gamma-aminobutyric acid receptor subunit alpha-6,ion channel,ALLOSTERIC MODULATOR,Drug: cenobamate | Target: gamma-aminobutyric acid receptor subunit alpha-6 | Type: ion channel | Action: ALLOSTERIC MODULATOR
19059,voxelotor,cytochrome p450 3a4,enzyme,INHIBITOR,Drug: voxelotor | Target: cytochrome p450 3a4 | Type: enzyme | Action: INHIBITOR
19060,voxelotor,cytochrome p450 2c8,enzyme,INHIBITOR,Drug: voxelotor | Target: cytochrome p450 2c8 | Type: enzyme | Action: INHIBITOR
19061,voxelotor,cytochrome p450 2c9,enzyme,INHIBITOR,Drug: voxelotor | Target: cytochrome p450 2c9 | Type: enzyme | Action: INHIBITOR
19062,voxelotor,hemoglobin subunit alpha,transporter,INHIBITOR,Drug: voxelotor | Target: hemoglobin subunit alpha | Type: transporter | Action: INHIBITOR
19063,golodirsen,exon 53 of dystrophin pre-mrna,rna,ANTISENSE INHIBITOR,Drug: golodirsen | Target: exon 53 of dystrophin pre-mrna | Type: rna | Action: ANTISENSE INHIBITOR
19064,lumateperone,5-hydroxytryptamine receptor 1a,gpcr,,Drug: lumateperone | Target: 5-hydroxytryptamine receptor 1a | Type: gpcr | Action: nan
19065,lumateperone,5-hydroxytryptamine receptor 2c,gpcr,,Drug: lumateperone | Target: 5-hydroxytryptamine receptor 2c | Type: gpcr | Action: nan
19066,lumateperone,alpha-1a adrenergic receptor,gpcr,,Drug: lumateperone | Target: alpha-1a adrenergic receptor | Type: gpcr | Action: nan
19067,lumateperone,d(4) dopamine receptor,gpcr,,Drug: lumateperone | Target: d(4) dopamine receptor | Type: gpcr | Action: nan
19068,lumateperone,alpha-1b adrenergic receptor,gpcr,,Drug: lumateperone | Target: alpha-1b adrenergic receptor | Type: gpcr | Action: nan
19069,lumateperone,d(2) dopamine receptor,gpcr,,Drug: lumateperone | Target: d(2) dopamine receptor | Type: gpcr | Action: nan
19070,lumateperone,d(1a) dopamine receptor,gpcr,ANTAGONIST,Drug: lumateperone | Target: d(1a) dopamine receptor | Type: gpcr | Action: ANTAGONIST
19071,lumateperone,sodium-dependent serotonin transporter,transporter,,Drug: lumateperone | Target: sodium-dependent serotonin transporter | Type: transporter | Action: nan
19072,lumateperone,d(2) dopamine receptor,gpcr,ANTAGONIST,Drug: lumateperone | Target: d(2) dopamine receptor | Type: gpcr | Action: ANTAGONIST
19073,lumateperone,5-hydroxytryptamine receptor 2a,gpcr,ANTAGONIST,Drug: lumateperone | Target: 5-hydroxytryptamine receptor 2a | Type: gpcr | Action: ANTAGONIST
19074,brilliant blue g,p2x purinoceptor 7,ion channel,ANTAGONIST,Drug: brilliant blue g | Target: p2x purinoceptor 7 | Type: ion channel | Action: ANTAGONIST
19075,brilliant blue g,alpha-synuclein,transporter,,Drug: brilliant blue g | Target: alpha-synuclein | Type: transporter | Action: nan
19076,lemborexant,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: lemborexant | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
19077,lemborexant,orexin receptor type 1,gpcr,ANTAGONIST,Drug: lemborexant | Target: orexin receptor type 1 | Type: gpcr | Action: ANTAGONIST
19078,lemborexant,orexin receptor type 2,gpcr,ANTAGONIST,Drug: lemborexant | Target: orexin receptor type 2 | Type: gpcr | Action: ANTAGONIST
19079,ubrogepant,calcitonin gene-related peptide type 1 receptor,gpcr,ANTAGONIST,Drug: ubrogepant | Target: calcitonin gene-related peptide type 1 receptor | Type: gpcr | Action: ANTAGONIST
19080,romosozumab,sclerostin,glycoprotein,BINDING AGENT,Drug: romosozumab | Target: sclerostin | Type: glycoprotein | Action: BINDING AGENT
19081,brolucizumab,vascular endothelial growth factor a,secreted,INHIBITOR,Drug: brolucizumab | Target: vascular endothelial growth factor a | Type: secreted | Action: INHIBITOR
19082,luspatercept,growth/differentiation factor 11,cytokine,BINDING AGENT,Drug: luspatercept | Target: growth/differentiation factor 11 | Type: cytokine | Action: BINDING AGENT
19083,luspatercept,growth/differentiation factor 8,cytokine,BINDING AGENT,Drug: luspatercept | Target: growth/differentiation factor 8 | Type: cytokine | Action: BINDING AGENT
19084,crizanlizumab,p-selectin,adhesion,INHIBITOR,Drug: crizanlizumab | Target: p-selectin | Type: adhesion | Action: INHIBITOR
19085,enfortumab vedotin,tubulin beta,tumour-associated antigen,BINDING AGENT,Drug: enfortumab vedotin | Target: tubulin beta | Type: tumour-associated antigen | Action: BINDING AGENT
19086,enfortumab vedotin,nectin-4,tumour-associated antigen,BINDING AGENT,Drug: enfortumab vedotin | Target: nectin-4 | Type: tumour-associated antigen | Action: BINDING AGENT
19087,trastuzumab deruxtecan,receptor tyrosine-protein kinase erbb-2,kinase,BINDING AGENT,Drug: trastuzumab deruxtecan | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: BINDING AGENT
19088,trastuzumab deruxtecan,dna topoisomerase 1,enzyme,INHIBITOR,Drug: trastuzumab deruxtecan | Target: dna topoisomerase 1 | Type: enzyme | Action: INHIBITOR
19089,botulinum toxin type a,synaptosomal-associated protein 25,cytosolic other,BLOCKER,Drug: botulinum toxin type a | Target: synaptosomal-associated protein 25 | Type: cytosolic other | Action: BLOCKER
19090,roxadustat,alpha-ketoglutarate-dependent dioxygenase fto,unclassified,,Drug: roxadustat | Target: alpha-ketoglutarate-dependent dioxygenase fto | Type: unclassified | Action: nan
19091,roxadustat,egl nine homolog 1,enzyme,INHIBITOR,Drug: roxadustat | Target: egl nine homolog 1 | Type: enzyme | Action: INHIBITOR
19092,roxadustat,egl nine homolog 2,enzyme,INHIBITOR,Drug: roxadustat | Target: egl nine homolog 2 | Type: enzyme | Action: INHIBITOR
19093,roxadustat,egl nine homolog 3,enzyme,INHIBITOR,Drug: roxadustat | Target: egl nine homolog 3 | Type: enzyme | Action: INHIBITOR
19094,elexacaftor,cystic fibrosis transmembrane conductance regulator,ion channel,,Drug: elexacaftor | Target: cystic fibrosis transmembrane conductance regulator | Type: ion channel | Action: nan
19095,cepharanthine,trypanothione reductase,enzyme,,Drug: cepharanthine | Target: trypanothione reductase | Type: enzyme | Action: nan
19096,cepharanthine,5'-amp-activated protein kinase catalytic subunit alpha-1,kinase,INHIBITOR,Drug: cepharanthine | Target: 5'-amp-activated protein kinase catalytic subunit alpha-1 | Type: kinase | Action: INHIBITOR
19097,cepharanthine,nuclear factor nf-kappa-b p105 subunit,cytosolic other,INHIBITOR,Drug: cepharanthine | Target: nuclear factor nf-kappa-b p105 subunit | Type: cytosolic other | Action: INHIBITOR
19098,remdesivir,replicase polyprotein 1ab,enzyme,INHIBITOR,Drug: remdesivir | Target: replicase polyprotein 1ab | Type: enzyme | Action: INHIBITOR
19099,mefuparib,poly [adp-ribose] polymerase 2,enzyme,INHIBITOR,Drug: mefuparib | Target: poly [adp-ribose] polymerase 2 | Type: enzyme | Action: INHIBITOR
19100,mefuparib,poly [adp-ribose] polymerase 1,enzyme,INHIBITOR,Drug: mefuparib | Target: poly [adp-ribose] polymerase 1 | Type: enzyme | Action: INHIBITOR
19101,avapritinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: avapritinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
19102,avapritinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: avapritinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
19103,avapritinib,platelet-derived growth factor receptor alpha,kinase,INHIBITOR,Drug: avapritinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: INHIBITOR
19104,tazemetostat,polycomb protein eed,unclassified,,Drug: tazemetostat | Target: polycomb protein eed | Type: unclassified | Action: nan
19105,tazemetostat,histone-lysine n-methyltransferase ezh1,enzyme,INHIBITOR,Drug: tazemetostat | Target: histone-lysine n-methyltransferase ezh1 | Type: enzyme | Action: INHIBITOR
19106,tazemetostat,histone-lysine n-methyltransferase ezh2,enzyme,INHIBITOR,Drug: tazemetostat | Target: histone-lysine n-methyltransferase ezh2 | Type: enzyme | Action: INHIBITOR
19107,rimegepant,calcitonin gene-related peptide type 1 receptor,gpcr,ANTAGONIST,Drug: rimegepant | Target: calcitonin gene-related peptide type 1 receptor | Type: gpcr | Action: ANTAGONIST
19108,bempedoic acid,atp-citrate synthase,enzyme,INHIBITOR,Drug: bempedoic acid | Target: atp-citrate synthase | Type: enzyme | Action: INHIBITOR
19109,ozanimod,sphingosine 1-phosphate receptor 4,gpcr,,Drug: ozanimod | Target: sphingosine 1-phosphate receptor 4 | Type: gpcr | Action: nan
19110,ozanimod,sphingosine 1-phosphate receptor 3,gpcr,,Drug: ozanimod | Target: sphingosine 1-phosphate receptor 3 | Type: gpcr | Action: nan
19111,ozanimod,sphingosine 1-phosphate receptor 2,gpcr,,Drug: ozanimod | Target: sphingosine 1-phosphate receptor 2 | Type: gpcr | Action: nan
19112,ozanimod,sphingosine 1-phosphate receptor 1,gpcr,AGONIST,Drug: ozanimod | Target: sphingosine 1-phosphate receptor 1 | Type: gpcr | Action: AGONIST
19113,ozanimod,sphingosine 1-phosphate receptor 5,gpcr,AGONIST,Drug: ozanimod | Target: sphingosine 1-phosphate receptor 5 | Type: gpcr | Action: AGONIST
19114,osilodrostat,aromatase,enzyme,,Drug: osilodrostat | Target: aromatase | Type: enzyme | Action: nan
19115,osilodrostat,"cytochrome p450 11b2, mitochondrial",enzyme,,"Drug: osilodrostat | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: nan"
19116,osilodrostat,"cytochrome p450 11b1, mitochondrial",enzyme,,"Drug: osilodrostat | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: nan"
19117,osilodrostat,"cytochrome p450 11b2, mitochondrial",enzyme,,"Drug: osilodrostat | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: nan"
19118,osilodrostat,"cytochrome p450 11b2, mitochondrial",enzyme,INHIBITOR,"Drug: osilodrostat | Target: cytochrome p450 11b2, mitochondrial | Type: enzyme | Action: INHIBITOR"
19119,osilodrostat,"cytochrome p450 11b1, mitochondrial",enzyme,INHIBITOR,"Drug: osilodrostat | Target: cytochrome p450 11b1, mitochondrial | Type: enzyme | Action: INHIBITOR"
19120,isatuximab,lymphocyte differentiation antigen cd38,tumour-associated antigen,BINDING AGENT,Drug: isatuximab | Target: lymphocyte differentiation antigen cd38 | Type: tumour-associated antigen | Action: BINDING AGENT
19121,eptinezumab,calcitonin gene-related peptide 1,gpcr,BINDING AGENT,Drug: eptinezumab | Target: calcitonin gene-related peptide 1 | Type: gpcr | Action: BINDING AGENT
19122,eptinezumab,calcitonin gene-related peptide 2,gpcr,BINDING AGENT,Drug: eptinezumab | Target: calcitonin gene-related peptide 2 | Type: gpcr | Action: BINDING AGENT
19123,teprotumumab,insulin-like growth factor 1 receptor,kinase,ANTAGONIST,Drug: teprotumumab | Target: insulin-like growth factor 1 receptor | Type: kinase | Action: ANTAGONIST
19124,selumetinib,epidermal growth factor receptor,kinase,,Drug: selumetinib | Target: epidermal growth factor receptor | Type: kinase | Action: nan
19125,selumetinib,dual specificity mitogen-activated protein kinase kinase 1,kinase,INHIBITOR,Drug: selumetinib | Target: dual specificity mitogen-activated protein kinase kinase 1 | Type: kinase | Action: INHIBITOR
19126,selumetinib,dual specificity mitogen-activated protein kinase kinase 2,kinase,INHIBITOR,Drug: selumetinib | Target: dual specificity mitogen-activated protein kinase kinase 2 | Type: kinase | Action: INHIBITOR
19127,tucatinib,epidermal growth factor receptor,kinase,INHIBITOR,Drug: tucatinib | Target: epidermal growth factor receptor | Type: kinase | Action: INHIBITOR
19128,tucatinib,receptor tyrosine-protein kinase erbb-4,kinase,INHIBITOR,Drug: tucatinib | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: INHIBITOR
19129,tucatinib,erbb2/erbb3,kinase,INHIBITOR,Drug: tucatinib | Target: erbb2/erbb3 | Type: kinase | Action: INHIBITOR
19130,pemigatinib,fibroblast growth factor receptor 4,kinase,INHIBITOR,Drug: pemigatinib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: INHIBITOR
19131,pemigatinib,fibroblast growth factor receptor 3,kinase,INHIBITOR,Drug: pemigatinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: INHIBITOR
19132,pemigatinib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: pemigatinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
19133,pemigatinib,fibroblast growth factor receptor 2,kinase,INHIBITOR,Drug: pemigatinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: INHIBITOR
19134,sacituzumab govitecan,igg receptor fcrn large subunit p51,membrane receptor,ANTIBODY BINDING,Drug: sacituzumab govitecan | Target: igg receptor fcrn large subunit p51 | Type: membrane receptor | Action: ANTIBODY BINDING
19135,sacituzumab govitecan,dna topoisomerase 1,enzyme,BINDING AGENT,Drug: sacituzumab govitecan | Target: dna topoisomerase 1 | Type: enzyme | Action: BINDING AGENT
19136,sacituzumab govitecan,tumor-associated calcium signal transducer 2,tumour-associated antigen,ANTIBODY BINDING,Drug: sacituzumab govitecan | Target: tumor-associated calcium signal transducer 2 | Type: tumour-associated antigen | Action: ANTIBODY BINDING
19137,capmatinib,hepatocyte growth factor receptor,kinase,INHIBITOR,Drug: capmatinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: INHIBITOR
19138,selpercatinib,aurora kinase b,kinase,INHIBITOR,Drug: selpercatinib | Target: aurora kinase b | Type: kinase | Action: INHIBITOR
19139,selpercatinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: selpercatinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
19140,ripretinib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: ripretinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
19141,ripretinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: ripretinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
19142,ripretinib,macrophage colony-stimulating factor 1 receptor,kinase,INHIBITOR,Drug: ripretinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: INHIBITOR
19143,ripretinib,angiopoietin-1 receptor,kinase,INHIBITOR,Drug: ripretinib | Target: angiopoietin-1 receptor | Type: kinase | Action: INHIBITOR
19144,ripretinib,mast/stem cell growth factor receptor kit,kinase,INHIBITOR,Drug: ripretinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: INHIBITOR
19145,ripretinib,platelet-derived growth factor receptor alpha,kinase,INHIBITOR,Drug: ripretinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: INHIBITOR
19146,fluoroestradiol f 18,estrogen receptor,nuclear hormone receptor,BINDING AGENT,Drug: fluoroestradiol f 18 | Target: estrogen receptor | Type: nuclear hormone receptor | Action: BINDING AGENT
19147,flortaucipir f 18,microtubule-associated protein tau,structural,BINDING AGENT,Drug: flortaucipir f 18 | Target: microtubule-associated protein tau | Type: structural | Action: BINDING AGENT
19148,inebilizumab,low affinity immunoglobulin gamma fc region receptor iii-a,membrane receptor,ANTIBODY BINDING,Drug: inebilizumab | Target: low affinity immunoglobulin gamma fc region receptor iii-a | Type: membrane receptor | Action: ANTIBODY BINDING
19149,inebilizumab,b-lymphocyte antigen cd19,surface antigen,ANTIBODY BINDING,Drug: inebilizumab | Target: b-lymphocyte antigen cd19 | Type: surface antigen | Action: ANTIBODY BINDING
19150,remimazolam,gaba a receptor alpha-3/beta-2/gamma-2,ion channel,MODULATOR,Drug: remimazolam | Target: gaba a receptor alpha-3/beta-2/gamma-2 | Type: ion channel | Action: MODULATOR
19151,remimazolam,gaba-a receptor; alpha-1/beta-2/gamma-2,ion channel,MODULATOR,Drug: remimazolam | Target: gaba-a receptor; alpha-1/beta-2/gamma-2 | Type: ion channel | Action: MODULATOR
19152,remimazolam,gaba a receptor alpha-2/beta-2/gamma-2,ion channel,MODULATOR,Drug: remimazolam | Target: gaba a receptor alpha-2/beta-2/gamma-2 | Type: ion channel | Action: MODULATOR
19153,remimazolam,gaba a receptor alpha-5/beta-2/gamma-2,ion channel,MODULATOR,Drug: remimazolam | Target: gaba a receptor alpha-5/beta-2/gamma-2 | Type: ion channel | Action: MODULATOR
19154,remimazolam,gaba-a receptor; benzodiazepine binding site,ion channel,MODULATOR,Drug: remimazolam | Target: gaba-a receptor; benzodiazepine binding site | Type: ion channel | Action: MODULATOR
19155,fostemsavir,envelope glycoprotein gp160,viral envelope protein,INHIBITOR,Drug: fostemsavir | Target: envelope glycoprotein gp160 | Type: viral envelope protein | Action: INHIBITOR
19156,inqovi,cytidine deaminase,enzyme,INHIBITOR,Drug: inqovi | Target: cytidine deaminase | Type: enzyme | Action: INHIBITOR
19157,abametapir,c-c chemokine receptor type 5,gpcr,,Drug: abametapir | Target: c-c chemokine receptor type 5 | Type: gpcr | Action: nan
19158,abametapir,c-c chemokine receptor type 1,gpcr,,Drug: abametapir | Target: c-c chemokine receptor type 1 | Type: gpcr | Action: nan
19161,abametapir,c-c chemokine receptor type 8,gpcr,,Drug: abametapir | Target: c-c chemokine receptor type 8 | Type: gpcr | Action: nan
19162,tafasitamab,b-lymphocyte antigen cd19,surface antigen,ANTIBODY BINDING,Drug: tafasitamab | Target: b-lymphocyte antigen cd19 | Type: surface antigen | Action: ANTIBODY BINDING
19163,belantamab mafodotin,igg receptor fcrn large subunit p51,membrane receptor,BINDING AGENT,Drug: belantamab mafodotin | Target: igg receptor fcrn large subunit p51 | Type: membrane receptor | Action: BINDING AGENT
19164,belantamab mafodotin,high affinity immunoglobulin gamma fc receptor i,membrane receptor,BINDING AGENT,Drug: belantamab mafodotin | Target: high affinity immunoglobulin gamma fc receptor i | Type: membrane receptor | Action: BINDING AGENT
19165,belantamab mafodotin,low affinity immunoglobulin gamma fc region receptor iii-a,membrane receptor,BINDING AGENT,Drug: belantamab mafodotin | Target: low affinity immunoglobulin gamma fc region receptor iii-a | Type: membrane receptor | Action: BINDING AGENT
19166,belantamab mafodotin,tumor necrosis factor receptor superfamily member 17,tumour-associated antigen,BINDING AGENT,Drug: belantamab mafodotin | Target: tumor necrosis factor receptor superfamily member 17 | Type: tumour-associated antigen | Action: BINDING AGENT
19167,oliceridine,sodium channel protein type 5 subunit alpha,ion channel,,Drug: oliceridine | Target: sodium channel protein type 5 subunit alpha | Type: ion channel | Action: nan
19168,oliceridine,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: oliceridine | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
19169,oliceridine,voltage-dependent l-type calcium channel subunit alpha-1c,ion channel,,Drug: oliceridine | Target: voltage-dependent l-type calcium channel subunit alpha-1c | Type: ion channel | Action: nan
19173,oliceridine,nociceptin receptor,gpcr,AGONIST,Drug: oliceridine | Target: nociceptin receptor | Type: gpcr | Action: AGONIST
19174,oliceridine,mu-type opioid receptor,gpcr,AGONIST,Drug: oliceridine | Target: mu-type opioid receptor | Type: gpcr | Action: AGONIST
19175,viltolarsen,exon 53 of dystrophin pre-mrna,rna,BINDING AGENT,Drug: viltolarsen | Target: exon 53 of dystrophin pre-mrna | Type: rna | Action: BINDING AGENT
19176,satralizumab,interleukin-6 receptor,membrane receptor,ANTAGONIST,Drug: satralizumab | Target: interleukin-6 receptor | Type: membrane receptor | Action: ANTAGONIST
19177,clascoterone,androgen receptor,nuclear hormone receptor,ANTAGONIST,Drug: clascoterone | Target: androgen receptor | Type: nuclear hormone receptor | Action: ANTAGONIST
19178,copper dotatate cu-64,somatostatin receptor type 2,gpcr,BINDING AGENT,Drug: copper dotatate cu-64 | Target: somatostatin receptor type 2 | Type: gpcr | Action: BINDING AGENT
19179,pralsetinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: pralsetinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
19180,pralsetinib,platelet-derived growth factor receptor beta,kinase,INHIBITOR,Drug: pralsetinib | Target: platelet-derived growth factor receptor beta | Type: kinase | Action: INHIBITOR
19181,pralsetinib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: pralsetinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
19182,pralsetinib,tyrosine-protein kinase jak1,kinase,INHIBITOR,Drug: pralsetinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: INHIBITOR
19183,pralsetinib,high affinity nerve growth factor receptor,kinase,INHIBITOR,Drug: pralsetinib | Target: high affinity nerve growth factor receptor | Type: kinase | Action: INHIBITOR
19184,pralsetinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: pralsetinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
19185,pralsetinib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: pralsetinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
19186,pralsetinib,epithelial discoidin domain-containing receptor 1,kinase,INHIBITOR,Drug: pralsetinib | Target: epithelial discoidin domain-containing receptor 1 | Type: kinase | Action: INHIBITOR
19187,pralsetinib,nt-3 growth factor receptor,kinase,INHIBITOR,Drug: pralsetinib | Target: nt-3 growth factor receptor | Type: kinase | Action: INHIBITOR
19188,pralsetinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,INHIBITOR,Drug: pralsetinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: INHIBITOR
19189,somapacitan,growth hormone receptor,gpcr,,Drug: somapacitan | Target: growth hormone receptor | Type: gpcr | Action: nan
19190,lonafarnib,gtpase hras,cytosolic other,INHIBITOR,Drug: lonafarnib | Target: gtpase hras | Type: cytosolic other | Action: INHIBITOR
19191,lonafarnib,gtpase kras,enzyme,INHIBITOR,Drug: lonafarnib | Target: gtpase kras | Type: enzyme | Action: INHIBITOR
19192,lonafarnib,gtpase nras,enzyme,INHIBITOR,Drug: lonafarnib | Target: gtpase nras | Type: enzyme | Action: INHIBITOR
19193,lonafarnib,gtpase hras,enzyme,INHIBITOR,Drug: lonafarnib | Target: gtpase hras | Type: enzyme | Action: INHIBITOR
19195,lonafarnib,protein farnesyltransferase,enzyme,INHIBITOR,Drug: lonafarnib | Target: protein farnesyltransferase | Type: enzyme | Action: INHIBITOR
19196,lumasiran,hydroxyacid oxidase 1 (hao1) mrna,rna,ANTISENSE INHIBITOR,Drug: lumasiran | Target: hydroxyacid oxidase 1 (hao1) mrna | Type: rna | Action: ANTISENSE INHIBITOR
19197,setmelanotide,melanocortin receptor 5,gpcr,AGONIST,Drug: setmelanotide | Target: melanocortin receptor 5 | Type: gpcr | Action: AGONIST
19198,setmelanotide,melanocortin receptor 3,gpcr,AGONIST,Drug: setmelanotide | Target: melanocortin receptor 3 | Type: gpcr | Action: AGONIST
19199,setmelanotide,melanocyte-stimulating hormone receptor,gpcr,AGONIST,Drug: setmelanotide | Target: melanocyte-stimulating hormone receptor | Type: gpcr | Action: AGONIST
19203,setmelanotide,melanocortin receptor 4,gpcr,AGONIST,Drug: setmelanotide | Target: melanocortin receptor 4 | Type: gpcr | Action: AGONIST
19204,bulevirtide,sodium/bile acid cotransporter,transporter,INHIBITOR,Drug: bulevirtide | Target: sodium/bile acid cotransporter | Type: transporter | Action: INHIBITOR
19205,imlifidase,"immunoglobulin gamma (igg), heavy chain",antibody,INHIBITOR,"Drug: imlifidase | Target: immunoglobulin gamma (igg), heavy chain | Type: antibody | Action: INHIBITOR"
19206,filgotinib,potassium voltage-gated channel subfamily h member 2,ion channel,,Drug: filgotinib | Target: potassium voltage-gated channel subfamily h member 2 | Type: ion channel | Action: nan
19207,filgotinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: filgotinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
19208,filgotinib,vascular endothelial growth factor receptor 3,kinase,,Drug: filgotinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: nan
19209,filgotinib,macrophage colony-stimulating factor 1 receptor,kinase,,Drug: filgotinib | Target: macrophage colony-stimulating factor 1 receptor | Type: kinase | Action: nan
19214,filgotinib,tyrosine-protein kinase jak3,kinase,INHIBITOR,Drug: filgotinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: INHIBITOR
19215,filgotinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: filgotinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
19216,filgotinib,non-receptor tyrosine-protein kinase tyk2,kinase,INHIBITOR,Drug: filgotinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: INHIBITOR
19217,filgotinib,tyrosine-protein kinase jak1,kinase,INHIBITOR,Drug: filgotinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: INHIBITOR
19218,vadadustat,vascular endothelial growth factor a,secreted,,Drug: vadadustat | Target: vascular endothelial growth factor a | Type: secreted | Action: nan
19219,vadadustat,hypoxia-inducible factor 1-alpha inhibitor,enzyme,,Drug: vadadustat | Target: hypoxia-inducible factor 1-alpha inhibitor | Type: enzyme | Action: nan
19220,vadadustat,vascular endothelial growth factor a,unclassified,,Drug: vadadustat | Target: vascular endothelial growth factor a | Type: unclassified | Action: nan
19221,vadadustat,prolyl 3-hydroxylase ogfod1,unclassified,,Drug: vadadustat | Target: prolyl 3-hydroxylase ogfod1 | Type: unclassified | Action: nan
19222,vadadustat,hypoxia-inducible factor 1-alpha inhibitor,unclassified,,Drug: vadadustat | Target: hypoxia-inducible factor 1-alpha inhibitor | Type: unclassified | Action: nan
19223,vadadustat,egl nine homolog 1,enzyme,INHIBITOR,Drug: vadadustat | Target: egl nine homolog 1 | Type: enzyme | Action: INHIBITOR
19224,vadadustat,egl nine homolog 2,enzyme,INHIBITOR,Drug: vadadustat | Target: egl nine homolog 2 | Type: enzyme | Action: INHIBITOR
19225,vadadustat,egl nine homolog 3,enzyme,INHIBITOR,Drug: vadadustat | Target: egl nine homolog 3 | Type: enzyme | Action: INHIBITOR
19226,daprodustat,egl nine homolog 1,enzyme,INHIBITOR,Drug: daprodustat | Target: egl nine homolog 1 | Type: enzyme | Action: INHIBITOR
19227,daprodustat,egl nine homolog 2,enzyme,INHIBITOR,Drug: daprodustat | Target: egl nine homolog 2 | Type: enzyme | Action: INHIBITOR
19228,daprodustat,egl nine homolog 3,enzyme,INHIBITOR,Drug: daprodustat | Target: egl nine homolog 3 | Type: enzyme | Action: INHIBITOR
19229,borofalan (10b),l-type amino acid transporter 1,transporter,SUBSTRATE,Drug: borofalan (10b) | Target: l-type amino acid transporter 1 | Type: transporter | Action: SUBSTRATE
19230,tirabrutinib hydrochloride,tyrosine-protein kinase lck,kinase,,Drug: tirabrutinib hydrochloride | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
19231,tirabrutinib hydrochloride,receptor tyrosine-protein kinase erbb-2,kinase,,Drug: tirabrutinib hydrochloride | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: nan
19234,tirabrutinib hydrochloride,receptor tyrosine-protein kinase erbb-4,kinase,INHIBITOR,Drug: tirabrutinib hydrochloride | Target: receptor tyrosine-protein kinase erbb-4 | Type: kinase | Action: INHIBITOR
19235,tirabrutinib hydrochloride,cytoplasmic tyrosine-protein kinase bmx,kinase,INHIBITOR,Drug: tirabrutinib hydrochloride | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: INHIBITOR
19236,tirabrutinib hydrochloride,tyrosine-protein kinase tec,kinase,INHIBITOR,Drug: tirabrutinib hydrochloride | Target: tyrosine-protein kinase tec | Type: kinase | Action: INHIBITOR
19237,tirabrutinib hydrochloride,tyrosine-protein kinase txk,kinase,INHIBITOR,Drug: tirabrutinib hydrochloride | Target: tyrosine-protein kinase txk | Type: kinase | Action: INHIBITOR
19238,tirabrutinib hydrochloride,tyrosine-protein kinase blk,kinase,INHIBITOR,Drug: tirabrutinib hydrochloride | Target: tyrosine-protein kinase blk | Type: kinase | Action: INHIBITOR
19239,tirabrutinib hydrochloride,tyrosine-protein kinase btk,kinase,INHIBITOR,Drug: tirabrutinib hydrochloride | Target: tyrosine-protein kinase btk | Type: kinase | Action: INHIBITOR
19240,tepotinib,interleukin-1 receptor-associated kinase 4,kinase,INHIBITOR,Drug: tepotinib | Target: interleukin-1 receptor-associated kinase 4 | Type: kinase | Action: INHIBITOR
19241,tepotinib,hepatocyte growth factor receptor,kinase,INHIBITOR,Drug: tepotinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: INHIBITOR
19242,dotinurad,atp-binding cassette sub-family g member 2,transporter,INHIBITOR,Drug: dotinurad | Target: atp-binding cassette sub-family g member 2 | Type: transporter | Action: INHIBITOR
19243,dotinurad,solute carrier family 22 member 6,transporter,INHIBITOR,Drug: dotinurad | Target: solute carrier family 22 member 6 | Type: transporter | Action: INHIBITOR
19244,dotinurad,solute carrier family 22 member 8,transporter,INHIBITOR,Drug: dotinurad | Target: solute carrier family 22 member 8 | Type: transporter | Action: INHIBITOR
19245,dotinurad,cytochrome p450 2c9,enzyme,INHIBITOR,Drug: dotinurad | Target: cytochrome p450 2c9 | Type: enzyme | Action: INHIBITOR
19246,dotinurad,solute carrier family 22 member 12,transporter,INHIBITOR,Drug: dotinurad | Target: solute carrier family 22 member 12 | Type: transporter | Action: INHIBITOR
19247,delgocitinib,rho-associated protein kinase 2,kinase,INHIBITOR,Drug: delgocitinib | Target: rho-associated protein kinase 2 | Type: kinase | Action: INHIBITOR
19248,delgocitinib,tyrosine-protein kinase jak3,kinase,INHIBITOR,Drug: delgocitinib | Target: tyrosine-protein kinase jak3 | Type: kinase | Action: INHIBITOR
19249,delgocitinib,tyrosine-protein kinase jak1,kinase,INHIBITOR,Drug: delgocitinib | Target: tyrosine-protein kinase jak1 | Type: kinase | Action: INHIBITOR
19250,delgocitinib,tyrosine-protein kinase jak2,kinase,INHIBITOR,Drug: delgocitinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: INHIBITOR
19251,delgocitinib,non-receptor tyrosine-protein kinase tyk2,kinase,INHIBITOR,Drug: delgocitinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: INHIBITOR
19252,enarodustat,egl nine homolog 1,enzyme,INHIBITOR,Drug: enarodustat | Target: egl nine homolog 1 | Type: enzyme | Action: INHIBITOR
19253,enarodustat,egl nine homolog 2,enzyme,INHIBITOR,Drug: enarodustat | Target: egl nine homolog 2 | Type: enzyme | Action: INHIBITOR
19254,enarodustat,egl nine homolog 3,enzyme,INHIBITOR,Drug: enarodustat | Target: egl nine homolog 3 | Type: enzyme | Action: INHIBITOR
19255,sofpironium bromide,muscarinic acetylcholine receptor m3,gpcr,INHIBITOR,Drug: sofpironium bromide | Target: muscarinic acetylcholine receptor m3 | Type: gpcr | Action: INHIBITOR
19256,gallium (68ga) gozetotide,prostate-specific antigen,surface antigen,BINDING AGENT,Drug: gallium (68ga) gozetotide | Target: prostate-specific antigen | Type: surface antigen | Action: BINDING AGENT
19257,berotralstat,plasma kallikrein,enzyme,INHIBITOR,Drug: berotralstat | Target: plasma kallikrein | Type: enzyme | Action: INHIBITOR
19258,tirbanibulin,proto-oncogene tyrosine-protein kinase src,kinase,INHIBITOR,Drug: tirbanibulin | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: INHIBITOR
19259,tirbanibulin,tyrosine-protein kinase lyn,kinase,,Drug: tirbanibulin | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
19262,relugolix,gonadotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: relugolix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
19264,relugolix,gonadotropin-releasing hormone receptor,gpcr,ANTAGONIST,Drug: relugolix | Target: gonadotropin-releasing hormone receptor | Type: gpcr | Action: ANTAGONIST
19265,ansuvimab,envelope glycoprotein,glycoprotein,ANTIBODY BINDING,Drug: ansuvimab | Target: envelope glycoprotein | Type: glycoprotein | Action: ANTIBODY BINDING
19266,margetuximab,receptor tyrosine-protein kinase erbb-2,kinase,ANTAGONIST,Drug: margetuximab | Target: receptor tyrosine-protein kinase erbb-2 | Type: kinase | Action: ANTAGONIST
19267,margetuximab,low affinity immunoglobulin gamma fc region receptor iii-a,membrane receptor,ANTAGONIST,Drug: margetuximab | Target: low affinity immunoglobulin gamma fc region receptor iii-a | Type: membrane receptor | Action: ANTAGONIST
19268,atoltivimab,low affinity immunoglobulin gamma fc region receptor iii-a,membrane receptor,ANTIBODY BINDING,Drug: atoltivimab | Target: low affinity immunoglobulin gamma fc region receptor iii-a | Type: membrane receptor | Action: ANTIBODY BINDING
19269,atoltivimab,envelope glycoprotein,glycoprotein,ANTIBODY BINDING,Drug: atoltivimab | Target: envelope glycoprotein | Type: glycoprotein | Action: ANTIBODY BINDING
19270,maftivimab,envelope glycoprotein,glycoprotein,ANTIBODY BINDING,Drug: maftivimab | Target: envelope glycoprotein | Type: glycoprotein | Action: ANTIBODY BINDING
19271,odesivimab,low affinity immunoglobulin gamma fc region receptor iii-a,membrane receptor,ANTIBODY BINDING,Drug: odesivimab | Target: low affinity immunoglobulin gamma fc region receptor iii-a | Type: membrane receptor | Action: ANTIBODY BINDING
19272,odesivimab,envelope glycoprotein,glycoprotein,ANTIBODY BINDING,Drug: odesivimab | Target: envelope glycoprotein | Type: glycoprotein | Action: ANTIBODY BINDING
19273,vericiguat,guanylate cyclase soluble subunit beta-1,enzyme,ACTIVATOR,Drug: vericiguat | Target: guanylate cyclase soluble subunit beta-1 | Type: enzyme | Action: ACTIVATOR
19274,vericiguat,guanylate cyclase soluble subunit beta-1,enzyme,ACTIVATOR,Drug: vericiguat | Target: guanylate cyclase soluble subunit beta-1 | Type: enzyme | Action: ACTIVATOR
19275,cabotegravir,integrase,enzyme,,Drug: cabotegravir | Target: integrase | Type: enzyme | Action: nan
19276,cabotegravir,integrase,unclassified,,Drug: cabotegravir | Target: integrase | Type: unclassified | Action: nan
19277,cabotegravir,integrase,enzyme,INHIBITOR,Drug: cabotegravir | Target: integrase | Type: enzyme | Action: INHIBITOR
19278,umbralisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform",kinase,INHIBITOR,"Drug: umbralisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Type: kinase | Action: INHIBITOR"
19279,umbralisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform",kinase,INHIBITOR,"Drug: umbralisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | Type: kinase | Action: INHIBITOR"
19280,umbralisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform",kinase,INHIBITOR,"Drug: umbralisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | Type: kinase | Action: INHIBITOR"
19281,umbralisib,"phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform",kinase,INHIBITOR,"Drug: umbralisib | Target: phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | Type: kinase | Action: INHIBITOR"
19282,umbralisib,casein kinase i isoform epsilon,kinase,INHIBITOR,Drug: umbralisib | Target: casein kinase i isoform epsilon | Type: kinase | Action: INHIBITOR
19283,trilaciclib,receptor-type tyrosine-protein kinase flt3,kinase,INHIBITOR,Drug: trilaciclib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: INHIBITOR
19284,trilaciclib,cyclin-dependent kinase 1,kinase,INHIBITOR,Drug: trilaciclib | Target: cyclin-dependent kinase 1 | Type: kinase | Action: INHIBITOR
19285,trilaciclib,cyclin-dependent kinase 2,kinase,INHIBITOR,Drug: trilaciclib | Target: cyclin-dependent kinase 2 | Type: kinase | Action: INHIBITOR
19286,trilaciclib,cyclin-dependent-like kinase 5,kinase,INHIBITOR,Drug: trilaciclib | Target: cyclin-dependent-like kinase 5 | Type: kinase | Action: INHIBITOR
19287,trilaciclib,cyclin-dependent kinase 9,kinase,INHIBITOR,Drug: trilaciclib | Target: cyclin-dependent kinase 9 | Type: kinase | Action: INHIBITOR
19288,trilaciclib,cyclin-dependent kinase 7,kinase,INHIBITOR,Drug: trilaciclib | Target: cyclin-dependent kinase 7 | Type: kinase | Action: INHIBITOR
19289,trilaciclib,nuak family snf1-like kinase 2,kinase,INHIBITOR,Drug: trilaciclib | Target: nuak family snf1-like kinase 2 | Type: kinase | Action: INHIBITOR
19290,trilaciclib,serine/threonine-protein kinase nek10,kinase,INHIBITOR,Drug: trilaciclib | Target: serine/threonine-protein kinase nek10 | Type: kinase | Action: INHIBITOR
19291,trilaciclib,cyclin-dependent kinase 6,kinase,INHIBITOR,Drug: trilaciclib | Target: cyclin-dependent kinase 6 | Type: kinase | Action: INHIBITOR
19292,trilaciclib,cyclin-dependent kinase 4,kinase,INHIBITOR,Drug: trilaciclib | Target: cyclin-dependent kinase 4 | Type: kinase | Action: INHIBITOR
19293,casimersen,exon 53 of dystrophin pre-mrna,rna,ANTISENSE INHIBITOR,Drug: casimersen | Target: exon 53 of dystrophin pre-mrna | Type: rna | Action: ANTISENSE INHIBITOR
19294,fosdenopterin,molybdenum cofactor biosynthesis protein 1,enzyme,,Drug: fosdenopterin | Target: molybdenum cofactor biosynthesis protein 1 | Type: enzyme | Action: nan
19295,ponesimod,sphingosine 1-phosphate receptor 5,gpcr,AGONIST,Drug: ponesimod | Target: sphingosine 1-phosphate receptor 5 | Type: gpcr | Action: AGONIST
19296,ponesimod,sphingosine 1-phosphate receptor 4,gpcr,AGONIST,Drug: ponesimod | Target: sphingosine 1-phosphate receptor 4 | Type: gpcr | Action: AGONIST
19297,ponesimod,sphingosine 1-phosphate receptor 3,gpcr,AGONIST,Drug: ponesimod | Target: sphingosine 1-phosphate receptor 3 | Type: gpcr | Action: AGONIST
19298,ponesimod,sphingosine 1-phosphate receptor 1,gpcr,AGONIST,Drug: ponesimod | Target: sphingosine 1-phosphate receptor 1 | Type: gpcr | Action: AGONIST
19299,dasiglucagon,glucagon receptor,gpcr,AGONIST,Drug: dasiglucagon | Target: glucagon receptor | Type: gpcr | Action: AGONIST
19300,evinacumab,angiopoietin-related protein 3,secreted,INHIBITOR,Drug: evinacumab | Target: angiopoietin-related protein 3 | Type: secreted | Action: INHIBITOR
19301,estetrol,estrogen receptor,nuclear hormone receptor,MODULATOR,Drug: estetrol | Target: estrogen receptor | Type: nuclear hormone receptor | Action: MODULATOR
19302,estetrol,estrogen receptor beta,nuclear hormone receptor,MODULATOR,Drug: estetrol | Target: estrogen receptor beta | Type: nuclear hormone receptor | Action: MODULATOR
19303,dostarlimab,programmed cell death protein 1,membrane receptor,ANTIBODY BINDING,Drug: dostarlimab | Target: programmed cell death protein 1 | Type: membrane receptor | Action: ANTIBODY BINDING
19304,loncastuximab tesirine,b-lymphocyte antigen cd19,surface antigen,ANTIBODY BINDING,Drug: loncastuximab tesirine | Target: b-lymphocyte antigen cd19 | Type: surface antigen | Action: ANTIBODY BINDING
19305,bamlanivimab,spike glycoprotein,glycoprotein,,Drug: bamlanivimab | Target: spike glycoprotein | Type: glycoprotein | Action: nan
19306,etesevimab,spike glycoprotein,glycoprotein,,Drug: etesevimab | Target: spike glycoprotein | Type: glycoprotein | Action: nan
19307,casirivimab,spike glycoprotein,glycoprotein,,Drug: casirivimab | Target: spike glycoprotein | Type: glycoprotein | Action: nan
19308,imdevimab,spike glycoprotein,glycoprotein,,Drug: imdevimab | Target: spike glycoprotein | Type: glycoprotein | Action: nan
19309,pegcetacoplan,complement c3,unclassified,INHIBITOR,Drug: pegcetacoplan | Target: complement c3 | Type: unclassified | Action: INHIBITOR
19310,piflufolastat f-18,glutamate carboxypeptidase 2,enzyme,BINDING AGENT,Drug: piflufolastat f-18 | Target: glutamate carboxypeptidase 2 | Type: enzyme | Action: BINDING AGENT
19311,infigratinib,macrophage-stimulating protein receptor,kinase,,Drug: infigratinib | Target: macrophage-stimulating protein receptor | Type: kinase | Action: nan
19312,infigratinib,tyrosine-protein kinase abl1,kinase,,Drug: infigratinib | Target: tyrosine-protein kinase abl1 | Type: kinase | Action: nan
19313,infigratinib,mast/stem cell growth factor receptor kit,kinase,,Drug: infigratinib | Target: mast/stem cell growth factor receptor kit | Type: kinase | Action: nan
19314,infigratinib,proto-oncogene tyrosine-protein kinase src,kinase,,Drug: infigratinib | Target: proto-oncogene tyrosine-protein kinase src | Type: kinase | Action: nan
19315,infigratinib,tyrosine-protein kinase lck,kinase,,Drug: infigratinib | Target: tyrosine-protein kinase lck | Type: kinase | Action: nan
19316,infigratinib,tyrosine-protein kinase yes,kinase,,Drug: infigratinib | Target: tyrosine-protein kinase yes | Type: kinase | Action: nan
19317,infigratinib,tyrosine-protein kinase fyn,kinase,,Drug: infigratinib | Target: tyrosine-protein kinase fyn | Type: kinase | Action: nan
19318,infigratinib,serine/threonine-protein kinase b-raf,kinase,,Drug: infigratinib | Target: serine/threonine-protein kinase b-raf | Type: kinase | Action: nan
19319,infigratinib,receptor-type tyrosine-protein kinase flt3,kinase,,Drug: infigratinib | Target: receptor-type tyrosine-protein kinase flt3 | Type: kinase | Action: nan
19320,infigratinib,proto-oncogene tyrosine-protein kinase receptor ret,kinase,,Drug: infigratinib | Target: proto-oncogene tyrosine-protein kinase receptor ret | Type: kinase | Action: nan
19321,infigratinib,vascular endothelial growth factor receptor 1,kinase,,Drug: infigratinib | Target: vascular endothelial growth factor receptor 1 | Type: kinase | Action: nan
19322,infigratinib,vascular endothelial growth factor receptor 2,kinase,INHIBITOR,Drug: infigratinib | Target: vascular endothelial growth factor receptor 2 | Type: kinase | Action: INHIBITOR
19323,infigratinib,vascular endothelial growth factor receptor 3,kinase,,Drug: infigratinib | Target: vascular endothelial growth factor receptor 3 | Type: kinase | Action: nan
19324,infigratinib,platelet-derived growth factor receptor alpha,kinase,,Drug: infigratinib | Target: platelet-derived growth factor receptor alpha | Type: kinase | Action: nan
19325,infigratinib,insulin receptor,kinase,,Drug: infigratinib | Target: insulin receptor | Type: kinase | Action: nan
19326,infigratinib,tyrosine-protein kinase jak2,kinase,,Drug: infigratinib | Target: tyrosine-protein kinase jak2 | Type: kinase | Action: nan
19327,infigratinib,tyrosine-protein kinase syk,kinase,,Drug: infigratinib | Target: tyrosine-protein kinase syk | Type: kinase | Action: nan
19328,infigratinib,angiopoietin-1 receptor,kinase,,Drug: infigratinib | Target: angiopoietin-1 receptor | Type: kinase | Action: nan
19329,infigratinib,hepatocyte growth factor receptor,kinase,,Drug: infigratinib | Target: hepatocyte growth factor receptor | Type: kinase | Action: nan
19330,infigratinib,tyrosine-protein kinase lyn,kinase,,Drug: infigratinib | Target: tyrosine-protein kinase lyn | Type: kinase | Action: nan
19331,infigratinib,cytoplasmic tyrosine-protein kinase bmx,kinase,,Drug: infigratinib | Target: cytoplasmic tyrosine-protein kinase bmx | Type: kinase | Action: nan
19332,infigratinib,alk tyrosine kinase receptor,kinase,,Drug: infigratinib | Target: alk tyrosine kinase receptor | Type: kinase | Action: nan
19333,infigratinib,ephrin type-b receptor 1,kinase,,Drug: infigratinib | Target: ephrin type-b receptor 1 | Type: kinase | Action: nan
19334,infigratinib,bdnf/nt-3 growth factors receptor,kinase,,Drug: infigratinib | Target: bdnf/nt-3 growth factors receptor | Type: kinase | Action: nan
19335,infigratinib,non-receptor tyrosine-protein kinase tyk2,kinase,,Drug: infigratinib | Target: non-receptor tyrosine-protein kinase tyk2 | Type: kinase | Action: nan
19336,infigratinib,proto-oncogene tyrosine-protein kinase ros,kinase,,Drug: infigratinib | Target: proto-oncogene tyrosine-protein kinase ros | Type: kinase | Action: nan
19337,infigratinib,smoothened homolog,gpcr,,Drug: infigratinib | Target: smoothened homolog | Type: gpcr | Action: nan
19367,infigratinib,fibroblast growth factor receptor 3,kinase,INHIBITOR,Drug: infigratinib | Target: fibroblast growth factor receptor 3 | Type: kinase | Action: INHIBITOR
19368,infigratinib,fibroblast growth factor receptor 2,kinase,INHIBITOR,Drug: infigratinib | Target: fibroblast growth factor receptor 2 | Type: kinase | Action: INHIBITOR
19369,infigratinib,fibroblast growth factor receptor 4,kinase,INHIBITOR,Drug: infigratinib | Target: fibroblast growth factor receptor 4 | Type: kinase | Action: INHIBITOR
19370,infigratinib,fibroblast growth factor receptor 1,kinase,INHIBITOR,Drug: infigratinib | Target: fibroblast growth factor receptor 1 | Type: kinase | Action: INHIBITOR
19371,samidorphan,mu-type opioid receptor,gpcr,ANTAGONIST,Drug: samidorphan | Target: mu-type opioid receptor | Type: gpcr | Action: ANTAGONIST
19372,samidorphan,kappa-type opioid receptor,gpcr,PARTIAL AGONIST,Drug: samidorphan | Target: kappa-type opioid receptor | Type: gpcr | Action: PARTIAL AGONIST
19373,samidorphan,delta-type opioid receptor,gpcr,PARTIAL AGONIST,Drug: samidorphan | Target: delta-type opioid receptor | Type: gpcr | Action: PARTIAL AGONIST
19374,sotorasib,gtpase kras,enzyme,INHIBITOR,Drug: sotorasib | Target: gtpase kras | Type: enzyme | Action: INHIBITOR
19375,ibrexafungerp,"beta-1,3-glucan synthase catalytic subunit 1",enzyme,INHIBITOR,"Drug: ibrexafungerp | Target: beta-1,3-glucan synthase catalytic subunit 1 | Type: enzyme | Action: INHIBITOR"
19376,ibrexafungerp,"1,3-beta-d-glucan-udp glucosyltransferase",enzyme,INHIBITOR,"Drug: ibrexafungerp | Target: 1,3-beta-d-glucan-udp glucosyltransferase | Type: enzyme | Action: INHIBITOR"
19377,ibrexafungerp,"1,3-beta-d-glucan-udp glucosyltransferase",enzyme,INHIBITOR,"Drug: ibrexafungerp | Target: 1,3-beta-d-glucan-udp glucosyltransferase | Type: enzyme | Action: INHIBITOR"
